"","X","miRNA","V2","V3.x","V4.x","V5","V6","V7","V8","V9","V10","V11","mRNA","PCC.cor","p_value","adjusted_p_value","V3.y","Protein.names","Organism","Gene.Ontology..biological.process.","Gene.Ontology.IDs"
"1",1,"Cluster_10060","Porites_evermani_scaffold_1755:94665-95665",176,-22.19,2,18,899,921,17,"94.12%","94.12%","Peve_00010610",-0.186221181778393,0.880751796865079,0.998935627800807,NA,NA,NA,NA,NA
"2",2,"Cluster_10060","Porites_evermani_scaffold_1891:50981-51981",162,-20.99,2,20,726,749,20,"75.00%","80.00%","Peve_00012152",NA,NA,NA,NA,NA,NA,NA,NA
"3",3,"Cluster_10060","Porites_evermani_scaffold_1:919565-920565",177,-24.72,2,21,797,816,19,"89.47%","89.47%","Peve_00000049",-0.0344953421434075,0.978035225581731,0.999448381576871,"P16065","Speract receptor (EC 4.6.1.2) (Guanylate cyclase)","Strongylocentrotus purpuratus (Purple sea urchin)","cGMP biosynthetic process [GO:0006182]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; receptor guanylyl cyclase signaling pathway [GO:0007168]; signal transduction [GO:0007165]","GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0006468; GO:0007165; GO:0007168; GO:0035556"
"4",4,"Cluster_10060","Porites_evermani_scaffold_1977:56240-57240",163,-20.82,2,21,905,927,20,"70.00%","85.00%","Peve_00013076",NA,NA,NA,NA,NA,NA,NA,NA
"5",5,"Cluster_10060","Porites_evermani_scaffold_209:141486-142486",158,-20.22,2,21,781,801,19,"68.42%","84.21%","Peve_00014408",NA,NA,NA,NA,NA,NA,NA,NA
"6",6,"Cluster_10060","Porites_evermani_scaffold_285:306283-307283",166,-20.5,2,20,353,376,20,"75.00%","85.00%","Peve_00021276",NA,NA,NA,"P35384","Extracellular calcium-sensing receptor (CaSR) (Parathyroid cell calcium-sensing receptor) (BoPCaR1) (PCaR1)","Bos taurus (Bovine)","calcium ion import [GO:0070509]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; detection of calcium ion [GO:0005513]; G protein-coupled receptor signaling pathway [GO:0007186]; JNK cascade [GO:0007254]; ossification [GO:0001503]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; regulation of calcium ion transport [GO:0051924]; vasodilation [GO:0042311]","GO:0001503; GO:0004930; GO:0005509; GO:0005513; GO:0005886; GO:0006816; GO:0006874; GO:0007186; GO:0007254; GO:0008284; GO:0010628; GO:0016597; GO:0032781; GO:0042311; GO:0042803; GO:0043679; GO:0051924; GO:0070509"
"7",7,"Cluster_10060","Porites_evermani_scaffold_311:126053-127053",167,-20.71,2,16,703,724,14,"85.71%","100.00%","Peve_00023467",NA,NA,NA,NA,NA,NA,NA,NA
"8",8,"Cluster_10060","Porites_evermani_scaffold_3744:8542-9542",169,-22.61,2,19,22,45,19,"78.95%","89.47%","Peve_00027308",0.258435386498628,0.833586180557278,0.995934364227446,"Q9EQD2","Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide G-protein coupled receptor)","Rattus norvegicus (Rat)","G protein-coupled receptor signaling pathway [GO:0007186]; regulation of adenylate cyclase activity [GO:0045761]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of MAPK cascade [GO:0043408]","GO:0004930; GO:0005886; GO:0007186; GO:0008188; GO:0015629; GO:0031628; GO:0042277; GO:0043408; GO:0045761; GO:2000479"
"9",9,"Cluster_10060","Porites_evermani_scaffold_3868:34389-35389",173,-20.78,2,20,309,329,18,"88.89%","88.89%","Peve_00027983",-0.779699360883204,0.430743806610484,0.978262075707395,NA,NA,NA,NA,NA
"10",10,"Cluster_10060","Porites_evermani_scaffold_422:57577-58262",167,-21.66,2,21,359,381,20,"75.00%","85.00%","Peve_00029974",0.999736312730338,0.0146200630686234,0.734958779208245,NA,NA,NA,NA,NA
"11",11,"Cluster_10060","Porites_evermani_scaffold_5347:10045-11045",184,-21.27,2,21,157,178,19,"84.21%","94.74%","Peve_00034902",NA,NA,NA,NA,NA,NA,NA,NA
"12",12,"Cluster_10060","Porites_evermani_scaffold_640:44753-45753",167,-22.12,2,21,310,332,20,"75.00%","85.00%","Peve_00038162",NA,NA,NA,NA,NA,NA,NA,NA
"13",13,"Cluster_10060","Porites_evermani_scaffold_674:36934-37934",173,-21,2,20,874,894,18,"88.89%","88.89%","Peve_00038919",NA,NA,NA,NA,NA,NA,NA,NA
"14",14,"Cluster_10060","Porites_evermani_scaffold_752:6900-7900",166,-20.16,2,21,204,224,19,"73.68%","89.47%","Peve_00040742",-0.999019150266648,0.0281988803309955,0.902129556693968,NA,NA,NA,NA,NA
"15",15,"Cluster_10060","Porites_evermani_scaffold_991:125134-126134",168,-21.08,2,18,878,900,17,"82.35%","94.12%","Peve_00045251",-0.0583399343807917,0.96283854375754,0.999448381576871,NA,NA,NA,NA,NA
"16",16,"Cluster_10061","Porites_evermani_scaffold_1090:55420-56420",163,-20.97,2,17,698,721,17,"82.35%","88.24%","Peve_00001612",NA,NA,NA,"Q91X17","Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form]","Mus musculus (Mouse)","antibacterial innate immune response [GO:0140367]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; autophagy [GO:0006914]; calcium ion homeostasis [GO:0055074]; cellular calcium ion homeostasis [GO:0006874]; cellular chloride ion homeostasis [GO:0030644]; cellular phosphate ion homeostasis [GO:0030643]; cellular response to unfolded protein [GO:0034620]; cellular sodium ion homeostasis [GO:0006883]; chaperone-mediated protein folding [GO:0061077]; chemical homeostasis [GO:0048878]; chloride ion homeostasis [GO:0055064]; citric acid secretion [GO:0046720]; collecting duct development [GO:0072044]; connective tissue replacement [GO:0097709]; creatinine homeostasis [GO:0097273]; defense response to Gram-negative bacterium [GO:0050829]; endoplasmic reticulum organization [GO:0007029]; gene expression [GO:0010467]; glomerular filtration [GO:0003094]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; inflammatory response [GO:0006954]; ion homeostasis [GO:0050801]; juxtaglomerular apparatus development [GO:0072051]; kidney development [GO:0001822]; leukocyte cell-cell adhesion [GO:0007159]; lipid metabolic process [GO:0006629]; loop of Henle development [GO:0072070]; metanephric ascending thin limb development [GO:0072218]; metanephric distal convoluted tubule development [GO:0072221]; metanephric thick ascending limb development [GO:0072233]; micturition [GO:0060073]; multicellular organismal homeostasis [GO:0048871]; multicellular organismal response to stress [GO:0033555]; neutrophil migration [GO:1990266]; organ or tissue specific immune response [GO:0002251]; peptidyl-threonine phosphorylation [GO:0018107]; phosphate ion homeostasis [GO:0055062]; potassium ion homeostasis [GO:0055075]; protein localization to vacuole [GO:0072665]; protein phosphorylation [GO:0006468]; protein transport into plasma membrane raft [GO:0044861]; regulation of blood pressure [GO:0008217]; regulation of protein transport [GO:0051223]; regulation of urine volume [GO:0035809]; renal sodium ion absorption [GO:0070294]; renal urate salt excretion [GO:0097744]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; response to lipopolysaccharide [GO:0032496]; response to unfolded protein [GO:0006986]; response to water deprivation [GO:0009414]; response to xenobiotic stimulus [GO:0009410]; RNA splicing [GO:0008380]; sodium ion homeostasis [GO:0055078]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; ubiquitin-dependent ERAD pathway [GO:0030433]; urate transport [GO:0015747]; urea transmembrane transport [GO:0071918]; water homeostasis [GO:0030104]","GO:0000922; GO:0001822; GO:0002251; GO:0003091; GO:0003094; GO:0005201; GO:0005509; GO:0005615; GO:0005783; GO:0005794; GO:0005886; GO:0005929; GO:0006468; GO:0006629; GO:0006874; GO:0006883; GO:0006914; GO:0006915; GO:0006954; GO:0006986; GO:0007029; GO:0007157; GO:0007159; GO:0008217; GO:0008380; GO:0009410; GO:0009414; GO:0009986; GO:0010467; GO:0015747; GO:0016020; GO:0016323; GO:0016324; GO:0018107; GO:0019864; GO:0030104; GO:0030433; GO:0030643; GO:0030644; GO:0031410; GO:0032496; GO:0033209; GO:0033555; GO:0034620; GO:0034976; GO:0035809; GO:0044861; GO:0045121; GO:0045177; GO:0046720; GO:0048871; GO:0048878; GO:0050801; GO:0050829; GO:0051223; GO:0055062; GO:0055064; GO:0055074; GO:0055075; GO:0055078; GO:0060073; GO:0060170; GO:0061077; GO:0070294; GO:0071918; GO:0072044; GO:0072051; GO:0072070; GO:0072218; GO:0072221; GO:0072233; GO:0072665; GO:0097190; GO:0097273; GO:0097709; GO:0097744; GO:0140367; GO:1990266"
"17",17,"Cluster_10061","Porites_evermani_scaffold_1186:61087-62087",179,-23.24,2,20,725,746,18,"88.89%","88.89%","Peve_00003122",-0.265726517903424,0.828776365879978,0.995934364227446,NA,NA,NA,NA,NA
"18",18,"Cluster_10061","Porites_evermani_scaffold_1186:74639-75639",179,-21.05,2,20,721,742,18,"88.89%","88.89%","Peve_00003113",-0.696836398553476,0.509180714719917,0.978262075707395,NA,NA,NA,NA,NA
"19",19,"Cluster_10061","Porites_evermani_scaffold_1221:71064-72064",168,-21.39,2,19,369,389,17,"88.24%","88.24%","Peve_00003694",-0.446077406355246,0.705641205133228,0.978262075707395,NA,NA,NA,NA,NA
"20",20,"Cluster_10061","Porites_evermani_scaffold_1221:71135-72135",168,-21.39,2,19,298,318,17,"88.24%","88.24%","Peve_00003695",-0.99199485658194,0.0806064549183684,0.978262075707395,"A0JNH6","Coiled-coil domain-containing protein 102A","Bos taurus (Bovine)","","GO:0016459"
"21",21,"Cluster_10061","Porites_evermani_scaffold_1269:83151-84151",171,-22.04,2,20,181,202,18,"77.78%","88.89%","Peve_00004323",-0.172899716820532,0.889372692042876,0.999448381576871,"Q6RFZ7","Pleckstrin homology domain-containing family G member 5 (PH domain-containing family G member 5) (Neuronal RhoA GEF protein) (Transcript highly enriched in cortex and hippocampus)","Rattus norvegicus (Rat)","endothelial cell chemotaxis [GO:0035767]; endothelial cell migration [GO:0043542]; regulation of protein catabolic process at presynapse, modulating synaptic transmission [GO:0099575]; regulation protein catabolic process at presynapse [GO:0140251]; Rho protein signal transduction [GO:0007266]","GO:0005085; GO:0005737; GO:0005886; GO:0005911; GO:0007266; GO:0030027; GO:0030139; GO:0030424; GO:0035767; GO:0043542; GO:0045202; GO:0048471; GO:0098793; GO:0099575; GO:0140251"
"22",22,"Cluster_10061","Porites_evermani_scaffold_1329:31126-32126",182,-28.4,2,19,634,655,17,"88.24%","100.00%","Peve_00005180",-0.783545101783734,0.426818694653127,0.978262075707395,"Q5VTL8","Pre-mRNA-splicing factor 38B (Sarcoma antigen NY-SAR-27)","Homo sapiens (Human)","mRNA processing [GO:0006397]; RNA splicing [GO:0008380]","GO:0003723; GO:0006397; GO:0008380; GO:0071011"
"23",23,"Cluster_10061","Porites_evermani_scaffold_139:79341-80341",172,-21.82,2,18,208,230,17,"88.24%","94.12%","Peve_00006031",NA,NA,NA,"Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"24",24,"Cluster_10061","Porites_evermani_scaffold_139:79341-80341",172,-21.82,2,18,328,350,17,"88.24%","94.12%","Peve_00006031",NA,NA,NA,"Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"25",25,"Cluster_10061","Porites_evermani_scaffold_1833:64421-65421",169,-22.25,2,18,352,373,16,"75.00%","100.00%","Peve_00011535",-0.990584526872304,0.0874294088582374,0.978262075707395,NA,NA,NA,NA,NA
"26",26,"Cluster_10061","Porites_evermani_scaffold_184:344967-345967",159,-21.63,2,21,61,85,22,"63.64%","81.82%","Peve_00011589",-0.448543039306733,0.703886164166127,0.978262075707395,"Q9CR50","RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363)","Mus musculus (Mouse)","positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0002039; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042803; GO:0043231; GO:0051865; GO:0061630"
"27",27,"Cluster_10061","Porites_evermani_scaffold_1854:80326-81326",159,-20.36,2,21,201,226,23,"69.57%","73.91%","Peve_00011752",-0.446077406355246,0.705641205133228,0.978262075707395,NA,NA,NA,NA,NA
"28",28,"Cluster_10061","Porites_evermani_scaffold_190:99320-100320",170,-20.02,2,21,916,936,19,"84.21%","84.21%","Peve_00012292",-0.634781973431444,0.562179825338467,0.978262075707395,"Q9Z2H5","Band 4.1-like protein 1 (Erythrocyte membrane protein band 4.1-like 1) (Neuronal protein 4.1) (4.1N)","Mus musculus (Mouse)","actomyosin structure organization [GO:0031032]; cortical actin cytoskeleton organization [GO:0030866]","GO:0003779; GO:0005102; GO:0005198; GO:0005829; GO:0005856; GO:0005886; GO:0014069; GO:0030866; GO:0031032; GO:0032991; GO:0097060"
"29",29,"Cluster_10061","Porites_evermani_scaffold_1939:46940-47940",160,-20.49,2,19,107,127,17,"70.59%","94.12%","Peve_00012696",NA,NA,NA,NA,NA,NA,NA,NA
"30",30,"Cluster_10061","Porites_evermani_scaffold_2161:1161-2161",158,-20.45,2,20,399,425,23,"69.57%","73.91%","Peve_00015166",-0.310086733470883,0.799283805240007,0.995934364227446,NA,NA,NA,NA,NA
"31",31,"Cluster_10061","Porites_evermani_scaffold_2229:13161-14161",174,-20.22,2,20,405,428,20,"85.00%","85.00%","Peve_00015845",-0.62367202905205,0.571280175998745,0.978262075707395,"O96952","Thioredoxin (Trx)","Geodia cydonium (Sponge)","","GO:0005737; GO:0015035"
"32",32,"Cluster_10061","Porites_evermani_scaffold_2351:48966-49966",165,-21.25,2,20,86,109,20,"80.00%","85.00%","Peve_00017023",NA,NA,NA,NA,NA,NA,NA,NA
"33",33,"Cluster_10061","Porites_evermani_scaffold_239:57853-58853",172,-20.49,2,21,639,660,19,"73.68%","89.47%","Peve_00017320",-0.750011420638398,0.46009592009726,0.978262075707395,"Q8N972","Zinc finger protein 709","Homo sapiens (Human)","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872"
"34",34,"Cluster_10061","Porites_evermani_scaffold_29:239887-240887",169,-20.7,2,21,947,968,20,"80.00%","90.00%","Peve_00021693",-0.754899233417341,0.455371491238179,0.978262075707395,NA,NA,NA,NA,NA
"35",35,"Cluster_10061","Porites_evermani_scaffold_2951:35792-36792",165,-20.58,2,20,245,265,18,"77.78%","88.89%","Peve_00022068",-0.733525650668393,0.475746867850307,0.978262075707395,NA,NA,NA,NA,NA
"36",36,"Cluster_10061","Porites_evermani_scaffold_3268:22076-23076",174,-20.4,2,21,526,546,19,"84.21%","89.47%","Peve_00024420",NA,NA,NA,NA,NA,NA,NA,NA
"37",37,"Cluster_10061","Porites_evermani_scaffold_342:245853-246853",162,-20.08,2,15,30,51,13,"84.62%","100.00%","Peve_00025417",-0.128787782015985,0.9177827944628,0.999448381576871,"Q3SZI0","Mannose-6-phosphate isomerase (EC 5.3.1.8) (Phosphohexomutase) (Phosphomannose isomerase) (PMI)","Bos taurus (Bovine)","GDP-mannose biosynthetic process [GO:0009298]; mannose to fructose-6-phosphate metabolic process [GO:0061611]","GO:0004476; GO:0005829; GO:0008270; GO:0009298; GO:0061611"
"38",38,"Cluster_10061","Porites_evermani_scaffold_3726:7672-8672",143,-20.03,2,21,2,32,28,"53.57%","67.86%","Peve_00027231",NA,NA,NA,NA,NA,NA,NA,NA
"39",39,"Cluster_10061","Porites_evermani_scaffold_3775:27917-28917",175,-23.52,2,21,249,272,21,"80.95%","85.71%","Peve_00027461",-0.981320798954527,0.123240263698277,0.978262075707395,NA,NA,NA,NA,NA
"40",40,"Cluster_10061","Porites_evermani_scaffold_397:104724-105724",173,-23.25,2,18,604,625,16,"87.50%","93.75%","Peve_00028560",-0.286575280096669,0.814966292437932,0.995934364227446,NA,NA,NA,NA,NA
"41",41,"Cluster_10061","Porites_evermani_scaffold_4062:21439-22439",168,-20.18,2,19,98,118,17,"82.35%","94.12%","Peve_00029179",-0.299379966368469,0.806440374640063,0.995934364227446,"E2JA28","Dapdiamide synthesis protein DdaC (EC 1.-.-.-)","Enterobacter agglomerans (Erwinia herbicola) (Pantoea agglomerans)","antibiotic biosynthetic process [GO:0017000]","GO:0016491; GO:0017000"
"42",42,"Cluster_10061","Porites_evermani_scaffold_4365:5718-6718",178,-20.8,2,21,294,318,22,"86.36%","86.36%","Peve_00030728",-0.446077406355246,0.705641205133228,0.978262075707395,NA,NA,NA,NA,NA
"43",43,"Cluster_10061","Porites_evermani_scaffold_4394:1389-2389",176,-22.39,2,21,436,457,19,"78.95%","89.47%","Peve_00030853",0.792067036948188,0.418009988238844,0.978262075707395,"B3EWZ3","Coadhesin","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0016020"
"44",44,"Cluster_10061","Porites_evermani_scaffold_481:100451-101451",149,-20.16,2,19,372,398,22,"63.64%","72.73%","Peve_00032812",NA,NA,NA,NA,NA,NA,NA,NA
"45",45,"Cluster_10061","Porites_evermani_scaffold_524:52331-53331",162,-22.62,2,20,44,71,24,"70.83%","75.00%","Peve_00034519",-0.349259760330053,0.772866161774938,0.991709304989928,"B8VIU6","Uncharacterized skeletal organic matrix protein 5 (Uncharacterized SOMP-5)","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0005576"
"46",46,"Cluster_10061","Porites_evermani_scaffold_726:80822-81822",172,-23.27,2,17,196,217,15,"86.67%","100.00%","Peve_00040157",0.306937330982347,0.801391595416986,0.995934364227446,NA,NA,NA,NA,NA
"47",47,"Cluster_10061","Porites_evermani_scaffold_82:329243-330243",187,-24.72,2,20,413,434,18,"94.44%","94.44%","Peve_00042163",NA,NA,NA,NA,NA,NA,NA,NA
"48",48,"Cluster_10061","Porites_evermani_scaffold_862:109847-110847",164,-20.28,2,18,618,640,17,"82.35%","88.24%","Peve_00043022",-0.24368758668536,0.843285695037324,0.995934364227446,NA,NA,NA,NA,NA
"49",49,"Cluster_10934","Porites_evermani_scaffold_1028:14295-15295",143,-20.27,2,21,965,987,20,"60.00%","70.00%","Peve_00000655",-0.260525256164665,0.832208541543335,0.995934364227446,"Q6P0F9","Insulinoma-associated protein 1a (Insulinoma-associated 1-like protein a) (Zinc finger protein IA-1a)","Danio rerio (Zebrafish) (Brachydanio rerio)","cell dedifferentiation [GO:0043697]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; pancreatic A cell differentiation [GO:0003310]; posterior lateral line neuromast hair cell development [GO:0035677]; posterior lateral line neuromast primordium migration [GO:0048920]; regulation of cell cycle process [GO:0010564]; retinal cone cell differentiation [GO:0042670]; retinal rod cell differentiation [GO:0060221]; sensory epithelium regeneration [GO:0070654]; spinal cord motor neuron differentiation [GO:0021522]; transdifferentiation [GO:0060290]; type B pancreatic cell differentiation [GO:0003309]","GO:0000122; GO:0000978; GO:0001227; GO:0003309; GO:0003310; GO:0003700; GO:0005634; GO:0010564; GO:0017053; GO:0021522; GO:0030182; GO:0031490; GO:0035677; GO:0042670; GO:0043565; GO:0043697; GO:0045892; GO:0046872; GO:0048920; GO:0060221; GO:0060290; GO:0070654"
"50",50,"Cluster_10934","Porites_evermani_scaffold_1055:72877-73877",162,-25.65,2,21,180,200,19,"78.95%","78.95%","Peve_00001078",-0.882764149204873,0.311359775758119,0.978262075707395,NA,NA,NA,NA,NA
"51",51,"Cluster_10934","Porites_evermani_scaffold_1155:39935-40935",170,-22.73,2,21,401,421,19,"78.95%","89.47%","Peve_00002622",-0.580143564805749,0.605992879379821,0.978262075707395,NA,NA,NA,NA,NA
"52",52,"Cluster_10934","Porites_evermani_scaffold_1179:28510-29510",168,-22.19,2,21,698,719,19,"78.95%","78.95%","Peve_00002995",NA,NA,NA,NA,NA,NA,NA,NA
"53",53,"Cluster_10934","Porites_evermani_scaffold_1203:79183-80183",164,-22.15,2,20,405,424,18,"77.78%","88.89%","Peve_00003442",NA,NA,NA,NA,NA,NA,NA,NA
"54",54,"Cluster_10934","Porites_evermani_scaffold_1262:90852-91852",159,-21.25,2,21,755,780,23,"69.57%","73.91%","Peve_00004260",0.334282353105803,0.783012176396057,0.994255504697718,"Q8WZ42","Titin (EC 2.7.11.1) (Connectin) (Rhabdomyosarcoma antigen MU-RMS-40.14)","Homo sapiens (Human)","cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]","GO:0000794; GO:0002020; GO:0003300; GO:0004674; GO:0004713; GO:0005509; GO:0005516; GO:0005524; GO:0005576; GO:0005829; GO:0005865; GO:0006936; GO:0006941; GO:0007076; GO:0008307; GO:0010628; GO:0010737; GO:0019899; GO:0019901; GO:0030018; GO:0030240; GO:0030241; GO:0031430; GO:0031433; GO:0031674; GO:0035995; GO:0042802; GO:0042805; GO:0043621; GO:0045214; GO:0045859; GO:0048769; GO:0050714; GO:0050790; GO:0051015; GO:0051371; GO:0051592; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0070062; GO:0097493; GO:0106310; GO:1990733"
"55",55,"Cluster_10934","Porites_evermani_scaffold_133:369248-370248",155,-21.82,2,21,250,275,23,"65.22%","73.91%","Peve_00005192",0.776427357148343,0.4340597609641,0.978262075707395,"P05099","Cartilage matrix protein (Matrilin-1)","Gallus gallus (Chicken)","extracellular matrix organization [GO:0030198]","GO:0005509; GO:0005576; GO:0030198"
"56",56,"Cluster_10934","Porites_evermani_scaffold_1359:17020-18020",159,-20.77,2,20,924,945,18,"72.22%","77.78%","Peve_00005615",NA,NA,NA,NA,NA,NA,NA,NA
"57",57,"Cluster_10934","Porites_evermani_scaffold_1371:73774-74774",163,-23.93,2,18,67,87,16,"87.50%","87.50%","Peve_00005803",-0.407469079995713,0.732822830955942,0.985284813434432,"O16118","Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein)","Homarus americanus (American lobster)","G protein-coupled receptor signaling pathway [GO:0007186]","GO:0003924; GO:0005525; GO:0007186; GO:0031683; GO:0046872"
"58",58,"Cluster_10934","Porites_evermani_scaffold_14:940131-941131",161,-26.39,2,21,672,691,19,"73.68%","84.21%","Peve_00006203",-0.396959973956809,0.740130346577029,0.986697151420032,NA,NA,NA,NA,NA
"59",59,"Cluster_10934","Porites_evermani_scaffold_150:99705-100705",154,-21.47,2,21,206,226,19,"68.42%","78.95%","Peve_00007541",NA,NA,NA,NA,NA,NA,NA,NA
"60",60,"Cluster_10934","Porites_evermani_scaffold_1533:28519-29519",152,-26.79,2,21,720,738,19,"68.42%","78.95%","Peve_00007922",0.439541803816799,0.710281665819416,0.978785040024827,"A0JNI4","Serine racemase (EC 4.3.1.17) (EC 4.3.1.18) (EC 5.1.1.18) (D-serine ammonia-lyase) (D-serine dehydratase) (L-serine ammonia-lyase) (L-serine dehydratase)","Bos taurus (Bovine)","D-serine biosynthetic process [GO:0070179]; D-serine metabolic process [GO:0070178]; L-serine metabolic process [GO:0006563]; pyruvate biosynthetic process [GO:0042866]; response to lipopolysaccharide [GO:0032496]","GO:0000287; GO:0003941; GO:0005509; GO:0005524; GO:0005737; GO:0006563; GO:0008721; GO:0016594; GO:0018114; GO:0030165; GO:0030170; GO:0030378; GO:0032496; GO:0042803; GO:0042866; GO:0043025; GO:0070178; GO:0070179"
"61",61,"Cluster_10934","Porites_evermani_scaffold_1556:112511-113511",149,-23.29,2,20,530,550,18,"61.11%","83.33%","Peve_00008188",0.978221707375421,0.133106230295136,0.978262075707395,NA,NA,NA,NA,NA
"62",62,"Cluster_10934","Porites_evermani_scaffold_1556:86789-87789",146,-23.41,2,21,504,521,19,"68.42%","78.95%","Peve_00008185",0.99960187302587,0.0179647150151243,0.782669382293497,NA,NA,NA,NA,NA
"63",63,"Cluster_10934","Porites_evermani_scaffold_1574:73966-74966",161,-26.17,2,21,330,355,23,"73.91%","82.61%","Peve_00008421",NA,NA,NA,NA,NA,NA,NA,NA
"64",64,"Cluster_10934","Porites_evermani_scaffold_15:874027-875027",164,-22.37,2,18,429,451,17,"82.35%","88.24%","Peve_00007468",-0.404347620474823,0.734997198400733,0.98584285229152,"Q6NW40","Repulsive guidance molecule B (DRG11-responsive axonal guidance and outgrowth of neurite) (DRAGON)","Homo sapiens (Human)","BMP signaling pathway [GO:0030509]; cell adhesion [GO:0007155]; positive regulation of DNA-templated transcription [GO:0045893]; signal transduction [GO:0007165]","GO:0005793; GO:0005886; GO:0007155; GO:0007165; GO:0015026; GO:0030509; GO:0042802; GO:0045121; GO:0045893"
"65",65,"Cluster_10934","Porites_evermani_scaffold_1594:57421-58421",173,-22.6,2,20,284,304,18,"88.89%","88.89%","Peve_00008683",0.613293099668174,0.579688907721827,0.978262075707395,NA,NA,NA,NA,NA
"66",66,"Cluster_10934","Porites_evermani_scaffold_1594:67902-68902",173,-22.6,2,20,160,180,18,"88.89%","88.89%","Peve_00008684",-0.021850717441934,0.986088294053319,0.999448381576871,NA,NA,NA,NA,NA
"67",67,"Cluster_10934","Porites_evermani_scaffold_1642:74991-75991",164,-26.65,2,21,709,727,19,"78.95%","84.21%","Peve_00009319",NA,NA,NA,NA,NA,NA,NA,NA
"68",68,"Cluster_10934","Porites_evermani_scaffold_165:252591-252781",155,-23.23,2,21,51,75,22,"63.64%","77.27%","Peve_00009398",0.998758250045998,0.0317290557481573,0.903929377050813,NA,NA,NA,NA,NA
"69",69,"Cluster_10934","Porites_evermani_scaffold_165:252591-253591",155,-23.23,2,21,51,75,22,"63.64%","77.27%","Peve_00009399",NA,NA,NA,NA,NA,NA,NA,NA
"70",70,"Cluster_10934","Porites_evermani_scaffold_1709:57475-58475",160,-21.1,2,21,674,695,19,"68.42%","78.95%","Peve_00010127",NA,NA,NA,NA,NA,NA,NA,NA
"71",71,"Cluster_10934","Porites_evermani_scaffold_173:319937-320937",176,-21.26,2,21,153,174,19,"84.21%","84.21%","Peve_00010377",0.879156733705841,0.316213250722529,0.978262075707395,"Q9D3B1","Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 2 (EC 4.2.1.134) (3-hydroxyacyl-CoA dehydratase 2) (HACD2) (Protein-tyrosine phosphatase-like member B)","Mus musculus (Mouse)","fatty acid elongation [GO:0030497]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761]","GO:0005783; GO:0005789; GO:0018812; GO:0019899; GO:0030148; GO:0030497; GO:0042761; GO:0080023; GO:0102158; GO:0102343; GO:0102344; GO:0102345"
"72",72,"Cluster_10934","Porites_evermani_scaffold_1765:79516-80516",156,-23.4,2,21,326,347,21,"76.19%","76.19%","Peve_00010720",-0.456234386365879,0.698395722414825,0.978262075707395,"Q8N1C3","Gamma-aminobutyric acid receptor subunit gamma-1 (GABA(A) receptor subunit gamma-1)","Homo sapiens (Human)","chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]","GO:0004890; GO:0005231; GO:0005237; GO:0005886; GO:0007165; GO:0007214; GO:0007268; GO:0022851; GO:0030594; GO:0032590; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050811; GO:0050877; GO:0051932; GO:0060078; GO:0098794; GO:1902476; GO:1902711; GO:1904315"
"73",73,"Cluster_10934","Porites_evermani_scaffold_1771:63860-64860",149,-22.11,2,19,306,328,18,"66.67%","77.78%","Peve_00010791",-0.142614701257427,0.908898043128191,0.999448381576871,"P70704","Phospholipid-transporting ATPase IA (EC 7.6.2.1) (ATPase class I type 8A member 1) (Chromaffin granule ATPase II) (P4-ATPase flippase complex alpha subunit ATP8A1)","Mus musculus (Mouse)","aminophospholipid translocation [GO:0140331]; learning [GO:0007612]; phospholipid translocation [GO:0045332]; positive regulation of cell migration [GO:0030335]; positive regulation of phospholipid translocation [GO:0061092]","GO:0000287; GO:0005524; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0007612; GO:0016887; GO:0030335; GO:0030672; GO:0031090; GO:0031410; GO:0042584; GO:0043231; GO:0045202; GO:0045332; GO:0061092; GO:0090556; GO:0140326; GO:0140331; GO:0140346; GO:1990531"
"74",74,"Cluster_10934","Porites_evermani_scaffold_178:251916-252916",156,-21.34,2,21,498,519,19,"68.42%","73.68%","Peve_00010861",NA,NA,NA,NA,NA,NA,NA,NA
"75",75,"Cluster_10934","Porites_evermani_scaffold_178:253868-254868",156,-21.34,2,21,498,519,19,"68.42%","73.68%","Peve_00010862",NA,NA,NA,NA,NA,NA,NA,NA
"76",76,"Cluster_10934","Porites_evermani_scaffold_186:96034-97034",156,-20.44,2,21,539,558,19,"73.68%","84.21%","Peve_00011797",NA,NA,NA,NA,NA,NA,NA,NA
"77",77,"Cluster_10934","Porites_evermani_scaffold_1879:55579-56579",160,-21.18,2,21,882,903,19,"68.42%","78.95%","Peve_00012001",NA,NA,NA,NA,NA,NA,NA,NA
"78",78,"Cluster_10934","Porites_evermani_scaffold_1894:53605-54605",160,-20.21,2,18,73,97,19,"78.95%","78.95%","Peve_00012174",0.356153247307574,0.768176213289814,0.990527675986719,NA,NA,NA,NA,NA
"79",79,"Cluster_10934","Porites_evermani_scaffold_1955:27564-28564",163,-20.34,2,20,329,350,18,"72.22%","83.33%","Peve_00012875",NA,NA,NA,NA,NA,NA,NA,NA
"80",80,"Cluster_10934","Porites_evermani_scaffold_2138:37715-38715",172,-25.71,2,21,482,503,19,"78.95%","84.21%","Peve_00014945",-0.804068199036874,0.405329312481883,0.978262075707395,NA,NA,NA,NA,NA
"81",81,"Cluster_10934","Porites_evermani_scaffold_2174:23969-24969",166,-21.95,2,20,801,825,21,"76.19%","80.95%","Peve_00015272",NA,NA,NA,NA,NA,NA,NA,NA
"82",82,"Cluster_10934","Porites_evermani_scaffold_2198:716-1716",152,-22.79,2,19,586,606,17,"70.59%","82.35%","Peve_00015485",0.719894660067005,0.488380177076864,0.978262075707395,NA,NA,NA,NA,NA
"83",83,"Cluster_10934","Porites_evermani_scaffold_2248:21440-22440",159,-20.26,2,21,168,193,23,"69.57%","73.91%","Peve_00016024",NA,NA,NA,NA,NA,NA,NA,NA
"84",84,"Cluster_10934","Porites_evermani_scaffold_2539:23918-24918",160,-21.52,2,19,17,37,17,"82.35%","82.35%","Peve_00018762",0.585385932164402,0.601886010785523,0.978262075707395,NA,NA,NA,NA,NA
"85",85,"Cluster_10934","Porites_evermani_scaffold_254:44147-45147",164,-24.96,2,21,323,344,19,"68.42%","84.21%","Peve_00018766",0.829541059534191,0.377204193909978,0.978262075707395,"Q03168","Lysosomal aspartic protease (EC 3.4.23.-)","Aedes aegypti (Yellowfever mosquito) (Culex aegypti)","proteolysis [GO:0006508]","GO:0004190; GO:0005764; GO:0006508"
"86",86,"Cluster_10934","Porites_evermani_scaffold_261:196205-197205",162,-20.21,2,15,80,101,13,"84.62%","100.00%","Peve_00019357",-0.456234386365879,0.698395722414825,0.978262075707395,NA,NA,NA,NA,NA
"87",87,"Cluster_10934","Porites_evermani_scaffold_2614:64308-65308",162,-21.88,2,20,405,427,19,"73.68%","84.21%","Peve_00019390",0.998758250045999,0.0317290557481559,0.903929377050813,NA,NA,NA,NA,NA
"88",88,"Cluster_10934","Porites_evermani_scaffold_265:149776-150313",159,-23.81,2,21,106,124,19,"78.95%","84.21%","Peve_00019651",NA,NA,NA,NA,NA,NA,NA,NA
"89",89,"Cluster_10934","Porites_evermani_scaffold_271:120661-121288",162,-27.04,2,21,123,143,19,"68.42%","89.47%","Peve_00020176",0.652936066388067,0.547074041945439,0.978262075707395,"A6QLE6","Anoctamin-4 (Transmembrane protein 16D)","Bos taurus (Bovine)","chloride transmembrane transport [GO:1902476]; lipid transport [GO:0006869]; transmembrane transport [GO:0055085]","GO:0005229; GO:0005254; GO:0005886; GO:0006869; GO:0046983; GO:0055085; GO:1902476"
"90",90,"Cluster_10934","Porites_evermani_scaffold_277:161132-162132",158,-22.84,2,21,140,160,19,"73.68%","78.95%","Peve_00020636",-0.0997418665077322,0.936396597753985,0.999448381576871,NA,NA,NA,NA,NA
"91",91,"Cluster_10934","Porites_evermani_scaffold_280:20910-21910",152,-25.43,2,21,801,822,19,"63.16%","73.68%","Peve_00020938",-0.0597397520423788,0.961945834865431,0.999448381576871,"P40893","Regulation of enolase protein 1","Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)","","GO:0005737"
"92",92,"Cluster_10934","Porites_evermani_scaffold_293:235963-236963",171,-25.58,2,21,785,807,20,"80.00%","85.00%","Peve_00021926",0.00207880825850537,0.998676588606499,0.999727833677456,NA,NA,NA,NA,NA
"93",93,"Cluster_10934","Porites_evermani_scaffold_2951:35792-36792",168,-28.1,2,21,581,600,19,"84.21%","89.47%","Peve_00022068",-0.725742959620026,0.48299235056871,0.978262075707395,NA,NA,NA,NA,NA
"94",94,"Cluster_10934","Porites_evermani_scaffold_2959:43155-44155",163,-21.06,2,20,44,65,18,"72.22%","83.33%","Peve_00022115",-0.456234386365879,0.698395722414825,0.978262075707395,NA,NA,NA,NA,NA
"95",95,"Cluster_10934","Porites_evermani_scaffold_2971:51810-52810",176,-24.3,2,17,459,480,15,"93.33%","100.00%","Peve_00022206",0.968742690131611,0.159591111198367,0.978262075707395,"Q9NXZ2","Probable ATP-dependent RNA helicase DDX43 (EC 3.6.4.13) (Cancer/testis antigen 13) (CT13) (DEAD box protein 43) (DEAD box protein HAGE) (Helical antigen)","Homo sapiens (Human)","","GO:0003723; GO:0003724; GO:0005524; GO:0016887"
"96",96,"Cluster_10934","Porites_evermani_scaffold_316:293162-294162",177,-28.7,2,21,224,243,19,"89.47%","89.47%","Peve_00023782",-0.146823538108318,0.906190105153662,0.999448381576871,"Q32LC7","Ras GTPase-activating protein-binding protein 1 (G3BP-1) (EC 3.6.4.12) (EC 3.6.4.13) (ATP-dependent DNA/RNA helicase G3BP)","Bos taurus (Bovine)","defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of stress granule assembly [GO:0062029]; positive regulation of type I interferon production [GO:0032481]; stress granule assembly [GO:0034063]","GO:0003677; GO:0003678; GO:0003724; GO:0003729; GO:0004519; GO:0005524; GO:0005634; GO:0005829; GO:0010494; GO:0016887; GO:0032481; GO:0033677; GO:0034063; GO:0043204; GO:0045087; GO:0051607; GO:0062029; GO:0090090; GO:1990904"
"97",97,"Cluster_10934","Porites_evermani_scaffold_3201:15161-16161",170,-24.32,2,20,711,734,20,"75.00%","90.00%","Peve_00024048",0.955274704842824,0.191118984586129,0.978262075707395,NA,NA,NA,NA,NA
"98",98,"Cluster_10934","Porites_evermani_scaffold_3233:38841-39841",155,-21,2,21,844,866,20,"70.00%","75.00%","Peve_00024223",0.641387907622702,0.55671788557703,0.978262075707395,NA,NA,NA,NA,NA
"99",99,"Cluster_10934","Porites_evermani_scaffold_3352:40343-41343",163,-21.06,2,20,395,416,18,"72.22%","83.33%","Peve_00025003",NA,NA,NA,NA,NA,NA,NA,NA
"100",100,"Cluster_10934","Porites_evermani_scaffold_3423:11033-12033",147,-20.08,2,17,882,904,16,"75.00%","75.00%","Peve_00025441",0.999999242056246,0.00078381512101461,0.239778920002343,NA,NA,NA,NA,NA
"101",101,"Cluster_10934","Porites_evermani_scaffold_3423:7309-8309",147,-20.08,2,17,882,904,16,"75.00%","75.00%","Peve_00025440",0.999990991243872,0.00270226453852998,0.439065053827702,NA,NA,NA,NA,NA
"102",102,"Cluster_10934","Porites_evermani_scaffold_3685:9304-10304",154,-21.89,2,21,230,247,19,"78.95%","78.95%","Peve_00026994",0.965266193074061,0.168281530961036,0.978262075707395,NA,NA,NA,NA,NA
"103",103,"Cluster_10934","Porites_evermani_scaffold_369:269432-270432",154,-22.25,2,20,40,62,19,"63.16%","84.21%","Peve_00027019",0.259676393993308,0.832768206868798,0.995934364227446,"Q9UBI9","Headcase protein homolog (hHDC)","Homo sapiens (Human)","negative regulation of mitotic cell cycle [GO:0045930]; respiratory tube development [GO:0030323]","GO:0005634; GO:0005737; GO:0016020; GO:0030323; GO:0045930"
"104",104,"Cluster_10934","Porites_evermani_scaffold_3706:17807-18807",164,-21.21,2,19,61,81,17,"82.35%","88.24%","Peve_00027153",0.318477872666164,0.793656688591821,0.995934364227446,"Q93104","Enhancer of rudimentary homolog","Aedes aegypti (Yellowfever mosquito) (Culex aegypti)","cell cycle [GO:0007049]","GO:0007049"
"105",105,"Cluster_10934","Porites_evermani_scaffold_388:370-1370",151,-20.63,2,19,30,49,17,"76.47%","76.47%","Peve_00028026",-0.988592600037905,0.0962503170939759,0.978262075707395,"Q8IV35","WD repeat-containing protein 49","Homo sapiens (Human)","",""
"106",106,"Cluster_10934","Porites_evermani_scaffold_3916:25367-26367",160,-22.47,2,17,784,805,15,"80.00%","86.67%","Peve_00028287",-0.456234386365879,0.698395722414825,0.978262075707395,NA,NA,NA,NA,NA
"107",107,"Cluster_10934","Porites_evermani_scaffold_4129:8936-9936",160,-22.04,2,21,752,773,19,"68.42%","78.95%","Peve_00029512",-0.298373082118559,0.807112079527598,0.995934364227446,NA,NA,NA,NA,NA
"108",108,"Cluster_10934","Porites_evermani_scaffold_4189:16706-17706",161,-23.82,2,21,322,341,19,"78.95%","78.95%","Peve_00029762",-0.994490928196904,0.0668550039584052,0.978262075707395,"Q3SZ45","Stromal cell-derived factor 2 (SDF-2)","Bos taurus (Bovine)","","GO:0005576"
"109",109,"Cluster_10934","Porites_evermani_scaffold_435:146090-147090",170,-21.8,2,15,140,161,13,"100.00%","100.00%","Peve_00030666",NA,NA,NA,NA,NA,NA,NA,NA
"110",110,"Cluster_10934","Porites_evermani_scaffold_4504:16216-17216",165,-22.15,2,20,302,322,18,"83.33%","83.33%","Peve_00031501",NA,NA,NA,NA,NA,NA,NA,NA
"111",111,"Cluster_10934","Porites_evermani_scaffold_460:128725-129725",155,-24.02,2,21,883,901,19,"78.95%","78.95%","Peve_00031921",-0.241116146854525,0.844973048802971,0.995934364227446,"O57525","Steroid 17-alpha-hydroxylase/17,20 lyase (EC 1.14.14.19) (EC 1.14.14.32) (17-alpha-hydroxyprogesterone aldolase) (CYPXVII) (Cytochrome P450 17A1) (Cytochrome P450-C17) (Cytochrome P450c17)","Rana dybowskii (Dybovsky's frog) (Korean brown frog)","steroid biosynthetic process [GO:0006694]","GO:0004508; GO:0005506; GO:0006694; GO:0016020; GO:0020037; GO:0047442"
"112",112,"Cluster_10934","Porites_evermani_scaffold_5205:0-689",154,-20.01,2,20,195,217,19,"73.68%","73.68%","Peve_00034418",NA,NA,NA,NA,NA,NA,NA,NA
"113",113,"Cluster_10934","Porites_evermani_scaffold_5440:9197-10197",158,-20.62,2,21,450,473,21,"76.19%","76.19%","Peve_00035277",NA,NA,NA,NA,NA,NA,NA,NA
"114",114,"Cluster_10934","Porites_evermani_scaffold_634:163425-164425",162,-22.04,2,21,538,563,23,"73.91%","78.26%","Peve_00037972",-0.672440822133068,0.530491896805832,0.978262075707395,NA,NA,NA,NA,NA
"115",115,"Cluster_10934","Porites_evermani_scaffold_686:53999-54999",160,-23.13,2,21,40,61,19,"68.42%","78.95%","Peve_00039182",-0.456234386365879,0.698395722414825,0.978262075707395,"Q6PBN2","Axin interactor, dorsalization-associated protein (Axin interaction partner and dorsalization antagonist)","Danio rerio (Zebrafish) (Brachydanio rerio)","determination of ventral identity [GO:0048264]; dorsal/ventral pattern formation [GO:0009953]; negative regulation of determination of dorsal identity [GO:2000016]; negative regulation of JNK cascade [GO:0046329]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of protein-containing complex assembly [GO:0031333]","GO:0009953; GO:0016020; GO:0031333; GO:0035091; GO:0043508; GO:0046329; GO:0048264; GO:2000016"
"116",116,"Cluster_10934","Porites_evermani_scaffold_706:4904-5904",158,-20.1,2,20,323,345,19,"68.42%","84.21%","Peve_00039731",0.611769438717012,0.580916053750474,0.978262075707395,"Q9NYR8","Retinol dehydrogenase 8 (EC 1.1.1.300) (Photoreceptor outer segment all-trans retinol dehydrogenase) (Short chain dehydrogenase/reductase family 28C member 2)","Homo sapiens (Human)","estrogen biosynthetic process [GO:0006703]; response to stimulus [GO:0050896]; retinol metabolic process [GO:0042572]; steroid biosynthetic process [GO:0006694]; visual perception [GO:0007601]","GO:0004303; GO:0004745; GO:0005829; GO:0005886; GO:0006694; GO:0006703; GO:0007601; GO:0016491; GO:0042572; GO:0050896; GO:0052650"
"117",117,"Cluster_10934","Porites_evermani_scaffold_724:23743-24743",160,-20.06,2,20,942,961,18,"77.78%","83.33%","Peve_00040130",0.998758250045998,0.0317290557481573,0.903929377050813,NA,NA,NA,NA,NA
"118",118,"Cluster_10934","Porites_evermani_scaffold_781:76082-77082",160,-27.41,2,21,488,507,19,"73.68%","89.47%","Peve_00041309",-0.173093623709525,0.889247357337725,0.999448381576871,"Q3ZCF5","Ornithine aminotransferase, mitochondrial (EC 2.6.1.13) (Ornithine--oxo-acid aminotransferase)","Bos taurus (Bovine)","L-proline biosynthetic process [GO:0055129]","GO:0004587; GO:0005759; GO:0030170; GO:0042802; GO:0050155; GO:0055129"
"119",119,"Cluster_10934","Porites_evermani_scaffold_820:153374-153585",155,-22.16,2,21,131,158,25,"64.00%","72.00%","Peve_00042221",NA,NA,NA,NA,NA,NA,NA,NA
"120",120,"Cluster_10934","Porites_evermani_scaffold_846:97271-98271",146,-20.45,2,20,814,841,24,"62.50%","66.67%","Peve_00042685",NA,NA,NA,NA,NA,NA,NA,NA
"121",121,"Cluster_10934","Porites_evermani_scaffold_866:177875-178805",164,-20.03,2,17,785,806,15,"86.67%","86.67%","Peve_00043066",0.126658887442541,0.919149282879606,0.999448381576871,"P09525","Annexin A4 (35-beta calcimedin) (Annexin IV) (Annexin-4) (Carbohydrate-binding protein p33/p41) (Chromobindin-4) (Endonexin I) (Lipocortin IV) (P32.5) (PP4-X) (Placental anticoagulant protein II) (PAP-II) (Protein II)","Homo sapiens (Human)","epithelial cell differentiation [GO:0030855]; negative regulation of apoptotic process [GO:0043066]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; Notch signaling pathway [GO:0007219]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]","GO:0004859; GO:0005509; GO:0005544; GO:0005634; GO:0005737; GO:0005886; GO:0006357; GO:0007165; GO:0007219; GO:0009986; GO:0012506; GO:0030855; GO:0031410; GO:0031965; GO:0032088; GO:0032717; GO:0042802; GO:0043066; GO:0048306; GO:0048471; GO:0051059; GO:0062023; GO:0070062"
"122",122,"Cluster_10934","Porites_evermani_scaffold_902:93750-94750",151,-20.02,2,21,736,761,23,"60.87%","73.91%","Peve_00043802",0.686936593099254,0.517909997858687,0.978262075707395,"Q9XVI9","Myosin-2 essential light chain","Caenorhabditis elegans","mitotic cytokinesis [GO:0000281]","GO:0000281; GO:0005509; GO:0005737; GO:0015629; GO:0016460"
"123",123,"Cluster_10934","Porites_evermani_scaffold_92:460575-461575",159,-21.06,2,21,794,816,20,"70.00%","80.00%","Peve_00044084",0.198744611650536,0.872627145119793,0.997476741937264,"Q5R6Q7","Sorting nexin-16","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","early endosome to late endosome transport [GO:0045022]; endosome to lysosome transport [GO:0008333]; protein targeting to lysosome [GO:0006622]","GO:0005764; GO:0005769; GO:0005770; GO:0005829; GO:0006622; GO:0008333; GO:0031313; GO:0031901; GO:0031902; GO:0035091; GO:0045022"
"124",124,"Cluster_10934","Porites_evermani_scaffold_99:506249-507249",143,-22.03,2,21,674,692,19,"68.42%","73.68%","Peve_00045202",NA,NA,NA,NA,NA,NA,NA,NA
"125",125,"Cluster_10965","Porites_evermani_scaffold_1022:149295-150189",175,-20.57,2,21,177,199,20,"80.00%","90.00%","Peve_00000582",0.95516544776331,0.191354050842816,0.978262075707395,NA,NA,NA,NA,NA
"126",126,"Cluster_10965","Porites_evermani_scaffold_110:397656-398656",173,-21.24,2,19,868,891,19,"84.21%","89.47%","Peve_00001869",0.979922861657745,0.127783662576102,0.978262075707395,NA,NA,NA,NA,NA
"127",127,"Cluster_10965","Porites_evermani_scaffold_119:63066-64066",159,-20.53,2,21,485,502,19,"78.95%","78.95%","Peve_00003185",-0.772907524361777,0.437603280036322,0.978262075707395,"Q10728","Protein phosphatase 1 regulatory subunit 12A (MBSP) (Myosin phosphatase-targeting subunit 1) (Myosin phosphatase target subunit 1) (Protein phosphatase myosin-binding subunit) (Protein phosphatase subunit 1M) (PP-1M) (Serine/threonine protein phosphatase PP1 smooth muscle regulatory subunit M110)","Rattus norvegicus (Rat)","cellular response to xenobiotic stimulus [GO:0071466]; centrosome cycle [GO:0007098]; mitotic cell cycle [GO:0000278]; negative regulation of catalytic activity [GO:0043086]; positive regulation of myosin-light-chain-phosphatase activity [GO:0035508]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein dephosphorylation [GO:0006470]; regulation of cell adhesion [GO:0030155]; regulation of myosin-light-chain-phosphatase activity [GO:0035507]; regulation of nucleocytoplasmic transport [GO:0046822]; signal transduction [GO:0007165]","GO:0000278; GO:0000776; GO:0004721; GO:0004857; GO:0005737; GO:0005813; GO:0005829; GO:0006470; GO:0007098; GO:0007165; GO:0019208; GO:0019901; GO:0030018; GO:0030155; GO:0031672; GO:0035507; GO:0035508; GO:0043086; GO:0043292; GO:0045944; GO:0046822; GO:0071466; GO:0071889; GO:0072357"
"128",128,"Cluster_10965","Porites_evermani_scaffold_122:390582-391582",170,-20.51,2,21,300,320,19,"78.95%","89.47%","Peve_00003648",NA,NA,NA,NA,NA,NA,NA,NA
"129",129,"Cluster_10965","Porites_evermani_scaffold_124:422073-423073",168,-20.19,2,21,199,220,19,"73.68%","84.21%","Peve_00003951",0.889595915128825,0.301972071014213,0.978262075707395,NA,NA,NA,NA,NA
"130",130,"Cluster_10965","Porites_evermani_scaffold_1437:121873-122873",154,-21.15,2,21,330,354,22,"72.73%","72.73%","Peve_00006687",NA,NA,NA,NA,NA,NA,NA,NA
"131",131,"Cluster_10965","Porites_evermani_scaffold_1595:29158-30158",165,-20.02,2,20,4,24,18,"77.78%","88.89%","Peve_00008708",NA,NA,NA,NA,NA,NA,NA,NA
"132",132,"Cluster_10965","Porites_evermani_scaffold_1635:84592-85592",143,-20.05,2,20,327,348,18,"50.00%","77.78%","Peve_00009244",NA,NA,NA,NA,NA,NA,NA,NA
"133",133,"Cluster_10965","Porites_evermani_scaffold_187:225369-226369",171,-20.87,2,20,650,671,18,"83.33%","83.33%","Peve_00011904",-0.56648049002244,0.616609305968153,0.978262075707395,"P17124","Histamine H2 receptor (H2R) (HH2R) (Gastric receptor I)","Canis lupus familiaris (Dog) (Canis familiaris)","chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; gastric acid secretion [GO:0001696]; positive regulation of vasoconstriction [GO:0045907]","GO:0001696; GO:0004969; GO:0004993; GO:0005886; GO:0007187; GO:0007268; GO:0030425; GO:0030594; GO:0045202; GO:0045907"
"134",134,"Cluster_10965","Porites_evermani_scaffold_1963:18198-19198",159,-20.2,2,20,690,711,18,"72.22%","77.78%","Peve_00012973",-0.231283764160379,0.851414843454204,0.995934364227446,NA,NA,NA,NA,NA
"135",135,"Cluster_10965","Porites_evermani_scaffold_200:292418-293418",149,-20.96,2,20,359,379,18,"66.67%","77.78%","Peve_00013573",-0.861501692342471,0.33904874167394,0.978262075707395,"B8VIU6","Uncharacterized skeletal organic matrix protein 5 (Uncharacterized SOMP-5)","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0005576"
"136",136,"Cluster_10965","Porites_evermani_scaffold_200:29742-30742",170,-22.19,2,20,370,392,19,"84.21%","84.21%","Peve_00013565",NA,NA,NA,NA,NA,NA,NA,NA
"137",137,"Cluster_10965","Porites_evermani_scaffold_207:354765-355765",171,-20.28,2,16,330,351,14,"92.86%","100.00%","Peve_00014247",-0.823646148137295,0.383872548980192,0.978262075707395,NA,NA,NA,NA,NA
"138",138,"Cluster_10965","Porites_evermani_scaffold_2135:78046-78805",178,-21.59,2,21,106,129,21,"85.71%","90.48%","Peve_00014927",NA,NA,NA,NA,NA,NA,NA,NA
"139",139,"Cluster_10965","Porites_evermani_scaffold_231:117592-118592",170,-21.03,2,21,367,387,19,"84.21%","84.21%","Peve_00016651",-0.605439487521153,0.585994736675805,0.978262075707395,"Q9GZV3","High affinity choline transporter 1 (Hemicholinium-3-sensitive choline transporter) (CHT) (Solute carrier family 5 member 7)","Homo sapiens (Human)","acetylcholine biosynthetic process [GO:0008292]; choline transport [GO:0015871]; in utero embryonic development [GO:0001701]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter transport [GO:0006836]; synaptic transmission, cholinergic [GO:0007271]; transmembrane transport [GO:0055085]","GO:0001701; GO:0005307; GO:0005886; GO:0006836; GO:0007271; GO:0007274; GO:0008292; GO:0015220; GO:0015871; GO:0016020; GO:0030424; GO:0030425; GO:0031594; GO:0033265; GO:0043204; GO:0045202; GO:0055085"
"140",140,"Cluster_10965","Porites_evermani_scaffold_2459:7071-8071",143,-21.13,2,20,326,347,18,"50.00%","77.78%","Peve_00018007",NA,NA,NA,NA,NA,NA,NA,NA
"141",141,"Cluster_10965","Porites_evermani_scaffold_2564:23537-24537",159,-21.6,2,21,262,284,20,"70.00%","80.00%","Peve_00018938",NA,NA,NA,NA,NA,NA,NA,NA
"142",142,"Cluster_10965","Porites_evermani_scaffold_2619:37353-38353",168,-20.19,2,21,374,395,19,"73.68%","84.21%","Peve_00019412",-0.899645286460304,0.287650213040785,0.978262075707395,NA,NA,NA,NA,NA
"143",143,"Cluster_10965","Porites_evermani_scaffold_2726:28871-29871",155,-20.36,2,20,186,204,18,"77.78%","77.78%","Peve_00020313",0.532173255053656,0.642750990513826,0.978262075707395,"Q9DC70","NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial (EC 7.1.1.2) (Complex I-20kD) (CI-20kD) (NADH-ubiquinone oxidoreductase 20 kDa subunit)","Mus musculus (Mouse)","aerobic respiration [GO:0009060]; electron transport coupled proton transport [GO:0015990]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]","GO:0002020; GO:0003954; GO:0005739; GO:0005743; GO:0005747; GO:0006120; GO:0008137; GO:0009060; GO:0015990; GO:0032981; GO:0042776; GO:0043005; GO:0043025; GO:0046872; GO:0048038; GO:0051539; GO:0097060"
"144",144,"Cluster_10965","Porites_evermani_scaffold_31:207774-208774",167,-20.74,2,20,362,383,18,"77.78%","83.33%","Peve_00023370",0.204093609767863,0.869150611355107,0.997306721212908,NA,NA,NA,NA,NA
"145",145,"Cluster_10965","Porites_evermani_scaffold_3170:36869-37458",168,-20.19,2,21,257,278,19,"73.68%","84.21%","Peve_00023854",-0.690316686109988,0.51494241614662,0.978262075707395,NA,NA,NA,NA,NA
"146",146,"Cluster_10965","Porites_evermani_scaffold_3808:416-1416",159,-21.01,2,20,331,352,18,"72.22%","77.78%","Peve_00027671",-0.879471278527915,0.315792781084436,0.978262075707395,"O54781","SRSF protein kinase 2 (EC 2.7.11.1) (SFRS protein kinase 2) (Serine/arginine-rich protein-specific kinase 2) (SR-protein-specific kinase 2) [Cleaved into: SRSF protein kinase 2 N-terminal; SRSF protein kinase 2 C-terminal]","Mus musculus (Mouse)","angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; intracellular signal transduction [GO:0035556]; negative regulation of viral genome replication [GO:0045071]; nuclear speck organization [GO:0035063]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; R-loop processing [GO:0062176]; regulation of mRNA processing [GO:0050684]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]","GO:0000245; GO:0000287; GO:0000785; GO:0001525; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006468; GO:0008284; GO:0008380; GO:0010628; GO:0016607; GO:0018105; GO:0030154; GO:0035063; GO:0035556; GO:0043525; GO:0045070; GO:0045071; GO:0045787; GO:0050684; GO:0062176; GO:0071889; GO:0106310"
"147",147,"Cluster_10965","Porites_evermani_scaffold_4347:6663-7663",168,-20.19,2,21,739,760,19,"73.68%","84.21%","Peve_00030651",NA,NA,NA,NA,NA,NA,NA,NA
"148",148,"Cluster_10965","Porites_evermani_scaffold_4679:13116-14116",151,-22.93,2,20,66,84,18,"72.22%","77.78%","Peve_00032219",0.174592020451243,0.88827869888136,0.999448381576871,NA,NA,NA,NA,NA
"149",149,"Cluster_10965","Porites_evermani_scaffold_5375:5388-6388",151,-20.76,2,21,278,295,19,"68.42%","78.95%","Peve_00035000",-0.0654063022535891,0.958331308989383,0.999448381576871,"Q9H867","Protein N-lysine methyltransferase METTL21D (EC 2.1.1.-) (Methyltransferase-like protein 21D) (VCP lysine methyltransferase) (VCP-KMT) (Valosin-containing protein lysine methyltransferase)","Homo sapiens (Human)","negative regulation of ATP-dependent activity [GO:0032780]; peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine trimethylation [GO:0018023]; protein methylation [GO:0006479]","GO:0005737; GO:0005829; GO:0006479; GO:0016279; GO:0018022; GO:0018023; GO:0018024; GO:0032780; GO:0032991; GO:0051117"
"150",150,"Cluster_10965","Porites_evermani_scaffold_5714:5163-6163",151,-22.14,2,20,788,806,18,"72.22%","77.78%","Peve_00036167",-0.904462534507429,0.28054452778154,0.978262075707395,"Q5ZIJ9","E3 ubiquitin-protein ligase MIB2 (EC 2.3.2.27) (Mind bomb homolog 2) (RING-type E3 ubiquitin transferase MIB2)","Gallus gallus (Chicken)","Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]","GO:0004842; GO:0005737; GO:0007219; GO:0008270; GO:0016567"
"151",151,"Cluster_10965","Porites_evermani_scaffold_5960:3027-4027",150,-20.57,2,20,300,323,20,"65.00%","75.00%","Peve_00036863",0.870479314169719,0.327617924992727,0.978262075707395,"Q9NZJ4","Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29)","Homo sapiens (Human)","negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]","GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0042802; GO:0051087; GO:0070628; GO:0070852; GO:0090084"
"152",152,"Cluster_10965","Porites_evermani_scaffold_617:25586-26586",159,-20.59,2,20,588,609,18,"72.22%","77.78%","Peve_00037517",-0.00897762182724763,0.994284591659394,0.999448381576871,NA,NA,NA,NA,NA
"153",153,"Cluster_10965","Porites_evermani_scaffold_632:110109-111109",168,-20.19,2,21,506,527,19,"73.68%","84.21%","Peve_00037942",0.33735209685042,0.78093742919351,0.993788708292501,NA,NA,NA,NA,NA
"154",154,"Cluster_10965","Porites_evermani_scaffold_72:597934-598934",163,-21.19,2,21,101,123,20,"70.00%","85.00%","Peve_00040015",-0.478569964078516,0.682310603328033,0.978262075707395,NA,NA,NA,NA,NA
"155",155,"Cluster_10965","Porites_evermani_scaffold_758:51594-52594",169,-20.1,2,19,390,414,20,"80.00%","85.00%","Peve_00040823",NA,NA,NA,NA,NA,NA,NA,NA
"156",156,"Cluster_10965","Porites_evermani_scaffold_855:72015-73015",158,-20.3,2,21,537,563,24,"70.83%","75.00%","Peve_00042869",0.870479314169719,0.327617924992727,0.978262075707395,NA,NA,NA,NA,NA
"157",157,"Cluster_10965","Porites_evermani_scaffold_859:62420-63420",171,-21.07,2,21,298,320,20,"75.00%","90.00%","Peve_00042921",0.854263270849532,0.348017342390147,0.978262075707395,NA,NA,NA,NA,NA
"158",158,"Cluster_11134","Porites_evermani_scaffold_100:134703-135703",168,-24.01,2,21,493,514,19,"73.68%","84.21%","Peve_00000217",-0.264018095147998,0.829904266424047,0.995934364227446,NA,NA,NA,NA,NA
"159",159,"Cluster_11134","Porites_evermani_scaffold_1012:121314-122314",164,-20.74,2,18,190,213,18,"83.33%","83.33%","Peve_00000438",-0.488584917443093,0.675026503664371,0.978262075707395,NA,NA,NA,NA,NA
"160",160,"Cluster_11134","Porites_evermani_scaffold_101:510412-511412",163,-21.85,2,21,836,858,20,"70.00%","85.00%","Peve_00000376",0.920902283169011,0.254907243946883,0.978262075707395,NA,NA,NA,NA,NA
"161",161,"Cluster_11134","Porites_evermani_scaffold_1021:76277-77277",168,-21.93,2,21,543,564,19,"73.68%","84.21%","Peve_00000567",NA,NA,NA,NA,NA,NA,NA,NA
"162",162,"Cluster_11134","Porites_evermani_scaffold_102:440897-441897",166,-21.26,2,19,595,616,17,"70.59%","94.12%","Peve_00000525",0.878635629686987,0.316908714438892,0.978262075707395,"Q8WWV3","Reticulon-4-interacting protein 1, mitochondrial (NOGO-interacting mitochondrial protein)","Homo sapiens (Human)","nervous system development [GO:0007399]; regulation of dendrite development [GO:0050773]","GO:0005739; GO:0005741; GO:0007399; GO:0008270; GO:0016491; GO:0050773"
"163",163,"Cluster_11134","Porites_evermani_scaffold_1025:2176-3176",174,-23.34,2,21,552,572,19,"78.95%","94.74%","Peve_00000617",0.475660865677406,0.684417915004705,0.978262075707395,NA,NA,NA,NA,NA
"164",164,"Cluster_11134","Porites_evermani_scaffold_1043:69671-70671",162,-24.71,2,16,908,931,16,"87.50%","87.50%","Peve_00000894",NA,NA,NA,NA,NA,NA,NA,NA
"165",165,"Cluster_11134","Porites_evermani_scaffold_1044:68033-69033",151,-22.16,2,16,357,378,14,"71.43%","85.71%","Peve_00000909",-0.0195622829453675,0.987545469442176,0.999448381576871,NA,NA,NA,NA,NA
"166",166,"Cluster_11134","Porites_evermani_scaffold_1067:148151-149151",161,-22.73,2,21,17,41,22,"72.73%","86.36%","Peve_00001246",0.875640822838247,0.320878802775509,0.978262075707395,NA,NA,NA,NA,NA
"167",167,"Cluster_11134","Porites_evermani_scaffold_1072:24129-25129",148,-21.02,2,13,5,26,11,"72.73%","100.00%","Peve_00001340",-0.0195622829453675,0.987545469442176,0.999448381576871,NA,NA,NA,NA,NA
"168",168,"Cluster_11134","Porites_evermani_scaffold_1074:6020-7020",158,-23.43,2,20,967,992,22,"68.18%","77.27%","Peve_00001360",0.400544462658562,0.737642001342943,0.986508276825124,"Q0IJ05","Oxysterol-binding protein-related protein 9","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","lipid transport [GO:0006869]","GO:0006869; GO:0008289"
"169",169,"Cluster_11134","Porites_evermani_scaffold_10:814185-815185",168,-22.65,2,21,628,649,19,"73.68%","84.21%","Peve_00000147",NA,NA,NA,NA,NA,NA,NA,NA
"170",170,"Cluster_11134","Porites_evermani_scaffold_1087:61454-62454",155,-23.45,2,17,423,445,16,"81.25%","81.25%","Peve_00001544",-0.0195622829453675,0.987545469442176,0.999448381576871,"O35474","EGF-like repeat and discoidin I-like domain-containing protein 3 (Developmentally-regulated endothelial cell locus 1 protein) (Integrin-binding protein DEL1)","Mus musculus (Mouse)","cell adhesion [GO:0007155]; positive regulation of cell-substrate adhesion [GO:0010811]","GO:0005509; GO:0005576; GO:0007155; GO:0010811"
"171",171,"Cluster_11134","Porites_evermani_scaffold_1091:4675-5675",162,-25.57,2,21,114,140,24,"70.83%","79.17%","Peve_00001620",0.999331428228842,0.0232805554536455,0.848115847217852,"Q0VD42","TLC domain-containing protein 5 (Transmembrane protein 136)","Bos taurus (Bovine)","","GO:0016020"
"172",172,"Cluster_11134","Porites_evermani_scaffold_1103:73107-74107",163,-25.25,2,21,103,125,20,"75.00%","80.00%","Peve_00001913",0.19480304383351,0.875186464509675,0.99759521253222,NA,NA,NA,NA,NA
"173",173,"Cluster_11134","Porites_evermani_scaffold_111:38053-39053",146,-20.63,2,21,56,80,22,"63.64%","72.73%","Peve_00001998",-0.0195622829453675,0.987545469442176,0.999448381576871,NA,NA,NA,NA,NA
"174",174,"Cluster_11134","Porites_evermani_scaffold_111:45436-46436",160,-20.3,2,17,930,951,15,"73.33%","93.33%","Peve_00002001",0.997882460106254,0.0414369314993325,0.909359886114279,NA,NA,NA,NA,NA
"175",175,"Cluster_11134","Porites_evermani_scaffold_1141:56322-57322",158,-24.34,2,21,829,849,19,"68.42%","84.21%","Peve_00002446",-0.271655901502837,0.82485748417322,0.995934364227446,NA,NA,NA,NA,NA
"176",176,"Cluster_11134","Porites_evermani_scaffold_1149:141720-142720",153,-22.89,2,19,195,217,18,"66.67%","83.33%","Peve_00002521",0.971850867627246,0.151408995134943,0.978262075707395,"Q60HE9","Lysosomal alpha-mannosidase (Laman) (EC 3.2.1.24) (Lysosomal acid alpha-mannosidase) (Mannosidase alpha class 2B member 1) (Mannosidase alpha-B)","Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)","mannose metabolic process [GO:0006013]","GO:0004559; GO:0005764; GO:0006013; GO:0030246; GO:0046872"
"177",177,"Cluster_11134","Porites_evermani_scaffold_1:1631357-1632357",167,-21.94,2,21,442,465,21,"76.19%","80.95%","Peve_00000085",-0.352836349643591,0.77043447347377,0.991104944526763,"Q6P1R4","tRNA-dihydrouridine(16/17) synthase [NAD(P)(+)]-like (EC 1.3.1.88) (tRNA-dihydrouridine synthase 1-like)","Homo sapiens (Human)","tRNA dihydrouridine synthesis [GO:0002943]","GO:0002943; GO:0017150; GO:0050660"
"178",178,"Cluster_11134","Porites_evermani_scaffold_117:293258-294258",176,-20.34,2,21,312,333,19,"84.21%","84.21%","Peve_00002873",0.675464832413145,0.527886027566047,0.978262075707395,NA,NA,NA,NA,NA
"179",179,"Cluster_11134","Porites_evermani_scaffold_117:371744-372744",152,-20.97,2,20,972,991,18,"72.22%","77.78%","Peve_00002881",0.334846211061197,0.782631262302743,0.994164441384955,NA,NA,NA,NA,NA
"180",180,"Cluster_11134","Porites_evermani_scaffold_1175:72732-73732",171,-23.13,2,21,761,784,21,"76.19%","85.71%","Peve_00002949",-0.107641953188398,0.93133997481459,0.999448381576871,NA,NA,NA,NA,NA
"181",181,"Cluster_11134","Porites_evermani_scaffold_1181:100866-101866",156,-25.65,2,21,436,454,19,"68.42%","84.21%","Peve_00003060",0.716328911462625,0.49164206225064,0.978262075707395,"Q6EV56","GDP-fucose protein O-fucosyltransferase 2 (EC 2.4.1.221) (Peptide-O-fucosyltransferase 2) (O-FucT-2)","Pan troglodytes (Chimpanzee)","fucose metabolic process [GO:0006004]; protein O-linked fucosylation [GO:0036066]","GO:0005783; GO:0005794; GO:0006004; GO:0036066; GO:0046922"
"182",182,"Cluster_11134","Porites_evermani_scaffold_1181:82549-83549",154,-23.78,2,21,446,470,22,"63.64%","81.82%","Peve_00003058",0.582900933455396,0.603835126804847,0.978262075707395,"Q6EV56","GDP-fucose protein O-fucosyltransferase 2 (EC 2.4.1.221) (Peptide-O-fucosyltransferase 2) (O-FucT-2)","Pan troglodytes (Chimpanzee)","fucose metabolic process [GO:0006004]; protein O-linked fucosylation [GO:0036066]","GO:0005783; GO:0005794; GO:0006004; GO:0036066; GO:0046922"
"183",183,"Cluster_11134","Porites_evermani_scaffold_1187:7320-8320",146,-21.85,2,21,83,109,24,"58.33%","75.00%","Peve_00003129",-0.0745910756184237,0.952469701667096,0.999448381576871,NA,NA,NA,NA,NA
"184",184,"Cluster_11134","Porites_evermani_scaffold_119:23950-24950",153,-20.18,2,21,254,273,19,"68.42%","78.95%","Peve_00003171",NA,NA,NA,NA,NA,NA,NA,NA
"185",185,"Cluster_11134","Porites_evermani_scaffold_1193:97529-98529",150,-20.6,2,16,952,974,15,"66.67%","93.33%","Peve_00003229",NA,NA,NA,NA,NA,NA,NA,NA
"186",186,"Cluster_11134","Porites_evermani_scaffold_1195:35632-36632",162,-22.96,2,20,464,486,19,"78.95%","78.95%","Peve_00003258",NA,NA,NA,NA,NA,NA,NA,NA
"187",187,"Cluster_11134","Porites_evermani_scaffold_123:28550-29550",166,-21.52,2,15,766,787,13,"92.31%","100.00%","Peve_00003796",0.199313465379079,0.872257608482443,0.997476741937264,"Q3SZX5","39S ribosomal protein L22, mitochondrial (L22mt) (MRP-L22)","Bos taurus (Bovine)","ribosome assembly [GO:0042255]; translation [GO:0006412]","GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0006412; GO:0015934; GO:0042255"
"188",188,"Cluster_11134","Porites_evermani_scaffold_1266:115145-116145",166,-21.25,2,20,284,306,19,"73.68%","89.47%","Peve_00004294",0.616266576479903,0.577288780618442,0.978262075707395,"P18460","Fibroblast growth factor receptor 3 (FGFR-3) (EC 2.7.10.1) (Tyrosine kinase receptor CEK2)","Gallus gallus (Chicken)","apoptotic process [GO:0006915]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]","GO:0004714; GO:0005007; GO:0005524; GO:0005886; GO:0006915; GO:0007169; GO:0008284; GO:0017134; GO:0033674; GO:0043235; GO:0043410"
"189",189,"Cluster_11134","Porites_evermani_scaffold_128:242650-243650",150,-20.56,2,17,909,929,15,"73.33%","86.67%","Peve_00004498",-0.997520581789295,0.0448393995312029,0.929559323183572,"S8FGV1","Laccase-2 (EC 1.10.3.2) (FpLCC2)","Fomitopsis pinicola (strain FP-58527) (Brown rot fungus)","","GO:0005507; GO:0005576; GO:0016682"
"190",190,"Cluster_11134","Porites_evermani_scaffold_1286:116058-117058",146,-20.43,2,17,426,450,18,"66.67%","83.33%","Peve_00004571",-0.586222670318268,0.601228743287346,0.978262075707395,NA,NA,NA,NA,NA
"191",191,"Cluster_11134","Porites_evermani_scaffold_129:255893-256893",155,-21.51,2,21,621,643,20,"65.00%","80.00%","Peve_00004628",-0.284769277961866,0.816166025346405,0.995934364227446,NA,NA,NA,NA,NA
"192",192,"Cluster_11134","Porites_evermani_scaffold_1300:17853-18853",163,-22.34,2,21,168,190,20,"75.00%","80.00%","Peve_00004808",0.875640822838247,0.320878802775509,0.978262075707395,NA,NA,NA,NA,NA
"193",193,"Cluster_11134","Porites_evermani_scaffold_1318:45309-46309",174,-23.34,2,21,1,21,19,"78.95%","94.74%","Peve_00005035",-0.0195622829453675,0.987545469442176,0.999448381576871,NA,NA,NA,NA,NA
"194",194,"Cluster_11134","Porites_evermani_scaffold_1318:85174-86174",155,-22.52,2,21,783,805,20,"60.00%","85.00%","Peve_00005045",NA,NA,NA,NA,NA,NA,NA,NA
"195",195,"Cluster_11134","Porites_evermani_scaffold_1321:95983-96983",160,-20.16,2,21,667,688,19,"68.42%","78.95%","Peve_00005112",-0.0199487886767692,0.987299364220091,0.999448381576871,NA,NA,NA,NA,NA
"196",196,"Cluster_11134","Porites_evermani_scaffold_1331:125375-126375",146,-20.67,2,21,524,547,21,"57.14%","80.95%","Peve_00005247",NA,NA,NA,NA,NA,NA,NA,NA
"197",197,"Cluster_11134","Porites_evermani_scaffold_1336:77948-78948",173,-25.55,2,18,397,418,16,"87.50%","93.75%","Peve_00005301",-0.215888796286578,0.861470263967076,0.996533940716573,"Q96KE9","BTB/POZ domain-containing protein 6 (Lens BTB domain protein)","Homo sapiens (Human)","neurogenesis [GO:0022008]","GO:0005829; GO:0022008"
"198",198,"Cluster_11134","Porites_evermani_scaffold_1338:72890-73890",146,-20.76,2,11,304,325,9,"88.89%","100.00%","Peve_00005320",-0.0195622829453675,0.987545469442176,0.999448381576871,NA,NA,NA,NA,NA
"199",199,"Cluster_11134","Porites_evermani_scaffold_1338:82507-83507",146,-20.76,2,11,742,763,9,"88.89%","100.00%","Peve_00005322",0.371508083208339,0.75768161354222,0.988219883885475,NA,NA,NA,NA,NA
"200",200,"Cluster_11134","Porites_evermani_scaffold_1345:34452-35452",158,-22.81,2,19,547,568,17,"64.71%","88.24%","Peve_00005429",NA,NA,NA,NA,NA,NA,NA,NA
"201",201,"Cluster_11134","Porites_evermani_scaffold_1407:117377-118377",152,-25.96,2,21,833,852,19,"68.42%","84.21%","Peve_00006341",0.852752038388295,0.349863667243708,0.978262075707395,NA,NA,NA,NA,NA
"202",202,"Cluster_11134","Porites_evermani_scaffold_14:1088062-1089062",148,-22.12,2,14,672,694,13,"84.62%","84.62%","Peve_00006216",-0.118748621066079,0.924223472714073,0.999448381576871,"Q3SYS4","Dynein axonemal assembly factor 1 (Leucine-rich repeat-containing protein 50)","Bos taurus (Bovine)","cilium assembly [GO:0060271]","GO:0005930; GO:0060271; GO:0070840"
"203",203,"Cluster_11134","Porites_evermani_scaffold_141:232957-233957",159,-20.47,2,21,289,312,21,"66.67%","80.95%","Peve_00006371",-0.0195622829453675,0.987545469442176,0.999448381576871,NA,NA,NA,NA,NA
"204",204,"Cluster_11134","Porites_evermani_scaffold_141:259521-260521",148,-20.89,2,16,658,679,15,"80.00%","86.67%","Peve_00006374",-0.390823503912697,0.744380556379656,0.987192817130998,"A0A2B4RP11",NA,NA,NA,NA
"205",205,"Cluster_11134","Porites_evermani_scaffold_1:413968-414968",156,-21.44,2,21,670,691,19,"57.89%","84.21%","Peve_00000123",0.77444760066262,0.436055811583654,0.978262075707395,"Q6P963","Hydroxyacylglutathione hydrolase, mitochondrial (EC 3.1.2.6) (Glyoxalase II) (Glx II)","Danio rerio (Zebrafish) (Brachydanio rerio)","glutathione metabolic process [GO:0006749]; methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione [GO:0019243]","GO:0004416; GO:0005739; GO:0005759; GO:0006749; GO:0019243; GO:0046872"
"206",206,"Cluster_11134","Porites_evermani_scaffold_1431:77254-78254",169,-20.08,2,18,295,316,16,"87.50%","87.50%","Peve_00006642",NA,NA,NA,NA,NA,NA,NA,NA
"207",207,"Cluster_11134","Porites_evermani_scaffold_150:308972-309972",150,-22.23,2,20,443,465,19,"57.89%","84.21%","Peve_00007526",NA,NA,NA,NA,NA,NA,NA,NA
"208",208,"Cluster_11134","Porites_evermani_scaffold_150:308972-309972",155,-20.1,2,21,746,763,19,"73.68%","78.95%","Peve_00007526",NA,NA,NA,NA,NA,NA,NA,NA
"209",209,"Cluster_11134","Porites_evermani_scaffold_153:12404-13404",155,-23.59,2,21,694,716,20,"60.00%","85.00%","Peve_00007871",0.883433218989714,0.310451943253182,0.978262075707395,"E7F240","Trafficking protein particle complex subunit 14 (Microtubule-associated protein 11)","Danio rerio (Zebrafish) (Brachydanio rerio)","cilium assembly [GO:0060271]; regulation of cell population proliferation [GO:0042127]","GO:0030496; GO:0042127; GO:0043014; GO:0060271; GO:0072686; GO:1990071"
"210",210,"Cluster_11134","Porites_evermani_scaffold_1535:114715-115715",150,-20.6,2,16,537,559,15,"66.67%","93.33%","Peve_00007940",0.915586804608501,0.263453344563559,0.978262075707395,"Q12873","Chromodomain-helicase-DNA-binding protein 3 (CHD-3) (EC 3.6.4.12) (ATP-dependent helicase CHD3) (Mi-2 autoantigen 240 kDa protein) (Mi2-alpha) (Zinc finger helicase) (hZFH)","Homo sapiens (Human)","centrosome cycle [GO:0007098]; chromatin remodeling [GO:0006338]; histone deacetylation [GO:0016575]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of cell fate specification [GO:0042659]; regulation of DNA-templated transcription [GO:0006355]; regulation of stem cell differentiation [GO:2000736]; spindle organization [GO:0007051]","GO:0000122; GO:0000785; GO:0000976; GO:0003677; GO:0003682; GO:0003723; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0006338; GO:0006355; GO:0007051; GO:0007098; GO:0008270; GO:0016575; GO:0016581; GO:0016605; GO:0016887; GO:0034451; GO:0042393; GO:0042659; GO:0045892; GO:0045893; GO:0140658; GO:2000736"
"211",211,"Cluster_11134","Porites_evermani_scaffold_1535:114715-115715",150,-20.6,2,16,843,865,15,"66.67%","93.33%","Peve_00007940",0.915586804608501,0.263453344563559,0.978262075707395,"Q12873","Chromodomain-helicase-DNA-binding protein 3 (CHD-3) (EC 3.6.4.12) (ATP-dependent helicase CHD3) (Mi-2 autoantigen 240 kDa protein) (Mi2-alpha) (Zinc finger helicase) (hZFH)","Homo sapiens (Human)","centrosome cycle [GO:0007098]; chromatin remodeling [GO:0006338]; histone deacetylation [GO:0016575]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of cell fate specification [GO:0042659]; regulation of DNA-templated transcription [GO:0006355]; regulation of stem cell differentiation [GO:2000736]; spindle organization [GO:0007051]","GO:0000122; GO:0000785; GO:0000976; GO:0003677; GO:0003682; GO:0003723; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0006338; GO:0006355; GO:0007051; GO:0007098; GO:0008270; GO:0016575; GO:0016581; GO:0016605; GO:0016887; GO:0034451; GO:0042393; GO:0042659; GO:0045892; GO:0045893; GO:0140658; GO:2000736"
"212",212,"Cluster_11134","Porites_evermani_scaffold_1535:114715-115715",150,-20.6,2,16,969,991,15,"66.67%","93.33%","Peve_00007940",0.915586804608501,0.263453344563559,0.978262075707395,"Q12873","Chromodomain-helicase-DNA-binding protein 3 (CHD-3) (EC 3.6.4.12) (ATP-dependent helicase CHD3) (Mi-2 autoantigen 240 kDa protein) (Mi2-alpha) (Zinc finger helicase) (hZFH)","Homo sapiens (Human)","centrosome cycle [GO:0007098]; chromatin remodeling [GO:0006338]; histone deacetylation [GO:0016575]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of cell fate specification [GO:0042659]; regulation of DNA-templated transcription [GO:0006355]; regulation of stem cell differentiation [GO:2000736]; spindle organization [GO:0007051]","GO:0000122; GO:0000785; GO:0000976; GO:0003677; GO:0003682; GO:0003723; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0006338; GO:0006355; GO:0007051; GO:0007098; GO:0008270; GO:0016575; GO:0016581; GO:0016605; GO:0016887; GO:0034451; GO:0042393; GO:0042659; GO:0045892; GO:0045893; GO:0140658; GO:2000736"
"213",213,"Cluster_11134","Porites_evermani_scaffold_1535:114715-115715",150,-21.15,2,16,699,721,15,"66.67%","93.33%","Peve_00007940",0.915586804608501,0.263453344563559,0.978262075707395,"Q12873","Chromodomain-helicase-DNA-binding protein 3 (CHD-3) (EC 3.6.4.12) (ATP-dependent helicase CHD3) (Mi-2 autoantigen 240 kDa protein) (Mi2-alpha) (Zinc finger helicase) (hZFH)","Homo sapiens (Human)","centrosome cycle [GO:0007098]; chromatin remodeling [GO:0006338]; histone deacetylation [GO:0016575]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of cell fate specification [GO:0042659]; regulation of DNA-templated transcription [GO:0006355]; regulation of stem cell differentiation [GO:2000736]; spindle organization [GO:0007051]","GO:0000122; GO:0000785; GO:0000976; GO:0003677; GO:0003682; GO:0003723; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0006338; GO:0006355; GO:0007051; GO:0007098; GO:0008270; GO:0016575; GO:0016581; GO:0016605; GO:0016887; GO:0034451; GO:0042393; GO:0042659; GO:0045892; GO:0045893; GO:0140658; GO:2000736"
"214",214,"Cluster_11134","Porites_evermani_scaffold_1535:114715-115715",153,-23.27,2,20,644,667,20,"65.00%","85.00%","Peve_00007940",0.915586804608501,0.263453344563559,0.978262075707395,"Q12873","Chromodomain-helicase-DNA-binding protein 3 (CHD-3) (EC 3.6.4.12) (ATP-dependent helicase CHD3) (Mi-2 autoantigen 240 kDa protein) (Mi2-alpha) (Zinc finger helicase) (hZFH)","Homo sapiens (Human)","centrosome cycle [GO:0007098]; chromatin remodeling [GO:0006338]; histone deacetylation [GO:0016575]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of cell fate specification [GO:0042659]; regulation of DNA-templated transcription [GO:0006355]; regulation of stem cell differentiation [GO:2000736]; spindle organization [GO:0007051]","GO:0000122; GO:0000785; GO:0000976; GO:0003677; GO:0003682; GO:0003723; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0006338; GO:0006355; GO:0007051; GO:0007098; GO:0008270; GO:0016575; GO:0016581; GO:0016605; GO:0016887; GO:0034451; GO:0042393; GO:0042659; GO:0045892; GO:0045893; GO:0140658; GO:2000736"
"215",215,"Cluster_11134","Porites_evermani_scaffold_1535:114715-115715",154,-20.71,2,16,555,577,15,"73.33%","93.33%","Peve_00007940",0.915586804608501,0.263453344563559,0.978262075707395,"Q12873","Chromodomain-helicase-DNA-binding protein 3 (CHD-3) (EC 3.6.4.12) (ATP-dependent helicase CHD3) (Mi-2 autoantigen 240 kDa protein) (Mi2-alpha) (Zinc finger helicase) (hZFH)","Homo sapiens (Human)","centrosome cycle [GO:0007098]; chromatin remodeling [GO:0006338]; histone deacetylation [GO:0016575]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of cell fate specification [GO:0042659]; regulation of DNA-templated transcription [GO:0006355]; regulation of stem cell differentiation [GO:2000736]; spindle organization [GO:0007051]","GO:0000122; GO:0000785; GO:0000976; GO:0003677; GO:0003682; GO:0003723; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0006338; GO:0006355; GO:0007051; GO:0007098; GO:0008270; GO:0016575; GO:0016581; GO:0016605; GO:0016887; GO:0034451; GO:0042393; GO:0042659; GO:0045892; GO:0045893; GO:0140658; GO:2000736"
"216",216,"Cluster_11134","Porites_evermani_scaffold_1539:4177-5177",154,-21.88,2,21,374,394,19,"63.16%","84.21%","Peve_00007966",0.225316964220354,0.855316472300514,0.995934364227446,"P46023","G-protein coupled receptor GRL101","Lymnaea stagnalis (Great pond snail) (Helix stagnalis)","","GO:0004930; GO:0005886"
"217",217,"Cluster_11134","Porites_evermani_scaffold_1545:2623-3623",162,-22.62,2,20,927,950,20,"75.00%","80.00%","Peve_00008039",-0.872048692568624,0.325582326145945,0.978262075707395,"A7RM45","Probable lysosomal cobalamin transporter","Nematostella vectensis (Starlet sea anemone)","protein localization to vacuole [GO:0072665]","GO:0005765; GO:0005774; GO:0031419; GO:0072665"
"218",218,"Cluster_11134","Porites_evermani_scaffold_1581:74075-74679",173,-24.08,2,19,309,331,18,"83.33%","94.44%","Peve_00008536",NA,NA,NA,NA,NA,NA,NA,NA
"219",219,"Cluster_11134","Porites_evermani_scaffold_1584:18570-19570",168,-25.2,2,21,738,759,19,"68.42%","89.47%","Peve_00008559",NA,NA,NA,NA,NA,NA,NA,NA
"220",220,"Cluster_11134","Porites_evermani_scaffold_1608:24703-25703",161,-21.19,2,20,385,409,21,"76.19%","80.95%","Peve_00008923",NA,NA,NA,NA,NA,NA,NA,NA
"221",221,"Cluster_11134","Porites_evermani_scaffold_1633:59585-60585",151,-21.12,2,12,301,322,10,"90.00%","100.00%","Peve_00009231",0.944247456833891,0.213582743500279,0.978262075707395,NA,NA,NA,NA,NA
"222",222,"Cluster_11134","Porites_evermani_scaffold_1640:7378-8378",151,-21.26,2,20,754,775,18,"61.11%","77.78%","Peve_00009308",-0.0726349013799293,0.953718429011232,0.999448381576871,"Q9JLC8","Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29)","Mus musculus (Mouse)","negative regulation of inclusion body assembly [GO:0090084]","GO:0005634; GO:0005737; GO:0005739; GO:0030544; GO:0042802; GO:0050750; GO:0051087; GO:0070628; GO:0090084"
"223",223,"Cluster_11134","Porites_evermani_scaffold_1702:13227-14227",158,-20.03,2,21,308,328,19,"68.42%","84.21%","Peve_00010086",-0.284746568365007,0.816181107118285,0.995934364227446,NA,NA,NA,NA,NA
"224",224,"Cluster_11134","Porites_evermani_scaffold_1710:87484-88484",146,-20.43,2,17,429,453,18,"66.67%","83.33%","Peve_00010164",0.369778155627397,0.758867375331273,0.988219883885475,NA,NA,NA,NA,NA
"225",225,"Cluster_11134","Porites_evermani_scaffold_1711:15486-16486",165,-20.97,2,20,668,688,18,"83.33%","83.33%","Peve_00010176",0.724028713889548,0.484576576184229,0.978262075707395,NA,NA,NA,NA,NA
"226",226,"Cluster_11134","Porites_evermani_scaffold_171:64454-65454",161,-20.27,2,16,263,283,14,"92.86%","92.86%","Peve_00010140",-0.122796889683951,0.921627259189534,0.999448381576871,"Q9V6X7","GDP-fucose protein O-fucosyltransferase 1 (EC 2.4.1.221) (Neurotic protein) (Peptide-O-fucosyltransferase 1) (O-FucT-1)","Drosophila melanogaster (Fruit fly)","cell fate commitment [GO:0045165]; fucose metabolic process [GO:0006004]; Notch signaling pathway [GO:0007219]; O-glycan processing [GO:0016266]; positive regulation of endocytosis [GO:0045807]; positive regulation of Notch signaling pathway [GO:0045747]; protein O-linked fucosylation [GO:0036066]; protein O-linked glycosylation [GO:0006493]; regulation of Notch signaling pathway [GO:0008593]","GO:0005112; GO:0005783; GO:0006004; GO:0006493; GO:0007219; GO:0008417; GO:0008593; GO:0016266; GO:0036066; GO:0045165; GO:0045747; GO:0045807; GO:0046922"
"227",227,"Cluster_11134","Porites_evermani_scaffold_174:18754-19754",163,-24.91,2,21,411,434,21,"66.67%","85.71%","Peve_00010487",NA,NA,NA,NA,NA,NA,NA,NA
"228",228,"Cluster_11134","Porites_evermani_scaffold_1747:56371-57371",152,-20.08,2,13,1,13,11,"81.82%","100.00%","Peve_00010540",-0.0195622829453675,0.987545469442176,0.999448381576871,NA,NA,NA,NA,NA
"229",229,"Cluster_11134","Porites_evermani_scaffold_1758:61110-62110",160,-22.68,2,21,371,392,19,"68.42%","78.95%","Peve_00010636",NA,NA,NA,NA,NA,NA,NA,NA
"230",230,"Cluster_11134","Porites_evermani_scaffold_1764:82439-83439",151,-21.58,2,18,359,379,16,"75.00%","81.25%","Peve_00010712",NA,NA,NA,NA,NA,NA,NA,NA
"231",231,"Cluster_11134","Porites_evermani_scaffold_1787:20140-21140",156,-23.62,2,17,498,519,15,"80.00%","80.00%","Peve_00010971",-0.961527782458912,0.17716217880607,0.978262075707395,NA,NA,NA,NA,NA
"232",232,"Cluster_11134","Porites_evermani_scaffold_1788:1417-2417",158,-21.63,2,21,804,824,19,"68.42%","84.21%","Peve_00010975",0.957871775200856,0.185446348415189,0.978262075707395,"Q2I0E5","Protein inturned (Inturned planar cell polarity effector homolog) (Xint)","Xenopus laevis (African clawed frog)","ciliary basal body organization [GO:0032053]; cilium assembly [GO:0060271]; establishment of planar polarity [GO:0001736]; protein localization [GO:0008104]; regulation of smoothened signaling pathway [GO:0008589]; vesicle-mediated transport [GO:0016192]","GO:0001736; GO:0005737; GO:0005886; GO:0008104; GO:0008589; GO:0009986; GO:0016192; GO:0032053; GO:0036064; GO:0045177; GO:0060271"
"233",233,"Cluster_11134","Porites_evermani_scaffold_17:996019-997019",156,-24.05,2,21,93,114,19,"63.16%","78.95%","Peve_00010005",0.119755931653916,0.923577589818828,0.999448381576871,"Q9WYP5","Myo-inositol 2-dehydrogenase (EC 1.1.1.18)","Thermotoga maritima (strain ATCC 43589 / DSM 3109 / JCM 10099 / NBRC 100826 / MSB8)","inositol metabolic process [GO:0006020]; NADPH regeneration [GO:0006740]","GO:0000166; GO:0006020; GO:0006740; GO:0016491; GO:0050112"
"234",234,"Cluster_11134","Porites_evermani_scaffold_1813:82317-83317",169,-22.32,2,20,507,527,18,"83.33%","88.89%","Peve_00011311",NA,NA,NA,NA,NA,NA,NA,NA
"235",235,"Cluster_11134","Porites_evermani_scaffold_1819:40455-41455",159,-22.23,2,21,380,404,22,"68.18%","77.27%","Peve_00011363",-0.0195622829453675,0.987545469442176,0.999448381576871,"Q96CG8","Collagen triple helix repeat-containing protein 1","Homo sapiens (Human)","cell migration [GO:0016477]; cochlea morphogenesis [GO:0090103]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein binding [GO:0032092]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0001649; GO:0005109; GO:0005576; GO:0005581; GO:0005615; GO:0016477; GO:0016528; GO:0017147; GO:0032092; GO:0033687; GO:0033690; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0062023; GO:0090090; GO:0090103; GO:0090177"
"236",236,"Cluster_11134","Porites_evermani_scaffold_1820:72751-73751",170,-25.63,2,21,713,733,19,"78.95%","89.47%","Peve_00011414",0.463990258905882,0.692834523376265,0.978262075707395,NA,NA,NA,NA,NA
"237",237,"Cluster_11134","Porites_evermani_scaffold_1826:77005-78005",147,-22.97,2,17,472,496,18,"66.67%","77.78%","Peve_00011453",0.136929400880599,0.912553304141609,0.999448381576871,"D3ZGB1","Nuclear factor of activated T-cells 5 (NF-AT5) (T-cell transcription factor NFAT5)","Rattus norvegicus (Rat)","calcineurin-NFAT signaling cascade [GO:0033173]; cellular response to cytokine stimulus [GO:0071345]; cellular response to DNA damage stimulus [GO:0006974]; positive regulation of gene expression [GO:0010628]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R-loop processing [GO:0062176]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]; regulation of transcription by RNA polymerase II [GO:0006357]; response to osmotic stress [GO:0006970]","GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005667; GO:0005694; GO:0005737; GO:0005829; GO:0006357; GO:0006970; GO:0006974; GO:0010628; GO:0033173; GO:0045944; GO:0062176; GO:0070884; GO:0071345; GO:1901224; GO:1904996; GO:1990837"
"238",238,"Cluster_11134","Porites_evermani_scaffold_1827:91969-92969",158,-21.62,2,21,860,880,19,"73.68%","78.95%","Peve_00011460",NA,NA,NA,NA,NA,NA,NA,NA
"239",239,"Cluster_11134","Porites_evermani_scaffold_18:300258-301258",149,-20.18,2,15,468,490,14,"78.57%","85.71%","Peve_00011140",-0.0195622829453675,0.987545469442176,0.999448381576871,NA,NA,NA,NA,NA
"240",240,"Cluster_11134","Porites_evermani_scaffold_183:245019-246019",159,-22.64,2,18,777,797,16,"75.00%","93.75%","Peve_00011514",NA,NA,NA,NA,NA,NA,NA,NA
"241",241,"Cluster_11134","Porites_evermani_scaffold_1843:20454-21454",158,-21.42,2,20,920,943,20,"70.00%","80.00%","Peve_00011623",0.952726791884519,0.196529865616979,0.978262075707395,"P08761","Peptide methionine sulfoxide reductase (EC 1.8.4.11) (Ecdysone-induced protein 28/29 kDa) (Methionine-S-sulfoxide reductase) (Peptide-methionine (S)-S-oxide reductase)","Drosophila melanogaster (Fruit fly)","cellular response to oxidative stress [GO:0034599]; determination of adult lifespan [GO:0008340]; response to oxidative stress [GO:0006979]; sulfur amino acid metabolic process [GO:0000096]","GO:0000096; GO:0005737; GO:0006979; GO:0008113; GO:0008340; GO:0034599; GO:0036456"
"242",242,"Cluster_11134","Porites_evermani_scaffold_1849:42090-43090",155,-22.46,2,21,458,480,20,"65.00%","80.00%","Peve_00011681",0.875640822838247,0.320878802775509,0.978262075707395,"Q96CG8","Collagen triple helix repeat-containing protein 1","Homo sapiens (Human)","cell migration [GO:0016477]; cochlea morphogenesis [GO:0090103]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein binding [GO:0032092]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0001649; GO:0005109; GO:0005576; GO:0005581; GO:0005615; GO:0016477; GO:0016528; GO:0017147; GO:0032092; GO:0033687; GO:0033690; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0062023; GO:0090090; GO:0090103; GO:0090177"
"243",243,"Cluster_11134","Porites_evermani_scaffold_1891:66544-67544",152,-20.79,2,21,447,469,21,"66.67%","85.71%","Peve_00012154",NA,NA,NA,NA,NA,NA,NA,NA
"244",244,"Cluster_11134","Porites_evermani_scaffold_1894:53605-54605",155,-21.11,2,21,66,84,19,"73.68%","84.21%","Peve_00012174",0.730014599987225,0.479026466262462,0.978262075707395,NA,NA,NA,NA,NA
"245",245,"Cluster_11134","Porites_evermani_scaffold_191:357579-358579",145,-20.86,2,15,819,841,14,"78.57%","78.57%","Peve_00012413",-0.765004420924229,0.445473496428568,0.978262075707395,"A4Q9F6","Tubulin polyglutamylase TTLL13 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 13)","Mus musculus (Mouse)","microtubule cytoskeleton organization [GO:0000226]; protein polyglutamylation [GO:0018095]","GO:0000226; GO:0005524; GO:0005874; GO:0005929; GO:0015631; GO:0018095; GO:0046872; GO:0070740"
"246",246,"Cluster_11134","Porites_evermani_scaffold_1958:61059-62059",159,-23.61,2,21,856,878,20,"65.00%","85.00%","Peve_00012904",0.964406508550788,0.170363705291115,0.978262075707395,"P51892","DNA ligase 1 (EC 6.5.1.1) (DNA ligase I) (Polydeoxyribonucleotide synthase [ATP] 1)","Xenopus laevis (African clawed frog)","cell cycle [GO:0007049]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]","GO:0003677; GO:0003910; GO:0005524; GO:0005634; GO:0006260; GO:0006281; GO:0006310; GO:0007049; GO:0046872; GO:0051301; GO:0071897"
"247",247,"Cluster_11134","Porites_evermani_scaffold_1969:82561-83561",149,-24.13,2,19,133,158,21,"61.90%","76.19%","Peve_00013010",-0.184205256303833,0.882057770620754,0.999293081550531,NA,NA,NA,NA,NA
"248",248,"Cluster_11134","Porites_evermani_scaffold_1996:30959-31959",162,-23.25,2,19,299,320,17,"76.47%","82.35%","Peve_00013307",0.360300652067444,0.765348208440559,0.989724323411462,NA,NA,NA,NA,NA
"249",249,"Cluster_11134","Porites_evermani_scaffold_202:207375-208375",161,-25.73,2,21,217,238,20,"75.00%","85.00%","Peve_00013771",NA,NA,NA,NA,NA,NA,NA,NA
"250",250,"Cluster_11134","Porites_evermani_scaffold_2042:19868-20868",159,-27.49,2,21,829,853,22,"63.64%","81.82%","Peve_00013994",-0.0195622829453675,0.987545469442176,0.999448381576871,NA,NA,NA,NA,NA
"251",251,"Cluster_11134","Porites_evermani_scaffold_206:349608-350608",162,-21.82,2,21,779,802,21,"71.43%","85.71%","Peve_00014160",-0.856078539892879,0.345787863891157,0.978262075707395,NA,NA,NA,NA,NA
"252",252,"Cluster_11134","Porites_evermani_scaffold_20:671996-672996",150,-20.26,2,16,826,848,15,"73.33%","86.67%","Peve_00013486",-0.940890786411763,0.219981172543431,0.978262075707395,NA,NA,NA,NA,NA
"253",253,"Cluster_11134","Porites_evermani_scaffold_20:671996-672996",150,-20.6,2,16,853,875,15,"66.67%","93.33%","Peve_00013486",-0.940890786411763,0.219981172543431,0.978262075707395,NA,NA,NA,NA,NA
"254",254,"Cluster_11134","Porites_evermani_scaffold_20:671996-672996",150,-20.6,2,16,880,902,15,"66.67%","93.33%","Peve_00013486",-0.940890786411763,0.219981172543431,0.978262075707395,NA,NA,NA,NA,NA
"255",255,"Cluster_11134","Porites_evermani_scaffold_20:671996-672996",157,-23.51,2,19,745,767,18,"66.67%","88.89%","Peve_00013486",-0.940890786411763,0.219981172543431,0.978262075707395,NA,NA,NA,NA,NA
"256",256,"Cluster_11134","Porites_evermani_scaffold_2094:54415-55415",158,-22.64,2,16,632,655,16,"81.25%","87.50%","Peve_00014478",-0.18821891248446,0.879457109085915,0.998568352723695,"Q7RTR2","NLR family CARD domain-containing protein 3 (CARD15-like protein) (Caterpiller protein 16.2) (CLR16.2) (NACHT, LRR and CARD domains-containing protein 3) (Nucleotide-binding oligomerization domain protein 3)","Homo sapiens (Human)","I-kappaB kinase/NF-kappaB signaling [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of tumor necrosis factor production [GO:0032720]; T cell activation [GO:0042110]","GO:0005524; GO:0005737; GO:0005829; GO:0007249; GO:0014067; GO:0032088; GO:0032687; GO:0032688; GO:0032715; GO:0032720; GO:0034451; GO:0035556; GO:0036312; GO:0042110; GO:0043124; GO:0043231; GO:0045824; GO:0048147; GO:0048471; GO:0050680; GO:0050728; GO:1900016; GO:1900226; GO:1901223"
"257",257,"Cluster_11134","Porites_evermani_scaffold_209:59143-60143",165,-21.62,2,20,968,988,18,"77.78%","88.89%","Peve_00014437",NA,NA,NA,NA,NA,NA,NA,NA
"258",258,"Cluster_11134","Porites_evermani_scaffold_2096:73765-74765",162,-20.66,2,20,870,892,19,"68.42%","89.47%","Peve_00014488",-0.0195622829453675,0.987545469442176,0.999448381576871,NA,NA,NA,NA,NA
"259",259,"Cluster_11134","Porites_evermani_scaffold_2121:68946-69946",160,-20.3,2,17,607,628,15,"73.33%","93.33%","Peve_00014784",NA,NA,NA,NA,NA,NA,NA,NA
"260",260,"Cluster_11134","Porites_evermani_scaffold_213:339008-340008",167,-24.02,2,21,822,844,20,"75.00%","85.00%","Peve_00014880",NA,NA,NA,"Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"261",261,"Cluster_11134","Porites_evermani_scaffold_2137:28605-29605",158,-21.28,2,15,144,165,13,"76.92%","100.00%","Peve_00014941",0.0296689251798404,0.981109403521548,0.999448381576871,"P34147","Rho-related protein racA","Dictyostelium discoideum (Social amoeba)","actin filament organization [GO:0007015]; cortical cytoskeleton organization [GO:0030865]; establishment or maintenance of cell polarity [GO:0007163]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; response to bacterium [GO:0009617]; small GTPase mediated signal transduction [GO:0007264]","GO:0003924; GO:0005525; GO:0005856; GO:0005886; GO:0005938; GO:0007015; GO:0007163; GO:0007264; GO:0008360; GO:0009617; GO:0019901; GO:0030865; GO:0031410; GO:0032956; GO:0042995"
"262",262,"Cluster_11134","Porites_evermani_scaffold_2184:31525-32525",141,-20.43,2,10,830,851,8,"87.50%","100.00%","Peve_00015350",-0.856078539892879,0.345787863891157,0.978262075707395,"Q9NZJ4","Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29)","Homo sapiens (Human)","negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]","GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0042802; GO:0051087; GO:0070628; GO:0070852; GO:0090084"
"263",263,"Cluster_11134","Porites_evermani_scaffold_219:275037-276037",160,-22.74,2,17,57,78,15,"80.00%","86.67%","Peve_00015413",0.989961369225796,0.0902809960576005,0.978262075707395,NA,NA,NA,NA,NA
"264",264,"Cluster_11134","Porites_evermani_scaffold_2193:16023-17023",162,-21.62,2,20,677,699,19,"73.68%","84.21%","Peve_00015457",NA,NA,NA,NA,NA,NA,NA,NA
"265",265,"Cluster_11134","Porites_evermani_scaffold_2204:37447-38447",155,-25.09,2,21,219,241,20,"65.00%","80.00%","Peve_00015619",0.120384517025059,0.923174503769994,0.999448381576871,"P22182","Fibroblast growth factor receptor 1 (FGFR-1) (EC 2.7.10.1)","Xenopus laevis (African clawed frog)","positive regulation of cell population proliferation [GO:0008284]","GO:0005007; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0008284; GO:0031410"
"266",266,"Cluster_11134","Porites_evermani_scaffold_221:68171-69171",163,-21.31,2,21,719,741,20,"75.00%","80.00%","Peve_00015675",0.242996449146425,0.843739322670171,0.995934364227446,"E9Q555","E3 ubiquitin-protein ligase RNF213 (EC 2.3.2.27) (EC 3.6.4.-) (E3 ubiquitin-lipopolysaccharide ligase RNF213) (EC 2.3.2.-) (Mysterin) (RING finger protein 213)","Mus musculus (Mouse)","angiogenesis [GO:0001525]; defense response to bacterium [GO:0042742]; immune system process [GO:0002376]; lipid droplet formation [GO:0140042]; lipid ubiquitination [GO:0120323]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; regulation of lipid metabolic process [GO:0019216]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]; xenophagy [GO:0098792]","GO:0001525; GO:0002040; GO:0002376; GO:0004842; GO:0005524; GO:0005730; GO:0005737; GO:0005811; GO:0005829; GO:0006511; GO:0016567; GO:0016887; GO:0019216; GO:0042742; GO:0046872; GO:0051865; GO:0061630; GO:0070534; GO:0098792; GO:0120323; GO:0140042; GO:2000051"
"267",267,"Cluster_11134","Porites_evermani_scaffold_2233:71691-72691",155,-20.49,2,16,494,515,14,"71.43%","92.86%","Peve_00015906",-0.0195622829453675,0.987545469442176,0.999448381576871,"Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"268",268,"Cluster_11134","Porites_evermani_scaffold_226:110078-111078",163,-20.64,2,21,222,244,20,"70.00%","85.00%","Peve_00016134",0.909259649682691,0.273297330327616,0.978262075707395,"P43351","DNA repair protein RAD52 homolog","Homo sapiens (Human)","cellular response to oxidative stress [GO:0034599]; DNA double-strand break processing involved in repair via single-strand annealing [GO:0010792]; DNA recombinase assembly [GO:0000730]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via single-strand annealing [GO:0045002]; mitotic recombination [GO:0006312]; regulation of nucleotide-excision repair [GO:2000819]","GO:0000724; GO:0000730; GO:0003677; GO:0003697; GO:0005634; GO:0005654; GO:0006302; GO:0006310; GO:0006312; GO:0010792; GO:0032991; GO:0032993; GO:0034599; GO:0042802; GO:0045002; GO:2000819"
"269",269,"Cluster_11134","Porites_evermani_scaffold_227:23136-24136",168,-22.18,2,18,48,71,18,"83.33%","88.89%","Peve_00016213",0.547526013168813,0.631139420735211,0.978262075707395,"B3EWZ3","Coadhesin","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0016020"
"270",270,"Cluster_11134","Porites_evermani_scaffold_227:45876-46876",145,-20.71,2,21,477,499,21,"61.90%","76.19%","Peve_00016215",0.739387375062451,0.470230495058446,0.978262075707395,NA,NA,NA,NA,NA
"271",271,"Cluster_11134","Porites_evermani_scaffold_2299:34318-35318",165,-21.2,2,21,458,479,20,"75.00%","90.00%","Peve_00016472",NA,NA,NA,NA,NA,NA,NA,NA
"272",272,"Cluster_11134","Porites_evermani_scaffold_2358:1802-2802",148,-21.35,2,20,806,831,22,"68.18%","77.27%","Peve_00017065",0.865546451391182,0.333942649501752,0.978262075707395,"F4IJK6","Kinesin-like protein KIN-14R","Arabidopsis thaliana (Mouse-ear cress)","microtubule-based movement [GO:0007018]; microtubule-based process [GO:0007017]","GO:0003777; GO:0005524; GO:0005634; GO:0005874; GO:0007017; GO:0007018; GO:0008017; GO:0015630"
"273",273,"Cluster_11134","Porites_evermani_scaffold_236:39346-40346",159,-21.8,2,21,802,825,21,"66.67%","80.95%","Peve_00017077",-0.0195622829453675,0.987545469442176,0.999448381576871,NA,NA,NA,NA,NA
"274",274,"Cluster_11134","Porites_evermani_scaffold_2386:30208-31208",154,-27.16,2,21,347,371,22,"68.18%","77.27%","Peve_00017289",-0.0195622829453675,0.987545469442176,0.999448381576871,NA,NA,NA,NA,NA
"275",275,"Cluster_11134","Porites_evermani_scaffold_2389:42220-43220",153,-24.13,2,15,809,831,14,"78.57%","92.86%","Peve_00017309",0.328226867630311,0.787097901544521,0.995158456348467,NA,NA,NA,NA,NA
"276",276,"Cluster_11134","Porites_evermani_scaffold_2389:42220-43220",155,-23.37,2,16,709,730,14,"78.57%","85.71%","Peve_00017309",0.328226867630311,0.787097901544521,0.995158456348467,NA,NA,NA,NA,NA
"277",277,"Cluster_11134","Porites_evermani_scaffold_2420:72542-73542",167,-22.19,2,21,368,391,21,"76.19%","80.95%","Peve_00017701",-0.928800659002611,0.24168194592484,0.978262075707395,"Q7K4Y6","Sodium-dependent dopamine transporter (Protein fumin)","Drosophila melanogaster (Fruit fly)","adult locomotory behavior [GO:0008344]; circadian sleep/wake cycle [GO:0042745]; dopamine transport [GO:0015872]; dopamine uptake involved in synaptic transmission [GO:0051583]; norepinephrine transport [GO:0015874]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; response to odorant [GO:1990834]; sleep [GO:0030431]; sodium ion transmembrane transport [GO:0035725]","GO:0005330; GO:0005886; GO:0008344; GO:0015872; GO:0015874; GO:0019811; GO:0030431; GO:0032809; GO:0035725; GO:0042734; GO:0042745; GO:0043005; GO:0046872; GO:0051583; GO:0099509; GO:1990834"
"278",278,"Cluster_11134","Porites_evermani_scaffold_242:223682-224682",171,-20.86,2,21,52,75,21,"76.19%","85.71%","Peve_00017685",NA,NA,NA,NA,NA,NA,NA,NA
"279",279,"Cluster_11134","Porites_evermani_scaffold_2434:59911-60911",157,-22.95,2,21,431,452,20,"70.00%","85.00%","Peve_00017813",-0.856078539892879,0.345787863891158,0.978262075707395,NA,NA,NA,NA,NA
"280",280,"Cluster_11134","Porites_evermani_scaffold_244:227795-228795",161,-21.19,2,20,366,390,21,"76.19%","80.95%","Peve_00017856",0.198077915741174,0.873060186281043,0.997476741937264,"Q9UK96","F-box only protein 10","Homo sapiens (Human)","apoptotic process [GO:0006915]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0004842; GO:0005737; GO:0005829; GO:0006511; GO:0006915; GO:0016567; GO:0042981"
"281",281,"Cluster_11134","Porites_evermani_scaffold_2444:66336-67336",161,-21.73,2,19,314,336,18,"72.22%","88.89%","Peve_00017897",0.951626992260969,0.198821378338647,0.978262075707395,"Q64459","Cytochrome P450 3A11 (EC 1.14.14.1) (CYPIIIA11) (Cytochrome P-450IIIAM1) (Cytochrome P-450UT)","Mus musculus (Mouse)","alkaloid catabolic process [GO:0009822]; estrogen metabolic process [GO:0008210]; lipid hydroxylation [GO:0002933]; oxidative demethylation [GO:0070989]; response to bacterium [GO:0009617]; retinoic acid metabolic process [GO:0042573]; steroid metabolic process [GO:0008202]; xenobiotic catabolic process [GO:0042178]","GO:0002933; GO:0004497; GO:0005506; GO:0005789; GO:0008202; GO:0008210; GO:0008395; GO:0008401; GO:0009617; GO:0009822; GO:0016491; GO:0020037; GO:0032451; GO:0042178; GO:0042573; GO:0043231; GO:0050649; GO:0070330; GO:0070989; GO:0101020"
"282",282,"Cluster_11134","Porites_evermani_scaffold_2452:17654-18654",154,-20.67,2,17,506,526,15,"80.00%","86.67%","Peve_00017968",0.875640822838247,0.320878802775509,0.978262075707395,NA,NA,NA,NA,NA
"283",283,"Cluster_11134","Porites_evermani_scaffold_2469:22172-23172",160,-25.03,2,20,657,676,18,"72.22%","88.89%","Peve_00018075",0.148493140036226,0.905115423217854,0.999448381576871,NA,NA,NA,NA,NA
"284",284,"Cluster_11134","Porites_evermani_scaffold_25:210839-211839",149,-21.97,2,21,192,213,20,"60.00%","85.00%","Peve_00018409",0.0690958585859112,0.955977133463423,0.999448381576871,NA,NA,NA,NA,NA
"285",285,"Cluster_11134","Porites_evermani_scaffold_25:210839-211839",158,-21.46,2,15,213,234,13,"76.92%","100.00%","Peve_00018409",0.0690958585859112,0.955977133463423,0.999448381576871,NA,NA,NA,NA,NA
"286",286,"Cluster_11134","Porites_evermani_scaffold_2532:13277-14277",158,-20.79,2,21,643,663,19,"68.42%","84.21%","Peve_00018722",0.904188650026307,0.2809530156494,0.978262075707395,"P27792","Protein lyl-1 (Lymphoblastic leukemia-derived sequence 1)","Mus musculus (Mouse)","B cell differentiation [GO:0030183]; blood vessel maturation [GO:0001955]; definitive hemopoiesis [GO:0060216]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0001955; GO:0003677; GO:0005634; GO:0006355; GO:0006357; GO:0030183; GO:0045893; GO:0046983; GO:0060216"
"287",287,"Cluster_11134","Porites_evermani_scaffold_2:546775-547775",164,-27.19,2,21,443,464,19,"63.16%","89.47%","Peve_00013351",-0.45050973187836,0.702484527536259,0.978262075707395,"Q05586","Glutamate receptor ionotropic, NMDA 1 (GluN1) (Glutamate [NMDA] receptor subunit zeta-1) (N-methyl-D-aspartate receptor subunit NR1) (NMD-R1)","Homo sapiens (Human)","brain development [GO:0007420]; calcium ion homeostasis [GO:0055074]; calcium ion transmembrane import into cytosol [GO:0097553]; cation transmembrane transport [GO:0098655]; cation transport [GO:0006812]; chemical synaptic transmission [GO:0007268]; excitatory chemical synaptic transmission [GO:0098976]; excitatory postsynaptic potential [GO:0060079]; ionotropic glutamate receptor signaling pathway [GO:0035235]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of transcription by RNA polymerase II [GO:0045944]; propylene metabolic process [GO:0018964]; protein heterotetramerization [GO:0051290]; regulation of cation transmembrane transport [GO:1904062]; regulation of membrane potential [GO:0042391]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of synaptic plasticity [GO:0048167]; response to ethanol [GO:0045471]; response to glycine [GO:1905429]; visual learning [GO:0008542]","GO:0001540; GO:0004972; GO:0005509; GO:0005516; GO:0005737; GO:0005789; GO:0005886; GO:0006812; GO:0007268; GO:0007420; GO:0008021; GO:0008542; GO:0009986; GO:0010524; GO:0014069; GO:0015276; GO:0016594; GO:0016595; GO:0017146; GO:0018964; GO:0022849; GO:0030425; GO:0035235; GO:0038023; GO:0042165; GO:0042391; GO:0043005; GO:0043083; GO:0043195; GO:0043197; GO:0044877; GO:0045202; GO:0045211; GO:0045471; GO:0045944; GO:0048167; GO:0048168; GO:0051290; GO:0051968; GO:0055074; GO:0060076; GO:0060079; GO:0097060; GO:0097553; GO:0098655; GO:0098976; GO:1903428; GO:1904062; GO:1905429; GO:2000463; GO:2001056"
"288",288,"Cluster_11134","Porites_evermani_scaffold_2562:29767-30767",174,-23.11,2,19,929,950,17,"88.24%","88.24%","Peve_00018934",0.178298324655481,0.885881581163597,0.999448381576871,NA,NA,NA,NA,NA
"289",289,"Cluster_11134","Porites_evermani_scaffold_2562:64664-65664",152,-21.08,2,20,947,968,19,"68.42%","84.21%","Peve_00018932",-0.856078539892879,0.345787863891157,0.978262075707395,NA,NA,NA,NA,NA
"290",290,"Cluster_11134","Porites_evermani_scaffold_2583:43545-44545",147,-20.36,2,13,962,984,12,"83.33%","91.67%","Peve_00019087",0.192619969167122,0.876603086215306,0.997968735215,NA,NA,NA,NA,NA
"291",291,"Cluster_11134","Porites_evermani_scaffold_2591:23286-24286",166,-25.5,2,21,861,884,21,"76.19%","85.71%","Peve_00019155",NA,NA,NA,NA,NA,NA,NA,NA
"292",292,"Cluster_11134","Porites_evermani_scaffold_2601:4370-5370",151,-20.33,2,21,387,406,20,"70.00%","80.00%","Peve_00019303",NA,NA,NA,NA,NA,NA,NA,NA
"293",293,"Cluster_11134","Porites_evermani_scaffold_265:160923-161923",153,-20.01,2,20,28,51,20,"70.00%","80.00%","Peve_00019656",NA,NA,NA,NA,NA,NA,NA,NA
"294",294,"Cluster_11134","Porites_evermani_scaffold_265:94414-95414",156,-21.3,2,21,30,52,21,"71.43%","85.71%","Peve_00019642",NA,NA,NA,NA,NA,NA,NA,NA
"295",295,"Cluster_11134","Porites_evermani_scaffold_2678:14590-15590",155,-22.29,2,21,145,167,20,"65.00%","80.00%","Peve_00019867",-0.279409234317276,0.819722787330387,0.995934364227446,"Q9TU32","Protein ERGIC-53 (ER-Golgi intermediate compartment 53 kDa protein) (Lectin mannose-binding 1)","Chlorocebus aethiops (Green monkey) (Cercopithecus aethiops)","protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]","GO:0000139; GO:0005789; GO:0015031; GO:0016192; GO:0030246; GO:0033116; GO:0046872"
"296",296,"Cluster_11134","Porites_evermani_scaffold_2694:45930-46930",170,-27.07,2,21,466,486,19,"78.95%","89.47%","Peve_00020007",0.174702519935704,0.888207254703637,0.999448381576871,NA,NA,NA,NA,NA
"297",297,"Cluster_11134","Porites_evermani_scaffold_270:165489-166489",151,-21.71,2,21,896,918,20,"60.00%","80.00%","Peve_00020101",-0.427015012517145,0.719130289509475,0.981296309253059,"Q00422","GA-binding protein alpha chain (GABP subunit alpha)","Mus musculus (Mouse)","blastocyst formation [GO:0001825]; cell differentiation [GO:0030154]; cellular response to dopamine [GO:1903351]; in utero embryonic development [GO:0001701]; negative regulation of megakaryocyte differentiation [GO:0045653]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0001701; GO:0001825; GO:0003682; GO:0005634; GO:0005654; GO:0006357; GO:0010628; GO:0030154; GO:0045653; GO:0045944; GO:1903351; GO:1990837"
"298",298,"Cluster_11134","Porites_evermani_scaffold_2729:33699-34699",148,-23.71,2,13,498,519,11,"81.82%","90.91%","Peve_00020330",NA,NA,NA,"P35859","Insulin-like growth factor-binding protein complex acid labile subunit (ALS)","Rattus norvegicus (Rat)","aging [GO:0007568]; cell adhesion [GO:0007155]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to growth hormone stimulus [GO:0071378]; cellular response to interleukin-1 [GO:0071347]; response to nutrient levels [GO:0031667]","GO:0005520; GO:0005615; GO:0007155; GO:0007568; GO:0031012; GO:0031667; GO:0042567; GO:0071347; GO:0071364; GO:0071378; GO:0071549"
"299",299,"Cluster_11134","Porites_evermani_scaffold_2745:8266-9266",163,-20.67,2,21,930,952,20,"75.00%","80.00%","Peve_00020477",NA,NA,NA,NA,NA,NA,NA,NA
"300",300,"Cluster_11134","Porites_evermani_scaffold_274:66375-67375",149,-20.29,2,21,304,326,21,"66.67%","76.19%","Peve_00020412",NA,NA,NA,NA,NA,NA,NA,NA
"301",301,"Cluster_11134","Porites_evermani_scaffold_27:684889-685889",161,-21.21,2,21,81,102,20,"70.00%","90.00%","Peve_00020063",-0.0195622829453675,0.987545469442176,0.999448381576871,"Q460N5","Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (B aggressive lymphoma protein 2) (Poly [ADP-ribose] polymerase 14) (PARP-14)","Homo sapiens (Human)","innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of type II interferon-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein poly-ADP-ribosylation [GO:0070212]","GO:0003714; GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0010629; GO:0016020; GO:0016779; GO:0019899; GO:0042531; GO:0042532; GO:0045087; GO:0060336; GO:0070212; GO:0070403; GO:1902216; GO:1990404"
"302",302,"Cluster_11134","Porites_evermani_scaffold_2783:51699-52699",154,-20.37,2,16,93,115,15,"80.00%","86.67%","Peve_00020754",-0.0195622829453675,0.987545469442176,0.999448381576871,"Q7TN88","Polycystic kidney disease protein 1-like 2 (PC1-like 2 protein) (Polycystin-1L2)","Mus musculus (Mouse)","detection of mechanical stimulus [GO:0050982]","GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982"
"303",303,"Cluster_11134","Porites_evermani_scaffold_281:86460-87460",151,-25.35,2,21,962,984,20,"70.00%","70.00%","Peve_00020980",0.992312543473778,0.0789887185924662,0.978262075707395,"Q9IB89","Zinc finger protein ZIC 5 (XZic5) (XlZic5) (Zinc finger protein of the cerebellum 5)","Xenopus laevis (African clawed frog)","nervous system development [GO:0007399]; neural crest formation [GO:0014029]","GO:0003677; GO:0005634; GO:0007399; GO:0014029; GO:0046872"
"304",304,"Cluster_11134","Porites_evermani_scaffold_2845:53721-54721",157,-20.6,2,15,411,433,14,"85.71%","92.86%","Peve_00021253",-0.191856361803342,0.877098453211229,0.998071642611787,"Q8WWZ7","Cholesterol transporter ABCA5 (EC 7.6.2.-) (ATP-binding cassette sub-family A member 5)","Homo sapiens (Human)","cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; high-density lipoprotein particle remodeling [GO:0034375]; lipid transport [GO:0006869]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; positive regulation of reverse cholesterol transport [GO:1903064]; regulation of cholesterol efflux [GO:0010874]; reverse cholesterol transport [GO:0043691]","GO:0000139; GO:0005319; GO:0005524; GO:0005764; GO:0005765; GO:0005770; GO:0005794; GO:0005886; GO:0006869; GO:0008203; GO:0010745; GO:0010874; GO:0016887; GO:0031902; GO:0033344; GO:0034375; GO:0042626; GO:0042632; GO:0043231; GO:0043691; GO:0140359; GO:1903064"
"305",305,"Cluster_11134","Porites_evermani_scaffold_2857:52880-53880",164,-21.33,2,21,920,941,19,"68.42%","84.21%","Peve_00021326",-0.145122333471337,0.907284852094695,0.999448381576871,"Q7ZV82","60S ribosomal protein L27","Danio rerio (Zebrafish) (Brachydanio rerio)","erythrocyte differentiation [GO:0030218]; translation [GO:0006412]","GO:0003735; GO:0006412; GO:0015934; GO:0022625; GO:0030218; GO:0098556"
"306",306,"Cluster_11134","Porites_evermani_scaffold_2876:38795-39795",159,-20.4,2,17,125,147,16,"81.25%","87.50%","Peve_00021482",NA,NA,NA,NA,NA,NA,NA,NA
"307",307,"Cluster_11134","Porites_evermani_scaffold_2929:23042-24042",161,-23.57,2,21,529,550,20,"75.00%","85.00%","Peve_00021908",-0.856078539892879,0.345787863891157,0.978262075707395,NA,NA,NA,NA,NA
"308",308,"Cluster_11134","Porites_evermani_scaffold_29:407275-408275",156,-26.91,2,20,962,983,19,"73.68%","84.21%","Peve_00021705",0.693486541487571,0.512147372352533,0.978262075707395,NA,NA,NA,NA,NA
"309",309,"Cluster_11134","Porites_evermani_scaffold_2951:34530-35530",157,-20.92,2,20,396,419,20,"75.00%","80.00%","Peve_00022067",NA,NA,NA,"P07524","Tyrosinase (EC 1.14.18.1) (Monophenol monooxygenase)","Streptomyces antibioticus","melanin biosynthetic process [GO:0042438]","GO:0004503; GO:0042438; GO:0046872"
"310",310,"Cluster_11134","Porites_evermani_scaffold_2963:42607-43607",159,-21.04,2,21,918,941,21,"61.90%","85.71%","Peve_00022151",0.604464840025692,0.586773977824979,0.978262075707395,"Q6NWZ9","Cysteine dioxygenase type 1 (EC 1.13.11.20) (Cysteine dioxygenase type I) (CDO) (CDO-I)","Danio rerio (Zebrafish) (Brachydanio rerio)","L-cysteine catabolic process [GO:0019448]; taurine biosynthetic process [GO:0042412]","GO:0008198; GO:0008270; GO:0016151; GO:0016702; GO:0017172; GO:0019448; GO:0042412"
"311",311,"Cluster_11134","Porites_evermani_scaffold_2963:48245-49245",166,-20.08,2,21,938,958,19,"73.68%","89.47%","Peve_00022152",0.732129573700442,0.477053087945423,0.978262075707395,NA,NA,NA,NA,NA
"312",312,"Cluster_11134","Porites_evermani_scaffold_2970:14233-15233",171,-26.89,2,20,864,885,18,"83.33%","83.33%","Peve_00022203",0.197959188681102,0.873137297204563,0.997476741937264,NA,NA,NA,NA,NA
"313",313,"Cluster_11134","Porites_evermani_scaffold_298:269695-270695",154,-23.76,2,16,721,743,15,"73.33%","93.33%","Peve_00022258",0.151347657769716,0.903277406982962,0.999448381576871,NA,NA,NA,NA,NA
"314",314,"Cluster_11134","Porites_evermani_scaffold_2983:2775-3775",167,-20.01,2,21,355,377,20,"75.00%","85.00%","Peve_00022308",-0.074091514276005,0.952788614776624,0.999448381576871,"P07911","Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form]","Homo sapiens (Human)","antibacterial innate immune response [GO:0140367]; apoptotic signaling pathway [GO:0097190]; autophagy [GO:0006914]; cellular calcium ion homeostasis [GO:0006874]; cellular chloride ion homeostasis [GO:0030644]; cellular defense response [GO:0006968]; cellular phosphate ion homeostasis [GO:0030643]; cellular response to unfolded protein [GO:0034620]; cellular sodium ion homeostasis [GO:0006883]; chaperone-mediated protein folding [GO:0061077]; citric acid secretion [GO:0046720]; collecting duct development [GO:0072044]; connective tissue replacement [GO:0097709]; creatinine homeostasis [GO:0097273]; defense response to Gram-negative bacterium [GO:0050829]; endoplasmic reticulum organization [GO:0007029]; glomerular filtration [GO:0003094]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; inflammatory response [GO:0006954]; juxtaglomerular apparatus development [GO:0072051]; leukocyte cell-cell adhesion [GO:0007159]; lipid metabolic process [GO:0006629]; metanephric ascending thin limb development [GO:0072218]; metanephric distal convoluted tubule development [GO:0072221]; metanephric thick ascending limb development [GO:0072233]; micturition [GO:0060073]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell population proliferation [GO:0008285]; neutrophil migration [GO:1990266]; organ or tissue specific immune response [GO:0002251]; peptidyl-threonine phosphorylation [GO:0018107]; potassium ion homeostasis [GO:0055075]; protein localization to vacuole [GO:0072665]; protein transport into plasma membrane raft [GO:0044861]; regulation of blood pressure [GO:0008217]; regulation of protein transport [GO:0051223]; regulation of urine volume [GO:0035809]; renal sodium ion absorption [GO:0070294]; renal urate salt excretion [GO:0097744]; renal water homeostasis [GO:0003091]; response to lipopolysaccharide [GO:0032496]; response to water deprivation [GO:0009414]; response to xenobiotic stimulus [GO:0009410]; RNA splicing [GO:0008380]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; ubiquitin-dependent ERAD pathway [GO:0030433]; urate transport [GO:0015747]; urea transmembrane transport [GO:0071918]","GO:0000922; GO:0002251; GO:0003091; GO:0003094; GO:0005201; GO:0005509; GO:0005615; GO:0005783; GO:0005796; GO:0005929; GO:0006629; GO:0006874; GO:0006883; GO:0006914; GO:0006954; GO:0006968; GO:0007029; GO:0007157; GO:0007159; GO:0008217; GO:0008285; GO:0008380; GO:0009410; GO:0009414; GO:0009986; GO:0015747; GO:0016020; GO:0016323; GO:0016324; GO:0018107; GO:0019864; GO:0019898; GO:0030433; GO:0030643; GO:0030644; GO:0032496; GO:0033209; GO:0033555; GO:0034620; GO:0035809; GO:0044861; GO:0046720; GO:0050829; GO:0051223; GO:0055075; GO:0060073; GO:0060170; GO:0061077; GO:0070062; GO:0070294; GO:0071918; GO:0072044; GO:0072051; GO:0072218; GO:0072221; GO:0072233; GO:0072665; GO:0097190; GO:0097273; GO:0097709; GO:0097744; GO:0140367; GO:1990266"
"315",315,"Cluster_11134","Porites_evermani_scaffold_29:833225-834225",163,-22.54,2,21,459,482,21,"66.67%","85.71%","Peve_00021678",NA,NA,NA,NA,NA,NA,NA,NA
"316",316,"Cluster_11134","Porites_evermani_scaffold_299:169780-170780",164,-24.95,2,18,637,659,17,"82.35%","88.24%","Peve_00022344",-0.219573322879214,0.859066961792312,0.995954908009369,"Q08DJ7","Protein AAR2 homolog (AAR2 splicing factor homolog)","Bos taurus (Bovine)","spliceosomal tri-snRNP complex assembly [GO:0000244]","GO:0000244; GO:0005681"
"317",317,"Cluster_11134","Porites_evermani_scaffold_301:289701-290701",159,-20.61,2,21,714,739,23,"65.22%","78.26%","Peve_00022708",NA,NA,NA,NA,NA,NA,NA,NA
"318",318,"Cluster_11134","Porites_evermani_scaffold_3052:7917-8917",153,-22.87,2,20,458,482,21,"66.67%","80.95%","Peve_00022998",NA,NA,NA,NA,NA,NA,NA,NA
"319",319,"Cluster_11134","Porites_evermani_scaffold_3057:12688-13688",164,-25.68,2,21,182,203,19,"73.68%","78.95%","Peve_00023021",NA,NA,NA,NA,NA,NA,NA,NA
"320",320,"Cluster_11134","Porites_evermani_scaffold_3067:51726-52726",158,-20.34,2,20,912,934,19,"68.42%","84.21%","Peve_00023104",NA,NA,NA,"D3YXG0","Hemicentin-1 (Fibulin-6) (FIBL-6)","Mus musculus (Mouse)","actin filament reorganization [GO:0090527]; basement membrane organization [GO:0071711]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]","GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0051301; GO:0062023; GO:0071711; GO:0090527"
"321",321,"Cluster_11134","Porites_evermani_scaffold_309:265218-266218",152,-22.89,2,13,597,618,11,"81.82%","100.00%","Peve_00023278",0.746080218671205,0.463867048712587,0.978262075707395,"A6H751","Folylpolyglutamate synthase, mitochondrial (EC 6.3.2.17) (Folylpoly-gamma-glutamate synthetase) (FPGS) (Tetrahydrofolate synthase) (Tetrahydrofolylpolyglutamate synthase)","Bos taurus (Bovine)","folic acid-containing compound biosynthetic process [GO:0009396]; one-carbon metabolic process [GO:0006730]; tetrahydrofolylpolyglutamate biosynthetic process [GO:0046901]","GO:0004326; GO:0005524; GO:0005737; GO:0005739; GO:0005743; GO:0005759; GO:0005829; GO:0006730; GO:0009396; GO:0046872; GO:0046901"
"322",322,"Cluster_11134","Porites_evermani_scaffold_3106:36193-37193",163,-21.32,2,20,834,855,18,"66.67%","88.89%","Peve_00023440",NA,NA,NA,NA,NA,NA,NA,NA
"323",323,"Cluster_11134","Porites_evermani_scaffold_3196:11470-12470",161,-21.55,2,19,329,351,18,"72.22%","88.89%","Peve_00023967",0.976396191639558,0.138593905133486,0.978262075707395,"Q64459","Cytochrome P450 3A11 (EC 1.14.14.1) (CYPIIIA11) (Cytochrome P-450IIIAM1) (Cytochrome P-450UT)","Mus musculus (Mouse)","alkaloid catabolic process [GO:0009822]; estrogen metabolic process [GO:0008210]; lipid hydroxylation [GO:0002933]; oxidative demethylation [GO:0070989]; response to bacterium [GO:0009617]; retinoic acid metabolic process [GO:0042573]; steroid metabolic process [GO:0008202]; xenobiotic catabolic process [GO:0042178]","GO:0002933; GO:0004497; GO:0005506; GO:0005789; GO:0008202; GO:0008210; GO:0008395; GO:0008401; GO:0009617; GO:0009822; GO:0016491; GO:0020037; GO:0032451; GO:0042178; GO:0042573; GO:0043231; GO:0050649; GO:0070330; GO:0070989; GO:0101020"
"324",324,"Cluster_11134","Porites_evermani_scaffold_3204:12114-13114",155,-22.29,2,21,126,148,20,"65.00%","80.00%","Peve_00024058",-0.386365950598864,0.747460373812127,0.987985196425894,"Q9TU32","Protein ERGIC-53 (ER-Golgi intermediate compartment 53 kDa protein) (Lectin mannose-binding 1)","Chlorocebus aethiops (Green monkey) (Cercopithecus aethiops)","protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]","GO:0000139; GO:0005789; GO:0015031; GO:0016192; GO:0030246; GO:0033116; GO:0046872"
"325",325,"Cluster_11134","Porites_evermani_scaffold_324:127658-128658",159,-30.32,2,21,190,214,22,"68.18%","77.27%","Peve_00024253",0.229361525455577,0.852672388815788,0.995934364227446,"Q9JKL4","NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 3 (Protein 2P1)","Mus musculus (Mouse)","mitochondrial respiratory chain complex I assembly [GO:0032981]","GO:0005634; GO:0005739; GO:0005743; GO:0032981"
"326",326,"Cluster_11134","Porites_evermani_scaffold_3252:15842-16842",162,-25.8,2,20,79,101,19,"73.68%","84.21%","Peve_00024340",0.875640822838247,0.320878802775509,0.978262075707395,"A8TX70","Collagen alpha-5(VI) chain (Collagen alpha-1(XXIX) chain) (von Willebrand factor A domain-containing protein 4)","Homo sapiens (Human)","cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]","GO:0005576; GO:0005581; GO:0007155; GO:0030020; GO:0030198; GO:0062023"
"327",327,"Cluster_11134","Porites_evermani_scaffold_3256:30076-31076",153,-22.37,2,20,662,682,18,"72.22%","77.78%","Peve_00024355",NA,NA,NA,NA,NA,NA,NA,NA
"328",328,"Cluster_11134","Porites_evermani_scaffold_3279:44455-45455",153,-20.48,2,21,523,545,21,"71.43%","76.19%","Peve_00024470",-0.0195622829453675,0.987545469442176,0.999448381576871,"Q9WTS8","Ficolin-1 (Collagen/fibrinogen domain-containing protein 1) (Ficolin-A) (Ficolin-alpha) (M-ficolin)","Rattus norvegicus (Rat)","cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation [GO:0006956]; complement activation, lectin pathway [GO:0001867]; defense response to virus [GO:0051607]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of RNA biosynthetic process [GO:1902679]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654]","GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005581; GO:0005615; GO:0006508; GO:0006956; GO:0007186; GO:0030246; GO:0031232; GO:0032757; GO:0038187; GO:0043654; GO:0046597; GO:0046872; GO:0051607; GO:0062023; GO:0097367; GO:1902679; GO:1903028; GO:1905370"
"329",329,"Cluster_11134","Porites_evermani_scaffold_329:42703-43703",155,-21.51,2,21,115,137,20,"65.00%","80.00%","Peve_00024528",0.952219934832638,0.197589134064504,0.978262075707395,"P38487","Creatinase (EC 3.5.3.3) (Creatine amidinohydrolase)","Bacillus sp. (strain B-0618)","","GO:0016980"
"330",330,"Cluster_11134","Porites_evermani_scaffold_3302:12854-13854",163,-21.7,2,21,489,511,20,"70.00%","85.00%","Peve_00024686",0.776327097700777,0.434161030733354,0.978262075707395,NA,NA,NA,NA,NA
"331",331,"Cluster_11134","Porites_evermani_scaffold_3306:16670-17670",167,-20.11,2,16,283,304,14,"85.71%","100.00%","Peve_00024704",NA,NA,NA,NA,NA,NA,NA,NA
"332",332,"Cluster_11134","Porites_evermani_scaffold_3309:34476-35476",150,-20.3,2,19,65,86,17,"64.71%","76.47%","Peve_00024712",0.0946103480460876,0.939678962358244,0.999448381576871,"O00562","Membrane-associated phosphatidylinositol transfer protein 1 (Drosophila retinal degeneration B homolog) (Phosphatidylinositol transfer protein, membrane-associated 1) (PITPnm 1) (Pyk2 N-terminal domain-interacting receptor 2) (NIR-2)","Homo sapiens (Human)","brain development [GO:0007420]; lipid metabolic process [GO:0006629]; phosphatidylinositol biosynthetic process [GO:0006661]; phospholipid transport [GO:0015914]; phototransduction [GO:0007602]; protein transport [GO:0015031]","GO:0005509; GO:0005737; GO:0005789; GO:0005811; GO:0005829; GO:0006629; GO:0006661; GO:0007420; GO:0007602; GO:0008525; GO:0008526; GO:0015031; GO:0015914; GO:0016020; GO:0030496; GO:0030971; GO:0031210; GO:0032154; GO:0032580; GO:0035091; GO:0043231; GO:0044297; GO:0070300"
"333",333,"Cluster_11134","Porites_evermani_scaffold_3317:23522-24522",159,-21.01,2,21,341,366,23,"60.87%","82.61%","Peve_00024767",NA,NA,NA,"Q8N972","Zinc finger protein 709","Homo sapiens (Human)","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872"
"334",334,"Cluster_11134","Porites_evermani_scaffold_332:74883-75883",142,-20.27,2,21,604,624,19,"57.89%","73.68%","Peve_00024777",0.117522899533947,0.925009294079345,0.999448381576871,NA,NA,NA,NA,NA
"335",335,"Cluster_11134","Porites_evermani_scaffold_3358:0-149",150,-23.01,2,21,38,58,19,"63.16%","78.95%","Peve_00025023",0.0390123914429895,0.975157635978805,0.999448381576871,"Q3ZBN8","Mitochondrial import inner membrane translocase subunit TIM14 (DnaJ homolog subfamily C member 19)","Bos taurus (Bovine)","protein import into mitochondrial matrix [GO:0030150]; regulation of cardiolipin metabolic process [GO:1900208]","GO:0001405; GO:0001671; GO:0030150; GO:0098800; GO:0099617; GO:1900208"
"336",336,"Cluster_11134","Porites_evermani_scaffold_33:730484-731484",150,-22.84,2,20,509,532,20,"60.00%","80.00%","Peve_00024612",NA,NA,NA,NA,NA,NA,NA,NA
"337",337,"Cluster_11134","Porites_evermani_scaffold_3395:4134-5134",150,-20.6,2,16,168,190,15,"66.67%","93.33%","Peve_00025232",0.22768070933745,0.853771513738068,0.995934364227446,"Q9CR50","RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363)","Mus musculus (Mouse)","positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0002039; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042803; GO:0043231; GO:0051865; GO:0061630"
"338",338,"Cluster_11134","Porites_evermani_scaffold_3395:4134-5134",150,-20.6,2,16,231,253,15,"66.67%","93.33%","Peve_00025232",0.22768070933745,0.853771513738068,0.995934364227446,"Q9CR50","RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363)","Mus musculus (Mouse)","positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0002039; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042803; GO:0043231; GO:0051865; GO:0061630"
"339",339,"Cluster_11134","Porites_evermani_scaffold_3395:4134-5134",150,-20.6,2,16,339,361,15,"66.67%","93.33%","Peve_00025232",0.22768070933745,0.853771513738068,0.995934364227446,"Q9CR50","RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363)","Mus musculus (Mouse)","positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0002039; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042803; GO:0043231; GO:0051865; GO:0061630"
"340",340,"Cluster_11134","Porites_evermani_scaffold_3395:4134-5134",150,-20.6,2,16,546,568,15,"66.67%","93.33%","Peve_00025232",0.22768070933745,0.853771513738068,0.995934364227446,"Q9CR50","RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363)","Mus musculus (Mouse)","positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0002039; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042803; GO:0043231; GO:0051865; GO:0061630"
"341",341,"Cluster_11134","Porites_evermani_scaffold_3395:4134-5134",150,-20.6,2,16,564,586,15,"66.67%","93.33%","Peve_00025232",0.22768070933745,0.853771513738068,0.995934364227446,"Q9CR50","RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363)","Mus musculus (Mouse)","positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0002039; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042803; GO:0043231; GO:0051865; GO:0061630"
"342",342,"Cluster_11134","Porites_evermani_scaffold_3395:4134-5134",150,-20.6,2,16,672,694,15,"66.67%","93.33%","Peve_00025232",0.22768070933745,0.853771513738068,0.995934364227446,"Q9CR50","RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363)","Mus musculus (Mouse)","positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0002039; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042803; GO:0043231; GO:0051865; GO:0061630"
"343",343,"Cluster_11134","Porites_evermani_scaffold_3395:4134-5134",150,-20.6,2,16,726,748,15,"66.67%","93.33%","Peve_00025232",0.22768070933745,0.853771513738068,0.995934364227446,"Q9CR50","RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363)","Mus musculus (Mouse)","positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0002039; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042803; GO:0043231; GO:0051865; GO:0061630"
"344",344,"Cluster_11134","Porites_evermani_scaffold_3395:4134-5134",150,-20.6,2,16,744,766,15,"66.67%","93.33%","Peve_00025232",0.22768070933745,0.853771513738068,0.995934364227446,"Q9CR50","RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363)","Mus musculus (Mouse)","positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0002039; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042803; GO:0043231; GO:0051865; GO:0061630"
"345",345,"Cluster_11134","Porites_evermani_scaffold_3395:4134-5134",150,-20.6,2,16,762,784,15,"66.67%","93.33%","Peve_00025232",0.22768070933745,0.853771513738068,0.995934364227446,"Q9CR50","RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363)","Mus musculus (Mouse)","positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0002039; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042803; GO:0043231; GO:0051865; GO:0061630"
"346",346,"Cluster_11134","Porites_evermani_scaffold_3395:4134-5134",150,-21.29,2,16,213,235,15,"66.67%","93.33%","Peve_00025232",0.22768070933745,0.853771513738068,0.995934364227446,"Q9CR50","RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363)","Mus musculus (Mouse)","positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0002039; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042803; GO:0043231; GO:0051865; GO:0061630"
"347",347,"Cluster_11134","Porites_evermani_scaffold_3395:4134-5134",150,-22.12,2,16,528,550,15,"66.67%","93.33%","Peve_00025232",0.22768070933745,0.853771513738068,0.995934364227446,"Q9CR50","RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363)","Mus musculus (Mouse)","positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0002039; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042803; GO:0043231; GO:0051865; GO:0061630"
"348",348,"Cluster_11134","Porites_evermani_scaffold_3395:4134-5134",153,-22.92,2,15,974,996,14,"78.57%","92.86%","Peve_00025232",0.22768070933745,0.853771513738068,0.995934364227446,"Q9CR50","RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363)","Mus musculus (Mouse)","positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0002039; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042803; GO:0043231; GO:0051865; GO:0061630"
"349",349,"Cluster_11134","Porites_evermani_scaffold_3395:4134-5134",154,-20.71,2,16,483,505,15,"73.33%","93.33%","Peve_00025232",0.22768070933745,0.853771513738068,0.995934364227446,"Q9CR50","RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363)","Mus musculus (Mouse)","positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0002039; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042803; GO:0043231; GO:0051865; GO:0061630"
"350",350,"Cluster_11134","Porites_evermani_scaffold_3395:4134-5134",154,-20.71,2,16,654,676,15,"73.33%","93.33%","Peve_00025232",0.22768070933745,0.853771513738068,0.995934364227446,"Q9CR50","RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363)","Mus musculus (Mouse)","positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0002039; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042803; GO:0043231; GO:0051865; GO:0061630"
"351",351,"Cluster_11134","Porites_evermani_scaffold_3395:4134-5134",156,-22.74,2,19,148,172,20,"70.00%","85.00%","Peve_00025232",0.22768070933745,0.853771513738068,0.995934364227446,"Q9CR50","RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363)","Mus musculus (Mouse)","positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0002039; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042803; GO:0043231; GO:0051865; GO:0061630"
"352",352,"Cluster_11134","Porites_evermani_scaffold_3395:4134-5134",157,-21.52,2,20,512,532,18,"66.67%","88.89%","Peve_00025232",0.22768070933745,0.853771513738068,0.995934364227446,"Q9CR50","RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363)","Mus musculus (Mouse)","positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0002039; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042803; GO:0043231; GO:0051865; GO:0061630"
"353",353,"Cluster_11134","Porites_evermani_scaffold_3395:4134-5134",161,-24.19,2,20,320,343,20,"70.00%","90.00%","Peve_00025232",0.22768070933745,0.853771513738068,0.995934364227446,"Q9CR50","RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363)","Mus musculus (Mouse)","positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0002039; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042803; GO:0043231; GO:0051865; GO:0061630"
"354",354,"Cluster_11134","Porites_evermani_scaffold_3450:34230-35230",167,-25.1,2,21,603,625,20,"75.00%","85.00%","Peve_00025621",0.255727949797053,0.835369734804158,0.995934364227446,"P22607","Fibroblast growth factor receptor 3 (FGFR-3) (EC 2.7.10.1) (CD antigen CD333)","Homo sapiens (Human)","bone maturation [GO:0070977]; bone mineralization [GO:0030282]; bone morphogenesis [GO:0060349]; cell-cell signaling [GO:0007267]; chondrocyte differentiation [GO:0002062]; chondrocyte proliferation [GO:0035988]; endochondral bone growth [GO:0003416]; endochondral ossification [GO:0001958]; fibroblast growth factor receptor apoptotic signaling pathway [GO:1902178]; fibroblast growth factor receptor signaling pathway [GO:0008543]; MAPK cascade [GO:0000165]; negative regulation of developmental growth [GO:0048640]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein autophosphorylation [GO:0046777]; skeletal system development [GO:0001501]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]","GO:0000165; GO:0001501; GO:0001958; GO:0002062; GO:0003416; GO:0004713; GO:0004714; GO:0005007; GO:0005524; GO:0005576; GO:0005634; GO:0005783; GO:0005794; GO:0005886; GO:0007169; GO:0007267; GO:0008284; GO:0008543; GO:0009986; GO:0010518; GO:0017134; GO:0018108; GO:0030133; GO:0030282; GO:0033674; GO:0035988; GO:0042531; GO:0042802; GO:0043235; GO:0043410; GO:0043552; GO:0046777; GO:0048640; GO:0060349; GO:0070374; GO:0070977; GO:1902178"
"355",355,"Cluster_11134","Porites_evermani_scaffold_3471:22412-23412",161,-20.36,2,21,188,207,19,"73.68%","84.21%","Peve_00025747",-0.955335097297379,0.190988930011587,0.978262075707395,"P10731","Peptidyl-glycine alpha-amidating monooxygenase (PAM) [Includes: Peptidylglycine alpha-hydroxylating monooxygenase (PHM) (EC 1.14.17.3); Peptidyl-alpha-hydroxyglycine alpha-amidating lyase (EC 4.3.2.5) (Peptidylamidoglycolate lyase) (PAL)]","Bos taurus (Bovine)","fatty acid primary amide biosynthetic process [GO:0062112]; peptide amidation [GO:0001519]","GO:0001519; GO:0004504; GO:0004598; GO:0005507; GO:0005509; GO:0008270; GO:0030658; GO:0030667; GO:0031418; GO:0062112"
"356",356,"Cluster_11134","Porites_evermani_scaffold_3471:22412-23412",161,-20.36,2,21,512,531,19,"73.68%","84.21%","Peve_00025747",-0.955335097297379,0.190988930011587,0.978262075707395,"P10731","Peptidyl-glycine alpha-amidating monooxygenase (PAM) [Includes: Peptidylglycine alpha-hydroxylating monooxygenase (PHM) (EC 1.14.17.3); Peptidyl-alpha-hydroxyglycine alpha-amidating lyase (EC 4.3.2.5) (Peptidylamidoglycolate lyase) (PAL)]","Bos taurus (Bovine)","fatty acid primary amide biosynthetic process [GO:0062112]; peptide amidation [GO:0001519]","GO:0001519; GO:0004504; GO:0004598; GO:0005507; GO:0005509; GO:0008270; GO:0030658; GO:0030667; GO:0031418; GO:0062112"
"357",357,"Cluster_11134","Porites_evermani_scaffold_3488:35677-36023",155,-21.06,2,21,298,324,24,"62.50%","75.00%","Peve_00025833",0.246673519166925,0.841324943312628,0.995934364227446,"Q8N137","Centrobin (Centrosomal BRCA2-interacting protein) (LYST-interacting protein 8)","Homo sapiens (Human)","centriole replication [GO:0007099]; centrosome separation [GO:0051299]; mitotic cytokinetic process [GO:1902410]; regulation of cilium assembly [GO:1902017]","GO:0005737; GO:0005813; GO:0005814; GO:0007099; GO:0019904; GO:0051299; GO:1902017; GO:1902410"
"358",358,"Cluster_11134","Porites_evermani_scaffold_3488:35677-36023",155,-21.06,2,21,298,324,24,"62.50%","75.00%","Peve_00025834",0.875640822838247,0.320878802775509,0.978262075707395,NA,NA,NA,NA,NA
"359",359,"Cluster_11134","Porites_evermani_scaffold_3489:31975-32975",147,-21.44,2,12,574,595,10,"90.00%","90.00%","Peve_00025837",NA,NA,NA,NA,NA,NA,NA,NA
"360",360,"Cluster_11134","Porites_evermani_scaffold_349:118323-118550",158,-20.3,2,21,35,59,22,"68.18%","81.82%","Peve_00025845",0.35494900797352,0.768996452996658,0.990685875926175,"Q6YP21","Kynurenine--oxoglutarate transaminase 3 (EC 2.6.1.7) (Cysteine-S-conjugate beta-lyase 2) (EC 4.4.1.13) (Kynurenine aminotransferase 3) (Kynurenine aminotransferase III) (KATIII) (Kynurenine--glyoxylate transaminase) (EC 2.6.1.63) (Kynurenine--oxoglutarate transaminase III)","Homo sapiens (Human)","2-oxoglutarate metabolic process [GO:0006103]; amino acid metabolic process [GO:0006520]; biosynthetic process [GO:0009058]; kynurenine metabolic process [GO:0070189]; L-kynurenine catabolic process [GO:0097053]","GO:0003723; GO:0005737; GO:0005739; GO:0006103; GO:0006520; GO:0009058; GO:0016212; GO:0030170; GO:0042803; GO:0047315; GO:0047804; GO:0070189; GO:0097053"
"361",361,"Cluster_11134","Porites_evermani_scaffold_349:118323-118550",158,-20.3,2,21,35,59,22,"68.18%","81.82%","Peve_00025846",-0.531933571579438,0.642931202271302,0.978262075707395,"Q61165","Sodium/hydrogen exchanger 1 (Na(+)/H(+) exchanger 1) (NHE-1) (Solute carrier family 9 member 1)","Mus musculus (Mouse)","cardiac muscle cell contraction [GO:0086003]; cardiac muscle cell differentiation [GO:0055007]; cellular response to acidic pH [GO:0071468]; cellular response to antibiotic [GO:0071236]; cellular response to cold [GO:0070417]; cellular response to electrical stimulus [GO:0071257]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular sodium ion homeostasis [GO:0006883]; hyaluronan catabolic process [GO:0030214]; negative regulation of apoptotic process [GO:0043066]; neuron death [GO:0070997]; positive regulation of action potential [GO:0045760]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium:sodium antiporter activity [GO:1903281]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell growth [GO:0030307]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of the force of heart contraction [GO:0098735]; positive regulation of transcription by RNA polymerase II [GO:0045944]; potassium ion transmembrane transport [GO:0071805]; protein complex oligomerization [GO:0051259]; proton transmembrane transport [GO:1902600]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; regulation of sensory perception of pain [GO:0051930]; regulation of the force of heart contraction [GO:0002026]; regulation of the force of heart contraction by cardiac conduction [GO:0086092]; response to acidic pH [GO:0010447]; response to muscle stretch [GO:0035994]; response to organic cyclic compound [GO:0014070]; sodium ion export across plasma membrane [GO:0036376]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transport [GO:0006814]; stem cell differentiation [GO:0048863]","GO:0002026; GO:0005516; GO:0005654; GO:0005737; GO:0005739; GO:0005783; GO:0005789; GO:0005886; GO:0006814; GO:0006883; GO:0006885; GO:0008047; GO:0009986; GO:0010447; GO:0010613; GO:0010882; GO:0014070; GO:0014704; GO:0015385; GO:0015386; GO:0016020; GO:0016323; GO:0016324; GO:0030214; GO:0030307; GO:0030315; GO:0030346; GO:0032869; GO:0035794; GO:0035994; GO:0036376; GO:0042383; GO:0043065; GO:0043066; GO:0043167; GO:0045121; GO:0045760; GO:0045944; GO:0048306; GO:0048471; GO:0048863; GO:0051259; GO:0051453; GO:0051930; GO:0055007; GO:0070417; GO:0070886; GO:0070997; GO:0071236; GO:0071257; GO:0071456; GO:0071468; GO:0071805; GO:0071872; GO:0086003; GO:0086092; GO:0090533; GO:0098719; GO:0098735; GO:1902533; GO:1902600; GO:1903281; GO:1990351"
"362",362,"Cluster_11134","Porites_evermani_scaffold_3512:8055-9055",163,-23.06,2,21,791,814,21,"66.67%","85.71%","Peve_00026049",NA,NA,NA,"P16092","Fibroblast growth factor receptor 1 (FGFR-1) (bFGF-R-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (MFR) (Proto-oncogene c-Fgr) (CD antigen CD331)","Mus musculus (Mouse)","angiogenesis [GO:0001525]; auditory receptor cell development [GO:0060117]; blood vessel morphogenesis [GO:0048514]; brain development [GO:0007420]; branching involved in salivary gland morphogenesis [GO:0060445]; calcium ion homeostasis [GO:0055074]; cardiac muscle cell proliferation [GO:0060038]; cell maturation [GO:0048469]; cell population proliferation [GO:0008283]; cementum mineralization [GO:0071529]; central nervous system neuron development [GO:0021954]; chondrocyte differentiation [GO:0002062]; diphosphate metabolic process [GO:0071344]; ear development [GO:0043583]; embryonic limb morphogenesis [GO:0030326]; epithelial to mesenchymal transition [GO:0001837]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development [GO:0035607]; gene expression [GO:0010467]; generation of neurons [GO:0048699]; in utero embryonic development [GO:0001701]; inner ear morphogenesis [GO:0042472]; lung development [GO:0030324]; lung-associated mesenchyme development [GO:0060484]; mesenchymal cell differentiation [GO:0048762]; mesenchymal cell proliferation [GO:0010463]; midbrain development [GO:0030901]; middle ear morphogenesis [GO:0042474]; motogenic signaling involved in postnatal olfactory bulb interneuron migration [GO:0021837]; negative regulation of fibroblast growth factor production [GO:0090272]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron projection development [GO:0031175]; orbitofrontal cortex development [GO:0021769]; organ induction [GO:0001759]; outer ear morphogenesis [GO:0042473]; paraxial mesoderm development [GO:0048339]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000546]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of inflammatory response [GO:0050729]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway [GO:0090080]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic cell cycle DNA replication [GO:1903465]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]; positive regulation of parathyroid hormone secretion [GO:2000830]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein autophosphorylation [GO:0046777]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001239]; regulation of gene expression [GO:0010468]; regulation of lateral mesodermal cell fate specification [GO:0048378]; regulation of phosphate transport [GO:0010966]; regulation of phosphorus metabolic process [GO:0051174]; regulation of sensory perception of pain [GO:0051930]; regulation of stem cell proliferation [GO:0072091]; response to sodium phosphate [GO:1904383]; salivary gland morphogenesis [GO:0007435]; sensory perception of sound [GO:0007605]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827]; stem cell proliferation [GO:0072089]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureteric bud development [GO:0001657]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; ventricular zone neuroblast division [GO:0021847]; vitamin D3 metabolic process [GO:0070640]","GO:0000122; GO:0001525; GO:0001657; GO:0001701; GO:0001759; GO:0001837; GO:0002053; GO:0002062; GO:0004713; GO:0004714; GO:0005007; GO:0005102; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007169; GO:0007420; GO:0007435; GO:0007605; GO:0008201; GO:0008283; GO:0008284; GO:0008543; GO:0010463; GO:0010467; GO:0010468; GO:0010629; GO:0010763; GO:0010863; GO:0010966; GO:0010976; GO:0017134; GO:0018108; GO:0019827; GO:0021769; GO:0021837; GO:0021847; GO:0021954; GO:0030324; GO:0030326; GO:0030901; GO:0031175; GO:0031410; GO:0033674; GO:0035607; GO:0042127; GO:0042169; GO:0042472; GO:0042473; GO:0042474; GO:0042802; GO:0042803; GO:0043235; GO:0043406; GO:0043410; GO:0043536; GO:0043583; GO:0044877; GO:0045597; GO:0045666; GO:0045668; GO:0045787; GO:0045944; GO:0046777; GO:0048339; GO:0048378; GO:0048469; GO:0048471; GO:0048514; GO:0048699; GO:0048762; GO:0048863; GO:0050678; GO:0050729; GO:0050839; GO:0051174; GO:0051897; GO:0051930; GO:0055074; GO:0060038; GO:0060045; GO:0060117; GO:0060445; GO:0060484; GO:0060665; GO:0060979; GO:0070640; GO:0071344; GO:0071529; GO:0072089; GO:0072091; GO:0090080; GO:0090272; GO:0090722; GO:1903465; GO:1904383; GO:1905564; GO:2000491; GO:2000546; GO:2000648; GO:2000830; GO:2001239"
"363",363,"Cluster_11134","Porites_evermani_scaffold_3547:16977-17977",167,-23.83,2,21,414,438,22,"72.73%","81.82%","Peve_00026224",-0.0195622829453675,0.987545469442176,0.999448381576871,NA,NA,NA,NA,NA
"364",364,"Cluster_11134","Porites_evermani_scaffold_355:254880-255880",166,-21.13,2,19,1,21,17,"76.47%","88.24%","Peve_00026250",-0.0195622829453675,0.987545469442176,0.999448381576871,NA,NA,NA,NA,NA
"365",365,"Cluster_11134","Porites_evermani_scaffold_356:67200-68200",154,-20.05,2,20,454,476,19,"68.42%","78.95%","Peve_00026289",0.890522429547277,0.300678125368599,0.978262075707395,"Q9ULJ7","Ankyrin repeat domain-containing protein 50","Homo sapiens (Human)","endocytic recycling [GO:0032456]; protein transport [GO:0015031]","GO:0005768; GO:0015031; GO:0032456"
"366",366,"Cluster_11134","Porites_evermani_scaffold_3666:22339-23339",156,-23.99,2,21,978,999,19,"63.16%","78.95%","Peve_00026900",0.217734698018865,0.860266492637813,0.996279941338491,NA,NA,NA,NA,NA
"367",367,"Cluster_11134","Porites_evermani_scaffold_370:73455-74455",156,-23.44,2,21,605,624,19,"73.68%","84.21%","Peve_00027116",-0.92734539058898,0.244169777719288,0.978262075707395,"Q96KE9","BTB/POZ domain-containing protein 6 (Lens BTB domain protein)","Homo sapiens (Human)","neurogenesis [GO:0022008]","GO:0005829; GO:0022008"
"368",368,"Cluster_11134","Porites_evermani_scaffold_374:190948-191948",146,-23.45,2,20,384,404,19,"68.42%","84.21%","Peve_00027286",0.945758748026463,0.21064097093369,0.978262075707395,NA,NA,NA,NA,NA
"369",369,"Cluster_11134","Porites_evermani_scaffold_3743:27449-27911",159,-23.98,2,21,134,160,24,"66.67%","75.00%","Peve_00027304",-0.127204995133143,0.918798784893349,0.999448381576871,NA,NA,NA,NA,NA
"370",370,"Cluster_11134","Porites_evermani_scaffold_3743:27449-27911",159,-23.98,2,21,134,160,24,"66.67%","75.00%","Peve_00027305",0.0355777438798112,0.977345723868795,0.999448381576871,NA,NA,NA,NA,NA
"371",371,"Cluster_11134","Porites_evermani_scaffold_3761:36945-37945",160,-21.39,2,21,337,358,19,"57.89%","89.47%","Peve_00027406",NA,NA,NA,NA,NA,NA,NA,NA
"372",372,"Cluster_11134","Porites_evermani_scaffold_376:194847-195847",156,-20.1,2,20,45,66,19,"78.95%","78.95%","Peve_00027395",0.0526272513798697,0.966480966507188,0.999448381576871,"Q6DCL6","Divergent protein kinase domain 1A (Protein FAM69A)","Xenopus laevis (African clawed frog)","","GO:0005789"
"373",373,"Cluster_11134","Porites_evermani_scaffold_3763:12310-12358",163,-22.1,2,17,25,47,16,"81.25%","93.75%","Peve_00027410",-0.0195622829453675,0.987545469442176,0.999448381576871,"Q2QL79","Caveolin-1","Didelphis virginiana (North American opossum) (Didelphis marsupialis virginiana)","caveola assembly [GO:0070836]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; receptor internalization [GO:0031623]; T cell costimulation [GO:0031295]","GO:0000139; GO:0005768; GO:0005901; GO:0030512; GO:0031295; GO:0031623; GO:0045121; GO:0070836"
"374",374,"Cluster_11134","Porites_evermani_scaffold_3820:9053-10053",149,-20.73,2,21,121,140,19,"63.16%","78.95%","Peve_00027757",0.875640822838247,0.320878802775509,0.978262075707395,NA,NA,NA,NA,NA
"375",375,"Cluster_11134","Porites_evermani_scaffold_384:184290-185290",163,-22.03,2,21,379,402,21,"71.43%","80.95%","Peve_00027833",-0.903355729545265,0.282191888851015,0.978262075707395,"Q98TX3","Programmed cell death protein 4 (Protein I11/6)","Gallus gallus (Chicken)","negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of JUN kinase activity [GO:0043508]","GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0043508; GO:0045892"
"376",376,"Cluster_11134","Porites_evermani_scaffold_384:205933-206933",153,-20.42,2,14,739,760,12,"83.33%","91.67%","Peve_00027835",NA,NA,NA,"P40313","Chymotrypsin-like protease CTRL-1 (EC 3.4.21.-)","Homo sapiens (Human)","protein catabolic process [GO:0030163]; proteolysis [GO:0006508]","GO:0004252; GO:0005615; GO:0006508; GO:0008236; GO:0030163"
"377",377,"Cluster_11134","Porites_evermani_scaffold_387:130363-131363",156,-26.07,2,18,904,926,17,"76.47%","82.35%","Peve_00027991",0.853237201662848,0.349271881513399,0.978262075707395,NA,NA,NA,NA,NA
"378",378,"Cluster_11134","Porites_evermani_scaffold_388:247085-248085",162,-26.36,2,15,832,853,13,"92.31%","92.31%","Peve_00028046",0.953479577455228,0.194946356448946,0.978262075707395,"P28476","Gamma-aminobutyric acid receptor subunit rho-2 (GABA(A) receptor subunit rho-2) (GABA(C) receptor)","Homo sapiens (Human)","chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; visual perception [GO:0007601]","GO:0004890; GO:0005231; GO:0005254; GO:0005886; GO:0007165; GO:0007214; GO:0007268; GO:0007601; GO:0019904; GO:0030594; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0098982; GO:1902476; GO:1902711; GO:1904315"
"379",379,"Cluster_11134","Porites_evermani_scaffold_390:137513-138513",166,-20.36,2,19,699,720,17,"76.47%","88.24%","Peve_00028190",0.186763955627687,0.880400086011251,0.998841464232249,"Q9ESK9","RB1-inducible coiled-coil protein 1 (Coiled-coil-forming protein 1) (FAK family kinase-interacting protein of 200 kDa) (FIP200) (LaXp180)","Mus musculus (Mouse)","apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of peroxisome [GO:0030242]; cell cycle [GO:0007049]; extrinsic apoptotic signaling pathway [GO:0097191]; glycophagy [GO:0061723]; heart development [GO:0007507]; liver development [GO:0001889]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of autophagy [GO:0010508]; positive regulation of cell size [GO:0045793]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of protein lipidation [GO:1903059]; reticulophagy [GO:0061709]","GO:0000045; GO:0000407; GO:0000421; GO:0000422; GO:0001889; GO:0001934; GO:0005634; GO:0005737; GO:0005764; GO:0005829; GO:0006468; GO:0006914; GO:0006915; GO:0007049; GO:0007507; GO:0008285; GO:0010508; GO:0019898; GO:0019901; GO:0030242; GO:0031965; GO:0034045; GO:0034727; GO:0043066; GO:0045793; GO:0046330; GO:0046777; GO:0060090; GO:0061709; GO:0061723; GO:0097191; GO:1903059; GO:1990316; GO:2001237"
"380",380,"Cluster_11134","Porites_evermani_scaffold_3909:32651-33651",156,-23.23,2,21,873,894,19,"63.16%","78.95%","Peve_00028230",0.273354142395539,0.823733824655293,0.995934364227446,"Q5TJ56","Formin-F (Diaphanous-related formin dia1)","Dictyostelium discoideum (Social amoeba)","'de novo' actin filament nucleation [GO:0070060]; actin filament polymerization [GO:0030041]; positive phototaxis [GO:0046956]","GO:0005522; GO:0015629; GO:0030041; GO:0031143; GO:0031267; GO:0046956; GO:0051015; GO:0070060"
"381",381,"Cluster_11134","Porites_evermani_scaffold_3910:0-657",154,-20.02,2,17,606,626,15,"80.00%","86.67%","Peve_00028254",0.781233992882104,0.429181134574216,0.978262075707395,"Q5R7K0","Inactive hydroxysteroid dehydrogenase-like protein 1","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","","GO:0005739; GO:0045111"
"382",382,"Cluster_11134","Porites_evermani_scaffold_392:189243-190243",166,-30.64,2,21,507,530,21,"76.19%","85.71%","Peve_00028312",0.364259947717681,0.762643936415443,0.98901870188763,"A2VEC9","SCO-spondin (SCO-spondin pseudogene)","Homo sapiens (Human)","cell adhesion [GO:0007155]; positive regulation of immune system process [GO:0002684]; positive regulation of response to stimulus [GO:0048584]","GO:0002684; GO:0005615; GO:0007155; GO:0030414; GO:0031012; GO:0048584"
"383",383,"Cluster_11134","Porites_evermani_scaffold_4000:19200-20200",155,-20.67,2,20,817,838,18,"72.22%","72.22%","Peve_00028854",0.324537082244681,0.789582981968077,0.995781307784761,"Q28689","ATP-binding cassette sub-family C member 2 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (Canalicular multidrug resistance protein) (Canalicular multispecific organic anion transporter 1) (Epithelial basolateral chloride conductance regulator) (Multidrug resistance-associated protein 2)","Oryctolagus cuniculus (Rabbit)","bile acid and bile salt transport [GO:0015721]; leukotriene transport [GO:0071716]","GO:0005524; GO:0008559; GO:0015431; GO:0015721; GO:0016324; GO:0016887; GO:0042626; GO:0071716"
"384",384,"Cluster_11134","Porites_evermani_scaffold_401:136789-137745",163,-20.67,2,21,886,908,20,"75.00%","80.00%","Peve_00028891",-0.0195622829453675,0.987545469442176,0.999448381576871,NA,NA,NA,NA,NA
"385",385,"Cluster_11134","Porites_evermani_scaffold_402:58014-59014",167,-23.33,2,20,184,205,18,"77.78%","83.33%","Peve_00028946",0.924115278249661,0.249607528928893,0.978262075707395,"Q3UDE2","Tubulin--tyrosine ligase-like protein 12 (Inactive tubulin--tyrosine ligase-like protein 12)","Mus musculus (Mouse)","innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein modification process [GO:0036211]; regulation of mitotic cell cycle [GO:0007346]","GO:0005524; GO:0005634; GO:0005737; GO:0005815; GO:0005819; GO:0007346; GO:0015631; GO:0016881; GO:0030496; GO:0036211; GO:0045087; GO:0060339; GO:1990889"
"386",386,"Cluster_11134","Porites_evermani_scaffold_4090:23191-24191",167,-27.84,2,21,240,262,20,"75.00%","85.00%","Peve_00029308",-0.981878291136862,0.121381564719363,0.978262075707395,NA,NA,NA,NA,NA
"387",387,"Cluster_11134","Porites_evermani_scaffold_409:237458-238458",152,-21.46,2,21,661,682,19,"57.89%","78.95%","Peve_00029300",-0.856078539892879,0.345787863891157,0.978262075707395,NA,NA,NA,NA,NA
"388",388,"Cluster_11134","Porites_evermani_scaffold_4:1020712-1021712",155,-20.13,2,21,851,876,23,"60.87%","78.26%","Peve_00028740",-0.0195622829453675,0.987545469442176,0.999448381576871,NA,NA,NA,NA,NA
"389",389,"Cluster_11134","Porites_evermani_scaffold_413:205591-206591",152,-20.01,2,19,105,130,21,"71.43%","76.19%","Peve_00029532",0.958315107586041,0.184461082694543,0.978262075707395,"J9VHE9","UHRF1-like protein","Cryptococcus neoformans var. grubii serotype A (strain H99 / ATCC 208821 / CBS 10515 / FGSC 9487) (Filobasidiella neoformans var. grubii)","","GO:0005634; GO:0044729"
"390",390,"Cluster_11134","Porites_evermani_scaffold_423:204528-205528",146,-21.85,2,20,860,879,19,"68.42%","78.95%","Peve_00030039",-0.399545324081871,0.738336027000242,0.986692034976365,NA,NA,NA,NA,NA
"391",391,"Cluster_11134","Porites_evermani_scaffold_4262:16819-17819",161,-24.51,2,18,783,804,16,"68.75%","93.75%","Peve_00030199",-0.0195622829453675,0.987545469442176,0.999448381576871,NA,NA,NA,NA,NA
"392",392,"Cluster_11134","Porites_evermani_scaffold_429:209770-210770",157,-21.25,2,19,397,419,18,"77.78%","77.78%","Peve_00030344",0.772134749687028,0.438378039543063,0.978262075707395,NA,NA,NA,NA,NA
"393",393,"Cluster_11134","Porites_evermani_scaffold_430:48388-49388",155,-21.06,2,21,952,978,24,"62.50%","75.00%","Peve_00030459",-0.856078539892879,0.345787863891157,0.978262075707395,NA,NA,NA,NA,NA
"394",394,"Cluster_11134","Porites_evermani_scaffold_43:17657-18657",164,-21.63,2,21,777,798,19,"68.42%","84.21%","Peve_00030436",0.474724523340357,0.685095385692902,0.978262075707395,NA,NA,NA,NA,NA
"395",395,"Cluster_11134","Porites_evermani_scaffold_436:88880-89880",150,-21.07,2,21,14,37,21,"61.90%","80.95%","Peve_00030715",-0.0195622829453675,0.987545469442176,0.999448381576871,NA,NA,NA,NA,NA
"396",396,"Cluster_11134","Porites_evermani_scaffold_439:105852-106852",164,-21.24,2,21,549,570,19,"68.42%","84.21%","Peve_00030830",0.802945520300324,0.406529926584344,0.978262075707395,"P56695","Wolframin","Mus musculus (Mouse)","calcium ion homeostasis [GO:0055074]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; endoplasmic reticulum unfolded protein response [GO:0030968]; glucose homeostasis [GO:0042593]; kidney development [GO:0001822]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ATF6-mediated unfolded protein response [GO:1903892]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of programmed cell death [GO:0043069]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; nervous system process [GO:0050877]; olfactory behavior [GO:0042048]; pancreas development [GO:0031016]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of ERAD pathway [GO:1904294]; positive regulation of growth [GO:0045927]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein ubiquitination [GO:0031398]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; sensory perception of sound [GO:0007605]; ubiquitin-dependent ERAD pathway [GO:0030433]; visual perception [GO:0007601]","GO:0000122; GO:0001822; GO:0003091; GO:0005516; GO:0005783; GO:0005789; GO:0007601; GO:0007605; GO:0017148; GO:0030141; GO:0030425; GO:0030433; GO:0030672; GO:0030968; GO:0031016; GO:0031398; GO:0031625; GO:0032469; GO:0034976; GO:0042048; GO:0042593; GO:0043066; GO:0043069; GO:0043433; GO:0043524; GO:0045182; GO:0045927; GO:0048306; GO:0050821; GO:0050877; GO:0051117; GO:0051247; GO:0051726; GO:0051928; GO:0055074; GO:0070628; GO:0140297; GO:1902236; GO:1903573; GO:1903892; GO:1904294; GO:2000675"
"397",397,"Cluster_11134","Porites_evermani_scaffold_440:216864-217864",172,-27,2,21,512,533,19,"73.68%","89.47%","Peve_00030953",NA,NA,NA,NA,NA,NA,NA,NA
"398",398,"Cluster_11134","Porites_evermani_scaffold_44:382972-383368",163,-20.5,2,21,215,238,21,"76.19%","76.19%","Peve_00030880",NA,NA,NA,NA,NA,NA,NA,NA
"399",399,"Cluster_11134","Porites_evermani_scaffold_44:382972-383368",163,-20.5,2,21,215,238,21,"76.19%","76.19%","Peve_00030881",NA,NA,NA,NA,NA,NA,NA,NA
"400",400,"Cluster_11134","Porites_evermani_scaffold_4440:13567-14567",158,-22.32,2,21,679,702,21,"66.67%","85.71%","Peve_00031173",0.232936491094434,0.850333142892311,0.995934364227446,NA,NA,NA,NA,NA
"401",401,"Cluster_11134","Porites_evermani_scaffold_44:401597-402597",163,-20.5,2,21,817,840,21,"76.19%","76.19%","Peve_00030884",NA,NA,NA,NA,NA,NA,NA,NA
"402",402,"Cluster_11134","Porites_evermani_scaffold_453:89112-90112",147,-22.55,2,20,16,35,18,"66.67%","83.33%","Peve_00031590",-0.0195622829453675,0.987545469442176,0.999448381576871,NA,NA,NA,NA,NA
"403",403,"Cluster_11134","Porites_evermani_scaffold_4550:11696-12696",161,-21.9,2,20,768,791,20,"75.00%","85.00%","Peve_00031661",0.103397871320212,0.934057012069585,0.999448381576871,"Q08CH6","Ciliogenesis-associated TTC17-interacting protein","Danio rerio (Zebrafish) (Brachydanio rerio)","actin filament polymerization [GO:0030041]; cilium assembly [GO:0060271]; cilium organization [GO:0044782]; determination of heart left/right asymmetry [GO:0061371]","GO:0005634; GO:0005737; GO:0005886; GO:0015629; GO:0030041; GO:0044782; GO:0060271; GO:0061371"
"404",404,"Cluster_11134","Porites_evermani_scaffold_455:82086-83086",159,-26.63,2,21,182,205,21,"66.67%","80.95%","Peve_00031647",-0.443391755293418,0.707550115971626,0.978262075707395,"Q9TTW3","Tektin-1","Canis lupus familiaris (Dog) (Canis familiaris)","cilium movement involved in cell motility [GO:0060294]","GO:0005879; GO:0031514; GO:0060294"
"405",405,"Cluster_11134","Porites_evermani_scaffold_456:163755-164755",159,-23.24,2,21,136,160,22,"68.18%","77.27%","Peve_00031697",-0.879608283136693,0.315609478861735,0.978262075707395,"Q5JU00","Dynein regulatory complex subunit 5 (T-complex-associated testis-expressed protein 1) (Tcte-1)","Homo sapiens (Human)","flagellated sperm motility [GO:0030317]; microtubule-based movement [GO:0007018]","GO:0005737; GO:0005856; GO:0007018; GO:0030317; GO:0036126"
"406",406,"Cluster_11134","Porites_evermani_scaffold_4565:19739-20739",154,-21.46,2,15,52,73,13,"84.62%","84.62%","Peve_00031722",NA,NA,NA,NA,NA,NA,NA,NA
"407",407,"Cluster_11134","Porites_evermani_scaffold_4579:22207-23207",147,-20.02,2,12,862,883,10,"80.00%","100.00%","Peve_00031779",-0.667704981952989,0.53455355141832,0.978262075707395,"Q4V8X0","Transmembrane protein adipocyte-associated 1 homolog (Integral membrane protein GPR175)","Danio rerio (Zebrafish) (Brachydanio rerio)","G protein-coupled receptor signaling pathway [GO:0007186]","GO:0004930; GO:0005886; GO:0007186"
"408",408,"Cluster_11134","Porites_evermani_scaffold_460:65457-66457",144,-21.38,2,21,467,485,19,"57.89%","78.95%","Peve_00031914",-0.0849106929983997,0.945879006785082,0.999448381576871,"P54315","Inactive pancreatic lipase-related protein 1 (PL-RP1)","Homo sapiens (Human)","lipid metabolic process [GO:0006629]","GO:0004806; GO:0005509; GO:0005576; GO:0006629"
"409",409,"Cluster_11134","Porites_evermani_scaffold_4610:15520-16520",160,-20.8,2,21,325,344,19,"78.95%","84.21%","Peve_00031970",-0.0195622829453675,0.987545469442176,0.999448381576871,"Q6ZHE5","Putative D-cysteine desulfhydrase 1, mitochondrial (EC 4.4.1.15) (OsD-CDes1) (D-CDes1)","Oryza sativa subsp. japonica (Rice)","","GO:0005739; GO:0019148"
"410",410,"Cluster_11134","Porites_evermani_scaffold_468:210692-211692",155,-21.17,2,21,486,509,21,"61.90%","80.95%","Peve_00032232",0.364468077738008,0.762501655882117,0.988952353192554,"Q5R5R4","RUN and FYVE domain-containing protein 2","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","","GO:0005634; GO:0046872"
"411",411,"Cluster_11134","Porites_evermani_scaffold_4700:16607-17607",155,-23.93,2,21,791,814,21,"57.14%","85.71%","Peve_00032345",0.960134112063399,0.180363767583405,0.978262075707395,NA,NA,NA,NA,NA
"412",412,"Cluster_11134","Porites_evermani_scaffold_4723:17696-18696",160,-23.45,2,21,348,366,19,"73.68%","84.21%","Peve_00032453",NA,NA,NA,NA,NA,NA,NA,NA
"413",413,"Cluster_11134","Porites_evermani_scaffold_4727:6418-7418",158,-22.26,2,21,625,649,22,"68.18%","81.82%","Peve_00032460",0.207627605390901,0.866851555757195,0.996752931127433,"P14629","DNA excision repair protein ERCC-5 homolog (EC 3.1.-.-) (DNA repair protein complementing XP-G cells homolog) (Xeroderma pigmentosum group G-complementing protein homolog)","Xenopus laevis (African clawed frog)","nucleotide-excision repair [GO:0006289]","GO:0003697; GO:0004519; GO:0005634; GO:0005694; GO:0006289; GO:0046872"
"414",414,"Cluster_11134","Porites_evermani_scaffold_472:7807-8807",158,-23.21,2,21,976,1000,23,"69.57%","78.26%","Peve_00032425",NA,NA,NA,NA,NA,NA,NA,NA
"415",415,"Cluster_11134","Porites_evermani_scaffold_47:289465-290465",150,-20.11,2,16,475,497,15,"73.33%","86.67%","Peve_00032292",NA,NA,NA,NA,NA,NA,NA,NA
"416",416,"Cluster_11134","Porites_evermani_scaffold_4745:19449-20449",155,-24.92,2,21,961,985,22,"68.18%","72.73%","Peve_00032526",NA,NA,NA,NA,NA,NA,NA,NA
"417",417,"Cluster_11134","Porites_evermani_scaffold_476:2117-3117",146,-21.15,2,20,865,887,19,"57.89%","78.95%","Peve_00032567",-0.764749869996368,0.445725061394812,0.978262075707395,"Q9BYG0","Lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase (EC 2.4.1.206) (Lactotriaosylceramide synthase) (Lc(3)Cer synthase) (Lc3 synthase) (UDP-GlcNAc:beta-Gal beta-1,3-N-acetylglucosaminyltransferase 5) (BGnT-5) (Beta-1,3-Gn-T5) (Beta-1,3-N-acetylglucosaminyltransferase 5) (Beta3Gn-T5)","Homo sapiens (Human)","brain development [GO:0007420]; central nervous system development [GO:0007417]; glycolipid biosynthetic process [GO:0009247]; O-glycan processing [GO:0016266]; protein glycosylation [GO:0006486]","GO:0000139; GO:0006486; GO:0007417; GO:0007420; GO:0008457; GO:0008499; GO:0009247; GO:0016266; GO:0016757; GO:0047256"
"418",418,"Cluster_11134","Porites_evermani_scaffold_4784:17916-18916",155,-24.5,2,16,527,548,14,"78.57%","85.71%","Peve_00032667",-0.0195622829453675,0.987545469442176,0.999448381576871,NA,NA,NA,NA,NA
"419",419,"Cluster_11134","Porites_evermani_scaffold_480:136060-137060",168,-20.94,2,21,551,572,19,"73.68%","84.21%","Peve_00032770",NA,NA,NA,NA,NA,NA,NA,NA
"420",420,"Cluster_11134","Porites_evermani_scaffold_480:186642-187642",161,-21.22,2,20,450,470,18,"77.78%","83.33%","Peve_00032752",NA,NA,NA,NA,NA,NA,NA,NA
"421",421,"Cluster_11134","Porites_evermani_scaffold_488:150497-151497",152,-23.69,2,17,119,140,15,"73.33%","80.00%","Peve_00033043",-0.0195622829453675,0.987545469442176,0.999448381576871,NA,NA,NA,NA,NA
"422",422,"Cluster_11134","Porites_evermani_scaffold_488:161158-162158",153,-20.89,2,20,117,137,18,"61.11%","88.89%","Peve_00033044",-0.0439365315583989,0.972020128206925,0.999448381576871,NA,NA,NA,NA,NA
"423",423,"Cluster_11134","Porites_evermani_scaffold_4938:11143-12143",150,-22.39,2,21,876,896,19,"52.63%","89.47%","Peve_00033285",0.926821779465183,0.245059033588931,0.978262075707395,NA,NA,NA,NA,NA
"424",424,"Cluster_11134","Porites_evermani_scaffold_501:135391-136391",149,-24.81,2,21,121,140,19,"57.89%","84.21%","Peve_00033692",NA,NA,NA,NA,NA,NA,NA,NA
"425",425,"Cluster_11134","Porites_evermani_scaffold_503:13949-14949",160,-20.07,2,21,127,148,19,"68.42%","78.95%","Peve_00033748",NA,NA,NA,"Q8R3H9","Tetratricopeptide repeat protein 4 (TPR repeat protein 4)","Mus musculus (Mouse)","defense response to virus [GO:0051607]; innate immune response [GO:0045087]; protein folding [GO:0006457]","GO:0005634; GO:0005654; GO:0005737; GO:0006457; GO:0030544; GO:0045087; GO:0051607; GO:0051879"
"426",426,"Cluster_11134","Porites_evermani_scaffold_5181:1687-2687",145,-21.68,2,20,735,759,21,"66.67%","71.43%","Peve_00034317",-0.400735814797783,0.737509045834727,0.986490381466794,"O70251","Elongation factor 1-beta (EF-1-beta)","Mus musculus (Mouse)","response to ethanol [GO:0045471]; translational elongation [GO:0006414]","GO:0003746; GO:0005085; GO:0005737; GO:0005783; GO:0005829; GO:0005853; GO:0006414; GO:0045471"
"427",427,"Cluster_11134","Porites_evermani_scaffold_5221:10743-11743",152,-22.34,2,14,171,193,13,"84.62%","92.31%","Peve_00034467",-0.799434121136838,0.410265568568552,0.978262075707395,"Q4A3R3","Deleted in malignant brain tumors 1 protein (Hensin)","Sus scrofa (Pig)","cell differentiation [GO:0030154]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; protein transport [GO:0015031]; zymogen activation [GO:0031638]","GO:0004252; GO:0005044; GO:0005576; GO:0005886; GO:0015031; GO:0019898; GO:0030154; GO:0030658; GO:0031638; GO:0035375; GO:0042589; GO:0050829; GO:0050830"
"428",428,"Cluster_11134","Porites_evermani_scaffold_5257:11399-12399",144,-23.13,2,19,55,80,21,"61.90%","76.19%","Peve_00034577",-0.0195622829453675,0.987545469442176,0.999448381576871,"Q8IS64","Endothelin-converting enzyme homolog (ECE) (EC 3.4.24.-)","Locusta migratoria (Migratory locust)","proteolysis [GO:0006508]","GO:0004175; GO:0004222; GO:0005886; GO:0006508; GO:0008270"
"429",429,"Cluster_11134","Porites_evermani_scaffold_5313:9880-10880",148,-20.4,2,18,585,607,17,"70.59%","76.47%","Peve_00034815",NA,NA,NA,NA,NA,NA,NA,NA
"430",430,"Cluster_11134","Porites_evermani_scaffold_532:168627-169627",180,-24.63,2,21,148,169,19,"84.21%","89.47%","Peve_00034837",NA,NA,NA,NA,NA,NA,NA,NA
"431",431,"Cluster_11134","Porites_evermani_scaffold_538:117108-118108",147,-20.18,2,16,948,969,14,"71.43%","78.57%","Peve_00035050",NA,NA,NA,NA,NA,NA,NA,NA
"432",432,"Cluster_11134","Porites_evermani_scaffold_541:62270-63270",168,-20.65,2,17,125,146,15,"80.00%","100.00%","Peve_00035177",-0.549776152861088,0.629426028038518,0.978262075707395,"Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"433",433,"Cluster_11134","Porites_evermani_scaffold_5426:7866-8866",166,-20.57,2,21,3,23,19,"78.95%","84.21%","Peve_00035225",-0.861131404675316,0.339512719283412,0.978262075707395,NA,NA,NA,NA,NA
"434",434,"Cluster_11134","Porites_evermani_scaffold_547:143844-144844",155,-24.42,2,16,954,975,14,"71.43%","92.86%","Peve_00035381",NA,NA,NA,NA,NA,NA,NA,NA
"435",435,"Cluster_11134","Porites_evermani_scaffold_548:130544-131544",164,-24.65,2,19,928,948,17,"82.35%","88.24%","Peve_00035401",NA,NA,NA,NA,NA,NA,NA,NA
"436",436,"Cluster_11134","Porites_evermani_scaffold_5:49015-50015",162,-23.83,2,21,449,469,19,"73.68%","84.21%","Peve_00033597",-0.470191761956589,0.688369500700202,0.978262075707395,"Q90610","Neogenin","Gallus gallus (Chicken)","cell adhesion [GO:0007155]","GO:0005886; GO:0007155"
"437",437,"Cluster_11134","Porites_evermani_scaffold_562:227740-228740",162,-20.96,2,19,60,81,17,"76.47%","82.35%","Peve_00035868",-0.0195622829453675,0.987545469442176,0.999448381576871,NA,NA,NA,NA,NA
"438",438,"Cluster_11134","Porites_evermani_scaffold_570:90094-91094",144,-20.49,2,21,343,364,19,"57.89%","68.42%","Peve_00036134",-0.0195622829453675,0.987545469442176,0.999448381576871,NA,NA,NA,NA,NA
"439",439,"Cluster_11134","Porites_evermani_scaffold_583:179698-180698",149,-20.66,2,21,659,684,24,"62.50%","75.00%","Peve_00036494",-0.264164440510842,0.829807670701482,0.995934364227446,"Q13217","DnaJ homolog subfamily C member 3 (Endoplasmic reticulum DNA J domain-containing protein 6) (ER-resident protein ERdj6) (ERdj6) (Interferon-induced, double-stranded RNA-activated protein kinase inhibitor) (Protein kinase inhibitor of 58 kDa) (Protein kinase inhibitor p58)","Homo sapiens (Human)","cellular response to cold [GO:0070417]; defense response to virus [GO:0051607]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; positive regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036494]; protein folding in endoplasmic reticulum [GO:0034975]; proteolysis involved in protein catabolic process [GO:0051603]; response to unfolded protein [GO:0006986]","GO:0004860; GO:0005576; GO:0005737; GO:0005783; GO:0005788; GO:0005790; GO:0005829; GO:0006986; GO:0016020; GO:0019901; GO:0034975; GO:0035578; GO:0036494; GO:0043066; GO:0051087; GO:0051603; GO:0051607; GO:0051787; GO:0070062; GO:0070417; GO:1903561; GO:1903912"
"440",440,"Cluster_11134","Porites_evermani_scaffold_58:63957-64957",150,-20.08,2,21,583,603,19,"57.89%","84.21%","Peve_00036358",NA,NA,NA,NA,NA,NA,NA,NA
"441",441,"Cluster_11134","Porites_evermani_scaffold_589:145090-146090",163,-21.97,2,17,380,402,16,"81.25%","93.75%","Peve_00036631",-0.0195622829453675,0.987545469442176,0.999448381576871,NA,NA,NA,NA,NA
"442",442,"Cluster_11134","Porites_evermani_scaffold_59:166926-167926",150,-20.92,2,20,802,827,22,"59.09%","77.27%","Peve_00036704",NA,NA,NA,NA,NA,NA,NA,NA
"443",443,"Cluster_11134","Porites_evermani_scaffold_598:56245-57245",157,-23.15,2,16,509,529,14,"85.71%","92.86%","Peve_00036890",NA,NA,NA,"P57756","Ficolin-2 (Collagen/fibrinogen domain-containing protein 2) (Ficolin-B) (Ficolin-beta) (L-ficolin)","Rattus norvegicus (Rat)","cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of opsonization [GO:1903028]; protein localization to cell surface [GO:0034394]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654]","GO:0001664; GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005581; GO:0005615; GO:0006508; GO:0007186; GO:0030246; GO:0031232; GO:0032757; GO:0033691; GO:0034394; GO:0038187; GO:0043654; GO:0046597; GO:0046872; GO:0062023; GO:0097367; GO:1903028; GO:1905370"
"444",444,"Cluster_11134","Porites_evermani_scaffold_601:140953-141953",151,-20.7,2,18,220,243,18,"72.22%","83.33%","Peve_00037125",NA,NA,NA,"Q8R4P9","ATP-binding cassette sub-family C member 10 (EC 7.6.2.2) (EC 7.6.2.3) (Multidrug resistance-associated protein 7)","Mus musculus (Mouse)","leukotriene metabolic process [GO:0006691]; leukotriene transport [GO:0071716]; lipid transport [GO:0006869]; transmembrane transport [GO:0055085]","GO:0005524; GO:0005886; GO:0006691; GO:0006869; GO:0008559; GO:0009925; GO:0015431; GO:0016020; GO:0016323; GO:0016887; GO:0042626; GO:0055085; GO:0071716; GO:0140359"
"445",445,"Cluster_11134","Porites_evermani_scaffold_60:390817-391817",153,-20.44,2,19,339,361,18,"61.11%","88.89%","Peve_00037063",-0.0195622829453675,0.987545469442176,0.999448381576871,"Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"446",446,"Cluster_11134","Porites_evermani_scaffold_6077:6936-7936",157,-20.32,2,21,63,82,19,"68.42%","84.21%","Peve_00037270",NA,NA,NA,NA,NA,NA,NA,NA
"447",447,"Cluster_11134","Porites_evermani_scaffold_6109:4756-5756",156,-20.7,2,21,260,281,19,"52.63%","89.47%","Peve_00037372",NA,NA,NA,NA,NA,NA,NA,NA
"448",448,"Cluster_11134","Porites_evermani_scaffold_615:102325-103325",162,-21.79,2,16,870,892,15,"86.67%","93.33%","Peve_00037454",NA,NA,NA,NA,NA,NA,NA,NA
"449",449,"Cluster_11134","Porites_evermani_scaffold_615:102345-103345",162,-21.79,2,16,850,872,15,"86.67%","93.33%","Peve_00037456",-0.810001202053613,0.398932790436367,0.978262075707395,NA,NA,NA,NA,NA
"450",450,"Cluster_11134","Porites_evermani_scaffold_617:153357-154357",164,-23.64,2,21,357,378,19,"73.68%","78.95%","Peve_00037523",NA,NA,NA,NA,NA,NA,NA,NA
"451",451,"Cluster_11134","Porites_evermani_scaffold_619:19296-20296",155,-20.6,2,21,974,997,21,"66.67%","76.19%","Peve_00037573",0.875640822838247,0.320878802775509,0.978262075707395,"P12394","Steroid 17-alpha-hydroxylase/17,20 lyase (EC 1.14.14.19) (EC 1.14.14.32) (17-alpha-hydroxyprogesterone aldolase) (CYPXVII) (Cytochrome P450 17A1) (Cytochrome P450-C17) (Cytochrome P450c17)","Gallus gallus (Chicken)","hormone biosynthetic process [GO:0042446]; progesterone metabolic process [GO:0042448]; steroid biosynthetic process [GO:0006694]; steroid metabolic process [GO:0008202]","GO:0004508; GO:0005506; GO:0006694; GO:0008202; GO:0016020; GO:0020037; GO:0042446; GO:0042448; GO:0047442"
"452",452,"Cluster_11134","Porites_evermani_scaffold_620:133682-134682",161,-21.62,2,21,977,998,20,"70.00%","90.00%","Peve_00037644",NA,NA,NA,NA,NA,NA,NA,NA
"453",453,"Cluster_11134","Porites_evermani_scaffold_622:201581-202581",149,-23.79,2,15,550,572,14,"71.43%","92.86%","Peve_00037686",NA,NA,NA,NA,NA,NA,NA,NA
"454",454,"Cluster_11134","Porites_evermani_scaffold_633:190228-191228",156,-21.54,2,17,86,107,15,"66.67%","93.33%","Peve_00037959",NA,NA,NA,NA,NA,NA,NA,NA
"455",455,"Cluster_11134","Porites_evermani_scaffold_64:434880-435880",156,-21.42,2,21,758,779,19,"57.89%","84.21%","Peve_00038099",-0.794845836527535,0.415103367289511,0.978262075707395,NA,NA,NA,NA,NA
"456",456,"Cluster_11134","Porites_evermani_scaffold_6455:4452-5452",157,-20.23,2,21,871,895,22,"72.73%","81.82%","Peve_00038294",NA,NA,NA,NA,NA,NA,NA,NA
"457",457,"Cluster_11134","Porites_evermani_scaffold_646:165124-166124",149,-20.09,2,21,808,829,20,"65.00%","80.00%","Peve_00038306",0.828435692032955,0.378462450063056,0.978262075707395,"Q3BJS1","Forkhead box protein N4","Xenopus laevis (African clawed frog)","amacrine cell differentiation [GO:0035881]; atrioventricular canal development [GO:0036302]; heart looping [GO:0001947]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of heart contraction [GO:0008016]; retina layer formation [GO:0010842]; ventral spinal cord interneuron fate commitment [GO:0060579]","GO:0000981; GO:0000987; GO:0001947; GO:0003682; GO:0005634; GO:0006355; GO:0008016; GO:0010842; GO:0035881; GO:0036302; GO:0043565; GO:0045944; GO:0060579"
"458",458,"Cluster_11134","Porites_evermani_scaffold_648:100956-101956",157,-21.68,2,15,633,655,14,"85.71%","92.86%","Peve_00038328",-0.944420867522372,0.213247178786566,0.978262075707395,"M0R2J8","Doublecortin domain-containing protein 1 (Doublecortin domain-containing 5 protein)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; intracellular signal transduction [GO:0035556]; regulation of mitotic cytokinesis [GO:1902412]","GO:0005737; GO:0005874; GO:0007049; GO:0008017; GO:0030246; GO:0030496; GO:0035556; GO:0051301; GO:0072686; GO:0090543; GO:1902412"
"459",459,"Cluster_11134","Porites_evermani_scaffold_650:111958-112958",156,-24.94,2,17,300,321,15,"73.33%","86.67%","Peve_00038407",0.561962874953815,0.620092748799537,0.978262075707395,NA,NA,NA,NA,NA
"460",460,"Cluster_11134","Porites_evermani_scaffold_655:89134-90134",164,-22.67,2,20,598,622,21,"80.95%","85.71%","Peve_00038503",NA,NA,NA,NA,NA,NA,NA,NA
"461",461,"Cluster_11134","Porites_evermani_scaffold_672:63103-64103",162,-20.08,2,20,347,369,19,"68.42%","89.47%","Peve_00038887",NA,NA,NA,NA,NA,NA,NA,NA
"462",462,"Cluster_11134","Porites_evermani_scaffold_675:171708-172708",164,-23.44,2,21,966,987,19,"73.68%","78.95%","Peve_00038941",0.753952461383747,0.456289753835957,0.978262075707395,NA,NA,NA,NA,NA
"463",463,"Cluster_11134","Porites_evermani_scaffold_675:175187-176187",164,-23.44,2,21,968,989,19,"73.68%","78.95%","Peve_00038942",0.200223200149857,0.871666539226437,0.997476741937264,NA,NA,NA,NA,NA
"464",464,"Cluster_11134","Porites_evermani_scaffold_6770:2612-3612",155,-20.27,2,21,174,196,20,"55.00%","90.00%","Peve_00038983",-0.752931767936669,0.457278012203027,0.978262075707395,NA,NA,NA,NA,NA
"465",465,"Cluster_11134","Porites_evermani_scaffold_698:73711-74711",149,-21.48,2,18,149,170,16,"62.50%","81.25%","Peve_00039487",-0.163800323504639,0.895249445366594,0.999448381576871,NA,NA,NA,NA,NA
"466",466,"Cluster_11134","Porites_evermani_scaffold_71:286409-287409",148,-20.4,2,18,907,929,17,"70.59%","76.47%","Peve_00039795",-0.0195622829453675,0.987545469442176,0.999448381576871,NA,NA,NA,NA,NA
"467",467,"Cluster_11134","Porites_evermani_scaffold_7188:0-782",157,-22.2,2,19,689,714,21,"71.43%","76.19%","Peve_00039983",NA,NA,NA,NA,NA,NA,NA,NA
"468",468,"Cluster_11134","Porites_evermani_scaffold_72:597934-598934",155,-20.66,2,20,86,107,18,"72.22%","72.22%","Peve_00040015",0.496559827154255,0.669192668903731,0.978262075707395,NA,NA,NA,NA,NA
"469",469,"Cluster_11134","Porites_evermani_scaffold_73:439170-440170",167,-21.6,2,20,515,536,18,"72.22%","88.89%","Peve_00040266",NA,NA,NA,NA,NA,NA,NA,NA
"470",470,"Cluster_11134","Porites_evermani_scaffold_742:89364-90364",155,-20.87,2,21,941,963,20,"65.00%","80.00%","Peve_00040558",-0.200445895043621,0.8715218337181,0.997476741937264,"O00338","Sulfotransferase 1C2 (ST1C2) (EC 2.8.2.1) (Sulfotransferase 1C1) (SULT1C#1) (humSULTC2)","Homo sapiens (Human)","amine metabolic process [GO:0009308]; sulfation [GO:0051923]","GO:0004062; GO:0005737; GO:0005764; GO:0005829; GO:0008146; GO:0009308; GO:0051923"
"471",471,"Cluster_11134","Porites_evermani_scaffold_74:410508-411508",148,-20.04,2,18,743,765,17,"64.71%","82.35%","Peve_00040511",-0.856078539892879,0.345787863891157,0.978262075707395,NA,NA,NA,NA,NA
"472",472,"Cluster_11134","Porites_evermani_scaffold_755:139758-140758",150,-20.86,2,15,700,721,13,"69.23%","92.31%","Peve_00040777",NA,NA,NA,NA,NA,NA,NA,NA
"473",473,"Cluster_11134","Porites_evermani_scaffold_760:120198-121198",154,-23.17,2,20,518,541,20,"70.00%","75.00%","Peve_00040880",0.812790752179306,0.395894460642405,0.978262075707395,"Q91X17","Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form]","Mus musculus (Mouse)","antibacterial innate immune response [GO:0140367]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; autophagy [GO:0006914]; calcium ion homeostasis [GO:0055074]; cellular calcium ion homeostasis [GO:0006874]; cellular chloride ion homeostasis [GO:0030644]; cellular phosphate ion homeostasis [GO:0030643]; cellular response to unfolded protein [GO:0034620]; cellular sodium ion homeostasis [GO:0006883]; chaperone-mediated protein folding [GO:0061077]; chemical homeostasis [GO:0048878]; chloride ion homeostasis [GO:0055064]; citric acid secretion [GO:0046720]; collecting duct development [GO:0072044]; connective tissue replacement [GO:0097709]; creatinine homeostasis [GO:0097273]; defense response to Gram-negative bacterium [GO:0050829]; endoplasmic reticulum organization [GO:0007029]; gene expression [GO:0010467]; glomerular filtration [GO:0003094]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; inflammatory response [GO:0006954]; ion homeostasis [GO:0050801]; juxtaglomerular apparatus development [GO:0072051]; kidney development [GO:0001822]; leukocyte cell-cell adhesion [GO:0007159]; lipid metabolic process [GO:0006629]; loop of Henle development [GO:0072070]; metanephric ascending thin limb development [GO:0072218]; metanephric distal convoluted tubule development [GO:0072221]; metanephric thick ascending limb development [GO:0072233]; micturition [GO:0060073]; multicellular organismal homeostasis [GO:0048871]; multicellular organismal response to stress [GO:0033555]; neutrophil migration [GO:1990266]; organ or tissue specific immune response [GO:0002251]; peptidyl-threonine phosphorylation [GO:0018107]; phosphate ion homeostasis [GO:0055062]; potassium ion homeostasis [GO:0055075]; protein localization to vacuole [GO:0072665]; protein phosphorylation [GO:0006468]; protein transport into plasma membrane raft [GO:0044861]; regulation of blood pressure [GO:0008217]; regulation of protein transport [GO:0051223]; regulation of urine volume [GO:0035809]; renal sodium ion absorption [GO:0070294]; renal urate salt excretion [GO:0097744]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; response to lipopolysaccharide [GO:0032496]; response to unfolded protein [GO:0006986]; response to water deprivation [GO:0009414]; response to xenobiotic stimulus [GO:0009410]; RNA splicing [GO:0008380]; sodium ion homeostasis [GO:0055078]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; ubiquitin-dependent ERAD pathway [GO:0030433]; urate transport [GO:0015747]; urea transmembrane transport [GO:0071918]; water homeostasis [GO:0030104]","GO:0000922; GO:0001822; GO:0002251; GO:0003091; GO:0003094; GO:0005201; GO:0005509; GO:0005615; GO:0005783; GO:0005794; GO:0005886; GO:0005929; GO:0006468; GO:0006629; GO:0006874; GO:0006883; GO:0006914; GO:0006915; GO:0006954; GO:0006986; GO:0007029; GO:0007157; GO:0007159; GO:0008217; GO:0008380; GO:0009410; GO:0009414; GO:0009986; GO:0010467; GO:0015747; GO:0016020; GO:0016323; GO:0016324; GO:0018107; GO:0019864; GO:0030104; GO:0030433; GO:0030643; GO:0030644; GO:0031410; GO:0032496; GO:0033209; GO:0033555; GO:0034620; GO:0034976; GO:0035809; GO:0044861; GO:0045121; GO:0045177; GO:0046720; GO:0048871; GO:0048878; GO:0050801; GO:0050829; GO:0051223; GO:0055062; GO:0055064; GO:0055074; GO:0055075; GO:0055078; GO:0060073; GO:0060170; GO:0061077; GO:0070294; GO:0071918; GO:0072044; GO:0072051; GO:0072070; GO:0072218; GO:0072221; GO:0072233; GO:0072665; GO:0097190; GO:0097273; GO:0097709; GO:0097744; GO:0140367; GO:1990266"
"474",474,"Cluster_11134","Porites_evermani_scaffold_778:46286-47286",155,-24.42,2,16,909,930,14,"78.57%","85.71%","Peve_00041208",-0.0834733212624514,0.946797326581875,0.999448381576871,"Q5R8Z6","Multiple coagulation factor deficiency protein 2 homolog","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]","GO:0005509; GO:0005783; GO:0005793; GO:0005794; GO:0015031; GO:0016192"
"475",475,"Cluster_11134","Porites_evermani_scaffold_786:185697-186697",164,-28.46,2,21,547,568,19,"68.42%","84.21%","Peve_00041403",-0.0195622829453675,0.987545469442176,0.999448381576871,NA,NA,NA,NA,NA
"476",476,"Cluster_11134","Porites_evermani_scaffold_822:154124-155124",155,-25.23,2,21,471,497,24,"62.50%","75.00%","Peve_00042248",0.478008300188395,0.682717760422611,0.978262075707395,"Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"477",477,"Cluster_11134","Porites_evermani_scaffold_82:29489-30489",161,-23.5,2,14,163,184,12,"91.67%","100.00%","Peve_00042196",-0.919811994532359,0.256682085783542,0.978262075707395,NA,NA,NA,NA,NA
"478",478,"Cluster_11134","Porites_evermani_scaffold_829:61476-62476",145,-20.07,2,14,405,426,12,"75.00%","83.33%","Peve_00042355",0.113932726800189,0.927310331073297,0.999448381576871,NA,NA,NA,NA,NA
"479",479,"Cluster_11134","Porites_evermani_scaffold_841:90936-91936",156,-21.53,2,17,124,145,15,"73.33%","86.67%","Peve_00042599",-0.0857728218363615,0.945328148828477,0.999448381576871,"Q8IYQ7","Threonine synthase-like 1 (TSH1)","Homo sapiens (Human)","","GO:0005737"
"480",480,"Cluster_11134","Porites_evermani_scaffold_871:94534-95534",163,-20.91,2,20,839,860,18,"72.22%","83.33%","Peve_00043162",NA,NA,NA,"P0ABQ2","2-hydroxy-3-oxopropionate reductase (EC 1.1.1.60) (Tartronate semialdehyde reductase) (TSAR)","Escherichia coli (strain K12)","D-glucarate catabolic process [GO:0042838]; galactarate catabolic process [GO:0046392]; glyoxylate metabolic process [GO:0046487]","GO:0008679; GO:0042838; GO:0046392; GO:0046487; GO:0050661; GO:0051287; GO:0103032"
"481",481,"Cluster_11134","Porites_evermani_scaffold_877:71379-72379",162,-20.67,2,20,111,133,19,"73.68%","84.21%","Peve_00043273",0.470418059856769,0.688206254165103,0.978262075707395,"P50211","Insulin gene enhancer protein ISL-1 (Islet-1)","Gallus gallus (Chicken)","atrial septum morphogenesis [GO:0060413]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; cardiac cell fate determination [GO:0060913]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac right ventricle morphogenesis [GO:0003215]; cell population proliferation [GO:0008283]; endocardial cushion morphogenesis [GO:0003203]; heart development [GO:0007507]; innervation [GO:0060384]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of inflammatory response [GO:0050728]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell migration [GO:0001755]; neuron fate specification [GO:0048665]; outflow tract septum morphogenesis [GO:0003148]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; pharyngeal system development [GO:0060037]; pituitary gland development [GO:0021983]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA binding [GO:0043388]; positive regulation of granulocyte colony-stimulating factor production [GO:0071657]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of histone acetylation [GO:0035066]; positive regulation of insulin secretion [GO:0032024]; positive regulation of interleukin-1 alpha production [GO:0032730]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type II interferon production [GO:0032729]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of transcription by RNA polymerase II [GO:0006357]; retinal ganglion cell axon guidance [GO:0031290]; secondary heart field specification [GO:0003139]; sensory system development [GO:0048880]; sinoatrial node cell development [GO:0060931]; spinal cord motor neuron cell fate specification [GO:0021520]; transcription by RNA polymerase II [GO:0006366]; trigeminal nerve development [GO:0021559]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; visceral motor neuron differentiation [GO:0021524]","GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0000987; GO:0001228; GO:0001755; GO:0003139; GO:0003148; GO:0003203; GO:0003215; GO:0003266; GO:0005634; GO:0006357; GO:0006366; GO:0007409; GO:0007507; GO:0008283; GO:0008284; GO:0010575; GO:0021520; GO:0021524; GO:0021559; GO:0021983; GO:0031016; GO:0031290; GO:0032024; GO:0032725; GO:0032729; GO:0032730; GO:0032731; GO:0032735; GO:0032755; GO:0032760; GO:0035066; GO:0042531; GO:0043388; GO:0043425; GO:0043524; GO:0045597; GO:0045665; GO:0045766; GO:0045892; GO:0045944; GO:0046872; GO:0048665; GO:0048880; GO:0048936; GO:0050728; GO:0055010; GO:0060037; GO:0060070; GO:0060379; GO:0060384; GO:0060413; GO:0060913; GO:0060931; GO:0061629; GO:0071657; GO:0086091; GO:0090090; GO:1990841"
"482",482,"Cluster_11134","Porites_evermani_scaffold_906:114616-115616",176,-25.33,2,21,172,193,19,"73.68%","94.74%","Peve_00043853",-0.978623848179068,0.131867132380441,0.978262075707395,"Q90Z00","Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A)","Danio rerio (Zebrafish) (Brachydanio rerio)","anatomical structure homeostasis [GO:0060249]; cardiac muscle tissue development [GO:0048738]; dorsal/ventral pattern formation [GO:0009953]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fin regeneration [GO:0031101]; liver development [GO:0001889]; negative regulation of endodermal cell fate specification [GO:0042664]; olfactory nerve formation [GO:0021628]; olfactory placode morphogenesis [GO:0071699]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of phospholipase C activity [GO:0010863]; post-anal tail morphogenesis [GO:0036342]; posterior lateral line development [GO:0048916]; response to ethanol [GO:0045471]; skin morphogenesis [GO:0043589]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]","GO:0001889; GO:0004714; GO:0005007; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0007169; GO:0008201; GO:0008284; GO:0008543; GO:0009953; GO:0010863; GO:0017134; GO:0018108; GO:0021628; GO:0031101; GO:0031410; GO:0033674; GO:0036342; GO:0042664; GO:0043235; GO:0043406; GO:0043589; GO:0045471; GO:0045597; GO:0048738; GO:0048916; GO:0060249; GO:0071699"
"483",483,"Cluster_11134","Porites_evermani_scaffold_911:104388-105388",166,-22.38,2,16,789,811,15,"93.33%","93.33%","Peve_00043951",0.875640822838247,0.320878802775509,0.978262075707395,NA,NA,NA,NA,NA
"484",484,"Cluster_11134","Porites_evermani_scaffold_91:291912-292912",154,-22.28,2,21,21,46,23,"65.22%","78.26%","Peve_00043915",-0.701687951489768,0.504860156108791,0.978262075707395,"Q863I2","Serine/threonine-protein kinase OSR1 (EC 2.7.11.1) (Oxidative stress-responsive 1 protein)","Sus scrofa (Pig)","intracellular signal transduction [GO:0035556]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of T cell chemotaxis [GO:0010820]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]","GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0010820; GO:0018107; GO:0035556; GO:0046777; GO:0106310; GO:1901017"
"485",485,"Cluster_11134","Porites_evermani_scaffold_91:467557-468557",151,-24.15,2,16,950,971,14,"71.43%","85.71%","Peve_00043889",-0.813033554248977,0.395629048149974,0.978262075707395,"Q6AY55","Dephospho-CoA kinase domain-containing protein","Rattus norvegicus (Rat)","coenzyme A biosynthetic process [GO:0015937]","GO:0004140; GO:0005524; GO:0015937"
"486",486,"Cluster_11134","Porites_evermani_scaffold_921:19047-20047",155,-21.47,2,16,515,536,14,"71.43%","92.86%","Peve_00044134",0.538312772742745,0.638123825823783,0.978262075707395,"Q6ITT3","Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C (EC 2.4.1.145) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase IVc) (GnT-IVc) (N-acetylglucosaminyltransferase IVc) (UDP-N-acetylglucosamine: alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IVc)","Sus scrofa (Pig)","protein N-linked glycosylation [GO:0006487]","GO:0000139; GO:0006487; GO:0008375; GO:0008454; GO:0046872"
"487",487,"Cluster_11134","Porites_evermani_scaffold_931:165382-166382",163,-22.34,2,21,168,190,20,"75.00%","80.00%","Peve_00044297",0.875640822838247,0.320878802775509,0.978262075707395,NA,NA,NA,NA,NA
"488",488,"Cluster_11134","Porites_evermani_scaffold_931:165382-166382",163,-22.34,2,21,784,806,20,"75.00%","80.00%","Peve_00044297",0.875640822838247,0.320878802775509,0.978262075707395,NA,NA,NA,NA,NA
"489",489,"Cluster_11134","Porites_evermani_scaffold_940:130038-131038",154,-22.13,2,15,596,617,13,"84.62%","84.62%","Peve_00044437",NA,NA,NA,NA,NA,NA,NA,NA
"490",490,"Cluster_11134","Porites_evermani_scaffold_953:11878-12878",157,-22.9,2,21,160,181,20,"75.00%","80.00%","Peve_00044635",NA,NA,NA,NA,NA,NA,NA,NA
"491",491,"Cluster_11134","Porites_evermani_scaffold_96:150092-151092",163,-23.52,2,21,715,739,22,"72.73%","77.27%","Peve_00044723",0.00633849848895941,0.99596475951415,0.999448381576871,NA,NA,NA,NA,NA
"492",492,"Cluster_11134","Porites_evermani_scaffold_969:23470-24470",149,-20.64,2,21,233,252,19,"57.89%","84.21%","Peve_00044883",NA,NA,NA,"Q9U8W8","Techylectin-5A","Tachypleus tridentatus (Japanese horseshoe crab)","cell-cell adhesion [GO:0098609]","GO:0005576; GO:0030246; GO:0046872; GO:0098609"
"493",493,"Cluster_11134","Porites_evermani_scaffold_994:42022-43022",162,-23.2,2,20,204,227,20,"75.00%","80.00%","Peve_00045285",-0.0195622829453675,0.987545469442176,0.999448381576871,"Q6L9W6","Beta-1,4-N-acetylgalactosaminyltransferase 3 (B4GalNAcT3) (Beta4GalNAc-T3) (Beta4GalNAcT3) (EC 2.4.1.244) (Beta-1,4-N-acetylgalactosaminyltransferase III) (N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 2) (NGalNAc-T2)","Homo sapiens (Human)","","GO:0005794; GO:0008376; GO:0032580; GO:0033842; GO:0043231"
"494",494,"Cluster_11134","Porites_evermani_scaffold_997:24444-25444",152,-21.56,2,13,432,453,11,"90.91%","90.91%","Peve_00045334",-0.856078539892879,0.345787863891157,0.978262075707395,NA,NA,NA,NA,NA
"495",495,"Cluster_11135","Porites_evermani_scaffold_1012:130448-131448",165,-22.31,2,19,687,709,18,"77.78%","88.89%","Peve_00000439",0.813973355256237,0.394600269922286,0.978262075707395,NA,NA,NA,NA,NA
"496",496,"Cluster_11135","Porites_evermani_scaffold_1012:130448-131448",165,-22.31,2,19,753,775,18,"77.78%","88.89%","Peve_00000439",0.813973355256237,0.394600269922286,0.978262075707395,NA,NA,NA,NA,NA
"497",497,"Cluster_11135","Porites_evermani_scaffold_1012:130448-131448",165,-22.31,2,19,819,841,18,"77.78%","88.89%","Peve_00000439",0.813973355256237,0.394600269922286,0.978262075707395,NA,NA,NA,NA,NA
"498",498,"Cluster_11135","Porites_evermani_scaffold_1040:156403-157403",166,-25.94,2,20,778,800,19,"73.68%","89.47%","Peve_00000858",NA,NA,NA,NA,NA,NA,NA,NA
"499",499,"Cluster_11135","Porites_evermani_scaffold_1040:156403-157403",166,-25.94,2,20,82,104,19,"73.68%","89.47%","Peve_00000858",NA,NA,NA,NA,NA,NA,NA,NA
"500",500,"Cluster_11135","Porites_evermani_scaffold_1074:101112-102112",151,-21.29,2,21,304,328,22,"59.09%","77.27%","Peve_00001364",0.738708864256152,0.470871706054746,0.978262075707395,NA,NA,NA,NA,NA
"501",501,"Cluster_11135","Porites_evermani_scaffold_1103:6679-7679",160,-20.87,2,18,260,282,17,"82.35%","82.35%","Peve_00001910",NA,NA,NA,"O94993","Transcription factor SOX-30","Homo sapiens (Human)","negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proacrosomal vesicle fusion [GO:0120211]; regulation of transcription by RNA polymerase II [GO:0006357]; response to corticosteroid [GO:0031960]; spermatid development [GO:0007286]","GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0007286; GO:0008013; GO:0010369; GO:0030178; GO:0031960; GO:0043231; GO:0045944; GO:0120211; GO:1990837"
"502",502,"Cluster_11135","Porites_evermani_scaffold_112:395442-396442",152,-20.09,2,15,226,246,13,"84.62%","92.31%","Peve_00002157",0.891576222496237,0.299200139617067,0.978262075707395,NA,NA,NA,NA,NA
"503",503,"Cluster_11135","Porites_evermani_scaffold_11:722063-723063",142,-20.32,2,11,629,650,9,"88.89%","88.89%","Peve_00001741",0.844443877729655,0.359862212804899,0.978262075707395,NA,NA,NA,NA,NA
"504",504,"Cluster_11135","Porites_evermani_scaffold_1192:42833-43833",154,-20.89,2,21,872,892,19,"68.42%","78.95%","Peve_00003223",-0.311208918715251,0.79853221500376,0.995934364227446,NA,NA,NA,NA,NA
"505",505,"Cluster_11135","Porites_evermani_scaffold_1192:53706-54706",154,-20.89,2,21,739,759,19,"68.42%","78.95%","Peve_00003225",-0.677149109642393,0.526430398948471,0.978262075707395,NA,NA,NA,NA,NA
"506",506,"Cluster_11135","Porites_evermani_scaffold_1271:87497-88497",160,-20.87,2,18,690,712,17,"82.35%","82.35%","Peve_00004376",-0.525055497422668,0.648089117915151,0.978262075707395,"Q8K4C0","Flavin-containing monooxygenase 5 (FMO 5) (Dimethylaniline monooxygenase [N-oxide-forming] 5) (EC 1.14.13.8) (Dimethylaniline oxidase 5) (Hepatic flavin-containing monooxygenase 5) (NADPH oxidase) (EC 1.6.3.1)","Rattus norvegicus (Rat)","lipid metabolic process [GO:0006629]; NADPH oxidation [GO:0070995]; regulation of cholesterol metabolic process [GO:0090181]; xenobiotic metabolic process [GO:0006805]","GO:0004031; GO:0004497; GO:0004499; GO:0005789; GO:0006629; GO:0006805; GO:0047822; GO:0050660; GO:0050661; GO:0070995; GO:0090181; GO:0106294"
"507",507,"Cluster_11135","Porites_evermani_scaffold_1274:58721-59721",161,-21.11,2,21,539,558,19,"73.68%","84.21%","Peve_00004417",-0.91130181646392,0.270156917796343,0.978262075707395,NA,NA,NA,NA,NA
"508",508,"Cluster_11135","Porites_evermani_scaffold_1304:49834-50834",160,-20.87,2,18,325,347,17,"82.35%","82.35%","Peve_00004859",0.787927883123848,0.422307906395058,0.978262075707395,"Q8R4V5","Oncoprotein-induced transcript 3 protein (Liver-specific zona pellucida domain-containing protein)","Mus musculus (Mouse)","urate homeostasis [GO:1903118]","GO:0005201; GO:0005509; GO:0005615; GO:0005635; GO:0009986; GO:1903118"
"509",509,"Cluster_11135","Porites_evermani_scaffold_1316:116933-117933",160,-20.87,2,18,810,832,17,"82.35%","82.35%","Peve_00005010",NA,NA,NA,NA,NA,NA,NA,NA
"510",510,"Cluster_11135","Porites_evermani_scaffold_1320:93826-94826",153,-20.05,2,18,142,163,16,"68.75%","81.25%","Peve_00005102",NA,NA,NA,NA,NA,NA,NA,NA
"511",511,"Cluster_11135","Porites_evermani_scaffold_1349:45121-46121",155,-20.13,2,16,682,703,14,"78.57%","85.71%","Peve_00005481",NA,NA,NA,NA,NA,NA,NA,NA
"512",512,"Cluster_11135","Porites_evermani_scaffold_135:96309-97309",160,-20.87,2,18,511,533,17,"82.35%","82.35%","Peve_00005495",-0.886103284710592,0.306804453861767,0.978262075707395,NA,NA,NA,NA,NA
"513",513,"Cluster_11135","Porites_evermani_scaffold_1361:126886-127346",169,-25.1,2,21,3,27,22,"81.82%","86.36%","Peve_00005690",-0.886103284710592,0.306804453861767,0.978262075707395,NA,NA,NA,NA,NA
"514",514,"Cluster_11135","Porites_evermani_scaffold_1364:59261-60261",150,-21.14,2,21,22,46,22,"68.18%","72.73%","Peve_00005714",0.124451082772196,0.920566026460492,0.999448381576871,"Q8WU66","Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR)","Homo sapiens (Human)","hair cycle process [GO:0022405]; Notch signaling pathway [GO:0007219]; regulation of Notch signaling pathway [GO:0008593]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]; tooth mineralization [GO:0034505]","GO:0005576; GO:0007165; GO:0007219; GO:0007605; GO:0008593; GO:0009986; GO:0022405; GO:0032420; GO:0034505; GO:0060170"
"515",515,"Cluster_11135","Porites_evermani_scaffold_1386:35897-36897",160,-20.87,2,18,972,994,17,"82.35%","82.35%","Peve_00005981",0.966937122651215,0.16416075816938,0.978262075707395,NA,NA,NA,NA,NA
"516",516,"Cluster_11135","Porites_evermani_scaffold_1390:38850-39850",158,-22.79,2,15,203,224,13,"76.92%","100.00%","Peve_00006063",0.80496506366335,0.404367983722814,0.978262075707395,"Q9CPR5","39S ribosomal protein L15, mitochondrial (L15mt) (MRP-L15)","Mus musculus (Mouse)","cellular response to leukemia inhibitory factor [GO:1990830]; mitochondrial genome maintenance [GO:0000002]; mitochondrial translation [GO:0032543]; translation [GO:0006412]","GO:0000002; GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0006412; GO:0032543; GO:1990830"
"517",517,"Cluster_11135","Porites_evermani_scaffold_1429:76781-77781",160,-20.87,2,18,806,828,17,"82.35%","82.35%","Peve_00006608",0.866516207790166,0.332707890023336,0.978262075707395,"O97860","Tartrate-resistant acid phosphatase type 5 (TR-AP) (EC 3.1.3.2) (Tartrate-resistant acid ATPase) (TrATPase) (Type 5 acid phosphatase)","Oryctolagus cuniculus (Rabbit)","","GO:0003993; GO:0005764; GO:0008198; GO:0008199"
"518",518,"Cluster_11135","Porites_evermani_scaffold_144:327645-328645",160,-24.79,2,21,908,927,19,"78.95%","84.21%","Peve_00006739",-0.865470280274489,0.33403946039202,0.978262075707395,NA,NA,NA,NA,NA
"519",519,"Cluster_11135","Porites_evermani_scaffold_146:266162-267162",161,-23.14,2,20,80,100,18,"77.78%","83.33%","Peve_00006955",NA,NA,NA,NA,NA,NA,NA,NA
"520",520,"Cluster_11135","Porites_evermani_scaffold_1478:53974-54974",156,-20.53,2,21,731,752,19,"63.16%","78.95%","Peve_00007178",NA,NA,NA,NA,NA,NA,NA,NA
"521",521,"Cluster_11135","Porites_evermani_scaffold_1487:92653-93653",158,-21.66,2,15,947,968,13,"84.62%","92.31%","Peve_00007299",0.315718578448589,0.795508898211476,0.995934364227446,"B5DF45","TNF receptor-associated factor 6 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF6) (RING-type E3 ubiquitin transferase TRAF6)","Rattus norvegicus (Rat)","activation of NF-kappaB-inducing kinase activity [GO:0007250]; activation of protein kinase activity [GO:0032147]; animal organ morphogenesis [GO:0009887]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; bone remodeling [GO:0046849]; bone resorption [GO:0045453]; cell development [GO:0048468]; cellular response to cytokine stimulus [GO:0071345]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-17-mediated signaling pathway [GO:0097400]; JNK cascade [GO:0007254]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; odontogenesis of dentin-containing tooth [GO:0042475]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of immunoglobulin production [GO:0002637]; response to interleukin-1 [GO:0070555]; response to ischemia [GO:0002931]; signal transduction [GO:0007165]; T cell receptor signaling pathway [GO:0050852]; T-helper 1 type immune response [GO:0042088]; tumor necrosis factor-mediated signaling pathway [GO:0033209]","GO:0000122; GO:0000209; GO:0001503; GO:0001701; GO:0001843; GO:0002637; GO:0002726; GO:0002931; GO:0004842; GO:0005164; GO:0005634; GO:0005737; GO:0005811; GO:0005829; GO:0005886; GO:0005938; GO:0006955; GO:0006974; GO:0007165; GO:0007249; GO:0007250; GO:0007254; GO:0008270; GO:0009887; GO:0009898; GO:0016567; GO:0019221; GO:0019886; GO:0019901; GO:0030316; GO:0031435; GO:0031624; GO:0031625; GO:0031666; GO:0031996; GO:0032147; GO:0032735; GO:0032743; GO:0032755; GO:0032813; GO:0032991; GO:0033209; GO:0035631; GO:0042088; GO:0042102; GO:0042475; GO:0042802; GO:0042826; GO:0042981; GO:0043011; GO:0043122; GO:0043123; GO:0043422; GO:0043507; GO:0045453; GO:0045672; GO:0045892; GO:0045944; GO:0046330; GO:0046849; GO:0047485; GO:0048468; GO:0048471; GO:0048661; GO:0050852; GO:0051091; GO:0051092; GO:0051865; GO:0061630; GO:0070498; GO:0070534; GO:0070555; GO:0071222; GO:0071345; GO:0097400; GO:1901224; GO:1904996; GO:2000679"
"522",522,"Cluster_11135","Porites_evermani_scaffold_1508:97538-98538",157,-21.55,2,18,974,995,16,"68.75%","87.50%","Peve_00007635",0.720205205667571,0.488095275597674,0.978262075707395,NA,NA,NA,NA,NA
"523",523,"Cluster_11135","Porites_evermani_scaffold_1525:35702-36702",154,-20.96,2,16,15,38,16,"75.00%","87.50%","Peve_00007829",NA,NA,NA,"A9JTG4","Major facilitator superfamily domain-containing protein 4B","Danio rerio (Zebrafish) (Brachydanio rerio)","","GO:0005355; GO:0016020"
"524",524,"Cluster_11135","Porites_evermani_scaffold_154:131282-132282",156,-20.61,2,18,624,646,17,"76.47%","82.35%","Peve_00007988",0.948202398740093,0.205798698012511,0.978262075707395,"P15170","Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (Eukaryotic peptide chain release factor subunit 3a) (eRF3a) (G1 to S phase transition protein 1 homolog)","Homo sapiens (Human)","G1/S transition of mitotic cell cycle [GO:0000082]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; protein methylation [GO:0006479]; regulation of translational termination [GO:0006449]; translation [GO:0006412]; translational termination [GO:0006415]","GO:0000082; GO:0000184; GO:0003723; GO:0003747; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0006412; GO:0006415; GO:0006449; GO:0006479; GO:0018444"
"525",525,"Cluster_11135","Porites_evermani_scaffold_1591:83392-84392",160,-20.87,2,18,562,584,17,"82.35%","82.35%","Peve_00008660",0.891393169396091,0.299457362935613,0.978262075707395,"Q5F464","Lipoma-preferred partner homolog","Gallus gallus (Chicken)","cell-cell adhesion [GO:0098609]","GO:0001725; GO:0005634; GO:0005737; GO:0005925; GO:0046872; GO:0098609"
"526",526,"Cluster_11135","Porites_evermani_scaffold_1612:55442-56442",159,-20.62,2,21,66,88,20,"70.00%","80.00%","Peve_00008983",-0.886103284710592,0.306804453861767,0.978262075707395,NA,NA,NA,NA,NA
"527",527,"Cluster_11135","Porites_evermani_scaffold_1612:63618-64618",163,-20.68,2,21,68,90,20,"75.00%","80.00%","Peve_00008984",NA,NA,NA,NA,NA,NA,NA,NA
"528",528,"Cluster_11135","Porites_evermani_scaffold_164:134823-135823",155,-20.51,2,21,490,514,22,"63.64%","77.27%","Peve_00009286",0.547010347742131,0.631531654382621,0.978262075707395,"Q75UQ2","Craniofacial development protein 1 (Bucentaur)","Rattus norvegicus (Rat)","cell adhesion [GO:0007155]; chromatin remodeling [GO:0006338]; fibroblast apoptotic process [GO:0044346]; negative regulation of fibroblast apoptotic process [GO:2000270]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]","GO:0000776; GO:0000812; GO:0005634; GO:0006338; GO:0007155; GO:0008360; GO:0042127; GO:0044346; GO:2000270"
"529",529,"Cluster_11135","Porites_evermani_scaffold_1647:90193-91193",155,-20.18,2,21,160,183,21,"61.90%","80.95%","Peve_00009364",NA,NA,NA,NA,NA,NA,NA,NA
"530",530,"Cluster_11135","Porites_evermani_scaffold_165:348392-349392",168,-28.05,2,21,554,575,19,"68.42%","89.47%","Peve_00009411",NA,NA,NA,NA,NA,NA,NA,NA
"531",531,"Cluster_11135","Porites_evermani_scaffold_1761:31114-32114",162,-22.24,2,21,548,568,19,"73.68%","84.21%","Peve_00010689",0.0199473249836992,0.987300296221492,0.999448381576871,"Q7RTR2","NLR family CARD domain-containing protein 3 (CARD15-like protein) (Caterpiller protein 16.2) (CLR16.2) (NACHT, LRR and CARD domains-containing protein 3) (Nucleotide-binding oligomerization domain protein 3)","Homo sapiens (Human)","I-kappaB kinase/NF-kappaB signaling [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of tumor necrosis factor production [GO:0032720]; T cell activation [GO:0042110]","GO:0005524; GO:0005737; GO:0005829; GO:0007249; GO:0014067; GO:0032088; GO:0032687; GO:0032688; GO:0032715; GO:0032720; GO:0034451; GO:0035556; GO:0036312; GO:0042110; GO:0043124; GO:0043231; GO:0045824; GO:0048147; GO:0048471; GO:0050680; GO:0050728; GO:1900016; GO:1900226; GO:1901223"
"532",532,"Cluster_11135","Porites_evermani_scaffold_1786:50991-51991",155,-20.69,2,21,757,781,22,"59.09%","81.82%","Peve_00010965",-0.324323173016597,0.789726947982674,0.995811317342119,"A0A2J6RX17",NA,NA,NA,NA
"533",533,"Cluster_11135","Porites_evermani_scaffold_1788:1417-2417",151,-21.54,2,21,895,917,20,"65.00%","75.00%","Peve_00010975",0.251672767426423,0.838038666168114,0.995934364227446,"Q2I0E5","Protein inturned (Inturned planar cell polarity effector homolog) (Xint)","Xenopus laevis (African clawed frog)","ciliary basal body organization [GO:0032053]; cilium assembly [GO:0060271]; establishment of planar polarity [GO:0001736]; protein localization [GO:0008104]; regulation of smoothened signaling pathway [GO:0008589]; vesicle-mediated transport [GO:0016192]","GO:0001736; GO:0005737; GO:0005886; GO:0008104; GO:0008589; GO:0009986; GO:0016192; GO:0032053; GO:0036064; GO:0045177; GO:0060271"
"534",534,"Cluster_11135","Porites_evermani_scaffold_1796:40192-41192",153,-21.52,2,21,276,300,22,"68.18%","81.82%","Peve_00011044",0.495612323918643,0.669887380258487,0.978262075707395,"Q9M0A5","Gamma-glutamyl peptidase 3 (EC 3.4.19.16)","Arabidopsis thaliana (Mouse-ear cress)","glucosinolate metabolic process [GO:0019760]; proteolysis [GO:0006508]","GO:0005829; GO:0006508; GO:0008233; GO:0019760"
"535",535,"Cluster_11135","Porites_evermani_scaffold_183:266237-267237",147,-21.64,2,18,936,959,18,"72.22%","77.78%","Peve_00011517",0.844443877729655,0.359862212804899,0.978262075707395,NA,NA,NA,NA,NA
"536",536,"Cluster_11135","Porites_evermani_scaffold_198:352885-353885",163,-20.34,2,21,215,238,21,"66.67%","85.71%","Peve_00013124",0.94993155441408,0.202304749593651,0.978262075707395,"O14059","Probable histidinol-phosphatase (HolPase) (EC 3.1.3.15)","Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)","histidine biosynthetic process [GO:0000105]","GO:0000105; GO:0004401; GO:0005634; GO:0005829"
"537",537,"Cluster_11135","Porites_evermani_scaffold_200:284109-285109",163,-21.77,2,21,669,691,20,"70.00%","85.00%","Peve_00013572",-0.10340417310554,0.934052978608075,0.999448381576871,"B8VIU6","Uncharacterized skeletal organic matrix protein 5 (Uncharacterized SOMP-5)","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0005576"
"538",538,"Cluster_11135","Porites_evermani_scaffold_2022:11804-12804",147,-21.26,2,21,7,31,22,"54.55%","77.27%","Peve_00013804",0.755031288556074,0.455243291440253,0.978262075707395,NA,NA,NA,NA,NA
"539",539,"Cluster_11135","Porites_evermani_scaffold_2022:11804-12804",154,-20.42,2,20,359,382,20,"65.00%","80.00%","Peve_00013804",0.755031288556074,0.455243291440253,0.978262075707395,NA,NA,NA,NA,NA
"540",540,"Cluster_11135","Porites_evermani_scaffold_2022:48720-49720",155,-22.38,2,20,633,652,18,"72.22%","88.89%","Peve_00013802",-0.330870607474826,0.785315262987461,0.994815525378617,NA,NA,NA,NA,NA
"541",541,"Cluster_11135","Porites_evermani_scaffold_2038:77467-78467",168,-20.46,2,21,358,379,19,"78.95%","78.95%","Peve_00013932",0.960010054456052,0.180646079562048,0.978262075707395,"O75175","CCR4-NOT transcription complex subunit 3 (CCR4-associated factor 3) (Leukocyte receptor cluster member 2)","Homo sapiens (Human)","nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of DNA-templated transcription [GO:0006355]; regulation of stem cell population maintenance [GO:2000036]; RNA-mediated gene silencing [GO:0031047]; trophectodermal cell differentiation [GO:0001829]","GO:0000289; GO:0000932; GO:0001829; GO:0005634; GO:0005829; GO:0006355; GO:0030014; GO:0030015; GO:0031047; GO:0120162; GO:2000036"
"542",542,"Cluster_11135","Porites_evermani_scaffold_2046:51060-52060",168,-23.87,2,21,122,140,19,"84.21%","84.21%","Peve_00014024",0.893890823594503,0.295929854384651,0.978262075707395,"B0UYT5","Major facilitator superfamily domain-containing protein 6-B (Macrophage MHC class I receptor 2 homolog B)","Danio rerio (Zebrafish) (Brachydanio rerio)","antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]","GO:0005886; GO:0016020; GO:0042590"
"543",543,"Cluster_11135","Porites_evermani_scaffold_204:79769-80769",166,-20.06,2,19,368,389,17,"76.47%","88.24%","Peve_00013945",-0.189879583273906,0.878380478867116,0.998309205917744,NA,NA,NA,NA,NA
"544",544,"Cluster_11135","Porites_evermani_scaffold_20:887859-888859",162,-21.84,2,21,708,728,19,"73.68%","84.21%","Peve_00013505",0.989301237709917,0.0932072839311227,0.978262075707395,NA,NA,NA,NA,NA
"545",545,"Cluster_11135","Porites_evermani_scaffold_2139:37753-38753",162,-24.53,2,20,846,868,19,"73.68%","84.21%","Peve_00014957",0.114087703866073,0.927211022072137,0.999448381576871,"Q99961","Endophilin-A2 (EEN fusion partner of MLL) (Endophilin-2) (Extra eleven-nineteen leukemia fusion gene protein) (EEN) (SH3 domain protein 2B) (SH3 domain-containing GRB2-like protein 1)","Homo sapiens (Human)","central nervous system development [GO:0007417]; signal transduction [GO:0007165]; synaptic vesicle uncoating [GO:0016191]","GO:0002102; GO:0005737; GO:0005829; GO:0007165; GO:0007417; GO:0008289; GO:0016191; GO:0031901; GO:0042802; GO:0042995; GO:0045296; GO:0070161; GO:0098793; GO:0098978"
"546",546,"Cluster_11135","Porites_evermani_scaffold_21:963695-964695",164,-23.19,2,17,497,518,15,"86.67%","86.67%","Peve_00014557",0.212241428882455,0.863847354107973,0.996660710141104,"A2CI35","Dual serine/threonine and tyrosine protein kinase (EC 2.7.12.1) (Dusty protein kinase) (Dusty PK) (Receptor-interacting serine/threonine-protein kinase 5)","Strongylocentrotus purpuratus (Purple sea urchin)","cellular response to fibroblast growth factor stimulus [GO:0044344]; embryonic organ development [GO:0048568]; negative regulation of apoptotic process [GO:0043066]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]","GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005737; GO:0016323; GO:0016324; GO:0043066; GO:0044344; GO:0045743; GO:0048568; GO:0070161; GO:0070374; GO:0106310"
"547",547,"Cluster_11135","Porites_evermani_scaffold_2223:7228-8228",155,-21.99,2,19,496,520,20,"80.00%","80.00%","Peve_00015807",-0.990445528519332,0.0880734178317149,0.978262075707395,"Q96CG8","Collagen triple helix repeat-containing protein 1","Homo sapiens (Human)","cell migration [GO:0016477]; cochlea morphogenesis [GO:0090103]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein binding [GO:0032092]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0001649; GO:0005109; GO:0005576; GO:0005581; GO:0005615; GO:0016477; GO:0016528; GO:0017147; GO:0032092; GO:0033687; GO:0033690; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0062023; GO:0090090; GO:0090103; GO:0090177"
"548",548,"Cluster_11135","Porites_evermani_scaffold_2228:5086-6086",160,-20.87,2,18,874,896,17,"82.35%","82.35%","Peve_00015840",NA,NA,NA,NA,NA,NA,NA,NA
"549",549,"Cluster_11135","Porites_evermani_scaffold_2229:81914-82914",162,-25.59,2,21,564,589,23,"73.91%","78.26%","Peve_00015847",NA,NA,NA,"P49287","Melatonin receptor type 1B (Mel-1B-R) (Mel1b receptor)","Rattus norvegicus (Rat)","camera-type eye development [GO:0043010]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transmission of nerve impulse [GO:0051970]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of circadian sleep/wake cycle, non-REM sleep [GO:0046010]; positive regulation of transmission of nerve impulse [GO:0051971]; regulation of insulin secretion [GO:0050796]; regulation of neuronal action potential [GO:0098908]","GO:0004930; GO:0005886; GO:0007186; GO:0008502; GO:0010754; GO:0042593; GO:0042753; GO:0043010; GO:0043524; GO:0045906; GO:0046010; GO:0046676; GO:0050796; GO:0051481; GO:0051970; GO:0051971; GO:0098908; GO:1902260"
"550",550,"Cluster_11135","Porites_evermani_scaffold_2234:939-1939",152,-21.87,2,21,66,85,19,"68.42%","84.21%","Peve_00015907",-0.886103284710592,0.306804453861767,0.978262075707395,NA,NA,NA,NA,NA
"551",551,"Cluster_11135","Porites_evermani_scaffold_225:42725-43725",171,-20.51,2,21,255,277,20,"75.00%","90.00%","Peve_00016030",0.982992686140211,0.11757918010117,0.978262075707395,"Q05973","Sodium channel protein 1 brain (Sodium channel protein I brain)","Heterololigo bleekeri (Spear squid) (Loligo bleekeri)","regulation of ion transmembrane transport [GO:0034765]","GO:0001518; GO:0005244; GO:0005248; GO:0034765"
"552",552,"Cluster_11135","Porites_evermani_scaffold_225:51551-52551",162,-23.61,2,20,111,133,19,"73.68%","84.21%","Peve_00016052",0.999263211767585,0.024439545782064,0.861227763182295,"A4FUY7","Molybdopterin synthase catalytic subunit (EC 2.8.1.12) (Molybdenum cofactor synthesis protein 2 large subunit) (Molybdenum cofactor synthesis protein 2B) (MOCS2B)","Bos taurus (Bovine)","Mo-molybdopterin cofactor biosynthetic process [GO:0006777]","GO:0005829; GO:0006777; GO:0016607; GO:0019008; GO:0030366"
"553",553,"Cluster_11135","Porites_evermani_scaffold_2294:26753-27753",170,-20.86,2,21,918,938,19,"78.95%","89.47%","Peve_00016434",0.99900571383746,0.0283914000687859,0.903496866948401,"Q5EBP3","Armadillo repeat-containing protein 5","Mus musculus (Mouse)","adrenal cortex development [GO:0035801]; anatomical structure morphogenesis [GO:0009653]; CD4-positive, alpha-beta T cell differentiation [GO:0043367]; defense response to virus [GO:0051607]; gastrulation [GO:0007369]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; mesoderm formation [GO:0001707]; regulation of steroid biosynthetic process [GO:0050810]; T cell proliferation [GO:0042098]","GO:0001701; GO:0001707; GO:0005654; GO:0005737; GO:0005829; GO:0005925; GO:0007369; GO:0009653; GO:0016020; GO:0030097; GO:0035801; GO:0042098; GO:0043367; GO:0050810; GO:0051607"
"554",554,"Cluster_11135","Porites_evermani_scaffold_2305:74921-75921",160,-20.87,2,18,517,539,17,"82.35%","82.35%","Peve_00016623",0.861402925128427,0.339172554982691,0.978262075707395,"P95896","Amidase (EC 3.5.1.4)","Saccharolobus solfataricus (strain ATCC 35092 / DSM 1617 / JCM 11322 / P2) (Sulfolobus solfataricus)","","GO:0004040; GO:0043864"
"555",555,"Cluster_11135","Porites_evermani_scaffold_2413:46445-47445",151,-21.96,2,18,249,269,16,"68.75%","87.50%","Peve_00017623",NA,NA,NA,"B8VIU6","Uncharacterized skeletal organic matrix protein 5 (Uncharacterized SOMP-5)","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0005576"
"556",556,"Cluster_11135","Porites_evermani_scaffold_2457:49509-50509",156,-24.59,2,18,461,483,17,"76.47%","82.35%","Peve_00017998",0.76355539763678,0.446903950507113,0.978262075707395,NA,NA,NA,NA,NA
"557",557,"Cluster_11135","Porites_evermani_scaffold_2514:58784-59784",161,-25.47,2,21,603,624,20,"75.00%","85.00%","Peve_00018562",-0.554144281136237,0.626091164446615,0.978262075707395,"Q8R2H5","Phosphatidylinositol-glycan-specific phospholipase D (PI-G PLD) (EC 3.1.4.50) (Glycoprotein phospholipase D) (Glycosyl-phosphatidylinositol-specific phospholipase D) (GPI-PLD) (GPI-specific phospholipase D)","Rattus norvegicus (Rat)","cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to calcium ion [GO:0071277]; cellular response to cholesterol [GO:0071397]; cellular response to inorganic substance [GO:0071241]; cellular response to insulin stimulus [GO:0032869]; cellular response to iron(II) ion [GO:0071282]; cellular response to pH [GO:0071467]; cellular response to triglyceride [GO:0071401]; cellular response to xenobiotic stimulus [GO:0071466]; chondrocyte differentiation [GO:0002062]; complement receptor mediated signaling pathway [GO:0002430]; GPI anchor release [GO:0006507]; insulin receptor signaling pathway [GO:0008286]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of triglyceride catabolic process [GO:0010897]; ossification [GO:0001503]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of high-density lipoprotein particle clearance [GO:0010983]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of secretion [GO:0051047]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of cellular response to insulin stimulus [GO:1900076]; response to glucose [GO:0009749]; transepithelial transport [GO:0070633]","GO:0001503; GO:0002042; GO:0002062; GO:0002430; GO:0004621; GO:0004630; GO:0005576; GO:0005615; GO:0005737; GO:0006507; GO:0008285; GO:0008286; GO:0009749; GO:0010595; GO:0010694; GO:0010867; GO:0010897; GO:0010907; GO:0010983; GO:0017080; GO:0031012; GO:0032869; GO:0034364; GO:0035774; GO:0043065; GO:0043231; GO:0046470; GO:0051044; GO:0051047; GO:0070633; GO:0071241; GO:0071277; GO:0071282; GO:0071397; GO:0071401; GO:0071466; GO:0071467; GO:1900076"
"558",558,"Cluster_11135","Porites_evermani_scaffold_2539:44176-45176",156,-20.04,2,21,164,186,21,"76.19%","80.95%","Peve_00018759",0.983999564489437,0.114035955000658,0.978262075707395,NA,NA,NA,NA,NA
"559",559,"Cluster_11135","Porites_evermani_scaffold_2595:9971-10971",178,-28.83,2,21,577,597,19,"89.47%","89.47%","Peve_00019184",0.590556238377592,0.597816772170959,0.978262075707395,"Q8IN35","Neuropeptide SIFamide receptor","Drosophila melanogaster (Fruit fly)","determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; mating behavior, sex discrimination [GO:0048047]; neuropeptide signaling pathway [GO:0007218]","GO:0004930; GO:0004983; GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0008340; GO:0008528; GO:0016020; GO:0042277; GO:0048047"
"560",560,"Cluster_11135","Porites_evermani_scaffold_2696:36585-37585",151,-20.81,2,13,148,170,12,"91.67%","91.67%","Peve_00020014",-0.923471280090712,0.250678283297943,0.978262075707395,NA,NA,NA,NA,NA
"561",561,"Cluster_11135","Porites_evermani_scaffold_2787:28268-29268",146,-20.94,2,21,264,290,24,"62.50%","70.83%","Peve_00020772",0.998797404481802,0.0312247122096777,0.903929377050813,NA,NA,NA,NA,NA
"562",562,"Cluster_11135","Porites_evermani_scaffold_2898:23410-24410",164,-20.81,2,20,843,864,19,"78.95%","89.47%","Peve_00021639",0.0416594069809366,0.973471120528434,0.999448381576871,NA,NA,NA,NA,NA
"563",563,"Cluster_11135","Porites_evermani_scaffold_2931:16052-17052",158,-20.49,2,16,905,927,15,"86.67%","86.67%","Peve_00021941",-0.284660739171018,0.816238106569497,0.995934364227446,NA,NA,NA,NA,NA
"564",564,"Cluster_11135","Porites_evermani_scaffold_29:67567-68567",176,-24.69,2,21,954,975,19,"78.95%","89.47%","Peve_00021658",NA,NA,NA,NA,NA,NA,NA,NA
"565",565,"Cluster_11135","Porites_evermani_scaffold_3026:29392-30392",151,-20.99,2,18,787,807,16,"68.75%","87.50%","Peve_00022815",0.837178204545888,0.368407403611606,0.978262075707395,NA,NA,NA,NA,NA
"566",566,"Cluster_11135","Porites_evermani_scaffold_304:78546-79546",160,-25.89,2,21,25,46,19,"63.16%","84.21%","Peve_00022904",NA,NA,NA,"Q13332","Receptor-type tyrosine-protein phosphatase S (R-PTP-S) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase sigma) (R-PTP-sigma)","Homo sapiens (Human)","cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; corpus callosum development [GO:0022038]; establishment of endothelial intestinal barrier [GO:0090557]; hippocampus development [GO:0021766]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of axon extension [GO:0030517]; negative regulation of axon regeneration [GO:0048681]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of dendritic spine development [GO:0061000]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of neuron projection development [GO:0010977]; negative regulation of toll-like receptor 9 signaling pathway [GO:0034164]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of postsynaptic density assembly [GO:0099151]; spinal cord development [GO:0021510]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling [GO:0099537]","GO:0004721; GO:0004725; GO:0005829; GO:0005886; GO:0006470; GO:0008201; GO:0010977; GO:0021510; GO:0021549; GO:0021766; GO:0021987; GO:0022038; GO:0030424; GO:0030426; GO:0030517; GO:0030672; GO:0032687; GO:0032688; GO:0034164; GO:0035335; GO:0035374; GO:0042734; GO:0043204; GO:0043395; GO:0048671; GO:0048681; GO:0050804; GO:0061000; GO:0070062; GO:0090557; GO:0098685; GO:0098839; GO:0098978; GO:0099151; GO:0099537; GO:0099560"
"567",567,"Cluster_11135","Porites_evermani_scaffold_3067:24953-25953",151,-23.62,2,21,497,522,23,"65.22%","69.57%","Peve_00023101",NA,NA,NA,NA,NA,NA,NA,NA
"568",568,"Cluster_11135","Porites_evermani_scaffold_3093:11439-12439",164,-20.32,2,19,538,558,17,"76.47%","94.12%","Peve_00023295",0.932243967010402,0.235696059223277,0.978262075707395,"Q804S5","E3 ubiquitin-protein ligase mib1 (EC 2.3.2.27) (Protein mind bomb) (RING-type E3 ubiquitin transferase mib1)","Danio rerio (Zebrafish) (Brachydanio rerio)","anterior lateral line development [GO:0048899]; blood vessel development [GO:0001568]; blood vessel morphogenesis [GO:0048514]; brain development [GO:0007420]; central nervous system development [GO:0007417]; definitive hemopoiesis [GO:0060216]; determination of left/right symmetry [GO:0007368]; developmental pigmentation [GO:0048066]; diencephalon development [GO:0021536]; digestive tract morphogenesis [GO:0048546]; embryonic camera-type eye development [GO:0031076]; embryonic pattern specification [GO:0009880]; endocytosis [GO:0006897]; endothelial cell development [GO:0001885]; epithelial cell development [GO:0002064]; floor plate formation [GO:0021508]; formation of anatomical boundary [GO:0048859]; generation of neurons [GO:0048699]; glial cell differentiation [GO:0010001]; habenula development [GO:0021986]; hair cell differentiation [GO:0035315]; heart development [GO:0007507]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hemopoiesis [GO:0030097]; hindbrain development [GO:0030902]; inner ear receptor cell differentiation [GO:0060113]; lateral line nerve development [GO:0048892]; melanocyte differentiation [GO:0030318]; neural retina development [GO:0003407]; neurogenesis [GO:0022008]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuron fate specification [GO:0048665]; Notch signaling pathway [GO:0007219]; notochord cell development [GO:0060035]; notochord development [GO:0030903]; optic cup formation involved in camera-type eye development [GO:0003408]; otic vesicle development [GO:0071599]; pigment cell differentiation [GO:0050931]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of protein ubiquitination [GO:0031398]; posterior lateral line development [GO:0048916]; posterior lateral line neuromast primordium migration [GO:0048920]; pronephric duct development [GO:0039022]; pronephros development [GO:0048793]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of glial cell differentiation [GO:0045685]; regulation of neuron differentiation [GO:0045664]; regulation of Notch signaling pathway [GO:0008593]; regulation of receptor internalization [GO:0002090]; regulation of receptor-mediated endocytosis [GO:0048259]; rhombomere boundary formation [GO:0021654]; rhombomere development [GO:0021546]; somitogenesis [GO:0001756]; spinal cord association neuron specification [GO:0021519]; spinal cord development [GO:0021510]; spinal cord motor neuron cell fate specification [GO:0021520]; sprouting angiogenesis [GO:0002040]; taste bud formation [GO:0061195]; trigeminal ganglion development [GO:0061551]; ubiquitin-dependent endocytosis [GO:0070086]; vasculogenesis [GO:0001570]; ventral spinal cord interneuron differentiation [GO:0021514]; ventral spinal cord interneuron specification [GO:0021521]","GO:0000151; GO:0001568; GO:0001570; GO:0001756; GO:0001885; GO:0002040; GO:0002064; GO:0002090; GO:0002244; GO:0003407; GO:0003408; GO:0004842; GO:0005737; GO:0005815; GO:0005886; GO:0006897; GO:0007219; GO:0007368; GO:0007417; GO:0007420; GO:0007507; GO:0008270; GO:0008284; GO:0008593; GO:0009880; GO:0010001; GO:0016567; GO:0021508; GO:0021510; GO:0021514; GO:0021519; GO:0021520; GO:0021521; GO:0021536; GO:0021546; GO:0021654; GO:0021986; GO:0022008; GO:0030097; GO:0030139; GO:0030182; GO:0030318; GO:0030902; GO:0030903; GO:0031076; GO:0031398; GO:0031410; GO:0032991; GO:0035315; GO:0039022; GO:0042802; GO:0045664; GO:0045685; GO:0045747; GO:0048066; GO:0048259; GO:0048471; GO:0048514; GO:0048546; GO:0048663; GO:0048665; GO:0048666; GO:0048699; GO:0048793; GO:0048859; GO:0048892; GO:0048899; GO:0048916; GO:0048920; GO:0050931; GO:0051865; GO:0060035; GO:0060113; GO:0060216; GO:0060218; GO:0061195; GO:0061551; GO:0070086; GO:0071599"
"569",569,"Cluster_11135","Porites_evermani_scaffold_3158:775-1775",151,-25.32,2,21,913,930,19,"68.42%","78.95%","Peve_00023756",NA,NA,NA,"Q5PQ59","Alpha-ketoglutarate-dependent dioxygenase alkB homolog 6 (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 6)","Xenopus laevis (African clawed frog)","","GO:0005634; GO:0005737; GO:0046872; GO:0051213"
"570",570,"Cluster_11135","Porites_evermani_scaffold_3179:8428-9428",160,-20.87,2,18,851,873,17,"82.35%","82.35%","Peve_00023875",NA,NA,NA,NA,NA,NA,NA,NA
"571",571,"Cluster_11135","Porites_evermani_scaffold_318:301526-302526",152,-22.21,2,13,563,584,11,"90.91%","90.91%","Peve_00023888",0.969358480018214,0.158003064261116,0.978262075707395,"Q6GM71","Leucine-rich repeat and WD repeat-containing protein 1 (ORC-associated protein) (ORCA) (Origin recognition complex-associated protein)","Xenopus laevis (African clawed frog)","chromatin organization [GO:0006325]; DNA replication [GO:0006260]; establishment of protein localization to chromatin [GO:0071169]","GO:0000776; GO:0000781; GO:0003682; GO:0005634; GO:0005664; GO:0005721; GO:0005737; GO:0005815; GO:0006260; GO:0006325; GO:0008327; GO:0035064; GO:0071169"
"572",572,"Cluster_11135","Porites_evermani_scaffold_3230:660-1660",162,-21.83,2,19,706,727,17,"70.59%","88.24%","Peve_00024210",0.0416594069809366,0.973471120528434,0.999448381576871,"Q9R062","Glycogenin-1 (GN-1) (GN1) (EC 2.4.1.186)","Mus musculus (Mouse)","glycogen biosynthetic process [GO:0005978]","GO:0005536; GO:0005978; GO:0008466; GO:0016757; GO:0030145; GO:0042803; GO:0102751"
"573",573,"Cluster_11135","Porites_evermani_scaffold_32:442334-443334",160,-22.38,2,18,538,560,17,"82.35%","82.35%","Peve_00023991",0.999999420671888,0.000685263252555419,0.239778920002343,"P34152","Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Focal adhesion kinase-related nonkinase) (FRNK) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK)","Mus musculus (Mouse)","angiogenesis [GO:0001525]; axonogenesis [GO:0007409]; blood vessel development [GO:0001568]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cellular chloride ion homeostasis [GO:0030644]; cellular response to transforming growth factor beta stimulus [GO:0071560]; central nervous system neuron axonogenesis [GO:0021955]; endothelial cell migration [GO:0043542]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; extracellular matrix organization [GO:0030198]; growth hormone receptor signaling pathway [GO:0060396]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell migration [GO:0030336]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of organ growth [GO:0046621]; negative regulation of synapse assembly [GO:0051964]; neuron migration [GO:0001764]; nuclear migration [GO:0007097]; organ growth [GO:0035265]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage proliferation [GO:0120041]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of synaptic transmission [GO:0050806]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of wound healing [GO:0090303]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cell adhesion [GO:0030155]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; regulation of epithelial cell migration [GO:0010632]; regulation of focal adhesion assembly [GO:0051893]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of osteoblast differentiation [GO:0045667]; regulation of protein phosphorylation [GO:0001932]; regulation of substrate adhesion-dependent cell spreading [GO:1900024]; signal complex assembly [GO:0007172]; transforming growth factor beta receptor signaling pathway [GO:0007179]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vasculogenesis [GO:0001570]; vasodilation [GO:0042311]","GO:0000165; GO:0000226; GO:0001525; GO:0001568; GO:0001570; GO:0001725; GO:0001764; GO:0001932; GO:0001934; GO:0003779; GO:0004713; GO:0004715; GO:0004725; GO:0005102; GO:0005178; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0005938; GO:0006468; GO:0007097; GO:0007169; GO:0007172; GO:0007173; GO:0007179; GO:0007229; GO:0007254; GO:0007409; GO:0008284; GO:0008360; GO:0008432; GO:0010507; GO:0010613; GO:0010632; GO:0010634; GO:0010718; GO:0010759; GO:0010763; GO:0014068; GO:0014704; GO:0014911; GO:0016323; GO:0016324; GO:0016477; GO:0016604; GO:0018108; GO:0019901; GO:0019902; GO:0019903; GO:0021955; GO:0022408; GO:0030027; GO:0030154; GO:0030155; GO:0030198; GO:0030307; GO:0030335; GO:0030336; GO:0030644; GO:0031234; GO:0033628; GO:0035265; GO:0036064; GO:0038083; GO:0042127; GO:0042169; GO:0042311; GO:0042383; GO:0042802; GO:0043066; GO:0043197; GO:0043231; GO:0043542; GO:0043548; GO:0044877; GO:0045087; GO:0045202; GO:0045667; GO:0045785; GO:0045860; GO:0046621; GO:0046777; GO:0048013; GO:0048471; GO:0048661; GO:0050766; GO:0050771; GO:0050806; GO:0051893; GO:0051897; GO:0051964; GO:0060252; GO:0060396; GO:0071560; GO:0090303; GO:0098794; GO:0098978; GO:0120041; GO:0140677; GO:1900024; GO:1905274; GO:2000060; GO:2000811"
"574",574,"Cluster_11135","Porites_evermani_scaffold_3266:31923-32923",161,-23.39,2,21,434,455,20,"80.00%","80.00%","Peve_00024409",0.642521666147326,0.555776535249034,0.978262075707395,NA,NA,NA,NA,NA
"575",575,"Cluster_11135","Porites_evermani_scaffold_3337:42077-43077",165,-21.18,2,18,286,307,16,"81.25%","87.50%","Peve_00024887",NA,NA,NA,NA,NA,NA,NA,NA
"576",576,"Cluster_11135","Porites_evermani_scaffold_33:392888-393888",158,-20.49,2,16,465,487,15,"86.67%","86.67%","Peve_00024656",-0.960116486627028,0.180403903147264,0.978262075707395,NA,NA,NA,NA,NA
"577",577,"Cluster_11135","Porites_evermani_scaffold_352:31063-32063",160,-21.12,2,18,219,241,17,"82.35%","82.35%","Peve_00026086",0.983968094909043,0.11414834372044,0.978262075707395,"Q9NVM9","Integrator complex subunit 13 (Cell cycle regulator Mat89Bb homolog) (Germ cell tumor 1) (Protein asunder homolog) (Sarcoma antigen NY-SAR-95)","Homo sapiens (Human)","cell division [GO:0051301]; centrosome localization [GO:0051642]; flagellated sperm motility [GO:0030317]; mitotic spindle organization [GO:0007052]; protein localization to nuclear envelope [GO:0090435]; regulation of fertilization [GO:0080154]; regulation of mitotic cell cycle [GO:0007346]; regulation of transcription elongation by RNA polymerase II [GO:0034243]; snRNA processing [GO:0016180]","GO:0005634; GO:0005654; GO:0005737; GO:0007052; GO:0007346; GO:0016180; GO:0016604; GO:0030317; GO:0032039; GO:0034243; GO:0043231; GO:0051301; GO:0051642; GO:0080154; GO:0090435"
"578",578,"Cluster_11135","Porites_evermani_scaffold_356:170758-171758",168,-20.85,2,17,862,883,15,"86.67%","93.33%","Peve_00026299",-0.0406047375074699,0.974143112694611,0.999448381576871,"Q810N6","Ankyrin repeat domain-containing protein 45","Mus musculus (Mouse)","cell population proliferation [GO:0008283]","GO:0005737; GO:0008283; GO:0030496; GO:0032154; GO:0090543"
"579",579,"Cluster_11135","Porites_evermani_scaffold_35:751286-752286",157,-22.98,2,18,550,571,16,"68.75%","87.50%","Peve_00025940",0.755334875783236,0.45494845462411,0.978262075707395,"F1MM41","E3 ubiquitin-protein ligase ZNRF1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase ZNRF1) (Zinc/RING finger protein 1)","Bos taurus (Bovine)","proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]","GO:0004842; GO:0005737; GO:0005764; GO:0005768; GO:0016020; GO:0030672; GO:0043161; GO:0043231; GO:0046872; GO:0061630; GO:0070936"
"580",580,"Cluster_11135","Porites_evermani_scaffold_3673:22642-23642",168,-21.41,2,21,331,352,19,"68.42%","89.47%","Peve_00026937",0.977763101014741,0.134505583791596,0.978262075707395,NA,NA,NA,NA,NA
"581",581,"Cluster_11135","Porites_evermani_scaffold_3745:17719-18719",149,-20.37,2,14,975,996,12,"75.00%","91.67%","Peve_00027311",NA,NA,NA,NA,NA,NA,NA,NA
"582",582,"Cluster_11135","Porites_evermani_scaffold_3816:29622-30622",161,-20.83,2,20,225,245,18,"72.22%","88.89%","Peve_00027719",0.0945169791258652,0.939738670421808,0.999448381576871,"Q6PBI5","40S ribosomal protein S25","Danio rerio (Zebrafish) (Brachydanio rerio)","","GO:0003735; GO:0022627"
"583",583,"Cluster_11135","Porites_evermani_scaffold_3886:33516-34516",160,-20.87,2,18,830,852,17,"82.35%","82.35%","Peve_00028069",-0.86371539504103,0.336262863454594,0.978262075707395,NA,NA,NA,NA,NA
"584",584,"Cluster_11135","Porites_evermani_scaffold_38:87238-88238",161,-21.14,2,20,127,150,20,"80.00%","80.00%","Peve_00027595",0.958905535521087,0.183140913183423,0.978262075707395,"Q3URF8","BTB/POZ domain-containing protein KCTD21 (KCASH2 protein) (Potassium channel tetramerization domain-containing protein 21)","Mus musculus (Mouse)","negative regulation of smoothened signaling pathway [GO:0045879]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0006511; GO:0016567; GO:0042802; GO:0042826; GO:0045879; GO:0051260; GO:0097602"
"585",585,"Cluster_11135","Porites_evermani_scaffold_4031:22620-23620",151,-21.96,2,18,237,257,16,"68.75%","87.50%","Peve_00029011",NA,NA,NA,"B8VIU6","Uncharacterized skeletal organic matrix protein 5 (Uncharacterized SOMP-5)","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0005576"
"586",586,"Cluster_11135","Porites_evermani_scaffold_404:230393-231393",157,-21.31,2,21,169,192,22,"68.18%","81.82%","Peve_00029052",0.787764391761977,0.422476905498312,0.978262075707395,NA,NA,NA,NA,NA
"587",587,"Cluster_11135","Porites_evermani_scaffold_405:217033-218033",157,-22.36,2,18,968,987,16,"87.50%","87.50%","Peve_00029093",NA,NA,NA,NA,NA,NA,NA,NA
"588",588,"Cluster_11135","Porites_evermani_scaffold_4054:0-362",160,-20.87,2,18,71,93,17,"82.35%","82.35%","Peve_00029139",0.890313508982585,0.300970347275884,0.978262075707395,"Q9WTN5","Two pore calcium channel protein 1 (Voltage-dependent calcium channel protein TPC1)","Rattus norvegicus (Rat)","endocytosis involved in viral entry into host cell [GO:0075509]; positive regulation of autophagy [GO:0010508]; regulation of ion transmembrane transport [GO:0034765]; sodium ion transmembrane transport [GO:0035725]","GO:0005244; GO:0005248; GO:0005765; GO:0010008; GO:0010508; GO:0015280; GO:0016020; GO:0019905; GO:0031901; GO:0034765; GO:0035725; GO:0036019; GO:0042802; GO:0042803; GO:0055038; GO:0072345; GO:0075509; GO:0080025; GO:0097682"
"589",589,"Cluster_11135","Porites_evermani_scaffold_408:26422-27422",149,-20.35,2,19,728,752,20,"65.00%","75.00%","Peve_00029263",0.965029144088679,0.168858171713333,0.978262075707395,NA,NA,NA,NA,NA
"590",590,"Cluster_11135","Porites_evermani_scaffold_4097:3187-4187",150,-20.35,2,20,409,433,21,"61.90%","76.19%","Peve_00029321",NA,NA,NA,NA,NA,NA,NA,NA
"591",591,"Cluster_11135","Porites_evermani_scaffold_414:112652-113652",165,-21.35,2,21,865,888,22,"77.27%","81.82%","Peve_00029572",0.513230661910051,0.656897076301109,0.978262075707395,"Q9EP71","Ankycorbin (Ankyrin repeat and coiled-coil structure-containing protein) (Novel retinal pigment epithelial cell protein) (Retinoic acid-induced protein 14) (p125)","Mus musculus (Mouse)","cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]","GO:0001650; GO:0003779; GO:0005654; GO:0005739; GO:0005829; GO:0005856; GO:0005938; GO:0007283; GO:0030154; GO:0070161"
"592",592,"Cluster_11135","Porites_evermani_scaffold_418:92843-93843",160,-21.52,2,20,477,498,19,"73.68%","89.47%","Peve_00029724",0.928316512562214,0.242512305188535,0.978262075707395,"Q8QGW7","Lipopolysaccharide-induced tumor necrosis factor-alpha factor homolog (LPS-induced TNF-alpha factor homolog) (Small integral membrane protein of lysosome/late endosome)","Gallus gallus (Chicken)","cytokine production [GO:0001816]; sexual reproduction [GO:0019953]","GO:0000139; GO:0001816; GO:0003677; GO:0005125; GO:0005634; GO:0005765; GO:0008270; GO:0009898; GO:0019953; GO:0098559; GO:0098560; GO:0098574"
"593",593,"Cluster_11135","Porites_evermani_scaffold_4306:12644-13644",156,-22.25,2,18,664,687,18,"77.78%","77.78%","Peve_00030477",0.926309352711956,0.24592633647409,0.978262075707395,"Q87NG3","Glycine betaine transporter 1","Vibrio parahaemolyticus serotype O3:K6 (strain RIMD 2210633)","amino acid transport [GO:0006865]","GO:0005886; GO:0006865; GO:0022857"
"594",594,"Cluster_11135","Porites_evermani_scaffold_4346:23701-24701",165,-20.13,2,18,88,109,16,"81.25%","87.50%","Peve_00030648",0.581586809893561,0.604864133781363,0.978262075707395,"Q16994","Antho-RFamide neuropeptides type 2 [Cleaved into: Antho-RFamide]","Anthopleura elegantissima (Green aggregating anemone) (Actinia elegantissima)","neuropeptide signaling pathway [GO:0007218]","GO:0005576; GO:0007218"
"595",595,"Cluster_11135","Porites_evermani_scaffold_438:131526-132526",154,-20.09,2,15,690,711,13,"76.92%","92.31%","Peve_00030788",NA,NA,NA,NA,NA,NA,NA,NA
"596",596,"Cluster_11135","Porites_evermani_scaffold_439:231901-232901",151,-22.1,2,21,619,643,22,"63.64%","72.73%","Peve_00030840",0.999931466060162,0.00745333172287407,0.573710369894872,NA,NA,NA,NA,NA
"597",597,"Cluster_11135","Porites_evermani_scaffold_4409:22352-23352",159,-21.09,2,17,730,753,17,"82.35%","82.35%","Peve_00031011",0.917931391622346,0.259716502014643,0.978262075707395,"P20611","Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)","Rattus norvegicus (Rat)","autophagic cell death [GO:0048102]; chemical synaptic transmission [GO:0007268]; dephosphorylation [GO:0016311]; lysosome organization [GO:0007040]; response to organic substance [GO:0010033]; skeletal system development [GO:0001501]","GO:0001501; GO:0001784; GO:0003993; GO:0004721; GO:0005764; GO:0005765; GO:0007040; GO:0007268; GO:0010033; GO:0016311; GO:0016791; GO:0031410; GO:0043005; GO:0043202; GO:0045202; GO:0048102"
"598",598,"Cluster_11135","Porites_evermani_scaffold_4433:25231-26231",153,-22.25,2,21,967,988,20,"65.00%","85.00%","Peve_00031149",0.844443877729655,0.359862212804899,0.978262075707395,"Q7ZY79","Apoptosis inhibitor 5-B (API-5B)","Xenopus laevis (African clawed frog)","apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]","GO:0005634; GO:0006915; GO:0017134; GO:0043066"
"599",599,"Cluster_11135","Porites_evermani_scaffold_44:359104-360104",172,-23.69,2,21,162,181,19,"89.47%","89.47%","Peve_00030875",0.844443877729655,0.359862212804899,0.978262075707395,NA,NA,NA,NA,NA
"600",600,"Cluster_11135","Porites_evermani_scaffold_4553:12242-13242",160,-20.87,2,18,633,655,17,"82.35%","82.35%","Peve_00031666",0.350044329007132,0.772333038911078,0.991524179071703,NA,NA,NA,NA,NA
"601",601,"Cluster_11135","Porites_evermani_scaffold_485:95609-96609",162,-20.09,2,21,262,288,24,"70.83%","79.17%","Peve_00032958",0.666339946698889,0.535719947371139,0.978262075707395,NA,NA,NA,NA,NA
"602",602,"Cluster_11135","Porites_evermani_scaffold_499:145536-146536",154,-20.96,2,16,15,38,16,"75.00%","87.50%","Peve_00033474",0.844443877729655,0.359862212804899,0.978262075707395,"Q8N468","Major facilitator superfamily domain-containing protein 4A (Major facilitator superfamily domain-containing protein 4)","Homo sapiens (Human)","","GO:0005355; GO:0016020"
"603",603,"Cluster_11135","Porites_evermani_scaffold_5:1251981-1252981",158,-20.46,2,16,658,680,15,"80.00%","93.33%","Peve_00033569",0.844443877729655,0.359862212804899,0.978262075707395,"I3PB37","4-coumarate:CoA ligase 1 (Ph-4CL1) (Ph4CL1) (EC 6.2.1.12) ((E)-caffeate:CoA ligase 4CL1) (EC 6.2.1.-) (Benzoate:CoA ligase 4CL1) (EC 6.2.1.25) (Trans-cinnamate:CoA ligase 4CL1) (EC 6.2.1.-) (Trans-ferulate:CoA ligase 4CL1) (EC 6.2.1.-)","Petunia hybrida (Petunia)","cinnamic acid biosynthetic process [GO:0009800]; cinnamic acid metabolic process [GO:0009803]; circadian rhythm [GO:0007623]; ferulate metabolic process [GO:0033494]; phenylpropanoid metabolic process [GO:0009698]; phytoalexin biosynthetic process [GO:0052315]","GO:0005524; GO:0005829; GO:0007623; GO:0009698; GO:0009800; GO:0009803; GO:0016207; GO:0016405; GO:0018858; GO:0033494; GO:0050563; GO:0052315; GO:0106286; GO:0106290"
"604",604,"Cluster_11135","Porites_evermani_scaffold_5127:2501-3501",155,-22.26,2,19,685,704,17,"76.47%","82.35%","Peve_00034151",NA,NA,NA,NA,NA,NA,NA,NA
"605",605,"Cluster_11135","Porites_evermani_scaffold_5315:949-1949",155,-20.59,2,21,849,872,21,"61.90%","80.95%","Peve_00034818",0.804869522213843,0.404470486094047,0.978262075707395,"Q5EA25","Sushi repeat-containing protein SRPX2","Bos taurus (Bovine)","angiogenesis [GO:0001525]; cell motility [GO:0048870]; cell-cell adhesion [GO:0098609]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of synapse assembly [GO:0051965]; regulation of phosphorylation [GO:0042325]","GO:0001525; GO:0005102; GO:0005615; GO:0005737; GO:0009986; GO:0036458; GO:0042325; GO:0042802; GO:0048870; GO:0051965; GO:0060076; GO:0090050; GO:0097060; GO:0098609"
"606",606,"Cluster_11135","Porites_evermani_scaffold_539:73154-73405",169,-21.44,2,20,15,35,18,"77.78%","94.44%","Peve_00035064",NA,NA,NA,NA,NA,NA,NA,NA
"607",607,"Cluster_11135","Porites_evermani_scaffold_54:360313-361313",170,-22.93,2,21,920,943,21,"80.95%","85.71%","Peve_00035103",NA,NA,NA,NA,NA,NA,NA,NA
"608",608,"Cluster_11135","Porites_evermani_scaffold_54:588966-589966",160,-22.17,2,18,825,847,17,"76.47%","88.24%","Peve_00035123",0.952247196283311,0.197532300906371,0.978262075707395,"Q96RL7","Intermembrane lipid transfer protein VPS13A (Chorea-acanthocytosis protein) (Chorein) (Vacuolar protein sorting-associated protein 13A)","Homo sapiens (Human)","autophagy [GO:0006914]; flagellated sperm motility [GO:0030317]; Golgi to endosome transport [GO:0006895]; lipid transport [GO:0006869]; locomotory behavior [GO:0007626]; lysosomal protein catabolic process [GO:1905146]; nervous system development [GO:0007399]; protein localization [GO:0008104]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]; social behavior [GO:0035176]; sperm mitochondrion organization [GO:0030382]","GO:0005741; GO:0005765; GO:0005789; GO:0005794; GO:0005811; GO:0005829; GO:0006623; GO:0006869; GO:0006895; GO:0006914; GO:0007399; GO:0007626; GO:0008104; GO:0010008; GO:0019898; GO:0030317; GO:0030382; GO:0031966; GO:0035176; GO:0044233; GO:0045053; GO:0097225; GO:0099013; GO:1905146"
"609",609,"Cluster_11135","Porites_evermani_scaffold_5503:10988-11988",150,-21.46,2,19,711,732,17,"64.71%","76.47%","Peve_00035509",NA,NA,NA,NA,NA,NA,NA,NA
"610",610,"Cluster_11135","Porites_evermani_scaffold_56:597487-598487",151,-20.2,2,20,390,411,18,"66.67%","72.22%","Peve_00035806",-0.886103284710592,0.306804453861767,0.978262075707395,NA,NA,NA,NA,NA
"611",611,"Cluster_11135","Porites_evermani_scaffold_5660:405-986",163,-20.38,2,16,369,390,14,"85.71%","92.86%","Peve_00035969",0.973665178856246,0.146425943662493,0.978262075707395,"A7RKF6","RNA-splicing ligase RtcB homolog (EC 6.5.1.8) (3'-phosphate/5'-hydroxy nucleic acid ligase)","Nematostella vectensis (Starlet sea anemone)","tRNA exon ligation utilizing 2',3' cyclic phosphate of 5'-exon as source of linkage phosphate [GO:0000971]","GO:0000971; GO:0003972; GO:0005525; GO:0005634; GO:0046872; GO:0072669"
"612",612,"Cluster_11135","Porites_evermani_scaffold_6104:2759-3759",155,-20.91,2,20,617,636,18,"72.22%","88.89%","Peve_00037371",0.793126855309448,0.416903458744124,0.978262075707395,NA,NA,NA,NA,NA
"613",613,"Cluster_11135","Porites_evermani_scaffold_6133:2755-3755",158,-21.67,2,20,678,700,19,"68.42%","84.21%","Peve_00037431",0.844443877729655,0.359862212804899,0.978262075707395,"P49285","Melatonin receptor type 1A (Mel-1A-R) (Mel1a receptor) (CKA)","Gallus gallus (Chicken)","adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; circadian rhythm [GO:0007623]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of glucose import [GO:0046325]; negative regulation of glycolytic process [GO:0045820]","GO:0004930; GO:0005886; GO:0007186; GO:0007193; GO:0007623; GO:0008502; GO:0042562; GO:0043235; GO:0045820; GO:0046325; GO:1904408"
"614",614,"Cluster_11135","Porites_evermani_scaffold_614:185739-186739",147,-20.01,2,13,195,217,12,"83.33%","91.67%","Peve_00037439",NA,NA,NA,NA,NA,NA,NA,NA
"615",615,"Cluster_11135","Porites_evermani_scaffold_659:44402-44910",160,-20.87,2,18,24,46,17,"82.35%","82.35%","Peve_00038580",0.733456190737752,0.475811925396534,0.978262075707395,"Q3UM45","Protein phosphatase 1 regulatory subunit 7 (Protein phosphatase 1 regulatory subunit 22)","Mus musculus (Mouse)","chromosome segregation [GO:0007059]; positive regulation of protein dephosphorylation [GO:0035307]","GO:0000164; GO:0004865; GO:0005634; GO:0005694; GO:0007059; GO:0035307"
"616",616,"Cluster_11135","Porites_evermani_scaffold_659:44402-44910",160,-20.87,2,18,24,46,17,"82.35%","82.35%","Peve_00038581",0.355821925476389,0.768401925577763,0.990527675986719,"Q9JHG1","Phosphatidylinositol N-acetylglucosaminyltransferase subunit P (Down syndrome critical region protein 5 homolog) (Phosphatidylinositol-glycan biosynthesis class P protein) (PIG-P)","Mus musculus (Mouse)","GPI anchor biosynthetic process [GO:0006506]","GO:0000506; GO:0005783; GO:0006506; GO:0017176"
"617",617,"Cluster_11135","Porites_evermani_scaffold_70:433557-434557",156,-20.21,2,21,278,300,21,"76.19%","80.95%","Peve_00039630",0.499313110331664,0.667171487323482,0.978262075707395,"B3EWY9","Mucin-like protein","Acropora millepora (Staghorn coral) (Heteropora millepora)","cell-matrix adhesion [GO:0007160]","GO:0005509; GO:0007160; GO:0016020"
"618",618,"Cluster_11135","Porites_evermani_scaffold_731:84683-85127",154,-20.65,2,15,91,112,13,"76.92%","92.31%","Peve_00040315",0.860233688759217,0.340635204632341,0.978262075707395,"P53492","Actin-7 (EC 3.6.4.-) (Actin-2)","Arabidopsis thaliana (Mouse-ear cress)","cell division [GO:0051301]; Golgi to plasma membrane transport [GO:0006893]; protein localization [GO:0008104]; protein transport [GO:0015031]; response to auxin [GO:0009733]; response to light stimulus [GO:0009416]; response to wounding [GO:0009611]; root development [GO:0048364]; root epidermal cell differentiation [GO:0010053]; root hair elongation [GO:0048767]; seed germination [GO:0009845]","GO:0005200; GO:0005524; GO:0005730; GO:0005739; GO:0005829; GO:0005856; GO:0005886; GO:0006893; GO:0008104; GO:0009416; GO:0009505; GO:0009506; GO:0009570; GO:0009611; GO:0009733; GO:0009845; GO:0009941; GO:0010053; GO:0015031; GO:0016787; GO:0048364; GO:0048767; GO:0051301"
"619",619,"Cluster_11135","Porites_evermani_scaffold_731:84683-85127",154,-20.65,2,15,91,112,13,"76.92%","92.31%","Peve_00040316",-0.350647702609858,0.771922926556141,0.991430209618377,"P40936","Indolethylamine N-methyltransferase (Indolamine N-methyltransferase) (EC 2.1.1.49) (EC 2.1.1.96) (Aromatic alkylamine N-methyltransferase) (Amine N-methyltransferase) (Arylamine N-methyltransferase) (Thioether S-methyltransferase) (TEMT)","Mus musculus (Mouse)","amine metabolic process [GO:0009308]; methylation [GO:0032259]; response to toxic substance [GO:0009636]","GO:0004790; GO:0005829; GO:0008170; GO:0009308; GO:0009636; GO:0030748; GO:0032259; GO:0098615; GO:0102707"
"620",620,"Cluster_11135","Porites_evermani_scaffold_7:386880-387880",164,-21.63,2,21,101,121,20,"80.00%","85.00%","Peve_00039526",NA,NA,NA,NA,NA,NA,NA,NA
"621",621,"Cluster_11135","Porites_evermani_scaffold_803:182524-183524",153,-21.36,2,15,239,261,14,"78.57%","92.86%","Peve_00041861",0.585170107429525,0.602055464111145,0.978262075707395,NA,NA,NA,NA,NA
"622",622,"Cluster_11135","Porites_evermani_scaffold_914:117551-118551",160,-22.25,2,18,393,415,17,"76.47%","88.24%","Peve_00043996",0.834681265554529,0.371303733779054,0.978262075707395,"Q64459","Cytochrome P450 3A11 (EC 1.14.14.1) (CYPIIIA11) (Cytochrome P-450IIIAM1) (Cytochrome P-450UT)","Mus musculus (Mouse)","alkaloid catabolic process [GO:0009822]; estrogen metabolic process [GO:0008210]; lipid hydroxylation [GO:0002933]; oxidative demethylation [GO:0070989]; response to bacterium [GO:0009617]; retinoic acid metabolic process [GO:0042573]; steroid metabolic process [GO:0008202]; xenobiotic catabolic process [GO:0042178]","GO:0002933; GO:0004497; GO:0005506; GO:0005789; GO:0008202; GO:0008210; GO:0008395; GO:0008401; GO:0009617; GO:0009822; GO:0016491; GO:0020037; GO:0032451; GO:0042178; GO:0042573; GO:0043231; GO:0050649; GO:0070330; GO:0070989; GO:0101020"
"623",623,"Cluster_11135","Porites_evermani_scaffold_91:501826-502826",161,-21.36,2,20,905,925,18,"77.78%","83.33%","Peve_00043892",-0.929649058906928,0.240220270845687,0.978262075707395,"Q86VD9","GPI mannosyltransferase 4 (EC 2.4.1.-) (GPI mannosyltransferase IV) (GPI-MT-IV) (Phosphatidylinositol-glycan biosynthesis class Z protein) (PIG-Z) (SMP3 homolog) (hSMP3)","Homo sapiens (Human)","GPI anchor biosynthetic process [GO:0006506]; preassembly of GPI anchor in ER membrane [GO:0016254]","GO:0000026; GO:0000030; GO:0005783; GO:0005789; GO:0006506; GO:0016254"
"624",624,"Cluster_11135","Porites_evermani_scaffold_917:109854-110854",158,-24.36,2,17,603,623,15,"80.00%","93.33%","Peve_00044037",NA,NA,NA,NA,NA,NA,NA,NA
"625",625,"Cluster_11135","Porites_evermani_scaffold_945:143136-144136",164,-23.7,2,18,147,169,17,"82.35%","88.24%","Peve_00044491",NA,NA,NA,NA,NA,NA,NA,NA
"626",626,"Cluster_11135","Porites_evermani_scaffold_968:56107-57107",167,-26.74,2,16,799,820,14,"85.71%","100.00%","Peve_00044854",NA,NA,NA,NA,NA,NA,NA,NA
"627",627,"Cluster_11135","Porites_evermani_scaffold_969:97683-98683",159,-20.89,2,21,623,642,20,"80.00%","80.00%","Peve_00044881",NA,NA,NA,NA,NA,NA,NA,NA
"628",628,"Cluster_11135","Porites_evermani_scaffold_993:55961-56961",156,-22.84,2,21,503,524,19,"57.89%","84.21%","Peve_00045270",-0.778317995412513,0.432146337937152,0.978262075707395,"Q9NW08","DNA-directed RNA polymerase III subunit RPC2 (RNA polymerase III subunit C2) (EC 2.7.7.6) (C128) (DNA-directed RNA polymerase III 127.6 kDa polypeptide) (DNA-directed RNA polymerase III subunit B)","Homo sapiens (Human)","defense response to virus [GO:0051607]; DNA-templated transcription [GO:0006351]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]","GO:0003677; GO:0003899; GO:0005654; GO:0005666; GO:0005829; GO:0006351; GO:0032549; GO:0032728; GO:0045087; GO:0045089; GO:0046872; GO:0051607"
"629",629,"Cluster_1140","Porites_evermani_scaffold_1764:85221-86221",177,-20.23,2,21,958,977,19,"89.47%","89.47%","Peve_00010713",0.123911893224521,0.920911962905627,0.999448381576871,"Q7RTR2","NLR family CARD domain-containing protein 3 (CARD15-like protein) (Caterpiller protein 16.2) (CLR16.2) (NACHT, LRR and CARD domains-containing protein 3) (Nucleotide-binding oligomerization domain protein 3)","Homo sapiens (Human)","I-kappaB kinase/NF-kappaB signaling [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of tumor necrosis factor production [GO:0032720]; T cell activation [GO:0042110]","GO:0005524; GO:0005737; GO:0005829; GO:0007249; GO:0014067; GO:0032088; GO:0032687; GO:0032688; GO:0032715; GO:0032720; GO:0034451; GO:0035556; GO:0036312; GO:0042110; GO:0043124; GO:0043231; GO:0045824; GO:0048147; GO:0048471; GO:0050680; GO:0050728; GO:1900016; GO:1900226; GO:1901223"
"630",630,"Cluster_1140","Porites_evermani_scaffold_450:67789-68789",170,-20.15,2,20,489,511,19,"78.95%","89.47%","Peve_00031475",0.572504791676501,0.61194357951493,0.978262075707395,"E7FAM5","E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71)","Danio rerio (Zebrafish) (Brachydanio rerio)","embryonic body morphogenesis [GO:0010172]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA metabolic process [GO:0010586]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of translation [GO:0017148]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of miRNA-mediated gene silencing [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089]","GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0010172; GO:0010586; GO:0017148; GO:0021915; GO:0030371; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0060964; GO:0061630; GO:0072089; GO:2000177"
"631",631,"Cluster_1140","Porites_evermani_scaffold_450:68201-69201",170,-20.15,2,20,77,99,19,"78.95%","89.47%","Peve_00031477",NA,NA,NA,NA,NA,NA,NA,NA
"632",632,"Cluster_1140","Porites_evermani_scaffold_480:146361-147190",196,-29.08,2,21,752,773,19,"94.74%","100.00%","Peve_00032772",0.709188629708108,0.498122907759411,0.978262075707395,NA,NA,NA,NA,NA
"633",633,"Cluster_1140","Porites_evermani_scaffold_64:121968-122968",184,-20.94,2,21,104,125,19,"84.21%","94.74%","Peve_00038128",-0.914915026563122,0.264514860239055,0.978262075707395,NA,NA,NA,NA,NA
"634",634,"Cluster_1167","Porites_evermani_scaffold_1038:121490-122490",152,-23.21,2,13,483,504,11,"90.91%","90.91%","Peve_00000784",0.965782715685222,0.167018314801323,0.978262075707395,NA,NA,NA,NA,NA
"635",635,"Cluster_1167","Porites_evermani_scaffold_1050:86266-86716",145,-22.17,2,10,331,352,8,"100.00%","100.00%","Peve_00001031",NA,NA,NA,NA,NA,NA,NA,NA
"636",636,"Cluster_1167","Porites_evermani_scaffold_1061:8364-9364",152,-20.4,2,19,634,654,17,"76.47%","76.47%","Peve_00001178",0.960506150441491,0.179514547161534,0.978262075707395,NA,NA,NA,NA,NA
"637",637,"Cluster_1167","Porites_evermani_scaffold_1074:28268-29268",147,-21.15,2,17,227,250,17,"70.59%","76.47%","Peve_00001371",-0.273022548984371,0.823953271201243,0.995934364227446,"Q91398","Casein kinase II subunit beta (CK II beta)","Danio rerio (Zebrafish) (Brachydanio rerio)","regulation of protein serine/threonine phosphatase activity [GO:0080163]; Wnt signaling pathway [GO:0016055]","GO:0005737; GO:0005956; GO:0016055; GO:0019887; GO:0046872; GO:0080163"
"638",638,"Cluster_1167","Porites_evermani_scaffold_1082:86413-87413",155,-21.98,2,16,285,306,14,"78.57%","85.71%","Peve_00001485",0.999909726776791,0.00855416971793915,0.573710369894872,NA,NA,NA,NA,NA
"639",639,"Cluster_1167","Porites_evermani_scaffold_1087:61454-62454",154,-23.08,2,21,464,484,19,"63.16%","84.21%","Peve_00001544",0.999909726776791,0.00855416971793915,0.573710369894872,"O35474","EGF-like repeat and discoidin I-like domain-containing protein 3 (Developmentally-regulated endothelial cell locus 1 protein) (Integrin-binding protein DEL1)","Mus musculus (Mouse)","cell adhesion [GO:0007155]; positive regulation of cell-substrate adhesion [GO:0010811]","GO:0005509; GO:0005576; GO:0007155; GO:0010811"
"640",640,"Cluster_1167","Porites_evermani_scaffold_114:121368-122368",151,-24.26,2,21,799,822,21,"61.90%","76.19%","Peve_00002400",0.988843283534253,0.0951848702730355,0.978262075707395,"Q5EA75","Ethanolamine-phosphate cytidylyltransferase (EC 2.7.7.14) (CTP:phosphoethanolamine cytidylyltransferase) (Phosphorylethanolamine transferase)","Bos taurus (Bovine)","phosphatidylethanolamine biosynthetic process [GO:0006646]","GO:0004306; GO:0005737; GO:0006646"
"641",641,"Cluster_1167","Porites_evermani_scaffold_1143:85437-86437",148,-22.32,2,19,190,210,17,"70.59%","76.47%","Peve_00002461",0.846685325470818,0.357189370060056,0.978262075707395,NA,NA,NA,NA,NA
"642",642,"Cluster_1167","Porites_evermani_scaffold_1148:80684-81684",155,-23.27,2,20,219,237,18,"77.78%","77.78%","Peve_00002512",-0.955655081378111,0.190298409068097,0.978262075707395,"Q3ZBA6","DnaJ homolog subfamily B member 11 (ER-associated DNAJ) (ER-associated Hsp40 co-chaperone) (Endoplasmic reticulum DNA J domain-containing protein 3) (ER-resident protein ERdj3) (ERdj3) (ERj3p)","Bos taurus (Bovine)","mRNA modification [GO:0016556]; negative regulation of neurogenesis [GO:0050768]; positive regulation of ATP-dependent activity [GO:0032781]; protein folding [GO:0006457]; protein maturation [GO:0051604]","GO:0005102; GO:0005615; GO:0005634; GO:0005783; GO:0005788; GO:0006457; GO:0016556; GO:0032781; GO:0050768; GO:0051082; GO:0051604; GO:0051787; GO:0101031"
"643",643,"Cluster_1167","Porites_evermani_scaffold_117:159842-160842",155,-22.32,2,16,402,423,14,"78.57%","85.71%","Peve_00002857",0.991638430820378,0.0823838520742093,0.978262075707395,"Q7ZXE2","CUGBP Elav-like family member 2 (CELF-2) (Bruno-like protein 3) (CUG triplet repeat RNA-binding protein 2) (CUG-BP2) (CUG-BP- and ETR-3-like factor 2) (ELAV-type RNA-binding protein 3) (ETR-3) (RNA-binding protein BRUNOL-3)","Xenopus laevis (African clawed frog)","mRNA processing [GO:0006397]","GO:0003723; GO:0005634; GO:0005737; GO:0006397"
"644",644,"Cluster_1167","Porites_evermani_scaffold_118:390399-391399",159,-23.79,2,17,69,92,17,"82.35%","82.35%","Peve_00003009",NA,NA,NA,"Q708S6","Acid-sensing ion channel 1C (ASIC1-C) (Acid-sensing ion channel 1.3-C) (Amiloride-sensitive cation channel 2-C, neuronal-C) (ZASIC1.3)","Danio rerio (Zebrafish) (Brachydanio rerio)","cellular response to pH [GO:0071467]; protein homotrimerization [GO:0070207]; sodium ion transmembrane transport [GO:0035725]","GO:0005261; GO:0005886; GO:0015280; GO:0035725; GO:0044736; GO:0070207; GO:0071467"
"645",645,"Cluster_1167","Porites_evermani_scaffold_1196:15249-16249",150,-21.09,2,21,46,69,21,"66.67%","76.19%","Peve_00003269",0.999909726776791,0.00855416971793915,0.573710369894872,NA,NA,NA,NA,NA
"646",646,"Cluster_1167","Porites_evermani_scaffold_1207:141219-142219",168,-24.38,2,21,739,760,19,"78.95%","78.95%","Peve_00003494",0.975906704651317,0.140029347725064,0.978262075707395,"A6H603","NACHT domain- and WD repeat-containing protein 1","Mus musculus (Mouse)","negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of gene expression [GO:0010628]","GO:0005524; GO:0005730; GO:0005829; GO:0010628; GO:0032088"
"647",647,"Cluster_1167","Porites_evermani_scaffold_1207:14720-15720",155,-22.07,2,21,487,509,20,"65.00%","80.00%","Peve_00003482",0.569810075093483,0.614033524724486,0.978262075707395,"Q6P5I8","Protein YIPF5 (YIP1 family member 5)","Danio rerio (Zebrafish) (Brachydanio rerio)","endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; vesicle fusion with Golgi apparatus [GO:0048280]","GO:0005789; GO:0005802; GO:0006888; GO:0015031; GO:0048280; GO:0060628"
"648",648,"Cluster_1167","Porites_evermani_scaffold_1217:57781-58781",155,-21.38,2,12,387,408,10,"100.00%","100.00%","Peve_00003627",-0.16477972369789,0.89461735096146,0.999448381576871,NA,NA,NA,NA,NA
"649",649,"Cluster_1167","Porites_evermani_scaffold_1235:131744-132744",159,-24.33,2,16,194,215,14,"85.71%","85.71%","Peve_00003875",NA,NA,NA,NA,NA,NA,NA,NA
"650",650,"Cluster_1167","Porites_evermani_scaffold_1235:71067-72067",143,-25.99,2,20,586,606,19,"68.42%","73.68%","Peve_00003869",-0.511591173923624,0.65811249694873,0.978262075707395,"Q04652","Ring canal kelch protein [Cleaved into: Kelch short protein]","Drosophila melanogaster (Fruit fly)","actin cytoskeleton organization [GO:0030036]; cellularization [GO:0007349]; female germline ring canal formation [GO:0007301]; follicle cell of egg chamber migration [GO:0007297]; oocyte karyosome formation [GO:0030717]; oogenesis [GO:0048477]; ovarian fusome organization [GO:0030723]; ovarian nurse cell to oocyte transport [GO:0007300]","GO:0003779; GO:0005737; GO:0005856; GO:0007297; GO:0007300; GO:0007301; GO:0007349; GO:0030036; GO:0030717; GO:0030723; GO:0035183; GO:0035324; GO:0045172; GO:0048477"
"651",651,"Cluster_1167","Porites_evermani_scaffold_1251:32384-33384",153,-20.25,2,20,485,505,18,"72.22%","77.78%","Peve_00004115",0.972925268735248,0.148477951024393,0.978262075707395,NA,NA,NA,NA,NA
"652",652,"Cluster_1167","Porites_evermani_scaffold_1265:87056-88056",141,-24.05,2,17,782,807,19,"73.68%","73.68%","Peve_00004286",NA,NA,NA,"F1NY98","Cell adhesion molecule DSCAM (Down syndrome cell adhesion molecule homolog)","Gallus gallus (Chicken)","axon guidance [GO:0007411]; camera-type eye photoreceptor cell differentiation [GO:0060219]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; locomotory behavior [GO:0007626]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of phosphorylation [GO:0042327]; post-embryonic retina morphogenesis in camera-type eye [GO:0060060]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]","GO:0005886; GO:0007156; GO:0007162; GO:0007411; GO:0007416; GO:0007626; GO:0010842; GO:0030425; GO:0030426; GO:0042327; GO:0043025; GO:0045202; GO:0048813; GO:0048842; GO:0060060; GO:0060219; GO:0070593; GO:1990782; GO:1990890"
"653",653,"Cluster_1167","Porites_evermani_scaffold_1307:122978-123978",148,-20.96,2,21,689,707,19,"68.42%","73.68%","Peve_00004884",0.696067656033044,0.509862702582939,0.978262075707395,NA,NA,NA,NA,NA
"654",654,"Cluster_1167","Porites_evermani_scaffold_1309:103014-104014",142,-21.05,2,21,845,871,24,"58.33%","70.83%","Peve_00004904",-0.0350210593665652,0.977700341245457,0.999448381576871,NA,NA,NA,NA,NA
"655",655,"Cluster_1167","Porites_evermani_scaffold_1330:26007-27007",150,-22.05,2,21,448,473,23,"65.22%","73.91%","Peve_00005227",NA,NA,NA,NA,NA,NA,NA,NA
"656",656,"Cluster_1167","Porites_evermani_scaffold_1331:79978-80978",150,-25.11,2,19,455,476,17,"64.71%","76.47%","Peve_00005255",0.999909726776791,0.00855416971793915,0.573710369894872,NA,NA,NA,NA,NA
"657",657,"Cluster_1167","Porites_evermani_scaffold_1334:104759-105759",145,-22.45,2,16,146,170,17,"76.47%","76.47%","Peve_00005281",0.70817728585047,0.499035476154869,0.978262075707395,"A1L1W9","Monocarboxylate transporter 10 (MCT 10) (Solute carrier family 16 member 10)","Danio rerio (Zebrafish) (Brachydanio rerio)","aromatic amino acid transport [GO:0015801]; thyroid hormone transport [GO:0070327]","GO:0005302; GO:0015173; GO:0015192; GO:0015196; GO:0015349; GO:0015801; GO:0016020; GO:0016323; GO:0070327"
"658",658,"Cluster_1167","Porites_evermani_scaffold_1342:37224-38224",147,-20.88,2,21,126,148,20,"65.00%","70.00%","Peve_00005406",0.999909726776791,0.00855416971793389,0.573710369894872,NA,NA,NA,NA,NA
"659",659,"Cluster_1167","Porites_evermani_scaffold_1381:84218-85218",159,-21.22,2,20,90,111,18,"72.22%","77.78%","Peve_00005930",0.761420315130249,0.449004775265516,0.978262075707395,NA,NA,NA,NA,NA
"660",660,"Cluster_1167","Porites_evermani_scaffold_1384:9317-10189",145,-22.18,2,10,176,197,8,"100.00%","100.00%","Peve_00005962",NA,NA,NA,"P34456","Uncharacterized protein F54H12.2","Caenorhabditis elegans","deoxyribonucleotide biosynthetic process [GO:0009263]","GO:0004748; GO:0005829; GO:0009263"
"661",661,"Cluster_1167","Porites_evermani_scaffold_1392:103600-104233",142,-22.14,2,11,217,238,9,"88.89%","88.89%","Peve_00006080",0.902160478754071,0.28396086773942,0.978262075707395,"Q9DBW0","Cytochrome P450 4V2 (Docosahexaenoic acid omega-hydroxylase CYP4V2) (EC 1.14.14.79) (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80)","Mus musculus (Mouse)","fatty acid omega-oxidation [GO:0010430]","GO:0005506; GO:0005789; GO:0010430; GO:0020037; GO:0102033"
"662",662,"Cluster_1167","Porites_evermani_scaffold_1392:103600-104233",142,-22.14,2,11,217,238,9,"88.89%","88.89%","Peve_00006081",0.500238640454954,0.666491226869748,0.978262075707395,"Q9DBW0","Cytochrome P450 4V2 (Docosahexaenoic acid omega-hydroxylase CYP4V2) (EC 1.14.14.79) (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80)","Mus musculus (Mouse)","fatty acid omega-oxidation [GO:0010430]","GO:0005506; GO:0005789; GO:0010430; GO:0020037; GO:0102033"
"663",663,"Cluster_1167","Porites_evermani_scaffold_1402:4672-5672",152,-23.7,2,13,120,141,11,"90.91%","90.91%","Peve_00006289",0.4638528899405,0.692933241224571,0.978262075707395,"Q9CPZ8","COX assembly mitochondrial protein homolog (Cmc1p)","Mus musculus (Mouse)","","GO:0005739; GO:0046872"
"664",664,"Cluster_1167","Porites_evermani_scaffold_1418:85334-86334",160,-21.94,2,21,814,836,21,"80.95%","80.95%","Peve_00006485",NA,NA,NA,NA,NA,NA,NA,NA
"665",665,"Cluster_1167","Porites_evermani_scaffold_143:348033-349033",140,-23.83,2,9,132,153,7,"100.00%","100.00%","Peve_00006630",0.884828146359679,0.308551329457271,0.978262075707395,NA,NA,NA,NA,NA
"666",666,"Cluster_1167","Porites_evermani_scaffold_1434:62439-63439",159,-21.67,2,21,595,618,21,"71.43%","76.19%","Peve_00006667",NA,NA,NA,NA,NA,NA,NA,NA
"667",667,"Cluster_1167","Porites_evermani_scaffold_1441:50874-51874",152,-20.28,2,13,735,756,11,"90.91%","90.91%","Peve_00006749",-0.898375013670939,0.289496829443243,0.978262075707395,"Q92626","Peroxidasin homolog (EC 1.11.2.-) (Melanoma-associated antigen MG50) (Peroxidasin 1) (hsPxd01) (Vascular peroxidase 1) (p53-responsive gene 2 protein) [Cleaved into: PXDN active fragment]","Homo sapiens (Human)","angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; hydrogen peroxide catabolic process [GO:0042744]; immune response [GO:0006955]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979]","GO:0001525; GO:0001654; GO:0004601; GO:0005152; GO:0005201; GO:0005576; GO:0005604; GO:0005615; GO:0005783; GO:0006955; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0030198; GO:0030199; GO:0031012; GO:0042744; GO:0043237; GO:0046872; GO:0051260; GO:0062023; GO:0070062; GO:0070207; GO:0070831; GO:0071711; GO:0140825"
"668",668,"Cluster_1167","Porites_evermani_scaffold_1442:66901-67901",155,-20.51,2,21,517,541,22,"63.64%","77.27%","Peve_00006756",-0.0488013656928044,0.968919740694112,0.999448381576871,"Q24439","ATP synthase subunit O, mitochondrial (Oligomycin sensitivity conferral protein) (OSCP)","Drosophila melanogaster (Fruit fly)","proton motive force-driven ATP synthesis [GO:0015986]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; proton transmembrane transport [GO:1902600]","GO:0000274; GO:0005739; GO:0015986; GO:0042776; GO:0045261; GO:0046933; GO:1902600"
"669",669,"Cluster_1167","Porites_evermani_scaffold_1469:50855-51855",153,-22.29,2,21,133,152,19,"68.42%","78.95%","Peve_00007065",-0.823395279853495,0.38415407833703,0.978262075707395,"Q9FT73","ATP-dependent DNA helicase Q-like 2 (EC 3.6.4.12) (RecQ-like protein 2) (AtRQ2) (AtRecQ2) (AtRecQl2)","Arabidopsis thaliana (Mouse-ear cress)","DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]","GO:0000724; GO:0003677; GO:0005524; GO:0005694; GO:0005737; GO:0006268; GO:0006281; GO:0006310; GO:0009378; GO:0016592; GO:0016887; GO:0032508; GO:0043138; GO:0046872"
"670",670,"Cluster_1167","Porites_evermani_scaffold_1473:2847-3847",156,-22.04,2,18,665,687,17,"76.47%","82.35%","Peve_00007142",0.999909726776791,0.00855416971793389,0.573710369894872,NA,NA,NA,NA,NA
"671",671,"Cluster_1167","Porites_evermani_scaffold_1473:3356-4356",156,-22.04,2,18,156,178,17,"76.47%","82.35%","Peve_00007143",-0.488318552853167,0.675220836384604,0.978262075707395,NA,NA,NA,NA,NA
"672",672,"Cluster_1167","Porites_evermani_scaffold_148:341467-342467",150,-20.7,2,19,847,868,17,"64.71%","76.47%","Peve_00007209",0.826076245677694,0.381136019118539,0.978262075707395,NA,NA,NA,NA,NA
"673",673,"Cluster_1167","Porites_evermani_scaffold_148:341645-342645",150,-20.7,2,19,669,690,17,"64.71%","76.47%","Peve_00007210",0.638137134963381,0.559410553476606,0.978262075707395,"Q7ZX59","Cytokine receptor-like factor 3","Xenopus laevis (African clawed frog)","","GO:0005737"
"674",674,"Cluster_1167","Porites_evermani_scaffold_1511:100291-101291",150,-25.62,2,19,312,333,17,"64.71%","76.47%","Peve_00007689",0.999909726776791,0.00855416971793915,0.573710369894872,NA,NA,NA,NA,NA
"675",675,"Cluster_1167","Porites_evermani_scaffold_1574:85312-86312",155,-20.54,2,17,120,142,16,"81.25%","81.25%","Peve_00008426",NA,NA,NA,NA,NA,NA,NA,NA
"676",676,"Cluster_1167","Porites_evermani_scaffold_1575:80722-81722",155,-23.35,2,12,448,469,10,"100.00%","100.00%","Peve_00008439",-0.488318552853167,0.675220836384604,0.978262075707395,NA,NA,NA,NA,NA
"677",677,"Cluster_1167","Porites_evermani_scaffold_1576:5580-6580",141,-21.08,2,21,57,78,20,"65.00%","70.00%","Peve_00008446",0.960715709871404,0.179034477636048,0.978262075707395,"Q5RBL0","Protein YIPF1 (YIP1 family member 1)","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","vesicle-mediated transport [GO:0016192]","GO:0000138; GO:0005797; GO:0005802; GO:0016192; GO:0031267; GO:0031902"
"678",678,"Cluster_1167","Porites_evermani_scaffold_1581:10768-11768",148,-21.85,2,21,227,248,19,"63.16%","68.42%","Peve_00008533",-0.842256602341279,0.362453510493191,0.978262075707395,"P51993","4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6 (EC 2.4.1.152) (Fucosyltransferase 6) (Fucosyltransferase VI) (Fuc-TVI) (FucT-VI) (Galactoside 3-L-fucosyltransferase)","Homo sapiens (Human)","ceramide metabolic process [GO:0006672]; fucosylation [GO:0036065]; glycosphingolipid biosynthetic process [GO:0006688]; L-fucose catabolic process [GO:0042355]; N-glycan fucosylation [GO:0036071]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]","GO:0000139; GO:0005576; GO:0005794; GO:0006486; GO:0006487; GO:0006493; GO:0006672; GO:0006688; GO:0008417; GO:0009312; GO:0017083; GO:0032580; GO:0036065; GO:0036071; GO:0042355; GO:0046920; GO:0070062"
"679",679,"Cluster_1167","Porites_evermani_scaffold_1584:18570-19570",151,-23.03,2,21,796,821,23,"65.22%","69.57%","Peve_00008559",NA,NA,NA,NA,NA,NA,NA,NA
"680",680,"Cluster_1167","Porites_evermani_scaffold_1595:39010-40010",154,-22.03,2,20,606,628,19,"73.68%","73.68%","Peve_00008696",NA,NA,NA,NA,NA,NA,NA,NA
"681",681,"Cluster_1167","Porites_evermani_scaffold_161:87445-87590",145,-20.48,2,10,93,114,8,"100.00%","100.00%","Peve_00008946",0.675750026596847,0.52763976454183,0.978262075707395,"Q7ZVP8","Trimeric intracellular cation channel type B (TRIC-B) (TRICB) (Transmembrane protein 38B)","Danio rerio (Zebrafish) (Brachydanio rerio)","","GO:0005267; GO:0005789; GO:0042802"
"682",682,"Cluster_1167","Porites_evermani_scaffold_161:87445-87590",145,-20.48,2,10,93,114,8,"100.00%","100.00%","Peve_00008947",0.00834691801029384,0.994686125251234,0.999448381576871,"Q9I8J6","Probable rRNA-processing protein EBP2 (Nucleolar protein p40-like protein)","Xenopus laevis (African clawed frog)","ribosome biogenesis [GO:0042254]","GO:0005730; GO:0042254"
"683",683,"Cluster_1167","Porites_evermani_scaffold_1621:60319-61319",142,-26.52,2,21,143,168,23,"65.22%","65.22%","Peve_00009087",-0.148766231085358,0.904939615344446,0.999448381576871,"Q9D4D4","Transketolase-like protein 2 (EC 2.2.1.1)","Mus musculus (Mouse)","","GO:0004802; GO:0005737; GO:0030976; GO:0046872"
"684",684,"Cluster_1167","Porites_evermani_scaffold_1641:59358-60358",157,-23.9,2,14,428,449,12,"91.67%","91.67%","Peve_00009312",-0.184643144158076,0.881774137316304,0.999189137506504,NA,NA,NA,NA,NA
"685",685,"Cluster_1167","Porites_evermani_scaffold_1651:10032-11032",152,-23.21,2,13,708,729,11,"90.91%","90.91%","Peve_00009438",NA,NA,NA,NA,NA,NA,NA,NA
"686",686,"Cluster_1167","Porites_evermani_scaffold_1665:106766-107766",145,-20.12,2,20,257,281,21,"66.67%","71.43%","Peve_00009568",0.262634654028422,0.830817213298689,0.995934364227446,NA,NA,NA,NA,NA
"687",687,"Cluster_1167","Porites_evermani_scaffold_1670:7445-8445",154,-23.15,2,17,260,280,15,"80.00%","86.67%","Peve_00009624",0.807543733924613,0.401592920957732,0.978262075707395,NA,NA,NA,NA,NA
"688",688,"Cluster_1167","Porites_evermani_scaffold_1674:39601-40601",153,-22.98,2,21,673,692,19,"73.68%","73.68%","Peve_00009670",0.218549664594765,0.859734865610147,0.996119339963704,"P63255","Cysteine-rich protein 1 (CRP-1) (Cysteine-rich intestinal protein) (CRIP)","Rattus norvegicus (Rat)","cellular response to antibiotic [GO:0071236]; cellular response to UV-B [GO:0071493]; immune response [GO:0006955]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; prostate gland stromal morphogenesis [GO:0060741]; regulation of gene expression [GO:0010468]; response to organic substance [GO:0010033]; response to zinc ion [GO:0010043]","GO:0005737; GO:0006955; GO:0008270; GO:0008630; GO:0010033; GO:0010043; GO:0010468; GO:0042277; GO:0060741; GO:0071236; GO:0071493"
"689",689,"Cluster_1167","Porites_evermani_scaffold_168:74200-75200",152,-23.21,2,13,599,620,11,"90.91%","90.91%","Peve_00009740",0.980302284805475,0.126566427059506,0.978262075707395,"P95896","Amidase (EC 3.5.1.4)","Saccharolobus solfataricus (strain ATCC 35092 / DSM 1617 / JCM 11322 / P2) (Sulfolobus solfataricus)","","GO:0004040; GO:0043864"
"690",690,"Cluster_1167","Porites_evermani_scaffold_170:136823-137823",153,-22.32,2,14,40,61,12,"83.33%","91.67%","Peve_00010047",0.95148227604782,0.199121005344782,0.978262075707395,"Q03601","RING finger protein nhl-1","Caenorhabditis elegans","negative regulation of translation [GO:0017148]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]","GO:0000209; GO:0004842; GO:0016567; GO:0017148; GO:0030371; GO:0043161; GO:0046872; GO:0061630"
"691",691,"Cluster_1167","Porites_evermani_scaffold_1720:64731-65731",153,-20.95,2,16,104,124,14,"85.71%","85.71%","Peve_00010286",0.999909726776791,0.00855416971793915,0.573710369894872,NA,NA,NA,NA,NA
"692",692,"Cluster_1167","Porites_evermani_scaffold_1749:104928-105459",142,-20.49,2,11,487,508,9,"88.89%","88.89%","Peve_00010556",NA,NA,NA,NA,NA,NA,NA,NA
"693",693,"Cluster_1167","Porites_evermani_scaffold_1753:57000-58000",152,-21.31,2,13,778,799,11,"90.91%","90.91%","Peve_00010599",NA,NA,NA,"B8VIU6","Uncharacterized skeletal organic matrix protein 5 (Uncharacterized SOMP-5)","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0005576"
"694",694,"Cluster_1167","Porites_evermani_scaffold_1766:64921-65921",155,-23.27,2,21,220,244,22,"63.64%","77.27%","Peve_00010729",NA,NA,NA,NA,NA,NA,NA,NA
"695",695,"Cluster_1167","Porites_evermani_scaffold_1766:81541-82541",155,-23.27,2,20,834,852,18,"77.78%","77.78%","Peve_00010724",NA,NA,NA,NA,NA,NA,NA,NA
"696",696,"Cluster_1167","Porites_evermani_scaffold_1775:1516-2516",143,-20.75,2,14,906,926,12,"83.33%","83.33%","Peve_00010820",0.757554210055621,0.452788285602119,0.978262075707395,NA,NA,NA,NA,NA
"697",697,"Cluster_1167","Porites_evermani_scaffold_1778:74171-75171",153,-23.31,2,21,290,317,25,"68.00%","76.00%","Peve_00010847",NA,NA,NA,NA,NA,NA,NA,NA
"698",698,"Cluster_1167","Porites_evermani_scaffold_1901:69153-70139",153,-22.41,2,17,509,531,17,"82.35%","82.35%","Peve_00012313",0.318138392502897,0.79388466610206,0.995934364227446,"Q4G0P3","Hydrocephalus-inducing protein homolog","Homo sapiens (Human)","axonemal central apparatus assembly [GO:1904158]; cilium movement [GO:0003341]; epithelial cell development [GO:0002064]; trachea development [GO:0060438]; ventricular system development [GO:0021591]","GO:0002064; GO:0003341; GO:0005930; GO:0021591; GO:0060438; GO:1904158; GO:1990716; GO:1990718"
"699",699,"Cluster_1167","Porites_evermani_scaffold_191:341868-342868",152,-20.58,2,13,912,933,11,"90.91%","90.91%","Peve_00012410",NA,NA,NA,"Q1PSW8","E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (mLin41) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71)","Mus musculus (Mouse)","3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to organic substance [GO:0071310]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA metabolic process [GO:0010586]; miRNA processing [GO:0035196]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of translation [GO:0017148]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; post-transcriptional regulation of gene expression [GO:0010608]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of miRNA-mediated gene silencing [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of protein metabolic process [GO:0051246]; stem cell proliferation [GO:0072089]","GO:0000082; GO:0000209; GO:0000932; GO:0001843; GO:0004842; GO:0008270; GO:0008543; GO:0010586; GO:0010608; GO:0017148; GO:0021915; GO:0030371; GO:0035196; GO:0035198; GO:0035278; GO:0043161; GO:0051246; GO:0051865; GO:0060964; GO:0061158; GO:0061630; GO:0071310; GO:0072089; GO:2000177; GO:2000637"
"700",700,"Cluster_1167","Porites_evermani_scaffold_2020:92440-92810",161,-21.39,2,21,18,37,19,"78.95%","78.95%","Peve_00013786",NA,NA,NA,"O16025","Allene oxide synthase-lipoxygenase protein [Includes: Allene oxide synthase (AOS) (EC 4.2.1.-) (Hydroperoxidehydrase); Arachidonate 8-lipoxygenase (EC 1.13.11.40)]","Plexaura homomalla (Black sea rod)","arachidonic acid metabolic process [GO:0019369]; fatty acid biosynthetic process [GO:0006633]; lipid oxidation [GO:0034440]; oxylipin biosynthetic process [GO:0031408]","GO:0005506; GO:0005737; GO:0006633; GO:0009978; GO:0016020; GO:0019369; GO:0020037; GO:0031408; GO:0034440; GO:0047677"
"701",701,"Cluster_1167","Porites_evermani_scaffold_2071:77434-78434",159,-23.98,2,21,696,718,20,"75.00%","75.00%","Peve_00014260",0.999909726776791,0.00855416971793915,0.573710369894872,NA,NA,NA,NA,NA
"702",702,"Cluster_1167","Porites_evermani_scaffold_2124:21881-22881",152,-20.58,2,13,941,962,11,"90.91%","90.91%","Peve_00014814",0.956909612698468,0.187567366559307,0.978262075707395,"Q0VD19","Sphingomyelin phosphodiesterase (EC 3.1.4.12) (EC 3.1.4.3) (Acid sphingomyelinase) (aSMase) [Cleaved into: Sphingomyelin phosphodiesterase, processed form]","Bos taurus (Bovine)","cellular response to calcium ion [GO:0071277]; cellular response to UV [GO:0034644]; ceramide biosynthetic process [GO:0046513]; cholesterol metabolic process [GO:0008203]; negative regulation of MAP kinase activity [GO:0043407]; plasma membrane repair [GO:0001778]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endocytosis [GO:0045807]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of viral entry into host cell [GO:0046598]; response to interleukin-1 [GO:0070555]; response to ionizing radiation [GO:0010212]; response to tumor necrosis factor [GO:0034612]; response to type I interferon [GO:0034340]; response to virus [GO:0009615]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021]; viral entry into host cell [GO:0046718]; wound healing [GO:0042060]","GO:0001778; GO:0004767; GO:0005615; GO:0005764; GO:0005765; GO:0005811; GO:0005886; GO:0006685; GO:0008081; GO:0008203; GO:0008270; GO:0009615; GO:0010212; GO:0016798; GO:0023021; GO:0034340; GO:0034480; GO:0034612; GO:0034644; GO:0035307; GO:0036019; GO:0042060; GO:0043065; GO:0043407; GO:0045121; GO:0045807; GO:0046513; GO:0046598; GO:0046718; GO:0061750; GO:0070555; GO:0071277"
"703",703,"Cluster_1167","Porites_evermani_scaffold_2128:42727-43631",142,-24.11,2,21,475,500,23,"60.87%","69.57%","Peve_00014840",NA,NA,NA,NA,NA,NA,NA,NA
"704",704,"Cluster_1167","Porites_evermani_scaffold_2139:37753-38753",160,-21.41,2,17,768,789,15,"80.00%","86.67%","Peve_00014957",-0.447859999419345,0.704372595405027,0.978262075707395,"Q99961","Endophilin-A2 (EEN fusion partner of MLL) (Endophilin-2) (Extra eleven-nineteen leukemia fusion gene protein) (EEN) (SH3 domain protein 2B) (SH3 domain-containing GRB2-like protein 1)","Homo sapiens (Human)","central nervous system development [GO:0007417]; signal transduction [GO:0007165]; synaptic vesicle uncoating [GO:0016191]","GO:0002102; GO:0005737; GO:0005829; GO:0007165; GO:0007417; GO:0008289; GO:0016191; GO:0031901; GO:0042802; GO:0042995; GO:0045296; GO:0070161; GO:0098793; GO:0098978"
"705",705,"Cluster_1167","Porites_evermani_scaffold_214:224614-225614",143,-24.37,2,21,419,443,22,"59.09%","68.18%","Peve_00014969",-0.430141504350382,0.716927325580555,0.98071325584856,NA,NA,NA,NA,NA
"706",706,"Cluster_1167","Porites_evermani_scaffold_215:225773-226773",155,-21.26,2,21,455,474,20,"75.00%","80.00%","Peve_00015061",-0.290479205555089,0.812370582964028,0.995934364227446,"P46530","Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]","Danio rerio (Zebrafish) (Brachydanio rerio)","angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514]","GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314"
"707",707,"Cluster_1167","Porites_evermani_scaffold_2177:51409-52409",157,-27.05,2,20,132,152,18,"77.78%","77.78%","Peve_00015290",-0.363554844917307,0.763125861977421,0.989132871287089,NA,NA,NA,NA,NA
"708",708,"Cluster_1167","Porites_evermani_scaffold_2179:38748-39748",160,-23.8,2,19,960,983,19,"78.95%","84.21%","Peve_00015298",0.89802004040682,0.290010903942382,0.978262075707395,"Q9QZ81","Protein argonaute-2 (Argonaute2) (EC 3.1.26.n2) (Argonaute RISC catalytic component 2) (Eukaryotic translation initiation factor 2C 2) (eIF-2C 2) (eIF2C 2) (Golgi ER protein 95 kDa) (GERp95) (Protein slicer)","Rattus norvegicus (Rat)","cell differentiation [GO:0030154]; miRNA metabolic process [GO:0010586]; miRNA processing [GO:0035196]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; miRNA-mediated gene silencing by mRNA destabilization [GO:0035279]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; negative regulation of translational initiation [GO:0045947]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation, ncRNA-mediated [GO:0045975]; positive regulation of trophoblast cell migration [GO:1901165]; post-embryonic development [GO:0009791]; pre-miRNA processing [GO:0031054]; RISC complex assembly [GO:0070922]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; RNA secondary structure unwinding [GO:0010501]; RNA-mediated gene silencing [GO:0031047]; siRNA processing [GO:0030422]; siRNA-mediated gene silencing by mRNA destabilization [GO:0090625]","GO:0000340; GO:0000932; GO:0000993; GO:0001046; GO:0003723; GO:0003725; GO:0003727; GO:0003729; GO:0004521; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005844; GO:0005845; GO:0008022; GO:0009791; GO:0010501; GO:0010586; GO:0010628; GO:0016442; GO:0030154; GO:0030422; GO:0030425; GO:0031047; GO:0031054; GO:0035196; GO:0035197; GO:0035198; GO:0035278; GO:0035279; GO:0042985; GO:0045766; GO:0045944; GO:0045947; GO:0045975; GO:0046872; GO:0060213; GO:0070062; GO:0070551; GO:0070578; GO:0070922; GO:0090502; GO:0090624; GO:0090625; GO:0098808; GO:1900153; GO:1901165; GO:1990904"
"709",709,"Cluster_1167","Porites_evermani_scaffold_220:245626-246626",152,-23.21,2,13,745,766,11,"90.91%","90.91%","Peve_00015576",0.999909726776791,0.00855416971793915,0.573710369894872,NA,NA,NA,NA,NA
"710",710,"Cluster_1167","Porites_evermani_scaffold_2233:21111-22111",152,-23.69,2,13,856,877,11,"90.91%","90.91%","Peve_00015903",NA,NA,NA,"Q94515","Sphingolipid delta(4)-desaturase DES1 (EC 1.14.19.17) (Degenerative spermatocyte homolog 1) (DES-1) (Dihydroceramide desaturase-1)","Drosophila melanogaster (Fruit fly)","ceramide biosynthetic process [GO:0046513]; negative regulation of lipophagy [GO:1904503]; spermatogenesis [GO:0007283]; spindle assembly involved in male meiosis [GO:0007053]","GO:0005739; GO:0005770; GO:0005783; GO:0005789; GO:0005886; GO:0007053; GO:0007283; GO:0016006; GO:0042284; GO:0046513; GO:0070938; GO:1904503"
"711",711,"Cluster_1167","Porites_evermani_scaffold_2239:8003-9003",140,-24.8,2,9,385,406,7,"100.00%","100.00%","Peve_00015940",0.998461753312847,0.0353153733346753,0.909359886114279,NA,NA,NA,NA,NA
"712",712,"Cluster_1167","Porites_evermani_scaffold_2:249493-250493",155,-20.43,2,20,296,317,18,"66.67%","77.78%","Peve_00013445",-0.51811085123885,0.65327093070982,0.978262075707395,"B3DJT0","Squamous cell carcinoma antigen recognized by T-cells 3 (SART-3)","Danio rerio (Zebrafish) (Brachydanio rerio)","exocrine pancreas development [GO:0031017]; lymphocyte differentiation [GO:0030098]; mRNA splicing, via spliceosome [GO:0000398]; nucleosome assembly [GO:0006334]; positive regulation of histone deubiquitination [GO:1903586]; spliceosomal complex assembly [GO:0000245]; spliceosomal snRNP assembly [GO:0000387]; thymus development [GO:0048538]","GO:0000245; GO:0000387; GO:0000398; GO:0005634; GO:0005654; GO:0005737; GO:0006334; GO:0015030; GO:0016607; GO:0017070; GO:0030098; GO:0031017; GO:0042393; GO:0048538; GO:0061574; GO:1903586"
"713",713,"Cluster_1167","Porites_evermani_scaffold_2295:68739-69739",143,-23.75,2,17,332,359,21,"61.90%","71.43%","Peve_00016445",0.999909726776791,0.00855416971793915,0.573710369894872,"Q9UHC3","Acid-sensing ion channel 3 (ASIC3) (hASIC3) (Amiloride-sensitive cation channel 3) (Neuronal amiloride-sensitive cation channel 3) (Testis sodium channel 1) (hTNaC1)","Homo sapiens (Human)","detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; response to acidic pH [GO:0010447]; response to heat [GO:0009408]; sensory perception [GO:0007600]; sensory perception of sour taste [GO:0050915]; signal transduction [GO:0007165]; sodium ion transmembrane transport [GO:0035725]","GO:0005261; GO:0005272; GO:0005886; GO:0007165; GO:0007600; GO:0009408; GO:0010447; GO:0015280; GO:0035725; GO:0042931; GO:0044736; GO:0048471; GO:0050915; GO:0050965; GO:0050966; GO:0050968"
"714",714,"Cluster_1167","Porites_evermani_scaffold_2311:64648-65648",142,-20.7,2,11,794,815,9,"88.89%","88.89%","Peve_00016678",0.96009718859771,0.180447837474829,0.978262075707395,NA,NA,NA,NA,NA
"715",715,"Cluster_1167","Porites_evermani_scaffold_2324:54933-55933",157,-24.81,2,21,148,167,19,"73.68%","78.95%","Peve_00016778",NA,NA,NA,NA,NA,NA,NA,NA
"716",716,"Cluster_1167","Porites_evermani_scaffold_233:99021-100021",142,-20.31,2,11,97,118,9,"88.89%","88.89%","Peve_00016818",-0.385832532508221,0.747828504163034,0.988103726337067,"Q6DCE8","Cationic amino acid transporter 2 (CAT-2) (CAT2) (Low affinity cationic amino acid transporter 2) (Solute carrier family 7 member 2)","Xenopus laevis (African clawed frog)","L-arginine transmembrane transport [GO:1903826]","GO:0005886; GO:0061459; GO:1903826"
"717",717,"Cluster_1167","Porites_evermani_scaffold_2414:47059-48059",144,-21.59,2,13,859,880,11,"81.82%","81.82%","Peve_00017626",0.999909726776791,0.00855416971793915,0.573710369894872,"Q7TQP6","Serine/threonine-protein kinase TNNI3K (EC 2.7.11.1) (Cardiac ankyrin repeat kinase) (TNNI3-interacting kinase)","Rattus norvegicus (Rat)","bundle of His cell to Purkinje myocyte communication [GO:0086069]; protein phosphorylation [GO:0006468]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart rate [GO:0002027]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0002027; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006357; GO:0006468; GO:0008022; GO:0031013; GO:0046872; GO:0055117; GO:0061629; GO:0086069; GO:0106310; GO:1903779"
"718",718,"Cluster_1167","Porites_evermani_scaffold_24:206534-207062",151,-24.65,2,17,79,101,16,"75.00%","81.25%","Peve_00017466",0.893445096175613,0.29656221631276,0.978262075707395,"P51144","Substance-K receptor (SKR) (NK-2 receptor) (NK-2R) (Neurokinin A receptor) (Tachykinin receptor 2)","Mesocricetus auratus (Golden hamster)","positive regulation of flagellated sperm motility [GO:1902093]; regulation of uterine smooth muscle contraction [GO:0070472]","GO:0004995; GO:0005886; GO:0061827; GO:0070472; GO:0097225; GO:1902093"
"719",719,"Cluster_1167","Porites_evermani_scaffold_2439:68108-69108",147,-25.15,2,19,309,330,18,"72.22%","77.78%","Peve_00017839",-0.511591173923624,0.65811249694873,0.978262075707395,NA,NA,NA,NA,NA
"720",720,"Cluster_1167","Porites_evermani_scaffold_244:227016-228016",145,-20.33,2,16,634,658,17,"76.47%","76.47%","Peve_00017855",0.0796365792776218,0.94924803762342,0.999448381576871,"Q6DED0","Translocating chain-associated membrane protein 1-like 1","Xenopus laevis (African clawed frog)","SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]","GO:0005789; GO:0006616"
"721",721,"Cluster_1167","Porites_evermani_scaffold_2449:71072-72072",147,-21.15,2,17,227,250,17,"70.59%","76.47%","Peve_00017918",-0.299185190175273,0.806570329561851,0.995934364227446,"Q91398","Casein kinase II subunit beta (CK II beta)","Danio rerio (Zebrafish) (Brachydanio rerio)","regulation of protein serine/threonine phosphatase activity [GO:0080163]; Wnt signaling pathway [GO:0016055]","GO:0005737; GO:0005956; GO:0016055; GO:0019887; GO:0046872; GO:0080163"
"722",722,"Cluster_1167","Porites_evermani_scaffold_2479:68295-69295",155,-22.96,2,21,89,112,21,"71.43%","71.43%","Peve_00018152",-0.501728030686617,0.665395648947687,0.978262075707395,"Q9Y535","DNA-directed RNA polymerase III subunit RPC8 (RNA polymerase III subunit C8) (DNA-directed RNA polymerase III subunit H) (RNA polymerase III subunit 22.9 kDa subunit) (RPC22.9)","Homo sapiens (Human)","defense response to virus [GO:0051607]; innate immune response [GO:0045087]; nucleobase-containing compound metabolic process [GO:0006139]; transcription by RNA polymerase III [GO:0006383]; transcription initiation at RNA polymerase III promoter [GO:0006384]","GO:0003677; GO:0003899; GO:0005654; GO:0005666; GO:0005813; GO:0005829; GO:0006139; GO:0006383; GO:0006384; GO:0043231; GO:0045087; GO:0051607"
"723",723,"Cluster_1167","Porites_evermani_scaffold_248:239409-240409",151,-24.56,2,19,16,35,17,"76.47%","76.47%","Peve_00018177",0.999909726776791,0.00855416971793915,0.573710369894872,NA,NA,NA,NA,NA
"724",724,"Cluster_1167","Porites_evermani_scaffold_248:239409-240409",151,-24.56,2,19,246,265,17,"76.47%","76.47%","Peve_00018177",0.999909726776791,0.00855416971793915,0.573710369894872,NA,NA,NA,NA,NA
"725",725,"Cluster_1167","Porites_evermani_scaffold_2488:67286-68286",156,-20.9,2,21,306,325,19,"78.95%","78.95%","Peve_00018238",0.920232426729026,0.255999057589426,0.978262075707395,NA,NA,NA,NA,NA
"726",726,"Cluster_1167","Porites_evermani_scaffold_249:256089-257089",146,-21.94,2,21,330,349,20,"75.00%","75.00%","Peve_00018256",NA,NA,NA,NA,NA,NA,NA,NA
"727",727,"Cluster_1167","Porites_evermani_scaffold_2529:61119-62119",152,-21.8,2,20,490,509,18,"72.22%","77.78%","Peve_00018680",NA,NA,NA,NA,NA,NA,NA,NA
"728",728,"Cluster_1167","Porites_evermani_scaffold_2543:33627-34627",144,-21.29,2,14,441,465,15,"73.33%","80.00%","Peve_00018803",0.574546423617037,0.610356953886587,0.978262075707395,"P54145","Putative ammonium transporter 1","Caenorhabditis elegans","ammonium homeostasis [GO:0097272]; ammonium transmembrane transport [GO:0072488]","GO:0005886; GO:0008519; GO:0072488; GO:0097272"
"729",729,"Cluster_1167","Porites_evermani_scaffold_254:68930-69930",157,-21.43,2,21,298,317,19,"73.68%","78.95%","Peve_00018767",-0.510409001226618,0.658988033906181,0.978262075707395,NA,NA,NA,NA,NA
"730",730,"Cluster_1167","Porites_evermani_scaffold_2550:21846-22846",144,-23.73,2,21,769,790,19,"57.89%","68.42%","Peve_00018849",-0.0497523177086847,0.968313609461831,0.999448381576871,"Q9GLK0","Protein-glutamine gamma-glutamyltransferase K (EC 2.3.2.13) (Epidermal TGase) (Transglutaminase K) (TG(K)) (TGK) (TGase K) (Transglutaminase-1) (TGase-1)","Canis lupus familiaris (Dog) (Canis familiaris)","keratinization [GO:0031424]; peptide cross-linking [GO:0018149]; positive regulation of cell cycle [GO:0045787]; positive regulation of keratinocyte proliferation [GO:0010838]","GO:0003810; GO:0010838; GO:0016020; GO:0018149; GO:0031424; GO:0045787; GO:0046872"
"731",731,"Cluster_1167","Porites_evermani_scaffold_2561:70596-70959",156,-31.58,2,13,73,94,11,"90.91%","100.00%","Peve_00018927",NA,NA,NA,NA,NA,NA,NA,NA
"732",732,"Cluster_1167","Porites_evermani_scaffold_256:88666-89666",154,-25.72,2,15,441,462,13,"84.62%","84.62%","Peve_00018908",NA,NA,NA,NA,NA,NA,NA,NA
"733",733,"Cluster_1167","Porites_evermani_scaffold_2634:29181-30181",160,-27.23,2,21,579,600,19,"68.42%","78.95%","Peve_00019541",0.998816193083452,0.0309797857569469,0.903929377050813,"O18638","Out at first protein","Drosophila virilis (Fruit fly)","",""
"734",734,"Cluster_1167","Porites_evermani_scaffold_2637:57677-57933",150,-23.27,2,21,201,226,23,"69.57%","69.57%","Peve_00019549",0.10442650121558,0.933398601588432,0.999448381576871,"Q9EPB1","Dipeptidyl peptidase 2 (EC 3.4.14.2) (Dipeptidyl aminopeptidase II) (Dipeptidyl peptidase 7) (Dipeptidyl peptidase II) (DPP II) (Quiescent cell proline dipeptidase)","Rattus norvegicus (Rat)","lysosomal protein catabolic process [GO:1905146]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]","GO:0004177; GO:0005576; GO:0005764; GO:0005829; GO:0006508; GO:0008236; GO:0008239; GO:0030163; GO:0031410; GO:0031982; GO:1905146"
"735",735,"Cluster_1167","Porites_evermani_scaffold_2637:57677-57933",150,-23.27,2,21,201,226,23,"69.57%","69.57%","Peve_00019550",0.854042551904694,0.34828755033113,0.978262075707395,"Q95JP0","Dynein axonemal intermediate chain 3 (WD repeat-containing protein 63)","Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)","negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; negative regulation of cell migration [GO:0030336]; positive regulation of osteoblast differentiation [GO:0045669]","GO:0005737; GO:0005858; GO:0030336; GO:0034316; GO:0045669; GO:0071933"
"736",736,"Cluster_1167","Porites_evermani_scaffold_270:250365-251365",142,-20.31,2,18,569,590,17,"70.59%","76.47%","Peve_00020108",0.751410097408905,0.458748078323386,0.978262075707395,"Q2KHV4","Presenilins-associated rhomboid-like protein, mitochondrial (EC 3.4.21.105) (Mitochondrial intramembrane cleaving protease PARL) [Cleaved into: P-beta (Pbeta)]","Bos taurus (Bovine)","signal peptide processing [GO:0006465]","GO:0004252; GO:0005634; GO:0005743; GO:0006465"
"737",737,"Cluster_1167","Porites_evermani_scaffold_270:250365-251365",142,-23,2,19,586,607,17,"58.82%","70.59%","Peve_00020108",0.751410097408905,0.458748078323386,0.978262075707395,"Q2KHV4","Presenilins-associated rhomboid-like protein, mitochondrial (EC 3.4.21.105) (Mitochondrial intramembrane cleaving protease PARL) [Cleaved into: P-beta (Pbeta)]","Bos taurus (Bovine)","signal peptide processing [GO:0006465]","GO:0004252; GO:0005634; GO:0005743; GO:0006465"
"738",738,"Cluster_1167","Porites_evermani_scaffold_2705:52545-53545",159,-21.93,2,20,493,514,18,"72.22%","77.78%","Peve_00020139",NA,NA,NA,NA,NA,NA,NA,NA
"739",739,"Cluster_1167","Porites_evermani_scaffold_2741:30391-31391",152,-21.31,2,13,919,940,11,"90.91%","90.91%","Peve_00020454",-0.627421216912667,0.568220890852804,0.978262075707395,"Q7TS68","tRNA (cytosine(72)-C(5))-methyltransferase NSUN6 (EC 2.1.1.-) (NOL1/NOP2/Sun domain family member 6)","Mus musculus (Mouse)","RNA methylation [GO:0001510]; tRNA C5-cytosine methylation [GO:0002946]; tRNA methylation [GO:0030488]","GO:0000049; GO:0001510; GO:0002946; GO:0005654; GO:0005737; GO:0016428; GO:0030488"
"740",740,"Cluster_1167","Porites_evermani_scaffold_2741:31286-32286",152,-21.31,2,13,24,45,11,"90.91%","90.91%","Peve_00020455",-0.468243398409822,0.689774088713824,0.978262075707395,"O42574","Beta-1 adrenergic receptor (Beta-1 adrenoreceptor) (Beta-1 adrenoceptor) (x-BETA1AR)","Xenopus laevis (African clawed frog)","adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; positive regulation of GTPase activity [GO:0043547]; positive regulation of heart contraction [GO:0045823]","GO:0004940; GO:0005085; GO:0005769; GO:0005886; GO:0043547; GO:0045823; GO:0071880"
"741",741,"Cluster_1167","Porites_evermani_scaffold_2747:3260-4260",153,-25.39,2,21,703,722,19,"73.68%","73.68%","Peve_00020492",0.523015441768171,0.649614004444966,0.978262075707395,NA,NA,NA,NA,NA
"742",742,"Cluster_1167","Porites_evermani_scaffold_2806:35850-36850",158,-24.07,2,20,774,797,20,"75.00%","75.00%","Peve_00020963",NA,NA,NA,NA,NA,NA,NA,NA
"743",743,"Cluster_1167","Porites_evermani_scaffold_2829:4694-5694",144,-21.93,2,21,707,730,22,"68.18%","72.73%","Peve_00021121",0.816965437908406,0.391309265959089,0.978262075707395,"O43741","5'-AMP-activated protein kinase subunit beta-2 (AMPK subunit beta-2)","Homo sapiens (Human)","cellular response to nutrient levels [GO:0031669]; fatty acid biosynthetic process [GO:0006633]; positive regulation of cold-induced thermogenesis [GO:0120162]; signal transduction [GO:0007165]","GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006633; GO:0007165; GO:0019901; GO:0031588; GO:0031669; GO:0120162"
"744",744,"Cluster_1167","Porites_evermani_scaffold_284:107316-108316",152,-23.21,2,13,595,616,11,"90.91%","90.91%","Peve_00021215",0.995345694859979,0.0614456490351611,0.978262075707395,NA,NA,NA,NA,NA
"745",745,"Cluster_1167","Porites_evermani_scaffold_2858:16088-17088",160,-25.15,2,21,389,410,19,"68.42%","78.95%","Peve_00021333",0.999909726776791,0.00855416971793915,0.573710369894872,"Q924H0","Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide NPFF receptor)","Mus musculus (Mouse)","G protein-coupled receptor signaling pathway [GO:0007186]; regulation of adenylate cyclase activity [GO:0045761]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of MAPK cascade [GO:0043408]","GO:0004930; GO:0005886; GO:0007186; GO:0008188; GO:0015629; GO:0031628; GO:0042277; GO:0043408; GO:0045761; GO:2000479"
"746",746,"Cluster_1167","Porites_evermani_scaffold_2858:6867-7867",156,-24.35,2,21,392,413,19,"63.16%","78.95%","Peve_00021330",0.999909726776791,0.00855416971793915,0.573710369894872,"Q924H0","Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide NPFF receptor)","Mus musculus (Mouse)","G protein-coupled receptor signaling pathway [GO:0007186]; regulation of adenylate cyclase activity [GO:0045761]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of MAPK cascade [GO:0043408]","GO:0004930; GO:0005886; GO:0007186; GO:0008188; GO:0015629; GO:0031628; GO:0042277; GO:0043408; GO:0045761; GO:2000479"
"747",747,"Cluster_1167","Porites_evermani_scaffold_287:124426-125426",152,-22.39,2,13,565,586,11,"90.91%","90.91%","Peve_00021428",0.122517738464043,0.921806324483304,0.999448381576871,"A7RR34","Protein Flattop homolog (Cilia- and flagella-associated protein 126)","Nematostella vectensis (Starlet sea anemone)","cilium organization [GO:0044782]","GO:0005737; GO:0005929; GO:0016324; GO:0036064; GO:0044782"
"748",748,"Cluster_1167","Porites_evermani_scaffold_290:129145-130145",144,-22.08,2,21,817,838,19,"57.89%","68.42%","Peve_00021718",0.999909726776791,0.00855416971793389,0.573710369894872,NA,NA,NA,NA,NA
"749",749,"Cluster_1167","Porites_evermani_scaffold_290:129145-130145",146,-24.73,2,21,693,718,23,"60.87%","73.91%","Peve_00021718",0.999909726776791,0.00855416971793389,0.573710369894872,NA,NA,NA,NA,NA
"750",750,"Cluster_1167","Porites_evermani_scaffold_291:147447-148447",160,-28.29,2,13,164,185,11,"100.00%","100.00%","Peve_00021780",-0.204413554170528,0.868942541903611,0.997252323136946,NA,NA,NA,NA,NA
"751",751,"Cluster_1167","Porites_evermani_scaffold_2947:6751-7751",142,-20.94,2,14,217,236,12,"83.33%","83.33%","Peve_00022021",-0.488318552853167,0.675220836384604,0.978262075707395,NA,NA,NA,NA,NA
"752",752,"Cluster_1167","Porites_evermani_scaffold_2948:4290-5290",153,-22.04,2,18,875,893,16,"81.25%","81.25%","Peve_00022025",NA,NA,NA,"Q92051","Carbonic anhydrase (EC 4.2.1.1) (Carbonate dehydratase)","Danio rerio (Zebrafish) (Brachydanio rerio)","carbon dioxide transport [GO:0015670]; hypotonic salinity response [GO:0042539]; one-carbon metabolic process [GO:0006730]","GO:0004089; GO:0005737; GO:0006730; GO:0008270; GO:0015670; GO:0016836; GO:0042539"
"753",753,"Cluster_1167","Porites_evermani_scaffold_295:294093-295093",152,-24.58,2,20,894,913,18,"72.22%","77.78%","Peve_00022058",0.445992939098454,0.705701286248999,0.978262075707395,NA,NA,NA,NA,NA
"754",754,"Cluster_1167","Porites_evermani_scaffold_3000:0-487",153,-27.86,2,20,111,136,22,"72.73%","72.73%","Peve_00022642",-0.22182211843193,0.857599140553088,0.995934364227446,"G1TFM5",NA,NA,NA,NA
"755",755,"Cluster_1167","Porites_evermani_scaffold_3012:47541-48541",151,-22.29,2,21,537,555,19,"73.68%","78.95%","Peve_00022723",0.502725333647473,0.664661433128686,0.978262075707395,"B3EWY9","Mucin-like protein","Acropora millepora (Staghorn coral) (Heteropora millepora)","cell-matrix adhesion [GO:0007160]","GO:0005509; GO:0007160; GO:0016020"
"756",756,"Cluster_1167","Porites_evermani_scaffold_3025:19902-20902",148,-24.69,2,14,887,909,13,"84.62%","84.62%","Peve_00022812",-0.488318552853167,0.675220836384604,0.978262075707395,NA,NA,NA,NA,NA
"757",757,"Cluster_1167","Porites_evermani_scaffold_306:119308-120308",150,-20.35,2,21,774,797,21,"71.43%","71.43%","Peve_00023053",0.992069771701524,0.0802278933643833,0.978262075707395,NA,NA,NA,NA,NA
"758",758,"Cluster_1167","Porites_evermani_scaffold_3079:36081-37081",152,-20.58,2,13,528,549,11,"90.91%","90.91%","Peve_00023186",0.848937360664505,0.35448579663787,0.978262075707395,"Q6NYI0","Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 2 protein","Danio rerio (Zebrafish) (Brachydanio rerio)","endoplasmic reticulum unfolded protein response [GO:0030968]","GO:0016020; GO:0030968"
"759",759,"Cluster_1167","Porites_evermani_scaffold_3:1493699-1494699",155,-20.89,2,21,312,334,20,"70.00%","75.00%","Peve_00022548",NA,NA,NA,NA,NA,NA,NA,NA
"760",760,"Cluster_1167","Porites_evermani_scaffold_324:289905-290905",149,-22.29,2,14,603,624,12,"83.33%","83.33%","Peve_00024263",NA,NA,NA,"Q96CG8","Collagen triple helix repeat-containing protein 1","Homo sapiens (Human)","cell migration [GO:0016477]; cochlea morphogenesis [GO:0090103]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein binding [GO:0032092]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0001649; GO:0005109; GO:0005576; GO:0005581; GO:0005615; GO:0016477; GO:0016528; GO:0017147; GO:0032092; GO:0033687; GO:0033690; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0062023; GO:0090090; GO:0090103; GO:0090177"
"761",761,"Cluster_1167","Porites_evermani_scaffold_3248:12927-13927",160,-28.48,2,13,586,607,11,"100.00%","100.00%","Peve_00024303",0.913398450560034,0.266896667241464,0.978262075707395,NA,NA,NA,NA,NA
"762",762,"Cluster_1167","Porites_evermani_scaffold_3299:22011-23011",152,-20.4,2,19,634,654,17,"76.47%","76.47%","Peve_00024580",0.948513538061105,0.205174245422385,0.978262075707395,NA,NA,NA,NA,NA
"763",763,"Cluster_1167","Porites_evermani_scaffold_3304:34815-35815",155,-23.27,2,20,246,264,18,"77.78%","77.78%","Peve_00024695",0.988080549610801,0.0983910422509776,0.978262075707395,"Q3ZBA6","DnaJ homolog subfamily B member 11 (ER-associated DNAJ) (ER-associated Hsp40 co-chaperone) (Endoplasmic reticulum DNA J domain-containing protein 3) (ER-resident protein ERdj3) (ERdj3) (ERj3p)","Bos taurus (Bovine)","mRNA modification [GO:0016556]; negative regulation of neurogenesis [GO:0050768]; positive regulation of ATP-dependent activity [GO:0032781]; protein folding [GO:0006457]; protein maturation [GO:0051604]","GO:0005102; GO:0005615; GO:0005634; GO:0005783; GO:0005788; GO:0006457; GO:0016556; GO:0032781; GO:0050768; GO:0051082; GO:0051604; GO:0051787; GO:0101031"
"764",764,"Cluster_1167","Porites_evermani_scaffold_3375:38972-39972",148,-22.42,2,13,509,530,11,"81.82%","90.91%","Peve_00025117",-0.511591173923624,0.65811249694873,0.978262075707395,"Q96CG8","Collagen triple helix repeat-containing protein 1","Homo sapiens (Human)","cell migration [GO:0016477]; cochlea morphogenesis [GO:0090103]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein binding [GO:0032092]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0001649; GO:0005109; GO:0005576; GO:0005581; GO:0005615; GO:0016477; GO:0016528; GO:0017147; GO:0032092; GO:0033687; GO:0033690; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0062023; GO:0090090; GO:0090103; GO:0090177"
"765",765,"Cluster_1167","Porites_evermani_scaffold_338:203492-204492",156,-20.78,2,21,235,256,19,"63.16%","78.95%","Peve_00025148",-0.488318552853167,0.675220836384603,0.978262075707395,"D8VNT0","Ryncolin-4","Cerberus rynchops (Dog-faced water snake)","","GO:0005576; GO:0090729"
"766",766,"Cluster_1167","Porites_evermani_scaffold_3400:24166-25166",145,-21.19,2,21,926,947,20,"70.00%","70.00%","Peve_00025326",0.982146793799861,0.12047626239292,0.978262075707395,"Q8IX03","Protein KIBRA (HBeAg-binding protein 3) (Kidney and brain protein) (KIBRA) (WW domain-containing protein 1)","Homo sapiens (Human)","cell migration [GO:0016477]; establishment of cell polarity [GO:0030010]; negative regulation of hippo signaling [GO:0035331]; negative regulation of organ growth [GO:0046621]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of MAPK cascade [GO:0043410]; regulation of DNA-templated transcription [GO:0006355]; regulation of hippo signaling [GO:0035330]; regulation of intracellular transport [GO:0032386]","GO:0000122; GO:0003713; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0016477; GO:0019900; GO:0030010; GO:0032386; GO:0032587; GO:0032991; GO:0035330; GO:0035331; GO:0043410; GO:0046621; GO:0048471; GO:0060090"
"767",767,"Cluster_1167","Porites_evermani_scaffold_340:274046-275046",149,-22.98,2,15,652,674,14,"78.57%","85.71%","Peve_00025298",0.839385585541614,0.365830047402497,0.978262075707395,NA,NA,NA,NA,NA
"768",768,"Cluster_1167","Porites_evermani_scaffold_3413:32781-33781",149,-25.06,2,20,391,411,18,"66.67%","77.78%","Peve_00025384",0.657918922938273,0.542873883416338,0.978262075707395,"Q867C9","ATP-dependent 6-phosphofructokinase, muscle type (ATP-PFK) (PFK-M) (EC 2.7.1.11) (6-phosphofructokinase type A) (Phosphofructo-1-kinase isozyme A) (PFK-A) (Phosphohexokinase)","Equus caballus (Horse)","canonical glycolysis [GO:0061621]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]","GO:0003872; GO:0005524; GO:0005945; GO:0006002; GO:0016020; GO:0016208; GO:0030388; GO:0042802; GO:0046872; GO:0048029; GO:0061621; GO:0070095"
"769",769,"Cluster_1167","Porites_evermani_scaffold_343:56231-57231",143,-23.32,2,21,394,417,21,"61.90%","66.67%","Peve_00025487",0.331807340363173,0.784683217132236,0.994676467236389,NA,NA,NA,NA,NA
"770",770,"Cluster_1167","Porites_evermani_scaffold_3464:144-1144",152,-23.21,2,13,599,620,11,"90.91%","90.91%","Peve_00025700",-0.867241914177684,0.331781145183968,0.978262075707395,"P95896","Amidase (EC 3.5.1.4)","Saccharolobus solfataricus (strain ATCC 35092 / DSM 1617 / JCM 11322 / P2) (Sulfolobus solfataricus)","","GO:0004040; GO:0043864"
"771",771,"Cluster_1167","Porites_evermani_scaffold_3534:18197-19197",149,-24.49,2,21,901,928,25,"68.00%","72.00%","Peve_00026155",0.696841788424087,0.509175930605768,0.978262075707395,NA,NA,NA,NA,NA
"772",772,"Cluster_1167","Porites_evermani_scaffold_3541:11132-11668",148,-20.23,2,14,456,479,14,"78.57%","85.71%","Peve_00026200",NA,NA,NA,NA,NA,NA,NA,NA
"773",773,"Cluster_1167","Porites_evermani_scaffold_3541:11132-11668",148,-20.23,2,14,456,479,14,"78.57%","85.71%","Peve_00026199",NA,NA,NA,NA,NA,NA,NA,NA
"774",774,"Cluster_1167","Porites_evermani_scaffold_3554:41319-42319",154,-23.05,2,16,516,538,15,"80.00%","86.67%","Peve_00026266",-0.0606175465880828,0.961385998849284,0.999448381576871,"P45974","Ubiquitin carboxyl-terminal hydrolase 5 (EC 3.4.19.12) (Deubiquitinating enzyme 5) (Isopeptidase T) (Ubiquitin thioesterase 5) (Ubiquitin-specific-processing protease 5)","Homo sapiens (Human)","positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0004197; GO:0004843; GO:0005634; GO:0005764; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016579; GO:0032436; GO:0043130; GO:0071108"
"775",775,"Cluster_1167","Porites_evermani_scaffold_3595:33413-34413",147,-23.25,2,21,781,803,20,"65.00%","70.00%","Peve_00026489",0.999909726776791,0.00855416971793389,0.573710369894872,NA,NA,NA,NA,NA
"776",776,"Cluster_1167","Porites_evermani_scaffold_362:199249-200249",151,-20.11,2,21,584,607,21,"66.67%","71.43%","Peve_00026679",NA,NA,NA,NA,NA,NA,NA,NA
"777",777,"Cluster_1167","Porites_evermani_scaffold_3746:26197-27197",152,-23.76,2,13,543,564,11,"90.91%","90.91%","Peve_00027319",NA,NA,NA,"O70497","Ficolin-2 (Collagen/fibrinogen domain-containing protein 2) (Ficolin-B) (Ficolin-beta) (L-ficolin)","Mus musculus (Mouse)","cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of opsonization [GO:1903028]; protein localization to cell surface [GO:0034394]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654]","GO:0001664; GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005581; GO:0005615; GO:0006508; GO:0007186; GO:0031232; GO:0032757; GO:0033691; GO:0034394; GO:0038187; GO:0042802; GO:0043394; GO:0043654; GO:0046597; GO:0046872; GO:0048306; GO:0062023; GO:0097367; GO:1903028; GO:1905370; GO:2001065"
"778",778,"Cluster_1167","Porites_evermani_scaffold_3782:1121-2121",155,-22.97,2,20,846,867,18,"66.67%","77.78%","Peve_00027496",NA,NA,NA,NA,NA,NA,NA,NA
"779",779,"Cluster_1167","Porites_evermani_scaffold_379:207327-208327",159,-25.64,2,21,815,838,21,"66.67%","80.95%","Peve_00027536",-0.122057117617096,0.922101782316212,0.999448381576871,NA,NA,NA,NA,NA
"780",780,"Cluster_1167","Porites_evermani_scaffold_380:23301-24301",145,-22.93,2,10,4,25,8,"100.00%","100.00%","Peve_00027635",0.90750772561574,0.275964686223183,0.978262075707395,"Q9VCA2","Organic cation transporter protein","Drosophila melanogaster (Fruit fly)","apoptotic process [GO:0006915]; ion transport [GO:0006811]","GO:0006811; GO:0006915; GO:0016020; GO:0022857"
"781",781,"Cluster_1167","Porites_evermani_scaffold_393:230579-231579",148,-23.31,2,13,828,849,11,"81.82%","90.91%","Peve_00028358",0.563567758129961,0.618856745796439,0.978262075707395,NA,NA,NA,NA,NA
"782",782,"Cluster_1167","Porites_evermani_scaffold_3949:1491-2491",145,-22.17,2,10,376,397,8,"100.00%","100.00%","Peve_00028453",NA,NA,NA,NA,NA,NA,NA,NA
"783",783,"Cluster_1167","Porites_evermani_scaffold_40:230333-231333",158,-22.63,2,21,423,443,19,"73.68%","78.95%","Peve_00028819",0.9334234388498,0.233612053800507,0.978262075707395,NA,NA,NA,NA,NA
"784",784,"Cluster_1167","Porites_evermani_scaffold_4047:3235-4235",152,-23.21,2,13,506,527,11,"90.91%","90.91%","Peve_00029075",NA,NA,NA,"Q92752","Tenascin-R (TN-R) (Janusin) (Restrictin)","Homo sapiens (Human)","associative learning [GO:0008306]; axon extension involved in regeneration [GO:0048677]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; locomotory exploration behavior [GO:0035641]; long-term synaptic potentiation [GO:0060291]; negative regulation of axon extension involved in regeneration [GO:0048692]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of neuron projection development [GO:0010977]; negative regulation of synaptic transmission [GO:0050805]; neuroblast migration [GO:0097402]; neuromuscular process controlling balance [GO:0050885]; neuron cell-cell adhesion [GO:0007158]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of transmission of nerve impulse [GO:0051971]; regulation of cell adhesion [GO:0030155]; regulation of cell differentiation [GO:0045595]; regulation of cell migration [GO:0030334]; synapse organization [GO:0050808]; synaptic transmission, glutamatergic [GO:0035249]; telencephalon cell migration [GO:0022029]","GO:0005102; GO:0005576; GO:0005615; GO:0007155; GO:0007158; GO:0007411; GO:0008306; GO:0009986; GO:0010977; GO:0022029; GO:0022408; GO:0030155; GO:0030198; GO:0030334; GO:0035249; GO:0035641; GO:0045121; GO:0045595; GO:0048677; GO:0048692; GO:0050805; GO:0050808; GO:0050885; GO:0051968; GO:0051971; GO:0060291; GO:0062023; GO:0072534; GO:0090733; GO:0097402; GO:0098685; GO:0098978"
"785",785,"Cluster_1167","Porites_evermani_scaffold_4052:19806-20806",146,-21.74,2,11,182,203,9,"88.89%","100.00%","Peve_00029134",0.969872496447224,0.156665409278015,0.978262075707395,"Q5R481","Septin-7","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","cell cycle [GO:0007049]; cell differentiation [GO:0030154]; cell division [GO:0051301]; cilium assembly [GO:0060271]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283]","GO:0000776; GO:0005525; GO:0005819; GO:0005930; GO:0007049; GO:0007283; GO:0016476; GO:0030154; GO:0030496; GO:0031105; GO:0031514; GO:0032154; GO:0051301; GO:0060271"
"786",786,"Cluster_1167","Porites_evermani_scaffold_41:392644-393644",148,-20.36,2,21,746,764,19,"68.42%","73.68%","Peve_00029384",-0.0409801550661512,0.973903915354569,0.999448381576871,"G3M4F8","Octopamine receptor beta-2R (CsOA2B2)","Chilo suppressalis (Asiatic rice borer moth)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to amine stimulus [GO:0071418]; octopamine signaling pathway [GO:0071927]; tyramine signaling pathway [GO:0071928]","GO:0004989; GO:0005886; GO:0007189; GO:0008226; GO:0016020; GO:0071418; GO:0071927; GO:0071928"
"787",787,"Cluster_1167","Porites_evermani_scaffold_4147:30376-31314",153,-25.03,2,21,120,145,23,"73.91%","73.91%","Peve_00029605",0.999850651123434,0.011002756609976,0.648044327003451,"Q9Y2W6","Tudor and KH domain-containing protein (Tudor domain-containing protein 2)","Homo sapiens (Human)","fertilization [GO:0009566]; male meiotic nuclear division [GO:0007140]; P granule organization [GO:0030719]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]","GO:0003723; GO:0005739; GO:0007140; GO:0007283; GO:0009566; GO:0030719; GO:0034587; GO:0043186; GO:0071546; GO:0071547"
"788",788,"Cluster_1167","Porites_evermani_scaffold_4157:26015-27015",155,-21.97,2,16,869,890,14,"78.57%","85.71%","Peve_00029642",0.999990221588804,0.00281533203902639,0.450074017033431,NA,NA,NA,NA,NA
"789",789,"Cluster_1167","Porites_evermani_scaffold_419:162655-163655",152,-20.24,2,13,360,381,11,"90.91%","90.91%","Peve_00029771",0.94071762097663,0.220306413440119,0.978262075707395,"Q26474","Lachesin","Schistocerca americana (American grasshopper)","cell adhesion [GO:0007155]","GO:0005886; GO:0007155"
"790",790,"Cluster_1167","Porites_evermani_scaffold_4284:23608-24608",145,-20.42,2,19,702,724,18,"66.67%","72.22%","Peve_00030309",0.349488956897893,0.772710437463127,0.991666733200134,"Q460N5","Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (B aggressive lymphoma protein 2) (Poly [ADP-ribose] polymerase 14) (PARP-14)","Homo sapiens (Human)","innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of type II interferon-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein poly-ADP-ribosylation [GO:0070212]","GO:0003714; GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0010629; GO:0016020; GO:0016779; GO:0019899; GO:0042531; GO:0042532; GO:0045087; GO:0060336; GO:0070212; GO:0070403; GO:1902216; GO:1990404"
"791",791,"Cluster_1167","Porites_evermani_scaffold_429:165386-166386",155,-29.15,2,12,843,864,10,"100.00%","100.00%","Peve_00030335",0.71165620382893,0.495890790154428,0.978262075707395,NA,NA,NA,NA,NA
"792",792,"Cluster_1167","Porites_evermani_scaffold_4306:12644-13644",154,-21.45,2,15,718,739,13,"84.62%","84.62%","Peve_00030477",0.981546823871618,0.122490046048747,0.978262075707395,"Q87NG3","Glycine betaine transporter 1","Vibrio parahaemolyticus serotype O3:K6 (strain RIMD 2210633)","amino acid transport [GO:0006865]","GO:0005886; GO:0006865; GO:0022857"
"793",793,"Cluster_1167","Porites_evermani_scaffold_4322:27145-28145",155,-23.27,2,20,238,256,18,"77.78%","77.78%","Peve_00030546",NA,NA,NA,NA,NA,NA,NA,NA
"794",794,"Cluster_1167","Porites_evermani_scaffold_433:181437-182437",152,-23.69,2,13,588,609,11,"90.91%","90.91%","Peve_00030572",0.644890860193738,0.553805632940818,0.978262075707395,"D2GXS7","Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2)","Ailuropoda melanoleuca (Giant panda)","regulation of neuron apoptotic process [GO:0043523]","GO:0004842; GO:0005737; GO:0008270; GO:0043523"
"795",795,"Cluster_1167","Porites_evermani_scaffold_4418:1574-2574",144,-20.48,2,21,731,752,19,"57.89%","68.42%","Peve_00031055",NA,NA,NA,"B8VIU6","Uncharacterized skeletal organic matrix protein 5 (Uncharacterized SOMP-5)","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0005576"
"796",796,"Cluster_1167","Porites_evermani_scaffold_4532:20264-21264",153,-24.53,2,21,53,75,21,"71.43%","76.19%","Peve_00031606",0.876038180789596,0.320354632242796,0.978262075707395,NA,NA,NA,NA,NA
"797",797,"Cluster_1167","Porites_evermani_scaffold_471:58833-59833",140,-26.28,2,9,795,816,7,"100.00%","100.00%","Peve_00032370",0.365137668134085,0.762043830226494,0.988821407749518,"Q13813","Spectrin alpha chain, non-erythrocytic 1 (Alpha-II spectrin) (Fodrin alpha chain) (Spectrin, non-erythroid alpha subunit)","Homo sapiens (Human)","actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]","GO:0003779; GO:0005200; GO:0005509; GO:0005516; GO:0005576; GO:0005829; GO:0005886; GO:0008091; GO:0015630; GO:0016020; GO:0030036; GO:0030054; GO:0030864; GO:0035580; GO:0042995; GO:0043231; GO:0045296; GO:0051015; GO:0051693; GO:0070062; GO:1903561; GO:1904724"
"798",798,"Cluster_1167","Porites_evermani_scaffold_4776:1435-2435",168,-23.37,2,21,390,411,19,"78.95%","78.95%","Peve_00032632",0.882025278264305,0.312359500535275,0.978262075707395,"Q9UJY5","ADP-ribosylation factor-binding protein GGA1 (Gamma-adaptin-related protein 1) (Golgi-localized, gamma ear-containing, ARF-binding protein 1)","Homo sapiens (Human)","Golgi to plasma membrane protein transport [GO:0043001]; Golgi to plasma membrane transport [GO:0006893]; intracellular protein transport [GO:0006886]; positive regulation of protein catabolic process [GO:0045732]; protein catabolic process [GO:0030163]; protein localization [GO:0008104]; protein localization to cell surface [GO:0034394]; protein localization to ciliary membrane [GO:1903441]; retrograde transport, endosome to Golgi [GO:0042147]; toxin transport [GO:1901998]","GO:0005654; GO:0005769; GO:0005794; GO:0005802; GO:0005829; GO:0006886; GO:0006893; GO:0008104; GO:0010008; GO:0016020; GO:0030163; GO:0031267; GO:0031901; GO:0032991; GO:0034394; GO:0035091; GO:0042147; GO:0043001; GO:0043130; GO:0043231; GO:0045732; GO:1901998; GO:1903441"
"799",799,"Cluster_1167","Porites_evermani_scaffold_48:119962-120962",148,-20.06,2,21,492,513,19,"57.89%","73.68%","Peve_00032729",0.988989889088951,0.0945562507601194,0.978262075707395,NA,NA,NA,NA,NA
"800",800,"Cluster_1167","Porites_evermani_scaffold_483:218414-219414",154,-20.27,2,15,664,685,13,"84.62%","84.62%","Peve_00032880",-0.484154824976475,0.678254292532074,0.978262075707395,"Q63638","Striated muscle-specific serine/threonine-protein kinase (EC 2.7.11.1) (Aortic preferentially expressed protein 1) (APEG-1)","Rattus norvegicus (Rat)","cardiac muscle cell development [GO:0055013]; circulatory system development [GO:0072359]; in utero embryonic development [GO:0001701]; muscle cell differentiation [GO:0042692]; protein phosphorylation [GO:0006468]; respiratory system development [GO:0060541]","GO:0001701; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0006468; GO:0042692; GO:0055013; GO:0060541; GO:0072359; GO:0106310"
"801",801,"Cluster_1167","Porites_evermani_scaffold_4840:4867-5867",149,-21.04,2,21,381,400,19,"68.42%","73.68%","Peve_00032926",NA,NA,NA,"Q9C9U3","Alpha-dioxygenase 2 (Alpha DOX2) (EC 1.14.99.-) (Fatty acid dioxygenase AlphaDOX2)","Arabidopsis thaliana (Mouse-ear cress)","fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631]; leaf senescence [GO:0010150]; long-chain fatty acid metabolic process [GO:0001676]; oxylipin biosynthetic process [GO:0031408]; response to oxidative stress [GO:0006979]","GO:0001676; GO:0004601; GO:0006631; GO:0006633; GO:0006979; GO:0010150; GO:0016702; GO:0020037; GO:0031408; GO:0046872; GO:0051213"
"802",802,"Cluster_1167","Porites_evermani_scaffold_484:39711-40711",148,-20.42,2,21,897,918,19,"63.16%","68.42%","Peve_00032901",0.484676006915013,0.677875028373691,0.978262075707395,"Q90Z12","Transcription factor HES-4-A (Hairy and enhancer of split 4-A) (Protein hairy-2) (Xhairy2) (Protein hairy-2a) (Xhairy2a)","Xenopus laevis (African clawed frog)","BMP signaling pathway [GO:0030509]; floor plate development [GO:0033504]; lens development in camera-type eye [GO:0002088]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest formation [GO:0014029]; prechordal plate formation [GO:0021501]","GO:0000122; GO:0002088; GO:0005634; GO:0014029; GO:0021501; GO:0030509; GO:0033504; GO:0043066; GO:0043425; GO:0043565; GO:0045892; GO:0046983"
"803",803,"Cluster_1167","Porites_evermani_scaffold_4869:8229-9229",143,-24.1,2,21,422,446,22,"63.64%","63.64%","Peve_00033000",-0.262934468244999,0.830619393158708,0.995934364227446,NA,NA,NA,NA,NA
"804",804,"Cluster_1167","Porites_evermani_scaffold_4901:3424-4424",151,-20.78,2,21,303,325,20,"60.00%","80.00%","Peve_00033154",0.484676006915013,0.677875028373691,0.978262075707395,NA,NA,NA,NA,NA
"805",805,"Cluster_1167","Porites_evermani_scaffold_4963:8541-9541",153,-20.86,2,21,934,959,23,"69.57%","78.26%","Peve_00033374",NA,NA,NA,NA,NA,NA,NA,NA
"806",806,"Cluster_1167","Porites_evermani_scaffold_496:69962-70962",146,-24.34,2,21,133,150,19,"68.42%","78.95%","Peve_00033367",0.876503724120225,0.31973951655349,0.978262075707395,"A0A1L8H0H2",NA,NA,NA,NA
"807",807,"Cluster_1167","Porites_evermani_scaffold_5119:15690-16690",145,-21.67,2,21,18,43,23,"69.57%","69.57%","Peve_00034125",0.665107858136436,0.536771105481511,0.978262075707395,NA,NA,NA,NA,NA
"808",808,"Cluster_1167","Porites_evermani_scaffold_520:1319-2319",140,-20.19,2,9,770,791,7,"100.00%","100.00%","Peve_00034405",NA,NA,NA,NA,NA,NA,NA,NA
"809",809,"Cluster_1167","Porites_evermani_scaffold_5244:9704-10704",147,-21.51,2,13,197,220,13,"84.62%","84.62%","Peve_00034545",-0.760345745612288,0.450059027283539,0.978262075707395,NA,NA,NA,NA,NA
"810",810,"Cluster_1167","Porites_evermani_scaffold_5247:3724-4724",146,-22.61,2,13,211,231,11,"90.91%","90.91%","Peve_00034549",0.998849404223647,0.0305420482403264,0.903929377050813,"P49285","Melatonin receptor type 1A (Mel-1A-R) (Mel1a receptor) (CKA)","Gallus gallus (Chicken)","adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; circadian rhythm [GO:0007623]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of glucose import [GO:0046325]; negative regulation of glycolytic process [GO:0045820]","GO:0004930; GO:0005886; GO:0007186; GO:0007193; GO:0007623; GO:0008502; GO:0042562; GO:0043235; GO:0045820; GO:0046325; GO:1904408"
"811",811,"Cluster_1167","Porites_evermani_scaffold_5290:9765-10765",159,-26.57,2,20,198,219,18,"72.22%","77.78%","Peve_00034692",0.833816116030113,0.372302615473381,0.978262075707395,NA,NA,NA,NA,NA
"812",812,"Cluster_1167","Porites_evermani_scaffold_538:35348-36348",148,-20.43,2,19,843,866,19,"68.42%","78.95%","Peve_00035030",NA,NA,NA,NA,NA,NA,NA,NA
"813",813,"Cluster_1167","Porites_evermani_scaffold_5393:6282-7282",149,-23.42,2,20,776,796,18,"72.22%","72.22%","Peve_00035083",0.696844657677088,0.509173383807957,0.978262075707395,"Q14623","Indian hedgehog protein (IHH) (EC 3.1.-.-) (HHG-2) [Cleaved into: Indian hedgehog protein N-product]","Homo sapiens (Human)","bone resorption [GO:0045453]; branching involved in blood vessel morphogenesis [GO:0001569]; camera-type eye photoreceptor cell fate commitment [GO:0060220]; cartilage development [GO:0051216]; cell fate specification [GO:0001708]; cell maturation [GO:0048469]; cell-cell signaling [GO:0007267]; chondrocyte differentiation involved in endochondral bone morphogenesis [GO:0003413]; chondrocyte proliferation [GO:0035988]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic digit morphogenesis [GO:0042733]; embryonic pattern specification [GO:0009880]; embryonic skeletal joint development [GO:0072498]; epithelial cell morphogenesis [GO:0003382]; epithelial cell-cell adhesion [GO:0090136]; head morphogenesis [GO:0060323]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; intein-mediated protein splicing [GO:0016539]; liver regeneration [GO:0097421]; maternal process involved in female pregnancy [GO:0060135]; multicellular organism growth [GO:0035264]; negative regulation of alpha-beta T cell differentiation [GO:0046639]; negative regulation of apoptotic process [GO:0043066]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of eye pigmentation [GO:0048074]; negative regulation of immature T cell proliferation in thymus [GO:0033088]; negative regulation of T cell differentiation in thymus [GO:0033085]; neuron development [GO:0048666]; osteoblast differentiation [GO:0001649]; pancreas development [GO:0031016]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of T cell differentiation in thymus [GO:0033089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autoprocessing [GO:0016540]; proteoglycan metabolic process [GO:0006029]; regulation of gene expression [GO:0010468]; regulation of growth [GO:0040008]; response to estradiol [GO:0032355]; response to mechanical stimulus [GO:0009612]; retinal pigment epithelium development [GO:0003406]; self proteolysis [GO:0097264]; skeletal system development [GO:0001501]; smooth muscle tissue development [GO:0048745]; smoothened signaling pathway [GO:0007224]; somite development [GO:0061053]; vitelline membrane formation [GO:0030704]","GO:0000139; GO:0001501; GO:0001569; GO:0001649; GO:0001701; GO:0001708; GO:0001947; GO:0002053; GO:0003382; GO:0003406; GO:0003413; GO:0005113; GO:0005509; GO:0005576; GO:0005615; GO:0005789; GO:0005886; GO:0006029; GO:0007224; GO:0007267; GO:0008233; GO:0009612; GO:0009880; GO:0010468; GO:0016539; GO:0016540; GO:0030704; GO:0031012; GO:0031016; GO:0032331; GO:0032355; GO:0032967; GO:0033085; GO:0033088; GO:0033089; GO:0034189; GO:0035264; GO:0035988; GO:0040008; GO:0042733; GO:0043066; GO:0045453; GO:0045880; GO:0045944; GO:0046638; GO:0046639; GO:0048074; GO:0048469; GO:0048557; GO:0048596; GO:0048666; GO:0048745; GO:0050679; GO:0051216; GO:0060135; GO:0060220; GO:0060323; GO:0061053; GO:0072498; GO:0090136; GO:0097264; GO:0097421; GO:0140853"
"814",814,"Cluster_1167","Porites_evermani_scaffold_540:186824-187824",145,-21.17,2,10,625,646,8,"100.00%","100.00%","Peve_00035158",NA,NA,NA,NA,NA,NA,NA,NA
"815",815,"Cluster_1167","Porites_evermani_scaffold_540:220328-221328",146,-22.6,2,21,673,697,22,"68.18%","68.18%","Peve_00035161",0.999909726776791,0.00855416971793915,0.573710369894872,NA,NA,NA,NA,NA
"816",816,"Cluster_1167","Porites_evermani_scaffold_542:150907-151907",148,-22.43,2,21,248,269,19,"63.16%","68.42%","Peve_00035214",0.911337471618246,0.270101783470307,0.978262075707395,NA,NA,NA,NA,NA
"817",817,"Cluster_1167","Porites_evermani_scaffold_5459:6291-7291",148,-22.64,2,14,145,169,15,"80.00%","80.00%","Peve_00035323",NA,NA,NA,NA,NA,NA,NA,NA
"818",818,"Cluster_1167","Porites_evermani_scaffold_553:42531-43531",160,-24.24,2,21,872,893,19,"68.42%","78.95%","Peve_00035570",NA,NA,NA,NA,NA,NA,NA,NA
"819",819,"Cluster_1167","Porites_evermani_scaffold_5609:4525-5525",152,-23.21,2,13,734,755,11,"90.91%","90.91%","Peve_00035831",0.58914394630894,0.598930182868877,0.978262075707395,"Q5PQ71","Isochorismatase domain-containing protein 2","Xenopus laevis (African clawed frog)","",""
"820",820,"Cluster_1167","Porites_evermani_scaffold_58:275115-276115",152,-20.58,2,13,505,526,11,"90.91%","90.91%","Peve_00036388",0.992829552903376,0.0762830568064257,0.978262075707395,NA,NA,NA,NA,NA
"821",821,"Cluster_1167","Porites_evermani_scaffold_590:154196-155196",142,-20.46,2,16,658,680,15,"73.33%","73.33%","Peve_00036721",0.999909726776791,0.00855416971793915,0.573710369894872,NA,NA,NA,NA,NA
"822",822,"Cluster_1167","Porites_evermani_scaffold_590:154832-155196",142,-20.46,2,16,22,44,15,"73.33%","73.33%","Peve_00036722",0.928754511141277,0.241761211074652,0.978262075707395,NA,NA,NA,NA,NA
"823",823,"Cluster_1167","Porites_evermani_scaffold_590:158279-159279",142,-20.46,2,16,658,680,15,"73.33%","73.33%","Peve_00036723",0.999909726776791,0.00855416971793389,0.573710369894872,NA,NA,NA,NA,NA
"824",824,"Cluster_1167","Porites_evermani_scaffold_590:158915-159279",142,-20.46,2,16,22,44,15,"73.33%","73.33%","Peve_00036724",0.254740496877977,0.836019900875247,0.995934364227446,NA,NA,NA,NA,NA
"825",825,"Cluster_1167","Porites_evermani_scaffold_59:244529-245529",142,-20.2,2,11,195,216,9,"88.89%","88.89%","Peve_00036654",NA,NA,NA,NA,NA,NA,NA,NA
"826",826,"Cluster_1167","Porites_evermani_scaffold_59:256142-257142",151,-21.94,2,21,508,531,21,"66.67%","71.43%","Peve_00036657",NA,NA,NA,NA,NA,NA,NA,NA
"827",827,"Cluster_1167","Porites_evermani_scaffold_61:99144-100144",153,-26.24,2,20,219,242,20,"70.00%","80.00%","Peve_00037343",0.999909726776791,0.00855416971793915,0.573710369894872,NA,NA,NA,NA,NA
"828",828,"Cluster_1167","Porites_evermani_scaffold_623:119858-120858",149,-27.26,2,21,130,152,21,"66.67%","76.19%","Peve_00037700",-0.631405342509224,0.564956861890799,0.978262075707395,NA,NA,NA,NA,NA
"829",829,"Cluster_1167","Porites_evermani_scaffold_6241:4776-5776",141,-20.82,2,12,597,617,10,"90.00%","90.00%","Peve_00037736",NA,NA,NA,NA,NA,NA,NA,NA
"830",830,"Cluster_1167","Porites_evermani_scaffold_6442:486-1486",153,-25.47,2,18,597,618,16,"68.75%","81.25%","Peve_00038269",NA,NA,NA,NA,NA,NA,NA,NA
"831",831,"Cluster_1167","Porites_evermani_scaffold_64:557112-558112",148,-24.04,2,21,628,646,19,"68.42%","73.68%","Peve_00038115",0.983635472613817,0.115329628033663,0.978262075707395,"Q5NVI9","DnaJ homolog subfamily A member 1","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","negative regulation of apoptotic process [GO:0043066]; negative regulation of JUN kinase activity [GO:0043508]; positive regulation of apoptotic process [GO:0043065]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; regulation of protein transport [GO:0051223]; response to heat [GO:0009408]","GO:0001671; GO:0005524; GO:0005634; GO:0005739; GO:0005783; GO:0006457; GO:0009408; GO:0016020; GO:0030544; GO:0043065; GO:0043066; GO:0043508; GO:0046872; GO:0048471; GO:0051082; GO:0051087; GO:0051223; GO:0070585"
"832",832,"Cluster_1167","Porites_evermani_scaffold_645:57822-58822",147,-21.64,2,16,155,176,14,"71.43%","78.57%","Peve_00038290",0.706101026284099,0.500904854799171,0.978262075707395,NA,NA,NA,NA,NA
"833",833,"Cluster_1167","Porites_evermani_scaffold_645:79515-80515",156,-24.39,2,21,807,828,19,"63.16%","78.95%","Peve_00038278",-0.511591173923624,0.65811249694873,0.978262075707395,NA,NA,NA,NA,NA
"834",834,"Cluster_1167","Porites_evermani_scaffold_65:230574-231574",152,-23.21,2,13,848,869,11,"90.91%","90.91%","Peve_00038388",0.762511311018754,0.447932305408178,0.978262075707395,"Q15269","Periodic tryptophan protein 2 homolog","Homo sapiens (Human)","maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit assembly [GO:0000028]","GO:0000028; GO:0000462; GO:0003723; GO:0005654; GO:0032040; GO:0034388"
"835",835,"Cluster_1167","Porites_evermani_scaffold_671:95563-96563",142,-21.29,2,11,480,501,9,"88.89%","88.89%","Peve_00038857",-0.0355121330176432,0.977387519452447,0.999448381576871,NA,NA,NA,NA,NA
"836",836,"Cluster_1167","Porites_evermani_scaffold_685:11293-12293",156,-23.78,2,17,847,868,15,"80.00%","80.00%","Peve_00039172",0.731196453425974,0.477924544900265,0.978262075707395,NA,NA,NA,NA,NA
"837",837,"Cluster_1167","Porites_evermani_scaffold_697:160930-161930",140,-24.8,2,9,379,400,7,"100.00%","100.00%","Peve_00039465",-0.354229847836622,0.769486100862895,0.990831922980971,NA,NA,NA,NA,NA
"838",838,"Cluster_1167","Porites_evermani_scaffold_73:353481-354481",164,-24.27,2,17,178,199,15,"86.67%","86.67%","Peve_00040261",-0.629293201124937,0.566688939700901,0.978262075707395,NA,NA,NA,NA,NA
"839",839,"Cluster_1167","Porites_evermani_scaffold_742:140467-141467",152,-23.21,2,13,59,80,11,"90.91%","90.91%","Peve_00040549",0.999909726776791,0.00855416971793389,0.573710369894872,NA,NA,NA,NA,NA
"840",840,"Cluster_1167","Porites_evermani_scaffold_74:388498-389498",152,-21.22,2,13,312,333,11,"90.91%","90.91%","Peve_00040506",NA,NA,NA,NA,NA,NA,NA,NA
"841",841,"Cluster_1167","Porites_evermani_scaffold_762:23322-24322",148,-24.15,2,21,737,758,19,"63.16%","68.42%","Peve_00040907",-0.07962362777704,0.949256309070908,0.999448381576871,NA,NA,NA,NA,NA
"842",842,"Cluster_1167","Porites_evermani_scaffold_77:340911-341911",145,-22.8,2,17,334,356,17,"76.47%","76.47%","Peve_00041061",NA,NA,NA,NA,NA,NA,NA,NA
"843",843,"Cluster_1167","Porites_evermani_scaffold_78:285712-286712",150,-20.28,2,11,394,415,9,"100.00%","100.00%","Peve_00041243",0.773554022555867,0.436954237959652,0.978262075707395,"B3EWZ8","Ectin","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0005576"
"844",844,"Cluster_1167","Porites_evermani_scaffold_792:122223-123223",152,-20.28,2,21,91,112,19,"63.16%","73.68%","Peve_00041552",0.999909726776791,0.00855416971793915,0.573710369894872,NA,NA,NA,NA,NA
"845",845,"Cluster_1167","Porites_evermani_scaffold_80:533287-534287",153,-23.22,2,21,209,228,19,"68.42%","78.95%","Peve_00041753",0.314459824305007,0.796353255906978,0.995934364227446,"P85118","N-acetyltransferase family 8 member 2 (EC 2.3.1.-) (Camello-like protein 2) (N-acetyltransferase-like protein CML2)","Rattus norvegicus (Rat)","gastrulation [GO:0007369]","GO:0007369; GO:0008080; GO:0016020"
"846",846,"Cluster_1167","Porites_evermani_scaffold_817:28265-29265",145,-21.34,2,21,772,794,21,"66.67%","71.43%","Peve_00042118",0.711318864053025,0.496196407873778,0.978262075707395,NA,NA,NA,NA,NA
"847",847,"Cluster_1167","Porites_evermani_scaffold_818:169331-170331",142,-20.81,2,20,363,386,20,"65.00%","65.00%","Peve_00042134",0.999909726776791,0.00855416971793915,0.573710369894872,"Q91909","Mast/stem cell growth factor receptor-related protein Kit (EC 2.7.10.1) (Kit-related kinase 1) (xKrk1) (Tyrosine-protein kinase kit)","Xenopus laevis (African clawed frog)","Fc receptor signaling pathway [GO:0038093]; Kit signaling pathway [GO:0038109]","GO:0004714; GO:0005524; GO:0005886; GO:0019955; GO:0038093; GO:0038109; GO:0046872"
"848",848,"Cluster_1167","Porites_evermani_scaffold_821:111687-112687",146,-21.74,2,11,153,174,9,"88.89%","100.00%","Peve_00042228",0.999990792524351,0.00273190594675139,0.442041167784887,"Q5R481","Septin-7","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","cell cycle [GO:0007049]; cell differentiation [GO:0030154]; cell division [GO:0051301]; cilium assembly [GO:0060271]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283]","GO:0000776; GO:0005525; GO:0005819; GO:0005930; GO:0007049; GO:0007283; GO:0016476; GO:0030154; GO:0030496; GO:0031105; GO:0031514; GO:0032154; GO:0051301; GO:0060271"
"849",849,"Cluster_1167","Porites_evermani_scaffold_82:37852-38852",150,-21.9,2,20,413,436,20,"65.00%","75.00%","Peve_00042162",NA,NA,NA,NA,NA,NA,NA,NA
"850",850,"Cluster_1167","Porites_evermani_scaffold_8:450170-451170",155,-22.86,2,19,743,765,19,"78.95%","78.95%","Peve_00041691",-0.924562518632303,0.248861347413281,0.978262075707395,"Q4UMH6","Putative ankyrin repeat protein RF_0381","Rickettsia felis (strain ATCC VR-1525 / URRWXCal2) (Rickettsia azadi)","guanosine tetraphosphate metabolic process [GO:0015969]","GO:0015969"
"851",851,"Cluster_1167","Porites_evermani_scaffold_849:40638-41638",140,-23.88,2,9,117,138,7,"100.00%","100.00%","Peve_00042737",-0.285784208331615,0.815491886870088,0.995934364227446,NA,NA,NA,NA,NA
"852",852,"Cluster_1167","Porites_evermani_scaffold_883:47432-48432",149,-21.78,2,14,403,424,12,"83.33%","83.33%","Peve_00043379",0.999909726776791,0.00855416971793389,0.573710369894872,"Q8L7C8","Protein REDUCED WALL ACETYLATION 1 (EC 2.3.1.-)","Arabidopsis thaliana (Mouse-ear cress)","carbohydrate metabolic process [GO:0005975]; plant-type secondary cell wall biogenesis [GO:0009834]; xylan acetylation [GO:1990937]; xylan biosynthetic process [GO:0045492]; xylan metabolic process [GO:0045491]; xyloglucan metabolic process [GO:0010411]","GO:0000139; GO:0005794; GO:0005975; GO:0009834; GO:0010411; GO:0016407; GO:0016491; GO:0045491; GO:0045492; GO:1990937"
"853",853,"Cluster_1167","Porites_evermani_scaffold_890:44983-45983",153,-20.63,2,21,74,93,19,"73.68%","73.68%","Peve_00043489",-0.511807621043075,0.657952114963207,0.978262075707395,NA,NA,NA,NA,NA
"854",854,"Cluster_1167","Porites_evermani_scaffold_898:26568-27568",145,-20.56,2,10,525,546,8,"100.00%","100.00%","Peve_00043580",0.850122427164383,0.353055691868721,0.978262075707395,"Q14738","Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform (PP2A B subunit isoform B'-delta) (PP2A B subunit isoform B56-delta) (PP2A B subunit isoform PR61-delta) (PP2A B subunit isoform R5-delta)","Homo sapiens (Human)","nervous system development [GO:0007399]; positive regulation of protein dephosphorylation [GO:0035307]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]","GO:0000159; GO:0004721; GO:0005634; GO:0005654; GO:0005829; GO:0006470; GO:0007165; GO:0007399; GO:0019888; GO:0035307; GO:0072542"
"855",855,"Cluster_1167","Porites_evermani_scaffold_898:38402-39402",145,-20.56,2,10,525,546,8,"100.00%","100.00%","Peve_00043581",0.971102039324845,0.15341935627486,0.978262075707395,"Q28653","Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform (PP2A B subunit isoform B'-delta) (PP2A B subunit isoform B'-gamma) (PP2A B subunit isoform B56-delta) (PP2A B subunit isoform PR61-delta) (PP2A B subunit isoform R5-delta)","Oryctolagus cuniculus (Rabbit)","signal transduction [GO:0007165]","GO:0000159; GO:0005634; GO:0007165; GO:0019888"
"856",856,"Cluster_1167","Porites_evermani_scaffold_917:18610-19610",140,-25.52,2,9,454,475,7,"100.00%","100.00%","Peve_00044049",NA,NA,NA,NA,NA,NA,NA,NA
"857",857,"Cluster_1167","Porites_evermani_scaffold_928:59222-60222",142,-21.15,2,12,965,988,12,"83.33%","83.33%","Peve_00044216",NA,NA,NA,NA,NA,NA,NA,NA
"858",858,"Cluster_1167","Porites_evermani_scaffold_930:99238-100238",152,-22.97,2,13,528,549,11,"90.91%","90.91%","Peve_00044277",-0.488318552853167,0.675220836384603,0.978262075707395,"P78357","Contactin-associated protein 1 (Caspr) (Caspr1) (Neurexin IV) (Neurexin-4) (p190)","Homo sapiens (Human)","axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; central nervous system myelination [GO:0022010]; cytoskeleton organization [GO:0007010]; mitochondrion organization [GO:0007005]; myelination in peripheral nervous system [GO:0022011]; neuromuscular junction development, skeletal muscle fiber [GO:0098529]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; neuron projection morphogenesis [GO:0048812]; neuronal action potential propagation [GO:0019227]; paranodal junction assembly [GO:0030913]; paranodal junction maintenance [GO:1990227]; postsynaptic density organization [GO:0097106]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; regulation of synapse maturation [GO:0090128]; signal transduction [GO:0007165]","GO:0002175; GO:0005886; GO:0007005; GO:0007010; GO:0007155; GO:0007165; GO:0007409; GO:0016020; GO:0017124; GO:0019227; GO:0022010; GO:0022011; GO:0030913; GO:0033010; GO:0033270; GO:0038023; GO:0048786; GO:0048812; GO:0050884; GO:0050885; GO:0071205; GO:0090128; GO:0097106; GO:0098529; GO:0098978; GO:1990227"
"859",859,"Cluster_1167","Porites_evermani_scaffold_948:72623-73623",144,-20.85,2,21,458,479,19,"57.89%","68.42%","Peve_00044523",-0.608396364493673,0.583626224620464,0.978262075707395,"Q96RT1","Erbin (Densin-180-like protein) (Erbb2-interacting protein) (Protein LAP2)","Homo sapiens (Human)","basal protein localization [GO:0045175]; cell adhesion [GO:0007155]; cellular response to tumor necrosis factor [GO:0071356]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070433]; positive regulation of Ras protein signal transduction [GO:0046579]; protein targeting [GO:0006605]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; signal transduction [GO:0007165]","GO:0005102; GO:0005176; GO:0005200; GO:0005604; GO:0005634; GO:0005737; GO:0005886; GO:0006605; GO:0007155; GO:0007165; GO:0007173; GO:0007229; GO:0009925; GO:0016323; GO:0016607; GO:0030054; GO:0030056; GO:0031965; GO:0032088; GO:0032495; GO:0032496; GO:0045104; GO:0045175; GO:0045197; GO:0046579; GO:0070433; GO:0071356; GO:0071638; GO:0098794; GO:0098978; GO:0099072"
"860",860,"Cluster_1167","Porites_evermani_scaffold_964:44388-45388",145,-20.5,2,10,788,809,8,"100.00%","100.00%","Peve_00044815",NA,NA,NA,NA,NA,NA,NA,NA
"861",861,"Cluster_1167","Porites_evermani_scaffold_977:122844-123844",160,-22.53,2,21,682,703,19,"73.68%","73.68%","Peve_00045022",0.982391766101847,0.119644392953077,0.978262075707395,"Q9P3U4","E3 ubiquitin-protein ligase dbl4 (EC 2.3.2.31) (DNA-break-localizing protein 4) (Histone E3 ligase 1) (RING-type E3 ubiquitin transferase dbl4)","Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)","histone catabolic process [GO:0036205]; histone ubiquitination [GO:0016574]; meiosis I [GO:0007127]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0000209; GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0007127; GO:0008270; GO:0016574; GO:0031624; GO:0032436; GO:0035861; GO:0036205; GO:0061630"
"862",862,"Cluster_1167","Porites_evermani_scaffold_99:32693-33542",155,-26.85,2,17,756,778,16,"81.25%","81.25%","Peve_00045222",0.998907226375474,0.0297645814333626,0.903929377050813,NA,NA,NA,NA,NA
"863",863,"Cluster_1167","Porites_evermani_scaffold_99:506249-507249",153,-20.72,2,16,922,942,14,"85.71%","85.71%","Peve_00045202",NA,NA,NA,NA,NA,NA,NA,NA
"864",864,"Cluster_11997","Porites_evermani_scaffold_1162:94085-95085",174,-21.06,2,20,486,509,20,"85.00%","85.00%","Peve_00002767",0.177142887114265,0.886629054635409,0.999448381576871,NA,NA,NA,NA,NA
"865",865,"Cluster_11997","Porites_evermani_scaffold_1330:7261-8261",167,-20.76,2,21,942,966,22,"72.73%","81.82%","Peve_00005244",NA,NA,NA,NA,NA,NA,NA,NA
"866",866,"Cluster_11997","Porites_evermani_scaffold_1338:24338-25338",176,-20.57,2,21,847,868,19,"84.21%","84.21%","Peve_00005321",0.467849177885566,0.690058084936882,0.978262075707395,NA,NA,NA,NA,NA
"867",867,"Cluster_11997","Porites_evermani_scaffold_155:250261-251261",160,-20.1,2,21,223,244,19,"68.42%","78.95%","Peve_00008108",NA,NA,NA,"Q7T3S3","Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4ST-1) (C4ST1) (zC4ST-1)","Danio rerio (Zebrafish) (Brachydanio rerio)","carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; motor neuron axon guidance [GO:0008045]; muscle organ development [GO:0007517]; proteoglycan biosynthetic process [GO:0030166]","GO:0000139; GO:0007517; GO:0008045; GO:0008146; GO:0016051; GO:0030166; GO:0030206; GO:0047756"
"868",868,"Cluster_11997","Porites_evermani_scaffold_1719:101679-102679",174,-20.78,2,21,602,622,19,"84.21%","89.47%","Peve_00010248",-0.972884261006854,0.148590864647565,0.978262075707395,NA,NA,NA,NA,NA
"869",869,"Cluster_11997","Porites_evermani_scaffold_189:165699-166699",150,-20.14,2,21,920,943,21,"66.67%","76.19%","Peve_00012123",0.798063320789557,0.411716010497342,0.978262075707395,"Q9CR50","RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363)","Mus musculus (Mouse)","positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0002039; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042803; GO:0043231; GO:0051865; GO:0061630"
"870",870,"Cluster_11997","Porites_evermani_scaffold_189:166507-167507",150,-20.14,2,21,112,135,21,"66.67%","76.19%","Peve_00012124",0.461037457768518,0.694954744008953,0.978262075707395,NA,NA,NA,NA,NA
"871",871,"Cluster_11997","Porites_evermani_scaffold_2545:34001-35001",151,-20.7,2,21,104,127,21,"61.90%","76.19%","Peve_00018810",0.28613696079016,0.815257531314231,0.995934364227446,NA,NA,NA,NA,NA
"872",872,"Cluster_11997","Porites_evermani_scaffold_3:1143702-1144702",179,-22.87,2,21,389,411,20,"80.00%","95.00%","Peve_00022489",NA,NA,NA,NA,NA,NA,NA,NA
"873",873,"Cluster_11997","Porites_evermani_scaffold_3268:42279-43279",167,-21.94,2,21,761,783,20,"75.00%","85.00%","Peve_00024422",0.28613696079016,0.815257531314231,0.995934364227446,NA,NA,NA,NA,NA
"874",874,"Cluster_11997","Porites_evermani_scaffold_462:255673-256673",151,-20.7,2,21,104,127,21,"61.90%","76.19%","Peve_00032006",0.28613696079016,0.815257531314231,0.995934364227446,NA,NA,NA,NA,NA
"875",875,"Cluster_11997","Porites_evermani_scaffold_7366:1935-2634",159,-20.93,2,21,596,618,20,"70.00%","80.00%","Peve_00040420",NA,NA,NA,NA,NA,NA,NA,NA
"876",876,"Cluster_11997","Porites_evermani_scaffold_775:89090-90090",178,-20.39,2,21,494,514,19,"84.21%","94.74%","Peve_00041153",0.862783368836325,0.337438325761085,0.978262075707395,NA,NA,NA,NA,NA
"877",877,"Cluster_11997","Porites_evermani_scaffold_90:104396-105396",163,-21.85,2,21,716,739,21,"71.43%","80.95%","Peve_00043723",-0.976058820177045,0.139584817697117,0.978262075707395,NA,NA,NA,NA,NA
"878",878,"Cluster_13502","Porites_evermani_scaffold_1016:71751-72751",160,-20.45,2,21,285,306,19,"68.42%","78.95%","Peve_00000479",NA,NA,NA,NA,NA,NA,NA,NA
"879",879,"Cluster_13502","Porites_evermani_scaffold_1072:126310-127310",150,-20.52,2,21,601,627,24,"66.67%","70.83%","Peve_00001338",NA,NA,NA,NA,NA,NA,NA,NA
"880",880,"Cluster_13502","Porites_evermani_scaffold_1099:147131-148131",159,-22.48,2,18,500,520,16,"75.00%","93.75%","Peve_00001711",0.997844556977271,0.0418062711782376,0.909359886114279,NA,NA,NA,NA,NA
"881",881,"Cluster_13502","Porites_evermani_scaffold_1165:10453-11453",156,-20.76,2,19,959,984,21,"76.19%","76.19%","Peve_00002803",-0.430581656408954,0.7166168979908,0.980647121511795,NA,NA,NA,NA,NA
"882",882,"Cluster_13502","Porites_evermani_scaffold_1170:30266-31266",160,-23.5,2,13,493,514,11,"100.00%","100.00%","Peve_00002887",-0.490352886787749,0.673735795143154,0.978262075707395,"Q96CG8","Collagen triple helix repeat-containing protein 1","Homo sapiens (Human)","cell migration [GO:0016477]; cochlea morphogenesis [GO:0090103]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein binding [GO:0032092]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0001649; GO:0005109; GO:0005576; GO:0005581; GO:0005615; GO:0016477; GO:0016528; GO:0017147; GO:0032092; GO:0033687; GO:0033690; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0062023; GO:0090090; GO:0090103; GO:0090177"
"883",883,"Cluster_13502","Porites_evermani_scaffold_1223:16711-17711",192,-35.54,2,21,283,304,19,"89.47%","100.00%","Peve_00003720",0.997844556977271,0.0418062711782387,0.909359886114279,NA,NA,NA,NA,NA
"884",884,"Cluster_13502","Porites_evermani_scaffold_1264:76265-77265",162,-24.77,2,19,210,231,17,"70.59%","88.24%","Peve_00004276",-0.910369319804917,0.271595124693792,0.978262075707395,"D4ACX8","Protocadherin-16 (Protein dachsous homolog 1)","Rattus norvegicus (Rat)","adherens junction organization [GO:0034332]; anatomical structure morphogenesis [GO:0009653]; branching involved in ureteric bud morphogenesis [GO:0001658]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell migration [GO:0016477]; cell migration involved in endocardial cushion formation [GO:0003273]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; cochlea development [GO:0090102]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; kidney development [GO:0001822]; mitral valve formation [GO:0003192]; mitral valve morphogenesis [GO:0003183]; nephron development [GO:0072006]; neural tube development [GO:0021915]; neurogenesis [GO:0022008]; ossification involved in bone maturation [GO:0043931]; pattern specification process [GO:0007389]; post-anal tail morphogenesis [GO:0036342]; protein localization to plasma membrane [GO:0072659]","GO:0000902; GO:0001658; GO:0001822; GO:0003007; GO:0003183; GO:0003192; GO:0003273; GO:0005509; GO:0005912; GO:0007043; GO:0007156; GO:0007157; GO:0007389; GO:0009653; GO:0016339; GO:0016342; GO:0016477; GO:0021915; GO:0022008; GO:0034332; GO:0035329; GO:0036342; GO:0043931; GO:0045177; GO:0045296; GO:0048565; GO:0072006; GO:0072137; GO:0072659; GO:0090102; GO:0098609; GO:0098742"
"885",885,"Cluster_13502","Porites_evermani_scaffold_1275:128747-129747",160,-22,2,20,74,93,18,"77.78%","83.33%","Peve_00004422",0.232072501499888,0.850898673969927,0.995934364227446,"O60447","Ecotropic viral integration site 5 protein homolog (EVI-5) (Neuroblastoma stage 4S gene protein)","Homo sapiens (Human)","activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of GTPase activity [GO:0043547]; retrograde transport, endosome to Golgi [GO:0042147]","GO:0005096; GO:0005634; GO:0005815; GO:0005819; GO:0005829; GO:0007049; GO:0031267; GO:0042147; GO:0043547; GO:0051301; GO:0090630"
"886",886,"Cluster_13502","Porites_evermani_scaffold_1328:49370-50370",167,-21.22,2,18,347,370,18,"88.89%","88.89%","Peve_00005178",-0.980079175760266,0.127283579146719,0.978262075707395,NA,NA,NA,NA,NA
"887",887,"Cluster_13502","Porites_evermani_scaffold_1374:49545-50545",167,-26.42,2,21,212,234,20,"80.00%","80.00%","Peve_00005826",-0.615467965669983,0.577934095769866,0.978262075707395,"B7PRF6","Acireductone dioxygenase (Acireductone dioxygenase (Fe(2+)-requiring)) (ARD') (Fe-ARD) (EC 1.13.11.54) (Acireductone dioxygenase (Ni(2+)-requiring)) (ARD) (Ni-ARD) (EC 1.13.11.53)","Ixodes scapularis (Black-legged tick) (Deer tick)","L-methionine salvage from methylthioadenosine [GO:0019509]; methionine metabolic process [GO:0006555]","GO:0005506; GO:0005634; GO:0005737; GO:0006555; GO:0010308; GO:0010309; GO:0016151; GO:0019509"
"888",888,"Cluster_13502","Porites_evermani_scaffold_1418:85334-86334",145,-20.6,2,19,601,628,23,"60.87%","69.57%","Peve_00006485",NA,NA,NA,NA,NA,NA,NA,NA
"889",889,"Cluster_13502","Porites_evermani_scaffold_1488:21909-22909",166,-21.8,2,19,481,502,17,"70.59%","94.12%","Peve_00007315",-0.351403246701699,0.77140924454196,0.991346090898579,"P97321","Prolyl endopeptidase FAP (EC 3.4.21.26) (Dipeptidyl peptidase FAP) (EC 3.4.14.5) (Fibroblast activation protein alpha) (FAPalpha) (Gelatine degradation protease FAP) (EC 3.4.21.-) (Integral membrane serine protease) (Post-proline cleaving enzyme) (Serine integral membrane protease) (SIMP) (Surface-expressed protease) (Seprase) [Cleaved into: Antiplasmin-cleaving enzyme FAP, soluble form (APCE) (EC 3.4.14.5) (EC 3.4.21.-) (EC 3.4.21.26)]","Mus musculus (Mouse)","angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; endothelial cell migration [GO:0043542]; melanocyte apoptotic process [GO:1902362]; melanocyte proliferation [GO:0097325]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; negative regulation of extracellular matrix disassembly [GO:0010716]; negative regulation of extracellular matrix organization [GO:1903054]; positive regulation of execution phase of apoptosis [GO:1900119]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of cell cycle [GO:0051726]; regulation of collagen catabolic process [GO:0010710]","GO:0001525; GO:0002020; GO:0004175; GO:0004252; GO:0005178; GO:0005615; GO:0005886; GO:0006508; GO:0007155; GO:0008233; GO:0008236; GO:0008239; GO:0009986; GO:0010710; GO:0010716; GO:0030027; GO:0031258; GO:0032587; GO:0042802; GO:0042803; GO:0043542; GO:0045177; GO:0045178; GO:0051603; GO:0051726; GO:0060244; GO:0070161; GO:0097325; GO:1900119; GO:1902362; GO:1903054; GO:1905368"
"890",890,"Cluster_13502","Porites_evermani_scaffold_16:577173-578173",200,-40.02,2,21,495,516,19,"100.00%","100.00%","Peve_00008800",-0.392974842863988,0.742891889826519,0.98675746977261,"Q7Z333","Probable helicase senataxin (EC 3.6.4.-) (Amyotrophic lateral sclerosis 4 protein) (SEN1 homolog) (Senataxin)","Homo sapiens (Human)","cell differentiation [GO:0030154]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to oxidative stress [GO:0034599]; cellular response to retinoic acid [GO:0071300]; circadian rhythm [GO:0007623]; DNA recombination [GO:0006310]; DNA-templated transcription termination [GO:0006353]; double-strand break repair [GO:0006302]; fibroblast growth factor receptor signaling pathway [GO:0008543]; MAPK cascade [GO:0000165]; mRNA splice site selection [GO:0006376]; negative regulation of apoptotic process [GO:0043066]; nervous system development [GO:0007399]; positive regulation of DNA-templated transcription initiation [GO:2000144]; positive regulation of neuron projection development [GO:0010976]; positive regulation of RNA splicing [GO:0033120]; positive regulation of termination of DNA-templated transcription [GO:0060566]; positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled [GO:2000806]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein kinase B signaling [GO:0043491]; RNA processing [GO:0006396]; spermatogenesis [GO:0007283]; termination of RNA polymerase II transcription [GO:0006369]","GO:0000165; GO:0000228; GO:0000781; GO:0001147; GO:0003677; GO:0003678; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006302; GO:0006310; GO:0006353; GO:0006369; GO:0006376; GO:0006396; GO:0006974; GO:0007283; GO:0007399; GO:0007623; GO:0008543; GO:0010976; GO:0016604; GO:0016787; GO:0030154; GO:0030424; GO:0030426; GO:0033120; GO:0034599; GO:0042802; GO:0043066; GO:0043491; GO:0044344; GO:0045171; GO:0045944; GO:0060566; GO:0070301; GO:0071300; GO:2000144; GO:2000806"
"891",891,"Cluster_13502","Porites_evermani_scaffold_2183:74981-75981",155,-20.82,2,21,82,104,20,"70.00%","75.00%","Peve_00015344",-0.555752552842411,0.624860395488428,0.978262075707395,NA,NA,NA,NA,NA
"892",892,"Cluster_13502","Porites_evermani_scaffold_2209:52957-53957",165,-20.12,2,20,920,943,20,"80.00%","85.00%","Peve_00015657",0.997844556977271,0.0418062711782397,0.909359886114279,"O08730","Glycogenin-1 (GN-1) (GN1) (EC 2.4.1.186)","Rattus norvegicus (Rat)","glycogen biosynthetic process [GO:0005978]","GO:0005536; GO:0005978; GO:0008466; GO:0016757; GO:0030145; GO:0042803; GO:0102751"
"893",893,"Cluster_13502","Porites_evermani_scaffold_2209:67849-68849",170,-22.55,2,21,920,943,21,"80.95%","85.71%","Peve_00015658",0.76692706628941,0.44356957375252,0.978262075707395,"Q9R062","Glycogenin-1 (GN-1) (GN1) (EC 2.4.1.186)","Mus musculus (Mouse)","glycogen biosynthetic process [GO:0005978]","GO:0005536; GO:0005978; GO:0008466; GO:0016757; GO:0030145; GO:0042803; GO:0102751"
"894",894,"Cluster_13502","Porites_evermani_scaffold_2303:40914-41914",167,-21.51,2,16,1,15,14,"85.71%","100.00%","Peve_00016603",-0.609999975312759,0.582338875779904,0.978262075707395,"A2AJ76","Hemicentin-2","Mus musculus (Mouse)","response to stimulus [GO:0050896]","GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005938; GO:0030054; GO:0031012; GO:0032154; GO:0050896; GO:0062023"
"895",895,"Cluster_13502","Porites_evermani_scaffold_2303:40914-41914",167,-22.14,2,16,287,308,14,"85.71%","100.00%","Peve_00016603",-0.609999975312759,0.582338875779904,0.978262075707395,"A2AJ76","Hemicentin-2","Mus musculus (Mouse)","response to stimulus [GO:0050896]","GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005938; GO:0030054; GO:0031012; GO:0032154; GO:0050896; GO:0062023"
"896",896,"Cluster_13502","Porites_evermani_scaffold_2373:62878-63878",196,-35.33,2,21,286,307,19,"94.74%","100.00%","Peve_00017190",-0.731459475399041,0.47767903372715,0.978262075707395,NA,NA,NA,NA,NA
"897",897,"Cluster_13502","Porites_evermani_scaffold_2454:21162-22162",158,-20.9,2,19,692,711,17,"82.35%","88.24%","Peve_00017978",-0.351503882872435,0.771340811928809,0.991307603343085,NA,NA,NA,NA,NA
"898",898,"Cluster_13502","Porites_evermani_scaffold_274:238317-239012",158,-21.65,2,20,480,502,19,"68.42%","84.21%","Peve_00020428",-0.44209200413486,0.708472937844906,0.978262075707395,NA,NA,NA,NA,NA
"899",899,"Cluster_13502","Porites_evermani_scaffold_2827:26005-27005",169,-20.09,2,18,638,659,16,"87.50%","87.50%","Peve_00021112",-0.44209200413486,0.708472937844906,0.978262075707395,NA,NA,NA,NA,NA
"900",900,"Cluster_13502","Porites_evermani_scaffold_3021:53225-54225",196,-33.26,2,21,731,752,19,"94.74%","100.00%","Peve_00022789",-0.177327318544737,0.886509753224617,0.999448381576871,NA,NA,NA,NA,NA
"901",901,"Cluster_13502","Porites_evermani_scaffold_3203:49505-50505",159,-20.54,2,21,343,366,21,"71.43%","76.19%","Peve_00024055",-0.861550784806077,0.338987184790229,0.978262075707395,"P25931","RYamide receptor (Neuropeptide Y-like receptor) (NPY-R)","Drosophila melanogaster (Fruit fly)","G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]","GO:0001653; GO:0004983; GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0016020"
"902",902,"Cluster_13502","Porites_evermani_scaffold_3220:28114-29114",153,-20.42,2,19,273,298,21,"66.67%","76.19%","Peve_00024155",-0.362169114252583,0.764072570550197,0.989336444293967,"Q14432","cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A (EC 3.1.4.17) (Cyclic GMP-inhibited phosphodiesterase A) (CGI-PDE A) (cGMP-inhibited cAMP phosphodiesterase) (cGI-PDE)","Homo sapiens (Human)","apoptotic signaling pathway [GO:0097190]; cAMP-mediated signaling [GO:0019933]; cellular response to cGMP [GO:0071321]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cGMP-mediated signaling [GO:0019934]; G protein-coupled receptor signaling pathway [GO:0007186]; lipid metabolic process [GO:0006629]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of vascular permeability [GO:0043116]; oocyte maturation [GO:0001556]; positive regulation of oocyte development [GO:0060282]; positive regulation of vascular permeability [GO:0043117]; regulation of meiotic nuclear division [GO:0040020]; regulation of ribonuclease activity [GO:0060700]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]","GO:0001556; GO:0004114; GO:0004115; GO:0004119; GO:0005829; GO:0006629; GO:0007165; GO:0007186; GO:0009410; GO:0016020; GO:0019933; GO:0019934; GO:0040020; GO:0043066; GO:0043116; GO:0043117; GO:0043951; GO:0046872; GO:0047555; GO:0060282; GO:0060700; GO:0071321; GO:0071560; GO:0097190; GO:0099130"
"903",903,"Cluster_13502","Porites_evermani_scaffold_325:102917-103917",190,-34.65,2,19,960,981,17,"100.00%","100.00%","Peve_00024312",-0.44209200413486,0.708472937844906,0.978262075707395,"Q6DCQ6","von Willebrand factor A domain-containing protein 2 (A domain-containing protein similar to matrilin and collagen) (AMACO)","Xenopus laevis (African clawed frog)","","GO:0005509; GO:0005576"
"904",904,"Cluster_13502","Porites_evermani_scaffold_3275:20865-21865",161,-21.35,2,14,128,149,12,"91.67%","100.00%","Peve_00024457",-0.464989517980989,0.69211618140913,0.978262075707395,"D3YXG0","Hemicentin-1 (Fibulin-6) (FIBL-6)","Mus musculus (Mouse)","actin filament reorganization [GO:0090527]; basement membrane organization [GO:0071711]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]","GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0051301; GO:0062023; GO:0071711; GO:0090527"
"905",905,"Cluster_13502","Porites_evermani_scaffold_342:249263-250263",196,-37.22,2,21,501,522,19,"94.74%","100.00%","Peve_00025418",0.981117902929458,0.123909891777932,0.978262075707395,"Q8BHR2","Ecto-NOX disulfide-thiol exchanger 1 (Constitutive Ecto-NOX) (cNOX) [Includes: Hydroquinone [NADH] oxidase (EC 1.-.-.-); Protein disulfide-thiol oxidoreductase (EC 1.-.-.-)]","Mus musculus (Mouse)","ultradian rhythm [GO:0007624]","GO:0003723; GO:0003756; GO:0003954; GO:0005615; GO:0005886; GO:0007624; GO:0009897"
"906",906,"Cluster_13502","Porites_evermani_scaffold_342:249263-250263",200,-40.02,2,21,863,884,19,"100.00%","100.00%","Peve_00025418",0.981117902929458,0.123909891777932,0.978262075707395,"Q8BHR2","Ecto-NOX disulfide-thiol exchanger 1 (Constitutive Ecto-NOX) (cNOX) [Includes: Hydroquinone [NADH] oxidase (EC 1.-.-.-); Protein disulfide-thiol oxidoreductase (EC 1.-.-.-)]","Mus musculus (Mouse)","ultradian rhythm [GO:0007624]","GO:0003723; GO:0003756; GO:0003954; GO:0005615; GO:0005886; GO:0007624; GO:0009897"
"907",907,"Cluster_13502","Porites_evermani_scaffold_3501:2390-3390",155,-20.82,2,21,81,103,20,"70.00%","75.00%","Peve_00025991",-0.555752552842411,0.624860395488428,0.978262075707395,NA,NA,NA,NA,NA
"908",908,"Cluster_13502","Porites_evermani_scaffold_373:213736-214736",156,-20.81,2,18,14,36,17,"76.47%","82.35%","Peve_00027248",NA,NA,NA,"E9Q236","ATP-binding cassette sub-family C member 4 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (Multidrug resistance-associated protein 4)","Mus musculus (Mouse)","bile acid and bile salt transport [GO:0015721]; cAMP transport [GO:0070730]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; fatty acid derivative transport [GO:1901571]; leukotriene transport [GO:0071716]; organic hydroxy compound transport [GO:0015850]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; prostaglandin transport [GO:0015732]; transmembrane transport [GO:0055085]; urate transport [GO:0015747]; xenobiotic transmembrane transport [GO:0006855]","GO:0001409; GO:0005524; GO:0005730; GO:0005794; GO:0005886; GO:0006855; GO:0008559; GO:0015132; GO:0015143; GO:0015216; GO:0015431; GO:0015432; GO:0015562; GO:0015665; GO:0015721; GO:0015732; GO:0015747; GO:0015850; GO:0016020; GO:0016323; GO:0016324; GO:0016887; GO:0031088; GO:0032310; GO:0034634; GO:0042626; GO:0042910; GO:0048661; GO:0055085; GO:0060271; GO:0070730; GO:0071716; GO:0098591; GO:0140115; GO:1901571"
"909",909,"Cluster_13502","Porites_evermani_scaffold_3863:28740-29740",145,-20.05,2,20,668,695,24,"66.67%","66.67%","Peve_00027961",NA,NA,NA,NA,NA,NA,NA,NA
"910",910,"Cluster_13502","Porites_evermani_scaffold_411:2692-3692",152,-20.9,2,19,564,588,20,"70.00%","80.00%","Peve_00029440",NA,NA,NA,NA,NA,NA,NA,NA
"911",911,"Cluster_13502","Porites_evermani_scaffold_411:50278-51278",152,-20.9,2,19,766,790,20,"70.00%","80.00%","Peve_00029441",NA,NA,NA,NA,NA,NA,NA,NA
"912",912,"Cluster_13502","Porites_evermani_scaffold_422:56346-56875",156,-21.17,2,18,358,380,17,"70.59%","88.24%","Peve_00029973",-0.44209200413486,0.708472937844906,0.978262075707395,NA,NA,NA,NA,NA
"913",913,"Cluster_13502","Porites_evermani_scaffold_429:165386-166386",161,-21.35,2,14,395,416,12,"91.67%","100.00%","Peve_00030335",-0.94908230114179,0.204027977972541,0.978262075707395,NA,NA,NA,NA,NA
"914",914,"Cluster_13502","Porites_evermani_scaffold_4354:23525-24521",172,-22.15,2,17,244,265,15,"93.33%","93.33%","Peve_00030681",NA,NA,NA,"P97259","Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (EC 2.4.1.155) (Alpha-mannoside beta-1,6-N-acetylglucosaminyltransferase) (GlcNAc-T V) (GNT-V) (Mannoside acetylglucosaminyltransferase 5) (N-acetylglucosaminyl-transferase V) [Cleaved into: Secreted alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (Secreted beta-1,6-N-acetylglucosaminyltransferase V) (Secreted GNT-V)]","Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)","negative regulation of protein tyrosine phosphatase activity [GO:1903614]; positive regulation of cell migration [GO:0030335]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; protein N-linked glycosylation via asparagine [GO:0018279]","GO:0000139; GO:0004864; GO:0005576; GO:0018279; GO:0030144; GO:0030145; GO:0030335; GO:1903614; GO:1904894"
"915",915,"Cluster_13502","Porites_evermani_scaffold_504:92338-93338",154,-21.17,2,20,540,562,19,"68.42%","78.95%","Peve_00033788",0.997844556977271,0.0418062711782387,0.909359886114279,NA,NA,NA,NA,NA
"916",916,"Cluster_13502","Porites_evermani_scaffold_5059:1493-2493",155,-20.52,2,21,770,792,20,"70.00%","75.00%","Peve_00033847",NA,NA,NA,NA,NA,NA,NA,NA
"917",917,"Cluster_13502","Porites_evermani_scaffold_525:4127-5127",155,-20.11,2,16,870,891,14,"71.43%","92.86%","Peve_00034553",NA,NA,NA,NA,NA,NA,NA,NA
"918",918,"Cluster_13502","Porites_evermani_scaffold_54:458458-459458",170,-22.61,2,19,163,184,17,"76.47%","94.12%","Peve_00035116",-0.44209200413486,0.708472937844906,0.978262075707395,NA,NA,NA,NA,NA
"919",919,"Cluster_13502","Porites_evermani_scaffold_640:140596-141596",170,-22.55,2,21,930,953,21,"80.95%","85.71%","Peve_00038172",-0.928456534998737,0.242272431075166,0.978262075707395,NA,NA,NA,NA,NA
"920",920,"Cluster_13502","Porites_evermani_scaffold_64:464446-465446",158,-22.37,2,19,427,448,17,"70.59%","82.35%","Peve_00038104",-0.751590566666792,0.458573931585498,0.978262075707395,NA,NA,NA,NA,NA
"921",921,"Cluster_13502","Porites_evermani_scaffold_716:95220-96220",152,-22,2,18,442,467,20,"65.00%","80.00%","Peve_00039936",-0.553031051986497,0.626942162943747,0.978262075707395,NA,NA,NA,NA,NA
"922",922,"Cluster_13502","Porites_evermani_scaffold_731:142644-143644",163,-21.34,2,21,407,429,20,"75.00%","80.00%","Peve_00040323",NA,NA,NA,NA,NA,NA,NA,NA
"923",923,"Cluster_13502","Porites_evermani_scaffold_789:28854-29854",157,-20.7,2,20,860,884,21,"71.43%","80.95%","Peve_00041454",-0.522548330335195,0.649962842069679,0.978262075707395,NA,NA,NA,NA,NA
"924",924,"Cluster_13502","Porites_evermani_scaffold_803:26950-27950",163,-22.71,2,21,495,517,20,"65.00%","90.00%","Peve_00041841",-0.564802205737421,0.617904919430933,0.978262075707395,"Q5ZMH6","Protein-L-histidine N-pros-methyltransferase (EC 2.1.1.-) (Methyltransferase-like protein 9)","Gallus gallus (Chicken)","","GO:0005739; GO:0005783; GO:0106370"
"925",925,"Cluster_13502","Porites_evermani_scaffold_815:42281-43281",168,-23.85,2,20,550,571,19,"84.21%","89.47%","Peve_00042089",NA,NA,NA,"M0R3Q7","Patched domain-containing protein 3","Rattus norvegicus (Rat)","","GO:0005783; GO:0005789; GO:0005886; GO:0016020; GO:0097225"
"926",926,"Cluster_13502","Porites_evermani_scaffold_882:57291-58291",157,-21.31,2,19,848,871,19,"73.68%","78.95%","Peve_00043358",NA,NA,NA,"B8VIV4","CUB and peptidase domain-containing protein 2","Acropora millepora (Staghorn coral) (Heteropora millepora)","proteolysis [GO:0006508]","GO:0004252; GO:0005576; GO:0006508"
"927",927,"Cluster_13502","Porites_evermani_scaffold_899:1146-2146",169,-20.45,2,19,198,220,18,"83.33%","88.89%","Peve_00043584",0.999808930883123,0.0124450682944078,0.68680754891219,NA,NA,NA,NA,NA
"928",928,"Cluster_13502","Porites_evermani_scaffold_902:163975-164975",152,-21.22,2,19,518,545,23,"69.57%","73.91%","Peve_00043808",-0.628762083306388,0.567123886378605,0.978262075707395,"Q9ERQ8","Carbonic anhydrase 7 (EC 4.2.1.1) (Carbonate dehydratase VII) (Carbonic anhydrase VII) (CA-VII)","Mus musculus (Mouse)","neuron cellular homeostasis [GO:0070050]; one-carbon metabolic process [GO:0006730]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]","GO:0004089; GO:0005829; GO:0006730; GO:0008270; GO:0016836; GO:0032230; GO:0032849; GO:0051453; GO:0070050; GO:2001225"
"929",929,"Cluster_13502","Porites_evermani_scaffold_94:310037-311037",165,-20.1,2,19,138,160,18,"77.78%","88.89%","Peve_00044425",NA,NA,NA,NA,NA,NA,NA,NA
"930",930,"Cluster_14500","Porites_evermani_scaffold_1096:93472-94472",162,-22.17,2,20,460,482,19,"68.42%","89.47%","Peve_00001677",NA,NA,NA,NA,NA,NA,NA,NA
"931",931,"Cluster_14500","Porites_evermani_scaffold_114:358019-359019",158,-20.8,2,20,856,880,21,"66.67%","80.95%","Peve_00002417",-0.914453433996429,0.265241929993803,0.978262075707395,"Q5R5S1","F-box only protein 21","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","","GO:0003677"
"932",932,"Cluster_14500","Porites_evermani_scaffold_1174:35568-36568",169,-20.93,2,19,223,246,19,"84.21%","84.21%","Peve_00002940",0.0169727387771541,0.989194300054264,0.999448381576871,NA,NA,NA,NA,NA
"933",933,"Cluster_14500","Porites_evermani_scaffold_1183:44054-45054",171,-22.7,2,21,186,210,22,"72.73%","86.36%","Peve_00003096",0.837039513166672,0.368568807287264,0.978262075707395,NA,NA,NA,NA,NA
"934",934,"Cluster_14500","Porites_evermani_scaffold_137:308344-309344",170,-23.54,2,21,878,898,19,"78.95%","89.47%","Peve_00005774",0.837039513166672,0.368568807287264,0.978262075707395,NA,NA,NA,NA,NA
"935",935,"Cluster_14500","Porites_evermani_scaffold_1412:87261-88261",172,-21.38,2,21,509,530,19,"73.68%","89.47%","Peve_00006418",-0.734562479329958,0.474774898882857,0.978262075707395,NA,NA,NA,NA,NA
"936",936,"Cluster_14500","Porites_evermani_scaffold_1478:118956-119956",169,-20.93,2,19,393,416,19,"84.21%","84.21%","Peve_00007189",NA,NA,NA,NA,NA,NA,NA,NA
"937",937,"Cluster_14500","Porites_evermani_scaffold_1698:107106-108106",166,-21.18,2,20,910,932,19,"78.95%","84.21%","Peve_00009955",-0.368302912819551,0.759877871829138,0.988260417653373,NA,NA,NA,NA,NA
"938",938,"Cluster_14500","Porites_evermani_scaffold_1698:61949-62949",166,-21.18,2,20,779,801,19,"78.95%","84.21%","Peve_00009954",0.834406566736011,0.371621151758835,0.978262075707395,NA,NA,NA,NA,NA
"939",939,"Cluster_14500","Porites_evermani_scaffold_186:31668-32668",170,-21.6,2,21,283,303,19,"84.21%","84.21%","Peve_00011794",-0.978068904395439,0.133574085154401,0.978262075707395,"Q9Y5Z4","Heme-binding protein 2 (Placental protein 23) (PP23) (Protein SOUL)","Homo sapiens (Human)","negative regulation of mitochondrial membrane potential [GO:0010917]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of necrotic cell death [GO:0010940]","GO:0005576; GO:0005737; GO:0005739; GO:0010917; GO:0010940; GO:0020037; GO:0035578; GO:0035794; GO:0070062"
"940",940,"Cluster_14500","Porites_evermani_scaffold_2:1229860-1230860",163,-20.16,2,20,845,864,18,"83.33%","88.89%","Peve_00013406",-0.938386260791745,0.224641196837114,0.978262075707395,NA,NA,NA,NA,NA
"941",941,"Cluster_14500","Porites_evermani_scaffold_212:65246-66246",165,-21.45,2,20,246,272,23,"78.26%","78.26%","Peve_00014755",NA,NA,NA,NA,NA,NA,NA,NA
"942",942,"Cluster_14500","Porites_evermani_scaffold_23:833055-834055",163,-22.96,2,19,566,587,18,"83.33%","88.89%","Peve_00016520",0.573673663086851,0.611035546342296,0.978262075707395,NA,NA,NA,NA,NA
"943",943,"Cluster_14500","Porites_evermani_scaffold_2673:6721-7721",164,-20.53,2,17,651,672,15,"86.67%","86.67%","Peve_00019846",0.0553194989118963,0.964764526046069,0.999448381576871,NA,NA,NA,NA,NA
"944",944,"Cluster_14500","Porites_evermani_scaffold_2865:147-1147",166,-23.44,2,19,426,447,17,"76.47%","88.24%","Peve_00021401",-0.420163076887038,0.723945737316371,0.982728587529591,"Q9H3R1","Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 4 (EC 2.8.2.8) (Glucosaminyl N-deacetylase/N-sulfotransferase 4) (NDST-4) (N-heparan sulfate sulfotransferase 4) (N-HSST 4) [Includes: Heparan sulfate N-deacetylase 4 (EC 3.-.-.-); Heparan sulfate N-sulfotransferase 4 (EC 2.8.2.-)]","Homo sapiens (Human)","heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]","GO:0000139; GO:0005794; GO:0015014; GO:0015016; GO:0019213; GO:0030210; GO:0050119"
"945",945,"Cluster_14500","Porites_evermani_scaffold_2888:47522-48522",162,-21.8,2,21,839,862,21,"76.19%","80.95%","Peve_00021567",-0.694180234404641,0.511534128521808,0.978262075707395,"Q6GNV7","Solute carrier family 49 member 4 homolog (Disrupted in renal carcinoma protein 2 homolog)","Xenopus laevis (African clawed frog)","","GO:0005765; GO:0022857"
"946",946,"Cluster_14500","Porites_evermani_scaffold_2972:38836-39836",167,-20.1,2,21,460,482,20,"75.00%","85.00%","Peve_00022217",-0.892359012078568,0.298097859379402,0.978262075707395,NA,NA,NA,NA,NA
"947",947,"Cluster_14500","Porites_evermani_scaffold_3050:95-1095",144,-20.32,2,20,789,811,20,"70.00%","70.00%","Peve_00022984",-0.127671672428489,0.918499246610269,0.999448381576871,NA,NA,NA,NA,NA
"948",948,"Cluster_14500","Porites_evermani_scaffold_3:1406249-1407249",159,-21.4,2,21,390,414,22,"68.18%","77.27%","Peve_00022539",-0.892359012078568,0.298097859379402,0.978262075707395,NA,NA,NA,NA,NA
"949",949,"Cluster_14500","Porites_evermani_scaffold_3161:52047-52251",159,-21.91,2,18,56,76,16,"75.00%","93.75%","Peve_00023793",-0.892359012078568,0.298097859379402,0.978262075707395,"Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"950",950,"Cluster_14500","Porites_evermani_scaffold_31:723541-724541",165,-21.31,2,20,642,668,23,"78.26%","78.26%","Peve_00023351",-0.535949971483496,0.639907121123781,0.978262075707395,"P32020","Sterol carrier protein 2 (SCP-2) (Acetyl-CoA C-myristoyltransferase) (EC 2.3.1.155) (Non-specific lipid-transfer protein) (NSL-TP) (Propanoyl-CoA C-acyltransferase) (EC 2.3.1.176) (SCP-2/3-oxoacyl-CoA thiolase) (SCP-2/thiolase) (EC 2.3.1.16) (SCP-chi) (Sterol carrier protein X) (SCP-X)","Mus musculus (Mouse)","aging [GO:0007568]; bile acid metabolic process [GO:0008206]; fatty acid beta-oxidation [GO:0006635]; inositol trisphosphate biosynthetic process [GO:0032959]; intracellular cholesterol transport [GO:0032367]; lipid hydroperoxide transport [GO:1901373]; phospholipid transport [GO:0015914]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of cholesterol import [GO:1904109]; positive regulation of intracellular cholesterol transport [GO:0032385]; positive regulation of steroid biosynthetic process [GO:0010893]; positive regulation of steroid metabolic process [GO:0045940]; progesterone biosynthetic process [GO:0006701]; protein localization to plasma membrane [GO:0072659]; regulation of phospholipid biosynthetic process [GO:0071071]; steroid biosynthetic process [GO:0006694]","GO:0000062; GO:0003988; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005777; GO:0005782; GO:0005783; GO:0005829; GO:0006635; GO:0006694; GO:0006701; GO:0007568; GO:0008206; GO:0008526; GO:0010893; GO:0015485; GO:0015914; GO:0016020; GO:0032367; GO:0032385; GO:0032934; GO:0032959; GO:0032991; GO:0033814; GO:0036042; GO:0042802; GO:0043065; GO:0043231; GO:0044877; GO:0045542; GO:0045940; GO:0050632; GO:0050633; GO:0070538; GO:0071071; GO:0072659; GO:0120019; GO:0120020; GO:1901373; GO:1904109; GO:1904121"
"951",951,"Cluster_14500","Porites_evermani_scaffold_326:142651-143651",159,-21.91,2,18,204,224,16,"75.00%","93.75%","Peve_00024375",-0.881591276333759,0.312945356346015,0.978262075707395,"Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"952",952,"Cluster_14500","Porites_evermani_scaffold_351:230817-231817",173,-20.69,2,21,596,617,20,"85.00%","90.00%","Peve_00026029",0.152988499604459,0.902220506502632,0.999448381576871,NA,NA,NA,NA,NA
"953",953,"Cluster_14500","Porites_evermani_scaffold_35:732157-733157",156,-21.35,2,19,365,392,23,"73.91%","73.91%","Peve_00025938",0.793419704188188,0.416597260872198,0.978262075707395,NA,NA,NA,NA,NA
"954",954,"Cluster_14500","Porites_evermani_scaffold_3585:14406-15406",161,-21.96,2,19,793,818,21,"71.43%","80.95%","Peve_00026439",-0.892359012078568,0.298097859379402,0.978262075707395,NA,NA,NA,NA,NA
"955",955,"Cluster_14500","Porites_evermani_scaffold_387:111999-112999",171,-22.57,2,21,791,814,21,"76.19%","85.71%","Peve_00027990",NA,NA,NA,NA,NA,NA,NA,NA
"956",956,"Cluster_14500","Porites_evermani_scaffold_392:108825-109825",174,-23.65,2,20,846,868,19,"84.21%","89.47%","Peve_00028308",-0.108445670596801,0.930825299566372,0.999448381576871,"Q6GX86","Homologous recombination OB-fold protein","Rattus norvegicus (Rat)","cellular response to DNA damage stimulus [GO:0006974]; DNA synthesis involved in DNA repair [GO:0000731]; female gamete generation [GO:0007292]; interstrand cross-link repair [GO:0036297]; male gamete generation [GO:0048232]; recombinational repair [GO:0000725]","GO:0000725; GO:0000731; GO:0003697; GO:0005634; GO:0006974; GO:0007292; GO:0036297; GO:0048232; GO:0090734"
"957",957,"Cluster_14500","Porites_evermani_scaffold_438:54158-55158",176,-23.73,2,21,65,86,19,"78.95%","89.47%","Peve_00030777",-0.865077083227585,0.334538796508057,0.978262075707395,NA,NA,NA,NA,NA
"958",958,"Cluster_14500","Porites_evermani_scaffold_4679:10921-11921",166,-24.54,2,21,624,650,24,"75.00%","79.17%","Peve_00032218",-0.892359012078568,0.298097859379402,0.978262075707395,NA,NA,NA,NA,NA
"959",959,"Cluster_14500","Porites_evermani_scaffold_5214:10873-11873",157,-20.88,2,19,499,524,21,"71.43%","76.19%","Peve_00034442",0.837039513166672,0.368568807287264,0.978262075707395,"Q91ZA3","Propionyl-CoA carboxylase alpha chain, mitochondrial (PCCase subunit alpha) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase subunit alpha)","Mus musculus (Mouse)","lipid catabolic process [GO:0016042]","GO:0004658; GO:0005524; GO:0005739; GO:0005759; GO:0016042; GO:0019899; GO:0046872; GO:1902494"
"960",960,"Cluster_14500","Porites_evermani_scaffold_6287:0-329",153,-21.48,2,20,290,314,21,"66.67%","80.95%","Peve_00037811",NA,NA,NA,NA,NA,NA,NA,NA
"961",961,"Cluster_14500","Porites_evermani_scaffold_63:596353-597353",153,-21.45,2,19,695,721,22,"63.64%","77.27%","Peve_00037857",-0.521675288208286,0.65061451388228,0.978262075707395,"Q58A42","Protein DD3-3","Dictyostelium discoideum (Social amoeba)","","GO:0016020"
"962",962,"Cluster_14500","Porites_evermani_scaffold_769:117509-118509",159,-21.91,2,18,56,76,16,"75.00%","93.75%","Peve_00041023",-0.892359012078568,0.298097859379402,0.978262075707395,"Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"963",963,"Cluster_14500","Porites_evermani_scaffold_786:92627-93627",160,-21,2,21,459,479,20,"80.00%","80.00%","Peve_00041417",0.0553194989118963,0.964764526046069,0.999448381576871,NA,NA,NA,NA,NA
"964",964,"Cluster_14500","Porites_evermani_scaffold_802:137082-138082",174,-22.38,2,20,650,673,20,"85.00%","85.00%","Peve_00041832",0.0553194989118963,0.964764526046069,0.999448381576871,NA,NA,NA,NA,NA
"965",965,"Cluster_14500","Porites_evermani_scaffold_853:76771-77771",177,-21.64,2,18,236,257,16,"93.75%","93.75%","Peve_00042839",NA,NA,NA,NA,NA,NA,NA,NA
"966",966,"Cluster_14500","Porites_evermani_scaffold_888:22010-23010",154,-20.43,2,19,519,538,17,"76.47%","88.24%","Peve_00043426",NA,NA,NA,NA,NA,NA,NA,NA
"967",967,"Cluster_14999","Porites_evermani_scaffold_1001:78958-79958",152,-21.32,2,19,390,417,23,"69.57%","73.91%","Peve_00000261",NA,NA,NA,NA,NA,NA,NA,NA
"968",968,"Cluster_14999","Porites_evermani_scaffold_110:482487-483487",162,-20.06,2,15,614,635,13,"92.31%","92.31%","Peve_00001876",0.999298315087297,0.0238501759994235,0.854711273077389,"Q6NUE2","Carbonyl reductase family member 4 (EC 1.-.-.-) (3-ketoacyl-[acyl-carrier-protein] reductase beta subunit) (KAR beta subunit) (3-oxoacyl-[acyl-carrier-protein] reductase) (EC 1.1.1.-) (Quinone reductase CBR4)","Xenopus laevis (African clawed frog)","fatty acid biosynthetic process [GO:0006633]; protein heterotetramerization [GO:0051290]","GO:0004316; GO:0005759; GO:0006633; GO:0051290; GO:1990204"
"969",969,"Cluster_14999","Porites_evermani_scaffold_1143:137410-138410",162,-20.32,2,21,159,183,22,"77.27%","77.27%","Peve_00002468",0.706899166079908,0.500186891837848,0.978262075707395,NA,NA,NA,NA,NA
"970",970,"Cluster_14999","Porites_evermani_scaffold_1163:2431-3431",150,-20.49,2,21,271,300,27,"66.67%","66.67%","Peve_00002774",0.418209113324838,0.725315857123914,0.983157552660308,"O70511","Ankyrin-3 (ANK-3) (Ankyrin-G)","Rattus norvegicus (Rat)","anterograde axonal transport [GO:0008089]; axon development [GO:0061564]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; establishment of protein localization [GO:0045184]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in cell [GO:0032507]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; negative regulation of endocytosis [GO:0045806]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; regulation of protein targeting [GO:1903533]; response to immobilization stress [GO:0035902]; signal transduction [GO:0007165]; synapse organization [GO:0050808]","GO:0000281; GO:0005200; GO:0005737; GO:0005764; GO:0005856; GO:0005886; GO:0007009; GO:0007165; GO:0007409; GO:0007411; GO:0007528; GO:0008089; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030507; GO:0030674; GO:0030951; GO:0031594; GO:0032507; GO:0033268; GO:0033270; GO:0034112; GO:0035902; GO:0042383; GO:0043001; GO:0043005; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045162; GO:0045184; GO:0045202; GO:0045211; GO:0045296; GO:0045806; GO:0045838; GO:0050808; GO:0061564; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0099612; GO:0140031; GO:1900827; GO:1901224; GO:1902260; GO:1903533; GO:1904115; GO:2000651; GO:2001259"
"971",971,"Cluster_14999","Porites_evermani_scaffold_1202:8663-9663",166,-25.77,2,21,25,49,22,"77.27%","81.82%","Peve_00003438",-0.255327757174855,0.835633253724067,0.995934364227446,"Q6NXH8","Probable methyltransferase-like protein 25 (EC 2.1.1.-)","Mus musculus (Mouse)","methylation [GO:0032259]","GO:0008168; GO:0032259"
"972",972,"Cluster_14999","Porites_evermani_scaffold_1210:133900-134900",155,-22.91,2,21,97,123,24,"66.67%","70.83%","Peve_00003561",0.890767522284077,0.300334973579661,0.978262075707395,"O62714","Extracellular calcium-sensing receptor (CaSR) (Parathyroid cell calcium-sensing receptor) (PCaR1)","Sus scrofa (Pig)","cellular calcium ion homeostasis [GO:0006874]; detection of calcium ion [GO:0005513]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of calcium ion transport [GO:0051924]","GO:0004930; GO:0005509; GO:0005513; GO:0005886; GO:0006874; GO:0007186; GO:0016597; GO:0042803; GO:0051924"
"973",973,"Cluster_14999","Porites_evermani_scaffold_1228:10203-11203",169,-20.78,2,20,821,841,18,"83.33%","88.89%","Peve_00003755",-0.856206957915484,0.345629653666803,0.978262075707395,NA,NA,NA,NA,NA
"974",974,"Cluster_14999","Porites_evermani_scaffold_1228:10560-11560",169,-20.78,2,20,464,484,18,"83.33%","88.89%","Peve_00003762",0.762988728828849,0.447462324372572,0.978262075707395,"Q5A761","CCR4-Not complex 3'-5'-exoribonuclease subunit Ccr4 (EC 3.1.13.4) (Carbon catabolite repressor protein 4) (Cytoplasmic deadenylase) (Glucose-repressible alcohol dehydrogenase transcriptional effector)","Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast)","DNA replication checkpoint signaling [GO:0000076]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; replication fork protection [GO:0048478]; transcription elongation by RNA polymerase II promoter [GO:0006368]; traversing start control point of mitotic cell cycle [GO:0007089]","GO:0000076; GO:0000175; GO:0000289; GO:0000932; GO:0003723; GO:0004535; GO:0005634; GO:0005737; GO:0006368; GO:0007089; GO:0016593; GO:0030014; GO:0030015; GO:0032968; GO:0046872; GO:0048478"
"975",975,"Cluster_14999","Porites_evermani_scaffold_1243:104204-105204",174,-23.86,2,21,248,272,22,"81.82%","86.36%","Peve_00004016",-0.0952838373357539,0.93924825997606,0.999448381576871,"Q5EAD5","Geranylgeranyl transferase type-1 subunit beta (EC 2.5.1.59) (Geranylgeranyl transferase type I subunit beta) (GGTase-I-beta) (Type I protein geranyl-geranyltransferase subunit beta)","Bos taurus (Bovine)","protein geranylgeranylation [GO:0018344]; protein prenylation [GO:0018342]","GO:0004661; GO:0004662; GO:0005953; GO:0008270; GO:0018342; GO:0018344"
"976",976,"Cluster_14999","Porites_evermani_scaffold_1255:29679-30679",165,-20.88,2,21,495,517,21,"76.19%","85.71%","Peve_00004152",0.407673031667356,0.732680645853413,0.985261383385836,NA,NA,NA,NA,NA
"977",977,"Cluster_14999","Porites_evermani_scaffold_1256:19699-20699",161,-23.38,2,19,103,126,19,"73.68%","84.21%","Peve_00004166",NA,NA,NA,NA,NA,NA,NA,NA
"978",978,"Cluster_14999","Porites_evermani_scaffold_1343:88917-89917",162,-23.99,2,20,755,778,20,"75.00%","80.00%","Peve_00005411",0.654257244158638,0.545962730650415,0.978262075707395,"Q5R573","Rab-like protein 2A","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","","GO:0003924; GO:0005525"
"979",979,"Cluster_14999","Porites_evermani_scaffold_1385:19019-20019",146,-21.36,2,21,195,225,28,"60.71%","67.86%","Peve_00005976",0.136395245030739,0.912896579032651,0.999448381576871,"Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"980",980,"Cluster_14999","Porites_evermani_scaffold_1422:39321-40321",160,-20.25,2,17,644,665,15,"80.00%","86.67%","Peve_00006544",-0.999322492966855,0.0234356254044225,0.849930477652765,"Q9ZQ31","Serine/threonine-protein kinase STY13 (EC 2.7.11.1) (AtSTYPK) (Serine/threonine/tyrosine-protein kinase 13)","Arabidopsis thaliana (Mouse-ear cress)","protein phosphorylation [GO:0006468]; regulation of embryonic development [GO:0045995]; seed oilbody biogenesis [GO:0010344]; signal transduction [GO:0007165]","GO:0004672; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005737; GO:0006468; GO:0007165; GO:0010344; GO:0045995; GO:0106310"
"981",981,"Cluster_14999","Porites_evermani_scaffold_1423:101886-102615",153,-21.4,2,19,556,582,22,"68.18%","72.73%","Peve_00006549",-0.437985660538252,0.711384124172668,0.979204948737045,NA,NA,NA,NA,NA
"982",982,"Cluster_14999","Porites_evermani_scaffold_1488:113002-113955",167,-21.6,2,16,121,142,14,"92.86%","92.86%","Peve_00007312",0.780564076327955,0.429863880561325,0.978262075707395,"P69341","Poly(A)-specific ribonuclease PARN (EC 3.1.13.4) (Deadenylating nuclease) (Deadenylation nuclease) (Polyadenylate-specific ribonuclease)","Bos taurus (Bovine)","box H/ACA RNA 3'-end processing [GO:0000495]; miRNA catabolic process [GO:0010587]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]","GO:0000175; GO:0000184; GO:0000289; GO:0000495; GO:0003723; GO:0004535; GO:0005730; GO:0005737; GO:0010587; GO:0043169; GO:0046872; GO:0071051"
"983",983,"Cluster_14999","Porites_evermani_scaffold_1488:113002-113955",167,-21.6,2,16,121,142,14,"92.86%","92.86%","Peve_00007313",-0.961355379089542,0.177561276153019,0.978262075707395,NA,NA,NA,NA,NA
"984",984,"Cluster_14999","Porites_evermani_scaffold_1612:101150-102150",166,-29.94,2,15,646,667,13,"92.31%","100.00%","Peve_00008986",0.671697632904499,0.531130838721701,0.978262075707395,NA,NA,NA,NA,NA
"985",985,"Cluster_14999","Porites_evermani_scaffold_1654:3037-4037",167,-22.34,2,21,315,337,20,"75.00%","85.00%","Peve_00009453",0.953449021034691,0.195010875316921,0.978262075707395,"Q99L13","3-hydroxyisobutyrate dehydrogenase, mitochondrial (HIBADH) (EC 1.1.1.31)","Mus musculus (Mouse)","valine catabolic process [GO:0006574]","GO:0005739; GO:0006574; GO:0008442; GO:0016616; GO:0050661; GO:0051287"
"986",986,"Cluster_14999","Porites_evermani_scaffold_1814:34040-35040",157,-22.23,2,20,47,70,20,"75.00%","80.00%","Peve_00011316",0.318154111801319,0.793874110430558,0.995934364227446,NA,NA,NA,NA,NA
"987",987,"Cluster_14999","Porites_evermani_scaffold_1821:37810-38810",159,-20.91,2,21,245,269,22,"68.18%","77.27%","Peve_00011423",NA,NA,NA,NA,NA,NA,NA,NA
"988",988,"Cluster_14999","Porites_evermani_scaffold_1840:8673-9673",170,-23.12,2,20,910,932,19,"73.68%","94.74%","Peve_00011591",NA,NA,NA,NA,NA,NA,NA,NA
"989",989,"Cluster_14999","Porites_evermani_scaffold_1991:81894-82484",160,-20.44,2,21,375,396,19,"68.42%","78.95%","Peve_00013263",-0.932864845864196,0.234601232318981,0.978262075707395,NA,NA,NA,NA,NA
"990",990,"Cluster_14999","Porites_evermani_scaffold_1991:81894-82484",160,-20.44,2,21,375,396,19,"68.42%","78.95%","Peve_00013264",0.694564540427373,0.511194145988135,0.978262075707395,NA,NA,NA,NA,NA
"991",991,"Cluster_14999","Porites_evermani_scaffold_204:93282-94282",163,-21.14,2,21,154,177,21,"76.19%","76.19%","Peve_00013948",0.730317209264449,0.478744517566809,0.978262075707395,NA,NA,NA,NA,NA
"992",992,"Cluster_14999","Porites_evermani_scaffold_2:1090290-1091290",170,-21.62,2,20,783,807,21,"80.95%","80.95%","Peve_00013392",0.890557634165448,0.300628858022911,0.978262075707395,"Q8MYQ1","Putative serine/threonine-protein kinase F31E3.2 (EC 2.7.11.1)","Caenorhabditis elegans","protein phosphorylation [GO:0006468]","GO:0004672; GO:0004674; GO:0005524; GO:0006468; GO:0106310"
"993",993,"Cluster_14999","Porites_evermani_scaffold_2133:8678-9678",159,-20.56,2,21,797,821,22,"68.18%","77.27%","Peve_00014906",NA,NA,NA,NA,NA,NA,NA,NA
"994",994,"Cluster_14999","Porites_evermani_scaffold_2218:38206-39206",166,-20.86,2,20,805,829,21,"76.19%","80.95%","Peve_00015733",0.189569232640359,0.878581709084844,0.998373279237184,"D3Z8N4","Kelch-like protein 20","Rattus norvegicus (Rat)","Golgi to endosome transport [GO:0006895]; negative regulation of apoptotic process [GO:0043066]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K33-linked ubiquitination [GO:1990390]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]","GO:0003779; GO:0004842; GO:0005737; GO:0005802; GO:0005829; GO:0006895; GO:0015031; GO:0016567; GO:0016605; GO:0019964; GO:0030424; GO:0030425; GO:0031463; GO:0043066; GO:0043161; GO:0048471; GO:1990390"
"995",995,"Cluster_14999","Porites_evermani_scaffold_2218:40270-41270",163,-22.91,2,21,472,497,23,"69.57%","78.26%","Peve_00015734",NA,NA,NA,NA,NA,NA,NA,NA
"996",996,"Cluster_14999","Porites_evermani_scaffold_2224:14185-15185",154,-24.53,2,21,508,536,26,"65.38%","73.08%","Peve_00015814",NA,NA,NA,NA,NA,NA,NA,NA
"997",997,"Cluster_14999","Porites_evermani_scaffold_2298:14237-15237",158,-21.3,2,16,509,531,15,"80.00%","93.33%","Peve_00016458",NA,NA,NA,"F1PZV2","Major facilitator superfamily domain-containing protein 12","Canis lupus familiaris (Dog) (Canis familiaris)","carbohydrate transport [GO:0008643]; cysteine transmembrane transport [GO:1903712]; melanin biosynthetic process [GO:0042438]; organic substance transport [GO:0071702]; pigment metabolic process involved in pigmentation [GO:0043474]; regulation of melanin biosynthetic process [GO:0048021]","GO:0005764; GO:0005765; GO:0005886; GO:0008643; GO:0015293; GO:0033162; GO:0033229; GO:0042438; GO:0043474; GO:0048021; GO:0071702; GO:1903712"
"998",998,"Cluster_14999","Porites_evermani_scaffold_230:194878-195878",163,-22.73,2,21,289,312,21,"76.19%","76.19%","Peve_00016563",0.675811008811725,0.527587095527025,0.978262075707395,"Q9NVS9","Pyridoxine-5'-phosphate oxidase (EC 1.4.3.5) (Pyridoxamine-phosphate oxidase)","Homo sapiens (Human)","pyridoxal phosphate biosynthetic process [GO:0042823]; pyridoxine biosynthetic process [GO:0008615]","GO:0004733; GO:0005829; GO:0008615; GO:0010181; GO:0030170; GO:0042803; GO:0042823"
"999",999,"Cluster_14999","Porites_evermani_scaffold_230:227776-228776",160,-22.68,2,13,351,372,11,"100.00%","100.00%","Peve_00016564",-0.876730001139805,0.319440148878291,0.978262075707395,"Q1PCB0","Pyridoxine/pyridoxamine 5'-phosphate oxidase (EC 1.4.3.5) (BmPNPO) (PNP/PMP oxidase) (PNPOx) (Pyridoxal 5'-phosphate synthase)","Bombyx mori (Silk moth)","instar larval development [GO:0002168]; pyridoxal phosphate biosynthetic process [GO:0042823]; pyridoxine biosynthetic process [GO:0008615]; pyridoxine metabolic process [GO:0008614]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hormone [GO:0009725]","GO:0002168; GO:0004733; GO:0006357; GO:0008614; GO:0008615; GO:0009725; GO:0010181; GO:0030170; GO:0042803; GO:0042823"
"1000",1000,"Cluster_14999","Porites_evermani_scaffold_232:136158-137158",175,-20.29,2,20,159,180,18,"77.78%","94.44%","Peve_00016733",0.840734477945104,0.364247109603411,0.978262075707395,"Q90744","Alpha-N-acetylgalactosaminidase (EC 3.2.1.49) (Alpha-galactosidase B)","Gallus gallus (Chicken)","glycoside catabolic process [GO:0016139]; lipid metabolic process [GO:0006629]; oligosaccharide metabolic process [GO:0009311]","GO:0004557; GO:0005737; GO:0005764; GO:0006629; GO:0008456; GO:0009311; GO:0016139"
"1001",1001,"Cluster_14999","Porites_evermani_scaffold_2349:18613-19613",161,-22.26,2,19,216,239,19,"73.68%","84.21%","Peve_00016985",0.796442670377609,0.413425193041451,0.978262075707395,"Q5F2F2","Protein ABHD15 (Alpha/beta hydrolase domain-containing protein 15) (Abhydrolase domain-containing protein 15)","Mus musculus (Mouse)","cellular lipid metabolic process [GO:0044255]","GO:0005576; GO:0034338; GO:0044255; GO:0047372"
"1002",1002,"Cluster_14999","Porites_evermani_scaffold_2381:29186-30186",170,-26.28,2,21,339,364,23,"78.26%","82.61%","Peve_00017259",0.353112616992757,0.770246496705582,0.991074441382385,"Q6ITT3","Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C (EC 2.4.1.145) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase IVc) (GnT-IVc) (N-acetylglucosaminyltransferase IVc) (UDP-N-acetylglucosamine: alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IVc)","Sus scrofa (Pig)","protein N-linked glycosylation [GO:0006487]","GO:0000139; GO:0006487; GO:0008375; GO:0008454; GO:0046872"
"1003",1003,"Cluster_14999","Porites_evermani_scaffold_248:79436-80436",161,-21.95,2,21,748,769,20,"75.00%","85.00%","Peve_00018156",0.987720046751441,0.0998708871626554,0.978262075707395,NA,NA,NA,NA,NA
"1004",1004,"Cluster_14999","Porites_evermani_scaffold_2495:25028-26028",169,-20.78,2,20,664,684,18,"83.33%","88.89%","Peve_00018314",NA,NA,NA,NA,NA,NA,NA,NA
"1005",1005,"Cluster_14999","Porites_evermani_scaffold_2:510173-511173",166,-29.96,2,15,427,448,13,"92.31%","100.00%","Peve_00013349",NA,NA,NA,NA,NA,NA,NA,NA
"1006",1006,"Cluster_14999","Porites_evermani_scaffold_2575:19200-20200",142,-21.11,2,16,959,987,21,"66.67%","66.67%","Peve_00019024",0.803571178415417,0.405861212912267,0.978262075707395,NA,NA,NA,NA,NA
"1007",1007,"Cluster_14999","Porites_evermani_scaffold_2575:19272-20272",142,-21.11,2,16,887,915,21,"66.67%","66.67%","Peve_00019025",NA,NA,NA,NA,NA,NA,NA,NA
"1008",1008,"Cluster_14999","Porites_evermani_scaffold_26:156614-157614",171,-23.12,2,21,210,232,20,"80.00%","85.00%","Peve_00019250",NA,NA,NA,NA,NA,NA,NA,NA
"1009",1009,"Cluster_14999","Porites_evermani_scaffold_2627:67671-68339",174,-22.18,2,19,274,295,17,"82.35%","94.12%","Peve_00019476",0.653013703672664,0.547008783476557,0.978262075707395,"Q12933","TNF receptor-associated factor 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF2) (RING-type E3 ubiquitin transferase TRAF2) (Tumor necrosis factor type 2 receptor-associated protein 3)","Homo sapiens (Human)","activation of NF-kappaB-inducing kinase activity [GO:0007250]; cellular response to nitric oxide [GO:0071732]; interleukin-17-mediated signaling pathway [GO:0097400]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; mRNA stabilization [GO:0048255]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of neuron death [GO:1901215]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of I-kappaB phosphorylation [GO:1903721]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; programmed necrotic cell death [GO:0097300]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein K63-linked ubiquitination [GO:0070534]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of immunoglobulin production [GO:0002637]; regulation of protein-containing complex assembly [GO:0043254]; response to endoplasmic reticulum stress [GO:0034976]; signal transduction [GO:0007165]; signal transduction involved in regulation of gene expression [GO:0023019]; tumor necrosis factor-mediated signaling pathway [GO:0033209]","GO:0000151; GO:0002637; GO:0002726; GO:0002947; GO:0004842; GO:0005164; GO:0005174; GO:0005654; GO:0005829; GO:0005938; GO:0007165; GO:0007250; GO:0008270; GO:0009898; GO:0012506; GO:0019899; GO:0019901; GO:0019903; GO:0023019; GO:0030163; GO:0030674; GO:0031435; GO:0031625; GO:0031996; GO:0032743; GO:0033209; GO:0034351; GO:0034976; GO:0035631; GO:0042802; GO:0042981; GO:0043120; GO:0043122; GO:0043123; GO:0043254; GO:0043507; GO:0044877; GO:0045121; GO:0046330; GO:0046625; GO:0048255; GO:0051091; GO:0051092; GO:0051865; GO:0065003; GO:0070059; GO:0070534; GO:0071732; GO:0097057; GO:0097300; GO:0097400; GO:1901215; GO:1903265; GO:1903721; GO:1990604; GO:2001238"
"1010",1010,"Cluster_14999","Porites_evermani_scaffold_2630:7523-8523",171,-20.8,2,20,918,939,18,"77.78%","88.89%","Peve_00019515",0.525134194156591,0.64803024914489,0.978262075707395,NA,NA,NA,NA,NA
"1011",1011,"Cluster_14999","Porites_evermani_scaffold_2687:33003-34003",159,-20.69,2,21,490,512,20,"70.00%","80.00%","Peve_00019958",-0.750217553632315,0.459897482539499,0.978262075707395,"Q9GKR6","Calcyphosin-2 (Calcyphosine-2)","Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)","","GO:0005509"
"1012",1012,"Cluster_14999","Porites_evermani_scaffold_28:100344-101344",170,-23.14,2,20,229,251,19,"84.21%","84.21%","Peve_00020896",0.967870466984914,0.16181435437352,0.978262075707395,"Q8BTS4","Nuclear pore complex protein Nup54 (54 kDa nucleoporin) (Nucleoporin Nup54)","Mus musculus (Mouse)","mRNA transport [GO:0051028]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; protein localization to nuclear inner membrane [GO:0036228]; protein targeting [GO:0006605]; regulation of protein import into nucleus [GO:0042306]","GO:0005635; GO:0005643; GO:0006605; GO:0006607; GO:0006913; GO:0006999; GO:0017056; GO:0031965; GO:0032991; GO:0036228; GO:0042306; GO:0042802; GO:0044613; GO:0044877; GO:0051028"
"1013",1013,"Cluster_14999","Porites_evermani_scaffold_2853:8551-9551",158,-20.34,2,16,591,613,15,"86.67%","86.67%","Peve_00021305",NA,NA,NA,NA,NA,NA,NA,NA
"1014",1014,"Cluster_14999","Porites_evermani_scaffold_2891:7045-8045",166,-21.63,2,19,197,218,17,"76.47%","88.24%","Peve_00021602",NA,NA,NA,NA,NA,NA,NA,NA
"1015",1015,"Cluster_14999","Porites_evermani_scaffold_2931:49092-50092",163,-20.26,2,21,664,690,24,"70.83%","75.00%","Peve_00021939",0.391485472612102,0.743922650355545,0.987063468658535,NA,NA,NA,NA,NA
"1016",1016,"Cluster_14999","Porites_evermani_scaffold_2991:42132-43132",157,-21.9,2,19,173,197,20,"75.00%","75.00%","Peve_00022361",0.999976158554056,0.00439604651623863,0.54328949385489,"P98160","Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) (Perlecan) (PLC) [Cleaved into: Endorepellin; LG3 peptide]","Homo sapiens (Human)","angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cell differentiation [GO:0030154]; circulatory system development [GO:0072359]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell death [GO:0060548]; receptor-mediated endocytosis [GO:0006898]; tissue development [GO:0009888]","GO:0001525; GO:0001540; GO:0005178; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005886; GO:0005925; GO:0006629; GO:0006898; GO:0006954; GO:0007420; GO:0008022; GO:0009887; GO:0009888; GO:0016525; GO:0030021; GO:0030154; GO:0043202; GO:0050750; GO:0060548; GO:0062023; GO:0070062; GO:0072359; GO:0098797; GO:1905907"
"1017",1017,"Cluster_14999","Porites_evermani_scaffold_301:7682-8682",163,-21.2,2,21,317,342,23,"69.57%","78.26%","Peve_00022680",0.881446804300615,0.313140154724105,0.978262075707395,"P35546","Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment]","Mus musculus (Mouse)","activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; anatomical structure morphogenesis [GO:0009653]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657]","GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0006919; GO:0007156; GO:0007158; GO:0007169; GO:0007399; GO:0009410; GO:0009653; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030155; GO:0030182; GO:0030335; GO:0030424; GO:0030425; GO:0033141; GO:0033619; GO:0033630; GO:0033674; GO:0035799; GO:0035860; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045121; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0098797; GO:2001241"
"1018",1018,"Cluster_14999","Porites_evermani_scaffold_3045:8454-9454",153,-22.84,2,21,338,365,25,"72.00%","72.00%","Peve_00022950",0.323400847545418,0.790347567343499,0.995934364227446,NA,NA,NA,NA,NA
"1019",1019,"Cluster_14999","Porites_evermani_scaffold_3:1180662-1181662",163,-21.68,2,21,890,915,23,"73.91%","73.91%","Peve_00022501",NA,NA,NA,NA,NA,NA,NA,NA
"1020",1020,"Cluster_14999","Porites_evermani_scaffold_317:122255-123255",162,-20.12,2,21,776,799,21,"76.19%","80.95%","Peve_00023833",NA,NA,NA,NA,NA,NA,NA,NA
"1021",1021,"Cluster_14999","Porites_evermani_scaffold_3191:20240-21240",158,-21.77,2,21,594,617,21,"71.43%","80.95%","Peve_00023950",0.852230964828937,0.350498256459954,0.978262075707395,"Q80XJ3","Tetratricopeptide repeat protein 28 (TPR repeat protein 28)","Mus musculus (Mouse)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0005737; GO:0005813; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301; GO:0072686; GO:0097431; GO:1990023"
"1022",1022,"Cluster_14999","Porites_evermani_scaffold_319:95278-96278",160,-21.22,2,20,26,47,19,"73.68%","89.47%","Peve_00023940",0.495910325496308,0.669668931558723,0.978262075707395,"P31649","Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Sodium- and chloride-dependent GABA transporter 3) (GAT-3) (Solute carrier family 6 member 13)","Mus musculus (Mouse)","amino acid import across plasma membrane [GO:0089718]; creatine transmembrane transport [GO:0015881]; gamma-aminobutyric acid import [GO:0051939]; monocarboxylic acid transport [GO:0015718]; neurotransmitter transport [GO:0006836]; nitrogen compound transport [GO:0071705]; positive regulation of necrotic cell death [GO:0010940]; sodium ion transmembrane transport [GO:0035725]; taurine transport [GO:0015734]","GO:0005283; GO:0005308; GO:0005332; GO:0005368; GO:0005369; GO:0005886; GO:0006836; GO:0008028; GO:0010940; GO:0015171; GO:0015185; GO:0015718; GO:0015734; GO:0015881; GO:0016323; GO:0035725; GO:0042165; GO:0043005; GO:0051939; GO:0071705; GO:0089718"
"1023",1023,"Cluster_14999","Porites_evermani_scaffold_33:295655-296655",162,-20.97,2,21,378,404,24,"70.83%","79.17%","Peve_00024648",0.245221834158176,0.842278402087241,0.995934364227446,"Q9H4G4","Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2)","Homo sapiens (Human)","positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]","GO:0000139; GO:0005615; GO:0010634; GO:0010718; GO:0042803; GO:0070062; GO:0070374"
"1024",1024,"Cluster_14999","Porites_evermani_scaffold_33:408206-409206",168,-26.97,2,18,505,529,19,"84.21%","84.21%","Peve_00024584",0.744241261801308,0.465622551142409,0.978262075707395,"A1L252","Ran-binding protein 9 (RanBP9)","Danio rerio (Zebrafish) (Brachydanio rerio)","cell surface receptor signaling pathway [GO:0007166]; cytoskeleton organization [GO:0007010]; retina development in camera-type eye [GO:0060041]","GO:0005634; GO:0005737; GO:0005886; GO:0007010; GO:0007166; GO:0060041"
"1025",1025,"Cluster_14999","Porites_evermani_scaffold_3429:12019-13019",166,-23.35,2,19,344,365,17,"76.47%","88.24%","Peve_00025466",0.85151526588895,0.351368194338186,0.978262075707395,"Q1JQC6","NAD-dependent protein lipoamidase sirtuin-4, mitochondrial (EC 2.3.1.-) (NAD-dependent ADP-ribosyltransferase sirtuin-4) (EC 2.4.2.-) (NAD-dependent protein biotinylase sirtuin-4) (EC 2.3.1.-) (NAD-dependent protein deacetylase sirtuin-4) (EC 2.3.1.286) (Regulatory protein SIR2 homolog 4) (SIR2-like protein 4)","Bos taurus (Bovine)","cellular response to DNA damage stimulus [GO:0006974]; glutamine metabolic process [GO:0006541]; negative regulation of fatty acid oxidation [GO:0046322]; negative regulation of insulin secretion [GO:0046676]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of lipid biosynthetic process [GO:0046889]; protein deacetylation [GO:0006476]; regulation of pyruvate dehydrogenase activity [GO:1904182]; tricarboxylic acid metabolic process [GO:0072350]","GO:0003950; GO:0005739; GO:0005759; GO:0006476; GO:0006541; GO:0006974; GO:0008270; GO:0016779; GO:0019213; GO:0034979; GO:0034983; GO:0046322; GO:0046676; GO:0046889; GO:0070403; GO:0072350; GO:0106419; GO:0106420; GO:0140803; GO:1904182"
"1026",1026,"Cluster_14999","Porites_evermani_scaffold_3443:31144-32144",159,-21.74,2,21,650,673,21,"71.43%","76.19%","Peve_00025580",0.722110966523401,0.486343979019272,0.978262075707395,"Q9UBN7","Histone deacetylase 6 (HD6) (EC 3.5.1.98) (Tubulin-lysine deacetylase HDAC6) (EC 3.5.1.-)","Homo sapiens (Human)","aggresome assembly [GO:0070842]; autophagy [GO:0006914]; axonal transport of mitochondrion [GO:0019896]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to misfolded protein [GO:0071218]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to topologically incorrect protein [GO:0035967]; cilium assembly [GO:0060271]; cilium disassembly [GO:0061523]; collateral sprouting [GO:0048668]; dendritic spine morphogenesis [GO:0060997]; epigenetic regulation of gene expression [GO:0040029]; histone deacetylation [GO:0016575]; Hsp90 deacetylation [GO:0070846]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of hydrogen peroxide metabolic process [GO:0010727]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of protein-containing complex disassembly [GO:0043242]; negative regulation of proteolysis [GO:0045861]; negative regulation of transcription by RNA polymerase II [GO:0000122]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; peptidyl-lysine deacetylation [GO:0034983]; polyubiquitinated misfolded protein transport [GO:0070845]; positive regulation of cholangiocyte proliferation [GO:1904056]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of hydrogen peroxide-mediated programmed cell death [GO:1901300]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of signaling receptor activity [GO:2000273]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of tubulin deacetylation [GO:0090044]; protein deacetylation [GO:0006476]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein-containing complex disassembly [GO:0032984]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of autophagy [GO:0010506]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of establishment of protein localization [GO:0070201]; regulation of fat cell differentiation [GO:0045598]; regulation of macroautophagy [GO:0016241]; regulation of microtubule-based movement [GO:0060632]; regulation of protein stability [GO:0031647]; response to amphetamine [GO:0001975]; response to corticosterone [GO:0051412]; response to dexamethasone [GO:0071548]; response to growth factor [GO:0070848]; response to immobilization stress [GO:0035902]; response to misfolded protein [GO:0051788]; tubulin deacetylation [GO:0090042]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]","GO:0000118; GO:0000122; GO:0000209; GO:0000978; GO:0001222; GO:0001975; GO:0003779; GO:0004407; GO:0005634; GO:0005654; GO:0005737; GO:0005771; GO:0005813; GO:0005829; GO:0005874; GO:0005875; GO:0005901; GO:0006476; GO:0006515; GO:0006886; GO:0006914; GO:0007026; GO:0008013; GO:0008017; GO:0008270; GO:0010506; GO:0010634; GO:0010727; GO:0016234; GO:0016235; GO:0016241; GO:0016575; GO:0019896; GO:0019899; GO:0030424; GO:0030425; GO:0031252; GO:0031333; GO:0031593; GO:0031625; GO:0031647; GO:0031648; GO:0032418; GO:0032984; GO:0033138; GO:0033558; GO:0034983; GO:0035902; GO:0035967; GO:0036064; GO:0040029; GO:0042826; GO:0042903; GO:0043014; GO:0043130; GO:0043162; GO:0043204; GO:0043242; GO:0045598; GO:0045861; GO:0045892; GO:0048156; GO:0048471; GO:0048487; GO:0048668; GO:0048843; GO:0050775; GO:0051354; GO:0051412; GO:0051787; GO:0051788; GO:0051879; GO:0051968; GO:0060271; GO:0060632; GO:0060765; GO:0060997; GO:0061523; GO:0061734; GO:0070201; GO:0070301; GO:0070840; GO:0070842; GO:0070845; GO:0070846; GO:0070848; GO:0071218; GO:0071374; GO:0071548; GO:0090042; GO:0090044; GO:1901300; GO:1901984; GO:1903146; GO:1903223; GO:1904056; GO:1904115; GO:2000273"
"1027",1027,"Cluster_14999","Porites_evermani_scaffold_3471:1998-2998",176,-22.3,2,21,752,773,19,"78.95%","89.47%","Peve_00025744",NA,NA,NA,NA,NA,NA,NA,NA
"1028",1028,"Cluster_14999","Porites_evermani_scaffold_3541:32700-33700",176,-22.97,2,21,157,178,19,"84.21%","84.21%","Peve_00026204",NA,NA,NA,NA,NA,NA,NA,NA
"1029",1029,"Cluster_14999","Porites_evermani_scaffold_3644:19371-20371",164,-21.17,2,21,801,822,19,"68.42%","84.21%","Peve_00026796",NA,NA,NA,NA,NA,NA,NA,NA
"1030",1030,"Cluster_14999","Porites_evermani_scaffold_36:651140-652140",162,-20.39,2,15,842,863,13,"92.31%","92.31%","Peve_00026521",0.709266302693917,0.498052766509297,0.978262075707395,"Q8NBN7","Retinol dehydrogenase 13 (EC 1.1.1.300) (Short chain dehydrogenase/reductase family 7C member 3)","Homo sapiens (Human)","eye photoreceptor cell development [GO:0042462]; response to high light intensity [GO:0009644]; retina layer formation [GO:0010842]; retinal metabolic process [GO:0042574]","GO:0005743; GO:0009644; GO:0010842; GO:0042462; GO:0042574; GO:0052650"
"1031",1031,"Cluster_14999","Porites_evermani_scaffold_3715:104-1104",158,-21.77,2,21,900,923,21,"71.43%","80.95%","Peve_00027185",NA,NA,NA,NA,NA,NA,NA,NA
"1032",1032,"Cluster_14999","Porites_evermani_scaffold_3782:26810-27810",150,-20.92,2,16,687,712,18,"72.22%","77.78%","Peve_00027500",-0.759644391257026,0.450746019664302,0.978262075707395,"Q6NWZ9","Cysteine dioxygenase type 1 (EC 1.13.11.20) (Cysteine dioxygenase type I) (CDO) (CDO-I)","Danio rerio (Zebrafish) (Brachydanio rerio)","L-cysteine catabolic process [GO:0019448]; taurine biosynthetic process [GO:0042412]","GO:0008198; GO:0008270; GO:0016151; GO:0016702; GO:0017172; GO:0019448; GO:0042412"
"1033",1033,"Cluster_14999","Porites_evermani_scaffold_3951:33602-34602",171,-20.67,2,20,729,750,18,"83.33%","83.33%","Peve_00028480",0.598325640622676,0.591665840314282,0.978262075707395,"Q9NRA2","Sialin (H(+)/nitrate cotransporter) (H(+)/sialic acid cotransporter) (AST) (Membrane glycoprotein HP59) (Solute carrier family 17 member 5) (Vesicular excitatory amino acid transporter) (VEAT)","Homo sapiens (Human)","amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]","GO:0005351; GO:0005764; GO:0005765; GO:0005829; GO:0005886; GO:0006811; GO:0006820; GO:0006865; GO:0009617; GO:0015136; GO:0015538; GO:0015739; GO:0016020; GO:0022857; GO:0030672; GO:0042880"
"1034",1034,"Cluster_14999","Porites_evermani_scaffold_403:26650-27650",158,-21.62,2,17,773,793,15,"86.67%","86.67%","Peve_00029005",0.503689227388215,0.663951344951323,0.978262075707395,"Q1L987","ATP synthase mitochondrial F1 complex assembly factor 1","Danio rerio (Zebrafish) (Brachydanio rerio)","mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]","GO:0005739; GO:0033615"
"1035",1035,"Cluster_14999","Porites_evermani_scaffold_423:54167-55167",157,-20.41,2,21,927,953,24,"75.00%","75.00%","Peve_00030032",-0.988105004029015,0.0982898577615692,0.978262075707395,NA,NA,NA,NA,NA
"1036",1036,"Cluster_14999","Porites_evermani_scaffold_42:416220-417220",166,-22.17,2,21,810,835,23,"78.26%","78.26%","Peve_00029811",0.952568832095687,0.196860573716011,0.978262075707395,"Q5ZJK8","T-complex protein 1 subunit eta (TCP-1-eta) (CCT-eta)","Gallus gallus (Chicken)","protein folding [GO:0006457]","GO:0005524; GO:0005832; GO:0006457; GO:0016887; GO:0051082; GO:0140662"
"1037",1037,"Cluster_14999","Porites_evermani_scaffold_4406:22905-23905",161,-20.13,2,21,382,403,20,"75.00%","85.00%","Peve_00031005",-0.440372424380459,0.709692825679803,0.978599181026883,"Q98943","Caspase-2 (CASP-2) (EC 3.4.22.55) (ICH-1L/1S) (Protease ICH-1) [Cleaved into: Caspase-2 subunit p18; Caspase-2 subunit p13; Caspase-2 subunit p12]","Gallus gallus (Chicken)","activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; cellular response to mechanical stimulus [GO:0071260]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; ectopic germ cell programmed cell death [GO:0035234]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; positive regulation of apoptotic signaling pathway [GO:2001235]; protein processing [GO:0016485]","GO:0005634; GO:0005737; GO:0006915; GO:0006919; GO:0006977; GO:0008630; GO:0016485; GO:0019904; GO:0035234; GO:0042802; GO:0071260; GO:0097153; GO:0097192; GO:0097199; GO:0097200; GO:1905369; GO:2001235"
"1038",1038,"Cluster_14999","Porites_evermani_scaffold_4443:9767-10767",162,-20.89,2,15,1,15,13,"92.31%","92.31%","Peve_00031180",0.955248072389153,0.191176310058987,0.978262075707395,"Q9YG88","Dihydroxy-acid dehydratase (DAD) (EC 4.2.1.9)","Aeropyrum pernix (strain ATCC 700893 / DSM 11879 / JCM 9820 / NBRC 100138 / K1)","isoleucine biosynthetic process [GO:0009097]; valine biosynthetic process [GO:0009099]","GO:0000287; GO:0004160; GO:0009097; GO:0009099; GO:0051537"
"1039",1039,"Cluster_14999","Porites_evermani_scaffold_449:195536-196536",157,-20.42,2,16,171,191,14,"85.71%","92.86%","Peve_00031408",0.604893203494098,0.586431585874993,0.978262075707395,"O35177","Enhancer of filamentation 1 (mEF1) (CRK-associated substrate-related protein) (CAS-L) (Neural precursor cell expressed developmentally down-regulated protein 9) (NEDD-9) (p105)","Mus musculus (Mouse)","actin filament reorganization [GO:0090527]; activation of GTPase activity [GO:0090630]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; cilium disassembly [GO:0061523]; learning or memory [GO:0007611]; lymphocyte migration into lymphoid organs [GO:0097021]; negative regulation of cell migration [GO:0030336]; positive regulation of cell migration [GO:0030335]; positive regulation of dendritic spine maintenance [GO:1902952]; positive regulation of immunological synapse formation [GO:2000522]; positive regulation of lymphocyte chemotaxis [GO:0140131]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of protein localization [GO:1903829]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of actin cytoskeleton organization [GO:0032956]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]","GO:0000922; GO:0001772; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0005925; GO:0005938; GO:0007049; GO:0007155; GO:0007169; GO:0007611; GO:0016323; GO:0016477; GO:0030027; GO:0030335; GO:0030336; GO:0032956; GO:0036064; GO:0045672; GO:0051301; GO:0061098; GO:0061523; GO:0072686; GO:0090527; GO:0090630; GO:0097021; GO:0140131; GO:1900026; GO:1902952; GO:1903829; GO:1990782; GO:2000522"
"1040",1040,"Cluster_14999","Porites_evermani_scaffold_4571:3677-4677",175,-20.03,2,21,430,453,21,"80.95%","85.71%","Peve_00031760",NA,NA,NA,"B0BN95","Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)","Rattus norvegicus (Rat)","","GO:0004518; GO:0005634; GO:0005737; GO:0046872"
"1041",1041,"Cluster_14999","Porites_evermani_scaffold_4595:18922-19922",167,-21.4,2,21,145,167,20,"70.00%","90.00%","Peve_00031861",NA,NA,NA,"P35556","Fibrillin-2 [Cleaved into: Placensin]","Homo sapiens (Human)","anatomical structure morphogenesis [GO:0009653]; bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583]","GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0009653; GO:0030023; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:0062023; GO:1901163"
"1042",1042,"Cluster_14999","Porites_evermani_scaffold_496:106003-107003",170,-22.6,2,21,260,283,21,"80.95%","85.71%","Peve_00033354",0.848216223039469,0.355353524617854,0.978262075707395,NA,NA,NA,NA,NA
"1043",1043,"Cluster_14999","Porites_evermani_scaffold_496:114085-115085",170,-22.6,2,21,260,283,21,"80.95%","85.71%","Peve_00033355",0.838369780417302,0.367018102997723,0.978262075707395,NA,NA,NA,NA,NA
"1044",1044,"Cluster_14999","Porites_evermani_scaffold_497:229136-230136",158,-20.23,2,21,580,604,22,"68.18%","81.82%","Peve_00033413",-0.846282546807785,0.357670981714357,0.978262075707395,NA,NA,NA,NA,NA
"1045",1045,"Cluster_14999","Porites_evermani_scaffold_497:25910-26910",168,-20.41,2,19,894,914,17,"88.24%","88.24%","Peve_00033402",0.799567282427878,0.410124436506455,0.978262075707395,NA,NA,NA,NA,NA
"1046",1046,"Cluster_14999","Porites_evermani_scaffold_50:139019-140019",163,-20.76,2,21,134,156,20,"75.00%","80.00%","Peve_00033632",NA,NA,NA,NA,NA,NA,NA,NA
"1047",1047,"Cluster_14999","Porites_evermani_scaffold_5:1194485-1195485",165,-26.35,2,19,131,156,21,"76.19%","80.95%","Peve_00033567",-0.755648796226438,0.454643416828908,0.978262075707395,"G5EBQ8","Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2)","Caenorhabditis elegans","cell wall chitin biosynthetic process [GO:0006038]; chitin biosynthetic process [GO:0006031]; positive regulation of nematode larval development [GO:0061063]","GO:0004100; GO:0005886; GO:0006031; GO:0006038; GO:0030428; GO:0061063; GO:0071944"
"1048",1048,"Cluster_14999","Porites_evermani_scaffold_540:214659-215659",153,-21.71,2,21,796,819,22,"68.18%","77.27%","Peve_00035160",0.525134194156591,0.64803024914489,0.978262075707395,"F1R332","Galanin receptor 2a","Danio rerio (Zebrafish) (Brachydanio rerio)","adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; neuropeptide signaling pathway [GO:0007218]","GO:0004966; GO:0005886; GO:0007188; GO:0007218; GO:0008528"
"1049",1049,"Cluster_14999","Porites_evermani_scaffold_560:142359-143359",154,-20.38,2,21,30,58,26,"69.23%","69.23%","Peve_00035813",0.999446977031752,0.0211732108231167,0.821343827072112,NA,NA,NA,NA,NA
"1050",1050,"Cluster_14999","Porites_evermani_scaffold_5655:0-575",167,-23.16,2,16,377,398,14,"92.86%","92.86%","Peve_00035953",0.672338940641381,0.530579521799596,0.978262075707395,"Q9MZL5","Voltage-dependent L-type calcium channel subunit beta-2 (CAB2) (Calcium channel voltage-dependent subunit beta 2)","Bos taurus (Bovine)","chemical synaptic transmission [GO:0007268]; neuromuscular junction development [GO:0007528]; regulation of voltage-gated calcium channel activity [GO:1901385]","GO:0005891; GO:0007268; GO:0007528; GO:0008331; GO:0045202; GO:1901385; GO:1990454"
"1051",1051,"Cluster_14999","Porites_evermani_scaffold_5763:7459-8459",166,-20.92,2,20,604,626,19,"78.95%","84.21%","Peve_00036279",NA,NA,NA,"Q14112","Nidogen-2 (NID-2) (Osteonidogen)","Homo sapiens (Human)","basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; cell-matrix adhesion [GO:0007160]","GO:0005201; GO:0005509; GO:0005518; GO:0005576; GO:0005604; GO:0005615; GO:0005886; GO:0007155; GO:0007160; GO:0062023; GO:0070062; GO:0071711"
"1052",1052,"Cluster_14999","Porites_evermani_scaffold_5783:8050-9050",166,-29.94,2,15,645,666,13,"92.31%","100.00%","Peve_00036320",0.301530424403161,0.805005031462185,0.995934364227446,NA,NA,NA,NA,NA
"1053",1053,"Cluster_14999","Porites_evermani_scaffold_602:200741-201741",162,-20.02,2,20,376,398,19,"78.95%","78.95%","Peve_00037145",0.711779564664217,0.495778992554015,0.978262075707395,"P12265","Beta-glucuronidase (EC 3.2.1.31)","Mus musculus (Mouse)","carbohydrate metabolic process [GO:0005975]; chondroitin sulfate catabolic process [GO:0030207]; glucuronoside catabolic process [GO:0019391]; heparan sulfate proteoglycan catabolic process [GO:0030200]; hyaluronan catabolic process [GO:0030214]","GO:0004566; GO:0005102; GO:0005615; GO:0005764; GO:0005783; GO:0005975; GO:0016787; GO:0019391; GO:0019904; GO:0030200; GO:0030207; GO:0030214; GO:0030246; GO:0043202; GO:0043231"
"1054",1054,"Cluster_14999","Porites_evermani_scaffold_615:30423-31423",150,-20.07,2,20,884,908,21,"66.67%","71.43%","Peve_00037463",NA,NA,NA,NA,NA,NA,NA,NA
"1055",1055,"Cluster_14999","Porites_evermani_scaffold_61:88103-89103",164,-20.05,2,17,167,188,15,"80.00%","93.33%","Peve_00037342",0.286348634331987,0.815116890953718,0.995934364227446,NA,NA,NA,NA,NA
"1056",1056,"Cluster_14999","Porites_evermani_scaffold_625:8895-9895",161,-21.27,2,20,558,582,21,"76.19%","80.95%","Peve_00037743",0.533719150404717,0.641587900208645,0.978262075707395,"Q62763","Casein kinase I isoform gamma-3 (CKI-gamma 3) (EC 2.7.11.1)","Rattus norvegicus (Rat)","endocytosis [GO:0006897]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]","GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0006468; GO:0006897; GO:0007165; GO:0016055; GO:0018105; GO:0046777; GO:0090263; GO:0106310"
"1057",1057,"Cluster_14999","Porites_evermani_scaffold_642:53404-54404",175,-27.69,2,21,241,264,21,"80.95%","85.71%","Peve_00038207",NA,NA,NA,NA,NA,NA,NA,NA
"1058",1058,"Cluster_14999","Porites_evermani_scaffold_694:27019-28019",174,-21.61,2,19,50,71,17,"82.35%","94.12%","Peve_00039396",0.998919516701524,0.0295966980402007,0.903929377050813,"Q6DGL2","NF-kappa-B inhibitor-interacting Ras-like protein 2 (I-kappa-B-interacting Ras-like protein 2) (Kappa B-Ras protein 2) (KappaB-Ras2)","Danio rerio (Zebrafish) (Brachydanio rerio)","I-kappaB kinase/NF-kappaB signaling [GO:0007249]; Ral protein signal transduction [GO:0032484]; surfactant homeostasis [GO:0043129]","GO:0003924; GO:0005525; GO:0005737; GO:0007249; GO:0032484; GO:0032794; GO:0043129"
"1059",1059,"Cluster_14999","Porites_evermani_scaffold_711:69547-70547",155,-20.21,2,21,917,942,23,"69.57%","69.57%","Peve_00039855",0.525134194156591,0.64803024914489,0.978262075707395,"Q8CH87","Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 3 (EC 2.4.1.102) (EC 2.4.1.148) (EC 2.4.1.150) (C2GnT-mucin type) (C2GnT-M) (dI/C2/C4GnT) (dIGnT)","Rattus norvegicus (Rat)","intestinal absorption [GO:0050892]; kidney morphogenesis [GO:0060993]; protein glycosylation [GO:0006486]; tissue morphogenesis [GO:0048729]","GO:0000139; GO:0003829; GO:0006486; GO:0008109; GO:0008375; GO:0047225; GO:0048729; GO:0050892; GO:0060993; GO:0106325; GO:0106326"
"1060",1060,"Cluster_14999","Porites_evermani_scaffold_731:12534-13534",176,-25.94,2,21,797,818,19,"73.68%","94.74%","Peve_00040318",NA,NA,NA,NA,NA,NA,NA,NA
"1061",1061,"Cluster_14999","Porites_evermani_scaffold_740:136418-137418",158,-21.65,2,17,349,369,15,"86.67%","86.67%","Peve_00040521",-0.423843848344173,0.721361058863604,0.981886421096281,NA,NA,NA,NA,NA
"1062",1062,"Cluster_14999","Porites_evermani_scaffold_740:136418-137418",158,-21.65,2,17,854,874,15,"86.67%","86.67%","Peve_00040521",-0.423843848344173,0.721361058863604,0.981886421096281,NA,NA,NA,NA,NA
"1063",1063,"Cluster_14999","Porites_evermani_scaffold_749:83574-84349",165,-22.64,2,20,392,417,22,"77.27%","81.82%","Peve_00040642",0.525134194156591,0.64803024914489,0.978262075707395,NA,NA,NA,NA,NA
"1064",1064,"Cluster_14999","Porites_evermani_scaffold_75:158518-159518",162,-23.23,2,16,663,685,15,"86.67%","93.33%","Peve_00040667",0.443290628463188,0.707621939621716,0.978262075707395,NA,NA,NA,NA,NA
"1065",1065,"Cluster_14999","Porites_evermani_scaffold_820:143480-144480",154,-24.81,2,21,313,340,25,"64.00%","76.00%","Peve_00042218",NA,NA,NA,NA,NA,NA,NA,NA
"1066",1066,"Cluster_14999","Porites_evermani_scaffold_837:21428-22428",171,-20.9,2,21,185,207,20,"75.00%","90.00%","Peve_00042492",0.863357313153938,0.33671491207289,0.978262075707395,NA,NA,NA,NA,NA
"1067",1067,"Cluster_14999","Porites_evermani_scaffold_844:51243-52243",146,-22.06,2,21,305,333,26,"61.54%","69.23%","Peve_00042650",0.997296425206163,0.0468233205724549,0.939470798087631,"P07850","Sulfite oxidase (EC 1.8.3.1)","Gallus gallus (Chicken)","sulfur compound metabolic process [GO:0006790]","GO:0005739; GO:0005758; GO:0006790; GO:0008482; GO:0020037; GO:0030151; GO:0043546"
"1068",1068,"Cluster_14999","Porites_evermani_scaffold_864:38410-39410",166,-26.73,2,21,943,966,21,"76.19%","85.71%","Peve_00043042",0.832834798586345,0.373432764374386,0.978262075707395,"A6NNA5","Dorsal root ganglia homeobox protein (Paired-related homeobox protein-like 1)","Homo sapiens (Human)","axon guidance [GO:0007411]; detection of chemical stimulus [GO:0009593]; detection of temperature stimulus [GO:0016048]; dorsal spinal cord development [GO:0021516]; neuron migration [GO:0001764]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory perception of mechanical stimulus [GO:0050954]; trigeminal nerve development [GO:0021559]","GO:0000785; GO:0000977; GO:0000981; GO:0001764; GO:0005634; GO:0006357; GO:0007411; GO:0009593; GO:0016048; GO:0021516; GO:0021559; GO:0050954; GO:1990837"
"1069",1069,"Cluster_14999","Porites_evermani_scaffold_889:132923-133923",172,-20.05,2,21,900,921,19,"73.68%","89.47%","Peve_00043446",0.965441627721329,0.167853526456995,0.978262075707395,NA,NA,NA,NA,NA
"1070",1070,"Cluster_14999","Porites_evermani_scaffold_97:275741-276741",158,-21.16,2,16,256,279,16,"81.25%","87.50%","Peve_00044930",NA,NA,NA,NA,NA,NA,NA,NA
"1071",1071,"Cluster_15726","Porites_evermani_scaffold_101:247237-248237",157,-22.15,2,20,341,366,22,"72.73%","77.27%","Peve_00000394",-0.51247072731938,0.657460619596406,0.978262075707395,"Q9Y6W6","Dual specificity protein phosphatase 10 (EC 3.1.3.16) (EC 3.1.3.48) (Mitogen-activated protein kinase phosphatase 5) (MAP kinase phosphatase 5) (MKP-5)","Homo sapiens (Human)","dephosphorylation [GO:0016311]; negative regulation of cell migration [GO:0030336]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelium regeneration [GO:1905042]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; oligodendrocyte differentiation [GO:0048709]; peptidyl-threonine dephosphorylation [GO:0035970]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; positive regulation of regulatory T cell differentiation [GO:0045591]; regulation of adaptive immune response [GO:0002819]; regulation of brown fat cell differentiation [GO:0090335]; response to lipopolysaccharide [GO:0032496]; stress-activated MAPK cascade [GO:0051403]","GO:0002819; GO:0004721; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0008330; GO:0008432; GO:0010633; GO:0016311; GO:0016607; GO:0016791; GO:0017017; GO:0017018; GO:0030336; GO:0032496; GO:0033549; GO:0035970; GO:0043409; GO:0043508; GO:0044387; GO:0045591; GO:0046329; GO:0048273; GO:0048709; GO:0048715; GO:0050680; GO:0051403; GO:0060266; GO:0070373; GO:0090335; GO:1903753; GO:1905042; GO:1990264"
"1072",1072,"Cluster_15726","Porites_evermani_scaffold_104:286114-287114",154,-21.88,2,19,583,601,17,"76.47%","82.35%","Peve_00000823",-0.969984946823956,0.156371278803181,0.978262075707395,NA,NA,NA,NA,NA
"1073",1073,"Cluster_15726","Porites_evermani_scaffold_107:341539-342539",146,-21.36,2,21,532,548,19,"68.42%","73.68%","Peve_00001303",-0.746822685298026,0.463156738031783,0.978262075707395,"G8HTB6","ZP domain-containing protein","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0016020"
"1074",1074,"Cluster_15726","Porites_evermani_scaffold_11:1149158-1150043",165,-20.01,2,20,251,271,18,"83.33%","83.33%","Peve_00001824",NA,NA,NA,NA,NA,NA,NA,NA
"1075",1075,"Cluster_15726","Porites_evermani_scaffold_1121:13739-14739",162,-21.88,2,21,908,928,19,"78.95%","78.95%","Peve_00002187",-0.741173448639479,0.468539205015213,0.978262075707395,NA,NA,NA,NA,NA
"1076",1076,"Cluster_15726","Porites_evermani_scaffold_1129:38587-39587",149,-20.82,2,20,662,689,24,"66.67%","70.83%","Peve_00002262",NA,NA,NA,NA,NA,NA,NA,NA
"1077",1077,"Cluster_15726","Porites_evermani_scaffold_1164:64504-65504",161,-20.14,2,18,429,450,16,"81.25%","81.25%","Peve_00002789",0.677274266080897,0.526322110911621,0.978262075707395,"Q56A24","Kelch-like protein 24 (Kainate receptor-interacting protein for GluR6) (KRIP6) (Protein DRE1)","Rattus norvegicus (Rat)","intermediate filament organization [GO:0045109]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of kainate selective glutamate receptor activity [GO:2000312]","GO:0005737; GO:0005912; GO:0016567; GO:0030057; GO:0030424; GO:0031463; GO:0043204; GO:0045109; GO:0051865; GO:2000312"
"1078",1078,"Cluster_15726","Porites_evermani_scaffold_1208:30841-31841",155,-23.06,2,21,761,784,21,"71.43%","71.43%","Peve_00003497",NA,NA,NA,NA,NA,NA,NA,NA
"1079",1079,"Cluster_15726","Porites_evermani_scaffold_1218:131643-132643",154,-20.21,2,20,200,222,19,"73.68%","73.68%","Peve_00003636",-0.5,0.666666666666667,0.978262075707395,NA,NA,NA,NA,NA
"1080",1080,"Cluster_15726","Porites_evermani_scaffold_124:290872-291872",162,-26.15,2,19,207,228,17,"76.47%","82.35%","Peve_00003924",NA,NA,NA,NA,NA,NA,NA,NA
"1081",1081,"Cluster_15726","Porites_evermani_scaffold_133:243218-243574",163,-20.08,2,21,139,161,20,"70.00%","85.00%","Peve_00005210",NA,NA,NA,NA,NA,NA,NA,NA
"1082",1082,"Cluster_15726","Porites_evermani_scaffold_133:280534-281534",152,-21.31,2,21,944,965,19,"63.16%","73.68%","Peve_00005218",NA,NA,NA,NA,NA,NA,NA,NA
"1083",1083,"Cluster_15726","Porites_evermani_scaffold_1343:63610-64610",150,-21.47,2,11,440,461,9,"100.00%","100.00%","Peve_00005409",-0.87566365860877,0.320848700408141,0.978262075707395,NA,NA,NA,NA,NA
"1084",1084,"Cluster_15726","Porites_evermani_scaffold_135:20161-21161",171,-23.54,2,20,7,28,18,"77.78%","88.89%","Peve_00005498",NA,NA,NA,NA,NA,NA,NA,NA
"1085",1085,"Cluster_15726","Porites_evermani_scaffold_139:404245-405245",178,-23.04,2,19,870,891,17,"88.24%","94.12%","Peve_00006027",-0.659916125019452,0.541183596408996,0.978262075707395,NA,NA,NA,NA,NA
"1086",1086,"Cluster_15726","Porites_evermani_scaffold_1399:51672-52672",151,-23.51,2,21,297,322,23,"65.22%","69.57%","Peve_00006147",-0.444941596416646,0.706448864638417,0.978262075707395,"Q2KIH4","Ribosome biogenesis regulatory protein homolog","Bos taurus (Bovine)","endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; mitotic metaphase plate congression [GO:0007080]; protein localization to nucleolus [GO:1902570]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055]","GO:0000027; GO:0000055; GO:0000447; GO:0000794; GO:0005730; GO:0007080; GO:0008097; GO:0030687; GO:0042273; GO:1901796; GO:1902570"
"1087",1087,"Cluster_15726","Porites_evermani_scaffold_1470:42185-43185",155,-21.08,2,16,571,592,14,"78.57%","85.71%","Peve_00007106",-0.987665487520108,0.100092959157602,0.978262075707395,"P54923","ADP-ribosylhydrolase ARH1 (EC 3.2.2.19) (ADP-ribose-L-arginine cleaving enzyme) ([Protein ADP-ribosylarginine] hydrolase) (ADP-ribosylarginine hydrolase)","Mus musculus (Mouse)","protein de-ADP-ribosylation [GO:0051725]; protein modification process [GO:0036211]","GO:0000287; GO:0003875; GO:0005615; GO:0005829; GO:0030955; GO:0036211; GO:0051725"
"1088",1088,"Cluster_15726","Porites_evermani_scaffold_1472:10763-11645",165,-25.09,2,21,684,703,19,"78.95%","84.21%","Peve_00007128",-0.5,0.666666666666667,0.978262075707395,"A2A8L5","Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) (Leukocyte common antigen related) (LAR)","Mus musculus (Mouse)","cell migration [GO:0016477]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell projection organization [GO:0031345]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of neurotrophin TRK receptor signaling pathway [GO:0051387]; negative regulation of receptor binding [GO:1900121]; nervous system development [GO:0007399]; neuron projection regeneration [GO:0031102]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of apoptotic process [GO:0043065]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of neuron apoptotic process [GO:0043525]; protein dephosphorylation [GO:0006470]; regulation of axon regeneration [GO:0048679]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; regulation of synapse structure or activity [GO:0050803]; synaptic membrane adhesion [GO:0099560]","GO:0001960; GO:0004721; GO:0004725; GO:0005001; GO:0005158; GO:0005768; GO:0005886; GO:0006470; GO:0007156; GO:0007399; GO:0008201; GO:0008285; GO:0010975; GO:0016020; GO:0016477; GO:0030426; GO:0030971; GO:0031102; GO:0031345; GO:0035335; GO:0035373; GO:0042059; GO:0042301; GO:0043005; GO:0043025; GO:0043065; GO:0043231; GO:0043525; GO:0044877; GO:0046627; GO:0048679; GO:0050775; GO:0050803; GO:0050839; GO:0051387; GO:0060076; GO:0098839; GO:0099175; GO:0099560; GO:1900121"
"1089",1089,"Cluster_15726","Porites_evermani_scaffold_14:984590-985590",163,-21.08,2,21,864,886,20,"75.00%","80.00%","Peve_00006207",0.855892306341749,0.346017186863555,0.978262075707395,NA,NA,NA,NA,NA
"1090",1090,"Cluster_15726","Porites_evermani_scaffold_1555:47165-48165",159,-20.67,2,16,483,504,14,"78.57%","92.86%","Peve_00008165",NA,NA,NA,NA,NA,NA,NA,NA
"1091",1091,"Cluster_15726","Porites_evermani_scaffold_1561:67201-68201",149,-21.47,2,20,35,61,23,"65.22%","73.91%","Peve_00008261",0.964239978133949,0.170764179750182,0.978262075707395,"Q96PM5","RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING finger protein 199) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363) (p53-induced RING-H2 protein) (hPirh2)","Homo sapiens (Human)","error-free translesion synthesis [GO:0070987]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0002039; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042803; GO:0043231; GO:0051865; GO:0061630; GO:0070987"
"1092",1092,"Cluster_15726","Porites_evermani_scaffold_159:203253-204253",152,-23.27,2,21,917,938,19,"63.16%","73.68%","Peve_00008631",-0.677088678930554,0.526482678829628,0.978262075707395,"Q9HCF6","Transient receptor potential cation channel subfamily M member 3 (Long transient receptor potential channel 3) (LTrpC-3) (LTrpC3) (Melastatin-2) (MLSN2)","Homo sapiens (Human)","calcium ion transmembrane transport [GO:0070588]; cation transmembrane transport [GO:0098655]; cation transport [GO:0006812]; protein tetramerization [GO:0051262]","GO:0005261; GO:0005262; GO:0005886; GO:0006812; GO:0051262; GO:0070588; GO:0098655"
"1093",1093,"Cluster_15726","Porites_evermani_scaffold_16:114739-115739",160,-21.57,2,13,450,471,11,"100.00%","100.00%","Peve_00008774",-0.5,0.666666666666667,0.978262075707395,"O64411","Polyamine oxidase 1 (EC 1.5.3.14) (EC 1.5.3.15)","Zea mays (Maize)","polyamine catabolic process [GO:0006598]; spermine catabolic process [GO:0046208]","GO:0006598; GO:0009505; GO:0016491; GO:0046208; GO:0046592; GO:0048046; GO:0050660; GO:0052893; GO:0052896; GO:0052897; GO:0052900"
"1094",1094,"Cluster_15726","Porites_evermani_scaffold_1618:105126-105204",145,-21.03,2,10,5,26,8,"100.00%","100.00%","Peve_00009040",NA,NA,NA,NA,NA,NA,NA,NA
"1095",1095,"Cluster_15726","Porites_evermani_scaffold_1618:109608-110608",146,-23.13,2,21,928,948,19,"68.42%","68.42%","Peve_00009041",NA,NA,NA,NA,NA,NA,NA,NA
"1096",1096,"Cluster_15726","Porites_evermani_scaffold_1692:98409-99409",158,-20.23,2,20,771,796,22,"68.18%","77.27%","Peve_00009911",-0.529117073817429,0.645046461615425,0.978262075707395,"F6Z5C0","Ubiquitin carboxyl-terminal hydrolase 15 (EC 3.4.19.12) (Deubiquitinating enzyme 15) (Ubiquitin thioesterase 15) (Ubiquitin-specific-processing protease 15)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","BMP signaling pathway [GO:0030509]; histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; monoubiquitinated protein deubiquitination [GO:0035520]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; protein deubiquitination [GO:0016579]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0006511; GO:0007179; GO:0016579; GO:0030509; GO:0035520; GO:0035616; GO:0060389"
"1097",1097,"Cluster_15726","Porites_evermani_scaffold_169:400759-401759",148,-21.94,2,20,454,473,18,"61.11%","83.33%","Peve_00009888",0.366808700563921,0.760900714534092,0.988500699648159,NA,NA,NA,NA,NA
"1098",1098,"Cluster_15726","Porites_evermani_scaffold_171:323091-324091",165,-22.33,2,19,804,826,18,"77.78%","88.89%","Peve_00010154",-0.499919939065833,0.666725518304754,0.978262075707395,"A0A0R4IBK5","E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (E3 ubiquitin-lipopolysaccharide ligase rnf213-alpha) (EC 2.3.2.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha)","Danio rerio (Zebrafish) (Brachydanio rerio)","blood circulation [GO:0008015]; defense response to bacterium [GO:0042742]; immune system process [GO:0002376]; lipid droplet formation [GO:0140042]; lipid ubiquitination [GO:0120323]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein K63-linked ubiquitination [GO:0070534]; regulation of lipid metabolic process [GO:0019216]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]; xenophagy [GO:0098792]","GO:0002040; GO:0002376; GO:0004842; GO:0005524; GO:0005730; GO:0005811; GO:0005829; GO:0006511; GO:0008015; GO:0016887; GO:0019216; GO:0042742; GO:0046872; GO:0061630; GO:0070534; GO:0098792; GO:0120323; GO:0140042; GO:2000051"
"1099",1099,"Cluster_15726","Porites_evermani_scaffold_1735:98835-99835",141,-20.27,2,10,505,526,8,"87.50%","100.00%","Peve_00010438",-0.258477077415142,0.833558705784274,0.995934364227446,"Q5ZIE6","NEDD8-activating enzyme E1 regulatory subunit (APP-BP1) (Amyloid protein-binding protein 1)","Gallus gallus (Chicken)","protein modification by small protein conjugation [GO:0032446]; protein neddylation [GO:0045116]","GO:0005737; GO:0019781; GO:0032446; GO:0045116"
"1100",1100,"Cluster_15726","Porites_evermani_scaffold_174:190776-191776",167,-20.72,2,21,624,646,20,"80.00%","80.00%","Peve_00010488",NA,NA,NA,NA,NA,NA,NA,NA
"1101",1101,"Cluster_15726","Porites_evermani_scaffold_177:148572-149572",147,-21.37,2,21,70,93,21,"61.90%","71.43%","Peve_00010766",-0.509548116688613,0.659625169893592,0.978262075707395,NA,NA,NA,NA,NA
"1102",1102,"Cluster_15726","Porites_evermani_scaffold_1774:24661-25661",148,-22.79,2,20,291,310,18,"66.67%","77.78%","Peve_00010819",NA,NA,NA,NA,NA,NA,NA,NA
"1103",1103,"Cluster_15726","Porites_evermani_scaffold_1781:68050-69050",156,-23.8,2,21,773,791,19,"73.68%","78.95%","Peve_00010908",-0.172528916004219,0.889612352806866,0.999448381576871,NA,NA,NA,NA,NA
"1104",1104,"Cluster_15726","Porites_evermani_scaffold_1823:80909-81909",159,-21.33,2,19,411,430,17,"82.35%","82.35%","Peve_00011436",-0.999947726180961,0.00650937254330571,0.573710369894872,NA,NA,NA,NA,NA
"1105",1105,"Cluster_15726","Porites_evermani_scaffold_183:289947-290318",159,-22.76,2,21,219,243,22,"68.18%","77.27%","Peve_00011488",-0.728267246957608,0.480651919233315,0.978262075707395,NA,NA,NA,NA,NA
"1106",1106,"Cluster_15726","Porites_evermani_scaffold_1862:27150-28150",167,-21.43,2,21,277,301,22,"72.73%","81.82%","Peve_00011843",-0.0714647685630032,0.954465299834552,0.999448381576871,NA,NA,NA,NA,NA
"1107",1107,"Cluster_15726","Porites_evermani_scaffold_18:69449-69913",175,-30.29,2,21,244,266,20,"85.00%","85.00%","Peve_00011143",-0.729486783881201,0.479517926919715,0.978262075707395,NA,NA,NA,NA,NA
"1108",1108,"Cluster_15726","Porites_evermani_scaffold_1918:41949-42949",147,-20.21,2,21,881,898,19,"68.42%","73.68%","Peve_00012489",1,0,0,NA,NA,NA,NA,NA
"1109",1109,"Cluster_15726","Porites_evermani_scaffold_1960:77252-78252",166,-20.11,2,20,367,391,21,"76.19%","80.95%","Peve_00012945",NA,NA,NA,NA,NA,NA,NA,NA
"1110",1110,"Cluster_15726","Porites_evermani_scaffold_196:129321-130270",156,-20.25,2,21,745,766,19,"68.42%","73.68%","Peve_00012916",-0.5,0.666666666666667,0.978262075707395,NA,NA,NA,NA,NA
"1111",1111,"Cluster_15726","Porites_evermani_scaffold_19:636072-637072",165,-24.64,2,20,366,390,21,"80.95%","80.95%","Peve_00012235",0.762696662439108,0.447749889813082,0.978262075707395,"Q14549","Homeobox protein GBX-1 (Gastrulation and brain-specific homeobox protein 1)","Homo sapiens (Human)","adult walking behavior [GO:0007628]; neuron fate commitment [GO:0048663]; proprioception [GO:0019230]; regulation of nervous system development [GO:0051960]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory neuron axon guidance [GO:0097374]; spinal cord motor neuron differentiation [GO:0021522]","GO:0000785; GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0007628; GO:0019230; GO:0021522; GO:0048663; GO:0051960; GO:0097374"
"1112",1112,"Cluster_15726","Porites_evermani_scaffold_19:689334-690334",160,-22.31,2,21,350,371,19,"68.42%","78.95%","Peve_00012241",NA,NA,NA,NA,NA,NA,NA,NA
"1113",1113,"Cluster_15726","Porites_evermani_scaffold_1997:12774-13050",159,-22.82,2,21,101,125,22,"72.73%","72.73%","Peve_00013312",-0.00595390741664787,0.996209602421182,0.999448381576871,NA,NA,NA,NA,NA
"1114",1114,"Cluster_15726","Porites_evermani_scaffold_1997:12774-13050",159,-22.82,2,21,101,125,22,"72.73%","72.73%","Peve_00013313",NA,NA,NA,NA,NA,NA,NA,NA
"1115",1115,"Cluster_15726","Porites_evermani_scaffold_2012:71970-72970",162,-25.32,2,15,938,959,13,"92.31%","92.31%","Peve_00013703",-0.563761693909444,0.618707275091036,0.978262075707395,NA,NA,NA,NA,NA
"1116",1116,"Cluster_15726","Porites_evermani_scaffold_201:332436-333436",147,-20.04,2,20,688,709,18,"61.11%","72.22%","Peve_00013682",0.999429765887112,0.0215001929584108,0.825175158091499,"B8VIU6","Uncharacterized skeletal organic matrix protein 5 (Uncharacterized SOMP-5)","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0005576"
"1117",1117,"Cluster_15726","Porites_evermani_scaffold_20:139600-140600",168,-23.01,2,21,515,536,19,"78.95%","78.95%","Peve_00013517",-0.851229754298808,0.351714697687155,0.978262075707395,"Q96KE9","BTB/POZ domain-containing protein 6 (Lens BTB domain protein)","Homo sapiens (Human)","neurogenesis [GO:0022008]","GO:0005829; GO:0022008"
"1118",1118,"Cluster_15726","Porites_evermani_scaffold_2014:34431-35431",163,-20.43,2,21,286,308,20,"75.00%","80.00%","Peve_00013719",0.985385015636057,0.108974442330309,0.978262075707395,"Q70CQ2","Ubiquitin carboxyl-terminal hydrolase 34 (EC 3.4.19.12) (Deubiquitinating enzyme 34) (Ubiquitin thioesterase 34) (Ubiquitin-specific-processing protease 34)","Homo sapiens (Human)","positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]","GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006511; GO:0016055; GO:0016579; GO:0071108; GO:0090263"
"1119",1119,"Cluster_15726","Porites_evermani_scaffold_204:218918-219918",155,-20.69,2,21,674,697,21,"71.43%","71.43%","Peve_00013959",-0.467506533716583,0.690304871117234,0.978262075707395,NA,NA,NA,NA,NA
"1120",1120,"Cluster_15726","Porites_evermani_scaffold_205:336777-337777",154,-23.14,2,20,951,978,24,"66.67%","70.83%","Peve_00014067",0.703527507575938,0.503214377199367,0.978262075707395,NA,NA,NA,NA,NA
"1121",1121,"Cluster_15726","Porites_evermani_scaffold_2078:34414-35414",170,-21.33,2,15,722,743,13,"100.00%","100.00%","Peve_00014309",NA,NA,NA,NA,NA,NA,NA,NA
"1122",1122,"Cluster_15726","Porites_evermani_scaffold_208:61172-62172",151,-20.7,2,20,251,272,18,"66.67%","72.22%","Peve_00014326",-0.12956397593223,0.917284479018069,0.999448381576871,NA,NA,NA,NA,NA
"1123",1123,"Cluster_15726","Porites_evermani_scaffold_2149:47463-48463",147,-20.26,2,20,419,437,18,"72.22%","72.22%","Peve_00015040",-0.5,0.666666666666667,0.978262075707395,NA,NA,NA,NA,NA
"1124",1124,"Cluster_15726","Porites_evermani_scaffold_2176:63262-64262",146,-21.11,2,11,673,694,9,"88.89%","100.00%","Peve_00015281",0.293554427089421,0.810323614201322,0.995934364227446,"Q9Y6H5","Synphilin-1 (Sph1) (Alpha-synuclein-interacting protein)","Homo sapiens (Human)","cell death [GO:0008219]; dopamine metabolic process [GO:0042417]; regulation of inclusion body assembly [GO:0090083]; regulation of neurotransmitter secretion [GO:0046928]","GO:0005654; GO:0005737; GO:0005829; GO:0008021; GO:0008219; GO:0031625; GO:0036464; GO:0042417; GO:0042734; GO:0042802; GO:0043025; GO:0046928; GO:0090083"
"1125",1125,"Cluster_15726","Porites_evermani_scaffold_21:813179-814179",166,-20.61,2,20,440,462,19,"73.68%","89.47%","Peve_00014547",0.635044646563453,0.561963378913513,0.978262075707395,"Q90XB6","Extracellular sulfatase Sulf-1 (qSulf1) (EC 3.1.6.-)","Coturnix coturnix (Common quail) (Tetrao coturnix)","bone development [GO:0060348]; cartilage condensation [GO:0001502]; cartilage development [GO:0051216]; cell adhesion [GO:0007155]; chondrocyte development [GO:0002063]; embryonic skeletal system development [GO:0048706]; esophagus smooth muscle contraction [GO:0014846]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; heparan sulfate proteoglycan metabolic process [GO:0030201]; innervation [GO:0060384]; kidney development [GO:0001822]; limb joint morphogenesis [GO:0036022]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of prostatic bud formation [GO:0060686]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of Wnt signaling pathway [GO:0030177]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]","GO:0001502; GO:0001822; GO:0001937; GO:0002063; GO:0004065; GO:0005509; GO:0005615; GO:0005783; GO:0005794; GO:0005795; GO:0007155; GO:0008449; GO:0009986; GO:0014846; GO:0016525; GO:0030177; GO:0030201; GO:0030336; GO:0030513; GO:0035860; GO:0036022; GO:0040037; GO:0045121; GO:0048010; GO:0048661; GO:0048706; GO:0051216; GO:0060348; GO:0060384; GO:0060686; GO:0090263"
"1126",1126,"Cluster_15726","Porites_evermani_scaffold_2230:31004-32004",160,-23.08,2,21,885,906,19,"73.68%","73.68%","Peve_00015888",1,1.34157585525081e-08,8.89340150118664e-06,"Q9TV36","Fibrillin-1 [Cleaved into: Asprosin]","Sus scrofa (Pig)","activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; protein kinase A signaling [GO:0010737]","GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0008201; GO:0009653; GO:0010737; GO:0031012; GO:0034199; GO:0042593"
"1127",1127,"Cluster_15726","Porites_evermani_scaffold_2246:38781-39781",159,-24.09,2,21,320,343,21,"71.43%","76.19%","Peve_00016011",-0.745475127168512,0.464445277801415,0.978262075707395,NA,NA,NA,NA,NA
"1128",1128,"Cluster_15726","Porites_evermani_scaffold_2256:23302-24302",165,-21.29,2,14,849,870,12,"100.00%","100.00%","Peve_00016106",1,9.48637384723993e-09,6.86838308108347e-06,"Q95LU3","Fibrinogen C domain-containing protein 1","Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)","","GO:0008061; GO:0016020; GO:0046872"
"1129",1129,"Cluster_15726","Porites_evermani_scaffold_2335:51068-52068",160,-20.05,2,21,302,323,19,"68.42%","78.95%","Peve_00016876",1,1.34157585525081e-08,8.89340150118664e-06,NA,NA,NA,NA,NA
"1130",1130,"Cluster_15726","Porites_evermani_scaffold_2344:590-1590",154,-20.39,2,15,143,164,13,"84.62%","84.62%","Peve_00016951",-0.665371811535715,0.536546043515851,0.978262075707395,NA,NA,NA,NA,NA
"1131",1131,"Cluster_15726","Porites_evermani_scaffold_236:25094-26094",166,-20.72,2,19,966,987,17,"76.47%","88.24%","Peve_00017075",NA,NA,NA,NA,NA,NA,NA,NA
"1132",1132,"Cluster_15726","Porites_evermani_scaffold_2421:48654-49654",158,-20.24,2,21,308,328,19,"68.42%","84.21%","Peve_00017705",0.928943295662936,0.241436791764143,0.978262075707395,NA,NA,NA,NA,NA
"1133",1133,"Cluster_15726","Porites_evermani_scaffold_244:147385-148385",150,-20.84,2,11,627,648,9,"100.00%","100.00%","Peve_00017849",NA,NA,NA,NA,NA,NA,NA,NA
"1134",1134,"Cluster_15726","Porites_evermani_scaffold_248:117007-118007",164,-20.71,2,20,880,899,18,"83.33%","83.33%","Peve_00018160",0.943008928985225,0.215964814797205,0.978262075707395,NA,NA,NA,NA,NA
"1135",1135,"Cluster_15726","Porites_evermani_scaffold_254:137366-138366",145,-20.49,2,10,888,909,8,"100.00%","100.00%","Peve_00018769",0.887467914112059,0.304924770769895,0.978262075707395,"Q9UPZ3","BLOC-2 complex member HPS5 (Alpha-integrin-binding protein 63) (Hermansky-Pudlak syndrome 5 protein) (Ruby-eye protein 2 homolog) (Ru2)","Homo sapiens (Human)","blood coagulation [GO:0007596]; developmental pigmentation [GO:0048066]; intracellular transport [GO:0046907]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155]","GO:0005737; GO:0005769; GO:0005829; GO:0007596; GO:0031084; GO:0046907; GO:0048066; GO:0060155; GO:1903232"
"1136",1136,"Cluster_15726","Porites_evermani_scaffold_2556:37584-38584",148,-20.13,2,21,954,974,20,"70.00%","75.00%","Peve_00018880",NA,NA,NA,NA,NA,NA,NA,NA
"1137",1137,"Cluster_15726","Porites_evermani_scaffold_2585:29904-30904",171,-22.33,2,20,717,738,18,"83.33%","83.33%","Peve_00019096",0.484267318509999,0.678172441560118,0.978262075707395,NA,NA,NA,NA,NA
"1138",1138,"Cluster_15726","Porites_evermani_scaffold_2682:62881-63881",164,-20.14,2,20,682,701,18,"83.33%","83.33%","Peve_00019926",NA,NA,NA,NA,NA,NA,NA,NA
"1139",1139,"Cluster_15726","Porites_evermani_scaffold_2692:48183-48484",151,-20.57,2,21,198,220,20,"65.00%","75.00%","Peve_00019996",-0.744402901705588,0.4654684631622,0.978262075707395,"O43447","Peptidyl-prolyl cis-trans isomerase H (PPIase H) (EC 5.2.1.8) (Rotamase H) (Small nuclear ribonucleoprotein particle-specific cyclophilin H) (CypH) (U-snRNP-associated cyclophilin SnuCyp-20) (USA-CYP)","Homo sapiens (Human)","mRNA splicing, via spliceosome [GO:0000398]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein-containing complex assembly [GO:0065003]","GO:0000398; GO:0000413; GO:0003755; GO:0005654; GO:0005681; GO:0005737; GO:0005829; GO:0006457; GO:0016018; GO:0016607; GO:0043021; GO:0043231; GO:0045070; GO:0046540; GO:0065003; GO:0071001"
"1140",1140,"Cluster_15726","Porites_evermani_scaffold_2692:48183-48484",151,-20.57,2,21,198,220,20,"65.00%","75.00%","Peve_00019997",-0.918915122468928,0.258133421739636,0.978262075707395,"P19623","Spermidine synthase (SPDSY) (EC 2.5.1.16) (Putrescine aminopropyltransferase)","Homo sapiens (Human)","cellular response to leukemia inhibitory factor [GO:1990830]; polyamine biosynthetic process [GO:0006596]; polyamine metabolic process [GO:0006595]; spermidine biosynthetic process [GO:0008295]","GO:0004766; GO:0005829; GO:0006595; GO:0006596; GO:0008295; GO:0042802; GO:0042803; GO:1990830"
"1141",1141,"Cluster_15726","Porites_evermani_scaffold_2734:58049-59049",166,-20.43,2,20,56,79,20,"80.00%","80.00%","Peve_00020382",-0.769459966085205,0.44105089979295,0.978262075707395,NA,NA,NA,NA,NA
"1142",1142,"Cluster_15726","Porites_evermani_scaffold_2836:49531-50531",160,-24.78,2,21,609,630,19,"73.68%","73.68%","Peve_00021185",-0.999137171835302,0.0264477364816598,0.885091958128636,"Q4R562","Beta-arrestin-1 (Arrestin beta-1)","Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)","negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0001934; GO:0002092; GO:0005634; GO:0005905; GO:0006511; GO:0007165; GO:0015031; GO:0031143; GO:0031410; GO:0045746"
"1143",1143,"Cluster_15726","Porites_evermani_scaffold_285:58972-59972",162,-21.88,2,21,908,928,19,"78.95%","78.95%","Peve_00021279",0.74835822283985,0.461684871919011,0.978262075707395,NA,NA,NA,NA,NA
"1144",1144,"Cluster_15726","Porites_evermani_scaffold_287:185349-186156",141,-20.07,2,10,312,333,8,"87.50%","100.00%","Peve_00021433",0.536104153755938,0.639790850819767,0.978262075707395,"P16157","Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin)","Homo sapiens (Human)","cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]","GO:0005198; GO:0005200; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0014731; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030507; GO:0031430; GO:0043005; GO:0044325; GO:0045199; GO:0051117; GO:0072659"
"1145",1145,"Cluster_15726","Porites_evermani_scaffold_287:185349-186156",141,-20.07,2,10,312,333,8,"87.50%","100.00%","Peve_00021434",-0.902845239365748,0.28294868030097,0.978262075707395,"Q62623","Cell division cycle protein 20 homolog (p55CDC)","Rattus norvegicus (Rat)","anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; mitotic sister chromatid cohesion [GO:0007064]; mitotic spindle assembly [GO:0090307]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein ubiquitination [GO:0016567]; regulation of dendrite development [GO:0050773]; regulation of meiotic nuclear division [GO:0040020]","GO:0000922; GO:0005654; GO:0005680; GO:0005813; GO:0005829; GO:0007064; GO:0008022; GO:0008284; GO:0010997; GO:0016567; GO:0019899; GO:0031145; GO:0031915; GO:0032991; GO:0033597; GO:0040020; GO:0042826; GO:0048471; GO:0050773; GO:0051301; GO:0051444; GO:0090129; GO:0090307; GO:1904668; GO:1905786; GO:1990757"
"1146",1146,"Cluster_15726","Porites_evermani_scaffold_30:198674-199674",167,-21.78,2,21,295,318,21,"76.19%","80.95%","Peve_00022599",NA,NA,NA,NA,NA,NA,NA,NA
"1147",1147,"Cluster_15726","Porites_evermani_scaffold_3044:24838-25838",159,-20.17,2,21,676,698,20,"70.00%","80.00%","Peve_00022946",-0.5,0.666666666666667,0.978262075707395,"Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"1148",1148,"Cluster_15726","Porites_evermani_scaffold_3067:24953-25953",166,-21.45,2,21,678,698,19,"78.95%","84.21%","Peve_00023101",NA,NA,NA,NA,NA,NA,NA,NA
"1149",1149,"Cluster_15726","Porites_evermani_scaffold_309:161086-162086",155,-20.4,2,21,566,588,20,"65.00%","80.00%","Peve_00023265",-0.5,0.666666666666667,0.978262075707395,"Q8TB37","Iron-sulfur protein NUBPL (IND1 homolog) (Nucleotide-binding protein-like) (huInd1)","Homo sapiens (Human)","iron-sulfur cluster assembly [GO:0016226]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrion morphogenesis [GO:0070584]","GO:0005524; GO:0005739; GO:0005759; GO:0005886; GO:0016226; GO:0032981; GO:0046872; GO:0051539; GO:0070584; GO:0140663"
"1150",1150,"Cluster_15726","Porites_evermani_scaffold_309:161259-162259",155,-20.4,2,21,393,415,20,"65.00%","80.00%","Peve_00023266",NA,NA,NA,"Q69ZW3","EH domain-binding protein 1","Mus musculus (Mouse)","actin cytoskeleton organization [GO:0030036]; endocytosis [GO:0006897]; protein transport [GO:0015031]","GO:0005654; GO:0005768; GO:0005815; GO:0005829; GO:0005886; GO:0006897; GO:0015031; GO:0030036; GO:0031941"
"1151",1151,"Cluster_15726","Porites_evermani_scaffold_3142:7881-8881",155,-24.71,2,21,668,693,23,"69.57%","69.57%","Peve_00023679",NA,NA,NA,NA,NA,NA,NA,NA
"1152",1152,"Cluster_15726","Porites_evermani_scaffold_31:487572-488572",147,-24.17,2,21,420,437,19,"63.16%","78.95%","Peve_00023335",-0.923838715631536,0.250067892900169,0.978262075707395,"Q9N126","Retinol dehydrogenase 8 (EC 1.1.1.300) (Photoreceptor outer segment all-trans retinol dehydrogenase)","Bos taurus (Bovine)","estrogen biosynthetic process [GO:0006703]; response to stimulus [GO:0050896]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601]","GO:0004303; GO:0004745; GO:0005829; GO:0006703; GO:0007601; GO:0016491; GO:0042572; GO:0042622; GO:0050896; GO:0052650"
"1153",1153,"Cluster_15726","Porites_evermani_scaffold_3161:36493-37493",166,-20.99,2,15,1,20,13,"92.31%","100.00%","Peve_00023791",-0.5,0.666666666666667,0.978262075707395,"Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"1154",1154,"Cluster_15726","Porites_evermani_scaffold_3161:52047-52251",166,-20.99,2,15,1,20,13,"92.31%","100.00%","Peve_00023793",-0.5,0.666666666666667,0.978262075707395,"Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"1155",1155,"Cluster_15726","Porites_evermani_scaffold_316:177468-178468",162,-21.3,2,21,609,629,19,"78.95%","78.95%","Peve_00023770",0.936358385198745,0.228347540389589,0.978262075707395,"Q566X8","Diencephalon/mesencephalon homeobox protein 1-B","Danio rerio (Zebrafish) (Brachydanio rerio)","midbrain development [GO:0030901]; regulation of cell cycle [GO:0051726]; regulation of mitotic cell cycle [GO:0007346]; regulation of neural retina development [GO:0061074]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041]","GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0007346; GO:0030901; GO:0050767; GO:0051726; GO:0060041; GO:0061074"
"1156",1156,"Cluster_15726","Porites_evermani_scaffold_3247:0-672",153,-23.32,2,21,567,586,19,"63.16%","84.21%","Peve_00024295",-0.498572708317195,0.66771537796827,0.978262075707395,"Q28343","Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP)","Canis lupus familiaris (Dog) (Canis familiaris)","cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]","GO:0001501; GO:0005509; GO:0005540; GO:0005576; GO:0007155; GO:0007417; GO:0030246; GO:0031012"
"1157",1157,"Cluster_15726","Porites_evermani_scaffold_3282:7602-8602",167,-21.1,2,21,118,140,20,"75.00%","85.00%","Peve_00024492",-0.835183063923179,0.370723279185725,0.978262075707395,"B2RRE7","OTU domain-containing protein 4 (EC 3.4.19.12)","Mus musculus (Mouse)","innate immune response [GO:0045087]; negative regulation of interleukin-1-mediated signaling pathway [GO:2000660]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; positive regulation of DNA demethylation [GO:1901537]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; regulation of protein K48-linked deubiquitination [GO:1903093]","GO:0004843; GO:0005634; GO:0005829; GO:0016579; GO:0034122; GO:0045087; GO:0060090; GO:0061578; GO:0070536; GO:0071108; GO:1901537; GO:1903093; GO:2000660"
"1158",1158,"Cluster_15726","Porites_evermani_scaffold_3359:14369-15369",151,-20.82,2,17,399,421,16,"75.00%","81.25%","Peve_00025028",-0.998577868479122,0.0339559968102885,0.909359886114279,NA,NA,NA,NA,NA
"1159",1159,"Cluster_15726","Porites_evermani_scaffold_33:800322-801322",168,-22.04,2,19,823,843,17,"88.24%","88.24%","Peve_00024619",-0.879417409054634,0.31586482782276,0.978262075707395,NA,NA,NA,NA,NA
"1160",1160,"Cluster_15726","Porites_evermani_scaffold_3425:29829-30829",164,-20.35,2,20,772,791,18,"83.33%","83.33%","Peve_00025450",NA,NA,NA,NA,NA,NA,NA,NA
"1161",1161,"Cluster_15726","Porites_evermani_scaffold_3440:20881-21881",155,-28.22,2,21,479,505,24,"66.67%","70.83%","Peve_00025569",NA,NA,NA,NA,NA,NA,NA,NA
"1162",1162,"Cluster_15726","Porites_evermani_scaffold_3479:39194-40194",153,-21.93,2,19,374,397,19,"73.68%","73.68%","Peve_00025774",-0.5,0.666666666666667,0.978262075707395,NA,NA,NA,NA,NA
"1163",1163,"Cluster_15726","Porites_evermani_scaffold_35:554927-555927",171,-21.77,2,21,498,520,20,"75.00%","90.00%","Peve_00025925",-0.057641198971576,0.963284122394317,0.999448381576871,"P78357","Contactin-associated protein 1 (Caspr) (Caspr1) (Neurexin IV) (Neurexin-4) (p190)","Homo sapiens (Human)","axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; central nervous system myelination [GO:0022010]; cytoskeleton organization [GO:0007010]; mitochondrion organization [GO:0007005]; myelination in peripheral nervous system [GO:0022011]; neuromuscular junction development, skeletal muscle fiber [GO:0098529]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; neuron projection morphogenesis [GO:0048812]; neuronal action potential propagation [GO:0019227]; paranodal junction assembly [GO:0030913]; paranodal junction maintenance [GO:1990227]; postsynaptic density organization [GO:0097106]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; regulation of synapse maturation [GO:0090128]; signal transduction [GO:0007165]","GO:0002175; GO:0005886; GO:0007005; GO:0007010; GO:0007155; GO:0007165; GO:0007409; GO:0016020; GO:0017124; GO:0019227; GO:0022010; GO:0022011; GO:0030913; GO:0033010; GO:0033270; GO:0038023; GO:0048786; GO:0048812; GO:0050884; GO:0050885; GO:0071205; GO:0090128; GO:0097106; GO:0098529; GO:0098978; GO:1990227"
"1164",1164,"Cluster_15726","Porites_evermani_scaffold_358:278711-279711",146,-20.27,2,21,596,622,24,"66.67%","66.67%","Peve_00026397",-0.14035981698669,0.910348135183509,0.999448381576871,NA,NA,NA,NA,NA
"1165",1165,"Cluster_15726","Porites_evermani_scaffold_3643:17608-18608",153,-21.75,2,21,323,348,24,"70.83%","70.83%","Peve_00026791",NA,NA,NA,NA,NA,NA,NA,NA
"1166",1166,"Cluster_15726","Porites_evermani_scaffold_3656:39852-40631",155,-21.23,2,21,178,201,21,"66.67%","76.19%","Peve_00026854",0.496496506681198,0.669239109120351,0.978262075707395,NA,NA,NA,NA,NA
"1167",1167,"Cluster_15726","Porites_evermani_scaffold_367:173010-174010",157,-22.44,2,21,266,285,19,"73.68%","78.95%","Peve_00026919",-0.758627105924624,0.451740937643866,0.978262075707395,"Q8N5G2","Macoilin (Macoilin-1) (Transmembrane protein 57)","Homo sapiens (Human)","brain development [GO:0007420]; chemotaxis [GO:0006935]; neuronal signal transduction [GO:0023041]","GO:0005634; GO:0006935; GO:0007420; GO:0008017; GO:0023041; GO:0030424; GO:0030867; GO:0031965; GO:0044306; GO:0045202"
"1168",1168,"Cluster_15726","Porites_evermani_scaffold_3741:4144-5144",152,-20.31,2,21,147,165,19,"63.16%","84.21%","Peve_00027294",0.133355238376914,0.914849755151884,0.999448381576871,"Q9NTJ4","Alpha-mannosidase 2C1 (EC 3.2.1.24) (Alpha mannosidase 6A8B) (Alpha-D-mannoside mannohydrolase) (Mannosidase alpha class 2C member 1)","Homo sapiens (Human)","mannose metabolic process [GO:0006013]; oligosaccharide catabolic process [GO:0009313]","GO:0004559; GO:0005654; GO:0005829; GO:0006013; GO:0009313; GO:0030246; GO:0046872"
"1169",1169,"Cluster_15726","Porites_evermani_scaffold_3818:30128-31128",163,-23.96,2,21,375,398,21,"76.19%","76.19%","Peve_00027729",-0.671852206231189,0.530997995348433,0.978262075707395,NA,NA,NA,NA,NA
"1170",1170,"Cluster_15726","Porites_evermani_scaffold_3882:13036-14036",166,-20.95,2,20,435,458,20,"75.00%","85.00%","Peve_00028059",-0.5,0.666666666666667,0.978262075707395,"Q96CG8","Collagen triple helix repeat-containing protein 1","Homo sapiens (Human)","cell migration [GO:0016477]; cochlea morphogenesis [GO:0090103]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein binding [GO:0032092]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0001649; GO:0005109; GO:0005576; GO:0005581; GO:0005615; GO:0016477; GO:0016528; GO:0017147; GO:0032092; GO:0033687; GO:0033690; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0062023; GO:0090090; GO:0090103; GO:0090177"
"1171",1171,"Cluster_15726","Porites_evermani_scaffold_3903:24091-25091",168,-24.94,2,21,874,895,19,"73.68%","84.21%","Peve_00028214",-0.367131187120343,0.760680015672611,0.988434691253704,"Q9NZC7","WW domain-containing oxidoreductase (EC 1.1.1.-) (Fragile site FRA16D oxidoreductase) (Short chain dehydrogenase/reductase family 41C member 1)","Homo sapiens (Human)","cellular response to transforming growth factor beta stimulus [GO:0071560]; extrinsic apoptotic signaling pathway [GO:0097191]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of Wnt signaling pathway [GO:0030178]; osteoblast differentiation [GO:0001649]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of transcription by RNA polymerase II [GO:0045944]; skeletal system morphogenesis [GO:0048705]; Wnt signaling pathway [GO:0016055]","GO:0001649; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005794; GO:0005829; GO:0016055; GO:0016491; GO:0019899; GO:0030178; GO:0042802; GO:0045944; GO:0048705; GO:0071560; GO:0072332; GO:0090575; GO:0097191; GO:2001238; GO:2001241"
"1172",1172,"Cluster_15726","Porites_evermani_scaffold_3974:30779-31779",157,-20.54,2,19,657,680,19,"73.68%","78.95%","Peve_00028583",1,9.48637384723993e-09,6.86838308108347e-06,NA,NA,NA,NA,NA
"1173",1173,"Cluster_15726","Porites_evermani_scaffold_401:2987-3987",154,-21.17,2,15,10,31,13,"84.62%","84.62%","Peve_00028877",-0.914766435387836,0.264749116328982,0.978262075707395,NA,NA,NA,NA,NA
"1174",1174,"Cluster_15726","Porites_evermani_scaffold_4025:32931-33382",167,-22.78,2,20,244,265,18,"77.78%","83.33%","Peve_00028966",-0.983596127127967,0.115468570086695,0.978262075707395,"Q8BUZ1","Actin-binding Rho-activating protein (Striated muscle activator of Rho-dependent signaling) (STARS)","Mus musculus (Mouse)","positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein import into nucleus [GO:0006606]; transcription by RNA polymerase II [GO:0006366]","GO:0003779; GO:0005886; GO:0006366; GO:0006606; GO:0015629; GO:0030016; GO:0030017; GO:0035025; GO:0045893; GO:0045944; GO:0051091"
"1175",1175,"Cluster_15726","Porites_evermani_scaffold_402:87361-88361",150,-22.45,2,21,766,789,21,"71.43%","71.43%","Peve_00028935",NA,NA,NA,"D3ZVM4","E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71)","Rattus norvegicus (Rat)","3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to organic substance [GO:0071310]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA metabolic process [GO:0010586]; miRNA processing [GO:0035196]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of translation [GO:0017148]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; post-transcriptional regulation of gene expression [GO:0010608]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of miRNA-mediated gene silencing [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of protein metabolic process [GO:0051246]; stem cell proliferation [GO:0072089]","GO:0000082; GO:0000209; GO:0000932; GO:0001843; GO:0004842; GO:0008270; GO:0008543; GO:0010586; GO:0010608; GO:0016567; GO:0017148; GO:0021915; GO:0030371; GO:0035196; GO:0035198; GO:0035278; GO:0043161; GO:0051246; GO:0051865; GO:0060964; GO:0061158; GO:0061630; GO:0071310; GO:0072089; GO:2000177; GO:2000637"
"1176",1176,"Cluster_15726","Porites_evermani_scaffold_4057:15413-16413",170,-22.16,2,20,110,134,21,"80.95%","80.95%","Peve_00029148",NA,NA,NA,NA,NA,NA,NA,NA
"1177",1177,"Cluster_15726","Porites_evermani_scaffold_4058:13828-14828",161,-20.54,2,20,542,566,21,"76.19%","80.95%","Peve_00029153",NA,NA,NA,NA,NA,NA,NA,NA
"1178",1178,"Cluster_15726","Porites_evermani_scaffold_406:23962-24962",160,-20.73,2,21,276,297,19,"68.42%","78.95%","Peve_00029160",-0.5,0.666666666666667,0.978262075707395,NA,NA,NA,NA,NA
"1179",1179,"Cluster_15726","Porites_evermani_scaffold_410:254593-254837",152,-20.32,2,21,198,216,19,"68.42%","78.95%","Peve_00029410",NA,NA,NA,NA,NA,NA,NA,NA
"1180",1180,"Cluster_15726","Porites_evermani_scaffold_41:217397-218397",153,-20.06,2,18,346,367,16,"68.75%","81.25%","Peve_00029370",-0.746100727562654,0.463847439983789,0.978262075707395,"P00920","Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase II) (CA-II)","Mus musculus (Mouse)","angiotensin-activated signaling pathway [GO:0038166]; carbon dioxide transport [GO:0015670]; morphogenesis of an epithelium [GO:0002009]; neuron cellular homeostasis [GO:0070050]; one-carbon metabolic process [GO:0006730]; positive regulation of bone resorption [GO:0045780]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of dipeptide transmembrane transport [GO:2001150]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of anion transport [GO:0044070]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; secretion [GO:0046903]","GO:0002009; GO:0004064; GO:0004089; GO:0005615; GO:0005737; GO:0005829; GO:0005886; GO:0005902; GO:0006730; GO:0006885; GO:0008270; GO:0015670; GO:0016323; GO:0016836; GO:0030424; GO:0032230; GO:0032849; GO:0038166; GO:0043209; GO:0044070; GO:0045177; GO:0045672; GO:0045780; GO:0046903; GO:0051453; GO:0070050; GO:2001150; GO:2001225"
"1181",1181,"Cluster_15726","Porites_evermani_scaffold_412:262767-263767",175,-22.8,2,21,7,29,20,"85.00%","85.00%","Peve_00029491",NA,NA,NA,NA,NA,NA,NA,NA
"1182",1182,"Cluster_15726","Porites_evermani_scaffold_4158:11263-12263",167,-20.08,2,21,765,787,20,"70.00%","90.00%","Peve_00029643",NA,NA,NA,NA,NA,NA,NA,NA
"1183",1183,"Cluster_15726","Porites_evermani_scaffold_4203:6482-7482",157,-20.76,2,20,881,901,18,"72.22%","83.33%","Peve_00029899",-0.794807051280562,0.415144056078292,0.978262075707395,NA,NA,NA,NA,NA
"1184",1184,"Cluster_15726","Porites_evermani_scaffold_4294:17556-18556",163,-21.32,2,21,692,715,21,"76.19%","76.19%","Peve_00030364",0.348415104989185,0.773439928235381,0.991819191632059,"Q5F389","WW domain-containing oxidoreductase (EC 1.1.1.-)","Gallus gallus (Chicken)","cellular response to transforming growth factor beta stimulus [GO:0071560]; extrinsic apoptotic signaling pathway [GO:0097191]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of Wnt signaling pathway [GO:0030178]; osteoblast differentiation [GO:0001649]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of transcription by RNA polymerase II [GO:0045944]; skeletal system morphogenesis [GO:0048705]; Wnt signaling pathway [GO:0016055]","GO:0001649; GO:0003713; GO:0005654; GO:0005739; GO:0005794; GO:0005829; GO:0005886; GO:0005902; GO:0016055; GO:0016491; GO:0019899; GO:0030178; GO:0045944; GO:0048705; GO:0071560; GO:0072332; GO:0090575; GO:0097191; GO:2001241"
"1185",1185,"Cluster_15726","Porites_evermani_scaffold_4337:16775-17525",159,-23.05,2,21,67,89,20,"70.00%","80.00%","Peve_00030613",-0.5,0.666666666666667,0.978262075707395,NA,NA,NA,NA,NA
"1186",1186,"Cluster_15726","Porites_evermani_scaffold_4353:37-1037",162,-20.27,2,21,951,974,21,"71.43%","85.71%","Peve_00030677",-0.614450158451458,0.578755792431613,0.978262075707395,"Q12882","Dihydropyrimidine dehydrogenase [NADP(+)] (DHPDHase) (DPD) (EC 1.3.1.2) (Dihydrothymine dehydrogenase) (Dihydrouracil dehydrogenase)","Homo sapiens (Human)","beta-alanine biosynthetic process [GO:0019483]; CMP catabolic process [GO:0006248]; dCMP catabolic process [GO:0006249]; dUMP catabolic process [GO:0046079]; purine nucleobase catabolic process [GO:0006145]; pyrimidine nucleobase catabolic process [GO:0006208]; thymidine catabolic process [GO:0006214]; thymine catabolic process [GO:0006210]; UMP catabolic process [GO:0046050]; uracil catabolic process [GO:0006212]","GO:0002058; GO:0005737; GO:0005829; GO:0006145; GO:0006208; GO:0006210; GO:0006212; GO:0006214; GO:0006248; GO:0006249; GO:0017113; GO:0019483; GO:0042803; GO:0046050; GO:0046079; GO:0046872; GO:0050660; GO:0050661; GO:0051536; GO:0051539"
"1187",1187,"Cluster_15726","Porites_evermani_scaffold_4392:22289-23289",170,-22.08,2,20,923,945,19,"78.95%","89.47%","Peve_00030847",0.996777302248536,0.0511236215341044,0.958578480136013,"P84060","Dystrobrevin beta (DTN-B) (Beta-dystrobrevin)","Rattus norvegicus (Rat)","neuron differentiation [GO:0030182]; synaptic signaling [GO:0099536]","GO:0003677; GO:0005634; GO:0005737; GO:0005886; GO:0008270; GO:0009925; GO:0014069; GO:0019902; GO:0030182; GO:0030425; GO:0045202; GO:0060077; GO:0099536"
"1188",1188,"Cluster_15726","Porites_evermani_scaffold_4449:298-1298",146,-20.24,2,11,228,249,9,"88.89%","100.00%","Peve_00031196",NA,NA,NA,NA,NA,NA,NA,NA
"1189",1189,"Cluster_15726","Porites_evermani_scaffold_45:429558-430558",158,-22.99,2,21,226,251,23,"69.57%","78.26%","Peve_00031471",-0.999762972739619,0.0138612644080488,0.719823225073345,NA,NA,NA,NA,NA
"1190",1190,"Cluster_15726","Porites_evermani_scaffold_4565:14080-15080",143,-21.08,2,21,848,865,19,"63.16%","73.68%","Peve_00031720",NA,NA,NA,NA,NA,NA,NA,NA
"1191",1191,"Cluster_15726","Porites_evermani_scaffold_4600:9566-10566",140,-21.48,2,9,350,371,7,"100.00%","100.00%","Peve_00031931",-0.442265313877214,0.708349926262363,0.978262075707395,NA,NA,NA,NA,NA
"1192",1192,"Cluster_15726","Porites_evermani_scaffold_4618:3869-4869",148,-20.74,2,20,671,690,18,"66.67%","77.78%","Peve_00031985",-0.5,0.666666666666667,0.978262075707395,NA,NA,NA,NA,NA
"1193",1193,"Cluster_15726","Porites_evermani_scaffold_4638:16917-17917",146,-24.18,2,21,651,679,26,"65.38%","65.38%","Peve_00032062",-0.725663601379911,0.483065781457189,0.978262075707395,"E7FAM5","E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71)","Danio rerio (Zebrafish) (Brachydanio rerio)","embryonic body morphogenesis [GO:0010172]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA metabolic process [GO:0010586]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of translation [GO:0017148]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of miRNA-mediated gene silencing [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089]","GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0010172; GO:0010586; GO:0017148; GO:0021915; GO:0030371; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0060964; GO:0061630; GO:0072089; GO:2000177"
"1194",1194,"Cluster_15726","Porites_evermani_scaffold_468:152709-153709",166,-21.47,2,20,653,676,20,"80.00%","80.00%","Peve_00032230",-0.517835697648662,0.653475710780726,0.978262075707395,NA,NA,NA,NA,NA
"1195",1195,"Cluster_15726","Porites_evermani_scaffold_47:439914-440914",152,-21.32,2,21,955,979,24,"70.83%","70.83%","Peve_00032299",-0.203536858629637,0.86951264955254,0.997416999308104,NA,NA,NA,NA,NA
"1196",1196,"Cluster_15726","Porites_evermani_scaffold_481:168248-169248",165,-21.46,2,19,137,159,18,"83.33%","83.33%","Peve_00032822",-0.981685924657958,0.122026081172365,0.978262075707395,NA,NA,NA,NA,NA
"1197",1197,"Cluster_15726","Porites_evermani_scaffold_4871:16006-17006",162,-21.88,2,21,645,665,19,"78.95%","78.95%","Peve_00033020",-0.5,0.666666666666667,0.978262075707395,NA,NA,NA,NA,NA
"1198",1198,"Cluster_15726","Porites_evermani_scaffold_4894:16489-17489",151,-21.37,2,19,790,817,23,"73.91%","73.91%","Peve_00033073",0.51863528014907,0.652880519630719,0.978262075707395,"Q32LU7","Pentatricopeptide repeat domain-containing protein 3, mitochondrial","Danio rerio (Zebrafish) (Brachydanio rerio)","mitochondrial translation [GO:0032543]; regulation of translation [GO:0006417]","GO:0005739; GO:0005840; GO:0006417; GO:0019843; GO:0032543; GO:0043024; GO:1990904"
"1199",1199,"Cluster_15726","Porites_evermani_scaffold_508:117334-118334",167,-22.94,2,21,945,967,20,"75.00%","85.00%","Peve_00033939",0.641944120960829,0.556256211863442,0.978262075707395,"Q8WV37","Zinc finger protein 480","Homo sapiens (Human)","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0046872"
"1200",1200,"Cluster_15726","Porites_evermani_scaffold_513:226908-227908",163,-21.77,2,20,350,371,18,"77.78%","77.78%","Peve_00034167",0.983638207245604,0.115319964981836,0.978262075707395,"Q98KK0","Probable gamma-butyrobetaine dioxygenase (EC 1.14.11.1) (Gamma-butyrobetaine hydroxylase) (Gamma-BBH) (Gamma-butyrobetaine,2-oxoglutarate dioxygenase)","Mesorhizobium japonicum (strain LMG 29417 / CECT 9101 / MAFF 303099) (Mesorhizobium loti (strain MAFF 303099))","carnitine biosynthetic process [GO:0045329]","GO:0005506; GO:0005737; GO:0008336; GO:0045329"
"1201",1201,"Cluster_15726","Porites_evermani_scaffold_5162:567-1567",154,-20.48,2,21,895,918,21,"71.43%","76.19%","Peve_00034254",-0.581784182960579,0.604709659391672,0.978262075707395,NA,NA,NA,NA,NA
"1202",1202,"Cluster_15726","Porites_evermani_scaffold_52:636104-637104",152,-20.77,2,18,346,368,17,"76.47%","76.47%","Peve_00034380",-0.594150609721103,0.594976614974916,0.978262075707395,"Q5RBV0","Importin subunit alpha-7 (Karyopherin subunit alpha-6)","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","protein import into nucleus [GO:0006606]","GO:0005737; GO:0006606; GO:0061608"
"1203",1203,"Cluster_15726","Porites_evermani_scaffold_5343:4024-5024",162,-20.95,2,21,711,731,19,"78.95%","78.95%","Peve_00034895",NA,NA,NA,"Q6DDT4",NA,NA,NA,NA
"1204",1204,"Cluster_15726","Porites_evermani_scaffold_5346:1030-2030",149,-21.02,2,21,71,98,25,"68.00%","72.00%","Peve_00034900",-0.997904126995256,0.0412243184290208,0.909359886114279,NA,NA,NA,NA,NA
"1205",1205,"Cluster_15726","Porites_evermani_scaffold_553:59536-60536",154,-20.68,2,21,871,894,21,"71.43%","76.19%","Peve_00035572",0.431626398789196,0.715879779433959,0.980418985870632,NA,NA,NA,NA,NA
"1206",1206,"Cluster_15726","Porites_evermani_scaffold_582:207205-208205",146,-24.75,2,21,608,636,26,"65.38%","65.38%","Peve_00036463",-0.471477051227416,0.687442023191232,0.978262075707395,"Q54468","Chitobiase (EC 3.2.1.52) (Beta-N-acetylhexosaminidase) (N-acetyl-beta-glucosaminidase)","Serratia marcescens","chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]","GO:0000272; GO:0004563; GO:0006032; GO:0030247; GO:0042597; GO:0102148"
"1207",1207,"Cluster_15726","Porites_evermani_scaffold_5828:2063-3063",168,-22.09,2,17,89,110,15,"86.67%","93.33%","Peve_00036472",NA,NA,NA,NA,NA,NA,NA,NA
"1208",1208,"Cluster_15726","Porites_evermani_scaffold_596:100968-101968",156,-20.09,2,13,951,972,11,"90.91%","100.00%","Peve_00036852",NA,NA,NA,"O17185","Two pore potassium channel protein sup-9 (Suppressor of unc-93 protein 9) (n2P38)","Caenorhabditis elegans","potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of muscle contraction [GO:0006937]; stabilization of membrane potential [GO:0030322]","GO:0005267; GO:0005886; GO:0006813; GO:0006937; GO:0015271; GO:0022841; GO:0030322; GO:0036195; GO:0055120; GO:0071805"
"1209",1209,"Cluster_15726","Porites_evermani_scaffold_62:184056-185056",165,-20.75,2,21,88,109,20,"80.00%","85.00%","Peve_00037625",0.369206411602622,0.759259078215887,0.988219883885475,NA,NA,NA,NA,NA
"1210",1210,"Cluster_15726","Porites_evermani_scaffold_6242:189-1189",146,-20.27,2,11,800,821,9,"88.89%","100.00%","Peve_00037737",-0.999593925615707,0.0181431468379987,0.782669382293497,"Q3ZCH0","Stress-70 protein, mitochondrial (75 kDa glucose-regulated protein) (GRP-75) (Heat shock 70 kDa protein 9)","Bos taurus (Bovine)","cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; erythrocyte differentiation [GO:0030218]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; negative regulation of hemopoiesis [GO:1903707]; protein export from nucleus [GO:0006611]; protein refolding [GO:0042026]; regulation of erythrocyte differentiation [GO:0045646]","GO:0005524; GO:0005730; GO:0005737; GO:0005739; GO:0006611; GO:0016226; GO:0016887; GO:0030218; GO:0031072; GO:0031625; GO:0034620; GO:0042026; GO:0042645; GO:0044183; GO:0045646; GO:0045647; GO:0051082; GO:0051085; GO:0051787; GO:0140662; GO:1902037; GO:1903707"
"1211",1211,"Cluster_15726","Porites_evermani_scaffold_651:190239-191239",158,-24.96,2,21,449,472,21,"71.43%","80.95%","Peve_00038435",-0.382791307210899,0.749925664636639,0.988219883885475,NA,NA,NA,NA,NA
"1212",1212,"Cluster_15726","Porites_evermani_scaffold_655:193061-194061",171,-23.8,2,21,575,599,22,"77.27%","81.82%","Peve_00038508",0.0143849577201196,0.99084193563037,0.999448381576871,NA,NA,NA,NA,NA
"1213",1213,"Cluster_15726","Porites_evermani_scaffold_65:573099-573438",159,-26.07,2,21,285,308,21,"66.67%","80.95%","Peve_00038364",-0.324855301111235,0.789368792404015,0.995742627848044,"P53621","Coatomer subunit alpha (Alpha-coat protein) (Alpha-COP) (HEP-COP) (HEPCOP) [Cleaved into: Xenin (Xenopsin-related peptide); Proxenin]","Homo sapiens (Human)","endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; pancreatic juice secretion [GO:0030157]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]","GO:0000139; GO:0005179; GO:0005198; GO:0005615; GO:0005737; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0016020; GO:0030126; GO:0030133; GO:0030157; GO:0030426; GO:0070062"
"1214",1214,"Cluster_15726","Porites_evermani_scaffold_65:573099-573438",159,-26.07,2,21,285,308,21,"66.67%","80.95%","Peve_00038365",0.310780079993113,0.798819466527941,0.995934364227446,"P63245","Receptor of activated protein C kinase 1 (Guanine nucleotide-binding protein subunit beta-2-like 1) (Receptor for activated C kinase) (Receptor of activated protein kinase C 1) [Cleaved into: Receptor of activated protein C kinase 1, N-terminally processed]","Rattus norvegicus (Rat)","activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; cell cycle [GO:0007049]; cellular response to glucose stimulus [GO:0071333]; cellular response to growth factor stimulus [GO:0071363]; gastrulation [GO:0007369]; negative regulation of cell growth [GO:0030308]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-induced neuron death [GO:1903208]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of phagocytosis [GO:0050765]; negative regulation of protein binding [GO:0032091]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of translation [GO:0017148]; negative regulation of Wnt signaling pathway [GO:0030178]; osteoblast differentiation [GO:0001649]; pigmentation [GO:0043473]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; positive regulation of gastrulation [GO:2000543]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of GTPase activity [GO:0043547]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein-containing complex assembly [GO:0031334]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; regulation of protein localization to plasma membrane [GO:1903076]; rescue of stalled ribosome [GO:0072344]; rhythmic process [GO:0048511]; translation [GO:0006412]","GO:0001649; GO:0001891; GO:0001934; GO:0005080; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006412; GO:0006919; GO:0007049; GO:0007205; GO:0007369; GO:0008200; GO:0008656; GO:0010629; GO:0015935; GO:0016020; GO:0016567; GO:0017148; GO:0019899; GO:0019903; GO:0030178; GO:0030292; GO:0030308; GO:0030332; GO:0030335; GO:0030425; GO:0030496; GO:0030971; GO:0031334; GO:0032091; GO:0032436; GO:0032880; GO:0033137; GO:0035591; GO:0042169; GO:0042803; GO:0042998; GO:0043005; GO:0043022; GO:0043025; GO:0043065; GO:0043204; GO:0043473; GO:0043547; GO:0044297; GO:0045182; GO:0045879; GO:0048471; GO:0048511; GO:0050765; GO:0051302; GO:0051343; GO:0051434; GO:0051726; GO:0051898; GO:0051901; GO:0071333; GO:0071363; GO:0072344; GO:1903076; GO:1903208; GO:1990630; GO:2000114; GO:2000543; GO:2001244"
"1215",1215,"Cluster_15726","Porites_evermani_scaffold_666:134706-135706",159,-21.26,2,21,227,249,20,"75.00%","75.00%","Peve_00038735",0.996750732809355,0.051334046358452,0.9595823243821,"Q20191","Zinc metalloproteinase nas-13 (EC 3.4.24.-) (Nematode astacin 13)","Caenorhabditis elegans","proteolysis [GO:0006508]","GO:0004222; GO:0005576; GO:0006508; GO:0008270"
"1216",1216,"Cluster_15726","Porites_evermani_scaffold_68:392802-393802",145,-20.98,2,20,439,465,23,"65.22%","69.57%","Peve_00039068",NA,NA,NA,NA,NA,NA,NA,NA
"1217",1217,"Cluster_15726","Porites_evermani_scaffold_6963:0-337",166,-26.25,2,21,231,251,19,"78.95%","84.21%","Peve_00039450",NA,NA,NA,"P18505","Gamma-aminobutyric acid receptor subunit beta-1 (GABA(A) receptor subunit beta-1)","Homo sapiens (Human)","cellular response to histamine [GO:0071420]; central nervous system neuron development [GO:0021954]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; nervous system process [GO:0050877]; ovulation cycle [GO:0042698]; regulation of membrane potential [GO:0042391]; response to progesterone [GO:0032570]; response to toxic substance [GO:0009636]; signal transduction [GO:0007165]","GO:0004890; GO:0005231; GO:0005635; GO:0005737; GO:0005886; GO:0006811; GO:0007165; GO:0007214; GO:0007268; GO:0009636; GO:0015276; GO:0021954; GO:0022851; GO:0030425; GO:0030594; GO:0032570; GO:0034220; GO:0034707; GO:0042391; GO:0042698; GO:0043005; GO:0045202; GO:0048787; GO:0050811; GO:0050877; GO:0071420; GO:0098685; GO:0098982; GO:0099507; GO:0099634; GO:0150047; GO:1902476; GO:1902711; GO:1904315"
"1218",1218,"Cluster_15726","Porites_evermani_scaffold_701:811-1811",146,-20.3,2,21,161,184,21,"66.67%","71.43%","Peve_00039647",-0.5,0.666666666666667,0.978262075707395,"Q8IN35","Neuropeptide SIFamide receptor","Drosophila melanogaster (Fruit fly)","determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; mating behavior, sex discrimination [GO:0048047]; neuropeptide signaling pathway [GO:0007218]","GO:0004930; GO:0004983; GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0008340; GO:0008528; GO:0016020; GO:0042277; GO:0048047"
"1219",1219,"Cluster_15726","Porites_evermani_scaffold_758:13938-14938",155,-21.22,2,21,198,220,20,"70.00%","75.00%","Peve_00040813",-0.355398511721376,0.768690330953606,0.990585610695204,"O43447","Peptidyl-prolyl cis-trans isomerase H (PPIase H) (EC 5.2.1.8) (Rotamase H) (Small nuclear ribonucleoprotein particle-specific cyclophilin H) (CypH) (U-snRNP-associated cyclophilin SnuCyp-20) (USA-CYP)","Homo sapiens (Human)","mRNA splicing, via spliceosome [GO:0000398]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein-containing complex assembly [GO:0065003]","GO:0000398; GO:0000413; GO:0003755; GO:0005654; GO:0005681; GO:0005737; GO:0005829; GO:0006457; GO:0016018; GO:0016607; GO:0043021; GO:0043231; GO:0045070; GO:0046540; GO:0065003; GO:0071001"
"1220",1220,"Cluster_15726","Porites_evermani_scaffold_76:293987-294987",146,-20.13,2,20,750,772,19,"63.16%","73.68%","Peve_00040868",-0.992808637727421,0.0763943627206976,0.978262075707395,NA,NA,NA,NA,NA
"1221",1221,"Cluster_15726","Porites_evermani_scaffold_795:100981-101981",159,-24.29,2,21,931,954,21,"71.43%","76.19%","Peve_00041586",0.180382212775758,0.884533073293612,0.999448381576871,"P98133","Fibrillin-1 (MP340) [Cleaved into: Asprosin]","Bos taurus (Bovine)","activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; protein kinase A signaling [GO:0010737]","GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0008201; GO:0009653; GO:0010737; GO:0031012; GO:0034199; GO:0042593"
"1222",1222,"Cluster_15726","Porites_evermani_scaffold_80:571054-572054",157,-20.4,2,19,534,557,19,"73.68%","78.95%","Peve_00041756",-0.410174088176854,0.730935875372584,0.984754300351916,NA,NA,NA,NA,NA
"1223",1223,"Cluster_15726","Porites_evermani_scaffold_812:93563-94563",150,-20.81,2,20,25,50,22,"68.18%","68.18%","Peve_00042048",-0.93830384680926,0.224792965301889,0.978262075707395,"Q90416","Retinoic acid receptor RXR-gamma-A (Nuclear receptor subfamily 2 group B member 3-A) (Retinoic acid receptor RXR-alpha) (Retinoid X receptor alpha) (Retinoid X receptor gamma-A)","Danio rerio (Zebrafish) (Brachydanio rerio)","anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to retinoic acid [GO:0032526]; retinoic acid receptor signaling pathway [GO:0048384]","GO:0000978; GO:0003700; GO:0003707; GO:0004879; GO:0006357; GO:0008270; GO:0030154; GO:0032526; GO:0044323; GO:0045893; GO:0045944; GO:0048384; GO:0048856; GO:0090575"
"1224",1224,"Cluster_15726","Porites_evermani_scaffold_870:126539-127539",164,-20.49,2,21,582,603,19,"73.68%","78.95%","Peve_00043151",-0.201545589731732,0.870807161342948,0.997476741937264,NA,NA,NA,NA,NA
"1225",1225,"Cluster_15726","Porites_evermani_scaffold_88:22111-23111",147,-21.44,2,21,698,715,19,"68.42%","73.68%","Peve_00043322",-0.126982565545133,0.918941545656466,0.999448381576871,NA,NA,NA,NA,NA
"1226",1226,"Cluster_15726","Porites_evermani_scaffold_896:119418-120418",141,-20.01,2,18,440,459,16,"75.00%","75.00%","Peve_00043552",NA,NA,NA,NA,NA,NA,NA,NA
"1227",1227,"Cluster_15726","Porites_evermani_scaffold_900:71166-72166",154,-21.91,2,21,236,260,22,"68.18%","77.27%","Peve_00043769",NA,NA,NA,NA,NA,NA,NA,NA
"1228",1228,"Cluster_15726","Porites_evermani_scaffold_986:47990-48990",158,-20.18,2,19,287,308,17,"70.59%","82.35%","Peve_00045142",1,1.34157585525081e-08,8.89340150118664e-06,"O54991","Contactin-associated protein 1 (Caspr) (Caspr1) (MHDNIV) (NCP1) (Neurexin IV) (Neurexin-4) (Paranodin)","Mus musculus (Mouse)","axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; central nervous system myelination [GO:0022010]; cytoskeleton organization [GO:0007010]; mitochondrion organization [GO:0007005]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; neuromuscular junction development, skeletal muscle fiber [GO:0098529]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; neuronal action potential propagation [GO:0019227]; paranodal junction assembly [GO:0030913]; paranodal junction maintenance [GO:1990227]; postsynaptic density organization [GO:0097106]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; regulation of synapse maturation [GO:0090128]","GO:0002175; GO:0005886; GO:0005918; GO:0007005; GO:0007010; GO:0007155; GO:0007409; GO:0016020; GO:0017124; GO:0019227; GO:0022010; GO:0022011; GO:0030424; GO:0030913; GO:0031175; GO:0033010; GO:0033270; GO:0042552; GO:0043209; GO:0048786; GO:0048812; GO:0050884; GO:0050885; GO:0050905; GO:0071205; GO:0090128; GO:0097106; GO:0098529; GO:0098978; GO:1990227"
"1229",1229,"Cluster_15726","Porites_evermani_scaffold_993:101373-102373",143,-21.08,2,21,848,865,19,"63.16%","73.68%","Peve_00045273",NA,NA,NA,NA,NA,NA,NA,NA
"1230",1230,"Cluster_15890","Porites_evermani_scaffold_1010:86650-87650",168,-20.39,2,19,781,804,19,"84.21%","89.47%","Peve_00000412",0.23429561341924,0.849443275066069,0.995934364227446,"A7RWC9","Inosine triphosphate pyrophosphatase (ITPase) (Inosine triphosphatase) (EC 3.6.1.9) (Non-canonical purine NTP pyrophosphatase) (Non-standard purine NTP pyrophosphatase) (Nucleoside-triphosphate diphosphatase) (Nucleoside-triphosphate pyrophosphatase) (NTPase)","Nematostella vectensis (Starlet sea anemone)","deoxyribonucleoside triphosphate catabolic process [GO:0009204]; nucleoside triphosphate catabolic process [GO:0009143]; nucleotide metabolic process [GO:0009117]","GO:0000166; GO:0005737; GO:0009117; GO:0009143; GO:0009204; GO:0035870; GO:0036220; GO:0036222; GO:0046872; GO:0047429"
"1231",1231,"Cluster_15890","Porites_evermani_scaffold_108:217534-218534",153,-20.6,2,21,754,776,21,"66.67%","80.95%","Peve_00001440",0.983732922457672,0.114984785151745,0.978262075707395,"Q66I24","Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase)","Danio rerio (Zebrafish) (Brachydanio rerio)","arginine biosynthetic process [GO:0006526]; argininosuccinate metabolic process [GO:0000053]; urea cycle [GO:0000050]","GO:0000050; GO:0000053; GO:0004055; GO:0005524; GO:0005737; GO:0005829; GO:0006526"
"1232",1232,"Cluster_15890","Porites_evermani_scaffold_1375:68119-69119",155,-20.46,2,21,203,226,21,"61.90%","80.95%","Peve_00005836",-0.247304210829139,0.840910595324098,0.995934364227446,NA,NA,NA,NA,NA
"1233",1233,"Cluster_15890","Porites_evermani_scaffold_1432:51459-52459",166,-21.18,2,21,620,640,19,"78.95%","84.21%","Peve_00006655",0.332763029826944,0.784038153079039,0.994494823328836,"Q99MM4","TRAF-type zinc finger domain-containing protein 1 (Protein FLN29)","Rattus norvegicus (Rat)","negative regulation of innate immune response [GO:0045824]; response to cytokine [GO:0034097]","GO:0008270; GO:0034097; GO:0045824"
"1234",1234,"Cluster_15890","Porites_evermani_scaffold_1499:0-640",168,-20.99,2,21,342,363,19,"78.95%","78.95%","Peve_00007437",NA,NA,NA,NA,NA,NA,NA,NA
"1235",1235,"Cluster_15890","Porites_evermani_scaffold_1548:71038-72038",176,-20.71,2,21,307,328,19,"78.95%","89.47%","Peve_00008072",-0.998282282435782,0.0373192738625068,0.909359886114279,NA,NA,NA,NA,NA
"1236",1236,"Cluster_15890","Porites_evermani_scaffold_1603:56438-57438",166,-22.05,2,21,87,113,24,"75.00%","79.17%","Peve_00008869",-0.991389595527837,0.083602451242444,0.978262075707395,"A2VDD2","Dynein light chain Tctex-type 5-B (Tctex1 domain-containing protein 1-B)","Xenopus laevis (African clawed frog)","",""
"1237",1237,"Cluster_15890","Porites_evermani_scaffold_1687:85648-86648",174,-22.1,2,20,29,52,20,"80.00%","90.00%","Peve_00009833",-0.717386000418893,0.490676851506115,0.978262075707395,"Q86W24","NACHT, LRR and PYD domains-containing protein 14 (Nucleotide-binding oligomerization domain protein 5)","Homo sapiens (Human)","cell differentiation [GO:0030154]; regulation of inflammatory response [GO:0050727]; spermatogenesis [GO:0007283]","GO:0005524; GO:0005737; GO:0007283; GO:0030154; GO:0050727"
"1238",1238,"Cluster_15890","Porites_evermani_scaffold_17:422643-423643",166,-21.7,2,21,603,628,23,"73.91%","82.61%","Peve_00010035",NA,NA,NA,NA,NA,NA,NA,NA
"1239",1239,"Cluster_15890","Porites_evermani_scaffold_2078:18199-19199",166,-24.63,2,21,789,809,19,"78.95%","84.21%","Peve_00014316",NA,NA,NA,NA,NA,NA,NA,NA
"1240",1240,"Cluster_15890","Porites_evermani_scaffold_2151:28337-29337",158,-21.49,2,21,923,943,19,"68.42%","84.21%","Peve_00015085",NA,NA,NA,"Q80XJ3","Tetratricopeptide repeat protein 28 (TPR repeat protein 28)","Mus musculus (Mouse)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0005737; GO:0005813; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301; GO:0072686; GO:0097431; GO:1990023"
"1241",1241,"Cluster_15890","Porites_evermani_scaffold_236:11697-12697",143,-20.27,2,21,432,456,22,"54.55%","72.73%","Peve_00017079",-0.941289661119933,0.21923024041668,0.978262075707395,NA,NA,NA,NA,NA
"1242",1242,"Cluster_15890","Porites_evermani_scaffold_2445:5634-6634",170,-20.19,2,21,224,244,19,"78.95%","89.47%","Peve_00017900",NA,NA,NA,NA,NA,NA,NA,NA
"1243",1243,"Cluster_15890","Porites_evermani_scaffold_3064:31341-32341",171,-21.1,2,21,791,814,21,"76.19%","85.71%","Peve_00023092",NA,NA,NA,"Q6LAF1","Histone H4","Dendronephthya klunzingeri (Klunzinger's soft coral)","","GO:0000786; GO:0003677; GO:0005634; GO:0030527; GO:0046982"
"1244",1244,"Cluster_15890","Porites_evermani_scaffold_308:185983-186983",157,-20.21,2,21,858,877,19,"73.68%","78.95%","Peve_00023196",-0.598210868211844,0.591757025589993,0.978262075707395,NA,NA,NA,NA,NA
"1245",1245,"Cluster_15890","Porites_evermani_scaffold_324:83855-84855",167,-20.44,2,21,272,294,20,"70.00%","90.00%","Peve_00024250",-0.115092190156434,0.926567305973123,0.999448381576871,NA,NA,NA,NA,NA
"1246",1246,"Cluster_15890","Porites_evermani_scaffold_33:388041-389041",178,-26.53,2,21,968,988,19,"84.21%","94.74%","Peve_00024655",0.00695551967601385,0.995571942942319,0.999448381576871,"Q6DHU1","Lipid scramblase CLPTM1L (Cisplatin resistance-related protein 9) (CRR9p) (Cleft lip and palate transmembrane protein 1-like protein) (CLPTM1-like protein)","Danio rerio (Zebrafish) (Brachydanio rerio)","apoptotic process [GO:0006915]","GO:0005789; GO:0006915; GO:0012505; GO:0016020; GO:0017128"
"1247",1247,"Cluster_15890","Porites_evermani_scaffold_3458:21557-22557",160,-22,2,21,588,608,20,"75.00%","85.00%","Peve_00025652",NA,NA,NA,NA,NA,NA,NA,NA
"1248",1248,"Cluster_15890","Porites_evermani_scaffold_3580:20292-21292",168,-22.19,2,21,36,55,19,"84.21%","89.47%","Peve_00026425",-0.955142180995664,0.191404073062533,0.978262075707395,"Q9JKM7","Ras-related protein Rab-37","Mus musculus (Mouse)","protein transport [GO:0015031]","GO:0003924; GO:0005525; GO:0005768; GO:0005793; GO:0005794; GO:0015031; GO:0030141"
"1249",1249,"Cluster_15890","Porites_evermani_scaffold_3590:5484-6374",158,-21.53,2,21,307,332,23,"69.57%","78.26%","Peve_00026473",NA,NA,NA,NA,NA,NA,NA,NA
"1250",1250,"Cluster_15890","Porites_evermani_scaffold_365:204684-205490",167,-20.69,2,21,314,336,20,"80.00%","80.00%","Peve_00026828",0.281740123530276,0.818176797708046,0.995934364227446,NA,NA,NA,NA,NA
"1251",1251,"Cluster_15890","Porites_evermani_scaffold_3706:17807-18807",155,-20.12,2,21,298,320,20,"65.00%","80.00%","Peve_00027153",-0.906530850571203,0.277441571002595,0.978262075707395,"Q93104","Enhancer of rudimentary homolog","Aedes aegypti (Yellowfever mosquito) (Culex aegypti)","cell cycle [GO:0007049]","GO:0007049"
"1252",1252,"Cluster_15890","Porites_evermani_scaffold_404:144952-145952",167,-21.52,2,21,786,808,20,"75.00%","85.00%","Peve_00029041",-0.97500541854178,0.142635232099788,0.978262075707395,NA,NA,NA,NA,NA
"1253",1253,"Cluster_15890","Porites_evermani_scaffold_4434:7555-8555",156,-20.29,2,21,487,508,19,"63.16%","78.95%","Peve_00031150",-0.935162775453945,0.23050601799076,0.978262075707395,NA,NA,NA,NA,NA
"1254",1254,"Cluster_15890","Porites_evermani_scaffold_4583:11247-12247",172,-21.33,2,18,841,863,17,"88.24%","94.12%","Peve_00031806",NA,NA,NA,"B8VIU6","Uncharacterized skeletal organic matrix protein 5 (Uncharacterized SOMP-5)","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0005576"
"1255",1255,"Cluster_15890","Porites_evermani_scaffold_527:23187-24187",169,-25.21,2,21,102,123,20,"80.00%","90.00%","Peve_00034616",0.747668670843368,0.462346305392344,0.978262075707395,"P35555","Fibrillin-1 [Cleaved into: Asprosin]","Homo sapiens (Human)","activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; positive regulation of appetite [GO:0032100]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]","GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0009653; GO:0010737; GO:0030023; GO:0031012; GO:0032100; GO:0033627; GO:0034199; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0062023; GO:0071560; GO:1990314; GO:2001205"
"1256",1256,"Cluster_15890","Porites_evermani_scaffold_527:23187-24187",169,-25.21,2,21,585,606,20,"80.00%","90.00%","Peve_00034616",0.747668670843368,0.462346305392344,0.978262075707395,"P35555","Fibrillin-1 [Cleaved into: Asprosin]","Homo sapiens (Human)","activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; positive regulation of appetite [GO:0032100]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]","GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0009653; GO:0010737; GO:0030023; GO:0031012; GO:0032100; GO:0033627; GO:0034199; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0062023; GO:0071560; GO:1990314; GO:2001205"
"1257",1257,"Cluster_15890","Porites_evermani_scaffold_546:142675-143675",165,-20.32,2,21,613,634,20,"80.00%","85.00%","Peve_00035330",NA,NA,NA,NA,NA,NA,NA,NA
"1258",1258,"Cluster_15890","Porites_evermani_scaffold_571:154479-155479",166,-20.05,2,21,474,494,19,"78.95%","84.21%","Peve_00036157",-0.808254074687775,0.400825568226457,0.978262075707395,"Q6ZV73","FYVE, RhoGEF and PH domain-containing protein 6 (Zinc finger FYVE domain-containing protein 24)","Homo sapiens (Human)","actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]","GO:0001726; GO:0005085; GO:0005737; GO:0005794; GO:0005856; GO:0007010; GO:0008360; GO:0030027; GO:0030036; GO:0031267; GO:0043087; GO:0046847; GO:0046872"
"1259",1259,"Cluster_15890","Porites_evermani_scaffold_598:169891-170891",171,-24.31,2,21,772,794,20,"75.00%","90.00%","Peve_00036901",NA,NA,NA,NA,NA,NA,NA,NA
"1260",1260,"Cluster_15890","Porites_evermani_scaffold_6023:6830-7830",170,-20.33,2,21,575,595,19,"84.21%","84.21%","Peve_00037152",0.677051195992688,0.526515104123499,0.978262075707395,NA,NA,NA,NA,NA
"1261",1261,"Cluster_15890","Porites_evermani_scaffold_774:43227-44227",168,-20.96,2,21,642,663,19,"73.68%","84.21%","Peve_00041150",-0.958585626352153,0.18385735901931,0.978262075707395,"O57382","Tolloid-like protein 2 (EC 3.4.24.-) (Metalloprotease xolloid) (Xenopus tolloid)","Xenopus laevis (African clawed frog)","cell differentiation [GO:0030154]; proteolysis [GO:0006508]","GO:0004222; GO:0005509; GO:0005576; GO:0006508; GO:0008270; GO:0030154"
"1262",1262,"Cluster_15890","Porites_evermani_scaffold_99:336116-337116",173,-20.32,2,20,824,844,18,"88.89%","88.89%","Peve_00045230",NA,NA,NA,NA,NA,NA,NA,NA
"1263",1263,"Cluster_16498","Porites_evermani_scaffold_1012:121314-122314",168,-22.53,2,21,529,550,19,"68.42%","89.47%","Peve_00000438",-0.850921087235153,0.352088959245108,0.978262075707395,NA,NA,NA,NA,NA
"1264",1264,"Cluster_16498","Porites_evermani_scaffold_207:354765-355765",157,-20.78,2,21,968,987,19,"68.42%","84.21%","Peve_00014247",-0.995807797050779,0.0583133656312188,0.978262075707395,NA,NA,NA,NA,NA
"1265",1265,"Cluster_16498","Porites_evermani_scaffold_41:15168-16168",173,-21.12,2,21,919,940,20,"85.00%","90.00%","Peve_00029366",0.988258277618615,0.0976532922528349,0.978262075707395,"Q9D864","Actin-related protein 6 (mArp6)","Mus musculus (Mouse)","negative regulation of transcription by RNA polymerase I [GO:0016479]; nucleolus organization [GO:0007000]; positive regulation of transcription by RNA polymerase I [GO:0045943]; regulation of DNA-templated transcription [GO:0006355]","GO:0000786; GO:0000812; GO:0005634; GO:0005730; GO:0005737; GO:0005856; GO:0006355; GO:0007000; GO:0016479; GO:0031491; GO:0045943"
"1266",1266,"Cluster_16498","Porites_evermani_scaffold_450:247702-248702",173,-21.12,2,21,806,827,20,"85.00%","90.00%","Peve_00031492",NA,NA,NA,NA,NA,NA,NA,NA
"1267",1267,"Cluster_16498","Porites_evermani_scaffold_666:29924-30924",146,-20.18,2,21,107,138,29,"62.07%","65.52%","Peve_00038739",-0.802882647021429,0.406597074250561,0.978262075707395,NA,NA,NA,NA,NA
"1268",1268,"Cluster_16738","Porites_evermani_scaffold_1004:48516-49516",159,-20.93,2,21,43,65,20,"70.00%","80.00%","Peve_00000308",-0.278306847399115,0.82045357742443,0.995934364227446,"Q8CG08","Collagen triple helix repeat-containing protein 1","Rattus norvegicus (Rat)","cell migration [GO:0016477]; cochlea morphogenesis [GO:0090103]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein binding [GO:0032092]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0001649; GO:0005109; GO:0005581; GO:0005615; GO:0005737; GO:0016477; GO:0016528; GO:0017147; GO:0031012; GO:0032092; GO:0033687; GO:0033690; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0090090; GO:0090103; GO:0090177"
"1269",1269,"Cluster_16738","Porites_evermani_scaffold_1074:87139-88139",153,-20.86,2,19,681,708,23,"65.22%","73.91%","Peve_00001362",-0.824695561945853,0.382692909861748,0.978262075707395,NA,NA,NA,NA,NA
"1270",1270,"Cluster_16738","Porites_evermani_scaffold_1074:87139-88139",153,-20.86,2,19,897,924,23,"65.22%","73.91%","Peve_00001362",-0.824695561945853,0.382692909861748,0.978262075707395,NA,NA,NA,NA,NA
"1271",1271,"Cluster_16738","Porites_evermani_scaffold_110:67113-68113",162,-21.4,2,21,572,592,19,"68.42%","89.47%","Peve_00001848",-0.996140994862849,0.0559464533371032,0.978262075707395,NA,NA,NA,NA,NA
"1272",1272,"Cluster_16738","Porites_evermani_scaffold_117:132618-133618",170,-21.36,2,21,764,787,21,"76.19%","90.48%","Peve_00002854",-0.493765079118584,0.671240542455818,0.978262075707395,NA,NA,NA,NA,NA
"1273",1273,"Cluster_16738","Porites_evermani_scaffold_1222:42015-43015",167,-21.52,2,21,76,98,20,"75.00%","85.00%","Peve_00003713",NA,NA,NA,NA,NA,NA,NA,NA
"1274",1274,"Cluster_16738","Porites_evermani_scaffold_1223:120-1120",162,-21.05,2,19,459,480,17,"76.47%","82.35%","Peve_00003714",-0.493765079118584,0.671240542455818,0.978262075707395,"Q8AWD2","Adenylyltransferase and sulfurtransferase MOCS3 (Molybdenum cofactor synthesis protein 3) [Includes: Molybdopterin-synthase adenylyltransferase (EC 2.7.7.80) (Adenylyltransferase MOCS3) (Sulfur carrier protein MOCS2A adenylyltransferase); Molybdopterin-synthase sulfurtransferase (EC 2.8.1.11) (Sulfur carrier protein MOCS2A sulfurtransferase) (Sulfurtransferase MOCS3)]","Danio rerio (Zebrafish) (Brachydanio rerio)","Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble position uridine thiolation [GO:0002143]; tRNA wobble uridine modification [GO:0002098]","GO:0002098; GO:0002143; GO:0004792; GO:0005524; GO:0005737; GO:0005829; GO:0006777; GO:0016779; GO:0016783; GO:0032447; GO:0034227; GO:0042292; GO:0046872; GO:0061604; GO:0061605"
"1275",1275,"Cluster_16738","Porites_evermani_scaffold_1349:7276-8276",164,-20.61,2,21,194,215,19,"68.42%","84.21%","Peve_00005468",-0.506209111557797,0.662092790877516,0.978262075707395,NA,NA,NA,NA,NA
"1276",1276,"Cluster_16738","Porites_evermani_scaffold_137:245527-246527",174,-23.52,2,21,529,549,19,"84.21%","89.47%","Peve_00005770",NA,NA,NA,"Q9HFV1","Cytochrome b5","Rhizopus stolonifer (Rhizopus nigricans)","","GO:0005789; GO:0020037; GO:0046872"
"1277",1277,"Cluster_16738","Porites_evermani_scaffold_1433:98724-99724",161,-21.16,2,14,106,127,12,"91.67%","100.00%","Peve_00006658",NA,NA,NA,"Q9W6R5","Retinoschisin (X-linked juvenile retinoschisis protein homolog)","Takifugu rubripes (Japanese pufferfish) (Fugu rubripes)","cell adhesion [GO:0007155]; regulation of response to external stimulus [GO:0032101]; response to stimulus [GO:0050896]; visual perception [GO:0007601]","GO:0005576; GO:0005886; GO:0007155; GO:0007601; GO:0008289; GO:0032101; GO:0050896"
"1278",1278,"Cluster_16738","Porites_evermani_scaffold_1448:40237-41237",161,-23.71,2,14,365,386,12,"91.67%","100.00%","Peve_00006802",0.664422391453218,0.537355243461218,0.978262075707395,NA,NA,NA,NA,NA
"1279",1279,"Cluster_16738","Porites_evermani_scaffold_1477:48504-49504",167,-24.53,2,21,582,604,20,"75.00%","85.00%","Peve_00007165",-0.688931753875651,0.516159918803619,0.978262075707395,"Q5FWY3","Cytochrome c oxidase assembly factor 7B (Beta-lactamase hcp-like protein) (Sel1 repeat-containing protein 1B)","Xenopus laevis (African clawed frog)","","GO:0005758"
"1280",1280,"Cluster_16738","Porites_evermani_scaffold_1477:48568-49568",167,-24.53,2,21,518,540,20,"75.00%","85.00%","Peve_00007166",-0.170983831189362,0.890610822259042,0.999448381576871,"P27986","Phosphatidylinositol 3-kinase regulatory subunit alpha (PI3-kinase regulatory subunit alpha) (PI3K regulatory subunit alpha) (PtdIns-3-kinase regulatory subunit alpha) (Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha) (PI3-kinase subunit p85-alpha) (PtdIns-3-kinase regulatory subunit p85-alpha)","Homo sapiens (Human)","B cell differentiation [GO:0030183]; cellular glucose homeostasis [GO:0001678]; cellular response to insulin stimulus [GO:0032869]; cellular response to UV [GO:0034644]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; growth hormone receptor signaling pathway [GO:0060396]; immune response [GO:0006955]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; myeloid leukocyte migration [GO:0097529]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of stress fiber assembly [GO:0051497]; osteoclast differentiation [GO:0030316]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of glucose import [GO:0046326]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of RNA splicing [GO:0033120]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; response to endoplasmic reticulum stress [GO:0034976]; substrate adhesion-dependent cell spreading [GO:0034446]; T cell differentiation [GO:0030217]; transcription by RNA polymerase II [GO:0006366]","GO:0001678; GO:0001784; GO:0001953; GO:0002687; GO:0005068; GO:0005158; GO:0005159; GO:0005168; GO:0005634; GO:0005737; GO:0005801; GO:0005829; GO:0005886; GO:0005911; GO:0005942; GO:0005943; GO:0006366; GO:0006468; GO:0006606; GO:0006955; GO:0008286; GO:0008625; GO:0008630; GO:0010592; GO:0014065; GO:0016020; GO:0019903; GO:0030183; GO:0030217; GO:0030316; GO:0032760; GO:0032869; GO:0033120; GO:0034446; GO:0034644; GO:0034976; GO:0035014; GO:0036312; GO:0042307; GO:0043066; GO:0043125; GO:0043539; GO:0043548; GO:0043551; GO:0043559; GO:0043560; GO:0045671; GO:0045944; GO:0046326; GO:0046626; GO:0046854; GO:0046935; GO:0046982; GO:0048009; GO:0048471; GO:0050821; GO:0051491; GO:0051497; GO:0060396; GO:0097529; GO:0120183; GO:1900103; GO:1903078; GO:1990578"
"1281",1281,"Cluster_16738","Porites_evermani_scaffold_1481:91913-92913",157,-20.89,2,19,230,253,19,"73.68%","78.95%","Peve_00007246",-0.178514412335414,0.885741772508498,0.999448381576871,"Q60803","TNF receptor-associated factor 3 (EC 2.3.2.27) (CD40 receptor-associated factor 1) (CRAF1) (CD40-binding protein) (CD40BP) (RING-type E3 ubiquitin transferase TRAF3)","Mus musculus (Mouse)","apoptotic process [GO:0006915]; innate immune response [GO:0045087]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of JNK cascade [GO:0046330]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of cytokine production [GO:0001817]; regulation of defense response to virus [GO:0050688]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of interferon-beta production [GO:0032648]; regulation of proteolysis [GO:0030162]; Toll signaling pathway [GO:0008063]; toll-like receptor signaling pathway [GO:0002224]; tumor necrosis factor-mediated signaling pathway [GO:0033209]","GO:0001817; GO:0002224; GO:0005164; GO:0005739; GO:0005768; GO:0006915; GO:0008063; GO:0008270; GO:0009898; GO:0016740; GO:0019901; GO:0019903; GO:0030162; GO:0031625; GO:0031996; GO:0032088; GO:0032648; GO:0033209; GO:0035631; GO:0042802; GO:0042981; GO:0043122; GO:0045087; GO:0046330; GO:0050688; GO:0070534"
"1282",1282,"Cluster_16738","Porites_evermani_scaffold_1522:115932-116932",161,-20.31,2,14,320,341,12,"91.67%","100.00%","Peve_00007806",0.999974190676381,0.00457387578917121,0.54328949385489,NA,NA,NA,NA,NA
"1283",1283,"Cluster_16738","Porites_evermani_scaffold_157:362549-362829",164,-21.36,2,21,175,196,19,"68.42%","84.21%","Peve_00008343",NA,NA,NA,NA,NA,NA,NA,NA
"1284",1284,"Cluster_16738","Porites_evermani_scaffold_157:362549-363549",164,-21.36,2,21,175,196,19,"68.42%","84.21%","Peve_00008344",NA,NA,NA,NA,NA,NA,NA,NA
"1285",1285,"Cluster_16738","Porites_evermani_scaffold_1581:38522-39522",164,-20.06,2,18,288,311,18,"83.33%","83.33%","Peve_00008531",-0.506209111557797,0.662092790877516,0.978262075707395,NA,NA,NA,NA,NA
"1286",1286,"Cluster_16738","Porites_evermani_scaffold_159:302024-303024",162,-20.25,2,21,364,384,19,"78.95%","78.95%","Peve_00008637",-0.975579453534686,0.140981005148576,0.978262075707395,"P35486","Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial (EC 1.2.4.1) (PDHE1-A type I)","Mus musculus (Mouse)","acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glucose metabolic process [GO:0006006]; tricarboxylic acid cycle [GO:0006099]","GO:0004738; GO:0004739; GO:0005730; GO:0005739; GO:0005967; GO:0006006; GO:0006086; GO:0006099; GO:0034604; GO:0043209; GO:0045254; GO:1902494"
"1287",1287,"Cluster_16738","Porites_evermani_scaffold_1598:1123-2123",161,-20.31,2,14,319,340,12,"91.67%","100.00%","Peve_00008726",NA,NA,NA,NA,NA,NA,NA,NA
"1288",1288,"Cluster_16738","Porites_evermani_scaffold_1608:87361-88361",158,-20.12,2,21,685,711,24,"66.67%","79.17%","Peve_00008920",-0.493765079118584,0.671240542455818,0.978262075707395,"Q3U481","Major facilitator superfamily domain-containing protein 12 (Protein grizzled)","Mus musculus (Mouse)","carbohydrate transport [GO:0008643]; cysteine transmembrane transport [GO:1903712]; melanin biosynthetic process [GO:0042438]; negative regulation of melanin biosynthetic process [GO:0048022]; organic substance transport [GO:0071702]; pigment metabolic process involved in pigmentation [GO:0043474]; regulation of melanin biosynthetic process [GO:0048021]","GO:0005764; GO:0005765; GO:0005770; GO:0005886; GO:0008643; GO:0015293; GO:0033162; GO:0033229; GO:0042438; GO:0042470; GO:0043474; GO:0048021; GO:0048022; GO:0071702; GO:1903712"
"1289",1289,"Cluster_16738","Porites_evermani_scaffold_1632:61117-62117",168,-22.84,2,20,27,46,18,"83.33%","88.89%","Peve_00009217",NA,NA,NA,NA,NA,NA,NA,NA
"1290",1290,"Cluster_16738","Porites_evermani_scaffold_1635:95267-96267",171,-20.94,2,21,552,574,20,"75.00%","90.00%","Peve_00009245",NA,NA,NA,NA,NA,NA,NA,NA
"1291",1291,"Cluster_16738","Porites_evermani_scaffold_1651:110751-111751",160,-20.13,2,13,367,388,11,"100.00%","100.00%","Peve_00009437",-0.954723484117802,0.192302090868265,0.978262075707395,"O14981","TATA-binding protein-associated factor 172 (EC 3.6.4.-) (ATP-dependent helicase BTAF1) (B-TFIID transcription factor-associated 170 kDa subunit) (TAF(II)170) (TBP-associated factor 172) (TAF-172)","Homo sapiens (Human)","negative regulation of chromatin binding [GO:0035562]; negative regulation of DNA-templated transcription [GO:0045892]","GO:0003677; GO:0003712; GO:0004386; GO:0005524; GO:0005654; GO:0008094; GO:0016887; GO:0017025; GO:0035562; GO:0043231; GO:0045892; GO:0140658"
"1292",1292,"Cluster_16738","Porites_evermani_scaffold_1709:27009-28009",168,-20.04,2,21,831,852,19,"73.68%","84.21%","Peve_00010135",NA,NA,NA,NA,NA,NA,NA,NA
"1293",1293,"Cluster_16738","Porites_evermani_scaffold_183:139571-140571",159,-22.22,2,21,664,686,20,"70.00%","80.00%","Peve_00011502",-0.957682839919199,0.185864697525058,0.978262075707395,"Q28343","Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP)","Canis lupus familiaris (Dog) (Canis familiaris)","cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]","GO:0001501; GO:0005509; GO:0005540; GO:0005576; GO:0007155; GO:0007417; GO:0030246; GO:0031012"
"1294",1294,"Cluster_16738","Porites_evermani_scaffold_1859:5382-6382",159,-21.28,2,21,162,184,20,"70.00%","80.00%","Peve_00011783",-0.66872574898418,0.533680071990296,0.978262075707395,NA,NA,NA,NA,NA
"1295",1295,"Cluster_16738","Porites_evermani_scaffold_191:316724-317724",159,-22.94,2,21,910,932,20,"70.00%","80.00%","Peve_00012408",0.442912233946915,0.707890652501274,0.978262075707395,"Q7Z7E8","Ubiquitin-conjugating enzyme E2 Q1 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme Q1) (Protein NICE-5) (Ubiquitin carrier protein Q1) (Ubiquitin-protein ligase Q1)","Homo sapiens (Human)","embryo implantation [GO:0007566]; fertilization [GO:0009566]; mating behavior [GO:0007617]; prolactin secretion [GO:0070459]; protein polyubiquitination [GO:0000209]; reproductive system development [GO:0061458]; suckling behavior [GO:0001967]","GO:0000209; GO:0001967; GO:0005524; GO:0005634; GO:0005829; GO:0007566; GO:0007617; GO:0009566; GO:0030175; GO:0061458; GO:0061631; GO:0070459"
"1296",1296,"Cluster_16738","Porites_evermani_scaffold_196:288795-289795",162,-20.89,2,21,117,141,22,"72.73%","81.82%","Peve_00012932",-0.745504015603163,0.464417685195864,0.978262075707395,NA,NA,NA,NA,NA
"1297",1297,"Cluster_16738","Porites_evermani_scaffold_2068:27000-28000",167,-21.93,2,20,836,857,18,"72.22%","88.89%","Peve_00014214",NA,NA,NA,"Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"1298",1298,"Cluster_16738","Porites_evermani_scaffold_2285:25203-26203",157,-20.36,2,21,615,637,21,"76.19%","76.19%","Peve_00016353",-0.493765079118584,0.671240542455818,0.978262075707395,NA,NA,NA,NA,NA
"1299",1299,"Cluster_16738","Porites_evermani_scaffold_2291:66962-67962",159,-20.86,2,18,343,366,18,"77.78%","88.89%","Peve_00016417",-0.956467675355095,0.188533818948305,0.978262075707395,"Q8K0H1","Multidrug and toxin extrusion protein 1 (MATE-1) (mMATE-1) (Solute carrier family 47 member 1)","Mus musculus (Mouse)","cation transmembrane transport [GO:0098655]; cation transport [GO:0006812]; L-arginine import across plasma membrane [GO:0097638]; organic cation transport [GO:0015695]; putrescine transport [GO:0015847]; transmembrane transport [GO:0055085]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transmembrane transport [GO:0006855]","GO:0005886; GO:0006812; GO:0006855; GO:0015101; GO:0015179; GO:0015234; GO:0015297; GO:0015299; GO:0015489; GO:0015695; GO:0015847; GO:0016020; GO:0016323; GO:0016324; GO:0022857; GO:0031982; GO:0042887; GO:0042910; GO:0055085; GO:0061459; GO:0097638; GO:0098655; GO:1990961"
"1300",1300,"Cluster_16738","Porites_evermani_scaffold_23:139901-140901",165,-20.27,2,20,713,733,18,"83.33%","83.33%","Peve_00016528",-0.433951435559481,0.714237879477248,0.979909465515968,NA,NA,NA,NA,NA
"1301",1301,"Cluster_16738","Porites_evermani_scaffold_23:33576-34406",146,-21.24,2,21,497,522,23,"65.22%","69.57%","Peve_00016531",NA,NA,NA,NA,NA,NA,NA,NA
"1302",1302,"Cluster_16738","Porites_evermani_scaffold_236:238201-239201",167,-22.42,2,21,854,877,21,"71.43%","85.71%","Peve_00017095",-0.506209111557797,0.662092790877516,0.978262075707395,NA,NA,NA,NA,NA
"1303",1303,"Cluster_16738","Porites_evermani_scaffold_2371:24055-25055",167,-23.23,2,21,865,889,22,"72.73%","81.82%","Peve_00017179",-0.959449643200581,0.181916068189621,0.978262075707395,NA,NA,NA,NA,NA
"1304",1304,"Cluster_16738","Porites_evermani_scaffold_2384:14845-15845",144,-24.15,2,21,501,531,28,"67.86%","67.86%","Peve_00017282",NA,NA,NA,NA,NA,NA,NA,NA
"1305",1305,"Cluster_16738","Porites_evermani_scaffold_2445:74389-75087",168,-23.63,2,21,110,131,19,"73.68%","84.21%","Peve_00017903",-0.710569561756357,0.496874718329255,0.978262075707395,"Q7SIA2","Bifunctional glutamate/proline--tRNA ligase (Bifunctional aminoacyl-tRNA synthetase) [Includes: Glutamate--tRNA ligase (EC 6.1.1.17) (Glutamyl-tRNA synthetase) (GluRS); Proline--tRNA ligase (EC 6.1.1.15) (Prolyl-tRNA synthetase) (ProRS)]","Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)","cellular response to insulin stimulus [GO:0032869]; cellular response to type II interferon [GO:0071346]; glutamyl-tRNA aminoacylation [GO:0006424]; negative regulation of translation [GO:0017148]; prolyl-tRNA aminoacylation [GO:0006433]; regulation of long-chain fatty acid import into cell [GO:0140212]","GO:0004818; GO:0004827; GO:0005524; GO:0005829; GO:0005886; GO:0006424; GO:0006433; GO:0008270; GO:0017101; GO:0017148; GO:0032869; GO:0035613; GO:0042803; GO:0051020; GO:0071346; GO:0097452; GO:0140212; GO:1990904"
"1306",1306,"Cluster_16738","Porites_evermani_scaffold_2459:21706-22706",171,-20.94,2,21,553,575,20,"75.00%","90.00%","Peve_00018008",-0.756073070895817,0.454230879201291,0.978262075707395,NA,NA,NA,NA,NA
"1307",1307,"Cluster_16738","Porites_evermani_scaffold_2462:26305-27305",159,-22.51,2,21,779,803,22,"68.18%","77.27%","Peve_00018043",NA,NA,NA,NA,NA,NA,NA,NA
"1308",1308,"Cluster_16738","Porites_evermani_scaffold_247:17265-18192",163,-21.65,2,21,659,681,20,"70.00%","85.00%","Peve_00018095",-0.506209111557797,0.662092790877516,0.978262075707395,NA,NA,NA,NA,NA
"1309",1309,"Cluster_16738","Porites_evermani_scaffold_2588:3657-4657",176,-22.77,2,21,748,769,19,"78.95%","89.47%","Peve_00019121",0.580136096286649,0.605998716713512,0.978262075707395,NA,NA,NA,NA,NA
"1310",1310,"Cluster_16738","Porites_evermani_scaffold_260:288386-289386",179,-21.31,2,20,162,183,18,"88.89%","88.89%","Peve_00019292",NA,NA,NA,NA,NA,NA,NA,NA
"1311",1311,"Cluster_16738","Porites_evermani_scaffold_2714:5418-6418",161,-21.83,2,14,340,361,12,"91.67%","100.00%","Peve_00020218",-0.833305914864995,0.372890573708838,0.978262075707395,"P51029","Protein Wnt-8b","Danio rerio (Zebrafish) (Brachydanio rerio)","canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; commissural neuron axon guidance [GO:0071679]; embryonic pattern specification [GO:0009880]; eye development [GO:0001654]; eye field cell fate commitment involved in camera-type eye formation [GO:0060898]; forebrain development [GO:0030900]; forebrain neuron differentiation [GO:0021879]; hypothalamus development [GO:0021854]; negative regulation of anterior neural cell fate commitment of the neural plate by Wnt signaling pathway [GO:0022002]; neuron differentiation [GO:0030182]; otic placode formation [GO:0043049]; sensory epithelium regeneration [GO:0070654]","GO:0001654; GO:0005109; GO:0005125; GO:0005615; GO:0009880; GO:0021854; GO:0021879; GO:0022002; GO:0030182; GO:0030900; GO:0043049; GO:0045165; GO:0060070; GO:0060898; GO:0070654; GO:0071679"
"1312",1312,"Cluster_16738","Porites_evermani_scaffold_271:65743-66743",166,-23.1,2,21,504,524,19,"73.68%","89.47%","Peve_00020170",-0.390144307674076,0.744850233968888,0.987285179593076,NA,NA,NA,NA,NA
"1313",1313,"Cluster_16738","Porites_evermani_scaffold_272:38236-39236",163,-20.1,2,21,789,811,20,"75.00%","80.00%","Peve_00020251",-0.916718344715992,0.261656160452949,0.978262075707395,NA,NA,NA,NA,NA
"1314",1314,"Cluster_16738","Porites_evermani_scaffold_2724:63988-64988",163,-21.95,2,21,651,673,20,"75.00%","80.00%","Peve_00020296",0.945628904462826,0.210895266490952,0.978262075707395,"Q8NCC3","Phospholipase A2 group XV (1-O-acylceramide synthase) (ACS) (LCAT-like lysophospholipase) (LLPL) (EC 3.1.1.5) (Lysophospholipase 3) (Lysosomal phospholipase A and acyltransferase) (EC 2.3.1.-, EC 3.1.1.32, EC 3.1.1.4) (Lysosomal phospholipase A2) (LPLA2)","Homo sapiens (Human)","ceramide metabolic process [GO:0006672]; diacylglycerol biosynthetic process [GO:0006651]; fatty acid catabolic process [GO:0009062]; glycerophospholipid metabolic process [GO:0006650]; lipid metabolic process [GO:0006629]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylcholine metabolic process [GO:0046470]; phosphatidylethanolamine catabolic process [GO:0046338]; phosphatidylglycerol metabolic process [GO:0046471]; phosphatidylserine metabolic process [GO:0006658]; phospholipid metabolic process [GO:0006644]","GO:0004622; GO:0005543; GO:0005576; GO:0005615; GO:0005654; GO:0005764; GO:0006629; GO:0006644; GO:0006650; GO:0006651; GO:0006658; GO:0006672; GO:0008270; GO:0008374; GO:0008970; GO:0009062; GO:0016020; GO:0016411; GO:0034638; GO:0043231; GO:0046338; GO:0046470; GO:0046471; GO:0047499; GO:0052739; GO:0052740; GO:0070062; GO:0102545"
"1315",1315,"Cluster_16738","Porites_evermani_scaffold_2986:40948-41948",163,-21.27,2,16,762,783,14,"85.71%","92.86%","Peve_00022325",-0.506209111557797,0.662092790877516,0.978262075707395,NA,NA,NA,NA,NA
"1316",1316,"Cluster_16738","Porites_evermani_scaffold_3088:49105-50105",168,-21.22,2,21,433,454,19,"73.68%","84.21%","Peve_00023252",-0.435550565980176,0.713107417561965,0.979677936019447,"Q6DH23","Vacuolar protein sorting-associated protein 26B-like (Vesicle protein sorting 26B-like)","Danio rerio (Zebrafish) (Brachydanio rerio)","intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147]","GO:0005768; GO:0005829; GO:0006886; GO:0030904; GO:0042147"
"1317",1317,"Cluster_16738","Porites_evermani_scaffold_3305:12534-13534",159,-21.43,2,21,388,410,20,"75.00%","75.00%","Peve_00024698",-0.679489353211111,0.524402753571037,0.978262075707395,NA,NA,NA,NA,NA
"1318",1318,"Cluster_16738","Porites_evermani_scaffold_3350:38651-39641",161,-20.14,2,21,443,462,19,"78.95%","78.95%","Peve_00024989",-0.50074413499795,0.666119513345017,0.978262075707395,NA,NA,NA,NA,NA
"1319",1319,"Cluster_16738","Porites_evermani_scaffold_3452:31198-32198",147,-20.39,2,21,289,311,20,"65.00%","70.00%","Peve_00025626",-0.506209111557797,0.662092790877516,0.978262075707395,NA,NA,NA,NA,NA
"1320",1320,"Cluster_16738","Porites_evermani_scaffold_3585:41327-42247",163,-20.79,2,20,837,858,18,"77.78%","77.78%","Peve_00026442",-0.493765079118584,0.671240542455818,0.978262075707395,"O95428","Papilin","Homo sapiens (Human)","extracellular matrix organization [GO:0030198]; negative regulation of peptidase activity [GO:0010466]","GO:0004222; GO:0004867; GO:0005576; GO:0010466; GO:0030198; GO:0031012"
"1321",1321,"Cluster_16738","Porites_evermani_scaffold_379:225750-226750",154,-20.22,2,21,755,772,19,"78.95%","78.95%","Peve_00027540",-0.891663367451407,0.299077612991479,0.978262075707395,"Q9BXI6","TBC1 domain family member 10A (EBP50-PDX interactor of 64 kDa) (EPI64 protein) (Rab27A-GAP-alpha)","Homo sapiens (Human)","activation of cysteine-type endopeptidase activity [GO:0097202]; activation of GTPase activity [GO:0090630]; positive regulation of proteolysis [GO:0045862]; retrograde transport, endosome to Golgi [GO:0042147]","GO:0005085; GO:0005096; GO:0005829; GO:0005886; GO:0005902; GO:0030165; GO:0042147; GO:0045296; GO:0045862; GO:0070062; GO:0090630; GO:0097202"
"1322",1322,"Cluster_16738","Porites_evermani_scaffold_3828:20577-21577",162,-22.47,2,21,828,851,21,"76.19%","80.95%","Peve_00027781",-0.506209111557797,0.662092790877516,0.978262075707395,NA,NA,NA,NA,NA
"1323",1323,"Cluster_16738","Porites_evermani_scaffold_41:707336-708336",163,-20.07,2,21,819,841,20,"75.00%","80.00%","Peve_00029352",-0.400815311815599,0.737453806056788,0.986473912706683,NA,NA,NA,NA,NA
"1324",1324,"Cluster_16738","Porites_evermani_scaffold_4203:6482-7482",159,-21.12,2,21,727,750,21,"71.43%","76.19%","Peve_00029899",-0.799146579187486,0.410570180289141,0.978262075707395,NA,NA,NA,NA,NA
"1325",1325,"Cluster_16738","Porites_evermani_scaffold_422:89585-90585",166,-22.03,2,19,380,401,17,"82.35%","82.35%","Peve_00029986",-0.506209111557797,0.662092790877516,0.978262075707395,NA,NA,NA,NA,NA
"1326",1326,"Cluster_16738","Porites_evermani_scaffold_431:267015-268015",161,-21.47,2,21,584,607,22,"77.27%","77.27%","Peve_00030497",0.0360337962976972,0.977055205590136,0.999448381576871,"O97490","Melanotransferrin (Membrane-bound transferrin-like protein p97) (CD antigen CD228)","Oryctolagus cuniculus (Rabbit)","ion transport [GO:0006811]; iron ion homeostasis [GO:0055072]","GO:0005615; GO:0005886; GO:0006811; GO:0046872; GO:0055072"
"1327",1327,"Cluster_16738","Porites_evermani_scaffold_43:248981-249981",153,-22.31,2,21,122,147,24,"66.67%","75.00%","Peve_00030430",NA,NA,NA,NA,NA,NA,NA,NA
"1328",1328,"Cluster_16738","Porites_evermani_scaffold_4334:18179-19085",155,-20.98,2,19,578,599,18,"77.78%","83.33%","Peve_00030607",-0.506209111557797,0.662092790877516,0.978262075707395,NA,NA,NA,NA,NA
"1329",1329,"Cluster_16738","Porites_evermani_scaffold_457:98477-99477",168,-22.84,2,20,479,498,18,"83.33%","88.89%","Peve_00031742",NA,NA,NA,NA,NA,NA,NA,NA
"1330",1330,"Cluster_16738","Porites_evermani_scaffold_4712:3111-4111",149,-21.87,2,21,168,191,22,"68.18%","72.73%","Peve_00032394",0.0137187780367586,0.991266080673441,0.999448381576871,"Q9C098","Serine/threonine-protein kinase DCLK3 (EC 2.7.11.1) (Doublecortin domain-containing protein 3C) (Doublecortin-like and CAM kinase-like 3) (Doublecortin-like kinase 3)","Homo sapiens (Human)","peptidyl-serine phosphorylation [GO:0018105]","GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0018105; GO:0106310"
"1331",1331,"Cluster_16738","Porites_evermani_scaffold_524:196655-197655",154,-20.06,2,20,972,989,18,"77.78%","77.78%","Peve_00034532",-0.977958032939804,0.133912545063329,0.978262075707395,NA,NA,NA,NA,NA
"1332",1332,"Cluster_16738","Porites_evermani_scaffold_5:288074-289072",156,-20.36,2,13,532,553,11,"90.91%","100.00%","Peve_00033590",-0.815059839364272,0.393408010013989,0.978262075707395,NA,NA,NA,NA,NA
"1333",1333,"Cluster_16738","Porites_evermani_scaffold_5:288074-289072",156,-20.36,2,13,532,553,11,"90.91%","100.00%","Peve_00033591",-0.214958993041799,0.862076427458138,0.996660710141104,"P49165","60S ribosomal protein L4 (L1)","Urechis caupo (Innkeeper worm) (Spoonworm)","translation [GO:0006412]","GO:0003735; GO:0005840; GO:0006412; GO:1990904"
"1334",1334,"Cluster_16738","Porites_evermani_scaffold_532:92889-93889",149,-22.9,2,21,472,500,26,"65.38%","73.08%","Peve_00034825",-0.368285600671082,0.759889726347841,0.988260417653373,"E7FAM5","E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71)","Danio rerio (Zebrafish) (Brachydanio rerio)","embryonic body morphogenesis [GO:0010172]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA metabolic process [GO:0010586]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of translation [GO:0017148]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of miRNA-mediated gene silencing [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089]","GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0010172; GO:0010586; GO:0017148; GO:0021915; GO:0030371; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0060964; GO:0061630; GO:0072089; GO:2000177"
"1335",1335,"Cluster_16738","Porites_evermani_scaffold_53:542460-543460",154,-20.16,2,21,756,776,19,"73.68%","73.68%","Peve_00034715",-0.506209111557797,0.662092790877516,0.978262075707395,NA,NA,NA,NA,NA
"1336",1336,"Cluster_16738","Porites_evermani_scaffold_5578:3001-4001",170,-22.46,2,19,484,505,17,"82.35%","88.24%","Peve_00035727",0.882835690836012,0.311262820151934,0.978262075707395,NA,NA,NA,NA,NA
"1337",1337,"Cluster_16738","Porites_evermani_scaffold_558:20855-21855",158,-20.12,2,21,947,973,24,"66.67%","79.17%","Peve_00035729",NA,NA,NA,"Q13077","TNF receptor-associated factor 1 (Epstein-Barr virus-induced protein 6)","Homo sapiens (Human)","apoptotic process [GO:0006915]; positive regulation of JNK cascade [GO:0046330]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein K63-linked ubiquitination [GO:0070534]; protein-containing complex assembly [GO:0065003]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; tumor necrosis factor-mediated signaling pathway [GO:0033209]","GO:0005164; GO:0005737; GO:0005829; GO:0006915; GO:0008270; GO:0009898; GO:0031625; GO:0031996; GO:0033209; GO:0042802; GO:0043122; GO:0046330; GO:0051092; GO:0065003; GO:0070534; GO:2001236"
"1338",1338,"Cluster_16738","Porites_evermani_scaffold_5684:5054-5689",154,-20.47,2,21,483,503,19,"68.42%","78.95%","Peve_00036032",-0.833141590828567,0.373079767288071,0.978262075707395,NA,NA,NA,NA,NA
"1339",1339,"Cluster_16738","Porites_evermani_scaffold_6041:1168-2168",154,-20.06,2,20,972,989,18,"77.78%","77.78%","Peve_00037188",-0.927161183197245,0.244482970091227,0.978262075707395,NA,NA,NA,NA,NA
"1340",1340,"Cluster_16738","Porites_evermani_scaffold_64:193301-194301",169,-20.46,2,20,166,186,18,"83.33%","88.89%","Peve_00038135",-0.981091717211122,0.123996053681244,0.978262075707395,"P49013","Fibropellin-3 (Epidermal growth factor-related protein 3) (Fibropellin III) (Fibropellin-c) (SpEGF III)","Strongylocentrotus purpuratus (Purple sea urchin)","","GO:0005509; GO:0005615; GO:0009374"
"1341",1341,"Cluster_16738","Porites_evermani_scaffold_65:129624-130355",183,-27.87,2,21,399,421,20,"85.00%","95.00%","Peve_00038377",-0.0714500716792706,0.954474680140664,0.999448381576871,NA,NA,NA,NA,NA
"1342",1342,"Cluster_16738","Porites_evermani_scaffold_651:30917-31917",168,-21.48,2,21,420,441,19,"73.68%","84.21%","Peve_00038431",-0.0816629885075562,0.947953769135285,0.999448381576871,NA,NA,NA,NA,NA
"1343",1343,"Cluster_16738","Porites_evermani_scaffold_6:631607-632607",170,-21.8,2,21,43,66,21,"80.95%","85.71%","Peve_00036960",-0.520153842378911,0.651749205496979,0.978262075707395,"D3Z3C6","AN1-type zinc finger protein 4 (AN1-type zinc finger and ubiquitin domain-containing protein-like 1)","Mus musculus (Mouse)","","GO:0008270"
"1344",1344,"Cluster_16738","Porites_evermani_scaffold_677:201870-202870",167,-20.99,2,20,739,760,18,"72.22%","88.89%","Peve_00038982",-0.506209111557797,0.662092790877516,0.978262075707395,NA,NA,NA,NA,NA
"1345",1345,"Cluster_16738","Porites_evermani_scaffold_698:73711-74711",192,-34.42,2,21,670,691,19,"94.74%","94.74%","Peve_00039487",-0.376305224184251,0.754388814953098,0.988219883885475,NA,NA,NA,NA,NA
"1346",1346,"Cluster_16738","Porites_evermani_scaffold_703:42041-43041",167,-20.64,2,16,200,221,14,"92.86%","92.86%","Peve_00039683",NA,NA,NA,NA,NA,NA,NA,NA
"1347",1347,"Cluster_16738","Porites_evermani_scaffold_710:121294-122294",192,-34.42,2,21,497,518,19,"94.74%","94.74%","Peve_00039841",NA,NA,NA,NA,NA,NA,NA,NA
"1348",1348,"Cluster_16738","Porites_evermani_scaffold_764:63399-64399",159,-21.2,2,21,375,397,20,"70.00%","80.00%","Peve_00040966",-0.881137638349994,0.313556644313467,0.978262075707395,NA,NA,NA,NA,NA
"1349",1349,"Cluster_16738","Porites_evermani_scaffold_863:139348-140348",166,-24.18,2,21,337,357,19,"78.95%","84.21%","Peve_00043030",-0.624426565682741,0.570665430374418,0.978262075707395,NA,NA,NA,NA,NA
"1350",1350,"Cluster_16738","Porites_evermani_scaffold_968:114390-115390",168,-20.64,2,18,979,1000,17,"88.24%","88.24%","Peve_00044865",-0.506209111557797,0.662092790877516,0.978262075707395,NA,NA,NA,NA,NA
"1351",1351,"Cluster_16738","Porites_evermani_scaffold_997:95498-96498",164,-20.53,2,21,741,762,19,"68.42%","84.21%","Peve_00045329",0.995802589559509,0.0583495977427045,0.978262075707395,NA,NA,NA,NA,NA
"1352",1352,"Cluster_2787","Porites_evermani_scaffold_102:224866-225866",172,-26.17,2,21,746,767,19,"78.95%","84.21%","Peve_00000541",NA,NA,NA,NA,NA,NA,NA,NA
"1353",1353,"Cluster_2787","Porites_evermani_scaffold_103:265240-266240",149,-20.12,2,20,546,569,20,"70.00%","75.00%","Peve_00000691",-0.567239649993248,0.616022648987077,0.978262075707395,"Q96CG8","Collagen triple helix repeat-containing protein 1","Homo sapiens (Human)","cell migration [GO:0016477]; cochlea morphogenesis [GO:0090103]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein binding [GO:0032092]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0001649; GO:0005109; GO:0005576; GO:0005581; GO:0005615; GO:0016477; GO:0016528; GO:0017147; GO:0032092; GO:0033687; GO:0033690; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0062023; GO:0090090; GO:0090103; GO:0090177"
"1354",1354,"Cluster_2787","Porites_evermani_scaffold_1048:142615-143615",165,-22.98,2,18,699,720,16,"81.25%","87.50%","Peve_00000965",0.952863406871599,0.196243410425031,0.978262075707395,"Q8K0U4","Heat shock 70 kDa protein 12A","Mus musculus (Mouse)","","GO:0005524; GO:0005634; GO:0005737"
"1355",1355,"Cluster_2787","Porites_evermani_scaffold_1055:68035-69035",164,-20.83,2,18,220,242,17,"82.35%","88.24%","Peve_00001077",-0.44194333058229,0.708578453847085,0.978276164944041,"Q6PCS6","Mitochondrial fission process protein 1 (Mitochondrial 18 kDa protein) (MTP18)","Danio rerio (Zebrafish) (Brachydanio rerio)","apoptotic process [GO:0006915]; mitochondrial fission [GO:0000266]","GO:0000266; GO:0005739; GO:0005743; GO:0006915"
"1356",1356,"Cluster_2787","Porites_evermani_scaffold_1071:25544-26544",153,-20.2,2,21,263,282,19,"68.42%","78.95%","Peve_00001326",-0.00887821256988511,0.994347880080551,0.999448381576871,"Q505F5","Leucine-rich repeat-containing protein 47","Mus musculus (Mouse)","phenylalanyl-tRNA aminoacylation [GO:0006432]","GO:0003723; GO:0004826; GO:0006432"
"1357",1357,"Cluster_2787","Porites_evermani_scaffold_107:317371-318371",171,-22.59,2,21,322,345,21,"80.95%","80.95%","Peve_00001298",-0.806272583110139,0.402962943630487,0.978262075707395,NA,NA,NA,NA,NA
"1358",1358,"Cluster_2787","Porites_evermani_scaffold_108:504907-505907",168,-23.92,2,17,558,579,15,"86.67%","93.33%","Peve_00001459",0.550272990789127,0.629047296747058,0.978262075707395,"A4IHH4","Surfeit locus protein 1","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","mitochondrial cytochrome c oxidase assembly [GO:0033617]","GO:0005743; GO:0033617"
"1359",1359,"Cluster_2787","Porites_evermani_scaffold_1089:3998-4998",162,-24.87,2,21,4,27,21,"76.19%","80.95%","Peve_00001575",NA,NA,NA,NA,NA,NA,NA,NA
"1360",1360,"Cluster_2787","Porites_evermani_scaffold_11:1043996-1044996",147,-21.41,2,21,660,682,20,"55.00%","80.00%","Peve_00001801",NA,NA,NA,NA,NA,NA,NA,NA
"1361",1361,"Cluster_2787","Porites_evermani_scaffold_11:1056805-1057805",159,-26.18,2,21,269,291,20,"65.00%","85.00%","Peve_00001804",NA,NA,NA,NA,NA,NA,NA,NA
"1362",1362,"Cluster_2787","Porites_evermani_scaffold_1119:128135-129135",147,-23.15,2,21,788,811,21,"61.90%","71.43%","Peve_00002133",0.52527581733883,0.647924300039023,0.978262075707395,"Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"1363",1363,"Cluster_2787","Porites_evermani_scaffold_1169:11348-12348",153,-20.34,2,21,564,588,22,"72.73%","77.27%","Peve_00002838",0.759029426139321,0.451347680073997,0.978262075707395,"Q9D8V7","Signal peptidase complex catalytic subunit SEC11C (EC 3.4.21.89) (Microsomal signal peptidase 21 kDa subunit) (SPase 21 kDa subunit) (SEC11 homolog C) (SEC11-like protein 3) (SPC21)","Mus musculus (Mouse)","signal peptide processing [GO:0006465]","GO:0004252; GO:0005787; GO:0006465; GO:0008233"
"1364",1364,"Cluster_2787","Porites_evermani_scaffold_1178:5029-6029",148,-20.71,2,21,612,633,19,"57.89%","73.68%","Peve_00002980",NA,NA,NA,NA,NA,NA,NA,NA
"1365",1365,"Cluster_2787","Porites_evermani_scaffold_1182:2593-3528",145,-20.68,2,21,521,548,26,"61.54%","69.23%","Peve_00003065",-0.802504185597196,0.407001063738318,0.978262075707395,NA,NA,NA,NA,NA
"1366",1366,"Cluster_2787","Porites_evermani_scaffold_1182:2593-3528",145,-20.68,2,21,521,548,26,"61.54%","69.23%","Peve_00003069",0.92792535123365,0.24318121578267,0.978262075707395,NA,NA,NA,NA,NA
"1367",1367,"Cluster_2787","Porites_evermani_scaffold_1195:1672-2672",163,-21.27,2,21,719,741,20,"65.00%","90.00%","Peve_00003247",0.77921107052756,0.431240017629997,0.978262075707395,"Q6L8S8","Beta-1,4-N-acetylgalactosaminyltransferase 3 (Beta4GalNAc-T3) (Beta4GalNAcT3) (EC 2.4.1.244) (Beta-1,4-N-acetylgalactosaminyltransferase III) (N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 2) (NGalNAc-T2)","Mus musculus (Mouse)","chondroitin sulfate biosynthetic process [GO:0030206]","GO:0005794; GO:0008376; GO:0030206; GO:0032580; GO:0033842; GO:0043231; GO:0047238"
"1368",1368,"Cluster_2787","Porites_evermani_scaffold_1207:53949-54949",155,-23.31,2,21,720,743,21,"66.67%","76.19%","Peve_00003496",NA,NA,NA,NA,NA,NA,NA,NA
"1369",1369,"Cluster_2787","Porites_evermani_scaffold_1210:103503-104503",158,-22.37,2,21,180,200,19,"68.42%","84.21%","Peve_00003559",0.905476298311258,0.279027677561973,0.978262075707395,"Q5ZLK1","DDB1- and CUL4-associated factor 13 (WD repeat and SOF domain-containing protein 1)","Gallus gallus (Chicken)","maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; protein ubiquitination [GO:0016567]","GO:0000462; GO:0005730; GO:0016567; GO:0032040; GO:0080008"
"1370",1370,"Cluster_2787","Porites_evermani_scaffold_124:338774-339774",149,-20.26,2,20,630,654,21,"71.43%","71.43%","Peve_00003935",NA,NA,NA,NA,NA,NA,NA,NA
"1371",1371,"Cluster_2787","Porites_evermani_scaffold_126:287008-288008",166,-26.8,2,21,278,298,19,"73.68%","89.47%","Peve_00004194",NA,NA,NA,NA,NA,NA,NA,NA
"1372",1372,"Cluster_2787","Porites_evermani_scaffold_1267:35724-36724",171,-25.61,2,21,236,258,20,"80.00%","85.00%","Peve_00004299",0.87678174369702,0.319371656695877,0.978262075707395,NA,NA,NA,NA,NA
"1373",1373,"Cluster_2787","Porites_evermani_scaffold_12:842288-843288",168,-24.53,2,21,816,837,19,"68.42%","89.47%","Peve_00003349",0.712363839995426,0.495249213754251,0.978262075707395,"Q0VC84","Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 (EC 2.4.1.122) (Core 1 O-glycan T-synthase) (Core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase 1) (Core 1 beta1,3-galactosyltransferase 1) (C1GalT1) (Core 1 beta3-Gal-T1)","Bos taurus (Bovine)","angiogenesis [GO:0001525]; intestinal epithelial cell development [GO:0060576]; kidney development [GO:0001822]; O-glycan processing, core 1 [GO:0016267]","GO:0001525; GO:0001822; GO:0016020; GO:0016263; GO:0016267; GO:0046872; GO:0060576"
"1374",1374,"Cluster_2787","Porites_evermani_scaffold_1285:69547-70547",154,-20.41,2,20,387,410,20,"70.00%","75.00%","Peve_00004556",0.880182696923724,0.314839890013522,0.978262075707395,"Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"1375",1375,"Cluster_2787","Porites_evermani_scaffold_1287:44742-45742",145,-22.13,2,21,614,639,23,"65.22%","73.91%","Peve_00004579",-0.225707741385185,0.855061117980351,0.995934364227446,NA,NA,NA,NA,NA
"1376",1376,"Cluster_2787","Porites_evermani_scaffold_1296:67593-68593",151,-20.53,2,13,288,310,12,"91.67%","91.67%","Peve_00004689",NA,NA,NA,"Q708S5","Acid-sensing ion channel 2 (ASIC2) (Amiloride-sensitive cation channel 1, neuronal) (ZASIC2)","Danio rerio (Zebrafish) (Brachydanio rerio)","response to steroid hormone [GO:0048545]; sodium ion transmembrane transport [GO:0035725]","GO:0005886; GO:0015280; GO:0035725; GO:0048545"
"1377",1377,"Cluster_2787","Porites_evermani_scaffold_1303:5922-6922",161,-20.55,2,18,192,213,16,"81.25%","81.25%","Peve_00004839",-0.864104211317102,0.335771391434576,0.978262075707395,NA,NA,NA,NA,NA
"1378",1378,"Cluster_2787","Porites_evermani_scaffold_1315:116195-117195",148,-22.43,2,21,774,795,19,"57.89%","73.68%","Peve_00004998",NA,NA,NA,NA,NA,NA,NA,NA
"1379",1379,"Cluster_2787","Porites_evermani_scaffold_132:452181-453181",156,-20.07,2,17,208,229,15,"73.33%","86.67%","Peve_00005095",NA,NA,NA,NA,NA,NA,NA,NA
"1380",1380,"Cluster_2787","Porites_evermani_scaffold_134:368413-369413",161,-23.52,2,21,22,44,21,"76.19%","80.95%","Peve_00005361",0.867933894665659,0.330895275232091,0.978262075707395,NA,NA,NA,NA,NA
"1381",1381,"Cluster_2787","Porites_evermani_scaffold_1351:97666-98666",156,-21.57,2,21,131,151,20,"70.00%","85.00%","Peve_00005539",NA,NA,NA,"Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"1382",1382,"Cluster_2787","Porites_evermani_scaffold_1365:39513-40513",152,-20.44,2,21,718,739,19,"57.89%","78.95%","Peve_00005728",0.793124913235104,0.416905488704248,0.978262075707395,NA,NA,NA,NA,NA
"1383",1383,"Cluster_2787","Porites_evermani_scaffold_138:190259-191259",160,-22.1,2,21,74,95,19,"68.42%","78.95%","Peve_00005904",-0.159580747063738,0.897971531912838,0.999448381576871,NA,NA,NA,NA,NA
"1384",1384,"Cluster_2787","Porites_evermani_scaffold_1382:46177-47094",154,-21.88,2,16,631,653,15,"73.33%","93.33%","Peve_00005940",0.856121093574324,0.345735445229939,0.978262075707395,"Q8AV58","Protein sidekick-1","Gallus gallus (Chicken)","homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]","GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0042802; GO:0045202"
"1385",1385,"Cluster_2787","Porites_evermani_scaffold_1382:46177-47094",154,-21.88,2,16,631,653,15,"73.33%","93.33%","Peve_00005941",0.867933894665659,0.330895275232091,0.978262075707395,NA,NA,NA,NA,NA
"1386",1386,"Cluster_2787","Porites_evermani_scaffold_1391:106300-107300",151,-21,2,21,372,395,21,"66.67%","71.43%","Peve_00006073",NA,NA,NA,NA,NA,NA,NA,NA
"1387",1387,"Cluster_2787","Porites_evermani_scaffold_139:175762-176762",157,-22.45,2,19,370,393,19,"73.68%","78.95%","Peve_00006036",0.993417500640558,0.0730851344378293,0.978262075707395,NA,NA,NA,NA,NA
"1388",1388,"Cluster_2787","Porites_evermani_scaffold_1432:51459-52459",159,-21.62,2,21,659,682,21,"66.67%","80.95%","Peve_00006655",-0.180545462745014,0.88442741032037,0.999448381576871,"Q99MM4","TRAF-type zinc finger domain-containing protein 1 (Protein FLN29)","Rattus norvegicus (Rat)","negative regulation of innate immune response [GO:0045824]; response to cytokine [GO:0034097]","GO:0008270; GO:0034097; GO:0045824"
"1389",1389,"Cluster_2787","Porites_evermani_scaffold_144:70965-71965",160,-22.62,2,18,576,598,17,"76.47%","88.24%","Peve_00006719",NA,NA,NA,NA,NA,NA,NA,NA
"1390",1390,"Cluster_2787","Porites_evermani_scaffold_1458:106166-107166",164,-28.29,2,21,843,862,19,"84.21%","84.21%","Peve_00006935",0.908838955299017,0.27394007062543,0.978262075707395,NA,NA,NA,NA,NA
"1391",1391,"Cluster_2787","Porites_evermani_scaffold_1458:77431-78431",160,-21.82,2,21,460,481,19,"63.16%","84.21%","Peve_00006932",-0.735591321891915,0.47380882585705,0.978262075707395,NA,NA,NA,NA,NA
"1392",1392,"Cluster_2787","Porites_evermani_scaffold_14:675969-676969",153,-23.43,2,21,22,43,20,"65.00%","85.00%","Peve_00006177",-0.864104211317102,0.335771391434576,0.978262075707395,NA,NA,NA,NA,NA
"1393",1393,"Cluster_2787","Porites_evermani_scaffold_1478:53974-54974",156,-23.68,2,21,565,586,19,"57.89%","84.21%","Peve_00007178",NA,NA,NA,NA,NA,NA,NA,NA
"1394",1394,"Cluster_2787","Porites_evermani_scaffold_14:999854-1000854",154,-21.01,2,19,386,407,17,"70.59%","76.47%","Peve_00006208",-0.993744917720982,0.0712423559945185,0.978262075707395,NA,NA,NA,NA,NA
"1395",1395,"Cluster_2787","Porites_evermani_scaffold_1513:10962-11962",168,-25.75,2,21,940,961,19,"73.68%","84.21%","Peve_00007703",0.695010901265888,0.510799045488532,0.978262075707395,"G5EDU6","Transcription factor ovo-like homolog lin-48 (Abnormal cell lineage protein 48)","Caenorhabditis elegans","epidermal cell differentiation [GO:0009913]; hindgut morphogenesis [GO:0007442]; nematode male tail tip morphogenesis [GO:0045138]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0007442; GO:0009913; GO:0045138; GO:0046872"
"1396",1396,"Cluster_2787","Porites_evermani_scaffold_1514:10290-11290",163,-20.43,2,21,453,475,20,"75.00%","80.00%","Peve_00007717",NA,NA,NA,NA,NA,NA,NA,NA
"1397",1397,"Cluster_2787","Porites_evermani_scaffold_153:58914-59914",164,-20.94,2,21,440,461,19,"73.68%","78.95%","Peve_00007865",0.759875136007123,0.450520095648851,0.978262075707395,"Q2EJA0","Transcriptional coactivator YAP1 (Yes-associated protein 1) (Protein yorkie homolog) (Yes-associated protein YAP65 homolog)","Rattus norvegicus (Rat)","blastocyst development [GO:0001824]; bud elongation involved in lung branching [GO:0060449]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue regeneration [GO:0061026]; cell morphogenesis [GO:0000902]; cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to retinoic acid [GO:0071300]; contact inhibition [GO:0060242]; embryonic heart tube morphogenesis [GO:0003143]; enterocyte differentiation [GO:1903703]; epithelial cell proliferation [GO:0050673]; extrinsic apoptotic signaling pathway [GO:0097191]; glandular epithelial cell differentiation [GO:0002067]; heart process [GO:0003015]; hippo signaling [GO:0035329]; interleukin-6-mediated signaling pathway [GO:0070102]; intestinal epithelial cell development [GO:0060576]; intestinal epithelial cell differentiation [GO:0060575]; keratinocyte differentiation [GO:0030216]; lateral mesoderm development [GO:0048368]; lung epithelial cell differentiation [GO:0060487]; negative regulation of cilium assembly [GO:1902018]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of gene expression [GO:0010629]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; notochord development [GO:0030903]; organ growth [GO:0035265]; paraxial mesoderm development [GO:0048339]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of organ growth [GO:0046622]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; protein-containing complex assembly [GO:0065003]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell population proliferation [GO:0042127]; regulation of gene expression [GO:0010468]; regulation of keratinocyte proliferation [GO:0010837]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]; regulation of neurogenesis [GO:0050767]; regulation of stem cell proliferation [GO:0072091]; response to progesterone [GO:0032570]; signal transduction in response to DNA damage [GO:0042770]; somatic stem cell population maintenance [GO:0035019]; stem cell proliferation [GO:0072089]; tissue homeostasis [GO:0001894]; trophectodermal cell differentiation [GO:0001829]; vasculogenesis [GO:0001570]; wound healing [GO:0042060]","GO:0000122; GO:0000902; GO:0000976; GO:0000978; GO:0001570; GO:0001674; GO:0001824; GO:0001829; GO:0001894; GO:0002067; GO:0003015; GO:0003143; GO:0003682; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006974; GO:0008022; GO:0008283; GO:0008284; GO:0010468; GO:0010628; GO:0010629; GO:0010837; GO:0016020; GO:0030054; GO:0030216; GO:0030307; GO:0030857; GO:0030903; GO:0032570; GO:0033148; GO:0035019; GO:0035265; GO:0035329; GO:0042060; GO:0042127; GO:0042770; GO:0045599; GO:0045669; GO:0045747; GO:0045893; GO:0045944; GO:0046622; GO:0048339; GO:0048368; GO:0050673; GO:0050679; GO:0050767; GO:0050847; GO:0060045; GO:0060070; GO:0060242; GO:0060449; GO:0060487; GO:0060575; GO:0060576; GO:0060828; GO:0061026; GO:0065003; GO:0070064; GO:0070102; GO:0071300; GO:0071480; GO:0072089; GO:0072091; GO:0072307; GO:0090263; GO:0097191; GO:0140297; GO:0140552; GO:0140678; GO:1900182; GO:1902018; GO:1902459; GO:1903703; GO:1904036; GO:2000648; GO:2000737; GO:2001237"
"1398",1398,"Cluster_2787","Porites_evermani_scaffold_155:146577-147577",165,-28.04,2,20,21,44,20,"75.00%","90.00%","Peve_00008099",-0.764934219049101,0.445542886602769,0.978262075707395,NA,NA,NA,NA,NA
"1399",1399,"Cluster_2787","Porites_evermani_scaffold_1551:83942-84942",154,-24.12,2,21,278,303,23,"65.22%","78.26%","Peve_00008132",0.967148940020634,0.163631141448825,0.978262075707395,"P62198","26S proteasome regulatory subunit 8 (26S proteasome AAA-ATPase subunit RPT6) (Proteasome 26S subunit ATPase 5) (Proteasome subunit p45) (Thyroid hormone receptor-interacting protein 1) (TRIP1) (p45/SUG)","Rattus norvegicus (Rat)","modulation of chemical synaptic transmission [GO:0050804]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of inclusion body assembly [GO:0090261]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000502; GO:0005102; GO:0005524; GO:0005634; GO:0005737; GO:0005838; GO:0006357; GO:0008540; GO:0016234; GO:0016887; GO:0017025; GO:0022624; GO:0031410; GO:0031531; GO:0031595; GO:0031597; GO:0036402; GO:0043161; GO:0045892; GO:0050804; GO:0090261; GO:0098794; GO:0099576; GO:0140296; GO:0140297"
"1400",1400,"Cluster_2787","Porites_evermani_scaffold_1567:108662-109662",147,-20.7,2,16,122,143,14,"71.43%","78.57%","Peve_00008303",NA,NA,NA,"Q95LU3","Fibrinogen C domain-containing protein 1","Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)","","GO:0008061; GO:0016020; GO:0046872"
"1401",1401,"Cluster_2787","Porites_evermani_scaffold_1568:12588-13588",163,-20.43,2,21,428,450,20,"75.00%","80.00%","Peve_00008316",NA,NA,NA,NA,NA,NA,NA,NA
"1402",1402,"Cluster_2787","Porites_evermani_scaffold_1572:107-1107",162,-24.65,2,20,314,339,22,"72.73%","77.27%","Peve_00008395",0.867933894665659,0.330895275232091,0.978262075707395,"Q8STF0","Calmodulin (CaM)","Strongylocentrotus intermedius (Sea urchin)","","GO:0005509"
"1403",1403,"Cluster_2787","Porites_evermani_scaffold_1603:37877-38877",174,-26.36,2,21,140,160,19,"84.21%","89.47%","Peve_00008868",-0.400615928497219,0.737592346789176,0.986508276825124,"Q16739","Ceramide glucosyltransferase (EC 2.4.1.80) (GLCT-1) (Glucosylceramide synthase) (GCS) (Glycosylceramide synthase) (UDP-glucose ceramide glucosyltransferase) (UDP-glucose:N-acylsphingosine D-glucosyltransferase)","Homo sapiens (Human)","cell differentiation [GO:0030154]; cornified envelope assembly [GO:1903575]; epidermis development [GO:0008544]; establishment of skin barrier [GO:0061436]; glucosylceramide biosynthetic process [GO:0006679]; glycosphingolipid metabolic process [GO:0006687]; intestinal lipid absorption [GO:0098856]; keratinocyte differentiation [GO:0030216]; leptin-mediated signaling pathway [GO:0033210]; neuron development [GO:0048666]; protein lipidation [GO:0006497]; regulation of signal transduction [GO:0009966]","GO:0000139; GO:0006497; GO:0006679; GO:0006687; GO:0008120; GO:0008544; GO:0009966; GO:0016020; GO:0030154; GO:0030216; GO:0033210; GO:0048666; GO:0061436; GO:0098856; GO:0102769; GO:1903575"
"1404",1404,"Cluster_2787","Porites_evermani_scaffold_1618:75963-76963",157,-21.77,2,21,365,386,20,"75.00%","80.00%","Peve_00009034",NA,NA,NA,NA,NA,NA,NA,NA
"1405",1405,"Cluster_2787","Porites_evermani_scaffold_163:284211-285211",152,-22.82,2,19,978,998,17,"70.59%","82.35%","Peve_00009181",NA,NA,NA,NA,NA,NA,NA,NA
"1406",1406,"Cluster_2787","Porites_evermani_scaffold_1669:63136-64136",157,-22.1,2,21,624,648,23,"73.91%","73.91%","Peve_00009586",-0.83375657328568,0.372371275071226,0.978262075707395,"P24507","Synaptotagmin-C (Synaptic vesicle protein O-p65-C)","Diplobatis ommata (Ocellated electric ray) (Discopyge ommata)","","GO:0030672; GO:0046872"
"1407",1407,"Cluster_2787","Porites_evermani_scaffold_1676:49020-50020",168,-23.55,2,21,455,476,19,"73.68%","84.21%","Peve_00009684",0.953040906704025,0.195870621845709,0.978262075707395,"O15460","Prolyl 4-hydroxylase subunit alpha-2 (4-PH alpha-2) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-2)","Homo sapiens (Human)","peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]","GO:0004656; GO:0005506; GO:0005654; GO:0005783; GO:0005788; GO:0005829; GO:0009055; GO:0018401; GO:0031418; GO:0043231"
"1408",1408,"Cluster_2787","Porites_evermani_scaffold_1686:23379-24199",160,-21.32,2,17,508,529,15,"80.00%","86.67%","Peve_00009822",0.865950811491994,0.33342829492293,0.978262075707395,NA,NA,NA,NA,NA
"1409",1409,"Cluster_2787","Porites_evermani_scaffold_169:315643-316643",164,-25.6,2,18,439,461,17,"82.35%","88.24%","Peve_00009882",0.867933894665659,0.330895275232091,0.978262075707395,NA,NA,NA,NA,NA
"1410",1410,"Cluster_2787","Porites_evermani_scaffold_1700:36385-37385",160,-22.18,2,21,888,909,19,"63.16%","84.21%","Peve_00010071",NA,NA,NA,NA,NA,NA,NA,NA
"1411",1411,"Cluster_2787","Porites_evermani_scaffold_1725:80248-81248",163,-20.67,2,21,240,263,21,"71.43%","80.95%","Peve_00010322",0.867933894665659,0.330895275232091,0.978262075707395,"F1PZV2","Major facilitator superfamily domain-containing protein 12","Canis lupus familiaris (Dog) (Canis familiaris)","carbohydrate transport [GO:0008643]; cysteine transmembrane transport [GO:1903712]; melanin biosynthetic process [GO:0042438]; organic substance transport [GO:0071702]; pigment metabolic process involved in pigmentation [GO:0043474]; regulation of melanin biosynthetic process [GO:0048021]","GO:0005764; GO:0005765; GO:0005886; GO:0008643; GO:0015293; GO:0033162; GO:0033229; GO:0042438; GO:0043474; GO:0048021; GO:0071702; GO:1903712"
"1412",1412,"Cluster_2787","Porites_evermani_scaffold_17:618889-619889",162,-21.93,2,19,546,567,17,"76.47%","82.35%","Peve_00009976",-0.423261828126495,0.721770085563277,0.982031822734853,"O93309","Structural maintenance of chromosomes protein 3 (SMC protein 3) (SMC-3)","Xenopus laevis (African clawed frog)","cell division [GO:0051301]; chromosome organization [GO:0051276]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; regulation of DNA replication [GO:0006275]","GO:0000775; GO:0000785; GO:0005524; GO:0005634; GO:0006275; GO:0006281; GO:0016887; GO:0030893; GO:0051276; GO:0051301; GO:0051321"
"1413",1413,"Cluster_2787","Porites_evermani_scaffold_17:835569-836569",146,-22.76,2,21,22,46,22,"63.64%","72.73%","Peve_00009992",0.849663023372972,0.353610701700759,0.978262075707395,"Q9W735","Prominin-1-A (Prominin-like protein 1)","Danio rerio (Zebrafish) (Brachydanio rerio)","","GO:0005783; GO:0005793; GO:0005886; GO:0005902; GO:0005929; GO:0009986; GO:0015485; GO:0016324; GO:0031528; GO:0071914"
"1414",1414,"Cluster_2787","Porites_evermani_scaffold_1811:0-894",154,-21.14,2,16,607,629,15,"73.33%","93.33%","Peve_00011298",0.960418031783507,0.179716041102548,0.978262075707395,NA,NA,NA,NA,NA
"1415",1415,"Cluster_2787","Porites_evermani_scaffold_1819:87913-88913",156,-21.33,2,21,384,409,24,"75.00%","75.00%","Peve_00011367",0.397920298852071,0.739464105147748,0.986697151420032,NA,NA,NA,NA,NA
"1416",1416,"Cluster_2787","Porites_evermani_scaffold_1820:52684-53684",156,-22.6,2,13,301,322,11,"90.91%","100.00%","Peve_00011411",NA,NA,NA,NA,NA,NA,NA,NA
"1417",1417,"Cluster_2787","Porites_evermani_scaffold_1844:81503-82503",162,-24.89,2,21,64,88,22,"72.73%","81.82%","Peve_00011631",NA,NA,NA,NA,NA,NA,NA,NA
"1418",1418,"Cluster_2787","Porites_evermani_scaffold_1848:62768-63768",162,-22.46,2,20,892,914,19,"73.68%","84.21%","Peve_00011671",NA,NA,NA,NA,NA,NA,NA,NA
"1419",1419,"Cluster_2787","Porites_evermani_scaffold_1849:73872-74872",151,-20.68,2,16,206,227,14,"71.43%","85.71%","Peve_00011684",NA,NA,NA,"Q96CG8","Collagen triple helix repeat-containing protein 1","Homo sapiens (Human)","cell migration [GO:0016477]; cochlea morphogenesis [GO:0090103]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein binding [GO:0032092]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0001649; GO:0005109; GO:0005576; GO:0005581; GO:0005615; GO:0016477; GO:0016528; GO:0017147; GO:0032092; GO:0033687; GO:0033690; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0062023; GO:0090090; GO:0090103; GO:0090177"
"1420",1420,"Cluster_2787","Porites_evermani_scaffold_188:162339-163339",154,-24.84,2,20,933,961,25,"68.00%","68.00%","Peve_00012018",0.877693495455672,0.318162548466908,0.978262075707395,NA,NA,NA,NA,NA
"1421",1421,"Cluster_2787","Porites_evermani_scaffold_1891:66544-67544",151,-20.36,2,21,277,300,21,"61.90%","76.19%","Peve_00012154",NA,NA,NA,NA,NA,NA,NA,NA
"1422",1422,"Cluster_2787","Porites_evermani_scaffold_190:167515-168515",150,-21.71,2,21,26,54,26,"65.38%","69.23%","Peve_00012296",0.75536976100575,0.454914564830824,0.978262075707395,"B8V7S0","CUB and peptidase domain-containing protein 1","Acropora millepora (Staghorn coral) (Heteropora millepora)","proteolysis [GO:0006508]","GO:0004252; GO:0005576; GO:0006508"
"1423",1423,"Cluster_2787","Porites_evermani_scaffold_1936:77335-78335",154,-23.53,2,19,169,190,17,"64.71%","82.35%","Peve_00012677",-0.70849568040453,0.498748320081156,0.978262075707395,"A7MBF6","Armadillo-like helical domain containing protein 1","Bos taurus (Bovine)","",""
"1424",1424,"Cluster_2787","Porites_evermani_scaffold_1947:11558-12558",161,-23.29,2,15,578,600,14,"92.86%","92.86%","Peve_00012782",NA,NA,NA,NA,NA,NA,NA,NA
"1425",1425,"Cluster_2787","Porites_evermani_scaffold_19:636072-637072",158,-20.09,2,21,366,386,19,"73.68%","78.95%","Peve_00012235",-0.333528550628899,0.783521281247658,0.994409335053505,"Q14549","Homeobox protein GBX-1 (Gastrulation and brain-specific homeobox protein 1)","Homo sapiens (Human)","adult walking behavior [GO:0007628]; neuron fate commitment [GO:0048663]; proprioception [GO:0019230]; regulation of nervous system development [GO:0051960]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory neuron axon guidance [GO:0097374]; spinal cord motor neuron differentiation [GO:0021522]","GO:0000785; GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0007628; GO:0019230; GO:0021522; GO:0048663; GO:0051960; GO:0097374"
"1426",1426,"Cluster_2787","Porites_evermani_scaffold_1971:3631-4631",161,-20.22,2,18,979,1000,16,"81.25%","81.25%","Peve_00013045",NA,NA,NA,NA,NA,NA,NA,NA
"1427",1427,"Cluster_2787","Porites_evermani_scaffold_1984:79987-80987",164,-22.62,2,21,483,504,19,"68.42%","84.21%","Peve_00013164",0.867933894665659,0.330895275232091,0.978262075707395,NA,NA,NA,NA,NA
"1428",1428,"Cluster_2787","Porites_evermani_scaffold_2011:8816-9816",153,-23.97,2,20,422,442,18,"66.67%","83.33%","Peve_00013695",NA,NA,NA,NA,NA,NA,NA,NA
"1429",1429,"Cluster_2787","Porites_evermani_scaffold_2036:76879-77879",159,-21.46,2,21,286,308,20,"75.00%","75.00%","Peve_00013921",0.917218077233008,0.260858737820843,0.978262075707395,NA,NA,NA,NA,NA
"1430",1430,"Cluster_2787","Porites_evermani_scaffold_203:72347-73347",155,-21.85,2,21,530,552,20,"70.00%","75.00%","Peve_00013861",NA,NA,NA,NA,NA,NA,NA,NA
"1431",1431,"Cluster_2787","Porites_evermani_scaffold_2058:20897-21897",156,-20.23,2,18,973,995,17,"70.59%","88.24%","Peve_00014122",0.867933894665659,0.330895275232091,0.978262075707395,"P25931","RYamide receptor (Neuropeptide Y-like receptor) (NPY-R)","Drosophila melanogaster (Fruit fly)","G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]","GO:0001653; GO:0004983; GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0016020"
"1432",1432,"Cluster_2787","Porites_evermani_scaffold_207:73123-74123",154,-21.98,2,21,447,467,19,"68.42%","78.95%","Peve_00014228",0.997036573432838,0.0490229581666764,0.949574829383869,NA,NA,NA,NA,NA
"1433",1433,"Cluster_2787","Porites_evermani_scaffold_207:73123-74123",161,-20.26,2,19,825,847,18,"77.78%","83.33%","Peve_00014228",0.997036573432838,0.0490229581666764,0.949574829383869,NA,NA,NA,NA,NA
"1434",1434,"Cluster_2787","Porites_evermani_scaffold_207:89134-90134",160,-22.91,2,21,33,54,19,"68.42%","78.95%","Peve_00014230",0.867933894665659,0.330895275232091,0.978262075707395,NA,NA,NA,NA,NA
"1435",1435,"Cluster_2787","Porites_evermani_scaffold_2108:63733-64733",162,-23.69,2,20,590,612,19,"73.68%","84.21%","Peve_00014658",-0.275514217786157,0.8223037719875,0.995934364227446,"Q7ZVL2","GATOR complex protein WDR24","Danio rerio (Zebrafish) (Brachydanio rerio)","autophagy [GO:0006914]; cellular response to amino acid starvation [GO:0034198]; positive regulation of macroautophagy [GO:0016239]; positive regulation of TORC1 signaling [GO:1904263]","GO:0005765; GO:0005774; GO:0005829; GO:0006914; GO:0016239; GO:0034198; GO:0061700; GO:1904263"
"1436",1436,"Cluster_2787","Porites_evermani_scaffold_2116:30522-31522",165,-22.98,2,18,40,61,16,"81.25%","87.50%","Peve_00014730",NA,NA,NA,"B3EWZ5","MAM and LDL-receptor class A domain-containing protein 1 (Skeletal organic matrix MAM and LDL-receptor 1) (SOM MAM and LDL-receptor 1)","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0005576; GO:0016020"
"1437",1437,"Cluster_2787","Porites_evermani_scaffold_211:86443-87443",158,-22.35,2,21,789,813,22,"72.73%","77.27%","Peve_00014690",0.702487256520204,0.504145565150355,0.978262075707395,"Q01974","Tyrosine-protein kinase transmembrane receptor ROR2 (EC 2.7.10.1) (Neurotrophic tyrosine kinase, receptor-related 2)","Homo sapiens (Human)","astrocyte development [GO:0014002]; bone mineralization [GO:0030282]; macrophage migration [GO:1905517]; male genitalia development [GO:0030539]; positive regulation of cell migration [GO:0030335]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of kinase activity [GO:0033674]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase C activity [GO:1900020]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; regulation of postsynapse organization [GO:0099175]; regulation of synaptic signaling by nitric oxide [GO:0150045]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]","GO:0004714; GO:0005524; GO:0005874; GO:0005886; GO:0007165; GO:0007169; GO:0009986; GO:0010976; GO:0014002; GO:0014068; GO:0017147; GO:0030282; GO:0030335; GO:0030425; GO:0030539; GO:0030669; GO:0031435; GO:0033674; GO:0043025; GO:0043235; GO:0043507; GO:0045651; GO:0046872; GO:0051968; GO:0098794; GO:0098978; GO:0099175; GO:0150045; GO:1900020; GO:1904929; GO:1905517"
"1438",1438,"Cluster_2787","Porites_evermani_scaffold_2123:50707-51707",146,-20.6,2,21,923,943,19,"57.89%","78.95%","Peve_00014800",NA,NA,NA,NA,NA,NA,NA,NA
"1439",1439,"Cluster_2787","Porites_evermani_scaffold_2180:28914-29914",153,-22.22,2,21,813,834,20,"70.00%","80.00%","Peve_00015330",-0.842538464645203,0.362120510683771,0.978262075707395,NA,NA,NA,NA,NA
"1440",1440,"Cluster_2787","Porites_evermani_scaffold_2181:1343-2343",161,-25.04,2,21,953,972,19,"73.68%","84.21%","Peve_00015331",0.547110106498069,0.631455786614436,0.978262075707395,NA,NA,NA,NA,NA
"1441",1441,"Cluster_2787","Porites_evermani_scaffold_2191:21902-22902",155,-20.63,2,16,20,41,14,"78.57%","85.71%","Peve_00015432",-0.00382968334855694,0.997561941898757,0.999448381576871,NA,NA,NA,NA,NA
"1442",1442,"Cluster_2787","Porites_evermani_scaffold_224:245995-246995",168,-24.73,2,21,36,57,19,"78.95%","78.95%","Peve_00015955",0.317718867152159,0.794166360026608,0.995934364227446,NA,NA,NA,NA,NA
"1443",1443,"Cluster_2787","Porites_evermani_scaffold_2244:779-1779",160,-20.98,2,19,710,730,17,"76.47%","88.24%","Peve_00015993",0.63941545446802,0.558352830999231,0.978262075707395,"O43451","Maltase-glucoamylase (Alpha-1,4-glucosidase) (EC 3.2.1.20)","Homo sapiens (Human)","dextrin catabolic process [GO:1901027]; maltose catabolic process [GO:0000025]; starch catabolic process [GO:0005983]","GO:0000025; GO:0003824; GO:0004339; GO:0004553; GO:0004558; GO:0005886; GO:0005983; GO:0016160; GO:0016324; GO:0030246; GO:0032450; GO:0070062; GO:0070821; GO:0101003; GO:1901027"
"1444",1444,"Cluster_2787","Porites_evermani_scaffold_2251:74486-75486",160,-27.45,2,21,501,522,19,"63.16%","84.21%","Peve_00016069",NA,NA,NA,NA,NA,NA,NA,NA
"1445",1445,"Cluster_2787","Porites_evermani_scaffold_2252:324-1324",159,-21.46,2,21,621,643,20,"75.00%","75.00%","Peve_00016074",0.981330359506124,0.123208621869001,0.978262075707395,NA,NA,NA,NA,NA
"1446",1446,"Cluster_2787","Porites_evermani_scaffold_225:237981-238981",165,-29.16,2,21,530,549,19,"73.68%","89.47%","Peve_00016045",0.832760319120477,0.373518416495646,0.978262075707395,"Q03147","Cyclin-dependent kinase 7 (EC 2.7.11.22) (EC 2.7.11.23) (39 kDa protein kinase) (P39 Mo15) (CDK-activating kinase) (CR4 protein kinase) (CRK4) (Cell division protein kinase 7) (Protein-tyrosine kinase MPK-7) (TFIIH basal transcription factor complex kinase subunit)","Mus musculus (Mouse)","cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; transcription by RNA polymerase II [GO:0006366]; transcription initiation at RNA polymerase II promoter [GO:0006367]","GO:0000079; GO:0000439; GO:0001650; GO:0001673; GO:0004672; GO:0004693; GO:0005524; GO:0005634; GO:0005654; GO:0005675; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0006281; GO:0006366; GO:0006367; GO:0006468; GO:0007049; GO:0008022; GO:0008094; GO:0008353; GO:0016020; GO:0016301; GO:0019907; GO:0044877; GO:0045944; GO:0048471; GO:0050821; GO:0051301; GO:0070516; GO:0070816; GO:0070985; GO:0106310; GO:2000045"
"1447",1447,"Cluster_2787","Porites_evermani_scaffold_225:246923-247923",165,-29.16,2,21,543,562,19,"73.68%","89.47%","Peve_00016046",0.549129768136896,0.629918534535529,0.978262075707395,"Q03147","Cyclin-dependent kinase 7 (EC 2.7.11.22) (EC 2.7.11.23) (39 kDa protein kinase) (P39 Mo15) (CDK-activating kinase) (CR4 protein kinase) (CRK4) (Cell division protein kinase 7) (Protein-tyrosine kinase MPK-7) (TFIIH basal transcription factor complex kinase subunit)","Mus musculus (Mouse)","cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; transcription by RNA polymerase II [GO:0006366]; transcription initiation at RNA polymerase II promoter [GO:0006367]","GO:0000079; GO:0000439; GO:0001650; GO:0001673; GO:0004672; GO:0004693; GO:0005524; GO:0005634; GO:0005654; GO:0005675; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0006281; GO:0006366; GO:0006367; GO:0006468; GO:0007049; GO:0008022; GO:0008094; GO:0008353; GO:0016020; GO:0016301; GO:0019907; GO:0044877; GO:0045944; GO:0048471; GO:0050821; GO:0051301; GO:0070516; GO:0070816; GO:0070985; GO:0106310; GO:2000045"
"1448",1448,"Cluster_2787","Porites_evermani_scaffold_2252:55384-56384",159,-21.46,2,21,593,615,20,"75.00%","75.00%","Peve_00016080",-0.561436898521268,0.620497475489057,0.978262075707395,NA,NA,NA,NA,NA
"1449",1449,"Cluster_2787","Porites_evermani_scaffold_2255:26339-27339",184,-30.12,2,21,489,510,19,"89.47%","89.47%","Peve_00016102",0.520323983067155,0.651622376114668,0.978262075707395,"Q5RBA4","Myosin regulatory light polypeptide 9 (Myosin regulatory light chain 2, smooth muscle isoform) (Myosin regulatory light chain 9)","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","","GO:0005509; GO:0005938; GO:0016459"
"1450",1450,"Cluster_2787","Porites_evermani_scaffold_2257:42516-43516",162,-20.37,2,21,830,850,19,"73.68%","84.21%","Peve_00016115",0.984477836405163,0.112314187659682,0.978262075707395,"Q9D733","Pancreatic secretory granule membrane major glycoprotein GP2 (Pancreatic zymogen granule membrane protein GP-2)","Mus musculus (Mouse)","antigen transcytosis by M cells in mucosal-associated lymphoid tissue [GO:0002412]; establishment of localization in cell [GO:0051649]; innate immune response [GO:0045087]; neutrophil migration [GO:1990266]","GO:0002412; GO:0003823; GO:0005201; GO:0005615; GO:0005768; GO:0009897; GO:0009986; GO:0016324; GO:0042589; GO:0045087; GO:0045121; GO:0051649; GO:1990266"
"1451",1451,"Cluster_2787","Porites_evermani_scaffold_2271:35526-36526",167,-20.99,2,20,449,470,18,"77.78%","83.33%","Peve_00016247",-0.00382968334855694,0.997561941898757,0.999448381576871,NA,NA,NA,NA,NA
"1452",1452,"Cluster_2787","Porites_evermani_scaffold_2276:9701-10701",169,-26.91,2,21,352,371,19,"78.95%","89.47%","Peve_00016269",NA,NA,NA,"P61315","Galactose-3-O-sulfotransferase 3 (Gal3ST-3) (EC 2.8.2.-) (Beta-galactose-3-O-sulfotransferase 3) (Gal-beta-1, 3-GalNAc 3'-sulfotransferase 3)","Mus musculus (Mouse)","glycolipid biosynthetic process [GO:0009247]","GO:0001733; GO:0008146; GO:0009247; GO:0032580; GO:0050694"
"1453",1453,"Cluster_2787","Porites_evermani_scaffold_228:242758-243758",163,-23.03,2,21,40,62,20,"70.00%","85.00%","Peve_00016311",0.85930558060466,0.341792192141912,0.978262075707395,NA,NA,NA,NA,NA
"1454",1454,"Cluster_2787","Porites_evermani_scaffold_23:322585-323585",161,-23.32,2,18,664,685,16,"75.00%","87.50%","Peve_00016476",0.987898067294905,0.0991428607337909,0.978262075707395,"Q9V9S7","Rho GTPase-activating protein 100F (RhoGAP-100F) (Synapse defective protein 1 homolog) (Protein syd-1 homolog)","Drosophila melanogaster (Fruit fly)","activation of GTPase activity [GO:0090630]; axon extension involved in axon guidance [GO:0048846]; cell migration [GO:0016477]; cell projection organization [GO:0030030]; cytoskeletal matrix organization at active zone [GO:0048789]; maintenance of presynaptic active zone structure [GO:0048790]; presynaptic active zone organization [GO:1990709]; R7 cell development [GO:0045467]; regulation of Ras protein signal transduction [GO:0046578]; Rho protein signal transduction [GO:0007266]; synapse assembly [GO:0007416]; synaptic vesicle localization [GO:0097479]","GO:0005096; GO:0007266; GO:0007416; GO:0016477; GO:0030030; GO:0031594; GO:0045467; GO:0046578; GO:0048786; GO:0048789; GO:0048790; GO:0048846; GO:0090630; GO:0097060; GO:0097479; GO:0098831; GO:1990709"
"1455",1455,"Cluster_2787","Porites_evermani_scaffold_2354:42233-43233",144,-20.11,2,21,968,987,19,"68.42%","73.68%","Peve_00017044",NA,NA,NA,NA,NA,NA,NA,NA
"1456",1456,"Cluster_2787","Porites_evermani_scaffold_2379:47679-48679",158,-20.77,2,21,20,40,19,"73.68%","78.95%","Peve_00017228",NA,NA,NA,NA,NA,NA,NA,NA
"1457",1457,"Cluster_2787","Porites_evermani_scaffold_2391:74054-75054",167,-28.71,2,21,660,686,24,"70.83%","79.17%","Peve_00017339",NA,NA,NA,NA,NA,NA,NA,NA
"1458",1458,"Cluster_2787","Porites_evermani_scaffold_239:79202-79797",158,-22.37,2,21,17,37,19,"68.42%","84.21%","Peve_00017322",0.467439460498699,0.690353174037636,0.978262075707395,"Q05481","Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10)","Homo sapiens (Human)","negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0045892; GO:0070895"
"1459",1459,"Cluster_2787","Porites_evermani_scaffold_240:1819-2819",166,-27.95,2,21,572,596,22,"77.27%","81.82%","Peve_00017481",-0.755599857470408,0.45469098191299,0.978262075707395,NA,NA,NA,NA,NA
"1460",1460,"Cluster_2787","Porites_evermani_scaffold_2418:47132-47437",159,-22.16,2,21,10,32,20,"70.00%","80.00%","Peve_00017655",0.96698625490025,0.164038059479203,0.978262075707395,"Q3SZ71","Mitochondrial-processing peptidase subunit beta (EC 3.4.24.64) (Beta-MPP)","Bos taurus (Bovine)","proteolysis [GO:0006508]","GO:0004222; GO:0005759; GO:0006508; GO:0046872"
"1461",1461,"Cluster_2787","Porites_evermani_scaffold_2418:50812-51812",159,-22.16,2,21,833,855,20,"70.00%","80.00%","Peve_00017657",0.978043813317606,0.13365075521055,0.978262075707395,"Q9Z2U1","Proteasome subunit alpha type-5 (Macropain zeta chain) (Multicatalytic endopeptidase complex zeta chain) (Proteasome zeta chain)","Mus musculus (Mouse)","proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]","GO:0000502; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0010498; GO:0019773; GO:0043161"
"1462",1462,"Cluster_2787","Porites_evermani_scaffold_2438:66784-67775",158,-21.35,2,20,727,749,19,"68.42%","84.21%","Peve_00017836",0.567107116603056,0.61612509378921,0.978262075707395,NA,NA,NA,NA,NA
"1463",1463,"Cluster_2787","Porites_evermani_scaffold_2438:66784-67775",158,-21.35,2,20,727,749,19,"68.42%","84.21%","Peve_00017837",-0.108639316784396,0.930701287889778,0.999448381576871,NA,NA,NA,NA,NA
"1464",1464,"Cluster_2787","Porites_evermani_scaffold_24:691598-692598",171,-23.62,2,21,391,413,20,"80.00%","85.00%","Peve_00017428",-0.819068211505842,0.38898192625102,0.978262075707395,NA,NA,NA,NA,NA
"1465",1465,"Cluster_2787","Porites_evermani_scaffold_247:16474-16863",162,-25.04,2,21,100,124,22,"72.73%","81.82%","Peve_00018090",NA,NA,NA,NA,NA,NA,NA,NA
"1466",1466,"Cluster_2787","Porites_evermani_scaffold_2497:42667-43667",158,-22.04,2,16,390,412,15,"86.67%","86.67%","Peve_00018330",0.548661554991545,0.630275128636904,0.978262075707395,NA,NA,NA,NA,NA
"1467",1467,"Cluster_2787","Porites_evermani_scaffold_2504:28044-28801",163,-22.5,2,21,241,264,21,"71.43%","80.95%","Peve_00018489",0.839840595979951,0.365296769139538,0.978262075707395,NA,NA,NA,NA,NA
"1468",1468,"Cluster_2787","Porites_evermani_scaffold_2504:51489-52489",166,-20.91,2,20,977,999,19,"78.95%","84.21%","Peve_00018483",NA,NA,NA,NA,NA,NA,NA,NA
"1469",1469,"Cluster_2787","Porites_evermani_scaffold_250:83024-84024",158,-20.37,2,20,955,978,20,"70.00%","80.00%","Peve_00018432",0.828199358590328,0.378730994731881,0.978262075707395,"Q76DT2","DELTA-thalatoxin-Avl2a (DELTA-TATX-Avl2a) (Toxin AvTX-60A) (Av60A)","Actineria villosa (Okinawan sea anemone)","hemolysis in another organism [GO:0044179]","GO:0005576; GO:0042151; GO:0044179; GO:0090729"
"1470",1470,"Cluster_2787","Porites_evermani_scaffold_25:18922-19922",153,-20.74,2,16,403,423,14,"78.57%","92.86%","Peve_00018407",0.565951523692793,0.617017856311167,0.978262075707395,"Q9N126","Retinol dehydrogenase 8 (EC 1.1.1.300) (Photoreceptor outer segment all-trans retinol dehydrogenase)","Bos taurus (Bovine)","estrogen biosynthetic process [GO:0006703]; response to stimulus [GO:0050896]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601]","GO:0004303; GO:0004745; GO:0005829; GO:0006703; GO:0007601; GO:0016491; GO:0042572; GO:0042622; GO:0050896; GO:0052650"
"1471",1471,"Cluster_2787","Porites_evermani_scaffold_2536:3783-4783",149,-20.94,2,21,177,201,23,"69.57%","69.57%","Peve_00018744",NA,NA,NA,"Q9EQD2","Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide G-protein coupled receptor)","Rattus norvegicus (Rat)","G protein-coupled receptor signaling pathway [GO:0007186]; regulation of adenylate cyclase activity [GO:0045761]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of MAPK cascade [GO:0043408]","GO:0004930; GO:0005886; GO:0007186; GO:0008188; GO:0015629; GO:0031628; GO:0042277; GO:0043408; GO:0045761; GO:2000479"
"1472",1472,"Cluster_2787","Porites_evermani_scaffold_2536:3783-4783",159,-20.27,2,21,312,334,20,"70.00%","80.00%","Peve_00018744",NA,NA,NA,"Q9EQD2","Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide G-protein coupled receptor)","Rattus norvegicus (Rat)","G protein-coupled receptor signaling pathway [GO:0007186]; regulation of adenylate cyclase activity [GO:0045761]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of MAPK cascade [GO:0043408]","GO:0004930; GO:0005886; GO:0007186; GO:0008188; GO:0015629; GO:0031628; GO:0042277; GO:0043408; GO:0045761; GO:2000479"
"1473",1473,"Cluster_2787","Porites_evermani_scaffold_2569:17394-18394",160,-22.47,2,21,495,516,19,"68.42%","78.95%","Peve_00018964",NA,NA,NA,NA,NA,NA,NA,NA
"1474",1474,"Cluster_2787","Porites_evermani_scaffold_2572:52731-53731",153,-22.52,2,21,667,686,19,"68.42%","78.95%","Peve_00019005",0.739646458615331,0.469985466960258,0.978262075707395,NA,NA,NA,NA,NA
"1475",1475,"Cluster_2787","Porites_evermani_scaffold_25:751216-751738",158,-21.08,2,17,225,245,15,"86.67%","86.67%","Peve_00018388",0.993179673579922,0.0743951880853572,0.978262075707395,"O70258","Epsilon-sarcoglycan (Epsilon-SG)","Mus musculus (Mouse)","","GO:0005794; GO:0005856; GO:0005886; GO:0016010; GO:0016012; GO:0032590; GO:0042383"
"1476",1476,"Cluster_2787","Porites_evermani_scaffold_25:751216-751738",158,-21.08,2,17,225,245,15,"86.67%","86.67%","Peve_00018389",0.515744088411765,0.65503106811805,0.978262075707395,"G1SMR7",NA,NA,NA,NA
"1477",1477,"Cluster_2787","Porites_evermani_scaffold_2577:47792-48792",164,-21.31,2,21,241,262,19,"73.68%","78.95%","Peve_00019043",0.867933894665659,0.330895275232091,0.978262075707395,NA,NA,NA,NA,NA
"1478",1478,"Cluster_2787","Porites_evermani_scaffold_26:179904-180904",161,-21.64,2,21,464,488,22,"72.73%","86.36%","Peve_00019253",0.909070559760948,0.273586398620915,0.978262075707395,"Q9GR88","Eukaryotic peptide chain release factor subunit 1 (Eukaryotic release factor 1) (eRF1)","Polyandrocarpa misakiensis (Tunicate)","","GO:0003747; GO:0005737"
"1479",1479,"Cluster_2787","Porites_evermani_scaffold_2655:58204-59204",163,-21.71,2,21,199,221,20,"75.00%","80.00%","Peve_00019695",0.998742428996946,0.0319305869438654,0.905632568744263,"Q91YK2","Ribosomal RNA processing protein 1 homolog B (RRP1-like protein B)","Mus musculus (Mouse)","apoptotic process [GO:0006915]; cellular response to virus [GO:0098586]; mRNA processing [GO:0006397]; negative regulation of GTPase activity [GO:0034260]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364]","GO:0000791; GO:0000792; GO:0001652; GO:0003713; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0006364; GO:0006397; GO:0006915; GO:0008380; GO:0030687; GO:0030688; GO:0034260; GO:0043065; GO:0043484; GO:0043923; GO:0045944; GO:0098586"
"1480",1480,"Cluster_2787","Porites_evermani_scaffold_266:58052-59052",161,-22.27,2,18,782,803,16,"75.00%","87.50%","Peve_00019754",0.93791149490326,0.225514154246386,0.978262075707395,"O16025","Allene oxide synthase-lipoxygenase protein [Includes: Allene oxide synthase (AOS) (EC 4.2.1.-) (Hydroperoxidehydrase); Arachidonate 8-lipoxygenase (EC 1.13.11.40)]","Plexaura homomalla (Black sea rod)","arachidonic acid metabolic process [GO:0019369]; fatty acid biosynthetic process [GO:0006633]; lipid oxidation [GO:0034440]; oxylipin biosynthetic process [GO:0031408]","GO:0005506; GO:0005737; GO:0006633; GO:0009978; GO:0016020; GO:0019369; GO:0020037; GO:0031408; GO:0034440; GO:0047677"
"1481",1481,"Cluster_2787","Porites_evermani_scaffold_26:799320-800320",164,-24.31,2,21,655,676,19,"68.42%","84.21%","Peve_00019238",NA,NA,NA,"Q29041","Ficolin-2 (Collagen/fibrinogen domain-containing protein 2) (Ficolin-B) (Ficolin-beta) (L-ficolin)","Sus scrofa (Pig)","complement activation, lectin pathway [GO:0001867]","GO:0001867; GO:0005576; GO:0005581; GO:0030246; GO:0046872"
"1482",1482,"Cluster_2787","Porites_evermani_scaffold_2699:58513-59513",156,-21.57,2,21,828,848,20,"70.00%","85.00%","Peve_00020030",0.797983982565951,0.411799824125143,0.978262075707395,"Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"1483",1483,"Cluster_2787","Porites_evermani_scaffold_2702:7294-8294",160,-21.65,2,20,821,842,19,"78.95%","84.21%","Peve_00020127",-0.0654582032015659,0.958298196860863,0.999448381576871,"P91254","Probable glutathione S-transferase 8 (EC 2.5.1.18) (GST class-sigma)","Caenorhabditis elegans","glutathione metabolic process [GO:0006749]","GO:0004364; GO:0006749"
"1484",1484,"Cluster_2787","Porites_evermani_scaffold_2736:34427-35427",168,-20.15,2,21,184,205,19,"73.68%","84.21%","Peve_00020393",0.626797626429818,0.568730550853454,0.978262075707395,NA,NA,NA,NA,NA
"1485",1485,"Cluster_2787","Porites_evermani_scaffold_2747:32521-33521",158,-20.78,2,21,320,340,19,"73.68%","78.95%","Peve_00020488",0.941696346310238,0.218462052789957,0.978262075707395,"Q9Z255","Ubiquitin-conjugating enzyme E2 A (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme A) (RAD6 homolog A) (HR6A) (mHR6A) (Ubiquitin carrier protein A) (Ubiquitin-protein ligase A)","Mus musculus (Mouse)","blastocyst hatching [GO:0001835]; DNA repair [GO:0006281]; histone H2A ubiquitination [GO:0033522]; histone ubiquitination [GO:0016574]; in utero embryonic development [GO:0001701]; maternal process involved in female pregnancy [GO:0060135]; positive regulation of cell population proliferation [GO:0008284]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; response to UV [GO:0009411]","GO:0000209; GO:0000785; GO:0001701; GO:0001741; GO:0001835; GO:0004842; GO:0005524; GO:0006281; GO:0008284; GO:0009411; GO:0016567; GO:0016574; GO:0031625; GO:0033503; GO:0033522; GO:0043161; GO:0051865; GO:0060135; GO:0061631; GO:0070936; GO:0070979"
"1486",1486,"Cluster_2787","Porites_evermani_scaffold_27:589282-590282",167,-22.23,2,20,764,785,18,"72.22%","88.89%","Peve_00020058",0.829160126511968,0.377638232101057,0.978262075707395,"Q98925","Interferon regulatory factor 2 (IRF-2)","Gallus gallus (Chicken)","immune system process [GO:0002376]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0002376; GO:0005634; GO:0006357"
"1487",1487,"Cluster_2787","Porites_evermani_scaffold_2763:54753-55753",165,-22.98,2,18,181,202,16,"81.25%","87.50%","Peve_00020605",NA,NA,NA,NA,NA,NA,NA,NA
"1488",1488,"Cluster_2787","Porites_evermani_scaffold_2777:55985-56985",158,-22.15,2,20,501,523,19,"73.68%","78.95%","Peve_00020696",0.867933894665659,0.330895275232091,0.978262075707395,NA,NA,NA,NA,NA
"1489",1489,"Cluster_2787","Porites_evermani_scaffold_280:190731-191731",168,-25.86,2,17,28,49,15,"86.67%","93.33%","Peve_00020931",-0.664868836096204,0.536974848399775,0.978262075707395,NA,NA,NA,NA,NA
"1490",1490,"Cluster_2787","Porites_evermani_scaffold_2861:44622-45622",154,-23.03,2,21,407,431,22,"68.18%","77.27%","Peve_00021380",-0.256637089930346,0.834770976693831,0.995934364227446,"Q7TNG5","Echinoderm microtubule-associated protein-like 2 (EMAP-2)","Mus musculus (Mouse)","microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule polymerization [GO:0031115]; regulation of microtubule nucleation [GO:0010968]","GO:0000226; GO:0005102; GO:0005737; GO:0005874; GO:0008017; GO:0008022; GO:0010968; GO:0015631; GO:0031115; GO:0043621; GO:0072686"
"1491",1491,"Cluster_2787","Porites_evermani_scaffold_286:296674-297674",148,-21.74,2,13,6,27,11,"81.82%","90.91%","Peve_00021369",NA,NA,NA,NA,NA,NA,NA,NA
"1492",1492,"Cluster_2787","Porites_evermani_scaffold_287:206805-207805",158,-22.58,2,21,517,544,25,"72.00%","72.00%","Peve_00021435",0.983052623242138,0.117371221301313,0.978262075707395,"Q9I9A2","Retinal homeobox protein Rx2","Oryzias latipes (Japanese rice fish) (Japanese killifish)","positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0045944"
"1493",1493,"Cluster_2787","Porites_evermani_scaffold_2886:59300-60300",160,-21.52,2,21,615,636,19,"73.68%","73.68%","Peve_00021556",0.953188346322894,0.195560443197803,0.978262075707395,NA,NA,NA,NA,NA
"1494",1494,"Cluster_2787","Porites_evermani_scaffold_2898:5115-6115",151,-20.41,2,18,578,598,16,"68.75%","87.50%","Peve_00021630",NA,NA,NA,NA,NA,NA,NA,NA
"1495",1495,"Cluster_2787","Porites_evermani_scaffold_2:917079-918079",161,-22.94,2,21,315,339,22,"77.27%","81.82%","Peve_00013381",0.985813907655144,0.107359693857486,0.978262075707395,"Q96J94","Piwi-like protein 1 (EC 3.1.26.-)","Homo sapiens (Human)","meiotic cell cycle [GO:0051321]; negative regulation of transposition [GO:0010529]; piRNA processing [GO:0034587]; regulation of translation [GO:0006417]; RNA-mediated gene silencing [GO:0031047]; sperm DNA condensation [GO:0035092]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]","GO:0003723; GO:0003727; GO:0003729; GO:0004521; GO:0005634; GO:0005737; GO:0006417; GO:0007283; GO:0007286; GO:0010529; GO:0019901; GO:0031047; GO:0033391; GO:0034584; GO:0034587; GO:0035092; GO:0043186; GO:0046872; GO:0051321; GO:0097433; GO:0140262; GO:1905538"
"1496",1496,"Cluster_2787","Porites_evermani_scaffold_2927:29136-30136",163,-21.71,2,16,45,66,14,"85.71%","92.86%","Peve_00021901",0.981539109042037,0.122515727748527,0.978262075707395,"Q0P4F7","Medium-chain acyl-CoA ligase ACSF2, mitochondrial (EC 6.2.1.2)","Danio rerio (Zebrafish) (Brachydanio rerio)","fatty acid metabolic process [GO:0006631]","GO:0005524; GO:0005739; GO:0006631; GO:0031956; GO:0047760"
"1497",1497,"Cluster_2787","Porites_evermani_scaffold_2927:29141-30141",163,-21.71,2,16,40,61,14,"85.71%","92.86%","Peve_00021902",0.742676227537318,0.467112323783069,0.978262075707395,NA,NA,NA,NA,NA
"1498",1498,"Cluster_2787","Porites_evermani_scaffold_2951:35792-36792",156,-24.13,2,19,612,632,17,"70.59%","88.24%","Peve_00022068",-0.720617686365663,0.487716651784373,0.978262075707395,NA,NA,NA,NA,NA
"1499",1499,"Cluster_2787","Porites_evermani_scaffold_301:130999-131999",163,-24.69,2,21,96,118,20,"70.00%","85.00%","Peve_00022691",-0.00382968334855694,0.997561941898757,0.999448381576871,NA,NA,NA,NA,NA
"1500",1500,"Cluster_2787","Porites_evermani_scaffold_3045:8454-9454",154,-20.91,2,21,711,731,19,"68.42%","78.95%","Peve_00022950",0.736225448684503,0.4732125934307,0.978262075707395,NA,NA,NA,NA,NA
"1501",1501,"Cluster_2787","Porites_evermani_scaffold_307:103663-104663",148,-21.14,2,21,708,726,19,"63.16%","78.95%","Peve_00023120",-0.885065833884194,0.308226400809345,0.978262075707395,NA,NA,NA,NA,NA
"1502",1502,"Cluster_2787","Porites_evermani_scaffold_3084:30702-31702",160,-22.17,2,20,4,23,18,"72.22%","88.89%","Peve_00023232",0.618154292010678,0.575761377561625,0.978262075707395,NA,NA,NA,NA,NA
"1503",1503,"Cluster_2787","Porites_evermani_scaffold_308:46933-47933",154,-20.08,2,20,339,361,19,"73.68%","73.68%","Peve_00023205",0.585438467441969,0.601844758140728,0.978262075707395,NA,NA,NA,NA,NA
"1504",1504,"Cluster_2787","Porites_evermani_scaffold_31:170822-171822",163,-23.72,2,21,229,251,20,"75.00%","80.00%","Peve_00023366",0.993775971013891,0.071065110665137,0.978262075707395,NA,NA,NA,NA,NA
"1505",1505,"Cluster_2787","Porites_evermani_scaffold_3121:36555-37555",166,-22.1,2,20,565,587,19,"78.95%","84.21%","Peve_00023546",0.846852938691537,0.356988780199974,0.978262075707395,"P95329","Malate synthase (EC 2.3.3.9)","Myxococcus xanthus (strain DK1622)","glyoxylate cycle [GO:0006097]; tricarboxylic acid cycle [GO:0006099]","GO:0004474; GO:0005737; GO:0006097; GO:0006099"
"1506",1506,"Cluster_2787","Porites_evermani_scaffold_3:1369786-1370786",153,-21.05,2,21,646,669,22,"72.73%","72.73%","Peve_00022528",NA,NA,NA,NA,NA,NA,NA,NA
"1507",1507,"Cluster_2787","Porites_evermani_scaffold_3184:10685-11685",153,-21.11,2,14,830,851,12,"83.33%","91.67%","Peve_00023907",-0.405200566345298,0.734403374789737,0.98573572910777,"Q5EA11","Tetratricopeptide repeat protein 4 (TPR repeat protein 4)","Bos taurus (Bovine)","defense response to virus [GO:0051607]; innate immune response [GO:0045087]; protein folding [GO:0006457]","GO:0005634; GO:0005654; GO:0005737; GO:0006457; GO:0030544; GO:0045087; GO:0051607; GO:0051879"
"1508",1508,"Cluster_2787","Porites_evermani_scaffold_3191:836-1836",154,-25.33,2,21,346,370,22,"68.18%","77.27%","Peve_00023945",-0.571226443247763,0.612935625291418,0.978262075707395,NA,NA,NA,NA,NA
"1509",1509,"Cluster_2787","Porites_evermani_scaffold_319:203593-204593",148,-21,2,20,696,720,22,"68.18%","72.73%","Peve_00023931",0.997268981044785,0.0470604815083167,0.940685113548625,"P50549","ETS translocation variant 1 (Ets-related protein 81)","Homo sapiens (Human)","axon guidance [GO:0007411]; cell differentiation [GO:0030154]; mechanosensory behavior [GO:0007638]; muscle organ development [GO:0007517]; peripheral nervous system neuron development [GO:0048935]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]","GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0006366; GO:0007411; GO:0007517; GO:0007638; GO:0030154; GO:0045944; GO:0048935; GO:1990837"
"1510",1510,"Cluster_2787","Porites_evermani_scaffold_3:223036-224036",147,-21.27,2,12,612,633,10,"90.00%","90.00%","Peve_00022553",NA,NA,NA,NA,NA,NA,NA,NA
"1511",1511,"Cluster_2787","Porites_evermani_scaffold_3226:18027-19027",162,-22.07,2,21,739,759,19,"73.68%","84.21%","Peve_00024177",-0.00382968334855694,0.997561941898757,0.999448381576871,NA,NA,NA,NA,NA
"1512",1512,"Cluster_2787","Porites_evermani_scaffold_3268:46094-47094",150,-20.33,2,21,679,705,24,"66.67%","70.83%","Peve_00024419",-0.938455188228301,0.224514188872229,0.978262075707395,NA,NA,NA,NA,NA
"1513",1513,"Cluster_2787","Porites_evermani_scaffold_3275:20865-21865",166,-20.77,2,21,801,821,19,"78.95%","84.21%","Peve_00024457",0.854887578402182,0.347252031667866,0.978262075707395,"D3YXG0","Hemicentin-1 (Fibulin-6) (FIBL-6)","Mus musculus (Mouse)","actin filament reorganization [GO:0090527]; basement membrane organization [GO:0071711]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]","GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0051301; GO:0062023; GO:0071711; GO:0090527"
"1514",1514,"Cluster_2787","Porites_evermani_scaffold_3328:4089-5089",154,-20.09,2,20,79,101,19,"73.68%","73.68%","Peve_00024819",NA,NA,NA,NA,NA,NA,NA,NA
"1515",1515,"Cluster_2787","Porites_evermani_scaffold_336:147176-148176",160,-20.13,2,21,620,641,19,"68.42%","78.95%","Peve_00025038",0.906688710045694,0.277203410791526,0.978262075707395,NA,NA,NA,NA,NA
"1516",1516,"Cluster_2787","Porites_evermani_scaffold_3370:21875-22875",171,-23.7,2,21,926,949,21,"76.19%","85.71%","Peve_00025103",-0.862091179305092,0.338308916943552,0.978262075707395,NA,NA,NA,NA,NA
"1517",1517,"Cluster_2787","Porites_evermani_scaffold_337:36583-37583",161,-27.23,2,20,966,990,21,"71.43%","85.71%","Peve_00025100",NA,NA,NA,NA,NA,NA,NA,NA
"1518",1518,"Cluster_2787","Porites_evermani_scaffold_337:73551-74551",152,-21.52,2,21,585,604,19,"73.68%","78.95%","Peve_00025086",-0.999963153550721,0.00546505171493988,0.551398425649056,NA,NA,NA,NA,NA
"1519",1519,"Cluster_2787","Porites_evermani_scaffold_338:199238-200238",162,-21.25,2,21,558,583,23,"73.91%","78.26%","Peve_00025147",0.892187554953332,0.298339618047128,0.978262075707395,"Q5I2E5","Ficolin-2 (Collagen/fibrinogen domain-containing protein 2) (Ficolin-B) (Ficolin-beta) (L-ficolin)","Bos taurus (Bovine)","complement activation, lectin pathway [GO:0001867]","GO:0001867; GO:0003823; GO:0005102; GO:0005581; GO:0005615; GO:0030246; GO:0046872; GO:0062023; GO:0097367"
"1520",1520,"Cluster_2787","Porites_evermani_scaffold_339:106899-107899",166,-24.2,2,21,683,707,22,"77.27%","81.82%","Peve_00025188",0.945230951483782,0.211672815070115,0.978262075707395,"Q92551","Inositol hexakisphosphate kinase 1 (InsP6 kinase 1) (EC 2.7.4.21) (Inositol hexaphosphate kinase 1)","Homo sapiens (Human)","inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; negative regulation of cold-induced thermogenesis [GO:0120163]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphorylation [GO:0016310]","GO:0000827; GO:0000828; GO:0000829; GO:0000832; GO:0001650; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016301; GO:0016310; GO:0032958; GO:0043647; GO:0046854; GO:0052723; GO:0052724; GO:0052836; GO:0052839; GO:0120163"
"1521",1521,"Cluster_2787","Porites_evermani_scaffold_339:117167-118167",166,-24.2,2,21,683,707,22,"77.27%","81.82%","Peve_00025189",0.797473109731085,0.412339165401967,0.978262075707395,"Q92551","Inositol hexakisphosphate kinase 1 (InsP6 kinase 1) (EC 2.7.4.21) (Inositol hexaphosphate kinase 1)","Homo sapiens (Human)","inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; negative regulation of cold-induced thermogenesis [GO:0120163]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphorylation [GO:0016310]","GO:0000827; GO:0000828; GO:0000829; GO:0000832; GO:0001650; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016301; GO:0016310; GO:0032958; GO:0043647; GO:0046854; GO:0052723; GO:0052724; GO:0052836; GO:0052839; GO:0120163"
"1522",1522,"Cluster_2787","Porites_evermani_scaffold_3398:25510-26510",168,-21.71,2,21,421,442,19,"68.42%","89.47%","Peve_00025241",0.291812194690017,0.811483548157131,0.995934364227446,"Q08013","Translocon-associated protein subunit gamma (TRAP-gamma) (Signal sequence receptor subunit gamma) (SSR-gamma)","Rattus norvegicus (Rat)","SRP-dependent cotranslational protein targeting to membrane [GO:0006614]","GO:0005783; GO:0005784; GO:0006614"
"1523",1523,"Cluster_2787","Porites_evermani_scaffold_3425:29829-30829",164,-20.14,2,21,766,787,19,"73.68%","78.95%","Peve_00025450",NA,NA,NA,NA,NA,NA,NA,NA
"1524",1524,"Cluster_2787","Porites_evermani_scaffold_3427:31756-32756",170,-25.27,2,21,313,333,19,"78.95%","89.47%","Peve_00025457",NA,NA,NA,NA,NA,NA,NA,NA
"1525",1525,"Cluster_2787","Porites_evermani_scaffold_3431:42638-43638",165,-22.06,2,18,932,953,16,"75.00%","93.75%","Peve_00025491",NA,NA,NA,"Q9PT63","Cytoskeleton-associated protein 5-A (Microtubule-associated protein 215 kDa) (XMAP215)","Xenopus laevis (African clawed frog)","cell division [GO:0051301]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; microtubule polymerization [GO:0046785]; regulation of cellular component organization [GO:0051128]; spindle organization [GO:0007051]","GO:0000776; GO:0000922; GO:0005737; GO:0005815; GO:0007051; GO:0030951; GO:0046785; GO:0051010; GO:0051128; GO:0051301; GO:0061863"
"1526",1526,"Cluster_2787","Porites_evermani_scaffold_3448:3714-4714",164,-24.83,2,19,26,46,17,"76.47%","94.12%","Peve_00025595",0.870734328514909,0.327287937228317,0.978262075707395,"P0C6B8","Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1","Rattus norvegicus (Rat)","cell adhesion [GO:0007155]; epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193]","GO:0001945; GO:0003017; GO:0003682; GO:0005509; GO:0005615; GO:0005634; GO:0005737; GO:0007155; GO:0008544; GO:0010467; GO:0016020; GO:0031012; GO:0036303; GO:0048014; GO:0120193"
"1527",1527,"Cluster_2787","Porites_evermani_scaffold_3485:10256-11256",156,-20.45,2,13,207,228,11,"90.91%","100.00%","Peve_00025825",0.985456238964401,0.108707936308663,0.978262075707395,"Q9Z255","Ubiquitin-conjugating enzyme E2 A (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme A) (RAD6 homolog A) (HR6A) (mHR6A) (Ubiquitin carrier protein A) (Ubiquitin-protein ligase A)","Mus musculus (Mouse)","blastocyst hatching [GO:0001835]; DNA repair [GO:0006281]; histone H2A ubiquitination [GO:0033522]; histone ubiquitination [GO:0016574]; in utero embryonic development [GO:0001701]; maternal process involved in female pregnancy [GO:0060135]; positive regulation of cell population proliferation [GO:0008284]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; response to UV [GO:0009411]","GO:0000209; GO:0000785; GO:0001701; GO:0001741; GO:0001835; GO:0004842; GO:0005524; GO:0006281; GO:0008284; GO:0009411; GO:0016567; GO:0016574; GO:0031625; GO:0033503; GO:0033522; GO:0043161; GO:0051865; GO:0060135; GO:0061631; GO:0070936; GO:0070979"
"1528",1528,"Cluster_2787","Porites_evermani_scaffold_3490:598-1598",149,-20.96,2,18,50,71,16,"68.75%","75.00%","Peve_00025856",NA,NA,NA,NA,NA,NA,NA,NA
"1529",1529,"Cluster_2787","Porites_evermani_scaffold_350:195545-196545",153,-21.6,2,21,190,209,19,"68.42%","78.95%","Peve_00025983",0.00785902328862404,0.994996738878287,0.999448381576871,"Q5T1B0","Axonemal dynein light chain domain-containing protein 1","Homo sapiens (Human)","",""
"1530",1530,"Cluster_2787","Porites_evermani_scaffold_3525:24915-25915",166,-20.92,2,20,627,649,19,"78.95%","84.21%","Peve_00026110",-0.64789371857608,0.551300167984584,0.978262075707395,NA,NA,NA,NA,NA
"1531",1531,"Cluster_2787","Porites_evermani_scaffold_3595:33413-34413",166,-22.08,2,21,374,394,19,"78.95%","84.21%","Peve_00026489",0.867933894665659,0.330895275232091,0.978262075707395,NA,NA,NA,NA,NA
"1532",1532,"Cluster_2787","Porites_evermani_scaffold_370:190415-191415",147,-21.54,2,21,412,430,19,"63.16%","84.21%","Peve_00027128",0.945656651611782,0.210840949173644,0.978262075707395,"Q5S007","Leucine-rich repeat serine/threonine-protein kinase 2 (EC 2.7.11.1) (EC 3.6.5.-) (Dardarin)","Homo sapiens (Human)","autophagy [GO:0006914]; calcium-mediated signaling [GO:0019722]; canonical Wnt signaling pathway [GO:0060070]; cellular response to dopamine [GO:1903351]; cellular response to manganese ion [GO:0071287]; cellular response to organic cyclic compound [GO:0071407]; cellular response to oxidative stress [GO:0034599]; cellular response to starvation [GO:0009267]; determination of adult lifespan [GO:0008340]; endocytosis [GO:0006897]; endoplasmic reticulum organization [GO:0007029]; excitatory postsynaptic potential [GO:0060079]; exploration behavior [GO:0035640]; Golgi organization [GO:0007030]; GTP metabolic process [GO:0046039]; intracellular distribution of mitochondria [GO:0048312]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; locomotory exploration behavior [GO:0035641]; lysosome organization [GO:0007040]; MAPK cascade [GO:0000165]; mitochondrion localization [GO:0051646]; mitochondrion organization [GO:0007005]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of GTPase activity [GO:0034260]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of macroautophagy [GO:0016242]; negative regulation of neuron death [GO:1901215]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein binding [GO:0032091]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein processing [GO:0010955]; negative regulation of protein processing involved in protein targeting to mitochondrion [GO:1903217]; negative regulation of protein targeting to mitochondrion [GO:1903215]; negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation [GO:1903125]; neuromuscular junction development [GO:0007528]; neuron death [GO:0070997]; neuron projection arborization [GO:0140058]; neuron projection morphogenesis [GO:0048812]; olfactory bulb development [GO:0021772]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of programmed cell death [GO:0043068]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein autoubiquitination [GO:1902499]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of tumor necrosis factor production [GO:0032760]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein localization [GO:0008104]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to mitochondrion [GO:0070585]; protein phosphorylation [GO:0006468]; reactive oxygen species metabolic process [GO:0072593]; regulation of autophagy [GO:0010506]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of kidney size [GO:0035564]; regulation of locomotion [GO:0040012]; regulation of lysosomal lumen pH [GO:0035751]; regulation of membrane potential [GO:0042391]; regulation of mitochondrial depolarization [GO:0051900]; regulation of mitochondrial fission [GO:0090140]; regulation of neuroblast proliferation [GO:1902692]; regulation of neuron death [GO:1901214]; regulation of neuron maturation [GO:0014041]; regulation of protein kinase A signaling [GO:0010738]; regulation of protein stability [GO:0031647]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle transport [GO:1902803]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]; striatum development [GO:0021756]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; Wnt signalosome assembly [GO:1904887]","GO:0000139; GO:0000149; GO:0000165; GO:0000287; GO:0001933; GO:0001934; GO:0003779; GO:0003924; GO:0004672; GO:0004674; GO:0004706; GO:0004709; GO:0004722; GO:0005096; GO:0005524; GO:0005525; GO:0005615; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005759; GO:0005764; GO:0005768; GO:0005783; GO:0005789; GO:0005794; GO:0005798; GO:0005802; GO:0005829; GO:0005886; GO:0005902; GO:0006468; GO:0006606; GO:0006897; GO:0006914; GO:0006979; GO:0007005; GO:0007029; GO:0007030; GO:0007040; GO:0007165; GO:0007254; GO:0007283; GO:0007528; GO:0008017; GO:0008104; GO:0008340; GO:0009267; GO:0010506; GO:0010508; GO:0010738; GO:0010955; GO:0010977; GO:0014041; GO:0015631; GO:0016234; GO:0016242; GO:0016301; GO:0016310; GO:0017075; GO:0018105; GO:0018107; GO:0019722; GO:0021756; GO:0021772; GO:0022028; GO:0030159; GO:0030276; GO:0030424; GO:0030425; GO:0030426; GO:0030672; GO:0031267; GO:0031398; GO:0031410; GO:0031647; GO:0031966; GO:0032091; GO:0032092; GO:0032436; GO:0032473; GO:0032760; GO:0032839; GO:0034211; GO:0034260; GO:0034599; GO:0035556; GO:0035564; GO:0035640; GO:0035641; GO:0035751; GO:0036479; GO:0039706; GO:0040012; GO:0042391; GO:0042802; GO:0042803; GO:0043005; GO:0043025; GO:0043068; GO:0043195; GO:0043204; GO:0043231; GO:0043406; GO:0044325; GO:0044753; GO:0044754; GO:0045121; GO:0045860; GO:0046039; GO:0046777; GO:0048312; GO:0048812; GO:0051018; GO:0051646; GO:0051770; GO:0051900; GO:0051966; GO:0060070; GO:0060079; GO:0060159; GO:0060161; GO:0060628; GO:0060828; GO:0061001; GO:0070062; GO:0070585; GO:0070971; GO:0070973; GO:0070997; GO:0071287; GO:0071407; GO:0072593; GO:0090140; GO:0090263; GO:0090394; GO:0097487; GO:0098794; GO:0098978; GO:0099400; GO:0099523; GO:0106310; GO:0140058; GO:1900244; GO:1901214; GO:1901215; GO:1901727; GO:1902236; GO:1902499; GO:1902692; GO:1902803; GO:1902823; GO:1902902; GO:1903125; GO:1903206; GO:1903215; GO:1903217; GO:1903351; GO:1903980; GO:1904713; GO:1904887; GO:1905279; GO:1905289; GO:1990904; GO:1990909; GO:2000172; GO:2000300"
"1533",1533,"Cluster_2787","Porites_evermani_scaffold_3737:17314-18314",151,-20.41,2,13,5,27,12,"91.67%","91.67%","Peve_00027273",0.905986972417062,0.278260650851161,0.978262075707395,"Q9P2E3","NFX1-type zinc finger-containing protein 1","Homo sapiens (Human)","activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; RNA-mediated heterochromatin formation [GO:0031048]","GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607"
"1534",1534,"Cluster_2787","Porites_evermani_scaffold_3751:17909-18909",149,-20.4,2,21,126,151,23,"65.22%","78.26%","Peve_00027358",NA,NA,NA,NA,NA,NA,NA,NA
"1535",1535,"Cluster_2787","Porites_evermani_scaffold_3752:25299-26299",154,-20.08,2,17,737,762,19,"78.95%","78.95%","Peve_00027361",0.69156538661655,0.513842768095415,0.978262075707395,NA,NA,NA,NA,NA
"1536",1536,"Cluster_2787","Porites_evermani_scaffold_3752:25886-26886",154,-20.08,2,17,150,175,19,"78.95%","78.95%","Peve_00027363",NA,NA,NA,NA,NA,NA,NA,NA
"1537",1537,"Cluster_2787","Porites_evermani_scaffold_380:216038-217038",157,-22.73,2,21,958,979,20,"75.00%","80.00%","Peve_00027641",NA,NA,NA,NA,NA,NA,NA,NA
"1538",1538,"Cluster_2787","Porites_evermani_scaffold_38:144131-145131",159,-20.68,2,16,744,765,14,"78.57%","92.86%","Peve_00027613",-0.58815399201298,0.599709788684688,0.978262075707395,"Q9H0J4","Glutamine-rich protein 2","Homo sapiens (Human)","cell projection assembly [GO:0030031]; flagellated sperm motility [GO:0030317]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]","GO:0005737; GO:0030031; GO:0030317; GO:0031965; GO:0036126; GO:2000059"
"1539",1539,"Cluster_2787","Porites_evermani_scaffold_385:3184-4184",155,-20.95,2,20,671,695,22,"77.27%","77.27%","Peve_00027881",-0.945817803408337,0.210525214478371,0.978262075707395,NA,NA,NA,NA,NA
"1540",1540,"Cluster_2787","Porites_evermani_scaffold_3967:8881-9881",164,-22.85,2,21,472,493,19,"68.42%","84.21%","Peve_00028547",-0.773654223740315,0.436853570205638,0.978262075707395,"A0PJX2","TLD domain-containing protein 2 (TBC/LysM-associated domain-containing protein 2)","Homo sapiens (Human)","response to oxidative stress [GO:0006979]","GO:0005634; GO:0006979"
"1541",1541,"Cluster_2787","Porites_evermani_scaffold_4025:19902-20902",152,-20.77,2,21,656,677,19,"63.16%","73.68%","Peve_00028964",0.82009134903134,0.387845120155505,0.978262075707395,"Q7TNH6","Nephrocystin-3","Mus musculus (Mouse)","atrial septum development [GO:0003283]; cilium assembly [GO:0060271]; convergent extension [GO:0060026]; convergent extension involved in gastrulation [GO:0060027]; determination of intestine left/right asymmetry [GO:0071908]; determination of left/right symmetry [GO:0007368]; determination of liver left/right asymmetry [GO:0071910]; determination of pancreatic left/right asymmetry [GO:0035469]; determination of stomach left/right asymmetry [GO:0071909]; establishment or maintenance of cell polarity [GO:0007163]; extracellular matrix organization [GO:0030198]; heart looping [GO:0001947]; kidney development [GO:0001822]; kidney morphogenesis [GO:0060993]; lipid metabolic process [GO:0006629]; lung development [GO:0030324]; maintenance of animal organ identity [GO:0048496]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; positive regulation of protein binding [GO:0032092]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; ureter development [GO:0072189]; Wnt signaling pathway [GO:0016055]","GO:0001822; GO:0001947; GO:0003283; GO:0005929; GO:0006629; GO:0007163; GO:0007368; GO:0016055; GO:0030198; GO:0030324; GO:0032092; GO:0035469; GO:0045494; GO:0048496; GO:0060026; GO:0060027; GO:0060271; GO:0060993; GO:0071908; GO:0071909; GO:0071910; GO:0072189; GO:0090090; GO:0097543; GO:0097546; GO:1905515; GO:2000095"
"1542",1542,"Cluster_2787","Porites_evermani_scaffold_403:252522-253522",160,-21.82,2,21,688,709,19,"63.16%","84.21%","Peve_00028993",NA,NA,NA,NA,NA,NA,NA,NA
"1543",1543,"Cluster_2787","Porites_evermani_scaffold_404:69652-70652",155,-20.55,2,21,928,950,20,"65.00%","80.00%","Peve_00029034",0.527641393169282,0.646152985007006,0.978262075707395,"Q9UI36","Dachshund homolog 1 (Dach1)","Homo sapiens (Human)","development of primary female sexual characteristics [GO:0046545]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of nuclear cell cycle DNA replication [GO:0033262]; regulation of transcription by RNA polymerase II [GO:0006357]; respiratory gaseous exchange by respiratory system [GO:0007585]; suckling behavior [GO:0001967]; type B pancreatic cell proliferation [GO:0044342]","GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001967; GO:0005634; GO:0005654; GO:0005667; GO:0005794; GO:0005829; GO:0006357; GO:0007585; GO:0010944; GO:0016607; GO:0030336; GO:0033262; GO:0044342; GO:0045892; GO:0046545; GO:0048147; GO:0060244; GO:2000279"
"1544",1544,"Cluster_2787","Porites_evermani_scaffold_4049:7658-8658",155,-20.19,2,21,287,309,20,"65.00%","80.00%","Peve_00029084",0.974999843712158,0.142651204888025,0.978262075707395,NA,NA,NA,NA,NA
"1545",1545,"Cluster_2787","Porites_evermani_scaffold_405:213512-214512",153,-20.7,2,19,599,621,18,"72.22%","77.78%","Peve_00029092",NA,NA,NA,NA,NA,NA,NA,NA
"1546",1546,"Cluster_2787","Porites_evermani_scaffold_408:235864-236864",160,-27.26,2,18,788,810,17,"76.47%","88.24%","Peve_00029261",0.740667339558218,0.469018958602179,0.978262075707395,"Q98SN7","Protein Wnt-2b","Gallus gallus (Chicken)","camera-type eye photoreceptor cell differentiation [GO:0060219]; canonical Wnt signaling pathway [GO:0060070]; cell population proliferation [GO:0008283]; cornea development in camera-type eye [GO:0061303]; embryonic camera-type eye formation [GO:0060900]; embryonic forelimb morphogenesis [GO:0035115]; iris morphogenesis [GO:0061072]; lens development in camera-type eye [GO:0002088]; limb development [GO:0060173]; morphogenesis of an epithelial sheet [GO:0002011]; negative regulation of glial cell differentiation [GO:0045686]; negative regulation of neuron differentiation [GO:0045665]; neural retina development [GO:0003407]; neuron differentiation [GO:0030182]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of fibroblast growth factor production [GO:0090270]; retina layer formation [GO:0010842]; Wnt signaling pathway [GO:0016055]","GO:0002011; GO:0002088; GO:0003407; GO:0005109; GO:0005576; GO:0008283; GO:0010842; GO:0016055; GO:0030182; GO:0035115; GO:0045665; GO:0045686; GO:0045743; GO:0060070; GO:0060173; GO:0060219; GO:0060828; GO:0060900; GO:0061072; GO:0061303; GO:0090270; GO:0090271"
"1547",1547,"Cluster_2787","Porites_evermani_scaffold_4090:11531-12531",154,-21.32,2,21,341,365,22,"68.18%","77.27%","Peve_00029307",NA,NA,NA,NA,NA,NA,NA,NA
"1548",1548,"Cluster_2787","Porites_evermani_scaffold_4095:23332-24332",160,-22.17,2,21,325,346,19,"63.16%","84.21%","Peve_00029318",-0.0182745358373588,0.988365421515772,0.999448381576871,"Q0DXS3","Probable RNA-dependent RNA polymerase 1 (OsRDR1) (EC 2.7.7.48)","Oryza sativa subsp. japonica (Rice)","positive regulation of post-transcriptional gene silencing [GO:0060148]; response to salicylic acid [GO:0009751]; response to virus [GO:0009615]; siRNA processing [GO:0030422]; wax biosynthetic process [GO:0010025]","GO:0003723; GO:0003968; GO:0009615; GO:0009751; GO:0010025; GO:0030422; GO:0031380; GO:0060148"
"1549",1549,"Cluster_2787","Porites_evermani_scaffold_410:243306-244306",148,-20.71,2,21,834,855,19,"57.89%","73.68%","Peve_00029408",-0.725138292678535,0.483551629245069,0.978262075707395,"P10950","Acetylserotonin O-methyltransferase (EC 2.1.1.4) (Hydroxyindole O-methyltransferase) (HIOMT)","Bos taurus (Bovine)","aromatic compound biosynthetic process [GO:0019438]; lipid metabolic process [GO:0006629]; melatonin biosynthetic process [GO:0030187]; methylation [GO:0032259]","GO:0006629; GO:0008171; GO:0008757; GO:0017096; GO:0019438; GO:0030187; GO:0032259; GO:0042803"
"1550",1550,"Cluster_2787","Porites_evermani_scaffold_4333:5913-6913",160,-24.85,2,18,671,694,18,"72.22%","88.89%","Peve_00030602",NA,NA,NA,NA,NA,NA,NA,NA
"1551",1551,"Cluster_2787","Porites_evermani_scaffold_4338:16116-17116",146,-21.46,2,21,34,61,25,"60.00%","72.00%","Peve_00030614",NA,NA,NA,"P79218","Substance-K receptor (SKR) (NK-2 receptor) (NK-2R) (Neurokinin A receptor) (Tachykinin receptor 2)","Oryctolagus cuniculus (Rabbit)","positive regulation of flagellated sperm motility [GO:1902093]; regulation of uterine smooth muscle contraction [GO:0070472]","GO:0004995; GO:0005886; GO:0061827; GO:0070472; GO:0097225; GO:1902093"
"1552",1552,"Cluster_2787","Porites_evermani_scaffold_43:677786-678786",163,-22.77,2,21,23,45,20,"75.00%","80.00%","Peve_00030408",NA,NA,NA,NA,NA,NA,NA,NA
"1553",1553,"Cluster_2787","Porites_evermani_scaffold_438:240861-241861",153,-20.15,2,14,863,884,12,"75.00%","100.00%","Peve_00030801",0.867933894665659,0.330895275232091,0.978262075707395,"Q12955","Ankyrin-3 (ANK-3) (Ankyrin-G)","Homo sapiens (Human)","axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]","GO:0000281; GO:0005200; GO:0005764; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0007009; GO:0007165; GO:0007409; GO:0007528; GO:0008092; GO:0008093; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014704; GO:0014731; GO:0016323; GO:0016328; GO:0016529; GO:0019228; GO:0030018; GO:0030315; GO:0030425; GO:0030507; GO:0030674; GO:0031594; GO:0033268; GO:0034112; GO:0042383; GO:0043001; GO:0043005; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045184; GO:0045211; GO:0045296; GO:0045838; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0099612; GO:1900827; GO:1902260; GO:2000651; GO:2001259"
"1554",1554,"Cluster_2787","Porites_evermani_scaffold_446:159302-160302",150,-20.65,2,21,730,756,24,"66.67%","70.83%","Peve_00031263",NA,NA,NA,NA,NA,NA,NA,NA
"1555",1555,"Cluster_2787","Porites_evermani_scaffold_4491:5628-6628",162,-28.18,2,21,105,125,19,"73.68%","84.21%","Peve_00031417",0.996177774303822,0.0556790366698033,0.978262075707395,"Q5T1H1","Protein eyes shut homolog (Epidermal growth factor-like protein 10) (EGF-like protein 10) (Epidermal growth factor-like protein 11) (EGF-like protein 11) (Protein spacemaker homolog)","Homo sapiens (Human)","detection of light stimulus involved in visual perception [GO:0050908]; skeletal muscle tissue regeneration [GO:0043403]","GO:0001750; GO:0005509; GO:0005737; GO:0005815; GO:0033165; GO:0043403; GO:0050908; GO:0070062"
"1556",1556,"Cluster_2787","Porites_evermani_scaffold_45:523365-524365",174,-25.57,2,21,599,623,22,"81.82%","86.36%","Peve_00031444",0.504291273104903,0.663507591243785,0.978262075707395,"Q99JY0","Trifunctional enzyme subunit beta, mitochondrial (TP-beta) [Includes: 3-ketoacyl-CoA thiolase (EC 2.3.1.155) (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase)]","Mus musculus (Mouse)","cellular response to lipopolysaccharide [GO:0071222]; fatty acid beta-oxidation [GO:0006635]; gene expression [GO:0010467]","GO:0003985; GO:0003988; GO:0005739; GO:0005741; GO:0005743; GO:0005783; GO:0006635; GO:0010467; GO:0016507; GO:0042645; GO:0044877; GO:0050633; GO:0071222; GO:0106222"
"1557",1557,"Cluster_2787","Porites_evermani_scaffold_4676:22102-23069",151,-22.47,2,21,15,38,21,"66.67%","71.43%","Peve_00032213",0.992556418296979,0.077724128520887,0.978262075707395,NA,NA,NA,NA,NA
"1558",1558,"Cluster_2787","Porites_evermani_scaffold_468:252681-253681",149,-20.94,2,21,267,291,23,"69.57%","69.57%","Peve_00032235",NA,NA,NA,NA,NA,NA,NA,NA
"1559",1559,"Cluster_2787","Porites_evermani_scaffold_468:252681-253681",159,-20.27,2,21,699,721,20,"70.00%","80.00%","Peve_00032235",NA,NA,NA,NA,NA,NA,NA,NA
"1560",1560,"Cluster_2787","Porites_evermani_scaffold_4:69960-70960",159,-21.43,2,20,725,746,18,"66.67%","83.33%","Peve_00028712",0.103898378968637,0.933736653559173,0.999448381576871,"Q7T2D4","Endoplasmic reticulum-Golgi intermediate compartment protein 2","Danio rerio (Zebrafish) (Brachydanio rerio)","endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]","GO:0005783; GO:0005789; GO:0005794; GO:0006888; GO:0006890; GO:0016020; GO:0030134; GO:0033116"
"1561",1561,"Cluster_2787","Porites_evermani_scaffold_4706:12803-13803",160,-21.82,2,21,348,369,19,"63.16%","84.21%","Peve_00032356",0.509865198763845,0.659390543137167,0.978262075707395,"Q6GP53","N-alpha-acetyltransferase 50 (EC 2.3.1.258) (N-acetyltransferase NAT13) (N-epsilon-acetyltransferase 50) (EC 2.3.1.-) (NatE catalytic subunit)","Xenopus laevis (African clawed frog)","establishment of mitotic sister chromatid cohesion [GO:0034087]; mitotic sister chromatid cohesion, centromeric [GO:0071962]; N-terminal protein amino acid acetylation [GO:0006474]","GO:0004596; GO:0005634; GO:0005737; GO:0005829; GO:0006474; GO:0010485; GO:0034087; GO:0052858; GO:0071962"
"1562",1562,"Cluster_2787","Porites_evermani_scaffold_480:91662-92662",167,-21.43,2,21,950,972,20,"75.00%","85.00%","Peve_00032762",0.604665625789622,0.586613506688145,0.978262075707395,NA,NA,NA,NA,NA
"1563",1563,"Cluster_2787","Porites_evermani_scaffold_481:150272-151272",160,-21.32,2,20,25,44,18,"77.78%","83.33%","Peve_00032820",NA,NA,NA,NA,NA,NA,NA,NA
"1564",1564,"Cluster_2787","Porites_evermani_scaffold_491:158986-159986",163,-24.79,2,21,126,149,21,"71.43%","80.95%","Peve_00033183",0.867933894665659,0.330895275232091,0.978262075707395,"A7SXG9","Nematocyst expressed protein 8 (NEP-8) (NEP8)","Nematostella vectensis (Starlet sea anemone)","","GO:0005576; GO:0042151; GO:0090729"
"1565",1565,"Cluster_2787","Porites_evermani_scaffold_493:226650-227650",166,-28.24,2,21,942,966,22,"72.73%","86.36%","Peve_00033270",0.856723233839431,0.344992946105774,0.978262075707395,"Q6NUQ1","RAD50-interacting protein 1 (RAD50 interactor 1) (HsRINT-1) (RINT-1)","Homo sapiens (Human)","endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; protein transport [GO:0015031]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]","GO:0005783; GO:0005789; GO:0005829; GO:0006888; GO:0006890; GO:0007095; GO:0015031; GO:0060628; GO:0070939"
"1566",1566,"Cluster_2787","Porites_evermani_scaffold_49:540967-541967",157,-20.96,2,21,232,251,19,"68.42%","84.21%","Peve_00033083",0.946919976905513,0.208353439883116,0.978262075707395,"P53111","NADPH-dependent aldehyde reductase ARI1 (EC 1.1.1.-)","Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)","","GO:0004090; GO:0005634; GO:0005737; GO:0016491; GO:0016616"
"1567",1567,"Cluster_2787","Porites_evermani_scaffold_4966:8844-9775",171,-24.9,2,21,203,225,20,"80.00%","85.00%","Peve_00033383",0.867933894665659,0.330895275232091,0.978262075707395,NA,NA,NA,NA,NA
"1568",1568,"Cluster_2787","Porites_evermani_scaffold_501:166807-167807",152,-20.12,2,21,71,92,19,"63.16%","73.68%","Peve_00033695",NA,NA,NA,NA,NA,NA,NA,NA
"1569",1569,"Cluster_2787","Porites_evermani_scaffold_5021:17431-18284",164,-25.46,2,19,566,589,19,"78.95%","89.47%","Peve_00033736",0.872816463273017,0.324582236001653,0.978262075707395,"Q8R4Y8","Rotatin","Mus musculus (Mouse)","centriole replication [GO:0007099]; centriole-centriole cohesion [GO:0010457]; ciliary basal body organization [GO:0032053]; determination of left/right symmetry [GO:0007368]","GO:0005737; GO:0005813; GO:0005814; GO:0007099; GO:0007368; GO:0010457; GO:0016020; GO:0032053; GO:0036064"
"1570",1570,"Cluster_2787","Porites_evermani_scaffold_5026:268-1268",163,-20.05,2,21,468,490,20,"75.00%","80.00%","Peve_00033744",0.867933894665659,0.330895275232091,0.978262075707395,"P51955","Serine/threonine-protein kinase Nek2 (EC 2.7.11.1) (HSPK 21) (Never in mitosis A-related kinase 2) (NimA-related protein kinase 2) (NimA-like protein kinase 1)","Homo sapiens (Human)","blastocyst development [GO:0001824]; cell division [GO:0051301]; centrosome separation [GO:0051299]; chromosome segregation [GO:0007059]; meiotic cell cycle [GO:0051321]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; negative regulation of centriole-centriole cohesion [GO:1903126]; negative regulation of DNA binding [GO:0043392]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of mitotic centrosome separation [GO:0046602]; regulation of mitotic nuclear division [GO:0007088]; spindle assembly [GO:0051225]","GO:0000070; GO:0000278; GO:0000776; GO:0000794; GO:0000922; GO:0001824; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0005874; GO:0006468; GO:0007059; GO:0007088; GO:0019903; GO:0030496; GO:0032212; GO:0032991; GO:0043392; GO:0046602; GO:0046777; GO:0046872; GO:0051225; GO:0051299; GO:0051301; GO:0051321; GO:0051973; GO:0051988; GO:0090307; GO:0106310; GO:1903126; GO:1904355"
"1571",1571,"Cluster_2787","Porites_evermani_scaffold_507:175282-176282",156,-20.36,2,21,577,598,19,"63.16%","78.95%","Peve_00033912",NA,NA,NA,NA,NA,NA,NA,NA
"1572",1572,"Cluster_2787","Porites_evermani_scaffold_509:26684-27684",149,-20.34,2,20,784,809,22,"68.18%","72.73%","Peve_00033966",-0.00382968334855694,0.997561941898757,0.999448381576871,NA,NA,NA,NA,NA
"1573",1573,"Cluster_2787","Porites_evermani_scaffold_5093:16329-17329",166,-21.71,2,21,248,268,19,"73.68%","89.47%","Peve_00033985",-0.131343880569665,0.916141589666122,0.999448381576871,"Q9GLK0","Protein-glutamine gamma-glutamyltransferase K (EC 2.3.2.13) (Epidermal TGase) (Transglutaminase K) (TG(K)) (TGK) (TGase K) (Transglutaminase-1) (TGase-1)","Canis lupus familiaris (Dog) (Canis familiaris)","keratinization [GO:0031424]; peptide cross-linking [GO:0018149]; positive regulation of cell cycle [GO:0045787]; positive regulation of keratinocyte proliferation [GO:0010838]","GO:0003810; GO:0010838; GO:0016020; GO:0018149; GO:0031424; GO:0045787; GO:0046872"
"1574",1574,"Cluster_2787","Porites_evermani_scaffold_510:211293-212293",153,-20.04,2,19,600,622,18,"66.67%","83.33%","Peve_00034068",-0.654675037143499,0.545610953977413,0.978262075707395,"Q9Y6L7","Tolloid-like protein 2 (EC 3.4.24.-)","Homo sapiens (Human)","cell differentiation [GO:0030154]; collagen fibril organization [GO:0030199]; dorsal/ventral pattern formation [GO:0009953]; negative regulation of skeletal muscle tissue growth [GO:0048632]; protein processing [GO:0016485]","GO:0004222; GO:0004252; GO:0005509; GO:0005576; GO:0005615; GO:0008270; GO:0009953; GO:0016485; GO:0030154; GO:0030199; GO:0048632"
"1575",1575,"Cluster_2787","Porites_evermani_scaffold_51:227484-228484",165,-20.54,2,19,96,118,18,"83.33%","83.33%","Peve_00034031",0.730035977725734,0.479006552463649,0.978262075707395,NA,NA,NA,NA,NA
"1576",1576,"Cluster_2787","Porites_evermani_scaffold_5158:12046-13046",149,-20.73,2,20,490,514,21,"66.67%","76.19%","Peve_00034238",-0.800221037286208,0.409430943920597,0.978262075707395,"Q9EQW8","Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 4 (EC 2.8.2.8) (Glucosaminyl N-deacetylase/N-sulfotransferase 4) (NDST-4) (N-heparan sulfate sulfotransferase 4) (N-HSST 4) [Includes: Heparan sulfate N-deacetylase 4 (EC 3.-.-.-); Heparan sulfate N-sulfotransferase 4 (EC 2.8.2.-)]","Mus musculus (Mouse)","heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]","GO:0000139; GO:0005794; GO:0008146; GO:0015014; GO:0015016; GO:0019213; GO:0030210; GO:0050119"
"1577",1577,"Cluster_2787","Porites_evermani_scaffold_52:314231-315231",161,-23.23,2,20,130,150,18,"77.78%","83.33%","Peve_00034359",0.947875716395419,0.206452383697475,0.978262075707395,"Q8BKG4","Frizzled-10 (Fz-10) (CD antigen CD350)","Mus musculus (Mouse)","canonical Wnt signaling pathway [GO:0060070]; negative regulation of GTPase activity [GO:0034260]; non-canonical Wnt signaling pathway via JNK cascade [GO:0038031]; positive regulation of GTPase activity [GO:0043547]; positive regulation of JUN kinase activity [GO:0043507]; regulation of actin cytoskeleton organization [GO:0032956]; Wnt signaling pathway [GO:0016055]","GO:0004930; GO:0005654; GO:0005737; GO:0005886; GO:0009986; GO:0016020; GO:0016055; GO:0017147; GO:0032956; GO:0034260; GO:0038031; GO:0042813; GO:0043507; GO:0043547; GO:0060070"
"1578",1578,"Cluster_2787","Porites_evermani_scaffold_5295:12013-13013",159,-20.07,2,21,745,767,20,"70.00%","80.00%","Peve_00034696",0.955872037586105,0.189828834828235,0.978262075707395,NA,NA,NA,NA,NA
"1579",1579,"Cluster_2787","Porites_evermani_scaffold_5372:11196-12196",159,-22.23,2,21,150,173,21,"71.43%","76.19%","Peve_00034997",NA,NA,NA,NA,NA,NA,NA,NA
"1580",1580,"Cluster_2787","Porites_evermani_scaffold_539:48932-49833",154,-20.59,2,21,470,493,21,"71.43%","76.19%","Peve_00035074",-0.087895103005773,0.94397193973631,0.999448381576871,"P43247","DNA mismatch repair protein Msh2 (MutS protein homolog 2)","Mus musculus (Mouse)","B cell differentiation [GO:0030183]; B cell mediated immunity [GO:0019724]; cellular response to DNA damage stimulus [GO:0006974]; determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; germ cell development [GO:0007281]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; isotype switching [GO:0045190]; maintenance of DNA repeat elements [GO:0043570]; male gonad development [GO:0008584]; mismatch repair [GO:0006298]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; mitotic recombination [GO:0006312]; negative regulation of DNA recombination [GO:0045910]; negative regulation of neuron apoptotic process [GO:0043524]; oxidative phosphorylation [GO:0006119]; positive regulation of helicase activity [GO:0051096]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; postreplication repair [GO:0006301]; protein localization to chromatin [GO:0071168]; regulation of cell cycle [GO:0051726]; response to UV-B [GO:0010224]; response to X-ray [GO:0010165]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]; somatic recombination of immunoglobulin genes involved in immune response [GO:0002204]","GO:0000287; GO:0000400; GO:0001701; GO:0002204; GO:0003677; GO:0003682; GO:0003684; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0006119; GO:0006281; GO:0006298; GO:0006301; GO:0006302; GO:0006312; GO:0006974; GO:0007281; GO:0008022; GO:0008094; GO:0008340; GO:0008584; GO:0008630; GO:0010165; GO:0010224; GO:0016446; GO:0016447; GO:0016887; GO:0019237; GO:0019724; GO:0019899; GO:0019901; GO:0030183; GO:0030983; GO:0031573; GO:0032137; GO:0032139; GO:0032142; GO:0032143; GO:0032181; GO:0032301; GO:0032302; GO:0032357; GO:0032405; GO:0042771; GO:0042803; GO:0043524; GO:0043531; GO:0043570; GO:0045190; GO:0045910; GO:0048298; GO:0048304; GO:0051096; GO:0051726; GO:0071168; GO:0140664"
"1581",1581,"Cluster_2787","Porites_evermani_scaffold_539:48932-49833",154,-20.59,2,21,470,493,21,"71.43%","76.19%","Peve_00035077",0.985821405650583,0.107331250450393,0.978262075707395,"O95684","Centrosomal protein 43 (FGFR1 oncogene partner)","Homo sapiens (Human)","cell projection organization [GO:0030030]; microtubule anchoring [GO:0034453]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]","GO:0005634; GO:0005813; GO:0005814; GO:0005829; GO:0006469; GO:0008284; GO:0019901; GO:0030030; GO:0030292; GO:0030307; GO:0030335; GO:0034453; GO:0042803; GO:0042995; GO:0048471"
"1582",1582,"Cluster_2787","Porites_evermani_scaffold_5451:9745-10745",150,-20.19,2,20,663,685,19,"68.42%","73.68%","Peve_00035312",NA,NA,NA,"P26714","Gamma-aminobutyric acid receptor subunit beta (GABA(A) receptor)","Lymnaea stagnalis (Great pond snail) (Helix stagnalis)","","GO:0004890; GO:0005230; GO:0005254; GO:0034707; GO:0045211"
"1583",1583,"Cluster_2787","Porites_evermani_scaffold_554:28122-29122",159,-22.27,2,21,126,149,21,"66.67%","80.95%","Peve_00035621",0.815408988174422,0.393024202180293,0.978262075707395,NA,NA,NA,NA,NA
"1584",1584,"Cluster_2787","Porites_evermani_scaffold_561:127410-128410",160,-22.17,2,21,67,88,19,"63.16%","84.21%","Peve_00035835",0.465844666343888,0.691501098780552,0.978262075707395,NA,NA,NA,NA,NA
"1585",1585,"Cluster_2787","Porites_evermani_scaffold_565:215421-216421",158,-25.58,2,21,77,101,22,"72.73%","77.27%","Peve_00035945",0.932112313509811,0.235927587561586,0.978262075707395,NA,NA,NA,NA,NA
"1586",1586,"Cluster_2787","Porites_evermani_scaffold_57:312852-313852",158,-23.01,2,21,595,615,19,"73.68%","78.95%","Peve_00036122",0.998020559760609,0.0400624940598234,0.909359886114279,NA,NA,NA,NA,NA
"1587",1587,"Cluster_2787","Porites_evermani_scaffold_57:483664-484664",159,-21.13,2,18,278,298,16,"81.25%","87.50%","Peve_00036082",0.818066843004554,0.390091745398863,0.978262075707395,"P35384","Extracellular calcium-sensing receptor (CaSR) (Parathyroid cell calcium-sensing receptor) (BoPCaR1) (PCaR1)","Bos taurus (Bovine)","calcium ion import [GO:0070509]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; detection of calcium ion [GO:0005513]; G protein-coupled receptor signaling pathway [GO:0007186]; JNK cascade [GO:0007254]; ossification [GO:0001503]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; regulation of calcium ion transport [GO:0051924]; vasodilation [GO:0042311]","GO:0001503; GO:0004930; GO:0005509; GO:0005513; GO:0005886; GO:0006816; GO:0006874; GO:0007186; GO:0007254; GO:0008284; GO:0010628; GO:0016597; GO:0032781; GO:0042311; GO:0042803; GO:0043679; GO:0051924; GO:0070509"
"1588",1588,"Cluster_2787","Porites_evermani_scaffold_5779:5072-6072",150,-23.8,2,20,664,688,21,"66.67%","71.43%","Peve_00036300",-0.802174169644711,0.40735305876833,0.978262075707395,NA,NA,NA,NA,NA
"1589",1589,"Cluster_2787","Porites_evermani_scaffold_5840:6118-7118",150,-20.19,2,20,680,702,19,"68.42%","73.68%","Peve_00036515",NA,NA,NA,"P26714","Gamma-aminobutyric acid receptor subunit beta (GABA(A) receptor)","Lymnaea stagnalis (Great pond snail) (Helix stagnalis)","","GO:0004890; GO:0005230; GO:0005254; GO:0034707; GO:0045211"
"1590",1590,"Cluster_2787","Porites_evermani_scaffold_59:56468-57468",153,-24.24,2,20,607,630,20,"65.00%","85.00%","Peve_00036682",NA,NA,NA,NA,NA,NA,NA,NA
"1591",1591,"Cluster_2787","Porites_evermani_scaffold_600:46040-47040",154,-20.33,2,21,456,482,24,"70.83%","70.83%","Peve_00037108",0.813002592887085,0.395662901316479,0.978262075707395,NA,NA,NA,NA,NA
"1592",1592,"Cluster_2787","Porites_evermani_scaffold_600:65939-66939",161,-20.1,2,21,722,746,22,"77.27%","81.82%","Peve_00037098",-0.00382968334855694,0.997561941898757,0.999448381576871,NA,NA,NA,NA,NA
"1593",1593,"Cluster_2787","Porites_evermani_scaffold_60:343976-344976",150,-21.21,2,21,349,373,22,"68.18%","72.73%","Peve_00037061",-0.999649545771953,0.0168547943103946,0.778328904052462,"Q92820","Gamma-glutamyl hydrolase (EC 3.4.19.9) (Conjugase) (GH) (Gamma-Glu-X carboxypeptidase)","Homo sapiens (Human)","tetrahydrofolylpolyglutamate metabolic process [GO:0046900]","GO:0005576; GO:0005615; GO:0005634; GO:0005773; GO:0008238; GO:0008242; GO:0034722; GO:0035578; GO:0035580; GO:0042470; GO:0046900; GO:0070062; GO:1904724"
"1594",1594,"Cluster_2787","Porites_evermani_scaffold_609:88638-89638",153,-23.24,2,21,781,807,24,"70.83%","75.00%","Peve_00037296",0.926169667772818,0.246162255363002,0.978262075707395,"P56517","Histone deacetylase 1 (HD1) (EC 3.5.1.98) (Protein deacetylase HDAC1) (EC 3.5.1.-) (Protein decrotonylase HDAC1) (EC 3.5.1.-)","Gallus gallus (Chicken)","chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; DNA methylation-dependent heterochromatin formation [GO:0006346]; embryonic digit morphogenesis [GO:0042733]; endoderm development [GO:0007492]; epidermal cell differentiation [GO:0009913]; eyelid development in camera-type eye [GO:0061029]; fungiform papilla formation [GO:0061198]; hippocampus development [GO:0021766]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; oligodendrocyte differentiation [GO:0048709]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of signaling receptor activity [GO:2000273]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of endopeptidase activity [GO:0052548]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000118; GO:0000122; GO:0000792; GO:0000979; GO:0001222; GO:0002039; GO:0003714; GO:0004407; GO:0005634; GO:0005737; GO:0005829; GO:0006325; GO:0006346; GO:0006357; GO:0007492; GO:0008284; GO:0009913; GO:0016580; GO:0016581; GO:0017053; GO:0021766; GO:0030182; GO:0032922; GO:0035851; GO:0042733; GO:0042826; GO:0043025; GO:0043124; GO:0043922; GO:0045944; GO:0047485; GO:0048709; GO:0048714; GO:0051059; GO:0052548; GO:0060766; GO:0061029; GO:0061198; GO:0070888; GO:0070932; GO:0070933; GO:0090090; GO:0140297; GO:0160009; GO:1990841; GO:2000273; GO:2001243"
"1595",1595,"Cluster_2787","Porites_evermani_scaffold_6152:6541-7513",163,-23.24,2,17,645,668,17,"82.35%","88.24%","Peve_00037466",0.867933894665659,0.330895275232091,0.978262075707395,NA,NA,NA,NA,NA
"1596",1596,"Cluster_2787","Porites_evermani_scaffold_617:145800-146800",161,-21.82,2,20,904,924,18,"72.22%","88.89%","Peve_00037519",NA,NA,NA,NA,NA,NA,NA,NA
"1597",1597,"Cluster_2787","Porites_evermani_scaffold_618:7168-8168",159,-20.96,2,21,294,316,20,"75.00%","75.00%","Peve_00037531",NA,NA,NA,NA,NA,NA,NA,NA
"1598",1598,"Cluster_2787","Porites_evermani_scaffold_6339:0-968",155,-21.98,2,21,263,290,25,"68.00%","68.00%","Peve_00037964",0.989591582855196,0.0919316128720343,0.978262075707395,NA,NA,NA,NA,NA
"1599",1599,"Cluster_2787","Porites_evermani_scaffold_649:75515-76515",164,-22.79,2,21,413,434,19,"63.16%","89.47%","Peve_00038338",-0.0783683236286482,0.950057965795359,0.999448381576871,NA,NA,NA,NA,NA
"1600",1600,"Cluster_2787","Porites_evermani_scaffold_6661:2520-3520",163,-20.4,2,21,897,919,20,"70.00%","85.00%","Peve_00038742",0.843030659965373,0.361538363431101,0.978262075707395,NA,NA,NA,NA,NA
"1601",1601,"Cluster_2787","Porites_evermani_scaffold_682:92964-93879",158,-21.8,2,21,666,691,23,"69.57%","78.26%","Peve_00039122",0.997623736355649,0.0438963560597039,0.922643131738102,"Q9BYE2","Transmembrane protease serine 13 (EC 3.4.21.-) (Membrane-type mosaic serine protease) (Mosaic serine protease)","Homo sapiens (Human)","proteolysis [GO:0006508]","GO:0004252; GO:0005044; GO:0006508; GO:0016020; GO:0072562"
"1602",1602,"Cluster_2787","Porites_evermani_scaffold_68:381435-382435",153,-20.52,2,20,189,214,22,"63.64%","81.82%","Peve_00039066",NA,NA,NA,"Q9VYB7","Protein-tyrosine sulfotransferase (EC 2.8.2.20) (Transport and Golgi organization protein 13) (Tango-13) (Tyrosylprotein sulfotransferase)","Drosophila melanogaster (Fruit fly)","peptidyl-tyrosine sulfation [GO:0006478]; protein secretion [GO:0009306]","GO:0000139; GO:0005794; GO:0006478; GO:0008146; GO:0008476; GO:0009306"
"1603",1603,"Cluster_2787","Porites_evermani_scaffold_68:560041-560981",164,-21.33,2,21,825,846,19,"68.42%","84.21%","Peve_00039034",-0.00382968334855694,0.997561941898757,0.999448381576871,NA,NA,NA,NA,NA
"1604",1604,"Cluster_2787","Porites_evermani_scaffold_689:140330-141330",166,-28.71,2,15,165,186,13,"92.31%","100.00%","Peve_00039239",0.871372492569002,0.326460824398788,0.978262075707395,"P42680","Tyrosine-protein kinase Tec (EC 2.7.10.2)","Homo sapiens (Human)","adaptive immune response [GO:0002250]; B cell receptor signaling pathway [GO:0050853]; integrin-mediated signaling pathway [GO:0007229]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of platelet activation [GO:0010543]; T cell receptor signaling pathway [GO:0050852]; tissue regeneration [GO:0042246]","GO:0002250; GO:0004713; GO:0004715; GO:0005524; GO:0005543; GO:0005829; GO:0005856; GO:0005886; GO:0006468; GO:0007229; GO:0010543; GO:0035556; GO:0042246; GO:0043621; GO:0046872; GO:0050852; GO:0050853"
"1605",1605,"Cluster_2787","Porites_evermani_scaffold_703:15039-16039",148,-20.62,2,13,53,74,11,"81.82%","90.91%","Peve_00039693",NA,NA,NA,NA,NA,NA,NA,NA
"1606",1606,"Cluster_2787","Porites_evermani_scaffold_710:161473-162473",165,-23.44,2,20,960,980,18,"77.78%","88.89%","Peve_00039845",NA,NA,NA,NA,NA,NA,NA,NA
"1607",1607,"Cluster_2787","Porites_evermani_scaffold_7:198829-199829",163,-22.22,2,20,476,497,18,"72.22%","83.33%","Peve_00039597",0.897846445368917,0.290261997079864,0.978262075707395,NA,NA,NA,NA,NA
"1608",1608,"Cluster_2787","Porites_evermani_scaffold_728:94295-95295",155,-20.05,2,20,234,255,18,"66.67%","77.78%","Peve_00040183",0.662102352506053,0.539328800927467,0.978262075707395,"Q6DBY9","Carbohydrate sulfotransferase 1 (EC 2.8.2.21) (Keratan sulfate Gal-6 sulfotransferase) (KS6ST) (KSGal6ST) (KSST)","Danio rerio (Zebrafish) (Brachydanio rerio)","carbohydrate metabolic process [GO:0005975]; keratan sulfate metabolic process [GO:0042339]; N-acetylglucosamine metabolic process [GO:0006044]; sulfur compound metabolic process [GO:0006790]","GO:0000139; GO:0001517; GO:0005802; GO:0005975; GO:0006044; GO:0006790; GO:0042339; GO:0045130"
"1609",1609,"Cluster_2787","Porites_evermani_scaffold_770:10826-11826",166,-26.22,2,21,524,547,21,"76.19%","85.71%","Peve_00041078",0.964899471722404,0.169172798039506,0.978262075707395,"Q9Z0J0","NPC intracellular cholesterol transporter 2 (Epididymal secretory protein E1) (mE1) (Niemann Pick type C2 protein homolog)","Mus musculus (Mouse)","cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; intracellular sterol transport [GO:0032366]; response to virus [GO:0009615]; sterol transport [GO:0015918]","GO:0005615; GO:0005764; GO:0005783; GO:0008203; GO:0009615; GO:0015485; GO:0015918; GO:0019899; GO:0030301; GO:0032366; GO:0032367; GO:0032934; GO:0033344; GO:0042632; GO:0120020"
"1610",1610,"Cluster_2787","Porites_evermani_scaffold_78:45522-46522",158,-24.16,2,16,650,672,15,"80.00%","93.33%","Peve_00041283",NA,NA,NA,"A0A1D5NSM8",NA,NA,NA,NA
"1611",1611,"Cluster_2787","Porites_evermani_scaffold_82:390904-391904",156,-20.37,2,19,52,75,19,"73.68%","84.21%","Peve_00042167",-0.00382968334855694,0.997561941898757,0.999448381576871,NA,NA,NA,NA,NA
"1612",1612,"Cluster_2787","Porites_evermani_scaffold_824:17918-18918",152,-20.01,2,21,750,771,19,"63.16%","73.68%","Peve_00042291",0.975799091534281,0.140342990862644,0.978262075707395,NA,NA,NA,NA,NA
"1613",1613,"Cluster_2787","Porites_evermani_scaffold_82:578818-579818",152,-21.18,2,21,347,368,19,"68.42%","68.42%","Peve_00042177",0.999318127749319,0.0235110112931456,0.850665296699579,"Q96LK0","Centrosomal protein of 19 kDa (Cep19)","Homo sapiens (Human)","cilium assembly [GO:0060271]; microtubule anchoring at centrosome [GO:0034454]; vesicle targeting, trans-Golgi to periciliary membrane compartment [GO:0097712]","GO:0000922; GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005929; GO:0034454; GO:0036064; GO:0060271; GO:0097712"
"1614",1614,"Cluster_2787","Porites_evermani_scaffold_830:95135-96135",156,-20.07,2,21,826,847,19,"68.42%","73.68%","Peve_00042404",0.953936713482104,0.193978647533455,0.978262075707395,"Q20191","Zinc metalloproteinase nas-13 (EC 3.4.24.-) (Nematode astacin 13)","Caenorhabditis elegans","proteolysis [GO:0006508]","GO:0004222; GO:0005576; GO:0006508; GO:0008270"
"1615",1615,"Cluster_2787","Porites_evermani_scaffold_85:54787-55787",157,-21.85,2,20,825,845,18,"72.22%","83.33%","Peve_00042761",-0.00382968334855694,0.997561941898757,0.999448381576871,NA,NA,NA,NA,NA
"1616",1616,"Cluster_2787","Porites_evermani_scaffold_85:557238-558238",160,-24.07,2,18,151,173,17,"76.47%","88.24%","Peve_00042759",-0.791483729799309,0.418617940815329,0.978262075707395,NA,NA,NA,NA,NA
"1617",1617,"Cluster_2787","Porites_evermani_scaffold_85:557238-558238",160,-24.07,2,18,522,544,17,"76.47%","88.24%","Peve_00042759",-0.791483729799309,0.418617940815329,0.978262075707395,NA,NA,NA,NA,NA
"1618",1618,"Cluster_2787","Porites_evermani_scaffold_859:24066-25066",169,-24.85,2,19,196,219,19,"84.21%","84.21%","Peve_00042927",0.934321856164511,0.232012657142967,0.978262075707395,NA,NA,NA,NA,NA
"1619",1619,"Cluster_2787","Porites_evermani_scaffold_871:167075-168075",157,-20.36,2,14,499,520,12,"83.33%","100.00%","Peve_00043170",-0.00382968334855694,0.997561941898757,0.999448381576871,"P33534","Kappa-type opioid receptor (K-OR-1) (KOR-1) (MSL-1)","Mus musculus (Mouse)","adenylate cyclase-inhibiting opioid receptor signaling pathway [GO:0031635]; behavioral response to cocaine [GO:0048148]; cellular response to glucose stimulus [GO:0071333]; conditioned place preference [GO:1990708]; defense response to virus [GO:0051607]; eating behavior [GO:0042755]; G protein-coupled opioid receptor signaling pathway [GO:0038003]; immune response [GO:0006955]; locomotory behavior [GO:0007626]; maternal behavior [GO:0042711]; negative regulation of luteinizing hormone secretion [GO:0033685]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of eating behavior [GO:1904000]; positive regulation of locomotion [GO:0040017]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of potassium ion transmembrane transport [GO:1901381]; regulation of saliva secretion [GO:0046877]; regulation of sensory perception of pain [GO:0051930]; response to insulin [GO:0032868]; sensory perception of pain [GO:0019233]; sensory perception of temperature stimulus [GO:0050951]","GO:0004930; GO:0004985; GO:0005654; GO:0005829; GO:0005886; GO:0006955; GO:0007200; GO:0007218; GO:0007626; GO:0016020; GO:0019233; GO:0030425; GO:0030672; GO:0031635; GO:0032868; GO:0033603; GO:0033612; GO:0033685; GO:0038003; GO:0038048; GO:0040017; GO:0042277; GO:0042711; GO:0042734; GO:0042755; GO:0042923; GO:0043005; GO:0043025; GO:0043204; GO:0043679; GO:0045202; GO:0045211; GO:0046877; GO:0048148; GO:0050951; GO:0051607; GO:0051930; GO:0071333; GO:1900745; GO:1901381; GO:1904000; GO:1990708"
"1620",1620,"Cluster_2787","Porites_evermani_scaffold_893:102659-103659",159,-21.46,2,21,399,421,20,"75.00%","75.00%","Peve_00043524",NA,NA,NA,NA,NA,NA,NA,NA
"1621",1621,"Cluster_2787","Porites_evermani_scaffold_904:127444-128444",162,-21.81,2,20,369,391,19,"73.68%","84.21%","Peve_00043828",0.729398904091229,0.479599714340973,0.978262075707395,NA,NA,NA,NA,NA
"1622",1622,"Cluster_2787","Porites_evermani_scaffold_911:104388-105388",160,-20.04,2,18,487,509,17,"76.47%","88.24%","Peve_00043951",-0.00382968334855694,0.997561941898757,0.999448381576871,NA,NA,NA,NA,NA
"1623",1623,"Cluster_2787","Porites_evermani_scaffold_91:133722-134722",168,-25.95,2,21,108,129,19,"73.68%","84.21%","Peve_00043904",-0.961246423948351,0.177813046987313,0.978262075707395,NA,NA,NA,NA,NA
"1624",1624,"Cluster_2787","Porites_evermani_scaffold_912:83492-84492",152,-21.05,2,17,710,731,15,"73.33%","80.00%","Peve_00043963",0.84513446579289,0.359040604033296,0.978262075707395,"S4R2P9","Sodium/calcium exchanger 3 (Na(+)/Ca(2+)-exchange protein 3) (Solute carrier family 8 member 3)","Mus musculus (Mouse)","calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport into cytosol [GO:0060402]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; cellular response to cAMP [GO:0071320]; cellular response to hypoxia [GO:0071456]; hematopoietic progenitor cell differentiation [GO:0002244]; learning [GO:0007612]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; metal ion transport [GO:0030001]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; modulation of excitatory postsynaptic potential [GO:0098815]; myelination [GO:0042552]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; oligodendrocyte differentiation [GO:0048709]; regulation of skeletal muscle contraction [GO:0014819]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; synapse organization [GO:0050808]","GO:0002244; GO:0005432; GO:0005516; GO:0005739; GO:0005741; GO:0005789; GO:0005874; GO:0005886; GO:0006814; GO:0006851; GO:0006874; GO:0007154; GO:0007611; GO:0007612; GO:0007613; GO:0014069; GO:0014819; GO:0015368; GO:0016020; GO:0016528; GO:0030001; GO:0030424; GO:0030425; GO:0031594; GO:0035725; GO:0042383; GO:0042552; GO:0042995; GO:0043025; GO:0043197; GO:0043204; GO:0043679; GO:0045202; GO:0045211; GO:0046872; GO:0048471; GO:0048709; GO:0050808; GO:0051560; GO:0060291; GO:0060402; GO:0070161; GO:0070588; GO:0071320; GO:0071456; GO:0071901; GO:0098703; GO:0098794; GO:0098815; GO:0099580; GO:1905060; GO:1990034"
"1625",1625,"Cluster_2787","Porites_evermani_scaffold_951:85626-86626",146,-22.02,2,21,399,424,23,"65.22%","69.57%","Peve_00044599",NA,NA,NA,NA,NA,NA,NA,NA
"1626",1626,"Cluster_2787","Porites_evermani_scaffold_960:166291-167291",147,-22.76,2,19,290,312,19,"68.42%","78.95%","Peve_00044757",0.705066530115396,0.501834231470428,0.978262075707395,"P23906","Interferon regulatory factor 2 (IRF-2)","Mus musculus (Mouse)","defense response to virus [GO:0051607]; immune system process [GO:0002376]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0002376; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0005925; GO:0006355; GO:0006357; GO:0045944; GO:0051607; GO:1990837"
"1627",1627,"Cluster_2787","Porites_evermani_scaffold_965:137981-138981",157,-20.96,2,21,691,713,21,"76.19%","76.19%","Peve_00044824",0.723264495432811,0.485281498442768,0.978262075707395,"Q9Y2L5","Trafficking protein particle complex subunit 8 (Protein TRS85 homolog)","Homo sapiens (Human)","COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; protein localization to phagophore assembly site [GO:0034497]; vesicle tethering [GO:0099022]","GO:0000407; GO:0005737; GO:0005829; GO:0006888; GO:0007030; GO:0030008; GO:0031410; GO:0034497; GO:0048208; GO:0099022; GO:1990072"
"1628",1628,"Cluster_2787","Porites_evermani_scaffold_984:58291-59291",167,-21.69,2,21,511,533,20,"75.00%","85.00%","Peve_00045107",0.279851993246082,0.819429206617321,0.995934364227446,NA,NA,NA,NA,NA
"1629",1629,"Cluster_2787","Porites_evermani_scaffold_998:130034-131034",158,-20.09,2,21,886,906,19,"73.68%","78.95%","Peve_00045342",0.867933894665659,0.330895275232091,0.978262075707395,NA,NA,NA,NA,NA
"1630",1630,"Cluster_2854","Porites_evermani_scaffold_100:25933-26933",162,-23.99,2,15,761,782,13,"92.31%","92.31%","Peve_00000225",0.837313824284079,0.368249513998577,0.978262075707395,"Q09LZ8","Cytosolic carboxypeptidase 6 (EC 3.4.17.-) (EC 3.4.17.24) (ATP/GTP-binding protein-like 4) (Protein deglutamylase CCP6)","Mus musculus (Mouse)","anterograde axonal transport of mitochondrion [GO:0098957]; axonal transport [GO:0098930]; C-terminal protein deglutamylation [GO:0035609]; central nervous system neuron development [GO:0021954]; defense response to virus [GO:0051607]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein deglutamylation [GO:0035608]; protein side chain deglutamylation [GO:0035610]; proteolysis [GO:0006508]; regulation of blastocyst development [GO:0120222]; retrograde axonal transport of mitochondrion [GO:0098958]","GO:0004181; GO:0005794; GO:0005814; GO:0005829; GO:0006508; GO:0008270; GO:0008285; GO:0015631; GO:0021954; GO:0035608; GO:0035609; GO:0035610; GO:0036064; GO:0051607; GO:0098930; GO:0098957; GO:0098958; GO:0120222; GO:1904115; GO:2000060"
"1631",1631,"Cluster_2854","Porites_evermani_scaffold_101:86928-87928",148,-20.88,2,14,173,196,14,"78.57%","85.71%","Peve_00000377",0.997896558563532,0.0412987102322654,0.909359886114279,"Q55DA0","ABC transporter G family member 22 (ABC transporter ABCG.22)","Dictyostelium discoideum (Social amoeba)","aggregation involved in sorocarp development [GO:0031152]; cell motility [GO:0048870]; sorocarp morphogenesis [GO:0031288]; transmembrane transport [GO:0055085]","GO:0005524; GO:0016020; GO:0016887; GO:0031152; GO:0031288; GO:0042626; GO:0048870; GO:0055085; GO:0140359"
"1632",1632,"Cluster_2854","Porites_evermani_scaffold_1053:36904-37904",166,-20.77,2,21,76,99,21,"80.95%","80.95%","Peve_00001060",-0.560419837337592,0.621279585944191,0.978262075707395,"Q2V2M9","FH1/FH2 domain-containing protein 3 (Formactin-2) (Formin homolog overexpressed in spleen 2) (hFHOS2)","Homo sapiens (Human)","cardiac myofibril assembly [GO:0055003]; cortical actin cytoskeleton organization [GO:0030866]; negative regulation of actin filament polymerization [GO:0030837]; sarcomere organization [GO:0045214]","GO:0005737; GO:0005856; GO:0030018; GO:0030837; GO:0030866; GO:0045214; GO:0051015; GO:0055003"
"1633",1633,"Cluster_2854","Porites_evermani_scaffold_1063:47696-48696",176,-26.57,2,21,330,351,19,"78.95%","89.47%","Peve_00001191",-0.795895351508178,0.41400104643473,0.978262075707395,"Q8IS64","Endothelin-converting enzyme homolog (ECE) (EC 3.4.24.-)","Locusta migratoria (Migratory locust)","proteolysis [GO:0006508]","GO:0004175; GO:0004222; GO:0005886; GO:0006508; GO:0008270"
"1634",1634,"Cluster_2854","Porites_evermani_scaffold_1069:139502-140502",159,-21.31,2,20,162,183,18,"72.22%","77.78%","Peve_00001268",0.999962448044095,0.00551712420276981,0.551398425649056,NA,NA,NA,NA,NA
"1635",1635,"Cluster_2854","Porites_evermani_scaffold_1074:106206-107206",155,-20.73,2,21,777,803,24,"66.67%","70.83%","Peve_00001365",-0.507486347355159,0.661149542463894,0.978262075707395,NA,NA,NA,NA,NA
"1636",1636,"Cluster_2854","Porites_evermani_scaffold_1074:115705-116705",155,-20.73,2,21,777,803,24,"66.67%","70.83%","Peve_00001367",-0.507486347355159,0.661149542463894,0.978262075707395,NA,NA,NA,NA,NA
"1637",1637,"Cluster_2854","Porites_evermani_scaffold_1092:143912-144912",167,-22.73,2,20,951,972,18,"72.22%","88.89%","Peve_00001631",-0.903507865095865,0.28196598422105,0.978262075707395,"Q8R5B6","SPRY domain-containing SOCS box protein 4 (SSB-4)","Mus musculus (Mouse)","intracellular signal transduction [GO:0035556]; positive regulation of protein polyubiquitination [GO:1902916]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0005829; GO:0006511; GO:0016567; GO:0019005; GO:0035556; GO:0042752; GO:0043161; GO:0048511; GO:1902916; GO:1990756"
"1638",1638,"Cluster_2854","Porites_evermani_scaffold_1103:122580-123580",158,-23.68,2,21,93,118,23,"69.57%","78.26%","Peve_00001908",0.0469681934889681,0.970088114811839,0.999448381576871,"B8A4F0","Palmitoyltransferase ZDHHC16A (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 16A) (DHHC-16A)","Danio rerio (Zebrafish) (Brachydanio rerio)","cellular response to DNA damage stimulus [GO:0006974]; commitment of multipotent stem cells to neuronal lineage in forebrain [GO:0021898]; eye development [GO:0001654]; fibroblast growth factor receptor signaling pathway involved in forebrain neuron fate commitment [GO:0021899]; heart development [GO:0007507]; protein palmitoylation [GO:0018345]; telencephalon development [GO:0021537]","GO:0001654; GO:0005789; GO:0005794; GO:0006974; GO:0007507; GO:0016409; GO:0018345; GO:0019706; GO:0021537; GO:0021898; GO:0021899"
"1639",1639,"Cluster_2854","Porites_evermani_scaffold_1155:24881-25881",158,-20.23,2,20,396,418,19,"68.42%","84.21%","Peve_00002634",0.911693208743301,0.269551119527104,0.978262075707395,NA,NA,NA,NA,NA
"1640",1640,"Cluster_2854","Porites_evermani_scaffold_1:1660003-1661003",169,-21.46,2,19,831,853,18,"83.33%","88.89%","Peve_00000092",0.648531753640938,0.550766737266284,0.978262075707395,"Q6INU8","Tetratricopeptide repeat protein 30A (TPR repeat protein 30A)","Xenopus laevis (African clawed frog)","intraciliary transport [GO:0042073]; protein polyglutamylation [GO:0018095]","GO:0005879; GO:0005929; GO:0018095; GO:0042073"
"1641",1641,"Cluster_2854","Porites_evermani_scaffold_1:1660565-1661565",169,-21.46,2,19,269,291,18,"83.33%","88.89%","Peve_00000093",-0.510588311447932,0.658855279771758,0.978262075707395,NA,NA,NA,NA,NA
"1642",1642,"Cluster_2854","Porites_evermani_scaffold_1197:64372-65372",161,-21.16,2,19,407,431,20,"70.00%","85.00%","Peve_00003271",NA,NA,NA,"O60494","Cubilin (460 kDa receptor) (Intestinal intrinsic factor receptor) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor)","Homo sapiens (Human)","cholesterol metabolic process [GO:0008203]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; establishment of localization in cell [GO:0051649]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; tissue homeostasis [GO:0001894]","GO:0001894; GO:0005509; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005905; GO:0006898; GO:0008203; GO:0009235; GO:0009617; GO:0015889; GO:0016020; GO:0016324; GO:0030139; GO:0031232; GO:0031419; GO:0031526; GO:0031528; GO:0038023; GO:0038024; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0051649; GO:0070062"
"1643",1643,"Cluster_2854","Porites_evermani_scaffold_1223:16711-17711",188,-31.56,2,21,655,676,19,"89.47%","94.74%","Peve_00003720",-0.492476100688937,0.672183790869439,0.978262075707395,NA,NA,NA,NA,NA
"1644",1644,"Cluster_2854","Porites_evermani_scaffold_1228:28116-29116",174,-24.11,2,20,782,805,20,"85.00%","85.00%","Peve_00003764",0.427201858793668,0.718998736777508,0.981274390240325,NA,NA,NA,NA,NA
"1645",1645,"Cluster_2854","Porites_evermani_scaffold_123:345854-346166",156,-21.5,2,18,270,292,17,"76.47%","82.35%","Peve_00003783",-0.283623533999139,0.8169267983109,0.995934364227446,"Q2EMV9","Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (Collaborator of STAT6) (CoaSt6) (Poly [ADP-ribose] polymerase 14) (PARP-14)","Mus musculus (Mouse)","innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of type II interferon-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein poly-ADP-ribosylation [GO:0070212]","GO:0003714; GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0010629; GO:0016779; GO:0019899; GO:0042531; GO:0042532; GO:0045087; GO:0060336; GO:0070212; GO:0070403; GO:1902216; GO:1990404"
"1646",1646,"Cluster_2854","Porites_evermani_scaffold_123:345854-346166",156,-21.5,2,18,270,292,17,"76.47%","82.35%","Peve_00003784",-0.345882712903867,0.775159009422827,0.992319436461782,NA,NA,NA,NA,NA
"1647",1647,"Cluster_2854","Porites_evermani_scaffold_1234:42376-43163",164,-22.38,2,20,370,391,19,"78.95%","89.47%","Peve_00003850",-0.492476100688937,0.672183790869439,0.978262075707395,NA,NA,NA,NA,NA
"1648",1648,"Cluster_2854","Porites_evermani_scaffold_1235:52979-53979",157,-21.73,2,14,135,156,12,"91.67%","91.67%","Peve_00003879",-0.735423209976035,0.473966790006913,0.978262075707395,"P11498","Pyruvate carboxylase, mitochondrial (EC 6.4.1.1) (Pyruvic carboxylase) (PCB)","Homo sapiens (Human)","gluconeogenesis [GO:0006094]; lipid metabolic process [GO:0006629]; NADH metabolic process [GO:0006734]; NADP metabolic process [GO:0006739]; negative regulation of gene expression [GO:0010629]; positive regulation by host of viral process [GO:0044794]; pyruvate metabolic process [GO:0006090]; viral release from host cell [GO:0019076]; viral RNA genome packaging [GO:0019074]","GO:0004736; GO:0005524; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006090; GO:0006094; GO:0006629; GO:0006734; GO:0006739; GO:0009374; GO:0010629; GO:0019074; GO:0019076; GO:0042802; GO:0044794; GO:0046872"
"1649",1649,"Cluster_2854","Porites_evermani_scaffold_1260:121667-122667",170,-28.91,2,15,786,807,13,"100.00%","100.00%","Peve_00004246",0.931887985198178,0.236321597156481,0.978262075707395,NA,NA,NA,NA,NA
"1650",1650,"Cluster_2854","Porites_evermani_scaffold_1260:121667-122667",192,-30.77,2,21,906,927,19,"94.74%","94.74%","Peve_00004246",0.931887985198178,0.236321597156481,0.978262075707395,NA,NA,NA,NA,NA
"1651",1651,"Cluster_2854","Porites_evermani_scaffold_1260:121667-122667",200,-38.33,2,21,571,592,19,"100.00%","100.00%","Peve_00004246",0.931887985198178,0.236321597156481,0.978262075707395,NA,NA,NA,NA,NA
"1652",1652,"Cluster_2854","Porites_evermani_scaffold_1261:104450-105450",164,-22.01,2,17,378,399,15,"80.00%","93.33%","Peve_00004252",-0.790127768327062,0.420028297280987,0.978262075707395,"Q5U508","Tubulin-specific chaperone E (Tubulin-folding cofactor E)","Xenopus laevis (African clawed frog)","post-chaperonin tubulin folding pathway [GO:0007023]","GO:0005737; GO:0005856; GO:0007023; GO:0043014"
"1653",1653,"Cluster_2854","Porites_evermani_scaffold_126:398749-399749",151,-20.43,2,13,393,415,12,"91.67%","91.67%","Peve_00004205",NA,NA,NA,NA,NA,NA,NA,NA
"1654",1654,"Cluster_2854","Porites_evermani_scaffold_1274:58721-59721",160,-20.55,2,19,748,771,19,"78.95%","84.21%","Peve_00004417",0.998804655877086,0.031130411862649,0.903929377050813,NA,NA,NA,NA,NA
"1655",1655,"Cluster_2854","Porites_evermani_scaffold_1277:101963-102963",169,-28.3,2,21,472,491,19,"78.95%","89.47%","Peve_00004446",0.836171690447977,0.369577328337934,0.978262075707395,NA,NA,NA,NA,NA
"1656",1656,"Cluster_2854","Porites_evermani_scaffold_128:388950-389357",160,-22.91,2,13,302,323,11,"100.00%","100.00%","Peve_00004474",-0.903009860824416,0.28270483887791,0.978262075707395,"Q91YL3","Uridine-cytidine kinase-like 1 (EC 2.7.1.48)","Mus musculus (Mouse)","phosphorylation [GO:0016310]; UMP salvage [GO:0044206]","GO:0004849; GO:0005524; GO:0005634; GO:0005737; GO:0016310; GO:0044206"
"1657",1657,"Cluster_2854","Porites_evermani_scaffold_128:388950-389357",160,-22.91,2,13,302,323,11,"100.00%","100.00%","Peve_00004477",0.95861939982142,0.183781850550462,0.978262075707395,NA,NA,NA,NA,NA
"1658",1658,"Cluster_2854","Porites_evermani_scaffold_1289:132568-133568",147,-20.47,2,21,451,477,24,"62.50%","66.67%","Peve_00004600",-0.644374073591316,0.554235979258813,0.978262075707395,"A3KG59","Xaa-Arg dipeptidase (EC 3.4.13.4)","Mus musculus (Mouse)","proteolysis [GO:0006508]; regulation of protein metabolic process [GO:0051246]","GO:0004180; GO:0005654; GO:0006508; GO:0016805; GO:0042802; GO:0051246"
"1659",1659,"Cluster_2854","Porites_evermani_scaffold_1291:123831-124831",155,-21.72,2,21,303,327,22,"68.18%","72.73%","Peve_00004646",-0.961062044298876,0.178238317911212,0.978262075707395,"O42446","Deoxyribonuclease-1 (EC 3.1.21.1) (Deoxyribonuclease I) (DNase I)","Oreochromis mossambicus (Mozambique tilapia) (Tilapia mossambica)","DNA catabolic process, endonucleolytic [GO:0000737]; neutrophil activation involved in immune response [GO:0002283]; regulation of acute inflammatory response [GO:0002673]; regulation of neutrophil mediated cytotoxicity [GO:0070948]","GO:0000737; GO:0002283; GO:0002673; GO:0004530; GO:0005576; GO:0005635; GO:0042588; GO:0070948"
"1660",1660,"Cluster_2854","Porites_evermani_scaffold_1318:133058-134058",170,-22.21,2,19,18,39,17,"76.47%","94.12%","Peve_00005023",-0.507486347355159,0.661149542463894,0.978262075707395,NA,NA,NA,NA,NA
"1661",1661,"Cluster_2854","Porites_evermani_scaffold_1349:97488-98129",161,-22.53,2,18,323,344,16,"75.00%","87.50%","Peve_00005486",-0.507486347355159,0.661149542463894,0.978262075707395,NA,NA,NA,NA,NA
"1662",1662,"Cluster_2854","Porites_evermani_scaffold_1356:55127-56127",155,-22.53,2,18,863,888,20,"75.00%","80.00%","Peve_00005580",-0.955600863931487,0.190415580421742,0.978262075707395,"Q9FXG3","Protein REDUCED WALL ACETYLATION 4 (EC 2.3.1.-)","Arabidopsis thaliana (Mouse-ear cress)","carbohydrate metabolic process [GO:0005975]; plant-type secondary cell wall biogenesis [GO:0009834]; xylan acetylation [GO:1990937]; xylan biosynthetic process [GO:0045492]; xylan metabolic process [GO:0045491]; xyloglucan metabolic process [GO:0010411]","GO:0000139; GO:0005794; GO:0005975; GO:0009834; GO:0010411; GO:0016407; GO:0016491; GO:0045491; GO:0045492; GO:1990937"
"1663",1663,"Cluster_2854","Porites_evermani_scaffold_139:131847-132847",154,-21.52,2,21,824,848,22,"68.18%","77.27%","Peve_00006033",0.681367135660428,0.522771461804471,0.978262075707395,"Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"1664",1664,"Cluster_2854","Porites_evermani_scaffold_1391:42772-43772",168,-20.82,2,21,862,883,19,"73.68%","84.21%","Peve_00006077",NA,NA,NA,NA,NA,NA,NA,NA
"1665",1665,"Cluster_2854","Porites_evermani_scaffold_1393:39691-40691",153,-21.3,2,21,265,287,21,"71.43%","76.19%","Peve_00006095",-0.507486347355159,0.661149542463894,0.978262075707395,"Q9Z2J0","Solute carrier family 23 member 1 (Na(+)/L-ascorbic acid transporter 1) (Sodium-dependent vitamin C transporter 1) (Yolk sac permease-like molecule 3)","Mus musculus (Mouse)","brain development [GO:0007420]; dehydroascorbic acid transport [GO:0070837]; L-ascorbic acid transmembrane transport [GO:0015882]; lung development [GO:0030324]; response to toxic substance [GO:0009636]; sodium ion transport [GO:0006814]","GO:0005737; GO:0005886; GO:0005903; GO:0006814; GO:0007420; GO:0008520; GO:0009636; GO:0009925; GO:0015081; GO:0015229; GO:0015882; GO:0016324; GO:0030324; GO:0033300; GO:0043229; GO:0070837"
"1666",1666,"Cluster_2854","Porites_evermani_scaffold_1408:26273-27273",171,-20.93,2,21,291,313,20,"80.00%","85.00%","Peve_00006349",-0.492476100688937,0.672183790869439,0.978262075707395,NA,NA,NA,NA,NA
"1667",1667,"Cluster_2854","Porites_evermani_scaffold_147:282660-283660",152,-20.69,2,20,213,234,19,"68.42%","84.21%","Peve_00007096",-0.98490225005372,0.110764134779807,0.978262075707395,"Q9D6J6","NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial (EC 7.1.1.2) (NADH-ubiquinone oxidoreductase 24 kDa subunit)","Mus musculus (Mouse)","aerobic respiration [GO:0009060]; cardiac muscle tissue development [GO:0048738]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; nervous system development [GO:0007399]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]","GO:0005739; GO:0005743; GO:0005747; GO:0006120; GO:0007399; GO:0008137; GO:0009060; GO:0042776; GO:0043209; GO:0046872; GO:0048738; GO:0051537"
"1668",1668,"Cluster_2854","Porites_evermani_scaffold_147:311475-312475",157,-22.33,2,20,904,929,22,"68.18%","81.82%","Peve_00007098",-0.984548096710571,0.112059047192982,0.978262075707395,"Q8NDH3","Probable aminopeptidase NPEPL1 (EC 3.4.11.-) (Aminopeptidase-like 1)","Homo sapiens (Human)","proteolysis [GO:0006508]","GO:0005634; GO:0005737; GO:0006508; GO:0008233; GO:0030145; GO:0070006"
"1669",1669,"Cluster_2854","Porites_evermani_scaffold_1:489252-490252",155,-20.07,2,20,867,888,18,"55.56%","88.89%","Peve_00000010",-0.217984906921151,0.860103284454545,0.996219032723144,NA,NA,NA,NA,NA
"1670",1670,"Cluster_2854","Porites_evermani_scaffold_1489:85137-86137",156,-20.08,2,21,694,713,19,"73.68%","84.21%","Peve_00007324",NA,NA,NA,NA,NA,NA,NA,NA
"1671",1671,"Cluster_2854","Porites_evermani_scaffold_149:223848-224848",151,-24.28,2,21,643,669,24,"58.33%","75.00%","Peve_00007339",NA,NA,NA,NA,NA,NA,NA,NA
"1672",1672,"Cluster_2854","Porites_evermani_scaffold_1501:52290-53290",155,-20.75,2,21,426,449,21,"66.67%","76.19%","Peve_00007575",NA,NA,NA,NA,NA,NA,NA,NA
"1673",1673,"Cluster_2854","Porites_evermani_scaffold_1501:52290-53290",155,-20.75,2,21,916,939,21,"66.67%","76.19%","Peve_00007575",NA,NA,NA,NA,NA,NA,NA,NA
"1674",1674,"Cluster_2854","Porites_evermani_scaffold_150:421322-422322",169,-21.19,2,18,380,401,16,"87.50%","87.50%","Peve_00007537",NA,NA,NA,"P41180","Extracellular calcium-sensing receptor (CaR) (CaSR) (hCasR) (Parathyroid cell calcium-sensing receptor 1) (PCaR1)","Homo sapiens (Human)","adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; anatomical structure morphogenesis [GO:0009653]; apoptotic process [GO:0006915]; bile acid secretion [GO:0032782]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium ion import [GO:0070509]; cellular calcium ion homeostasis [GO:0006874]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hypoxia [GO:0071456]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to peptide [GO:1901653]; cellular response to vitamin D [GO:0071305]; chemosensory behavior [GO:0007635]; chloride transmembrane transport [GO:1902476]; detection of calcium ion [GO:0005513]; fat pad development [GO:0060613]; G protein-coupled receptor signaling pathway [GO:0007186]; JNK cascade [GO:0007254]; ossification [GO:0001503]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of calcium ion import [GO:0090280]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of insulin secretion [GO:0032024]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of vasoconstriction [GO:0045907]; regulation of calcium ion transport [GO:0051924]; response to fibroblast growth factor [GO:0071774]; response to ischemia [GO:0002931]; vasodilation [GO:0042311]","GO:0001503; GO:0002931; GO:0004435; GO:0004930; GO:0005178; GO:0005509; GO:0005513; GO:0005634; GO:0005737; GO:0005886; GO:0006874; GO:0006915; GO:0007186; GO:0007193; GO:0007200; GO:0007254; GO:0007635; GO:0008284; GO:0009653; GO:0009986; GO:0010628; GO:0016323; GO:0016324; GO:0016597; GO:0019901; GO:0032024; GO:0032781; GO:0032782; GO:0035729; GO:0042311; GO:0042802; GO:0042803; GO:0043025; GO:0043679; GO:0044325; GO:0045907; GO:0048754; GO:0050927; GO:0051924; GO:0060613; GO:0070374; GO:0070509; GO:0071305; GO:0071333; GO:0071404; GO:0071456; GO:0071774; GO:0090280; GO:1901653; GO:1902476"
"1675",1675,"Cluster_2854","Porites_evermani_scaffold_1505:74071-75071",164,-22.78,2,17,973,994,15,"86.67%","86.67%","Peve_00007609",NA,NA,NA,NA,NA,NA,NA,NA
"1676",1676,"Cluster_2854","Porites_evermani_scaffold_151:156896-157775",152,-20.3,2,20,293,314,19,"73.68%","78.95%","Peve_00007679",NA,NA,NA,NA,NA,NA,NA,NA
"1677",1677,"Cluster_2854","Porites_evermani_scaffold_1562:48572-49572",160,-22.91,2,13,882,903,11,"100.00%","100.00%","Peve_00008263",NA,NA,NA,NA,NA,NA,NA,NA
"1678",1678,"Cluster_2854","Porites_evermani_scaffold_1575:56997-57997",153,-24.31,2,20,560,584,21,"71.43%","76.19%","Peve_00008435",NA,NA,NA,"Q8TDB6","E3 ubiquitin-protein ligase DTX3L (EC 2.3.2.27) (B-lymphoma- and BAL-associated protein) (Protein deltex-3-like) (RING-type E3 ubiquitin transferase DTX3L) (Rhysin-2) (Rhysin2)","Homo sapiens (Human)","cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; defense response to virus [GO:0051607]; DNA damage checkpoint signaling [GO:0000077]; double-strand break repair [GO:0006302]; endosome to lysosome transport [GO:0008333]; histone H2A ubiquitination [GO:0033522]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; innate immune response [GO:0045087]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; Notch signaling pathway [GO:0007219]; positive regulation of chromatin binding [GO:0035563]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of receptor catabolic process [GO:2000646]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000077; GO:0002230; GO:0004842; GO:0004857; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005765; GO:0005829; GO:0006302; GO:0006325; GO:0006511; GO:0006974; GO:0007219; GO:0008333; GO:0010390; GO:0015031; GO:0016567; GO:0019899; GO:0031901; GO:0032092; GO:0032991; GO:0033522; GO:0033523; GO:0035563; GO:0042393; GO:0044389; GO:0045087; GO:0045893; GO:0046872; GO:0051444; GO:0051607; GO:0051865; GO:0061630; GO:0070936; GO:0097677; GO:0140768; GO:1900182; GO:1902966; GO:2000646"
"1679",1679,"Cluster_2854","Porites_evermani_scaffold_16:577173-578173",167,-25.8,2,20,692,713,18,"77.78%","83.33%","Peve_00008800",-0.553307911753505,0.626730590482281,0.978262075707395,"Q7Z333","Probable helicase senataxin (EC 3.6.4.-) (Amyotrophic lateral sclerosis 4 protein) (SEN1 homolog) (Senataxin)","Homo sapiens (Human)","cell differentiation [GO:0030154]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to oxidative stress [GO:0034599]; cellular response to retinoic acid [GO:0071300]; circadian rhythm [GO:0007623]; DNA recombination [GO:0006310]; DNA-templated transcription termination [GO:0006353]; double-strand break repair [GO:0006302]; fibroblast growth factor receptor signaling pathway [GO:0008543]; MAPK cascade [GO:0000165]; mRNA splice site selection [GO:0006376]; negative regulation of apoptotic process [GO:0043066]; nervous system development [GO:0007399]; positive regulation of DNA-templated transcription initiation [GO:2000144]; positive regulation of neuron projection development [GO:0010976]; positive regulation of RNA splicing [GO:0033120]; positive regulation of termination of DNA-templated transcription [GO:0060566]; positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled [GO:2000806]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein kinase B signaling [GO:0043491]; RNA processing [GO:0006396]; spermatogenesis [GO:0007283]; termination of RNA polymerase II transcription [GO:0006369]","GO:0000165; GO:0000228; GO:0000781; GO:0001147; GO:0003677; GO:0003678; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006302; GO:0006310; GO:0006353; GO:0006369; GO:0006376; GO:0006396; GO:0006974; GO:0007283; GO:0007399; GO:0007623; GO:0008543; GO:0010976; GO:0016604; GO:0016787; GO:0030154; GO:0030424; GO:0030426; GO:0033120; GO:0034599; GO:0042802; GO:0043066; GO:0043491; GO:0044344; GO:0045171; GO:0045944; GO:0060566; GO:0070301; GO:0071300; GO:2000144; GO:2000806"
"1680",1680,"Cluster_2854","Porites_evermani_scaffold_16:577173-578173",196,-35.53,2,21,850,871,19,"94.74%","100.00%","Peve_00008800",-0.553307911753505,0.626730590482281,0.978262075707395,"Q7Z333","Probable helicase senataxin (EC 3.6.4.-) (Amyotrophic lateral sclerosis 4 protein) (SEN1 homolog) (Senataxin)","Homo sapiens (Human)","cell differentiation [GO:0030154]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to oxidative stress [GO:0034599]; cellular response to retinoic acid [GO:0071300]; circadian rhythm [GO:0007623]; DNA recombination [GO:0006310]; DNA-templated transcription termination [GO:0006353]; double-strand break repair [GO:0006302]; fibroblast growth factor receptor signaling pathway [GO:0008543]; MAPK cascade [GO:0000165]; mRNA splice site selection [GO:0006376]; negative regulation of apoptotic process [GO:0043066]; nervous system development [GO:0007399]; positive regulation of DNA-templated transcription initiation [GO:2000144]; positive regulation of neuron projection development [GO:0010976]; positive regulation of RNA splicing [GO:0033120]; positive regulation of termination of DNA-templated transcription [GO:0060566]; positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled [GO:2000806]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein kinase B signaling [GO:0043491]; RNA processing [GO:0006396]; spermatogenesis [GO:0007283]; termination of RNA polymerase II transcription [GO:0006369]","GO:0000165; GO:0000228; GO:0000781; GO:0001147; GO:0003677; GO:0003678; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006302; GO:0006310; GO:0006353; GO:0006369; GO:0006376; GO:0006396; GO:0006974; GO:0007283; GO:0007399; GO:0007623; GO:0008543; GO:0010976; GO:0016604; GO:0016787; GO:0030154; GO:0030424; GO:0030426; GO:0033120; GO:0034599; GO:0042802; GO:0043066; GO:0043491; GO:0044344; GO:0045171; GO:0045944; GO:0060566; GO:0070301; GO:0071300; GO:2000144; GO:2000806"
"1681",1681,"Cluster_2854","Porites_evermani_scaffold_1791:63755-64755",146,-20.55,2,21,100,126,24,"66.67%","66.67%","Peve_00011018",-0.999898831254468,0.00905569870901151,0.591707940755134,NA,NA,NA,NA,NA
"1682",1682,"Cluster_2854","Porites_evermani_scaffold_1806:71038-72038",155,-20.7,2,21,277,299,20,"70.00%","75.00%","Peve_00011238",NA,NA,NA,NA,NA,NA,NA,NA
"1683",1683,"Cluster_2854","Porites_evermani_scaffold_182:331707-332707",164,-22.92,2,17,31,52,15,"80.00%","93.33%","Peve_00011399",0.985067702881347,0.11015401608044,0.978262075707395,"Q9UL62","Short transient receptor potential channel 5 (TrpC5) (Transient receptor protein 5) (TRP-5) (hTRP-5) (hTRP5)","Homo sapiens (Human)","calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; negative regulation of dendrite morphogenesis [GO:0050774]; nervous system development [GO:0007399]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]; positive regulation of axon extension [GO:0045773]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of membrane hyperpolarization [GO:1902630]","GO:0003779; GO:0005262; GO:0005737; GO:0005886; GO:0006816; GO:0007204; GO:0007399; GO:0008284; GO:0010800; GO:0015279; GO:0030182; GO:0030276; GO:0030425; GO:0030426; GO:0034703; GO:0034704; GO:0042805; GO:0043025; GO:0045121; GO:0045666; GO:0045773; GO:0050774; GO:0051117; GO:0051402; GO:0051480; GO:0070588; GO:0070679; GO:0070782; GO:1902630"
"1684",1684,"Cluster_2854","Porites_evermani_scaffold_183:372977-373977",156,-24.22,2,15,43,63,13,"92.31%","92.31%","Peve_00011494",-0.818360785662434,0.389766253744164,0.978262075707395,"Q8VIJ5","Protein O-GlcNAcase (OGA) (EC 3.2.1.169) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase) (Bifunctional protein NCOAT) (Meningioma-expressed antigen 5) (N-acetyl-beta-D-glucosaminidase) (N-acetyl-beta-glucosaminidase)","Rattus norvegicus (Rat)","aging [GO:0007568]; dATP metabolic process [GO:0046060]; glycoprotein metabolic process [GO:0009100]; N-acetylglucosamine metabolic process [GO:0006044]; necrotic cell death [GO:0070265]; negative regulation of cardiac muscle adaptation [GO:0010616]; negative regulation of protein glycosylation [GO:0060051]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cell killing [GO:0031343]; positive regulation of DNA metabolic process [GO:0051054]; positive regulation of glucose import [GO:0046326]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of insulin secretion [GO:0032024]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of proteolysis [GO:0045862]; protein deglycosylation [GO:0006517]; protein targeting to membrane [GO:0006612]; response to steroid hormone [GO:0048545]","GO:0004402; GO:0005634; GO:0005739; GO:0006044; GO:0006517; GO:0006612; GO:0007568; GO:0009100; GO:0010524; GO:0010616; GO:0016231; GO:0031343; GO:0032024; GO:0042802; GO:0043243; GO:0045862; GO:0046060; GO:0046326; GO:0048545; GO:0051054; GO:0051901; GO:0051928; GO:0060051; GO:0060124; GO:0070265; GO:0102166; GO:0102167; GO:0102571"
"1685",1685,"Cluster_2854","Porites_evermani_scaffold_18:431398-432398",153,-21.61,2,14,478,499,12,"83.33%","91.67%","Peve_00011155",0.999983740199231,0.00363039030884399,0.527140119669662,NA,NA,NA,NA,NA
"1686",1686,"Cluster_2854","Porites_evermani_scaffold_1855:63402-64402",170,-24.78,2,20,328,352,21,"76.19%","85.71%","Peve_00011764",NA,NA,NA,NA,NA,NA,NA,NA
"1687",1687,"Cluster_2854","Porites_evermani_scaffold_1879:89885-90885",160,-20.41,2,21,943,964,19,"63.16%","84.21%","Peve_00012010",NA,NA,NA,NA,NA,NA,NA,NA
"1688",1688,"Cluster_2854","Porites_evermani_scaffold_1984:87861-88861",159,-21.82,2,21,104,128,22,"68.18%","77.27%","Peve_00013165",-0.569466332107023,0.614299779459825,0.978262075707395,"Q86YI8","PHD finger protein 13 (Survival time-associated PHD finger protein in ovarian cancer 1) (SPOC1)","Homo sapiens (Human)","cell division [GO:0051301]; chromatin organization [GO:0006325]; chromosome segregation [GO:0007059]; mitotic cell cycle [GO:0000278]; mitotic chromosome condensation [GO:0007076]","GO:0000278; GO:0003682; GO:0005634; GO:0005654; GO:0006325; GO:0007059; GO:0007076; GO:0035064; GO:0046872; GO:0051301"
"1689",1689,"Cluster_2854","Porites_evermani_scaffold_2040:84488-85488",166,-20.5,2,21,65,85,19,"73.68%","89.47%","Peve_00013972",0.999962448044095,0.00551712420276981,0.551398425649056,"Q9VBW3","Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14)","Drosophila melanogaster (Fruit fly)","calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of kinase activity [GO:0033674]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing [GO:0042060]","GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0014068; GO:0016339; GO:0033674; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0090303"
"1690",1690,"Cluster_2854","Porites_evermani_scaffold_2040:87844-88844",155,-21.4,2,12,866,887,10,"100.00%","100.00%","Peve_00013975",NA,NA,NA,NA,NA,NA,NA,NA
"1691",1691,"Cluster_2854","Porites_evermani_scaffold_2059:83918-84918",170,-21.69,2,19,387,408,17,"82.35%","88.24%","Peve_00014135",-0.256109864401102,0.835118224687769,0.995934364227446,"A0A2J6RX17",NA,NA,NA,NA
"1692",1692,"Cluster_2854","Porites_evermani_scaffold_2062:58875-59875",153,-20.49,2,20,789,809,18,"66.67%","83.33%","Peve_00014181",-0.167068979779977,0.893139479379882,0.999448381576871,NA,NA,NA,NA,NA
"1693",1693,"Cluster_2854","Porites_evermani_scaffold_2073:85600-86600",164,-21.82,2,21,136,157,19,"73.68%","78.95%","Peve_00014272",NA,NA,NA,NA,NA,NA,NA,NA
"1694",1694,"Cluster_2854","Porites_evermani_scaffold_209:39519-40519",164,-21.67,2,17,862,883,15,"80.00%","93.33%","Peve_00014434",-0.740197732593379,0.469463754701141,0.978262075707395,NA,NA,NA,NA,NA
"1695",1695,"Cluster_2854","Porites_evermani_scaffold_2133:61443-62443",159,-21.32,2,20,497,518,18,"66.67%","83.33%","Peve_00014910",-0.922344427203612,0.252541510716047,0.978262075707395,NA,NA,NA,NA,NA
"1696",1696,"Cluster_2854","Porites_evermani_scaffold_2190:26878-27878",187,-31.13,2,20,507,528,18,"94.44%","94.44%","Peve_00015429",-0.493618781434543,0.671347640029776,0.978262075707395,"Q5RH71","Tetraspanin-33 (Tspan-33)","Danio rerio (Zebrafish) (Brachydanio rerio)","protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604]","GO:0005886; GO:0051604; GO:0072659"
"1697",1697,"Cluster_2854","Porites_evermani_scaffold_22:387983-388983",172,-21.57,2,21,159,180,19,"78.95%","84.21%","Peve_00015499",0.992405631679434,0.0785084099815234,0.978262075707395,NA,NA,NA,NA,NA
"1698",1698,"Cluster_2854","Porites_evermani_scaffold_224:69410-70410",166,-26.08,2,15,913,934,13,"92.31%","100.00%","Peve_00015945",-0.995793660477359,0.0584116713714293,0.978262075707395,NA,NA,NA,NA,NA
"1699",1699,"Cluster_2854","Porites_evermani_scaffold_231:183936-184936",153,-20.02,2,21,146,167,20,"70.00%","80.00%","Peve_00016657",-0.471823517701122,0.687191885984539,0.978262075707395,"Q8STF6","Dystrophin-like protein 1 (Dyb-1-binding and CAPON-related protein)","Caenorhabditis elegans","locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; positive regulation of locomotion [GO:0040017]; regulation of oviposition [GO:0046662]; sarcomere organization [GO:0045214]","GO:0007626; GO:0008307; GO:0016010; GO:0030235; GO:0030424; GO:0040017; GO:0045214; GO:0046662; GO:0046716; GO:0050998; GO:0055120"
"1700",1700,"Cluster_2854","Porites_evermani_scaffold_2346:43694-44694",157,-22.2,2,20,746,766,18,"72.22%","83.33%","Peve_00016965",NA,NA,NA,NA,NA,NA,NA,NA
"1701",1701,"Cluster_2854","Porites_evermani_scaffold_2373:62878-63878",196,-35.53,2,21,658,679,19,"94.74%","100.00%","Peve_00017190",-0.168921002701635,0.89194344658165,0.999448381576871,NA,NA,NA,NA,NA
"1702",1702,"Cluster_2854","Porites_evermani_scaffold_2436:49827-50827",167,-22.02,2,21,794,817,21,"76.19%","80.95%","Peve_00017825",-0.507486347355159,0.661149542463894,0.978262075707395,NA,NA,NA,NA,NA
"1703",1703,"Cluster_2854","Porites_evermani_scaffold_2455:49920-50156",162,-20.93,2,18,37,56,16,"87.50%","87.50%","Peve_00017982",NA,NA,NA,NA,NA,NA,NA,NA
"1704",1704,"Cluster_2854","Porites_evermani_scaffold_2530:2477-3477",164,-20.53,2,21,857,878,19,"68.42%","84.21%","Peve_00018707",NA,NA,NA,NA,NA,NA,NA,NA
"1705",1705,"Cluster_2854","Porites_evermani_scaffold_2530:2917-3917",164,-20.53,2,21,417,438,19,"68.42%","84.21%","Peve_00018710",-0.526541044247986,0.646977292848569,0.978262075707395,NA,NA,NA,NA,NA
"1706",1706,"Cluster_2854","Porites_evermani_scaffold_2530:2917-3917",164,-20.53,2,21,773,794,19,"68.42%","84.21%","Peve_00018710",-0.526541044247986,0.646977292848569,0.978262075707395,NA,NA,NA,NA,NA
"1707",1707,"Cluster_2854","Porites_evermani_scaffold_2540:63095-64095",155,-20.21,2,21,770,794,22,"68.18%","72.73%","Peve_00018784",-0.507486347355159,0.661149542463894,0.978262075707395,"Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"1708",1708,"Cluster_2854","Porites_evermani_scaffold_2548:0-601",163,-21.24,2,21,491,514,21,"76.19%","76.19%","Peve_00018827",0.619011618497415,0.575066738988247,0.978262075707395,NA,NA,NA,NA,NA
"1709",1709,"Cluster_2854","Porites_evermani_scaffold_2548:41242-42242",163,-21.24,2,21,889,912,21,"76.19%","76.19%","Peve_00018828",0.998059288344699,0.0396685101306057,0.909359886114279,NA,NA,NA,NA,NA
"1710",1710,"Cluster_2854","Porites_evermani_scaffold_2675:23684-24684",157,-24.87,2,20,182,208,23,"69.57%","78.26%","Peve_00019853",-0.705027046368905,0.501869676371025,0.978262075707395,"Q9WUA2","Phenylalanine--tRNA ligase beta subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase beta subunit) (PheRS)","Mus musculus (Mouse)","phenylalanyl-tRNA aminoacylation [GO:0006432]; protein heterotetramerization [GO:0051290]","GO:0000287; GO:0003723; GO:0004826; GO:0005524; GO:0006432; GO:0009328; GO:0051290"
"1711",1711,"Cluster_2854","Porites_evermani_scaffold_26:811594-812594",160,-20.84,2,18,897,919,17,"76.47%","88.24%","Peve_00019240",-0.955834550038996,0.189910052374814,0.978262075707395,"G5EFZ1","2,3-bisphosphoglycerate-independent phosphoglycerate mutase (iPGM) (EC 5.4.2.12) (Cofactor-independent phosphoglycerate mutase homolog)","Caenorhabditis elegans","cellular carbohydrate metabolic process [GO:0044262]; glucose catabolic process [GO:0006007]; glycolytic process [GO:0006096]","GO:0005737; GO:0006007; GO:0006096; GO:0030145; GO:0044262; GO:0046537"
"1712",1712,"Cluster_2854","Porites_evermani_scaffold_2747:63820-64651",165,-21.26,2,20,129,153,21,"80.95%","80.95%","Peve_00020491",-0.776939778205102,0.433541865897478,0.978262075707395,"O60610","Protein diaphanous homolog 1 (Diaphanous-related formin-1) (DRF1)","Homo sapiens (Human)","actin cytoskeleton organization [GO:0030036]; actin filament polymerization [GO:0030041]; cellular response to histamine [GO:0071420]; cytoskeleton organization [GO:0007010]; positive regulation of cell migration [GO:0030335]; protein localization to microtubule [GO:0035372]; regulation of cell shape [GO:0008360]; regulation of cytoskeleton organization [GO:0051493]; regulation of microtubule-based process [GO:0032886]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; sensory perception of sound [GO:0007605]","GO:0003723; GO:0003779; GO:0005102; GO:0005634; GO:0005737; GO:0005815; GO:0005829; GO:0005884; GO:0005886; GO:0007010; GO:0007605; GO:0008360; GO:0030036; GO:0030041; GO:0030335; GO:0030667; GO:0031267; GO:0032587; GO:0032886; GO:0035372; GO:0044325; GO:0051279; GO:0051493; GO:0071420; GO:0072686; GO:0101003"
"1713",1713,"Cluster_2854","Porites_evermani_scaffold_282:156407-157035",150,-20.88,2,21,255,281,24,"62.50%","75.00%","Peve_00021064",-0.507486347355159,0.661149542463894,0.978262075707395,"Q60997","Deleted in malignant brain tumors 1 protein (Apactin) (CRP-ductin) (Glycoprotein 300) (gp300) (Hensin) (Mucin-like glycoprotein) (Muclin) (Vomeroglandin) (p80)","Mus musculus (Mouse)","antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; blastocyst development [GO:0001824]; columnar/cuboidal epithelial cell differentiation [GO:0002065]; defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; detection of bacterial lipoprotein [GO:0042494]; induction of bacterial agglutination [GO:0043152]; inner cell mass cell proliferation [GO:0001833]; positive regulation of epithelial cell differentiation [GO:0030858]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]","GO:0001530; GO:0001824; GO:0001833; GO:0002065; GO:0003677; GO:0005044; GO:0005615; GO:0005737; GO:0006898; GO:0006952; GO:0009617; GO:0015031; GO:0019898; GO:0030658; GO:0030670; GO:0030858; GO:0031012; GO:0035375; GO:0038187; GO:0042494; GO:0042589; GO:0043152; GO:0050829; GO:0050830; GO:0050840; GO:0061844; GO:0062023; GO:0070891; GO:1904399"
"1714",1714,"Cluster_2854","Porites_evermani_scaffold_283:300961-301961",145,-21.47,2,20,47,73,23,"65.22%","69.57%","Peve_00021146",NA,NA,NA,NA,NA,NA,NA,NA
"1715",1715,"Cluster_2854","Porites_evermani_scaffold_287:267429-268429",154,-20.51,2,16,1,22,15,"80.00%","86.67%","Peve_00021440",NA,NA,NA,NA,NA,NA,NA,NA
"1716",1716,"Cluster_2854","Porites_evermani_scaffold_2881:54698-55698",168,-21.19,2,21,1,22,19,"73.68%","84.21%","Peve_00021534",NA,NA,NA,NA,NA,NA,NA,NA
"1717",1717,"Cluster_2854","Porites_evermani_scaffold_290:98531-99531",152,-20.54,2,15,808,828,13,"84.62%","92.31%","Peve_00021713",-0.235472557355179,0.848672443989597,0.995934364227446,NA,NA,NA,NA,NA
"1718",1718,"Cluster_2854","Porites_evermani_scaffold_2945:38734-39734",144,-20.9,2,19,548,572,20,"65.00%","75.00%","Peve_00022015",0.0913806193301776,0.941744021313152,0.999448381576871,"Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"1719",1719,"Cluster_2854","Porites_evermani_scaffold_3060:27010-28010",167,-20.56,2,20,420,441,18,"77.78%","83.33%","Peve_00023071",0.999962448044095,0.00551712420276166,0.551398425649056,NA,NA,NA,NA,NA
"1720",1720,"Cluster_2854","Porites_evermani_scaffold_3063:41567-42567",161,-21.94,2,16,766,786,14,"92.86%","92.86%","Peve_00023087",-0.420430080919902,0.723758408109469,0.982650334327478,NA,NA,NA,NA,NA
"1721",1721,"Cluster_2854","Porites_evermani_scaffold_3071:46529-47529",147,-20.9,2,18,721,748,22,"68.18%","72.73%","Peve_00023159",-0.511332348736656,0.658304248461737,0.978262075707395,NA,NA,NA,NA,NA
"1722",1722,"Cluster_2854","Porites_evermani_scaffold_310:211470-212470",154,-23.56,2,21,111,134,21,"71.43%","76.19%","Peve_00023407",-0.713864305584652,0.493886644015996,0.978262075707395,NA,NA,NA,NA,NA
"1723",1723,"Cluster_2854","Porites_evermani_scaffold_317:47012-48012",167,-20.99,2,21,694,716,20,"80.00%","80.00%","Peve_00023828",-0.507486347355159,0.661149542463894,0.978262075707395,"Q5QJU3","Alkaline ceramidase 2 (AlkCDase 2) (Alkaline CDase 2) (haCER2) (EC 3.5.1.-) (EC 3.5.1.23) (Acylsphingosine deacylase 3-like) (N-acylsphingosine amidohydrolase 3-like)","Homo sapiens (Human)","activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to xenobiotic stimulus [GO:0071466]; ceramide catabolic process [GO:0046514]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of cell-matrix adhesion [GO:0001953]; positive regulation of cell death [GO:0010942]; positive regulation of cell population proliferation [GO:0008284]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of protein glycosylation [GO:0060049]; response to retinoic acid [GO:0032526]; sphingolipid biosynthetic process [GO:0030148]; sphingosine biosynthetic process [GO:0046512]","GO:0000139; GO:0001953; GO:0005794; GO:0006919; GO:0006974; GO:0008284; GO:0010506; GO:0010942; GO:0017040; GO:0030148; GO:0030330; GO:0032526; GO:0033629; GO:0042981; GO:0046512; GO:0046514; GO:0046872; GO:0060049; GO:0071466; GO:0071633; GO:0102121"
"1724",1724,"Cluster_2854","Porites_evermani_scaffold_3227:0-978",162,-20.83,2,15,897,918,13,"92.31%","92.31%","Peve_00024179",-0.587887121941013,0.599919834564848,0.978262075707395,NA,NA,NA,NA,NA
"1725",1725,"Cluster_2854","Porites_evermani_scaffold_326:86511-87511",149,-20.62,2,21,138,159,20,"65.00%","80.00%","Peve_00024367",-0.981087728208354,0.124009173971415,0.978262075707395,"Q2HJA9","Phosducin-like protein (PHLP)","Bos taurus (Bovine)","cell projection organization [GO:0030030]; heterotrimeric G-protein complex assembly [GO:1902605]; positive regulation of smoothened signaling pathway [GO:0045880]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to stimulus [GO:0050896]; visual perception [GO:0007601]","GO:0005737; GO:0005929; GO:0007601; GO:0008277; GO:0030030; GO:0045880; GO:0050896; GO:1902605"
"1726",1726,"Cluster_2854","Porites_evermani_scaffold_3281:3141-4141",156,-20.27,2,21,316,337,19,"63.16%","78.95%","Peve_00024490",-0.915781699380004,0.263144625058944,0.978262075707395,"Q6DED0","Translocating chain-associated membrane protein 1-like 1","Xenopus laevis (African clawed frog)","SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]","GO:0005789; GO:0006616"
"1727",1727,"Cluster_2854","Porites_evermani_scaffold_3292:10142-11142",151,-20.74,2,21,270,293,21,"66.67%","71.43%","Peve_00024548",-0.771606303489839,0.438907184031234,0.978262075707395,NA,NA,NA,NA,NA
"1728",1728,"Cluster_2854","Porites_evermani_scaffold_3300:9660-10587",167,-20.56,2,20,418,439,18,"77.78%","83.33%","Peve_00024676",NA,NA,NA,NA,NA,NA,NA,NA
"1729",1729,"Cluster_2854","Porites_evermani_scaffold_3300:9660-10587",167,-20.56,2,20,418,439,18,"77.78%","83.33%","Peve_00024677",-0.26693896412439,0.827975574931996,0.995934364227446,"P08183","ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)","Homo sapiens (Human)","carboxylic acid transmembrane transport [GO:1905039]; ceramide translocation [GO:0099040]; export across plasma membrane [GO:0140115]; G2/M transition of mitotic cell cycle [GO:0000086]; phospholipid translocation [GO:0045332]; positive regulation of anion channel activity [GO:1901529]; regulation of chloride transport [GO:2001225]; regulation of response to osmotic stress [GO:0047484]; response to xenobiotic stimulus [GO:0009410]; stem cell proliferation [GO:0072089]; terpenoid transport [GO:0046865]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic metabolic process [GO:0006805]; xenobiotic transport across blood-brain barrier [GO:1990962]","GO:0000086; GO:0005524; GO:0005654; GO:0005737; GO:0005886; GO:0006805; GO:0008559; GO:0009410; GO:0009986; GO:0015562; GO:0016020; GO:0016324; GO:0016887; GO:0022857; GO:0031625; GO:0042626; GO:0042910; GO:0045332; GO:0046865; GO:0046943; GO:0047484; GO:0055085; GO:0070062; GO:0070633; GO:0072089; GO:0090554; GO:0090555; GO:0098591; GO:0099038; GO:0099040; GO:0140115; GO:0140328; GO:0150104; GO:1901529; GO:1905039; GO:1990961; GO:1990962; GO:2001225"
"1730",1730,"Cluster_2854","Porites_evermani_scaffold_3342:28423-29423",160,-21.96,2,21,169,189,20,"75.00%","85.00%","Peve_00024933",-0.492705809293136,0.672015752722656,0.978262075707395,"P35061","Histone H2A","Acropora formosa (Staghorn coral)","","GO:0000786; GO:0003677; GO:0005634; GO:0030527; GO:0046982"
"1731",1731,"Cluster_2854","Porites_evermani_scaffold_33:436056-437056",159,-20.29,2,20,562,583,18,"61.11%","88.89%","Peve_00024587",-0.997501684128481,0.0450100248602691,0.930633997430282,"Q9VCA2","Organic cation transporter protein","Drosophila melanogaster (Fruit fly)","apoptotic process [GO:0006915]; ion transport [GO:0006811]","GO:0006811; GO:0006915; GO:0016020; GO:0022857"
"1732",1732,"Cluster_2854","Porites_evermani_scaffold_3346:3715-4715",164,-21.98,2,21,11,32,19,"73.68%","78.95%","Peve_00024945",-0.777492087867163,0.432983073255818,0.978262075707395,"Q6GM44","E3 ubiquitin-protein ligase MARCHF5 (EC 2.3.2.27) (Membrane-associated RING finger protein 5) (Membrane-associated RING-CH protein V) (MARCH-V) (RING-type E3 ubiquitin transferase MARCHF5)","Xenopus laevis (African clawed frog)","protein autoubiquitination [GO:0051865]; regulation of mitochondrial fission [GO:0090140]","GO:0005741; GO:0005783; GO:0005789; GO:0008270; GO:0051865; GO:0061630; GO:0090140"
"1733",1733,"Cluster_2854","Porites_evermani_scaffold_342:249263-250263",168,-26.08,2,21,732,753,19,"73.68%","84.21%","Peve_00025418",-0.376452795563219,0.754287411469132,0.988219883885475,"Q8BHR2","Ecto-NOX disulfide-thiol exchanger 1 (Constitutive Ecto-NOX) (cNOX) [Includes: Hydroquinone [NADH] oxidase (EC 1.-.-.-); Protein disulfide-thiol oxidoreductase (EC 1.-.-.-)]","Mus musculus (Mouse)","ultradian rhythm [GO:0007624]","GO:0003723; GO:0003756; GO:0003954; GO:0005615; GO:0005886; GO:0007624; GO:0009897"
"1734",1734,"Cluster_2854","Porites_evermani_scaffold_342:249263-250263",200,-38.33,2,21,892,913,19,"100.00%","100.00%","Peve_00025418",-0.376452795563219,0.754287411469132,0.988219883885475,"Q8BHR2","Ecto-NOX disulfide-thiol exchanger 1 (Constitutive Ecto-NOX) (cNOX) [Includes: Hydroquinone [NADH] oxidase (EC 1.-.-.-); Protein disulfide-thiol oxidoreductase (EC 1.-.-.-)]","Mus musculus (Mouse)","ultradian rhythm [GO:0007624]","GO:0003723; GO:0003756; GO:0003954; GO:0005615; GO:0005886; GO:0007624; GO:0009897"
"1735",1735,"Cluster_2854","Porites_evermani_scaffold_3463:17704-18704",177,-25.85,2,19,734,756,18,"88.89%","94.44%","Peve_00025698",-0.563728726677658,0.618732685374174,0.978262075707395,"Q7Z408","CUB and sushi domain-containing protein 2 (CUB and sushi multiple domains protein 2)","Homo sapiens (Human)","","GO:0005886"
"1736",1736,"Cluster_2854","Porites_evermani_scaffold_3463:9485-10485",177,-26.03,2,18,60,81,16,"93.75%","93.75%","Peve_00025697",-0.507486347355159,0.661149542463894,0.978262075707395,NA,NA,NA,NA,NA
"1737",1737,"Cluster_2854","Porites_evermani_scaffold_3557:29770-30770",161,-23.02,2,18,636,657,16,"68.75%","93.75%","Peve_00026276",NA,NA,NA,NA,NA,NA,NA,NA
"1738",1738,"Cluster_2854","Porites_evermani_scaffold_3598:29010-30010",154,-20.43,2,21,629,649,19,"68.42%","78.95%","Peve_00026503",-0.803974044428814,0.405430120775383,0.978262075707395,"Q6P2X9","Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449]","GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0046449"
"1739",1739,"Cluster_2854","Porites_evermani_scaffold_3650:15676-16676",166,-23.13,2,20,932,955,20,"80.00%","80.00%","Peve_00026838",-0.293480747245611,0.810372681480109,0.995934364227446,NA,NA,NA,NA,NA
"1740",1740,"Cluster_2854","Porites_evermani_scaffold_366:186177-187177",160,-20.8,2,19,261,286,21,"76.19%","80.95%","Peve_00026874",NA,NA,NA,"P63079","Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3)","Rattus norvegicus (Rat)","brain development [GO:0007420]; cellular response to histamine [GO:0071420]; cellular response to zinc ion [GO:0071294]; cerebellum development [GO:0021549]; chemical synaptic transmission [GO:0007268]; chemical synaptic transmission, postsynaptic [GO:0099565]; chloride transmembrane transport [GO:1902476]; circadian sleep/wake cycle, REM sleep [GO:0042747]; cochlea development [GO:0090102]; exploration behavior [GO:0035640]; gamma-aminobutyric acid signaling pathway [GO:0007214]; hard palate development [GO:0060022]; inhibitory postsynaptic potential [GO:0060080]; inhibitory synapse assembly [GO:1904862]; inner ear receptor cell development [GO:0060119]; innervation [GO:0060384]; ion transmembrane transport [GO:0034220]; learning [GO:0007612]; memory [GO:0007613]; motor behavior [GO:0061744]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; neuron development [GO:0048666]; regulation of membrane potential [GO:0042391]; regulation of neuron apoptotic process [GO:0043523]; regulation of postsynaptic membrane potential [GO:0060078]; reproductive behavior [GO:0019098]; response to anesthetic [GO:0072347]; response to xenobiotic stimulus [GO:0009410]; roof of mouth development [GO:0060021]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]; social behavior [GO:0035176]; synaptic transmission, GABAergic [GO:0051932]","GO:0004890; GO:0005216; GO:0005231; GO:0005254; GO:0005886; GO:0007165; GO:0007214; GO:0007268; GO:0007399; GO:0007420; GO:0007605; GO:0007612; GO:0007613; GO:0009410; GO:0009986; GO:0019098; GO:0021549; GO:0022851; GO:0030594; GO:0030659; GO:0034220; GO:0034707; GO:0035176; GO:0035612; GO:0035640; GO:0042391; GO:0042747; GO:0042802; GO:0043005; GO:0043195; GO:0043523; GO:0043524; GO:0045202; GO:0045211; GO:0048666; GO:0050877; GO:0051932; GO:0060021; GO:0060022; GO:0060077; GO:0060078; GO:0060080; GO:0060119; GO:0060384; GO:0061744; GO:0071294; GO:0071420; GO:0072347; GO:0090102; GO:0098982; GO:0099565; GO:0099634; GO:1901215; GO:1902476; GO:1902711; GO:1904315; GO:1904862"
"1741",1741,"Cluster_2854","Porites_evermani_scaffold_368:161635-162635",154,-20.9,2,20,135,157,19,"63.16%","84.21%","Peve_00026970",NA,NA,NA,NA,NA,NA,NA,NA
"1742",1742,"Cluster_2854","Porites_evermani_scaffold_3690:38665-39665",159,-22.05,2,21,305,327,20,"70.00%","80.00%","Peve_00027023",0.101356913639656,0.935363189457291,0.999448381576871,"Q5U3N5","Protein phosphatase PTC7 homolog (EC 3.1.3.16)","Danio rerio (Zebrafish) (Brachydanio rerio)","","GO:0005739; GO:0005759; GO:0017018; GO:0046872"
"1743",1743,"Cluster_2854","Porites_evermani_scaffold_3715:8572-9572",166,-24.77,2,15,16,37,13,"92.31%","100.00%","Peve_00027186",-0.969989777374515,0.156358631644984,0.978262075707395,"Q5RG45","Centrosomal protein of 135 kDa (Cep135)","Danio rerio (Zebrafish) (Brachydanio rerio)","centriole replication [GO:0007099]","GO:0005737; GO:0005813; GO:0005814; GO:0007099"
"1744",1744,"Cluster_2854","Porites_evermani_scaffold_3766:3-1003",172,-20.46,2,21,856,877,19,"78.95%","84.21%","Peve_00027417",-0.58117772958935,0.60518421593675,0.978262075707395,"Q5RH71","Tetraspanin-33 (Tspan-33)","Danio rerio (Zebrafish) (Brachydanio rerio)","protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604]","GO:0005886; GO:0051604; GO:0072659"
"1745",1745,"Cluster_2854","Porites_evermani_scaffold_404:116352-117352",163,-22.06,2,21,857,882,23,"73.91%","73.91%","Peve_00029039",-0.0434093787106285,0.972356044640934,0.999448381576871,"D4ACX8","Protocadherin-16 (Protein dachsous homolog 1)","Rattus norvegicus (Rat)","adherens junction organization [GO:0034332]; anatomical structure morphogenesis [GO:0009653]; branching involved in ureteric bud morphogenesis [GO:0001658]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell migration [GO:0016477]; cell migration involved in endocardial cushion formation [GO:0003273]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; cochlea development [GO:0090102]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; kidney development [GO:0001822]; mitral valve formation [GO:0003192]; mitral valve morphogenesis [GO:0003183]; nephron development [GO:0072006]; neural tube development [GO:0021915]; neurogenesis [GO:0022008]; ossification involved in bone maturation [GO:0043931]; pattern specification process [GO:0007389]; post-anal tail morphogenesis [GO:0036342]; protein localization to plasma membrane [GO:0072659]","GO:0000902; GO:0001658; GO:0001822; GO:0003007; GO:0003183; GO:0003192; GO:0003273; GO:0005509; GO:0005912; GO:0007043; GO:0007156; GO:0007157; GO:0007389; GO:0009653; GO:0016339; GO:0016342; GO:0016477; GO:0021915; GO:0022008; GO:0034332; GO:0035329; GO:0036342; GO:0043931; GO:0045177; GO:0045296; GO:0048565; GO:0072006; GO:0072137; GO:0072659; GO:0090102; GO:0098609; GO:0098742"
"1746",1746,"Cluster_2854","Porites_evermani_scaffold_404:22800-23800",154,-20.75,2,20,624,647,20,"65.00%","80.00%","Peve_00029047",0.994908480000944,0.0642692583489764,0.978262075707395,NA,NA,NA,NA,NA
"1747",1747,"Cluster_2854","Porites_evermani_scaffold_404:22800-23800",158,-21.1,2,20,273,296,20,"70.00%","80.00%","Peve_00029047",0.994908480000944,0.0642692583489764,0.978262075707395,NA,NA,NA,NA,NA
"1748",1748,"Cluster_2854","Porites_evermani_scaffold_404:22800-23800",158,-21.1,2,20,351,374,20,"70.00%","80.00%","Peve_00029047",0.994908480000944,0.0642692583489764,0.978262075707395,NA,NA,NA,NA,NA
"1749",1749,"Cluster_2854","Porites_evermani_scaffold_404:22800-23800",162,-21.34,2,20,195,218,20,"75.00%","80.00%","Peve_00029047",0.994908480000944,0.0642692583489764,0.978262075707395,NA,NA,NA,NA,NA
"1750",1750,"Cluster_2854","Porites_evermani_scaffold_404:22800-23800",163,-21.02,2,21,78,101,21,"71.43%","80.95%","Peve_00029047",0.994908480000944,0.0642692583489764,0.978262075707395,NA,NA,NA,NA,NA
"1751",1751,"Cluster_2854","Porites_evermani_scaffold_404:22800-23800",166,-28,2,20,1,23,20,"75.00%","85.00%","Peve_00029047",0.994908480000944,0.0642692583489764,0.978262075707395,NA,NA,NA,NA,NA
"1752",1752,"Cluster_2854","Porites_evermani_scaffold_404:22800-23800",166,-28,2,20,507,530,20,"75.00%","85.00%","Peve_00029047",0.994908480000944,0.0642692583489764,0.978262075707395,NA,NA,NA,NA,NA
"1753",1753,"Cluster_2854","Porites_evermani_scaffold_4062:21439-22439",163,-21.49,2,20,219,240,18,"72.22%","83.33%","Peve_00029179",-0.636999830054695,0.560350372957059,0.978262075707395,"E2JA28","Dapdiamide synthesis protein DdaC (EC 1.-.-.-)","Enterobacter agglomerans (Erwinia herbicola) (Pantoea agglomerans)","antibiotic biosynthetic process [GO:0017000]","GO:0016491; GO:0017000"
"1754",1754,"Cluster_2854","Porites_evermani_scaffold_4251:23356-24356",169,-21.46,2,19,525,547,18,"83.33%","88.89%","Peve_00030149",-0.290266915040753,0.812511816561799,0.995934364227446,"Q6INU8","Tetratricopeptide repeat protein 30A (TPR repeat protein 30A)","Xenopus laevis (African clawed frog)","intraciliary transport [GO:0042073]; protein polyglutamylation [GO:0018095]","GO:0005879; GO:0005929; GO:0018095; GO:0042073"
"1755",1755,"Cluster_2854","Porites_evermani_scaffold_4251:23586-24586",169,-21.46,2,19,295,317,18,"83.33%","88.89%","Peve_00030150",-0.995606658463612,0.0596968935853925,0.978262075707395,NA,NA,NA,NA,NA
"1756",1756,"Cluster_2854","Porites_evermani_scaffold_4258:18910-19910",156,-21.32,2,21,957,978,19,"63.16%","78.95%","Peve_00030168",NA,NA,NA,NA,NA,NA,NA,NA
"1757",1757,"Cluster_2854","Porites_evermani_scaffold_4352:21678-22678",172,-23.56,2,21,132,153,19,"73.68%","89.47%","Peve_00030676",-0.936749594593518,0.227637025896264,0.978262075707395,NA,NA,NA,NA,NA
"1758",1758,"Cluster_2854","Porites_evermani_scaffold_4353:20316-21316",171,-22.97,2,21,407,430,21,"76.19%","85.71%","Peve_00030680",0.940089698086235,0.221481938999977,0.978262075707395,NA,NA,NA,NA,NA
"1759",1759,"Cluster_2854","Porites_evermani_scaffold_445:159760-160760",162,-21.67,2,20,115,137,19,"73.68%","84.21%","Peve_00031213",-0.919225074799696,0.257632724383229,0.978262075707395,NA,NA,NA,NA,NA
"1760",1760,"Cluster_2854","Porites_evermani_scaffold_4459:15634-16634",162,-21.97,2,15,126,147,13,"92.31%","92.31%","Peve_00031241",0.104756549864637,0.933187327308214,0.999448381576871,NA,NA,NA,NA,NA
"1761",1761,"Cluster_2854","Porites_evermani_scaffold_4459:15634-16634",167,-22.7,2,21,507,530,21,"76.19%","80.95%","Peve_00031241",0.104756549864637,0.933187327308214,0.999448381576871,NA,NA,NA,NA,NA
"1762",1762,"Cluster_2854","Porites_evermani_scaffold_4511:3881-4881",161,-23.37,2,20,800,824,21,"76.19%","80.95%","Peve_00031526",-0.0764780177439363,0.951264995195362,0.999448381576871,"O15439","ATP-binding cassette sub-family C member 4 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (MRP/cMOAT-related ABC transporter) (Multi-specific organic anion transporter B) (MOAT-B) (Multidrug resistance-associated protein 4)","Homo sapiens (Human)","bile acid and bile salt transport [GO:0015721]; cAMP transport [GO:0070730]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; leukotriene transport [GO:0071716]; platelet degranulation [GO:0002576]; prostaglandin secretion [GO:0032310]; prostaglandin transport [GO:0015732]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; urate transport [GO:0015747]; xenobiotic metabolic process [GO:0006805]; xenobiotic transmembrane transport [GO:0006855]","GO:0001409; GO:0002576; GO:0005524; GO:0005730; GO:0005794; GO:0005886; GO:0006805; GO:0006855; GO:0008559; GO:0015132; GO:0015143; GO:0015216; GO:0015431; GO:0015432; GO:0015562; GO:0015721; GO:0015732; GO:0015747; GO:0016020; GO:0016323; GO:0016324; GO:0016404; GO:0016887; GO:0031088; GO:0032310; GO:0034634; GO:0042626; GO:0042910; GO:0043225; GO:0055085; GO:0060271; GO:0070730; GO:0071716; GO:0098591; GO:0140115; GO:0140359; GO:0150104"
"1763",1763,"Cluster_2854","Porites_evermani_scaffold_459:227043-228043",159,-21.24,2,21,333,355,20,"70.00%","80.00%","Peve_00031836",NA,NA,NA,"E1BPW0","Ectonucleoside triphosphate diphosphohydrolase 5 (NTPDase 5) (EC 3.6.1.6) (Guanosine-diphosphatase ENTPD5) (GDPase ENTPD5) (Uridine-diphosphatase ENTPD5) (UDPase ENTPD5)","Bos taurus (Bovine)","'de novo' post-translational protein folding [GO:0051084]; protein N-linked glycosylation [GO:0006487]; UDP catabolic process [GO:0006256]; UDP-glucose metabolic process [GO:0006011]","GO:0004382; GO:0005576; GO:0005783; GO:0006011; GO:0006256; GO:0006487; GO:0036384; GO:0043262; GO:0045134; GO:0051084; GO:1990003"
"1764",1764,"Cluster_2854","Porites_evermani_scaffold_4:627138-628138",150,-20.67,2,21,159,185,24,"66.67%","70.83%","Peve_00028706",-0.532014712422893,0.642870198174766,0.978262075707395,"Q32NW2","Leukocyte receptor cluster member 8 homolog","Xenopus laevis (African clawed frog)","",""
"1765",1765,"Cluster_2854","Porites_evermani_scaffold_4780:2653-3653",153,-21.69,2,21,774,798,23,"69.57%","73.91%","Peve_00032658",-0.574788508751809,0.610168636889486,0.978262075707395,"Q9HCF6","Transient receptor potential cation channel subfamily M member 3 (Long transient receptor potential channel 3) (LTrpC-3) (LTrpC3) (Melastatin-2) (MLSN2)","Homo sapiens (Human)","calcium ion transmembrane transport [GO:0070588]; cation transmembrane transport [GO:0098655]; cation transport [GO:0006812]; protein tetramerization [GO:0051262]","GO:0005261; GO:0005262; GO:0005886; GO:0006812; GO:0051262; GO:0070588; GO:0098655"
"1766",1766,"Cluster_2854","Porites_evermani_scaffold_4859:11842-12842",147,-22.31,2,21,873,899,24,"58.33%","70.83%","Peve_00032977",-0.478490620510153,0.682368129065585,0.978262075707395,NA,NA,NA,NA,NA
"1767",1767,"Cluster_2854","Porites_evermani_scaffold_495:146844-147844",162,-21.15,2,21,288,312,22,"72.73%","81.82%","Peve_00033324",NA,NA,NA,"P86982","Insoluble matrix shell protein 1 (IMSP1)","Ruditapes philippinarum (Japanese littleneck clam) (Venerupis philippinarum)","","GO:0005576"
"1768",1768,"Cluster_2854","Porites_evermani_scaffold_503:88953-89953",164,-20.17,2,21,703,724,19,"73.68%","78.95%","Peve_00033756",NA,NA,NA,"Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"1769",1769,"Cluster_2854","Porites_evermani_scaffold_5198:13270-14270",163,-23.42,2,21,640,662,20,"75.00%","80.00%","Peve_00034355",-0.507486347355159,0.661149542463894,0.978262075707395,"Q5R9R1","Erythroid differentiation-related factor 1","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","","GO:0005634"
"1770",1770,"Cluster_2854","Porites_evermani_scaffold_5309:12291-13291",147,-20.22,2,21,689,713,22,"59.09%","72.73%","Peve_00034792",-0.492476100688937,0.672183790869439,0.978262075707395,NA,NA,NA,NA,NA
"1771",1771,"Cluster_2854","Porites_evermani_scaffold_5316:7809-8809",162,-22.48,2,20,898,920,19,"73.68%","84.21%","Peve_00034819",-0.507486347355159,0.661149542463894,0.978262075707395,NA,NA,NA,NA,NA
"1772",1772,"Cluster_2854","Porites_evermani_scaffold_53:179027-180027",171,-26.48,2,21,246,268,20,"75.00%","90.00%","Peve_00034742",-0.507486347355159,0.661149542463894,0.978262075707395,"Q54KD0","TPR repeat-containing protein DDB_G0287407","Dictyostelium discoideum (Social amoeba)","",""
"1773",1773,"Cluster_2854","Porites_evermani_scaffold_546:130408-131408",150,-20.22,2,15,853,874,13,"76.92%","84.62%","Peve_00035329",0.998029698096393,0.0399698798387951,0.909359886114279,NA,NA,NA,NA,NA
"1774",1774,"Cluster_2854","Porites_evermani_scaffold_547:152312-153312",156,-20.54,2,18,564,588,19,"68.42%","84.21%","Peve_00035351",NA,NA,NA,NA,NA,NA,NA,NA
"1775",1775,"Cluster_2854","Porites_evermani_scaffold_55:611267-612267",157,-21,2,21,476,495,19,"68.42%","84.21%","Peve_00035449",NA,NA,NA,NA,NA,NA,NA,NA
"1776",1776,"Cluster_2854","Porites_evermani_scaffold_557:46073-47073",144,-21.49,2,21,111,136,24,"62.50%","75.00%","Peve_00035696",-0.587458122747916,0.600257382182744,0.978262075707395,NA,NA,NA,NA,NA
"1777",1777,"Cluster_2854","Porites_evermani_scaffold_558:168810-169810",149,-20.69,2,20,931,960,26,"65.38%","69.23%","Peve_00035737",NA,NA,NA,NA,NA,NA,NA,NA
"1778",1778,"Cluster_2854","Porites_evermani_scaffold_5:612477-613477",160,-20.86,2,20,546,565,18,"77.78%","83.33%","Peve_00033520",-0.843774977102233,0.360656428917876,0.978262075707395,"O57478","Ferrochelatase, mitochondrial (EC 4.98.1.1) (Heme synthase) (Protoheme ferro-lyase)","Xenopus laevis (African clawed frog)","heme biosynthetic process [GO:0006783]","GO:0004325; GO:0005743; GO:0006783; GO:0046872; GO:0051537"
"1779",1779,"Cluster_2854","Porites_evermani_scaffold_568:17263-18263",160,-23.12,2,20,638,659,19,"78.95%","84.21%","Peve_00036027",-0.617065500943788,0.576642699439585,0.978262075707395,NA,NA,NA,NA,NA
"1780",1780,"Cluster_2854","Porites_evermani_scaffold_5:760210-761210",162,-21.97,2,15,961,982,13,"92.31%","92.31%","Peve_00033534",NA,NA,NA,NA,NA,NA,NA,NA
"1781",1781,"Cluster_2854","Porites_evermani_scaffold_577:46320-47320",162,-25.86,2,20,503,527,21,"71.43%","80.95%","Peve_00036294",-0.515941903989965,0.654884067082322,0.978262075707395,"Q2TCH3","ATP-citrate synthase (EC 2.3.3.8) (ATP-citrate (pro-S-)-lyase) (Citrate cleavage enzyme)","Ovis aries (Sheep)","acetyl-CoA biosynthetic process [GO:0006085]; citrate metabolic process [GO:0006101]; lipid biosynthetic process [GO:0008610]; tricarboxylic acid cycle [GO:0006099]","GO:0003878; GO:0005524; GO:0005829; GO:0006085; GO:0006099; GO:0006101; GO:0008610; GO:0046872"
"1782",1782,"Cluster_2854","Porites_evermani_scaffold_5:812372-813372",166,-26.56,2,19,544,565,17,"76.47%","88.24%","Peve_00033538",-0.993514672711541,0.072543091779404,0.978262075707395,NA,NA,NA,NA,NA
"1783",1783,"Cluster_2854","Porites_evermani_scaffold_60:622460-623460",157,-20.1,2,21,173,194,20,"70.00%","85.00%","Peve_00037077",NA,NA,NA,"P05696","Protein kinase C alpha type (PKC-A) (PKC-alpha) (EC 2.7.11.13)","Rattus norvegicus (Rat)","aging [GO:0007568]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular response to carbohydrate stimulus [GO:0071322]; central nervous system neuron axonogenesis [GO:0021955]; chondrocyte differentiation [GO:0002062]; desmosome assembly [GO:0002159]; establishment of protein localization [GO:0045184]; induction of positive chemotaxis [GO:0050930]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway [GO:0097193]; learning or memory [GO:0007611]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of anion channel activity [GO:0010360]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of glucose import [GO:0046325]; negative regulation of heart contraction [GO:0045822]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of translation [GO:0017148]; neutrophil chemotaxis [GO:0030593]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of bone resorption [GO:0045780]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of dense core granule biogenesis [GO:2000707]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of exocytosis [GO:0045921]; positive regulation of inflammatory response [GO:0050729]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of synapse assembly [GO:0051965]; post-translational protein modification [GO:0043687]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of muscle contraction [GO:0006937]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of platelet aggregation [GO:0090330]; regulation of receptor-mediated endocytosis [GO:0048259]; regulation of response to osmotic stress [GO:0047484]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of the force of heart contraction [GO:0002026]; response to antibiotic [GO:0046677]; response to corticosterone [GO:0051412]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to interleukin-1 [GO:0070555]; response to mechanical stimulus [GO:0009612]; response to organic cyclic compound [GO:0014070]; response to peptide hormone [GO:0043434]; response to reactive oxygen species [GO:0000302]; response to toxic substance [GO:0009636]; stem cell differentiation [GO:0048863]","GO:0000302; GO:0001525; GO:0001750; GO:0001933; GO:0001934; GO:0001938; GO:0002026; GO:0002062; GO:0002159; GO:0004672; GO:0004674; GO:0004697; GO:0004698; GO:0005178; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0005886; GO:0006468; GO:0006469; GO:0006874; GO:0006937; GO:0007155; GO:0007568; GO:0007611; GO:0008270; GO:0008283; GO:0008285; GO:0008289; GO:0009612; GO:0009636; GO:0010360; GO:0010595; GO:0010613; GO:0014070; GO:0014704; GO:0016020; GO:0017148; GO:0018105; GO:0018107; GO:0019899; GO:0021955; GO:0030335; GO:0030424; GO:0030425; GO:0030593; GO:0031666; GO:0031966; GO:0032355; GO:0032991; GO:0034351; GO:0035403; GO:0035556; GO:0035866; GO:0036289; GO:0043005; GO:0043025; GO:0043409; GO:0043434; GO:0043536; GO:0043687; GO:0044305; GO:0045121; GO:0045177; GO:0045184; GO:0045471; GO:0045651; GO:0045766; GO:0045780; GO:0045785; GO:0045822; GO:0045921; GO:0045931; GO:0046325; GO:0046627; GO:0046677; GO:0046716; GO:0046777; GO:0047484; GO:0048259; GO:0048471; GO:0048661; GO:0048863; GO:0050729; GO:0050730; GO:0050930; GO:0051412; GO:0051965; GO:0070374; GO:0070555; GO:0071322; GO:0090330; GO:0097193; GO:0098793; GO:0099171; GO:0099523; GO:0106310; GO:0120199; GO:1990917; GO:2000300; GO:2000707"
"1784",1784,"Cluster_2854","Porites_evermani_scaffold_60:639646-640646",157,-20.1,2,21,173,194,20,"70.00%","85.00%","Peve_00037078",NA,NA,NA,"P05696","Protein kinase C alpha type (PKC-A) (PKC-alpha) (EC 2.7.11.13)","Rattus norvegicus (Rat)","aging [GO:0007568]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular response to carbohydrate stimulus [GO:0071322]; central nervous system neuron axonogenesis [GO:0021955]; chondrocyte differentiation [GO:0002062]; desmosome assembly [GO:0002159]; establishment of protein localization [GO:0045184]; induction of positive chemotaxis [GO:0050930]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway [GO:0097193]; learning or memory [GO:0007611]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of anion channel activity [GO:0010360]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of glucose import [GO:0046325]; negative regulation of heart contraction [GO:0045822]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of translation [GO:0017148]; neutrophil chemotaxis [GO:0030593]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of bone resorption [GO:0045780]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of dense core granule biogenesis [GO:2000707]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of exocytosis [GO:0045921]; positive regulation of inflammatory response [GO:0050729]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of synapse assembly [GO:0051965]; post-translational protein modification [GO:0043687]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of muscle contraction [GO:0006937]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of platelet aggregation [GO:0090330]; regulation of receptor-mediated endocytosis [GO:0048259]; regulation of response to osmotic stress [GO:0047484]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of the force of heart contraction [GO:0002026]; response to antibiotic [GO:0046677]; response to corticosterone [GO:0051412]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to interleukin-1 [GO:0070555]; response to mechanical stimulus [GO:0009612]; response to organic cyclic compound [GO:0014070]; response to peptide hormone [GO:0043434]; response to reactive oxygen species [GO:0000302]; response to toxic substance [GO:0009636]; stem cell differentiation [GO:0048863]","GO:0000302; GO:0001525; GO:0001750; GO:0001933; GO:0001934; GO:0001938; GO:0002026; GO:0002062; GO:0002159; GO:0004672; GO:0004674; GO:0004697; GO:0004698; GO:0005178; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0005886; GO:0006468; GO:0006469; GO:0006874; GO:0006937; GO:0007155; GO:0007568; GO:0007611; GO:0008270; GO:0008283; GO:0008285; GO:0008289; GO:0009612; GO:0009636; GO:0010360; GO:0010595; GO:0010613; GO:0014070; GO:0014704; GO:0016020; GO:0017148; GO:0018105; GO:0018107; GO:0019899; GO:0021955; GO:0030335; GO:0030424; GO:0030425; GO:0030593; GO:0031666; GO:0031966; GO:0032355; GO:0032991; GO:0034351; GO:0035403; GO:0035556; GO:0035866; GO:0036289; GO:0043005; GO:0043025; GO:0043409; GO:0043434; GO:0043536; GO:0043687; GO:0044305; GO:0045121; GO:0045177; GO:0045184; GO:0045471; GO:0045651; GO:0045766; GO:0045780; GO:0045785; GO:0045822; GO:0045921; GO:0045931; GO:0046325; GO:0046627; GO:0046677; GO:0046716; GO:0046777; GO:0047484; GO:0048259; GO:0048471; GO:0048661; GO:0048863; GO:0050729; GO:0050730; GO:0050930; GO:0051412; GO:0051965; GO:0070374; GO:0070555; GO:0071322; GO:0090330; GO:0097193; GO:0098793; GO:0099171; GO:0099523; GO:0106310; GO:0120199; GO:1990917; GO:2000300; GO:2000707"
"1785",1785,"Cluster_2854","Porites_evermani_scaffold_612:183024-184024",159,-22.28,2,21,540,562,20,"65.00%","85.00%","Peve_00037400",NA,NA,NA,"P79218","Substance-K receptor (SKR) (NK-2 receptor) (NK-2R) (Neurokinin A receptor) (Tachykinin receptor 2)","Oryctolagus cuniculus (Rabbit)","positive regulation of flagellated sperm motility [GO:1902093]; regulation of uterine smooth muscle contraction [GO:0070472]","GO:0004995; GO:0005886; GO:0061827; GO:0070472; GO:0097225; GO:1902093"
"1786",1786,"Cluster_2854","Porites_evermani_scaffold_623:5404-6404",147,-20.22,2,21,793,817,22,"59.09%","72.73%","Peve_00037694",-0.67798731236385,0.525704844093537,0.978262075707395,"Q9JJS6","Beta,beta-carotene 15,15'-dioxygenase (EC 1.13.11.63) (Beta-carotene dioxygenase 1) (Beta-carotene oxygenase 1)","Mus musculus (Mouse)","beta-carotene metabolic process [GO:1901810]; carotene catabolic process [GO:0016121]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]","GO:0001523; GO:0003834; GO:0005829; GO:0010436; GO:0016121; GO:0042572; GO:0042574; GO:0046872; GO:1901810"
"1787",1787,"Cluster_2854","Porites_evermani_scaffold_62:81027-82027",162,-23.62,2,15,950,971,13,"84.62%","100.00%","Peve_00037605",-0.0903322723031934,0.942414191614869,0.999448381576871,"Q5R7V3","Acyl-CoA-binding domain-containing protein 5","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","autophagy of peroxisome [GO:0030242]","GO:0000062; GO:0005778; GO:0030242"
"1788",1788,"Cluster_2854","Porites_evermani_scaffold_62:91544-92544",162,-23.62,2,15,975,996,13,"84.62%","100.00%","Peve_00037608",-0.227466318735986,0.853911676786141,0.995934364227446,NA,NA,NA,NA,NA
"1789",1789,"Cluster_2854","Porites_evermani_scaffold_630:211711-212711",168,-24.41,2,21,146,167,19,"73.68%","84.21%","Peve_00037904",NA,NA,NA,NA,NA,NA,NA,NA
"1790",1790,"Cluster_2854","Porites_evermani_scaffold_6610:5-1005",159,-21.34,2,21,218,240,20,"65.00%","85.00%","Peve_00038651",-0.546728028136177,0.631746329928167,0.978262075707395,"Q5RBP4","EH domain-containing protein 1","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","cellular response to nerve growth factor stimulus [GO:1990090]; cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; neuron projection development [GO:0031175]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of myoblast fusion [GO:1901741]; protein localization to cilium [GO:0061512]","GO:0005509; GO:0005524; GO:0005525; GO:0005886; GO:0006886; GO:0006897; GO:0010008; GO:0020018; GO:0031175; GO:0031901; GO:0032456; GO:0055038; GO:0060271; GO:0061512; GO:1901741; GO:1990090; GO:2001137"
"1791",1791,"Cluster_2854","Porites_evermani_scaffold_684:1102-2102",192,-30.77,2,21,373,394,19,"94.74%","94.74%","Peve_00039149",-0.375970677180188,0.754618674211849,0.988219883885475,"Q92890","Ubiquitin recognition factor in ER-associated degradation protein 1 (Ubiquitin fusion degradation protein 1) (UB fusion protein 1)","Homo sapiens (Human)","ER-associated misfolded protein catabolic process [GO:0071712]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; retrograde protein transport, ER to cytosol [GO:0030970]; skeletal system development [GO:0001501]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0001501; GO:0004843; GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0030433; GO:0030970; GO:0031593; GO:0032480; GO:0034098; GO:0036435; GO:0036501; GO:0039536; GO:0071712"
"1792",1792,"Cluster_2854","Porites_evermani_scaffold_684:1102-2102",200,-38.33,2,21,30,51,19,"100.00%","100.00%","Peve_00039149",-0.375970677180188,0.754618674211849,0.988219883885475,"Q92890","Ubiquitin recognition factor in ER-associated degradation protein 1 (Ubiquitin fusion degradation protein 1) (UB fusion protein 1)","Homo sapiens (Human)","ER-associated misfolded protein catabolic process [GO:0071712]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; retrograde protein transport, ER to cytosol [GO:0030970]; skeletal system development [GO:0001501]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0001501; GO:0004843; GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0030433; GO:0030970; GO:0031593; GO:0032480; GO:0034098; GO:0036435; GO:0036501; GO:0039536; GO:0071712"
"1793",1793,"Cluster_2854","Porites_evermani_scaffold_6869:3658-3892",149,-22.41,2,21,76,98,21,"66.67%","76.19%","Peve_00039198",-0.997118363096831,0.0483413856135186,0.946447951505117,"O75897","Sulfotransferase 1C4 (ST1C4) (EC 2.8.2.1) (Sulfotransferase 1C2) (SULT1C#2)","Homo sapiens (Human)","3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; doxorubicin metabolic process [GO:0044598]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; sulfation [GO:0051923]; xenobiotic metabolic process [GO:0006805]","GO:0004062; GO:0005737; GO:0005829; GO:0006068; GO:0006805; GO:0008146; GO:0009812; GO:0044598; GO:0050427; GO:0051923"
"1794",1794,"Cluster_2854","Porites_evermani_scaffold_69:576356-577356",162,-24.22,2,15,46,67,13,"92.31%","92.31%","Peve_00039256",NA,NA,NA,NA,NA,NA,NA,NA
"1795",1795,"Cluster_2854","Porites_evermani_scaffold_69:576356-577356",192,-30.77,2,21,166,187,19,"94.74%","94.74%","Peve_00039256",NA,NA,NA,NA,NA,NA,NA,NA
"1796",1796,"Cluster_2854","Porites_evermani_scaffold_698:45062-45920",164,-20.14,2,21,447,468,19,"68.42%","84.21%","Peve_00039485",-0.0851720906996053,0.945711990810708,0.999448381576871,NA,NA,NA,NA,NA
"1797",1797,"Cluster_2854","Porites_evermani_scaffold_6988:2234-3234",147,-20.22,2,21,686,710,22,"59.09%","72.73%","Peve_00039498",NA,NA,NA,NA,NA,NA,NA,NA
"1798",1798,"Cluster_2854","Porites_evermani_scaffold_6997:247-1247",168,-20.24,2,21,44,65,19,"73.68%","84.21%","Peve_00039520",-0.736401779756976,0.473046691653457,0.978262075707395,"P50429","Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S)","Mus musculus (Mouse)","anterior head development [GO:0097065]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; chondroitin sulfate catabolic process [GO:0030207]; colon epithelial cell migration [GO:0061580]; dermatan sulfate catabolic process [GO:0030209]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]","GO:0003943; GO:0004065; GO:0005739; GO:0005764; GO:0005791; GO:0005794; GO:0006914; GO:0007417; GO:0007584; GO:0008484; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0030207; GO:0030209; GO:0043627; GO:0043890; GO:0046872; GO:0051597; GO:0061580; GO:0097065"
"1799",1799,"Cluster_2854","Porites_evermani_scaffold_728:116313-117313",166,-23.2,2,20,884,906,19,"78.95%","84.21%","Peve_00040186",-0.744324725728089,0.46554299189638,0.978262075707395,NA,NA,NA,NA,NA
"1800",1800,"Cluster_2854","Porites_evermani_scaffold_747:47096-48096",157,-22.72,2,19,652,674,18,"72.22%","83.33%","Peve_00040608",-0.437714356814205,0.711576235505291,0.979287943735746,NA,NA,NA,NA,NA
"1801",1801,"Cluster_2854","Porites_evermani_scaffold_747:47621-48621",157,-22.72,2,19,127,149,18,"72.22%","83.33%","Peve_00040609",-0.640247157509407,0.557663867981066,0.978262075707395,"Q91ZS8","Double-stranded RNA-specific editase 1 (EC 3.5.4.37) (RNA-editing deaminase 1) (RNA-editing enzyme 1) (dsRNA adenosine deaminase)","Mus musculus (Mouse)","adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; facial nerve morphogenesis [GO:0021610]; hypoglossal nerve morphogenesis [GO:0021618]; innervation [GO:0060384]; motor behavior [GO:0061744]; motor neuron apoptotic process [GO:0097049]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; multicellular organism growth [GO:0035264]; muscle tissue morphogenesis [GO:0060415]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; neuromuscular process controlling posture [GO:0050884]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of mRNA processing [GO:0050685]; positive regulation of viral genome replication [GO:0045070]; regulation of cell cycle [GO:0051726]; RNA processing [GO:0006396]; spinal cord ventral commissure morphogenesis [GO:0021965]","GO:0003723; GO:0003725; GO:0003726; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006382; GO:0006396; GO:0006397; GO:0007274; GO:0008251; GO:0008285; GO:0016553; GO:0016556; GO:0021610; GO:0021618; GO:0021965; GO:0030336; GO:0035264; GO:0042802; GO:0044387; GO:0045070; GO:0045202; GO:0046872; GO:0050685; GO:0050884; GO:0051726; GO:0060384; GO:0060415; GO:0061744; GO:0097049"
"1802",1802,"Cluster_2854","Porites_evermani_scaffold_751:108808-109808",151,-20.97,2,12,238,259,10,"90.00%","100.00%","Peve_00040718",0.656335754365651,0.544210981217533,0.978262075707395,"Q8BZM0","Kelch-like protein 12 (CUL3-interacting protein 1)","Mus musculus (Mouse)","COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; protein monoubiquitination [GO:0006513]; Wnt signaling pathway [GO:0016055]","GO:0006513; GO:0006888; GO:0014029; GO:0014032; GO:0016055; GO:0030127; GO:0030134; GO:0031463; GO:0034451; GO:0042802; GO:0043231; GO:0048208"
"1803",1803,"Cluster_2854","Porites_evermani_scaffold_7604:1195-2195",155,-23.11,2,12,915,936,10,"100.00%","100.00%","Peve_00040889",-0.662701542899819,0.538819614266404,0.978262075707395,"P38650","Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic) (MAP 1C)","Rattus norvegicus (Rat)","cell division [GO:0051301]; cellular response to 3,3',5-triiodo-L-thyronine [GO:1905243]; cellular response to nerve growth factor stimulus [GO:1990090]; cytoplasmic microtubule organization [GO:0031122]; establishment of spindle localization [GO:0051293]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitotic cell cycle [GO:0000278]; nuclear migration [GO:0007097]; P-body assembly [GO:0033962]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; retrograde axonal transport [GO:0008090]; spermatid development [GO:0007286]; stress granule assembly [GO:0034063]","GO:0000278; GO:0002177; GO:0005524; GO:0005635; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0005881; GO:0005938; GO:0007018; GO:0007097; GO:0007286; GO:0008090; GO:0008569; GO:0030175; GO:0030286; GO:0030424; GO:0031122; GO:0032388; GO:0033962; GO:0034063; GO:0043025; GO:0045505; GO:0051293; GO:0051301; GO:0051959; GO:0060236; GO:0072382; GO:0090235; GO:0120162; GO:1904115; GO:1905243; GO:1905832; GO:1990090"
"1804",1804,"Cluster_2854","Porites_evermani_scaffold_792:113859-114859",160,-21.54,2,21,681,702,19,"68.42%","78.95%","Peve_00041551",-0.624957014084625,0.570232972541941,0.978262075707395,NA,NA,NA,NA,NA
"1805",1805,"Cluster_2854","Porites_evermani_scaffold_84:341261-342261",162,-21.3,2,21,77,102,23,"73.91%","78.26%","Peve_00042526",-0.817957082562987,0.390213225790772,0.978262075707395,"Q16514","Transcription initiation factor TFIID subunit 12 (Transcription initiation factor TFIID 20/15 kDa subunits) (TAFII-20/TAFII-15) (TAFII20/TAFII15)","Homo sapiens (Human)","DNA-templated transcription initiation [GO:0006352]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; protein phosphorylation [GO:0006468]; regulation of DNA repair [GO:0006282]; regulation of DNA-templated transcription [GO:0006355]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription initiation at RNA polymerase II promoter [GO:0006367]","GO:0000124; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0005669; GO:0006282; GO:0006352; GO:0006355; GO:0006357; GO:0006366; GO:0006367; GO:0006468; GO:0016573; GO:0017025; GO:0033276; GO:0035521; GO:0035522; GO:0042789; GO:0043484; GO:0043966; GO:0045893; GO:0045944; GO:0046695; GO:0046982; GO:0051091; GO:0051123; GO:0060261; GO:0140297"
"1806",1806,"Cluster_2854","Porites_evermani_scaffold_8:450170-451170",161,-23.3,2,21,427,446,19,"73.68%","84.21%","Peve_00041691",0.78934333241422,0.42084236476855,0.978262075707395,"Q4UMH6","Putative ankyrin repeat protein RF_0381","Rickettsia felis (strain ATCC VR-1525 / URRWXCal2) (Rickettsia azadi)","guanosine tetraphosphate metabolic process [GO:0015969]","GO:0015969"
"1807",1807,"Cluster_2854","Porites_evermani_scaffold_88:429816-430816",159,-24.4,2,20,801,822,18,"61.11%","88.89%","Peve_00043325",-0.838032253881331,0.367412109788206,0.978262075707395,"Q7TPS5","C2 domain-containing protein 5 (138 kDa C2 domain-containing phosphoprotein)","Mus musculus (Mouse)","cellular response to insulin stimulus [GO:0032869]; insulin receptor signaling pathway via phosphatidylinositol 3-kinase [GO:0038028]; intracellular protein transmembrane transport [GO:0065002]; positive regulation of glucose import [GO:0046326]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of vesicle fusion [GO:0031340]; protein localization to plasma membrane [GO:0072659]; vesicle fusion [GO:0006906]","GO:0005509; GO:0005544; GO:0005829; GO:0005886; GO:0005938; GO:0006906; GO:0010828; GO:0030659; GO:0031340; GO:0032587; GO:0032869; GO:0034451; GO:0038028; GO:0046326; GO:0065002; GO:0072659; GO:0090314"
"1808",1808,"Cluster_2854","Porites_evermani_scaffold_895:148512-149512",160,-23.57,2,18,707,730,18,"72.22%","88.89%","Peve_00043539",0.845563913702845,0.358528833428846,0.978262075707395,NA,NA,NA,NA,NA
"1809",1809,"Cluster_2854","Porites_evermani_scaffold_915:52015-53015",155,-20.66,2,21,652,676,22,"63.64%","77.27%","Peve_00044004",-0.21662536590121,0.860989984048834,0.996391574220818,NA,NA,NA,NA,NA
"1810",1810,"Cluster_2854","Porites_evermani_scaffold_917:147739-148739",162,-20.28,2,20,470,493,20,"75.00%","80.00%","Peve_00044045",-0.734523636270649,0.474811341030635,0.978262075707395,"A1L1K4","CDC42 small effector protein 2","Rattus norvegicus (Rat)","phagocytosis [GO:0006909]; regulation of cell shape [GO:0008360]; regulation of Rho protein signal transduction [GO:0035023]; regulation of signal transduction [GO:0009966]","GO:0001891; GO:0005737; GO:0005856; GO:0005886; GO:0006909; GO:0008360; GO:0009966; GO:0031267; GO:0035023; GO:0035591; GO:0042995"
"1811",1811,"Cluster_2854","Porites_evermani_scaffold_94:88073-89073",156,-20.41,2,21,734,755,19,"68.42%","73.68%","Peve_00044399",-0.412542525336649,0.729281637214367,0.984292668049156,"P46100","Transcriptional regulator ATRX (EC 3.6.4.12) (ATP-dependent helicase ATRX) (X-linked helicase II) (X-linked nuclear protein) (XNP) (Znf-HX)","Homo sapiens (Human)","cellular response to hydroxyurea [GO:0072711]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA methylation [GO:0006306]; DNA repair [GO:0006281]; forebrain development [GO:0030900]; meiotic spindle organization [GO:0000212]; multicellular organism growth [GO:0035264]; negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric [GO:1904908]; nucleosome assembly [GO:0006334]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of telomeric RNA transcription from RNA pol II promoter [GO:1901582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic forelimb morphogenesis [GO:0035128]; protein localization to chromosome, telomeric region [GO:0070198]; regulation of DNA-templated transcription [GO:0006355]; replication fork processing [GO:0031297]; seminiferous tubule development [GO:0072520]; Sertoli cell development [GO:0060009]; spermatogenesis [GO:0007283]; subtelomeric heterochromatin formation [GO:0031509]; transcription by RNA polymerase II [GO:0006366]","GO:0000212; GO:0000228; GO:0000779; GO:0000781; GO:0000792; GO:0003682; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005721; GO:0006281; GO:0006306; GO:0006325; GO:0006334; GO:0006338; GO:0006355; GO:0006366; GO:0007283; GO:0010571; GO:0015616; GO:0016604; GO:0016605; GO:0016887; GO:0030330; GO:0030900; GO:0031297; GO:0031490; GO:0031509; GO:0032206; GO:0035064; GO:0035128; GO:0035264; GO:0042393; GO:0045944; GO:0046872; GO:0060009; GO:0070087; GO:0070192; GO:0070198; GO:0072520; GO:0072711; GO:0099115; GO:0140658; GO:1901582; GO:1904908"
"1812",1812,"Cluster_2854","Porites_evermani_scaffold_952:96359-97359",171,-20.48,2,20,889,910,18,"83.33%","83.33%","Peve_00044611",-0.120092753447779,0.923361603639043,0.999448381576871,NA,NA,NA,NA,NA
"1813",1813,"Cluster_2854","Porites_evermani_scaffold_959:57744-58744",143,-23.36,2,21,590,619,27,"59.26%","62.96%","Peve_00044704",0.975622768703594,0.140855406339273,0.978262075707395,"Q6A051","Attractin-like protein 1","Mus musculus (Mouse)","animal organ morphogenesis [GO:0009887]; cell migration [GO:0016477]; G protein-coupled receptor signaling pathway [GO:0007186]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]","GO:0005604; GO:0005886; GO:0007186; GO:0009887; GO:0009888; GO:0016477; GO:0030246; GO:0034446"
"1814",1814,"Cluster_2854","Porites_evermani_scaffold_993:33451-34451",167,-20.51,2,20,50,71,18,"72.22%","88.89%","Peve_00045269",0.310799226131117,0.798806642663714,0.995934364227446,"Q9CZV8","F-box/LRR-repeat protein 20 (F-box and leucine-rich repeat protein 20) (F-box/LRR-repeat protein 2-like)","Mus musculus (Mouse)","behavioral fear response [GO:0001662]; regulation of protein catabolic process at presynapse, modulating synaptic transmission [GO:0099575]; regulation of synaptic vesicle exocytosis [GO:2000300]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]","GO:0001662; GO:0005737; GO:0019005; GO:0031146; GO:0045202; GO:0098685; GO:0098793; GO:0098978; GO:0099575; GO:2000300"
"1815",1815,"Cluster_2882","Porites_evermani_scaffold_103:479096-480096",166,-21.95,2,21,652,672,19,"78.95%","84.21%","Peve_00000674",-0.923390935798123,0.250811565042745,0.978262075707395,NA,NA,NA,NA,NA
"1816",1816,"Cluster_2882","Porites_evermani_scaffold_1044:73439-74439",164,-23.21,2,20,595,614,18,"83.33%","83.33%","Peve_00000910",NA,NA,NA,NA,NA,NA,NA,NA
"1817",1817,"Cluster_2882","Porites_evermani_scaffold_1060:90026-91026",151,-20.66,2,21,810,832,20,"70.00%","70.00%","Peve_00001167",-0.956663766326917,0.188105591535368,0.978262075707395,"A6H6W9","Sin3 histone deacetylase corepressor complex component SDS3 (Suppressor of defective silencing 3 protein homolog)","Bos taurus (Bovine)","apoptotic process [GO:0006915]; chromatin organization [GO:0006325]; histone deacetylation [GO:0016575]; negative regulation of cell migration [GO:0030336]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of apoptotic process [GO:0043065]; positive regulation of stem cell population maintenance [GO:1902459]","GO:0000122; GO:0005634; GO:0006325; GO:0006915; GO:0016575; GO:0030336; GO:0030512; GO:0042826; GO:0043065; GO:0070822; GO:1902455; GO:1902459"
"1818",1818,"Cluster_2882","Porites_evermani_scaffold_1060:90182-91182",151,-20.66,2,21,654,676,20,"70.00%","70.00%","Peve_00001168",NA,NA,NA,"Q5ZIL2","Vacuolar protein sorting-associated protein 29 (Vesicle protein sorting 29)","Gallus gallus (Chicken)","endocytic recycling [GO:0032456]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147]","GO:0005768; GO:0005829; GO:0006886; GO:0010008; GO:0030904; GO:0032456; GO:0042147; GO:0046872"
"1819",1819,"Cluster_2882","Porites_evermani_scaffold_1097:8945-9945",166,-28.12,2,20,936,961,22,"77.27%","77.27%","Peve_00001683",-0.443562609990128,0.707428760155075,0.978262075707395,"Q76NI1","Kinase non-catalytic C-lobe domain-containing protein 1 (KIND domain-containing protein 1) (Cerebral protein 9) (Protein very KIND) (v-KIND) (Ras-GEF domain-containing family member 2)","Homo sapiens (Human)","cerebellar granule cell differentiation [GO:0021707]; positive regulation of protein phosphorylation [GO:0001934]; regulation of dendrite development [GO:0050773]; regulation of dendrite morphogenesis [GO:0048814]; small GTPase mediated signal transduction [GO:0007264]","GO:0001934; GO:0005085; GO:0007264; GO:0021707; GO:0030425; GO:0032045; GO:0043025; GO:0043204; GO:0048814; GO:0050773"
"1820",1820,"Cluster_2882","Porites_evermani_scaffold_114:12570-13570",163,-24.55,2,21,678,703,23,"69.57%","78.26%","Peve_00002395",-0.535700493135716,0.640095226549302,0.978262075707395,NA,NA,NA,NA,NA
"1821",1821,"Cluster_2882","Porites_evermani_scaffold_116:72913-73913",149,-20.51,2,21,148,175,25,"68.00%","72.00%","Peve_00002716",NA,NA,NA,NA,NA,NA,NA,NA
"1822",1822,"Cluster_2882","Porites_evermani_scaffold_1183:46737-47737",159,-22.27,2,21,350,372,20,"75.00%","75.00%","Peve_00003097",-0.888080611342826,0.304077338171024,0.978262075707395,NA,NA,NA,NA,NA
"1823",1823,"Cluster_2882","Porites_evermani_scaffold_121:326921-327921",161,-21.19,2,14,36,57,12,"91.67%","100.00%","Peve_00003546",-0.919372064440609,0.257394955504494,0.978262075707395,"Q69ZX6","ATPase MORC2A (EC 3.6.1.-) (MORC family CW-type zinc finger protein 2A) (Zinc finger CW-type coiled-coil domain protein 1)","Mus musculus (Mouse)","cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; positive regulation of DNA methylation-dependent heterochromatin formation [GO:0090309]","GO:0000287; GO:0000792; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006338; GO:0006974; GO:0008270; GO:0016363; GO:0016887; GO:0042393; GO:0042802; GO:0042803; GO:0045814; GO:0045869; GO:0090309"
"1824",1824,"Cluster_2882","Porites_evermani_scaffold_1219:87520-88520",155,-20.39,2,16,460,481,14,"71.43%","92.86%","Peve_00003640",-0.898389711968954,0.289475524970989,0.978262075707395,NA,NA,NA,NA,NA
"1825",1825,"Cluster_2882","Porites_evermani_scaffold_1225:87445-88445",160,-21.11,2,18,255,277,17,"76.47%","88.24%","Peve_00003736",0.0688372031480257,0.956142191637655,0.999448381576871,NA,NA,NA,NA,NA
"1826",1826,"Cluster_2882","Porites_evermani_scaffold_1231:62654-63654",152,-22.3,2,21,601,622,19,"63.16%","73.68%","Peve_00003818",0.0688372031480257,0.956142191637655,0.999448381576871,"B3EX02","MAM and fibronectin type III domain-containing protein 1","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0005576; GO:0016020"
"1827",1827,"Cluster_2882","Porites_evermani_scaffold_130:394209-395209",159,-21.28,2,21,549,571,20,"70.00%","80.00%","Peve_00004803",-0.987441654590092,0.100998955971363,0.978262075707395,"F1NZI4","Protein-glucosylgalactosylhydroxylysine glucosidase (EC 3.2.1.107) (Acid trehalase-like protein 1)","Gallus gallus (Chicken)","carbohydrate metabolic process [GO:0005975]","GO:0004553; GO:0005829; GO:0005975; GO:0047402"
"1828",1828,"Cluster_2882","Porites_evermani_scaffold_1368:16795-17795",148,-21.89,2,18,502,527,20,"65.00%","75.00%","Peve_00005746",NA,NA,NA,NA,NA,NA,NA,NA
"1829",1829,"Cluster_2882","Porites_evermani_scaffold_1368:16795-17795",164,-21.54,2,17,888,909,15,"86.67%","86.67%","Peve_00005746",NA,NA,NA,NA,NA,NA,NA,NA
"1830",1830,"Cluster_2882","Porites_evermani_scaffold_1374:48574-49574",163,-25.2,2,21,719,741,20,"75.00%","80.00%","Peve_00005832",0.887225020743181,0.305260120235466,0.978262075707395,NA,NA,NA,NA,NA
"1831",1831,"Cluster_2882","Porites_evermani_scaffold_1386:35897-36897",150,-21.45,2,21,567,590,21,"71.43%","71.43%","Peve_00005981",-0.98917096143799,0.0937740703354697,0.978262075707395,NA,NA,NA,NA,NA
"1832",1832,"Cluster_2882","Porites_evermani_scaffold_1469:5271-6271",154,-24.73,2,16,885,909,17,"76.47%","82.35%","Peve_00007061",NA,NA,NA,NA,NA,NA,NA,NA
"1833",1833,"Cluster_2882","Porites_evermani_scaffold_147:218471-219471",167,-20.89,2,21,343,365,20,"80.00%","80.00%","Peve_00007091",-0.898389711968954,0.289475524970989,0.978262075707395,NA,NA,NA,NA,NA
"1834",1834,"Cluster_2882","Porites_evermani_scaffold_147:282660-283660",147,-21.07,2,20,813,834,18,"61.11%","72.22%","Peve_00007096",-0.917186068696345,0.260909882713098,0.978262075707395,"Q9D6J6","NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial (EC 7.1.1.2) (NADH-ubiquinone oxidoreductase 24 kDa subunit)","Mus musculus (Mouse)","aerobic respiration [GO:0009060]; cardiac muscle tissue development [GO:0048738]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; nervous system development [GO:0007399]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]","GO:0005739; GO:0005743; GO:0005747; GO:0006120; GO:0007399; GO:0008137; GO:0009060; GO:0042776; GO:0043209; GO:0046872; GO:0048738; GO:0051537"
"1835",1835,"Cluster_2882","Porites_evermani_scaffold_1485:25942-26942",153,-20.34,2,19,632,654,18,"72.22%","77.78%","Peve_00007283",0.310190421930364,0.799214371429762,0.995934364227446,"F1LZF0","Kelch-like protein 2 (Mayven)","Rattus norvegicus (Rat)","protein ubiquitination [GO:0016567]","GO:0001726; GO:0003779; GO:0005737; GO:0005829; GO:0015629; GO:0016567; GO:0030027; GO:0031463; GO:0042802"
"1836",1836,"Cluster_2882","Porites_evermani_scaffold_1563:17166-18166",153,-20.29,2,16,855,878,16,"81.25%","87.50%","Peve_00008271",0.108284445334864,0.930928546761436,0.999448381576871,NA,NA,NA,NA,NA
"1837",1837,"Cluster_2882","Porites_evermani_scaffold_1568:104204-105204",145,-23.54,2,10,361,382,8,"100.00%","100.00%","Peve_00008314",-0.2316941769971,0.85114627144567,0.995934364227446,"A0A1D5P556","Disheveled-associated activator of morphogenesis 2","Gallus gallus (Chicken)","actin cytoskeleton organization [GO:0030036]; dorsal spinal cord development [GO:0021516]; negative regulation of oligodendrocyte differentiation [GO:0048715]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of non-canonical Wnt signaling pathway [GO:2000050]; Wnt signaling pathway [GO:0016055]","GO:0003779; GO:0016055; GO:0021516; GO:0030036; GO:0031267; GO:0048715; GO:0060828; GO:0090263; GO:2000050"
"1838",1838,"Cluster_2882","Porites_evermani_scaffold_157:212246-213246",151,-21.94,2,17,174,197,17,"76.47%","76.47%","Peve_00008369",-0.0925647626843386,0.940986963427686,0.999448381576871,NA,NA,NA,NA,NA
"1839",1839,"Cluster_2882","Porites_evermani_scaffold_1574:83099-84099",163,-20.19,2,21,758,780,20,"75.00%","80.00%","Peve_00008423",NA,NA,NA,NA,NA,NA,NA,NA
"1840",1840,"Cluster_2882","Porites_evermani_scaffold_15:78876-79876",157,-25.53,2,20,66,89,20,"75.00%","80.00%","Peve_00007454",-0.779159656868403,0.431292237298546,0.978262075707395,NA,NA,NA,NA,NA
"1841",1841,"Cluster_2882","Porites_evermani_scaffold_1608:87361-88361",151,-20.53,2,18,509,529,16,"75.00%","81.25%","Peve_00008920",0.0688372031480257,0.956142191637655,0.999448381576871,"Q3U481","Major facilitator superfamily domain-containing protein 12 (Protein grizzled)","Mus musculus (Mouse)","carbohydrate transport [GO:0008643]; cysteine transmembrane transport [GO:1903712]; melanin biosynthetic process [GO:0042438]; negative regulation of melanin biosynthetic process [GO:0048022]; organic substance transport [GO:0071702]; pigment metabolic process involved in pigmentation [GO:0043474]; regulation of melanin biosynthetic process [GO:0048021]","GO:0005764; GO:0005765; GO:0005770; GO:0005886; GO:0008643; GO:0015293; GO:0033162; GO:0033229; GO:0042438; GO:0042470; GO:0043474; GO:0048021; GO:0048022; GO:0071702; GO:1903712"
"1842",1842,"Cluster_2882","Porites_evermani_scaffold_1655:79552-80552",170,-29.65,2,15,614,635,13,"100.00%","100.00%","Peve_00009465",NA,NA,NA,NA,NA,NA,NA,NA
"1843",1843,"Cluster_2882","Porites_evermani_scaffold_1683:2939-3939",164,-21.59,2,19,161,181,17,"76.47%","94.12%","Peve_00009781",-0.412390590441588,0.729387814659548,0.98431573749212,"Q9Y2L9","Leucine-rich repeat and calponin homology domain-containing protein 1 (Calponin homology domain-containing protein 1) (Neuronal protein 81) (NP81)","Homo sapiens (Human)","cellular response to chemokine [GO:1990869]; negative regulation of GTPase activity [GO:0034260]; negative regulation of T cell migration [GO:2000405]","GO:0005737; GO:0034260; GO:1990869; GO:2000405"
"1844",1844,"Cluster_2882","Porites_evermani_scaffold_16:950595-951595",157,-22.64,2,14,221,242,12,"91.67%","91.67%","Peve_00008763",-0.894769972468497,0.294678902647284,0.978262075707395,"Q9UKU7","Isobutyryl-CoA dehydrogenase, mitochondrial (IBDH) (EC 1.3.8.-) (Activator-recruited cofactor 42 kDa component) (ARC42) (Acyl-CoA dehydrogenase family member 8) (ACAD-8)","Homo sapiens (Human)","lipid metabolic process [GO:0006629]; valine catabolic process [GO:0006574]","GO:0003995; GO:0005759; GO:0006574; GO:0006629; GO:0050660"
"1845",1845,"Cluster_2882","Porites_evermani_scaffold_1695:108503-109503",149,-20.52,2,15,1,25,16,"75.00%","81.25%","Peve_00009931",-0.967788936693933,0.162020644243819,0.978262075707395,"P97813","Phospholipase D2 (PLD 2) (mPLD2) (EC 3.1.4.4) (Choline phosphatase 2) (PLD1C) (Phosphatidylcholine-hydrolyzing phospholipase D2)","Mus musculus (Mouse)","G protein-coupled receptor internalization [GO:0002031]; inositol lipid-mediated signaling [GO:0048017]; neuron projection development [GO:0031175]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid catabolic process [GO:0009395]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of receptor-mediated endocytosis [GO:0048260]; receptor-mediated endocytosis [GO:0006898]; regulation of vesicle-mediated transport [GO:0060627]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to organic cyclic compound [GO:0014070]; response to peptide hormone [GO:0043434]","GO:0001666; GO:0002031; GO:0004630; GO:0005080; GO:0005634; GO:0005789; GO:0005794; GO:0005886; GO:0005901; GO:0006654; GO:0006898; GO:0009395; GO:0014068; GO:0014070; GO:0030027; GO:0030335; GO:0031175; GO:0031526; GO:0035091; GO:0042383; GO:0042542; GO:0043231; GO:0043306; GO:0043434; GO:0045785; GO:0048017; GO:0048260; GO:0060627; GO:0070290"
"1846",1846,"Cluster_2882","Porites_evermani_scaffold_1730:24455-25455",149,-22.09,2,15,732,755,15,"80.00%","80.00%","Peve_00010387",0.829552508820929,0.377191141695678,0.978262075707395,NA,NA,NA,NA,NA
"1847",1847,"Cluster_2882","Porites_evermani_scaffold_1735:0-787",147,-21.44,2,21,121,147,24,"62.50%","66.67%","Peve_00010433",-0.99813899500858,0.0388451018771475,0.909359886114279,"Q6NSI8","SANT and BTB domain regulator of class switch recombination (SANT and BTB domain regulator of CSR)","Homo sapiens (Human)","isotype switching [GO:0045190]","GO:0042802; GO:0045190"
"1848",1848,"Cluster_2882","Porites_evermani_scaffold_1744:103593-104593",150,-20.48,2,21,482,505,21,"66.67%","76.19%","Peve_00010522",-0.898389711968954,0.289475524970989,0.978262075707395,NA,NA,NA,NA,NA
"1849",1849,"Cluster_2882","Porites_evermani_scaffold_176:347965-348965",167,-23.83,2,21,792,814,20,"80.00%","80.00%","Peve_00010669",NA,NA,NA,NA,NA,NA,NA,NA
"1850",1850,"Cluster_2882","Porites_evermani_scaffold_1789:99745-100745",176,-21,2,21,535,556,19,"84.21%","84.21%","Peve_00010993",NA,NA,NA,NA,NA,NA,NA,NA
"1851",1851,"Cluster_2882","Porites_evermani_scaffold_1826:77005-78005",157,-21.69,2,20,102,126,21,"71.43%","80.95%","Peve_00011453",-0.955989422997286,0.189574298554773,0.978262075707395,"D3ZGB1","Nuclear factor of activated T-cells 5 (NF-AT5) (T-cell transcription factor NFAT5)","Rattus norvegicus (Rat)","calcineurin-NFAT signaling cascade [GO:0033173]; cellular response to cytokine stimulus [GO:0071345]; cellular response to DNA damage stimulus [GO:0006974]; positive regulation of gene expression [GO:0010628]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R-loop processing [GO:0062176]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]; regulation of transcription by RNA polymerase II [GO:0006357]; response to osmotic stress [GO:0006970]","GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005667; GO:0005694; GO:0005737; GO:0005829; GO:0006357; GO:0006970; GO:0006974; GO:0010628; GO:0033173; GO:0045944; GO:0062176; GO:0070884; GO:0071345; GO:1901224; GO:1904996; GO:1990837"
"1852",1852,"Cluster_2882","Porites_evermani_scaffold_1829:6288-7288",154,-24.22,2,20,861,883,19,"63.16%","84.21%","Peve_00011471",0.829552508820929,0.377191141695678,0.978262075707395,NA,NA,NA,NA,NA
"1853",1853,"Cluster_2882","Porites_evermani_scaffold_1829:6417-7417",154,-24.22,2,20,732,754,19,"63.16%","84.21%","Peve_00011477",NA,NA,NA,NA,NA,NA,NA,NA
"1854",1854,"Cluster_2882","Porites_evermani_scaffold_1890:93851-94851",169,-23.55,2,19,372,395,19,"78.95%","89.47%","Peve_00012142",-0.997089131731783,0.0485860732748588,0.947668828184205,"Q12834","Cell division cycle protein 20 homolog (p55CDC)","Homo sapiens (Human)","anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell differentiation [GO:0030154]; cell division [GO:0051301]; mitotic sister chromatid cohesion [GO:0007064]; mitotic spindle assembly [GO:0090307]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; nervous system development [GO:0007399]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein ubiquitination [GO:0016567]; regulation of dendrite development [GO:0050773]; regulation of meiotic cell cycle [GO:0051445]; regulation of meiotic nuclear division [GO:0040020]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005654; GO:0005680; GO:0005813; GO:0005819; GO:0005829; GO:0007064; GO:0007094; GO:0007346; GO:0007399; GO:0008022; GO:0008284; GO:0010997; GO:0016567; GO:0019899; GO:0030154; GO:0031145; GO:0031915; GO:0033597; GO:0040020; GO:0042826; GO:0048471; GO:0050773; GO:0051301; GO:0051444; GO:0051445; GO:0090129; GO:0090307; GO:1904668; GO:1905786; GO:1990757"
"1855",1855,"Cluster_2882","Porites_evermani_scaffold_191:78396-79396",151,-23.42,2,21,715,741,24,"62.50%","70.83%","Peve_00012391",NA,NA,NA,NA,NA,NA,NA,NA
"1856",1856,"Cluster_2882","Porites_evermani_scaffold_19:185179-186179",159,-23.72,2,21,479,507,26,"69.23%","69.23%","Peve_00012263",-0.591223089577397,0.597290550370676,0.978262075707395,"O95980","Reversion-inducing cysteine-rich protein with Kazal motifs (hRECK) (Suppressor of tumorigenicity 15 protein)","Homo sapiens (Human)","blood vessel maturation [GO:0001955]; embryo implantation [GO:0007566]; embryonic forelimb morphogenesis [GO:0035115]; extracellular matrix organization [GO:0030198]; negative regulation of cell migration [GO:0030336]; negative regulation of metalloendopeptidase activity [GO:1904684]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of angiogenesis [GO:0045765]; regulation of establishment of blood-brain barrier [GO:0090210]; sprouting angiogenesis [GO:0002040]","GO:0001955; GO:0002040; GO:0004866; GO:0004867; GO:0005576; GO:0005886; GO:0007566; GO:0008191; GO:0016020; GO:0017147; GO:0030198; GO:0030336; GO:0035115; GO:0045765; GO:0090210; GO:0090263; GO:1904684; GO:1904928; GO:1990909"
"1857",1857,"Cluster_2882","Porites_evermani_scaffold_1989:22511-23511",162,-24.47,2,15,425,446,13,"84.62%","100.00%","Peve_00013211",-0.961786639588217,0.176561299212694,0.978262075707395,"F6QEU4","E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA metabolic process [GO:0010586]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube development [GO:0021915]; protein autoubiquitination [GO:0051865]; regulation of miRNA-mediated gene silencing [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089]","GO:0000082; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0010586; GO:0021915; GO:0035198; GO:0035278; GO:0051865; GO:0060964; GO:0072089; GO:2000177"
"1858",1858,"Cluster_2882","Porites_evermani_scaffold_2017:12735-13735",154,-21.3,2,19,628,649,17,"64.71%","82.35%","Peve_00013734",NA,NA,NA,NA,NA,NA,NA,NA
"1859",1859,"Cluster_2882","Porites_evermani_scaffold_2133:17958-18958",148,-20.59,2,21,688,709,19,"57.89%","73.68%","Peve_00014914",NA,NA,NA,NA,NA,NA,NA,NA
"1860",1860,"Cluster_2882","Porites_evermani_scaffold_2133:24444-25444",148,-20.59,2,21,688,709,19,"57.89%","73.68%","Peve_00014907",NA,NA,NA,NA,NA,NA,NA,NA
"1861",1861,"Cluster_2882","Porites_evermani_scaffold_216:225665-226665",163,-21.2,2,21,128,150,20,"70.00%","85.00%","Peve_00015148",-0.551115700805702,0.62840457310125,0.978262075707395,"Q8MJ44","cAMP-dependent protein kinase catalytic subunit alpha (PKA C-alpha) (EC 2.7.11.11)","Canis lupus familiaris (Dog) (Canis familiaris)","cellular response to heat [GO:0034605]; protein kinase A signaling [GO:0010737]; protein phosphorylation [GO:0006468]","GO:0001669; GO:0004674; GO:0004679; GO:0004691; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005886; GO:0006468; GO:0010737; GO:0034237; GO:0034605; GO:0036126; GO:0048471; GO:0106310"
"1862",1862,"Cluster_2882","Porites_evermani_scaffold_2182:23986-24986",163,-24.46,2,16,44,65,14,"85.71%","92.86%","Peve_00015341",-0.194255249691547,0.875541992847611,0.997654495933106,NA,NA,NA,NA,NA
"1863",1863,"Cluster_2882","Porites_evermani_scaffold_2193:82584-83584",175,-20.39,2,21,182,204,20,"80.00%","90.00%","Peve_00015459",0.0688372031480257,0.956142191637655,0.999448381576871,NA,NA,NA,NA,NA
"1864",1864,"Cluster_2882","Porites_evermani_scaffold_2210:45944-46561",160,-21.44,2,21,492,511,19,"78.95%","84.21%","Peve_00015677",NA,NA,NA,"Q18579","ETS domain-containing transcription factor ets-5","Caenorhabditis elegans","cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000981; GO:0005634; GO:0006357; GO:0030154; GO:0043565"
"1865",1865,"Cluster_2882","Porites_evermani_scaffold_2306:28130-29130",150,-20.76,2,21,881,904,21,"66.67%","76.19%","Peve_00016627",-0.898389711968954,0.289475524970988,0.978262075707395,"Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"1866",1866,"Cluster_2882","Porites_evermani_scaffold_243:33309-34309",154,-21.51,2,21,763,786,21,"71.43%","76.19%","Peve_00017771",-0.725608755618149,0.483116525510657,0.978262075707395,NA,NA,NA,NA,NA
"1867",1867,"Cluster_2882","Porites_evermani_scaffold_2462:26305-27305",151,-21.95,2,13,589,611,12,"91.67%","91.67%","Peve_00018043",NA,NA,NA,NA,NA,NA,NA,NA
"1868",1868,"Cluster_2882","Porites_evermani_scaffold_250:22591-23591",157,-22.61,2,15,126,148,14,"85.71%","92.86%","Peve_00018434",NA,NA,NA,NA,NA,NA,NA,NA
"1869",1869,"Cluster_2882","Porites_evermani_scaffold_2512:34612-35612",170,-23.76,2,20,54,76,19,"78.95%","89.47%","Peve_00018549",-0.093157318229869,0.940608093779417,0.999448381576871,"A0A2J6RX17",NA,NA,NA,NA
"1870",1870,"Cluster_2882","Porites_evermani_scaffold_2615:17150-18150",144,-21.97,2,18,821,843,17,"70.59%","70.59%","Peve_00019394",-0.936560895540817,0.227980005640782,0.978262075707395,NA,NA,NA,NA,NA
"1871",1871,"Cluster_2882","Porites_evermani_scaffold_2615:3928-4928",155,-22.47,2,20,949,968,18,"77.78%","83.33%","Peve_00019393",0.0558073009813391,0.964453501117112,0.999448381576871,"Q60HG9","Carnitine O-palmitoyltransferase 2, mitochondrial (EC 2.3.1.21) (Carnitine palmitoyltransferase II) (CPT II)","Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)","carnitine metabolic process [GO:0009437]; fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid metabolic process [GO:0001676]","GO:0001676; GO:0004095; GO:0005743; GO:0006635; GO:0008458; GO:0009437; GO:0016746"
"1872",1872,"Cluster_2882","Porites_evermani_scaffold_2677:1288-2288",158,-21.74,2,21,253,273,19,"73.68%","78.95%","Peve_00019858",0.0688372031480257,0.956142191637655,0.999448381576871,"P48040","Melatonin receptor type 1A (Mel-1A-R) (Mel1a receptor)","Ovis aries (Sheep)","","GO:0005886; GO:0008502"
"1873",1873,"Cluster_2882","Porites_evermani_scaffold_2677:54972-55972",158,-21.74,2,21,472,492,19,"73.68%","78.95%","Peve_00019859",-0.468847227114081,0.689338960648014,0.978262075707395,NA,NA,NA,NA,NA
"1874",1874,"Cluster_2882","Porites_evermani_scaffold_2695:60994-61321",164,-21.81,2,21,131,150,19,"84.21%","84.21%","Peve_00020009",-0.536674283874308,0.639360793111286,0.978262075707395,"Q8C729","Hyccin 2","Mus musculus (Mouse)","phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein localization to plasma membrane [GO:0072659]","GO:0005829; GO:0005886; GO:0046854; GO:0072659"
"1875",1875,"Cluster_2882","Porites_evermani_scaffold_2695:60994-61321",164,-21.81,2,21,131,150,19,"84.21%","84.21%","Peve_00020010",0.194841007929424,0.875161823662687,0.997587557068499,"Q3TBW2","39S ribosomal protein L10, mitochondrial (L10mt) (MRP-L10)","Mus musculus (Mouse)","mitochondrial translation [GO:0032543]; translation [GO:0006412]","GO:0003735; GO:0005654; GO:0005739; GO:0005743; GO:0005762; GO:0006412; GO:0015934; GO:0032543; GO:1990904"
"1876",1876,"Cluster_2882","Porites_evermani_scaffold_2725:43946-44946",158,-23.28,2,20,842,865,20,"70.00%","80.00%","Peve_00020303",-0.93007612054418,0.239481290107406,0.978262075707395,NA,NA,NA,NA,NA
"1877",1877,"Cluster_2882","Porites_evermani_scaffold_2740:59133-60133",160,-20.72,2,19,83,103,17,"76.47%","88.24%","Peve_00020443",0.326250797714092,0.788429206471863,0.995505100330447,"Q5R7B8","Kelch-like protein 20","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","Golgi to endosome transport [GO:0006895]; negative regulation of apoptotic process [GO:0043066]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K33-linked ubiquitination [GO:1990390]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]","GO:0003779; GO:0004842; GO:0005737; GO:0005802; GO:0005829; GO:0006895; GO:0015031; GO:0016567; GO:0016605; GO:0019964; GO:0030424; GO:0030425; GO:0031463; GO:0043066; GO:0043161; GO:0048471; GO:1990390"
"1878",1878,"Cluster_2882","Porites_evermani_scaffold_277:266875-267392",165,-23.91,2,14,282,303,12,"100.00%","100.00%","Peve_00020645",0.760614780325686,0.449795271357613,0.978262075707395,NA,NA,NA,NA,NA
"1879",1879,"Cluster_2882","Porites_evermani_scaffold_2777:55985-56985",158,-20.64,2,20,205,228,20,"70.00%","80.00%","Peve_00020696",-0.898389711968954,0.289475524970989,0.978262075707395,NA,NA,NA,NA,NA
"1880",1880,"Cluster_2882","Porites_evermani_scaffold_2783:60557-61557",156,-21.1,2,14,144,166,13,"92.31%","92.31%","Peve_00020752",NA,NA,NA,"P25291","Pancreatic secretory granule membrane major glycoprotein GP2 (Pancreatic zymogen granule membrane protein GP-2) (ZAP75)","Canis lupus familiaris (Dog) (Canis familiaris)","antigen transcytosis by M cells in mucosal-associated lymphoid tissue [GO:0002412]; innate immune response [GO:0045087]; neutrophil migration [GO:1990266]","GO:0002412; GO:0005201; GO:0005615; GO:0005768; GO:0009897; GO:0009986; GO:0016324; GO:0042589; GO:0045087; GO:0045121; GO:1990266"
"1881",1881,"Cluster_2882","Porites_evermani_scaffold_2902:5096-6096",164,-23.01,2,21,293,314,19,"73.68%","78.95%","Peve_00021748",NA,NA,NA,NA,NA,NA,NA,NA
"1882",1882,"Cluster_2882","Porites_evermani_scaffold_2919:12095-13095",151,-21.54,2,21,382,404,20,"70.00%","70.00%","Peve_00021845",NA,NA,NA,NA,NA,NA,NA,NA
"1883",1883,"Cluster_2882","Porites_evermani_scaffold_2919:12274-13274",151,-21.54,2,21,203,225,20,"70.00%","70.00%","Peve_00021846",NA,NA,NA,NA,NA,NA,NA,NA
"1884",1884,"Cluster_2882","Porites_evermani_scaffold_2926:26623-27623",155,-20.39,2,16,449,470,14,"71.43%","92.86%","Peve_00021897",-0.898389711968954,0.289475524970988,0.978262075707395,NA,NA,NA,NA,NA
"1885",1885,"Cluster_2882","Porites_evermani_scaffold_2939:5442-6442",151,-22.21,2,14,932,952,12,"91.67%","91.67%","Peve_00021976",-0.593239555117859,0.595697383702214,0.978262075707395,"P18886","Carnitine O-palmitoyltransferase 2, mitochondrial (EC 2.3.1.21) (Carnitine palmitoyltransferase II) (CPT II)","Rattus norvegicus (Rat)","carnitine metabolic process [GO:0009437]; fatty acid beta-oxidation [GO:0006635]; in utero embryonic development [GO:0001701]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty acid transport [GO:0015909]; positive regulation of cold-induced thermogenesis [GO:0120162]; response to fatty acid [GO:0070542]","GO:0001676; GO:0001701; GO:0004095; GO:0005739; GO:0005743; GO:0006635; GO:0008458; GO:0009437; GO:0015909; GO:0016746; GO:0070542; GO:0120162"
"1886",1886,"Cluster_2882","Porites_evermani_scaffold_304:114772-115772",159,-22.98,2,21,688,710,20,"75.00%","75.00%","Peve_00022910",-0.639259484888388,0.558481963431585,0.978262075707395,NA,NA,NA,NA,NA
"1887",1887,"Cluster_2882","Porites_evermani_scaffold_304:126234-127234",159,-22.98,2,21,688,710,20,"75.00%","75.00%","Peve_00022912",0.660383755856175,0.540787258187844,0.978262075707395,NA,NA,NA,NA,NA
"1888",1888,"Cluster_2882","Porites_evermani_scaffold_310:30150-31150",162,-24.47,2,15,257,278,13,"84.62%","100.00%","Peve_00023391",-0.999656503413255,0.0166866349892639,0.775337211553618,"Q1PSW8","E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (mLin41) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71)","Mus musculus (Mouse)","3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to organic substance [GO:0071310]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA metabolic process [GO:0010586]; miRNA processing [GO:0035196]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of translation [GO:0017148]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; post-transcriptional regulation of gene expression [GO:0010608]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of miRNA-mediated gene silencing [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of protein metabolic process [GO:0051246]; stem cell proliferation [GO:0072089]","GO:0000082; GO:0000209; GO:0000932; GO:0001843; GO:0004842; GO:0008270; GO:0008543; GO:0010586; GO:0010608; GO:0017148; GO:0021915; GO:0030371; GO:0035196; GO:0035198; GO:0035278; GO:0043161; GO:0051246; GO:0051865; GO:0060964; GO:0061158; GO:0061630; GO:0071310; GO:0072089; GO:2000177; GO:2000637"
"1889",1889,"Cluster_2882","Porites_evermani_scaffold_3168:49424-50424",152,-22.3,2,21,501,522,19,"63.16%","73.68%","Peve_00023817",0.159121335878744,0.898267787721173,0.999448381576871,NA,NA,NA,NA,NA
"1890",1890,"Cluster_2882","Porites_evermani_scaffold_3216:19519-20512",160,-22.85,2,17,91,112,15,"80.00%","86.67%","Peve_00024123",-0.821787955739242,0.385953582615432,0.978262075707395,"P23228","Hydroxymethylglutaryl-CoA synthase, cytoplasmic (HMG-CoA synthase) (EC 2.3.3.10) (3-hydroxy-3-methylglutaryl coenzyme A synthase)","Gallus gallus (Chicken)","acetyl-CoA metabolic process [GO:0006084]; cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate biosynthetic process, mevalonate pathway [GO:0010142]","GO:0004421; GO:0005829; GO:0006084; GO:0006695; GO:0010142"
"1891",1891,"Cluster_2882","Porites_evermani_scaffold_3301:4766-5766",145,-20.08,2,16,204,228,17,"76.47%","76.47%","Peve_00024678",NA,NA,NA,"A7MCS3","UPF0764 protein C16orf89 homolog","Danio rerio (Zebrafish) (Brachydanio rerio)","","GO:0005576; GO:0005829; GO:0016020"
"1892",1892,"Cluster_2882","Porites_evermani_scaffold_3358:31354-32354",160,-22.36,2,19,946,966,17,"76.47%","88.24%","Peve_00025026",-0.282894705273373,0.817410599966281,0.995934364227446,"Q9ULJ7","Ankyrin repeat domain-containing protein 50","Homo sapiens (Human)","endocytic recycling [GO:0032456]; protein transport [GO:0015031]","GO:0005768; GO:0015031; GO:0032456"
"1893",1893,"Cluster_2882","Porites_evermani_scaffold_3463:9485-10485",155,-22.12,2,21,869,894,23,"65.22%","73.91%","Peve_00025697",-0.898389711968954,0.289475524970989,0.978262075707395,NA,NA,NA,NA,NA
"1894",1894,"Cluster_2882","Porites_evermani_scaffold_3489:22653-23653",163,-20.98,2,20,736,755,18,"83.33%","88.89%","Peve_00025836",NA,NA,NA,NA,NA,NA,NA,NA
"1895",1895,"Cluster_2882","Porites_evermani_scaffold_3489:23372-23653",163,-20.98,2,20,17,36,18,"83.33%","88.89%","Peve_00025841",NA,NA,NA,NA,NA,NA,NA,NA
"1896",1896,"Cluster_2882","Porites_evermani_scaffold_351:110798-111798",159,-20.52,2,18,911,936,20,"80.00%","80.00%","Peve_00026023",NA,NA,NA,NA,NA,NA,NA,NA
"1897",1897,"Cluster_2882","Porites_evermani_scaffold_354:75961-76961",150,-20.55,2,17,974,998,18,"77.78%","77.78%","Peve_00026176",NA,NA,NA,NA,NA,NA,NA,NA
"1898",1898,"Cluster_2882","Porites_evermani_scaffold_3643:17608-18608",162,-20.85,2,20,929,951,19,"78.95%","78.95%","Peve_00026791",NA,NA,NA,NA,NA,NA,NA,NA
"1899",1899,"Cluster_2882","Porites_evermani_scaffold_3723:16194-17194",146,-23.37,2,21,561,589,26,"65.38%","65.38%","Peve_00027223",-0.946237081508244,0.209701603500124,0.978262075707395,"O46470","Regulator of G-protein signaling 7 (RGS7)","Bos taurus (Bovine)","G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]","GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0007186; GO:0008277; GO:0009968; GO:0031681; GO:0035556; GO:0043005; GO:0043547"
"1900",1900,"Cluster_2882","Porites_evermani_scaffold_3904:18485-19485",156,-21.1,2,14,144,166,13,"92.31%","92.31%","Peve_00028217",NA,NA,NA,"P25291","Pancreatic secretory granule membrane major glycoprotein GP2 (Pancreatic zymogen granule membrane protein GP-2) (ZAP75)","Canis lupus familiaris (Dog) (Canis familiaris)","antigen transcytosis by M cells in mucosal-associated lymphoid tissue [GO:0002412]; innate immune response [GO:0045087]; neutrophil migration [GO:1990266]","GO:0002412; GO:0005201; GO:0005615; GO:0005768; GO:0009897; GO:0009986; GO:0016324; GO:0042589; GO:0045087; GO:0045121; GO:1990266"
"1901",1901,"Cluster_2882","Porites_evermani_scaffold_411:67791-68791",165,-22.12,2,21,932,951,19,"73.68%","89.47%","Peve_00029443",-0.576662455482982,0.608709574551507,0.978262075707395,"Q8VIJ8","GATOR complex protein NPRL3 (Nitrogen permease regulator 3-like protein)","Mus musculus (Mouse)","aorta morphogenesis [GO:0035909]; cardiac muscle tissue development [GO:0048738]; cellular response to amino acid starvation [GO:0034198]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of autophagy [GO:0010508]; roof of mouth development [GO:0060021]; TORC1 signaling [GO:0038202]; ventricular septum development [GO:0003281]","GO:0003281; GO:0005096; GO:0005765; GO:0010508; GO:0032007; GO:0034198; GO:0035909; GO:0038202; GO:0048738; GO:0060021; GO:1904262; GO:1990130"
"1902",1902,"Cluster_2882","Porites_evermani_scaffold_436:172637-173637",150,-20.07,2,19,314,335,17,"70.59%","70.59%","Peve_00030701",NA,NA,NA,NA,NA,NA,NA,NA
"1903",1903,"Cluster_2882","Porites_evermani_scaffold_444:63122-64122",155,-20.8,2,21,334,361,25,"68.00%","68.00%","Peve_00031172",-0.898389711968954,0.289475524970988,0.978262075707395,"Q9UMZ3","Phosphatidylinositol phosphatase PTPRQ (EC 3.1.3.-) (Receptor-type tyrosine-protein phosphatase Q) (PTP-RQ) (R-PTP-Q) (EC 3.1.3.48)","Homo sapiens (Human)","peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; regulation of fat cell differentiation [GO:0045598]","GO:0004725; GO:0016020; GO:0043235; GO:0045598; GO:1990264"
"1904",1904,"Cluster_2882","Porites_evermani_scaffold_446:117648-118648",152,-21.42,2,13,656,677,11,"81.82%","100.00%","Peve_00031257",NA,NA,NA,NA,NA,NA,NA,NA
"1905",1905,"Cluster_2882","Porites_evermani_scaffold_4507:22623-23623",150,-20.15,2,11,611,632,9,"100.00%","100.00%","Peve_00031511",-0.834036102027894,0.372048849384075,0.978262075707395,NA,NA,NA,NA,NA
"1906",1906,"Cluster_2882","Porites_evermani_scaffold_45:5053-6053",166,-22.51,2,21,763,788,23,"73.91%","82.61%","Peve_00031436",-0.998016621951657,0.0401023366876437,0.909359886114279,"Q0P5B1","Peroxisomal membrane protein PEX13 (Peroxin-13)","Bos taurus (Bovine)","cerebral cortex cell migration [GO:0021795]; fatty acid alpha-oxidation [GO:0001561]; locomotory behavior [GO:0007626]; microtubule-based peroxisome localization [GO:0060152]; neuron migration [GO:0001764]; protein import into peroxisome matrix, docking [GO:0016560]; suckling behavior [GO:0001967]","GO:0001561; GO:0001764; GO:0001967; GO:0005778; GO:0007626; GO:0008320; GO:0016560; GO:0021795; GO:0060152; GO:1990429"
"1907",1907,"Cluster_2882","Porites_evermani_scaffold_470:134052-135052",151,-21.22,2,14,618,638,12,"91.67%","91.67%","Peve_00032335",-0.940700792767285,0.220337995770116,0.978262075707395,NA,NA,NA,NA,NA
"1908",1908,"Cluster_2882","Porites_evermani_scaffold_472:5070-6070",150,-21.72,2,11,906,927,9,"100.00%","100.00%","Peve_00032411",NA,NA,NA,NA,NA,NA,NA,NA
"1909",1909,"Cluster_2882","Porites_evermani_scaffold_48:209890-210890",156,-20.42,2,21,975,996,19,"68.42%","73.68%","Peve_00032736",-0.93730963498128,0.226616170528585,0.978262075707395,"Q9NX07","tRNA selenocysteine 1-associated protein 1 (SECp43) (tRNA selenocysteine-associated protein 1)","Homo sapiens (Human)","selenocysteine incorporation [GO:0001514]","GO:0000049; GO:0001514; GO:0003723; GO:0005634; GO:0005737"
"1910",1910,"Cluster_2882","Porites_evermani_scaffold_4829:20174-21124",144,-22.33,2,19,688,716,24,"62.50%","70.83%","Peve_00032867",-0.945263595635341,0.211609136217347,0.978262075707395,"O54922","Exocyst complex component 7 (Exocyst complex component Exo70) (rExo70)","Rattus norvegicus (Rat)","exocytosis [GO:0006887]; protein transport [GO:0015031]; regulation of entry of bacterium into host cell [GO:2000535]","GO:0000145; GO:0005546; GO:0005815; GO:0005829; GO:0006887; GO:0015031; GO:0032584; GO:0034451; GO:0090543; GO:2000535"
"1911",1911,"Cluster_2882","Porites_evermani_scaffold_484:181157-182157",149,-22.09,2,15,822,845,15,"80.00%","80.00%","Peve_00032920",-0.184871370119517,0.881626298999331,0.999143261208691,NA,NA,NA,NA,NA
"1912",1912,"Cluster_2882","Porites_evermani_scaffold_4846:1103-2103",172,-23.06,2,20,248,267,18,"88.89%","88.89%","Peve_00032939",NA,NA,NA,NA,NA,NA,NA,NA
"1913",1913,"Cluster_2882","Porites_evermani_scaffold_5068:2561-3561",158,-21.74,2,21,254,274,19,"73.68%","78.95%","Peve_00033888",-0.898389711968954,0.289475524970988,0.978262075707395,"P48040","Melatonin receptor type 1A (Mel-1A-R) (Mel1a receptor)","Ovis aries (Sheep)","","GO:0005886; GO:0008502"
"1914",1914,"Cluster_2882","Porites_evermani_scaffold_531:179629-180629",160,-21.56,2,21,326,347,19,"68.42%","78.95%","Peve_00034802",-0.562932282415628,0.619346353720843,0.978262075707395,NA,NA,NA,NA,NA
"1915",1915,"Cluster_2882","Porites_evermani_scaffold_538:169017-170017",153,-20.61,2,20,259,284,22,"68.18%","77.27%","Peve_00035012",NA,NA,NA,NA,NA,NA,NA,NA
"1916",1916,"Cluster_2882","Porites_evermani_scaffold_543:134439-135439",165,-26.96,2,21,784,803,19,"78.95%","84.21%","Peve_00035227",NA,NA,NA,NA,NA,NA,NA,NA
"1917",1917,"Cluster_2882","Porites_evermani_scaffold_5:881779-882779",152,-22.3,2,21,300,321,19,"63.16%","73.68%","Peve_00033544",0.875697298601862,0.320804351091959,0.978262075707395,NA,NA,NA,NA,NA
"1918",1918,"Cluster_2882","Porites_evermani_scaffold_596:100968-101968",174,-25.68,2,19,145,166,17,"88.24%","88.24%","Peve_00036852",NA,NA,NA,"O17185","Two pore potassium channel protein sup-9 (Suppressor of unc-93 protein 9) (n2P38)","Caenorhabditis elegans","potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of muscle contraction [GO:0006937]; stabilization of membrane potential [GO:0030322]","GO:0005267; GO:0005886; GO:0006813; GO:0006937; GO:0015271; GO:0022841; GO:0030322; GO:0036195; GO:0055120; GO:0071805"
"1919",1919,"Cluster_2882","Porites_evermani_scaffold_605:207440-208440",163,-21.68,2,20,316,337,18,"66.67%","88.89%","Peve_00037212",NA,NA,NA,NA,NA,NA,NA,NA
"1920",1920,"Cluster_2882","Porites_evermani_scaffold_6219:558-1558",157,-22.98,2,14,868,889,12,"91.67%","91.67%","Peve_00037678",0.0688372031480257,0.956142191637655,0.999448381576871,NA,NA,NA,NA,NA
"1921",1921,"Cluster_2882","Porites_evermani_scaffold_636:11875-12875",164,-20.62,2,21,474,495,19,"68.42%","84.21%","Peve_00038010",-0.331412367953729,0.784949745455559,0.994752644192887,NA,NA,NA,NA,NA
"1922",1922,"Cluster_2882","Porites_evermani_scaffold_640:6296-7296",162,-20.9,2,21,510,534,22,"77.27%","77.27%","Peve_00038175",NA,NA,NA,NA,NA,NA,NA,NA
"1923",1923,"Cluster_2882","Porites_evermani_scaffold_641:68881-69881",156,-21.76,2,21,96,122,24,"75.00%","79.17%","Peve_00038184",0.389914600513983,0.74500904776386,0.98731808346964,NA,NA,NA,NA,NA
"1924",1924,"Cluster_2882","Porites_evermani_scaffold_6445:241-1241",152,-20.49,2,13,906,927,11,"90.91%","90.91%","Peve_00038271",-0.898389711968954,0.289475524970989,0.978262075707395,NA,NA,NA,NA,NA
"1925",1925,"Cluster_2882","Porites_evermani_scaffold_665:151568-152568",169,-21.9,2,20,752,772,18,"83.33%","88.89%","Peve_00038721",-0.554391545802746,0.625902042339483,0.978262075707395,"Q63505","General transcription factor 3C polypeptide 1 (TF3C-alpha) (TFIIIC box B-binding subunit) (Transcription factor IIIC 220 kDa subunit) (TFIIIC 220 kDa subunit) (TFIIIC220) (Transcription factor IIIC subunit alpha)","Rattus norvegicus (Rat)","5S class rRNA transcription by RNA polymerase III [GO:0042791]; transcription initiation at RNA polymerase III promoter [GO:0006384]","GO:0000127; GO:0000995; GO:0003677; GO:0005634; GO:0006384; GO:0042791; GO:1990904"
"1926",1926,"Cluster_2882","Porites_evermani_scaffold_6727:2035-3035",145,-21.17,2,10,554,575,8,"100.00%","100.00%","Peve_00038890",-0.898389711968954,0.289475524970989,0.978262075707395,NA,NA,NA,NA,NA
"1927",1927,"Cluster_2882","Porites_evermani_scaffold_720:5412-6412",158,-23.28,2,20,842,865,20,"70.00%","80.00%","Peve_00040050",-0.786564267237704,0.423715708888207,0.978262075707395,NA,NA,NA,NA,NA
"1928",1928,"Cluster_2882","Porites_evermani_scaffold_74:408411-408972",179,-30.07,2,21,12,34,20,"85.00%","90.00%","Peve_00040510",NA,NA,NA,NA,NA,NA,NA,NA
"1929",1929,"Cluster_2882","Porites_evermani_scaffold_756:137758-138758",154,-21.56,2,21,196,216,19,"73.68%","73.68%","Peve_00040787",NA,NA,NA,NA,NA,NA,NA,NA
"1930",1930,"Cluster_2882","Porites_evermani_scaffold_855:72015-73015",157,-25.03,2,20,19,39,18,"72.22%","83.33%","Peve_00042869",0.0688372031480257,0.956142191637655,0.999448381576871,NA,NA,NA,NA,NA
"1931",1931,"Cluster_2882","Porites_evermani_scaffold_874:120480-121480",148,-22.53,2,14,820,842,13,"84.62%","84.62%","Peve_00043225",-0.898389711968954,0.289475524970988,0.978262075707395,NA,NA,NA,NA,NA
"1932",1932,"Cluster_2882","Porites_evermani_scaffold_87:451487-452487",175,-25.04,2,21,402,424,20,"85.00%","85.00%","Peve_00043142",0.829552508820929,0.377191141695678,0.978262075707395,"Q6UW60","Proprotein convertase subtilisin/kexin type 4 (EC 3.4.21.-) (Proprotein convertase 4) (PC4)","Homo sapiens (Human)","acrosome reaction [GO:0007340]; binding of sperm to zona pellucida [GO:0007339]; fertilization [GO:0009566]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485]; reproductive process [GO:0022414]; sperm capacitation [GO:0048240]","GO:0000139; GO:0001669; GO:0002080; GO:0004252; GO:0005802; GO:0007339; GO:0007340; GO:0009566; GO:0016020; GO:0016485; GO:0016486; GO:0022414; GO:0048240"
"1933",1933,"Cluster_2882","Porites_evermani_scaffold_89:211968-212968",150,-20.07,2,19,329,350,17,"70.59%","70.59%","Peve_00043483",NA,NA,NA,NA,NA,NA,NA,NA
"1934",1934,"Cluster_2882","Porites_evermani_scaffold_902:98030-99030",173,-21.87,2,18,394,415,16,"87.50%","93.75%","Peve_00043803",-0.294860460504949,0.809453664844096,0.995934364227446,NA,NA,NA,NA,NA
"1935",1935,"Cluster_2882","Porites_evermani_scaffold_9:1051953-1052953",150,-21.12,2,20,860,882,19,"68.42%","73.68%","Peve_00043666",-0.976731385616712,0.137602434252465,0.978262075707395,"F8W2M1","E3 ubiquitin-protein ligase HACE1 (EC 2.3.2.26) (HECT domain and ankyrin repeat-containing E3 ubiquitin-protein ligase 1) (HECT-type E3 ubiquitin transferase HACE1)","Danio rerio (Zebrafish) (Brachydanio rerio)","atrioventricular valve formation [GO:0003190]; cardiac ventricle morphogenesis [GO:0003208]; cell cycle [GO:0007049]; Golgi organization [GO:0007030]; heart looping [GO:0001947]; membrane fusion [GO:0061025]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of cell migration [GO:0030334]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000139; GO:0000209; GO:0001947; GO:0003190; GO:0003208; GO:0004842; GO:0005634; GO:0005737; GO:0005783; GO:0006511; GO:0007030; GO:0007049; GO:0016567; GO:0030334; GO:0031267; GO:0032580; GO:0043161; GO:0061025; GO:0061630; GO:0070936; GO:1903427"
"1936",1936,"Cluster_2882","Porites_evermani_scaffold_936:129100-130100",158,-21.74,2,21,413,433,19,"73.68%","78.95%","Peve_00044344",-0.898389711968954,0.289475524970989,0.978262075707395,"Q61184","Melatonin receptor type 1A (Mel-1A-R) (Mel1a receptor)","Mus musculus (Mouse)","adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; circadian rhythm [GO:0007623]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of insulin secretion [GO:0046676]","GO:0004930; GO:0005886; GO:0007186; GO:0007193; GO:0007623; GO:0008502; GO:0042562; GO:0043025; GO:0043235; GO:0046676; GO:0097159"
"1937",1937,"Cluster_2882","Porites_evermani_scaffold_971:27216-28216",150,-20.07,2,19,332,353,17,"70.59%","70.59%","Peve_00044950",NA,NA,NA,NA,NA,NA,NA,NA
"1938",1938,"Cluster_2882","Porites_evermani_scaffold_993:13390-14390",165,-22.21,2,21,911,932,20,"80.00%","85.00%","Peve_00045266",NA,NA,NA,NA,NA,NA,NA,NA
"1939",1939,"Cluster_29","Porites_evermani_scaffold_1041:73204-74204",158,-21.72,2,20,641,664,20,"70.00%","80.00%","Peve_00000863",NA,NA,NA,NA,NA,NA,NA,NA
"1940",1940,"Cluster_29","Porites_evermani_scaffold_1159:34865-35865",152,-20.57,2,21,23,44,19,"63.16%","73.68%","Peve_00002681",-0.368569774287229,0.759695126986102,0.988219883885475,NA,NA,NA,NA,NA
"1941",1941,"Cluster_29","Porites_evermani_scaffold_1256:2525-3525",159,-21.09,2,21,938,961,21,"71.43%","76.19%","Peve_00004161",-0.135050152935361,0.913760888902263,0.999448381576871,"A7S641","Protein ST7 homolog","Nematostella vectensis (Starlet sea anemone)","","GO:0016020"
"1942",1942,"Cluster_29","Porites_evermani_scaffold_1328:66440-67440",164,-20.36,2,21,854,875,19,"73.68%","78.95%","Peve_00005174",-0.315290319097753,0.795796211363545,0.995934364227446,NA,NA,NA,NA,NA
"1943",1943,"Cluster_29","Porites_evermani_scaffold_13:35090-36090",157,-20.62,2,19,831,854,19,"73.68%","78.95%","Peve_00004748",-0.368569774287229,0.759695126986102,0.988219883885475,NA,NA,NA,NA,NA
"1944",1944,"Cluster_29","Porites_evermani_scaffold_1445:118018-119018",166,-20.19,2,19,69,90,17,"76.47%","88.24%","Peve_00006784",0.907222684816448,0.276396387442189,0.978262075707395,"P70187","Hippocampus abundant transcript 1 protein (Major facilitator superfamily domain-containing 14A)","Mus musculus (Mouse)","acrosome assembly [GO:0001675]; sperm mitochondrion organization [GO:0030382]; spermatid development [GO:0007286]; spermatid nucleus differentiation [GO:0007289]; spermatogenesis [GO:0007283]","GO:0001675; GO:0007283; GO:0007286; GO:0007289; GO:0016020; GO:0022857; GO:0030382"
"1945",1945,"Cluster_29","Porites_evermani_scaffold_1548:12903-13903",161,-22.67,2,20,846,871,22,"72.73%","81.82%","Peve_00008077",-0.348245355435407,0.773555214307246,0.991859416893832,NA,NA,NA,NA,NA
"1946",1946,"Cluster_29","Porites_evermani_scaffold_1622:14785-15785",172,-25.6,2,21,785,806,19,"78.95%","84.21%","Peve_00009097",-0.993298331760008,0.0737444639626909,0.978262075707395,NA,NA,NA,NA,NA
"1947",1947,"Cluster_29","Porites_evermani_scaffold_1627:56330-57330",165,-20.05,2,14,639,660,12,"100.00%","100.00%","Peve_00009127",-0.0976583512675886,0.937729513330168,0.999448381576871,NA,NA,NA,NA,NA
"1948",1948,"Cluster_29","Porites_evermani_scaffold_1804:5245-6245",159,-20.13,2,21,365,388,21,"71.43%","76.19%","Peve_00011220",NA,NA,NA,NA,NA,NA,NA,NA
"1949",1949,"Cluster_29","Porites_evermani_scaffold_1852:5720-6720",171,-22.12,2,20,207,228,18,"77.78%","88.89%","Peve_00011736",-0.600808399270135,0.589690922836297,0.978262075707395,"Q08CX1","Ras and EF-hand domain-containing protein","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","","GO:0003924; GO:0005509; GO:0005525; GO:0048471"
"1950",1950,"Cluster_29","Porites_evermani_scaffold_1906:82275-83275",159,-21.22,2,18,152,172,16,"81.25%","87.50%","Peve_00012359",-0.535866256962954,0.639970245385617,0.978262075707395,"Q9BX70","BTB/POZ domain-containing protein 2","Homo sapiens (Human)","neurogenesis [GO:0022008]","GO:0000932; GO:0005829; GO:0022008"
"1951",1951,"Cluster_29","Porites_evermani_scaffold_1975:38039-38917",158,-20.59,2,20,159,182,20,"70.00%","80.00%","Peve_00013068",-0.00549470492098332,0.996501944601738,0.999448381576871,NA,NA,NA,NA,NA
"1952",1952,"Cluster_29","Porites_evermani_scaffold_2014:26035-27035",155,-20.25,2,20,449,467,18,"72.22%","83.33%","Peve_00013718",0.999652457614836,0.0167846228939752,0.776954707475336,NA,NA,NA,NA,NA
"1953",1953,"Cluster_29","Porites_evermani_scaffold_202:197963-198963",167,-20.02,2,20,838,859,18,"77.78%","83.33%","Peve_00013770",-0.62077240343352,0.573638206347232,0.978262075707395,NA,NA,NA,NA,NA
"1954",1954,"Cluster_29","Porites_evermani_scaffold_210:331401-332401",165,-20.8,2,20,838,862,21,"80.95%","80.95%","Peve_00014608",-0.394629889667962,0.741745630778676,0.986697151420032,"Q0VGW6","Solute carrier family 12 member 9 (Cation-chloride cotransporter-interacting protein 1)","Xenopus laevis (African clawed frog)","","GO:0005886; GO:0015377"
"1955",1955,"Cluster_29","Porites_evermani_scaffold_2308:39857-40857",162,-20.56,2,20,809,831,19,"68.42%","89.47%","Peve_00016639",-0.281182622686541,0.818546666628628,0.995934364227446,"P97292","Histamine H2 receptor (H2R) (HH2R) (Gastric receptor I)","Mus musculus (Mouse)","chemical synaptic transmission [GO:0007268]; digestive tract development [GO:0048565]; epithelial cell morphogenesis [GO:0003382]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; gastric acid secretion [GO:0001696]; gastrin-induced gastric acid secretion [GO:0001698]; gland development [GO:0048732]; histamine-induced gastric acid secretion [GO:0001697]; memory [GO:0007613]; negative regulation of arachidonic acid secretion [GO:1900139]; positive regulation of vasoconstriction [GO:0045907]; regulation of synaptic plasticity [GO:0048167]; toxin transport [GO:1901998]; visual learning [GO:0008542]","GO:0001696; GO:0001697; GO:0001698; GO:0003382; GO:0004969; GO:0004993; GO:0005886; GO:0007187; GO:0007268; GO:0007613; GO:0008542; GO:0016020; GO:0030425; GO:0030594; GO:0045202; GO:0045907; GO:0048167; GO:0048565; GO:0048732; GO:1900139; GO:1901363; GO:1901998"
"1956",1956,"Cluster_29","Porites_evermani_scaffold_243:267965-268965",162,-22.27,2,20,177,199,19,"73.68%","84.21%","Peve_00017776",0.994457102369677,0.067060124911526,0.978262075707395,"Q64380","Sarcosine dehydrogenase, mitochondrial (SarDH) (EC 1.5.8.3)","Rattus norvegicus (Rat)","choline catabolic process [GO:0042426]; glycine biosynthetic process [GO:0006545]; sarcosine catabolic process [GO:1901053]; tetrahydrofolate interconversion [GO:0035999]","GO:0005542; GO:0005737; GO:0005739; GO:0005759; GO:0006545; GO:0008480; GO:0016491; GO:0035999; GO:0042426; GO:0050660; GO:1901053"
"1957",1957,"Cluster_29","Porites_evermani_scaffold_2507:44659-45659",158,-24.53,2,20,171,196,22,"68.18%","77.27%","Peve_00018503",-0.368569774287229,0.759695126986102,0.988219883885475,NA,NA,NA,NA,NA
"1958",1958,"Cluster_29","Porites_evermani_scaffold_2728:63999-64999",151,-24.17,2,21,805,831,24,"62.50%","70.83%","Peve_00020328",-0.496687991385932,0.669098665337295,0.978262075707395,NA,NA,NA,NA,NA
"1959",1959,"Cluster_29","Porites_evermani_scaffold_2768:31048-32048",164,-20.54,2,21,878,899,19,"68.42%","84.21%","Peve_00020622",-0.368569774287229,0.759695126986102,0.988219883885475,NA,NA,NA,NA,NA
"1960",1960,"Cluster_29","Porites_evermani_scaffold_27:867342-868342",159,-20.95,2,21,842,864,20,"65.00%","85.00%","Peve_00020075",-0.99757215116682,0.0443704514965721,0.926335665692565,NA,NA,NA,NA,NA
"1961",1961,"Cluster_29","Porites_evermani_scaffold_2901:26599-27599",170,-21.5,2,20,352,375,20,"80.00%","85.00%","Peve_00021741",-0.27369329094777,0.823509355922801,0.995934364227446,NA,NA,NA,NA,NA
"1962",1962,"Cluster_29","Porites_evermani_scaffold_292:278563-279563",159,-21.78,2,21,244,266,20,"70.00%","80.00%","Peve_00021872",NA,NA,NA,NA,NA,NA,NA,NA
"1963",1963,"Cluster_29","Porites_evermani_scaffold_2931:35483-36483",163,-24.56,2,21,378,401,21,"71.43%","80.95%","Peve_00021943",0.986839441718067,0.103397425906711,0.978262075707395,NA,NA,NA,NA,NA
"1964",1964,"Cluster_29","Porites_evermani_scaffold_2970:14233-15233",157,-21.29,2,21,344,363,19,"68.42%","84.21%","Peve_00022203",-0.157966556853489,0.899012360339363,0.999448381576871,NA,NA,NA,NA,NA
"1965",1965,"Cluster_29","Porites_evermani_scaffold_317:127274-128274",162,-22.94,2,20,436,459,20,"75.00%","80.00%","Peve_00023834",NA,NA,NA,NA,NA,NA,NA,NA
"1966",1966,"Cluster_29","Porites_evermani_scaffold_3305:12534-13534",165,-23.51,2,19,978,1000,18,"83.33%","83.33%","Peve_00024698",-0.160489939800326,0.897385164292581,0.999448381576871,NA,NA,NA,NA,NA
"1967",1967,"Cluster_29","Porites_evermani_scaffold_3465:10091-11091",167,-21.58,2,16,946,967,14,"92.86%","92.86%","Peve_00025703",0.989342177720749,0.0930284603194344,0.978262075707395,NA,NA,NA,NA,NA
"1968",1968,"Cluster_29","Porites_evermani_scaffold_350:104909-105909",172,-21.86,2,21,527,548,19,"73.68%","89.47%","Peve_00025971",0.138873184557931,0.911303916127524,0.999448381576871,"Q8C1B2","Protein mono-ADP-ribosyltransferase TIPARP (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 14) (ARTD14) (TCDD-inducible poly [ADP-ribose] polymerase)","Mus musculus (Mouse)","androgen metabolic process [GO:0008209]; cellular response to organic cyclic compound [GO:0071407]; estrogen metabolic process [GO:0008210]; face morphogenesis [GO:0060325]; female gonad development [GO:0008585]; hemopoiesis [GO:0030097]; kidney development [GO:0001822]; negative regulation of gene expression [GO:0010629]; nitrogen compound metabolic process [GO:0006807]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of protein catabolic process [GO:0045732]; post-embryonic development [GO:0009791]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; smooth muscle tissue development [GO:0048745]; vasculogenesis [GO:0001570]","GO:0000987; GO:0001570; GO:0001822; GO:0003950; GO:0005634; GO:0006807; GO:0008209; GO:0008210; GO:0008585; GO:0009791; GO:0010629; GO:0016779; GO:0030097; GO:0045732; GO:0046872; GO:0048008; GO:0048705; GO:0048745; GO:0060021; GO:0060325; GO:0071407; GO:0140803; GO:1990404"
"1969",1969,"Cluster_29","Porites_evermani_scaffold_3599:7907-8907",158,-24.19,2,20,23,46,20,"75.00%","75.00%","Peve_00026505",0.401516231773299,0.736966669751355,0.986318672774603,"Q5PQ71","Isochorismatase domain-containing protein 2","Xenopus laevis (African clawed frog)","",""
"1970",1970,"Cluster_29","Porites_evermani_scaffold_3821:30440-31440",167,-22.36,2,20,515,536,18,"72.22%","88.89%","Peve_00027763",-0.690385629741446,0.514881749347577,0.978262075707395,"Q6ZMY6","WD repeat-containing protein 88 (PQQ repeat and WD repeat-containing protein)","Homo sapiens (Human)","",""
"1971",1971,"Cluster_29","Porites_evermani_scaffold_3839:35673-36673",159,-22.18,2,21,826,849,21,"66.67%","80.95%","Peve_00027820",0.738824297415642,0.470762668601666,0.978262075707395,"A7RUD5","Cytosolic Fe-S cluster assembly factor NUBP1 homolog","Nematostella vectensis (Starlet sea anemone)","iron-sulfur cluster assembly [GO:0016226]","GO:0005524; GO:0005829; GO:0016226; GO:0046872; GO:0051536; GO:0051539; GO:0140663"
"1972",1972,"Cluster_29","Porites_evermani_scaffold_3913:16293-17293",176,-22.92,2,21,457,478,19,"78.95%","89.47%","Peve_00028266",NA,NA,NA,"Q2T9V8","D-aminoacyl-tRNA deacylase 1 (DTD) (EC 3.1.1.96) (DNA-unwinding element-binding protein B) (DUE-B) (Gly-tRNA(Ala) deacylase)","Bos taurus (Bovine)","DNA replication [GO:0006260]; tRNA metabolic process [GO:0006399]","GO:0000049; GO:0003677; GO:0005634; GO:0005737; GO:0006260; GO:0006399; GO:0046872; GO:0051500"
"1973",1973,"Cluster_29","Porites_evermani_scaffold_4079:28053-29053",159,-22.31,2,21,85,108,21,"71.43%","76.19%","Peve_00029246",0.0504439830962152,0.967872727976198,0.999448381576871,NA,NA,NA,NA,NA
"1974",1974,"Cluster_29","Porites_evermani_scaffold_4117:13422-14422",160,-21.6,2,19,525,545,17,"76.47%","88.24%","Peve_00029474",NA,NA,NA,"Q8CG08","Collagen triple helix repeat-containing protein 1","Rattus norvegicus (Rat)","cell migration [GO:0016477]; cochlea morphogenesis [GO:0090103]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein binding [GO:0032092]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0001649; GO:0005109; GO:0005581; GO:0005615; GO:0005737; GO:0016477; GO:0016528; GO:0017147; GO:0031012; GO:0032092; GO:0033687; GO:0033690; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0090090; GO:0090103; GO:0090177"
"1975",1975,"Cluster_29","Porites_evermani_scaffold_440:186868-187868",165,-22.01,2,21,726,750,22,"81.82%","81.82%","Peve_00030988",NA,NA,NA,NA,NA,NA,NA,NA
"1976",1976,"Cluster_29","Porites_evermani_scaffold_5320:264-1264",157,-22.66,2,21,356,377,20,"70.00%","85.00%","Peve_00034841",-0.471133868113977,0.687689738132207,0.978262075707395,"Q5ZKI6","Glucoside xylosyltransferase 1 (EC 2.4.2.42) (Glycosyltransferase 8 domain-containing protein 3)","Gallus gallus (Chicken)","O-glycan processing [GO:0016266]","GO:0016020; GO:0016266; GO:0035252; GO:0140563"
"1977",1977,"Cluster_29","Porites_evermani_scaffold_59:465845-466845",167,-22.53,2,21,40,62,20,"75.00%","85.00%","Peve_00036673",-0.858008416756797,0.343403354366577,0.978262075707395,"Q9NXC2","Glucose-fructose oxidoreductase domain-containing protein 1 (EC 1.-.-.-)","Homo sapiens (Human)","","GO:0000166; GO:0005576; GO:0016491"
"1978",1978,"Cluster_29","Porites_evermani_scaffold_65:523286-524286",163,-23.15,2,17,80,102,16,"81.25%","93.75%","Peve_00038361",0.793662075283328,0.416343696460807,0.978262075707395,"Q8K3X2","GDP-L-fucose synthase (EC 1.1.1.271) (GDP-4-keto-6-deoxy-D-mannose-3,5-epimerase-4-reductase) (Protein FX) (Red cell NADP(H)-binding protein)","Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)","'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell-matrix adhesion via fibronectin [GO:1904906]","GO:0010595; GO:0016853; GO:0042351; GO:0050577; GO:1904906"
"1979",1979,"Cluster_29","Porites_evermani_scaffold_660:99158-100158",158,-22.52,2,20,595,617,19,"73.68%","78.95%","Peve_00038629",0.844119138590246,0.360247985170503,0.978262075707395,"Q9BX10","GTP-binding protein 2","Homo sapiens (Human)","translational elongation [GO:0006414]","GO:0003746; GO:0003924; GO:0005525; GO:0005576; GO:0006414; GO:0031093; GO:0042802"
"1980",1980,"Cluster_29","Porites_evermani_scaffold_70:11175-12175",168,-21.6,2,21,826,847,19,"78.95%","78.95%","Peve_00039604",0.43497812559626,0.713512200173271,0.979751949398416,NA,NA,NA,NA,NA
"1981",1981,"Cluster_29","Porites_evermani_scaffold_803:182524-183524",159,-20.06,2,21,898,921,21,"71.43%","76.19%","Peve_00041861",-0.687402333560786,0.517501875679857,0.978262075707395,NA,NA,NA,NA,NA
"1982",1982,"Cluster_29","Porites_evermani_scaffold_824:30506-31309",159,-20.6,2,21,240,262,20,"70.00%","80.00%","Peve_00042272",-0.368569774287229,0.759695126986102,0.988219883885475,NA,NA,NA,NA,NA
"1983",1983,"Cluster_29","Porites_evermani_scaffold_824:30506-31309",159,-20.6,2,21,240,262,20,"70.00%","80.00%","Peve_00042273",-0.932863482269909,0.234603642154651,0.978262075707395,NA,NA,NA,NA,NA
"1984",1984,"Cluster_29","Porites_evermani_scaffold_8:538140-539140",163,-21.23,2,16,976,997,14,"85.71%","92.86%","Peve_00041697",0.026761608200241,0.982960996823868,0.999448381576871,NA,NA,NA,NA,NA
"1985",1985,"Cluster_29","Porites_evermani_scaffold_88:447192-448192",159,-20.91,2,21,766,790,22,"68.18%","77.27%","Peve_00043292",-0.332044404146673,0.784523227079429,0.99466797136136,"Q86YS7","C2 domain-containing protein 5 (C2 domain-containing phosphoprotein of 138 kDa)","Homo sapiens (Human)","cellular response to insulin stimulus [GO:0032869]; insulin receptor signaling pathway via phosphatidylinositol 3-kinase [GO:0038028]; intracellular protein transmembrane transport [GO:0065002]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of vesicle fusion [GO:0031340]; protein localization to plasma membrane [GO:0072659]","GO:0005509; GO:0005544; GO:0005829; GO:0005886; GO:0005938; GO:0010828; GO:0030659; GO:0031340; GO:0032587; GO:0032869; GO:0034451; GO:0038028; GO:0065002; GO:0072659; GO:0090314"
"1986",1986,"Cluster_29","Porites_evermani_scaffold_931:123937-124937",159,-21.21,2,21,437,461,22,"68.18%","77.27%","Peve_00044292",NA,NA,NA,NA,NA,NA,NA,NA
"1987",1987,"Cluster_4079","Porites_evermani_scaffold_1006:107870-108870",162,-20.78,2,15,612,633,13,"84.62%","100.00%","Peve_00000338",-0.787952096804316,0.422282872116966,0.978262075707395,NA,NA,NA,NA,NA
"1988",1988,"Cluster_4079","Porites_evermani_scaffold_102:440897-441897",163,-22.04,2,20,698,719,18,"72.22%","83.33%","Peve_00000525",-0.903524374636377,0.281941459196547,0.978262075707395,"Q8WWV3","Reticulon-4-interacting protein 1, mitochondrial (NOGO-interacting mitochondrial protein)","Homo sapiens (Human)","nervous system development [GO:0007399]; regulation of dendrite development [GO:0050773]","GO:0005739; GO:0005741; GO:0007399; GO:0008270; GO:0016491; GO:0050773"
"1989",1989,"Cluster_4079","Porites_evermani_scaffold_107:45527-46527",166,-20.13,2,21,927,947,19,"73.68%","89.47%","Peve_00001280",0.167266968438951,0.893011636940771,0.999448381576871,NA,NA,NA,NA,NA
"1990",1990,"Cluster_4079","Porites_evermani_scaffold_1105:46928-47928",166,-24.52,2,20,162,185,20,"75.00%","85.00%","Peve_00001925",-0.986946135309293,0.102976527790942,0.978262075707395,"Q5M8H5","2-acylglycerol O-acyltransferase 2 (EC 2.3.1.22) (Acyl-CoA:monoacylglycerol acyltransferase 2) (MGAT2) (Monoacylglycerol O-acyltransferase 2)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","glycerol metabolic process [GO:0006071]; monoacylglycerol biosynthetic process [GO:0006640]; triglyceride biosynthetic process [GO:0019432]","GO:0003846; GO:0005789; GO:0006071; GO:0006640; GO:0019432; GO:1990578"
"1991",1991,"Cluster_4079","Porites_evermani_scaffold_1125:1358-2358",158,-25.04,2,21,628,648,19,"68.42%","84.21%","Peve_00002213",NA,NA,NA,NA,NA,NA,NA,NA
"1992",1992,"Cluster_4079","Porites_evermani_scaffold_1237:6035-7035",167,-22.42,2,18,548,568,16,"87.50%","93.75%","Peve_00003891",NA,NA,NA,"P11960","2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial (EC 1.2.4.4) (Branched-chain alpha-keto acid dehydrogenase E1 component alpha chain) (BCKDE1A) (BCKDH E1-alpha)","Rattus norvegicus (Rat)","branched-chain amino acid catabolic process [GO:0009083]; response to cAMP [GO:0051591]; response to glucocorticoid [GO:0051384]; response to nutrient [GO:0007584]","GO:0003863; GO:0005739; GO:0005947; GO:0007584; GO:0009083; GO:0044877; GO:0046872; GO:0047101; GO:0051384; GO:0051591"
"1993",1993,"Cluster_4079","Porites_evermani_scaffold_1237:6234-7234",167,-22.42,2,18,349,369,16,"87.50%","93.75%","Peve_00003894",NA,NA,NA,NA,NA,NA,NA,NA
"1994",1994,"Cluster_4079","Porites_evermani_scaffold_127:431101-432101",164,-21.94,2,21,191,212,19,"68.42%","84.21%","Peve_00004361",-0.796272454187231,0.413604356922386,0.978262075707395,NA,NA,NA,NA,NA
"1995",1995,"Cluster_4079","Porites_evermani_scaffold_1285:69547-70547",150,-21.77,2,15,934,955,13,"69.23%","92.31%","Peve_00004556",-0.811274004916923,0.397548971703817,0.978262075707395,"Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"1996",1996,"Cluster_4079","Porites_evermani_scaffold_1316:123913-124913",163,-21.66,2,20,420,441,18,"72.22%","83.33%","Peve_00005011",0.922028042287347,0.253062309744281,0.978262075707395,NA,NA,NA,NA,NA
"1997",1997,"Cluster_4079","Porites_evermani_scaffold_1326:112372-113372",159,-22.62,2,20,862,883,18,"66.67%","83.33%","Peve_00005158",-0.959841762244989,0.181028369357098,0.978262075707395,"P42700","RNA-binding protein RO60 (60 kDa SS-A/Ro ribonucleoprotein) (60 kDa Ro protein) (60 kDa ribonucleoprotein Ro) (RoRNP) (TROVE domain family member 2)","Xenopus laevis (African clawed frog)","cell projection organization [GO:0030030]","GO:0005737; GO:0030030; GO:0034336; GO:0046872; GO:1990904"
"1998",1998,"Cluster_4079","Porites_evermani_scaffold_1451:10407-11407",155,-21.49,2,16,610,631,14,"78.57%","85.71%","Peve_00006872",-0.967067328124104,0.163835397674753,0.978262075707395,NA,NA,NA,NA,NA
"1999",1999,"Cluster_4079","Porites_evermani_scaffold_1451:10782-11782",155,-21.49,2,16,235,256,14,"78.57%","85.71%","Peve_00006874",0.835981061739292,0.369798537087943,0.978262075707395,"P15043","ATP-dependent DNA helicase RecQ (EC 3.6.4.12)","Escherichia coli (strain K12)","cellular response to DNA damage stimulus [GO:0006974]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; SOS response [GO:0009432]","GO:0003677; GO:0003678; GO:0005524; GO:0005694; GO:0005737; GO:0006260; GO:0006281; GO:0006310; GO:0006974; GO:0008094; GO:0008270; GO:0009378; GO:0009432; GO:0016887; GO:0017116; GO:0017117; GO:0030894; GO:0032508; GO:0043138; GO:0043590; GO:0046914"
"2000",2000,"Cluster_4079","Porites_evermani_scaffold_1540:106794-107794",150,-20.17,2,20,223,250,24,"66.67%","66.67%","Peve_00008001",-0.382151382789086,0.750366576916224,0.988219883885475,"P52046","Short-chain-enoyl-CoA hydratase (EC 4.2.1.150) (3-hydroxybutyryl-CoA dehydratase) (Crotonase)","Clostridium acetobutylicum (strain ATCC 824 / DSM 792 / JCM 1419 / LMG 5710 / VKM B-1787)","butyrate metabolic process [GO:0019605]","GO:0016829; GO:0019605"
"2001",2001,"Cluster_4079","Porites_evermani_scaffold_1540:115329-116329",150,-20.17,2,20,223,250,24,"66.67%","66.67%","Peve_00008003",-0.395522709492801,0.741126910010092,0.986697151420032,"P52046","Short-chain-enoyl-CoA hydratase (EC 4.2.1.150) (3-hydroxybutyryl-CoA dehydratase) (Crotonase)","Clostridium acetobutylicum (strain ATCC 824 / DSM 792 / JCM 1419 / LMG 5710 / VKM B-1787)","butyrate metabolic process [GO:0019605]","GO:0016829; GO:0019605"
"2002",2002,"Cluster_4079","Porites_evermani_scaffold_1568:51056-52056",151,-20.09,2,17,531,554,17,"76.47%","76.47%","Peve_00008310",0.224085094337563,0.856121285978941,0.995934364227446,"Q55E58","Probable serine/threonine-protein kinase pats1 (EC 2.7.11.1) (Protein associated with the transduction of signal 1)","Dictyostelium discoideum (Social amoeba)","cheating during chimeric sorocarp development [GO:0099139]; mitotic cytokinesis [GO:0000281]; phosphatidylinositol dephosphorylation [GO:0046856]; protein phosphorylation [GO:0006468]","GO:0000281; GO:0004438; GO:0004674; GO:0004721; GO:0005524; GO:0005525; GO:0005829; GO:0006468; GO:0042641; GO:0046856; GO:0099139; GO:0106310"
"2003",2003,"Cluster_4079","Porites_evermani_scaffold_1576:88975-89975",155,-22.44,2,20,507,528,18,"66.67%","77.78%","Peve_00008451",0.902373253089871,0.283646713594473,0.978262075707395,"A4QP81","Putative ferric-chelate reductase 1 (EC 1.-.-.-)","Danio rerio (Zebrafish) (Brachydanio rerio)","","GO:0016020; GO:0016491; GO:0046872"
"2004",2004,"Cluster_4079","Porites_evermani_scaffold_1632:2767-3213",159,-23.04,2,20,318,339,18,"66.67%","83.33%","Peve_00009215",0.969562731099693,0.157472862423124,0.978262075707395,NA,NA,NA,NA,NA
"2005",2005,"Cluster_4079","Porites_evermani_scaffold_1632:2767-3213",159,-23.04,2,20,318,339,18,"66.67%","83.33%","Peve_00009218",-0.0756340701460482,0.951803829649429,0.999448381576871,"Q7TT28","RNA exonuclease 1 homolog (EC 3.1.-.-) (Transcription elongation factor B polypeptide 3-binding protein 1)","Mus musculus (Mouse)","","GO:0003676; GO:0004527; GO:0005634; GO:0005654; GO:0016604"
"2006",2006,"Cluster_4079","Porites_evermani_scaffold_163:355828-356828",147,-21.34,2,17,865,888,17,"70.59%","76.47%","Peve_00009150",0.953448846780075,0.195011243190473,0.978262075707395,NA,NA,NA,NA,NA
"2007",2007,"Cluster_4079","Porites_evermani_scaffold_163:356130-357130",147,-21.34,2,17,563,586,17,"70.59%","76.47%","Peve_00009152",-0.768368951198172,0.44213725356944,0.978262075707395,"Q9N126","Retinol dehydrogenase 8 (EC 1.1.1.300) (Photoreceptor outer segment all-trans retinol dehydrogenase)","Bos taurus (Bovine)","estrogen biosynthetic process [GO:0006703]; response to stimulus [GO:0050896]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601]","GO:0004303; GO:0004745; GO:0005829; GO:0006703; GO:0007601; GO:0016491; GO:0042572; GO:0042622; GO:0050896; GO:0052650"
"2008",2008,"Cluster_4079","Porites_evermani_scaffold_1652:1530-2530",163,-21.87,2,16,872,893,14,"78.57%","100.00%","Peve_00009440",NA,NA,NA,NA,NA,NA,NA,NA
"2009",2009,"Cluster_4079","Porites_evermani_scaffold_1652:2180-3180",163,-21.87,2,16,222,243,14,"78.57%","100.00%","Peve_00009441",NA,NA,NA,NA,NA,NA,NA,NA
"2010",2010,"Cluster_4079","Porites_evermani_scaffold_1666:29878-30878",182,-23.15,2,21,330,350,19,"89.47%","94.74%","Peve_00009570",-0.972600120710292,0.14937093500349,0.978262075707395,NA,NA,NA,NA,NA
"2011",2011,"Cluster_4079","Porites_evermani_scaffold_173:69471-70471",166,-26.12,2,20,595,617,19,"78.95%","84.21%","Peve_00010381",-0.465567501177327,0.691700489625945,0.978262075707395,NA,NA,NA,NA,NA
"2012",2012,"Cluster_4079","Porites_evermani_scaffold_1773:80466-81466",170,-26.17,2,20,171,193,19,"78.95%","89.47%","Peve_00010806",NA,NA,NA,NA,NA,NA,NA,NA
"2013",2013,"Cluster_4079","Porites_evermani_scaffold_1789:88046-89046",151,-20.03,2,19,801,820,17,"64.71%","88.24%","Peve_00010992",NA,NA,NA,NA,NA,NA,NA,NA
"2014",2014,"Cluster_4079","Porites_evermani_scaffold_1815:65502-66502",146,-20.05,2,16,605,627,15,"73.33%","80.00%","Peve_00011328",-0.990826176346345,0.0862984282766916,0.978262075707395,"O80668","Amino acid transporter AVT1A (AtAvt1A)","Arabidopsis thaliana (Mouse-ear cress)","amino acid transmembrane transport [GO:0003333]","GO:0000325; GO:0003333; GO:0015171; GO:0016020"
"2015",2015,"Cluster_4079","Porites_evermani_scaffold_1934:27737-28737",164,-25.91,2,21,953,974,19,"68.42%","84.21%","Peve_00012664",-0.796272454187231,0.413604356922386,0.978262075707395,NA,NA,NA,NA,NA
"2016",2016,"Cluster_4079","Porites_evermani_scaffold_1999:59920-60920",146,-20.33,2,11,669,690,9,"88.89%","100.00%","Peve_00013337",-0.955940610835288,0.189680182161158,0.978262075707395,"A1DWM3","Major facilitator superfamily domain-containing protein 6 (Macrophage MHC class I receptor 2 homolog)","Sus scrofa (Pig)","antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]","GO:0005886; GO:0016020; GO:0042590"
"2017",2017,"Cluster_4079","Porites_evermani_scaffold_2008:10894-11894",159,-22.53,2,21,505,529,22,"68.18%","77.27%","Peve_00013636",NA,NA,NA,"O77656","Collagenase 3 (EC 3.4.24.-) (Matrix metalloproteinase-13) (MMP-13)","Bos taurus (Bovine)","bone morphogenesis [GO:0060349]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; proteolysis [GO:0006508]","GO:0004175; GO:0004222; GO:0005509; GO:0005518; GO:0005576; GO:0006508; GO:0008270; GO:0022617; GO:0030574; GO:0031012; GO:0060349"
"2018",2018,"Cluster_4079","Porites_evermani_scaffold_2021:39937-40937",162,-20.6,2,15,816,837,13,"84.62%","100.00%","Peve_00013791",-0.929416552142006,0.240621688331785,0.978262075707395,"Q9ZQ47","Glycine-rich domain-containing protein 1 (AtGRDP1)","Arabidopsis thaliana (Mouse-ear cress)","abscisic acid-activated signaling pathway [GO:0009738]; cellular response to osmotic stress [GO:0071470]; regulation of abscisic acid-activated signaling pathway [GO:0009787]","GO:0005886; GO:0009738; GO:0009787; GO:0071470"
"2019",2019,"Cluster_4079","Porites_evermani_scaffold_2082:44124-45124",162,-21.64,2,17,799,819,15,"86.67%","93.33%","Peve_00014371",-0.125755588100116,0.919728976410948,0.999448381576871,NA,NA,NA,NA,NA
"2020",2020,"Cluster_4079","Porites_evermani_scaffold_2093:86912-87912",170,-25.98,2,20,474,496,19,"84.21%","84.21%","Peve_00014471",-0.796272454187231,0.413604356922386,0.978262075707395,NA,NA,NA,NA,NA
"2021",2021,"Cluster_4079","Porites_evermani_scaffold_2:1132302-1133302",156,-20.02,2,21,84,105,19,"63.16%","78.95%","Peve_00013396",-0.999820977218369,0.0120463575804017,0.676535186799302,"Q925Q3","Mitochondrial sodium/calcium exchanger protein (Na(+)/K(+)/Ca(2+)-exchange protein 6) (Sodium/calcium exchanger protein, mitochondrial) (Sodium/potassium/calcium exchanger 6) (Solute carrier family 24 member 6) (Solute carrier family 8 member B1)","Mus musculus (Mouse)","calcium export from the mitochondrion [GO:0099093]; calcium ion transmembrane transport [GO:0070588]; cation transport [GO:0006812]; cellular calcium ion homeostasis [GO:0006874]; glucose homeostasis [GO:0042593]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of insulin secretion [GO:0050796]; regulation of lymphocyte chemotaxis [GO:1901623]; regulation of store-operated calcium entry [GO:2001256]; response to stimulus [GO:0050896]; sodium ion transmembrane transport [GO:0035725]","GO:0005432; GO:0005739; GO:0005743; GO:0005886; GO:0006812; GO:0006851; GO:0006874; GO:0008324; GO:0016020; GO:0030061; GO:0031966; GO:0035725; GO:0042383; GO:0042593; GO:0042802; GO:0042803; GO:0050796; GO:0050896; GO:0051480; GO:0051560; GO:0070588; GO:0086036; GO:0086038; GO:0099093; GO:1901623; GO:2001256"
"2022",2022,"Cluster_4079","Porites_evermani_scaffold_2:1175966-1176966",159,-21.03,2,16,425,446,14,"78.57%","92.86%","Peve_00013402",-0.901019912393114,0.285639381081007,0.978262075707395,NA,NA,NA,NA,NA
"2023",2023,"Cluster_4079","Porites_evermani_scaffold_212:121484-122484",175,-21.57,2,21,685,707,20,"85.00%","85.00%","Peve_00014759",0.817155190492903,0.391099744166755,0.978262075707395,NA,NA,NA,NA,NA
"2024",2024,"Cluster_4079","Porites_evermani_scaffold_213:223044-224044",157,-21.25,2,19,437,459,18,"72.22%","83.33%","Peve_00014872",-0.796272454187231,0.413604356922386,0.978262075707395,NA,NA,NA,NA,NA
"2025",2025,"Cluster_4079","Porites_evermani_scaffold_21:412787-413787",155,-22.11,2,20,581,602,18,"61.11%","83.33%","Peve_00014513",NA,NA,NA,"P19491","Glutamate receptor 2 (GluR-2) (AMPA-selective glutamate receptor 2) (GluR-B) (GluR-K2) (Glutamate receptor ionotropic, AMPA 2) (GluA2)","Rattus norvegicus (Rat)","cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to glycine [GO:1905430]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; establishment of protein localization [GO:0045184]; ionotropic glutamate receptor signaling pathway [GO:0035235]; positive regulation of synaptic transmission [GO:0050806]; protein tetramerization [GO:0051262]; receptor internalization [GO:0031623]; regulation of receptor recycling [GO:0001919]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to fungicide [GO:0060992]; response to lithium ion [GO:0010226]","GO:0000149; GO:0001540; GO:0001919; GO:0004970; GO:0004971; GO:0005234; GO:0005783; GO:0005789; GO:0005886; GO:0007268; GO:0008021; GO:0008092; GO:0008328; GO:0009986; GO:0010226; GO:0014069; GO:0015276; GO:0015277; GO:0016020; GO:0019865; GO:0019901; GO:0021987; GO:0030165; GO:0030424; GO:0030425; GO:0030426; GO:0030672; GO:0031623; GO:0032279; GO:0032281; GO:0032590; GO:0032839; GO:0032991; GO:0035235; GO:0035254; GO:0035255; GO:0036477; GO:0038023; GO:0042734; GO:0042802; GO:0043005; GO:0043025; GO:0043195; GO:0043197; GO:0043198; GO:0043204; GO:0044326; GO:0044327; GO:0045184; GO:0045202; GO:0045211; GO:0048787; GO:0050806; GO:0051117; GO:0051262; GO:0051966; GO:0060992; GO:0097060; GO:0097110; GO:0098685; GO:0098793; GO:0098839; GO:0098978; GO:0099507; GO:0099544; GO:0106033; GO:1904315; GO:1905430; GO:1990416"
"2026",2026,"Cluster_4079","Porites_evermani_scaffold_2147:59838-60838",151,-20.88,2,12,529,550,10,"90.00%","100.00%","Peve_00015027",0.858115774076756,0.343270268331987,0.978262075707395,"P25916","Polycomb complex protein BMI-1 (Polycomb group RING finger protein 4)","Mus musculus (Mouse)","apoptotic signaling pathway [GO:0097190]; brain development [GO:0007420]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to interleukin-1 [GO:0071347]; DNA methylation [GO:0006306]; embryonic skeletal system development [GO:0048706]; embryonic skeletal system morphogenesis [GO:0048704]; hematopoietic stem cell homeostasis [GO:0061484]; hemopoiesis [GO:0030097]; histone acetylation [GO:0016573]; histone H2A-K119 monoubiquitination [GO:0036353]; histone ubiquitination [GO:0016574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of immature T cell proliferation in thymus [GO:0033092]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; regulation of adaxial/abaxial pattern formation [GO:2000011]; rostrocaudal neural tube patterning [GO:0021903]; skeletal system development [GO:0001501]; somatic stem cell division [GO:0048103]","GO:0000122; GO:0000151; GO:0000792; GO:0000978; GO:0001501; GO:0001701; GO:0003682; GO:0005634; GO:0005829; GO:0006306; GO:0006959; GO:0007420; GO:0008270; GO:0016573; GO:0016574; GO:0016604; GO:0021903; GO:0030097; GO:0030890; GO:0031519; GO:0033092; GO:0035102; GO:0036353; GO:0043565; GO:0045814; GO:0048103; GO:0048146; GO:0048704; GO:0048706; GO:0051443; GO:0061484; GO:0071347; GO:0071535; GO:0071549; GO:0097027; GO:0097190; GO:1990841; GO:2000011; GO:2001234"
"2027",2027,"Cluster_4079","Porites_evermani_scaffold_216:299558-300558",159,-20.52,2,20,319,340,18,"72.22%","77.78%","Peve_00015151",NA,NA,NA,NA,NA,NA,NA,NA
"2028",2028,"Cluster_4079","Porites_evermani_scaffold_2219:68259-69259",171,-21.11,2,20,653,674,18,"83.33%","83.33%","Peve_00015748",-0.999044377811527,0.0278338206502373,0.899469696283718,"P0CI65","Nephrocystin-3","Danio rerio (Zebrafish) (Brachydanio rerio)","cilium assembly [GO:0060271]; convergent extension [GO:0060026]; determination of left/right symmetry [GO:0007368]; heart jogging [GO:0003146]; kidney development [GO:0001822]; Kupffer's vesicle development [GO:0070121]; left/right pattern formation [GO:0060972]; pronephros development [GO:0048793]; visual perception [GO:0007601]; Wnt signaling pathway [GO:0016055]","GO:0001822; GO:0003146; GO:0005929; GO:0007368; GO:0007601; GO:0016055; GO:0048793; GO:0060026; GO:0060271; GO:0060972; GO:0070121; GO:0097543; GO:0097546"
"2029",2029,"Cluster_4079","Porites_evermani_scaffold_230:194878-195878",142,-20.82,2,21,849,875,24,"58.33%","70.83%","Peve_00016563",-0.365182769843735,0.762012987749529,0.988808843294358,"Q9NVS9","Pyridoxine-5'-phosphate oxidase (EC 1.4.3.5) (Pyridoxamine-phosphate oxidase)","Homo sapiens (Human)","pyridoxal phosphate biosynthetic process [GO:0042823]; pyridoxine biosynthetic process [GO:0008615]","GO:0004733; GO:0005829; GO:0008615; GO:0010181; GO:0030170; GO:0042803; GO:0042823"
"2030",2030,"Cluster_4079","Porites_evermani_scaffold_2329:40624-41624",145,-21.27,2,10,515,536,8,"100.00%","100.00%","Peve_00016814",-0.721230558402799,0.487153652323321,0.978262075707395,"Q5I597","Betaine--homocysteine S-methyltransferase 1 (EC 2.1.1.5)","Bos taurus (Bovine)","amino-acid betaine catabolic process [GO:0006579]; L-methionine salvage [GO:0071267]; methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]","GO:0005634; GO:0005829; GO:0006579; GO:0008270; GO:0009086; GO:0032259; GO:0047150; GO:0071267"
"2031",2031,"Cluster_4079","Porites_evermani_scaffold_242:69784-70784",151,-20.51,2,21,58,82,22,"59.09%","77.27%","Peve_00017670",NA,NA,NA,NA,NA,NA,NA,NA
"2032",2032,"Cluster_4079","Porites_evermani_scaffold_24:768952-769952",163,-23.87,2,21,424,446,20,"70.00%","85.00%","Peve_00017439",NA,NA,NA,"Q7T1N4","Acid-sensing ion channel 1 (ASIC1) (Amiloride-sensitive cation channel 2, neuronal)","Opsanus tau (Oyster toadfish) (Gadus tau)","cellular response to pH [GO:0071467]; protein homotrimerization [GO:0070207]; sodium ion transmembrane transport [GO:0035725]","GO:0005886; GO:0035725; GO:0044736; GO:0070207; GO:0071467"
"2033",2033,"Cluster_4079","Porites_evermani_scaffold_24:771222-772222",159,-21.77,2,20,797,818,18,"66.67%","83.33%","Peve_00017441",0.433230538745209,0.714747181663292,0.979987104665135,NA,NA,NA,NA,NA
"2034",2034,"Cluster_4079","Porites_evermani_scaffold_2497:19723-20723",159,-21.77,2,20,958,979,18,"66.67%","83.33%","Peve_00018334",-0.956598728198271,0.188247727909082,0.978262075707395,NA,NA,NA,NA,NA
"2035",2035,"Cluster_4079","Porites_evermani_scaffold_251:173424-174424",173,-26.4,2,18,769,790,16,"81.25%","100.00%","Peve_00018530",-0.767111725285263,0.443386354942308,0.978262075707395,NA,NA,NA,NA,NA
"2036",2036,"Cluster_4079","Porites_evermani_scaffold_2678:14590-15590",172,-22.97,2,18,173,195,17,"88.24%","94.12%","Peve_00019867",-0.611134313559636,0.581427039034174,0.978262075707395,"Q9TU32","Protein ERGIC-53 (ER-Golgi intermediate compartment 53 kDa protein) (Lectin mannose-binding 1)","Chlorocebus aethiops (Green monkey) (Cercopithecus aethiops)","protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]","GO:0000139; GO:0005789; GO:0015031; GO:0016192; GO:0030246; GO:0033116; GO:0046872"
"2037",2037,"Cluster_4079","Porites_evermani_scaffold_2816:3490-4490",150,-20.12,2,15,16,37,13,"76.92%","84.62%","Peve_00021028",-0.701795472923065,0.504764076309461,0.978262075707395,"Q80UV9","Transcription initiation factor TFIID subunit 1 (EC 2.3.1.48) (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250)","Mus musculus (Mouse)","cell cycle [GO:0007049]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; protein phosphorylation [GO:0006468]; RNA polymerase II preinitiation complex assembly [GO:0051123]","GO:0000785; GO:0000979; GO:0001091; GO:0001181; GO:0002039; GO:0003677; GO:0004402; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005667; GO:0005669; GO:0005730; GO:0006468; GO:0007049; GO:0016251; GO:0016301; GO:0016922; GO:0017025; GO:0042789; GO:0045120; GO:0046982; GO:0051123; GO:0060261; GO:0061628; GO:0061629; GO:0061631; GO:0070577; GO:0071339; GO:0106310; GO:0140416; GO:1990841"
"2038",2038,"Cluster_4079","Porites_evermani_scaffold_287:286904-287904",153,-21.69,2,16,133,153,14,"85.71%","85.71%","Peve_00021444",NA,NA,NA,NA,NA,NA,NA,NA
"2039",2039,"Cluster_4079","Porites_evermani_scaffold_29:281872-282872",153,-22.46,2,20,230,255,22,"68.18%","77.27%","Peve_00021695",-0.836667562387459,0.369001360525747,0.978262075707395,NA,NA,NA,NA,NA
"2040",2040,"Cluster_4079","Porites_evermani_scaffold_2934:29546-30141",143,-21.38,2,12,315,336,10,"80.00%","90.00%","Peve_00021957",0.662592422974353,0.53891237023425,0.978262075707395,NA,NA,NA,NA,NA
"2041",2041,"Cluster_4079","Porites_evermani_scaffold_2966:16092-16435",149,-20.4,2,15,4,27,15,"80.00%","80.00%","Peve_00022163",NA,NA,NA,NA,NA,NA,NA,NA
"2042",2042,"Cluster_4079","Porites_evermani_scaffold_2966:16092-17092",149,-20.4,2,15,4,27,15,"80.00%","80.00%","Peve_00022165",-0.796272454187231,0.413604356922386,0.978262075707395,NA,NA,NA,NA,NA
"2043",2043,"Cluster_4079","Porites_evermani_scaffold_2986:5245-6245",167,-23.91,2,16,150,171,14,"85.71%","100.00%","Peve_00022328",-0.943529286415167,0.214967099288618,0.978262075707395,"G3M4F8","Octopamine receptor beta-2R (CsOA2B2)","Chilo suppressalis (Asiatic rice borer moth)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to amine stimulus [GO:0071418]; octopamine signaling pathway [GO:0071927]; tyramine signaling pathway [GO:0071928]","GO:0004989; GO:0005886; GO:0007189; GO:0008226; GO:0016020; GO:0071418; GO:0071927; GO:0071928"
"2044",2044,"Cluster_4079","Porites_evermani_scaffold_300:192865-193865",159,-22.92,2,18,1,16,16,"81.25%","87.50%","Peve_00022631",0.945754049438686,0.210650178163359,0.978262075707395,NA,NA,NA,NA,NA
"2045",2045,"Cluster_4079","Porites_evermani_scaffold_3021:53225-54225",154,-21.51,2,20,62,85,20,"60.00%","85.00%","Peve_00022789",0.999909031516669,0.0085870479919059,0.575101679046124,NA,NA,NA,NA,NA
"2046",2046,"Cluster_4079","Porites_evermani_scaffold_3057:20023-21023",150,-20.86,2,21,722,747,23,"60.87%","78.26%","Peve_00023022",NA,NA,NA,"B8VIV4","CUB and peptidase domain-containing protein 2","Acropora millepora (Staghorn coral) (Heteropora millepora)","proteolysis [GO:0006508]","GO:0004252; GO:0005576; GO:0006508"
"2047",2047,"Cluster_4079","Porites_evermani_scaffold_308:113834-114834",179,-26.43,2,20,801,822,18,"88.89%","88.89%","Peve_00023191",-0.962982779439511,0.173758439561106,0.978262075707395,"Q9SSA4",NA,NA,NA,NA
"2048",2048,"Cluster_4079","Porites_evermani_scaffold_3144:32412-33412",159,-23.04,2,20,65,86,18,"66.67%","83.33%","Peve_00023685",-0.956266836079586,0.188971439385225,0.978262075707395,"Q7TT28","RNA exonuclease 1 homolog (EC 3.1.-.-) (Transcription elongation factor B polypeptide 3-binding protein 1)","Mus musculus (Mouse)","","GO:0003676; GO:0004527; GO:0005634; GO:0005654; GO:0016604"
"2049",2049,"Cluster_4079","Porites_evermani_scaffold_3144:32412-33412",159,-23.04,2,20,872,893,18,"66.67%","83.33%","Peve_00023685",-0.956266836079586,0.188971439385225,0.978262075707395,"Q7TT28","RNA exonuclease 1 homolog (EC 3.1.-.-) (Transcription elongation factor B polypeptide 3-binding protein 1)","Mus musculus (Mouse)","","GO:0003676; GO:0004527; GO:0005634; GO:0005654; GO:0016604"
"2050",2050,"Cluster_4079","Porites_evermani_scaffold_316:23841-24841",154,-21.11,2,21,335,360,23,"65.22%","78.26%","Peve_00023783",-0.796272454187231,0.413604356922386,0.978262075707395,NA,NA,NA,NA,NA
"2051",2051,"Cluster_4079","Porites_evermani_scaffold_319:64628-65628",163,-23.07,2,21,518,541,21,"66.67%","85.71%","Peve_00023941",-0.897976170123689,0.290074378335297,0.978262075707395,"Q00589","Sodium- and chloride-dependent taurine transporter (Solute carrier family 6 member 6)","Canis lupus familiaris (Dog) (Canis familiaris)","neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725]; taurine transport [GO:0015734]","GO:0005332; GO:0005369; GO:0005886; GO:0006836; GO:0015734; GO:0035725"
"2052",2052,"Cluster_4079","Porites_evermani_scaffold_3200:29366-30366",145,-20.01,2,10,30,51,8,"100.00%","100.00%","Peve_00024045",NA,NA,NA,"Q96CG8","Collagen triple helix repeat-containing protein 1","Homo sapiens (Human)","cell migration [GO:0016477]; cochlea morphogenesis [GO:0090103]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein binding [GO:0032092]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0001649; GO:0005109; GO:0005576; GO:0005581; GO:0005615; GO:0016477; GO:0016528; GO:0017147; GO:0032092; GO:0033687; GO:0033690; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0062023; GO:0090090; GO:0090103; GO:0090177"
"2053",2053,"Cluster_4079","Porites_evermani_scaffold_3204:12114-13114",172,-22.97,2,18,154,176,17,"88.24%","94.12%","Peve_00024058",-0.517548445483443,0.653689452552434,0.978262075707395,"Q9TU32","Protein ERGIC-53 (ER-Golgi intermediate compartment 53 kDa protein) (Lectin mannose-binding 1)","Chlorocebus aethiops (Green monkey) (Cercopithecus aethiops)","protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]","GO:0000139; GO:0005789; GO:0015031; GO:0016192; GO:0030246; GO:0033116; GO:0046872"
"2054",2054,"Cluster_4079","Porites_evermani_scaffold_3285:48554-49281",154,-23.85,2,21,447,467,19,"63.16%","84.21%","Peve_00024501",-0.922658797310656,0.252023018914762,0.978262075707395,"O46392","Collagen alpha-2(I) chain (Alpha-2 type I collagen)","Canis lupus familiaris (Dog) (Canis familiaris)","","GO:0005201; GO:0005576; GO:0005581; GO:0046872"
"2055",2055,"Cluster_4079","Porites_evermani_scaffold_3325:38974-39974",170,-23.27,2,21,479,499,19,"78.95%","89.47%","Peve_00024808",-0.959194478474388,0.182491466923609,0.978262075707395,"Q9Y5P8","Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit beta (PP2A subunit B isoform PR48) (Protein phosphatase 2A 48 kDa regulatory subunit)","Homo sapiens (Human)","protein dephosphorylation [GO:0006470]; regulation of cell cycle [GO:0051726]","GO:0000159; GO:0005509; GO:0005634; GO:0005654; GO:0005829; GO:0006470; GO:0019888; GO:0051726"
"2056",2056,"Cluster_4079","Porites_evermani_scaffold_3338:44214-45214",170,-25.98,2,20,474,496,19,"84.21%","84.21%","Peve_00024891",-0.669940535390136,0.532639161536072,0.978262075707395,NA,NA,NA,NA,NA
"2057",2057,"Cluster_4079","Porites_evermani_scaffold_3372:24739-25739",162,-20.13,2,15,451,472,13,"84.62%","100.00%","Peve_00025109",0.767573326616988,0.442928077629796,0.978262075707395,NA,NA,NA,NA,NA
"2058",2058,"Cluster_4079","Porites_evermani_scaffold_3643:14928-15928",143,-20.25,2,13,918,940,12,"83.33%","83.33%","Peve_00026790",NA,NA,NA,NA,NA,NA,NA,NA
"2059",2059,"Cluster_4079","Porites_evermani_scaffold_37:154477-154742",154,-22.37,2,20,175,200,22,"63.64%","77.27%","Peve_00027075",-0.996529258885895,0.0530556844217824,0.968102145604275,"Q9NVH1","DnaJ homolog subfamily C member 11","Homo sapiens (Human)","cristae formation [GO:0042407]; inner mitochondrial membrane organization [GO:0007007]","GO:0001401; GO:0005654; GO:0005739; GO:0005741; GO:0007007; GO:0016607; GO:0042407; GO:0140275"
"2060",2060,"Cluster_4079","Porites_evermani_scaffold_37:154477-154742",154,-22.37,2,20,175,200,22,"63.64%","77.27%","Peve_00027083",-0.73966630233088,0.469966695506425,0.978262075707395,"Q8CHT0","Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial (P5C dehydrogenase) (EC 1.2.1.88) (Aldehyde dehydrogenase family 4 member A1) (L-glutamate gamma-semialdehyde dehydrogenase)","Mus musculus (Mouse)","proline catabolic process to glutamate [GO:0010133]","GO:0003842; GO:0004029; GO:0005739; GO:0005759; GO:0005829; GO:0010133; GO:0042802"
"2061",2061,"Cluster_4079","Porites_evermani_scaffold_3966:12379-13379",163,-20.8,2,20,555,576,18,"66.67%","88.89%","Peve_00028545",-0.693781452004843,0.511886732795746,0.978262075707395,NA,NA,NA,NA,NA
"2062",2062,"Cluster_4079","Porites_evermani_scaffold_4148:29435-30435",182,-23.15,2,21,330,350,19,"89.47%","94.74%","Peve_00029606",0.823785364314642,0.383716239790421,0.978262075707395,NA,NA,NA,NA,NA
"2063",2063,"Cluster_4079","Porites_evermani_scaffold_41:567312-568312",169,-21.36,2,19,111,133,18,"77.78%","94.44%","Peve_00029339",NA,NA,NA,NA,NA,NA,NA,NA
"2064",2064,"Cluster_4079","Porites_evermani_scaffold_4231:19536-20536",149,-21.24,2,21,119,145,24,"66.67%","75.00%","Peve_00030053",NA,NA,NA,NA,NA,NA,NA,NA
"2065",2065,"Cluster_4079","Porites_evermani_scaffold_42:602628-603628",156,-23.07,2,18,421,444,18,"72.22%","83.33%","Peve_00029825",NA,NA,NA,NA,NA,NA,NA,NA
"2066",2066,"Cluster_4079","Porites_evermani_scaffold_426:204010-205010",166,-22.73,2,21,75,95,19,"78.95%","84.21%","Peve_00030186",0.969367959320803,0.157978496134696,0.978262075707395,"Q5RGB8","Kelch-like protein 26","Danio rerio (Zebrafish) (Brachydanio rerio)","",""
"2067",2067,"Cluster_4079","Porites_evermani_scaffold_433:45871-46871",167,-21.89,2,20,627,648,18,"77.78%","83.33%","Peve_00030575",NA,NA,NA,"Q3ZBV2","ATP-dependent RNA helicase DDX19A (EC 3.6.4.13) (DEAD box protein 19A)","Bos taurus (Bovine)","poly(A)+ mRNA export from nucleus [GO:0016973]","GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0010494; GO:0016887; GO:0016973"
"2068",2068,"Cluster_4079","Porites_evermani_scaffold_4371:16660-17660",142,-21.18,2,20,280,307,24,"58.33%","66.67%","Peve_00030757",-0.796272454187231,0.413604356922386,0.978262075707395,"Q8U3Y2","Glyoxylate reductase (EC 1.1.1.26)","Pyrococcus furiosus (strain ATCC 43587 / DSM 3638 / JCM 8422 / Vc1)","","GO:0005737; GO:0047964; GO:0051287"
"2069",2069,"Cluster_4079","Porites_evermani_scaffold_444:264992-265992",162,-21.36,2,20,645,668,20,"70.00%","85.00%","Peve_00031170",-0.185670850068458,0.881108367523852,0.999028044811293,"Q9Y5N5","Methyltransferase N6AMT1 (HemK methyltransferase family member 2) (M.HsaHemK2P) (Lysine N-methyltransferase 9) (EC 2.1.1.-) (Methylarsonite methyltransferase N6AMT1) (EC 2.1.1.-) (Protein N(5)-glutamine methyltransferase) (EC 2.1.1.-)","Homo sapiens (Human)","arsonoacetate metabolic process [GO:0018872]; chromatin organization [GO:0006325]; DNA methylation on adenine [GO:0032775]; histone lysine methylation [GO:0034968]; methylation [GO:0032259]; peptidyl-glutamine methylation [GO:0018364]; positive regulation of cell growth [GO:0030307]; toxin metabolic process [GO:0009404]","GO:0003676; GO:0005634; GO:0005829; GO:0006325; GO:0008276; GO:0008757; GO:0009007; GO:0009404; GO:0018024; GO:0018364; GO:0018872; GO:0030307; GO:0030792; GO:0032259; GO:0032775; GO:0032991; GO:0034968; GO:0035657; GO:0036009; GO:1904047"
"2070",2070,"Cluster_4079","Porites_evermani_scaffold_4616:19923-20923",155,-21.21,2,17,551,574,17,"70.59%","88.24%","Peve_00031981",-0.967172895563379,0.163571138762293,0.978262075707395,"Q58D55","Beta-galactosidase (EC 3.2.1.23) (Acid beta-galactosidase) (Lactase)","Bos taurus (Bovine)","carbohydrate metabolic process [GO:0005975]","GO:0004565; GO:0005764; GO:0005975"
"2071",2071,"Cluster_4079","Porites_evermani_scaffold_4616:20440-21440",155,-21.21,2,17,34,57,17,"70.59%","88.24%","Peve_00031982",0.567164236807472,0.616080942775346,0.978262075707395,NA,NA,NA,NA,NA
"2072",2072,"Cluster_4079","Porites_evermani_scaffold_468:210692-211692",168,-24.16,2,21,589,610,19,"73.68%","84.21%","Peve_00032232",-0.967140817186758,0.163651482246678,0.978262075707395,"Q5R5R4","RUN and FYVE domain-containing protein 2","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","","GO:0005634; GO:0046872"
"2073",2073,"Cluster_4079","Porites_evermani_scaffold_4792:19141-20141",162,-25.91,2,15,198,219,13,"84.62%","100.00%","Peve_00032689",-0.597163642303094,0.592588584081701,0.978262075707395,"Q80U44","Zinc finger FYVE domain-containing protein 16 (Endofin) (Endosomal-associated FYVE domain protein)","Mus musculus (Mouse)","endosomal transport [GO:0016197]; protein targeting to lysosome [GO:0006622]","GO:0005545; GO:0005547; GO:0005769; GO:0005829; GO:0006622; GO:0016197; GO:0031901; GO:0043231; GO:0046872"
"2074",2074,"Cluster_4079","Porites_evermani_scaffold_480:146361-147190",150,-20.99,2,20,687,711,21,"61.90%","76.19%","Peve_00032772",0.922028042287347,0.253062309744281,0.978262075707395,NA,NA,NA,NA,NA
"2075",2075,"Cluster_4079","Porites_evermani_scaffold_480:209625-210625",151,-22.05,2,19,582,601,17,"70.59%","82.35%","Peve_00032755",-0.66849197919497,0.533880205954255,0.978262075707395,NA,NA,NA,NA,NA
"2076",2076,"Cluster_4079","Porites_evermani_scaffold_4834:2263-3263",142,-21.37,2,11,457,478,9,"88.89%","88.89%","Peve_00032889",-0.796272454187231,0.413604356922386,0.978262075707395,NA,NA,NA,NA,NA
"2077",2077,"Cluster_4079","Porites_evermani_scaffold_486:118942-119412",145,-21.14,2,10,72,93,8,"100.00%","100.00%","Peve_00032980",NA,NA,NA,NA,NA,NA,NA,NA
"2078",2078,"Cluster_4079","Porites_evermani_scaffold_4869:5294-6294",159,-22.49,2,21,341,359,19,"78.95%","84.21%","Peve_00032999",NA,NA,NA,NA,NA,NA,NA,NA
"2079",2079,"Cluster_4079","Porites_evermani_scaffold_507:129061-129947",160,-22.09,2,20,369,388,18,"72.22%","88.89%","Peve_00033903",-0.695466683174744,0.510395361104472,0.978262075707395,NA,NA,NA,NA,NA
"2080",2080,"Cluster_4079","Porites_evermani_scaffold_5131:8571-9571",162,-20.6,2,15,888,909,13,"84.62%","100.00%","Peve_00034173",NA,NA,NA,NA,NA,NA,NA,NA
"2081",2081,"Cluster_4079","Porites_evermani_scaffold_5173:14166-15166",146,-23.22,2,16,587,612,18,"66.67%","77.78%","Peve_00034291",-0.426228177057564,0.719684135487727,0.981369881295541,NA,NA,NA,NA,NA
"2082",2082,"Cluster_4079","Porites_evermani_scaffold_524:52331-53331",164,-23.24,2,21,278,297,19,"78.95%","89.47%","Peve_00034519",-0.855597926015459,0.346379400280676,0.978262075707395,"B8VIU6","Uncharacterized skeletal organic matrix protein 5 (Uncharacterized SOMP-5)","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0005576"
"2083",2083,"Cluster_4079","Porites_evermani_scaffold_5:276447-277447",151,-20.74,2,12,804,825,10,"90.00%","100.00%","Peve_00033589",-0.976683665883894,0.137744013357602,0.978262075707395,"P62958","Adenosine 5'-monophosphoramidase HINT1 (EC 3.9.1.-) (17 kDa inhibitor of protein kinase C) (Desumoylating isopeptidase HINT1) (EC 3.4.22.-) (Histidine triad nucleotide-binding protein 1) (Protein kinase C inhibitor 1) (Protein kinase C-interacting protein 1) (PKCI-1)","Bos taurus (Bovine)","intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; protein desumoylation [GO:0016926]; purine ribonucleotide catabolic process [GO:0009154]; regulation of DNA-templated transcription [GO:0006355]","GO:0000118; GO:0000166; GO:0005634; GO:0005737; GO:0006355; GO:0009154; GO:0016787; GO:0016926; GO:0016929; GO:0043530; GO:0072332"
"2084",2084,"Cluster_4079","Porites_evermani_scaffold_534:98871-99871",156,-22.54,2,18,439,461,17,"76.47%","82.35%","Peve_00034884",NA,NA,NA,NA,NA,NA,NA,NA
"2085",2085,"Cluster_4079","Porites_evermani_scaffold_541:193793-194793",158,-20.23,2,20,417,439,19,"68.42%","84.21%","Peve_00035192",-0.998775289031826,0.03151056991983,0.903929377050813,"Q80XJ3","Tetratricopeptide repeat protein 28 (TPR repeat protein 28)","Mus musculus (Mouse)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0005737; GO:0005813; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301; GO:0072686; GO:0097431; GO:1990023"
"2086",2086,"Cluster_4079","Porites_evermani_scaffold_5446:1521-2521",147,-20.16,2,21,17,41,22,"63.64%","68.18%","Peve_00035283",-0.923924767679851,0.249924737496997,0.978262075707395,NA,NA,NA,NA,NA
"2087",2087,"Cluster_4079","Porites_evermani_scaffold_54:540693-541693",159,-26.23,2,17,931,953,16,"81.25%","87.50%","Peve_00035122",-0.910841757958809,0.270867370640051,0.978262075707395,"Q04721","Neurogenic locus notch homolog protein 2 (Notch 2) (hN2) [Cleaved into: Notch 2 extracellular truncation (N2ECD); Notch 2 intracellular domain (N2ICD)]","Homo sapiens (Human)","animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; atrioventricular node development [GO:0003162]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hemopoiesis [GO:0030097]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of osteoclast development [GO:2001204]; wound healing [GO:0042060]","GO:0000122; GO:0000139; GO:0001701; GO:0001709; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003162; GO:0003184; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005886; GO:0005929; GO:0006915; GO:0006959; GO:0007219; GO:0007399; GO:0007411; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0016020; GO:0019899; GO:0030097; GO:0030326; GO:0030509; GO:0030513; GO:0035264; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043066; GO:0043235; GO:0045672; GO:0046579; GO:0046849; GO:0051059; GO:0060413; GO:0060674; GO:0061073; GO:0061314; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:1990705; GO:2000249; GO:2001204"
"2088",2088,"Cluster_4079","Porites_evermani_scaffold_555:178909-179909",163,-22.04,2,20,359,380,18,"72.22%","83.33%","Peve_00035643",-0.907585160471052,0.275847299967234,0.978262075707395,"Q8N5T2","TBC1 domain family member 19","Homo sapiens (Human)","","GO:0005096"
"2089",2089,"Cluster_4079","Porites_evermani_scaffold_559:11748-12748",160,-20.25,2,20,784,806,20,"75.00%","85.00%","Peve_00035772",NA,NA,NA,NA,NA,NA,NA,NA
"2090",2090,"Cluster_4079","Porites_evermani_scaffold_559:12301-13301",160,-20.25,2,20,231,253,20,"75.00%","85.00%","Peve_00035773",-0.665490761089185,0.536444597050948,0.978262075707395,NA,NA,NA,NA,NA
"2091",2091,"Cluster_4079","Porites_evermani_scaffold_599:115248-116248",179,-24.41,2,21,492,514,20,"85.00%","90.00%","Peve_00036918",0.922028042287347,0.253062309744281,0.978262075707395,NA,NA,NA,NA,NA
"2092",2092,"Cluster_4079","Porites_evermani_scaffold_614:189464-190464",155,-20.65,2,21,757,781,22,"63.64%","77.27%","Peve_00037441",NA,NA,NA,NA,NA,NA,NA,NA
"2093",2093,"Cluster_4079","Porites_evermani_scaffold_623:192394-193394",163,-22.04,2,20,161,182,18,"72.22%","83.33%","Peve_00037705",-0.899560144789129,0.287774329657578,0.978262075707395,NA,NA,NA,NA,NA
"2094",2094,"Cluster_4079","Porites_evermani_scaffold_636:90422-91422",146,-20.12,2,20,13,35,19,"63.16%","73.68%","Peve_00038009",-0.999936297068816,0.00718583323943983,0.573710369894872,"P15178","Aspartate--tRNA ligase, cytoplasmic (EC 6.1.1.12) (Aspartyl-tRNA synthetase) (AspRS)","Rattus norvegicus (Rat)","aspartyl-tRNA aminoacylation [GO:0006422]","GO:0003723; GO:0004815; GO:0005524; GO:0005737; GO:0005829; GO:0006422; GO:0017101; GO:0045202"
"2095",2095,"Cluster_4079","Porites_evermani_scaffold_6:586985-587985",146,-21.88,2,11,852,873,9,"88.89%","100.00%","Peve_00036956",-0.974993628837409,0.142669009436416,0.978262075707395,"Q5F471","Serine/threonine-protein phosphatase 6 regulatory subunit 3 (SAPS domain family member 3)","Gallus gallus (Chicken)","regulation of phosphoprotein phosphatase activity [GO:0043666]","GO:0005634; GO:0005829; GO:0019888; GO:0019903; GO:0043666"
"2096",2096,"Cluster_4079","Porites_evermani_scaffold_665:198909-199909",154,-21.75,2,18,419,438,16,"75.00%","87.50%","Peve_00038724",-0.674553737223421,0.528672167553385,0.978262075707395,NA,NA,NA,NA,NA
"2097",2097,"Cluster_4079","Porites_evermani_scaffold_669:82092-83092",157,-26.3,2,21,163,189,24,"70.83%","79.17%","Peve_00038777",NA,NA,NA,NA,NA,NA,NA,NA
"2098",2098,"Cluster_4079","Porites_evermani_scaffold_716:60521-61521",158,-22.29,2,20,507,529,19,"68.42%","84.21%","Peve_00039945",-0.897044324632434,0.291419596826896,0.978262075707395,NA,NA,NA,NA,NA
"2099",2099,"Cluster_4079","Porites_evermani_scaffold_729:178550-179550",148,-20.53,2,13,854,875,11,"81.82%","90.91%","Peve_00040217",NA,NA,NA,NA,NA,NA,NA,NA
"2100",2100,"Cluster_4079","Porites_evermani_scaffold_7312:184-1184",151,-24.88,2,17,1,20,19,"68.42%","78.95%","Peve_00040329",-0.125755588100116,0.919728976410948,0.999448381576871,NA,NA,NA,NA,NA
"2101",2101,"Cluster_4079","Porites_evermani_scaffold_755:105663-106663",166,-23.16,2,15,653,674,13,"92.31%","100.00%","Peve_00040775",-0.163215336376967,0.89562694005433,0.999448381576871,"Q7RTR2","NLR family CARD domain-containing protein 3 (CARD15-like protein) (Caterpiller protein 16.2) (CLR16.2) (NACHT, LRR and CARD domains-containing protein 3) (Nucleotide-binding oligomerization domain protein 3)","Homo sapiens (Human)","I-kappaB kinase/NF-kappaB signaling [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of tumor necrosis factor production [GO:0032720]; T cell activation [GO:0042110]","GO:0005524; GO:0005737; GO:0005829; GO:0007249; GO:0014067; GO:0032088; GO:0032687; GO:0032688; GO:0032715; GO:0032720; GO:0034451; GO:0035556; GO:0036312; GO:0042110; GO:0043124; GO:0043231; GO:0045824; GO:0048147; GO:0048471; GO:0050680; GO:0050728; GO:1900016; GO:1900226; GO:1901223"
"2102",2102,"Cluster_4079","Porites_evermani_scaffold_787:117175-118175",155,-20.92,2,21,474,492,19,"78.95%","78.95%","Peve_00041436",0.88443772526171,0.309084368772461,0.978262075707395,NA,NA,NA,NA,NA
"2103",2103,"Cluster_4079","Porites_evermani_scaffold_793:186431-187431",165,-24.24,2,19,817,839,18,"77.78%","88.89%","Peve_00041561",-0.833119238691468,0.373105495754532,0.978262075707395,NA,NA,NA,NA,NA
"2104",2104,"Cluster_4079","Porites_evermani_scaffold_845:82257-83257",158,-22.45,2,20,175,197,19,"68.42%","84.21%","Peve_00042677",-0.125755588100116,0.919728976410948,0.999448381576871,"Q96CG8","Collagen triple helix repeat-containing protein 1","Homo sapiens (Human)","cell migration [GO:0016477]; cochlea morphogenesis [GO:0090103]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein binding [GO:0032092]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0001649; GO:0005109; GO:0005576; GO:0005581; GO:0005615; GO:0016477; GO:0016528; GO:0017147; GO:0032092; GO:0033687; GO:0033690; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0062023; GO:0090090; GO:0090103; GO:0090177"
"2105",2105,"Cluster_4079","Porites_evermani_scaffold_906:21351-22351",151,-20.09,2,17,127,150,17,"76.47%","76.47%","Peve_00043847",-0.784530968294082,0.425807562754758,0.978262075707395,NA,NA,NA,NA,NA
"2106",2106,"Cluster_4079","Porites_evermani_scaffold_9:263374-264374",163,-22.04,2,20,620,641,18,"72.22%","83.33%","Peve_00043691",-0.941021876406315,0.219734650825927,0.978262075707395,"Q9JIQ8","Transmembrane protease serine 2 (EC 3.4.21.-) (Epitheliasin) (Plasmic transmembrane protein X) [Cleaved into: Transmembrane protease serine 2 non-catalytic chain; Transmembrane protease serine 2 catalytic chain]","Mus musculus (Mouse)","positive regulation of viral entry into host cell [GO:0046598]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]","GO:0004252; GO:0005044; GO:0005576; GO:0005654; GO:0005886; GO:0006508; GO:0016540; GO:0046598"
"2107",2107,"Cluster_4079","Porites_evermani_scaffold_9:315755-316755",148,-20.61,2,15,562,585,15,"80.00%","86.67%","Peve_00043696",-0.125755588100116,0.919728976410948,0.999448381576871,NA,NA,NA,NA,NA
"2108",2108,"Cluster_4079","Porites_evermani_scaffold_93:57316-58316",173,-22.51,2,18,838,859,16,"87.50%","93.75%","Peve_00044265",NA,NA,NA,NA,NA,NA,NA,NA
"2109",2109,"Cluster_4079","Porites_evermani_scaffold_974:129626-130626",152,-21.38,2,18,344,366,17,"76.47%","76.47%","Peve_00044985",NA,NA,NA,"Q4AEE3","Deoxyribonuclease-1 (EC 3.1.21.1) (Deoxyribonuclease I) (DNase I)","Equus caballus (Horse)","apoptotic process [GO:0006915]; DNA catabolic process [GO:0006308]; DNA catabolic process, endonucleolytic [GO:0000737]; neutrophil activation involved in immune response [GO:0002283]; regulation of acute inflammatory response [GO:0002673]; regulation of neutrophil mediated cytotoxicity [GO:0070948]","GO:0000737; GO:0002283; GO:0002673; GO:0003677; GO:0003779; GO:0004530; GO:0005576; GO:0005634; GO:0005635; GO:0006308; GO:0006915; GO:0042588; GO:0070948"
"2110",2110,"Cluster_4079","Porites_evermani_scaffold_976:1035-2035",149,-22.66,2,15,303,326,15,"73.33%","86.67%","Peve_00044996",NA,NA,NA,NA,NA,NA,NA,NA
"2111",2111,"Cluster_4080","Porites_evermani_scaffold_100:412680-413680",166,-25.29,2,21,748,773,23,"78.26%","78.26%","Peve_00000197",0.0134356424902081,0.991446346977206,0.999448381576871,"Q13002","Glutamate receptor ionotropic, kainate 2 (GluK2) (Excitatory amino acid receptor 4) (EAA4) (Glutamate receptor 6) (GluR-6) (GluR6)","Homo sapiens (Human)","behavioral fear response [GO:0001662]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; detection of cold stimulus involved in thermoception [GO:0120169]; glutamate receptor signaling pathway [GO:0007215]; inhibitory postsynaptic potential [GO:0060080]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; neuron apoptotic process [GO:0051402]; neuronal action potential [GO:0019228]; positive regulation of synaptic transmission [GO:0050806]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic transmission, glutamatergic [GO:0035249]","GO:0001662; GO:0005234; GO:0005886; GO:0006874; GO:0007215; GO:0007268; GO:0008066; GO:0014069; GO:0015276; GO:0015277; GO:0019228; GO:0032983; GO:0035249; GO:0038023; GO:0042734; GO:0043025; GO:0043524; GO:0045211; GO:0048169; GO:0048172; GO:0050804; GO:0050806; GO:0051402; GO:0051967; GO:0060080; GO:0097471; GO:0098686; GO:0098978; GO:0099171; GO:0099507; GO:0120169; GO:1904315"
"2112",2112,"Cluster_4080","Porites_evermani_scaffold_101:86928-87928",153,-22.44,2,19,911,938,23,"65.22%","73.91%","Peve_00000377",0.973808684319214,0.146024678374106,0.978262075707395,"Q55DA0","ABC transporter G family member 22 (ABC transporter ABCG.22)","Dictyostelium discoideum (Social amoeba)","aggregation involved in sorocarp development [GO:0031152]; cell motility [GO:0048870]; sorocarp morphogenesis [GO:0031288]; transmembrane transport [GO:0055085]","GO:0005524; GO:0016020; GO:0016887; GO:0031152; GO:0031288; GO:0042626; GO:0048870; GO:0055085; GO:0140359"
"2113",2113,"Cluster_4080","Porites_evermani_scaffold_1026:152357-153357",172,-21.19,2,21,659,680,19,"73.68%","89.47%","Peve_00000629",-0.791123376688458,0.418993143826648,0.978262075707395,"Q5IS62","Neuropeptide Y receptor type 2 (NPY2-R) (NPY-Y2 receptor) (Y2 receptor)","Pan troglodytes (Chimpanzee)","G protein-coupled receptor signaling pathway [GO:0007186]","GO:0004983; GO:0005886; GO:0007186; GO:0008188; GO:0042923; GO:0043005"
"2114",2114,"Cluster_4080","Porites_evermani_scaffold_1037:116075-117075",160,-20.81,2,21,437,460,22,"77.27%","81.82%","Peve_00000773",-0.235777127616489,0.848472931070267,0.995934364227446,"A0A8B8EY61",NA,NA,NA,NA
"2115",2115,"Cluster_4080","Porites_evermani_scaffold_1089:44748-45748",149,-21.15,2,21,422,450,27,"66.67%","66.67%","Peve_00001564",NA,NA,NA,NA,NA,NA,NA,NA
"2116",2116,"Cluster_4080","Porites_evermani_scaffold_1152:44714-45714",157,-20.57,2,15,631,654,15,"86.67%","86.67%","Peve_00002592",-0.327110108965791,0.787850395352954,0.99535616417183,"Q25410","Putative molluscan insulin-related peptide(s) receptor (EC 2.7.10.1) [Cleaved into: Putative molluscan insulin-related peptide(s) receptor alpha chain; Putative molluscan insulin-related peptide(s) receptor beta chain]","Lymnaea stagnalis (Great pond snail) (Helix stagnalis)","transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]","GO:0004714; GO:0005524; GO:0007169; GO:0016020; GO:0046872"
"2117",2117,"Cluster_4080","Porites_evermani_scaffold_1216:91519-92519",162,-20.12,2,20,887,909,19,"78.95%","78.95%","Peve_00003608",-0.0325065866495544,0.979302017930459,0.999448381576871,"O75899","Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20)","Homo sapiens (Human)","adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932]","GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712"
"2118",2118,"Cluster_4080","Porites_evermani_scaffold_1242:42993-43993",168,-21.59,2,20,743,764,19,"84.21%","89.47%","Peve_00004006",-0.951767824490651,0.19852937297252,0.978262075707395,NA,NA,NA,NA,NA
"2119",2119,"Cluster_4080","Porites_evermani_scaffold_1307:0-838",166,-21.05,2,20,89,111,19,"73.68%","89.47%","Peve_00004877",NA,NA,NA,"Q95LU3","Fibrinogen C domain-containing protein 1","Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)","","GO:0008061; GO:0016020; GO:0046872"
"2120",2120,"Cluster_4080","Porites_evermani_scaffold_1309:37491-38491",157,-20.42,2,21,345,366,20,"70.00%","85.00%","Peve_00004907",-0.654399920461242,0.545842617834322,0.978262075707395,NA,NA,NA,NA,NA
"2121",2121,"Cluster_4080","Porites_evermani_scaffold_1349:3340-3991",162,-21.52,2,20,180,206,23,"73.91%","73.91%","Peve_00005467",-0.235777127616489,0.848472931070267,0.995934364227446,NA,NA,NA,NA,NA
"2122",2122,"Cluster_4080","Porites_evermani_scaffold_1349:3340-3991",162,-21.52,2,20,180,206,23,"73.91%","73.91%","Peve_00005478",0.959498247432244,0.1818062644036,0.978262075707395,NA,NA,NA,NA,NA
"2123",2123,"Cluster_4080","Porites_evermani_scaffold_1388:119247-120247",165,-20.66,2,20,254,274,18,"72.22%","94.44%","Peve_00006007",0.973411203807968,0.147133465556887,0.978262075707395,"Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"2124",2124,"Cluster_4080","Porites_evermani_scaffold_142:279028-280028",175,-24.89,2,21,509,531,20,"80.00%","90.00%","Peve_00006514",NA,NA,NA,NA,NA,NA,NA,NA
"2125",2125,"Cluster_4080","Porites_evermani_scaffold_1427:24185-25185",167,-21.42,2,21,10,33,21,"71.43%","85.71%","Peve_00006589",NA,NA,NA,NA,NA,NA,NA,NA
"2126",2126,"Cluster_4080","Porites_evermani_scaffold_144:306746-307746",159,-20.35,2,21,939,962,21,"66.67%","80.95%","Peve_00006737",-0.194509791526689,0.875376795475125,0.997615815858545,"Q6PDL0","Cytoplasmic dynein 1 light intermediate chain 2 (Dynein light intermediate chain 2, cytosolic)","Mus musculus (Mouse)","cellular response to nerve growth factor stimulus [GO:1990090]; centrosome localization [GO:0051642]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based movement [GO:0007018]","GO:0000226; GO:0000776; GO:0005524; GO:0005764; GO:0005770; GO:0005813; GO:0005868; GO:0005874; GO:0007018; GO:0030286; GO:0042802; GO:0045504; GO:0051642; GO:1990090"
"2127",2127,"Cluster_4080","Porites_evermani_scaffold_1453:55173-56173",169,-21.92,2,18,111,132,16,"81.25%","93.75%","Peve_00006884",-0.0467469400763632,0.97022912399647,0.999448381576871,NA,NA,NA,NA,NA
"2128",2128,"Cluster_4080","Porites_evermani_scaffold_14:578859-579859",163,-23.62,2,20,119,140,18,"72.22%","83.33%","Peve_00006166",-0.23806924988789,0.846970956675923,0.995934364227446,"A0A0G2JDV3","Guanylate-binding protein 6 (EC 3.6.5.-) (GTP-binding protein 6) (GBP-6) (Guanine nucleotide-binding protein 6) (Macrophage activation 2 like protein)","Mus musculus (Mouse)","adhesion of symbiont to host [GO:0044406]; cellular response to interferon-beta [GO:0035458]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; defense response to Gram-positive bacterium [GO:0050830]; defense response to protozoan [GO:0042832]; response to bacterium [GO:0009617]","GO:0003924; GO:0005525; GO:0009617; GO:0020005; GO:0031410; GO:0035458; GO:0042832; GO:0044406; GO:0050830; GO:0071222; GO:0071346"
"2129",2129,"Cluster_4080","Porites_evermani_scaffold_1461:30812-31812",165,-20.75,2,20,758,781,20,"75.00%","90.00%","Peve_00006985",-0.998052429938545,0.0397385645947719,0.909359886114279,"Q9H4G4","Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2)","Homo sapiens (Human)","positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]","GO:0000139; GO:0005615; GO:0010634; GO:0010718; GO:0042803; GO:0070062; GO:0070374"
"2130",2130,"Cluster_4080","Porites_evermani_scaffold_1504:1009-2009",155,-20.82,2,21,681,705,22,"63.64%","77.27%","Peve_00007593",0.815416249131946,0.393016216988718,0.978262075707395,"P80386","5'-AMP-activated protein kinase subunit beta-1 (AMPK subunit beta-1) (AMPKb) (5'-AMP-activated protein kinase 40 kDa subunit)","Rattus norvegicus (Rat)","cellular response to nutrient levels [GO:0031669]; fatty acid biosynthetic process [GO:0006633]; nail development [GO:0035878]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]","GO:0004672; GO:0005634; GO:0005737; GO:0005829; GO:0006468; GO:0006633; GO:0007165; GO:0010628; GO:0019901; GO:0031588; GO:0031669; GO:0032991; GO:0035878; GO:0120162"
"2131",2131,"Cluster_4080","Porites_evermani_scaffold_158:266806-267806",158,-20.14,2,20,123,146,20,"70.00%","80.00%","Peve_00008510",-0.203563823382311,0.869495116187745,0.997415816669909,"Q01085","Nucleolysin TIAR (TIA-1-related protein)","Homo sapiens (Human)","apoptotic process [GO:0006915]; defense response [GO:0006952]; germ cell development [GO:0007281]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of hippo signaling [GO:0035332]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; positive regulation of stem cell proliferation [GO:2000648]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell division [GO:0017145]; stem cell proliferation [GO:0072089]","GO:0003677; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0006357; GO:0006915; GO:0006952; GO:0007281; GO:0008285; GO:0010494; GO:0017145; GO:0035332; GO:0035925; GO:0044194; GO:0072089; GO:0140517; GO:2000637; GO:2000648"
"2132",2132,"Cluster_4080","Porites_evermani_scaffold_166:328982-329982",163,-22.19,2,20,55,76,18,"72.22%","83.33%","Peve_00009515",NA,NA,NA,NA,NA,NA,NA,NA
"2133",2133,"Cluster_4080","Porites_evermani_scaffold_1674:29535-30535",152,-20.55,2,18,576,599,18,"66.67%","83.33%","Peve_00009669",-0.888857524444084,0.302999631430264,0.978262075707395,"P50238","Cysteine-rich protein 1 (CRP-1) (Cysteine-rich heart protein) (CRHP) (hCRHP) (Cysteine-rich intestinal protein) (CRIP)","Homo sapiens (Human)","cellular response to antibiotic [GO:0071236]; cellular response to UV-B [GO:0071493]; heart development [GO:0007507]; immune response [GO:0006955]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; prostate gland stromal morphogenesis [GO:0060741]; regulation of gene expression [GO:0010468]; response to organic substance [GO:0010033]; response to zinc ion [GO:0010043]","GO:0005737; GO:0006955; GO:0007507; GO:0008270; GO:0008630; GO:0010033; GO:0010043; GO:0010468; GO:0042277; GO:0060741; GO:0071236; GO:0071493"
"2134",2134,"Cluster_4080","Porites_evermani_scaffold_171:26309-27309",161,-22.22,2,18,271,292,16,"68.75%","93.75%","Peve_00010148",0.954909190306051,0.191904292472107,0.978262075707395,NA,NA,NA,NA,NA
"2135",2135,"Cluster_4080","Porites_evermani_scaffold_1734:43148-44148",166,-20.28,2,19,682,703,17,"76.47%","88.24%","Peve_00010425",-0.23220075810155,0.850814730205305,0.995934364227446,NA,NA,NA,NA,NA
"2136",2136,"Cluster_4080","Porites_evermani_scaffold_174:339446-340446",167,-20.4,2,21,956,979,21,"76.19%","80.95%","Peve_00010476",-0.379311601034989,0.752321687073996,0.988219883885475,"Q9TST5","Beta-2 adrenergic receptor (Beta-2 adrenoreceptor) (Beta-2 adrenoceptor)","Felis catus (Cat) (Felis silvestris catus)","activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; bone resorption [GO:0045453]; brown fat cell differentiation [GO:0050873]; cellular response to amyloid-beta [GO:1904646]; desensitization of G protein-coupled receptor signaling pathway by arrestin [GO:0002032]; diet induced thermogenesis [GO:0002024]; heat generation [GO:0031649]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of smooth muscle contraction [GO:0045986]; norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure [GO:0002025]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of autophagosome maturation [GO:1901098]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of lipophagy [GO:1904504]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mini excitatory postsynaptic potential [GO:0061885]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor-mediated endocytosis [GO:0006898]; regulation of sodium ion transport [GO:0002028]; response to cold [GO:0009409]; smooth muscle contraction [GO:0006939]; transcription by RNA polymerase II [GO:0006366]","GO:0001540; GO:0002024; GO:0002025; GO:0002028; GO:0002032; GO:0004930; GO:0004941; GO:0005634; GO:0005769; GO:0005794; GO:0005886; GO:0006366; GO:0006898; GO:0006939; GO:0007190; GO:0008179; GO:0009409; GO:0010739; GO:0015459; GO:0016324; GO:0030501; GO:0031649; GO:0040015; GO:0042803; GO:0043235; GO:0043410; GO:0044877; GO:0045453; GO:0045944; GO:0045986; GO:0050873; GO:0051380; GO:0061885; GO:0071880; GO:0071902; GO:0098992; GO:0120162; GO:1901098; GO:1904504; GO:1904646; GO:2000969"
"2137",2137,"Cluster_4080","Porites_evermani_scaffold_1759:68611-69611",160,-21,2,21,122,141,19,"78.95%","84.21%","Peve_00010643",-0.945982285842947,0.210202483202885,0.978262075707395,"Q8STF0","Calmodulin (CaM)","Strongylocentrotus intermedius (Sea urchin)","","GO:0005509"
"2138",2138,"Cluster_4080","Porites_evermani_scaffold_1760:10592-11592",168,-21.43,2,18,591,613,17,"88.24%","88.24%","Peve_00010683",NA,NA,NA,"A8TX70","Collagen alpha-5(VI) chain (Collagen alpha-1(XXIX) chain) (von Willebrand factor A domain-containing protein 4)","Homo sapiens (Human)","cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]","GO:0005576; GO:0005581; GO:0007155; GO:0030020; GO:0030198; GO:0062023"
"2139",2139,"Cluster_4080","Porites_evermani_scaffold_177:260659-261659",164,-20.22,2,21,799,820,19,"68.42%","84.21%","Peve_00010777",-0.502461275288166,0.664855881141313,0.978262075707395,NA,NA,NA,NA,NA
"2140",2140,"Cluster_4080","Porites_evermani_scaffold_1816:64596-65596",153,-22.41,2,21,7,32,24,"70.83%","70.83%","Peve_00011334",NA,NA,NA,NA,NA,NA,NA,NA
"2141",2141,"Cluster_4080","Porites_evermani_scaffold_1831:24858-25858",158,-21.5,2,21,850,874,22,"68.18%","81.82%","Peve_00011526",0.967635526270968,0.16240811192644,0.978262075707395,"P62516","POU domain, class 3, transcription factor 4 (Brain-specific homeobox/POU domain protein 4) (Brain-4) (Brn-4) (Octamer-binding protein 9) (Oct-9) (Octamer-binding transcription factor 9) (OTF-9) (RHS2 class III POU protein)","Rattus norvegicus (Rat)","cochlea morphogenesis [GO:0090103]; forebrain neuron differentiation [GO:0021879]; inner ear development [GO:0048839]; negative regulation of mesenchymal cell apoptotic process [GO:2001054]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory perception of sound [GO:0007605]; transcription by RNA polymerase II [GO:0006366]","GO:0000977; GO:0000978; GO:0000981; GO:0003680; GO:0003690; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0006366; GO:0007605; GO:0021879; GO:0043565; GO:0048839; GO:0090103; GO:1990837; GO:2001054"
"2142",2142,"Cluster_4080","Porites_evermani_scaffold_1843:16972-17972",164,-21.25,2,17,627,648,15,"73.33%","100.00%","Peve_00011622",-0.972497432141416,0.149651871190385,0.978262075707395,"Q9CY64","Biliverdin reductase A (BVR A) (EC 1.3.1.24) (Biliverdin-IX alpha-reductase)","Mus musculus (Mouse)","heme catabolic process [GO:0042167]","GO:0000166; GO:0004074; GO:0005829; GO:0008270; GO:0042167; GO:0106276; GO:0106277"
"2143",2143,"Cluster_4080","Porites_evermani_scaffold_185:171141-172141",161,-21.13,2,21,615,638,22,"77.27%","77.27%","Peve_00011705",0.998232761629708,0.037853554466726,0.909359886114279,NA,NA,NA,NA,NA
"2144",2144,"Cluster_4080","Porites_evermani_scaffold_188:171545-172545",168,-24.01,2,21,111,130,19,"84.21%","89.47%","Peve_00012019",-0.235777127616489,0.848472931070267,0.995934364227446,NA,NA,NA,NA,NA
"2145",2145,"Cluster_4080","Porites_evermani_scaffold_1924:31387-32387",165,-21.89,2,19,580,603,19,"78.95%","84.21%","Peve_00012560",NA,NA,NA,NA,NA,NA,NA,NA
"2146",2146,"Cluster_4080","Porites_evermani_scaffold_1925:84105-85105",158,-20.04,2,20,952,976,21,"71.43%","76.19%","Peve_00012563",0.118845872469587,0.924161118991889,0.999448381576871,"Q08DY8","Autophagy-related protein 13","Bos taurus (Bovine)","autophagosome assembly [GO:0000045]; mitophagy [GO:0000423]; negative regulation of cell population proliferation [GO:0008285]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of autophagy [GO:0010508]; protein autophosphorylation [GO:0046777]; protein localization to phagophore assembly site [GO:0034497]; regulation of protein lipidation [GO:1903059]; response to mitochondrial depolarisation [GO:0098780]","GO:0000045; GO:0000407; GO:0000423; GO:0005739; GO:0005829; GO:0008285; GO:0010508; GO:0019898; GO:0019901; GO:0034497; GO:0034727; GO:0046777; GO:0098780; GO:1903059; GO:1990316"
"2147",2147,"Cluster_4080","Porites_evermani_scaffold_195:282052-283052",175,-22.05,2,20,339,360,18,"83.33%","88.89%","Peve_00012828",-0.931910076285492,0.236282824249997,0.978262075707395,NA,NA,NA,NA,NA
"2148",2148,"Cluster_4080","Porites_evermani_scaffold_1959:45606-46606",162,-21.17,2,21,864,884,19,"63.16%","94.74%","Peve_00012907",0.625261286373051,0.569984802791591,0.978262075707395,NA,NA,NA,NA,NA
"2149",2149,"Cluster_4080","Porites_evermani_scaffold_1978:17170-17866",162,-20.91,2,15,566,587,13,"84.62%","100.00%","Peve_00013087",-0.999999672229045,0.000515442667547547,0.239778920002343,"Q7TN88","Polycystic kidney disease protein 1-like 2 (PC1-like 2 protein) (Polycystin-1L2)","Mus musculus (Mouse)","detection of mechanical stimulus [GO:0050982]","GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982"
"2150",2150,"Cluster_4080","Porites_evermani_scaffold_207:25674-26674",174,-23.26,2,21,891,911,19,"78.95%","94.74%","Peve_00014239",-0.372369196277201,0.757091042776524,0.988219883885475,"P97393","Rho GTPase-activating protein 5 (Rho-type GTPase-activating protein 5) (p190-B)","Mus musculus (Mouse)","cell migration [GO:0016477]; epithelial cell migration [GO:0010631]; mammary gland development [GO:0030879]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of mesenchymal cell proliferation [GO:0002053]; regulation of cell size [GO:0008361]; Rho protein signal transduction [GO:0007266]","GO:0002053; GO:0003924; GO:0005096; GO:0005525; GO:0005783; GO:0005829; GO:0005886; GO:0007266; GO:0008361; GO:0010631; GO:0010634; GO:0016477; GO:0030879; GO:0042169"
"2151",2151,"Cluster_4080","Porites_evermani_scaffold_2144:38599-39599",164,-20.37,2,19,211,234,19,"84.21%","84.21%","Peve_00015012",-0.990320400643558,0.0886491858718649,0.978262075707395,NA,NA,NA,NA,NA
"2152",2152,"Cluster_4080","Porites_evermani_scaffold_217:351171-352171",157,-21.74,2,20,884,908,21,"66.67%","85.71%","Peve_00015242",-0.698180059023921,0.507986981770028,0.978262075707395,"O70247","Sodium-dependent multivitamin transporter (Na(+)-dependent multivitamin transporter) (Solute carrier family 5 member 6)","Rattus norvegicus (Rat)","biotin import across plasma membrane [GO:1905135]; biotin transport [GO:0015878]; iodide transmembrane transport [GO:1904200]; pantothenate transmembrane transport [GO:0015887]; sodium ion transport [GO:0006814]; transport across blood-brain barrier [GO:0150104]","GO:0005886; GO:0006814; GO:0008523; GO:0012506; GO:0015225; GO:0015233; GO:0015293; GO:0015878; GO:0015887; GO:0031526; GO:0090482; GO:0150104; GO:1904200; GO:1905135"
"2153",2153,"Cluster_4080","Porites_evermani_scaffold_2173:64574-65574",170,-22.64,2,19,29,50,17,"76.47%","94.12%","Peve_00015264",-0.845056042313494,0.359133990614187,0.978262075707395,"P80109","Phosphatidylinositol-glycan-specific phospholipase D (PI-G PLD) (EC 3.1.4.50) (Glycoprotein phospholipase D) (Glycosyl-phosphatidylinositol-specific phospholipase D) (GPI-PLD) (GPI-specific phospholipase D)","Bos taurus (Bovine)","cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to calcium ion [GO:0071277]; cellular response to cholesterol [GO:0071397]; cellular response to insulin stimulus [GO:0032869]; cellular response to pH [GO:0071467]; cellular response to triglyceride [GO:0071401]; cellular response to xenobiotic stimulus [GO:0071466]; chondrocyte differentiation [GO:0002062]; complement receptor mediated signaling pathway [GO:0002430]; GPI anchor release [GO:0006507]; insulin receptor signaling pathway [GO:0008286]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of triglyceride catabolic process [GO:0010897]; ossification [GO:0001503]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of high-density lipoprotein particle clearance [GO:0010983]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of secretion [GO:0051047]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of cellular response to insulin stimulus [GO:1900076]; response to glucose [GO:0009749]; transepithelial transport [GO:0070633]","GO:0001503; GO:0002042; GO:0002062; GO:0002430; GO:0004621; GO:0005615; GO:0005737; GO:0006507; GO:0008285; GO:0008286; GO:0009749; GO:0010595; GO:0010694; GO:0010867; GO:0010897; GO:0010907; GO:0010983; GO:0017080; GO:0031012; GO:0032869; GO:0034364; GO:0035774; GO:0043065; GO:0043231; GO:0046470; GO:0051044; GO:0051047; GO:0070633; GO:0071277; GO:0071397; GO:0071401; GO:0071466; GO:0071467; GO:1900076"
"2154",2154,"Cluster_4080","Porites_evermani_scaffold_2199:53857-54857",175,-27.25,2,21,195,219,22,"81.82%","81.82%","Peve_00015495",0.55206839780058,0.627677447312548,0.978262075707395,NA,NA,NA,NA,NA
"2155",2155,"Cluster_4080","Porites_evermani_scaffold_22:324890-325890",150,-23.33,2,21,27,56,27,"62.96%","70.37%","Peve_00015565",-0.979920103825456,0.12779246816026,0.978262075707395,NA,NA,NA,NA,NA
"2156",2156,"Cluster_4080","Porites_evermani_scaffold_2255:22888-23888",174,-23.15,2,21,831,854,21,"85.71%","85.71%","Peve_00016100",-0.917960546346939,0.259669715475283,0.978262075707395,NA,NA,NA,NA,NA
"2157",2157,"Cluster_4080","Porites_evermani_scaffold_2255:23266-24266",174,-23.15,2,21,453,476,21,"85.71%","85.71%","Peve_00016101",-0.985203461314008,0.109650887457998,0.978262075707395,"Q5RBA4","Myosin regulatory light polypeptide 9 (Myosin regulatory light chain 2, smooth muscle isoform) (Myosin regulatory light chain 9)","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","","GO:0005509; GO:0005938; GO:0016459"
"2158",2158,"Cluster_4080","Porites_evermani_scaffold_2258:70837-71837",163,-20.13,2,21,128,153,23,"73.91%","73.91%","Peve_00016116",NA,NA,NA,NA,NA,NA,NA,NA
"2159",2159,"Cluster_4080","Porites_evermani_scaffold_2268:16197-17197",170,-22.08,2,21,878,902,22,"77.27%","86.36%","Peve_00016200",0.994780922629084,0.0650700370599386,0.978262075707395,NA,NA,NA,NA,NA
"2160",2160,"Cluster_4080","Porites_evermani_scaffold_2276:58139-59139",161,-21.13,2,21,615,638,22,"77.27%","77.27%","Peve_00016271",0.996532176701645,0.0530333651415926,0.967863918911507,NA,NA,NA,NA,NA
"2161",2161,"Cluster_4080","Porites_evermani_scaffold_230:116306-117306",163,-20.81,2,21,751,774,21,"71.43%","80.95%","Peve_00016555",0.844020392384722,0.360365217313678,0.978262075707395,"O57382","Tolloid-like protein 2 (EC 3.4.24.-) (Metalloprotease xolloid) (Xenopus tolloid)","Xenopus laevis (African clawed frog)","cell differentiation [GO:0030154]; proteolysis [GO:0006508]","GO:0004222; GO:0005509; GO:0005576; GO:0006508; GO:0008270; GO:0030154"
"2162",2162,"Cluster_4080","Porites_evermani_scaffold_2309:63507-64507",160,-21.85,2,21,936,958,21,"76.19%","85.71%","Peve_00016642",NA,NA,NA,NA,NA,NA,NA,NA
"2163",2163,"Cluster_4080","Porites_evermani_scaffold_2309:64060-65060",160,-21.85,2,21,383,405,21,"76.19%","85.71%","Peve_00016643",NA,NA,NA,NA,NA,NA,NA,NA
"2164",2164,"Cluster_4080","Porites_evermani_scaffold_232:66469-67469",168,-21.4,2,21,336,357,19,"73.68%","84.21%","Peve_00016726",0.277893968164318,0.820727219126672,0.995934364227446,"Q3KR37","Protein Aster-B (GRAM domain-containing protein 1B)","Homo sapiens (Human)","cellular response to cholesterol [GO:0071397]; cholesterol homeostasis [GO:0042632]; intracellular sterol transport [GO:0032366]","GO:0001786; GO:0005789; GO:0005886; GO:0015485; GO:0016020; GO:0032366; GO:0032934; GO:0042632; GO:0070300; GO:0071397; GO:0120015; GO:0120020; GO:0140268"
"2165",2165,"Cluster_4080","Porites_evermani_scaffold_2346:29310-30310",166,-21.93,2,19,623,644,17,"76.47%","88.24%","Peve_00016964",NA,NA,NA,NA,NA,NA,NA,NA
"2166",2166,"Cluster_4080","Porites_evermani_scaffold_2447:59203-60203",175,-23.77,2,21,939,962,21,"80.95%","85.71%","Peve_00017907",NA,NA,NA,NA,NA,NA,NA,NA
"2167",2167,"Cluster_4080","Porites_evermani_scaffold_2502:51303-52303",158,-21.58,2,20,933,955,19,"68.42%","84.21%","Peve_00018476",-0.552415911696862,0.62741207783634,0.978262075707395,"P0DPE1","EEF1A lysine methyltransferase 4 (EC 2.1.1.-)","Bos taurus (Bovine)","","GO:0008168; GO:0016279"
"2168",2168,"Cluster_4080","Porites_evermani_scaffold_2544:8111-9111",166,-20.96,2,20,264,286,19,"73.68%","89.47%","Peve_00018805",0.380267819658502,0.751663633252708,0.988219883885475,"Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"2169",2169,"Cluster_4080","Porites_evermani_scaffold_2588:49505-50226",155,-20.29,2,16,439,460,14,"71.43%","92.86%","Peve_00019122",-0.235777127616489,0.848472931070267,0.995934364227446,NA,NA,NA,NA,NA
"2170",2170,"Cluster_4080","Porites_evermani_scaffold_2588:49505-50226",155,-20.29,2,16,439,460,14,"71.43%","92.86%","Peve_00019123",-0.260743716097077,0.832064486743851,0.995934364227446,NA,NA,NA,NA,NA
"2171",2171,"Cluster_4080","Porites_evermani_scaffold_261:168158-169158",162,-20.79,2,21,749,769,19,"73.68%","84.21%","Peve_00019353",-0.945436064903263,0.211272394158867,0.978262075707395,"D4A3U0","G-protein coupled receptor 22","Rattus norvegicus (Rat)","cell projection organization [GO:0030030]; G protein-coupled receptor signaling pathway [GO:0007186]","GO:0004930; GO:0005886; GO:0007186; GO:0030030; GO:0042277"
"2172",2172,"Cluster_4080","Porites_evermani_scaffold_266:185749-186749",172,-22.74,2,17,842,863,15,"86.67%","100.00%","Peve_00019740",0.959498247432244,0.1818062644036,0.978262075707395,NA,NA,NA,NA,NA
"2173",2173,"Cluster_4080","Porites_evermani_scaffold_2700:8242-9242",162,-20.17,2,15,627,648,13,"84.62%","100.00%","Peve_00020119",NA,NA,NA,"P23415","Glycine receptor subunit alpha-1 (Glycine receptor 48 kDa subunit) (Glycine receptor strychnine-binding subunit)","Homo sapiens (Human)","acrosome reaction [GO:0007340]; adult walking behavior [GO:0007628]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; inhibitory postsynaptic potential [GO:0060080]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; muscle contraction [GO:0006936]; negative regulation of transmission of nerve impulse [GO:0051970]; nervous system process [GO:0050877]; neuromuscular process controlling posture [GO:0050884]; neuronal action potential [GO:0019228]; neuropeptide signaling pathway [GO:0007218]; positive regulation of acrosome reaction [GO:2000344]; regulation of membrane potential [GO:0042391]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; response to alcohol [GO:0097305]; response to amino acid [GO:0043200]; righting reflex [GO:0060013]; signal transduction [GO:0007165]; startle response [GO:0001964]; synaptic transmission, glycinergic [GO:0060012]; visual perception [GO:0007601]","GO:0001964; GO:0002087; GO:0004888; GO:0005231; GO:0005886; GO:0006811; GO:0006821; GO:0006936; GO:0007165; GO:0007218; GO:0007268; GO:0007340; GO:0007601; GO:0007628; GO:0008270; GO:0009897; GO:0016020; GO:0016594; GO:0016934; GO:0019228; GO:0030425; GO:0030594; GO:0030977; GO:0034220; GO:0034707; GO:0042391; GO:0042802; GO:0043005; GO:0043025; GO:0043200; GO:0043204; GO:0043231; GO:0045202; GO:0045211; GO:0050877; GO:0050884; GO:0051970; GO:0060012; GO:0060013; GO:0060077; GO:0060080; GO:0071230; GO:0071294; GO:0071361; GO:0097305; GO:0098690; GO:0099507; GO:1902476; GO:1904315; GO:2000344"
"2174",2174,"Cluster_4080","Porites_evermani_scaffold_271:102928-103928",165,-20.13,2,20,128,148,18,"83.33%","83.33%","Peve_00020178",-0.0572871274211,0.963509904434458,0.999448381576871,"Q8C5H1","Anoctamin-4 (Transmembrane protein 16D)","Mus musculus (Mouse)","calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; establishment of localization in cell [GO:0051649]; transmembrane transport [GO:0055085]","GO:0005254; GO:0005886; GO:0006821; GO:0017128; GO:0046983; GO:0051649; GO:0055085; GO:0061589; GO:0061590; GO:0061591; GO:1902476"
"2175",2175,"Cluster_4080","Porites_evermani_scaffold_2777:806-1806",162,-20.58,2,20,658,680,19,"73.68%","84.21%","Peve_00020690",-0.66339452592756,0.538230273641261,0.978262075707395,"Q6RUV5","Ras-related C3 botulinum toxin substrate 1 (EC 3.6.5.2) (p21-Rac1)","Rattus norvegicus (Rat)","actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; angiotensin-activated signaling pathway involved in heart process [GO:0086098]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell motility [GO:0048870]; cell population proliferation [GO:0008283]; cell projection assembly [GO:0030031]; cell-cell junction organization [GO:0045216]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; cortical cytoskeleton organization [GO:0030865]; cytoskeleton organization [GO:0007010]; dendrite development [GO:0016358]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; endocytosis [GO:0006897]; engulfment of apoptotic cell [GO:0043652]; epithelial cell morphogenesis [GO:0003382]; establishment or maintenance of cell polarity [GO:0007163]; forebrain development [GO:0030900]; G protein-coupled receptor signaling pathway [GO:0007186]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; interneuron migration [GO:1904936]; lamellipodium assembly [GO:0030032]; localization [GO:0051179]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; midbrain dopaminergic neuron differentiation [GO:1904948]; motor neuron axon guidance [GO:0008045]; negative regulation of fibroblast migration [GO:0010764]; negative regulation of interleukin-23 production [GO:0032707]; neuron migration [GO:0001764]; neuron projection morphogenesis [GO:0048812]; non-canonical Wnt signaling pathway [GO:0035567]; phagocytosis, engulfment [GO:0006911]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of DNA replication [GO:0045740]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of ovarian follicle development [GO:2000386]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; postsynaptic actin cytoskeleton organization [GO:0098974]; protein localization to plasma membrane [GO:0072659]; Rac protein signal transduction [GO:0016601]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell morphogenesis [GO:0022604]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of ERK5 cascade [GO:0070376]; regulation of fibroblast migration [GO:0010762]; regulation of lamellipodium assembly [GO:0010591]; regulation of neuron maturation [GO:0014041]; regulation of neuron migration [GO:2001222]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neutrophil migration [GO:1902622]; regulation of nitric oxide biosynthetic process [GO:0045428]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of respiratory burst [GO:0060263]; regulation of stress fiber assembly [GO:0051492]; ruffle assembly [GO:0097178]; ruffle organization [GO:0031529]; semaphorin-plexin signaling pathway [GO:0071526]; small GTPase mediated signal transduction [GO:0007264]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0000139; GO:0000242; GO:0001764; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003376; GO:0003382; GO:0003924; GO:0003925; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0006897; GO:0006911; GO:0006935; GO:0006972; GO:0007010; GO:0007015; GO:0007155; GO:0007163; GO:0007186; GO:0007264; GO:0007411; GO:0008045; GO:0008283; GO:0008360; GO:0008361; GO:0010591; GO:0010592; GO:0010595; GO:0010762; GO:0010764; GO:0010811; GO:0014041; GO:0016020; GO:0016358; GO:0016477; GO:0016601; GO:0019897; GO:0019899; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0022604; GO:0030027; GO:0030031; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030742; GO:0030838; GO:0030865; GO:0030900; GO:0031116; GO:0031234; GO:0031267; GO:0031410; GO:0031529; GO:0031901; GO:0031996; GO:0032587; GO:0032707; GO:0032956; GO:0034446; GO:0035567; GO:0035774; GO:0036464; GO:0042470; GO:0042826; GO:0042995; GO:0043197; GO:0043552; GO:0043652; GO:0044877; GO:0045216; GO:0045428; GO:0045453; GO:0045740; GO:0046425; GO:0048012; GO:0048168; GO:0048532; GO:0048812; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051117; GO:0051179; GO:0051491; GO:0051492; GO:0051496; GO:0051668; GO:0051894; GO:0051932; GO:0055038; GO:0060071; GO:0060090; GO:0060091; GO:0060263; GO:0060999; GO:0061344; GO:0070376; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0086098; GO:0090023; GO:0090103; GO:0097178; GO:0098794; GO:0098974; GO:0098978; GO:0098982; GO:1900026; GO:1902622; GO:1904936; GO:1904948; GO:2000386; GO:2001222"
"2176",2176,"Cluster_4080","Porites_evermani_scaffold_2828:25696-26696",160,-21.85,2,21,574,596,21,"76.19%","85.71%","Peve_00021114",0.903962587927359,0.281289760802021,0.978262075707395,"Q09328","Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (EC 2.4.1.155) (Alpha-mannoside beta-1,6-N-acetylglucosaminyltransferase V) (GlcNAc-T V) (GNT-V) (Mannoside acetylglucosaminyltransferase 5) (N-acetylglucosaminyl-transferase V) [Cleaved into: Secreted alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (Secreted beta-1,6-N-acetylglucosaminyltransferase V) (Secreted GNT-V)]","Homo sapiens (Human)","negative regulation of protein tyrosine phosphatase activity [GO:1903614]; positive regulation of cell migration [GO:0030335]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; viral protein processing [GO:0019082]","GO:0000139; GO:0004864; GO:0005794; GO:0006487; GO:0016020; GO:0018279; GO:0019082; GO:0030144; GO:0030145; GO:0030335; GO:0070062; GO:1903614; GO:1904894"
"2177",2177,"Cluster_4080","Porites_evermani_scaffold_2924:32431-33431",162,-20.77,2,20,679,703,21,"71.43%","80.95%","Peve_00021890",-0.365633156482123,0.761704961943791,0.988693897927668,NA,NA,NA,NA,NA
"2178",2178,"Cluster_4080","Porites_evermani_scaffold_2981:21624-22624",160,-21.85,2,21,674,696,21,"76.19%","85.71%","Peve_00022298",0.931350438416364,0.237263203552309,0.978262075707395,NA,NA,NA,NA,NA
"2179",2179,"Cluster_4080","Porites_evermani_scaffold_304:167030-168030",162,-20.98,2,15,758,779,13,"92.31%","92.31%","Peve_00022917",-0.799961288021964,0.409706602316098,0.978262075707395,"Q9JJZ8","Cyclic nucleotide-gated cation channel alpha-3 (Cone photoreceptor cGMP-gated channel subunit alpha) (Cyclic nucleotide-gated channel alpha-3) (CNG channel alpha-3) (CNG-3) (CNG3)","Mus musculus (Mouse)","cation transmembrane transport [GO:0098655]; cation transport [GO:0006812]; inorganic cation import across plasma membrane [GO:0098659]; ion transmembrane transport [GO:0034220]; response to cAMP [GO:0051591]; response to magnesium ion [GO:0032026]; retinal cone cell development [GO:0046549]; visual perception [GO:0007601]","GO:0001750; GO:0005221; GO:0005222; GO:0005223; GO:0005737; GO:0005886; GO:0006812; GO:0007601; GO:0008022; GO:0017071; GO:0030425; GO:0030553; GO:0032026; GO:0034220; GO:0043025; GO:0043194; GO:0043204; GO:0044877; GO:0046549; GO:0051591; GO:0097386; GO:0098655; GO:0098659; GO:0120199; GO:1902495"
"2180",2180,"Cluster_4080","Porites_evermani_scaffold_3112:26772-27772",154,-20.4,2,21,821,844,21,"66.67%","80.95%","Peve_00023490",0.759600905544464,0.450788586382634,0.978262075707395,NA,NA,NA,NA,NA
"2181",2181,"Cluster_4080","Porites_evermani_scaffold_3114:40244-41244",162,-20.75,2,21,323,346,21,"71.43%","85.71%","Peve_00023503",0.95308896567672,0.195769569227048,0.978262075707395,NA,NA,NA,NA,NA
"2182",2182,"Cluster_4080","Porites_evermani_scaffold_3134:30421-31421",161,-20.27,2,21,222,243,20,"70.00%","90.00%","Peve_00023614",0.766411237955464,0.444081045543138,0.978262075707395,NA,NA,NA,NA,NA
"2183",2183,"Cluster_4080","Porites_evermani_scaffold_31:627238-628238",169,-20.97,2,21,320,341,20,"85.00%","85.00%","Peve_00023342",NA,NA,NA,NA,NA,NA,NA,NA
"2184",2184,"Cluster_4080","Porites_evermani_scaffold_33:119650-120650",154,-21.21,2,21,514,537,21,"66.67%","80.95%","Peve_00024627",-0.912664418605211,0.268042322156862,0.978262075707395,"P04813","Chymotrypsinogen 2 (EC 3.4.21.1) [Cleaved into: Chymotrypsin 2 chain A; Chymotrypsin 2 chain B; Chymotrypsin 2 chain C]","Canis lupus familiaris (Dog) (Canis familiaris)","digestion [GO:0007586]; proteolysis [GO:0006508]","GO:0004252; GO:0005615; GO:0006508; GO:0007586"
"2185",2185,"Cluster_4080","Porites_evermani_scaffold_331:255762-256739",161,-21.65,2,21,199,221,21,"76.19%","80.95%","Peve_00024731",-0.163757181112048,0.895277286604309,0.999448381576871,"Q8R1R3","StAR-related lipid transfer protein 7, mitochondrial (START domain-containing protein 7) (StARD7)","Mus musculus (Mouse)","establishment of skin barrier [GO:0061436]; inflammatory response [GO:0006954]; mucociliary clearance [GO:0120197]; myeloid dendritic cell activation [GO:0001773]; type 2 immune response [GO:0042092]","GO:0001773; GO:0005576; GO:0005737; GO:0005739; GO:0006954; GO:0008289; GO:0042092; GO:0061436; GO:0120197"
"2186",2186,"Cluster_4080","Porites_evermani_scaffold_331:255762-256739",161,-21.65,2,21,199,221,21,"76.19%","80.95%","Peve_00024732",-0.35572220238116,0.768469855756272,0.990527675986719,NA,NA,NA,NA,NA
"2187",2187,"Cluster_4080","Porites_evermani_scaffold_3334:32167-33167",164,-20.79,2,19,316,336,17,"82.35%","88.24%","Peve_00024875",-0.754692659177609,0.455571974980701,0.978262075707395,NA,NA,NA,NA,NA
"2188",2188,"Cluster_4080","Porites_evermani_scaffold_3626:37870-38870",164,-22.22,2,19,403,423,17,"82.35%","88.24%","Peve_00026705",NA,NA,NA,"P28824","Neuropilin-1 (A5 antigen) (A5 protein)","Xenopus laevis (African clawed frog)","angiogenesis [GO:0001525]; axon guidance [GO:0007411]; regulation of plasma membrane bounded cell projection organization [GO:0120035]","GO:0001525; GO:0005021; GO:0005886; GO:0007411; GO:0008201; GO:0017154; GO:0031966; GO:0046872; GO:0120035"
"2189",2189,"Cluster_4080","Porites_evermani_scaffold_3650:13586-14586",175,-22.05,2,20,906,927,18,"83.33%","88.89%","Peve_00026837",-0.133789061088581,0.914571077831633,0.999448381576871,"Q96CG8","Collagen triple helix repeat-containing protein 1","Homo sapiens (Human)","cell migration [GO:0016477]; cochlea morphogenesis [GO:0090103]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein binding [GO:0032092]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0001649; GO:0005109; GO:0005576; GO:0005581; GO:0005615; GO:0016477; GO:0016528; GO:0017147; GO:0032092; GO:0033687; GO:0033690; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0062023; GO:0090090; GO:0090103; GO:0090177"
"2190",2190,"Cluster_4080","Porites_evermani_scaffold_365:33186-34186",159,-20.78,2,21,505,529,22,"68.18%","77.27%","Peve_00026826",NA,NA,NA,NA,NA,NA,NA,NA
"2191",2191,"Cluster_4080","Porites_evermani_scaffold_3658:13321-14321",169,-20.46,2,21,169,188,19,"78.95%","89.47%","Peve_00026860",-0.591909416845537,0.596748626550192,0.978262075707395,"P49748","Very long-chain specific acyl-CoA dehydrogenase, mitochondrial (VLCAD) (EC 1.3.8.9)","Homo sapiens (Human)","energy derivation by oxidation of organic compounds [GO:0015980]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of fatty acid oxidation [GO:0046322]; regulation of cholesterol metabolic process [GO:0090181]; response to cold [GO:0009409]; temperature homeostasis [GO:0001659]","GO:0000062; GO:0001659; GO:0003995; GO:0004466; GO:0005654; GO:0005730; GO:0005739; GO:0005759; GO:0009409; GO:0015980; GO:0017099; GO:0030855; GO:0031314; GO:0031966; GO:0033539; GO:0042645; GO:0042802; GO:0045717; GO:0046322; GO:0050660; GO:0090181"
"2192",2192,"Cluster_4080","Porites_evermani_scaffold_367:193138-194138",163,-20.13,2,21,937,962,23,"73.91%","73.91%","Peve_00026922",NA,NA,NA,NA,NA,NA,NA,NA
"2193",2193,"Cluster_4080","Porites_evermani_scaffold_3792:10080-11080",166,-20.27,2,20,472,495,20,"75.00%","85.00%","Peve_00027548",0.0950241088050289,0.939414361971399,0.999448381576871,"G8HTB6","ZP domain-containing protein","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0016020"
"2194",2194,"Cluster_4080","Porites_evermani_scaffold_38:541097-542097",163,-21.82,2,21,652,675,21,"71.43%","80.95%","Peve_00027589",-0.714848515510958,0.492991268503627,0.978262075707395,NA,NA,NA,NA,NA
"2195",2195,"Cluster_4080","Porites_evermani_scaffold_3890:9144-10144",177,-29.95,2,21,570,591,20,"90.00%","90.00%","Peve_00028098",-0.802995408290489,0.40647664021158,0.978262075707395,"B8VIU6","Uncharacterized skeletal organic matrix protein 5 (Uncharacterized SOMP-5)","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0005576"
"2196",2196,"Cluster_4080","Porites_evermani_scaffold_3950:28075-29075",151,-20.06,2,21,345,368,21,"66.67%","71.43%","Peve_00028477",-0.235777127616489,0.848472931070267,0.995934364227446,NA,NA,NA,NA,NA
"2197",2197,"Cluster_4080","Porites_evermani_scaffold_400:60347-61347",152,-21.74,2,21,555,575,20,"70.00%","80.00%","Peve_00028851",-0.629803231519796,0.566271035485669,0.978262075707395,"Q5RC90","Neuronal calcium sensor 1 (NCS-1) (Frequenin homolog)","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","regulation of neuron projection development [GO:0010975]","GO:0005245; GO:0005509; GO:0005794; GO:0005886; GO:0010975; GO:0014069; GO:0048471"
"2198",2198,"Cluster_4080","Porites_evermani_scaffold_4025:19902-20902",161,-20.34,2,20,450,473,20,"75.00%","85.00%","Peve_00028964",-0.148015686603718,0.905422775993681,0.999448381576871,"Q7TNH6","Nephrocystin-3","Mus musculus (Mouse)","atrial septum development [GO:0003283]; cilium assembly [GO:0060271]; convergent extension [GO:0060026]; convergent extension involved in gastrulation [GO:0060027]; determination of intestine left/right asymmetry [GO:0071908]; determination of left/right symmetry [GO:0007368]; determination of liver left/right asymmetry [GO:0071910]; determination of pancreatic left/right asymmetry [GO:0035469]; determination of stomach left/right asymmetry [GO:0071909]; establishment or maintenance of cell polarity [GO:0007163]; extracellular matrix organization [GO:0030198]; heart looping [GO:0001947]; kidney development [GO:0001822]; kidney morphogenesis [GO:0060993]; lipid metabolic process [GO:0006629]; lung development [GO:0030324]; maintenance of animal organ identity [GO:0048496]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; positive regulation of protein binding [GO:0032092]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; ureter development [GO:0072189]; Wnt signaling pathway [GO:0016055]","GO:0001822; GO:0001947; GO:0003283; GO:0005929; GO:0006629; GO:0007163; GO:0007368; GO:0016055; GO:0030198; GO:0030324; GO:0032092; GO:0035469; GO:0045494; GO:0048496; GO:0060026; GO:0060027; GO:0060271; GO:0060993; GO:0071908; GO:0071909; GO:0071910; GO:0072189; GO:0090090; GO:0097543; GO:0097546; GO:1905515; GO:2000095"
"2199",2199,"Cluster_4080","Porites_evermani_scaffold_4084:14963-15963",163,-20.87,2,21,143,165,20,"70.00%","85.00%","Peve_00029275",-0.523507558035404,0.649246366346324,0.978262075707395,"Q80XJ3","Tetratricopeptide repeat protein 28 (TPR repeat protein 28)","Mus musculus (Mouse)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0005737; GO:0005813; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301; GO:0072686; GO:0097431; GO:1990023"
"2200",2200,"Cluster_4080","Porites_evermani_scaffold_41:364218-365218",167,-21.61,2,21,858,881,21,"76.19%","80.95%","Peve_00029381",NA,NA,NA,"P42674","Blastula protease 10 (EC 3.4.24.-)","Paracentrotus lividus (Common sea urchin)","proteolysis [GO:0006508]","GO:0004222; GO:0005615; GO:0005938; GO:0006508; GO:0008270; GO:0048471"
"2201",2201,"Cluster_4080","Porites_evermani_scaffold_41:39752-40752",160,-21.85,2,21,482,504,21,"76.19%","85.71%","Peve_00029386",-0.563557745506534,0.618864462102467,0.978262075707395,"Q3ZBK2","Peroxiredoxin-like 2A (Peroxiredoxin-like 2 activated in M-CSF stimulated monocytes) (Protein PAMM) (Redox-regulatory protein FAM213A)","Bos taurus (Bovine)","regulation of osteoclast differentiation [GO:0045670]","GO:0005576; GO:0005737; GO:0016209; GO:0045670"
"2202",2202,"Cluster_4080","Porites_evermani_scaffold_4167:2816-3816",155,-20.64,2,21,709,733,22,"63.64%","77.27%","Peve_00029680",-0.235777127616489,0.848472931070267,0.995934364227446,"Q7TN88","Polycystic kidney disease protein 1-like 2 (PC1-like 2 protein) (Polycystin-1L2)","Mus musculus (Mouse)","detection of mechanical stimulus [GO:0050982]","GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982"
"2203",2203,"Cluster_4080","Porites_evermani_scaffold_421:87348-88348",169,-20.47,2,18,172,193,16,"81.25%","93.75%","Peve_00029914",-0.942392335094056,0.217141344853051,0.978262075707395,"P49219","Melatonin receptor type 1C (Mel-1C-R) (Mel1c (alpha) receptor) (Mel1c receptor)","Xenopus laevis (African clawed frog)","","GO:0005886; GO:0008502"
"2204",2204,"Cluster_4080","Porites_evermani_scaffold_421:93519-94519",169,-20.47,2,18,204,225,16,"81.25%","93.75%","Peve_00029915",0.276581100811969,0.821597115223368,0.995934364227446,"P49219","Melatonin receptor type 1C (Mel-1C-R) (Mel1c (alpha) receptor) (Mel1c receptor)","Xenopus laevis (African clawed frog)","","GO:0005886; GO:0008502"
"2205",2205,"Cluster_4080","Porites_evermani_scaffold_427:192722-193722",154,-20.58,2,21,698,722,22,"68.18%","77.27%","Peve_00030236",-0.723721119815755,0.484860402263066,0.978262075707395,"Q9NVH2","Integrator complex subunit 7 (Int7)","Homo sapiens (Human)","cellular response to ionizing radiation [GO:0071479]; DNA damage checkpoint signaling [GO:0000077]; regulation of transcription elongation by RNA polymerase II [GO:0034243]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]","GO:0000077; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0016180; GO:0016604; GO:0032039; GO:0034243; GO:0034472; GO:0071479"
"2206",2206,"Cluster_4080","Porites_evermani_scaffold_4284:11833-12833",163,-22.55,2,21,591,616,23,"69.57%","78.26%","Peve_00030310",-0.18152017155103,0.88379646634198,0.999448381576871,NA,NA,NA,NA,NA
"2207",2207,"Cluster_4080","Porites_evermani_scaffold_4312:16691-17691",157,-20.08,2,20,343,369,23,"69.57%","78.26%","Peve_00030511",NA,NA,NA,NA,NA,NA,NA,NA
"2208",2208,"Cluster_4080","Porites_evermani_scaffold_4312:16691-17691",157,-21.59,2,20,922,948,23,"69.57%","78.26%","Peve_00030511",NA,NA,NA,NA,NA,NA,NA,NA
"2209",2209,"Cluster_4080","Porites_evermani_scaffold_435:266898-267898",165,-21.11,2,20,244,267,20,"75.00%","90.00%","Peve_00030669",0.959498247432244,0.1818062644036,0.978262075707395,NA,NA,NA,NA,NA
"2210",2210,"Cluster_4080","Porites_evermani_scaffold_4370:25961-26961",166,-23.66,2,21,871,897,24,"75.00%","79.17%","Peve_00030755",-0.979980548176843,0.127599335749281,0.978262075707395,"P48441","Alpha-L-iduronidase (EC 3.2.1.76)","Mus musculus (Mouse)","adult locomotory behavior [GO:0008344]; adult walking behavior [GO:0007628]; bone development [GO:0060348]; carbohydrate metabolic process [GO:0005975]; cartilage homeostasis [GO:1990079]; cell morphogenesis [GO:0000902]; chemical homeostasis [GO:0048878]; dermatan sulfate catabolic process [GO:0030209]; extracellular matrix organization [GO:0030198]; glycosaminoglycan catabolic process [GO:0006027]; heparan sulfate proteoglycan catabolic process [GO:0030200]; heparin catabolic process [GO:0030211]; limb morphogenesis [GO:0035108]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; memory [GO:0007613]; negative regulation of cartilage development [GO:0061037]; negative regulation of secretion of lysosomal enzymes [GO:0090341]; positive regulation of bone resorption [GO:0045780]; positive regulation of collagen catabolic process [GO:0120158]; skeletal system morphogenesis [GO:0048705]; visual learning [GO:0008542]","GO:0000902; GO:0003940; GO:0004553; GO:0005102; GO:0005615; GO:0005764; GO:0005975; GO:0006027; GO:0007040; GO:0007613; GO:0007626; GO:0007628; GO:0008344; GO:0008542; GO:0030135; GO:0030198; GO:0030200; GO:0030209; GO:0030211; GO:0035108; GO:0043202; GO:0045780; GO:0048705; GO:0048878; GO:0060348; GO:0061037; GO:0090341; GO:0120158; GO:1990079"
"2211",2211,"Cluster_4080","Porites_evermani_scaffold_4390:15614-16614",165,-21.54,2,21,486,510,22,"77.27%","86.36%","Peve_00030844",-0.338251522606777,0.780329076294973,0.993593610010774,NA,NA,NA,NA,NA
"2212",2212,"Cluster_4080","Porites_evermani_scaffold_4426:6206-7206",172,-21.09,2,21,893,912,19,"89.47%","89.47%","Peve_00031101",NA,NA,NA,NA,NA,NA,NA,NA
"2213",2213,"Cluster_4080","Porites_evermani_scaffold_45:400343-401343",169,-20.66,2,20,372,392,18,"83.33%","88.89%","Peve_00031469",NA,NA,NA,NA,NA,NA,NA,NA
"2214",2214,"Cluster_4080","Porites_evermani_scaffold_4578:200-1200",170,-22.2,2,20,965,987,19,"84.21%","84.21%","Peve_00031776",NA,NA,NA,NA,NA,NA,NA,NA
"2215",2215,"Cluster_4080","Porites_evermani_scaffold_4617:577-1577",175,-22.05,2,20,122,143,18,"83.33%","88.89%","Peve_00031984",NA,NA,NA,NA,NA,NA,NA,NA
"2216",2216,"Cluster_4080","Porites_evermani_scaffold_512:211476-212476",163,-22.7,2,21,786,809,21,"71.43%","80.95%","Peve_00034136",-0.74000514808784,0.469646065440826,0.978262075707395,"A1L157","Tetraspanin-11 (Tspan-11)","Homo sapiens (Human)","cell migration [GO:0016477]","GO:0005886; GO:0016477"
"2217",2217,"Cluster_4080","Porites_evermani_scaffold_51:677151-678151",153,-20.9,2,21,328,354,24,"70.83%","75.00%","Peve_00034017",-0.249983602172121,0.839149535006338,0.995934364227446,NA,NA,NA,NA,NA
"2218",2218,"Cluster_4080","Porites_evermani_scaffold_5354:8727-9727",166,-21.05,2,20,966,988,19,"73.68%","89.47%","Peve_00034935",0.234679755005013,0.849191709045844,0.995934364227446,"Q6GMH0","Pre-mRNA-splicing factor 18 (PRP18 homolog)","Danio rerio (Zebrafish) (Brachydanio rerio)","generation of catalytic spliceosome for second transesterification step [GO:0000350]","GO:0000350; GO:0005682; GO:0016607; GO:0046540; GO:0071021"
"2219",2219,"Cluster_4080","Porites_evermani_scaffold_55:11840-12840",172,-20.65,2,21,251,272,19,"78.95%","84.21%","Peve_00035455",0.600384961442097,0.590028072708168,0.978262075707395,"Q9GRC0","Serine/threonine-protein kinase mos (EC 2.7.11.1) (Oocyte maturation factor mos)","Patiria pectinifera (Starfish) (Asterina pectinifera)","female gamete generation [GO:0007292]; female meiosis II [GO:0007147]; negative regulation of mitotic cell cycle [GO:0045930]; protein phosphorylation [GO:0006468]","GO:0004709; GO:0005524; GO:0006468; GO:0007147; GO:0007292; GO:0045930; GO:0106310"
"2220",2220,"Cluster_4080","Porites_evermani_scaffold_554:138491-139491",166,-21.61,2,21,555,575,19,"78.95%","84.21%","Peve_00035614",-0.762912880112445,0.44753701894064,0.978262075707395,"Q6DCX5","Proton-coupled folate transporter (Heme carrier protein 1) (Solute carrier family 46 member 1)","Xenopus laevis (African clawed frog)","","GO:0005542; GO:0005768; GO:0010008; GO:0015293; GO:0015350; GO:0016323; GO:0016324"
"2221",2221,"Cluster_4080","Porites_evermani_scaffold_563:175532-176532",161,-20.29,2,21,329,350,20,"75.00%","85.00%","Peve_00035886",-0.999981340367671,0.00388908412218857,0.54328949385489,"Q6DE14","Transcription factor E2F4 (E2F-4)","Xenopus laevis (African clawed frog)","centriole assembly [GO:0098534]; motile cilium assembly [GO:0044458]; multi-ciliated epithelial cell differentiation [GO:1903251]; positive regulation of transcription by RNA polymerase II [GO:0045944]","GO:0000978; GO:0003700; GO:0005634; GO:0005667; GO:0044458; GO:0045944; GO:0046983; GO:0098534; GO:1903251"
"2222",2222,"Cluster_4080","Porites_evermani_scaffold_567:55993-56993",156,-22.96,2,20,389,410,19,"68.42%","89.47%","Peve_00035987",NA,NA,NA,NA,NA,NA,NA,NA
"2223",2223,"Cluster_4080","Porites_evermani_scaffold_5717:10003-10315",151,-21.69,2,21,126,149,21,"61.90%","76.19%","Peve_00036169",-0.817780975116836,0.390408068723167,0.978262075707395,"Q502L2","Serine/threonine-protein phosphatase PGAM5, mitochondrial (EC 3.1.3.16) (Phosphoglycerate mutase family member 5)","Danio rerio (Zebrafish) (Brachydanio rerio)","peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of mitochondrial fission [GO:0090141]; programmed cell death [GO:0012501]","GO:0004722; GO:0005739; GO:0005741; GO:0012501; GO:0017018; GO:0035970; GO:0090141"
"2224",2224,"Cluster_4080","Porites_evermani_scaffold_57:72235-73235",171,-20.94,2,16,893,914,14,"92.86%","100.00%","Peve_00036098",NA,NA,NA,NA,NA,NA,NA,NA
"2225",2225,"Cluster_4080","Porites_evermani_scaffold_58:635983-636983",160,-21.44,2,19,450,473,19,"78.95%","84.21%","Peve_00036368",-0.258744498456419,0.8333824648266,0.995934364227446,"Q20191","Zinc metalloproteinase nas-13 (EC 3.4.24.-) (Nematode astacin 13)","Caenorhabditis elegans","proteolysis [GO:0006508]","GO:0004222; GO:0005576; GO:0006508; GO:0008270"
"2226",2226,"Cluster_4080","Porites_evermani_scaffold_6020:7607-8268",170,-25.67,2,19,477,498,17,"76.47%","94.12%","Peve_00037150",0.478268843784097,0.682528906785081,0.978262075707395,"Q6ZPV2","Chromatin-remodeling ATPase INO80 (EC 3.6.4.-) (DNA helicase-related INO80 complex homolog 1) (DNA helicase-related protein INO80)","Mus musculus (Mouse)","cell division [GO:0051301]; cellular response to ionizing radiation [GO:0071479]; cellular response to UV [GO:0034644]; chromatin remodeling [GO:0006338]; DNA repair [GO:0006281]; DNA-templated transcription [GO:0006351]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; mitotic sister chromatid segregation [GO:0000070]; positive regulation of cell growth [GO:0030307]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA repair [GO:0006282]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]; spindle assembly [GO:0051225]; telomere maintenance [GO:0000723]; UV-damage excision repair [GO:0070914]","GO:0000070; GO:0000723; GO:0000724; GO:0003677; GO:0003779; GO:0005524; GO:0005634; GO:0005654; GO:0005819; GO:0005829; GO:0005874; GO:0006275; GO:0006281; GO:0006282; GO:0006302; GO:0006338; GO:0006351; GO:0008094; GO:0010571; GO:0016604; GO:0016887; GO:0030307; GO:0031011; GO:0033044; GO:0034644; GO:0042393; GO:0043014; GO:0043618; GO:0045739; GO:0045893; GO:0045944; GO:0045995; GO:0051225; GO:0051301; GO:0051726; GO:0060382; GO:0070914; GO:0071479; GO:0140658; GO:1904507; GO:2000045"
"2227",2227,"Cluster_4080","Porites_evermani_scaffold_6023:6830-7830",173,-23.81,2,18,160,181,16,"81.25%","100.00%","Peve_00037152",0.989699758886054,0.091451808956009,0.978262075707395,NA,NA,NA,NA,NA
"2228",2228,"Cluster_4080","Porites_evermani_scaffold_623:104387-105387",172,-21.91,2,19,957,977,17,"88.24%","94.12%","Peve_00037697",-0.999168966643069,0.0259558006313078,0.879507868160642,"O62742","Sterol carrier protein 2 (SCP-2) (Acetyl-CoA C-myristoyltransferase) (EC 2.3.1.155) (Non-specific lipid-transfer protein) (NSL-TP) (Propanoyl-CoA C-acyltransferase) (EC 2.3.1.176) (SCP-2/3-oxoacyl-CoA thiolase) (SCP-2/thiolase) (EC 2.3.1.16) (SCP-chi) (SCPX) (Sterol carrier protein X) (SCP-X)","Oryctolagus cuniculus (Rabbit)","bile acid metabolic process [GO:0008206]; fatty acid beta-oxidation [GO:0006635]; intracellular cholesterol transport [GO:0032367]; lipid transport [GO:0006869]; regulation of phospholipid biosynthetic process [GO:0071071]","GO:0003988; GO:0005737; GO:0005739; GO:0005777; GO:0005782; GO:0005783; GO:0006635; GO:0006869; GO:0008206; GO:0008289; GO:0032367; GO:0033814; GO:0050632; GO:0050633; GO:0071071; GO:0120019; GO:0120020"
"2229",2229,"Cluster_4080","Porites_evermani_scaffold_623:104777-105777",172,-21.91,2,19,567,587,17,"88.24%","94.12%","Peve_00037698",NA,NA,NA,NA,NA,NA,NA,NA
"2230",2230,"Cluster_4080","Porites_evermani_scaffold_66:390964-391964",160,-21.8,2,20,948,967,18,"72.22%","88.89%","Peve_00038605",-0.454513200013351,0.699626477374976,0.978262075707395,"P08043","Zinc finger protein ZFP2 (Zfp-2) (Protein mKR2)","Mus musculus (Mouse)","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872"
"2231",2231,"Cluster_4080","Porites_evermani_scaffold_6:665825-666825",167,-21.47,2,20,777,798,18,"77.78%","83.33%","Peve_00036963",0.999351594621176,0.0229267182870592,0.843538272975541,"Q8WU76","Sec1 family domain-containing protein 2 (Syntaxin-binding protein 1-like 1)","Homo sapiens (Human)","intracellular protein transport [GO:0006886]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]","GO:0005886; GO:0006886; GO:0006904; GO:0016192; GO:0019905; GO:0030141"
"2232",2232,"Cluster_4080","Porites_evermani_scaffold_673:165373-166373",162,-21.65,2,20,340,364,21,"71.43%","80.95%","Peve_00038907",NA,NA,NA,NA,NA,NA,NA,NA
"2233",2233,"Cluster_4080","Porites_evermani_scaffold_680:198829-199829",166,-21.05,2,20,809,831,19,"73.68%","89.47%","Peve_00039088",NA,NA,NA,NA,NA,NA,NA,NA
"2234",2234,"Cluster_4080","Porites_evermani_scaffold_699:47205-48205",167,-23.27,2,20,305,324,18,"88.89%","88.89%","Peve_00039500",-0.950616541917703,0.200904433979147,0.978262075707395,NA,NA,NA,NA,NA
"2235",2235,"Cluster_4080","Porites_evermani_scaffold_706:104508-105508",163,-22.73,2,21,965,987,20,"70.00%","85.00%","Peve_00039736",NA,NA,NA,NA,NA,NA,NA,NA
"2236",2236,"Cluster_4080","Porites_evermani_scaffold_737:151402-152402",166,-20.52,2,21,968,988,19,"73.68%","89.47%","Peve_00040429",0.155205393587571,0.900792126691933,0.999448381576871,"F6VAN0","Cyclic AMP-dependent transcription factor ATF-6 alpha (cAMP-dependent transcription factor ATF-6 alpha) (Activating transcription factor 6 alpha) (ATF6-alpha) [Cleaved into: Processed cyclic AMP-dependent transcription factor ATF-6 alpha]","Mus musculus (Mouse)","endoplasmic reticulum unfolded protein response [GO:0030968]; eye development [GO:0001654]; positive regulation of apoptotic process [GO:0043065]; positive regulation of ATF6-mediated unfolded protein response [GO:1903893]; positive regulation of autophagy [GO:0010508]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; regulation of transcription by RNA polymerase II [GO:0006357]; visual perception [GO:0007601]","GO:0000139; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001654; GO:0003700; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0005794; GO:0006357; GO:0007601; GO:0010508; GO:0016020; GO:0030968; GO:0031625; GO:0042802; GO:0043065; GO:0043565; GO:0045944; GO:0046982; GO:0090575; GO:1903893; GO:1990440; GO:1990837"
"2237",2237,"Cluster_4080","Porites_evermani_scaffold_770:18353-19353",155,-20.04,2,21,532,556,22,"63.64%","77.27%","Peve_00041079",-0.840706165063913,0.36428039778725,0.978262075707395,NA,NA,NA,NA,NA
"2238",2238,"Cluster_4080","Porites_evermani_scaffold_805:5166-6166",167,-21.79,2,20,652,673,18,"72.22%","88.89%","Peve_00041881",-0.922052514742211,0.253022062024675,0.978262075707395,NA,NA,NA,NA,NA
"2239",2239,"Cluster_4080","Porites_evermani_scaffold_805:5744-6744",167,-21.79,2,20,74,95,18,"72.22%","88.89%","Peve_00041887",0.166283983467401,0.893646313344958,0.999448381576871,"Q4R4C7","Zinc finger protein 14","Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)","regulation of DNA-templated transcription [GO:0006355]","GO:0003677; GO:0005634; GO:0006355; GO:0046872"
"2240",2240,"Cluster_4080","Porites_evermani_scaffold_826:50909-51909",153,-22.83,2,21,507,531,22,"72.73%","77.27%","Peve_00042321",NA,NA,NA,"Q61382","TNF receptor-associated factor 4 (EC 2.3.2.27) (Cysteine-rich motif associated to RING and Traf domains protein 1)","Mus musculus (Mouse)","activation of NF-kappaB-inducing kinase activity [GO:0007250]; apoptotic process [GO:0006915]; innate immune response [GO:0045087]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein kinase activity [GO:0045860]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of apoptotic process [GO:0042981]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; respiratory gaseous exchange by respiratory system [GO:0007585]; respiratory tube development [GO:0030323]","GO:0001650; GO:0005164; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005923; GO:0006915; GO:0007250; GO:0007585; GO:0008270; GO:0016740; GO:0019901; GO:0030323; GO:0031625; GO:0031996; GO:0042802; GO:0042981; GO:0043122; GO:0043161; GO:0045087; GO:0045860; GO:0046330; GO:0048471; GO:0050699"
"2241",2241,"Cluster_4080","Porites_evermani_scaffold_829:94401-95125",161,-21.13,2,21,339,362,22,"77.27%","77.27%","Peve_00042364",0.937642204017856,0.226007866772794,0.978262075707395,NA,NA,NA,NA,NA
"2242",2242,"Cluster_4080","Porites_evermani_scaffold_849:167244-168244",153,-20.02,2,21,464,485,20,"70.00%","80.00%","Peve_00042733",NA,NA,NA,NA,NA,NA,NA,NA
"2243",2243,"Cluster_4080","Porites_evermani_scaffold_860:78647-79647",166,-21.48,2,20,771,793,19,"73.68%","89.47%","Peve_00042987",0.560974642254184,0.62085302690826,0.978262075707395,"P0C5E4","Phosphatidylinositol phosphatase PTPRQ (EC 3.1.3.-) (Receptor-type tyrosine-protein phosphatase Q) (PTP-RQ) (R-PTP-Q) (EC 3.1.3.48)","Mus musculus (Mouse)","detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; inner ear morphogenesis [GO:0042472]; neuromuscular process controlling balance [GO:0050885]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; regulation of fat cell differentiation [GO:0045598]; vestibular receptor cell morphogenesis [GO:0060116]","GO:0002244; GO:0004725; GO:0016020; GO:0032421; GO:0042472; GO:0043235; GO:0045598; GO:0050885; GO:0050910; GO:0060116; GO:1990264"
"2244",2244,"Cluster_4080","Porites_evermani_scaffold_893:112442-113442",161,-20.29,2,18,577,598,16,"75.00%","87.50%","Peve_00043526",0.998465344822469,0.0352741113828147,0.909359886114279,NA,NA,NA,NA,NA
"2245",2245,"Cluster_4080","Porites_evermani_scaffold_912:11464-12464",164,-20.52,2,20,795,816,19,"78.95%","89.47%","Peve_00043966",-0.992155866388476,0.079790632892045,0.978262075707395,NA,NA,NA,NA,NA
"2246",2246,"Cluster_4080","Porites_evermani_scaffold_914:117551-118551",155,-20.82,2,21,319,343,22,"63.64%","77.27%","Peve_00043996",-0.983071116129626,0.117306984486313,0.978262075707395,"Q64459","Cytochrome P450 3A11 (EC 1.14.14.1) (CYPIIIA11) (Cytochrome P-450IIIAM1) (Cytochrome P-450UT)","Mus musculus (Mouse)","alkaloid catabolic process [GO:0009822]; estrogen metabolic process [GO:0008210]; lipid hydroxylation [GO:0002933]; oxidative demethylation [GO:0070989]; response to bacterium [GO:0009617]; retinoic acid metabolic process [GO:0042573]; steroid metabolic process [GO:0008202]; xenobiotic catabolic process [GO:0042178]","GO:0002933; GO:0004497; GO:0005506; GO:0005789; GO:0008202; GO:0008210; GO:0008395; GO:0008401; GO:0009617; GO:0009822; GO:0016491; GO:0020037; GO:0032451; GO:0042178; GO:0042573; GO:0043231; GO:0050649; GO:0070330; GO:0070989; GO:0101020"
"2247",2247,"Cluster_4080","Porites_evermani_scaffold_926:124524-125524",160,-21.85,2,21,753,775,21,"76.19%","85.71%","Peve_00044199",-0.735942447806812,0.473478757640068,0.978262075707395,NA,NA,NA,NA,NA
"2248",2248,"Cluster_4080","Porites_evermani_scaffold_964:61389-62389",158,-20.25,2,18,82,103,17,"82.35%","88.24%","Peve_00044804",0.280337051260371,0.81910753328753,0.995934364227446,"Q9VBW3","Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14)","Drosophila melanogaster (Fruit fly)","calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of kinase activity [GO:0033674]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing [GO:0042060]","GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0014068; GO:0016339; GO:0033674; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0090303"
"2249",2249,"Cluster_4080","Porites_evermani_scaffold_968:122042-123042",174,-24.53,2,20,493,515,19,"78.95%","94.74%","Peve_00044866",-0.700738530824903,0.50570792773587,0.978262075707395,"Q9JLV6","Bifunctional polynucleotide phosphatase/kinase (DNA 5'-kinase/3'-phosphatase) (Polynucleotide kinase-3'-phosphatase) [Includes: Polynucleotide 3'-phosphatase (EC 3.1.3.32) (2'(3')-polynucleotidase); Polynucleotide 5'-hydroxyl-kinase (EC 2.7.1.78)]","Mus musculus (Mouse)","cellular response to DNA damage stimulus [GO:0006974]; DNA ligation involved in DNA repair [GO:0051103]; DNA repair [GO:0006281]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of protein ADP-ribosylation [GO:0010836]; nucleotide phosphorylation [GO:0046939]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein K63-linked ubiquitination [GO:0070534]; response to oxidative stress [GO:0006979]","GO:0003690; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005739; GO:0006281; GO:0006303; GO:0006974; GO:0006979; GO:0010836; GO:0019005; GO:0032212; GO:0035861; GO:0046403; GO:0046404; GO:0046939; GO:0051103; GO:0051973; GO:0070534; GO:1904355; GO:1990756; GO:2001034"
"2250",2250,"Cluster_4080","Porites_evermani_scaffold_982:116879-117879",160,-20.16,2,20,416,435,18,"72.22%","88.89%","Peve_00045083",-0.395955906280648,0.740826612984754,0.986697151420032,"Q9QYJ0","DnaJ homolog subfamily A member 2 (mDj3)","Mus musculus (Mouse)","protein refolding [GO:0042026]; response to heat [GO:0009408]","GO:0001671; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0009408; GO:0016020; GO:0030544; GO:0042026; GO:0046872; GO:0051082; GO:0051087"
"2251",2251,"Cluster_4080","Porites_evermani_scaffold_994:42022-43022",173,-25.71,2,18,698,719,16,"87.50%","93.75%","Peve_00045285",-0.235777127616489,0.848472931070267,0.995934364227446,"Q6L9W6","Beta-1,4-N-acetylgalactosaminyltransferase 3 (B4GalNAcT3) (Beta4GalNAc-T3) (Beta4GalNAcT3) (EC 2.4.1.244) (Beta-1,4-N-acetylgalactosaminyltransferase III) (N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 2) (NGalNAc-T2)","Homo sapiens (Human)","","GO:0005794; GO:0008376; GO:0032580; GO:0033842; GO:0043231"
"2252",2252,"Cluster_4115","Porites_evermani_scaffold_108:315264-316264",175,-29.34,2,21,152,174,20,"75.00%","95.00%","Peve_00001445",0.0739815845754968,0.952858790793645,0.999448381576871,NA,NA,NA,NA,NA
"2253",2253,"Cluster_4115","Porites_evermani_scaffold_108:331903-332903",151,-21.09,2,18,575,595,16,"68.75%","87.50%","Peve_00001446",0.0800660801138673,0.948973732982765,0.999448381576871,NA,NA,NA,NA,NA
"2254",2254,"Cluster_4115","Porites_evermani_scaffold_111:110074-111074",154,-20.67,2,20,202,224,19,"68.42%","78.95%","Peve_00002015",-0.983662757338596,0.11523317926684,0.978262075707395,NA,NA,NA,NA,NA
"2255",2255,"Cluster_4115","Porites_evermani_scaffold_117:45277-46277",156,-20.51,2,17,490,511,15,"66.67%","93.33%","Peve_00002880",-0.802199537700138,0.407326010478144,0.978262075707395,"P35224","Catenin beta (Beta-catenin)","Urechis caupo (Innkeeper worm) (Spoonworm)","cell adhesion [GO:0007155]","GO:0005737; GO:0005856; GO:0007155; GO:0045296"
"2256",2256,"Cluster_4115","Porites_evermani_scaffold_1207:110287-111287",161,-20.13,2,20,356,376,18,"72.22%","88.89%","Peve_00003489",NA,NA,NA,NA,NA,NA,NA,NA
"2257",2257,"Cluster_4115","Porites_evermani_scaffold_127:2399-3399",169,-22.8,2,19,617,640,19,"78.95%","89.47%","Peve_00004330",-0.94973573695349,0.202703339860884,0.978262075707395,NA,NA,NA,NA,NA
"2258",2258,"Cluster_4115","Porites_evermani_scaffold_1365:103847-104847",166,-22.61,2,21,731,755,22,"77.27%","81.82%","Peve_00005723",NA,NA,NA,NA,NA,NA,NA,NA
"2259",2259,"Cluster_4115","Porites_evermani_scaffold_1472:41605-42605",171,-25.5,2,21,203,225,20,"80.00%","85.00%","Peve_00007133",-0.95912143718489,0.18265585115168,0.978262075707395,"Q9HAR2","Adhesion G protein-coupled receptor L3 (Calcium-independent alpha-latrotoxin receptor 3) (CIRL-3) (Latrophilin-3) (Lectomedin-3)","Homo sapiens (Human)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; G protein-coupled receptor signaling pathway [GO:0007186]; neuron migration [GO:0001764]; synapse assembly [GO:0007416]","GO:0001764; GO:0004930; GO:0005509; GO:0005886; GO:0005911; GO:0007166; GO:0007186; GO:0007189; GO:0007416; GO:0007420; GO:0016020; GO:0030246; GO:0030424; GO:0098742; GO:0098978"
"2260",2260,"Cluster_4115","Porites_evermani_scaffold_1519:84603-85603",152,-20.31,2,13,281,302,11,"90.91%","90.91%","Peve_00007756",0.146754686511502,0.906234417440672,0.999448381576871,NA,NA,NA,NA,NA
"2261",2261,"Cluster_4115","Porites_evermani_scaffold_1541:118379-119379",169,-26.04,2,18,185,206,16,"81.25%","93.75%","Peve_00008015",NA,NA,NA,"P14381","Transposon TX1 uncharacterized 149 kDa protein (ORF 2)","Xenopus laevis (African clawed frog)","","GO:0003824"
"2262",2262,"Cluster_4115","Porites_evermani_scaffold_1569:67182-68182",159,-21.07,2,21,33,56,21,"66.67%","80.95%","Peve_00008321",NA,NA,NA,NA,NA,NA,NA,NA
"2263",2263,"Cluster_4115","Porites_evermani_scaffold_1591:112854-113854",171,-20.85,2,21,225,248,21,"76.19%","85.71%","Peve_00008662",-0.760650387464273,0.449760353280902,0.978262075707395,NA,NA,NA,NA,NA
"2264",2264,"Cluster_4115","Porites_evermani_scaffold_1615:13762-14762",158,-20.36,2,21,13,37,22,"68.18%","81.82%","Peve_00009012",-0.991993600186936,0.0806127886650207,0.978262075707395,NA,NA,NA,NA,NA
"2265",2265,"Cluster_4115","Porites_evermani_scaffold_163:78400-79059",150,-21.48,2,21,113,140,25,"64.00%","72.00%","Peve_00009163",NA,NA,NA,NA,NA,NA,NA,NA
"2266",2266,"Cluster_4115","Porites_evermani_scaffold_163:78400-79059",150,-21.48,2,21,113,140,25,"64.00%","72.00%","Peve_00009164",-0.706769683642758,0.500303422122629,0.978262075707395,"Q6P2Z6","60S ribosomal export protein NMD3","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","protein transport [GO:0015031]","GO:0005634; GO:0005737; GO:0015031; GO:0043023"
"2267",2267,"Cluster_4115","Porites_evermani_scaffold_1654:3037-4037",172,-23.05,2,21,137,158,19,"73.68%","89.47%","Peve_00009453",0.129397867373487,0.917391124764184,0.999448381576871,"Q99L13","3-hydroxyisobutyrate dehydrogenase, mitochondrial (HIBADH) (EC 1.1.1.31)","Mus musculus (Mouse)","valine catabolic process [GO:0006574]","GO:0005739; GO:0006574; GO:0008442; GO:0016616; GO:0050661; GO:0051287"
"2268",2268,"Cluster_4115","Porites_evermani_scaffold_169:171039-171287",158,-25.76,2,21,192,220,26,"69.23%","73.08%","Peve_00009872",0.231424695119834,0.851322622012369,0.995934364227446,NA,NA,NA,NA,NA
"2269",2269,"Cluster_4115","Porites_evermani_scaffold_169:171039-171287",158,-25.76,2,21,192,220,26,"69.23%","73.08%","Peve_00009873",-0.931662886812049,0.236716330619367,0.978262075707395,"Q9H8V3","Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene)","Homo sapiens (Human)","activation of GTPase activity [GO:0090630]; activation of protein kinase activity [GO:0032147]; bicellular tight junction assembly [GO:0070830]; cell differentiation [GO:0030154]; cell morphogenesis [GO:0000902]; cellular response to calcium ion [GO:0071277]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to ionizing radiation [GO:0071479]; intracellular signal transduction [GO:0035556]; mitotic cytokinesis [GO:0000281]; nervous system development [GO:0007399]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cytokinesis [GO:0032467]; positive regulation of GTPase activity [GO:0043547]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein import into nucleus [GO:0042307]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of cytokinesis, actomyosin contractile ring assembly [GO:2000431]; regulation of protein kinase activity [GO:0045859]; regulation of small GTPase mediated signal transduction [GO:0051056]","GO:0000281; GO:0000902; GO:0005085; GO:0005096; GO:0005634; GO:0005654; GO:0005737; GO:0005815; GO:0005829; GO:0005911; GO:0005923; GO:0005938; GO:0007399; GO:0015031; GO:0016604; GO:0030154; GO:0030496; GO:0031267; GO:0032147; GO:0032154; GO:0032467; GO:0035556; GO:0042307; GO:0042803; GO:0043065; GO:0043123; GO:0043547; GO:0045666; GO:0045859; GO:0051056; GO:0051260; GO:0051988; GO:0070301; GO:0070830; GO:0071277; GO:0071479; GO:0072686; GO:0090630; GO:0097149; GO:2000431"
"2270",2270,"Cluster_4115","Porites_evermani_scaffold_1886:78875-79128",167,-21.65,2,21,49,72,21,"71.43%","85.71%","Peve_00012088",0.915189744134946,0.264081248753984,0.978262075707395,NA,NA,NA,NA,NA
"2271",2271,"Cluster_4115","Porites_evermani_scaffold_197:340333-341333",180,-25.2,2,17,397,418,15,"100.00%","100.00%","Peve_00013037",-0.843100713709534,0.361455439073629,0.978262075707395,"Q8N9F7","Lysophospholipase D GDPD1 (EC 3.1.4.-) (Glycerophosphodiester phosphodiesterase 4) (Glycerophosphodiester phosphodiesterase domain-containing protein 1)","Homo sapiens (Human)","glycerophospholipid catabolic process [GO:0046475]; N-acylethanolamine metabolic process [GO:0070291]","GO:0004622; GO:0005783; GO:0005789; GO:0008081; GO:0016020; GO:0046475; GO:0046872; GO:0048471; GO:0070291"
"2272",2272,"Cluster_4115","Porites_evermani_scaffold_2098:73795-74795",154,-23.59,2,18,614,635,17,"76.47%","88.24%","Peve_00014502",0.0418895937151828,0.97332445106878,0.999448381576871,"Q8N0W3","L-fucose kinase (Fucokinase) (EC 2.7.1.52)","Homo sapiens (Human)","carbohydrate phosphorylation [GO:0046835]; GDP-L-fucose salvage [GO:0042352]; response to dopamine [GO:1903350]","GO:0005524; GO:0005829; GO:0042352; GO:0046835; GO:0050201; GO:1903350"
"2273",2273,"Cluster_4115","Porites_evermani_scaffold_2:1046483-1047483",154,-21.7,2,20,646,670,21,"71.43%","71.43%","Peve_00013388",NA,NA,NA,NA,NA,NA,NA,NA
"2274",2274,"Cluster_4115","Porites_evermani_scaffold_2264:74884-75884",162,-21.74,2,20,42,64,19,"78.95%","78.95%","Peve_00016180",NA,NA,NA,NA,NA,NA,NA,NA
"2275",2275,"Cluster_4115","Porites_evermani_scaffold_2296:62926-63926",171,-22.81,2,21,571,596,23,"78.26%","78.26%","Peve_00016450",-0.930026219102899,0.239567750774005,0.978262075707395,NA,NA,NA,NA,NA
"2276",2276,"Cluster_4115","Porites_evermani_scaffold_2326:43643-44643",164,-20.64,2,21,427,448,19,"73.68%","78.95%","Peve_00016789",NA,NA,NA,NA,NA,NA,NA,NA
"2277",2277,"Cluster_4115","Porites_evermani_scaffold_2482:18570-19570",164,-24.38,2,19,420,440,17,"82.35%","88.24%","Peve_00018208",0.0754998652643505,0.951889512120137,0.999448381576871,NA,NA,NA,NA,NA
"2278",2278,"Cluster_4115","Porites_evermani_scaffold_2632:58691-59691",168,-20.8,2,19,29,49,17,"88.24%","88.24%","Peve_00019531",-0.930026219102899,0.239567750774005,0.978262075707395,NA,NA,NA,NA,NA
"2279",2279,"Cluster_4115","Porites_evermani_scaffold_2674:12782-13782",169,-22.8,2,19,350,373,19,"78.95%","89.47%","Peve_00019850",-0.930026219102899,0.239567750774005,0.978262075707395,"P97402","N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase (N-acetylglucosaminyltransferase) (EC 2.4.1.150) (I-branching enzyme) (IGNT) (Large I antigen-forming beta-1,6-N-acetylglucosaminyltransferase)","Mus musculus (Mouse)","maintenance of lens transparency [GO:0036438]; negative regulation of cell-substrate adhesion [GO:0010812]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of protein kinase B signaling [GO:0051897]; post-transcriptional regulation of gene expression [GO:0010608]; protein glycosylation [GO:0006486]; transforming growth factor beta receptor signaling pathway [GO:0007179]","GO:0000139; GO:0005794; GO:0006486; GO:0007179; GO:0008109; GO:0008284; GO:0008375; GO:0010608; GO:0010718; GO:0010812; GO:0030335; GO:0034116; GO:0036438; GO:0051897; GO:0070374"
"2280",2280,"Cluster_4115","Porites_evermani_scaffold_2787:18146-19146",150,-22.2,2,20,383,405,19,"57.89%","84.21%","Peve_00020771",NA,NA,NA,NA,NA,NA,NA,NA
"2281",2281,"Cluster_4115","Porites_evermani_scaffold_292:250768-251768",168,-21.23,2,21,782,803,19,"68.42%","89.47%","Peve_00021867",NA,NA,NA,NA,NA,NA,NA,NA
"2282",2282,"Cluster_4115","Porites_evermani_scaffold_293:306815-307815",167,-24.38,2,21,214,236,20,"70.00%","90.00%","Peve_00021930",-0.642364403959359,0.555907178404039,0.978262075707395,"Q6GM16","Nucleoredoxin (EC 1.8.1.8)","Xenopus laevis (African clawed frog)","cell differentiation [GO:0030154]; circulatory system development [GO:0072359]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055]","GO:0004791; GO:0005634; GO:0005829; GO:0016055; GO:0030154; GO:0030178; GO:0031397; GO:0072359"
"2283",2283,"Cluster_4115","Porites_evermani_scaffold_3015:12634-13634",169,-22.8,2,19,953,976,19,"78.95%","89.47%","Peve_00022741",NA,NA,NA,NA,NA,NA,NA,NA
"2284",2284,"Cluster_4115","Porites_evermani_scaffold_307:120141-121141",165,-22.69,2,21,537,559,21,"76.19%","85.71%","Peve_00023125",0.367678196170785,0.760305592147323,0.988336795073143,NA,NA,NA,NA,NA
"2285",2285,"Cluster_4115","Porites_evermani_scaffold_31:688431-689431",168,-24.72,2,19,945,965,17,"88.24%","88.24%","Peve_00023349",NA,NA,NA,NA,NA,NA,NA,NA
"2286",2286,"Cluster_4115","Porites_evermani_scaffold_3176:3483-4483",169,-22.8,2,19,203,226,19,"78.95%","89.47%","Peve_00023866",NA,NA,NA,NA,NA,NA,NA,NA
"2287",2287,"Cluster_4115","Porites_evermani_scaffold_324:187050-188050",156,-21.33,2,18,905,927,17,"76.47%","82.35%","Peve_00024255",-0.891208514120002,0.29971663067648,0.978262075707395,"Q5VVW2","GTPase-activating Rap/Ran-GAP domain-like protein 3","Homo sapiens (Human)","activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056]","GO:0005096; GO:0005737; GO:0051056; GO:0090630"
"2288",2288,"Cluster_4115","Porites_evermani_scaffold_333:117107-118107",156,-20.45,2,21,824,845,19,"68.42%","73.68%","Peve_00024838",NA,NA,NA,NA,NA,NA,NA,NA
"2289",2289,"Cluster_4115","Porites_evermani_scaffold_333:117482-118482",156,-20.45,2,21,449,470,19,"68.42%","73.68%","Peve_00024839",-0.850808312754881,0.35222561043016,0.978262075707395,NA,NA,NA,NA,NA
"2290",2290,"Cluster_4115","Porites_evermani_scaffold_342:268558-269558",162,-20.69,2,21,930,954,22,"72.73%","81.82%","Peve_00025419",-0.930026219102899,0.239567750774005,0.978262075707395,"J3S6Y1","Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR)","Mus musculus (Mouse)","hair cycle process [GO:0022405]; Notch signaling pathway [GO:0007219]; regulation of Notch signaling pathway [GO:0008593]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]; tooth mineralization [GO:0034505]","GO:0005576; GO:0007165; GO:0007219; GO:0007605; GO:0008593; GO:0009986; GO:0022405; GO:0032420; GO:0034505; GO:0060170"
"2291",2291,"Cluster_4115","Porites_evermani_scaffold_34:93198-94198",169,-22.8,2,19,247,270,19,"78.95%","89.47%","Peve_00025273",-0.179088119063592,0.885370557402815,0.999448381576871,NA,NA,NA,NA,NA
"2292",2292,"Cluster_4115","Porites_evermani_scaffold_3542:11350-12350",155,-21.28,2,21,25,49,22,"63.64%","77.27%","Peve_00026208",NA,NA,NA,NA,NA,NA,NA,NA
"2293",2293,"Cluster_4115","Porites_evermani_scaffold_35:66061-67061",172,-24.54,2,21,795,816,19,"78.95%","84.21%","Peve_00025909",-0.957602164107626,0.18604305514665,0.978262075707395,"Q00004","Signal recognition particle subunit SRP68 (SRP68) (Signal recognition particle 68 kDa protein)","Canis lupus familiaris (Dog) (Canis familiaris)","SRP-dependent cotranslational protein targeting to membrane [GO:0006614]","GO:0005047; GO:0005730; GO:0005783; GO:0005786; GO:0005829; GO:0006614; GO:0008312; GO:0030942"
"2294",2294,"Cluster_4115","Porites_evermani_scaffold_3632:18374-19374",163,-23.35,2,21,70,93,21,"71.43%","80.95%","Peve_00026736",-0.906898744734039,0.276886237368734,0.978262075707395,"O00602","Ficolin-1 (Collagen/fibrinogen domain-containing protein 1) (Ficolin-A) (Ficolin-alpha) (M-ficolin)","Homo sapiens (Human)","cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of opsonization [GO:1903028]; protein localization to cell surface [GO:0034394]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654]","GO:0001664; GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006508; GO:0007186; GO:0009897; GO:0030246; GO:0031232; GO:0032757; GO:0033691; GO:0034394; GO:0034774; GO:0038187; GO:0043654; GO:0046597; GO:0046872; GO:0062023; GO:0097367; GO:1903028; GO:1904813; GO:1905370"
"2295",2295,"Cluster_4115","Porites_evermani_scaffold_3824:32421-33421",155,-21.27,2,18,894,914,16,"75.00%","87.50%","Peve_00027772",-0.840649270187309,0.364347282389282,0.978262075707395,NA,NA,NA,NA,NA
"2296",2296,"Cluster_4115","Porites_evermani_scaffold_3885:17541-18541",169,-22.8,2,19,92,115,19,"78.95%","89.47%","Peve_00028066",-0.930026219102899,0.239567750774005,0.978262075707395,NA,NA,NA,NA,NA
"2297",2297,"Cluster_4115","Porites_evermani_scaffold_3:931048-932048",169,-20.02,2,18,67,88,16,"81.25%","93.75%","Peve_00022448",0.988031642813979,0.0985930937624424,0.978262075707395,"Q9JHA8","von Willebrand factor A domain-containing protein 7 (Protein G7c)","Mus musculus (Mouse)","","GO:0005576"
"2298",2298,"Cluster_4115","Porites_evermani_scaffold_4002:22381-23381",161,-20.54,2,19,49,72,19,"73.68%","84.21%","Peve_00028859",-0.930026219102899,0.239567750774005,0.978262075707395,NA,NA,NA,NA,NA
"2299",2299,"Cluster_4115","Porites_evermani_scaffold_4192:10284-11284",154,-20.74,2,21,548,572,22,"72.73%","72.73%","Peve_00029782",0.256695304498082,0.834732631592291,0.995934364227446,NA,NA,NA,NA,NA
"2300",2300,"Cluster_4115","Porites_evermani_scaffold_421:261334-262334",156,-21,2,21,702,721,19,"73.68%","84.21%","Peve_00029930",0.951557250545376,0.198965829229218,0.978262075707395,NA,NA,NA,NA,NA
"2301",2301,"Cluster_4115","Porites_evermani_scaffold_446:243998-244998",163,-21.05,2,21,175,197,20,"75.00%","80.00%","Peve_00031245",-0.930026219102899,0.239567750774005,0.978262075707395,NA,NA,NA,NA,NA
"2302",2302,"Cluster_4115","Porites_evermani_scaffold_4526:8796-9796",155,-20.57,2,21,908,931,21,"66.67%","76.19%","Peve_00031580",NA,NA,NA,NA,NA,NA,NA,NA
"2303",2303,"Cluster_4115","Porites_evermani_scaffold_4581:20505-21505",176,-22.88,2,21,414,435,19,"73.68%","94.74%","Peve_00031801",0.783271532591398,0.427098915892661,0.978262075707395,NA,NA,NA,NA,NA
"2304",2304,"Cluster_4115","Porites_evermani_scaffold_521:65304-66304",155,-22.15,2,21,969,992,21,"61.90%","80.95%","Peve_00034427",-0.992845506240112,0.0761980479146135,0.978262075707395,NA,NA,NA,NA,NA
"2305",2305,"Cluster_4115","Porites_evermani_scaffold_541:66724-67724",154,-24.67,2,17,45,65,15,"80.00%","86.67%","Peve_00035178",-0.970138851454112,0.155967837735805,0.978262075707395,"O95801","Tetratricopeptide repeat protein 4 (TPR repeat protein 4)","Homo sapiens (Human)","defense response to virus [GO:0051607]; innate immune response [GO:0045087]; protein folding [GO:0006457]","GO:0005634; GO:0005654; GO:0005737; GO:0006457; GO:0030544; GO:0045087; GO:0051607; GO:0051879"
"2306",2306,"Cluster_4115","Porites_evermani_scaffold_5422:10710-11710",179,-24.24,2,21,677,700,21,"80.95%","90.48%","Peve_00035222",-0.378190159942869,0.753093089204442,0.988219883885475,NA,NA,NA,NA,NA
"2307",2307,"Cluster_4115","Porites_evermani_scaffold_563:191782-192782",159,-23.46,2,19,95,114,17,"76.47%","88.24%","Peve_00035887",-0.887206250893735,0.305286020589567,0.978262075707395,"Q4KTY1","Serine/threonine-protein kinase H1 homolog (EC 2.7.11.1)","Pinctada fucata (Akoya pearl oyster) (Pinctada imbricata fucata)","protein phosphorylation [GO:0006468]","GO:0004674; GO:0005524; GO:0006468; GO:0106310"
"2308",2308,"Cluster_4115","Porites_evermani_scaffold_580:135478-136478",154,-22.67,2,20,976,998,19,"63.16%","84.21%","Peve_00036396",-0.870241673150248,0.327925159667443,0.978262075707395,"Q0VCW8","Phosducin-like protein 3","Bos taurus (Bovine)","angiogenesis [GO:0001525]; apoptotic process [GO:0006915]","GO:0001525; GO:0005783; GO:0006915; GO:0048471"
"2309",2309,"Cluster_4115","Porites_evermani_scaffold_583:197235-198235",169,-21.75,2,18,575,596,16,"81.25%","93.75%","Peve_00036498",NA,NA,NA,"P57695","Glycine receptor subunit alpha-1 (Glycine receptor 48 kDa subunit) (Glycine receptor strychnine-binding subunit)","Bos taurus (Bovine)","acrosome reaction [GO:0007340]; adult walking behavior [GO:0007628]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; inhibitory postsynaptic potential [GO:0060080]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; muscle contraction [GO:0006936]; negative regulation of transmission of nerve impulse [GO:0051970]; nervous system process [GO:0050877]; neuromuscular process controlling posture [GO:0050884]; neuronal action potential [GO:0019228]; neuropeptide signaling pathway [GO:0007218]; positive regulation of acrosome reaction [GO:2000344]; regulation of membrane potential [GO:0042391]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; response to alcohol [GO:0097305]; response to amino acid [GO:0043200]; righting reflex [GO:0060013]; signal transduction [GO:0007165]; startle response [GO:0001964]; synaptic transmission, glycinergic [GO:0060012]; visual perception [GO:0007601]","GO:0001964; GO:0002087; GO:0004888; GO:0005231; GO:0005886; GO:0006811; GO:0006821; GO:0006936; GO:0007165; GO:0007218; GO:0007268; GO:0007340; GO:0007601; GO:0007628; GO:0008270; GO:0009897; GO:0016594; GO:0016934; GO:0019228; GO:0030425; GO:0030594; GO:0030977; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0043025; GO:0043200; GO:0043204; GO:0043231; GO:0045202; GO:0045211; GO:0050877; GO:0050884; GO:0051970; GO:0060012; GO:0060013; GO:0060077; GO:0060080; GO:0071230; GO:0071294; GO:0071361; GO:0097305; GO:0098690; GO:0099507; GO:1902476; GO:1904315; GO:2000344"
"2310",2310,"Cluster_4115","Porites_evermani_scaffold_6183:1732-2732",167,-21.08,2,21,246,268,20,"70.00%","90.00%","Peve_00037551",0.146754686511502,0.906234417440672,0.999448381576871,"O35231","Kinesin-like protein KIFC3","Mus musculus (Mouse)","epithelial cell-cell adhesion [GO:0090136]; Golgi organization [GO:0007030]; microtubule-based movement [GO:0007018]; microtubule-based process [GO:0007017]; zonula adherens maintenance [GO:0045218]","GO:0005524; GO:0005794; GO:0005813; GO:0005871; GO:0005874; GO:0005915; GO:0007017; GO:0007018; GO:0007030; GO:0008017; GO:0008569; GO:0015630; GO:0030659; GO:0042802; GO:0045218; GO:0090136"
"2311",2311,"Cluster_4115","Porites_evermani_scaffold_6636:1874-2874",157,-21.01,2,21,385,406,20,"70.00%","85.00%","Peve_00038692",0.146754686511502,0.906234417440672,0.999448381576871,NA,NA,NA,NA,NA
"2312",2312,"Cluster_4115","Porites_evermani_scaffold_674:154482-155482",159,-20.39,2,20,768,789,18,"61.11%","88.89%","Peve_00038926",-0.620776093105684,0.573635210237408,0.978262075707395,NA,NA,NA,NA,NA
"2313",2313,"Cluster_4115","Porites_evermani_scaffold_686:142181-143181",165,-20.03,2,20,857,877,18,"83.33%","83.33%","Peve_00039189",-0.906573812307753,0.277376774233303,0.978262075707395,"Q90752","Bone morphogenetic protein 4 (BMP-4)","Gallus gallus (Chicken)","beak formation [GO:0071730]; beak morphogenesis [GO:0071729]; cartilage development [GO:0051216]; cloacal septation [GO:0060197]; embryonic skeletal system morphogenesis [GO:0048704]; intermediate mesodermal cell differentiation [GO:0048392]; mesenchymal cell proliferation involved in ureter development [GO:0072198]; mesenchymal cell proliferation involved in ureteric bud development [GO:0072138]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nephric duct formation [GO:0072179]; ossification [GO:0001503]; polarity specification of dorsal/ventral axis [GO:0009951]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epidermal cell differentiation [GO:0045606]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of progesterone secretion [GO:2000872]; regulation of cell fate commitment [GO:0010453]; regulation of myotome development [GO:2000290]; SMAD protein signal transduction [GO:0060395]; ureteric bud morphogenesis [GO:0060675]","GO:0000122; GO:0001503; GO:0005125; GO:0005615; GO:0008083; GO:0009951; GO:0010453; GO:0010862; GO:0043066; GO:0045606; GO:0045892; GO:0045893; GO:0048392; GO:0048704; GO:0051216; GO:0060197; GO:0060395; GO:0060675; GO:0070700; GO:0071729; GO:0071730; GO:0072138; GO:0072179; GO:0072198; GO:2000290; GO:2000872"
"2314",2314,"Cluster_4115","Porites_evermani_scaffold_727:39173-40173",171,-20.05,2,21,857,879,20,"80.00%","85.00%","Peve_00040169",0.783271532591397,0.427098915892661,0.978262075707395,"Q9UGM3","Deleted in malignant brain tumors 1 protein (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein)","Homo sapiens (Human)","antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; detection of bacterial lipoprotein [GO:0042494]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]","GO:0001530; GO:0003677; GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006898; GO:0006952; GO:0015031; GO:0019898; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042494; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0050840; GO:0051607; GO:0061844; GO:0070062; GO:0070891; GO:1904399"
"2315",2315,"Cluster_4115","Porites_evermani_scaffold_780:123660-124660",173,-20.73,2,19,420,442,18,"83.33%","94.44%","Peve_00041292",0.410007150747331,0.731052399989305,0.984754300351916,"Q96CG8","Collagen triple helix repeat-containing protein 1","Homo sapiens (Human)","cell migration [GO:0016477]; cochlea morphogenesis [GO:0090103]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein binding [GO:0032092]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0001649; GO:0005109; GO:0005576; GO:0005581; GO:0005615; GO:0016477; GO:0016528; GO:0017147; GO:0032092; GO:0033687; GO:0033690; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0062023; GO:0090090; GO:0090103; GO:0090177"
"2316",2316,"Cluster_4115","Porites_evermani_scaffold_780:123917-124917",173,-20.73,2,19,163,185,18,"83.33%","94.44%","Peve_00041293",-0.944290764636882,0.213498986694021,0.978262075707395,"Q13425","Beta-2-syntrophin (59 kDa dystrophin-associated protein A1 basic component 2) (Syntrophin-3) (SNT3) (Syntrophin-like) (SNTL)","Homo sapiens (Human)","","GO:0003723; GO:0003779; GO:0005198; GO:0005516; GO:0005654; GO:0005737; GO:0005794; GO:0005874; GO:0005886; GO:0005925; GO:0016010; GO:0016020; GO:0030658; GO:0032991; GO:0045202"
"2317",2317,"Cluster_4115","Porites_evermani_scaffold_827:117460-118460",158,-20.1,2,21,616,636,19,"68.42%","84.21%","Peve_00042333",NA,NA,NA,NA,NA,NA,NA,NA
"2318",2318,"Cluster_4115","Porites_evermani_scaffold_846:152507-153507",169,-22.8,2,19,382,405,19,"78.95%","89.47%","Peve_00042690",0.923157708465687,0.251198082137527,0.978262075707395,NA,NA,NA,NA,NA
"2319",2319,"Cluster_4115","Porites_evermani_scaffold_9:1053489-1054489",157,-20.24,2,20,387,412,22,"68.18%","81.82%","Peve_00043667",0.67471453733895,0.528533485418076,0.978262075707395,NA,NA,NA,NA,NA
"2320",2320,"Cluster_4115","Porites_evermani_scaffold_939:140092-141092",170,-22.41,2,21,520,540,19,"84.21%","84.21%","Peve_00044386",0.139765565940317,0.910730213439296,0.999448381576871,"B4E2M5","Ankyrin repeat domain-containing protein 66","Homo sapiens (Human)","",""
"2321",2321,"Cluster_4629","Porites_evermani_scaffold_1001:36423-37423",154,-20.4,2,19,941,962,17,"64.71%","82.35%","Peve_00000250",NA,NA,NA,NA,NA,NA,NA,NA
"2322",2322,"Cluster_4629","Porites_evermani_scaffold_1009:130247-131247",176,-29.75,2,21,40,61,19,"78.95%","89.47%","Peve_00000366",NA,NA,NA,NA,NA,NA,NA,NA
"2323",2323,"Cluster_4629","Porites_evermani_scaffold_1014:57846-58846",145,-23.34,2,19,269,293,20,"65.00%","70.00%","Peve_00000456",-0.602130253113823,0.588637570880823,0.978262075707395,"Q3UQ28","Peroxidasin homolog (EC 1.11.2.-) [Cleaved into: PXDN active fragment]","Mus musculus (Mouse)","angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; hydrogen peroxide catabolic process [GO:0042744]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979]","GO:0001525; GO:0001654; GO:0004601; GO:0005201; GO:0005604; GO:0005615; GO:0005783; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0030198; GO:0030199; GO:0031012; GO:0042744; GO:0043237; GO:0046872; GO:0051260; GO:0062023; GO:0070207; GO:0070831; GO:0071711; GO:0140825"
"2324",2324,"Cluster_4629","Porites_evermani_scaffold_1017:132695-133695",152,-20.92,2,17,97,118,15,"73.33%","80.00%","Peve_00000498",0.0621713030671367,0.960394977172142,0.999448381576871,NA,NA,NA,NA,NA
"2325",2325,"Cluster_4629","Porites_evermani_scaffold_1021:41236-42236",163,-21.17,2,21,186,208,20,"75.00%","80.00%","Peve_00000576",NA,NA,NA,NA,NA,NA,NA,NA
"2326",2326,"Cluster_4629","Porites_evermani_scaffold_103:393388-394388",145,-21.76,2,21,797,816,19,"63.16%","73.68%","Peve_00000666",0.471177930633166,0.687657935998024,0.978262075707395,NA,NA,NA,NA,NA
"2327",2327,"Cluster_4629","Porites_evermani_scaffold_1037:65607-66607",150,-21.9,2,11,803,824,9,"100.00%","100.00%","Peve_00000769",-0.554554668634826,0.625777256211528,0.978262075707395,"Q80XJ3","Tetratricopeptide repeat protein 28 (TPR repeat protein 28)","Mus musculus (Mouse)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0005737; GO:0005813; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301; GO:0072686; GO:0097431; GO:1990023"
"2328",2328,"Cluster_4629","Porites_evermani_scaffold_105:105111-106111",152,-21.68,2,21,969,990,19,"57.89%","78.95%","Peve_00001007",-0.193204473729531,0.876223855586555,0.997870773001459,NA,NA,NA,NA,NA
"2329",2329,"Cluster_4629","Porites_evermani_scaffold_1071:25544-26544",150,-20.45,2,21,296,316,19,"68.42%","73.68%","Peve_00001326",-0.997041811903654,0.0489795884758296,0.949444666171571,"Q505F5","Leucine-rich repeat-containing protein 47","Mus musculus (Mouse)","phenylalanyl-tRNA aminoacylation [GO:0006432]","GO:0003723; GO:0004826; GO:0006432"
"2330",2330,"Cluster_4629","Porites_evermani_scaffold_108:16280-17280",147,-21.7,2,21,814,836,20,"65.00%","70.00%","Peve_00001448",0.105525860743988,0.932694839065459,0.999448381576871,"Q62746","Synaptotagmin-6 (Synaptotagmin VI) (SytVI)","Rattus norvegicus (Rat)","acrosomal vesicle exocytosis [GO:0060478]; acrosome reaction [GO:0007340]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; postsynaptic dense core vesicle exocytosis [GO:0150038]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; vesicle-mediated transport [GO:0016192]","GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005829; GO:0005886; GO:0007340; GO:0014059; GO:0016020; GO:0016192; GO:0017156; GO:0017158; GO:0019898; GO:0019905; GO:0030276; GO:0030672; GO:0042802; GO:0042803; GO:0046982; GO:0048306; GO:0060478; GO:0070382; GO:0071277; GO:0097038; GO:0097060; GO:0098794; GO:0098978; GO:0150038"
"2331",2331,"Cluster_4629","Porites_evermani_scaffold_108:416129-417129",163,-26.9,2,18,29,52,18,"83.33%","88.89%","Peve_00001453",-0.53021987003237,0.644218758190279,0.978262075707395,"D3YXG0","Hemicentin-1 (Fibulin-6) (FIBL-6)","Mus musculus (Mouse)","actin filament reorganization [GO:0090527]; basement membrane organization [GO:0071711]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]","GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0051301; GO:0062023; GO:0071711; GO:0090527"
"2332",2332,"Cluster_4629","Porites_evermani_scaffold_108:44104-45104",151,-20.69,2,20,516,537,18,"61.11%","77.78%","Peve_00001433",NA,NA,NA,NA,NA,NA,NA,NA
"2333",2333,"Cluster_4629","Porites_evermani_scaffold_108:458909-459909",159,-21.62,2,20,178,196,18,"77.78%","83.33%","Peve_00001455",0.743868164611713,0.465978058428886,0.978262075707395,"O35244","Peroxiredoxin-6 (EC 1.11.1.27) (1-Cys peroxiredoxin) (1-Cys PRX) (Acidic calcium-independent phospholipase A2) (aiPLA2) (EC 3.1.1.4) (Antioxidant protein 2) (Glutathione-dependent peroxiredoxin) (Lysophosphatidylcholine acyltransferase 5) (LPC acyltransferase 5) (LPCAT-5) (Lyso-PC acyltransferase 5) (EC 2.3.1.23) (Non-selenium glutathione peroxidase) (NSGPx) (Thiol-specific antioxidant protein)","Rattus norvegicus (Rat)","bleb assembly [GO:0032060]; cell redox homeostasis [GO:0045454]; cellular oxidant detoxification [GO:0098869]; glycerophospholipid catabolic process [GO:0046475]; hydrogen peroxide catabolic process [GO:0042744]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]","GO:0000302; GO:0004601; GO:0004602; GO:0004623; GO:0005634; GO:0005737; GO:0005739; GO:0005764; GO:0005829; GO:0006979; GO:0031625; GO:0032060; GO:0042744; GO:0042802; GO:0045454; GO:0046475; GO:0047184; GO:0047499; GO:0048026; GO:0048471; GO:0051920; GO:0098869"
"2334",2334,"Cluster_4629","Porites_evermani_scaffold_1137:25604-26604",140,-21.96,2,9,1,17,7,"100.00%","100.00%","Peve_00002365",0.997938030915672,0.0408894104551393,0.909359886114279,NA,NA,NA,NA,NA
"2335",2335,"Cluster_4629","Porites_evermani_scaffold_1144:119483-120483",161,-23.63,2,21,861,885,22,"77.27%","81.82%","Peve_00002477",0.997938030915672,0.0408894104551393,0.909359886114279,NA,NA,NA,NA,NA
"2336",2336,"Cluster_4629","Porites_evermani_scaffold_1144:83964-84964",157,-21.45,2,19,920,944,20,"70.00%","80.00%","Peve_00002474",NA,NA,NA,NA,NA,NA,NA,NA
"2337",2337,"Cluster_4629","Porites_evermani_scaffold_1:1484980-1485980",161,-25.67,2,19,566,588,18,"77.78%","83.33%","Peve_00000081",NA,NA,NA,NA,NA,NA,NA,NA
"2338",2338,"Cluster_4629","Porites_evermani_scaffold_1:1551339-1552339",172,-21,2,21,130,151,19,"78.95%","84.21%","Peve_00000084",-0.82233803091896,0.385338565133516,0.978262075707395,"H2LRU7","Polycystin-2 (Polycystic kidney disease 2 protein homolog)","Oryzias latipes (Japanese rice fish) (Japanese killifish)","calcium ion transmembrane transport [GO:0070588]; cell-cell signaling by wnt [GO:0198738]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus [GO:0050982]; detection of nodal flow [GO:0003127]; inorganic cation transmembrane transport [GO:0098662]; potassium ion transmembrane transport [GO:0071805]; protein heterotetramerization [GO:0051290]; protein tetramerization [GO:0051262]; regulation of ion transmembrane transport [GO:0034765]; release of sequestered calcium ion into cytosol [GO:0051209]; Wnt signaling pathway [GO:0016055]","GO:0003127; GO:0005102; GO:0005245; GO:0005248; GO:0005261; GO:0005262; GO:0005267; GO:0005509; GO:0005789; GO:0005886; GO:0005929; GO:0015271; GO:0016020; GO:0016055; GO:0016323; GO:0030659; GO:0034703; GO:0034765; GO:0050982; GO:0051209; GO:0051262; GO:0051290; GO:0051371; GO:0060170; GO:0070588; GO:0071277; GO:0071805; GO:0098662; GO:0198738"
"2339",2339,"Cluster_4629","Porites_evermani_scaffold_1162:137434-138434",147,-20.17,2,12,751,772,10,"90.00%","90.00%","Peve_00002771",0.605020987682788,0.586329420578943,0.978262075707395,"E7FAM5","E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71)","Danio rerio (Zebrafish) (Brachydanio rerio)","embryonic body morphogenesis [GO:0010172]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA metabolic process [GO:0010586]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of translation [GO:0017148]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of miRNA-mediated gene silencing [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089]","GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0010172; GO:0010586; GO:0017148; GO:0021915; GO:0030371; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0060964; GO:0061630; GO:0072089; GO:2000177"
"2340",2340,"Cluster_4629","Porites_evermani_scaffold_1171:45437-46437",165,-23.01,2,20,687,707,18,"77.78%","88.89%","Peve_00002900",0.618106009483945,0.575800480167698,0.978262075707395,"A0A2B4RP11",NA,NA,NA,NA
"2341",2341,"Cluster_4629","Porites_evermani_scaffold_117:215251-216251",150,-21.56,2,21,949,973,22,"63.64%","77.27%","Peve_00002862",-0.883927636586406,0.309779517609428,0.978262075707395,NA,NA,NA,NA,NA
"2342",2342,"Cluster_4629","Porites_evermani_scaffold_121:457406-458406",148,-22.02,2,21,527,546,19,"73.68%","73.68%","Peve_00003525",-0.330415442966395,0.785622298663783,0.994872125597952,"P53667","LIM domain kinase 1 (LIMK-1) (EC 2.7.11.1)","Homo sapiens (Human)","actin cytoskeleton organization [GO:0030036]; axon extension [GO:0048675]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; nervous system development [GO:0007399]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of axon extension [GO:0045773]; positive regulation of stress fiber assembly [GO:0051496]; protein phosphorylation [GO:0006468]; Rho protein signal transduction [GO:0007266]; signal transduction [GO:0007165]; stress fiber assembly [GO:0043149]","GO:0001673; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005925; GO:0006468; GO:0007165; GO:0007266; GO:0007399; GO:0016020; GO:0016607; GO:0030027; GO:0030036; GO:0031072; GO:0032233; GO:0038096; GO:0043005; GO:0043149; GO:0045773; GO:0046872; GO:0048675; GO:0051444; GO:0051496; GO:0106310"
"2343",2343,"Cluster_4629","Porites_evermani_scaffold_1220:111564-112564",146,-20.5,2,15,551,572,13,"76.92%","76.92%","Peve_00003681",-0.443383362280846,0.707556077121805,0.978262075707395,NA,NA,NA,NA,NA
"2344",2344,"Cluster_4629","Porites_evermani_scaffold_1260:10376-11376",155,-21.05,2,20,50,71,18,"72.22%","72.22%","Peve_00004235",-0.68075769828541,0.523301325890193,0.978262075707395,NA,NA,NA,NA,NA
"2345",2345,"Cluster_4629","Porites_evermani_scaffold_1261:77438-78438",163,-22.61,2,20,153,174,18,"72.22%","83.33%","Peve_00004251",-0.421947721688668,0.722693149967351,0.982309858021349,NA,NA,NA,NA,NA
"2346",2346,"Cluster_4629","Porites_evermani_scaffold_127:149335-150335",154,-20.8,2,21,124,144,19,"63.16%","84.21%","Peve_00004338",-0.344156970817176,0.776329526305787,0.992668200478906,"O08919","Numb-like protein","Mus musculus (Mouse)","adherens junction organization [GO:0034332]; axonogenesis [GO:0007409]; cytokine-mediated signaling pathway [GO:0019221]; forebrain development [GO:0030900]; lateral ventricle development [GO:0021670]; nervous system development [GO:0007399]; neuroblast division in subventricular zone [GO:0021849]; neuroblast proliferation [GO:0007405]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of neurogenesis [GO:0050769]; protein metabolic process [GO:0019538]; regulation of postsynapse assembly [GO:0150052]","GO:0005737; GO:0007399; GO:0007405; GO:0007409; GO:0019221; GO:0019538; GO:0021670; GO:0021849; GO:0030900; GO:0034332; GO:0050769; GO:0050775; GO:0098978; GO:0150052"
"2347",2347,"Cluster_4629","Porites_evermani_scaffold_1273:10135-11135",164,-21.33,2,21,69,90,19,"73.68%","78.95%","Peve_00004402",NA,NA,NA,NA,NA,NA,NA,NA
"2348",2348,"Cluster_4629","Porites_evermani_scaffold_1288:64366-65366",154,-22.21,2,17,33,57,18,"77.78%","83.33%","Peve_00004587",0.561248659377929,0.620642278733236,0.978262075707395,"Q924H0","Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide NPFF receptor)","Mus musculus (Mouse)","G protein-coupled receptor signaling pathway [GO:0007186]; regulation of adenylate cyclase activity [GO:0045761]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of MAPK cascade [GO:0043408]","GO:0004930; GO:0005886; GO:0007186; GO:0008188; GO:0015629; GO:0031628; GO:0042277; GO:0043408; GO:0045761; GO:2000479"
"2349",2349,"Cluster_4629","Porites_evermani_scaffold_1307:128934-129934",145,-21.55,2,15,452,474,14,"78.57%","78.57%","Peve_00004885",-0.55946759778136,0.622011260277229,0.978262075707395,"Q9D5V5","Cullin-5 (CUL-5)","Mus musculus (Mouse)","cerebral cortex radially oriented cell migration [GO:0021799]; protein ubiquitination [GO:0016567]; radial glia guided migration of Purkinje cell [GO:0021942]; regulation of cytosolic calcium ion concentration [GO:0051480]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]","GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0016567; GO:0019005; GO:0021799; GO:0021942; GO:0030674; GO:0031146; GO:0031461; GO:0031466; GO:0031625; GO:0051480; GO:0090734"
"2350",2350,"Cluster_4629","Porites_evermani_scaffold_1316:116933-117933",159,-20.52,2,21,860,882,20,"75.00%","75.00%","Peve_00005010",NA,NA,NA,NA,NA,NA,NA,NA
"2351",2351,"Cluster_4629","Porites_evermani_scaffold_133:270053-271053",168,-23.85,2,21,353,374,19,"73.68%","84.21%","Peve_00005213",-0.790981427900404,0.419140863718246,0.978262075707395,NA,NA,NA,NA,NA
"2352",2352,"Cluster_4629","Porites_evermani_scaffold_1347:20083-21083",172,-30.34,2,21,633,654,19,"73.68%","89.47%","Peve_00005452",0.997938030915672,0.0408894104551393,0.909359886114279,"Q9FGB1",NA,NA,NA,NA
"2353",2353,"Cluster_4629","Porites_evermani_scaffold_1350:65858-66858",163,-27.5,2,21,148,170,20,"70.00%","85.00%","Peve_00005524",NA,NA,NA,NA,NA,NA,NA,NA
"2354",2354,"Cluster_4629","Porites_evermani_scaffold_1366:22223-23223",155,-21.74,2,16,760,781,14,"78.57%","85.71%","Peve_00005735",NA,NA,NA,NA,NA,NA,NA,NA
"2355",2355,"Cluster_4629","Porites_evermani_scaffold_1390:56629-57629",141,-22.81,2,10,96,117,8,"87.50%","100.00%","Peve_00006053",-0.443383362280846,0.707556077121805,0.978262075707395,NA,NA,NA,NA,NA
"2356",2356,"Cluster_4629","Porites_evermani_scaffold_139:112881-113881",162,-25.77,2,19,550,571,17,"76.47%","82.35%","Peve_00006032",-0.784115997510351,0.426233415513041,0.978262075707395,NA,NA,NA,NA,NA
"2357",2357,"Cluster_4629","Porites_evermani_scaffold_1420:88540-89540",158,-20.84,2,21,769,789,19,"68.42%","84.21%","Peve_00006531",0.739183677280466,0.470423069398487,0.978262075707395,"P24603","Rhodopsin","Loligo forbesii (Veined squid)","phototransduction [GO:0007602]; visual perception [GO:0007601]","GO:0004930; GO:0005886; GO:0007601; GO:0007602; GO:0009881; GO:0016020; GO:0016918"
"2358",2358,"Cluster_4629","Porites_evermani_scaffold_1423:100271-101271",157,-20.09,2,19,736,759,19,"73.68%","78.95%","Peve_00006548",-0.269348508899236,0.826383299750636,0.995934364227446,NA,NA,NA,NA,NA
"2359",2359,"Cluster_4629","Porites_evermani_scaffold_142:356238-357238",143,-20.37,2,21,832,858,24,"54.17%","70.83%","Peve_00006521",0.879987510700739,0.315101590178005,0.978262075707395,"Q5R7A7","Serine/threonine-protein kinase Sgk3 (EC 2.7.11.1) (Serum/glucocorticoid-regulated kinase 3)","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; protein phosphorylation [GO:0006468]","GO:0004674; GO:0005524; GO:0005769; GO:0006468; GO:0035091; GO:0055037; GO:0106310; GO:2001240"
"2360",2360,"Cluster_4629","Porites_evermani_scaffold_145:120373-121373",146,-27.42,2,21,802,831,27,"59.26%","70.37%","Peve_00006832",0.916348873387069,0.262244254911181,0.978262075707395,NA,NA,NA,NA,NA
"2361",2361,"Cluster_4629","Porites_evermani_scaffold_145:167905-168905",163,-22.02,2,21,196,218,20,"70.00%","85.00%","Peve_00006839",-0.916455645489068,0.262074431589912,0.978262075707395,NA,NA,NA,NA,NA
"2362",2362,"Cluster_4629","Porites_evermani_scaffold_147:401006-402006",156,-20.53,2,21,732,753,19,"68.42%","73.68%","Peve_00007100",0.577186840756608,0.608300863580568,0.978262075707395,"Q7TSH2","Phosphorylase b kinase regulatory subunit beta (Phosphorylase kinase subunit beta)","Mus musculus (Mouse)","glycogen metabolic process [GO:0005977]; protein phosphorylation [GO:0006468]","GO:0005516; GO:0005886; GO:0005964; GO:0005977; GO:0006468"
"2363",2363,"Cluster_4629","Porites_evermani_scaffold_1484:80754-81754",151,-20.44,2,21,596,619,21,"66.67%","71.43%","Peve_00007266",-0.995540363242901,0.0601459509429835,0.978262075707395,NA,NA,NA,NA,NA
"2364",2364,"Cluster_4629","Porites_evermani_scaffold_1484:80754-81754",160,-22.71,2,21,544,565,19,"73.68%","73.68%","Peve_00007266",-0.995540363242901,0.0601459509429835,0.978262075707395,NA,NA,NA,NA,NA
"2365",2365,"Cluster_4629","Porites_evermani_scaffold_14:942538-943538",151,-22.31,2,21,434,459,23,"60.87%","73.91%","Peve_00006204",-0.100362844756586,0.935999277029594,0.999448381576871,"Q91Z40","Guanylate-binding protein 7 (EC 3.6.5.-) (GTP-binding protein 7) (GBP-7) (Guanine nucleotide-binding protein 7) (Guanylate-binding protein 4-like)","Mus musculus (Mouse)","adhesion of symbiont to host [GO:0044406]; cellular response to interferon-beta [GO:0035458]; cellular response to type II interferon [GO:0071346]; defense response to Gram-positive bacterium [GO:0050830]; defense response to protozoan [GO:0042832]; defense response to virus [GO:0051607]; negative regulation of cytokine production [GO:0001818]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of type I interferon production [GO:0032480]; negative regulation of type III interferon production [GO:0034345]; positive regulation of viral genome replication [GO:0045070]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]","GO:0001818; GO:0003924; GO:0005525; GO:0016020; GO:0020005; GO:0031410; GO:0032480; GO:0034345; GO:0035458; GO:0042832; GO:0043122; GO:0044406; GO:0045070; GO:0046426; GO:0050830; GO:0051607; GO:0071346"
"2366",2366,"Cluster_4629","Porites_evermani_scaffold_150:140818-141818",151,-20.27,2,16,520,541,14,"71.43%","85.71%","Peve_00007551",-0.266755449943795,0.828096799427902,0.995934364227446,NA,NA,NA,NA,NA
"2367",2367,"Cluster_4629","Porites_evermani_scaffold_151:283063-284063",167,-21.24,2,16,296,317,14,"92.86%","92.86%","Peve_00007657",-0.554554668634826,0.625777256211528,0.978262075707395,NA,NA,NA,NA,NA
"2368",2368,"Cluster_4629","Porites_evermani_scaffold_15:338535-339535",165,-23.62,2,19,574,597,19,"78.95%","84.21%","Peve_00007506",-0.701533887660424,0.504997800721965,0.978262075707395,"Q7TN88","Polycystic kidney disease protein 1-like 2 (PC1-like 2 protein) (Polycystin-1L2)","Mus musculus (Mouse)","detection of mechanical stimulus [GO:0050982]","GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982"
"2369",2369,"Cluster_4629","Porites_evermani_scaffold_1539:4177-5177",155,-20.95,2,12,212,233,10,"100.00%","100.00%","Peve_00007966",-0.334425746837908,0.782915314468838,0.994224010516173,"P46023","G-protein coupled receptor GRL101","Lymnaea stagnalis (Great pond snail) (Helix stagnalis)","","GO:0004930; GO:0005886"
"2370",2370,"Cluster_4629","Porites_evermani_scaffold_155:414946-415946",162,-20.12,2,15,174,195,13,"92.31%","92.31%","Peve_00008118",-0.596421250067171,0.59317759727259,0.978262075707395,"P78357","Contactin-associated protein 1 (Caspr) (Caspr1) (Neurexin IV) (Neurexin-4) (p190)","Homo sapiens (Human)","axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; central nervous system myelination [GO:0022010]; cytoskeleton organization [GO:0007010]; mitochondrion organization [GO:0007005]; myelination in peripheral nervous system [GO:0022011]; neuromuscular junction development, skeletal muscle fiber [GO:0098529]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; neuron projection morphogenesis [GO:0048812]; neuronal action potential propagation [GO:0019227]; paranodal junction assembly [GO:0030913]; paranodal junction maintenance [GO:1990227]; postsynaptic density organization [GO:0097106]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; regulation of synapse maturation [GO:0090128]; signal transduction [GO:0007165]","GO:0002175; GO:0005886; GO:0007005; GO:0007010; GO:0007155; GO:0007165; GO:0007409; GO:0016020; GO:0017124; GO:0019227; GO:0022010; GO:0022011; GO:0030913; GO:0033010; GO:0033270; GO:0038023; GO:0048786; GO:0048812; GO:0050884; GO:0050885; GO:0071205; GO:0090128; GO:0097106; GO:0098529; GO:0098978; GO:1990227"
"2371",2371,"Cluster_4629","Porites_evermani_scaffold_1601:43555-44555",163,-23.97,2,16,900,921,14,"85.71%","92.86%","Peve_00008849",0.882869435565999,0.311217078533245,0.978262075707395,NA,NA,NA,NA,NA
"2372",2372,"Cluster_4629","Porites_evermani_scaffold_1617:69447-70447",147,-21.78,2,21,467,489,20,"65.00%","70.00%","Peve_00009025",-0.323654672359315,0.790176792976558,0.995919926835577,"Q8WUM4","Programmed cell death 6-interacting protein (PDCD6-interacting protein) (ALG-2-interacting protein 1) (ALG-2-interacting protein X) (Hp95)","Homo sapiens (Human)","actomyosin contractile ring assembly [GO:0000915]; apoptotic process [GO:0006915]; bicellular tight junction assembly [GO:0070830]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; midbody abscission [GO:0061952]; mitotic cytokinesis [GO:0000281]; multivesicular body assembly [GO:0036258]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of extracellular exosome assembly [GO:1903553]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of extracellular exosome assembly [GO:1903551]; regulation of membrane permeability [GO:0090559]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702]","GO:0000281; GO:0000915; GO:0001772; GO:0005768; GO:0005815; GO:0005829; GO:0005923; GO:0005925; GO:0006915; GO:0010824; GO:0015031; GO:0016020; GO:0031871; GO:0036258; GO:0039702; GO:0042470; GO:0042641; GO:0042803; GO:0045199; GO:0046755; GO:0048306; GO:0051260; GO:0061952; GO:0070062; GO:0070830; GO:0070971; GO:0090543; GO:0090559; GO:0090611; GO:1903543; GO:1903551; GO:1903553; GO:1903561"
"2373",2373,"Cluster_4629","Porites_evermani_scaffold_1632:72457-73457",152,-21.7,2,19,153,173,17,"70.59%","82.35%","Peve_00009219",-0.554554668634826,0.625777256211528,0.978262075707395,"P25931","RYamide receptor (Neuropeptide Y-like receptor) (NPY-R)","Drosophila melanogaster (Fruit fly)","G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]","GO:0001653; GO:0004983; GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0016020"
"2374",2374,"Cluster_4629","Porites_evermani_scaffold_1641:104582-105582",167,-25.57,2,21,78,100,20,"80.00%","80.00%","Peve_00009311",-0.516235299562245,0.654666000827079,0.978262075707395,"Q9H2X6","Homeodomain-interacting protein kinase 2 (hHIPk2) (EC 2.7.11.1)","Homo sapiens (Human)","adult walking behavior [GO:0007628]; anterior/posterior pattern specification [GO:0009952]; cell population proliferation [GO:0008283]; cellular response to hypoxia [GO:0071456]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; erythrocyte differentiation [GO:0030218]; eye development [GO:0001654]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; iris morphogenesis [GO:0061072]; lens induction in camera-type eye [GO:0060235]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; PML body organization [GO:0030578]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein binding [GO:0032092]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of signal transduction by p53 class mediator [GO:1901796]; retina layer formation [GO:0010842]; SMAD protein signal transduction [GO:0060395]; smoothened signaling pathway [GO:0007224]; transforming growth factor beta receptor signaling pathway [GO:0007179]; voluntary musculoskeletal movement [GO:0050882]","GO:0000122; GO:0001654; GO:0001934; GO:0003713; GO:0003714; GO:0004672; GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006468; GO:0006978; GO:0007179; GO:0007224; GO:0007628; GO:0008283; GO:0008284; GO:0009952; GO:0010494; GO:0010842; GO:0016604; GO:0016605; GO:0018105; GO:0018107; GO:0030182; GO:0030218; GO:0030511; GO:0030514; GO:0030578; GO:0032092; GO:0042771; GO:0043388; GO:0043524; GO:0045766; GO:0045893; GO:0045944; GO:0046330; GO:0046332; GO:0046790; GO:0048596; GO:0050882; GO:0051091; GO:0051402; GO:0051726; GO:0060059; GO:0060235; GO:0060395; GO:0061072; GO:0061629; GO:0071456; GO:0090575; GO:0097193; GO:0106310; GO:1901796; GO:2000059"
"2375",2375,"Cluster_4629","Porites_evermani_scaffold_1654:21847-22847",159,-21.5,2,21,367,390,21,"71.43%","76.19%","Peve_00009458",-0.281173880402381,0.818552466116687,0.995934364227446,"Q14674","Separin (EC 3.4.22.49) (Caspase-like protein ESPL1) (Extra spindle poles-like 1 protein) (Separase)","Homo sapiens (Human)","apoptotic process [GO:0006915]; establishment of mitotic spindle localization [GO:0040001]; homologous chromosome segregation [GO:0045143]; meiotic chromosome separation [GO:0051307]; meiotic spindle organization [GO:0000212]; mitotic cytokinesis [GO:0000281]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of sister chromatid cohesion [GO:0045875]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; proteolysis [GO:0006508]","GO:0000070; GO:0000212; GO:0000281; GO:0003824; GO:0004197; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0006508; GO:0006915; GO:0008234; GO:0040001; GO:0045143; GO:0045842; GO:0045875; GO:0051307; GO:0072686"
"2376",2376,"Cluster_4629","Porites_evermani_scaffold_1657:98762-99762",155,-21.78,2,20,508,529,18,"61.11%","83.33%","Peve_00009475",0.91544629829297,0.263675699734702,0.978262075707395,NA,NA,NA,NA,NA
"2377",2377,"Cluster_4629","Porites_evermani_scaffold_166:197887-198887",168,-26.37,2,21,684,705,19,"68.42%","89.47%","Peve_00009504",-0.333293904336629,0.783679727791193,0.994451161479978,"Q5F371","Protein strawberry notch homolog 1","Gallus gallus (Chicken)","regulation of DNA-templated transcription [GO:0006355]; regulation of response to stimulus [GO:0048583]","GO:0005634; GO:0006355; GO:0031490; GO:0042393; GO:0048583"
"2378",2378,"Cluster_4629","Porites_evermani_scaffold_1686:37355-38355",161,-21.15,2,18,183,204,16,"75.00%","87.50%","Peve_00009813",0.997938030915672,0.0408894104551393,0.909359886114279,NA,NA,NA,NA,NA
"2379",2379,"Cluster_4629","Porites_evermani_scaffold_1720:49819-50819",157,-23.38,2,19,265,287,18,"72.22%","83.33%","Peve_00010285",NA,NA,NA,NA,NA,NA,NA,NA
"2380",2380,"Cluster_4629","Porites_evermani_scaffold_1722:99891-100891",159,-22.6,2,21,761,783,20,"70.00%","80.00%","Peve_00010301",-0.691658603958334,0.513760604824189,0.978262075707395,"Q63570","26S proteasome regulatory subunit 6B (26S proteasome AAA-ATPase subunit RPT3) (Proteasome 26S subunit ATPase 4) (S6 ATPase) (Tat-binding protein 7) (TBP-7)","Rattus norvegicus (Rat)","blastocyst development [GO:0001824]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]","GO:0000502; GO:0001824; GO:0005524; GO:0005634; GO:0008540; GO:0016234; GO:0016887; GO:0022624; GO:0031597; GO:0036402; GO:0043161; GO:0045202"
"2381",2381,"Cluster_4629","Porites_evermani_scaffold_173:349159-350159",153,-22.05,2,20,401,421,18,"72.22%","77.78%","Peve_00010380",-0.958365734688354,0.184348243057148,0.978262075707395,"O42574","Beta-1 adrenergic receptor (Beta-1 adrenoreceptor) (Beta-1 adrenoceptor) (x-BETA1AR)","Xenopus laevis (African clawed frog)","adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; positive regulation of GTPase activity [GO:0043547]; positive regulation of heart contraction [GO:0045823]","GO:0004940; GO:0005085; GO:0005769; GO:0005886; GO:0043547; GO:0045823; GO:0071880"
"2382",2382,"Cluster_4629","Porites_evermani_scaffold_17:364343-365343",157,-20.21,2,20,239,263,21,"71.43%","80.95%","Peve_00010031",0.976225578179013,0.139095891662677,0.978262075707395,NA,NA,NA,NA,NA
"2383",2383,"Cluster_4629","Porites_evermani_scaffold_1744:74487-75487",162,-25.77,2,19,565,586,17,"76.47%","82.35%","Peve_00010520",0.392975900551201,0.742891157571256,0.98675746977261,NA,NA,NA,NA,NA
"2384",2384,"Cluster_4629","Porites_evermani_scaffold_175:268628-269628",150,-21.48,2,11,565,586,9,"100.00%","100.00%","Peve_00010575",-0.443383362280846,0.707556077121805,0.978262075707395,NA,NA,NA,NA,NA
"2385",2385,"Cluster_4629","Porites_evermani_scaffold_1772:71637-72637",158,-21.7,2,21,797,817,19,"68.42%","84.21%","Peve_00010794",0.968216292956042,0.160936461450943,0.978262075707395,"Q5R5D8","Gamma-butyrobetaine dioxygenase (EC 1.14.11.1) (Gamma-butyrobetaine hydroxylase) (Gamma-BBH) (Gamma-butyrobetaine,2-oxoglutarate dioxygenase)","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","carnitine biosynthetic process [GO:0045329]","GO:0005506; GO:0005737; GO:0008270; GO:0008336; GO:0045329"
"2386",2386,"Cluster_4629","Porites_evermani_scaffold_1780:15505-16505",159,-20.88,2,21,339,361,20,"70.00%","80.00%","Peve_00010903",-0.418844891992169,0.724870198300146,0.983021525332294,"A2AAY5","SH3 and PX domain-containing protein 2B (Factor for adipocyte differentiation 49) (Tyrosine kinase substrate with four SH3 domains)","Mus musculus (Mouse)","adipose tissue development [GO:0060612]; bone development [GO:0060348]; cranial skeletal system development [GO:1904888]; extracellular matrix disassembly [GO:0022617]; eye development [GO:0001654]; heart development [GO:0007507]; osteoblast fate commitment [GO:0002051]; podosome assembly [GO:0071800]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of gene expression [GO:0010628]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of stress fiber assembly [GO:0051496]; protein localization to membrane [GO:0072657]; regulation of brood size [GO:0060378]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]","GO:0001501; GO:0001654; GO:0002051; GO:0002102; GO:0005737; GO:0006801; GO:0007507; GO:0010314; GO:0010628; GO:0016176; GO:0022617; GO:0032266; GO:0040018; GO:0042169; GO:0042554; GO:0042995; GO:0045600; GO:0048705; GO:0051496; GO:0060348; GO:0060378; GO:0060612; GO:0070161; GO:0070273; GO:0071800; GO:0072657; GO:0080025; GO:1904179; GO:1904888"
"2387",2387,"Cluster_4629","Porites_evermani_scaffold_1788:44190-45190",147,-20.3,2,21,266,286,21,"66.67%","76.19%","Peve_00010976",-0.443383362280846,0.707556077121805,0.978262075707395,NA,NA,NA,NA,NA
"2388",2388,"Cluster_4629","Porites_evermani_scaffold_17:955669-956669",155,-28.23,2,21,578,602,22,"63.64%","77.27%","Peve_00010001",0.748368259944358,0.461675238383681,0.978262075707395,"Q9Z0R0","Serine/threonine-protein kinase haspin (EC 2.7.11.1) (Germ cell-specific gene 2 protein) (Haploid germ cell-specific nuclear protein kinase)","Mus musculus (Mouse)","chromatin organization [GO:0006325]; chromosome organization involved in meiotic cell cycle [GO:0070192]; gene expression [GO:0010467]; homologous chromosome segregation [GO:0045143]; intracellular signal transduction [GO:0035556]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid cohesion [GO:0007064]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; protein localization to chromosome, centromeric region [GO:0071459]; protein phosphorylation [GO:0006468]","GO:0000278; GO:0001673; GO:0003677; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005813; GO:0005819; GO:0006325; GO:0006468; GO:0007064; GO:0007094; GO:0010467; GO:0035173; GO:0035556; GO:0045143; GO:0070192; GO:0071459; GO:0072354; GO:0106310; GO:2000134"
"2389",2389,"Cluster_4629","Porites_evermani_scaffold_180:165139-166139",156,-20.44,2,20,746,765,18,"72.22%","83.33%","Peve_00011173",NA,NA,NA,NA,NA,NA,NA,NA
"2390",2390,"Cluster_4629","Porites_evermani_scaffold_1821:80320-81320",153,-20.92,2,20,400,420,18,"66.67%","83.33%","Peve_00011418",NA,NA,NA,NA,NA,NA,NA,NA
"2391",2391,"Cluster_4629","Porites_evermani_scaffold_18:221018-222018",156,-25.45,2,19,131,151,17,"76.47%","82.35%","Peve_00011134",NA,NA,NA,NA,NA,NA,NA,NA
"2392",2392,"Cluster_4629","Porites_evermani_scaffold_1829:19242-20242",154,-23.42,2,15,594,615,13,"84.62%","84.62%","Peve_00011483",NA,NA,NA,NA,NA,NA,NA,NA
"2393",2393,"Cluster_4629","Porites_evermani_scaffold_1831:24858-25858",153,-20.61,2,18,922,943,16,"62.50%","87.50%","Peve_00011526",-0.470485049948399,0.688157924644645,0.978262075707395,"P62516","POU domain, class 3, transcription factor 4 (Brain-specific homeobox/POU domain protein 4) (Brain-4) (Brn-4) (Octamer-binding protein 9) (Oct-9) (Octamer-binding transcription factor 9) (OTF-9) (RHS2 class III POU protein)","Rattus norvegicus (Rat)","cochlea morphogenesis [GO:0090103]; forebrain neuron differentiation [GO:0021879]; inner ear development [GO:0048839]; negative regulation of mesenchymal cell apoptotic process [GO:2001054]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory perception of sound [GO:0007605]; transcription by RNA polymerase II [GO:0006366]","GO:0000977; GO:0000978; GO:0000981; GO:0003680; GO:0003690; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0006366; GO:0007605; GO:0021879; GO:0043565; GO:0048839; GO:0090103; GO:1990837; GO:2001054"
"2394",2394,"Cluster_4629","Porites_evermani_scaffold_1835:97478-98478",159,-21.29,2,21,383,407,22,"68.18%","77.27%","Peve_00011548",NA,NA,NA,NA,NA,NA,NA,NA
"2395",2395,"Cluster_4629","Porites_evermani_scaffold_1858:54893-55893",148,-23.02,2,21,124,145,19,"57.89%","73.68%","Peve_00011778",-0.0428580854289105,0.972707335792973,0.999448381576871,"P42858","Huntingtin (Huntington disease protein) (HD protein) [Cleaved into: Huntingtin, myristoylated N-terminal fragment]","Homo sapiens (Human)","apoptotic process [GO:0006915]; establishment of mitotic spindle orientation [GO:0000132]; Golgi organization [GO:0007030]; microtubule-based transport [GO:0099111]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of aggrephagy [GO:1905337]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of cilium assembly [GO:0045724]; positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031587]; positive regulation of lipophagy [GO:1904504]; protein destabilization [GO:0031648]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of phosphoprotein phosphatase activity [GO:0043666]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle transport along microtubule [GO:0047496]; vocal learning [GO:0042297]","GO:0000132; GO:0002039; GO:0005522; GO:0005634; GO:0005654; GO:0005737; GO:0005769; GO:0005770; GO:0005776; GO:0005783; GO:0005794; GO:0005814; GO:0005829; GO:0006890; GO:0006915; GO:0007030; GO:0016234; GO:0019900; GO:0030424; GO:0030425; GO:0030659; GO:0031072; GO:0031587; GO:0031648; GO:0032991; GO:0034452; GO:0042297; GO:0042802; GO:0043065; GO:0043666; GO:0044325; GO:0045505; GO:0045724; GO:0047496; GO:0048471; GO:0048487; GO:0099111; GO:0099523; GO:0099524; GO:1903599; GO:1904504; GO:1905289; GO:1905337; GO:2000479; GO:2001237"
"2396",2396,"Cluster_4629","Porites_evermani_scaffold_186:181644-182644",142,-20.88,2,21,936,959,21,"61.90%","71.43%","Peve_00011804",0.86892430703146,0.329623592772481,0.978262075707395,NA,NA,NA,NA,NA
"2397",2397,"Cluster_4629","Porites_evermani_scaffold_1873:73495-74495",161,-24.17,2,20,324,348,21,"76.19%","80.95%","Peve_00011950",0.543039478454836,0.634546777725813,0.978262075707395,NA,NA,NA,NA,NA
"2398",2398,"Cluster_4629","Porites_evermani_scaffold_1903:1390-2390",155,-22.47,2,18,629,649,16,"75.00%","87.50%","Peve_00012332",-0.554554668634826,0.625777256211528,0.978262075707395,NA,NA,NA,NA,NA
"2399",2399,"Cluster_4629","Porites_evermani_scaffold_191:123250-124250",143,-22.57,2,21,222,247,23,"60.87%","65.22%","Peve_00012396",-0.504899951317957,0.663058765170343,0.978262075707395,NA,NA,NA,NA,NA
"2400",2400,"Cluster_4629","Porites_evermani_scaffold_1923:49111-50111",146,-20.05,2,20,292,314,19,"68.42%","68.42%","Peve_00012552",-0.443383362280846,0.707556077121805,0.978262075707395,NA,NA,NA,NA,NA
"2401",2401,"Cluster_4629","Porites_evermani_scaffold_1940:94526-95526",141,-21.42,2,10,517,538,8,"87.50%","100.00%","Peve_00012742",-0.443383362280846,0.707556077121805,0.978262075707395,NA,NA,NA,NA,NA
"2402",2402,"Cluster_4629","Porites_evermani_scaffold_194:158626-159626",154,-22.91,2,20,34,57,20,"60.00%","85.00%","Peve_00012721",-0.0896627466935657,0.942842161570466,0.999448381576871,"B2RQL2","Storkhead-box protein 1","Mus musculus (Mouse)","cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to nitrosative stress [GO:0071500]; inner ear development [GO:0048839]; negative regulation of gene expression [GO:0010629]; positive regulation of cell cycle [GO:0045787]; positive regulation of cyclin-dependent protein kinase activity [GO:1904031]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of gene expression [GO:0010628]; positive regulation of otic vesicle morphogenesis [GO:1904120]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of mitochondrial DNA metabolic process [GO:1901858]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of mitochondrion organization [GO:0010821]; regulation of mitotic cell cycle [GO:0007346]; regulation of response to oxidative stress [GO:1902882]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]","GO:0000977; GO:0001228; GO:0001650; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005938; GO:0007049; GO:0007346; GO:0010468; GO:0010628; GO:0010629; GO:0010800; GO:0010821; GO:0010971; GO:0033138; GO:0045787; GO:0045944; GO:0048839; GO:0051301; GO:0051881; GO:0051897; GO:0061418; GO:0071500; GO:1900087; GO:1901858; GO:1902882; GO:1904031; GO:1904120"
"2403",2403,"Cluster_4629","Porites_evermani_scaffold_1944:10374-11374",150,-21.1,2,21,354,379,23,"65.22%","73.91%","Peve_00012765",0.819960430657554,0.387990745488474,0.978262075707395,NA,NA,NA,NA,NA
"2404",2404,"Cluster_4629","Porites_evermani_scaffold_1945:90428-91428",159,-22.15,2,17,426,448,16,"81.25%","87.50%","Peve_00012774",0.0494158323013178,0.968528086543132,0.999448381576871,"Q6DIF4","WD repeat-containing protein 1 (Actin-interacting protein 1) (AIP1)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","actin filament fragmentation [GO:0030043]","GO:0003779; GO:0005634; GO:0005737; GO:0005884; GO:0005886; GO:0030043; GO:0051015"
"2405",2405,"Cluster_4629","Porites_evermani_scaffold_1948:87804-88804",150,-20.23,2,20,67,91,21,"61.90%","76.19%","Peve_00012794",-0.933020029141755,0.234326827475868,0.978262075707395,"A1L1W9","Monocarboxylate transporter 10 (MCT 10) (Solute carrier family 16 member 10)","Danio rerio (Zebrafish) (Brachydanio rerio)","aromatic amino acid transport [GO:0015801]; thyroid hormone transport [GO:0070327]","GO:0005302; GO:0015173; GO:0015192; GO:0015196; GO:0015349; GO:0015801; GO:0016020; GO:0016323; GO:0070327"
"2406",2406,"Cluster_4629","Porites_evermani_scaffold_1977:10816-11816",158,-22.49,2,21,963,983,19,"73.68%","78.95%","Peve_00013081",-0.554554668634826,0.625777256211528,0.978262075707395,NA,NA,NA,NA,NA
"2407",2407,"Cluster_4629","Porites_evermani_scaffold_199:265498-266498",166,-27.77,2,21,255,278,21,"76.19%","85.71%","Peve_00013245",NA,NA,NA,NA,NA,NA,NA,NA
"2408",2408,"Cluster_4629","Porites_evermani_scaffold_1997:26628-27628",156,-23.05,2,21,934,955,19,"63.16%","78.95%","Peve_00013314",-0.554554668634826,0.625777256211528,0.978262075707395,NA,NA,NA,NA,NA
"2409",2409,"Cluster_4629","Porites_evermani_scaffold_1997:27416-27628",156,-23.05,2,21,146,167,19,"63.16%","78.95%","Peve_00013315",-0.554554668634826,0.625777256211528,0.978262075707395,NA,NA,NA,NA,NA
"2410",2410,"Cluster_4629","Porites_evermani_scaffold_2012:71970-72970",149,-22.79,2,20,82,109,24,"66.67%","70.83%","Peve_00013703",0.990276830270465,0.0888488020307703,0.978262075707395,NA,NA,NA,NA,NA
"2411",2411,"Cluster_4629","Porites_evermani_scaffold_2024:36900-37900",163,-24.38,2,16,503,524,14,"85.71%","92.86%","Peve_00013814",0.968205765446467,0.160963255090163,0.978262075707395,"P24524","Glycine receptor subunit alpha-3","Rattus norvegicus (Rat)","cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]","GO:0004888; GO:0005231; GO:0005886; GO:0007165; GO:0007218; GO:0007268; GO:0016594; GO:0016934; GO:0016935; GO:0022852; GO:0030425; GO:0030594; GO:0034220; GO:0042391; GO:0042734; GO:0043005; GO:0043200; GO:0043204; GO:0045202; GO:0046872; GO:0050877; GO:0051260; GO:0060012; GO:0071230; GO:0071294; GO:0071361; GO:0098690; GO:0098793; GO:0098978; GO:0098982; GO:0099171; GO:0099634; GO:1902476; GO:1904315; GO:2000300"
"2412",2412,"Cluster_4629","Porites_evermani_scaffold_2041:33001-34001",166,-25.62,2,21,602,622,19,"78.95%","84.21%","Peve_00013977",NA,NA,NA,NA,NA,NA,NA,NA
"2413",2413,"Cluster_4629","Porites_evermani_scaffold_20:63448-64448",152,-21.54,2,21,867,888,19,"63.16%","73.68%","Peve_00013471",-0.642927557861102,0.555439242975818,0.978262075707395,NA,NA,NA,NA,NA
"2414",2414,"Cluster_4629","Porites_evermani_scaffold_207:7641-8641",143,-20.77,2,18,972,992,16,"68.75%","75.00%","Peve_00014227",-0.426188421485614,0.719712113027259,0.981369881295541,"Q08BH7","Ubiquitin-conjugating enzyme E2 T (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme T) (Ubiquitin carrier protein T) (Ubiquitin-protein ligase T)","Danio rerio (Zebrafish) (Brachydanio rerio)","cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]","GO:0000209; GO:0003682; GO:0004842; GO:0005524; GO:0005634; GO:0006281; GO:0006513; GO:0006974; GO:0051865; GO:0061631"
"2415",2415,"Cluster_4629","Porites_evermani_scaffold_207:8486-9486",143,-20.77,2,18,127,147,16,"68.75%","75.00%","Peve_00014235",-0.881577802812606,0.312963528029334,0.978262075707395,"Q9M9E8","Lysine-specific demethylase JMJ21 (EC 1.14.11.-) (F-box protein JMJ21) (Jumonji domain-containing protein 21) (AtJMJ21) (Protein JUMONJI 21) (Lysine-specific histone demethylase JMJ21) ([histone H3]-trimethyl-L-lysine monodemethylase JMJ21)","Arabidopsis thaliana (Mouse-ear cress)","","GO:0005634; GO:0005737; GO:0016491; GO:0046872"
"2416",2416,"Cluster_4629","Porites_evermani_scaffold_2082:45868-46868",159,-21.59,2,21,798,820,20,"70.00%","80.00%","Peve_00014372",-0.438315167658912,0.711150760772796,0.979150940786481,NA,NA,NA,NA,NA
"2417",2417,"Cluster_4629","Porites_evermani_scaffold_2084:26796-27796",155,-20.02,2,20,479,500,18,"66.67%","77.78%","Peve_00014381",-0.297039833005095,0.808001165793787,0.995934364227446,"B8VIW9","Fibronectin type III domain-containing protein (Neuroglian-like protein)","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0016020"
"2418",2418,"Cluster_4629","Porites_evermani_scaffold_208:61172-62172",161,-25.45,2,18,785,806,16,"75.00%","87.50%","Peve_00014326",0.946223464092175,0.209728401896264,0.978262075707395,NA,NA,NA,NA,NA
"2419",2419,"Cluster_4629","Porites_evermani_scaffold_2:1144979-1145979",150,-22.42,2,16,533,556,16,"75.00%","81.25%","Peve_00013398",-0.746802030097906,0.463176510694124,0.978262075707395,NA,NA,NA,NA,NA
"2420",2420,"Cluster_4629","Porites_evermani_scaffold_2119:25253-26253",161,-26.7,2,19,415,438,19,"78.95%","78.95%","Peve_00014748",-0.579527966285445,0.606473898350742,0.978262075707395,NA,NA,NA,NA,NA
"2421",2421,"Cluster_4629","Porites_evermani_scaffold_2128:42727-43631",141,-20.29,2,10,493,514,8,"87.50%","100.00%","Peve_00014840",NA,NA,NA,NA,NA,NA,NA,NA
"2422",2422,"Cluster_4629","Porites_evermani_scaffold_2:132550-133550",156,-20.92,2,17,423,444,15,"80.00%","80.00%","Peve_00013414",0.152131522127085,0.902772537284604,0.999448381576871,NA,NA,NA,NA,NA
"2423",2423,"Cluster_4629","Porites_evermani_scaffold_2135:42236-43236",161,-23.73,2,19,473,495,18,"77.78%","83.33%","Peve_00014929",0.19118490768233,0.877533976338662,0.998168974281477,NA,NA,NA,NA,NA
"2424",2424,"Cluster_4629","Porites_evermani_scaffold_2153:65467-66467",150,-21.38,2,21,33,53,19,"63.16%","78.95%","Peve_00015095",-0.607715563999278,0.584172155188832,0.978262075707395,NA,NA,NA,NA,NA
"2425",2425,"Cluster_4629","Porites_evermani_scaffold_2187:38027-39027",160,-20.88,2,13,286,307,11,"100.00%","100.00%","Peve_00015369",-0.554554668634826,0.625777256211528,0.978262075707395,NA,NA,NA,NA,NA
"2426",2426,"Cluster_4629","Porites_evermani_scaffold_219:124419-125419",156,-21.82,2,21,916,937,19,"68.42%","73.68%","Peve_00015400",NA,NA,NA,NA,NA,NA,NA,NA
"2427",2427,"Cluster_4629","Porites_evermani_scaffold_2202:2874-3874",147,-22.68,2,21,251,276,23,"60.87%","69.57%","Peve_00015601",0.997938030915672,0.0408894104551393,0.909359886114279,NA,NA,NA,NA,NA
"2428",2428,"Cluster_4629","Porites_evermani_scaffold_220:86816-87816",162,-22.17,2,15,360,381,13,"92.31%","92.31%","Peve_00015569",-0.419763121159664,0.724226297287417,0.982829933689274,"P46530","Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]","Danio rerio (Zebrafish) (Brachydanio rerio)","angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514]","GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314"
"2429",2429,"Cluster_4629","Porites_evermani_scaffold_2228:5086-6086",159,-20.52,2,21,924,946,20,"75.00%","75.00%","Peve_00015840",NA,NA,NA,NA,NA,NA,NA,NA
"2430",2430,"Cluster_4629","Porites_evermani_scaffold_2239:73656-74656",142,-20.12,2,20,483,505,19,"52.63%","78.95%","Peve_00015939",-0.443018251315328,0.707815371036479,0.978262075707395,NA,NA,NA,NA,NA
"2431",2431,"Cluster_4629","Porites_evermani_scaffold_2271:76107-77107",153,-21.02,2,18,4,25,16,"75.00%","75.00%","Peve_00016249",NA,NA,NA,NA,NA,NA,NA,NA
"2432",2432,"Cluster_4629","Porites_evermani_scaffold_2276:72523-73523",167,-24.68,2,21,734,757,21,"76.19%","80.95%","Peve_00016275",NA,NA,NA,NA,NA,NA,NA,NA
"2433",2433,"Cluster_4629","Porites_evermani_scaffold_2296:62926-63926",151,-21.56,2,12,878,899,10,"90.00%","100.00%","Peve_00016450",-0.554554668634826,0.625777256211528,0.978262075707395,NA,NA,NA,NA,NA
"2434",2434,"Cluster_4629","Porites_evermani_scaffold_2319:23854-24854",172,-23.64,2,21,928,949,19,"78.95%","84.21%","Peve_00016720",-0.843703852706025,0.360740786519766,0.978262075707395,NA,NA,NA,NA,NA
"2435",2435,"Cluster_4629","Porites_evermani_scaffold_233:327896-328896",155,-23.98,2,17,632,654,16,"81.25%","81.25%","Peve_00016839",-0.423243377830191,0.721783049880618,0.982031836078578,NA,NA,NA,NA,NA
"2436",2436,"Cluster_4629","Porites_evermani_scaffold_234:210996-211777",145,-21.27,2,20,457,481,21,"61.90%","76.19%","Peve_00016917",-0.652201715493459,0.547691019930977,0.978262075707395,"P35738","2-oxoisovalerate dehydrogenase subunit beta, mitochondrial (EC 1.2.4.4) (Branched-chain alpha-keto acid dehydrogenase E1 component beta chain) (BCKDE1B) (BCKDH E1-beta)","Rattus norvegicus (Rat)","branched-chain amino acid catabolic process [GO:0009083]; lipid metabolic process [GO:0006629]; response to cAMP [GO:0051591]; response to glucocorticoid [GO:0051384]; response to nutrient [GO:0007584]","GO:0003863; GO:0005654; GO:0005730; GO:0005739; GO:0005947; GO:0006629; GO:0007584; GO:0009083; GO:0044877; GO:0051384; GO:0051591"
"2437",2437,"Cluster_4629","Porites_evermani_scaffold_2364:52228-53228",142,-20.95,2,20,902,926,21,"61.90%","66.67%","Peve_00017125",NA,NA,NA,NA,NA,NA,NA,NA
"2438",2438,"Cluster_4629","Porites_evermani_scaffold_2368:53924-54924",160,-29.1,2,19,45,65,17,"76.47%","88.24%","Peve_00017138",-0.443383362280846,0.707556077121805,0.978262075707395,"Q9Z2V5","Histone deacetylase 6 (HD6) (EC 3.5.1.98) (Histone deacetylase mHDA2) (Tubulin-lysine deacetylase HDAC6) (EC 3.5.1.-)","Mus musculus (Mouse)","aggresome assembly [GO:0070842]; axonal transport of mitochondrion [GO:0019896]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to misfolded protein [GO:0071218]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to topologically incorrect protein [GO:0035967]; cilium disassembly [GO:0061523]; collateral sprouting [GO:0048668]; dendritic spine morphogenesis [GO:0060997]; epigenetic regulation of gene expression [GO:0040029]; histone deacetylation [GO:0016575]; Hsp90 deacetylation [GO:0070846]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; mitochondrion localization [GO:0051646]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of protein-containing complex disassembly [GO:0043242]; negative regulation of proteolysis [GO:0045861]; negative regulation of transcription by RNA polymerase II [GO:0000122]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; peptidyl-lysine deacetylation [GO:0034983]; polyubiquitinated misfolded protein transport [GO:0070845]; positive regulation of cholangiocyte proliferation [GO:1904056]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of hydrogen peroxide-mediated programmed cell death [GO:1901300]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of signaling receptor activity [GO:2000273]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of tubulin deacetylation [GO:0090044]; protein deacetylation [GO:0006476]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein-containing complex disassembly [GO:0032984]; regulation of establishment of protein localization [GO:0070201]; regulation of fat cell differentiation [GO:0045598]; regulation of macroautophagy [GO:0016241]; regulation of mitochondrion organization [GO:0010821]; regulation of protein stability [GO:0031647]; response to amphetamine [GO:0001975]; response to corticosterone [GO:0051412]; response to dexamethasone [GO:0071548]; response to growth factor [GO:0070848]; response to immobilization stress [GO:0035902]; response to misfolded protein [GO:0051788]; tubulin deacetylation [GO:0090042]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]","GO:0000118; GO:0000122; GO:0000209; GO:0000978; GO:0001222; GO:0001975; GO:0003779; GO:0004407; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005874; GO:0005875; GO:0005901; GO:0006476; GO:0006511; GO:0006515; GO:0006886; GO:0007026; GO:0008013; GO:0008017; GO:0008270; GO:0010634; GO:0010821; GO:0015630; GO:0016234; GO:0016235; GO:0016241; GO:0016575; GO:0019896; GO:0030424; GO:0030425; GO:0031252; GO:0031333; GO:0031593; GO:0031625; GO:0031647; GO:0031648; GO:0032418; GO:0032984; GO:0032991; GO:0033138; GO:0033558; GO:0034983; GO:0035902; GO:0035967; GO:0036064; GO:0040029; GO:0042826; GO:0042903; GO:0043005; GO:0043014; GO:0043025; GO:0043130; GO:0043162; GO:0043204; GO:0043242; GO:0045598; GO:0045861; GO:0048156; GO:0048471; GO:0048487; GO:0048668; GO:0048843; GO:0050775; GO:0051412; GO:0051646; GO:0051787; GO:0051788; GO:0051879; GO:0051968; GO:0060997; GO:0061523; GO:0061734; GO:0070201; GO:0070301; GO:0070840; GO:0070842; GO:0070845; GO:0070846; GO:0070848; GO:0071218; GO:0071374; GO:0071548; GO:0090042; GO:0090044; GO:0098779; GO:1901300; GO:1901984; GO:1903223; GO:1904056; GO:1904115; GO:2000273"
"2439",2439,"Cluster_4629","Porites_evermani_scaffold_237:15238-16238",147,-20.3,2,21,599,619,21,"66.67%","76.19%","Peve_00017147",0.0551945401871667,0.964844198968192,0.999448381576871,"Q9MYM7","Beta-1,3-galactosyltransferase 1 (Beta-1,3-GalTase 1) (Beta3Gal-T1) (Beta3GalT1) (EC 2.4.1.86) (UDP-galactose:beta-N-acetyl-glucosamine-beta-1,3-galactosyltransferase 1)","Pongo pygmaeus (Bornean orangutan)","lipid metabolic process [GO:0006629]; protein glycosylation [GO:0006486]","GO:0000139; GO:0006486; GO:0006629; GO:0047275"
"2440",2440,"Cluster_4629","Porites_evermani_scaffold_237:68057-69057",150,-20.79,2,20,768,790,19,"63.16%","78.95%","Peve_00017148",-0.975836350936704,0.140234474809289,0.978262075707395,"Q6DBR9","KxDL motif-containing protein 1","Danio rerio (Zebrafish) (Brachydanio rerio)","lysosome localization [GO:0032418]; vesicle-mediated transport [GO:0016192]","GO:0005765; GO:0016192; GO:0032418; GO:0099078"
"2441",2441,"Cluster_4629","Porites_evermani_scaffold_242:223682-224682",165,-23.01,2,20,130,150,18,"77.78%","88.89%","Peve_00017685",NA,NA,NA,NA,NA,NA,NA,NA
"2442",2442,"Cluster_4629","Porites_evermani_scaffold_2426:23543-24543",151,-23.1,2,21,334,362,26,"65.38%","65.38%","Peve_00017727",-0.914498242651073,0.265171432663067,0.978262075707395,"O57382","Tolloid-like protein 2 (EC 3.4.24.-) (Metalloprotease xolloid) (Xenopus tolloid)","Xenopus laevis (African clawed frog)","cell differentiation [GO:0030154]; proteolysis [GO:0006508]","GO:0004222; GO:0005509; GO:0005576; GO:0006508; GO:0008270; GO:0030154"
"2443",2443,"Cluster_4629","Porites_evermani_scaffold_2427:67810-68520",145,-20.33,2,20,661,685,21,"66.67%","71.43%","Peve_00017736",NA,NA,NA,NA,NA,NA,NA,NA
"2444",2444,"Cluster_4629","Porites_evermani_scaffold_2464:44047-45047",164,-20.66,2,21,682,703,19,"68.42%","84.21%","Peve_00018052",0.890931691287798,0.300104919378212,0.978262075707395,"Q5TYP4","Uncharacterized protein C1orf112 homolog","Danio rerio (Zebrafish) (Brachydanio rerio)","",""
"2445",2445,"Cluster_4629","Porites_evermani_scaffold_2480:73437-74208",157,-21.58,2,20,168,188,18,"72.22%","83.33%","Peve_00018195",0.207925672569485,0.866657566738275,0.996730298201722,"Q91W89","Alpha-mannosidase 2C1 (EC 3.2.1.24) (Alpha-D-mannoside mannohydrolase) (Mannosidase alpha class 2C member 1) (Neutral/cytosolic alpha-mannosidase)","Mus musculus (Mouse)","mannose metabolic process [GO:0006013]; oligosaccharide catabolic process [GO:0009313]","GO:0004559; GO:0005654; GO:0005829; GO:0006013; GO:0009313; GO:0030246; GO:0046872"
"2446",2446,"Cluster_4629","Porites_evermani_scaffold_249:285459-286459",155,-25.11,2,21,528,552,22,"68.18%","72.73%","Peve_00018263",NA,NA,NA,NA,NA,NA,NA,NA
"2447",2447,"Cluster_4629","Porites_evermani_scaffold_2504:11726-12726",168,-24.82,2,21,545,566,19,"73.68%","84.21%","Peve_00018487",NA,NA,NA,NA,NA,NA,NA,NA
"2448",2448,"Cluster_4629","Porites_evermani_scaffold_2556:21499-22499",152,-20.61,2,17,573,594,15,"66.67%","86.67%","Peve_00018879",NA,NA,NA,NA,NA,NA,NA,NA
"2449",2449,"Cluster_4629","Porites_evermani_scaffold_2568:30557-31557",141,-20.79,2,10,117,138,8,"87.50%","100.00%","Peve_00018957",0.845821941434403,0.358221029681041,0.978262075707395,NA,NA,NA,NA,NA
"2450",2450,"Cluster_4629","Porites_evermani_scaffold_258:80601-81601",145,-21.45,2,10,924,945,8,"100.00%","100.00%","Peve_00019054",NA,NA,NA,NA,NA,NA,NA,NA
"2451",2451,"Cluster_4629","Porites_evermani_scaffold_263:44737-45737",160,-25.9,2,20,651,670,18,"72.22%","88.89%","Peve_00019513",-0.709158741556041,0.498149895668506,0.978262075707395,"Q0JRZ9","F-BAR domain only protein 2","Homo sapiens (Human)","clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; membrane invagination [GO:0010324]; protein localization to plasma membrane [GO:0072659]; synaptic vesicle endocytosis [GO:0048488]","GO:0001786; GO:0005546; GO:0005737; GO:0005829; GO:0005886; GO:0005905; GO:0010324; GO:0030136; GO:0035091; GO:0042802; GO:0048268; GO:0048488; GO:0072583; GO:0072659; GO:0098835"
"2452",2452,"Cluster_4629","Porites_evermani_scaffold_263:45077-46077",160,-25.9,2,20,311,330,18,"72.22%","88.89%","Peve_00019493",-0.883261232520695,0.310685537260709,0.978262075707395,NA,NA,NA,NA,NA
"2453",2453,"Cluster_4629","Porites_evermani_scaffold_265:141285-142285",162,-21.24,2,20,228,250,19,"73.68%","84.21%","Peve_00019649",NA,NA,NA,NA,NA,NA,NA,NA
"2454",2454,"Cluster_4629","Porites_evermani_scaffold_2677:39141-40141",146,-20.39,2,19,126,147,17,"64.71%","70.59%","Peve_00019862",-0.996804452005128,0.0509077041705065,0.958334495488436,"P07911","Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form]","Homo sapiens (Human)","antibacterial innate immune response [GO:0140367]; apoptotic signaling pathway [GO:0097190]; autophagy [GO:0006914]; cellular calcium ion homeostasis [GO:0006874]; cellular chloride ion homeostasis [GO:0030644]; cellular defense response [GO:0006968]; cellular phosphate ion homeostasis [GO:0030643]; cellular response to unfolded protein [GO:0034620]; cellular sodium ion homeostasis [GO:0006883]; chaperone-mediated protein folding [GO:0061077]; citric acid secretion [GO:0046720]; collecting duct development [GO:0072044]; connective tissue replacement [GO:0097709]; creatinine homeostasis [GO:0097273]; defense response to Gram-negative bacterium [GO:0050829]; endoplasmic reticulum organization [GO:0007029]; glomerular filtration [GO:0003094]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; inflammatory response [GO:0006954]; juxtaglomerular apparatus development [GO:0072051]; leukocyte cell-cell adhesion [GO:0007159]; lipid metabolic process [GO:0006629]; metanephric ascending thin limb development [GO:0072218]; metanephric distal convoluted tubule development [GO:0072221]; metanephric thick ascending limb development [GO:0072233]; micturition [GO:0060073]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell population proliferation [GO:0008285]; neutrophil migration [GO:1990266]; organ or tissue specific immune response [GO:0002251]; peptidyl-threonine phosphorylation [GO:0018107]; potassium ion homeostasis [GO:0055075]; protein localization to vacuole [GO:0072665]; protein transport into plasma membrane raft [GO:0044861]; regulation of blood pressure [GO:0008217]; regulation of protein transport [GO:0051223]; regulation of urine volume [GO:0035809]; renal sodium ion absorption [GO:0070294]; renal urate salt excretion [GO:0097744]; renal water homeostasis [GO:0003091]; response to lipopolysaccharide [GO:0032496]; response to water deprivation [GO:0009414]; response to xenobiotic stimulus [GO:0009410]; RNA splicing [GO:0008380]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; ubiquitin-dependent ERAD pathway [GO:0030433]; urate transport [GO:0015747]; urea transmembrane transport [GO:0071918]","GO:0000922; GO:0002251; GO:0003091; GO:0003094; GO:0005201; GO:0005509; GO:0005615; GO:0005783; GO:0005796; GO:0005929; GO:0006629; GO:0006874; GO:0006883; GO:0006914; GO:0006954; GO:0006968; GO:0007029; GO:0007157; GO:0007159; GO:0008217; GO:0008285; GO:0008380; GO:0009410; GO:0009414; GO:0009986; GO:0015747; GO:0016020; GO:0016323; GO:0016324; GO:0018107; GO:0019864; GO:0019898; GO:0030433; GO:0030643; GO:0030644; GO:0032496; GO:0033209; GO:0033555; GO:0034620; GO:0035809; GO:0044861; GO:0046720; GO:0050829; GO:0051223; GO:0055075; GO:0060073; GO:0060170; GO:0061077; GO:0070062; GO:0070294; GO:0071918; GO:0072044; GO:0072051; GO:0072218; GO:0072221; GO:0072233; GO:0072665; GO:0097190; GO:0097273; GO:0097709; GO:0097744; GO:0140367; GO:1990266"
"2455",2455,"Cluster_4629","Porites_evermani_scaffold_2680:12440-13440",152,-22.41,2,21,816,837,19,"57.89%","78.95%","Peve_00019915",0.997938030915672,0.0408894104551393,0.909359886114279,NA,NA,NA,NA,NA
"2456",2456,"Cluster_4629","Porites_evermani_scaffold_268:322331-323331",161,-25.42,2,20,663,686,20,"80.00%","80.00%","Peve_00019877",NA,NA,NA,NA,NA,NA,NA,NA
"2457",2457,"Cluster_4629","Porites_evermani_scaffold_271:65743-66743",157,-20.26,2,20,649,669,18,"77.78%","77.78%","Peve_00020170",-0.657746278247535,0.543019813120157,0.978262075707395,NA,NA,NA,NA,NA
"2458",2458,"Cluster_4629","Porites_evermani_scaffold_2718:46040-47040",147,-20.22,2,21,823,849,24,"62.50%","66.67%","Peve_00020244",NA,NA,NA,NA,NA,NA,NA,NA
"2459",2459,"Cluster_4629","Porites_evermani_scaffold_272:21822-22822",148,-20.99,2,20,409,428,18,"72.22%","72.22%","Peve_00020256",NA,NA,NA,NA,NA,NA,NA,NA
"2460",2460,"Cluster_4629","Porites_evermani_scaffold_27:373754-374754",165,-26.18,2,21,963,982,19,"78.95%","84.21%","Peve_00020041",NA,NA,NA,"Q20191","Zinc metalloproteinase nas-13 (EC 3.4.24.-) (Nematode astacin 13)","Caenorhabditis elegans","proteolysis [GO:0006508]","GO:0004222; GO:0005576; GO:0006508; GO:0008270"
"2461",2461,"Cluster_4629","Porites_evermani_scaffold_274:77418-78418",159,-24.55,2,19,820,841,18,"83.33%","83.33%","Peve_00020414",-0.699978801652754,0.506385519119979,0.978262075707395,NA,NA,NA,NA,NA
"2462",2462,"Cluster_4629","Porites_evermani_scaffold_2748:9157-10157",163,-23.51,2,20,976,997,18,"72.22%","83.33%","Peve_00020495",-0.81762473404887,0.390580860850921,0.978262075707395,"Q9H0J9","Protein mono-ADP-ribosyltransferase PARP12 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 12) (ARTD12) (Poly [ADP-ribose] polymerase 12) (PARP-12) (Zinc finger CCCH domain-containing protein 1)","Homo sapiens (Human)","protein auto-ADP-ribosylation [GO:0070213]","GO:0003723; GO:0003950; GO:0005634; GO:0016779; GO:0046872; GO:0070213; GO:0140803; GO:1990404"
"2463",2463,"Cluster_4629","Porites_evermani_scaffold_2768:31048-32048",152,-22.88,2,21,512,533,19,"63.16%","73.68%","Peve_00020622",-0.554554668634826,0.625777256211528,0.978262075707395,NA,NA,NA,NA,NA
"2464",2464,"Cluster_4629","Porites_evermani_scaffold_2776:12760-13760",147,-21.45,2,18,629,649,16,"68.75%","81.25%","Peve_00020679",NA,NA,NA,NA,NA,NA,NA,NA
"2465",2465,"Cluster_4629","Porites_evermani_scaffold_2778:30767-31767",155,-20.55,2,20,919,937,18,"72.22%","83.33%","Peve_00020698",NA,NA,NA,NA,NA,NA,NA,NA
"2466",2466,"Cluster_4629","Porites_evermani_scaffold_27:82177-83177",155,-21.26,2,21,952,970,19,"73.68%","84.21%","Peve_00020067",NA,NA,NA,"Q20191","Zinc metalloproteinase nas-13 (EC 3.4.24.-) (Nematode astacin 13)","Caenorhabditis elegans","proteolysis [GO:0006508]","GO:0004222; GO:0005576; GO:0006508; GO:0008270"
"2467",2467,"Cluster_4629","Porites_evermani_scaffold_2829:11701-12701",143,-21.65,2,21,393,419,24,"58.33%","66.67%","Peve_00021128",-0.992231330825797,0.0794053918783923,0.978262075707395,NA,NA,NA,NA,NA
"2468",2468,"Cluster_4629","Porites_evermani_scaffold_2834:21366-22366",146,-20.79,2,15,4,25,13,"76.92%","76.92%","Peve_00021175",-0.544580377513021,0.633377858178985,0.978262075707395,"O08663","Methionine aminopeptidase 2 (MAP 2) (MetAP 2) (EC 3.4.11.18) (Initiation factor 2-associated 67 kDa glycoprotein) (p67) (p67eIF2) (Peptidase M)","Mus musculus (Mouse)","N-terminal protein amino acid modification [GO:0031365]; peptidyl-methionine modification [GO:0018206]; protein initiator methionine removal involved in protein maturation [GO:0035551]; protein processing [GO:0016485]","GO:0004177; GO:0005737; GO:0005829; GO:0005886; GO:0008235; GO:0016485; GO:0018206; GO:0031365; GO:0035551; GO:0046872; GO:0070006"
"2469",2469,"Cluster_4629","Porites_evermani_scaffold_284:291607-292607",160,-22.16,2,21,112,133,19,"68.42%","78.95%","Peve_00021208",-0.554554668634826,0.625777256211528,0.978262075707395,NA,NA,NA,NA,NA
"2470",2470,"Cluster_4629","Porites_evermani_scaffold_2848:15276-16276",147,-22.95,2,17,306,328,16,"68.75%","81.25%","Peve_00021267",NA,NA,NA,NA,NA,NA,NA,NA
"2471",2471,"Cluster_4629","Porites_evermani_scaffold_2853:5357-6357",171,-23.35,2,21,292,314,20,"80.00%","85.00%","Peve_00021304",NA,NA,NA,NA,NA,NA,NA,NA
"2472",2472,"Cluster_4629","Porites_evermani_scaffold_2864:24494-25494",150,-28.07,2,21,508,536,26,"65.38%","69.23%","Peve_00021394",-0.383065272774395,0.749736861826649,0.988219883885475,NA,NA,NA,NA,NA
"2473",2473,"Cluster_4629","Porites_evermani_scaffold_2873:44902-45902",155,-20.69,2,21,431,454,21,"66.67%","76.19%","Peve_00021470",NA,NA,NA,NA,NA,NA,NA,NA
"2474",2474,"Cluster_4629","Porites_evermani_scaffold_292:188470-189470",158,-20.69,2,21,179,199,19,"73.68%","78.95%","Peve_00021859",NA,NA,NA,"Q921Y4","Molybdate-anion transporter (Major facilitator superfamily domain-containing protein 5) (Molybdate transporter 2 homolog)","Mus musculus (Mouse)","","GO:0005886; GO:0015098"
"2475",2475,"Cluster_4629","Porites_evermani_scaffold_29:322928-323928",151,-21.47,2,21,108,130,20,"65.00%","75.00%","Peve_00021701",-0.233559666365651,0.849925164010938,0.995934364227446,NA,NA,NA,NA,NA
"2476",2476,"Cluster_4629","Porites_evermani_scaffold_29:790115-791115",168,-20.3,2,21,689,710,19,"73.68%","84.21%","Peve_00021672",0.287875012824211,0.814102457475352,0.995934364227446,"Q6ZSS7","Major facilitator superfamily domain-containing protein 6 (Macrophage MHC class I receptor 2 homolog)","Homo sapiens (Human)","antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]","GO:0005886; GO:0016020; GO:0042590"
"2477",2477,"Cluster_4629","Porites_evermani_scaffold_3053:22483-23483",149,-20.47,2,20,831,851,18,"72.22%","72.22%","Peve_00023003",-0.488744428037692,0.674910112954302,0.978262075707395,NA,NA,NA,NA,NA
"2478",2478,"Cluster_4629","Porites_evermani_scaffold_3055:47112-48112",157,-21.69,2,20,831,851,18,"72.22%","83.33%","Peve_00023015",-0.554554668634826,0.625777256211528,0.978262075707395,NA,NA,NA,NA,NA
"2479",2479,"Cluster_4629","Porites_evermani_scaffold_3111:24259-25259",165,-22.19,2,20,317,337,18,"77.78%","88.89%","Peve_00023485",-0.167656603312458,0.892760034690396,0.999448381576871,"Q6DH69","Fatty-acid amide hydrolase 2-A (EC 3.5.1.99)","Danio rerio (Zebrafish) (Brachydanio rerio)","lipid catabolic process [GO:0016042]","GO:0016020; GO:0016042; GO:0017064"
"2480",2480,"Cluster_4629","Porites_evermani_scaffold_3111:31887-32887",165,-20.66,2,20,981,1000,18,"77.78%","88.89%","Peve_00023486",-0.0290088782503553,0.981529783419599,0.999448381576871,"Q6GMR7","Fatty-acid amide hydrolase 2 (EC 3.5.1.99) (Amidase domain-containing protein) (Anandamide amidohydrolase 2) (Oleamide hydrolase 2)","Homo sapiens (Human)","arachidonic acid metabolic process [GO:0019369]; lipid catabolic process [GO:0016042]","GO:0005811; GO:0016020; GO:0016042; GO:0017064; GO:0019369"
"2481",2481,"Cluster_4629","Porites_evermani_scaffold_3111:31887-32887",165,-22.19,2,20,379,399,18,"77.78%","88.89%","Peve_00023486",-0.0290088782503553,0.981529783419599,0.999448381576871,"Q6GMR7","Fatty-acid amide hydrolase 2 (EC 3.5.1.99) (Amidase domain-containing protein) (Anandamide amidohydrolase 2) (Oleamide hydrolase 2)","Homo sapiens (Human)","arachidonic acid metabolic process [GO:0019369]; lipid catabolic process [GO:0016042]","GO:0005811; GO:0016020; GO:0016042; GO:0017064; GO:0019369"
"2482",2482,"Cluster_4629","Porites_evermani_scaffold_31:222901-223901",156,-23.27,2,21,541,562,19,"68.42%","73.68%","Peve_00023371",0.864921575292769,0.334736095738345,0.978262075707395,"P25324","Thiosulfate sulfurtransferase (EC 2.8.1.1) (Rhodanese)","Gallus gallus (Chicken)","rRNA import into mitochondrion [GO:0035928]; rRNA transport [GO:0051029]; transsulfuration [GO:0019346]","GO:0004792; GO:0005739; GO:0005759; GO:0008097; GO:0019346; GO:0035928; GO:0051029"
"2483",2483,"Cluster_4629","Porites_evermani_scaffold_313:264579-265579",161,-20.17,2,18,361,382,16,"75.00%","87.50%","Peve_00023597",-0.046258952370145,0.970540123075513,0.999448381576871,"E9PUQ8","Diacylglycerol kinase delta (DAG kinase delta) (EC 2.7.1.107)","Mus musculus (Mouse)","diacylglycerol metabolic process [GO:0046339]; endocytosis [GO:0006897]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of protein kinase C signaling [GO:0090038]; phosphatidic acid biosynthetic process [GO:0006654]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein transport [GO:0015031]; response to organic substance [GO:0010033]","GO:0004143; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005905; GO:0006654; GO:0006897; GO:0007205; GO:0010033; GO:0015031; GO:0019900; GO:0031410; GO:0035556; GO:0042802; GO:0042803; GO:0045742; GO:0046339; GO:0046834; GO:0046872; GO:0046982; GO:0090038; GO:2000370"
"2484",2484,"Cluster_4629","Porites_evermani_scaffold_31:38942-39942",158,-22.57,2,20,305,328,20,"70.00%","80.00%","Peve_00023376",0.874657683043993,0.322172351264192,0.978262075707395,"Q5ZLN0","Leucine-rich repeat-containing protein 40","Gallus gallus (Chicken)","cardiac muscle cell development [GO:0055013]","GO:0003779; GO:0005856; GO:0030017; GO:0055013"
"2485",2485,"Cluster_4629","Porites_evermani_scaffold_318:301526-302526",149,-20.74,2,20,151,171,18,"66.67%","77.78%","Peve_00023888",-0.267452361190883,0.827636404755311,0.995934364227446,"Q6GM71","Leucine-rich repeat and WD repeat-containing protein 1 (ORC-associated protein) (ORCA) (Origin recognition complex-associated protein)","Xenopus laevis (African clawed frog)","chromatin organization [GO:0006325]; DNA replication [GO:0006260]; establishment of protein localization to chromatin [GO:0071169]","GO:0000776; GO:0000781; GO:0003682; GO:0005634; GO:0005664; GO:0005721; GO:0005737; GO:0005815; GO:0006260; GO:0006325; GO:0008327; GO:0035064; GO:0071169"
"2486",2486,"Cluster_4629","Porites_evermani_scaffold_318:301526-302526",154,-22.34,2,19,318,339,17,"64.71%","82.35%","Peve_00023888",-0.267452361190883,0.827636404755311,0.995934364227446,"Q6GM71","Leucine-rich repeat and WD repeat-containing protein 1 (ORC-associated protein) (ORCA) (Origin recognition complex-associated protein)","Xenopus laevis (African clawed frog)","chromatin organization [GO:0006325]; DNA replication [GO:0006260]; establishment of protein localization to chromatin [GO:0071169]","GO:0000776; GO:0000781; GO:0003682; GO:0005634; GO:0005664; GO:0005721; GO:0005737; GO:0005815; GO:0006260; GO:0006325; GO:0008327; GO:0035064; GO:0071169"
"2487",2487,"Cluster_4629","Porites_evermani_scaffold_322:18772-19772",161,-21.38,2,21,96,117,20,"75.00%","85.00%","Peve_00024135",-0.459291304587532,0.696206820742941,0.978262075707395,"Q5JVF3","PCI domain-containing protein 2 (CSN12-like protein)","Homo sapiens (Human)","heterochromatin organization [GO:0070828]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity [GO:2000117]; negative regulation of lymphoid progenitor cell differentiation [GO:1905457]; negative regulation of transcription initiation by RNA polymerase II [GO:0060633]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; post-transcriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; protein transport [GO:0015031]; regulation of mRNA stability [GO:0043488]; spleen development [GO:0048536]; transcription elongation by RNA polymerase II promoter [GO:0006368]","GO:0000973; GO:0003690; GO:0003723; GO:0005634; GO:0005737; GO:0006368; GO:0015031; GO:0016973; GO:0043066; GO:0043488; GO:0044615; GO:0045579; GO:0045893; GO:0048536; GO:0060633; GO:0070390; GO:0070828; GO:0090267; GO:1905457; GO:2000117"
"2488",2488,"Cluster_4629","Porites_evermani_scaffold_3258:37779-38779",153,-23.12,2,18,805,826,16,"68.75%","81.25%","Peve_00024361",NA,NA,NA,NA,NA,NA,NA,NA
"2489",2489,"Cluster_4629","Porites_evermani_scaffold_326:76602-77602",156,-22.46,2,20,619,638,18,"77.78%","77.78%","Peve_00024365",-0.718558826944806,0.489604196090012,0.978262075707395,"A0A0G2JUG7","IQ motif and SEC7 domain-containing protein 1","Rattus norvegicus (Rat)","actin cytoskeleton organization [GO:0030036]; dendritic spine development [GO:0060996]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of keratinocyte migration [GO:0051549]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of ARF protein signal transduction [GO:0032012]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]","GO:0005085; GO:0005634; GO:0008021; GO:0008289; GO:0019901; GO:0030036; GO:0032012; GO:0051549; GO:0060996; GO:0098685; GO:0098794; GO:0098978; GO:0099092; GO:0099149; GO:0099170; GO:0120183"
"2490",2490,"Cluster_4629","Porites_evermani_scaffold_3271:25359-26359",146,-20.47,2,19,197,215,17,"70.59%","76.47%","Peve_00024444",-0.999839766742431,0.0113966510517457,0.658396521887265,"Q9QYP0","Multiple epidermal growth factor-like domains protein 8 (Multiple EGF-like domains protein 8) (Epidermal growth factor-like protein 4) (EGF-like protein 4)","Rattus norvegicus (Rat)","animal organ morphogenesis [GO:0009887]; BMP signaling pathway [GO:0030509]; cell migration involved in gastrulation [GO:0042074]; coronary vasculature development [GO:0060976]; craniofacial suture morphogenesis [GO:0097094]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right symmetry [GO:0007368]; embryonic heart tube left/right pattern formation [GO:0060971]; embryonic heart tube morphogenesis [GO:0003143]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; epiboly involved in gastrulation with mouth forming second [GO:0055113]; fasciculation of sensory neuron axon [GO:0097155]; left/right pattern formation [GO:0060972]; limb morphogenesis [GO:0035108]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of axon extension involved in axon guidance [GO:0048842]; regulation of gene expression [GO:0010468]; tissue development [GO:0009888]","GO:0003143; GO:0005509; GO:0005634; GO:0007368; GO:0009887; GO:0009888; GO:0010468; GO:0016020; GO:0030326; GO:0030509; GO:0035108; GO:0042074; GO:0045879; GO:0048704; GO:0048842; GO:0055113; GO:0060971; GO:0060972; GO:0060976; GO:0061371; GO:0071907; GO:0097094; GO:0097155"
"2491",2491,"Cluster_4629","Porites_evermani_scaffold_332:260725-261725",162,-21.13,2,15,393,414,13,"92.31%","92.31%","Peve_00024785",-0.606773931150992,0.584926656127986,0.978262075707395,"A2AVA0","Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom)","Mus musculus (Mouse)","cell migration [GO:0016477]; epidermis development [GO:0008544]; epithelial cell-cell adhesion [GO:0090136]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193]","GO:0001945; GO:0003017; GO:0003682; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0016020; GO:0016477; GO:0031012; GO:0036303; GO:0048014; GO:0090136; GO:0120193"
"2492",2492,"Cluster_4629","Porites_evermani_scaffold_33:392888-393888",159,-20.52,2,21,515,537,20,"75.00%","75.00%","Peve_00024656",-0.257873213446526,0.833956627836309,0.995934364227446,NA,NA,NA,NA,NA
"2493",2493,"Cluster_4629","Porites_evermani_scaffold_3351:11762-12762",153,-21.38,2,21,173,192,19,"68.42%","78.95%","Peve_00024997",NA,NA,NA,NA,NA,NA,NA,NA
"2494",2494,"Cluster_4629","Porites_evermani_scaffold_33:567220-568220",158,-21.11,2,20,839,862,20,"70.00%","80.00%","Peve_00024599",-0.791127932999699,0.418988401538617,0.978262075707395,"P14316","Interferon regulatory factor 2 (IRF-2)","Homo sapiens (Human)","cell population proliferation [GO:0008283]; defense response to virus [GO:0051607]; immune system process [GO:0002376]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0002376; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0005925; GO:0006355; GO:0006357; GO:0008283; GO:0045944; GO:0051607; GO:1990837"
"2495",2495,"Cluster_4629","Porites_evermani_scaffold_3367:23266-24266",151,-21.2,2,21,310,333,21,"66.67%","71.43%","Peve_00025076",-0.554554668634826,0.625777256211528,0.978262075707395,NA,NA,NA,NA,NA
"2496",2496,"Cluster_4629","Porites_evermani_scaffold_3373:19066-20066",156,-21.82,2,21,916,937,19,"68.42%","73.68%","Peve_00025111",NA,NA,NA,NA,NA,NA,NA,NA
"2497",2497,"Cluster_4629","Porites_evermani_scaffold_33:817713-818713",156,-25.18,2,21,796,817,19,"63.16%","78.95%","Peve_00024621",NA,NA,NA,"Q6P6V0","Glucose-6-phosphate isomerase (GPI) (EC 5.3.1.9) (Autocrine motility factor) (AMF) (Neuroleukin) (NLK) (Phosphoglucose isomerase) (PGI) (Phosphohexose isomerase) (PHI)","Rattus norvegicus (Rat)","carbohydrate metabolic process [GO:0005975]; erythrocyte homeostasis [GO:0034101]; gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; in utero embryonic development [GO:0001701]; learning or memory [GO:0007611]; mesoderm formation [GO:0001707]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of immunoglobulin production [GO:0002639]; response to cadmium ion [GO:0046686]; response to estradiol [GO:0032355]; response to immobilization stress [GO:0035902]; response to morphine [GO:0043278]; response to muscle stretch [GO:0035994]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]","GO:0001701; GO:0001707; GO:0002639; GO:0004347; GO:0005125; GO:0005615; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005975; GO:0006094; GO:0006096; GO:0007611; GO:0008083; GO:0010595; GO:0031625; GO:0032355; GO:0032570; GO:0033574; GO:0034101; GO:0035902; GO:0035994; GO:0042593; GO:0043005; GO:0043154; GO:0043278; GO:0043524; GO:0046686; GO:0048029; GO:0051156; GO:0060170; GO:0097367"
"2498",2498,"Cluster_4629","Porites_evermani_scaffold_3390:26408-27408",161,-26.72,2,21,116,135,19,"73.68%","84.21%","Peve_00025211",NA,NA,NA,NA,NA,NA,NA,NA
"2499",2499,"Cluster_4629","Porites_evermani_scaffold_3426:29729-30729",167,-21.13,2,16,530,551,14,"92.86%","92.86%","Peve_00025456",-0.554554668634826,0.625777256211528,0.978262075707395,NA,NA,NA,NA,NA
"2500",2500,"Cluster_4629","Porites_evermani_scaffold_345:261915-262915",148,-20.96,2,13,274,295,11,"81.82%","90.91%","Peve_00025615",-0.602055989427761,0.588696784556896,0.978262075707395,NA,NA,NA,NA,NA
"2501",2501,"Cluster_4629","Porites_evermani_scaffold_3453:34421-35421",152,-20.6,2,14,328,351,14,"85.71%","85.71%","Peve_00025631",NA,NA,NA,NA,NA,NA,NA,NA
"2502",2502,"Cluster_4629","Porites_evermani_scaffold_3456:11521-12521",151,-21.6,2,12,413,434,10,"90.00%","100.00%","Peve_00025643",-0.381422561612814,0.750868585911891,0.988219883885475,"Q9Z138","Tyrosine-protein kinase transmembrane receptor ROR2 (mROR2) (EC 2.7.10.1) (Neurotrophic tyrosine kinase, receptor-related 2)","Mus musculus (Mouse)","astrocyte development [GO:0014002]; BMP signaling pathway [GO:0030509]; cartilage condensation [GO:0001502]; cell fate commitment [GO:0045165]; chondrocyte differentiation [GO:0002062]; embryonic digit morphogenesis [GO:0042733]; embryonic genitalia morphogenesis [GO:0030538]; inner ear morphogenesis [GO:0042472]; JNK cascade [GO:0007254]; macrophage migration [GO:1905517]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of kinase activity [GO:0033674]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase C activity [GO:1900020]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of postsynapse organization [GO:0099175]; regulation of synaptic signaling by nitric oxide [GO:0150045]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]; smoothened signaling pathway [GO:0007224]; somitogenesis [GO:0001756]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0001501; GO:0001502; GO:0001756; GO:0002062; GO:0004714; GO:0005109; GO:0005524; GO:0005737; GO:0005874; GO:0005886; GO:0007165; GO:0007169; GO:0007223; GO:0007224; GO:0007254; GO:0009986; GO:0010976; GO:0014002; GO:0014068; GO:0017147; GO:0030335; GO:0030425; GO:0030509; GO:0030538; GO:0031435; GO:0033674; GO:0042472; GO:0042733; GO:0043025; GO:0043235; GO:0043507; GO:0045165; GO:0045651; GO:0045893; GO:0046872; GO:0050804; GO:0051968; GO:0060071; GO:0060395; GO:0060828; GO:0090090; GO:0090263; GO:0098794; GO:0098978; GO:0099175; GO:0150045; GO:1900020; GO:1905517"
"2503",2503,"Cluster_4629","Porites_evermani_scaffold_3484:11813-12813",146,-21.23,2,15,853,874,13,"69.23%","84.62%","Peve_00025821",NA,NA,NA,NA,NA,NA,NA,NA
"2504",2504,"Cluster_4629","Porites_evermani_scaffold_350:133431-134431",162,-23.03,2,21,805,829,22,"77.27%","77.27%","Peve_00025976",-0.673856182789247,0.529273454446282,0.978262075707395,"Q9H0J9","Protein mono-ADP-ribosyltransferase PARP12 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 12) (ARTD12) (Poly [ADP-ribose] polymerase 12) (PARP-12) (Zinc finger CCCH domain-containing protein 1)","Homo sapiens (Human)","protein auto-ADP-ribosylation [GO:0070213]","GO:0003723; GO:0003950; GO:0005634; GO:0016779; GO:0046872; GO:0070213; GO:0140803; GO:1990404"
"2505",2505,"Cluster_4629","Porites_evermani_scaffold_350:134173-135173",162,-23.03,2,21,63,87,22,"77.27%","77.27%","Peve_00025978",NA,NA,NA,NA,NA,NA,NA,NA
"2506",2506,"Cluster_4629","Porites_evermani_scaffold_351:288938-289938",159,-21.31,2,21,80,102,20,"70.00%","80.00%","Peve_00026035",0.958107762378328,0.184922523433754,0.978262075707395,NA,NA,NA,NA,NA
"2507",2507,"Cluster_4629","Porites_evermani_scaffold_3576:164-1164",170,-23.57,2,21,206,226,19,"78.95%","89.47%","Peve_00026381",-0.382258654518696,0.750292674781136,0.988219883885475,"Q26636","Cathepsin L (EC 3.4.22.15) [Cleaved into: Cathepsin L heavy chain; Cathepsin L light chain]","Sarcophaga peregrina (Flesh fly) (Boettcherisca peregrina)","cell differentiation [GO:0030154]; proteolysis [GO:0006508]","GO:0004197; GO:0005764; GO:0006508; GO:0030154"
"2508",2508,"Cluster_4629","Porites_evermani_scaffold_3595:3383-4383",156,-21.82,2,21,923,944,19,"68.42%","73.68%","Peve_00026487",NA,NA,NA,NA,NA,NA,NA,NA
"2509",2509,"Cluster_4629","Porites_evermani_scaffold_3642:14028-15028",153,-24.24,2,21,880,899,19,"73.68%","73.68%","Peve_00026785",-0.19477763486302,0.875202956263836,0.997601026681886,"Q8BTK5","SET and MYND domain-containing protein 4 (EC 2.1.1.-)","Mus musculus (Mouse)","heart development [GO:0007507]; methylation [GO:0032259]","GO:0005634; GO:0005737; GO:0007507; GO:0008168; GO:0032259; GO:0042826; GO:0046872"
"2510",2510,"Cluster_4629","Porites_evermani_scaffold_3643:17608-18608",167,-27.55,2,20,182,203,18,"72.22%","88.89%","Peve_00026791",NA,NA,NA,NA,NA,NA,NA,NA
"2511",2511,"Cluster_4629","Porites_evermani_scaffold_3741:9939-10939",167,-25.95,2,21,449,472,21,"71.43%","85.71%","Peve_00027295",-0.998044922586829,0.0398151065215797,0.909359886114279,"Q9NTJ4","Alpha-mannosidase 2C1 (EC 3.2.1.24) (Alpha mannosidase 6A8B) (Alpha-D-mannoside mannohydrolase) (Mannosidase alpha class 2C member 1)","Homo sapiens (Human)","mannose metabolic process [GO:0006013]; oligosaccharide catabolic process [GO:0009313]","GO:0004559; GO:0005654; GO:0005829; GO:0006013; GO:0009313; GO:0030246; GO:0046872"
"2512",2512,"Cluster_4629","Porites_evermani_scaffold_375:118603-119603",157,-21.97,2,18,685,706,16,"68.75%","87.50%","Peve_00027334",NA,NA,NA,NA,NA,NA,NA,NA
"2513",2513,"Cluster_4629","Porites_evermani_scaffold_3792:33159-34159",152,-20.53,2,21,908,929,19,"63.16%","73.68%","Peve_00027550",0.571302454741968,0.612876667663425,0.978262075707395,"Q96MD2","KICSTOR subunit 2 (KICSTOR complex protein C12orf66)","Homo sapiens (Human)","cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; negative regulation of TORC1 signaling [GO:1904262]; protein localization to lysosome [GO:0061462]","GO:0005764; GO:0005765; GO:0034198; GO:0042149; GO:0045171; GO:0061462; GO:0140007; GO:1904262"
"2514",2514,"Cluster_4629","Porites_evermani_scaffold_3793:6900-7900",166,-22.27,2,20,635,657,19,"78.95%","84.21%","Peve_00027556",NA,NA,NA,NA,NA,NA,NA,NA
"2515",2515,"Cluster_4629","Porites_evermani_scaffold_39:129877-130877",153,-20.35,2,21,770,791,20,"70.00%","80.00%","Peve_00028178",0.697796407001289,0.508328047720552,0.978262075707395,"P55345","Protein arginine N-methyltransferase 2 (EC 2.1.1.319) (Histone-arginine N-methyltransferase PRMT2)","Homo sapiens (Human)","developmental cell growth [GO:0048588]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; peptidyl-arginine methylation [GO:0018216]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-templated transcription [GO:0045893]; protein methylation [GO:0006479]; regulation of androgen receptor signaling pathway [GO:0060765]; signal transduction [GO:0007165]","GO:0003713; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006479; GO:0007165; GO:0008469; GO:0016274; GO:0018216; GO:0030331; GO:0032088; GO:0033142; GO:0035242; GO:0042054; GO:0042803; GO:0042974; GO:0042975; GO:0043065; GO:0044877; GO:0045892; GO:0045893; GO:0046966; GO:0048588; GO:0050681; GO:0060765; GO:0140592; GO:2000134"
"2516",2516,"Cluster_4629","Porites_evermani_scaffold_39:130570-131570",153,-20.35,2,21,77,98,20,"70.00%","80.00%","Peve_00028179",-0.239657388103944,0.845929777547931,0.995934364227446,NA,NA,NA,NA,NA
"2517",2517,"Cluster_4629","Porites_evermani_scaffold_391:57455-58455",151,-20.45,2,19,778,797,17,"70.59%","82.35%","Peve_00028239",-0.774151006597593,0.436354186775047,0.978262075707395,"Q5ZKI0","Calcium/calmodulin-dependent protein kinase type II delta chain (CaM kinase II subunit delta) (CaM-kinase II delta chain) (CaMK-II subunit delta) (EC 2.7.11.17)","Gallus gallus (Chicken)","protein phosphorylation [GO:0006468]","GO:0004683; GO:0005516; GO:0005524; GO:0005737; GO:0006468; GO:0043005; GO:0106310"
"2518",2518,"Cluster_4629","Porites_evermani_scaffold_3936:16792-17792",148,-22.86,2,19,311,337,22,"63.64%","77.27%","Peve_00028386",NA,NA,NA,NA,NA,NA,NA,NA
"2519",2519,"Cluster_4629","Porites_evermani_scaffold_394:227963-228963",149,-23.25,2,21,887,906,19,"63.16%","78.95%","Peve_00028414",NA,NA,NA,NA,NA,NA,NA,NA
"2520",2520,"Cluster_4629","Porites_evermani_scaffold_3948:27569-28569",160,-21.7,2,13,38,59,11,"100.00%","100.00%","Peve_00028449",NA,NA,NA,NA,NA,NA,NA,NA
"2521",2521,"Cluster_4629","Porites_evermani_scaffold_395:123122-124122",171,-24.94,2,21,341,363,20,"80.00%","85.00%","Peve_00028461",-0.851786011880871,0.351039327685955,0.978262075707395,"P07221","Calsequestrin-1 (Aspartactin) (Calsequestrin, skeletal muscle isoform) (Laminin-binding protein)","Oryctolagus cuniculus (Rabbit)","positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of store-operated calcium channel activity [GO:1901341]; protein polymerization [GO:0051258]; regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [GO:0014809]; regulation of store-operated calcium entry [GO:2001256]; sarcomere organization [GO:0045214]; sequestering of metal ion [GO:0051238]","GO:0000287; GO:0005509; GO:0005759; GO:0014809; GO:0016529; GO:0030955; GO:0033017; GO:0033018; GO:0042803; GO:0043167; GO:0045214; GO:0046872; GO:0051238; GO:0051258; GO:0051281; GO:1901341; GO:2001256"
"2522",2522,"Cluster_4629","Porites_evermani_scaffold_396:100831-101831",148,-20.96,2,13,26,47,11,"81.82%","90.91%","Peve_00028516",-0.544485737532404,0.633449691795426,0.978262075707395,NA,NA,NA,NA,NA
"2523",2523,"Cluster_4629","Porites_evermani_scaffold_4048:29456-30456",158,-26.35,2,20,543,566,20,"70.00%","80.00%","Peve_00029081",-0.208990564762429,0.865964407462674,0.996660710141104,NA,NA,NA,NA,NA
"2524",2524,"Cluster_4629","Porites_evermani_scaffold_41:450707-451707",142,-22.78,2,20,930,955,22,"59.09%","68.18%","Peve_00029334",0.960070902630821,0.180507663958758,0.978262075707395,"P23978","Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1)","Rattus norvegicus (Rat)","associative learning [GO:0008306]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid import [GO:0051939]; inorganic anion import across plasma membrane [GO:0098658]; learning [GO:0007612]; memory [GO:0007613]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; neurotransmitter reuptake [GO:0098810]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; response to calcium ion [GO:0051592]; response to cocaine [GO:0042220]; response to estradiol [GO:0032355]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to organonitrogen compound [GO:0010243]; response to purine-containing compound [GO:0014074]; response to sucrose [GO:0009744]; response to toxic substance [GO:0009636]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; synapse organization [GO:0050808]","GO:0005283; GO:0005332; GO:0005886; GO:0007612; GO:0007613; GO:0008306; GO:0009636; GO:0009744; GO:0009986; GO:0010033; GO:0010035; GO:0010243; GO:0010288; GO:0014054; GO:0014070; GO:0014074; GO:0015185; GO:0015378; GO:0030424; GO:0032229; GO:0032355; GO:0035725; GO:0042220; GO:0042734; GO:0042802; GO:0043005; GO:0043025; GO:0045211; GO:0046872; GO:0050808; GO:0051592; GO:0051939; GO:0098658; GO:0098719; GO:0098793; GO:0098810; GO:0098982; GO:1902476"
"2525",2525,"Cluster_4629","Porites_evermani_scaffold_417:72236-73236",150,-22.07,2,20,195,217,19,"68.42%","73.68%","Peve_00029687",-0.554554668634826,0.625777256211528,0.978262075707395,NA,NA,NA,NA,NA
"2526",2526,"Cluster_4629","Porites_evermani_scaffold_418:96558-97558",159,-22.64,2,20,187,208,18,"72.22%","77.78%","Peve_00029725",NA,NA,NA,NA,NA,NA,NA,NA
"2527",2527,"Cluster_4629","Porites_evermani_scaffold_421:87348-88348",162,-23.21,2,21,843,863,19,"73.68%","84.21%","Peve_00029914",0.392975900551201,0.742891157571256,0.98675746977261,"P49219","Melatonin receptor type 1C (Mel-1C-R) (Mel1c (alpha) receptor) (Mel1c receptor)","Xenopus laevis (African clawed frog)","","GO:0005886; GO:0008502"
"2528",2528,"Cluster_4629","Porites_evermani_scaffold_422:48434-49434",166,-25.57,2,20,129,151,19,"73.68%","89.47%","Peve_00029962",-0.554554668634826,0.625777256211528,0.978262075707395,NA,NA,NA,NA,NA
"2529",2529,"Cluster_4629","Porites_evermani_scaffold_423:49195-50195",160,-23.29,2,17,228,249,15,"80.00%","86.67%","Peve_00030031",-0.751503103682617,0.458658337187502,0.978262075707395,NA,NA,NA,NA,NA
"2530",2530,"Cluster_4629","Porites_evermani_scaffold_426:255731-256731",150,-23.9,2,20,429,452,20,"65.00%","75.00%","Peve_00030173",0.951485142731905,0.199115074265915,0.978262075707395,"Q53HC5","Kelch-like protein 26","Homo sapiens (Human)","",""
"2531",2531,"Cluster_4629","Porites_evermani_scaffold_4305:13987-14987",159,-23.95,2,20,850,871,18,"72.22%","77.78%","Peve_00030474",0.654294271390404,0.545931560959327,0.978262075707395,"Q80W94","2-acylglycerol O-acyltransferase 2 (EC 2.3.1.22) (Acyl-CoA:monoacylglycerol acyltransferase 2) (MGAT2) (Diacylglycerol acyltransferase 2-like protein 5) (Monoacylglycerol O-acyltransferase 1-like) (Monoacylglycerol O-acyltransferase 2)","Mus musculus (Mouse)","diacylglycerol biosynthetic process [GO:0006651]; glycerol metabolic process [GO:0006071]; intestinal absorption [GO:0050892]; lipid metabolic process [GO:0006629]; monoacylglycerol biosynthetic process [GO:0006640]; monoacylglycerol metabolic process [GO:0046462]; triglyceride biosynthetic process [GO:0019432]","GO:0003846; GO:0005783; GO:0005789; GO:0006071; GO:0006629; GO:0006640; GO:0006651; GO:0008374; GO:0016407; GO:0019432; GO:0046462; GO:0050892; GO:1990578"
"2532",2532,"Cluster_4629","Porites_evermani_scaffold_432:190931-191931",146,-22.18,2,11,749,770,9,"88.89%","100.00%","Peve_00030534",0.563782824692633,0.618690987669942,0.978262075707395,"Q8IVN8","Somatomedin-B and thrombospondin type-1 domain-containing protein (RPE-spondin)","Homo sapiens (Human)","","GO:0005576; GO:0062023"
"2533",2533,"Cluster_4629","Porites_evermani_scaffold_4334:3468-4468",158,-24.39,2,20,967,989,19,"68.42%","84.21%","Peve_00030606",0.99730289693183,0.0467672197087773,0.939470798087631,"Q9VCA2","Organic cation transporter protein","Drosophila melanogaster (Fruit fly)","apoptotic process [GO:0006915]; ion transport [GO:0006811]","GO:0006811; GO:0006915; GO:0016020; GO:0022857"
"2534",2534,"Cluster_4629","Porites_evermani_scaffold_43:537023-538023",151,-23.24,2,16,974,995,14,"78.57%","78.57%","Peve_00030389",NA,NA,NA,NA,NA,NA,NA,NA
"2535",2535,"Cluster_4629","Porites_evermani_scaffold_4394:1389-2389",147,-22,2,21,616,640,22,"63.64%","68.18%","Peve_00030853",0.709464295696174,0.497873937160544,0.978262075707395,"B3EWZ3","Coadhesin","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0016020"
"2536",2536,"Cluster_4629","Porites_evermani_scaffold_4425:24261-25261",159,-20.49,2,21,862,884,20,"65.00%","85.00%","Peve_00031100",-0.642383148671762,0.555891607700891,0.978262075707395,"Q6ISB3","Grainyhead-like protein 2 homolog (Brother of mammalian grainyhead) (Transcription factor CP2-like 3)","Homo sapiens (Human)","anterior neural tube closure [GO:0061713]; bicellular tight junction assembly [GO:0070830]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; cardiac ventricle morphogenesis [GO:0003208]; cell adhesion [GO:0007155]; cell junction assembly [GO:0034329]; cell population proliferation [GO:0008283]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; epithelial cell morphogenesis involved in placental branching [GO:0060672]; epithelium migration [GO:0090132]; face development [GO:0060324]; lung epithelial cell differentiation [GO:0060487]; lung lobe morphogenesis [GO:0060463]; multicellular organism growth [GO:0035264]; negative regulation of keratinocyte differentiation [GO:0045617]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; positive regulation of telomerase activity [GO:0051973]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA methylation [GO:0044030]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000785; GO:0000978; GO:0000981; GO:0001161; GO:0001228; GO:0001843; GO:0003208; GO:0003382; GO:0003700; GO:0005634; GO:0005654; GO:0005911; GO:0006357; GO:0007155; GO:0007420; GO:0008283; GO:0008544; GO:0016020; GO:0021915; GO:0031490; GO:0034329; GO:0035264; GO:0042733; GO:0043010; GO:0043565; GO:0044030; GO:0045617; GO:0045944; GO:0048701; GO:0051973; GO:0060324; GO:0060463; GO:0060487; GO:0060672; GO:0061713; GO:0070830; GO:0090132"
"2537",2537,"Cluster_4629","Porites_evermani_scaffold_4428:2330-3330",157,-20.72,2,19,442,464,18,"72.22%","83.33%","Peve_00031107",-0.975121334247356,0.14230271548239,0.978262075707395,NA,NA,NA,NA,NA
"2538",2538,"Cluster_4629","Porites_evermani_scaffold_443:223307-224026",163,-22.22,2,20,328,349,18,"72.22%","83.33%","Peve_00031126",-0.443383362280846,0.707556077121805,0.978262075707395,NA,NA,NA,NA,NA
"2539",2539,"Cluster_4629","Porites_evermani_scaffold_443:223307-224026",163,-22.22,2,20,328,349,18,"72.22%","83.33%","Peve_00031127",-0.554554668634826,0.625777256211528,0.978262075707395,NA,NA,NA,NA,NA
"2540",2540,"Cluster_4629","Porites_evermani_scaffold_4461:5648-6648",146,-21.82,2,20,43,65,19,"63.16%","73.68%","Peve_00031278",-0.532289894889534,0.642663280461873,0.978262075707395,NA,NA,NA,NA,NA
"2541",2541,"Cluster_4629","Porites_evermani_scaffold_4469:13943-14943",158,-25.32,2,20,864,887,20,"70.00%","80.00%","Peve_00031294",-0.703396748890669,0.503331500781409,0.978262075707395,"Q9Y5R4","MTRF1L release factor glutamine methyltransferase (EC 2.1.1.297) (HemK methyltransferase family member 1) (M.HsaHemKP)","Homo sapiens (Human)","DNA methylation [GO:0006306]","GO:0003677; GO:0005739; GO:0006306; GO:0008170; GO:0008276; GO:0008757; GO:0102559"
"2542",2542,"Cluster_4629","Porites_evermani_scaffold_453:135592-136592",147,-21.53,2,21,468,492,22,"59.09%","72.73%","Peve_00031591",0.586537123945392,0.600981609388654,0.978262075707395,"P87498","Vitellogenin-1 (Minor vitellogenin) (Vitellogenin I) [Cleaved into: Lipovitellin-1 (Lipovitellin I) (LVI); Phosvitin (PV); Lipovitellin-2 (Lipovitellin II) (LVII); YGP42]","Gallus gallus (Chicken)","cellular response to estrogen stimulus [GO:0071391]; response to estradiol [GO:0032355]","GO:0005319; GO:0032355; GO:0045735; GO:0071391"
"2543",2543,"Cluster_4629","Porites_evermani_scaffold_454:102379-103379",172,-23.43,2,21,237,258,19,"78.95%","84.21%","Peve_00031619",-0.668288051687503,0.534054745301893,0.978262075707395,NA,NA,NA,NA,NA
"2544",2544,"Cluster_4629","Porites_evermani_scaffold_45:621578-622578",153,-20.8,2,15,429,451,14,"85.71%","85.71%","Peve_00031450",0.766775718721959,0.443719693957543,0.978262075707395,"Q9R2B6","Alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3-N-acetyl-galactosaminide alpha-2,6-sialyltransferase (EC 2.4.3.7) (NeuAc-alpha-2,3-Gal-beta-1,3-GalNAc-alpha-2,6-sialyltransferase) (ST6GalNAc IV) (ST6GalNAcIV) (Sialyltransferase 7D) (SIAT7-D)","Mus musculus (Mouse)","ganglioside biosynthetic process [GO:0001574]; oligosaccharide metabolic process [GO:0009311]; protein glycosylation [GO:0006486]","GO:0000139; GO:0001574; GO:0001665; GO:0006486; GO:0009311; GO:0047290"
"2545",2545,"Cluster_4629","Porites_evermani_scaffold_457:98477-99477",153,-21.11,2,20,330,350,18,"66.67%","83.33%","Peve_00031742",NA,NA,NA,NA,NA,NA,NA,NA
"2546",2546,"Cluster_4629","Porites_evermani_scaffold_4598:16130-17130",160,-23.87,2,21,826,847,19,"73.68%","73.68%","Peve_00031865",-0.554554668634826,0.625777256211528,0.978262075707395,NA,NA,NA,NA,NA
"2547",2547,"Cluster_4629","Porites_evermani_scaffold_4623:13499-14499",156,-21.82,2,21,916,937,19,"68.42%","73.68%","Peve_00032013",-0.892387216503713,0.298058073074651,0.978262075707395,NA,NA,NA,NA,NA
"2548",2548,"Cluster_4629","Porites_evermani_scaffold_467:171849-172849",155,-21.75,2,17,34,57,17,"76.47%","82.35%","Peve_00032194",0.762069126959693,0.448367237052908,0.978262075707395,"Q9V4P1","Anillin (Actin-binding protein 8) (ABP8) (Protein scraps)","Drosophila melanogaster (Fruit fly)","actomyosin contractile ring assembly [GO:0000915]; asymmetric cell division [GO:0008356]; cellularization [GO:0007349]; establishment of actomyosin contractile ring localization [GO:0032188]; intercellular bridge organization [GO:0043063]; male germline ring canal formation [GO:0030726]; male meiosis cytokinesis [GO:0007112]; mitotic cytokinesis [GO:0000281]; oogenesis [GO:0048477]; plasma membrane organization [GO:0007009]; pole cell formation [GO:0007279]; protein localization [GO:0008104]; regulation of cytokinesis [GO:0032465]; sensory organ development [GO:0007423]; sensory organ precursor cell division [GO:0045035]; septin ring organization [GO:0031106]","GO:0000281; GO:0000915; GO:0003779; GO:0005634; GO:0005737; GO:0005826; GO:0007009; GO:0007112; GO:0007279; GO:0007349; GO:0007423; GO:0008017; GO:0008104; GO:0008356; GO:0017022; GO:0030726; GO:0031106; GO:0032154; GO:0032188; GO:0032465; GO:0035323; GO:0043063; GO:0045035; GO:0045172; GO:0048477; GO:0051015; GO:0070938"
"2549",2549,"Cluster_4629","Porites_evermani_scaffold_4:676320-677320",149,-20.09,2,21,834,853,19,"63.16%","78.95%","Peve_00028716",-0.669784068553254,0.532773318907101,0.978262075707395,NA,NA,NA,NA,NA
"2550",2550,"Cluster_4629","Porites_evermani_scaffold_4747:15763-16763",156,-21.82,2,21,742,763,19,"68.42%","73.68%","Peve_00032533",NA,NA,NA,NA,NA,NA,NA,NA
"2551",2551,"Cluster_4629","Porites_evermani_scaffold_4844:11384-12384",162,-27.06,2,20,753,776,20,"75.00%","80.00%","Peve_00032936",-0.554554668634826,0.625777256211528,0.978262075707395,"P25291","Pancreatic secretory granule membrane major glycoprotein GP2 (Pancreatic zymogen granule membrane protein GP-2) (ZAP75)","Canis lupus familiaris (Dog) (Canis familiaris)","antigen transcytosis by M cells in mucosal-associated lymphoid tissue [GO:0002412]; innate immune response [GO:0045087]; neutrophil migration [GO:1990266]","GO:0002412; GO:0005201; GO:0005615; GO:0005768; GO:0009897; GO:0009986; GO:0016324; GO:0042589; GO:0045087; GO:0045121; GO:1990266"
"2552",2552,"Cluster_4629","Porites_evermani_scaffold_4906:0-496",151,-20.05,2,20,320,341,18,"66.67%","72.22%","Peve_00033164",NA,NA,NA,"P62958","Adenosine 5'-monophosphoramidase HINT1 (EC 3.9.1.-) (17 kDa inhibitor of protein kinase C) (Desumoylating isopeptidase HINT1) (EC 3.4.22.-) (Histidine triad nucleotide-binding protein 1) (Protein kinase C inhibitor 1) (Protein kinase C-interacting protein 1) (PKCI-1)","Bos taurus (Bovine)","intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; protein desumoylation [GO:0016926]; purine ribonucleotide catabolic process [GO:0009154]; regulation of DNA-templated transcription [GO:0006355]","GO:0000118; GO:0000166; GO:0005634; GO:0005737; GO:0006355; GO:0009154; GO:0016787; GO:0016926; GO:0016929; GO:0043530; GO:0072332"
"2553",2553,"Cluster_4629","Porites_evermani_scaffold_49:264575-265575",154,-23.75,2,21,566,586,19,"63.16%","84.21%","Peve_00033118",-0.440781881239364,0.709402456900418,0.978542556101155,NA,NA,NA,NA,NA
"2554",2554,"Cluster_4629","Porites_evermani_scaffold_493:189028-190028",167,-27.28,2,21,98,120,20,"75.00%","85.00%","Peve_00033266",0.912495628491449,0.268305114088849,0.978262075707395,NA,NA,NA,NA,NA
"2555",2555,"Cluster_4629","Porites_evermani_scaffold_4938:11143-12143",161,-24.09,2,21,932,951,19,"73.68%","84.21%","Peve_00033285",0.983242735824399,0.116709179641717,0.978262075707395,NA,NA,NA,NA,NA
"2556",2556,"Cluster_4629","Porites_evermani_scaffold_50:43135-44135",156,-27.43,2,18,222,245,18,"72.22%","83.33%","Peve_00033616",0.596782134149212,0.592891322861109,0.978262075707395,"Q7KZ85","Transcription elongation factor SPT6 (hSPT6) (Histone chaperone suppressor of Ty6) (Tat-cotransactivator 2 protein) (Tat-CT2 protein)","Homo sapiens (Human)","blastocyst formation [GO:0001825]; mRNA processing [GO:0006397]; mRNA transcription by RNA polymerase II [GO:0042789]; mRNA transport [GO:0051028]; nucleosome organization [GO:0034728]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; regulation of isotype switching [GO:0045191]; regulation of mRNA export from nucleus [GO:0010793]; regulation of mRNA processing [GO:0050684]; regulation of muscle cell differentiation [GO:0051147]; RNA splicing [GO:0008380]; transcription elongation by RNA polymerase II promoter [GO:0006368]; transcription elongation-coupled chromatin remodeling [GO:0140673]","GO:0001825; GO:0003677; GO:0003723; GO:0005654; GO:0006368; GO:0006397; GO:0008023; GO:0008380; GO:0010793; GO:0031491; GO:0032968; GO:0034728; GO:0042393; GO:0042789; GO:0045191; GO:0050684; GO:0051028; GO:0051147; GO:0140673"
"2557",2557,"Cluster_4629","Porites_evermani_scaffold_5054:1753-2753",144,-21.25,2,13,18,39,11,"81.82%","81.82%","Peve_00033838",NA,NA,NA,NA,NA,NA,NA,NA
"2558",2558,"Cluster_4629","Porites_evermani_scaffold_508:6997-7997",160,-20.78,2,21,311,332,19,"63.16%","84.21%","Peve_00033929",-0.421144898192056,0.723256768697269,0.982482510500178,"Q61115","Protein patched homolog 1 (PTC) (PTC1)","Mus musculus (Mouse)","animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell differentiation involved in kidney development [GO:0061005]; cell fate determination [GO:0001709]; cell proliferation involved in metanephros development [GO:0072203]; cellular response to cholesterol [GO:0071397]; commissural neuron axon guidance [GO:0071679]; dorsal/ventral neural tube patterning [GO:0021904]; dorsal/ventral pattern formation [GO:0009953]; embryonic limb morphogenesis [GO:0030326]; embryonic organ development [GO:0048568]; epidermal cell fate specification [GO:0009957]; epidermis development [GO:0008544]; epithelial cell proliferation [GO:0050673]; glucose homeostasis [GO:0042593]; heart morphogenesis [GO:0003007]; hindlimb morphogenesis [GO:0035137]; in utero embryonic development [GO:0001701]; keratinocyte proliferation [GO:0043616]; limb morphogenesis [GO:0035108]; liver regeneration [GO:0097421]; mammary gland development [GO:0030879]; mammary gland duct morphogenesis [GO:0060603]; mammary gland epithelial cell differentiation [GO:0060644]; metanephric collecting duct development [GO:0072205]; negative regulation of cell division [GO:0051782]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural plate axis specification [GO:0021997]; neural tube closure [GO:0001843]; neural tube formation [GO:0001841]; neural tube patterning [GO:0021532]; pattern specification process [GO:0007389]; pharyngeal system development [GO:0060037]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epidermal cell differentiation [GO:0045606]; prostate gland development [GO:0030850]; protein localization to plasma membrane [GO:0072659]; protein processing [GO:0016485]; regulation of cell population proliferation [GO:0042127]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein localization [GO:0032880]; response to chlorate [GO:0010157]; response to estradiol [GO:0032355]; response to mechanical stimulus [GO:0009612]; response to retinoic acid [GO:0032526]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; smooth muscle tissue development [GO:0048745]; somite development [GO:0061053]; spermatid development [GO:0007286]; spinal cord motor neuron differentiation [GO:0021522]; stem cell proliferation [GO:0072089]","GO:0000122; GO:0001658; GO:0001701; GO:0001709; GO:0001841; GO:0001843; GO:0003007; GO:0005113; GO:0005119; GO:0005576; GO:0005634; GO:0005794; GO:0005886; GO:0005901; GO:0005929; GO:0007165; GO:0007286; GO:0007346; GO:0007389; GO:0007420; GO:0008158; GO:0008201; GO:0008270; GO:0008285; GO:0008544; GO:0009410; GO:0009612; GO:0009887; GO:0009953; GO:0009957; GO:0010157; GO:0010839; GO:0010875; GO:0014069; GO:0015485; GO:0016485; GO:0021522; GO:0021532; GO:0021904; GO:0021997; GO:0030326; GO:0030332; GO:0030496; GO:0030850; GO:0030879; GO:0032355; GO:0032526; GO:0032880; GO:0035108; GO:0035137; GO:0040008; GO:0040015; GO:0042127; GO:0042593; GO:0043231; GO:0043433; GO:0043616; GO:0044294; GO:0044295; GO:0044877; GO:0045177; GO:0045606; GO:0045668; GO:0045879; GO:0045892; GO:0045893; GO:0048471; GO:0048568; GO:0048745; GO:0050673; GO:0050680; GO:0051782; GO:0060037; GO:0060603; GO:0060644; GO:0061005; GO:0061053; GO:0071397; GO:0071679; GO:0072089; GO:0072203; GO:0072205; GO:0072659; GO:0097108; GO:0097421; GO:2000647"
"2559",2559,"Cluster_4629","Porites_evermani_scaffold_5116:5896-6896",153,-20.54,2,15,648,672,16,"81.25%","81.25%","Peve_00034119",NA,NA,NA,NA,NA,NA,NA,NA
"2560",2560,"Cluster_4629","Porites_evermani_scaffold_517:183919-184919",145,-23.37,2,19,486,510,20,"60.00%","75.00%","Peve_00034276",0.832744628378597,0.373536458793268,0.978262075707395,NA,NA,NA,NA,NA
"2561",2561,"Cluster_4629","Porites_evermani_scaffold_524:54318-55318",157,-21.91,2,20,815,835,18,"77.78%","77.78%","Peve_00034520",-0.554554668634826,0.625777256211528,0.978262075707395,"B8VIU6","Uncharacterized skeletal organic matrix protein 5 (Uncharacterized SOMP-5)","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0005576"
"2562",2562,"Cluster_4629","Porites_evermani_scaffold_530:197223-198223",155,-20.69,2,21,926,949,21,"66.67%","76.19%","Peve_00034775",0.428616744018399,0.718002141892526,0.981009433316356,NA,NA,NA,NA,NA
"2563",2563,"Cluster_4629","Porites_evermani_scaffold_536:104836-105836",156,-21.82,2,21,916,937,19,"68.42%","73.68%","Peve_00034950",NA,NA,NA,NA,NA,NA,NA,NA
"2564",2564,"Cluster_4629","Porites_evermani_scaffold_54:116235-117235",152,-20.19,2,21,924,945,19,"57.89%","78.95%","Peve_00035133",NA,NA,NA,NA,NA,NA,NA,NA
"2565",2565,"Cluster_4629","Porites_evermani_scaffold_545:174134-175134",144,-23.75,2,20,363,389,23,"65.22%","73.91%","Peve_00035304",NA,NA,NA,NA,NA,NA,NA,NA
"2566",2566,"Cluster_4629","Porites_evermani_scaffold_547:133439-134439",156,-23.62,2,21,302,323,19,"63.16%","78.95%","Peve_00035379",-0.554554668634826,0.625777256211528,0.978262075707395,NA,NA,NA,NA,NA
"2567",2567,"Cluster_4629","Porites_evermani_scaffold_547:85919-86919",162,-24.89,2,20,50,72,19,"78.95%","78.95%","Peve_00035367",0.997938030915672,0.0408894104551393,0.909359886114279,NA,NA,NA,NA,NA
"2568",2568,"Cluster_4629","Porites_evermani_scaffold_548:51465-52465",144,-20.88,2,14,699,723,15,"73.33%","80.00%","Peve_00035396",NA,NA,NA,NA,NA,NA,NA,NA
"2569",2569,"Cluster_4629","Porites_evermani_scaffold_548:55592-56592",144,-20.88,2,14,699,723,15,"73.33%","80.00%","Peve_00035397",NA,NA,NA,NA,NA,NA,NA,NA
"2570",2570,"Cluster_4629","Porites_evermani_scaffold_553:134470-135470",159,-20.69,2,20,526,547,18,"72.22%","77.78%","Peve_00035584",-0.488628904001026,0.674994409013275,0.978262075707395,NA,NA,NA,NA,NA
"2571",2571,"Cluster_4629","Porites_evermani_scaffold_557:92550-93550",156,-29.11,2,19,94,120,22,"72.73%","77.27%","Peve_00035703",-0.443383362280846,0.707556077121805,0.978262075707395,"Q92626","Peroxidasin homolog (EC 1.11.2.-) (Melanoma-associated antigen MG50) (Peroxidasin 1) (hsPxd01) (Vascular peroxidase 1) (p53-responsive gene 2 protein) [Cleaved into: PXDN active fragment]","Homo sapiens (Human)","angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; hydrogen peroxide catabolic process [GO:0042744]; immune response [GO:0006955]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979]","GO:0001525; GO:0001654; GO:0004601; GO:0005152; GO:0005201; GO:0005576; GO:0005604; GO:0005615; GO:0005783; GO:0006955; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0030198; GO:0030199; GO:0031012; GO:0042744; GO:0043237; GO:0046872; GO:0051260; GO:0062023; GO:0070062; GO:0070207; GO:0070831; GO:0071711; GO:0140825"
"2572",2572,"Cluster_4629","Porites_evermani_scaffold_5594:4012-5012",142,-20.93,2,19,512,533,17,"64.71%","64.71%","Peve_00035777",-0.975709876577718,0.140602489911479,0.978262075707395,"Q6ZMV9","Kinesin-like protein KIF6","Homo sapiens (Human)","microtubule-based movement [GO:0007018]","GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0016887"
"2573",2573,"Cluster_4629","Porites_evermani_scaffold_568:113071-114071",159,-22.63,2,21,891,913,20,"70.00%","80.00%","Peve_00036017",0.841509677405326,0.363334634922356,0.978262075707395,"B1WAR9","Serine/threonine-protein kinase greatwall (GW) (GWL) (EC 2.7.11.1) (Microtubule-associated serine/threonine-protein kinase-like) (MAST-L)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; protein phosphorylation [GO:0006468]","GO:0000086; GO:0000278; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0006468; GO:0006974; GO:0032154; GO:0032515; GO:0051301; GO:0051721; GO:0106310"
"2574",2574,"Cluster_4629","Porites_evermani_scaffold_568:194648-195648",155,-20.37,2,17,754,776,16,"75.00%","87.50%","Peve_00036024",0.970140697589961,0.155962992122895,0.978262075707395,NA,NA,NA,NA,NA
"2575",2575,"Cluster_4629","Porites_evermani_scaffold_568:5249-6249",150,-21.11,2,20,708,731,20,"65.00%","75.00%","Peve_00036022",-0.482615098010803,0.67937402298029,0.978262075707395,NA,NA,NA,NA,NA
"2576",2576,"Cluster_4629","Porites_evermani_scaffold_5700:6585-7585",144,-20.32,2,13,800,821,11,"81.82%","81.82%","Peve_00036147",-0.520448962834295,0.651529201603118,0.978262075707395,"B2KIE9","Septin-8","Rhinolophus ferrumequinum (Greater horseshoe bat)","regulation of intracellular protein transport [GO:0033157]; regulation of protein stability [GO:0031647]; regulation of SNARE complex assembly [GO:0035542]","GO:0005525; GO:0005856; GO:0030424; GO:0030672; GO:0031647; GO:0033157; GO:0035542; GO:0098793"
"2577",2577,"Cluster_4629","Porites_evermani_scaffold_570:45194-46194",164,-22.33,2,21,496,517,19,"73.68%","78.95%","Peve_00036129",NA,NA,NA,NA,NA,NA,NA,NA
"2578",2578,"Cluster_4629","Porites_evermani_scaffold_571:201310-202310",146,-20.11,2,11,804,825,9,"88.89%","100.00%","Peve_00036161",-0.593200191265247,0.595728512331607,0.978262075707395,"Q6XLQ7","Calumenin","Oryctolagus cuniculus (Rabbit)","","GO:0005509; GO:0005576; GO:0005789; GO:0005794; GO:0033018; GO:0042470"
"2579",2579,"Cluster_4629","Porites_evermani_scaffold_572:124846-125846",155,-22.3,2,12,44,65,10,"100.00%","100.00%","Peve_00036182",0.887885359953914,0.304347630213487,0.978262075707395,"Q06136","3-ketodihydrosphingosine reductase (KDS reductase) (EC 1.1.1.102) (3-dehydrosphinganine reductase) (Follicular variant translocation protein 1) (FVT-1) (Short chain dehydrogenase/reductase family 35C member 1)","Homo sapiens (Human)","3-keto-sphinganine metabolic process [GO:0006666]; sphingolipid biosynthetic process [GO:0030148]","GO:0005615; GO:0005783; GO:0005789; GO:0006666; GO:0016020; GO:0030148; GO:0047560"
"2580",2580,"Cluster_4629","Porites_evermani_scaffold_57:27861-28861",151,-20.55,2,12,359,380,10,"90.00%","100.00%","Peve_00036078",-0.554554668634826,0.625777256211528,0.978262075707395,NA,NA,NA,NA,NA
"2581",2581,"Cluster_4629","Porites_evermani_scaffold_575:195943-196943",142,-21.49,2,21,775,792,19,"68.42%","73.68%","Peve_00036260",-0.716041411338086,0.491904314095913,0.978262075707395,"Q5RA50","Protein FAM124A","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","",""
"2582",2582,"Cluster_4629","Porites_evermani_scaffold_57:659205-660205",154,-21.05,2,20,856,878,19,"73.68%","73.68%","Peve_00036097",-0.282951084299559,0.817373179043983,0.995934364227446,"Q6XUX3","Dual serine/threonine and tyrosine protein kinase (EC 2.7.12.1) (Dusty protein kinase) (Dusty PK) (RIP-homologous kinase) (Receptor-interacting serine/threonine-protein kinase 5) (Sugen kinase 496) (SgK496)","Homo sapiens (Human)","cellular response to fibroblast growth factor stimulus [GO:0044344]; negative regulation of apoptotic process [GO:0043066]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of kinase activity [GO:0033674]","GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005737; GO:0016323; GO:0016324; GO:0033674; GO:0043066; GO:0044344; GO:0045743; GO:0070161; GO:0070374; GO:0106310"
"2583",2583,"Cluster_4629","Porites_evermani_scaffold_582:223564-224564",160,-23.12,2,21,75,96,19,"68.42%","78.95%","Peve_00036465",-0.849928503924096,0.353290067464647,0.978262075707395,"Q04786","Beta-hexosaminidase (EC 3.2.1.52) (Beta-N-acetylhexosaminidase) (Chitobiase) (N-acetyl-beta-glucosaminidase)","Vibrio vulnificus","chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]","GO:0000272; GO:0004563; GO:0006032; GO:0030247; GO:0102148"
"2584",2584,"Cluster_4629","Porites_evermani_scaffold_586:61606-62606",149,-20.1,2,16,480,503,16,"75.00%","87.50%","Peve_00036546",0.901437503204605,0.285025903435085,0.978262075707395,"Q4R6T3","Translation initiation factor eIF-2B subunit gamma (eIF-2B GDP-GTP exchange factor subunit gamma)","Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)","oligodendrocyte development [GO:0014003]; T cell receptor signaling pathway [GO:0050852]; translational initiation [GO:0006413]","GO:0003743; GO:0005737; GO:0005851; GO:0006413; GO:0014003; GO:0016779; GO:0050852"
"2585",2585,"Cluster_4629","Porites_evermani_scaffold_590:67502-68502",143,-21.93,2,12,509,530,10,"80.00%","90.00%","Peve_00036714",NA,NA,NA,NA,NA,NA,NA,NA
"2586",2586,"Cluster_4629","Porites_evermani_scaffold_59:171438-171572",151,-21.65,2,16,4,25,14,"71.43%","85.71%","Peve_00036702",-0.443383362280846,0.707556077121805,0.978262075707395,NA,NA,NA,NA,NA
"2587",2587,"Cluster_4629","Porites_evermani_scaffold_593:15876-16876",162,-24.92,2,21,572,597,23,"73.91%","78.26%","Peve_00036785",0.997938030915672,0.0408894104551393,0.909359886114279,"Q17LW0","Myosin-VIIa (Protein crinkled)","Aedes aegypti (Yellowfever mosquito) (Culex aegypti)","actin filament-based movement [GO:0030048]; antennal morphogenesis [GO:0048800]; chaeta morphogenesis [GO:0008407]; imaginal disc-derived wing hair organization [GO:0035317]; sensory perception of sound [GO:0007605]","GO:0000146; GO:0003779; GO:0005524; GO:0005737; GO:0007605; GO:0008407; GO:0016459; GO:0030048; GO:0032027; GO:0035317; GO:0048800; GO:0071944; GO:0120025"
"2588",2588,"Cluster_4629","Porites_evermani_scaffold_5952:1440-2440",157,-22.38,2,20,776,796,18,"72.22%","83.33%","Peve_00036842",0.726035829919398,0.482721277689274,0.978262075707395,NA,NA,NA,NA,NA
"2589",2589,"Cluster_4629","Porites_evermani_scaffold_596:72408-73408",158,-25.38,2,15,401,422,13,"84.62%","92.31%","Peve_00036862",-0.352870704575894,0.770411098962629,0.9911023463657,"P10079","Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1)","Strongylocentrotus purpuratus (Purple sea urchin)","","GO:0005509; GO:0005615; GO:0009374; GO:0031410; GO:0032579"
"2590",2590,"Cluster_4629","Porites_evermani_scaffold_5995:8018-8401",154,-22.72,2,20,96,120,21,"66.67%","76.19%","Peve_00036936",-0.643007828463055,0.555372521080643,0.978262075707395,"Q8BXG3","Intraflagellar transport protein 57 homolog (HIP1-interacting protein)","Mus musculus (Mouse)","activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; cilium assembly [GO:0060271]; heart looping [GO:0001947]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; keratinocyte proliferation [GO:0043616]; left/right pattern formation [GO:0060972]; motile cilium assembly [GO:0044458]; negative regulation of keratinocyte proliferation [GO:0010839]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; regulation of apoptotic process [GO:0042981]; smoothened signaling pathway [GO:0007224]","GO:0001843; GO:0001947; GO:0003677; GO:0005794; GO:0005813; GO:0005929; GO:0005930; GO:0006915; GO:0006919; GO:0007224; GO:0010839; GO:0030992; GO:0032391; GO:0035720; GO:0036064; GO:0042073; GO:0042981; GO:0043616; GO:0044292; GO:0044458; GO:0060271; GO:0060972; GO:0097546; GO:1905515"
"2591",2591,"Cluster_4629","Porites_evermani_scaffold_605:110233-111233",154,-22.92,2,21,508,528,19,"63.16%","84.21%","Peve_00037200",-0.659618788789716,0.541435489592007,0.978262075707395,"Q5ZI78","Tumor necrosis factor alpha-induced protein 8 (TNF alpha-induced protein 8)","Gallus gallus (Chicken)","positive regulation of apoptotic process [GO:0043065]","GO:0005737; GO:0043027; GO:0043065"
"2592",2592,"Cluster_4629","Porites_evermani_scaffold_609:155312-156312",145,-20.88,2,21,484,500,19,"73.68%","73.68%","Peve_00037303",0.319199572167066,0.79317194093182,0.995934364227446,"J3S9D9","Reticulocalbin-2 (Taipoxin-associated calcium-binding protein 49 homolog)","Crotalus adamanteus (Eastern diamondback rattlesnake)","","GO:0005509; GO:0005576"
"2593",2593,"Cluster_4629","Porites_evermani_scaffold_6136:3868-4868",159,-22.6,2,21,761,783,20,"70.00%","80.00%","Peve_00037434",0.972586140816563,0.149409211794811,0.978262075707395,"Q63570","26S proteasome regulatory subunit 6B (26S proteasome AAA-ATPase subunit RPT3) (Proteasome 26S subunit ATPase 4) (S6 ATPase) (Tat-binding protein 7) (TBP-7)","Rattus norvegicus (Rat)","blastocyst development [GO:0001824]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]","GO:0000502; GO:0001824; GO:0005524; GO:0005634; GO:0008540; GO:0016234; GO:0016887; GO:0022624; GO:0031597; GO:0036402; GO:0043161; GO:0045202"
"2594",2594,"Cluster_4629","Porites_evermani_scaffold_617:25586-26586",171,-28.77,2,20,329,350,18,"83.33%","83.33%","Peve_00037517",-0.443383362280846,0.707556077121805,0.978262075707395,NA,NA,NA,NA,NA
"2595",2595,"Cluster_4629","Porites_evermani_scaffold_6208:1165-2165",165,-23.01,2,20,48,68,18,"77.78%","88.89%","Peve_00037658",-0.3049070009849,0.80274923386234,0.995934364227446,NA,NA,NA,NA,NA
"2596",2596,"Cluster_4629","Porites_evermani_scaffold_631:180542-181542",150,-21.56,2,21,468,493,23,"69.57%","69.57%","Peve_00037921",0.573473461280276,0.61119113664702,0.978262075707395,"C9S5C6","Extracellular metalloprotease VDBG_01143 (EC 3.4.24.-)","Verticillium alfalfae (strain VaMs.102 / ATCC MYA-4576 / FGSC 10136) (Verticillium wilt of alfalfa) (Verticillium albo-atrum)","proteolysis [GO:0006508]","GO:0005576; GO:0006508; GO:0008237; GO:0046872"
"2597",2597,"Cluster_4629","Porites_evermani_scaffold_643:204088-205088",156,-25.91,2,21,851,872,19,"63.16%","78.95%","Peve_00038241",-0.995439006523776,0.06082611131423,0.978262075707395,"P62907","60S ribosomal protein L10a","Rattus norvegicus (Rat)","cytoplasmic translation [GO:0002181]; maturation of LSU-rRNA [GO:0000470]; response to ethanol [GO:0045471]; translation [GO:0006412]","GO:0000470; GO:0002181; GO:0003723; GO:0003735; GO:0006412; GO:0014069; GO:0022625; GO:0022626; GO:0042788; GO:0045202; GO:0045471"
"2598",2598,"Cluster_4629","Porites_evermani_scaffold_644:156916-157916",154,-21.29,2,20,923,946,20,"70.00%","75.00%","Peve_00038262",NA,NA,NA,NA,NA,NA,NA,NA
"2599",2599,"Cluster_4629","Porites_evermani_scaffold_6:466025-467025",164,-26.7,2,21,765,786,19,"73.68%","78.95%","Peve_00036947",0.99868990037373,0.0325907764753561,0.909359886114279,NA,NA,NA,NA,NA
"2600",2600,"Cluster_4629","Porites_evermani_scaffold_663:81971-82971",160,-20.66,2,21,686,707,19,"73.68%","73.68%","Peve_00038678",-0.319151511841377,0.793204225721589,0.995934364227446,"P55878","Zinc finger protein GLI1 (GLI)","Gallus gallus (Chicken)","cell differentiation [GO:0030154]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; smoothened signaling pathway [GO:0007224]","GO:0000978; GO:0000981; GO:0003682; GO:0005634; GO:0005737; GO:0006357; GO:0007224; GO:0010628; GO:0030154; GO:0043565; GO:0045893; GO:0045944; GO:0046872"
"2601",2601,"Cluster_4629","Porites_evermani_scaffold_673:19374-20374",145,-24.7,2,21,971,990,19,"63.16%","73.68%","Peve_00038893",NA,NA,NA,NA,NA,NA,NA,NA
"2602",2602,"Cluster_4629","Porites_evermani_scaffold_677:201870-202870",157,-28.57,2,20,612,632,18,"66.67%","88.89%","Peve_00038982",-0.554554668634826,0.625777256211528,0.978262075707395,NA,NA,NA,NA,NA
"2603",2603,"Cluster_4629","Porites_evermani_scaffold_68:305838-306838",152,-24.78,2,13,200,221,11,"81.82%","100.00%","Peve_00039059",-0.481075308654953,0.680492714541193,0.978262075707395,NA,NA,NA,NA,NA
"2604",2604,"Cluster_4629","Porites_evermani_scaffold_6834:427-1427",160,-20.59,2,17,459,480,15,"80.00%","86.67%","Peve_00039146",-0.549020204121286,0.630001990941992,0.978262075707395,"H2LRU7","Polycystin-2 (Polycystic kidney disease 2 protein homolog)","Oryzias latipes (Japanese rice fish) (Japanese killifish)","calcium ion transmembrane transport [GO:0070588]; cell-cell signaling by wnt [GO:0198738]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus [GO:0050982]; detection of nodal flow [GO:0003127]; inorganic cation transmembrane transport [GO:0098662]; potassium ion transmembrane transport [GO:0071805]; protein heterotetramerization [GO:0051290]; protein tetramerization [GO:0051262]; regulation of ion transmembrane transport [GO:0034765]; release of sequestered calcium ion into cytosol [GO:0051209]; Wnt signaling pathway [GO:0016055]","GO:0003127; GO:0005102; GO:0005245; GO:0005248; GO:0005261; GO:0005262; GO:0005267; GO:0005509; GO:0005789; GO:0005886; GO:0005929; GO:0015271; GO:0016020; GO:0016055; GO:0016323; GO:0030659; GO:0034703; GO:0034765; GO:0050982; GO:0051209; GO:0051262; GO:0051290; GO:0051371; GO:0060170; GO:0070588; GO:0071277; GO:0071805; GO:0098662; GO:0198738"
"2605",2605,"Cluster_4629","Porites_evermani_scaffold_688:123882-124882",150,-21.81,2,21,582,602,19,"57.89%","84.21%","Peve_00039221",0.10567165592414,0.93260150110166,0.999448381576871,NA,NA,NA,NA,NA
"2606",2606,"Cluster_4629","Porites_evermani_scaffold_69:137552-138552",150,-21.12,2,11,687,708,9,"100.00%","100.00%","Peve_00039268",0.545573440365325,0.632623786074284,0.978262075707395,"Q9JKA9","Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2","Rattus norvegicus (Rat)","aging [GO:0007568]; brain development [GO:0007420]; cellular response to aldosterone [GO:1904045]; cellular response to cAMP [GO:0071320]; cellular response to cGMP [GO:0071321]; inflammatory response [GO:0006954]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane depolarization [GO:0003254]; regulation of membrane potential [GO:0042391]; response to cisplatin [GO:0072718]; response to hormone [GO:0009725]; response to xenobiotic stimulus [GO:0009410]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]","GO:0003254; GO:0005222; GO:0005248; GO:0005249; GO:0005737; GO:0005886; GO:0006954; GO:0007420; GO:0007568; GO:0009410; GO:0009725; GO:0016020; GO:0030165; GO:0030424; GO:0030425; GO:0030552; GO:0032590; GO:0034765; GO:0035725; GO:0036477; GO:0042391; GO:0042802; GO:0043025; GO:0043198; GO:0044877; GO:0045202; GO:0060090; GO:0071320; GO:0071321; GO:0071805; GO:0072718; GO:0098719; GO:0098855; GO:1904045; GO:1990573"
"2607",2607,"Cluster_4629","Porites_evermani_scaffold_6924:2304-3304",160,-20.78,2,21,446,467,19,"63.16%","84.21%","Peve_00039349",-0.443383362280846,0.707556077121805,0.978262075707395,NA,NA,NA,NA,NA
"2608",2608,"Cluster_4629","Porites_evermani_scaffold_694:111932-112932",151,-21.15,2,21,610,632,20,"65.00%","75.00%","Peve_00039379",-0.963384418692656,0.172807360226309,0.978262075707395,NA,NA,NA,NA,NA
"2609",2609,"Cluster_4629","Porites_evermani_scaffold_701:106518-107518",158,-26.42,2,21,805,830,23,"69.57%","78.26%","Peve_00039652",-0.76711659237429,0.443381524959697,0.978262075707395,NA,NA,NA,NA,NA
"2610",2610,"Cluster_4629","Porites_evermani_scaffold_708:169150-170150",147,-20.01,2,20,520,541,18,"61.11%","72.22%","Peve_00039770",NA,NA,NA,"Q96CG8","Collagen triple helix repeat-containing protein 1","Homo sapiens (Human)","cell migration [GO:0016477]; cochlea morphogenesis [GO:0090103]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein binding [GO:0032092]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0001649; GO:0005109; GO:0005576; GO:0005581; GO:0005615; GO:0016477; GO:0016528; GO:0017147; GO:0032092; GO:0033687; GO:0033690; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0062023; GO:0090090; GO:0090103; GO:0090177"
"2611",2611,"Cluster_4629","Porites_evermani_scaffold_7099:0-645",151,-21.78,2,20,35,56,18,"61.11%","77.78%","Peve_00039793",0.981638582841496,0.122184183160886,0.978262075707395,"P36514","UDP-glucuronosyltransferase 2C1 (UDPGT 2C1) (EC 2.4.1.17)","Oryctolagus cuniculus (Rabbit)","lipid metabolic process [GO:0006629]","GO:0005789; GO:0006629; GO:0015020"
"2612",2612,"Cluster_4629","Porites_evermani_scaffold_710:195562-196562",156,-21.19,2,21,620,641,19,"63.16%","78.95%","Peve_00039849",0.7735783539092,0.436929795098007,0.978262075707395,NA,NA,NA,NA,NA
"2613",2613,"Cluster_4629","Porites_evermani_scaffold_710:4049-5049",172,-32.19,2,18,473,495,17,"88.24%","94.12%","Peve_00039833",NA,NA,NA,NA,NA,NA,NA,NA
"2614",2614,"Cluster_4629","Porites_evermani_scaffold_71:38058-39058",153,-22.8,2,20,766,786,18,"66.67%","83.33%","Peve_00039808",-0.443383362280846,0.707556077121805,0.978262075707395,NA,NA,NA,NA,NA
"2615",2615,"Cluster_4629","Porites_evermani_scaffold_720:112738-113738",151,-24.14,2,21,112,137,23,"65.22%","69.57%","Peve_00040059",-0.106399088302506,0.932135777674098,0.999448381576871,NA,NA,NA,NA,NA
"2616",2616,"Cluster_4629","Porites_evermani_scaffold_720:132238-133238",154,-21.22,2,20,335,358,20,"70.00%","75.00%","Peve_00040060",-0.970952147370556,0.153818672056047,0.978262075707395,NA,NA,NA,NA,NA
"2617",2617,"Cluster_4629","Porites_evermani_scaffold_720:132238-133238",155,-27.85,2,21,198,222,22,"68.18%","72.73%","Peve_00040060",-0.970952147370556,0.153818672056047,0.978262075707395,NA,NA,NA,NA,NA
"2618",2618,"Cluster_4629","Porites_evermani_scaffold_72:247829-248829",152,-20.62,2,14,141,164,14,"85.71%","85.71%","Peve_00040030",NA,NA,NA,NA,NA,NA,NA,NA
"2619",2619,"Cluster_4629","Porites_evermani_scaffold_735:51697-52697",156,-23.16,2,18,946,968,17,"70.59%","88.24%","Peve_00040405",-0.437498186425551,0.711729286485125,0.979322411633365,"Q7TN88","Polycystic kidney disease protein 1-like 2 (PC1-like 2 protein) (Polycystin-1L2)","Mus musculus (Mouse)","detection of mechanical stimulus [GO:0050982]","GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982"
"2620",2620,"Cluster_4629","Porites_evermani_scaffold_73:57737-58737",162,-22.39,2,21,764,784,19,"68.42%","89.47%","Peve_00040286",NA,NA,NA,NA,NA,NA,NA,NA
"2621",2621,"Cluster_4629","Porites_evermani_scaffold_73:73620-74620",155,-22.46,2,20,770,791,18,"66.67%","77.78%","Peve_00040288",NA,NA,NA,NA,NA,NA,NA,NA
"2622",2622,"Cluster_4629","Porites_evermani_scaffold_75:16834-17834",163,-20.47,2,20,182,203,18,"72.22%","83.33%","Peve_00040661",-0.753386650468146,0.456837801820151,0.978262075707395,"L8E946","Homeobox protein unc-42 (Uncoordinated protein 42)","Caenorhabditis elegans","axon development [GO:0061564]; axon guidance [GO:0007411]; larval locomotory behavior [GO:0008345]; neuron differentiation [GO:0030182]; neuron fate specification [GO:0048665]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; synapse organization [GO:0050808]","GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0007411; GO:0008345; GO:0010468; GO:0030182; GO:0045944; GO:0048665; GO:0050808; GO:0061564"
"2623",2623,"Cluster_4629","Porites_evermani_scaffold_763:139463-140463",145,-27.81,2,20,148,177,26,"61.54%","69.23%","Peve_00040944",0.977123835176588,0.136432594987179,0.978262075707395,NA,NA,NA,NA,NA
"2624",2624,"Cluster_4629","Porites_evermani_scaffold_7:65062-66062",152,-22.41,2,21,816,837,19,"57.89%","78.95%","Peve_00039525",0.984163526706953,0.113448607492124,0.978262075707395,NA,NA,NA,NA,NA
"2625",2625,"Cluster_4629","Porites_evermani_scaffold_766:5920-6920",166,-26.09,2,21,942,962,19,"78.95%","84.21%","Peve_00040982",NA,NA,NA,NA,NA,NA,NA,NA
"2626",2626,"Cluster_4629","Porites_evermani_scaffold_777:9630-10630",155,-22.47,2,18,959,979,16,"75.00%","87.50%","Peve_00041181",-0.554554668634826,0.625777256211528,0.978262075707395,NA,NA,NA,NA,NA
"2627",2627,"Cluster_4629","Porites_evermani_scaffold_7:826182-827182",147,-22.49,2,16,426,447,14,"71.43%","78.57%","Peve_00039559",-0.554554668634826,0.625777256211528,0.978262075707395,NA,NA,NA,NA,NA
"2628",2628,"Cluster_4629","Porites_evermani_scaffold_78:448934-449934",148,-21.4,2,18,885,908,18,"72.22%","72.22%","Peve_00041254",NA,NA,NA,NA,NA,NA,NA,NA
"2629",2629,"Cluster_4629","Porites_evermani_scaffold_79:224085-225085",143,-20.14,2,20,834,855,18,"55.56%","72.22%","Peve_00041493",0.13641434172416,0.912884306995568,0.999448381576871,"Q5R7N3","ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","proteolysis involved in protein catabolic process [GO:0051603]","GO:0005524; GO:0005759; GO:0008270; GO:0009368; GO:0016887; GO:0042645; GO:0046983; GO:0051082; GO:0051603; GO:0140662"
"2630",2630,"Cluster_4629","Porites_evermani_scaffold_801:183166-184166",146,-20.9,2,20,874,897,20,"60.00%","75.00%","Peve_00041823",NA,NA,NA,NA,NA,NA,NA,NA
"2631",2631,"Cluster_4629","Porites_evermani_scaffold_819:70668-71668",157,-24.55,2,14,624,645,12,"91.67%","91.67%","Peve_00042151",0.997938030915672,0.0408894104551393,0.909359886114279,NA,NA,NA,NA,NA
"2632",2632,"Cluster_4629","Porites_evermani_scaffold_824:160796-161796",146,-20.28,2,20,135,157,19,"63.16%","73.68%","Peve_00042270",NA,NA,NA,NA,NA,NA,NA,NA
"2633",2633,"Cluster_4629","Porites_evermani_scaffold_832:137129-138129",157,-21.66,2,21,660,679,19,"73.68%","78.95%","Peve_00042435",0.997262417278732,0.0471170262500777,0.94113497813925,NA,NA,NA,NA,NA
"2634",2634,"Cluster_4629","Porites_evermani_scaffold_840:157442-158442",150,-20.82,2,21,524,548,22,"68.18%","72.73%","Peve_00042588",-0.569847673823218,0.614004397003134,0.978262075707395,NA,NA,NA,NA,NA
"2635",2635,"Cluster_4629","Porites_evermani_scaffold_842:78165-79165",147,-20.83,2,21,409,432,21,"61.90%","71.43%","Peve_00042619",-0.643329245801105,0.555105296251916,0.978262075707395,"Q92626","Peroxidasin homolog (EC 1.11.2.-) (Melanoma-associated antigen MG50) (Peroxidasin 1) (hsPxd01) (Vascular peroxidase 1) (p53-responsive gene 2 protein) [Cleaved into: PXDN active fragment]","Homo sapiens (Human)","angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; hydrogen peroxide catabolic process [GO:0042744]; immune response [GO:0006955]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979]","GO:0001525; GO:0001654; GO:0004601; GO:0005152; GO:0005201; GO:0005576; GO:0005604; GO:0005615; GO:0005783; GO:0006955; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0030198; GO:0030199; GO:0031012; GO:0042744; GO:0043237; GO:0046872; GO:0051260; GO:0062023; GO:0070062; GO:0070207; GO:0070831; GO:0071711; GO:0140825"
"2636",2636,"Cluster_4629","Porites_evermani_scaffold_858:82397-83397",170,-29.73,2,19,831,852,17,"82.35%","88.24%","Peve_00042909",-0.379144741361919,0.752436488544915,0.988219883885475,"Q969R8","KICSTOR complex protein ITFG2 (Integrin-alpha FG-GAP repeat-containing protein 2)","Homo sapiens (Human)","cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; germinal center B cell differentiation [GO:0002314]; negative regulation of TORC1 signaling [GO:1904262]; regulation of TOR signaling [GO:0032006]","GO:0002314; GO:0005654; GO:0005765; GO:0005829; GO:0032006; GO:0034198; GO:0042149; GO:0140007; GO:1904262"
"2637",2637,"Cluster_4629","Porites_evermani_scaffold_858:82794-83794",170,-29.73,2,19,434,455,17,"82.35%","88.24%","Peve_00042910",0.592046882578819,0.596640042930344,0.978262075707395,"Q4G0X4","BTB/POZ domain-containing protein KCTD21 (KCASH2 protein) (Potassium channel tetramerization domain-containing protein 21)","Homo sapiens (Human)","negative regulation of smoothened signaling pathway [GO:0045879]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0006511; GO:0016567; GO:0042802; GO:0042826; GO:0045879; GO:0051260; GO:0097602"
"2638",2638,"Cluster_4629","Porites_evermani_scaffold_877:121195-122195",153,-21.26,2,21,243,262,19,"73.68%","73.68%","Peve_00043268",-0.554554668634826,0.625777256211528,0.978262075707395,NA,NA,NA,NA,NA
"2639",2639,"Cluster_4629","Porites_evermani_scaffold_881:42929-43929",156,-21.82,2,21,916,937,19,"68.42%","73.68%","Peve_00043348",-0.554554668634826,0.625777256211528,0.978262075707395,NA,NA,NA,NA,NA
"2640",2640,"Cluster_4629","Porites_evermani_scaffold_892:89419-90419",154,-20.17,2,15,709,730,13,"84.62%","84.62%","Peve_00043512",-0.3437932531995,0.776576123819463,0.992735940319267,NA,NA,NA,NA,NA
"2641",2641,"Cluster_4629","Porites_evermani_scaffold_897:166757-167757",150,-21.16,2,11,536,557,9,"100.00%","100.00%","Peve_00043569",-0.668574993772775,0.533809142356055,0.978262075707395,"Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"2642",2642,"Cluster_4629","Porites_evermani_scaffold_900:13228-14228",146,-20.9,2,20,932,955,20,"60.00%","75.00%","Peve_00043768",0.997938030915673,0.0408894104551382,0.909359886114279,NA,NA,NA,NA,NA
"2643",2643,"Cluster_4629","Porites_evermani_scaffold_905:109341-110341",146,-21.6,2,21,414,434,19,"63.16%","73.68%","Peve_00043845",0.34033133567179,0.778921532122966,0.993229127488468,"P98133","Fibrillin-1 (MP340) [Cleaved into: Asprosin]","Bos taurus (Bovine)","activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; protein kinase A signaling [GO:0010737]","GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0008201; GO:0009653; GO:0010737; GO:0031012; GO:0034199; GO:0042593"
"2644",2644,"Cluster_4629","Porites_evermani_scaffold_905:131738-132738",158,-21.56,2,20,964,987,20,"70.00%","80.00%","Peve_00043837",-0.448355559535223,0.704019697647163,0.978262075707395,"Q8VDJ3","Vigilin (High density lipoprotein-binding protein) (HDL-binding protein)","Mus musculus (Mouse)","cholesterol metabolic process [GO:0008203]; lipid transport [GO:0006869]","GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0005844; GO:0006869; GO:0008203; GO:0034364"
"2645",2645,"Cluster_4629","Porites_evermani_scaffold_907:60079-61079",154,-21.48,2,15,265,286,13,"84.62%","84.62%","Peve_00043870",NA,NA,NA,"P48040","Melatonin receptor type 1A (Mel-1A-R) (Mel1a receptor)","Ovis aries (Sheep)","","GO:0005886; GO:0008502"
"2646",2646,"Cluster_4629","Porites_evermani_scaffold_91:320476-321476",162,-22.28,2,21,114,134,19,"73.68%","84.21%","Peve_00043916",-0.94953842265521,0.203104212619977,0.978262075707395,"Q5E985","Hyaluronidase-1 (Hyal-1) (EC 3.2.1.35) (Hyaluronoglucosaminidase-1)","Bos taurus (Bovine)","carbohydrate metabolic process [GO:0005975]; cartilage development [GO:0051216]; cellular response to interleukin-1 [GO:0071347]; cellular response to pH [GO:0071467]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to UV-B [GO:0071493]; hyaluronan biosynthetic process [GO:0030213]; hyaluronan catabolic process [GO:0030214]; hyaluronan metabolic process [GO:0030212]; inflammatory response [GO:0006954]; negative regulation of cell growth [GO:0030308]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell growth [GO:0030307]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of growth [GO:0045927]; positive regulation of hyaluranon cable assembly [GO:1900106]; response to antibiotic [GO:0046677]; response to reactive oxygen species [GO:0000302]; response to virus [GO:0009615]","GO:0000302; GO:0004415; GO:0005615; GO:0005737; GO:0005764; GO:0005975; GO:0006954; GO:0009615; GO:0010634; GO:0030212; GO:0030213; GO:0030214; GO:0030307; GO:0030308; GO:0031410; GO:0036117; GO:0036120; GO:0045766; GO:0045785; GO:0045927; GO:0046677; GO:0050501; GO:0050679; GO:0051216; GO:0071347; GO:0071467; GO:0071493; GO:1900087; GO:1900106"
"2647",2647,"Cluster_4629","Porites_evermani_scaffold_915:13455-14455",147,-20.52,2,20,457,478,18,"55.56%","77.78%","Peve_00044010",-0.989543011702968,0.092146238258004,0.978262075707395,NA,NA,NA,NA,NA
"2648",2648,"Cluster_4629","Porites_evermani_scaffold_915:20578-21578",147,-20.52,2,20,523,544,18,"55.56%","77.78%","Peve_00044012",-0.784010518474915,0.426341603210729,0.978262075707395,NA,NA,NA,NA,NA
"2649",2649,"Cluster_4629","Porites_evermani_scaffold_91:547425-548425",158,-23.4,2,16,302,324,15,"80.00%","93.33%","Peve_00043896",-0.518121997700191,0.65326263423622,0.978262075707395,NA,NA,NA,NA,NA
"2650",2650,"Cluster_4629","Porites_evermani_scaffold_917:26787-27787",153,-22.81,2,14,379,400,12,"83.33%","91.67%","Peve_00044051",0.513345547614267,0.656811854771502,0.978262075707395,NA,NA,NA,NA,NA
"2651",2651,"Cluster_4629","Porites_evermani_scaffold_918:86588-87588",161,-25.71,2,20,672,692,18,"72.22%","88.89%","Peve_00044062",-0.434517092711135,0.713838114218382,0.979835926349238,"O14638","Ectonucleotide pyrophosphatase/phosphodiesterase family member 3 (E-NPP 3) (NPP3) (Phosphodiesterase I beta) (PD-Ibeta) (Phosphodiesterase I/nucleotide pyrophosphatase 3) (CD antigen CD203c) [Includes: Alkaline phosphodiesterase I (EC 3.1.4.1); Nucleotide pyrophosphatase (NPPase) (EC 3.6.1.9) (Nucleotide diphosphatase)]","Homo sapiens (Human)","ATP metabolic process [GO:0046034]; basophil activation involved in immune response [GO:0002276]; negative regulation of inflammatory response [GO:0050728]; negative regulation of mast cell activation involved in immune response [GO:0033007]; negative regulation of mast cell proliferation [GO:0070667]; nucleoside triphosphate catabolic process [GO:0009143]; phosphate ion homeostasis [GO:0055062]; phosphate-containing compound metabolic process [GO:0006796]; pyrimidine nucleotide metabolic process [GO:0006220]","GO:0002276; GO:0003676; GO:0004528; GO:0005509; GO:0006220; GO:0006796; GO:0008270; GO:0009143; GO:0009897; GO:0016324; GO:0033007; GO:0046034; GO:0047429; GO:0048471; GO:0050728; GO:0055062; GO:0070062; GO:0070667"
"2652",2652,"Cluster_4629","Porites_evermani_scaffold_919:101643-102643",151,-21.56,2,12,317,338,10,"90.00%","100.00%","Peve_00044073",NA,NA,NA,NA,NA,NA,NA,NA
"2653",2653,"Cluster_4629","Porites_evermani_scaffold_920:31927-32927",163,-22.44,2,20,49,70,18,"72.22%","83.33%","Peve_00044122",0.638290112582594,0.559284051692112,0.978262075707395,"Q56A55","Mitochondrial potassium channel ATP-binding subunit (ATP-binding cassette sub-family B member 8, mitochondrial) (ABCB8) (Mitochondrial sulfonylurea-receptor) (MITOSUR)","Danio rerio (Zebrafish) (Brachydanio rerio)","potassium ion transmembrane transport [GO:0071805]","GO:0005524; GO:0005739; GO:0005743; GO:0016887; GO:0062157; GO:0071805; GO:0140359"
"2654",2654,"Cluster_4629","Porites_evermani_scaffold_931:87058-88058",154,-21.4,2,19,919,940,17,"64.71%","82.35%","Peve_00044288",-0.431285871439608,0.716120083497427,0.980509562631722,"B6YWH0","Glyoxylate reductase (EC 1.1.1.26)","Thermococcus onnurineus (strain NA1)","","GO:0005737; GO:0047964; GO:0051287"
"2655",2655,"Cluster_4629","Porites_evermani_scaffold_939:35499-36499",153,-20.35,2,21,870,891,20,"70.00%","80.00%","Peve_00044377",-0.443383362280846,0.707556077121805,0.978262075707395,NA,NA,NA,NA,NA
"2656",2656,"Cluster_4629","Porites_evermani_scaffold_939:36294-36499",153,-20.35,2,21,75,96,20,"70.00%","80.00%","Peve_00044376",-0.809374722159792,0.399612388949559,0.978262075707395,NA,NA,NA,NA,NA
"2657",2657,"Cluster_4629","Porites_evermani_scaffold_94:0-199",160,-21.33,2,13,33,54,11,"100.00%","100.00%","Peve_00044391",-0.720909203517639,0.48744892148264,0.978262075707395,"Q28GW8","Maternal embryonic leucine zipper kinase (EC 2.7.11.1)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell population proliferation [GO:0008283]; erythrocyte development [GO:0048821]; hemopoiesis [GO:0030097]; neural precursor cell proliferation [GO:0061351]; positive regulation of apoptotic process [GO:0043065]; protein autophosphorylation [GO:0046777]; regulation of heart contraction [GO:0008016]","GO:0004674; GO:0004715; GO:0005509; GO:0005524; GO:0005886; GO:0005938; GO:0006915; GO:0007049; GO:0008016; GO:0008283; GO:0008289; GO:0030097; GO:0043065; GO:0046777; GO:0048821; GO:0061351; GO:0106310"
"2658",2658,"Cluster_4629","Porites_evermani_scaffold_9:533373-534373",152,-21.26,2,19,146,170,20,"70.00%","80.00%","Peve_00043615",0.999186729228898,0.0256768734393112,0.876415971818516,"P55006","Retinol dehydrogenase 7 (EC 1.1.1.105) (Retinol dehydrogenase 3) (Retinol dehydrogenase type III) (RODH III)","Rattus norvegicus (Rat)","retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202]","GO:0004745; GO:0005783; GO:0008202; GO:0016491; GO:0042572; GO:0043231"
"2659",2659,"Cluster_4629","Porites_evermani_scaffold_989:87031-88031",150,-28.07,2,21,273,301,26,"65.38%","69.23%","Peve_00045181",-0.492567472307836,0.672116953030069,0.978262075707395,NA,NA,NA,NA,NA
"2660",2660,"Cluster_4629","Porites_evermani_scaffold_994:115492-116492",162,-20.3,2,15,406,427,13,"92.31%","92.31%","Peve_00045290",-0.580505073281198,0.605710281693394,0.978262075707395,"P41035","Eukaryotic translation initiation factor 2 subunit 2 (Eukaryotic translation initiation factor 2 subunit beta) (eIF-2-beta)","Oryctolagus cuniculus (Rabbit)","in utero embryonic development [GO:0001701]; male germ cell proliferation [GO:0002176]; male gonad development [GO:0008584]","GO:0001701; GO:0002176; GO:0003743; GO:0005850; GO:0008584; GO:0045202; GO:0046872"
"2661",2661,"Cluster_4735","Porites_evermani_scaffold_101:373915-374915",164,-24.6,2,17,487,508,15,"80.00%","93.33%","Peve_00000401",0.663494557810868,0.538145162564059,0.978262075707395,NA,NA,NA,NA,NA
"2662",2662,"Cluster_4735","Porites_evermani_scaffold_1114:12274-13274",173,-22.62,2,18,243,264,16,"87.50%","93.75%","Peve_00002079",-0.485042930351901,0.677607943037408,0.978262075707395,"Q8MIR4","Bifunctional coenzyme A synthase (CoA synthase) (NBP) (POV-2) [Includes: Phosphopantetheine adenylyltransferase (EC 2.7.7.3) (Dephospho-CoA pyrophosphorylase) (Pantetheine-phosphate adenylyltransferase) (PPAT); Dephospho-CoA kinase (DPCK) (EC 2.7.1.24) (Dephosphocoenzyme A kinase) (DPCOAK)]","Sus scrofa (Pig)","coenzyme A biosynthetic process [GO:0015937]; phosphorylation [GO:0016310]","GO:0004140; GO:0004595; GO:0005524; GO:0005759; GO:0015937; GO:0016310"
"2663",2663,"Cluster_4735","Porites_evermani_scaffold_1141:56322-57322",159,-22.15,2,21,69,93,22,"63.64%","81.82%","Peve_00002446",-0.265901582554203,0.828660757159394,0.995934364227446,NA,NA,NA,NA,NA
"2664",2664,"Cluster_4735","Porites_evermani_scaffold_1144:51055-52055",151,-23.76,2,12,755,776,10,"90.00%","100.00%","Peve_00002481",-0.499055763751742,0.667360561442895,0.978262075707395,NA,NA,NA,NA,NA
"2665",2665,"Cluster_4735","Porites_evermani_scaffold_1152:137164-138164",151,-21.11,2,12,11,32,10,"90.00%","100.00%","Peve_00002590",0.0301349683996731,0.98081257846109,0.999448381576871,NA,NA,NA,NA,NA
"2666",2666,"Cluster_4735","Porites_evermani_scaffold_1191:127272-128272",168,-21.3,2,21,250,271,19,"78.95%","78.95%","Peve_00003213",-0.817897001704258,0.390279707979208,0.978262075707395,NA,NA,NA,NA,NA
"2667",2667,"Cluster_4735","Porites_evermani_scaffold_1204:76027-77027",161,-22.79,2,19,840,863,19,"73.68%","84.21%","Peve_00003450",-0.356864423670546,0.767691622847399,0.990417209763172,NA,NA,NA,NA,NA
"2668",2668,"Cluster_4735","Porites_evermani_scaffold_1206:84957-85957",147,-26.29,2,21,855,885,28,"60.71%","64.29%","Peve_00003474",-0.499055763751742,0.667360561442895,0.978262075707395,NA,NA,NA,NA,NA
"2669",2669,"Cluster_4735","Porites_evermani_scaffold_121:434668-435668",155,-20.18,2,21,913,939,24,"66.67%","70.83%","Peve_00003524",-0.145154703239697,0.90726402432204,0.999448381576871,"Q5RE49","Trichoplein keratin filament-binding protein (Protein TCHP) (Mitochondrial protein with oncostatic activity) (Mitostatin)","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","apoptotic process [GO:0006915]; cell projection organization [GO:0030030]; negative regulation of cell growth [GO:0030308]; negative regulation of cilium assembly [GO:1902018]","GO:0005737; GO:0005739; GO:0005856; GO:0005886; GO:0006915; GO:0030030; GO:0030308; GO:1902018"
"2670",2670,"Cluster_4735","Porites_evermani_scaffold_1218:131643-132643",166,-26.05,2,21,965,985,19,"78.95%","84.21%","Peve_00003636",-0.500943642233887,0.665972771890438,0.978262075707395,NA,NA,NA,NA,NA
"2671",2671,"Cluster_4735","Porites_evermani_scaffold_1300:125498-126498",155,-22.09,2,21,520,542,20,"60.00%","85.00%","Peve_00004815",-0.494114378272845,0.670984795777062,0.978262075707395,"A7SIM4","Hapless 2 (Generative cell specific 1)","Nematostella vectensis (Starlet sea anemone)","single fertilization [GO:0007338]","GO:0005886; GO:0007338; GO:0008289"
"2672",2672,"Cluster_4735","Porites_evermani_scaffold_132:156885-157885",164,-20.28,2,18,449,471,17,"76.47%","94.12%","Peve_00005076",NA,NA,NA,NA,NA,NA,NA,NA
"2673",2673,"Cluster_4735","Porites_evermani_scaffold_1322:5578-6578",163,-20.36,2,21,511,534,21,"71.43%","80.95%","Peve_00005120",-0.54725185406363,0.631347975671633,0.978262075707395,NA,NA,NA,NA,NA
"2674",2674,"Cluster_4735","Porites_evermani_scaffold_1323:104889-105889",157,-24.05,2,20,822,847,22,"72.73%","77.27%","Peve_00005135",-0.68736449555845,0.517535041857855,0.978262075707395,NA,NA,NA,NA,NA
"2675",2675,"Cluster_4735","Porites_evermani_scaffold_1330:12431-13431",163,-20.23,2,21,753,775,20,"70.00%","85.00%","Peve_00005220",NA,NA,NA,NA,NA,NA,NA,NA
"2676",2676,"Cluster_4735","Porites_evermani_scaffold_1341:46863-47863",149,-20.54,2,15,51,73,14,"71.43%","92.86%","Peve_00005391",-0.0158478749265933,0.989910507103665,0.999448381576871,NA,NA,NA,NA,NA
"2677",2677,"Cluster_4735","Porites_evermani_scaffold_135:365739-366739",164,-22.41,2,17,291,312,15,"86.67%","86.67%","Peve_00005515",-0.697331529928923,0.508741084228226,0.978262075707395,"Q8T882","Tauropine dehydrogenase (TaDH) (EC 1.5.1.23) (NAD: tauropine oxidoreductase)","Arabella iricolor (Opal worm)","","GO:0050325"
"2678",2678,"Cluster_4735","Porites_evermani_scaffold_135:388663-389663",164,-22.41,2,17,295,316,15,"86.67%","86.67%","Peve_00005516",-0.322489481841884,0.790960608995896,0.995934364227446,"Q8T882","Tauropine dehydrogenase (TaDH) (EC 1.5.1.23) (NAD: tauropine oxidoreductase)","Arabella iricolor (Opal worm)","","GO:0050325"
"2679",2679,"Cluster_4735","Porites_evermani_scaffold_13:783653-784653",165,-23.35,2,20,440,460,18,"83.33%","83.33%","Peve_00004731",-0.999783900702665,0.0132351729066914,0.705702184467113,"Q6DEW6","RNA exonuclease 4 (EC 3.1.-.-) (Exonuclease XPMC2) (Prevents mitotic catastrophe 2 protein)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","rRNA processing [GO:0006364]","GO:0003676; GO:0005634; GO:0006364; GO:0008408"
"2680",2680,"Cluster_4735","Porites_evermani_scaffold_1406:43489-44489",153,-21.69,2,20,882,905,20,"70.00%","80.00%","Peve_00006330",-0.499055763751742,0.667360561442895,0.978262075707395,NA,NA,NA,NA,NA
"2681",2681,"Cluster_4735","Porites_evermani_scaffold_1412:69733-70733",167,-23.35,2,16,166,187,14,"92.86%","92.86%","Peve_00006417",-0.500943642233887,0.665972771890438,0.978262075707395,"O76093","Fibroblast growth factor 18 (FGF-18) (zFGF5)","Homo sapiens (Human)","anatomical structure morphogenesis [GO:0009653]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cell-cell signaling [GO:0007267]; chondrocyte development [GO:0002063]; endochondral ossification [GO:0001958]; ERK1 and ERK2 cascade [GO:0070371]; fibroblast growth factor receptor signaling pathway [GO:0008543]; intramembranous ossification [GO:0001957]; lung development [GO:0030324]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000546]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; regulation of cell migration [GO:0030334]; signal transduction [GO:0007165]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]","GO:0001525; GO:0001934; GO:0001957; GO:0001958; GO:0002063; GO:0005104; GO:0005105; GO:0005111; GO:0005576; GO:0005615; GO:0005730; GO:0005737; GO:0007165; GO:0007267; GO:0008083; GO:0008283; GO:0008284; GO:0008543; GO:0009653; GO:0009887; GO:0010628; GO:0030154; GO:0030324; GO:0030334; GO:0030949; GO:0032332; GO:0043406; GO:0043536; GO:0045766; GO:0048010; GO:0070371; GO:0070374; GO:2000546"
"2682",2682,"Cluster_4735","Porites_evermani_scaffold_1445:118018-119018",152,-20.56,2,17,286,307,15,"73.33%","80.00%","Peve_00006784",-0.232332521392507,0.85072848856565,0.995934364227446,"P70187","Hippocampus abundant transcript 1 protein (Major facilitator superfamily domain-containing 14A)","Mus musculus (Mouse)","acrosome assembly [GO:0001675]; sperm mitochondrion organization [GO:0030382]; spermatid development [GO:0007286]; spermatid nucleus differentiation [GO:0007289]; spermatogenesis [GO:0007283]","GO:0001675; GO:0007283; GO:0007286; GO:0007289; GO:0016020; GO:0022857; GO:0030382"
"2683",2683,"Cluster_4735","Porites_evermani_scaffold_1451:66637-67637",151,-20.21,2,12,761,782,10,"90.00%","100.00%","Peve_00006869",-0.87461195453991,0.322232402273784,0.978262075707395,"Q99759","Mitogen-activated protein kinase kinase kinase 3 (EC 2.7.11.25) (MAPK/ERK kinase kinase 3) (MEK kinase 3) (MEKK 3)","Homo sapiens (Human)","blood vessel development [GO:0001568]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; negative regulation of cellular senescence [GO:2000773]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell proliferation in bone marrow [GO:0071864]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of p38MAPK cascade [GO:1900745]; protein autophosphorylation [GO:0046777]","GO:0000165; GO:0001568; GO:0004672; GO:0004674; GO:0004709; GO:0005524; GO:0005737; GO:0005829; GO:0035556; GO:0043123; GO:0046777; GO:0046872; GO:0071864; GO:0090050; GO:0106310; GO:1900745; GO:2000773"
"2684",2684,"Cluster_4735","Porites_evermani_scaffold_14:57292-58292",163,-22.3,2,20,64,85,18,"72.22%","83.33%","Peve_00006174",-0.998701518193497,0.032445917538854,0.909359886114279,NA,NA,NA,NA,NA
"2685",2685,"Cluster_4735","Porites_evermani_scaffold_1533:28519-29519",165,-25.27,2,19,248,270,18,"77.78%","88.89%","Peve_00007922",-0.993132897004083,0.0746501601246803,0.978262075707395,"A0JNI4","Serine racemase (EC 4.3.1.17) (EC 4.3.1.18) (EC 5.1.1.18) (D-serine ammonia-lyase) (D-serine dehydratase) (L-serine ammonia-lyase) (L-serine dehydratase)","Bos taurus (Bovine)","D-serine biosynthetic process [GO:0070179]; D-serine metabolic process [GO:0070178]; L-serine metabolic process [GO:0006563]; pyruvate biosynthetic process [GO:0042866]; response to lipopolysaccharide [GO:0032496]","GO:0000287; GO:0003941; GO:0005509; GO:0005524; GO:0005737; GO:0006563; GO:0008721; GO:0016594; GO:0018114; GO:0030165; GO:0030170; GO:0030378; GO:0032496; GO:0042803; GO:0042866; GO:0043025; GO:0070178; GO:0070179"
"2686",2686,"Cluster_4735","Porites_evermani_scaffold_1596:0-765",151,-20.92,2,12,219,240,10,"90.00%","100.00%","Peve_00008709",NA,NA,NA,NA,NA,NA,NA,NA
"2687",2687,"Cluster_4735","Porites_evermani_scaffold_160:73062-74062",161,-25.68,2,14,609,630,12,"91.67%","100.00%","Peve_00008821",-0.991990071020765,0.080630577273076,0.978262075707395,"Q6PBT5","Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 1 (EC 1.8.1.-)","Danio rerio (Zebrafish) (Brachydanio rerio)","","GO:0005634; GO:0016491; GO:0030017; GO:0050660"
"2688",2688,"Cluster_4735","Porites_evermani_scaffold_161:412260-413196",160,-24.34,2,17,79,100,15,"73.33%","93.33%","Peve_00008942",-0.00357915086628129,0.997721436925367,0.999470707733341,NA,NA,NA,NA,NA
"2689",2689,"Cluster_4735","Porites_evermani_scaffold_163:225403-226290",166,-23.72,2,21,583,606,21,"76.19%","85.71%","Peve_00009170",-0.600648536438474,0.589818224658096,0.978262075707395,NA,NA,NA,NA,NA
"2690",2690,"Cluster_4735","Porites_evermani_scaffold_1659:50666-51666",151,-20.36,2,12,164,185,10,"90.00%","100.00%","Peve_00009486",-0.311163194351996,0.798562844839185,0.995934364227446,"Q28EW0","Transmembrane protein 87A","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","","GO:0000139; GO:0032580"
"2691",2691,"Cluster_4735","Porites_evermani_scaffold_1713:103238-104238",162,-27.54,2,21,114,140,24,"70.83%","79.17%","Peve_00010191",-0.173448115498593,0.8890182148934,0.999448381576871,NA,NA,NA,NA,NA
"2692",2692,"Cluster_4735","Porites_evermani_scaffold_177:148572-149572",168,-20.08,2,21,973,994,19,"68.42%","89.47%","Peve_00010766",-0.508609960317104,0.660319064669821,0.978262075707395,NA,NA,NA,NA,NA
"2693",2693,"Cluster_4735","Porites_evermani_scaffold_1779:64084-65084",145,-20.31,2,21,910,937,25,"64.00%","72.00%","Peve_00010855",-0.649251262175629,0.550164733211012,0.978262075707395,NA,NA,NA,NA,NA
"2694",2694,"Cluster_4735","Porites_evermani_scaffold_1781:37927-38927",162,-20.86,2,20,212,234,19,"73.68%","84.21%","Peve_00010915",-0.177632996658605,0.88631201324759,0.999448381576871,"Q6AZS2","Polycomb protein eed-B (Xeed-B) (psXEED)","Xenopus laevis (African clawed frog)","chromatin organization [GO:0006325]","GO:0006325; GO:0035098"
"2695",2695,"Cluster_4735","Porites_evermani_scaffold_1818:54370-55370",151,-21.31,2,21,891,909,19,"73.68%","78.95%","Peve_00011355",NA,NA,NA,NA,NA,NA,NA,NA
"2696",2696,"Cluster_4735","Porites_evermani_scaffold_182:389992-390992",151,-21.11,2,12,929,950,10,"90.00%","100.00%","Peve_00011374",-0.00241944110959533,0.998459734448843,0.999679004881277,"Q61143","Short transient receptor potential channel 6 (TrpC6) (Calcium entry channel) (Transient receptor protein 6) (TRP-6)","Mus musculus (Mouse)","calcium ion transmembrane transport [GO:0070588]; cellular response to hydrogen peroxide [GO:0070301]; negative regulation of dendrite morphogenesis [GO:0050774]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ion transmembrane transporter activity [GO:0032414]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; regulation of cytosolic calcium ion concentration [GO:0051480]; single fertilization [GO:0007338]","GO:0003779; GO:0005216; GO:0005261; GO:0005262; GO:0005737; GO:0005886; GO:0007204; GO:0007338; GO:0010800; GO:0015279; GO:0016020; GO:0030276; GO:0032414; GO:0034703; GO:0036057; GO:0042803; GO:0042805; GO:0045666; GO:0050774; GO:0051117; GO:0051480; GO:0051928; GO:0070301; GO:0070588; GO:0070679"
"2697",2697,"Cluster_4735","Porites_evermani_scaffold_1864:26530-27530",157,-28.51,2,21,932,953,20,"70.00%","85.00%","Peve_00011856",-0.523814975023719,0.649016642632276,0.978262075707395,NA,NA,NA,NA,NA
"2698",2698,"Cluster_4735","Porites_evermani_scaffold_1873:68312-68675",156,-22.03,2,14,103,125,13,"92.31%","92.31%","Peve_00011948",-0.718783674876225,0.489398339125938,0.978262075707395,NA,NA,NA,NA,NA
"2699",2699,"Cluster_4735","Porites_evermani_scaffold_189:367702-368702",155,-23.22,2,21,843,865,20,"70.00%","75.00%","Peve_00012113",-0.408419794148611,0.732159918587073,0.985093162587276,"Q8MYF0","Mitochondrial genome maintenance protein mgm101 homolog","Dictyostelium discoideum (Social amoeba)","interstrand cross-link repair [GO:0036297]; mitochondrial genome maintenance [GO:0000002]; recombinational repair [GO:0000725]","GO:0000002; GO:0000262; GO:0000725; GO:0003677; GO:0003697; GO:0005739; GO:0036297; GO:0042645"
"2700",2700,"Cluster_4735","Porites_evermani_scaffold_1951:38266-39266",150,-20.15,2,21,869,892,21,"61.90%","80.95%","Peve_00012845",-0.873065020043858,0.324257866066149,0.978262075707395,"O75096","Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7)","Homo sapiens (Human)","amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055]","GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0016055; GO:0030279; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0044853; GO:0048699; GO:0048813; GO:0050731; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150094; GO:1901631; GO:1904395"
"2701",2701,"Cluster_4735","Porites_evermani_scaffold_196:13324-14324",161,-24.46,2,14,871,892,12,"91.67%","100.00%","Peve_00012921",NA,NA,NA,NA,NA,NA,NA,NA
"2702",2702,"Cluster_4735","Porites_evermani_scaffold_1987:27579-28579",160,-20.5,2,20,186,207,19,"73.68%","89.47%","Peve_00013191",-0.498492134157548,0.667774550671003,0.978262075707395,NA,NA,NA,NA,NA
"2703",2703,"Cluster_4735","Porites_evermani_scaffold_201:132826-133826",151,-21.56,2,21,730,752,20,"70.00%","70.00%","Peve_00013661",0.254191863105037,0.836381060767804,0.995934364227446,NA,NA,NA,NA,NA
"2704",2704,"Cluster_4735","Porites_evermani_scaffold_2011:80383-81383",164,-23.16,2,21,795,816,19,"68.42%","84.21%","Peve_00013696",NA,NA,NA,NA,NA,NA,NA,NA
"2705",2705,"Cluster_4735","Porites_evermani_scaffold_2016:22295-23295",162,-22.6,2,21,98,121,21,"71.43%","85.71%","Peve_00013727",-0.195609221415468,0.874663168867318,0.997476741937264,NA,NA,NA,NA,NA
"2706",2706,"Cluster_4735","Porites_evermani_scaffold_2103:5937-6937",163,-20.46,2,20,40,61,18,"72.22%","83.33%","Peve_00014629",-0.954389874783272,0.193014713931979,0.978262075707395,"Q7ZWG6","Proton-coupled folate transporter (Solute carrier family 46 member 1)","Danio rerio (Zebrafish) (Brachydanio rerio)","transmembrane transport [GO:0055085]","GO:0005542; GO:0005768; GO:0005886; GO:0010008; GO:0015293; GO:0015350; GO:0016020; GO:0016323; GO:0016324; GO:0022857; GO:0055085"
"2707",2707,"Cluster_4735","Porites_evermani_scaffold_2111:70955-71955",172,-21.82,2,21,931,952,19,"68.42%","94.74%","Peve_00014700",NA,NA,NA,NA,NA,NA,NA,NA
"2708",2708,"Cluster_4735","Porites_evermani_scaffold_2135:21422-22422",145,-21.11,2,21,448,470,21,"61.90%","76.19%","Peve_00014928",-0.546069328351483,0.632247020921693,0.978262075707395,NA,NA,NA,NA,NA
"2709",2709,"Cluster_4735","Porites_evermani_scaffold_214:362679-363679",159,-22.91,2,21,667,689,20,"70.00%","80.00%","Peve_00014983",NA,NA,NA,NA,NA,NA,NA,NA
"2710",2710,"Cluster_4735","Porites_evermani_scaffold_2267:10882-11882",155,-20.37,2,21,955,978,21,"71.43%","71.43%","Peve_00016195",-0.0194052921558153,0.987645431858553,0.999448381576871,"P27093","Inhibin beta B chain (Activin beta-B chain)","Gallus gallus (Chicken)","activin receptor signaling pathway [GO:0032924]; cellular response to insulin stimulus [GO:0032869]; cellular response to starvation [GO:0009267]; fat cell differentiation [GO:0045444]; negative regulation of follicle-stimulating hormone secretion [GO:0046882]; negative regulation of hepatocyte growth factor production [GO:0032686]; negative regulation of insulin secretion [GO:0046676]; nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry [GO:1900164]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of ovulation [GO:0060279]; response to wounding [GO:0009611]","GO:0005179; GO:0005576; GO:0008083; GO:0009267; GO:0009611; GO:0032686; GO:0032869; GO:0032924; GO:0042803; GO:0045444; GO:0046676; GO:0046881; GO:0046882; GO:0048471; GO:0060279; GO:1900164"
"2711",2711,"Cluster_4735","Porites_evermani_scaffold_233:251358-252358",166,-23.58,2,21,590,614,22,"77.27%","81.82%","Peve_00016832",0.0253010432278207,0.983891136645702,0.999448381576871,"Q05A56","Hyaluronidase-4 (Hyal-4) (EC 3.2.1.35) (Chondroitin sulfate endo-beta-N-acetylgalactosaminidase) (Chondroitin sulfate hydrolase) (CSHY) (Hyaluronoglucosaminidase-4)","Mus musculus (Mouse)","carbohydrate metabolic process [GO:0005975]; chondroitin sulfate catabolic process [GO:0030207]; hyaluronan catabolic process [GO:0030214]","GO:0004415; GO:0005764; GO:0005975; GO:0009986; GO:0016020; GO:0030207; GO:0030214; GO:0031410; GO:0052757"
"2712",2712,"Cluster_4735","Porites_evermani_scaffold_233:251437-252437",166,-23.58,2,21,511,535,22,"77.27%","81.82%","Peve_00016833",NA,NA,NA,NA,NA,NA,NA,NA
"2713",2713,"Cluster_4735","Porites_evermani_scaffold_2398:49429-50429",151,-20.38,2,16,923,944,14,"71.43%","85.71%","Peve_00017378",NA,NA,NA,NA,NA,NA,NA,NA
"2714",2714,"Cluster_4735","Porites_evermani_scaffold_2421:55596-56596",155,-23.17,2,21,816,841,23,"65.22%","73.91%","Peve_00017706",-0.993938103744247,0.0701324486045105,0.978262075707395,NA,NA,NA,NA,NA
"2715",2715,"Cluster_4735","Porites_evermani_scaffold_24:280731-281731",168,-20.33,2,21,713,734,19,"73.68%","84.21%","Peve_00017478",NA,NA,NA,NA,NA,NA,NA,NA
"2716",2716,"Cluster_4735","Porites_evermani_scaffold_2465:2030-3030",167,-22.35,2,21,633,658,23,"73.91%","78.26%","Peve_00018053",-0.765104546820965,0.445374512677998,0.978262075707395,"Q9NR99","Matrix-remodeling-associated protein 5 (Adhesion protein with leucine-rich repeats and immunoglobulin domains related to perlecan) (Adlican)","Homo sapiens (Human)","response to transforming growth factor beta [GO:0071559]","GO:0005201; GO:0005576; GO:0062023; GO:0070062; GO:0071559"
"2717",2717,"Cluster_4735","Porites_evermani_scaffold_2500:34746-35746",153,-20.95,2,21,119,140,20,"70.00%","80.00%","Peve_00018464",NA,NA,NA,NA,NA,NA,NA,NA
"2718",2718,"Cluster_4735","Porites_evermani_scaffold_2519:66350-67350",159,-21.44,2,21,684,706,20,"75.00%","75.00%","Peve_00018594",-0.500943642233887,0.665972771890438,0.978262075707395,NA,NA,NA,NA,NA
"2719",2719,"Cluster_4735","Porites_evermani_scaffold_2565:15902-16818",161,-20.99,2,20,729,752,20,"75.00%","85.00%","Peve_00018944",-0.500943642233887,0.665972771890438,0.978262075707395,"F6YVB9","Transcription factor E2F7 (E2F-7)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","chorionic trophoblast cell differentiation [GO:0060718]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; hepatocyte differentiation [GO:0070365]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cytokinesis [GO:0032466]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0071930]; positive regulation of DNA endoreduplication [GO:0032877]; sprouting angiogenesis [GO:0002040]","GO:0000122; GO:0000978; GO:0001217; GO:0002040; GO:0003700; GO:0005634; GO:0005667; GO:0008285; GO:0030330; GO:0032466; GO:0032877; GO:0060718; GO:0070365; GO:0071930; GO:2000134"
"2720",2720,"Cluster_4735","Porites_evermani_scaffold_2677:39141-40141",158,-22.68,2,19,26,47,17,"76.47%","76.47%","Peve_00019862",0.512630357402402,0.657342267727529,0.978262075707395,"P07911","Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form]","Homo sapiens (Human)","antibacterial innate immune response [GO:0140367]; apoptotic signaling pathway [GO:0097190]; autophagy [GO:0006914]; cellular calcium ion homeostasis [GO:0006874]; cellular chloride ion homeostasis [GO:0030644]; cellular defense response [GO:0006968]; cellular phosphate ion homeostasis [GO:0030643]; cellular response to unfolded protein [GO:0034620]; cellular sodium ion homeostasis [GO:0006883]; chaperone-mediated protein folding [GO:0061077]; citric acid secretion [GO:0046720]; collecting duct development [GO:0072044]; connective tissue replacement [GO:0097709]; creatinine homeostasis [GO:0097273]; defense response to Gram-negative bacterium [GO:0050829]; endoplasmic reticulum organization [GO:0007029]; glomerular filtration [GO:0003094]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; inflammatory response [GO:0006954]; juxtaglomerular apparatus development [GO:0072051]; leukocyte cell-cell adhesion [GO:0007159]; lipid metabolic process [GO:0006629]; metanephric ascending thin limb development [GO:0072218]; metanephric distal convoluted tubule development [GO:0072221]; metanephric thick ascending limb development [GO:0072233]; micturition [GO:0060073]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell population proliferation [GO:0008285]; neutrophil migration [GO:1990266]; organ or tissue specific immune response [GO:0002251]; peptidyl-threonine phosphorylation [GO:0018107]; potassium ion homeostasis [GO:0055075]; protein localization to vacuole [GO:0072665]; protein transport into plasma membrane raft [GO:0044861]; regulation of blood pressure [GO:0008217]; regulation of protein transport [GO:0051223]; regulation of urine volume [GO:0035809]; renal sodium ion absorption [GO:0070294]; renal urate salt excretion [GO:0097744]; renal water homeostasis [GO:0003091]; response to lipopolysaccharide [GO:0032496]; response to water deprivation [GO:0009414]; response to xenobiotic stimulus [GO:0009410]; RNA splicing [GO:0008380]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; ubiquitin-dependent ERAD pathway [GO:0030433]; urate transport [GO:0015747]; urea transmembrane transport [GO:0071918]","GO:0000922; GO:0002251; GO:0003091; GO:0003094; GO:0005201; GO:0005509; GO:0005615; GO:0005783; GO:0005796; GO:0005929; GO:0006629; GO:0006874; GO:0006883; GO:0006914; GO:0006954; GO:0006968; GO:0007029; GO:0007157; GO:0007159; GO:0008217; GO:0008285; GO:0008380; GO:0009410; GO:0009414; GO:0009986; GO:0015747; GO:0016020; GO:0016323; GO:0016324; GO:0018107; GO:0019864; GO:0019898; GO:0030433; GO:0030643; GO:0030644; GO:0032496; GO:0033209; GO:0033555; GO:0034620; GO:0035809; GO:0044861; GO:0046720; GO:0050829; GO:0051223; GO:0055075; GO:0060073; GO:0060170; GO:0061077; GO:0070062; GO:0070294; GO:0071918; GO:0072044; GO:0072051; GO:0072218; GO:0072221; GO:0072233; GO:0072665; GO:0097190; GO:0097273; GO:0097709; GO:0097744; GO:0140367; GO:1990266"
"2721",2721,"Cluster_4735","Porites_evermani_scaffold_268:155101-156101",162,-21.26,2,20,254,278,21,"76.19%","76.19%","Peve_00019891",-0.576978946580214,0.608462920494096,0.978262075707395,"Q0EEE2","Patched domain-containing protein 3 (RND-type protein RNDEu-3)","Mus musculus (Mouse)","","GO:0005783; GO:0005789; GO:0005886; GO:0016020; GO:0097225"
"2722",2722,"Cluster_4735","Porites_evermani_scaffold_2697:62214-63214",156,-24.38,2,21,563,584,19,"68.42%","73.68%","Peve_00020027",0.549793840878942,0.629412547303161,0.978262075707395,"Q90YJ2","Neuroglobin","Danio rerio (Zebrafish) (Brachydanio rerio)","oxygen transport [GO:0015671]; response to hypoxia [GO:0001666]","GO:0001666; GO:0005344; GO:0005737; GO:0015671; GO:0019825; GO:0020037; GO:0043204; GO:0046872; GO:0098809"
"2723",2723,"Cluster_4735","Porites_evermani_scaffold_2707:36085-37085",159,-23.29,2,16,160,181,14,"78.57%","92.86%","Peve_00020151",-0.500943642233887,0.665972771890438,0.978262075707395,"Q09596","Probable glutathione S-transferase 5 (EC 2.5.1.18) (GST class-sigma)","Caenorhabditis elegans","glutathione metabolic process [GO:0006749]; innate immune response [GO:0045087]","GO:0004364; GO:0006749; GO:0045087"
"2724",2724,"Cluster_4735","Porites_evermani_scaffold_273:139498-140498",155,-20.75,2,20,605,623,18,"77.78%","77.78%","Peve_00020339",-0.519741795524434,0.652056297263125,0.978262075707395,"Q13423","NAD(P) transhydrogenase, mitochondrial (EC 7.1.1.1) (Nicotinamide nucleotide transhydrogenase) (Pyridine nucleotide transhydrogenase)","Homo sapiens (Human)","NADPH regeneration [GO:0006740]; proton transmembrane transport [GO:1902600]; reactive oxygen species metabolic process [GO:0072593]; tricarboxylic acid cycle [GO:0006099]","GO:0003957; GO:0005739; GO:0005743; GO:0005746; GO:0006099; GO:0006740; GO:0008746; GO:0016020; GO:0050661; GO:0051287; GO:0072593; GO:1902600"
"2725",2725,"Cluster_4735","Porites_evermani_scaffold_2785:23421-24421",161,-21.98,2,15,1,15,14,"92.86%","92.86%","Peve_00020761",-0.307281453127903,0.801161395881371,0.995934364227446,NA,NA,NA,NA,NA
"2726",2726,"Cluster_4735","Porites_evermani_scaffold_2791:34427-35427",152,-20.68,2,21,239,260,19,"57.89%","78.95%","Peve_00020815",NA,NA,NA,NA,NA,NA,NA,NA
"2727",2727,"Cluster_4735","Porites_evermani_scaffold_283:48199-49199",160,-21.86,2,21,748,769,19,"68.42%","78.95%","Peve_00021130",-0.88957070953471,0.302007200895513,0.978262075707395,NA,NA,NA,NA,NA
"2728",2728,"Cluster_4735","Porites_evermani_scaffold_284:53492-54492",152,-24.48,2,21,800,824,23,"69.57%","78.26%","Peve_00021212",-0.277532583831931,0.820966703911355,0.995934364227446,"Q6ZN08","Putative zinc finger protein 66 (Zinc finger protein 66 pseudogene)","Homo sapiens (Human)","regulation of DNA-templated transcription [GO:0006355]","GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872"
"2729",2729,"Cluster_4735","Porites_evermani_scaffold_2953:48839-49839",158,-21.71,2,15,501,522,13,"84.62%","92.31%","Peve_00022081",-0.11373855645448,0.927434752544652,0.999448381576871,NA,NA,NA,NA,NA
"2730",2730,"Cluster_4735","Porites_evermani_scaffold_301:22120-23120",151,-21.31,2,21,891,909,19,"73.68%","78.95%","Peve_00022698",-0.090760448575947,0.942140481797585,0.999448381576871,NA,NA,NA,NA,NA
"2731",2731,"Cluster_4735","Porites_evermani_scaffold_3054:11255-12255",163,-20.74,2,21,606,628,20,"75.00%","80.00%","Peve_00023009",-0.766238135800773,0.444252575870952,0.978262075707395,"Q9BXW9","Fanconi anemia group D2 protein (Protein FACD2)","Homo sapiens (Human)","brain morphogenesis [GO:0048854]; cellular response to oxidative stress [GO:0034599]; double-strand break repair involved in meiotic recombination [GO:1990918]; gamete generation [GO:0007276]; homologous chromosome pairing at meiosis [GO:0007129]; interstrand cross-link repair [GO:0036297]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; neuronal stem cell population maintenance [GO:0097150]; regulation of CD40 signaling pathway [GO:2000348]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of inflammatory response [GO:0050727]; regulation of regulatory T cell differentiation [GO:0045589]; response to gamma radiation [GO:0010332]","GO:0000785; GO:0000793; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0007129; GO:0007276; GO:0010332; GO:0016604; GO:0031573; GO:0034599; GO:0036297; GO:0045589; GO:0048854; GO:0050727; GO:0051090; GO:0070182; GO:0097150; GO:1990391; GO:1990918; GO:2000348"
"2732",2732,"Cluster_4735","Porites_evermani_scaffold_308:285471-286471",163,-22.54,2,21,890,908,19,"84.21%","84.21%","Peve_00023207",0.32865158425964,0.786811638103324,0.995085018105274,NA,NA,NA,NA,NA
"2733",2733,"Cluster_4735","Porites_evermani_scaffold_3:1307349-1308349",159,-20.29,2,21,203,225,20,"70.00%","80.00%","Peve_00022524",NA,NA,NA,NA,NA,NA,NA,NA
"2734",2734,"Cluster_4735","Porites_evermani_scaffold_316:23841-24841",155,-21.68,2,21,651,673,20,"70.00%","75.00%","Peve_00023783",-0.500943642233887,0.665972771890438,0.978262075707395,NA,NA,NA,NA,NA
"2735",2735,"Cluster_4735","Porites_evermani_scaffold_3226:21092-22092",163,-25.92,2,21,736,761,23,"69.57%","78.26%","Peve_00024178",NA,NA,NA,NA,NA,NA,NA,NA
"2736",2736,"Cluster_4735","Porites_evermani_scaffold_328:47495-48495",140,-20.12,2,9,551,572,7,"100.00%","100.00%","Peve_00024488",NA,NA,NA,NA,NA,NA,NA,NA
"2737",2737,"Cluster_4735","Porites_evermani_scaffold_329:196196-197196",167,-27.4,2,21,56,78,20,"80.00%","80.00%","Peve_00024525",NA,NA,NA,NA,NA,NA,NA,NA
"2738",2738,"Cluster_4735","Porites_evermani_scaffold_336:194729-195729",151,-20.32,2,21,710,727,19,"73.68%","73.68%","Peve_00025044",-0.999885283611896,0.00964299640621119,0.610514562090407,"Q04073","DNA-binding protein P3A2","Strongylocentrotus purpuratus (Purple sea urchin)","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0005634; GO:0006357"
"2739",2739,"Cluster_4735","Porites_evermani_scaffold_3385:532-1532",156,-20.98,2,18,508,531,18,"77.78%","77.78%","Peve_00025175",-0.237036830990821,0.847647583737012,0.995934364227446,NA,NA,NA,NA,NA
"2740",2740,"Cluster_4735","Porites_evermani_scaffold_3447:37717-38717",151,-21.85,2,21,821,839,19,"73.68%","78.95%","Peve_00025593",NA,NA,NA,NA,NA,NA,NA,NA
"2741",2741,"Cluster_4735","Porites_evermani_scaffold_3468:6145-7145",159,-23.05,2,21,881,903,20,"75.00%","75.00%","Peve_00025712",NA,NA,NA,"E9Q236","ATP-binding cassette sub-family C member 4 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (Multidrug resistance-associated protein 4)","Mus musculus (Mouse)","bile acid and bile salt transport [GO:0015721]; cAMP transport [GO:0070730]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; fatty acid derivative transport [GO:1901571]; leukotriene transport [GO:0071716]; organic hydroxy compound transport [GO:0015850]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; prostaglandin transport [GO:0015732]; transmembrane transport [GO:0055085]; urate transport [GO:0015747]; xenobiotic transmembrane transport [GO:0006855]","GO:0001409; GO:0005524; GO:0005730; GO:0005794; GO:0005886; GO:0006855; GO:0008559; GO:0015132; GO:0015143; GO:0015216; GO:0015431; GO:0015432; GO:0015562; GO:0015665; GO:0015721; GO:0015732; GO:0015747; GO:0015850; GO:0016020; GO:0016323; GO:0016324; GO:0016887; GO:0031088; GO:0032310; GO:0034634; GO:0042626; GO:0042910; GO:0048661; GO:0055085; GO:0060271; GO:0070730; GO:0071716; GO:0098591; GO:0140115; GO:1901571"
"2742",2742,"Cluster_4735","Porites_evermani_scaffold_348:145194-146194",155,-20.35,2,21,765,783,19,"73.68%","84.21%","Peve_00025792",-0.762936460466554,0.447513798503761,0.978262075707395,NA,NA,NA,NA,NA
"2743",2743,"Cluster_4735","Porites_evermani_scaffold_371:193959-194959",165,-22.36,2,18,396,417,16,"81.25%","87.50%","Peve_00027167",0.313507680774676,0.796991696319524,0.995934364227446,NA,NA,NA,NA,NA
"2744",2744,"Cluster_4735","Porites_evermani_scaffold_394:21301-22301",151,-21.11,2,12,539,560,10,"90.00%","100.00%","Peve_00028406",NA,NA,NA,NA,NA,NA,NA,NA
"2745",2745,"Cluster_4735","Porites_evermani_scaffold_394:282282-282428",148,-20.83,2,17,77,98,15,"66.67%","80.00%","Peve_00028423",-0.343781582986366,0.776584035547478,0.992737008885275,"Q80Y56","Rabenosyn-5 (FYVE finger-containing Rab5 effector protein rabenosyn-5) (RAB effector RBSN) (Zinc finger FYVE domain-containing protein 20)","Mus musculus (Mouse)","early endosome to Golgi transport [GO:0034498]; Golgi to lysosome transport [GO:0090160]; protein transport [GO:0015031]; regulation of Golgi organization [GO:1903358]","GO:0005829; GO:0005886; GO:0015031; GO:0031267; GO:0031901; GO:0034498; GO:0043231; GO:0046872; GO:0090160; GO:1903358"
"2746",2746,"Cluster_4735","Porites_evermani_scaffold_3997:5635-6635",155,-22.93,2,16,937,958,14,"78.57%","85.71%","Peve_00028677",-0.0386523520320113,0.975387017201222,0.999448381576871,"Q9NPF5","DNA methyltransferase 1-associated protein 1 (DNMAP1) (DNMT1-associated protein 1)","Homo sapiens (Human)","chromatin remodeling [GO:0006338]; DNA methylation [GO:0006306]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of protein import into nucleus [GO:0042307]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of DNA-templated transcription [GO:0006355]; regulation of double-strand break repair [GO:2000779]; response to ethanol [GO:0045471]","GO:0000122; GO:0000786; GO:0000812; GO:0003714; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005829; GO:0006281; GO:0006306; GO:0006338; GO:0006355; GO:0016573; GO:0035267; GO:0042307; GO:0042981; GO:0043967; GO:0043968; GO:0045471; GO:0045892; GO:0045893; GO:0051726; GO:0061629; GO:1905168; GO:2000779"
"2747",2747,"Cluster_4735","Porites_evermani_scaffold_422:228852-229852",159,-25.14,2,21,671,700,27,"66.67%","70.37%","Peve_00029961",-0.500943642233887,0.665972771890438,0.978262075707395,NA,NA,NA,NA,NA
"2748",2748,"Cluster_4735","Porites_evermani_scaffold_4258:18910-19910",160,-20.21,2,19,515,535,17,"82.35%","82.35%","Peve_00030168",NA,NA,NA,NA,NA,NA,NA,NA
"2749",2749,"Cluster_4735","Porites_evermani_scaffold_4275:28431-29297",154,-20.99,2,20,202,225,20,"65.00%","80.00%","Peve_00030259",-0.656248099405095,0.544284940606311,0.978262075707395,"F4JTP5","Serine/threonine-protein kinase STY46 (EC 2.7.11.1) (Serine/threonine/tyrosine-protein kinase 46)","Arabidopsis thaliana (Mouse-ear cress)","cellular response to hypoxia [GO:0071456]; chloroplast organization [GO:0009658]; protein phosphorylation [GO:0006468]; response to abscisic acid [GO:0009737]","GO:0004674; GO:0004712; GO:0005524; GO:0005829; GO:0006468; GO:0009658; GO:0009737; GO:0071456; GO:0106310"
"2750",2750,"Cluster_4735","Porites_evermani_scaffold_44:105330-106330",157,-20.69,2,19,284,306,18,"72.22%","83.33%","Peve_00030927",NA,NA,NA,NA,NA,NA,NA,NA
"2751",2751,"Cluster_4735","Porites_evermani_scaffold_4417:11410-12410",163,-22.3,2,20,64,85,18,"72.22%","83.33%","Peve_00031054",-0.903263095360904,0.282329357802336,0.978262075707395,NA,NA,NA,NA,NA
"2752",2752,"Cluster_4735","Porites_evermani_scaffold_44:258389-259389",162,-22.6,2,21,98,121,21,"71.43%","85.71%","Peve_00030937",-0.00990849173219211,0.993691955027315,0.999448381576871,NA,NA,NA,NA,NA
"2753",2753,"Cluster_4735","Porites_evermani_scaffold_4605:8956-9956",172,-25.76,2,21,22,43,19,"68.42%","94.74%","Peve_00031942",-0.738583823837187,0.470989795377078,0.978262075707395,NA,NA,NA,NA,NA
"2754",2754,"Cluster_4735","Porites_evermani_scaffold_4607:20905-21905",156,-20.38,2,21,735,758,22,"72.73%","81.82%","Peve_00031947",-0.754942707301466,0.455329289852718,0.978262075707395,"G8HTB6","ZP domain-containing protein","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0016020"
"2755",2755,"Cluster_4735","Porites_evermani_scaffold_4642:4675-5675",160,-22.13,2,21,851,872,19,"68.42%","78.95%","Peve_00032090",NA,NA,NA,NA,NA,NA,NA,NA
"2756",2756,"Cluster_4735","Porites_evermani_scaffold_4939:12948-13948",147,-20.12,2,12,895,916,10,"90.00%","90.00%","Peve_00033287",-0.998878569589875,0.0301523995600735,0.903929377050813,"Q9R1L5","Microtubule-associated serine/threonine-protein kinase 1 (EC 2.7.11.1) (Syntrophin-associated serine/threonine-protein kinase)","Mus musculus (Mouse)","brain development [GO:0007420]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]","GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0005856; GO:0005886; GO:0006468; GO:0007010; GO:0007420; GO:0008017; GO:0016020; GO:0018105; GO:0030424; GO:0030425; GO:0035556; GO:0043005; GO:0043025; GO:0106310"
"2757",2757,"Cluster_4735","Porites_evermani_scaffold_508:239946-240946",157,-25.35,2,21,263,282,19,"73.68%","78.95%","Peve_00033935",-0.730730648217797,0.478359090121043,0.978262075707395,"P50533","Structural maintenance of chromosomes protein 2 (SMC protein 2) (SMC-2) (Chromosome assembly protein XCAP-E) (Chromosome-associated protein E)","Xenopus laevis (African clawed frog)","cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome condensation [GO:0030261]","GO:0005524; GO:0005634; GO:0005694; GO:0005829; GO:0007049; GO:0016887; GO:0030261; GO:0051301"
"2758",2758,"Cluster_4735","Porites_evermani_scaffold_510:219735-220735",148,-20.37,2,20,547,571,22,"63.64%","77.27%","Peve_00034069",0.99999940598563,0.000693894776259953,0.239778920002343,NA,NA,NA,NA,NA
"2759",2759,"Cluster_4735","Porites_evermani_scaffold_514:140247-140920",159,-25.02,2,16,457,478,14,"78.57%","92.86%","Peve_00034189",-0.999325369433971,0.0233858169858483,0.84919156053953,"Q6P3D0","U8 snoRNA-decapping enzyme (EC 3.6.1.62) (IDP phosphatase) (IDPase) (EC 3.6.1.64) (Inosine diphosphate phosphatase) (Nucleoside diphosphate-linked moiety X motif 16) (Nudix motif 16) (m7GpppN-mRNA hydrolase)","Mus musculus (Mouse)","chromosome organization [GO:0051276]; dITP catabolic process [GO:0035863]; mRNA catabolic process [GO:0006402]; NAD-cap decapping [GO:0110155]; negative regulation of rRNA processing [GO:2000233]; positive regulation of cell cycle process [GO:0090068]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; sno(s)RNA catabolic process [GO:0016077]","GO:0000166; GO:0000287; GO:0003729; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006402; GO:0008235; GO:0016077; GO:0030145; GO:0030515; GO:0031404; GO:0035863; GO:0035870; GO:0042802; GO:0042803; GO:0050072; GO:0050897; GO:0051276; GO:0090068; GO:0090502; GO:0097383; GO:0110152; GO:0110155; GO:0140933; GO:1990003; GO:1990174; GO:2000233"
"2760",2760,"Cluster_4735","Porites_evermani_scaffold_5142:15378-16378",160,-20.07,2,17,631,652,15,"80.00%","86.67%","Peve_00034200",0.956443871323869,0.18858573842779,0.978262075707395,"Q9DAQ4","Uncharacterized protein C2orf81 homolog","Mus musculus (Mouse)","",""
"2761",2761,"Cluster_4735","Porites_evermani_scaffold_518:227108-228108",154,-20.43,2,20,239,257,18,"77.78%","83.33%","Peve_00034312",0.591933703526745,0.596729443589458,0.978262075707395,NA,NA,NA,NA,NA
"2762",2762,"Cluster_4735","Porites_evermani_scaffold_543:180249-181249",156,-21.28,2,21,707,728,19,"63.16%","78.95%","Peve_00035232",0.99999940598563,0.000693894776195108,0.239778920002343,NA,NA,NA,NA,NA
"2763",2763,"Cluster_4735","Porites_evermani_scaffold_54:492646-493646",146,-22.05,2,21,275,300,23,"56.52%","78.26%","Peve_00035118",NA,NA,NA,NA,NA,NA,NA,NA
"2764",2764,"Cluster_4735","Porites_evermani_scaffold_564:138214-139214",170,-23.02,2,19,180,201,17,"76.47%","94.12%","Peve_00035918",-0.903781343604152,0.281559473058454,0.978262075707395,NA,NA,NA,NA,NA
"2765",2765,"Cluster_4735","Porites_evermani_scaffold_5806:5494-6494",164,-22.62,2,19,718,738,17,"82.35%","88.24%","Peve_00036410",NA,NA,NA,NA,NA,NA,NA,NA
"2766",2766,"Cluster_4735","Porites_evermani_scaffold_60:303565-304565",164,-23.22,2,21,86,107,19,"73.68%","78.95%","Peve_00037059",-0.687671513422842,0.517265883993264,0.978262075707395,NA,NA,NA,NA,NA
"2767",2767,"Cluster_4735","Porites_evermani_scaffold_609:155312-156312",159,-21.72,2,20,275,296,18,"72.22%","77.78%","Peve_00037303",-0.99111605670398,0.084921969033786,0.978262075707395,"J3S9D9","Reticulocalbin-2 (Taipoxin-associated calcium-binding protein 49 homolog)","Crotalus adamanteus (Eastern diamondback rattlesnake)","","GO:0005509; GO:0005576"
"2768",2768,"Cluster_4735","Porites_evermani_scaffold_610:141957-142957",178,-21.37,2,19,391,412,17,"88.24%","94.12%","Peve_00037359",-0.494387573585163,0.670784729417901,0.978262075707395,NA,NA,NA,NA,NA
"2769",2769,"Cluster_4735","Porites_evermani_scaffold_612:196050-197050",158,-25.58,2,21,5,31,24,"70.83%","75.00%","Peve_00037401",0.855126418138642,0.346958847547051,0.978262075707395,NA,NA,NA,NA,NA
"2770",2770,"Cluster_4735","Porites_evermani_scaffold_61:406448-407448",144,-20.35,2,19,863,889,22,"68.18%","68.18%","Peve_00037320",NA,NA,NA,NA,NA,NA,NA,NA
"2771",2771,"Cluster_4735","Porites_evermani_scaffold_6148:611-1611",155,-20.77,2,21,396,419,21,"66.67%","76.19%","Peve_00037451",NA,NA,NA,NA,NA,NA,NA,NA
"2772",2772,"Cluster_4735","Porites_evermani_scaffold_6371:5590-5804",162,-27.54,2,21,135,161,24,"70.83%","79.17%","Peve_00038053",0.197749977691986,0.873273171096057,0.997476741937264,NA,NA,NA,NA,NA
"2773",2773,"Cluster_4735","Porites_evermani_scaffold_67:55757-56204",159,-26.56,2,21,172,195,21,"71.43%","76.19%","Peve_00038807",-0.317221889476556,0.794500005954114,0.995934364227446,"Q7Z569","BRCA1-associated protein (EC 2.3.2.27) (BRAP2) (Impedes mitogenic signal propagation) (IMP) (RING finger protein 52) (RING-type E3 ubiquitin transferase BRAP2) (Renal carcinoma antigen NY-REN-63)","Homo sapiens (Human)","MAPK cascade [GO:0000165]; negative regulation of signal transduction [GO:0009968]; protein ubiquitination [GO:0016567]; Ras protein signal transduction [GO:0007265]","GO:0000151; GO:0000165; GO:0003676; GO:0004842; GO:0005654; GO:0005737; GO:0005829; GO:0007265; GO:0008139; GO:0008270; GO:0009968; GO:0016567; GO:0031965; GO:0042802; GO:0061630"
"2774",2774,"Cluster_4735","Porites_evermani_scaffold_67:55757-56204",159,-26.56,2,21,172,195,21,"71.43%","76.19%","Peve_00038812",-0.756897533589201,0.453428339683993,0.978262075707395,"Q9BW91","ADP-ribose pyrophosphatase, mitochondrial (EC 3.6.1.13) (ADP-ribose diphosphatase) (ADP-ribose phosphohydrolase) (Adenosine diphosphoribose pyrophosphatase) (ADPR-PPase) (Nucleoside diphosphate-linked moiety X motif 9) (Nudix motif 9)","Homo sapiens (Human)","ADP catabolic process [GO:0046032]; IDP catabolic process [GO:0046709]; nucleobase-containing small molecule metabolic process [GO:0055086]","GO:0005739; GO:0005759; GO:0016604; GO:0019144; GO:0030054; GO:0031965; GO:0046032; GO:0046709; GO:0047631; GO:0055086; GO:0070062"
"2775",2775,"Cluster_4735","Porites_evermani_scaffold_694:10300-11300",172,-24.72,2,18,97,119,17,"88.24%","94.12%","Peve_00039381",-0.344412584246861,0.776156201581116,0.992639613187605,"Q6PCF7","Ubiquitin-conjugating enzyme E2 Z (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme Z) (Ubiquitin carrier protein Z) (Ubiquitin-protein ligase Z)","Xenopus laevis (African clawed frog)","apoptotic process [GO:0006915]","GO:0005524; GO:0005634; GO:0005737; GO:0006915; GO:0061631"
"2776",2776,"Cluster_4735","Porites_evermani_scaffold_695:182933-183933",155,-20.08,2,21,821,845,22,"63.64%","77.27%","Peve_00039424",NA,NA,NA,NA,NA,NA,NA,NA
"2777",2777,"Cluster_4735","Porites_evermani_scaffold_696:186619-187619",153,-20.57,2,21,134,153,19,"68.42%","78.95%","Peve_00039445",-0.708369687275721,0.498861967252584,0.978262075707395,"Q91VN6","Probable ATP-dependent RNA helicase DDX41 (EC 3.6.4.13) (DEAD box protein 41)","Mus musculus (Mouse)","cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cellular response to interferon-beta [GO:0035458]; defense response to virus [GO:0051607]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]","GO:0000398; GO:0003677; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005681; GO:0005783; GO:0008283; GO:0016887; GO:0030154; GO:0035458; GO:0045944; GO:0046872; GO:0051607; GO:0071013"
"2778",2778,"Cluster_4735","Porites_evermani_scaffold_714:154714-155714",174,-21.39,2,20,912,934,19,"78.95%","94.74%","Peve_00039909",-0.875752770788604,0.320731207042707,0.978262075707395,"Q9D2G9","HHIP-like protein 2","Mus musculus (Mouse)","","GO:0005576"
"2779",2779,"Cluster_4735","Porites_evermani_scaffold_729:69907-70907",149,-22.58,2,20,536,563,24,"66.67%","70.83%","Peve_00040204",-0.875378176908559,0.321224840235704,0.978262075707395,NA,NA,NA,NA,NA
"2780",2780,"Cluster_4735","Porites_evermani_scaffold_751:195082-195405",156,-22.96,2,17,292,313,15,"73.33%","86.67%","Peve_00040727",-0.499055763751742,0.667360561442895,0.978262075707395,"Q5ZJW8","Denticleless protein homolog","Gallus gallus (Chicken)","cellular response to DNA damage stimulus [GO:0006974]; DNA replication [GO:0006260]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; regulation of cell cycle [GO:0051726]; response to UV [GO:0009411]; rhythmic process [GO:0048511]; translesion synthesis [GO:0019985]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000209; GO:0005634; GO:0005694; GO:0005737; GO:0005813; GO:0006260; GO:0006511; GO:0006513; GO:0006974; GO:0007095; GO:0009411; GO:0019985; GO:0030674; GO:0031464; GO:0031465; GO:0043161; GO:0048511; GO:0051726"
"2781",2781,"Cluster_4735","Porites_evermani_scaffold_751:30956-31532",148,-20.46,2,18,120,144,19,"68.42%","73.68%","Peve_00040717",0.122907348776062,0.921556402003384,0.999448381576871,NA,NA,NA,NA,NA
"2782",2782,"Cluster_4735","Porites_evermani_scaffold_751:30956-31532",148,-20.46,2,18,120,144,19,"68.42%","73.68%","Peve_00040720",-0.827291527182755,0.379761007167784,0.978262075707395,NA,NA,NA,NA,NA
"2783",2783,"Cluster_4735","Porites_evermani_scaffold_771:174817-175817",140,-22.43,2,9,218,239,7,"100.00%","100.00%","Peve_00041095",-0.838641216827272,0.366700973291279,0.978262075707395,"Q8IS64","Endothelin-converting enzyme homolog (ECE) (EC 3.4.24.-)","Locusta migratoria (Migratory locust)","proteolysis [GO:0006508]","GO:0004175; GO:0004222; GO:0005886; GO:0006508; GO:0008270"
"2784",2784,"Cluster_4735","Porites_evermani_scaffold_772:11666-12666",157,-22.19,2,14,8,29,12,"83.33%","100.00%","Peve_00041103",NA,NA,NA,NA,NA,NA,NA,NA
"2785",2785,"Cluster_4735","Porites_evermani_scaffold_7:771995-772995",162,-20.53,2,21,13,33,19,"73.68%","84.21%","Peve_00039553",-0.877014859401906,0.319062912139364,0.978262075707395,"P83852","Carboxypeptidase D (EC 3.4.17.22) (CPD-2) (Metallocarboxypeptidase D)","Lophonetta specularioides (Crested duck) (Anas specularioides)","proteolysis [GO:0006508]","GO:0004181; GO:0006508; GO:0008270; GO:0016020"
"2786",2786,"Cluster_4735","Porites_evermani_scaffold_782:44592-45592",159,-23.99,2,21,621,643,20,"70.00%","80.00%","Peve_00041327",NA,NA,NA,NA,NA,NA,NA,NA
"2787",2787,"Cluster_4735","Porites_evermani_scaffold_80:437564-438187",154,-20.55,2,17,218,238,15,"80.00%","86.67%","Peve_00041787",-0.776258805875802,0.434229999381391,0.978262075707395,"Q0VGT4","Protein ZGRF1 (GRF-type zinc finger domain-containing protein 1)","Mus musculus (Mouse)","replication fork reversal [GO:0071932]","GO:0003723; GO:0004386; GO:0005737; GO:0008270; GO:0016020; GO:0017108; GO:0071932"
"2788",2788,"Cluster_4735","Porites_evermani_scaffold_80:437564-438187",154,-20.55,2,17,218,238,15,"80.00%","86.67%","Peve_00041789",0.959815676214547,0.181087555662038,0.978262075707395,"O73853","Steroid 17-alpha-hydroxylase/17,20 lyase (EC 1.14.14.19) (EC 1.14.14.32) (17-alpha-hydroxyprogesterone aldolase) (CYPXVII) (Cytochrome P450 17A1) (Cytochrome P450-C17) (Cytochrome P450c17)","Ictalurus punctatus (Channel catfish) (Silurus punctatus)","steroid biosynthetic process [GO:0006694]","GO:0004508; GO:0005506; GO:0006694; GO:0016020; GO:0020037; GO:0047442"
"2789",2789,"Cluster_4735","Porites_evermani_scaffold_810:20913-21913",150,-20.66,2,15,547,568,13,"76.92%","84.62%","Peve_00042022",-0.500943642233887,0.665972771890438,0.978262075707395,NA,NA,NA,NA,NA
"2790",2790,"Cluster_4735","Porites_evermani_scaffold_812:68119-69119",169,-21.32,2,20,469,489,18,"83.33%","88.89%","Peve_00042045",NA,NA,NA,NA,NA,NA,NA,NA
"2791",2791,"Cluster_4735","Porites_evermani_scaffold_82:157256-158256",151,-21.11,2,12,630,651,10,"90.00%","100.00%","Peve_00042186",NA,NA,NA,NA,NA,NA,NA,NA
"2792",2792,"Cluster_4735","Porites_evermani_scaffold_838:73392-74392",150,-21.28,2,19,563,584,17,"64.71%","76.47%","Peve_00042498",0.999891079350943,0.00939624156020117,0.602954859488328,NA,NA,NA,NA,NA
"2793",2793,"Cluster_4735","Porites_evermani_scaffold_845:3432-4432",149,-21.91,2,21,378,406,26,"65.38%","73.08%","Peve_00042666",-0.930063618701479,0.239502953948888,0.978262075707395,"P12606","Integrin beta-1-A","Xenopus laevis (African clawed frog)","cell adhesion [GO:0007155]; integrin-mediated signaling pathway [GO:0007229]; muscle organ development [GO:0007517]; myoblast differentiation [GO:0045445]; myoblast fusion [GO:0007520]","GO:0007155; GO:0007229; GO:0007517; GO:0007520; GO:0030027; GO:0032154; GO:0032587; GO:0042470; GO:0045445; GO:0070161"
"2794",2794,"Cluster_4735","Porites_evermani_scaffold_85:495645-496645",167,-22.62,2,21,853,877,22,"77.27%","77.27%","Peve_00042754",-0.275639926957824,0.822220519418791,0.995934364227446,"P54357","Myosin-2 essential light chain (Myosin II essential light chain) (Non-muscle myosin essential light chain)","Drosophila melanogaster (Fruit fly)","actin filament-based movement [GO:0030048]","GO:0005509; GO:0005829; GO:0016460; GO:0017022; GO:0030048; GO:0031475; GO:0031476; GO:0031477; GO:0032036"
"2795",2795,"Cluster_4735","Porites_evermani_scaffold_85:496215-497215",167,-22.62,2,21,283,307,22,"77.27%","77.27%","Peve_00042755",-0.485785386712216,0.677067315224847,0.978262075707395,NA,NA,NA,NA,NA
"2796",2796,"Cluster_4735","Porites_evermani_scaffold_883:47432-48432",154,-24.16,2,16,150,172,15,"73.33%","93.33%","Peve_00043379",-0.500943642233887,0.665972771890438,0.978262075707395,"Q8L7C8","Protein REDUCED WALL ACETYLATION 1 (EC 2.3.1.-)","Arabidopsis thaliana (Mouse-ear cress)","carbohydrate metabolic process [GO:0005975]; plant-type secondary cell wall biogenesis [GO:0009834]; xylan acetylation [GO:1990937]; xylan biosynthetic process [GO:0045492]; xylan metabolic process [GO:0045491]; xyloglucan metabolic process [GO:0010411]","GO:0000139; GO:0005794; GO:0005975; GO:0009834; GO:0010411; GO:0016407; GO:0016491; GO:0045491; GO:0045492; GO:1990937"
"2797",2797,"Cluster_4735","Porites_evermani_scaffold_903:77249-78249",145,-20.72,2,10,671,692,8,"100.00%","100.00%","Peve_00043821",-0.974578452781498,0.143853510687682,0.978262075707395,"Q8IZ69","tRNA (uracil-5-)-methyltransferase homolog A (EC 2.1.1.35) (mRNA (uracil-5-)-methyltransferase TRMT2A) (EC 2.1.1.-)","Homo sapiens (Human)","mRNA processing [GO:0006397]","GO:0003723; GO:0005829; GO:0006397; GO:0008169; GO:0030697"
"2798",2798,"Cluster_4735","Porites_evermani_scaffold_91:133722-134722",162,-22.22,2,20,358,380,19,"78.95%","78.95%","Peve_00043904",0.969642834381726,0.157264449671035,0.978262075707395,NA,NA,NA,NA,NA
"2799",2799,"Cluster_4735","Porites_evermani_scaffold_957:74850-75850",157,-25.2,2,14,840,861,12,"83.33%","100.00%","Peve_00044675",-0.858192107241776,0.343175613254827,0.978262075707395,NA,NA,NA,NA,NA
"2800",2800,"Cluster_4735","Porites_evermani_scaffold_986:146478-147478",160,-21.09,2,17,78,99,15,"80.00%","86.67%","Peve_00045138",-0.777491309657739,0.43298386102631,0.978262075707395,"Q9XTR8","Lipase ZK262.3 (EC 3.1.1.-)","Caenorhabditis elegans","lipid catabolic process [GO:0016042]","GO:0005576; GO:0016042; GO:0016787"
"2801",2801,"Cluster_5563","Porites_evermani_scaffold_1099:120188-121188",169,-20.37,2,21,69,91,20,"85.00%","85.00%","Peve_00001707",NA,NA,NA,NA,NA,NA,NA,NA
"2802",2802,"Cluster_5563","Porites_evermani_scaffold_1099:63351-64351",159,-21.66,2,17,604,627,16,"81.25%","87.50%","Peve_00001704",NA,NA,NA,NA,NA,NA,NA,NA
"2803",2803,"Cluster_5563","Porites_evermani_scaffold_1293:92114-93114",164,-20.74,2,21,29,50,20,"80.00%","85.00%","Peve_00004659",0.0533239704113661,0.966036797687887,0.999448381576871,"Q9TST5","Beta-2 adrenergic receptor (Beta-2 adrenoreceptor) (Beta-2 adrenoceptor)","Felis catus (Cat) (Felis silvestris catus)","activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; bone resorption [GO:0045453]; brown fat cell differentiation [GO:0050873]; cellular response to amyloid-beta [GO:1904646]; desensitization of G protein-coupled receptor signaling pathway by arrestin [GO:0002032]; diet induced thermogenesis [GO:0002024]; heat generation [GO:0031649]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of smooth muscle contraction [GO:0045986]; norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure [GO:0002025]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of autophagosome maturation [GO:1901098]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of lipophagy [GO:1904504]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mini excitatory postsynaptic potential [GO:0061885]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor-mediated endocytosis [GO:0006898]; regulation of sodium ion transport [GO:0002028]; response to cold [GO:0009409]; smooth muscle contraction [GO:0006939]; transcription by RNA polymerase II [GO:0006366]","GO:0001540; GO:0002024; GO:0002025; GO:0002028; GO:0002032; GO:0004930; GO:0004941; GO:0005634; GO:0005769; GO:0005794; GO:0005886; GO:0006366; GO:0006898; GO:0006939; GO:0007190; GO:0008179; GO:0009409; GO:0010739; GO:0015459; GO:0016324; GO:0030501; GO:0031649; GO:0040015; GO:0042803; GO:0043235; GO:0043410; GO:0044877; GO:0045453; GO:0045944; GO:0045986; GO:0050873; GO:0051380; GO:0061885; GO:0071880; GO:0071902; GO:0098992; GO:0120162; GO:1901098; GO:1904504; GO:1904646; GO:2000969"
"2804",2804,"Cluster_5563","Porites_evermani_scaffold_1307:107547-108547",156,-23.44,2,22,90,118,26,"61.54%","73.08%","Peve_00004882",0.219497875425183,0.859116194182611,0.995967512630608,"D8VNS9","Ryncolin-3","Cerberus rynchops (Dog-faced water snake)","","GO:0005576; GO:0090729"
"2805",2805,"Cluster_5563","Porites_evermani_scaffold_1383:38446-39446",171,-24.46,2,22,638,659,20,"80.00%","85.00%","Peve_00005950",NA,NA,NA,"Q6DIV6","Vesicular inhibitory amino acid transporter (GABA and glycine transporter) (Solute carrier family 32 member 1) (Vesicular GABA transporter)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","beta-alanine transport [GO:0001762]; gamma-aminobutyric acid import [GO:0051939]; gamma-aminobutyric acid transport [GO:0015812]; glycine transport [GO:0015816]; neurotransmitter transport [GO:0006836]","GO:0001762; GO:0006836; GO:0008021; GO:0015185; GO:0015187; GO:0015812; GO:0015816; GO:0030659; GO:0042995; GO:0051939; GO:0098793; GO:0140799; GO:0140800"
"2806",2806,"Cluster_5563","Porites_evermani_scaffold_1425:8177-9177",164,-21.15,2,22,40,67,25,"72.00%","72.00%","Peve_00006566",NA,NA,NA,NA,NA,NA,NA,NA
"2807",2807,"Cluster_5563","Porites_evermani_scaffold_1486:845-1845",156,-22.03,2,22,904,932,26,"61.54%","73.08%","Peve_00007285",0.793648159095157,0.416358258898947,0.978262075707395,"A5HUI5","Aminopeptidase A (AP-A) (APA) (EC 3.4.11.7) (Glutamyl aminopeptidase) (EAP)","Gloydius brevicaudus (Korean slamosa snake) (Agkistrodon halys brevicaudus)","proteolysis [GO:0006508]","GO:0004177; GO:0005886; GO:0006508; GO:0008237; GO:0008270"
"2808",2808,"Cluster_5563","Porites_evermani_scaffold_1499:35336-36336",171,-22.57,2,22,415,439,22,"81.82%","81.82%","Peve_00007444",-0.609995443364507,0.582342516764631,0.978262075707395,NA,NA,NA,NA,NA
"2809",2809,"Cluster_5563","Porites_evermani_scaffold_156:125238-126238",159,-23.27,2,22,1,30,27,"70.37%","70.37%","Peve_00008233",-0.824083203962473,0.383381643842214,0.978262075707395,"P53776","LIM/homeobox protein Lhx4 (LIM homeobox protein 4)","Mus musculus (Mouse)","animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; medial motor column neuron differentiation [GO:0021526]; motor neuron axon guidance [GO:0008045]; negative regulation of apoptotic process [GO:0043066]; neuron differentiation [GO:0030182]; placenta development [GO:0001890]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000977; GO:0000981; GO:0001228; GO:0001890; GO:0005634; GO:0005654; GO:0006357; GO:0006915; GO:0008045; GO:0008327; GO:0009887; GO:0021526; GO:0030182; GO:0043066; GO:0043565; GO:0045944; GO:0046872; GO:1990837"
"2810",2810,"Cluster_5563","Porites_evermani_scaffold_1674:65525-66525",153,-20.09,2,20,299,323,20,"75.00%","75.00%","Peve_00009662",0.369782205679131,0.758864600291409,0.988219883885475,"Q8IMA8","Protein pangolin, isoform J (dTCF)","Drosophila melanogaster (Fruit fly)","canonical Wnt signaling pathway [GO:0060070]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; chitin-based larval cuticle pattern formation [GO:0035293]; digestive tract morphogenesis [GO:0048546]; embryonic pattern specification [GO:0009880]; heart development [GO:0007507]; imaginal disc-derived wing morphogenesis [GO:0007476]; mesodermal cell fate determination [GO:0007500]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; segment polarity determination [GO:0007367]; spiracle morphogenesis, open tracheal system [GO:0035277]","GO:0000978; GO:0000981; GO:0001222; GO:0001228; GO:0005634; GO:0005667; GO:0006355; GO:0006357; GO:0007367; GO:0007435; GO:0007476; GO:0007500; GO:0007507; GO:0009880; GO:0010628; GO:0019900; GO:0035277; GO:0035293; GO:0045892; GO:0045893; GO:0045944; GO:0048546; GO:0060070; GO:0072091; GO:0090254; GO:1990907"
"2811",2811,"Cluster_5563","Porites_evermani_scaffold_187:225369-226369",152,-22.7,2,22,97,127,28,"60.71%","67.86%","Peve_00011904",-0.992444854316364,0.0783051546700206,0.978262075707395,"P17124","Histamine H2 receptor (H2R) (HH2R) (Gastric receptor I)","Canis lupus familiaris (Dog) (Canis familiaris)","chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; gastric acid secretion [GO:0001696]; positive regulation of vasoconstriction [GO:0045907]","GO:0001696; GO:0004969; GO:0004993; GO:0005886; GO:0007187; GO:0007268; GO:0030425; GO:0030594; GO:0045202; GO:0045907"
"2812",2812,"Cluster_5563","Porites_evermani_scaffold_2103:5937-6937",176,-21.82,2,21,604,626,19,"78.95%","89.47%","Peve_00014629",0.985895621336203,0.10704931186547,0.978262075707395,"Q7ZWG6","Proton-coupled folate transporter (Solute carrier family 46 member 1)","Danio rerio (Zebrafish) (Brachydanio rerio)","transmembrane transport [GO:0055085]","GO:0005542; GO:0005768; GO:0005886; GO:0010008; GO:0015293; GO:0015350; GO:0016020; GO:0016323; GO:0016324; GO:0022857; GO:0055085"
"2813",2813,"Cluster_5563","Porites_evermani_scaffold_2123:65123-66123",169,-20.37,2,21,918,940,20,"85.00%","85.00%","Peve_00014802",-0.891455264339301,0.299370131021221,0.978262075707395,NA,NA,NA,NA,NA
"2814",2814,"Cluster_5563","Porites_evermani_scaffold_2130:25493-26493",167,-22.72,2,21,895,918,20,"75.00%","85.00%","Peve_00014887",-0.87182787159332,0.32586944721388,0.978262075707395,NA,NA,NA,NA,NA
"2815",2815,"Cluster_5563","Porites_evermani_scaffold_21:535108-536108",164,-21.33,2,22,904,928,22,"72.73%","77.27%","Peve_00014523",-0.838673873070233,0.366662803341602,0.978262075707395,"P23819","Glutamate receptor 2 (GluR-2) (AMPA-selective glutamate receptor 2) (GluR-B) (GluR-K2) (Glutamate receptor ionotropic, AMPA 2) (GluA2)","Mus musculus (Mouse)","cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to glycine [GO:1905430]; chemical synaptic transmission [GO:0007268]; establishment of protein localization [GO:0045184]; ionotropic glutamate receptor signaling pathway [GO:0035235]; positive regulation of synaptic transmission [GO:0050806]; protein tetramerization [GO:0051262]; receptor internalization [GO:0031623]; regulation of receptor recycling [GO:0001919]; regulation of synaptic transmission, glutamatergic [GO:0051966]","GO:0000149; GO:0001540; GO:0001919; GO:0004970; GO:0004971; GO:0005234; GO:0005783; GO:0005789; GO:0005886; GO:0007268; GO:0008021; GO:0008092; GO:0009986; GO:0014069; GO:0015276; GO:0015277; GO:0016020; GO:0019865; GO:0019901; GO:0030165; GO:0030424; GO:0030425; GO:0030426; GO:0030672; GO:0031623; GO:0032279; GO:0032281; GO:0032590; GO:0032839; GO:0032991; GO:0035235; GO:0035254; GO:0035255; GO:0036477; GO:0038023; GO:0042734; GO:0042802; GO:0043005; GO:0043025; GO:0043195; GO:0043197; GO:0043198; GO:0043204; GO:0044326; GO:0044327; GO:0044877; GO:0045184; GO:0045202; GO:0045211; GO:0048787; GO:0050806; GO:0051117; GO:0051262; GO:0051966; GO:0097060; GO:0097110; GO:0098685; GO:0098793; GO:0098839; GO:0098978; GO:0099507; GO:0099544; GO:0106033; GO:1904315; GO:1905430; GO:1990416"
"2816",2816,"Cluster_5563","Porites_evermani_scaffold_23:214641-215641",177,-24.53,2,22,23,45,20,"80.00%","85.00%","Peve_00016539",-0.743620212517016,0.466214198488226,0.978262075707395,NA,NA,NA,NA,NA
"2817",2817,"Cluster_5563","Porites_evermani_scaffold_2597:21415-22415",161,-25.46,2,21,245,272,24,"75.00%","79.17%","Peve_00019199",0.0533239704113661,0.966036797687887,0.999448381576871,NA,NA,NA,NA,NA
"2818",2818,"Cluster_5563","Porites_evermani_scaffold_2999:53828-54828",163,-21.86,2,17,777,800,16,"87.50%","87.50%","Peve_00022402",0.838131293927935,0.367296535645446,0.978262075707395,NA,NA,NA,NA,NA
"2819",2819,"Cluster_5563","Porites_evermani_scaffold_3068:15060-16060",169,-21.77,2,22,951,973,20,"70.00%","85.00%","Peve_00023106",0.985656512603257,0.107955053627541,0.978262075707395,"Q9D1D6","Collagen triple helix repeat-containing protein 1","Mus musculus (Mouse)","cell migration [GO:0016477]; cochlea morphogenesis [GO:0090103]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein binding [GO:0032092]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0001649; GO:0005109; GO:0005581; GO:0005615; GO:0016477; GO:0016528; GO:0017147; GO:0031012; GO:0032092; GO:0033687; GO:0033690; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0090090; GO:0090103; GO:0090177"
"2820",2820,"Cluster_5563","Porites_evermani_scaffold_318:37748-38748",163,-25.1,2,22,21,46,23,"69.57%","82.61%","Peve_00023889",-0.798735746884897,0.41100506555827,0.978262075707395,NA,NA,NA,NA,NA
"2821",2821,"Cluster_5563","Porites_evermani_scaffold_3617:27504-28504",161,-20.24,2,21,542,564,20,"75.00%","85.00%","Peve_00026650",-0.314973634404773,0.796008642946053,0.995934364227446,"Q7ZVH1","Membrane progestin receptor gamma-A (mPR gamma-A) (Progestin and adipoQ receptor family member V-A)","Danio rerio (Zebrafish) (Brachydanio rerio)","oogenesis [GO:0048477]","GO:0005496; GO:0016020; GO:0038023; GO:0048477"
"2822",2822,"Cluster_5563","Porites_evermani_scaffold_3629:13311-14311",159,-21.66,2,17,368,391,16,"81.25%","87.50%","Peve_00026718",0.838131293927935,0.367296535645446,0.978262075707395,NA,NA,NA,NA,NA
"2823",2823,"Cluster_5563","Porites_evermani_scaffold_3783:27430-28430",162,-20.2,2,20,445,468,19,"78.95%","78.95%","Peve_00027502",NA,NA,NA,NA,NA,NA,NA,NA
"2824",2824,"Cluster_5563","Porites_evermani_scaffold_421:150610-151150",179,-23,2,21,363,386,20,"85.00%","90.00%","Peve_00029918",0.995565641257577,0.0599751231877625,0.978262075707395,"P49739","Maternal DNA replication licensing factor mcm3 (EC 3.6.4.12) (Maternal minichromosome maintenance protein 3) (mMCM3) (xMCM3) (P1 homolog) (XRLF subunit beta) (p100)","Xenopus laevis (African clawed frog)","cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; regulation of DNA-templated DNA replication initiation [GO:0030174]","GO:0000785; GO:0003677; GO:0004386; GO:0005524; GO:0006268; GO:0006270; GO:0007049; GO:0016887; GO:0030174; GO:0042555; GO:0071162"
"2825",2825,"Cluster_5563","Porites_evermani_scaffold_5320:12254-13254",154,-20.27,2,21,595,620,22,"68.18%","77.27%","Peve_00034842",0.0533239704113661,0.966036797687887,0.999448381576871,"Q58DG1","MYG1 exonuclease (EC 3.1.-.-)","Bos taurus (Bovine)","locomotory exploration behavior [GO:0035641]","GO:0004518; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005759; GO:0035641"
"2826",2826,"Cluster_5563","Porites_evermani_scaffold_543:209356-210356",173,-22.44,2,18,869,891,16,"87.50%","93.75%","Peve_00035234",NA,NA,NA,NA,NA,NA,NA,NA
"2827",2827,"Cluster_5563","Porites_evermani_scaffold_609:220303-221303",164,-20.41,2,21,492,512,19,"84.21%","84.21%","Peve_00037307",0.0533239704113661,0.966036797687887,0.999448381576871,NA,NA,NA,NA,NA
"2828",2828,"Cluster_5563","Porites_evermani_scaffold_765:26293-27293",168,-20.58,2,19,799,820,17,"88.24%","88.24%","Peve_00040979",-0.0709040158716284,0.954823194005512,0.999448381576871,"Q9EQJ0","Two pore calcium channel protein 1 (Voltage-dependent calcium channel protein TPC1)","Mus musculus (Mouse)","endocytosis involved in viral entry into host cell [GO:0075509]; positive regulation of autophagy [GO:0010508]; regulation of ion transmembrane transport [GO:0034765]; sodium ion transmembrane transport [GO:0035725]","GO:0005244; GO:0005248; GO:0005765; GO:0010008; GO:0010508; GO:0015280; GO:0016020; GO:0019905; GO:0031901; GO:0034765; GO:0035725; GO:0036019; GO:0042802; GO:0042803; GO:0055038; GO:0072345; GO:0075509; GO:0080025; GO:0097682"
"2829",2829,"Cluster_5563","Porites_evermani_scaffold_77:318764-319764",170,-21.45,2,20,447,470,19,"84.21%","84.21%","Peve_00041059",0.0533239704113661,0.966036797687887,0.999448381576871,NA,NA,NA,NA,NA
"2830",2830,"Cluster_5563","Porites_evermani_scaffold_83:348910-349910",161,-21.87,2,19,946,971,20,"75.00%","80.00%","Peve_00042396",-0.616155532524895,0.577378539984852,0.978262075707395,"Q07496","Ephrin type-A receptor 4 (EC 2.7.10.1) (EPH-like kinase 8) (EK8) (cEK8)","Gallus gallus (Chicken)","axon guidance [GO:0007411]; cell adhesion [GO:0007155]; fasciculation of sensory neuron axon [GO:0097155]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of kinase activity [GO:0033674]; positive regulation of Rho guanyl-nucleotide exchange factor activity [GO:2001108]; protein autophosphorylation [GO:0046777]; regulation of GTPase activity [GO:0043087]; segmentation [GO:0035282]; somitogenesis [GO:0001756]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]","GO:0001756; GO:0004672; GO:0004714; GO:0005004; GO:0005005; GO:0005524; GO:0005737; GO:0005886; GO:0007155; GO:0007169; GO:0007411; GO:0018108; GO:0031901; GO:0033674; GO:0035282; GO:0043005; GO:0043087; GO:0043197; GO:0043235; GO:0046777; GO:0097155; GO:0097161; GO:2001108"
"2831",2831,"Cluster_5563","Porites_evermani_scaffold_860:12836-13836",168,-20.67,2,22,196,219,21,"76.19%","80.95%","Peve_00042980",0.478898663147561,0.6820722594739,0.978262075707395,"Q96RW7","Hemicentin-1 (Fibulin-6) (FIBL-6)","Homo sapiens (Human)","actin filament reorganization [GO:0090527]; basement membrane organization [GO:0071711]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]","GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711; GO:0090527"
"2832",2832,"Cluster_5563","Porites_evermani_scaffold_869:121210-122210",168,-21.84,2,22,611,634,21,"71.43%","85.71%","Peve_00043104",NA,NA,NA,NA,NA,NA,NA,NA
"2833",2833,"Cluster_5563","Porites_evermani_scaffold_908:162030-163030",170,-23.04,2,22,440,462,21,"80.95%","85.71%","Peve_00043873",NA,NA,NA,NA,NA,NA,NA,NA
"2834",2834,"Cluster_5563","Porites_evermani_scaffold_94:212617-213617",170,-20.34,2,22,760,782,21,"80.95%","85.71%","Peve_00044419",NA,NA,NA,"P97292","Histamine H2 receptor (H2R) (HH2R) (Gastric receptor I)","Mus musculus (Mouse)","chemical synaptic transmission [GO:0007268]; digestive tract development [GO:0048565]; epithelial cell morphogenesis [GO:0003382]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; gastric acid secretion [GO:0001696]; gastrin-induced gastric acid secretion [GO:0001698]; gland development [GO:0048732]; histamine-induced gastric acid secretion [GO:0001697]; memory [GO:0007613]; negative regulation of arachidonic acid secretion [GO:1900139]; positive regulation of vasoconstriction [GO:0045907]; regulation of synaptic plasticity [GO:0048167]; toxin transport [GO:1901998]; visual learning [GO:0008542]","GO:0001696; GO:0001697; GO:0001698; GO:0003382; GO:0004969; GO:0004993; GO:0005886; GO:0007187; GO:0007268; GO:0007613; GO:0008542; GO:0016020; GO:0030425; GO:0030594; GO:0045202; GO:0045907; GO:0048167; GO:0048565; GO:0048732; GO:1900139; GO:1901363; GO:1901998"
"2835",2835,"Cluster_5882","Porites_evermani_scaffold_1018:61056-62056",151,-21.91,2,12,215,236,10,"90.00%","100.00%","Peve_00000499",0.35858591312742,0.766518028004359,0.990060950224971,"Q0P4M4","Cytosolic carboxypeptidase 2 (EC 3.4.17.-) (ATP/GTP-binding protein-like 2) (Protein deglutamylase CCP2)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","protein side chain deglutamylation [GO:0035610]; proteolysis [GO:0006508]","GO:0004181; GO:0005814; GO:0005829; GO:0006508; GO:0008270; GO:0035610; GO:0036064"
"2836",2836,"Cluster_5882","Porites_evermani_scaffold_102:119166-120166",165,-22.84,2,20,230,250,18,"77.78%","88.89%","Peve_00000532",0.503606578938083,0.664012249093443,0.978262075707395,NA,NA,NA,NA,NA
"2837",2837,"Cluster_5882","Porites_evermani_scaffold_105:272347-273347",146,-20.8,2,21,520,540,19,"57.89%","78.95%","Peve_00000983",0.96096960812843,0.178451150156414,0.978262075707395,NA,NA,NA,NA,NA
"2838",2838,"Cluster_5882","Porites_evermani_scaffold_107:317371-318371",167,-22.48,2,21,384,406,20,"70.00%","90.00%","Peve_00001298",-0.764898466229221,0.445578222582943,0.978262075707395,NA,NA,NA,NA,NA
"2839",2839,"Cluster_5882","Porites_evermani_scaffold_1085:76740-77740",167,-22.28,2,21,91,113,20,"75.00%","85.00%","Peve_00001521",-0.692781830516684,0.512769774778855,0.978262075707395,"Q61555","Fibrillin-2 [Cleaved into: Placensin]","Mus musculus (Mouse)","anatomical structure morphogenesis [GO:0009653]; bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583]","GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0009653; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:0062023; GO:1901163"
"2840",2840,"Cluster_5882","Porites_evermani_scaffold_1091:42018-43018",170,-20.26,2,19,137,158,17,"76.47%","94.12%","Peve_00001619",-0.0771732356210654,0.950821093808617,0.999448381576871,NA,NA,NA,NA,NA
"2841",2841,"Cluster_5882","Porites_evermani_scaffold_11:1126068-1127068",156,-20.91,2,18,929,952,18,"72.22%","83.33%","Peve_00001817",-0.609663697464484,0.582608999188419,0.978262075707395,NA,NA,NA,NA,NA
"2842",2842,"Cluster_5882","Porites_evermani_scaffold_1122:35941-36941",149,-20.74,2,16,918,938,14,"78.57%","85.71%","Peve_00002193",-0.207343170374616,0.86703666095078,0.996794491634024,"A0JPI9","Leucine-rich repeat-containing protein 74A (Leucine-rich repeat-containing protein 74)","Rattus norvegicus (Rat)","",""
"2843",2843,"Cluster_5882","Porites_evermani_scaffold_115:449830-450830",158,-22,2,20,586,609,20,"65.00%","85.00%","Peve_00002534",0.371092416113135,0.757966608944233,0.988219883885475,"A4IH36","Adipolin (Adipose-derived insulin-sensitizing factor) (Complement C1q tumor necrosis factor-related protein 12)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","regulation of glucose import [GO:0046324]","GO:0005179; GO:0005576; GO:0046324"
"2844",2844,"Cluster_5882","Porites_evermani_scaffold_1193:84748-85748",149,-21.74,2,20,552,569,18,"77.78%","77.78%","Peve_00003228",-0.268479834672512,0.826957464824234,0.995934364227446,"Q01528","Hemagglutinin/amebocyte aggregation factor (18K-LAF)","Limulus polyphemus (Atlantic horseshoe crab)","","GO:0005576"
"2845",2845,"Cluster_5882","Porites_evermani_scaffold_120:296699-297699",167,-22,2,21,906,928,20,"75.00%","85.00%","Peve_00003401",-0.552197978739124,0.62757850494186,0.978262075707395,NA,NA,NA,NA,NA
"2846",2846,"Cluster_5882","Porites_evermani_scaffold_121:460476-461476",152,-20.2,2,18,865,888,18,"66.67%","83.33%","Peve_00003526",NA,NA,NA,NA,NA,NA,NA,NA
"2847",2847,"Cluster_5882","Porites_evermani_scaffold_1272:123508-124508",169,-20.42,2,19,914,936,18,"77.78%","94.44%","Peve_00004391",0.0640471266608689,0.959198405390803,0.999448381576871,"Q9H0A0","RNA cytidine acetyltransferase (EC 2.3.1.-) (18S rRNA cytosine acetyltransferase) (N-acetyltransferase 10) (N-acetyltransferase-like protein) (hALP)","Homo sapiens (Human)","negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of translation [GO:0045727]; protein acetylation [GO:0006473]; regulation of centrosome duplication [GO:0010824]; rRNA acetylation involved in maturation of SSU-rRNA [GO:1904812]; rRNA modification [GO:0000154]; tRNA acetylation [GO:0051391]","GO:0000049; GO:0000154; GO:0000781; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005697; GO:0005730; GO:0006473; GO:0008080; GO:0010824; GO:0016020; GO:0030496; GO:0032211; GO:0045727; GO:0051391; GO:0070182; GO:0106162; GO:1904812; GO:1990883"
"2848",2848,"Cluster_5882","Porites_evermani_scaffold_1305:27238-28238",150,-20.66,2,21,902,922,19,"63.16%","78.95%","Peve_00004860",-0.905735288972264,0.27863892333508,0.978262075707395,NA,NA,NA,NA,NA
"2849",2849,"Cluster_5882","Porites_evermani_scaffold_1325:92991-93991",146,-20.8,2,21,590,610,19,"57.89%","78.95%","Peve_00005151",NA,NA,NA,NA,NA,NA,NA,NA
"2850",2850,"Cluster_5882","Porites_evermani_scaffold_1330:7261-8261",155,-25.44,2,21,450,474,22,"63.64%","77.27%","Peve_00005244",NA,NA,NA,NA,NA,NA,NA,NA
"2851",2851,"Cluster_5882","Porites_evermani_scaffold_1342:39878-40878",172,-20.88,2,21,202,223,19,"78.95%","84.21%","Peve_00005395",NA,NA,NA,NA,NA,NA,NA,NA
"2852",2852,"Cluster_5882","Porites_evermani_scaffold_1359:3692-4692",156,-21.46,2,21,971,990,19,"68.42%","89.47%","Peve_00005621",-0.692781830516684,0.512769774778855,0.978262075707395,NA,NA,NA,NA,NA
"2853",2853,"Cluster_5882","Porites_evermani_scaffold_1364:60829-61829",153,-20.87,2,16,667,687,14,"85.71%","85.71%","Peve_00005715",NA,NA,NA,NA,NA,NA,NA,NA
"2854",2854,"Cluster_5882","Porites_evermani_scaffold_1379:129667-129939",160,-21.08,2,21,86,107,19,"68.42%","78.95%","Peve_00005885",-0.996782179226849,0.0510849028598445,0.958334495488436,NA,NA,NA,NA,NA
"2855",2855,"Cluster_5882","Porites_evermani_scaffold_1420:88540-89540",151,-22.07,2,20,846,864,18,"72.22%","77.78%","Peve_00006531",0.907723963017985,0.275636767055537,0.978262075707395,"P24603","Rhodopsin","Loligo forbesii (Veined squid)","phototransduction [GO:0007602]; visual perception [GO:0007601]","GO:0004930; GO:0005886; GO:0007601; GO:0007602; GO:0009881; GO:0016020; GO:0016918"
"2856",2856,"Cluster_5882","Porites_evermani_scaffold_1440:37142-38142",162,-23.1,2,21,17,40,21,"76.19%","80.95%","Peve_00006740",-0.179185755923419,0.885307377864559,0.999448381576871,"O35242","Protein FAN (Factor associated with neutral sphingomyelinase activation) (Factor associated with N-SMase activation)","Mus musculus (Mouse)","positive regulation of apoptotic process [GO:0043065]","GO:0005123; GO:0016230; GO:0043065"
"2857",2857,"Cluster_5882","Porites_evermani_scaffold_1499:21176-22176",167,-25.61,2,21,70,93,21,"71.43%","85.71%","Peve_00007443",-0.692781830516684,0.512769774778855,0.978262075707395,NA,NA,NA,NA,NA
"2858",2858,"Cluster_5882","Porites_evermani_scaffold_1545:29813-30813",151,-20.63,2,17,412,434,16,"75.00%","81.25%","Peve_00008042",-0.374605396666432,0.755556377263331,0.988219883885475,"P55097","Cathepsin K (EC 3.4.22.38)","Mus musculus (Mouse)","bone resorption [GO:0045453]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to zinc ion starvation [GO:0034224]; collagen catabolic process [GO:0030574]; immune response [GO:0006955]; intramembranous ossification [GO:0001957]; mononuclear cell differentiation [GO:1903131]; negative regulation of cartilage development [GO:0061037]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; response to ethanol [GO:0045471]; response to insulin [GO:0032868]; response to organic cyclic compound [GO:0014070]; thyroid hormone generation [GO:0006590]","GO:0001957; GO:0001968; GO:0004197; GO:0005518; GO:0005615; GO:0005654; GO:0005737; GO:0005764; GO:0006508; GO:0006590; GO:0006955; GO:0008234; GO:0009897; GO:0014070; GO:0016324; GO:0030574; GO:0032868; GO:0034224; GO:0043231; GO:0043394; GO:0045453; GO:0045471; GO:0051603; GO:0061037; GO:0071356; GO:0071560; GO:1903131"
"2859",2859,"Cluster_5882","Porites_evermani_scaffold_1608:54441-55441",171,-20.81,2,21,238,260,20,"75.00%","90.00%","Peve_00008917",NA,NA,NA,NA,NA,NA,NA,NA
"2860",2860,"Cluster_5882","Porites_evermani_scaffold_161:136377-136572",159,-20.75,2,18,119,139,16,"81.25%","87.50%","Peve_00008953",-0.692781830516684,0.512769774778855,0.978262075707395,"Q1T7B7","Centromere protein P (CENP-P)","Gallus gallus (Chicken)","CENP-A containing chromatin assembly [GO:0034080]","GO:0000775; GO:0005634; GO:0034080"
"2861",2861,"Cluster_5882","Porites_evermani_scaffold_161:136377-136572",159,-20.75,2,18,119,139,16,"81.25%","87.50%","Peve_00008954",0.127884174662368,0.918362845378624,0.999448381576871,"Q66KC4","Hydroxysteroid dehydrogenase-like protein 2 (EC 1.-.-.-)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","","GO:0005777; GO:0016491"
"2862",2862,"Cluster_5882","Porites_evermani_scaffold_1625:55597-55761",148,-20.61,2,21,40,59,19,"63.16%","84.21%","Peve_00009114",0.627313514033296,0.568308939805228,0.978262075707395,"P12074","Cytochrome c oxidase subunit 6A1, mitochondrial (Cytochrome c oxidase polypeptide VIa-liver) (Cytochrome c oxidase subunit VIA-liver) (COX VIa-L)","Homo sapiens (Human)","cellular respiration [GO:0045333]; generation of precursor metabolites and energy [GO:0006091]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]","GO:0005739; GO:0005743; GO:0005751; GO:0006091; GO:0006123; GO:0016491; GO:0030234; GO:0045333"
"2863",2863,"Cluster_5882","Porites_evermani_scaffold_1625:55597-55761",148,-20.61,2,21,40,59,19,"63.16%","84.21%","Peve_00009115",0.0259352364353067,0.983487264153225,0.999448381576871,"Q58728","Uncharacterized GTP-binding protein MJ1332","Methanocaldococcus jannaschii (strain ATCC 43067 / DSM 2661 / JAL-1 / JCM 10045 / NBRC 100440) (Methanococcus jannaschii)","","GO:0005525; GO:0005737; GO:0016887"
"2864",2864,"Cluster_5882","Porites_evermani_scaffold_166:86611-87611",159,-20.14,2,21,211,236,23,"69.57%","73.91%","Peve_00009491",NA,NA,NA,NA,NA,NA,NA,NA
"2865",2865,"Cluster_5882","Porites_evermani_scaffold_1677:87567-87731",148,-20.61,2,21,40,59,19,"63.16%","84.21%","Peve_00009692",0.68401024946487,0.520468683228911,0.978262075707395,"P12074","Cytochrome c oxidase subunit 6A1, mitochondrial (Cytochrome c oxidase polypeptide VIa-liver) (Cytochrome c oxidase subunit VIA-liver) (COX VIa-L)","Homo sapiens (Human)","cellular respiration [GO:0045333]; generation of precursor metabolites and energy [GO:0006091]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]","GO:0005739; GO:0005743; GO:0005751; GO:0006091; GO:0006123; GO:0016491; GO:0030234; GO:0045333"
"2866",2866,"Cluster_5882","Porites_evermani_scaffold_1677:87567-87731",148,-20.61,2,21,40,59,19,"63.16%","84.21%","Peve_00009693",0.780844364292616,0.429578336217013,0.978262075707395,"P42942","Uncharacterized GTP-binding protein YGR210C","Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)","","GO:0005525; GO:0005737; GO:0016887"
"2867",2867,"Cluster_5882","Porites_evermani_scaffold_168:74200-75200",155,-22.16,2,21,835,857,20,"65.00%","80.00%","Peve_00009740",-0.0963352507884064,0.938575815896048,0.999448381576871,"P95896","Amidase (EC 3.5.1.4)","Saccharolobus solfataricus (strain ATCC 35092 / DSM 1617 / JCM 11322 / P2) (Sulfolobus solfataricus)","","GO:0004040; GO:0043864"
"2868",2868,"Cluster_5882","Porites_evermani_scaffold_1697:21808-22808",157,-26.03,2,21,223,250,25,"72.00%","76.00%","Peve_00009952",0.531557976922546,0.643213537673573,0.978262075707395,"Q90Z12","Transcription factor HES-4-A (Hairy and enhancer of split 4-A) (Protein hairy-2) (Xhairy2) (Protein hairy-2a) (Xhairy2a)","Xenopus laevis (African clawed frog)","BMP signaling pathway [GO:0030509]; floor plate development [GO:0033504]; lens development in camera-type eye [GO:0002088]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest formation [GO:0014029]; prechordal plate formation [GO:0021501]","GO:0000122; GO:0002088; GO:0005634; GO:0014029; GO:0021501; GO:0030509; GO:0033504; GO:0043066; GO:0043425; GO:0043565; GO:0045892; GO:0046983"
"2869",2869,"Cluster_5882","Porites_evermani_scaffold_1719:1941-2941",167,-21.31,2,21,89,111,20,"75.00%","85.00%","Peve_00010246",0.0970300531636868,0.938131409025737,0.999448381576871,"Q6AYD3","Proliferation-associated protein 2G4","Rattus norvegicus (Rat)","negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of cell differentiation [GO:0045597]; regulation of translation [GO:0006417]; rRNA processing [GO:0006364]","GO:0003676; GO:0003714; GO:0003723; GO:0005634; GO:0005730; GO:0005737; GO:0006364; GO:0006417; GO:0031625; GO:0043066; GO:0045597; GO:0045892; GO:1990904"
"2870",2870,"Cluster_5882","Porites_evermani_scaffold_1725:80248-81248",146,-20.8,2,21,882,902,19,"57.89%","78.95%","Peve_00010322",-0.27814091057559,0.820563558554478,0.995934364227446,"F1PZV2","Major facilitator superfamily domain-containing protein 12","Canis lupus familiaris (Dog) (Canis familiaris)","carbohydrate transport [GO:0008643]; cysteine transmembrane transport [GO:1903712]; melanin biosynthetic process [GO:0042438]; organic substance transport [GO:0071702]; pigment metabolic process involved in pigmentation [GO:0043474]; regulation of melanin biosynthetic process [GO:0048021]","GO:0005764; GO:0005765; GO:0005886; GO:0008643; GO:0015293; GO:0033162; GO:0033229; GO:0042438; GO:0043474; GO:0048021; GO:0071702; GO:1903712"
"2871",2871,"Cluster_5882","Porites_evermani_scaffold_173:198194-199194",158,-23.13,2,17,568,588,15,"80.00%","93.33%","Peve_00010366",NA,NA,NA,"P97288","5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)","Mus musculus (Mouse)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; gamma-aminobutyric acid signaling pathway [GO:0007214]; regulation of appetite [GO:0032098]","GO:0004993; GO:0005737; GO:0005768; GO:0005886; GO:0007187; GO:0007189; GO:0007198; GO:0007214; GO:0007268; GO:0016020; GO:0030425; GO:0030594; GO:0032098; GO:0045202; GO:0051378"
"2872",2872,"Cluster_5882","Porites_evermani_scaffold_1755:94665-95665",163,-22.22,2,21,363,387,22,"68.18%","81.82%","Peve_00010610",-0.665502812869217,0.536434317851971,0.978262075707395,NA,NA,NA,NA,NA
"2873",2873,"Cluster_5882","Porites_evermani_scaffold_1791:40313-41313",157,-20.69,2,21,376,400,22,"72.73%","81.82%","Peve_00011022",-0.27814091057559,0.820563558554478,0.995934364227446,"P16092","Fibroblast growth factor receptor 1 (FGFR-1) (bFGF-R-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (MFR) (Proto-oncogene c-Fgr) (CD antigen CD331)","Mus musculus (Mouse)","angiogenesis [GO:0001525]; auditory receptor cell development [GO:0060117]; blood vessel morphogenesis [GO:0048514]; brain development [GO:0007420]; branching involved in salivary gland morphogenesis [GO:0060445]; calcium ion homeostasis [GO:0055074]; cardiac muscle cell proliferation [GO:0060038]; cell maturation [GO:0048469]; cell population proliferation [GO:0008283]; cementum mineralization [GO:0071529]; central nervous system neuron development [GO:0021954]; chondrocyte differentiation [GO:0002062]; diphosphate metabolic process [GO:0071344]; ear development [GO:0043583]; embryonic limb morphogenesis [GO:0030326]; epithelial to mesenchymal transition [GO:0001837]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development [GO:0035607]; gene expression [GO:0010467]; generation of neurons [GO:0048699]; in utero embryonic development [GO:0001701]; inner ear morphogenesis [GO:0042472]; lung development [GO:0030324]; lung-associated mesenchyme development [GO:0060484]; mesenchymal cell differentiation [GO:0048762]; mesenchymal cell proliferation [GO:0010463]; midbrain development [GO:0030901]; middle ear morphogenesis [GO:0042474]; motogenic signaling involved in postnatal olfactory bulb interneuron migration [GO:0021837]; negative regulation of fibroblast growth factor production [GO:0090272]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron projection development [GO:0031175]; orbitofrontal cortex development [GO:0021769]; organ induction [GO:0001759]; outer ear morphogenesis [GO:0042473]; paraxial mesoderm development [GO:0048339]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000546]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of inflammatory response [GO:0050729]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway [GO:0090080]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic cell cycle DNA replication [GO:1903465]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]; positive regulation of parathyroid hormone secretion [GO:2000830]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein autophosphorylation [GO:0046777]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001239]; regulation of gene expression [GO:0010468]; regulation of lateral mesodermal cell fate specification [GO:0048378]; regulation of phosphate transport [GO:0010966]; regulation of phosphorus metabolic process [GO:0051174]; regulation of sensory perception of pain [GO:0051930]; regulation of stem cell proliferation [GO:0072091]; response to sodium phosphate [GO:1904383]; salivary gland morphogenesis [GO:0007435]; sensory perception of sound [GO:0007605]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827]; stem cell proliferation [GO:0072089]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureteric bud development [GO:0001657]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; ventricular zone neuroblast division [GO:0021847]; vitamin D3 metabolic process [GO:0070640]","GO:0000122; GO:0001525; GO:0001657; GO:0001701; GO:0001759; GO:0001837; GO:0002053; GO:0002062; GO:0004713; GO:0004714; GO:0005007; GO:0005102; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007169; GO:0007420; GO:0007435; GO:0007605; GO:0008201; GO:0008283; GO:0008284; GO:0008543; GO:0010463; GO:0010467; GO:0010468; GO:0010629; GO:0010763; GO:0010863; GO:0010966; GO:0010976; GO:0017134; GO:0018108; GO:0019827; GO:0021769; GO:0021837; GO:0021847; GO:0021954; GO:0030324; GO:0030326; GO:0030901; GO:0031175; GO:0031410; GO:0033674; GO:0035607; GO:0042127; GO:0042169; GO:0042472; GO:0042473; GO:0042474; GO:0042802; GO:0042803; GO:0043235; GO:0043406; GO:0043410; GO:0043536; GO:0043583; GO:0044877; GO:0045597; GO:0045666; GO:0045668; GO:0045787; GO:0045944; GO:0046777; GO:0048339; GO:0048378; GO:0048469; GO:0048471; GO:0048514; GO:0048699; GO:0048762; GO:0048863; GO:0050678; GO:0050729; GO:0050839; GO:0051174; GO:0051897; GO:0051930; GO:0055074; GO:0060038; GO:0060045; GO:0060117; GO:0060445; GO:0060484; GO:0060665; GO:0060979; GO:0070640; GO:0071344; GO:0071529; GO:0072089; GO:0072091; GO:0090080; GO:0090272; GO:0090722; GO:1903465; GO:1904383; GO:1905564; GO:2000491; GO:2000546; GO:2000648; GO:2000830; GO:2001239"
"2874",2874,"Cluster_5882","Porites_evermani_scaffold_1805:99826-100826",154,-22.1,2,21,76,101,23,"65.22%","78.26%","Peve_00011229",-0.455010439997765,0.69927104490449,0.978262075707395,"Q5ZM55","Protein fem-1 homolog B (FEM1b) (FEM1-beta)","Gallus gallus (Chicken)","apoptotic process [GO:0006915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627]","GO:0005634; GO:0005737; GO:0006915; GO:0016567; GO:0031462; GO:0043161; GO:0140627; GO:1990756; GO:2000001"
"2875",2875,"Cluster_5882","Porites_evermani_scaffold_1812:85959-86959",159,-21.35,2,21,707,729,20,"70.00%","80.00%","Peve_00011306",0.970922741092274,0.153896891887812,0.978262075707395,"P04409","Protein kinase C alpha type (PKC-A) (PKC-alpha) (EC 2.7.11.13)","Bos taurus (Bovine)","angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; intracellular signal transduction [GO:0035556]; negative regulation of glial cell apoptotic process [GO:0034351]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106071]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of dense core granule biogenesis [GO:2000707]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of mitotic cell cycle [GO:0045931]; protein phosphorylation [GO:0006468]; regulation of platelet aggregation [GO:0090330]","GO:0001525; GO:0001938; GO:0004674; GO:0004697; GO:0004698; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006915; GO:0007155; GO:0008270; GO:0010595; GO:0010613; GO:0018105; GO:0030165; GO:0030335; GO:0031666; GO:0031966; GO:0034351; GO:0035556; GO:0045651; GO:0045766; GO:0045785; GO:0045931; GO:0048471; GO:0070374; GO:0090330; GO:0097110; GO:0097381; GO:0106071; GO:0106310; GO:2000707"
"2876",2876,"Cluster_5882","Porites_evermani_scaffold_1827:60568-61568",160,-20.96,2,21,666,685,19,"78.95%","84.21%","Peve_00011457",0.66859756036653,0.533789823270919,0.978262075707395,"P46850","RNA-splicing ligase RtcB (EC 6.5.1.8) (3'-phosphate/5'-hydroxy nucleic acid ligase)","Escherichia coli (strain K12)","cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; RNA processing [GO:0006396]; RNA repair [GO:0042245]; tRNA processing [GO:0008033]","GO:0003909; GO:0005525; GO:0006281; GO:0006396; GO:0006974; GO:0008033; GO:0008452; GO:0030145; GO:0042245"
"2877",2877,"Cluster_5882","Porites_evermani_scaffold_1828:9004-10004",160,-21.52,2,21,290,311,19,"63.16%","84.21%","Peve_00011470",0.94688475566595,0.208423178783454,0.978262075707395,"A0A0C2SRU0","Decarboxylase iboD (EC 4.1.1.-) (Ibotenic acid biosynthesis cluster protein D)","Amanita muscaria (strain Koide BX008)","phospholipid biosynthetic process [GO:0008654]","GO:0004609; GO:0008654"
"2878",2878,"Cluster_5882","Porites_evermani_scaffold_185:212288-213288",172,-22.51,2,19,502,522,17,"88.24%","94.12%","Peve_00011712",NA,NA,NA,NA,NA,NA,NA,NA
"2879",2879,"Cluster_5882","Porites_evermani_scaffold_1866:29388-30388",147,-20.26,2,21,561,584,21,"66.67%","66.67%","Peve_00011871",NA,NA,NA,NA,NA,NA,NA,NA
"2880",2880,"Cluster_5882","Porites_evermani_scaffold_189:185228-186057",150,-21.15,2,20,151,173,19,"68.42%","73.68%","Peve_00012126",-0.328958771778991,0.786604562594177,0.995049185611985,NA,NA,NA,NA,NA
"2881",2881,"Cluster_5882","Porites_evermani_scaffold_193:341838-342838",160,-21.21,2,17,489,510,15,"80.00%","86.67%","Peve_00012624",NA,NA,NA,NA,NA,NA,NA,NA
"2882",2882,"Cluster_5882","Porites_evermani_scaffold_2004:10273-11273",159,-22.68,2,18,470,493,18,"77.78%","88.89%","Peve_00013611",0.404861693118346,0.734639328760491,0.985780696469479,NA,NA,NA,NA,NA
"2883",2883,"Cluster_5882","Porites_evermani_scaffold_2020:26463-27463",158,-25.87,2,21,695,719,22,"63.64%","86.36%","Peve_00013782",NA,NA,NA,NA,NA,NA,NA,NA
"2884",2884,"Cluster_5882","Porites_evermani_scaffold_2020:26607-27463",158,-25.87,2,21,551,575,22,"63.64%","86.36%","Peve_00013789",NA,NA,NA,NA,NA,NA,NA,NA
"2885",2885,"Cluster_5882","Porites_evermani_scaffold_202:214071-215071",167,-23.87,2,20,420,441,18,"77.78%","83.33%","Peve_00013772",NA,NA,NA,NA,NA,NA,NA,NA
"2886",2886,"Cluster_5882","Porites_evermani_scaffold_203:58149-59149",160,-24.13,2,19,101,121,17,"70.59%","94.12%","Peve_00013860",-0.692781830516684,0.512769774778855,0.978262075707395,NA,NA,NA,NA,NA
"2887",2887,"Cluster_5882","Porites_evermani_scaffold_2039:52844-53844",160,-20.28,2,21,40,59,19,"78.95%","84.21%","Peve_00013937",-0.27814091057559,0.820563558554478,0.995934364227446,"O88488","Phosphatidylinositol phosphatase PTPRQ (EC 3.1.3.-) (Protein-tyrosine phosphatase receptor-type expressed by glomerular mesangial cells protein 1) (rPTP-GMC1) (Receptor-type tyrosine-protein phosphatase Q) (PTP-RQ) (R-PTP-Q) (EC 3.1.3.48)","Rattus norvegicus (Rat)","detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; inner ear morphogenesis [GO:0042472]; neuromuscular process controlling balance [GO:0050885]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; regulation of fat cell differentiation [GO:0045598]; vestibular receptor cell morphogenesis [GO:0060116]","GO:0002244; GO:0004725; GO:0005886; GO:0032421; GO:0042472; GO:0043235; GO:0045598; GO:0050885; GO:0050910; GO:0060116; GO:1990264"
"2888",2888,"Cluster_5882","Porites_evermani_scaffold_2056:80731-81731",152,-20.64,2,19,654,674,17,"64.71%","88.24%","Peve_00014114",NA,NA,NA,NA,NA,NA,NA,NA
"2889",2889,"Cluster_5882","Porites_evermani_scaffold_2056:80731-81731",152,-20.75,2,19,906,926,17,"64.71%","88.24%","Peve_00014114",NA,NA,NA,NA,NA,NA,NA,NA
"2890",2890,"Cluster_5882","Porites_evermani_scaffold_2058:3465-4465",150,-20.27,2,21,929,953,22,"68.18%","72.73%","Peve_00014121",0.970922741092274,0.153896891887811,0.978262075707395,"E7F7V7","Galanin receptor 2b","Danio rerio (Zebrafish) (Brachydanio rerio)","adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; neuropeptide signaling pathway [GO:0007218]","GO:0004966; GO:0005886; GO:0007188; GO:0007218; GO:0008528"
"2891",2891,"Cluster_5882","Porites_evermani_scaffold_2081:39412-40412",167,-21.86,2,21,186,209,21,"71.43%","85.71%","Peve_00014363",0.970922741092274,0.153896891887811,0.978262075707395,NA,NA,NA,NA,NA
"2892",2892,"Cluster_5882","Porites_evermani_scaffold_2084:13753-14753",174,-26.59,2,19,235,256,17,"82.35%","94.12%","Peve_00014378",0.595297237660631,0.594068617791287,0.978262075707395,"B8VIW9","Fibronectin type III domain-containing protein (Neuroglian-like protein)","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0016020"
"2893",2893,"Cluster_5882","Porites_evermani_scaffold_209:111529-112529",152,-22.97,2,21,487,508,19,"63.16%","73.68%","Peve_00014447",NA,NA,NA,NA,NA,NA,NA,NA
"2894",2894,"Cluster_5882","Porites_evermani_scaffold_2100:1015-2015",153,-20.48,2,19,636,658,18,"72.22%","77.78%","Peve_00014611",0.970922741092274,0.153896891887811,0.978262075707395,"D3YXG0","Hemicentin-1 (Fibulin-6) (FIBL-6)","Mus musculus (Mouse)","actin filament reorganization [GO:0090527]; basement membrane organization [GO:0071711]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]","GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0051301; GO:0062023; GO:0071711; GO:0090527"
"2895",2895,"Cluster_5882","Porites_evermani_scaffold_214:345249-346249",166,-21.1,2,21,760,780,19,"73.68%","89.47%","Peve_00014981",0.933595937174111,0.233305777966395,0.978262075707395,"P97402","N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase (N-acetylglucosaminyltransferase) (EC 2.4.1.150) (I-branching enzyme) (IGNT) (Large I antigen-forming beta-1,6-N-acetylglucosaminyltransferase)","Mus musculus (Mouse)","maintenance of lens transparency [GO:0036438]; negative regulation of cell-substrate adhesion [GO:0010812]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of protein kinase B signaling [GO:0051897]; post-transcriptional regulation of gene expression [GO:0010608]; protein glycosylation [GO:0006486]; transforming growth factor beta receptor signaling pathway [GO:0007179]","GO:0000139; GO:0005794; GO:0006486; GO:0007179; GO:0008109; GO:0008284; GO:0008375; GO:0010608; GO:0010718; GO:0010812; GO:0030335; GO:0034116; GO:0036438; GO:0051897; GO:0070374"
"2896",2896,"Cluster_5882","Porites_evermani_scaffold_222:260328-261132",149,-20.53,2,19,583,606,19,"68.42%","73.68%","Peve_00015767",-0.272625875259522,0.824215759314995,0.995934364227446,"Q6XPS3","Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase TPTE2 (EC 3.1.3.67) (Lipid phosphatase TPIP) (TPTE and PTEN homologous inositol lipid phosphatase)","Homo sapiens (Human)","cell motility [GO:0048870]; dephosphorylation [GO:0016311]; negative regulation of cell population proliferation [GO:0008285]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]; regulation of protein kinase B signaling [GO:0051896]","GO:0000139; GO:0004725; GO:0005634; GO:0005737; GO:0005789; GO:0005829; GO:0005886; GO:0006470; GO:0006661; GO:0008285; GO:0014065; GO:0016311; GO:0016314; GO:0042995; GO:0046856; GO:0048870; GO:0051800; GO:0051896"
"2897",2897,"Cluster_5882","Porites_evermani_scaffold_222:260328-261132",149,-20.53,2,19,583,606,19,"68.42%","73.68%","Peve_00015768",NA,NA,NA,NA,NA,NA,NA,NA
"2898",2898,"Cluster_5882","Porites_evermani_scaffold_224:174645-175645",175,-24.96,2,20,831,852,18,"77.78%","94.44%","Peve_00015952",0.970922741092274,0.153896891887811,0.978262075707395,NA,NA,NA,NA,NA
"2899",2899,"Cluster_5882","Porites_evermani_scaffold_227:81051-82051",161,-21.02,2,21,971,990,19,"73.68%","84.21%","Peve_00016212",-0.961471080693544,0.177293534550042,0.978262075707395,NA,NA,NA,NA,NA
"2900",2900,"Cluster_5882","Porites_evermani_scaffold_228:134937-135937",161,-24.37,2,20,144,168,21,"71.43%","85.71%","Peve_00016299",-0.181204357345606,0.884000910336952,0.999448381576871,"Q5R7B8","Kelch-like protein 20","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","Golgi to endosome transport [GO:0006895]; negative regulation of apoptotic process [GO:0043066]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K33-linked ubiquitination [GO:1990390]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]","GO:0003779; GO:0004842; GO:0005737; GO:0005802; GO:0005829; GO:0006895; GO:0015031; GO:0016567; GO:0016605; GO:0019964; GO:0030424; GO:0030425; GO:0031463; GO:0043066; GO:0043161; GO:0048471; GO:1990390"
"2901",2901,"Cluster_5882","Porites_evermani_scaffold_232:100587-101587",169,-25.23,2,20,967,987,18,"83.33%","88.89%","Peve_00016729",0.177135409274064,0.886633891670088,0.999448381576871,NA,NA,NA,NA,NA
"2902",2902,"Cluster_5882","Porites_evermani_scaffold_232:101196-101587",169,-25.23,2,20,358,378,18,"83.33%","88.89%","Peve_00016728",-0.237516159406828,0.847333463180817,0.995934364227446,NA,NA,NA,NA,NA
"2903",2903,"Cluster_5882","Porites_evermani_scaffold_241:148307-149307",162,-25.04,2,21,421,446,23,"69.57%","82.61%","Peve_00017594",NA,NA,NA,NA,NA,NA,NA,NA
"2904",2904,"Cluster_5882","Porites_evermani_scaffold_241:148486-149486",162,-25.04,2,21,242,267,23,"69.57%","82.61%","Peve_00017595",-0.370769880489276,0.758187715134991,0.988219883885475,"Q8NCH0","Carbohydrate sulfotransferase 14 (EC 2.8.2.35) (Dermatan 4-sulfotransferase 1) (D4ST-1) (hD4ST1)","Homo sapiens (Human)","carbohydrate biosynthetic process [GO:0016051]; dermatan sulfate biosynthetic process [GO:0030208]; dermatan sulfate proteoglycan metabolic process [GO:0050655]","GO:0000139; GO:0001537; GO:0008146; GO:0016020; GO:0016051; GO:0030208; GO:0042301; GO:0050655; GO:0070062"
"2905",2905,"Cluster_5882","Porites_evermani_scaffold_2472:22895-23085",165,-20.08,2,19,46,68,18,"83.33%","83.33%","Peve_00018117",-0.369384922353985,0.759136790459336,0.988219883885475,"D3ZVM4","E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71)","Rattus norvegicus (Rat)","3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to organic substance [GO:0071310]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA metabolic process [GO:0010586]; miRNA processing [GO:0035196]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of translation [GO:0017148]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; post-transcriptional regulation of gene expression [GO:0010608]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of miRNA-mediated gene silencing [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of protein metabolic process [GO:0051246]; stem cell proliferation [GO:0072089]","GO:0000082; GO:0000209; GO:0000932; GO:0001843; GO:0004842; GO:0008270; GO:0008543; GO:0010586; GO:0010608; GO:0016567; GO:0017148; GO:0021915; GO:0030371; GO:0035196; GO:0035198; GO:0035278; GO:0043161; GO:0051246; GO:0051865; GO:0060964; GO:0061158; GO:0061630; GO:0071310; GO:0072089; GO:2000177; GO:2000637"
"2906",2906,"Cluster_5882","Porites_evermani_scaffold_2490:6772-7772",164,-22.16,2,18,948,970,17,"82.35%","88.24%","Peve_00018294",-0.27814091057559,0.820563558554478,0.995934364227446,"Q7RTR2","NLR family CARD domain-containing protein 3 (CARD15-like protein) (Caterpiller protein 16.2) (CLR16.2) (NACHT, LRR and CARD domains-containing protein 3) (Nucleotide-binding oligomerization domain protein 3)","Homo sapiens (Human)","I-kappaB kinase/NF-kappaB signaling [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of tumor necrosis factor production [GO:0032720]; T cell activation [GO:0042110]","GO:0005524; GO:0005737; GO:0005829; GO:0007249; GO:0014067; GO:0032088; GO:0032687; GO:0032688; GO:0032715; GO:0032720; GO:0034451; GO:0035556; GO:0036312; GO:0042110; GO:0043124; GO:0043231; GO:0045824; GO:0048147; GO:0048471; GO:0050680; GO:0050728; GO:1900016; GO:1900226; GO:1901223"
"2907",2907,"Cluster_5882","Porites_evermani_scaffold_249:268447-269447",160,-22.06,2,21,418,437,19,"73.68%","89.47%","Peve_00018258",NA,NA,NA,NA,NA,NA,NA,NA
"2908",2908,"Cluster_5882","Porites_evermani_scaffold_253:253951-254951",159,-22.17,2,21,89,111,20,"65.00%","85.00%","Peve_00018701",-0.9744747389849,0.144147913457722,0.978262075707395,NA,NA,NA,NA,NA
"2909",2909,"Cluster_5882","Porites_evermani_scaffold_2576:7898-8898",153,-20.7,2,20,60,80,18,"66.67%","83.33%","Peve_00019035",0.37246670947834,0.757024152177399,0.988219883885475,NA,NA,NA,NA,NA
"2910",2910,"Cluster_5882","Porites_evermani_scaffold_258:58959-59959",178,-20.52,2,19,815,836,17,"88.24%","94.12%","Peve_00019070",NA,NA,NA,"Q93Z30",NA,NA,NA,NA
"2911",2911,"Cluster_5882","Porites_evermani_scaffold_2624:31271-31828",156,-21.4,2,18,199,221,17,"76.47%","82.35%","Peve_00019461",NA,NA,NA,NA,NA,NA,NA,NA
"2912",2912,"Cluster_5882","Porites_evermani_scaffold_2624:31271-31828",156,-21.4,2,18,199,221,17,"76.47%","82.35%","Peve_00019463",NA,NA,NA,NA,NA,NA,NA,NA
"2913",2913,"Cluster_5882","Porites_evermani_scaffold_271:260959-261959",160,-21.98,2,19,32,57,21,"76.19%","80.95%","Peve_00020191",-0.381386461959776,0.75089344695472,0.988219883885475,NA,NA,NA,NA,NA
"2914",2914,"Cluster_5882","Porites_evermani_scaffold_2812:1111-2111",154,-23.49,2,21,626,650,22,"63.64%","81.82%","Peve_00021007",0.970922741092274,0.153896891887811,0.978262075707395,NA,NA,NA,NA,NA
"2915",2915,"Cluster_5882","Porites_evermani_scaffold_2818:45760-46760",152,-20.19,2,18,963,986,18,"72.22%","77.78%","Peve_00021044",0.522357720752299,0.650105155162201,0.978262075707395,NA,NA,NA,NA,NA
"2916",2916,"Cluster_5882","Porites_evermani_scaffold_2857:45677-46677",154,-23.49,2,21,541,565,22,"63.64%","81.82%","Peve_00021325",0.970922741092274,0.153896891887811,0.978262075707395,NA,NA,NA,NA,NA
"2917",2917,"Cluster_5882","Porites_evermani_scaffold_2877:18086-19086",159,-22.34,2,21,230,253,21,"71.43%","76.19%","Peve_00021488",0.0558724565509883,0.964411956973385,0.999448381576871,"Q8NBX0","Saccharopine dehydrogenase-like oxidoreductase (EC 1.-.-.-)","Homo sapiens (Human)","glycolipid biosynthetic process [GO:0009247]","GO:0005576; GO:0005634; GO:0005739; GO:0005811; GO:0009247; GO:0016020; GO:0016491; GO:0030496; GO:0031093"
"2918",2918,"Cluster_5882","Porites_evermani_scaffold_2891:7045-8045",151,-21.28,2,12,151,172,10,"90.00%","100.00%","Peve_00021602",NA,NA,NA,NA,NA,NA,NA,NA
"2919",2919,"Cluster_5882","Porites_evermani_scaffold_2961:0-765",165,-23.62,2,19,505,527,18,"83.33%","83.33%","Peve_00022137",0.970345369234399,0.155424865834392,0.978262075707395,"Q8IVG5","Sterile alpha motif domain-containing protein 9-like (SAM domain-containing protein 9-like)","Homo sapiens (Human)","","GO:0005737; GO:0005739; GO:0005769"
"2920",2920,"Cluster_5882","Porites_evermani_scaffold_297:89284-90284",170,-22.99,2,21,752,772,19,"73.68%","94.74%","Peve_00022187",-0.197115460622449,0.873685227962632,0.997476741937264,NA,NA,NA,NA,NA
"2921",2921,"Cluster_5882","Porites_evermani_scaffold_3018:13217-14217",165,-20.87,2,21,743,764,20,"80.00%","85.00%","Peve_00022752",-0.27814091057559,0.820563558554478,0.995934364227446,NA,NA,NA,NA,NA
"2922",2922,"Cluster_5882","Porites_evermani_scaffold_3055:42705-43705",155,-21.71,2,21,819,842,21,"61.90%","80.95%","Peve_00023014",-0.27814091057559,0.820563558554478,0.995934364227446,NA,NA,NA,NA,NA
"2923",2923,"Cluster_5882","Porites_evermani_scaffold_306:226830-227327",160,-20.1,2,21,63,81,19,"73.68%","84.21%","Peve_00023065",NA,NA,NA,NA,NA,NA,NA,NA
"2924",2924,"Cluster_5882","Porites_evermani_scaffold_3129:28725-29725",167,-20.52,2,20,720,740,18,"77.78%","88.89%","Peve_00023577",NA,NA,NA,NA,NA,NA,NA,NA
"2925",2925,"Cluster_5882","Porites_evermani_scaffold_3129:28725-29725",174,-20.32,2,21,642,662,19,"84.21%","89.47%","Peve_00023577",NA,NA,NA,NA,NA,NA,NA,NA
"2926",2926,"Cluster_5882","Porites_evermani_scaffold_313:121663-122663",178,-23.96,2,21,840,860,19,"89.47%","89.47%","Peve_00023588",-0.695555407230605,0.510316749723204,0.978262075707395,"P50453","Serpin B9 (Cytoplasmic antiproteinase 3) (CAP-3) (CAP3) (Peptidase inhibitor 9) (PI-9)","Homo sapiens (Human)","cellular response to estrogen stimulus [GO:0071391]; immune response [GO:0006955]; mast cell mediated immunity [GO:0002448]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endopeptidase activity [GO:0010951]; protection from natural killer cell mediated cytotoxicity [GO:0042270]","GO:0002020; GO:0002448; GO:0004867; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006955; GO:0010951; GO:0016020; GO:0042270; GO:0043027; GO:0043066; GO:0062023; GO:0070062; GO:0071391"
"2927",2927,"Cluster_5882","Porites_evermani_scaffold_3266:2675-3675",159,-21.63,2,21,570,593,21,"71.43%","76.19%","Peve_00024411",-0.476915524200603,0.683509521587819,0.978262075707395,NA,NA,NA,NA,NA
"2928",2928,"Cluster_5882","Porites_evermani_scaffold_3322:9696-10696",175,-23.14,2,21,430,453,21,"76.19%","90.48%","Peve_00024794",-0.638999486157626,0.558697176691756,0.978262075707395,NA,NA,NA,NA,NA
"2929",2929,"Cluster_5882","Porites_evermani_scaffold_3355:14703-15703",158,-20.56,2,21,793,813,19,"73.68%","78.95%","Peve_00025013",-0.144087962560808,0.907950347833332,0.999448381576871,"Q9P2K3","REST corepressor 3","Homo sapiens (Human)","histone deacetylation [GO:0016575]; negative regulation of DNA-templated transcription [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000118; GO:0003714; GO:0005654; GO:0005667; GO:0005829; GO:0006357; GO:0016575; GO:0045892"
"2930",2930,"Cluster_5882","Porites_evermani_scaffold_3415:36125-36348",160,-24.38,2,18,173,196,18,"72.22%","88.89%","Peve_00025389",-0.896895194130327,0.291634347270537,0.978262075707395,NA,NA,NA,NA,NA
"2931",2931,"Cluster_5882","Porites_evermani_scaffold_3464:144-1144",155,-22.16,2,21,835,857,20,"65.00%","80.00%","Peve_00025700",-0.223950101806319,0.856209465979491,0.995934364227446,"P95896","Amidase (EC 3.5.1.4)","Saccharolobus solfataricus (strain ATCC 35092 / DSM 1617 / JCM 11322 / P2) (Sulfolobus solfataricus)","","GO:0004040; GO:0043864"
"2932",2932,"Cluster_5882","Porites_evermani_scaffold_350:83989-84989",171,-22.5,2,21,605,627,20,"75.00%","90.00%","Peve_00025967",0.235933419103788,0.848370544303256,0.995934364227446,"Q9H0J9","Protein mono-ADP-ribosyltransferase PARP12 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 12) (ARTD12) (Poly [ADP-ribose] polymerase 12) (PARP-12) (Zinc finger CCCH domain-containing protein 1)","Homo sapiens (Human)","protein auto-ADP-ribosylation [GO:0070213]","GO:0003723; GO:0003950; GO:0005634; GO:0016779; GO:0046872; GO:0070213; GO:0140803; GO:1990404"
"2933",2933,"Cluster_5882","Porites_evermani_scaffold_352:178628-179628",156,-20.82,2,13,630,651,11,"90.91%","100.00%","Peve_00026079",NA,NA,NA,NA,NA,NA,NA,NA
"2934",2934,"Cluster_5882","Porites_evermani_scaffold_35:94007-95007",169,-20.68,2,19,197,220,19,"78.95%","89.47%","Peve_00025950",0.567701426057836,0.615665619559046,0.978262075707395,NA,NA,NA,NA,NA
"2935",2935,"Cluster_5882","Porites_evermani_scaffold_36:178101-179101",166,-24.94,2,21,625,645,19,"73.68%","89.47%","Peve_00026545",-0.671319398272677,0.531455795107495,0.978262075707395,"P51690","Arylsulfatase L (EC 3.1.6.1) (Arylsulfatase E) (ASE)","Homo sapiens (Human)","skeletal system development [GO:0001501]","GO:0001501; GO:0004065; GO:0005788; GO:0005794; GO:0005795; GO:0046872; GO:0070062"
"2936",2936,"Cluster_5882","Porites_evermani_scaffold_365:255268-256268",164,-25.25,2,19,963,983,17,"76.47%","94.12%","Peve_00026834",NA,NA,NA,NA,NA,NA,NA,NA
"2937",2937,"Cluster_5882","Porites_evermani_scaffold_367:193138-194138",155,-20.51,2,17,670,692,16,"81.25%","81.25%","Peve_00026922",NA,NA,NA,NA,NA,NA,NA,NA
"2938",2938,"Cluster_5882","Porites_evermani_scaffold_3672:36543-37543",153,-21.31,2,21,835,859,22,"68.18%","81.82%","Peve_00026934",-0.856454371056703,0.345324658319907,0.978262075707395,"P61589","Transforming protein RhoA (EC 3.6.5.2)","Rattus norvegicus (Rat)","actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; actin filament organization [GO:0007015]; alpha-beta T cell lineage commitment [GO:0002363]; androgen receptor signaling pathway [GO:0030521]; angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001998]; aortic valve formation [GO:0003189]; apical junction assembly [GO:0043297]; apolipoprotein A-I-mediated signaling pathway [GO:0038027]; beta selection [GO:0043366]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell junction assembly [GO:0034329]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell-matrix adhesion [GO:0007160]; cellular response to chemokine [GO:1990869]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to progesterone stimulus [GO:0071393]; cerebral cortex cell migration [GO:0021795]; cleavage furrow formation [GO:0036089]; cortical cytoskeleton organization [GO:0030865]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton organization [GO:0007010]; endothelial cell migration [GO:0043542]; endothelial tube lumen extension [GO:0097498]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment or maintenance of cell polarity [GO:0007163]; forebrain radial glial cell differentiation [GO:0021861]; GTP metabolic process [GO:0046039]; kidney development [GO:0001822]; mitotic cleavage furrow formation [GO:1903673]; mitotic spindle assembly [GO:0090307]; motor neuron apoptotic process [GO:0097049]; negative chemotaxis [GO:0050919]; negative regulation of cell death [GO:0060548]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell size [GO:0045792]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of intracellular steroid hormone receptor signaling pathway [GO:0033144]; negative regulation of motor neuron apoptotic process [GO:2000672]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of neuron projection development [GO:0010977]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; neuron migration [GO:0001764]; neuron projection morphogenesis [GO:0048812]; odontogenesis [GO:0042476]; ossification involved in bone maturation [GO:0043931]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cytokinesis [GO:0032467]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of lipase activity [GO:0060193]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of T cell migration [GO:2000406]; positive regulation of translation [GO:0045727]; positive regulation of vascular associated smooth muscle contraction [GO:1904695]; positive regulation of vasoconstriction [GO:0045907]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of calcium ion transport [GO:0051924]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of dendrite development [GO:0050773]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of modification of synaptic structure [GO:1905244]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of neuron projection development [GO:0010975]; regulation of osteoblast proliferation [GO:0033688]; regulation of systemic arterial blood pressure by endothelin [GO:0003100]; regulation of transcription by RNA polymerase II [GO:0006357]; response to amino acid [GO:0043200]; response to ethanol [GO:0045471]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to xenobiotic stimulus [GO:0009410]; Rho protein signal transduction [GO:0007266]; Roundabout signaling pathway [GO:0035385]; skeletal muscle satellite cell migration [GO:1902766]; skeletal muscle tissue development [GO:0007519]; stress fiber assembly [GO:0043149]; stress-activated protein kinase signaling cascade [GO:0031098]; substrate adhesion-dependent cell spreading [GO:0034446]; trabecula morphogenesis [GO:0061383]; wound healing, spreading of cells [GO:0044319]","GO:0000902; GO:0001666; GO:0001764; GO:0001822; GO:0001998; GO:0002363; GO:0003100; GO:0003189; GO:0003924; GO:0003925; GO:0005525; GO:0005634; GO:0005737; GO:0005768; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0006357; GO:0007010; GO:0007015; GO:0007155; GO:0007160; GO:0007163; GO:0007266; GO:0007519; GO:0008064; GO:0008360; GO:0009410; GO:0009612; GO:0009749; GO:0010812; GO:0010975; GO:0010977; GO:0016020; GO:0016477; GO:0017022; GO:0019003; GO:0019901; GO:0019904; GO:0021795; GO:0021861; GO:0030027; GO:0030036; GO:0030154; GO:0030307; GO:0030334; GO:0030335; GO:0030424; GO:0030496; GO:0030521; GO:0030838; GO:0030865; GO:0031098; GO:0031122; GO:0031234; GO:0031410; GO:0031532; GO:0031982; GO:0032154; GO:0032467; GO:0032587; GO:0032956; GO:0033144; GO:0033688; GO:0034329; GO:0034446; GO:0035385; GO:0036089; GO:0038027; GO:0042476; GO:0042995; GO:0043123; GO:0043124; GO:0043149; GO:0043197; GO:0043200; GO:0043280; GO:0043296; GO:0043297; GO:0043366; GO:0043524; GO:0043525; GO:0043542; GO:0043931; GO:0044319; GO:0045198; GO:0045471; GO:0045665; GO:0045666; GO:0045727; GO:0045785; GO:0045792; GO:0045907; GO:0045987; GO:0046039; GO:0046638; GO:0048812; GO:0050773; GO:0050919; GO:0051022; GO:0051384; GO:0051496; GO:0051924; GO:0060193; GO:0060548; GO:0061383; GO:0070507; GO:0071222; GO:0071345; GO:0071393; GO:0071803; GO:0071902; GO:0071944; GO:0090051; GO:0090307; GO:0090324; GO:0097049; GO:0097498; GO:0098794; GO:0098978; GO:0099159; GO:1901224; GO:1902766; GO:1903427; GO:1903673; GO:1904695; GO:1904706; GO:1904753; GO:1904996; GO:1905244; GO:1905274; GO:1990869; GO:2000177; GO:2000406; GO:2000672"
"2939",2939,"Cluster_5882","Porites_evermani_scaffold_37:17100-18100",155,-22.61,2,17,748,770,16,"75.00%","87.50%","Peve_00027080",-0.441657860502533,0.708781032387555,0.978335633186359,NA,NA,NA,NA,NA
"2940",2940,"Cluster_5882","Porites_evermani_scaffold_3745:0-579",157,-21.59,2,19,46,70,20,"70.00%","80.00%","Peve_00027310",-0.944387006034381,0.213312743610695,0.978262075707395,NA,NA,NA,NA,NA
"2941",2941,"Cluster_5882","Porites_evermani_scaffold_3815:31314-32314",156,-20.39,2,13,662,683,11,"90.91%","100.00%","Peve_00027714",-0.0981672483680115,0.937403975158673,0.999448381576871,NA,NA,NA,NA,NA
"2942",2942,"Cluster_5882","Porites_evermani_scaffold_382:276890-277890",172,-23.18,2,21,333,354,19,"78.95%","84.21%","Peve_00027756",-0.814535230283822,0.393984084388826,0.978262075707395,NA,NA,NA,NA,NA
"2943",2943,"Cluster_5882","Porites_evermani_scaffold_3936:5550-6550",158,-25.87,2,21,63,87,22,"63.64%","86.36%","Peve_00028385",-0.692781830516684,0.512769774778855,0.978262075707395,NA,NA,NA,NA,NA
"2944",2944,"Cluster_5882","Porites_evermani_scaffold_3962:4303-5303",156,-20.1,2,13,372,393,11,"90.91%","100.00%","Peve_00028533",-0.261506692488771,0.831561302877319,0.995934364227446,NA,NA,NA,NA,NA
"2945",2945,"Cluster_5882","Porites_evermani_scaffold_408:26422-27422",165,-21.06,2,21,785,808,22,"77.27%","81.82%","Peve_00029263",0.521539202148654,0.650716056927289,0.978262075707395,NA,NA,NA,NA,NA
"2946",2946,"Cluster_5882","Porites_evermani_scaffold_41:122310-123310",163,-21.55,2,21,111,135,22,"68.18%","81.82%","Peve_00029361",-0.747444981351585,0.462560707103084,0.978262075707395,"P56597","Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)","Homo sapiens (Human)","cilium assembly [GO:0060271]; cilium movement [GO:0003341]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]","GO:0003341; GO:0003351; GO:0004550; GO:0005576; GO:0005929; GO:0006165; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0051649; GO:0060271; GO:1902176"
"2947",2947,"Cluster_5882","Porites_evermani_scaffold_4214:13360-14360",165,-20.87,2,18,172,193,16,"81.25%","87.50%","Peve_00029946",NA,NA,NA,NA,NA,NA,NA,NA
"2948",2948,"Cluster_5882","Porites_evermani_scaffold_4223:3781-3975",159,-20.75,2,18,118,138,16,"81.25%","87.50%","Peve_00030011",-0.692781830516684,0.512769774778855,0.978262075707395,"Q6IPU0","Centromere protein P (CENP-P)","Homo sapiens (Human)","CENP-A containing chromatin assembly [GO:0034080]","GO:0000775; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0034080"
"2949",2949,"Cluster_5882","Porites_evermani_scaffold_4223:3781-3975",159,-20.75,2,18,118,138,16,"81.25%","87.50%","Peve_00030012",NA,NA,NA,"Q6PAY8","Hydroxysteroid dehydrogenase-like protein 2 (EC 1.-.-.-)","Xenopus laevis (African clawed frog)","","GO:0005777; GO:0016491"
"2950",2950,"Cluster_5882","Porites_evermani_scaffold_422:84225-85225",170,-21.4,2,21,577,597,19,"78.95%","89.47%","Peve_00029985",NA,NA,NA,NA,NA,NA,NA,NA
"2951",2951,"Cluster_5882","Porites_evermani_scaffold_4405:22616-23616",159,-21.34,2,21,962,984,20,"70.00%","80.00%","Peve_00031001",-0.27814091057559,0.820563558554478,0.995934364227446,"O95847","Mitochondrial uncoupling protein 4 (UCP 4) (Solute carrier family 25 member 27)","Homo sapiens (Human)","response to cold [GO:0009409]","GO:0005739; GO:0005743; GO:0009409; GO:0022857; GO:0031966"
"2952",2952,"Cluster_5882","Porites_evermani_scaffold_4596:22606-23606",178,-21.24,2,19,355,376,17,"88.24%","94.12%","Peve_00031862",-0.626962170044188,0.568596101385479,0.978262075707395,"B0JZG0","Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Sodium-dependent vitamin C transporter 2)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","sodium ion transport [GO:0006814]","GO:0006814; GO:0015229; GO:0015293; GO:0098590"
"2953",2953,"Cluster_5882","Porites_evermani_scaffold_4634:20043-21043",157,-20.09,2,18,589,610,16,"75.00%","81.25%","Peve_00032051",0.334132907670111,0.783113120663872,0.994289271631111,"P78357","Contactin-associated protein 1 (Caspr) (Caspr1) (Neurexin IV) (Neurexin-4) (p190)","Homo sapiens (Human)","axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; central nervous system myelination [GO:0022010]; cytoskeleton organization [GO:0007010]; mitochondrion organization [GO:0007005]; myelination in peripheral nervous system [GO:0022011]; neuromuscular junction development, skeletal muscle fiber [GO:0098529]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; neuron projection morphogenesis [GO:0048812]; neuronal action potential propagation [GO:0019227]; paranodal junction assembly [GO:0030913]; paranodal junction maintenance [GO:1990227]; postsynaptic density organization [GO:0097106]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; regulation of synapse maturation [GO:0090128]; signal transduction [GO:0007165]","GO:0002175; GO:0005886; GO:0007005; GO:0007010; GO:0007155; GO:0007165; GO:0007409; GO:0016020; GO:0017124; GO:0019227; GO:0022010; GO:0022011; GO:0030913; GO:0033010; GO:0033270; GO:0038023; GO:0048786; GO:0048812; GO:0050884; GO:0050885; GO:0071205; GO:0090128; GO:0097106; GO:0098529; GO:0098978; GO:1990227"
"2954",2954,"Cluster_5882","Porites_evermani_scaffold_4839:17855-18855",169,-20.85,2,21,544,565,20,"80.00%","90.00%","Peve_00032897",-0.629639785555241,0.56640498260752,0.978262075707395,NA,NA,NA,NA,NA
"2955",2955,"Cluster_5882","Porites_evermani_scaffold_4878:2290-3290",154,-20.09,2,21,189,213,22,"63.64%","81.82%","Peve_00033029",-0.892433385114507,0.297992935147524,0.978262075707395,"Q6DCV0","WD repeat domain phosphoinositide-interacting protein 4 (WIPI-4) (WD repeat-containing protein 45)","Xenopus laevis (African clawed frog)","autophagosome assembly [GO:0000045]; cellular response to starvation [GO:0009267]; positive regulation of autophagosome assembly [GO:2000786]","GO:0000045; GO:0000407; GO:0009267; GO:0032266; GO:1901981; GO:2000786"
"2956",2956,"Cluster_5882","Porites_evermani_scaffold_498:135236-136236",145,-20.23,2,19,667,690,19,"57.89%","78.95%","Peve_00033439",-0.987849568331708,0.0993417248123896,0.978262075707395,NA,NA,NA,NA,NA
"2957",2957,"Cluster_5882","Porites_evermani_scaffold_5013:17773-18392",166,-24.22,2,20,434,456,19,"73.68%","89.47%","Peve_00033709",-0.10989992286894,0.929893926716165,0.999448381576871,NA,NA,NA,NA,NA
"2958",2958,"Cluster_5882","Porites_evermani_scaffold_507:188220-189220",156,-21.08,2,17,86,107,15,"80.00%","80.00%","Peve_00033913",0.970922741092274,0.153896891887811,0.978262075707395,"Q5ZM55","Protein fem-1 homolog B (FEM1b) (FEM1-beta)","Gallus gallus (Chicken)","apoptotic process [GO:0006915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627]","GO:0005634; GO:0005737; GO:0006915; GO:0016567; GO:0031462; GO:0043161; GO:0140627; GO:1990756; GO:2000001"
"2959",2959,"Cluster_5882","Porites_evermani_scaffold_51:106237-107237",161,-21.42,2,14,258,279,12,"91.67%","100.00%","Peve_00034022",-0.692781830516684,0.512769774778855,0.978262075707395,"Q9QXM0","Monoacylglycerol lipase ABHD2 (EC 3.1.1.23) (2-arachidonoylglycerol hydrolase) (Abhydrolase domain-containing protein 2) (Acetylesterase) (EC 3.1.1.6) (Lung alpha/beta hydrolase 2) (MmLABH2) (Triacylglycerol lipase) (EC 3.1.1.79)","Mus musculus (Mouse)","acrosome reaction [GO:0007340]; acylglycerol catabolic process [GO:0046464]; cellular lipid metabolic process [GO:0044255]; medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty acid catabolic process [GO:0051793]; negative regulation of smooth muscle cell migration [GO:0014912]; response to progesterone [GO:0032570]; response to wounding [GO:0009611]; smooth muscle cell migration [GO:0014909]; sperm capacitation [GO:0048240]; steroid hormone mediated signaling pathway [GO:0043401]","GO:0001669; GO:0002080; GO:0003707; GO:0004806; GO:0007340; GO:0008126; GO:0009611; GO:0014909; GO:0014912; GO:0032570; GO:0033878; GO:0034338; GO:0036126; GO:0042562; GO:0043401; GO:0044255; GO:0046464; GO:0047372; GO:0048240; GO:0051792; GO:0051793; GO:0097524"
"2960",2960,"Cluster_5882","Porites_evermani_scaffold_5140:10024-11024",156,-20.82,2,21,802,824,21,"76.19%","80.95%","Peve_00034198",0.520769834096877,0.651289948621566,0.978262075707395,NA,NA,NA,NA,NA
"2961",2961,"Cluster_5882","Porites_evermani_scaffold_517:119366-120000",156,-22.71,2,21,240,259,19,"78.95%","78.95%","Peve_00034270",0.205096715810079,0.868498213807969,0.997179203169283,NA,NA,NA,NA,NA
"2962",2962,"Cluster_5882","Porites_evermani_scaffold_517:119366-120000",156,-22.71,2,21,240,259,19,"78.95%","78.95%","Peve_00034271",-0.123222753488054,0.92135407112986,0.999448381576871,"Q8CFK2","Transcription factor IIIB 90 kDa subunit (TFIIIB90) (mTFIIIB90) (B-related factor 1) (BRF-1)","Mus musculus (Mouse)","DNA-templated transcription initiation [GO:0006352]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of mRNA stability [GO:0043488]; transcription by RNA polymerase III [GO:0006383]; transcription preinitiation complex assembly [GO:0070897]","GO:0000126; GO:0000995; GO:0001006; GO:0005634; GO:0006352; GO:0006383; GO:0017025; GO:0043488; GO:0045945; GO:0046872; GO:0070897; GO:0097550"
"2963",2963,"Cluster_5882","Porites_evermani_scaffold_518:171978-172978",167,-20.67,2,21,448,471,21,"71.43%","85.71%","Peve_00034310",-0.692781830516684,0.512769774778855,0.978262075707395,"P29122","Proprotein convertase subtilisin/kexin type 6 (EC 3.4.21.-) (Paired basic amino acid cleaving enzyme 4) (Subtilisin-like proprotein convertase 4) (SPC4) (Subtilisin/kexin-like protease PACE4)","Homo sapiens (Human)","determination of left/right symmetry [GO:0007368]; glycoprotein metabolic process [GO:0009100]; nerve growth factor production [GO:0032902]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485]; regulation of BMP signaling pathway [GO:0030510]; regulation of lipoprotein lipase activity [GO:0051004]; secretion by cell [GO:0032940]; zygotic determination of anterior/posterior axis, embryo [GO:0007354]","GO:0004175; GO:0004252; GO:0005576; GO:0005615; GO:0005783; GO:0005796; GO:0005886; GO:0007354; GO:0007368; GO:0008201; GO:0009100; GO:0009986; GO:0016020; GO:0016485; GO:0016486; GO:0030510; GO:0032902; GO:0032940; GO:0048406; GO:0051004; GO:0062023"
"2964",2964,"Cluster_5882","Porites_evermani_scaffold_519:57198-58198",159,-21.15,2,18,927,947,16,"81.25%","87.50%","Peve_00034341",-0.505622514805958,0.662525722161762,0.978262075707395,"P83852","Carboxypeptidase D (EC 3.4.17.22) (CPD-2) (Metallocarboxypeptidase D)","Lophonetta specularioides (Crested duck) (Anas specularioides)","proteolysis [GO:0006508]","GO:0004181; GO:0006508; GO:0008270; GO:0016020"
"2965",2965,"Cluster_5882","Porites_evermani_scaffold_519:57199-58199",159,-21.15,2,18,926,946,16,"81.25%","87.50%","Peve_00034328",0.0317604546298433,0.979777265763137,0.999448381576871,"P83852","Carboxypeptidase D (EC 3.4.17.22) (CPD-2) (Metallocarboxypeptidase D)","Lophonetta specularioides (Crested duck) (Anas specularioides)","proteolysis [GO:0006508]","GO:0004181; GO:0006508; GO:0008270; GO:0016020"
"2966",2966,"Cluster_5882","Porites_evermani_scaffold_5196:14310-15310",159,-22.43,2,20,477,496,18,"77.78%","88.89%","Peve_00034353",NA,NA,NA,"A6QLU6","Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133)","Bos taurus (Bovine)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]","GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189"
"2967",2967,"Cluster_5882","Porites_evermani_scaffold_532:59159-60159",182,-32.35,2,19,527,548,17,"88.24%","100.00%","Peve_00034834",0.446281750864674,0.705495844266941,0.978262075707395,"P17244","Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (EC 1.2.1.12) (Peptidyl-cysteine S-nitrosylase GAPDH) (EC 2.6.99.-)","Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)","glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; innate immune response [GO:0045087]; microtubule cytoskeleton organization [GO:0000226]; neuron apoptotic process [GO:0051402]; peptidyl-cysteine S-trans-nitrosylation [GO:0035606]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of type I interferon production [GO:0032481]; protein stabilization [GO:0050821]; regulation of translation [GO:0006417]","GO:0000226; GO:0004365; GO:0005634; GO:0005737; GO:0005829; GO:0006006; GO:0006096; GO:0006417; GO:0008017; GO:0015630; GO:0032481; GO:0035605; GO:0035606; GO:0043123; GO:0045087; GO:0050661; GO:0050821; GO:0051287; GO:0051402; GO:0097452"
"2968",2968,"Cluster_5882","Porites_evermani_scaffold_559:88900-89900",162,-25.69,2,21,347,367,19,"68.42%","89.47%","Peve_00035767",NA,NA,NA,NA,NA,NA,NA,NA
"2969",2969,"Cluster_5882","Porites_evermani_scaffold_5670:3878-4878",164,-24.94,2,21,346,365,19,"84.21%","84.21%","Peve_00036007",-0.952592774101917,0.196810482789926,0.978262075707395,NA,NA,NA,NA,NA
"2970",2970,"Cluster_5882","Porites_evermani_scaffold_569:144424-145424",149,-20.07,2,16,572,595,16,"75.00%","87.50%","Peve_00036051",0.729898325660517,0.479134766517142,0.978262075707395,"Q6GMK0","Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B (EC 2.4.1.145) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase IVb) (GlcNAc-T IVb) (GnT-IVb) (N-acetylglucosaminyltransferase IVb) (UDP-N-acetylglucosamine: alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IVb)","Danio rerio (Zebrafish) (Brachydanio rerio)","protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]","GO:0000139; GO:0005783; GO:0005793; GO:0005795; GO:0006486; GO:0006487; GO:0008375; GO:0008454; GO:0046872"
"2971",2971,"Cluster_5882","Porites_evermani_scaffold_570:154104-155104",157,-21.28,2,20,785,808,20,"75.00%","80.00%","Peve_00036141",NA,NA,NA,NA,NA,NA,NA,NA
"2972",2972,"Cluster_5882","Porites_evermani_scaffold_5754:1822-2822",167,-20.17,2,21,518,540,20,"75.00%","85.00%","Peve_00036264",0.997786572068102,0.0423650724088565,0.91271866035762,NA,NA,NA,NA,NA
"2973",2973,"Cluster_5882","Porites_evermani_scaffold_581:221098-222098",161,-21.99,2,21,26,47,20,"75.00%","85.00%","Peve_00036433",NA,NA,NA,"P19540","Coagulation factor IX (EC 3.4.21.22) (Christmas factor) [Cleaved into: Coagulation factor IXa light chain; Coagulation factor IXa heavy chain]","Canis lupus familiaris (Dog) (Canis familiaris)","blood coagulation [GO:0007596]; proteolysis [GO:0006508]; zymogen activation [GO:0031638]","GO:0004175; GO:0004252; GO:0005509; GO:0005615; GO:0006508; GO:0007596; GO:0031638"
"2974",2974,"Cluster_5882","Porites_evermani_scaffold_58:275115-276115",155,-20.39,2,21,737,759,20,"65.00%","80.00%","Peve_00036388",-0.174570758703348,0.888292445642967,0.999448381576871,NA,NA,NA,NA,NA
"2975",2975,"Cluster_5882","Porites_evermani_scaffold_592:93636-94636",166,-22.78,2,21,691,711,19,"78.95%","84.21%","Peve_00036762",-0.297213437197618,0.807885418565211,0.995934364227446,NA,NA,NA,NA,NA
"2976",2976,"Cluster_5882","Porites_evermani_scaffold_593:33649-34649",171,-21.67,2,21,203,226,21,"80.95%","80.95%","Peve_00036787",NA,NA,NA,NA,NA,NA,NA,NA
"2977",2977,"Cluster_5882","Porites_evermani_scaffold_603:75125-76125",155,-21.94,2,18,964,984,16,"75.00%","87.50%","Peve_00037158",-0.692781830516684,0.512769774778855,0.978262075707395,"P15043","ATP-dependent DNA helicase RecQ (EC 3.6.4.12)","Escherichia coli (strain K12)","cellular response to DNA damage stimulus [GO:0006974]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; SOS response [GO:0009432]","GO:0003677; GO:0003678; GO:0005524; GO:0005694; GO:0005737; GO:0006260; GO:0006281; GO:0006310; GO:0006974; GO:0008094; GO:0008270; GO:0009378; GO:0009432; GO:0016887; GO:0017116; GO:0017117; GO:0030894; GO:0032508; GO:0043138; GO:0043590; GO:0046914"
"2978",2978,"Cluster_5882","Porites_evermani_scaffold_605:161597-162597",154,-20.49,2,21,347,367,19,"68.42%","78.95%","Peve_00037205",-0.692781830516684,0.512769774778856,0.978262075707395,NA,NA,NA,NA,NA
"2979",2979,"Cluster_5882","Porites_evermani_scaffold_618:7168-8168",153,-20.02,2,21,157,176,19,"68.42%","78.95%","Peve_00037531",NA,NA,NA,NA,NA,NA,NA,NA
"2980",2980,"Cluster_5882","Porites_evermani_scaffold_660:209909-210909",152,-20.61,2,19,837,857,17,"64.71%","88.24%","Peve_00038635",NA,NA,NA,NA,NA,NA,NA,NA
"2981",2981,"Cluster_5882","Porites_evermani_scaffold_695:83313-84313",167,-20.17,2,21,722,744,20,"75.00%","85.00%","Peve_00039412",0.96798479307876,0.161524649653704,0.978262075707395,NA,NA,NA,NA,NA
"2982",2982,"Cluster_5882","Porites_evermani_scaffold_702:168359-169359",152,-21.54,2,21,702,721,19,"68.42%","84.21%","Peve_00039676",-0.140578779039439,0.910207343668066,0.999448381576871,NA,NA,NA,NA,NA
"2983",2983,"Cluster_5882","Porites_evermani_scaffold_710:163273-164273",166,-20.42,2,19,384,405,17,"76.47%","88.24%","Peve_00039846",-0.495512346897077,0.669960658376196,0.978262075707395,"A2RT91","Ankyrin and armadillo repeat-containing protein","Mus musculus (Mouse)","","GO:0016020"
"2984",2984,"Cluster_5882","Porites_evermani_scaffold_725:118842-119842",163,-21.67,2,21,453,477,22,"72.73%","77.27%","Peve_00040143",-0.27814091057559,0.820563558554478,0.995934364227446,"Q922M5","Cell division cycle-associated 7-like protein (Transcription factor RAM2)","Mus musculus (Mouse)","positive regulation of cell population proliferation [GO:0008284]; regulation of DNA-templated transcription [GO:0006355]","GO:0001650; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006355; GO:0008284"
"2985",2985,"Cluster_5882","Porites_evermani_scaffold_725:183975-184975",152,-20.61,2,19,837,857,17,"64.71%","88.24%","Peve_00040148",NA,NA,NA,NA,NA,NA,NA,NA
"2986",2986,"Cluster_5882","Porites_evermani_scaffold_776:125364-126364",154,-22.35,2,17,493,518,19,"78.95%","78.95%","Peve_00041171",0.963377828477847,0.172823007002885,0.978262075707395,NA,NA,NA,NA,NA
"2987",2987,"Cluster_5882","Porites_evermani_scaffold_792:181807-182807",162,-21.24,2,21,252,276,22,"72.73%","81.82%","Peve_00041539",NA,NA,NA,NA,NA,NA,NA,NA
"2988",2988,"Cluster_5882","Porites_evermani_scaffold_819:70668-71668",163,-21.81,2,21,584,606,20,"75.00%","80.00%","Peve_00042151",0.970922741092274,0.153896891887811,0.978262075707395,NA,NA,NA,NA,NA
"2989",2989,"Cluster_5882","Porites_evermani_scaffold_83:119284-120284",157,-20.38,2,18,19,40,16,"75.00%","81.25%","Peve_00042379",-0.27814091057559,0.820563558554478,0.995934364227446,NA,NA,NA,NA,NA
"2990",2990,"Cluster_5882","Porites_evermani_scaffold_83:373174-374174",159,-25.67,2,18,919,939,16,"75.00%","93.75%","Peve_00042397",NA,NA,NA,NA,NA,NA,NA,NA
"2991",2991,"Cluster_5882","Porites_evermani_scaffold_847:52180-53180",164,-20.15,2,18,635,657,17,"82.35%","88.24%","Peve_00042694",-0.570677482839626,0.613361308730054,0.978262075707395,NA,NA,NA,NA,NA
"2992",2992,"Cluster_5882","Porites_evermani_scaffold_904:21202-22202",156,-20.1,2,13,353,374,11,"90.91%","100.00%","Peve_00043831",0.163616173896025,0.895368281896276,0.999448381576871,NA,NA,NA,NA,NA
"2993",2993,"Cluster_5882","Porites_evermani_scaffold_9:125779-126779",166,-21.48,2,21,237,260,21,"76.19%","85.71%","Peve_00043671",0.382912174543486,0.749842372021715,0.988219883885475,"Q9QUM9","Proteasome subunit alpha type-6 (Macropain iota chain) (Multicatalytic endopeptidase complex iota chain) (Proteasome iota chain)","Mus musculus (Mouse)","positive regulation of NF-kappaB transcription factor activity [GO:0051092]; proteasomal protein catabolic process [GO:0010498]; proteolysis involved in protein catabolic process [GO:0051603]; skeletal muscle tissue development [GO:0007519]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000502; GO:0000932; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0005844; GO:0006511; GO:0007519; GO:0010498; GO:0016363; GO:0019773; GO:0030016; GO:0030017; GO:0051059; GO:0051092; GO:0051603"
"2994",2994,"Cluster_5882","Porites_evermani_scaffold_91:392913-393913",172,-22.13,2,17,883,904,15,"93.33%","93.33%","Peve_00043926",-0.327855989686499,0.787347840570283,0.995210176673595,NA,NA,NA,NA,NA
"2995",2995,"Cluster_5882","Porites_evermani_scaffold_914:147457-148457",170,-21.29,2,21,41,64,21,"80.95%","85.71%","Peve_00043997",0.987705637808612,0.0999295833269188,0.978262075707395,NA,NA,NA,NA,NA
"2996",2996,"Cluster_5882","Porites_evermani_scaffold_94:124784-125784",157,-20.05,2,21,969,988,19,"73.68%","78.95%","Peve_00044402",-0.189622645497109,0.878547077259004,0.998359995424846,"Q66L32","Mitochondrial import inner membrane translocase subunit Tim8 A","Xenopus laevis (African clawed frog)","protein transport [GO:0015031]","GO:0005743; GO:0015031; GO:0046872"
"2997",2997,"Cluster_5882","Porites_evermani_scaffold_95:330535-331535",162,-20.86,2,21,98,118,19,"73.68%","84.21%","Peve_00044564",-0.352598890254464,0.770596027953423,0.991143946224458,"P00973","2'-5'-oligoadenylate synthase 1 ((2-5')oligo(A) synthase 1) (2-5A synthase 1) (EC 2.7.7.84) (E18/E16) (p46/p42 OAS)","Homo sapiens (Human)","antiviral innate immune response [GO:0140374]; cellular response to interferon-alpha [GO:0035457]; cellular response to interferon-beta [GO:0035458]; cellular response to virus [GO:0098586]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; interleukin-27-mediated signaling pathway [GO:0070106]; negative regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000342]; negative regulation of IP-10 production [GO:0071659]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of viral genome replication [GO:0045071]; positive regulation of cellular respiration [GO:1901857]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of tumor necrosis factor production [GO:0032760]; protein complex oligomerization [GO:0051259]; regulation of ribonuclease activity [GO:0060700]; response to virus [GO:0009615]; surfactant homeostasis [GO:0043129]; toll-like receptor 3 signaling pathway [GO:0034138]; toll-like receptor 4 signaling pathway [GO:0034142]; type I interferon-mediated signaling pathway [GO:0060337]","GO:0001730; GO:0003725; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0005840; GO:0006006; GO:0009615; GO:0016020; GO:0032728; GO:0032760; GO:0034138; GO:0034142; GO:0035457; GO:0035458; GO:0042593; GO:0042742; GO:0043129; GO:0045071; GO:0046872; GO:0051259; GO:0051607; GO:0060337; GO:0060339; GO:0060700; GO:0070106; GO:0071639; GO:0071659; GO:0098586; GO:0140374; GO:1901857; GO:2000342"
"2998",2998,"Cluster_589","Porites_evermani_scaffold_101:115490-116490",147,-21.21,2,21,116,138,20,"65.00%","70.00%","Peve_00000381",-0.993052957926222,0.0750839009369241,0.978262075707395,NA,NA,NA,NA,NA
"2999",2999,"Cluster_589","Porites_evermani_scaffold_1014:116612-117612",144,-20.86,2,18,498,521,18,"61.11%","77.78%","Peve_00000460",0.0517098839330999,0.967065777123652,0.999448381576871,"Q21565","Putative ammonium transporter 3","Caenorhabditis elegans","ammonium homeostasis [GO:0097272]; ammonium transmembrane transport [GO:0072488]","GO:0005886; GO:0008519; GO:0072488; GO:0097272"
"3000",3000,"Cluster_589","Porites_evermani_scaffold_1016:80378-81378",158,-20.94,2,20,1,25,21,"71.43%","76.19%","Peve_00000481",-0.482215578551875,0.679664386744685,0.978262075707395,"Q5RA02","Exportin-T (Exportin(tRNA)) (tRNA exportin)","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","intracellular protein transport [GO:0006886]; tRNA re-export from nucleus [GO:0071528]","GO:0000049; GO:0005634; GO:0005737; GO:0006886; GO:0031267; GO:0071528"
"3001",3001,"Cluster_589","Porites_evermani_scaffold_10:207208-208208",155,-24.03,2,17,735,757,16,"75.00%","87.50%","Peve_00000175",-0.996612257170601,0.0524171037591006,0.964671132194833,"A8MY62","Putative beta-lactamase-like 1","Homo sapiens (Human)","",""
"3002",3002,"Cluster_589","Porites_evermani_scaffold_1026:107280-108280",153,-20.6,2,14,498,519,12,"83.33%","91.67%","Peve_00000626",-0.957432734001503,0.186417090630163,0.978262075707395,"Q80UP3","Diacylglycerol kinase zeta (DAG kinase zeta) (EC 2.7.1.107) (Diglyceride kinase zeta) (DGK-zeta)","Mus musculus (Mouse)","diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; maintenance of postsynaptic density structure [GO:0099562]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of T cell receptor signaling pathway [GO:0050860]; phosphatidic acid biosynthetic process [GO:0006654]; positive regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0090216]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; Ras protein signal transduction [GO:0007265]; regulation of synaptic transmission, glutamatergic [GO:0051966]","GO:0001727; GO:0004143; GO:0004857; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0006654; GO:0007205; GO:0007265; GO:0008022; GO:0014069; GO:0016301; GO:0016607; GO:0030027; GO:0031571; GO:0035556; GO:0045930; GO:0046339; GO:0046486; GO:0046580; GO:0046834; GO:0046872; GO:0050860; GO:0051966; GO:0090216; GO:0098685; GO:0098978; GO:0099562"
"3003",3003,"Cluster_589","Porites_evermani_scaffold_1026:107280-108280",153,-20.6,2,14,8,29,12,"83.33%","91.67%","Peve_00000626",-0.957432734001503,0.186417090630163,0.978262075707395,"Q80UP3","Diacylglycerol kinase zeta (DAG kinase zeta) (EC 2.7.1.107) (Diglyceride kinase zeta) (DGK-zeta)","Mus musculus (Mouse)","diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; maintenance of postsynaptic density structure [GO:0099562]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of T cell receptor signaling pathway [GO:0050860]; phosphatidic acid biosynthetic process [GO:0006654]; positive regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0090216]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; Ras protein signal transduction [GO:0007265]; regulation of synaptic transmission, glutamatergic [GO:0051966]","GO:0001727; GO:0004143; GO:0004857; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0006654; GO:0007205; GO:0007265; GO:0008022; GO:0014069; GO:0016301; GO:0016607; GO:0030027; GO:0031571; GO:0035556; GO:0045930; GO:0046339; GO:0046486; GO:0046580; GO:0046834; GO:0046872; GO:0050860; GO:0051966; GO:0090216; GO:0098685; GO:0098978; GO:0099562"
"3004",3004,"Cluster_589","Porites_evermani_scaffold_1036:52953-53953",163,-23.4,2,20,875,896,18,"72.22%","83.33%","Peve_00000754",NA,NA,NA,NA,NA,NA,NA,NA
"3005",3005,"Cluster_589","Porites_evermani_scaffold_1038:90482-91482",147,-27.02,2,21,856,884,26,"61.54%","65.38%","Peve_00000780",-0.875141958759686,0.321535768302677,0.978262075707395,"Q63081","Protein disulfide-isomerase A6 (EC 5.3.4.1) (Calcium-binding protein 1) (CaBP1) (Protein disulfide isomerase P5) (Thioredoxin domain-containing protein 7)","Rattus norvegicus (Rat)","negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]","GO:0003756; GO:0005509; GO:0005615; GO:0005788; GO:0005790; GO:0005793; GO:0005886; GO:0006457; GO:0015035; GO:0030168; GO:0034663; GO:0034976; GO:0042470; GO:0070527; GO:0140721; GO:1903895"
"3006",3006,"Cluster_589","Porites_evermani_scaffold_1083:110244-111244",160,-23.07,2,18,473,495,17,"76.47%","88.24%","Peve_00001499",-0.934753615028442,0.231240264998328,0.978262075707395,NA,NA,NA,NA,NA
"3007",3007,"Cluster_589","Porites_evermani_scaffold_1083:115500-116500",160,-23.07,2,18,511,533,17,"76.47%","88.24%","Peve_00001500",-0.801870730140498,0.407676476779065,0.978262075707395,NA,NA,NA,NA,NA
"3008",3008,"Cluster_589","Porites_evermani_scaffold_1098:70891-71891",150,-22.59,2,16,833,856,16,"75.00%","81.25%","Peve_00001702",NA,NA,NA,"P35555","Fibrillin-1 [Cleaved into: Asprosin]","Homo sapiens (Human)","activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; positive regulation of appetite [GO:0032100]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]","GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0009653; GO:0010737; GO:0030023; GO:0031012; GO:0032100; GO:0033627; GO:0034199; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0062023; GO:0071560; GO:1990314; GO:2001205"
"3009",3009,"Cluster_589","Porites_evermani_scaffold_1109:50898-51898",155,-20.34,2,16,324,345,14,"78.57%","85.71%","Peve_00001970",0.775072695353894,0.435426401668339,0.978262075707395,NA,NA,NA,NA,NA
"3010",3010,"Cluster_589","Porites_evermani_scaffold_1126:38540-39540",159,-22.43,2,18,118,138,16,"81.25%","87.50%","Peve_00002223",NA,NA,NA,NA,NA,NA,NA,NA
"3011",3011,"Cluster_589","Porites_evermani_scaffold_1144:51055-52055",155,-22.2,2,12,565,586,10,"100.00%","100.00%","Peve_00002481",0.159680919674548,0.897906931664995,0.999448381576871,NA,NA,NA,NA,NA
"3012",3012,"Cluster_589","Porites_evermani_scaffold_1:1484980-1485980",155,-22.63,2,19,350,371,18,"77.78%","83.33%","Peve_00000081",NA,NA,NA,NA,NA,NA,NA,NA
"3013",3013,"Cluster_589","Porites_evermani_scaffold_1175:134065-135065",159,-23.02,2,21,457,482,23,"60.87%","82.61%","Peve_00002945",-0.934753615028442,0.231240264998328,0.978262075707395,NA,NA,NA,NA,NA
"3014",3014,"Cluster_589","Porites_evermani_scaffold_1194:21043-22043",157,-24.32,2,18,883,904,16,"68.75%","87.50%","Peve_00003246",-0.603771657257412,0.587327744717177,0.978262075707395,"A7S7Z9","Zinc finger protein-like 1 homolog","Nematostella vectensis (Starlet sea anemone)","","GO:0005794; GO:0016020; GO:0046872"
"3015",3015,"Cluster_589","Porites_evermani_scaffold_1195:104125-105125",155,-23.41,2,12,316,337,10,"100.00%","100.00%","Peve_00003252",0.729740541805313,0.479281698131629,0.978262075707395,"P36514","UDP-glucuronosyltransferase 2C1 (UDPGT 2C1) (EC 2.4.1.17)","Oryctolagus cuniculus (Rabbit)","lipid metabolic process [GO:0006629]","GO:0005789; GO:0006629; GO:0015020"
"3016",3016,"Cluster_589","Porites_evermani_scaffold_1195:106266-107266",161,-21.08,2,18,652,673,16,"81.25%","81.25%","Peve_00003253",-0.934753615028442,0.231240264998328,0.978262075707395,NA,NA,NA,NA,NA
"3017",3017,"Cluster_589","Porites_evermani_scaffold_1207:45722-46722",160,-21.39,2,17,890,911,15,"73.33%","93.33%","Peve_00003487",-0.934753615028442,0.231240264998328,0.978262075707395,"Q9ULI1","NACHT and WD repeat domain-containing protein 2 (Leucine-rich repeat and WD repeat-containing protein KIAA1239)","Homo sapiens (Human)","",""
"3018",3018,"Cluster_589","Porites_evermani_scaffold_12:1132814-1133814",158,-22.52,2,21,145,165,19,"73.68%","78.95%","Peve_00003375",NA,NA,NA,NA,NA,NA,NA,NA
"3019",3019,"Cluster_589","Porites_evermani_scaffold_1224:114464-115464",150,-20.07,2,15,133,154,13,"69.23%","92.31%","Peve_00003728",-0.934753615028442,0.231240264998328,0.978262075707395,NA,NA,NA,NA,NA
"3020",3020,"Cluster_589","Porites_evermani_scaffold_1247:26652-27652",171,-25.47,2,20,352,373,18,"83.33%","83.33%","Peve_00004057",0.867327324614731,0.331671919396594,0.978262075707395,NA,NA,NA,NA,NA
"3021",3021,"Cluster_589","Porites_evermani_scaffold_1248:131285-132285",162,-23.2,2,19,814,835,17,"76.47%","82.35%","Peve_00004067",-0.763110781138406,0.447342107545092,0.978262075707395,NA,NA,NA,NA,NA
"3022",3022,"Cluster_589","Porites_evermani_scaffold_1254:114574-115574",171,-27.75,2,21,840,862,20,"80.00%","85.00%","Peve_00004149",-0.277080619837655,0.82126617806343,0.995934364227446,"Q9LMG7","Probable inactive purple acid phosphatase 2","Arabidopsis thaliana (Mouse-ear cress)","protein insertion into mitochondrial outer membrane [GO:0045040]; protein targeting to mitochondrion [GO:0006626]; regulation of carbohydrate metabolic process [GO:0006109]","GO:0003993; GO:0005576; GO:0005739; GO:0005740; GO:0005768; GO:0005794; GO:0005802; GO:0006109; GO:0006626; GO:0009507; GO:0009941; GO:0030943; GO:0045040; GO:0046872"
"3023",3023,"Cluster_589","Porites_evermani_scaffold_1261:77438-78438",157,-22.75,2,19,805,827,18,"77.78%","77.78%","Peve_00004251",-0.977822755637869,0.134324371242506,0.978262075707395,NA,NA,NA,NA,NA
"3024",3024,"Cluster_589","Porites_evermani_scaffold_1264:122290-123290",154,-22.98,2,21,369,394,23,"65.22%","78.26%","Peve_00004280",-0.284416215689877,0.816400487114355,0.995934364227446,NA,NA,NA,NA,NA
"3025",3025,"Cluster_589","Porites_evermani_scaffold_1267:93622-94622",150,-21.37,2,20,844,866,19,"63.16%","78.95%","Peve_00004304",NA,NA,NA,NA,NA,NA,NA,NA
"3026",3026,"Cluster_589","Porites_evermani_scaffold_1296:1392-2392",155,-23.41,2,12,860,881,10,"100.00%","100.00%","Peve_00004686",NA,NA,NA,"Q708S7","Acid-sensing ion channel 1A (ASIC1-A) (Acid-sensing ion channel 1.2-A) (Amiloride-sensitive cation channel 2-B, neuronal-A) (ZASIC1.2)","Danio rerio (Zebrafish) (Brachydanio rerio)","cellular response to pH [GO:0071467]; protein homotrimerization [GO:0070207]; sodium ion transmembrane transport [GO:0035725]","GO:0005261; GO:0005886; GO:0015280; GO:0035725; GO:0044736; GO:0070207; GO:0071467"
"3027",3027,"Cluster_589","Porites_evermani_scaffold_1336:91392-92392",160,-22.1,2,21,767,788,19,"68.42%","78.95%","Peve_00005304",-0.895325092319675,0.293886472723474,0.978262075707395,"Q96KE9","BTB/POZ domain-containing protein 6 (Lens BTB domain protein)","Homo sapiens (Human)","neurogenesis [GO:0022008]","GO:0005829; GO:0022008"
"3028",3028,"Cluster_589","Porites_evermani_scaffold_1356:2145-3145",155,-21.34,2,12,330,351,10,"100.00%","100.00%","Peve_00005577",NA,NA,NA,"P78348","Acid-sensing ion channel 1 (ASIC1) (Amiloride-sensitive cation channel 2, neuronal) (Brain sodium channel 2) (BNaC2)","Homo sapiens (Human)","associative learning [GO:0008306]; behavioral fear response [GO:0001662]; calcium ion transmembrane transport [GO:0070588]; cellular response to pH [GO:0071467]; memory [GO:0007613]; negative regulation of neurotransmitter secretion [GO:0046929]; neurotransmitter secretion [GO:0007269]; protein homotrimerization [GO:0070207]; regulation of membrane potential [GO:0042391]; response to acidic pH [GO:0010447]; response to amphetamine [GO:0001975]; response to pH [GO:0009268]; sensory perception of sour taste [GO:0050915]; signal transduction [GO:0007165]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]","GO:0001662; GO:0001975; GO:0005794; GO:0005886; GO:0006814; GO:0007165; GO:0007269; GO:0007613; GO:0008306; GO:0009268; GO:0009986; GO:0010447; GO:0015280; GO:0022839; GO:0035725; GO:0042391; GO:0044736; GO:0046929; GO:0050915; GO:0070207; GO:0070588; GO:0071467; GO:0098793"
"3029",3029,"Cluster_589","Porites_evermani_scaffold_1370:126689-127689",157,-22.66,2,19,708,730,18,"77.78%","77.78%","Peve_00005797",NA,NA,NA,NA,NA,NA,NA,NA
"3030",3030,"Cluster_589","Porites_evermani_scaffold_1370:126802-127802",157,-22.66,2,19,595,617,18,"77.78%","77.78%","Peve_00005798",NA,NA,NA,NA,NA,NA,NA,NA
"3031",3031,"Cluster_589","Porites_evermani_scaffold_1377:24014-25014",151,-20.34,2,20,704,725,18,"66.67%","72.22%","Peve_00005853",-0.864944363722551,0.334707189722557,0.978262075707395,"Q54271","Phosphonopyruvate decarboxylase (EC 4.1.1.82)","Streptomyces hygroscopicus","antibiotic biosynthetic process [GO:0017000]; organic phosphonate biosynthetic process [GO:0032923]","GO:0000287; GO:0017000; GO:0030976; GO:0032923; GO:0033980"
"3032",3032,"Cluster_589","Porites_evermani_scaffold_1426:66773-67773",159,-26.73,2,21,480,502,20,"70.00%","80.00%","Peve_00006584",-0.723449506712772,0.485110917359547,0.978262075707395,"A0A0R4IBK5","E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (E3 ubiquitin-lipopolysaccharide ligase rnf213-alpha) (EC 2.3.2.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha)","Danio rerio (Zebrafish) (Brachydanio rerio)","blood circulation [GO:0008015]; defense response to bacterium [GO:0042742]; immune system process [GO:0002376]; lipid droplet formation [GO:0140042]; lipid ubiquitination [GO:0120323]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein K63-linked ubiquitination [GO:0070534]; regulation of lipid metabolic process [GO:0019216]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]; xenophagy [GO:0098792]","GO:0002040; GO:0002376; GO:0004842; GO:0005524; GO:0005730; GO:0005811; GO:0005829; GO:0006511; GO:0008015; GO:0016887; GO:0019216; GO:0042742; GO:0046872; GO:0061630; GO:0070534; GO:0098792; GO:0120323; GO:0140042; GO:2000051"
"3033",3033,"Cluster_589","Porites_evermani_scaffold_1434:30021-31021",148,-23.9,2,13,394,415,11,"81.82%","90.91%","Peve_00006666",-0.842518101999296,0.362144576797786,0.978262075707395,"Q99ME9","GTP-binding protein 4 (Chronic renal failure gene protein) (GTP-binding protein NGB) (Nucleolar GTP-binding protein 1)","Mus musculus (Mouse)","maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of collagen binding [GO:0033342]; negative regulation of DNA replication [GO:0008156]; negative regulation of protein ubiquitination [GO:0031397]; protein stabilization [GO:0050821]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; ribosomal large subunit biogenesis [GO:0042273]","GO:0000079; GO:0000463; GO:0003723; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0008156; GO:0008285; GO:0022408; GO:0030336; GO:0031397; GO:0031965; GO:0033342; GO:0042273; GO:0048471; GO:0050821; GO:1990275"
"3034",3034,"Cluster_589","Porites_evermani_scaffold_144:306746-307746",154,-20.05,2,20,235,259,21,"61.90%","80.95%","Peve_00006737",-0.918908487774628,0.258144129403186,0.978262075707395,"Q6PDL0","Cytoplasmic dynein 1 light intermediate chain 2 (Dynein light intermediate chain 2, cytosolic)","Mus musculus (Mouse)","cellular response to nerve growth factor stimulus [GO:1990090]; centrosome localization [GO:0051642]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based movement [GO:0007018]","GO:0000226; GO:0000776; GO:0005524; GO:0005764; GO:0005770; GO:0005813; GO:0005868; GO:0005874; GO:0007018; GO:0030286; GO:0042802; GO:0045504; GO:0051642; GO:1990090"
"3035",3035,"Cluster_589","Porites_evermani_scaffold_145:7169-8169",150,-21.46,2,15,442,463,13,"76.92%","84.62%","Peve_00006831",0.775072695353894,0.435426401668339,0.978262075707395,NA,NA,NA,NA,NA
"3036",3036,"Cluster_589","Porites_evermani_scaffold_1458:77431-78431",147,-20.49,2,20,502,523,18,"61.11%","72.22%","Peve_00006932",0.620987115357972,0.573463836090813,0.978262075707395,NA,NA,NA,NA,NA
"3037",3037,"Cluster_589","Porites_evermani_scaffold_1469:60291-61291",158,-26.49,2,21,602,626,22,"72.73%","77.27%","Peve_00007066",NA,NA,NA,NA,NA,NA,NA,NA
"3038",3038,"Cluster_589","Porites_evermani_scaffold_1472:10763-11645",155,-21.82,2,12,791,812,10,"100.00%","100.00%","Peve_00007128",-0.934753615028442,0.231240264998328,0.978262075707395,"A2A8L5","Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) (Leukocyte common antigen related) (LAR)","Mus musculus (Mouse)","cell migration [GO:0016477]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell projection organization [GO:0031345]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of neurotrophin TRK receptor signaling pathway [GO:0051387]; negative regulation of receptor binding [GO:1900121]; nervous system development [GO:0007399]; neuron projection regeneration [GO:0031102]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of apoptotic process [GO:0043065]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of neuron apoptotic process [GO:0043525]; protein dephosphorylation [GO:0006470]; regulation of axon regeneration [GO:0048679]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; regulation of synapse structure or activity [GO:0050803]; synaptic membrane adhesion [GO:0099560]","GO:0001960; GO:0004721; GO:0004725; GO:0005001; GO:0005158; GO:0005768; GO:0005886; GO:0006470; GO:0007156; GO:0007399; GO:0008201; GO:0008285; GO:0010975; GO:0016020; GO:0016477; GO:0030426; GO:0030971; GO:0031102; GO:0031345; GO:0035335; GO:0035373; GO:0042059; GO:0042301; GO:0043005; GO:0043025; GO:0043065; GO:0043231; GO:0043525; GO:0044877; GO:0046627; GO:0048679; GO:0050775; GO:0050803; GO:0050839; GO:0051387; GO:0060076; GO:0098839; GO:0099175; GO:0099560; GO:1900121"
"3039",3039,"Cluster_589","Porites_evermani_scaffold_148:106654-107654",155,-23.41,2,21,38,61,21,"61.90%","80.95%","Peve_00007218",-0.161272925365772,0.896880121365859,0.999448381576871,"Q90YS3","40S ribosomal protein S2","Ictalurus punctatus (Channel catfish) (Silurus punctatus)","translation [GO:0006412]","GO:0003723; GO:0003735; GO:0006412; GO:0015935"
"3040",3040,"Cluster_589","Porites_evermani_scaffold_1482:50697-51697",157,-22.58,2,18,420,441,16,"68.75%","87.50%","Peve_00007252",NA,NA,NA,"Q8VIG3","Radial spoke head 1 homolog (Male meiotic metaphase chromosome-associated acidic protein) (Meichroacidin) (Testis-specific gene A2 protein)","Mus musculus (Mouse)","axoneme assembly [GO:0035082]; meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286]","GO:0000794; GO:0001520; GO:0005634; GO:0005737; GO:0005829; GO:0005929; GO:0007286; GO:0031514; GO:0035082; GO:0036126; GO:0051321; GO:0072687"
"3041",3041,"Cluster_589","Porites_evermani_scaffold_148:4324-5324",153,-23.09,2,18,320,341,16,"68.75%","81.25%","Peve_00007201",-0.358760450925818,0.76639899362406,0.990004516694992,NA,NA,NA,NA,NA
"3042",3042,"Cluster_589","Porites_evermani_scaffold_1485:115959-116959",160,-21.09,2,17,383,404,15,"80.00%","86.67%","Peve_00007280",0.48836901985195,0.675184019516139,0.978262075707395,"A1L2H9","Replication protein A 32 kDa subunit-B (RP-A p32) (Replication factor A protein 2) (RF-A protein 2) (Replication protein A 34 kDa subunit) (RP-A p34)","Xenopus laevis (African clawed frog)","base-excision repair [GO:0006284]; DNA replication [GO:0006260]; DNA replication checkpoint signaling [GO:0000076]; double-strand break repair via homologous recombination [GO:0000724]; mismatch repair [GO:0006298]; nucleotide-excision repair [GO:0006289]; protein localization to chromosome [GO:0034502]; regulation of DNA damage checkpoint [GO:2000001]; telomere maintenance [GO:0000723]","GO:0000076; GO:0000723; GO:0000724; GO:0000785; GO:0003684; GO:0003697; GO:0005634; GO:0005662; GO:0006260; GO:0006284; GO:0006289; GO:0006298; GO:0016605; GO:0034502; GO:2000001"
"3043",3043,"Cluster_589","Porites_evermani_scaffold_149:353925-354925",160,-20.58,2,17,926,947,15,"80.00%","86.67%","Peve_00007351",0.965322460889242,0.168144371372092,0.978262075707395,NA,NA,NA,NA,NA
"3044",3044,"Cluster_589","Porites_evermani_scaffold_1509:120318-121318",155,-23.41,2,12,748,769,10,"100.00%","100.00%","Peve_00007646",-0.714344736812349,0.493449736925696,0.978262075707395,"P25962","Beta-3 adrenergic receptor (Beta-3 adrenoreceptor) (Beta-3 adrenoceptor)","Mus musculus (Mouse)","activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; aging [GO:0007568]; brown fat cell differentiation [GO:0050873]; diet induced thermogenesis [GO:0002024]; eating behavior [GO:0042755]; heat generation [GO:0031649]; negative regulation of multicellular organism growth [GO:0040015]; norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure [GO:0002025]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of MAPK cascade [GO:0043410]; response to antibiotic [GO:0046677]; response to cold [GO:0009409]","GO:0002024; GO:0002025; GO:0004930; GO:0004939; GO:0005634; GO:0005886; GO:0007189; GO:0007190; GO:0007568; GO:0009409; GO:0015052; GO:0016020; GO:0031649; GO:0031699; GO:0040015; GO:0042755; GO:0042803; GO:0043235; GO:0043410; GO:0046677; GO:0050873; GO:0051379; GO:0051380; GO:0071880; GO:0120162"
"3045",3045,"Cluster_589","Porites_evermani_scaffold_1526:77441-78441",156,-20.47,2,21,864,885,19,"63.16%","78.95%","Peve_00007835",0.484084811308915,0.678305231958078,0.978262075707395,NA,NA,NA,NA,NA
"3046",3046,"Cluster_589","Porites_evermani_scaffold_157:272383-273383",155,-20.03,2,21,84,106,20,"70.00%","75.00%","Peve_00008377",-0.999957293079344,0.00588363598502496,0.570680688799154,NA,NA,NA,NA,NA
"3047",3047,"Cluster_589","Porites_evermani_scaffold_1579:20576-21576",160,-23.3,2,13,235,256,11,"100.00%","100.00%","Peve_00008476",-0.848420290467355,0.355108167419108,0.978262075707395,"Q90YQ1","40S ribosomal protein S23","Ictalurus punctatus (Channel catfish) (Silurus punctatus)","cytoplasmic translation [GO:0002181]","GO:0002181; GO:0003735; GO:0005791; GO:0022627; GO:0042788"
"3048",3048,"Cluster_589","Porites_evermani_scaffold_1582:39450-40450",160,-26.89,2,18,586,610,19,"73.68%","84.21%","Peve_00008547",-0.547572963630764,0.631103700675354,0.978262075707395,NA,NA,NA,NA,NA
"3049",3049,"Cluster_589","Porites_evermani_scaffold_160:413218-414218",151,-20.12,2,18,641,661,16,"75.00%","81.25%","Peve_00008819",-0.934753615028442,0.231240264998328,0.978262075707395,NA,NA,NA,NA,NA
"3050",3050,"Cluster_589","Porites_evermani_scaffold_1629:88240-89240",155,-23.41,2,12,808,829,10,"100.00%","100.00%","Peve_00009144",NA,NA,NA,"P00767","Chymotrypsinogen B (EC 3.4.21.1) [Cleaved into: Chymotrypsin B chain A; Chymotrypsin B chain B; Chymotrypsin B chain C]","Bos taurus (Bovine)","digestion [GO:0007586]; proteolysis [GO:0006508]","GO:0004252; GO:0005615; GO:0006508; GO:0007586"
"3051",3051,"Cluster_589","Porites_evermani_scaffold_1654:21847-22847",160,-23.47,2,19,629,649,17,"76.47%","88.24%","Peve_00009458",-0.998175220682579,0.0384650550931703,0.909359886114279,"Q14674","Separin (EC 3.4.22.49) (Caspase-like protein ESPL1) (Extra spindle poles-like 1 protein) (Separase)","Homo sapiens (Human)","apoptotic process [GO:0006915]; establishment of mitotic spindle localization [GO:0040001]; homologous chromosome segregation [GO:0045143]; meiotic chromosome separation [GO:0051307]; meiotic spindle organization [GO:0000212]; mitotic cytokinesis [GO:0000281]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of sister chromatid cohesion [GO:0045875]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; proteolysis [GO:0006508]","GO:0000070; GO:0000212; GO:0000281; GO:0003824; GO:0004197; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0006508; GO:0006915; GO:0008234; GO:0040001; GO:0045143; GO:0045842; GO:0045875; GO:0051307; GO:0072686"
"3052",3052,"Cluster_589","Porites_evermani_scaffold_1657:100111-101111",175,-28.91,2,21,895,917,20,"85.00%","85.00%","Peve_00009476",-0.916861062227457,0.261428660318589,0.978262075707395,"Q5U395","CTD nuclear envelope phosphatase 1A (EC 3.1.3.16) (Serine/threonine-protein phosphatase dullard-A)","Danio rerio (Zebrafish) (Brachydanio rerio)","nuclear envelope organization [GO:0006998]; positive regulation of triglyceride biosynthetic process [GO:0010867]; protein dephosphorylation [GO:0006470]","GO:0004721; GO:0004722; GO:0005635; GO:0005737; GO:0005789; GO:0006470; GO:0006998; GO:0010867; GO:0017018; GO:0031965; GO:0071595"
"3053",3053,"Cluster_589","Porites_evermani_scaffold_1702:100900-101900",142,-24.7,2,20,757,784,24,"58.33%","66.67%","Peve_00010085",-0.356889320531357,0.767674655754787,0.990416445349413,NA,NA,NA,NA,NA
"3054",3054,"Cluster_589","Porites_evermani_scaffold_1716:66238-67238",149,-20.6,2,18,970,991,16,"68.75%","75.00%","Peve_00010224",NA,NA,NA,NA,NA,NA,NA,NA
"3055",3055,"Cluster_589","Porites_evermani_scaffold_1749:100454-101454",152,-23.06,2,14,864,887,14,"85.71%","85.71%","Peve_00010555",NA,NA,NA,NA,NA,NA,NA,NA
"3056",3056,"Cluster_589","Porites_evermani_scaffold_1756:81799-82799",158,-22.64,2,15,957,978,13,"84.62%","92.31%","Peve_00010622",-0.934753615028442,0.231240264998328,0.978262075707395,NA,NA,NA,NA,NA
"3057",3057,"Cluster_589","Porites_evermani_scaffold_1777:47227-48227",155,-23.55,2,12,201,222,10,"100.00%","100.00%","Peve_00010841",-0.934753615028442,0.231240264998328,0.978262075707395,NA,NA,NA,NA,NA
"3058",3058,"Cluster_589","Porites_evermani_scaffold_1779:4385-5385",142,-21.66,2,20,234,263,26,"61.54%","61.54%","Peve_00010854",-0.549287947412284,0.629798034539238,0.978262075707395,"Q9D820","Prolyl-tRNA synthetase associated domain-containing protein 1 (PrdX deacylase domain-containing protein 1)","Mus musculus (Mouse)","","GO:0002161"
"3059",3059,"Cluster_589","Porites_evermani_scaffold_1781:79260-80260",167,-24.01,2,20,853,874,18,"72.22%","88.89%","Peve_00010910",0.434056324357235,0.714163760854519,0.979902141721869,"Q6DFA8","Poly(A) RNA polymerase GLD2-B (xGLD-2) (EC 2.7.7.19) (PAP-associated domain-containing protein 4-B)","Xenopus laevis (African clawed frog)","mRNA processing [GO:0006397]; negative regulation of miRNA catabolic process [GO:2000626]; oogenesis [GO:0048477]; RNA stabilization [GO:0043489]","GO:0004652; GO:0005524; GO:0005737; GO:0006397; GO:0034062; GO:0043489; GO:0046872; GO:0048477; GO:0070566; GO:2000626"
"3060",3060,"Cluster_589","Porites_evermani_scaffold_1801:72812-73812",163,-27.93,2,21,201,221,20,"85.00%","85.00%","Peve_00011196",-0.394284565059296,0.741984870145301,0.986697151420032,NA,NA,NA,NA,NA
"3061",3061,"Cluster_589","Porites_evermani_scaffold_1809:21624-22624",144,-23.27,2,18,297,321,19,"63.16%","73.68%","Peve_00011258",0.512228202414813,0.657640405665626,0.978262075707395,NA,NA,NA,NA,NA
"3062",3062,"Cluster_589","Porites_evermani_scaffold_185:357084-358084",163,-24.98,2,21,542,564,20,"75.00%","80.00%","Peve_00011692",NA,NA,NA,NA,NA,NA,NA,NA
"3063",3063,"Cluster_589","Porites_evermani_scaffold_1859:358-1041",158,-23.77,2,20,382,404,19,"73.68%","78.95%","Peve_00011779",NA,NA,NA,NA,NA,NA,NA,NA
"3064",3064,"Cluster_589","Porites_evermani_scaffold_1886:78875-79128",155,-24.21,2,18,225,245,16,"75.00%","87.50%","Peve_00012088",0.404502678810159,0.734889264526318,0.985827694744578,NA,NA,NA,NA,NA
"3065",3065,"Cluster_589","Porites_evermani_scaffold_190:199009-200009",158,-22.75,2,20,99,121,19,"73.68%","78.95%","Peve_00012298",-0.99593535921453,0.0574187085390782,0.978262075707395,"Q2VL80","Homeobox protein MSX-1 (Msh homeobox 1-like protein)","Perodicticus potto edwarsi (Potto)","","GO:0000981; GO:0003677; GO:0005634"
"3066",3066,"Cluster_589","Porites_evermani_scaffold_1911:64279-65279",162,-24.68,2,20,424,446,19,"73.68%","84.21%","Peve_00012432",-0.758792292441526,0.45157950635548,0.978262075707395,"Q9D404","3-oxoacyl-[acyl-carrier-protein] synthase, mitochondrial (EC 2.3.1.41) (Beta-ketoacyl-ACP synthase)","Mus musculus (Mouse)","acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633]; medium-chain fatty acid biosynthetic process [GO:0051792]; short-chain fatty acid biosynthetic process [GO:0051790]","GO:0004315; GO:0005739; GO:0005829; GO:0006633; GO:0006637; GO:0051790; GO:0051792"
"3067",3067,"Cluster_589","Porites_evermani_scaffold_191:38259-39259",154,-21.63,2,21,903,926,21,"66.67%","80.95%","Peve_00012392",-0.959899918625501,0.180896351170588,0.978262075707395,NA,NA,NA,NA,NA
"3068",3068,"Cluster_589","Porites_evermani_scaffold_191:78396-79396",162,-25.97,2,16,334,356,15,"86.67%","93.33%","Peve_00012391",NA,NA,NA,NA,NA,NA,NA,NA
"3069",3069,"Cluster_589","Porites_evermani_scaffold_1965:61322-62322",159,-23.68,2,16,790,811,14,"85.71%","85.71%","Peve_00012986",-0.981779022380542,0.121714581822426,0.978262075707395,"Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"3070",3070,"Cluster_589","Porites_evermani_scaffold_200:158069-159069",151,-21.02,2,20,191,212,18,"66.67%","72.22%","Peve_00013561",0.838690433907775,0.366643445011928,0.978262075707395,"Q8N8K9","Uncharacterized protein KIAA1958","Homo sapiens (Human)","",""
"3071",3071,"Cluster_589","Porites_evermani_scaffold_2055:33321-34321",155,-23.41,2,12,540,561,10,"100.00%","100.00%","Peve_00014110",NA,NA,NA,NA,NA,NA,NA,NA
"3072",3072,"Cluster_589","Porites_evermani_scaffold_2086:1029-2029",156,-21.33,2,17,490,511,15,"80.00%","80.00%","Peve_00014393",-0.934753615028442,0.231240264998328,0.978262075707395,NA,NA,NA,NA,NA
"3073",3073,"Cluster_589","Porites_evermani_scaffold_2090:48881-49881",158,-22.15,2,21,147,167,19,"73.68%","78.95%","Peve_00014455",NA,NA,NA,NA,NA,NA,NA,NA
"3074",3074,"Cluster_589","Porites_evermani_scaffold_211:210232-211232",155,-21.2,2,21,887,910,21,"66.67%","76.19%","Peve_00014672",-0.854809908856242,0.347347325818434,0.978262075707395,NA,NA,NA,NA,NA
"3075",3075,"Cluster_589","Porites_evermani_scaffold_2:1217146-1217541",162,-22.91,2,19,29,50,17,"76.47%","82.35%","Peve_00013404",-0.961224104146676,0.177864580197486,0.978262075707395,NA,NA,NA,NA,NA
"3076",3076,"Cluster_589","Porites_evermani_scaffold_2135:21422-22422",155,-21.82,2,12,227,248,10,"100.00%","100.00%","Peve_00014928",0.105017199600145,0.933020472186197,0.999448381576871,NA,NA,NA,NA,NA
"3077",3077,"Cluster_589","Porites_evermani_scaffold_2149:1783-2783",154,-22.3,2,19,202,223,17,"64.71%","82.35%","Peve_00015039",-0.978326963121339,0.132783011611409,0.978262075707395,"P40946","ADP-ribosylation factor 6 (ARF6) (ADP ribosylation factor at 51F) (ADP-ribosylation factor 3)","Drosophila melanogaster (Fruit fly)","actin cytoskeleton organization [GO:0030036]; behavioral response to ethanol [GO:0048149]; compound eye morphogenesis [GO:0001745]; imaginal disc-derived wing morphogenesis [GO:0007476]; intracellular protein transport [GO:0006886]; male meiosis cytokinesis [GO:0007112]; myoblast fusion [GO:0007520]; neurotransmitter secretion [GO:0007269]; positive regulation of gene expression [GO:0010628]; response to alcohol [GO:0097305]; spermatogenesis [GO:0007283]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192]","GO:0001745; GO:0003924; GO:0005525; GO:0005737; GO:0005769; GO:0005794; GO:0005829; GO:0005886; GO:0006886; GO:0007112; GO:0007269; GO:0007283; GO:0007476; GO:0007520; GO:0008047; GO:0010628; GO:0016192; GO:0030036; GO:0032154; GO:0048149; GO:0048488; GO:0055037; GO:0097305; GO:0098793"
"3078",3078,"Cluster_589","Porites_evermani_scaffold_215:268587-269587",155,-23.55,2,12,394,415,10,"100.00%","100.00%","Peve_00015064",-0.181426355427544,0.883857199969692,0.999448381576871,"P42674","Blastula protease 10 (EC 3.4.24.-)","Paracentrotus lividus (Common sea urchin)","proteolysis [GO:0006508]","GO:0004222; GO:0005615; GO:0005938; GO:0006508; GO:0008270; GO:0048471"
"3079",3079,"Cluster_589","Porites_evermani_scaffold_215:287759-288759",155,-23.55,2,12,597,618,10,"100.00%","100.00%","Peve_00015066",-0.999604063448837,0.0179152242682217,0.782669382293497,"P42674","Blastula protease 10 (EC 3.4.24.-)","Paracentrotus lividus (Common sea urchin)","proteolysis [GO:0006508]","GO:0004222; GO:0005615; GO:0005938; GO:0006508; GO:0008270; GO:0048471"
"3080",3080,"Cluster_589","Porites_evermani_scaffold_2174:56084-57084",159,-25.08,2,21,798,824,24,"62.50%","79.17%","Peve_00015266",NA,NA,NA,"P35555","Fibrillin-1 [Cleaved into: Asprosin]","Homo sapiens (Human)","activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; positive regulation of appetite [GO:0032100]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]","GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0009653; GO:0010737; GO:0030023; GO:0031012; GO:0032100; GO:0033627; GO:0034199; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0062023; GO:0071560; GO:1990314; GO:2001205"
"3081",3081,"Cluster_589","Porites_evermani_scaffold_2186:77516-78516",167,-21.36,2,20,919,940,18,"77.78%","83.33%","Peve_00015363",-0.934753615028442,0.231240264998328,0.978262075707395,NA,NA,NA,NA,NA
"3082",3082,"Cluster_589","Porites_evermani_scaffold_2194:75276-76276",162,-21.01,2,21,429,449,19,"73.68%","84.21%","Peve_00015466",NA,NA,NA,NA,NA,NA,NA,NA
"3083",3083,"Cluster_589","Porites_evermani_scaffold_2195:64829-65829",150,-22.69,2,21,883,910,25,"60.00%","76.00%","Peve_00015472",NA,NA,NA,"P35555","Fibrillin-1 [Cleaved into: Asprosin]","Homo sapiens (Human)","activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; positive regulation of appetite [GO:0032100]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]","GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0009653; GO:0010737; GO:0030023; GO:0031012; GO:0032100; GO:0033627; GO:0034199; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0062023; GO:0071560; GO:1990314; GO:2001205"
"3084",3084,"Cluster_589","Porites_evermani_scaffold_222:93065-94065",158,-23.79,2,19,71,92,17,"70.59%","82.35%","Peve_00015774",0.0658541946108254,0.958045555775693,0.999448381576871,"Q8IV35","WD repeat-containing protein 49","Homo sapiens (Human)","",""
"3085",3085,"Cluster_589","Porites_evermani_scaffold_22:526637-527637",151,-20.76,2,21,356,379,21,"66.67%","71.43%","Peve_00015514",-0.995828179124179,0.0581713370636212,0.978262075707395,"Q28HF8","Sodium/bile acid cotransporter 7 (Na(+)/bile acid cotransporter 7) (Solute carrier family 10 member 7)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","sodium ion transport [GO:0006814]","GO:0000139; GO:0005789; GO:0005886; GO:0006814; GO:0015293"
"3086",3086,"Cluster_589","Porites_evermani_scaffold_22:602421-603421",155,-23.55,2,12,660,681,10,"100.00%","100.00%","Peve_00015525",-0.957989793235133,0.185184561624248,0.978262075707395,NA,NA,NA,NA,NA
"3087",3087,"Cluster_589","Porites_evermani_scaffold_2298:77274-78274",150,-20.31,2,11,494,515,9,"100.00%","100.00%","Peve_00016462",NA,NA,NA,NA,NA,NA,NA,NA
"3088",3088,"Cluster_589","Porites_evermani_scaffold_230:116306-117306",162,-26.12,2,21,377,401,22,"68.18%","86.36%","Peve_00016555",0.0351819006172488,0.977597883385617,0.999448381576871,"O57382","Tolloid-like protein 2 (EC 3.4.24.-) (Metalloprotease xolloid) (Xenopus tolloid)","Xenopus laevis (African clawed frog)","cell differentiation [GO:0030154]; proteolysis [GO:0006508]","GO:0004222; GO:0005509; GO:0005576; GO:0006508; GO:0008270; GO:0030154"
"3089",3089,"Cluster_589","Porites_evermani_scaffold_2321:77469-78469",164,-22.33,2,21,885,906,19,"68.42%","84.21%","Peve_00016760",NA,NA,NA,NA,NA,NA,NA,NA
"3090",3090,"Cluster_589","Porites_evermani_scaffold_233:202388-203388",155,-21.34,2,12,356,377,10,"100.00%","100.00%","Peve_00016828",-0.931241598856441,0.237453421529189,0.978262075707395,"Q9P2R6","Arginine-glutamic acid dipeptide repeats protein (Atrophin-1-like protein) (Atrophin-1-related protein)","Homo sapiens (Human)","branching morphogenesis of a nerve [GO:0048755]; cerebellar granule cell precursor proliferation [GO:0021930]; cerebellar Purkinje cell layer maturation [GO:0021691]; chromatin remodeling [GO:0006338]; dendrite morphogenesis [GO:0048813]; radial glia guided migration of Purkinje cell [GO:0021942]","GO:0000118; GO:0003682; GO:0003713; GO:0003714; GO:0005634; GO:0006338; GO:0021691; GO:0021930; GO:0021942; GO:0043565; GO:0046872; GO:0048755; GO:0048813"
"3091",3091,"Cluster_589","Porites_evermani_scaffold_235:314100-315100",149,-22.32,2,21,222,243,20,"70.00%","75.00%","Peve_00017006",NA,NA,NA,NA,NA,NA,NA,NA
"3092",3092,"Cluster_589","Porites_evermani_scaffold_23:707395-708395",167,-28.92,2,16,851,872,14,"92.86%","92.86%","Peve_00016511",-0.47896935336965,0.682020994740065,0.978262075707395,"Q9NZ01","Very-long-chain enoyl-CoA reductase (EC 1.3.1.93) (Synaptic glycoprotein SC2) (Trans-2,3-enoyl-CoA reductase) (TER)","Homo sapiens (Human)","fatty acid elongation [GO:0030497]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid metabolic process [GO:0006665]; very long-chain fatty acid biosynthetic process [GO:0042761]","GO:0005634; GO:0005783; GO:0005789; GO:0006665; GO:0016491; GO:0017099; GO:0030497; GO:0035338; GO:0042761; GO:0102758"
"3093",3093,"Cluster_589","Porites_evermani_scaffold_2402:34600-35600",149,-21.31,2,20,553,573,18,"61.11%","83.33%","Peve_00017523",-0.979206204515399,0.130052122033999,0.978262075707395,NA,NA,NA,NA,NA
"3094",3094,"Cluster_589","Porites_evermani_scaffold_241:334802-335802",162,-22.05,2,19,567,588,17,"76.47%","82.35%","Peve_00017581",0.683220465224407,0.521157588530259,0.978262075707395,"Q6BZW3","Protein BTN1","Yarrowia lipolytica (strain CLIB 122 / E 150) (Yeast) (Candida lipolytica)","L-arginine transmembrane transport [GO:1903826]; lysine transport [GO:0015819]; regulation of intracellular pH [GO:0051453]","GO:0000324; GO:0005773; GO:0005774; GO:0015819; GO:0022857; GO:0051453; GO:1903826"
"3095",3095,"Cluster_589","Porites_evermani_scaffold_2426:40028-41028",155,-23.55,2,12,882,903,10,"100.00%","100.00%","Peve_00017731",NA,NA,NA,NA,NA,NA,NA,NA
"3096",3096,"Cluster_589","Porites_evermani_scaffold_2427:67810-68520",162,-23.3,2,20,560,582,19,"73.68%","84.21%","Peve_00017736",NA,NA,NA,NA,NA,NA,NA,NA
"3097",3097,"Cluster_589","Porites_evermani_scaffold_2447:59203-60203",155,-23.41,2,12,213,234,10,"100.00%","100.00%","Peve_00017907",NA,NA,NA,NA,NA,NA,NA,NA
"3098",3098,"Cluster_589","Porites_evermani_scaffold_248:239409-240409",157,-20.83,2,18,783,804,16,"68.75%","87.50%","Peve_00018177",-0.934753615028442,0.231240264998328,0.978262075707395,NA,NA,NA,NA,NA
"3099",3099,"Cluster_589","Porites_evermani_scaffold_2571:6733-7733",152,-20.16,2,21,662,680,19,"68.42%","78.95%","Peve_00018998",NA,NA,NA,NA,NA,NA,NA,NA
"3100",3100,"Cluster_589","Porites_evermani_scaffold_2574:48457-49457",153,-21.94,2,20,9,34,22,"68.18%","77.27%","Peve_00019018",-0.912789567190739,0.267847319902596,0.978262075707395,NA,NA,NA,NA,NA
"3101",3101,"Cluster_589","Porites_evermani_scaffold_2609:44069-45069",151,-21.31,2,21,802,825,21,"66.67%","71.43%","Peve_00019334",-0.822141748157951,0.385558119645507,0.978262075707395,NA,NA,NA,NA,NA
"3102",3102,"Cluster_589","Porites_evermani_scaffold_262:300448-301448",158,-21.25,2,19,783,804,17,"76.47%","76.47%","Peve_00019432",0.374527955311886,0.755609548853626,0.988219883885475,"Q866A2","Neuronal acetylcholine receptor subunit alpha-7","Macaca mulatta (Rhesus macaque)","associative learning [GO:0008306]; B cell activation [GO:0042113]; behavioral response to ethanol [GO:0048149]; behavioral response to nicotine [GO:0035095]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; dendrite arborization [GO:0140059]; dendritic spine organization [GO:0097061]; endocytosis [GO:0006897]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; generation of ovulation cycle rhythm [GO:0060112]; ion transmembrane transport [GO:0034220]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of tumor necrosis factor production [GO:0032720]; nervous system process [GO:0050877]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of CoA-transferase activity [GO:1905920]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure [GO:0001988]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of amyloid fibril formation [GO:1905906]; regulation of membrane potential [GO:0042391]; regulation of neuron death [GO:1901214]; regulation of norepinephrine secretion [GO:0014061]; regulation of synaptic transmission, dopaminergic [GO:0032225]; response to amyloid-beta [GO:1904645]; response to cold [GO:0009409]; response to food [GO:0032094]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; sensory processing [GO:0050893]; short-term memory [GO:0007614]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]; T cell activation [GO:0042110]","GO:0001540; GO:0001666; GO:0001933; GO:0001988; GO:0005231; GO:0005886; GO:0005892; GO:0006816; GO:0006874; GO:0006897; GO:0007165; GO:0007268; GO:0007271; GO:0007614; GO:0008284; GO:0008306; GO:0009409; GO:0009897; GO:0014061; GO:0015464; GO:0015643; GO:0016324; GO:0017081; GO:0022848; GO:0030317; GO:0030594; GO:0030673; GO:0032094; GO:0032225; GO:0032691; GO:0032715; GO:0032720; GO:0033138; GO:0034220; GO:0035094; GO:0035095; GO:0042110; GO:0042113; GO:0042166; GO:0042391; GO:0042734; GO:0042803; GO:0043005; GO:0043410; GO:0045202; GO:0045766; GO:0048149; GO:0050728; GO:0050877; GO:0050890; GO:0050893; GO:0051649; GO:0060112; GO:0070374; GO:0097061; GO:0098839; GO:0098978; GO:0098981; GO:0140059; GO:1900273; GO:1901214; GO:1902004; GO:1904315; GO:1904645; GO:1905906; GO:1905920; GO:2000463"
"3103",3103,"Cluster_589","Porites_evermani_scaffold_2628:18811-19811",158,-22.77,2,20,390,413,20,"70.00%","80.00%","Peve_00019480",-0.973401375116937,0.147160779102813,0.978262075707395,"Q9CR98","Protein FAM136A","Mus musculus (Mouse)","","GO:0005737; GO:0005739"
"3104",3104,"Cluster_589","Porites_evermani_scaffold_2653:700-1700",147,-20.85,2,21,535,559,22,"59.09%","72.73%","Peve_00019681",-0.557969192191504,0.62316144582037,0.978262075707395,"Q8BYI9","Tenascin-R (TN-R) (Janusin) (Neural recognition molecule J1-160/180) (Restrictin)","Mus musculus (Mouse)","associative learning [GO:0008306]; axon extension [GO:0048675]; axon extension involved in regeneration [GO:0048677]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; locomotory exploration behavior [GO:0035641]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of axon extension [GO:0030517]; negative regulation of axon extension involved in regeneration [GO:0048692]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of neuron projection development [GO:0010977]; negative regulation of synaptic transmission [GO:0050805]; neuroblast migration [GO:0097402]; neuromuscular process controlling balance [GO:0050885]; neuron cell-cell adhesion [GO:0007158]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of transmission of nerve impulse [GO:0051971]; regulation of cell adhesion [GO:0030155]; regulation of cell differentiation [GO:0045595]; regulation of cell migration [GO:0030334]; synapse organization [GO:0050808]; synaptic transmission, glutamatergic [GO:0035249]; telencephalon cell migration [GO:0022029]","GO:0005102; GO:0005178; GO:0005615; GO:0007155; GO:0007158; GO:0007162; GO:0008306; GO:0009986; GO:0010977; GO:0022029; GO:0022408; GO:0030155; GO:0030198; GO:0030334; GO:0030517; GO:0031012; GO:0035249; GO:0035641; GO:0045121; GO:0045595; GO:0046625; GO:0048675; GO:0048677; GO:0048692; GO:0050804; GO:0050805; GO:0050808; GO:0050885; GO:0051968; GO:0051971; GO:0060291; GO:0062023; GO:0072534; GO:0090733; GO:0097402; GO:0098685; GO:0098686; GO:0098965; GO:0098966; GO:0098978"
"3105",3105,"Cluster_589","Porites_evermani_scaffold_2654:24653-25653",154,-20.37,2,21,774,794,19,"68.42%","78.95%","Peve_00019686",NA,NA,NA,NA,NA,NA,NA,NA
"3106",3106,"Cluster_589","Porites_evermani_scaffold_268:293944-294944",155,-23.41,2,12,463,484,10,"100.00%","100.00%","Peve_00019903",NA,NA,NA,NA,NA,NA,NA,NA
"3107",3107,"Cluster_589","Porites_evermani_scaffold_2683:15655-16655",159,-26.88,2,21,710,736,24,"66.67%","75.00%","Peve_00019939",NA,NA,NA,NA,NA,NA,NA,NA
"3108",3108,"Cluster_589","Porites_evermani_scaffold_2689:11018-12018",146,-23.32,2,21,264,290,24,"66.67%","66.67%","Peve_00019963",-0.932615782748664,0.235041002270661,0.978262075707395,"P46471","26S proteasome regulatory subunit 7 (26S proteasome AAA-ATPase subunit RPT1) (Proteasome 26S subunit ATPase 2)","Mus musculus (Mouse)","proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000502; GO:0000932; GO:0005524; GO:0005634; GO:0005829; GO:0006511; GO:0008540; GO:0016887; GO:0017025; GO:0022624; GO:0036402; GO:0036464; GO:0043161; GO:0043197; GO:0140296"
"3109",3109,"Cluster_589","Porites_evermani_scaffold_2726:41466-42466",158,-21.34,2,19,559,580,17,"64.71%","88.24%","Peve_00020315",NA,NA,NA,NA,NA,NA,NA,NA
"3110",3110,"Cluster_589","Porites_evermani_scaffold_2740:2431-3431",155,-23.55,2,12,539,560,10,"100.00%","100.00%","Peve_00020438",0.220151712172447,0.858689511853318,0.995934364227446,"O88696","ATP-dependent Clp protease proteolytic subunit, mitochondrial (EC 3.4.21.92) (Endopeptidase Clp)","Mus musculus (Mouse)","membrane protein proteolysis [GO:0033619]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]","GO:0004175; GO:0004176; GO:0004252; GO:0005739; GO:0005759; GO:0006508; GO:0006515; GO:0009368; GO:0033619; GO:0042802; GO:0051117; GO:0051603"
"3111",3111,"Cluster_589","Porites_evermani_scaffold_2760:3658-4658",165,-28.29,2,18,749,770,16,"81.25%","87.50%","Peve_00020586",-0.963538422963391,0.172441322278564,0.978262075707395,"Q9QXL7","Nucleoside diphosphate kinase 7 (NDK 7) (NDP kinase 7) (EC 2.7.4.6) (nm23-R7)","Rattus norvegicus (Rat)","brain development [GO:0007420]; cellular response to leukemia inhibitory factor [GO:1990830]; ciliary receptor clustering involved in smoothened signaling pathway [GO:0060830]; CTP biosynthetic process [GO:0006241]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; intraciliary transport [GO:0042073]; left/right pattern formation [GO:0060972]; nucleoside diphosphate phosphorylation [GO:0006165]; UTP biosynthetic process [GO:0006228]","GO:0003351; GO:0004550; GO:0005524; GO:0005576; GO:0005813; GO:0005879; GO:0005886; GO:0005929; GO:0006165; GO:0006183; GO:0006228; GO:0006241; GO:0007368; GO:0007420; GO:0036064; GO:0042073; GO:0046872; GO:0060830; GO:0060972; GO:1990830"
"3112",3112,"Cluster_589","Porites_evermani_scaffold_2769:46194-47194",171,-27.99,2,21,417,439,20,"80.00%","85.00%","Peve_00020630",NA,NA,NA,NA,NA,NA,NA,NA
"3113",3113,"Cluster_589","Porites_evermani_scaffold_278:185339-185981",162,-26.28,2,21,470,494,22,"77.27%","77.27%","Peve_00020722",-0.934753615028442,0.231240264998328,0.978262075707395,"A2AJ76","Hemicentin-2","Mus musculus (Mouse)","response to stimulus [GO:0050896]","GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005938; GO:0030054; GO:0031012; GO:0032154; GO:0050896; GO:0062023"
"3114",3114,"Cluster_589","Porites_evermani_scaffold_2787:281-1281",155,-23.95,2,12,499,520,10,"100.00%","100.00%","Peve_00020768",-0.014366509416504,0.990853681398981,0.999448381576871,"B0R0T1","von Willebrand factor A domain-containing protein 8","Danio rerio (Zebrafish) (Brachydanio rerio)","","GO:0005524; GO:0005737; GO:0005739; GO:0016887"
"3115",3115,"Cluster_589","Porites_evermani_scaffold_280:190731-191731",156,-20.45,2,21,917,938,19,"63.16%","78.95%","Peve_00020931",0.540288973980432,0.636629858633538,0.978262075707395,NA,NA,NA,NA,NA
"3116",3116,"Cluster_589","Porites_evermani_scaffold_2822:59690-60690",160,-21.67,2,21,304,325,19,"68.42%","78.95%","Peve_00021093",-0.999211152128301,0.025288338918848,0.871601074988914,"P98133","Fibrillin-1 (MP340) [Cleaved into: Asprosin]","Bos taurus (Bovine)","activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; protein kinase A signaling [GO:0010737]","GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0008201; GO:0009653; GO:0010737; GO:0031012; GO:0034199; GO:0042593"
"3117",3117,"Cluster_589","Porites_evermani_scaffold_2835:55496-56496",155,-21.34,2,12,32,53,10,"100.00%","100.00%","Peve_00021180",0.311348059598886,0.798439004342634,0.995934364227446,NA,NA,NA,NA,NA
"3118",3118,"Cluster_589","Porites_evermani_scaffold_2855:25751-26363",150,-22.3,2,19,276,298,19,"78.95%","78.95%","Peve_00021316",-0.934753615028442,0.231240264998328,0.978262075707395,NA,NA,NA,NA,NA
"3119",3119,"Cluster_589","Porites_evermani_scaffold_2871:53154-54154",157,-21.16,2,20,912,932,18,"66.67%","88.89%","Peve_00021457",NA,NA,NA,"A1L1W9","Monocarboxylate transporter 10 (MCT 10) (Solute carrier family 16 member 10)","Danio rerio (Zebrafish) (Brachydanio rerio)","aromatic amino acid transport [GO:0015801]; thyroid hormone transport [GO:0070327]","GO:0005302; GO:0015173; GO:0015192; GO:0015196; GO:0015349; GO:0015801; GO:0016020; GO:0016323; GO:0070327"
"3120",3120,"Cluster_589","Porites_evermani_scaffold_2919:39178-40178",159,-21.01,2,21,972,994,20,"70.00%","80.00%","Peve_00021843",NA,NA,NA,"Q7Z020","Transient receptor potential cation channel subfamily A member 1 (dTRPA1) (Ankyrin-like with transmembrane domains protein 1) (dANKTM1)","Drosophila melanogaster (Fruit fly)","calcium ion transport [GO:0006816]; cation transport [GO:0006812]; cellular response to heat [GO:0034605]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; detection of temperature stimulus involved in thermoception [GO:0050960]; mechanosensory behavior [GO:0007638]; negative phototaxis [GO:0046957]; neuronal signal transduction [GO:0023041]; phototransduction [GO:0007602]; positive regulation of calcium-mediated signaling [GO:0050850]; response to heat [GO:0009408]; response to light stimulus [GO:0009416]; temperature compensation of the circadian clock [GO:0010378]; thermosensory behavior [GO:0040040]; thermotaxis [GO:0043052]","GO:0001580; GO:0005261; GO:0005262; GO:0005886; GO:0006812; GO:0006816; GO:0007602; GO:0007638; GO:0009408; GO:0009416; GO:0010378; GO:0015276; GO:0016020; GO:0023041; GO:0034605; GO:0034703; GO:0040040; GO:0043052; GO:0046957; GO:0050850; GO:0050960; GO:0050965; GO:0050968; GO:0097604"
"3121",3121,"Cluster_589","Porites_evermani_scaffold_292:124120-125120",159,-23.84,2,21,340,363,21,"66.67%","80.95%","Peve_00021856",-0.722164063351836,0.486295113802169,0.978262075707395,"Q60467","Collagen alpha-1(V) chain","Cricetulus longicaudatus (Long-tailed dwarf hamster) (Chinese hamster)","","GO:0005201; GO:0005576; GO:0005581; GO:0008201"
"3122",3122,"Cluster_589","Porites_evermani_scaffold_2931:8165-9165",149,-22.12,2,18,800,821,16,"68.75%","75.00%","Peve_00021938",-0.993856951264415,0.0706008088024391,0.978262075707395,"Q28728","Sodium/myo-inositol cotransporter 2 (Na(+)/myo-inositol cotransporter 2) (Sodium-dependent glucose cotransporter) (Sodium/glucose cotransporter KST1) (rKST1) (Sodium/myo-inositol transporter 2) (SMIT2) (Solute carrier family 5 member 11)","Oryctolagus cuniculus (Rabbit)","apoptotic process [GO:0006915]; carbohydrate transport [GO:0008643]; myo-inositol transport [GO:0015798]; regulation of transporter activity [GO:0032409]; sodium ion transport [GO:0006814]","GO:0005365; GO:0005886; GO:0006814; GO:0006915; GO:0008643; GO:0015293; GO:0015798; GO:0016324; GO:0032409"
"3123",3123,"Cluster_589","Porites_evermani_scaffold_293:87203-88203",163,-27.23,2,20,906,927,18,"72.22%","83.33%","Peve_00021914",-0.0570373968476522,0.963669148235058,0.999448381576871,"P34730","Protein BMH2","Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)","ascospore formation [GO:0030437]; DNA damage checkpoint signaling [GO:0000077]; DNA replication initiation [GO:0006270]; fungal-type cell wall chitin biosynthetic process [GO:0034221]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]; pseudohyphal growth [GO:0007124]; Ras protein signal transduction [GO:0007265]; regulation of glycogen metabolic process [GO:0070873]; regulation of mitotic cell cycle [GO:0007346]; signal transduction [GO:0007165]; signal transduction involved in filamentous growth [GO:0001402]","GO:0000077; GO:0001402; GO:0003688; GO:0005634; GO:0005737; GO:0005886; GO:0006267; GO:0006270; GO:0007124; GO:0007165; GO:0007265; GO:0007346; GO:0030437; GO:0034221; GO:0043066; GO:0050815; GO:0070873; GO:1904667"
"3124",3124,"Cluster_589","Porites_evermani_scaffold_29:576971-577971",160,-20.32,2,21,361,382,19,"73.68%","73.68%","Peve_00021654",-0.881782730848516,0.312687037643998,0.978262075707395,"Q04400","Adenylate cyclase type 5 (EC 4.6.1.1) (ATP pyrophosphate-lyase 5) (Adenylate cyclase type V) (Adenylyl cyclase 5)","Rattus norvegicus (Rat)","adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; aging [GO:0007568]; brain development [GO:0007420]; cAMP biosynthetic process [GO:0006171]; cellular response to forskolin [GO:1904322]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; heart development [GO:0007507]; intracellular signal transduction [GO:0035556]; locomotory behavior [GO:0007626]; neuromuscular process controlling balance [GO:0050885]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; response to morphine [GO:0043278]","GO:0001973; GO:0004016; GO:0005524; GO:0005768; GO:0005886; GO:0005929; GO:0006171; GO:0007189; GO:0007191; GO:0007193; GO:0007195; GO:0007204; GO:0007420; GO:0007507; GO:0007568; GO:0007626; GO:0008179; GO:0008294; GO:0016020; GO:0035556; GO:0043278; GO:0045121; GO:0046872; GO:0050885; GO:0061178; GO:0097110; GO:1904322"
"3125",3125,"Cluster_589","Porites_evermani_scaffold_2958:18326-19326",157,-20.65,2,20,648,668,18,"72.22%","83.33%","Peve_00022104",NA,NA,NA,NA,NA,NA,NA,NA
"3126",3126,"Cluster_589","Porites_evermani_scaffold_2959:524-1524",155,-23.55,2,12,417,438,10,"100.00%","100.00%","Peve_00022113",0.0509259307201539,0.967565515724053,0.999448381576871,"B3EWY9","Mucin-like protein","Acropora millepora (Staghorn coral) (Heteropora millepora)","cell-matrix adhesion [GO:0007160]","GO:0005509; GO:0007160; GO:0016020"
"3127",3127,"Cluster_589","Porites_evermani_scaffold_2981:3983-4983",157,-24.32,2,18,767,788,16,"68.75%","87.50%","Peve_00022296",-0.0629643852095606,0.959889094215842,0.999448381576871,"A7S7Z9","Zinc finger protein-like 1 homolog","Nematostella vectensis (Starlet sea anemone)","","GO:0005794; GO:0016020; GO:0046872"
"3128",3128,"Cluster_589","Porites_evermani_scaffold_3009:18581-19581",155,-20.4,2,17,31,53,16,"81.25%","81.25%","Peve_00022679",-0.934753615028442,0.231240264998328,0.978262075707395,"Q8NKE2","Alternative oxidase, mitochondrial (EC 1.-.-.-)","Cryptococcus neoformans var. grubii serotype A (strain H99 / ATCC 208821 / CBS 10515 / FGSC 9487) (Filobasidiella neoformans var. grubii)","","GO:0005743; GO:0009916; GO:0046872; GO:0070469"
"3129",3129,"Cluster_589","Porites_evermani_scaffold_3014:26264-27264",156,-21.34,2,17,345,366,15,"73.33%","86.67%","Peve_00022732",-0.934753615028442,0.231240264998328,0.978262075707395,NA,NA,NA,NA,NA
"3130",3130,"Cluster_589","Porites_evermani_scaffold_3015:12634-13634",172,-29.48,2,18,395,417,17,"88.24%","94.12%","Peve_00022741",NA,NA,NA,NA,NA,NA,NA,NA
"3131",3131,"Cluster_589","Porites_evermani_scaffold_30:556289-557289",158,-23.77,2,20,372,394,19,"73.68%","78.95%","Peve_00022560",NA,NA,NA,NA,NA,NA,NA,NA
"3132",3132,"Cluster_589","Porites_evermani_scaffold_30:558796-559796",158,-23.77,2,20,372,394,19,"73.68%","78.95%","Peve_00022561",NA,NA,NA,NA,NA,NA,NA,NA
"3133",3133,"Cluster_589","Porites_evermani_scaffold_3069:30578-31578",162,-23.4,2,21,435,458,21,"71.43%","85.71%","Peve_00023109",NA,NA,NA,NA,NA,NA,NA,NA
"3134",3134,"Cluster_589","Porites_evermani_scaffold_308:113834-114834",156,-20.13,2,17,772,793,15,"66.67%","93.33%","Peve_00023191",-0.847575811832119,0.356122531485163,0.978262075707395,"Q9SSA4",NA,NA,NA,NA
"3135",3135,"Cluster_589","Porites_evermani_scaffold_3094:52412-53412",151,-25.71,2,21,240,268,26,"61.54%","69.23%","Peve_00023299",0.976441118820529,0.13846142047683,0.978262075707395,"P51029","Protein Wnt-8b","Danio rerio (Zebrafish) (Brachydanio rerio)","canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; commissural neuron axon guidance [GO:0071679]; embryonic pattern specification [GO:0009880]; eye development [GO:0001654]; eye field cell fate commitment involved in camera-type eye formation [GO:0060898]; forebrain development [GO:0030900]; forebrain neuron differentiation [GO:0021879]; hypothalamus development [GO:0021854]; negative regulation of anterior neural cell fate commitment of the neural plate by Wnt signaling pathway [GO:0022002]; neuron differentiation [GO:0030182]; otic placode formation [GO:0043049]; sensory epithelium regeneration [GO:0070654]","GO:0001654; GO:0005109; GO:0005125; GO:0005615; GO:0009880; GO:0021854; GO:0021879; GO:0022002; GO:0030182; GO:0030900; GO:0043049; GO:0045165; GO:0060070; GO:0060898; GO:0070654; GO:0071679"
"3136",3136,"Cluster_589","Porites_evermani_scaffold_310:65590-66590",159,-20.77,2,20,460,481,18,"72.22%","77.78%","Peve_00023399",-0.934753615028442,0.231240264998328,0.978262075707395,"Q3UES3","Poly [ADP-ribose] polymerase tankyrase-2 (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 6) (ARTD6) (Protein poly-ADP-ribosyltransferase tankyrase-2) (EC 2.4.2.-) (TNKS-2) (TRF1-interacting ankyrin-related ADP-ribose polymerase 2) (Tankyrase II) (Tankyrase-2) (TANK2)","Mus musculus (Mouse)","multicellular organism growth [GO:0035264]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomere capping [GO:1904355]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; regulation of multicellular organism growth [GO:0040014]; telomere maintenance [GO:0000723]; Wnt signaling pathway [GO:0016055]","GO:0000139; GO:0000209; GO:0000242; GO:0000723; GO:0000781; GO:0003950; GO:0005634; GO:0005635; GO:0005737; GO:0016055; GO:0016779; GO:0019899; GO:0035264; GO:0040014; GO:0046872; GO:0047485; GO:0048471; GO:0070198; GO:0070212; GO:0070213; GO:0090263; GO:1904355; GO:1904357; GO:1990404"
"3137",3137,"Cluster_589","Porites_evermani_scaffold_3115:52059-53059",146,-23.12,2,21,280,307,25,"64.00%","68.00%","Peve_00023506",-0.638682537804428,0.558959448135206,0.978262075707395,NA,NA,NA,NA,NA
"3138",3138,"Cluster_589","Porites_evermani_scaffold_3138:8385-9385",154,-21.6,2,17,355,375,15,"80.00%","86.67%","Peve_00023635",-0.483985529470715,0.678377461986635,0.978262075707395,NA,NA,NA,NA,NA
"3139",3139,"Cluster_589","Porites_evermani_scaffold_31:49553-50553",166,-26.94,2,21,550,574,22,"72.73%","86.36%","Peve_00023339",NA,NA,NA,NA,NA,NA,NA,NA
"3140",3140,"Cluster_589","Porites_evermani_scaffold_316:56019-57019",158,-21.41,2,21,489,509,19,"68.42%","84.21%","Peve_00023762",-0.938208053832946,0.224969248411911,0.978262075707395,"O75366","Advillin (p92)","Homo sapiens (Human)","actin filament organization [GO:0007015]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cilium assembly [GO:0060271]; nervous system development [GO:0007399]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuron projection development [GO:0010976]; regulation of diacylglycerol biosynthetic process [GO:1900480]","GO:0003779; GO:0005546; GO:0005737; GO:0005884; GO:0005925; GO:0007015; GO:0007399; GO:0008154; GO:0010592; GO:0010976; GO:0015629; GO:0030027; GO:0030424; GO:0042995; GO:0043005; GO:0051014; GO:0051015; GO:0051016; GO:0060271; GO:0071933; GO:1900480"
"3141",3141,"Cluster_589","Porites_evermani_scaffold_316:73763-74763",163,-23.09,2,20,393,414,18,"72.22%","83.33%","Peve_00023763",-0.962662263159857,0.174513793902184,0.978262075707395,"Q9HD45","Transmembrane 9 superfamily member 3 (EP70-P-iso) (SM-11044-binding protein)","Homo sapiens (Human)","protein localization to membrane [GO:0072657]","GO:0016020; GO:0072657"
"3142",3142,"Cluster_589","Porites_evermani_scaffold_3168:31932-32932",174,-29.85,2,21,953,973,19,"84.21%","89.47%","Peve_00023821",-0.204654625557145,0.868785756562208,0.997252323136946,NA,NA,NA,NA,NA
"3143",3143,"Cluster_589","Porites_evermani_scaffold_319:287504-288504",162,-23.06,2,20,869,891,19,"73.68%","84.21%","Peve_00023936",-0.613306540487991,0.579678074412289,0.978262075707395,"A0A1B0GVB3",NA,NA,NA,NA
"3144",3144,"Cluster_589","Porites_evermani_scaffold_3227:0-978",163,-29.46,2,21,133,155,20,"75.00%","80.00%","Peve_00024179",-0.96455304250446,0.170010557099282,0.978262075707395,NA,NA,NA,NA,NA
"3145",3145,"Cluster_589","Porites_evermani_scaffold_3232:49619-50619",155,-23.41,2,12,447,468,10,"100.00%","100.00%","Peve_00024220",-0.993547797337621,0.0723573929124004,0.978262075707395,"Q9QZD4","DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4)","Mus musculus (Mouse)","cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of double-stranded telomeric DNA binding [GO:1905768]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of telomere maintenance [GO:0032205]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair involved in interstrand cross-link repair [GO:1901255]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; regulation of autophagy [GO:0010506]; resolution of meiotic recombination intermediates [GO:0000712]; response to UV [GO:0009411]; telomere maintenance [GO:0000723]; telomeric DNA-containing double minutes formation [GO:0061819]; UV protection [GO:0009650]","GO:0000014; GO:0000109; GO:0000110; GO:0000712; GO:0000723; GO:0000724; GO:0000781; GO:0001094; GO:0003677; GO:0003684; GO:0003697; GO:0004520; GO:0005634; GO:0006281; GO:0006289; GO:0006295; GO:0006296; GO:0006303; GO:0008022; GO:0009411; GO:0009650; GO:0010506; GO:0032205; GO:0034644; GO:0042802; GO:0047485; GO:0061819; GO:0070522; GO:1901255; GO:1904357; GO:1905765; GO:1905768; GO:1990599; GO:1990841"
"3146",3146,"Cluster_589","Porites_evermani_scaffold_3268:22076-23076",158,-20.35,2,21,215,235,19,"73.68%","78.95%","Peve_00024420",NA,NA,NA,NA,NA,NA,NA,NA
"3147",3147,"Cluster_589","Porites_evermani_scaffold_327:4836-5836",155,-22.77,2,16,429,450,14,"78.57%","85.71%","Peve_00024427",0.159680919674548,0.897906931664995,0.999448381576871,"O75382","Tripartite motif-containing protein 3 (Brain-expressed RING finger protein) (RING finger protein 22) (RING finger protein 97)","Homo sapiens (Human)","nervous system development [GO:0007399]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]","GO:0000209; GO:0005737; GO:0005769; GO:0005794; GO:0007399; GO:0008022; GO:0008270; GO:0015031; GO:0030425; GO:0042802; GO:0043161; GO:0061630"
"3148",3148,"Cluster_589","Porites_evermani_scaffold_3301:39799-40799",166,-26.91,2,21,911,931,19,"73.68%","89.47%","Peve_00024680",NA,NA,NA,NA,NA,NA,NA,NA
"3149",3149,"Cluster_589","Porites_evermani_scaffold_3345:37344-38344",150,-20.31,2,11,496,517,9,"100.00%","100.00%","Peve_00024943",NA,NA,NA,NA,NA,NA,NA,NA
"3150",3150,"Cluster_589","Porites_evermani_scaffold_3345:44228-45228",150,-20.31,2,11,496,517,9,"100.00%","100.00%","Peve_00024944",NA,NA,NA,NA,NA,NA,NA,NA
"3151",3151,"Cluster_589","Porites_evermani_scaffold_342:223932-224932",155,-24.24,2,21,189,212,21,"66.67%","76.19%","Peve_00025415",-0.878569361889531,0.316997055037225,0.978262075707395,NA,NA,NA,NA,NA
"3152",3152,"Cluster_589","Porites_evermani_scaffold_3472:10349-11349",170,-24.57,2,21,604,624,19,"78.95%","89.47%","Peve_00025749",NA,NA,NA,NA,NA,NA,NA,NA
"3153",3153,"Cluster_589","Porites_evermani_scaffold_3482:40618-41618",150,-20.31,2,11,953,974,9,"100.00%","100.00%","Peve_00025813",0.981643447578786,0.12216794627667,0.978262075707395,"Q3UMR0","Ankyrin repeat domain-containing protein 27 (VPS9 domain-containing protein) (VPS9-ankyrin-repeat protein)","Mus musculus (Mouse)","early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; endosome to melanosome transport [GO:0035646]; negative regulation of SNARE complex assembly [GO:0035544]; neuron projection morphogenesis [GO:0048812]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of neuron projection development [GO:0010976]; protein transport [GO:0015031]","GO:0000149; GO:0005085; GO:0005096; GO:0005764; GO:0005769; GO:0005770; GO:0005829; GO:0005886; GO:0010976; GO:0015031; GO:0030133; GO:0030659; GO:0031267; GO:0032456; GO:0035544; GO:0035646; GO:0042470; GO:0043005; GO:0043231; GO:0045022; GO:0048812; GO:0050775; GO:0097422"
"3154",3154,"Cluster_589","Porites_evermani_scaffold_3496:8454-9454",158,-21.06,2,20,222,244,19,"68.42%","84.21%","Peve_00025877",NA,NA,NA,NA,NA,NA,NA,NA
"3155",3155,"Cluster_589","Porites_evermani_scaffold_350:52698-53698",154,-20.1,2,15,390,411,13,"76.92%","92.31%","Peve_00025963",NA,NA,NA,NA,NA,NA,NA,NA
"3156",3156,"Cluster_589","Porites_evermani_scaffold_3525:6991-7991",155,-21.82,2,12,883,904,10,"100.00%","100.00%","Peve_00026108",-0.934753615028442,0.231240264998328,0.978262075707395,NA,NA,NA,NA,NA
"3157",3157,"Cluster_589","Porites_evermani_scaffold_3550:37425-38425",157,-21.11,2,20,718,738,18,"72.22%","83.33%","Peve_00026254",NA,NA,NA,"P97717","Alpha-1B adrenergic receptor (Alpha-1B adrenoreceptor) (Alpha-1B adrenoceptor)","Mus musculus (Mouse)","adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adult heart development [GO:0007512]; behavioral response to cocaine [GO:0048148]; blood vessel remodeling [GO:0001974]; cell growth involved in cardiac muscle cell development [GO:0061049]; cell-cell signaling [GO:0007267]; glucose homeostasis [GO:0042593]; glycogen catabolic process [GO:0005980]; locomotory behavior [GO:0007626]; multicellular organism aging [GO:0010259]; negative regulation of glycogen catabolic process [GO:0045818]; negative regulation of Rho protein signal transduction [GO:0035024]; neuron-glial cell signaling [GO:0150099]; organ growth [GO:0035265]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of glycogen catabolic process [GO:0045819]; positive regulation of heart rate by epinephrine-norepinephrine [GO:0001996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of the force of heart contraction by epinephrine-norepinephrine [GO:0001997]; positive regulation of vasoconstriction [GO:0045907]; regulation of blood pressure [GO:0008217]; regulation of cardiac muscle contraction [GO:0055117]; response to amphetamine [GO:0001975]; response to hormone [GO:0009725]; response to morphine [GO:0043278]; response to steroid hormone [GO:0048545]; vasoconstriction of artery involved in baroreceptor response to lowering of systemic arterial blood pressure [GO:0001987]; visual learning [GO:0008542]","GO:0001974; GO:0001975; GO:0001987; GO:0001996; GO:0001997; GO:0004930; GO:0004937; GO:0005634; GO:0005737; GO:0005886; GO:0005901; GO:0005980; GO:0007200; GO:0007204; GO:0007267; GO:0007512; GO:0007626; GO:0008217; GO:0008542; GO:0009725; GO:0010259; GO:0014704; GO:0016020; GO:0030315; GO:0031965; GO:0035024; GO:0035265; GO:0042593; GO:0043278; GO:0043410; GO:0045818; GO:0045819; GO:0045907; GO:0046982; GO:0048148; GO:0048545; GO:0055117; GO:0061049; GO:0071880; GO:0150099"
"3158",3158,"Cluster_589","Porites_evermani_scaffold_3560:17645-18645",154,-20.71,2,19,278,299,17,"64.71%","82.35%","Peve_00026308",-0.156093088014409,0.900220030359414,0.999448381576871,NA,NA,NA,NA,NA
"3159",3159,"Cluster_589","Porites_evermani_scaffold_370:137334-138334",156,-20.91,2,21,90,111,19,"63.16%","78.95%","Peve_00027123",0.703621872347543,0.50312983923493,0.978262075707395,"Q9VFJ3","Serine protease HTRA2, mitochondrial (EC 3.4.21.108) (High temperature requirement protein A2) (DmHtrA2) (HtrA2) (Omi stress-regulated endoprotease) (dOmi) [Cleaved into: Serine protease HTRA2, mitochondrial, long; Serine protease HTRA2, mitochondrial, short]","Drosophila melanogaster (Fruit fly)","apoptotic process [GO:0006915]; ectopic germ cell programmed cell death [GO:0035234]; mitochondrion organization [GO:0007005]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; programmed cell death [GO:0012501]; proteolysis [GO:0006508]; regulation of apoptotic process [GO:0042981]; spermatogenesis [GO:0007283]","GO:0004222; GO:0004252; GO:0005739; GO:0005758; GO:0005829; GO:0006508; GO:0006915; GO:0007005; GO:0007283; GO:0008233; GO:0012501; GO:0016006; GO:0017171; GO:0031966; GO:0035234; GO:0042981; GO:0043065; GO:2001056"
"3160",3160,"Cluster_589","Porites_evermani_scaffold_3750:32788-33788",165,-27.84,2,18,787,808,16,"81.25%","87.50%","Peve_00027353",NA,NA,NA,NA,NA,NA,NA,NA
"3161",3161,"Cluster_589","Porites_evermani_scaffold_382:91154-92154",155,-22.07,2,20,507,528,18,"66.67%","77.78%","Peve_00027744",NA,NA,NA,NA,NA,NA,NA,NA
"3162",3162,"Cluster_589","Porites_evermani_scaffold_3858:3832-4832",150,-26.73,2,21,49,77,26,"65.38%","69.23%","Peve_00027928",-0.934753615028442,0.231240264998328,0.978262075707395,NA,NA,NA,NA,NA
"3163",3163,"Cluster_589","Porites_evermani_scaffold_386:168674-169295",143,-21.53,2,18,164,188,19,"68.42%","73.68%","Peve_00027944",-0.798381787482379,0.4113794321744,0.978262075707395,NA,NA,NA,NA,NA
"3164",3164,"Cluster_589","Porites_evermani_scaffold_389:19236-20236",159,-21,2,21,757,779,20,"70.00%","80.00%","Peve_00028080",-0.780471961959789,0.429957687482135,0.978262075707395,NA,NA,NA,NA,NA
"3165",3165,"Cluster_589","Porites_evermani_scaffold_389:19844-20844",159,-21,2,21,149,171,20,"70.00%","80.00%","Peve_00028084",NA,NA,NA,NA,NA,NA,NA,NA
"3166",3166,"Cluster_589","Porites_evermani_scaffold_391:48688-49688",156,-21.84,2,18,536,558,17,"76.47%","82.35%","Peve_00028238",-0.999566973841129,0.0187356109725696,0.784805430107369,"P28575","Actin-binding protein IPP (Intracisternal A particle-promoted polypeptide) (IPP) (Murine IAP-promoted placenta-expressed protein) (Protein MIPP)","Mus musculus (Mouse)","","GO:0003779; GO:0005737; GO:0005856"
"3167",3167,"Cluster_589","Porites_evermani_scaffold_3938:16846-17846",159,-28.64,2,21,8,30,20,"65.00%","85.00%","Peve_00028389",0.716688450083315,0.491313942172371,0.978262075707395,NA,NA,NA,NA,NA
"3168",3168,"Cluster_589","Porites_evermani_scaffold_396:67947-68947",155,-20.68,2,12,252,273,10,"100.00%","100.00%","Peve_00028514",-0.934753615028442,0.231240264998328,0.978262075707395,NA,NA,NA,NA,NA
"3169",3169,"Cluster_589","Porites_evermani_scaffold_397:255999-256999",154,-24.35,2,20,12,37,22,"63.64%","77.27%","Peve_00028570",-0.990382713359162,0.0883629237728628,0.978262075707395,"Q5R5H1","S-adenosylmethionine synthase isoform type-2 (AdoMet synthase 2) (EC 2.5.1.6) (Methionine adenosyltransferase 2) (MAT 2)","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","cellular response to leukemia inhibitory factor [GO:1990830]; one-carbon metabolic process [GO:0006730]; protein heterooligomerization [GO:0051291]; protein hexamerization [GO:0034214]; S-adenosylmethionine biosynthetic process [GO:0006556]","GO:0004478; GO:0005524; GO:0006556; GO:0006730; GO:0034214; GO:0042802; GO:0046872; GO:0048269; GO:0051291; GO:1990830"
"3170",3170,"Cluster_589","Porites_evermani_scaffold_401:136789-137745",144,-20.49,2,18,662,688,21,"61.90%","71.43%","Peve_00028891",-0.934753615028442,0.231240264998328,0.978262075707395,NA,NA,NA,NA,NA
"3171",3171,"Cluster_589","Porites_evermani_scaffold_403:252522-253522",147,-20.49,2,20,730,751,18,"61.11%","72.22%","Peve_00028993",NA,NA,NA,NA,NA,NA,NA,NA
"3172",3172,"Cluster_589","Porites_evermani_scaffold_404:1625-2625",162,-23.2,2,19,899,920,17,"76.47%","82.35%","Peve_00029029",0.064058116121463,0.959191394886989,0.999448381576871,NA,NA,NA,NA,NA
"3173",3173,"Cluster_589","Porites_evermani_scaffold_405:17864-18864",158,-23.16,2,21,260,285,23,"73.91%","73.91%","Peve_00029090",NA,NA,NA,NA,NA,NA,NA,NA
"3174",3174,"Cluster_589","Porites_evermani_scaffold_405:20863-21863",158,-23.16,2,21,260,285,23,"73.91%","73.91%","Peve_00029099",NA,NA,NA,NA,NA,NA,NA,NA
"3175",3175,"Cluster_589","Porites_evermani_scaffold_405:84309-85309",156,-20.71,2,21,754,775,19,"63.16%","78.95%","Peve_00029108",NA,NA,NA,NA,NA,NA,NA,NA
"3176",3176,"Cluster_589","Porites_evermani_scaffold_4097:5099-6099",162,-34.22,2,20,529,557,25,"72.00%","72.00%","Peve_00029322",NA,NA,NA,NA,NA,NA,NA,NA
"3177",3177,"Cluster_589","Porites_evermani_scaffold_4134:10000-11000",159,-21.01,2,21,972,994,20,"70.00%","80.00%","Peve_00029551",NA,NA,NA,"Q7Z020","Transient receptor potential cation channel subfamily A member 1 (dTRPA1) (Ankyrin-like with transmembrane domains protein 1) (dANKTM1)","Drosophila melanogaster (Fruit fly)","calcium ion transport [GO:0006816]; cation transport [GO:0006812]; cellular response to heat [GO:0034605]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; detection of temperature stimulus involved in thermoception [GO:0050960]; mechanosensory behavior [GO:0007638]; negative phototaxis [GO:0046957]; neuronal signal transduction [GO:0023041]; phototransduction [GO:0007602]; positive regulation of calcium-mediated signaling [GO:0050850]; response to heat [GO:0009408]; response to light stimulus [GO:0009416]; temperature compensation of the circadian clock [GO:0010378]; thermosensory behavior [GO:0040040]; thermotaxis [GO:0043052]","GO:0001580; GO:0005261; GO:0005262; GO:0005886; GO:0006812; GO:0006816; GO:0007602; GO:0007638; GO:0009408; GO:0009416; GO:0010378; GO:0015276; GO:0016020; GO:0023041; GO:0034605; GO:0034703; GO:0040040; GO:0043052; GO:0046957; GO:0050850; GO:0050960; GO:0050965; GO:0050968; GO:0097604"
"3178",3178,"Cluster_589","Porites_evermani_scaffold_4137:27104-27464",162,-23.25,2,21,60,80,19,"73.68%","84.21%","Peve_00029558",-0.973049249545664,0.148136059440161,0.978262075707395,"O95985","DNA topoisomerase 3-beta-1 (EC 5.6.2.1) (DNA topoisomerase III beta-1)","Homo sapiens (Human)","chromosome segregation [GO:0007059]; DNA topological change [GO:0006265]","GO:0000793; GO:0003677; GO:0003723; GO:0003916; GO:0003917; GO:0005634; GO:0006265; GO:0007059; GO:0140225"
"3179",3179,"Cluster_589","Porites_evermani_scaffold_4137:27104-27464",162,-23.25,2,21,60,80,19,"73.68%","84.21%","Peve_00029556",-0.997545167599482,0.0446164413451834,0.928064198164883,NA,NA,NA,NA,NA
"3180",3180,"Cluster_589","Porites_evermani_scaffold_422:91608-92608",167,-22.83,2,21,84,106,20,"75.00%","85.00%","Peve_00029987",0.832912196610828,0.37334373750668,0.978262075707395,NA,NA,NA,NA,NA
"3181",3181,"Cluster_589","Porites_evermani_scaffold_4266:22491-23491",165,-27.84,2,18,761,782,16,"81.25%","87.50%","Peve_00030211",NA,NA,NA,NA,NA,NA,NA,NA
"3182",3182,"Cluster_589","Porites_evermani_scaffold_4339:421-1421",160,-23,2,21,87,108,19,"68.42%","78.95%","Peve_00030615",0.72459923178248,0.484049790584232,0.978262075707395,"P42291","D(1C) dopamine receptor","Xenopus laevis (African clawed frog)","regulation of biological quality [GO:0065008]","GO:0004930; GO:0005886; GO:0065008"
"3183",3183,"Cluster_589","Porites_evermani_scaffold_4355:20180-21180",171,-27.99,2,21,417,439,20,"80.00%","85.00%","Peve_00030685",NA,NA,NA,NA,NA,NA,NA,NA
"3184",3184,"Cluster_589","Porites_evermani_scaffold_4358:15326-16326",156,-20.29,2,19,914,934,17,"76.47%","82.35%","Peve_00030695",0.99896776402964,0.0289282378876426,0.903929377050813,"Q9IA76","60S ribosomal protein L31","Paralichthys olivaceus (Bastard halibut) (Hippoglossus olivaceus)","translation [GO:0006412]","GO:0003735; GO:0005737; GO:0005840; GO:0006412; GO:1990904"
"3185",3185,"Cluster_589","Porites_evermani_scaffold_440:216864-217864",168,-25.59,2,21,739,760,19,"73.68%","84.21%","Peve_00030953",NA,NA,NA,NA,NA,NA,NA,NA
"3186",3186,"Cluster_589","Porites_evermani_scaffold_449:224568-225568",155,-21.13,2,12,900,921,10,"100.00%","100.00%","Peve_00031411",-0.961455776424833,0.177328972293778,0.978262075707395,"Q0P4Y1","Histidine N-acetyltransferase (EC 2.3.1.33)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","","GO:0047981"
"3187",3187,"Cluster_589","Porites_evermani_scaffold_4547:23288-24288",159,-24.21,2,20,292,313,18,"72.22%","77.78%","Peve_00031640",-0.944144540264345,0.213781656321376,0.978262075707395,"K7FQW8","Amiloride-sensitive sodium channel subunit beta (Beta-NaCH) (Epithelial Na(+) channel subunit beta) (Beta-ENaC) (Nonvoltage-gated sodium channel 1 subunit beta) (SCNEB)","Pelodiscus sinensis (Chinese softshell turtle) (Trionyx sinensis)","aldosterone metabolic process [GO:0032341]; artery smooth muscle contraction [GO:0014824]; cellular response to acidic pH [GO:0071468]; cellular response to aldosterone [GO:1904045]; cellular response to amiloride [GO:0036254]; cellular sodium ion homeostasis [GO:0006883]; epithelial fluid transport [GO:0042045]; erythrocyte homeostasis [GO:0034101]; gene expression [GO:0010467]; leukocyte activation involved in inflammatory response [GO:0002269]; mucus secretion [GO:0070254]; multicellular organism growth [GO:0035264]; multicellular organismal water homeostasis [GO:0050891]; neutrophil activation involved in immune response [GO:0002283]; neutrophil-mediated killing of bacterium [GO:0070944]; potassium ion homeostasis [GO:0055075]; response to food [GO:0032094]; response to xenobiotic stimulus [GO:0009410]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; urea homeostasis [GO:0097274]","GO:0002269; GO:0002283; GO:0006883; GO:0009410; GO:0009897; GO:0010467; GO:0014824; GO:0015280; GO:0016324; GO:0030659; GO:0032094; GO:0032341; GO:0034101; GO:0034706; GO:0035264; GO:0035725; GO:0036254; GO:0042045; GO:0050699; GO:0050891; GO:0055075; GO:0070062; GO:0070254; GO:0070944; GO:0071468; GO:0097274; GO:0098719; GO:1904045"
"3188",3188,"Cluster_589","Porites_evermani_scaffold_456:191181-192181",155,-23.55,2,12,716,737,10,"100.00%","100.00%","Peve_00031701",-0.125806185908114,0.919696506975199,0.999448381576871,"A8MPX8","Protein phosphatase 2C-like domain-containing protein 1","Homo sapiens (Human)","protein dephosphorylation [GO:0006470]","GO:0004722; GO:0006470"
"3189",3189,"Cluster_589","Porites_evermani_scaffold_4577:9161-10161",150,-21.21,2,11,579,600,9,"100.00%","100.00%","Peve_00031774",NA,NA,NA,NA,NA,NA,NA,NA
"3190",3190,"Cluster_589","Porites_evermani_scaffold_462:62845-63845",158,-21.78,2,18,674,693,16,"81.25%","87.50%","Peve_00031989",NA,NA,NA,NA,NA,NA,NA,NA
"3191",3191,"Cluster_589","Porites_evermani_scaffold_4652:9627-10627",171,-25.07,2,20,803,824,18,"83.33%","83.33%","Peve_00032127",0.72137401242393,0.487021797027853,0.978262075707395,"P54106","Methylosome subunit pICln (Chloride conductance regulatory protein ICln) (I(Cln))","Xenopus laevis (African clawed frog)","cell volume homeostasis [GO:0006884]; chloride transport [GO:0006821]; spliceosomal snRNP assembly [GO:0000387]","GO:0000387; GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0006821; GO:0006884; GO:0034709; GO:0034715"
"3192",3192,"Cluster_589","Porites_evermani_scaffold_4700:553-1553",155,-23.41,2,12,787,808,10,"100.00%","100.00%","Peve_00032344",-0.566340787703404,0.616717223404246,0.978262075707395,NA,NA,NA,NA,NA
"3193",3193,"Cluster_589","Porites_evermani_scaffold_470:45515-46515",167,-25.96,2,18,589,609,16,"87.50%","93.75%","Peve_00032325",0.775072695353894,0.435426401668339,0.978262075707395,"Q9GZX3","Carbohydrate sulfotransferase 6 (Corneal N-acetylglucosamine-6-O-sulfotransferase) (C-GlcNAc6ST) (hCGn6ST) (EC 2.8.2.21) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 4-beta) (GST4-beta) (N-acetylglucosamine 6-O-sulfotransferase 5) (GlcNAc6ST-5) (Gn6st-5)","Homo sapiens (Human)","carbohydrate metabolic process [GO:0005975]; keratan sulfate biosynthetic process [GO:0018146]; N-acetylglucosamine metabolic process [GO:0006044]; sulfur compound metabolic process [GO:0006790]","GO:0000139; GO:0001517; GO:0005794; GO:0005802; GO:0005975; GO:0006044; GO:0006790; GO:0018146; GO:0045130"
"3194",3194,"Cluster_589","Porites_evermani_scaffold_4706:12803-13803",147,-20.49,2,20,390,411,18,"61.11%","72.22%","Peve_00032356",-0.369518097710641,0.759045553370929,0.988219883885475,"Q6GP53","N-alpha-acetyltransferase 50 (EC 2.3.1.258) (N-acetyltransferase NAT13) (N-epsilon-acetyltransferase 50) (EC 2.3.1.-) (NatE catalytic subunit)","Xenopus laevis (African clawed frog)","establishment of mitotic sister chromatid cohesion [GO:0034087]; mitotic sister chromatid cohesion, centromeric [GO:0071962]; N-terminal protein amino acid acetylation [GO:0006474]","GO:0004596; GO:0005634; GO:0005737; GO:0005829; GO:0006474; GO:0010485; GO:0034087; GO:0052858; GO:0071962"
"3195",3195,"Cluster_589","Porites_evermani_scaffold_4711:11638-12638",162,-23.01,2,21,612,632,19,"73.68%","84.21%","Peve_00032393",0.34045778336451,0.778835920527656,0.993199287066305,NA,NA,NA,NA,NA
"3196",3196,"Cluster_589","Porites_evermani_scaffold_47:263908-264908",154,-20.49,2,21,223,243,19,"73.68%","73.68%","Peve_00032289",-0.852871148926974,0.349718463474863,0.978262075707395,"Q5UU75","Doublesex- and mab-3-related transcription factor A2 (Doublesex- and mab-3-related transcription factor 5)","Danio rerio (Zebrafish) (Brachydanio rerio)","corticotropin hormone secreting cell differentiation [GO:0060128]; regulation of transcription by RNA polymerase II [GO:0006357]; sex differentiation [GO:0007548]; telencephalon development [GO:0021537]","GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007548; GO:0021537; GO:0046872; GO:0060128"
"3197",3197,"Cluster_589","Porites_evermani_scaffold_476:205223-206223",142,-20.43,2,21,876,899,21,"66.67%","66.67%","Peve_00032575",-0.649591407300909,0.549879968715536,0.978262075707395,"Q5ZID0","NmrA-like family domain-containing protein 1","Gallus gallus (Chicken)","","GO:0005634; GO:0048471"
"3198",3198,"Cluster_589","Porites_evermani_scaffold_479:243427-244427",162,-25.97,2,16,712,734,15,"86.67%","93.33%","Peve_00032685",-0.69324065488159,0.512364606472249,0.978262075707395,NA,NA,NA,NA,NA
"3199",3199,"Cluster_589","Porites_evermani_scaffold_485:197263-198263",151,-20.55,2,12,492,513,10,"90.00%","100.00%","Peve_00032954",NA,NA,NA,NA,NA,NA,NA,NA
"3200",3200,"Cluster_589","Porites_evermani_scaffold_491:69417-70417",151,-22.59,2,17,728,750,16,"75.00%","81.25%","Peve_00033174",-0.118099403975096,0.924639706144054,0.999448381576871,NA,NA,NA,NA,NA
"3201",3201,"Cluster_589","Porites_evermani_scaffold_497:163232-164232",162,-23.82,2,15,753,774,13,"84.62%","100.00%","Peve_00033407",-0.980441755326252,0.126116075124827,0.978262075707395,"Q5RKI1","Eukaryotic initiation factor 4A-II (eIF-4A-II) (eIF4A-II) (EC 3.6.4.13) (ATP-dependent RNA helicase eIF4A-2)","Rattus norvegicus (Rat)","cellular response to leukemia inhibitory factor [GO:1990830]; cytoplasmic translational initiation [GO:0002183]; negative regulation of RNA-dependent RNA polymerase activity [GO:1900260]","GO:0002183; GO:0003723; GO:0003724; GO:0003743; GO:0005524; GO:0016887; GO:0048471; GO:1900260; GO:1990830"
"3202",3202,"Cluster_589","Porites_evermani_scaffold_4:980168-981168",155,-21.34,2,12,331,352,10,"100.00%","100.00%","Peve_00028738",-0.992260720420171,0.0792548559226486,0.978262075707395,NA,NA,NA,NA,NA
"3203",3203,"Cluster_589","Porites_evermani_scaffold_5036:15751-16751",158,-21.34,2,19,559,580,17,"64.71%","88.24%","Peve_00033775",NA,NA,NA,NA,NA,NA,NA,NA
"3204",3204,"Cluster_589","Porites_evermani_scaffold_50:546022-547022",155,-21.05,2,21,185,208,21,"66.67%","76.19%","Peve_00033624",-0.93983924756715,0.221949137283024,0.978262075707395,"Q09225","Nose resistant to fluoxetine protein 6 (Protein nrf-6)","Caenorhabditis elegans","lipid transport [GO:0006869]","GO:0006869; GO:0008289; GO:0016020; GO:0016747"
"3205",3205,"Cluster_589","Porites_evermani_scaffold_505:47204-48204",152,-21.27,2,20,103,127,22,"68.18%","77.27%","Peve_00033813",-0.999435010130582,0.0214010903728724,0.824328633796369,"Q07076","Annexin A7 (Annexin VII) (Annexin-7) (Synexin)","Mus musculus (Mouse)","autophagy [GO:0006914]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; establishment of localization in cell [GO:0051649]; glial cell proliferation [GO:0014009]; hemostasis [GO:0007599]; insulin secretion [GO:0030073]; ion channel modulating, G protein-coupled receptor signaling pathway [GO:0099105]; ligand-gated ion channel signaling pathway [GO:1990806]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway [GO:0007207]; positive regulation of insulin secretion [GO:0032024]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]","GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005737; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007207; GO:0007599; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014009; GO:0014070; GO:0030073; GO:0031982; GO:0032024; GO:0042584; GO:0045202; GO:0048306; GO:0051592; GO:0051649; GO:0061025; GO:0062023; GO:0099105; GO:1990806"
"3206",3206,"Cluster_589","Porites_evermani_scaffold_5089:5138-6138",159,-22.8,2,20,631,652,18,"66.67%","83.33%","Peve_00033956",NA,NA,NA,NA,NA,NA,NA,NA
"3207",3207,"Cluster_589","Porites_evermani_scaffold_5127:10381-11381",155,-23.55,2,12,225,246,10,"100.00%","100.00%","Peve_00034154",0.775072695353894,0.435426401668339,0.978262075707395,NA,NA,NA,NA,NA
"3208",3208,"Cluster_589","Porites_evermani_scaffold_51:348719-349719",147,-20.51,2,21,411,435,22,"59.09%","72.73%","Peve_00034048",-0.934753615028442,0.231240264998328,0.978262075707395,NA,NA,NA,NA,NA
"3209",3209,"Cluster_589","Porites_evermani_scaffold_517:180624-181624",156,-24.25,2,21,814,835,19,"68.42%","73.68%","Peve_00034275",NA,NA,NA,NA,NA,NA,NA,NA
"3210",3210,"Cluster_589","Porites_evermani_scaffold_518:44140-45140",156,-22.03,2,21,567,588,19,"63.16%","78.95%","Peve_00034315",NA,NA,NA,NA,NA,NA,NA,NA
"3211",3211,"Cluster_589","Porites_evermani_scaffold_5247:3724-4724",164,-27.83,2,18,533,557,19,"78.95%","84.21%","Peve_00034549",-0.946465098328866,0.20925238647594,0.978262075707395,"P49285","Melatonin receptor type 1A (Mel-1A-R) (Mel1a receptor) (CKA)","Gallus gallus (Chicken)","adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; circadian rhythm [GO:0007623]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of glucose import [GO:0046325]; negative regulation of glycolytic process [GO:0045820]","GO:0004930; GO:0005886; GO:0007186; GO:0007193; GO:0007623; GO:0008502; GO:0042562; GO:0043235; GO:0045820; GO:0046325; GO:1904408"
"3212",3212,"Cluster_589","Porites_evermani_scaffold_529:39248-40248",162,-24.05,2,20,733,755,19,"73.68%","84.21%","Peve_00034677",-0.554280696796143,0.625986830603106,0.978262075707395,"Q76KP1","N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 1 (NGalNAc-T1) (EC 2.4.1.244) (Beta-1,4-N-acetylgalactosaminyltransferase IV) (Beta4GalNAc-T4) (Beta4GalNAcT4)","Homo sapiens (Human)","","GO:0008376; GO:0032580; GO:0033842"
"3213",3213,"Cluster_589","Porites_evermani_scaffold_537:126765-127765",170,-25.19,2,21,788,808,19,"78.95%","89.47%","Peve_00034979",-0.0136614876158864,0.991302556306427,0.999448381576871,"Q92611","ER degradation-enhancing alpha-mannosidase-like protein 1","Homo sapiens (Human)","carbohydrate metabolic process [GO:0005975]; endoplasmic reticulum mannose trimming [GO:1904380]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; positive regulation of retrograde protein transport, ER to cytosol [GO:1904154]; protein targeting to ER [GO:0045047]; response to unfolded protein [GO:0006986]; trimming of terminal mannose on C branch [GO:0036510]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent glycoprotein ERAD pathway [GO:0097466]","GO:0004571; GO:0005509; GO:0005783; GO:0005789; GO:0005975; GO:0006986; GO:0016235; GO:0030433; GO:0036510; GO:0044322; GO:0045047; GO:0051787; GO:0097466; GO:1904154; GO:1904380; GO:1904382"
"3214",3214,"Cluster_589","Porites_evermani_scaffold_5412:1023-2023",167,-27.02,2,20,795,816,18,"72.22%","88.89%","Peve_00035199",NA,NA,NA,NA,NA,NA,NA,NA
"3215",3215,"Cluster_589","Porites_evermani_scaffold_541:68986-69986",158,-22.64,2,15,748,769,13,"84.62%","92.31%","Peve_00035180",-0.744944590068841,0.4649517793733,0.978262075707395,NA,NA,NA,NA,NA
"3216",3216,"Cluster_589","Porites_evermani_scaffold_543:95651-96651",154,-20.08,2,21,939,962,21,"71.43%","76.19%","Peve_00035247",NA,NA,NA,NA,NA,NA,NA,NA
"3217",3217,"Cluster_589","Porites_evermani_scaffold_545:174134-175134",157,-23.77,2,20,168,188,18,"77.78%","77.78%","Peve_00035304",NA,NA,NA,NA,NA,NA,NA,NA
"3218",3218,"Cluster_589","Porites_evermani_scaffold_54:540693-541693",159,-23.15,2,21,764,786,20,"75.00%","75.00%","Peve_00035122",-0.990352186317196,0.0885032787159942,0.978262075707395,"Q04721","Neurogenic locus notch homolog protein 2 (Notch 2) (hN2) [Cleaved into: Notch 2 extracellular truncation (N2ECD); Notch 2 intracellular domain (N2ICD)]","Homo sapiens (Human)","animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; atrioventricular node development [GO:0003162]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hemopoiesis [GO:0030097]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of osteoclast development [GO:2001204]; wound healing [GO:0042060]","GO:0000122; GO:0000139; GO:0001701; GO:0001709; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003162; GO:0003184; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005886; GO:0005929; GO:0006915; GO:0006959; GO:0007219; GO:0007399; GO:0007411; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0016020; GO:0019899; GO:0030097; GO:0030326; GO:0030509; GO:0030513; GO:0035264; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043066; GO:0043235; GO:0045672; GO:0046579; GO:0046849; GO:0051059; GO:0060413; GO:0060674; GO:0061073; GO:0061314; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:1990705; GO:2000249; GO:2001204"
"3219",3219,"Cluster_589","Porites_evermani_scaffold_555:144487-145487",159,-21.87,2,21,372,394,20,"75.00%","75.00%","Peve_00035640",-0.934753615028442,0.231240264998328,0.978262075707395,NA,NA,NA,NA,NA
"3220",3220,"Cluster_589","Porites_evermani_scaffold_5571:10484-11484",148,-20.68,2,19,405,431,22,"63.64%","77.27%","Peve_00035722",-0.767686158358001,0.442815998307695,0.978262075707395,NA,NA,NA,NA,NA
"3221",3221,"Cluster_589","Porites_evermani_scaffold_561:184403-185403",150,-20.84,2,11,718,739,9,"100.00%","100.00%","Peve_00035839",-0.999999999503679,2.00574810710951e-05,0.0131777650637095,"P59750","Merlin (Moesin-ezrin-radixin-like protein) (Neurofibromin-2) (Schwannomin)","Papio anubis (Olive baboon)","actin cytoskeleton organization [GO:0030036]; cell-cell junction organization [GO:0045216]; ectoderm development [GO:0007398]; hippocampus development [GO:0021766]; lens fiber cell differentiation [GO:0070306]; MAPK cascade [GO:0000165]; mesoderm formation [GO:0001707]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of Schwann cell proliferation [GO:0010626]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast proliferation [GO:0033687]; positive regulation of cell differentiation [GO:0045597]; positive regulation of stress fiber assembly [GO:0051496]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of hippo signaling [GO:0035330]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of protein localization to nucleus [GO:1900180]; regulation of protein stability [GO:0031647]; regulation of stem cell proliferation [GO:0072091]; Schwann cell proliferation [GO:0014010]","GO:0000165; GO:0001707; GO:0001726; GO:0003779; GO:0005730; GO:0005769; GO:0005829; GO:0005912; GO:0006469; GO:0007398; GO:0010626; GO:0014010; GO:0021766; GO:0022408; GO:0030027; GO:0030036; GO:0030175; GO:0030864; GO:0031647; GO:0032154; GO:0033687; GO:0033689; GO:0035330; GO:0042475; GO:0042532; GO:0042981; GO:0043005; GO:0043409; GO:0044297; GO:0045177; GO:0045216; GO:0045597; GO:0048471; GO:0051496; GO:0051726; GO:0070306; GO:0072091; GO:1900180; GO:2000177"
"3222",3222,"Cluster_589","Porites_evermani_scaffold_563:50383-51383",170,-26.57,2,21,222,242,19,"78.95%","89.47%","Peve_00035893",-0.889515090376282,0.302084705828089,0.978262075707395,"P22892","AP-1 complex subunit gamma-1 (Adaptor protein complex AP-1 subunit gamma-1) (Adaptor-related protein complex 1 subunit gamma-1) (Clathrin assembly protein complex 1 gamma-1 large chain) (Gamma-adaptin) (Gamma1-adaptin) (Golgi adaptor HA1/AP1 adaptin subunit gamma-1)","Mus musculus (Mouse)","basolateral protein secretion [GO:0110010]; endosome to melanosome transport [GO:0035646]; Golgi to lysosome transport [GO:0090160]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155]; positive regulation of natural killer cell degranulation [GO:0043323]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; vesicle-mediated transport [GO:0016192]","GO:0005765; GO:0005769; GO:0005794; GO:0005802; GO:0005829; GO:0005905; GO:0006886; GO:0006896; GO:0016192; GO:0019894; GO:0030121; GO:0030136; GO:0030742; GO:0031267; GO:0032588; GO:0035615; GO:0035646; GO:0043231; GO:0043323; GO:0045954; GO:0048471; GO:0055037; GO:0060155; GO:0090160; GO:0110010; GO:0140312; GO:1903232"
"3223",3223,"Cluster_589","Porites_evermani_scaffold_567:1653-2602",167,-24.24,2,20,670,691,18,"66.67%","94.44%","Peve_00035985",-0.943043387739941,0.2158988818285,0.978262075707395,NA,NA,NA,NA,NA
"3224",3224,"Cluster_589","Porites_evermani_scaffold_567:1653-2602",167,-24.24,2,20,670,691,18,"66.67%","94.44%","Peve_00035990",NA,NA,NA,NA,NA,NA,NA,NA
"3225",3225,"Cluster_589","Porites_evermani_scaffold_567:61667-62667",157,-23.13,2,14,924,945,12,"91.67%","91.67%","Peve_00035988",0.450961302820326,0.70216247906743,0.978262075707395,"Q9Y4C8","Probable RNA-binding protein 19 (RNA-binding motif protein 19)","Homo sapiens (Human)","mRNA splicing, via spliceosome [GO:0000398]; positive regulation of embryonic development [GO:0040019]","GO:0000398; GO:0003723; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0016020; GO:0016607; GO:0040019"
"3226",3226,"Cluster_589","Porites_evermani_scaffold_62:544938-545938",159,-25.76,2,21,654,676,20,"75.00%","75.00%","Peve_00037600",NA,NA,NA,"P18505","Gamma-aminobutyric acid receptor subunit beta-1 (GABA(A) receptor subunit beta-1)","Homo sapiens (Human)","cellular response to histamine [GO:0071420]; central nervous system neuron development [GO:0021954]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; nervous system process [GO:0050877]; ovulation cycle [GO:0042698]; regulation of membrane potential [GO:0042391]; response to progesterone [GO:0032570]; response to toxic substance [GO:0009636]; signal transduction [GO:0007165]","GO:0004890; GO:0005231; GO:0005635; GO:0005737; GO:0005886; GO:0006811; GO:0007165; GO:0007214; GO:0007268; GO:0009636; GO:0015276; GO:0021954; GO:0022851; GO:0030425; GO:0030594; GO:0032570; GO:0034220; GO:0034707; GO:0042391; GO:0042698; GO:0043005; GO:0045202; GO:0048787; GO:0050811; GO:0050877; GO:0071420; GO:0098685; GO:0098982; GO:0099507; GO:0099634; GO:0150047; GO:1902476; GO:1902711; GO:1904315"
"3227",3227,"Cluster_589","Porites_evermani_scaffold_64:451537-452537",155,-23.41,2,12,351,372,10,"100.00%","100.00%","Peve_00038102",-0.398077932490683,0.739354715301677,0.986697151420032,NA,NA,NA,NA,NA
"3228",3228,"Cluster_589","Porites_evermani_scaffold_64:464446-465446",154,-20.25,2,17,878,901,17,"82.35%","82.35%","Peve_00038104",0.585606416244301,0.601712865571269,0.978262075707395,NA,NA,NA,NA,NA
"3229",3229,"Cluster_589","Porites_evermani_scaffold_672:115274-116274",162,-22.64,2,20,83,105,19,"73.68%","84.21%","Peve_00038877",NA,NA,NA,"P13608","Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP)","Bos taurus (Bovine)","cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]","GO:0001501; GO:0005509; GO:0005540; GO:0005576; GO:0007155; GO:0007417; GO:0030246; GO:0031012"
"3230",3230,"Cluster_589","Porites_evermani_scaffold_674:679-1679",157,-24.15,2,20,269,289,18,"77.78%","77.78%","Peve_00038918",-0.962807379139275,0.174172197612475,0.978262075707395,"Q6MG55","Phosphatidylserine lipase ABHD16A (EC 3.1.-.-) (Alpha/beta hydrolase domain-containing protein 16A) (Abhydrolase domain-containing protein 16A) (HLA-B-associated transcript 5 homolog) (Monoacylglycerol lipase ABHD16A) (EC 3.1.1.23)","Rattus norvegicus (Rat)","monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660]; prostaglandin catabolic process [GO:1905344]","GO:0004620; GO:0006660; GO:0008474; GO:0016020; GO:0047372; GO:0052651; GO:1905344"
"3231",3231,"Cluster_589","Porites_evermani_scaffold_69:186338-187338",173,-28.75,2,20,76,96,18,"88.89%","88.89%","Peve_00039270",-0.149315799408862,0.904585797492262,0.999448381576871,NA,NA,NA,NA,NA
"3232",3232,"Cluster_589","Porites_evermani_scaffold_69:451614-452614",153,-22.25,2,16,694,714,14,"85.71%","85.71%","Peve_00039250",-0.932285564107168,0.23562286066758,0.978262075707395,"Q38SD2","Leucine-rich repeat serine/threonine-protein kinase 1 (EC 2.7.11.1)","Homo sapiens (Human)","bone resorption [GO:0045453]; intracellular signal transduction [GO:0035556]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; osteoclast development [GO:0036035]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; signal transduction [GO:0007165]","GO:0004674; GO:0004722; GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005829; GO:0007165; GO:0018108; GO:0035556; GO:0036035; GO:0042802; GO:0043231; GO:0045453; GO:0046872; GO:0050731; GO:0050732; GO:0090263; GO:0106310; GO:1902533"
"3233",3233,"Cluster_589","Porites_evermani_scaffold_6979:899-1899",161,-22.16,2,20,684,704,18,"72.22%","88.89%","Peve_00039479",NA,NA,NA,"Q24JV9","Galectin-3-binding protein A (Lectin galactoside-binding soluble 3-binding protein A)","Danio rerio (Zebrafish) (Brachydanio rerio)","cell adhesion [GO:0007155]","GO:0005044; GO:0005576; GO:0007155; GO:0016020"
"3234",3234,"Cluster_589","Porites_evermani_scaffold_708:60409-61409",152,-21.27,2,18,221,244,18,"72.22%","77.78%","Peve_00039762",NA,NA,NA,"B5DF45","TNF receptor-associated factor 6 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF6) (RING-type E3 ubiquitin transferase TRAF6)","Rattus norvegicus (Rat)","activation of NF-kappaB-inducing kinase activity [GO:0007250]; activation of protein kinase activity [GO:0032147]; animal organ morphogenesis [GO:0009887]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; bone remodeling [GO:0046849]; bone resorption [GO:0045453]; cell development [GO:0048468]; cellular response to cytokine stimulus [GO:0071345]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-17-mediated signaling pathway [GO:0097400]; JNK cascade [GO:0007254]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; odontogenesis of dentin-containing tooth [GO:0042475]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of immunoglobulin production [GO:0002637]; response to interleukin-1 [GO:0070555]; response to ischemia [GO:0002931]; signal transduction [GO:0007165]; T cell receptor signaling pathway [GO:0050852]; T-helper 1 type immune response [GO:0042088]; tumor necrosis factor-mediated signaling pathway [GO:0033209]","GO:0000122; GO:0000209; GO:0001503; GO:0001701; GO:0001843; GO:0002637; GO:0002726; GO:0002931; GO:0004842; GO:0005164; GO:0005634; GO:0005737; GO:0005811; GO:0005829; GO:0005886; GO:0005938; GO:0006955; GO:0006974; GO:0007165; GO:0007249; GO:0007250; GO:0007254; GO:0008270; GO:0009887; GO:0009898; GO:0016567; GO:0019221; GO:0019886; GO:0019901; GO:0030316; GO:0031435; GO:0031624; GO:0031625; GO:0031666; GO:0031996; GO:0032147; GO:0032735; GO:0032743; GO:0032755; GO:0032813; GO:0032991; GO:0033209; GO:0035631; GO:0042088; GO:0042102; GO:0042475; GO:0042802; GO:0042826; GO:0042981; GO:0043011; GO:0043122; GO:0043123; GO:0043422; GO:0043507; GO:0045453; GO:0045672; GO:0045892; GO:0045944; GO:0046330; GO:0046849; GO:0047485; GO:0048468; GO:0048471; GO:0048661; GO:0050852; GO:0051091; GO:0051092; GO:0051865; GO:0061630; GO:0070498; GO:0070534; GO:0070555; GO:0071222; GO:0071345; GO:0097400; GO:1901224; GO:1904996; GO:2000679"
"3235",3235,"Cluster_589","Porites_evermani_scaffold_709:173199-174199",158,-23.85,2,20,693,716,20,"75.00%","75.00%","Peve_00039786",-0.356889320531357,0.767674655754787,0.990416445349413,NA,NA,NA,NA,NA
"3236",3236,"Cluster_589","Porites_evermani_scaffold_709:191695-192695",166,-27.13,2,20,134,156,19,"78.95%","84.21%","Peve_00039788",-0.457712561365747,0.697337761263666,0.978262075707395,NA,NA,NA,NA,NA
"3237",3237,"Cluster_589","Porites_evermani_scaffold_711:182905-183905",146,-20.97,2,21,250,275,23,"60.87%","73.91%","Peve_00039865",-0.748093807556517,0.461938596459541,0.978262075707395,"O42412","Thyroxine 5-deiodinase (EC 1.21.99.3) (5DIII) (DIOIII) (Type 3 DI) (Type III iodothyronine deiodinase)","Gallus gallus (Chicken)","hormone biosynthetic process [GO:0042446]; thyroid hormone metabolic process [GO:0042403]","GO:0004800; GO:0005886; GO:0010008; GO:0033798; GO:0042403; GO:0042446"
"3238",3238,"Cluster_589","Porites_evermani_scaffold_712:1496-2496",157,-21.93,2,18,467,488,16,"75.00%","81.25%","Peve_00039876",-0.829967201103977,0.376718123208099,0.978262075707395,NA,NA,NA,NA,NA
"3239",3239,"Cluster_589","Porites_evermani_scaffold_71:261956-262956",155,-22.19,2,18,253,273,16,"81.25%","81.25%","Peve_00039830",-0.985800330500785,0.107411179374672,0.978262075707395,NA,NA,NA,NA,NA
"3240",3240,"Cluster_589","Porites_evermani_scaffold_7211:762-1762",155,-23.55,2,12,341,362,10,"100.00%","100.00%","Peve_00040083",0.329701319954382,0.786103912920048,0.994986230405791,NA,NA,NA,NA,NA
"3241",3241,"Cluster_589","Porites_evermani_scaffold_723:48047-49047",146,-20.7,2,16,790,814,17,"70.59%","76.47%","Peve_00040112",-0.97611958473449,0.139406854481068,0.978262075707395,"Q9JHA8","von Willebrand factor A domain-containing protein 7 (Protein G7c)","Mus musculus (Mouse)","","GO:0005576"
"3242",3242,"Cluster_589","Porites_evermani_scaffold_738:128993-129993",163,-22.73,2,20,94,115,18,"77.78%","77.78%","Peve_00040448",NA,NA,NA,NA,NA,NA,NA,NA
"3243",3243,"Cluster_589","Porites_evermani_scaffold_745:195636-196636",159,-24.87,2,17,99,121,16,"81.25%","87.50%","Peve_00040596",-0.935149733627607,0.230529456310327,0.978262075707395,"Q60803","TNF receptor-associated factor 3 (EC 2.3.2.27) (CD40 receptor-associated factor 1) (CRAF1) (CD40-binding protein) (CD40BP) (RING-type E3 ubiquitin transferase TRAF3)","Mus musculus (Mouse)","apoptotic process [GO:0006915]; innate immune response [GO:0045087]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of JNK cascade [GO:0046330]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of cytokine production [GO:0001817]; regulation of defense response to virus [GO:0050688]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of interferon-beta production [GO:0032648]; regulation of proteolysis [GO:0030162]; Toll signaling pathway [GO:0008063]; toll-like receptor signaling pathway [GO:0002224]; tumor necrosis factor-mediated signaling pathway [GO:0033209]","GO:0001817; GO:0002224; GO:0005164; GO:0005739; GO:0005768; GO:0006915; GO:0008063; GO:0008270; GO:0009898; GO:0016740; GO:0019901; GO:0019903; GO:0030162; GO:0031625; GO:0031996; GO:0032088; GO:0032648; GO:0033209; GO:0035631; GO:0042802; GO:0042981; GO:0043122; GO:0045087; GO:0046330; GO:0050688; GO:0070534"
"3244",3244,"Cluster_589","Porites_evermani_scaffold_798:41196-42196",163,-26.55,2,21,410,435,23,"73.91%","73.91%","Peve_00041622",0.159680919674548,0.897906931664995,0.999448381576871,"P79218","Substance-K receptor (SKR) (NK-2 receptor) (NK-2R) (Neurokinin A receptor) (Tachykinin receptor 2)","Oryctolagus cuniculus (Rabbit)","positive regulation of flagellated sperm motility [GO:1902093]; regulation of uterine smooth muscle contraction [GO:0070472]","GO:0004995; GO:0005886; GO:0061827; GO:0070472; GO:0097225; GO:1902093"
"3245",3245,"Cluster_589","Porites_evermani_scaffold_80:173496-174496",154,-23.27,2,21,872,895,21,"66.67%","80.95%","Peve_00041770",NA,NA,NA,NA,NA,NA,NA,NA
"3246",3246,"Cluster_589","Porites_evermani_scaffold_806:69471-70471",152,-20.29,2,16,668,689,15,"86.67%","86.67%","Peve_00041893",-0.838780378560122,0.366538290880222,0.978262075707395,"Q29RU2","Oncoprotein-induced transcript 3 protein","Bos taurus (Bovine)","","GO:0005509; GO:0005635"
"3247",3247,"Cluster_589","Porites_evermani_scaffold_820:151825-152825",154,-20.13,2,21,254,280,24,"66.67%","75.00%","Peve_00042220",0.159680919674548,0.897906931664995,0.999448381576871,NA,NA,NA,NA,NA
"3248",3248,"Cluster_589","Porites_evermani_scaffold_83:202658-203658",155,-21.96,2,12,732,753,10,"100.00%","100.00%","Peve_00042389",-0.941599902337214,0.218644460242491,0.978262075707395,"Q07496","Ephrin type-A receptor 4 (EC 2.7.10.1) (EPH-like kinase 8) (EK8) (cEK8)","Gallus gallus (Chicken)","axon guidance [GO:0007411]; cell adhesion [GO:0007155]; fasciculation of sensory neuron axon [GO:0097155]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of kinase activity [GO:0033674]; positive regulation of Rho guanyl-nucleotide exchange factor activity [GO:2001108]; protein autophosphorylation [GO:0046777]; regulation of GTPase activity [GO:0043087]; segmentation [GO:0035282]; somitogenesis [GO:0001756]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]","GO:0001756; GO:0004672; GO:0004714; GO:0005004; GO:0005005; GO:0005524; GO:0005737; GO:0005886; GO:0007155; GO:0007169; GO:0007411; GO:0018108; GO:0031901; GO:0033674; GO:0035282; GO:0043005; GO:0043087; GO:0043197; GO:0043235; GO:0046777; GO:0097155; GO:0097161; GO:2001108"
"3249",3249,"Cluster_589","Porites_evermani_scaffold_839:96814-97814",159,-20.49,2,20,466,487,18,"61.11%","88.89%","Peve_00042511",-0.876397355009244,0.319880155846579,0.978262075707395,"A0JMD4","Two pore channel protein 2 (Two pore calcium channel protein 2) (Voltage-dependent calcium channel protein TPC2)","Danio rerio (Zebrafish) (Brachydanio rerio)","calcium-mediated signaling [GO:0019722]; endocytosis involved in viral entry into host cell [GO:0075509]; regulation of ion transmembrane transport [GO:0034765]; regulation of myotome development [GO:2000290]; skeletal myofibril assembly [GO:0014866]; smooth muscle contraction [GO:0006939]; sodium ion transmembrane transport [GO:0035725]","GO:0005245; GO:0005764; GO:0005765; GO:0006939; GO:0014866; GO:0015280; GO:0019722; GO:0031902; GO:0034765; GO:0035725; GO:0042802; GO:0072345; GO:0075509; GO:0080025; GO:0097682; GO:2000290"
"3250",3250,"Cluster_589","Porites_evermani_scaffold_84:328999-329999",152,-21.01,2,13,778,799,11,"90.91%","90.91%","Peve_00042524",-0.998208451660281,0.0381130974955327,0.909359886114279,NA,NA,NA,NA,NA
"3251",3251,"Cluster_589","Porites_evermani_scaffold_850:45091-46091",155,-23.41,2,12,364,385,10,"100.00%","100.00%","Peve_00042798",0.708664910983509,0.498595640199703,0.978262075707395,NA,NA,NA,NA,NA
"3252",3252,"Cluster_589","Porites_evermani_scaffold_854:82186-83186",155,-23.41,2,12,749,770,10,"100.00%","100.00%","Peve_00042852",NA,NA,NA,NA,NA,NA,NA,NA
"3253",3253,"Cluster_589","Porites_evermani_scaffold_855:3561-4561",164,-26.44,2,21,827,848,19,"73.68%","78.95%","Peve_00042880",-0.2108440538548,0.864757549631125,0.996660710141104,NA,NA,NA,NA,NA
"3254",3254,"Cluster_589","Porites_evermani_scaffold_876:161860-162860",146,-21.38,2,20,264,290,23,"60.87%","69.57%","Peve_00043259",0.14807298338271,0.90538589331086,0.999448381576871,"A8E657","Alpha-aminoadipic semialdehyde synthase, mitochondrial (LKR/SDH) [Includes: Lysine ketoglutarate reductase (LKR) (LOR) (EC 1.5.1.8); Saccharopine dehydrogenase (SDH) (EC 1.5.1.9)]","Bos taurus (Bovine)","L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; lysine biosynthetic process via aminoadipic acid [GO:0019878]; lysine catabolic process [GO:0006554]","GO:0004753; GO:0005737; GO:0005739; GO:0006554; GO:0019878; GO:0033512; GO:0047130; GO:0047131"
"3255",3255,"Cluster_589","Porites_evermani_scaffold_876:43636-44636",155,-23.55,2,12,785,806,10,"100.00%","100.00%","Peve_00043252",-0.934753615028442,0.231240264998328,0.978262075707395,NA,NA,NA,NA,NA
"3256",3256,"Cluster_589","Porites_evermani_scaffold_89:540690-541690",158,-21.83,2,15,877,898,13,"84.62%","92.31%","Peve_00043472",-0.996573984211656,0.0527125311193094,0.966469227311012,"P50416","Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A)","Homo sapiens (Human)","carnitine metabolic process [GO:0009437]; carnitine shuttle [GO:0006853]; cellular response to fatty acid [GO:0071398]; eating behavior [GO:0042755]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; glucose metabolic process [GO:0006006]; liver regeneration [GO:0097421]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of fatty acid beta-oxidation [GO:0032000]; regulation of insulin secretion [GO:0050796]; regulation of lipid storage [GO:0010883]; response to alkaloid [GO:0043279]; response to antibiotic [GO:0046677]; response to ethanol [GO:0045471]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; response to tetrachloromethane [GO:1904772]; response to xenobiotic stimulus [GO:0009410]; triglyceride metabolic process [GO:0006641]","GO:0001676; GO:0004095; GO:0005739; GO:0005741; GO:0006006; GO:0006631; GO:0006635; GO:0006641; GO:0006853; GO:0009410; GO:0009437; GO:0010883; GO:0014070; GO:0016020; GO:0030855; GO:0031667; GO:0032000; GO:0042755; GO:0042802; GO:0043279; GO:0045471; GO:0046677; GO:0050796; GO:0071398; GO:0097421; GO:1904772; GO:1990698"
"3257",3257,"Cluster_589","Porites_evermani_scaffold_910:157089-158089",155,-23.41,2,12,280,301,10,"100.00%","100.00%","Peve_00043940",NA,NA,NA,NA,NA,NA,NA,NA
"3258",3258,"Cluster_589","Porites_evermani_scaffold_91:133722-134722",147,-20.82,2,12,66,87,10,"90.00%","90.00%","Peve_00043904",0.9065132869,0.277468057221075,0.978262075707395,NA,NA,NA,NA,NA
"3259",3259,"Cluster_589","Porites_evermani_scaffold_927:132682-133682",148,-22.02,2,20,752,773,19,"68.42%","78.95%","Peve_00044206",0.159680919674548,0.897906931664995,0.999448381576871,NA,NA,NA,NA,NA
"3260",3260,"Cluster_589","Porites_evermani_scaffold_927:147289-148289",153,-23.84,2,20,754,774,18,"66.67%","83.33%","Peve_00044209",0.56544047637693,0.617412395925478,0.978262075707395,"P97292","Histamine H2 receptor (H2R) (HH2R) (Gastric receptor I)","Mus musculus (Mouse)","chemical synaptic transmission [GO:0007268]; digestive tract development [GO:0048565]; epithelial cell morphogenesis [GO:0003382]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; gastric acid secretion [GO:0001696]; gastrin-induced gastric acid secretion [GO:0001698]; gland development [GO:0048732]; histamine-induced gastric acid secretion [GO:0001697]; memory [GO:0007613]; negative regulation of arachidonic acid secretion [GO:1900139]; positive regulation of vasoconstriction [GO:0045907]; regulation of synaptic plasticity [GO:0048167]; toxin transport [GO:1901998]; visual learning [GO:0008542]","GO:0001696; GO:0001697; GO:0001698; GO:0003382; GO:0004969; GO:0004993; GO:0005886; GO:0007187; GO:0007268; GO:0007613; GO:0008542; GO:0016020; GO:0030425; GO:0030594; GO:0045202; GO:0045907; GO:0048167; GO:0048565; GO:0048732; GO:1900139; GO:1901363; GO:1901998"
"3261",3261,"Cluster_589","Porites_evermani_scaffold_928:53398-54398",154,-20.71,2,19,294,315,17,"64.71%","82.35%","Peve_00044215",-0.87859189634995,0.316967017219483,0.978262075707395,"Q6NSJ0","Myogenesis-regulating glycosidase (EC 3.2.1.-) (Uncharacterized family 31 glucosidase KIAA1161)","Homo sapiens (Human)","carbohydrate metabolic process [GO:0005975]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of protein kinase B signaling [GO:0051897]; skeletal muscle fiber development [GO:0048741]","GO:0004553; GO:0005789; GO:0005975; GO:0031965; GO:0043568; GO:0048741; GO:0051897"
"3262",3262,"Cluster_589","Porites_evermani_scaffold_932:106659-107659",164,-27.09,2,17,727,748,15,"80.00%","93.33%","Peve_00044304",-0.992192706244304,0.0796027995427675,0.978262075707395,NA,NA,NA,NA,NA
"3263",3263,"Cluster_589","Porites_evermani_scaffold_9:335781-336781",152,-21.48,2,20,614,633,18,"66.67%","83.33%","Peve_00043697",-0.0416456590339519,0.973479880345463,0.999448381576871,"Q8QFV1","Isthmin","Xenopus laevis (African clawed frog)","","GO:0005576"
"3264",3264,"Cluster_589","Porites_evermani_scaffold_9:336059-337059",152,-21.48,2,20,336,355,18,"66.67%","83.33%","Peve_00043699",-0.522870398060347,0.6497223352652,0.978262075707395,"Q5F3K0","Tetratricopeptide repeat protein 27 (TPR repeat protein 27)","Gallus gallus (Chicken)","",""
"3265",3265,"Cluster_589","Porites_evermani_scaffold_939:14042-15042",154,-23.43,2,19,653,674,17,"70.59%","76.47%","Peve_00044390",-0.934753615028442,0.231240264998328,0.978262075707395,NA,NA,NA,NA,NA
"3266",3266,"Cluster_589","Porites_evermani_scaffold_94:133708-134708",158,-24.6,2,16,799,822,16,"81.25%","87.50%","Peve_00044403",-0.999992423016843,0.00247824110430817,0.414802988923135,NA,NA,NA,NA,NA
"3267",3267,"Cluster_589","Porites_evermani_scaffold_94:135578-136578",155,-22.2,2,16,405,426,14,"78.57%","85.71%","Peve_00044404",0.19665683574309,0.873983026636362,0.997476741937264,"Q9WV04","Kinesin-like protein KIF9","Mus musculus (Mouse)","extracellular matrix disassembly [GO:0022617]; microtubule-based movement [GO:0007018]; organelle disassembly [GO:1903008]; regulation of flagellated sperm motility [GO:1901317]; regulation of podosome assembly [GO:0071801]","GO:0002102; GO:0003777; GO:0005524; GO:0005829; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0016887; GO:0022617; GO:0031982; GO:0036126; GO:0042802; GO:0071801; GO:1901317; GO:1903008"
"3268",3268,"Cluster_589","Porites_evermani_scaffold_944:97645-98645",154,-22.63,2,21,955,980,23,"69.57%","73.91%","Peve_00044484",NA,NA,NA,NA,NA,NA,NA,NA
"3269",3269,"Cluster_589","Porites_evermani_scaffold_951:5654-6654",155,-23.55,2,12,620,641,10,"100.00%","100.00%","Peve_00044595",0.985065031875859,0.110163892161744,0.978262075707395,"Q1JQ66","Solute carrier family 35 member E3","Danio rerio (Zebrafish) (Brachydanio rerio)","","GO:0005338; GO:0005794; GO:0015297; GO:0016020"
"3270",3270,"Cluster_589","Porites_evermani_scaffold_960:10637-11637",172,-27.44,2,21,209,230,19,"78.95%","84.21%","Peve_00044760",-0.37779220934919,0.753366734379749,0.988219883885475,"P53657","Pyruvate kinase PKLR (EC 2.7.1.40) (L-PK) (Pyruvate kinase isozymes L/R)","Mus musculus (Mouse)","ATP biosynthetic process [GO:0006754]; carbohydrate metabolic process [GO:0005975]; cellular response to insulin stimulus [GO:0032869]; glycolytic process [GO:0006096]; pyruvate biosynthetic process [GO:0042866]; response to ATP [GO:0033198]; response to cAMP [GO:0051591]; response to heat [GO:0009408]; response to lithium ion [GO:0010226]; response to other organism [GO:0051707]","GO:0000287; GO:0004743; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005975; GO:0006096; GO:0006754; GO:0009408; GO:0010226; GO:0016301; GO:0030955; GO:0032869; GO:0033198; GO:0042866; GO:0048029; GO:0051591; GO:0051707"
"3271",3271,"Cluster_589","Porites_evermani_scaffold_961:151103-152103",151,-21.14,2,14,859,879,12,"91.67%","91.67%","Peve_00044772",-0.997856253350184,0.0416926466893275,0.909359886114279,"Q91XW8","Inactive peptidyl-prolyl cis-trans isomerase FKBP6 (Inactive PPIase FKBP6) (36 kDa FK506-binding protein) (36 kDa FKBP) (FKBP-36) (FK506-binding protein 6) (FKBP-6) (Immunophilin FKBP36)","Mus musculus (Mouse)","cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; meiotic cell cycle [GO:0051321]; piRNA processing [GO:0034587]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; RNA-mediated gene silencing [GO:0031047]; spermatogenesis [GO:0007283]","GO:0000795; GO:0005654; GO:0005737; GO:0005829; GO:0006457; GO:0007283; GO:0030154; GO:0031047; GO:0034587; GO:0042802; GO:0043046; GO:0045070; GO:0051321; GO:0051879"
"3272",3272,"Cluster_589","Porites_evermani_scaffold_970:148026-149026",150,-20.13,2,16,866,888,15,"73.33%","86.67%","Peve_00044947",0.117154878887994,0.92524521304489,0.999448381576871,"Q91437","CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5); Aspartate carbamoyltransferase (EC 2.1.3.2); Dihydroorotase (EC 3.5.2.3)]","Squalus acanthias (Spiny dogfish)","'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; glutamine metabolic process [GO:0006541]","GO:0004070; GO:0004088; GO:0004151; GO:0005524; GO:0005634; GO:0005737; GO:0006207; GO:0006541; GO:0008270; GO:0016597; GO:0044205"
"3273",3273,"Cluster_589","Porites_evermani_scaffold_970:148631-149631",150,-20.13,2,16,261,283,15,"73.33%","86.67%","Peve_00044948",0.520212645785519,0.651705372927099,0.978262075707395,"Q10567","AP-1 complex subunit beta-1 (Adaptor protein complex AP-1 subunit beta-1) (Adaptor-related protein complex 1 subunit beta-1) (Beta-1-adaptin) (Beta-adaptin 1) (Clathrin assembly protein complex 1 beta large chain) (Golgi adaptor HA1/AP1 adaptin beta subunit)","Homo sapiens (Human)","basolateral protein secretion [GO:0110010]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; kidney development [GO:0001822]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155]; vesicle-mediated transport [GO:0016192]","GO:0000139; GO:0001822; GO:0005765; GO:0005769; GO:0005794; GO:0005829; GO:0006886; GO:0007368; GO:0007507; GO:0016192; GO:0019901; GO:0030121; GO:0030276; GO:0030659; GO:0032588; GO:0043231; GO:0060155; GO:0110010; GO:1903232"
"3274",3274,"Cluster_6255","Porites_evermani_scaffold_1242:18927-19927",159,-21.18,2,21,805,831,24,"66.67%","75.00%","Peve_00003999",-0.999977919419974,0.00423059214486466,0.54328949385489,NA,NA,NA,NA,NA
"3275",3275,"Cluster_6255","Porites_evermani_scaffold_1391:85374-86374",153,-20.28,2,20,704,729,22,"68.18%","77.27%","Peve_00006068",NA,NA,NA,NA,NA,NA,NA,NA
"3276",3276,"Cluster_6255","Porites_evermani_scaffold_1607:28837-29837",167,-20.52,2,21,774,798,22,"77.27%","77.27%","Peve_00008904",NA,NA,NA,NA,NA,NA,NA,NA
"3277",3277,"Cluster_6255","Porites_evermani_scaffold_1607:28837-29837",167,-20.52,2,21,949,973,22,"77.27%","77.27%","Peve_00008904",NA,NA,NA,NA,NA,NA,NA,NA
"3278",3278,"Cluster_6255","Porites_evermani_scaffold_183:287857-288857",159,-21.21,2,21,157,182,23,"69.57%","73.91%","Peve_00011486",NA,NA,NA,NA,NA,NA,NA,NA
"3279",3279,"Cluster_6255","Porites_evermani_scaffold_185:318836-319836",159,-21.21,2,21,6,31,23,"69.57%","73.91%","Peve_00011690",NA,NA,NA,NA,NA,NA,NA,NA
"3280",3280,"Cluster_6255","Porites_evermani_scaffold_235:320939-321939",167,-20.95,2,20,456,477,18,"77.78%","83.33%","Peve_00017007",NA,NA,NA,NA,NA,NA,NA,NA
"3281",3281,"Cluster_6255","Porites_evermani_scaffold_2392:9897-10897",171,-22.04,2,21,543,565,20,"80.00%","85.00%","Peve_00017344",NA,NA,NA,NA,NA,NA,NA,NA
"3282",3282,"Cluster_6255","Porites_evermani_scaffold_249:1300-1907",153,-20.28,2,20,310,335,22,"68.18%","77.27%","Peve_00018270",-0.717137721049396,0.490903686631738,0.978262075707395,NA,NA,NA,NA,NA
"3283",3283,"Cluster_6255","Porites_evermani_scaffold_249:907-1907",153,-20.28,2,20,703,728,22,"68.18%","77.27%","Peve_00018272",-0.675015113868665,0.528274178955442,0.978262075707395,NA,NA,NA,NA,NA
"3284",3284,"Cluster_6255","Porites_evermani_scaffold_270:269146-270146",162,-20.29,2,21,453,473,19,"73.68%","84.21%","Peve_00020111",NA,NA,NA,NA,NA,NA,NA,NA
"3285",3285,"Cluster_6255","Porites_evermani_scaffold_3436:19112-20112",157,-21.67,2,19,137,165,24,"70.83%","70.83%","Peve_00025510",NA,NA,NA,NA,NA,NA,NA,NA
"3286",3286,"Cluster_6255","Porites_evermani_scaffold_353:106986-107986",171,-20.03,2,21,408,430,20,"75.00%","90.00%","Peve_00026126",NA,NA,NA,"Q91X34","Bile acid-CoA:amino acid N-acyltransferase (BACAT) (BAT) (EC 2.3.1.65) (Bile acid-CoA thioesterase) (Choloyl-CoA hydrolase) (EC 3.1.2.27) (Glycine N-choloyltransferase) (Long-chain fatty-acyl-CoA hydrolase) (EC 3.1.2.2)","Mus musculus (Mouse)","acyl-CoA metabolic process [GO:0006637]; animal organ regeneration [GO:0031100]; bile acid biosynthetic process [GO:0006699]; bile acid conjugation [GO:0002152]; bile acid metabolic process [GO:0008206]; fatty acid metabolic process [GO:0006631]; glycine metabolic process [GO:0006544]; liver development [GO:0001889]; taurine metabolic process [GO:0019530]","GO:0001889; GO:0002152; GO:0005777; GO:0005829; GO:0006544; GO:0006631; GO:0006637; GO:0006699; GO:0008206; GO:0016290; GO:0016410; GO:0019530; GO:0031100; GO:0033882; GO:0047617; GO:0047963; GO:0052815; GO:0052816; GO:0052817; GO:0102991"
"3287",3287,"Cluster_6255","Porites_evermani_scaffold_3818:15589-15854",154,-21.35,2,21,41,66,23,"65.22%","78.26%","Peve_00027726",-0.582398965247837,0.604228326962126,0.978262075707395,"Q8BGV4","TELO2-interacting protein 2","Mus musculus (Mouse)","","GO:0005654; GO:0005813; GO:0005829; GO:0070209; GO:0110078"
"3288",3288,"Cluster_6255","Porites_evermani_scaffold_3818:15589-15854",154,-21.35,2,21,41,66,23,"65.22%","78.26%","Peve_00027728",-0.471172669023845,0.687661733610477,0.978262075707395,NA,NA,NA,NA,NA
"3289",3289,"Cluster_6255","Porites_evermani_scaffold_396:76051-77051",180,-20.45,2,21,15,36,19,"84.21%","89.47%","Peve_00028515",-0.578562157249557,0.607228046005521,0.978262075707395,NA,NA,NA,NA,NA
"3290",3290,"Cluster_6255","Porites_evermani_scaffold_820:171132-172132",167,-20.13,2,21,207,229,20,"80.00%","80.00%","Peve_00042224",NA,NA,NA,NA,NA,NA,NA,NA
"3291",3291,"Cluster_6904","Porites_evermani_scaffold_100:75892-76892",153,-23.61,2,20,748,768,18,"72.22%","77.78%","Peve_00000210",-0.922155114408482,0.252853259251034,0.978262075707395,"Q9D8V0","Minor histocompatibility antigen H13 (EC 3.4.23.-) (Presenilin-like protein 3) (Signal peptide peptidase)","Mus musculus (Mouse)","in utero embryonic development [GO:0001701]; membrane protein proteolysis [GO:0033619]; membrane protein proteolysis involved in retrograde protein transport, ER to cytosol [GO:1904211]; signal peptide processing [GO:0006465]","GO:0001701; GO:0005783; GO:0005789; GO:0005791; GO:0005886; GO:0006465; GO:0008233; GO:0009986; GO:0031625; GO:0033619; GO:0036513; GO:0042500; GO:0042803; GO:0098553; GO:0098554; GO:1904211"
"3292",3292,"Cluster_6904","Porites_evermani_scaffold_10:520657-521657",150,-21.16,2,19,635,656,17,"70.59%","70.59%","Peve_00000125",-0.993096867201726,0.0748459636546061,0.978262075707395,NA,NA,NA,NA,NA
"3293",3293,"Cluster_6904","Porites_evermani_scaffold_1073:55466-56466",160,-22.11,2,19,367,387,17,"82.35%","82.35%","Peve_00001344",-0.792203933671743,0.417867198307417,0.978262075707395,NA,NA,NA,NA,NA
"3294",3294,"Cluster_6904","Porites_evermani_scaffold_1083:110244-111244",156,-20.48,2,21,632,653,19,"63.16%","78.95%","Peve_00001499",-0.951310992493219,0.199475076059675,0.978262075707395,NA,NA,NA,NA,NA
"3295",3295,"Cluster_6904","Porites_evermani_scaffold_1090:117899-118899",147,-20.41,2,13,732,754,12,"83.33%","91.67%","Peve_00001609",NA,NA,NA,NA,NA,NA,NA,NA
"3296",3296,"Cluster_6904","Porites_evermani_scaffold_1103:122580-123580",150,-20.53,2,16,430,455,18,"72.22%","77.78%","Peve_00001908",-0.964852235325099,0.169287266664592,0.978262075707395,"B8A4F0","Palmitoyltransferase ZDHHC16A (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 16A) (DHHC-16A)","Danio rerio (Zebrafish) (Brachydanio rerio)","cellular response to DNA damage stimulus [GO:0006974]; commitment of multipotent stem cells to neuronal lineage in forebrain [GO:0021898]; eye development [GO:0001654]; fibroblast growth factor receptor signaling pathway involved in forebrain neuron fate commitment [GO:0021899]; heart development [GO:0007507]; protein palmitoylation [GO:0018345]; telencephalon development [GO:0021537]","GO:0001654; GO:0005789; GO:0005794; GO:0006974; GO:0007507; GO:0016409; GO:0018345; GO:0019706; GO:0021537; GO:0021898; GO:0021899"
"3297",3297,"Cluster_6904","Porites_evermani_scaffold_11:1031454-1032454",163,-21.19,2,16,384,405,14,"85.71%","92.86%","Peve_00001797",NA,NA,NA,NA,NA,NA,NA,NA
"3298",3298,"Cluster_6904","Porites_evermani_scaffold_1112:125721-126721",154,-21.47,2,21,511,535,22,"68.18%","77.27%","Peve_00002053",0.0436755582245061,0.972186428631166,0.999448381576871,"Q149M9","NACHT domain- and WD repeat-containing protein 1","Homo sapiens (Human)","negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of gene expression [GO:0010628]","GO:0005524; GO:0005730; GO:0005829; GO:0010628; GO:0032088"
"3299",3299,"Cluster_6904","Porites_evermani_scaffold_1112:125721-126721",156,-20.46,2,18,495,517,17,"76.47%","82.35%","Peve_00002053",0.0436755582245061,0.972186428631166,0.999448381576871,"Q149M9","NACHT domain- and WD repeat-containing protein 1","Homo sapiens (Human)","negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of gene expression [GO:0010628]","GO:0005524; GO:0005730; GO:0005829; GO:0010628; GO:0032088"
"3300",3300,"Cluster_6904","Porites_evermani_scaffold_11:181036-182036",145,-20.49,2,18,965,986,16,"68.75%","68.75%","Peve_00001826",-0.538544704090589,0.637948606699533,0.978262075707395,"Q63028","Alpha-adducin (Erythrocyte adducin subunit alpha)","Rattus norvegicus (Rat)","actin filament bundle assembly [GO:0051017]; barbed-end actin filament capping [GO:0051016]; cell morphogenesis [GO:0000902]; cell volume homeostasis [GO:0006884]; cellular response to calcium ion [GO:0071277]; cellular response to retinoic acid [GO:0071300]; cytoskeleton organization [GO:0007010]; erythrocyte differentiation [GO:0030218]; hemoglobin metabolic process [GO:0020027]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; ion transport [GO:0006811]; multicellular organism growth [GO:0035264]; negative regulation of actin filament polymerization [GO:0030837]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endocytosis [GO:0045807]; positive regulation of establishment of endothelial barrier [GO:1903142]; positive regulation of protein binding [GO:0032092]","GO:0000902; GO:0001701; GO:0005200; GO:0005516; GO:0005634; GO:0005737; GO:0005856; GO:0005886; GO:0005912; GO:0006811; GO:0006884; GO:0007010; GO:0008290; GO:0014069; GO:0016020; GO:0020027; GO:0030218; GO:0030425; GO:0030507; GO:0030837; GO:0032092; GO:0035264; GO:0042608; GO:0042803; GO:0043197; GO:0045202; GO:0045766; GO:0045807; GO:0046982; GO:0048471; GO:0048873; GO:0051015; GO:0051016; GO:0051017; GO:0061629; GO:0071277; GO:0071300; GO:1903142; GO:1903393"
"3301",3301,"Cluster_6904","Porites_evermani_scaffold_117:424125-425125",160,-20.21,2,21,542,563,19,"63.16%","84.21%","Peve_00002847",NA,NA,NA,NA,NA,NA,NA,NA
"3302",3302,"Cluster_6904","Porites_evermani_scaffold_1249:13443-14443",151,-20.25,2,20,358,377,18,"72.22%","83.33%","Peve_00004080",-0.951310992493219,0.199475076059675,0.978262075707395,"A1L1W9","Monocarboxylate transporter 10 (MCT 10) (Solute carrier family 16 member 10)","Danio rerio (Zebrafish) (Brachydanio rerio)","aromatic amino acid transport [GO:0015801]; thyroid hormone transport [GO:0070327]","GO:0005302; GO:0015173; GO:0015192; GO:0015196; GO:0015349; GO:0015801; GO:0016020; GO:0016323; GO:0070327"
"3303",3303,"Cluster_6904","Porites_evermani_scaffold_1256:19699-20699",163,-26.04,2,21,808,833,23,"69.57%","78.26%","Peve_00004166",NA,NA,NA,NA,NA,NA,NA,NA
"3304",3304,"Cluster_6904","Porites_evermani_scaffold_126:239172-240172",150,-20.09,2,16,515,538,16,"75.00%","81.25%","Peve_00004233",-0.301001752961272,0.805357992700643,0.995934364227446,"Q8BG58","Transmembrane prolyl 4-hydroxylase (P4H-TM) (EC 1.14.11.29) (Hypoxia-inducible factor prolyl hydroxylase 4) (HIF-PH4) (HIF-prolyl hydroxylase 4) (HPH-4)","Mus musculus (Mouse)","peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; regulation of erythrocyte differentiation [GO:0045646]","GO:0004656; GO:0005506; GO:0005509; GO:0005783; GO:0005789; GO:0016706; GO:0018401; GO:0031418; GO:0045646"
"3305",3305,"Cluster_6904","Porites_evermani_scaffold_128:45145-46145",148,-20.38,2,21,570,589,19,"68.42%","78.95%","Peve_00004497",0.407706581007172,0.732657255541392,0.98526089765136,NA,NA,NA,NA,NA
"3306",3306,"Cluster_6904","Porites_evermani_scaffold_129:252266-253266",166,-22.13,2,20,120,142,19,"73.68%","89.47%","Peve_00004627",0.208718150280978,0.866141742726342,0.996660710141104,NA,NA,NA,NA,NA
"3307",3307,"Cluster_6904","Porites_evermani_scaffold_130:28768-29670",166,-26,2,19,547,568,17,"82.35%","82.35%","Peve_00004785",-0.119566462319435,0.923699082696013,0.999448381576871,NA,NA,NA,NA,NA
"3308",3308,"Cluster_6904","Porites_evermani_scaffold_130:28768-29670",166,-26,2,19,547,568,17,"82.35%","82.35%","Peve_00004788",-0.905510213410227,0.278976798616128,0.978262075707395,NA,NA,NA,NA,NA
"3309",3309,"Cluster_6904","Porites_evermani_scaffold_130:292780-293780",161,-23.83,2,19,607,630,19,"78.95%","78.95%","Peve_00004795",0.166893550643635,0.893252751367815,0.999448381576871,"Q2XWK0","Synaptic vesicle 2-related protein (SV2-related protein)","Xenopus laevis (African clawed frog)","","GO:0022857; GO:0030672"
"3310",3310,"Cluster_6904","Porites_evermani_scaffold_133:255563-256563",155,-20.16,2,18,634,654,16,"81.25%","81.25%","Peve_00005212",-0.951310992493219,0.199475076059675,0.978262075707395,NA,NA,NA,NA,NA
"3311",3311,"Cluster_6904","Porites_evermani_scaffold_144:15024-16024",163,-26.97,2,21,299,321,20,"70.00%","85.00%","Peve_00006721",0.705191411371007,0.501722111567684,0.978262075707395,NA,NA,NA,NA,NA
"3312",3312,"Cluster_6904","Porites_evermani_scaffold_1444:45783-46783",160,-26.45,2,21,440,459,19,"78.95%","84.21%","Peve_00006776",0.270265079307212,0.82577731979662,0.995934364227446,"P12527","Polyunsaturated fatty acid 5-lipoxygenase (EC 1.13.11.-) (Arachidonate 5-lipoxygenase) (5-LO) (5-lipoxygenase) (EC 1.13.11.34)","Rattus norvegicus (Rat)","acute inflammatory response [GO:0002526]; arachidonic acid metabolic process [GO:0019369]; dendritic cell migration [GO:0036336]; glucose homeostasis [GO:0042593]; hepoxilin biosynthetic process [GO:0051122]; humoral immune response [GO:0006959]; inflammatory response [GO:0006954]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; leukocyte migration involved in inflammatory response [GO:0002523]; leukotriene A4 biosynthetic process [GO:1901753]; leukotriene biosynthetic process [GO:0019370]; leukotriene metabolic process [GO:0006691]; leukotriene production involved in inflammatory response [GO:0002540]; linoleic acid metabolic process [GO:0043651]; lipid oxidation [GO:0034440]; lipoxin biosynthetic process [GO:2001301]; lipoxygenase pathway [GO:0019372]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of inflammatory response [GO:0050728]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular wound healing [GO:0061044]; negative regulation of wound healing [GO:0061045]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cytochrome-c oxidase activity [GO:1904960]; positive regulation of leukocyte adhesion to arterial endothelial cell [GO:1904999]; positive regulation of vasoconstriction [GO:0045907]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of fat cell differentiation [GO:0045598]; regulation of inflammatory response [GO:0050727]; regulation of inflammatory response to wounding [GO:0106014]; regulation of insulin secretion [GO:0050796]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; response to hyperoxia [GO:0055093]; response to nutrient [GO:0007584]; sensory perception of pain [GO:0019233]","GO:0001937; GO:0002232; GO:0002523; GO:0002526; GO:0002540; GO:0004051; GO:0004052; GO:0005506; GO:0005634; GO:0005635; GO:0005641; GO:0005737; GO:0005829; GO:0006691; GO:0006954; GO:0006959; GO:0007584; GO:0016363; GO:0016525; GO:0016702; GO:0016787; GO:0019233; GO:0019369; GO:0019370; GO:0019372; GO:0030425; GO:0030501; GO:0031965; GO:0034440; GO:0036336; GO:0036403; GO:0042383; GO:0042593; GO:0043651; GO:0045598; GO:0045907; GO:0048471; GO:0050727; GO:0050728; GO:0050796; GO:0051122; GO:0055093; GO:0061044; GO:0061045; GO:0106014; GO:1900015; GO:1900407; GO:1901753; GO:1903426; GO:1903573; GO:1903671; GO:1904960; GO:1904999; GO:2001301"
"3313",3313,"Cluster_6904","Porites_evermani_scaffold_1457:27387-28387",155,-20.5,2,12,751,772,10,"100.00%","100.00%","Peve_00006922",0.873245826816635,0.324021724746782,0.978262075707395,"Q9NTG1","Polycystin family receptor for egg jelly (PKD and REJ homolog) (Polycystic kidney disease and receptor for egg jelly-related protein)","Homo sapiens (Human)","acrosome reaction [GO:0007340]; detection of mechanical stimulus [GO:0050982]","GO:0005262; GO:0005509; GO:0007340; GO:0016020; GO:0050982"
"3314",3314,"Cluster_6904","Porites_evermani_scaffold_1472:95434-96434",153,-21.79,2,21,795,816,20,"75.00%","75.00%","Peve_00007129",0.42433177180203,0.721018065821722,0.981782014768518,NA,NA,NA,NA,NA
"3315",3315,"Cluster_6904","Porites_evermani_scaffold_1483:70481-71481",161,-23.17,2,19,934,956,18,"77.78%","83.33%","Peve_00007262",-0.997139931185431,0.048160049624566,0.945590536869992,"Q02763","Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (hTIE2) (p140 TEK) (CD antigen CD202b)","Homo sapiens (Human)","angiogenesis [GO:0001525]; cell-cell signaling [GO:0007267]; definitive hemopoiesis [GO:0060216]; endothelial cell proliferation [GO:0001935]; glomerulus vasculature development [GO:0072012]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of inflammatory response [GO:0050728]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; regulation of endothelial cell apoptotic process [GO:2000351]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of vascular permeability [GO:0043114]; signal transduction [GO:0007165]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]","GO:0001525; GO:0001934; GO:0001935; GO:0001938; GO:0002040; GO:0004672; GO:0004713; GO:0004714; GO:0005524; GO:0005576; GO:0005737; GO:0005886; GO:0005902; GO:0005911; GO:0005925; GO:0007165; GO:0007169; GO:0007267; GO:0007507; GO:0009925; GO:0009986; GO:0010595; GO:0014068; GO:0016323; GO:0016324; GO:0016525; GO:0018108; GO:0032878; GO:0033674; GO:0034446; GO:0034451; GO:0038023; GO:0042802; GO:0043066; GO:0043114; GO:0043235; GO:0043410; GO:0043552; GO:0045121; GO:0045766; GO:0046777; GO:0048014; GO:0050728; GO:0051894; GO:0051897; GO:0060216; GO:0060347; GO:0070374; GO:0072012; GO:1902533; GO:2000251; GO:2000351; GO:2000352"
"3316",3316,"Cluster_6904","Porites_evermani_scaffold_153:237652-238652",147,-21.59,2,21,244,266,20,"60.00%","75.00%","Peve_00007878",-0.883089594243936,0.310918497488648,0.978262075707395,"Q16281","Cyclic nucleotide-gated cation channel alpha-3 (Cone photoreceptor cGMP-gated channel subunit alpha) (Cyclic nucleotide-gated channel alpha-3) (CNG channel alpha-3) (CNG-3) (CNG3)","Homo sapiens (Human)","cation transmembrane transport [GO:0098655]; cation transport [GO:0006812]; inorganic cation import across plasma membrane [GO:0098659]; response to cAMP [GO:0051591]; response to corticosteroid [GO:0031960]; response to magnesium ion [GO:0032026]; signal transduction [GO:0007165]; visual perception [GO:0007601]","GO:0005222; GO:0005223; GO:0005737; GO:0005886; GO:0006812; GO:0007165; GO:0007601; GO:0008022; GO:0015276; GO:0017071; GO:0030425; GO:0030553; GO:0031960; GO:0032026; GO:0043194; GO:0043204; GO:0044877; GO:0051591; GO:0097386; GO:0098655; GO:0098659; GO:1902495"
"3317",3317,"Cluster_6904","Porites_evermani_scaffold_1538:101195-102195",158,-21.88,2,19,542,563,17,"70.59%","82.35%","Peve_00007962",NA,NA,NA,NA,NA,NA,NA,NA
"3318",3318,"Cluster_6904","Porites_evermani_scaffold_158:79921-80921",156,-24.72,2,21,257,276,19,"73.68%","84.21%","Peve_00008497",-0.850957699891545,0.35204458470937,0.978262075707395,NA,NA,NA,NA,NA
"3319",3319,"Cluster_6904","Porites_evermani_scaffold_1612:53593-54593",159,-24.11,2,17,1,21,17,"76.47%","88.24%","Peve_00008982",0.54773860656949,0.630977668525786,0.978262075707395,"Q60847","Collagen alpha-1(XII) chain","Mus musculus (Mouse)","cell adhesion [GO:0007155]; endodermal cell differentiation [GO:0035987]","GO:0005595; GO:0005615; GO:0007155; GO:0035987; GO:0062023"
"3320",3320,"Cluster_6904","Porites_evermani_scaffold_1634:70641-71641",149,-23.93,2,21,880,906,24,"66.67%","75.00%","Peve_00009239",NA,NA,NA,NA,NA,NA,NA,NA
"3321",3321,"Cluster_6904","Porites_evermani_scaffold_1645:83866-84866",172,-26.03,2,21,10,31,19,"78.95%","84.21%","Peve_00009347",-0.431867112099507,0.715709886168179,0.980356517106326,NA,NA,NA,NA,NA
"3322",3322,"Cluster_6904","Porites_evermani_scaffold_1745:68482-69482",151,-20.71,2,21,626,650,22,"63.64%","72.73%","Peve_00010526",NA,NA,NA,"Q4G0Z9","Minichromosome maintenance domain-containing protein 2 (MCM domain-containing protein 2)","Homo sapiens (Human)","DNA duplex unwinding [GO:0032508]; DNA-templated DNA replication [GO:0006261]; double-strand break repair via break-induced replication [GO:0000727]; meiotic cell cycle [GO:0051321]","GO:0000727; GO:0003677; GO:0005524; GO:0006261; GO:0032508; GO:0051321"
"3323",3323,"Cluster_6904","Porites_evermani_scaffold_1781:37927-38927",149,-20.54,2,18,961,982,16,"68.75%","75.00%","Peve_00010915",-0.999463001694963,0.0208641652974758,0.817190070029867,"Q6AZS2","Polycomb protein eed-B (Xeed-B) (psXEED)","Xenopus laevis (African clawed frog)","chromatin organization [GO:0006325]","GO:0006325; GO:0035098"
"3324",3324,"Cluster_6904","Porites_evermani_scaffold_1789:53279-54279",151,-21.13,2,19,507,530,20,"75.00%","75.00%","Peve_00010989",-0.105327013606539,0.932822138511555,0.999448381576871,"Q7SXM0","Histone deacetylase 8 (HD8) (EC 3.5.1.98) (Protein deacetylase HDAC8) (EC 3.5.1.-) (Protein decrotonylase HDAC8) (EC 3.5.1.-)","Danio rerio (Zebrafish) (Brachydanio rerio)","central nervous system development [GO:0007417]; chromatin organization [GO:0006325]; histone deacetylation [GO:0016575]; neuron cellular homeostasis [GO:0070050]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000118; GO:0004407; GO:0005694; GO:0005737; GO:0006325; GO:0006357; GO:0007417; GO:0016575; GO:0046872; GO:0070050; GO:0160009"
"3325",3325,"Cluster_6904","Porites_evermani_scaffold_1805:39684-40684",152,-20.13,2,15,293,313,13,"84.62%","92.31%","Peve_00011224",0.655265667132262,0.545113363183657,0.978262075707395,"Q5ZM55","Protein fem-1 homolog B (FEM1b) (FEM1-beta)","Gallus gallus (Chicken)","apoptotic process [GO:0006915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627]","GO:0005634; GO:0005737; GO:0006915; GO:0016567; GO:0031462; GO:0043161; GO:0140627; GO:1990756; GO:2000001"
"3326",3326,"Cluster_6904","Porites_evermani_scaffold_1805:77289-78289",152,-20.13,2,15,300,320,13,"84.62%","92.31%","Peve_00011228",-0.997022666930234,0.0491379058163316,0.94992237160644,"Q6GPE5","Protein fem-1 homolog B (FEM1b) (FEM1-beta)","Xenopus laevis (African clawed frog)","apoptotic process [GO:0006915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627]","GO:0005634; GO:0005737; GO:0006915; GO:0016567; GO:0031462; GO:0043161; GO:0140627; GO:1990756; GO:2000001"
"3327",3327,"Cluster_6904","Porites_evermani_scaffold_182:132313-133313",171,-28.5,2,20,699,720,18,"72.22%","94.44%","Peve_00011385",-0.893756311740002,0.296120820749749,0.978262075707395,NA,NA,NA,NA,NA
"3328",3328,"Cluster_6904","Porites_evermani_scaffold_1833:70031-71031",149,-21.26,2,19,808,831,19,"68.42%","73.68%","Peve_00011536",-0.962625276299045,0.174600755066767,0.978262075707395,NA,NA,NA,NA,NA
"3329",3329,"Cluster_6904","Porites_evermani_scaffold_186:285445-286445",167,-29.06,2,21,562,584,20,"75.00%","85.00%","Peve_00011813",-0.939046521476951,0.22342173616756,0.978262075707395,"P91685","Metabotropic glutamate receptor (DmGluRA)","Drosophila melanogaster (Fruit fly)","G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning [GO:0007612]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; neuromuscular junction development [GO:0007528]; regulation of synaptic transmission, glutamatergic [GO:0051966]; short-term memory [GO:0007614]; terminal button organization [GO:0072553]","GO:0001640; GO:0001641; GO:0004930; GO:0005886; GO:0007216; GO:0007528; GO:0007612; GO:0007614; GO:0007616; GO:0008049; GO:0008066; GO:0015485; GO:0016020; GO:0016595; GO:0038038; GO:0045121; GO:0051966; GO:0072553"
"3330",3330,"Cluster_6904","Porites_evermani_scaffold_1871:11342-12342",168,-26.26,2,21,341,362,19,"73.68%","84.21%","Peve_00011923",NA,NA,NA,NA,NA,NA,NA,NA
"3331",3331,"Cluster_6904","Porites_evermani_scaffold_1872:54748-55748",158,-21.76,2,17,546,566,15,"80.00%","93.33%","Peve_00011933",NA,NA,NA,NA,NA,NA,NA,NA
"3332",3332,"Cluster_6904","Porites_evermani_scaffold_1884:3233-4233",161,-22.15,2,21,608,632,22,"77.27%","81.82%","Peve_00012069",NA,NA,NA,NA,NA,NA,NA,NA
"3333",3333,"Cluster_6904","Porites_evermani_scaffold_1895:94556-95556",155,-20.16,2,18,511,531,16,"81.25%","81.25%","Peve_00012184",-0.903299498519464,0.282275343039935,0.978262075707395,"Q1RMT1","General transcription and DNA repair factor IIH helicase subunit XPB (TFIIH subunit XPB) (EC 3.6.4.12) (DNA excision repair protein ERCC-3)","Bos taurus (Bovine)","apoptotic process [GO:0006915]; DNA repair [GO:0006281]; DNA topological change [GO:0006265]; embryonic organ development [GO:0048568]; hair cell differentiation [GO:0035315]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; positive regulation of apoptotic process [GO:0043065]; protein localization [GO:0008104]; regulation of mitotic cell cycle phase transition [GO:1901990]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; transcription by RNA polymerase II [GO:0006366]; transcription initiation at RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283]; UV protection [GO:0009650]","GO:0000112; GO:0000439; GO:0000717; GO:0003677; GO:0005524; GO:0005669; GO:0005675; GO:0006265; GO:0006281; GO:0006283; GO:0006289; GO:0006366; GO:0006367; GO:0006915; GO:0006979; GO:0008022; GO:0008104; GO:0009411; GO:0009650; GO:0016887; GO:0035315; GO:0043065; GO:0043138; GO:0047485; GO:0048568; GO:0097550; GO:1901990; GO:1990841"
"3334",3334,"Cluster_6904","Porites_evermani_scaffold_1914:56730-57730",154,-22.87,2,21,971,994,21,"71.43%","76.19%","Peve_00012455",0.208718150280978,0.866141742726342,0.996660710141104,NA,NA,NA,NA,NA
"3335",3335,"Cluster_6904","Porites_evermani_scaffold_1980:59509-60509",159,-20.98,2,17,940,962,16,"81.25%","87.50%","Peve_00013132",-0.709681387239053,0.497677799668757,0.978262075707395,NA,NA,NA,NA,NA
"3336",3336,"Cluster_6904","Porites_evermani_scaffold_2036:18308-19308",150,-20.64,2,11,756,777,9,"100.00%","100.00%","Peve_00013923",NA,NA,NA,NA,NA,NA,NA,NA
"3337",3337,"Cluster_6904","Porites_evermani_scaffold_20:414258-415258",155,-20.16,2,18,373,393,16,"81.25%","81.25%","Peve_00013461",-0.0328658066045187,0.979073209142382,0.999448381576871,NA,NA,NA,NA,NA
"3338",3338,"Cluster_6904","Porites_evermani_scaffold_2045:8264-9264",154,-21.95,2,21,477,500,21,"71.43%","76.19%","Peve_00014016",-0.987584865623096,0.10042022219693,0.978262075707395,NA,NA,NA,NA,NA
"3339",3339,"Cluster_6904","Porites_evermani_scaffold_204:79769-80769",166,-26.16,2,21,433,453,19,"73.68%","89.47%","Peve_00013945",-0.634657669764847,0.56228223226831,0.978262075707395,NA,NA,NA,NA,NA
"3340",3340,"Cluster_6904","Porites_evermani_scaffold_211:141024-142024",164,-21.06,2,21,433,454,19,"73.68%","78.95%","Peve_00014665",-0.951310992493219,0.199475076059675,0.978262075707395,"P35590","Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1)","Homo sapiens (Human)","angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; branching involved in lymph vessel morphogenesis [GO:0060854]; in utero embryonic development [GO:0001701]; lymphatic endothelial cell differentiation [GO:0060836]; mesoderm development [GO:0007498]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; plasma membrane fusion [GO:0045026]; positive regulation of angiogenesis [GO:0045766]; positive regulation of kinase activity [GO:0033674]; regulation of endothelial cell proliferation [GO:0001936]; regulation of extracellular matrix assembly [GO:1901201]; response to retinoic acid [GO:0032526]; signal transduction [GO:0007165]; tissue remodeling [GO:0048771]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vasculogenesis [GO:0001570]","GO:0001525; GO:0001570; GO:0001701; GO:0001936; GO:0003180; GO:0004714; GO:0005524; GO:0005886; GO:0007165; GO:0007169; GO:0007498; GO:0016525; GO:0030336; GO:0032526; GO:0033674; GO:0043235; GO:0045026; GO:0045766; GO:0048771; GO:0060836; GO:0060854; GO:1901201"
"3341",3341,"Cluster_6904","Porites_evermani_scaffold_211:71562-72562",151,-20.43,2,21,96,118,20,"65.00%","75.00%","Peve_00014687",-0.488306671739018,0.675229503764934,0.978262075707395,"P16092","Fibroblast growth factor receptor 1 (FGFR-1) (bFGF-R-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (MFR) (Proto-oncogene c-Fgr) (CD antigen CD331)","Mus musculus (Mouse)","angiogenesis [GO:0001525]; auditory receptor cell development [GO:0060117]; blood vessel morphogenesis [GO:0048514]; brain development [GO:0007420]; branching involved in salivary gland morphogenesis [GO:0060445]; calcium ion homeostasis [GO:0055074]; cardiac muscle cell proliferation [GO:0060038]; cell maturation [GO:0048469]; cell population proliferation [GO:0008283]; cementum mineralization [GO:0071529]; central nervous system neuron development [GO:0021954]; chondrocyte differentiation [GO:0002062]; diphosphate metabolic process [GO:0071344]; ear development [GO:0043583]; embryonic limb morphogenesis [GO:0030326]; epithelial to mesenchymal transition [GO:0001837]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development [GO:0035607]; gene expression [GO:0010467]; generation of neurons [GO:0048699]; in utero embryonic development [GO:0001701]; inner ear morphogenesis [GO:0042472]; lung development [GO:0030324]; lung-associated mesenchyme development [GO:0060484]; mesenchymal cell differentiation [GO:0048762]; mesenchymal cell proliferation [GO:0010463]; midbrain development [GO:0030901]; middle ear morphogenesis [GO:0042474]; motogenic signaling involved in postnatal olfactory bulb interneuron migration [GO:0021837]; negative regulation of fibroblast growth factor production [GO:0090272]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron projection development [GO:0031175]; orbitofrontal cortex development [GO:0021769]; organ induction [GO:0001759]; outer ear morphogenesis [GO:0042473]; paraxial mesoderm development [GO:0048339]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000546]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of inflammatory response [GO:0050729]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway [GO:0090080]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic cell cycle DNA replication [GO:1903465]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]; positive regulation of parathyroid hormone secretion [GO:2000830]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein autophosphorylation [GO:0046777]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001239]; regulation of gene expression [GO:0010468]; regulation of lateral mesodermal cell fate specification [GO:0048378]; regulation of phosphate transport [GO:0010966]; regulation of phosphorus metabolic process [GO:0051174]; regulation of sensory perception of pain [GO:0051930]; regulation of stem cell proliferation [GO:0072091]; response to sodium phosphate [GO:1904383]; salivary gland morphogenesis [GO:0007435]; sensory perception of sound [GO:0007605]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827]; stem cell proliferation [GO:0072089]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureteric bud development [GO:0001657]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; ventricular zone neuroblast division [GO:0021847]; vitamin D3 metabolic process [GO:0070640]","GO:0000122; GO:0001525; GO:0001657; GO:0001701; GO:0001759; GO:0001837; GO:0002053; GO:0002062; GO:0004713; GO:0004714; GO:0005007; GO:0005102; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007169; GO:0007420; GO:0007435; GO:0007605; GO:0008201; GO:0008283; GO:0008284; GO:0008543; GO:0010463; GO:0010467; GO:0010468; GO:0010629; GO:0010763; GO:0010863; GO:0010966; GO:0010976; GO:0017134; GO:0018108; GO:0019827; GO:0021769; GO:0021837; GO:0021847; GO:0021954; GO:0030324; GO:0030326; GO:0030901; GO:0031175; GO:0031410; GO:0033674; GO:0035607; GO:0042127; GO:0042169; GO:0042472; GO:0042473; GO:0042474; GO:0042802; GO:0042803; GO:0043235; GO:0043406; GO:0043410; GO:0043536; GO:0043583; GO:0044877; GO:0045597; GO:0045666; GO:0045668; GO:0045787; GO:0045944; GO:0046777; GO:0048339; GO:0048378; GO:0048469; GO:0048471; GO:0048514; GO:0048699; GO:0048762; GO:0048863; GO:0050678; GO:0050729; GO:0050839; GO:0051174; GO:0051897; GO:0051930; GO:0055074; GO:0060038; GO:0060045; GO:0060117; GO:0060445; GO:0060484; GO:0060665; GO:0060979; GO:0070640; GO:0071344; GO:0071529; GO:0072089; GO:0072091; GO:0090080; GO:0090272; GO:0090722; GO:1903465; GO:1904383; GO:1905564; GO:2000491; GO:2000546; GO:2000648; GO:2000830; GO:2001239"
"3342",3342,"Cluster_6904","Porites_evermani_scaffold_2120:55495-56495",149,-24.13,2,20,590,613,20,"70.00%","75.00%","Peve_00014777",-0.927524466132732,0.243864944139934,0.978262075707395,NA,NA,NA,NA,NA
"3343",3343,"Cluster_6904","Porites_evermani_scaffold_2134:81858-82858",158,-22.8,2,19,246,267,17,"70.59%","82.35%","Peve_00014920",0.0248400575105503,0.98418470154274,0.999448381576871,"P13804","Electron transfer flavoprotein subunit alpha, mitochondrial (Alpha-ETF)","Homo sapiens (Human)","amino acid catabolic process [GO:0009063]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904]","GO:0005739; GO:0005759; GO:0009055; GO:0009063; GO:0016491; GO:0022904; GO:0033539; GO:0045251; GO:0050660"
"3344",3344,"Cluster_6904","Porites_evermani_scaffold_2134:81957-82957",158,-22.8,2,19,147,168,17,"70.59%","82.35%","Peve_00014921",0.742592842212241,0.467191590606991,0.978262075707395,NA,NA,NA,NA,NA
"3345",3345,"Cluster_6904","Porites_evermani_scaffold_2225:53942-54942",148,-20.01,2,13,620,641,11,"81.82%","90.91%","Peve_00015821",-0.00820779355760993,0.994774697663009,0.999448381576871,"Q08CY9","EGF domain-specific O-linked N-acetylglucosamine transferase (EC 2.4.1.255) (Extracellular O-linked N-acetylglucosamine transferase)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","protein O-linked glycosylation [GO:0006493]","GO:0005788; GO:0006493; GO:0097363"
"3346",3346,"Cluster_6904","Porites_evermani_scaffold_2259:70606-71606",153,-20.46,2,21,588,607,19,"73.68%","73.68%","Peve_00016125",-0.695946414534131,0.509970196980651,0.978262075707395,"Q9H0H5","Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4)","Homo sapiens (Human)","actomyosin contractile ring assembly [GO:0000915]; erythrocyte differentiation [GO:0030218]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; neuroblast proliferation [GO:0007405]; positive regulation of cytokinesis [GO:0032467]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of embryonic development [GO:0045995]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; sulfate transport [GO:0008272]","GO:0000281; GO:0000915; GO:0001669; GO:0005096; GO:0005547; GO:0005634; GO:0005654; GO:0005819; GO:0005829; GO:0005874; GO:0007266; GO:0007283; GO:0007405; GO:0008017; GO:0008272; GO:0019901; GO:0030218; GO:0030496; GO:0031234; GO:0032154; GO:0032467; GO:0043014; GO:0043015; GO:0045995; GO:0046872; GO:0048487; GO:0051056; GO:0051233; GO:0051256; GO:0051988; GO:0070062; GO:0072686; GO:0090543; GO:0097149"
"3347",3347,"Cluster_6904","Porites_evermani_scaffold_22:602421-603421",162,-22.22,2,21,775,795,19,"73.68%","84.21%","Peve_00015525",-0.926543272156746,0.245530779433755,0.978262075707395,NA,NA,NA,NA,NA
"3348",3348,"Cluster_6904","Porites_evermani_scaffold_2276:9701-10701",149,-23.08,2,21,388,413,23,"69.57%","73.91%","Peve_00016269",NA,NA,NA,"P61315","Galactose-3-O-sulfotransferase 3 (Gal3ST-3) (EC 2.8.2.-) (Beta-galactose-3-O-sulfotransferase 3) (Gal-beta-1, 3-GalNAc 3'-sulfotransferase 3)","Mus musculus (Mouse)","glycolipid biosynthetic process [GO:0009247]","GO:0001733; GO:0008146; GO:0009247; GO:0032580; GO:0050694"
"3349",3349,"Cluster_6904","Porites_evermani_scaffold_2383:17791-18791",165,-23.47,2,19,181,203,18,"83.33%","83.33%","Peve_00017275",NA,NA,NA,NA,NA,NA,NA,NA
"3350",3350,"Cluster_6904","Porites_evermani_scaffold_2393:22171-23171",158,-25.58,2,19,268,289,17,"70.59%","82.35%","Peve_00017353",0.0421087716445266,0.973184794838646,0.999448381576871,NA,NA,NA,NA,NA
"3351",3351,"Cluster_6904","Porites_evermani_scaffold_2396:12008-13008",147,-20.78,2,21,247,270,21,"61.90%","71.43%","Peve_00017369",-0.995698885695115,0.0590665218967147,0.978262075707395,NA,NA,NA,NA,NA
"3352",3352,"Cluster_6904","Porites_evermani_scaffold_2410:32623-33623",151,-21.22,2,19,490,513,20,"75.00%","75.00%","Peve_00017610",-0.987613421744205,0.100304427366373,0.978262075707395,"Q4UMH6","Putative ankyrin repeat protein RF_0381","Rickettsia felis (strain ATCC VR-1525 / URRWXCal2) (Rickettsia azadi)","guanosine tetraphosphate metabolic process [GO:0015969]","GO:0015969"
"3353",3353,"Cluster_6904","Porites_evermani_scaffold_24:280731-281731",149,-20.7,2,15,353,376,15,"73.33%","86.67%","Peve_00017478",NA,NA,NA,NA,NA,NA,NA,NA
"3354",3354,"Cluster_6904","Porites_evermani_scaffold_2436:57085-58085",147,-22.62,2,21,334,357,21,"57.14%","76.19%","Peve_00017826",-0.989963021484299,0.0902735536005643,0.978262075707395,NA,NA,NA,NA,NA
"3355",3355,"Cluster_6904","Porites_evermani_scaffold_246:105408-106408",156,-22.17,2,17,90,111,15,"73.33%","86.67%","Peve_00018011",NA,NA,NA,NA,NA,NA,NA,NA
"3356",3356,"Cluster_6904","Porites_evermani_scaffold_246:202103-203103",147,-20.72,2,18,307,327,16,"68.75%","81.25%","Peve_00018020",NA,NA,NA,NA,NA,NA,NA,NA
"3357",3357,"Cluster_6904","Porites_evermani_scaffold_248:268130-269130",164,-24.87,2,17,685,706,15,"80.00%","93.33%","Peve_00018182",-0.824950861375556,0.382405447283312,0.978262075707395,"Q6AY39","UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 1 (Beta-1,3-GalNAc-T1) (EC 2.4.1.79) (Beta-1,3-galactosyltransferase 3) (Beta-1,3-GalTase 3) (Beta3Gal-T3) (Beta3GalT3) (b3Gal-T3) (Beta-3-Gx-T3) (Galactosylgalactosylglucosylceramide beta-D-acetyl-galactosaminyltransferase) (Globoside synthase) (UDP-N-acetylgalactosamine:globotriaosylceramide beta-1,3-N-acetylgalactosaminyltransferase)","Rattus norvegicus (Rat)","lipid metabolic process [GO:0006629]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]","GO:0000139; GO:0006486; GO:0006629; GO:0008194; GO:0008499; GO:0009312; GO:0016757; GO:0047273"
"3358",3358,"Cluster_6904","Porites_evermani_scaffold_251:152518-153518",153,-24.19,2,21,839,863,23,"69.57%","73.91%","Peve_00018528",-0.516754204736953,0.654280214273389,0.978262075707395,"A1DWM3","Major facilitator superfamily domain-containing protein 6 (Macrophage MHC class I receptor 2 homolog)","Sus scrofa (Pig)","antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]","GO:0005886; GO:0016020; GO:0042590"
"3359",3359,"Cluster_6904","Porites_evermani_scaffold_2518:34717-35717",159,-21.77,2,16,855,876,14,"85.71%","85.71%","Peve_00018584",-0.777696081683063,0.432776531592363,0.978262075707395,"Q7QGL0","Kelch-like protein diablo","Anopheles gambiae (African malaria mosquito)","negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; protein ubiquitination [GO:0016567]","GO:0003779; GO:0016567; GO:0045886"
"3360",3360,"Cluster_6904","Porites_evermani_scaffold_254:137366-138366",166,-22.13,2,20,899,921,19,"73.68%","89.47%","Peve_00018769",-0.265488578317903,0.828933486503763,0.995934364227446,"Q9UPZ3","BLOC-2 complex member HPS5 (Alpha-integrin-binding protein 63) (Hermansky-Pudlak syndrome 5 protein) (Ruby-eye protein 2 homolog) (Ru2)","Homo sapiens (Human)","blood coagulation [GO:0007596]; developmental pigmentation [GO:0048066]; intracellular transport [GO:0046907]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155]","GO:0005737; GO:0005769; GO:0005829; GO:0007596; GO:0031084; GO:0046907; GO:0048066; GO:0060155; GO:1903232"
"3361",3361,"Cluster_6904","Porites_evermani_scaffold_2547:27197-28197",151,-23.47,2,21,496,517,21,"71.43%","80.95%","Peve_00018824",-0.349279285834766,0.772852896004957,0.991707871360626,"Q8VE62","Polyadenylate-binding protein-interacting protein 1 (PABP-interacting protein 1) (PAIP-1) (Poly(A)-binding protein-interacting protein 1)","Mus musculus (Mouse)","CRD-mediated mRNA stabilization [GO:0070934]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; positive regulation by host of viral process [GO:0044794]; positive regulation of cytoplasmic translation [GO:2000767]; regulation of translational initiation [GO:0006446]","GO:0003723; GO:0005829; GO:0006446; GO:0008494; GO:0044794; GO:0070934; GO:0106002; GO:1900152; GO:2000767"
"3362",3362,"Cluster_6904","Porites_evermani_scaffold_2568:37495-38495",171,-25.56,2,20,546,567,18,"72.22%","94.44%","Peve_00018954",-0.776331403588458,0.434156681862708,0.978262075707395,NA,NA,NA,NA,NA
"3363",3363,"Cluster_6904","Porites_evermani_scaffold_257:117883-118883",155,-20.05,2,12,79,100,10,"100.00%","100.00%","Peve_00018966",-0.63221129072062,0.564294926260064,0.978262075707395,"Q68CZ1","Protein fantom (Nephrocystin-8) (RPGR-interacting protein 1-like protein) (RPGRIP1-like protein)","Homo sapiens (Human)","cerebellum development [GO:0021549]; cochlea development [GO:0090102]; corpus callosum development [GO:0022038]; determination of left/right symmetry [GO:0007368]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; establishment of planar polarity [GO:0001736]; establishment or maintenance of cell polarity [GO:0007163]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; lateral ventricle development [GO:0021670]; liver development [GO:0001889]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; nose development [GO:0043584]; olfactory bulb development [GO:0021772]; pericardium development [GO:0060039]; regulation of smoothened signaling pathway [GO:0008589]; retinal rod cell development [GO:0046548]","GO:0001701; GO:0001736; GO:0001822; GO:0001889; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005879; GO:0005886; GO:0005911; GO:0005923; GO:0005929; GO:0005930; GO:0007163; GO:0007368; GO:0008589; GO:0021532; GO:0021549; GO:0021670; GO:0021772; GO:0022038; GO:0031870; GO:0032391; GO:0035115; GO:0035116; GO:0035253; GO:0035869; GO:0036064; GO:0043584; GO:0045744; GO:0046548; GO:0060039; GO:0090102; GO:1905515"
"3364",3364,"Cluster_6904","Porites_evermani_scaffold_257:327172-328172",150,-20.09,2,16,561,584,16,"75.00%","81.25%","Peve_00018986",-0.307147664571009,0.801250896549722,0.995934364227446,"Q8BG58","Transmembrane prolyl 4-hydroxylase (P4H-TM) (EC 1.14.11.29) (Hypoxia-inducible factor prolyl hydroxylase 4) (HIF-PH4) (HIF-prolyl hydroxylase 4) (HPH-4)","Mus musculus (Mouse)","peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; regulation of erythrocyte differentiation [GO:0045646]","GO:0004656; GO:0005506; GO:0005509; GO:0005783; GO:0005789; GO:0016706; GO:0018401; GO:0031418; GO:0045646"
"3365",3365,"Cluster_6904","Porites_evermani_scaffold_258:123945-124945",155,-20.24,2,20,709,730,18,"72.22%","72.22%","Peve_00019060",-0.84344234992553,0.361050792856367,0.978262075707395,NA,NA,NA,NA,NA
"3366",3366,"Cluster_6904","Porites_evermani_scaffold_2629:15619-16619",154,-21.08,2,17,850,870,15,"73.33%","93.33%","Peve_00019486",-0.954498262487767,0.192783466920403,0.978262075707395,NA,NA,NA,NA,NA
"3367",3367,"Cluster_6904","Porites_evermani_scaffold_266:305635-306635",154,-23.42,2,19,762,783,17,"64.71%","82.35%","Peve_00019751",-0.349553828086841,0.772666359087158,0.991649927131629,NA,NA,NA,NA,NA
"3368",3368,"Cluster_6904","Porites_evermani_scaffold_26:851088-852088",161,-22.37,2,19,604,626,18,"77.78%","83.33%","Peve_00019243",-0.870333224153512,0.327806828797645,0.978262075707395,"Q66IC8","Dynein light chain Tctex-type 5 (Tctex1 domain-containing protein 1)","Danio rerio (Zebrafish) (Brachydanio rerio)","cilium assembly [GO:0060271]; microtubule-based movement [GO:0007018]","GO:0005737; GO:0005868; GO:0007018; GO:0045505; GO:0060271"
"3369",3369,"Cluster_6904","Porites_evermani_scaffold_2690:64851-65851",164,-21.03,2,19,808,828,17,"82.35%","88.24%","Peve_00019983",-0.84999857626795,0.353205394107049,0.978262075707395,"O73853","Steroid 17-alpha-hydroxylase/17,20 lyase (EC 1.14.14.19) (EC 1.14.14.32) (17-alpha-hydroxyprogesterone aldolase) (CYPXVII) (Cytochrome P450 17A1) (Cytochrome P450-C17) (Cytochrome P450c17)","Ictalurus punctatus (Channel catfish) (Silurus punctatus)","steroid biosynthetic process [GO:0006694]","GO:0004508; GO:0005506; GO:0006694; GO:0016020; GO:0020037; GO:0047442"
"3370",3370,"Cluster_6904","Porites_evermani_scaffold_269:170868-171868",158,-20.38,2,20,436,458,19,"68.42%","84.21%","Peve_00019973",NA,NA,NA,NA,NA,NA,NA,NA
"3371",3371,"Cluster_6904","Porites_evermani_scaffold_2737:54318-55318",158,-24.36,2,21,171,194,21,"71.43%","80.95%","Peve_00020404",-0.749091067626203,0.460981060077508,0.978262075707395,"Q14679","Tubulin monoglutamylase TTLL4 (EC 6.3.2.-) (Protein monoglutamylase TTLL4) (Tubulin--tyrosine ligase-like protein 4)","Homo sapiens (Human)","microtubule cytoskeleton organization [GO:0000226]; peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]; regulation of blastocyst development [GO:0120222]","GO:0000226; GO:0005524; GO:0005829; GO:0005874; GO:0005929; GO:0015631; GO:0018095; GO:0018200; GO:0036064; GO:0046872; GO:0070739; GO:0070740; GO:0097731; GO:0120222"
"3372",3372,"Cluster_6904","Porites_evermani_scaffold_278:12292-13292",148,-20.86,2,18,542,564,17,"70.59%","76.47%","Peve_00020714",NA,NA,NA,NA,NA,NA,NA,NA
"3373",3373,"Cluster_6904","Porites_evermani_scaffold_2785:63000-63612",162,-22.28,2,21,206,226,19,"73.68%","84.21%","Peve_00020762",NA,NA,NA,NA,NA,NA,NA,NA
"3374",3374,"Cluster_6904","Porites_evermani_scaffold_278:59519-60519",162,-21.51,2,15,228,249,13,"84.62%","100.00%","Peve_00020719",-0.932226844264257,0.235726183879708,0.978262075707395,"P07949","Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Cadherin family member 12) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment]","Homo sapiens (Human)","activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; axon guidance [GO:0007411]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; lymphocyte migration into lymphoid organs [GO:0097021]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of protein kinase B signaling [GO:0051897]; posterior midgut development [GO:0007497]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657]","GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0006468; GO:0006919; GO:0007156; GO:0007158; GO:0007165; GO:0007169; GO:0007411; GO:0007497; GO:0009410; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030155; GO:0030335; GO:0030424; GO:0030425; GO:0033141; GO:0033619; GO:0033630; GO:0033674; GO:0035799; GO:0035860; GO:0038023; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045121; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0097021; GO:0098797; GO:2001241"
"3375",3375,"Cluster_6904","Porites_evermani_scaffold_28:712998-713998",160,-22.87,2,13,234,255,11,"100.00%","100.00%","Peve_00020885",-0.951310992493219,0.199475076059675,0.978262075707395,NA,NA,NA,NA,NA
"3376",3376,"Cluster_6904","Porites_evermani_scaffold_288:292124-293124",155,-20.16,2,18,692,712,16,"81.25%","81.25%","Peve_00021519",-0.999968700996602,0.00503687888605023,0.551398425649056,NA,NA,NA,NA,NA
"3377",3377,"Cluster_6904","Porites_evermani_scaffold_2897:33535-33964",162,-21.14,2,15,17,38,13,"92.31%","92.31%","Peve_00021625",0.2658102396176,0.828721078683041,0.995934364227446,"P14314","Glucosidase 2 subunit beta (80K-H protein) (Glucosidase II subunit beta) (Protein kinase C substrate 60.1 kDa protein heavy chain) (PKCSH)","Homo sapiens (Human)","intracellular signal transduction [GO:0035556]; liver development [GO:0001889]; N-glycan processing [GO:0006491]","GO:0001889; GO:0005080; GO:0005509; GO:0005783; GO:0005788; GO:0006491; GO:0017177; GO:0035556; GO:0043231; GO:0044325; GO:0051219"
"3378",3378,"Cluster_6904","Porites_evermani_scaffold_2897:33535-33964",162,-21.14,2,15,17,38,13,"92.31%","92.31%","Peve_00021626",-0.998711375947948,0.0323224956188328,0.909244498015575,"Q2VJ60","E3 ubiquitin-protein ligase RNF19A (EC 2.3.2.31) (Double ring-finger protein) (Dorfin) (RING finger protein 19A)","Sus scrofa (Pig)","positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0000209; GO:0005737; GO:0005815; GO:0006511; GO:0016020; GO:0031624; GO:0032436; GO:0046872; GO:0061630; GO:0098686; GO:0098794; GO:0098978; GO:0099576"
"3379",3379,"Cluster_6904","Porites_evermani_scaffold_2944:26324-27324",150,-21.11,2,18,158,177,16,"75.00%","81.25%","Peve_00022011",-0.798443965571,0.411313690403875,0.978262075707395,"P51950","CDK-activating kinase assembly factor MAT1 (CDK7/cyclin-H assembly factor) (Menage a trois) (RING finger protein MAT1)","Marthasterias glacialis (Spiny starfish)","cell cycle [GO:0007049]; cell division [GO:0051301]; nucleotide-excision repair [GO:0006289]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]","GO:0005675; GO:0006289; GO:0007049; GO:0045737; GO:0046872; GO:0051301; GO:0061575"
"3380",3380,"Cluster_6904","Porites_evermani_scaffold_296:139235-140235",155,-20.84,2,21,815,837,20,"70.00%","75.00%","Peve_00022124",-0.914144667471446,0.265727232792749,0.978262075707395,"P30825","High affinity cationic amino acid transporter 1 (CAT-1) (CAT1) (Ecotropic retroviral leukemia receptor homolog) (Ecotropic retrovirus receptor homolog) (Solute carrier family 7 member 1) (System Y+ basic amino acid transporter)","Homo sapiens (Human)","amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; L-amino acid transport [GO:0015807]; L-arginine import across plasma membrane [GO:0097638]; L-arginine transmembrane transport [GO:1903826]; L-histidine import across plasma membrane [GO:1903810]; L-ornithine transmembrane transport [GO:1903352]; lysine transport [GO:0015819]; ornithine transport [GO:0015822]; positive regulation of T cell proliferation [GO:0042102]; transport across blood-brain barrier [GO:0150104]","GO:0000064; GO:0001618; GO:0005290; GO:0005886; GO:0006865; GO:0009925; GO:0015171; GO:0015174; GO:0015189; GO:0015807; GO:0015819; GO:0015822; GO:0016020; GO:0016323; GO:0016324; GO:0032991; GO:0042102; GO:0061459; GO:0089718; GO:0097638; GO:0150104; GO:1903352; GO:1903810; GO:1903826"
"3381",3381,"Cluster_6904","Porites_evermani_scaffold_2984:11773-12773",151,-20.77,2,12,213,234,10,"90.00%","100.00%","Peve_00022313",0.319290570509916,0.793110810780699,0.995934364227446,"Q9H0H5","Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4)","Homo sapiens (Human)","actomyosin contractile ring assembly [GO:0000915]; erythrocyte differentiation [GO:0030218]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; neuroblast proliferation [GO:0007405]; positive regulation of cytokinesis [GO:0032467]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of embryonic development [GO:0045995]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; sulfate transport [GO:0008272]","GO:0000281; GO:0000915; GO:0001669; GO:0005096; GO:0005547; GO:0005634; GO:0005654; GO:0005819; GO:0005829; GO:0005874; GO:0007266; GO:0007283; GO:0007405; GO:0008017; GO:0008272; GO:0019901; GO:0030218; GO:0030496; GO:0031234; GO:0032154; GO:0032467; GO:0043014; GO:0043015; GO:0045995; GO:0046872; GO:0048487; GO:0051056; GO:0051233; GO:0051256; GO:0051988; GO:0070062; GO:0072686; GO:0090543; GO:0097149"
"3382",3382,"Cluster_6904","Porites_evermani_scaffold_308:216060-217060",163,-22.66,2,19,531,550,17,"82.35%","88.24%","Peve_00023198",NA,NA,NA,NA,NA,NA,NA,NA
"3383",3383,"Cluster_6904","Porites_evermani_scaffold_3:1107404-1108404",152,-20.81,2,17,158,179,15,"66.67%","86.67%","Peve_00022486",NA,NA,NA,NA,NA,NA,NA,NA
"3384",3384,"Cluster_6904","Porites_evermani_scaffold_3129:28725-29725",152,-21.62,2,21,608,627,19,"73.68%","78.95%","Peve_00023577",NA,NA,NA,NA,NA,NA,NA,NA
"3385",3385,"Cluster_6904","Porites_evermani_scaffold_3:1343395-1344395",159,-24.39,2,18,885,908,18,"77.78%","88.89%","Peve_00022527",NA,NA,NA,NA,NA,NA,NA,NA
"3386",3386,"Cluster_6904","Porites_evermani_scaffold_3187:12513-13513",162,-21.06,2,21,953,973,19,"73.68%","84.21%","Peve_00023919",-0.790320788483911,0.419827780157978,0.978262075707395,NA,NA,NA,NA,NA
"3387",3387,"Cluster_6904","Porites_evermani_scaffold_325:16527-17527",164,-27.56,2,21,128,149,19,"68.42%","84.21%","Peve_00024319",-0.876238330284392,0.320090310043292,0.978262075707395,"O75762","Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Transformation-sensitive protein p120) (p120) (Wasabi receptor)","Homo sapiens (Human)","calcium ion transmembrane transport [GO:0070588]; cell surface receptor signaling pathway [GO:0007166]; cellular calcium ion homeostasis [GO:0006874]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to organic substance [GO:0071310]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; ion transport [GO:0006811]; protein homotetramerization [GO:0051289]; response to cold [GO:0009409]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; sensory perception of pain [GO:0019233]; thermoception [GO:0050955]","GO:0005262; GO:0005886; GO:0006811; GO:0006874; GO:0007166; GO:0009409; GO:0009410; GO:0010033; GO:0014070; GO:0015267; GO:0015278; GO:0019233; GO:0032421; GO:0042802; GO:0048265; GO:0050955; GO:0050966; GO:0050968; GO:0051289; GO:0070301; GO:0070588; GO:0071310; GO:0097604"
"3388",3388,"Cluster_6904","Porites_evermani_scaffold_328:47495-48495",155,-20.13,2,18,702,722,16,"75.00%","87.50%","Peve_00024488",NA,NA,NA,NA,NA,NA,NA,NA
"3389",3389,"Cluster_6904","Porites_evermani_scaffold_3361:33478-34478",164,-21.29,2,17,245,266,15,"80.00%","93.33%","Peve_00025061",0.349753968898036,0.772530361155785,0.991606266389191,"Q8BX80","Cytosolic endo-beta-N-acetylglucosaminidase (ENGase) (EC 3.2.1.96)","Mus musculus (Mouse)","protein deglycosylation [GO:0006517]","GO:0004553; GO:0005829; GO:0006517; GO:0033925"
"3390",3390,"Cluster_6904","Porites_evermani_scaffold_3364:43633-44633",163,-26.4,2,21,949,972,21,"71.43%","80.95%","Peve_00025070",NA,NA,NA,NA,NA,NA,NA,NA
"3391",3391,"Cluster_6904","Porites_evermani_scaffold_339:3825-4825",160,-20.17,2,13,250,271,11,"100.00%","100.00%","Peve_00025187",-0.883055603633799,0.31096461303986,0.978262075707395,"P42325","Neurocalcin homolog (DrosNCa)","Drosophila melanogaster (Fruit fly)","negative regulation of neuronal signal transduction [GO:1902848]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]","GO:0005509; GO:0045938; GO:1902848"
"3392",3392,"Cluster_6904","Porites_evermani_scaffold_343:52957-53957",149,-22.26,2,14,709,730,12,"75.00%","91.67%","Peve_00025484",-0.791156349140769,0.418958824493309,0.978262075707395,"Q8K2G4","Bardet-Biedl syndrome 7 protein homolog (BBS2-like protein 1)","Mus musculus (Mouse)","brain development [GO:0007420]; cilium assembly [GO:0060271]; eye development [GO:0001654]; fat cell differentiation [GO:0045444]; heart development [GO:0007507]; intracellular transport [GO:0046907]; limb development [GO:0060173]; non-motile cilium assembly [GO:1905515]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; primary palate development [GO:1903929]; protein localization [GO:0008104]; protein transport [GO:0015031]; regulation of transcription by RNA polymerase II [GO:0006357]; smoothened signaling pathway [GO:0007224]","GO:0001654; GO:0001750; GO:0005634; GO:0005813; GO:0005930; GO:0006357; GO:0007224; GO:0007420; GO:0007507; GO:0008104; GO:0015031; GO:0016020; GO:0032436; GO:0034464; GO:0036064; GO:0043005; GO:0045444; GO:0046907; GO:0060170; GO:0060173; GO:0060271; GO:0061629; GO:1903929; GO:1905515"
"3393",3393,"Cluster_6904","Porites_evermani_scaffold_346:180727-181491",163,-22.77,2,20,571,592,18,"72.22%","83.33%","Peve_00025680",NA,NA,NA,NA,NA,NA,NA,NA
"3394",3394,"Cluster_6904","Porites_evermani_scaffold_3509:46-1046",164,-22.93,2,20,405,426,19,"84.21%","84.21%","Peve_00026018",-0.874687891654625,0.322132675486594,0.978262075707395,"P25931","RYamide receptor (Neuropeptide Y-like receptor) (NPY-R)","Drosophila melanogaster (Fruit fly)","G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]","GO:0001653; GO:0004983; GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0016020"
"3395",3395,"Cluster_6904","Porites_evermani_scaffold_351:94684-95684",151,-20.97,2,17,60,84,18,"72.22%","77.78%","Peve_00026021",NA,NA,NA,"Q61554","Fibrillin-1 [Cleaved into: Asprosin]","Mus musculus (Mouse)","activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; kidney development [GO:0001822]; metanephros development [GO:0001656]; negative regulation of brown fat cell differentiation [GO:1903444]; negative regulation of insulin secretion [GO:0046676]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; positive regulation of appetite [GO:0032100]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]","GO:0001501; GO:0001527; GO:0001656; GO:0001822; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0006006; GO:0007507; GO:0008201; GO:0009653; GO:0010737; GO:0031012; GO:0032100; GO:0033627; GO:0034199; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0046676; GO:0048048; GO:0048050; GO:0062023; GO:0071560; GO:1903444; GO:1990314; GO:2001205"
"3396",3396,"Cluster_6904","Porites_evermani_scaffold_3539:38895-39895",156,-25.49,2,18,272,298,21,"71.43%","76.19%","Peve_00026173",-0.951310992493219,0.199475076059675,0.978262075707395,"Q2MJB4","Doublesex- and mab-3-related transcription factor A2 (Doublesex- and mab-3-related transcription factor 5)","Xenopus laevis (African clawed frog)","neurogenesis [GO:0022008]; regulation of DNA-templated transcription [GO:0006355]","GO:0005634; GO:0006355; GO:0022008; GO:0043565; GO:0046872"
"3397",3397,"Cluster_6904","Porites_evermani_scaffold_380:114375-115375",152,-21.01,2,17,600,621,15,"73.33%","80.00%","Peve_00027632",-0.837706716356676,0.367791766880501,0.978262075707395,"Q5TCZ1","SH3 and PX domain-containing protein 2A (Adapter protein TKS5) (Five SH3 domain-containing protein) (SH3 multiple domains protein 1) (Tyrosine kinase substrate with five SH3 domains)","Homo sapiens (Human)","in utero embryonic development [GO:0001701]; osteoclast fusion [GO:0072675]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]","GO:0001701; GO:0002020; GO:0002102; GO:0005546; GO:0005737; GO:0005829; GO:0006801; GO:0010314; GO:0016176; GO:0032266; GO:0042554; GO:0042995; GO:0043325; GO:0070161; GO:0070273; GO:0072675"
"3398",3398,"Cluster_6904","Porites_evermani_scaffold_3846:19456-20456",153,-22.78,2,20,342,367,22,"68.18%","77.27%","Peve_00027865",-0.628452694440593,0.56737714251774,0.978262075707395,"Q76KP1","N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 1 (NGalNAc-T1) (EC 2.4.1.244) (Beta-1,4-N-acetylgalactosaminyltransferase IV) (Beta4GalNAc-T4) (Beta4GalNAcT4)","Homo sapiens (Human)","","GO:0008376; GO:0032580; GO:0033842"
"3399",3399,"Cluster_6904","Porites_evermani_scaffold_389:269583-270583",152,-20.06,2,19,453,476,19,"73.68%","78.95%","Peve_00028094",-0.847452976180482,0.356269863193665,0.978262075707395,NA,NA,NA,NA,NA
"3400",3400,"Cluster_6904","Porites_evermani_scaffold_389:269583-270583",162,-23.24,2,20,64,86,19,"73.68%","84.21%","Peve_00028094",-0.847452976180482,0.356269863193665,0.978262075707395,NA,NA,NA,NA,NA
"3401",3401,"Cluster_6904","Porites_evermani_scaffold_3903:2599-3599",168,-24.76,2,18,85,107,17,"88.24%","88.24%","Peve_00028212",NA,NA,NA,"Q6PC72",NA,NA,NA,NA
"3402",3402,"Cluster_6904","Porites_evermani_scaffold_4003:18500-19500",151,-20.82,2,18,411,436,20,"75.00%","75.00%","Peve_00028863",NA,NA,NA,NA,NA,NA,NA,NA
"3403",3403,"Cluster_6904","Porites_evermani_scaffold_40:295870-296870",157,-23.11,2,20,554,574,18,"77.78%","77.78%","Peve_00028827",-0.803377148545432,0.406068696590646,0.978262075707395,NA,NA,NA,NA,NA
"3404",3404,"Cluster_6904","Porites_evermani_scaffold_4058:13828-14828",163,-28.98,2,21,620,643,21,"76.19%","76.19%","Peve_00029153",NA,NA,NA,NA,NA,NA,NA,NA
"3405",3405,"Cluster_6904","Porites_evermani_scaffold_407:195366-196366",151,-21.25,2,21,609,633,22,"63.64%","72.73%","Peve_00029221",NA,NA,NA,NA,NA,NA,NA,NA
"3406",3406,"Cluster_6904","Porites_evermani_scaffold_412:91263-92263",155,-22.23,2,21,290,316,24,"66.67%","70.83%","Peve_00029478",-0.388283965154299,0.746135947052081,0.987609351020743,"Q2PC93","SCO-spondin","Gallus gallus (Chicken)","cell adhesion [GO:0007155]","GO:0005615; GO:0007155; GO:0031012"
"3407",3407,"Cluster_6904","Porites_evermani_scaffold_412:91263-92263",155,-22.23,2,21,776,802,24,"66.67%","70.83%","Peve_00029478",-0.388283965154299,0.746135947052081,0.987609351020743,"Q2PC93","SCO-spondin","Gallus gallus (Chicken)","cell adhesion [GO:0007155]","GO:0005615; GO:0007155; GO:0031012"
"3408",3408,"Cluster_6904","Porites_evermani_scaffold_416:231573-232573",149,-20.39,2,20,497,517,18,"66.67%","77.78%","Peve_00029658",-0.97987094915793,0.127949315615584,0.978262075707395,"O95685","Protein phosphatase 1 regulatory subunit 3D (Protein phosphatase 1 regulatory subunit 6) (PP1 subunit R6) (Protein phosphatase 1-binding subunit R6)","Homo sapiens (Human)","glycogen metabolic process [GO:0005977]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of glycogen catabolic process [GO:0005981]","GO:0000164; GO:0004722; GO:0005977; GO:0005979; GO:0005981; GO:0008157; GO:0042587; GO:0043231; GO:2001069"
"3409",3409,"Cluster_6904","Porites_evermani_scaffold_4214:17480-18480",158,-21.52,2,20,296,318,19,"73.68%","78.95%","Peve_00029947",NA,NA,NA,NA,NA,NA,NA,NA
"3410",3410,"Cluster_6904","Porites_evermani_scaffold_428:134688-135688",162,-25.27,2,16,50,72,15,"86.67%","93.33%","Peve_00030287",-0.0041990960045849,0.997326764601443,0.999448381576871,"Q8TF09","Dynein light chain roadblock-type 2 (Dynein light chain 2B, cytoplasmic) (Roadblock domain-containing protein 2)","Homo sapiens (Human)","microtubule-based movement [GO:0007018]","GO:0003777; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0005929; GO:0007018; GO:0045505; GO:0097542"
"3411",3411,"Cluster_6904","Porites_evermani_scaffold_4337:3321-4321",154,-20.56,2,17,4,24,15,"80.00%","86.67%","Peve_00030611",-0.70192408797432,0.504649128751416,0.978262075707395,"Q95LU3","Fibrinogen C domain-containing protein 1","Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)","","GO:0008061; GO:0016020; GO:0046872"
"3412",3412,"Cluster_6904","Porites_evermani_scaffold_4337:3321-4321",154,-20.56,2,17,572,592,15,"80.00%","86.67%","Peve_00030611",-0.70192408797432,0.504649128751416,0.978262075707395,"Q95LU3","Fibrinogen C domain-containing protein 1","Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)","","GO:0008061; GO:0016020; GO:0046872"
"3413",3413,"Cluster_6904","Porites_evermani_scaffold_4346:9159-9515",156,-20.48,2,21,305,326,19,"68.42%","73.68%","Peve_00030646",-0.99368031840117,0.0716096749134969,0.978262075707395,"Q15007","Pre-mRNA-splicing regulator WTAP (Female-lethal(2)D homolog) (hFL(2)D) (WT1-associated protein) (Wilms tumor 1-associating protein)","Homo sapiens (Human)","cell cycle [GO:0007049]; mRNA methylation [GO:0080009]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]","GO:0000381; GO:0005634; GO:0005654; GO:0005737; GO:0006397; GO:0007049; GO:0008380; GO:0016607; GO:0031965; GO:0036396; GO:0042802; GO:0080009"
"3414",3414,"Cluster_6904","Porites_evermani_scaffold_4346:9159-9515",156,-20.48,2,21,305,326,19,"68.42%","73.68%","Peve_00030647",0.546424604492996,0.631977000275137,0.978262075707395,"Q99ND9","RWD domain-containing protein 1 (Small androgen receptor-interacting protein)","Rattus norvegicus (Rat)","androgen receptor signaling pathway [GO:0030521]; cellular response to oxidative stress [GO:0034599]; cellular response to testosterone stimulus [GO:0071394]; cytoplasmic translation [GO:0002181]; positive regulation of androgen receptor activity [GO:2000825]","GO:0002181; GO:0005737; GO:0005844; GO:0030521; GO:0034599; GO:0071394; GO:2000825"
"3415",3415,"Cluster_6904","Porites_evermani_scaffold_4436:19765-20612",152,-20.61,2,17,390,411,15,"73.33%","80.00%","Peve_00031156",NA,NA,NA,NA,NA,NA,NA,NA
"3416",3416,"Cluster_6904","Porites_evermani_scaffold_4722:19199-20199",146,-21.09,2,17,781,801,15,"66.67%","86.67%","Peve_00032451",-0.985374991933587,0.109011897592771,0.978262075707395,NA,NA,NA,NA,NA
"3417",3417,"Cluster_6904","Porites_evermani_scaffold_4722:19199-20199",146,-21.09,2,17,9,29,15,"66.67%","86.67%","Peve_00032451",-0.985374991933587,0.109011897592771,0.978262075707395,NA,NA,NA,NA,NA
"3418",3418,"Cluster_6904","Porites_evermani_scaffold_4748:21064-22064",164,-21.45,2,19,557,577,17,"82.35%","88.24%","Peve_00032536",0.5058099375042,0.662387415668995,0.978262075707395,"A2AV25","Fibrinogen C domain-containing protein 1","Mus musculus (Mouse)","cell adhesion [GO:0007155]","GO:0005102; GO:0005615; GO:0007155; GO:0008061; GO:0016020; GO:0046872; GO:0062023"
"3419",3419,"Cluster_6904","Porites_evermani_scaffold_487:58647-59647",161,-20.44,2,18,446,467,16,"75.00%","87.50%","Peve_00033003",-0.950135068746438,0.201889686570281,0.978262075707395,NA,NA,NA,NA,NA
"3420",3420,"Cluster_6904","Porites_evermani_scaffold_5015:2723-3723",147,-20.69,2,21,788,811,21,"61.90%","71.43%","Peve_00033713",-0.919804879312496,0.256693630284396,0.978262075707395,"Q96KC8","DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1)","Homo sapiens (Human)","negative regulation of proteolysis [GO:0045861]; protein folding [GO:0006457]; regulation of protein secretion [GO:0050708]; regulation of translation [GO:0006417]","GO:0001671; GO:0003677; GO:0005783; GO:0005789; GO:0005886; GO:0006417; GO:0006457; GO:0012505; GO:0016020; GO:0031965; GO:0045861; GO:0050708; GO:0051087"
"3421",3421,"Cluster_6904","Porites_evermani_scaffold_507:188220-189220",152,-20.13,2,15,455,475,13,"84.62%","92.31%","Peve_00033913",0.742592842212241,0.467191590606991,0.978262075707395,"Q5ZM55","Protein fem-1 homolog B (FEM1b) (FEM1-beta)","Gallus gallus (Chicken)","apoptotic process [GO:0006915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627]","GO:0005634; GO:0005737; GO:0006915; GO:0016567; GO:0031462; GO:0043161; GO:0140627; GO:1990756; GO:2000001"
"3422",3422,"Cluster_6904","Porites_evermani_scaffold_51:378117-379117",164,-20.72,2,21,44,65,19,"68.42%","84.21%","Peve_00033998",-0.944518951046765,0.213057153488498,0.978262075707395,"P30349","Leukotriene A-4 hydrolase (LTA-4 hydrolase) (EC 3.3.2.6) (Leukotriene A(4) hydrolase) (Tripeptide aminopeptidase LTA4H) (EC 3.4.11.4)","Rattus norvegicus (Rat)","leukotriene biosynthetic process [GO:0019370]; leukotriene metabolic process [GO:0006691]; peptide catabolic process [GO:0043171]; protein metabolic process [GO:0019538]; proteolysis [GO:0006508]; response to peptide hormone [GO:0043434]; response to zinc ion [GO:0010043]; type I pneumocyte differentiation [GO:0060509]","GO:0004177; GO:0004301; GO:0004463; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006508; GO:0006691; GO:0008270; GO:0010043; GO:0019370; GO:0019538; GO:0043171; GO:0043434; GO:0045148; GO:0060509; GO:0070006"
"3423",3423,"Cluster_6904","Porites_evermani_scaffold_523:164025-165025",150,-20.19,2,20,139,161,19,"63.16%","78.95%","Peve_00034493",-0.182353576701284,0.883256898860773,0.999448381576871,NA,NA,NA,NA,NA
"3424",3424,"Cluster_6904","Porites_evermani_scaffold_5258:12849-13250",152,-21.41,2,21,85,105,20,"65.00%","85.00%","Peve_00034579",NA,NA,NA,NA,NA,NA,NA,NA
"3425",3425,"Cluster_6904","Porites_evermani_scaffold_5258:12849-13849",152,-21.41,2,21,85,105,20,"65.00%","85.00%","Peve_00034580",NA,NA,NA,NA,NA,NA,NA,NA
"3426",3426,"Cluster_6904","Porites_evermani_scaffold_5389:0-810",159,-22.47,2,21,385,409,22,"68.18%","77.27%","Peve_00035059",-0.397691640938709,0.739622767793615,0.986697151420032,"Q3MHG1","Serine palmitoyltransferase 1 (EC 2.3.1.50) (Long chain base biosynthesis protein 1) (LCB 1) (Serine-palmitoyl-CoA transferase 1) (SPT 1) (SPT1)","Bos taurus (Bovine)","ceramide biosynthetic process [GO:0046513]; positive regulation of lipophagy [GO:1904504]; regulation of fat cell apoptotic process [GO:1904649]; sphingolipid metabolic process [GO:0006665]; sphingosine biosynthetic process [GO:0046512]","GO:0004758; GO:0005783; GO:0005789; GO:0006665; GO:0030170; GO:0035339; GO:0046512; GO:0046513; GO:1904504; GO:1904649"
"3427",3427,"Cluster_6904","Porites_evermani_scaffold_5:502052-503052",156,-23.26,2,21,31,52,19,"63.16%","78.95%","Peve_00033513",NA,NA,NA,NA,NA,NA,NA,NA
"3428",3428,"Cluster_6904","Porites_evermani_scaffold_554:18773-19773",158,-23.07,2,20,858,880,19,"68.42%","84.21%","Peve_00035620",-0.841558872693933,0.363276659214107,0.978262075707395,"P58307","Orexin/Hypocretin receptor type 1 (Hypocretin receptor type 1) (Orexin receptor type 1) (Ox-1-R) (Ox1-R) (Ox1R)","Mus musculus (Mouse)","feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of cytosolic calcium ion concentration [GO:0051480]","GO:0004930; GO:0005886; GO:0007186; GO:0007218; GO:0007631; GO:0016499; GO:0017046; GO:0051480; GO:0070374"
"3429",3429,"Cluster_6904","Porites_evermani_scaffold_570:62268-63268",157,-21.4,2,17,293,314,16,"87.50%","87.50%","Peve_00036130",NA,NA,NA,NA,NA,NA,NA,NA
"3430",3430,"Cluster_6904","Porites_evermani_scaffold_573:103854-104854",155,-20.24,2,20,698,719,18,"72.22%","72.22%","Peve_00036208",-0.723209899251904,0.485331827175764,0.978262075707395,NA,NA,NA,NA,NA
"3431",3431,"Cluster_6904","Porites_evermani_scaffold_58:454799-455799",153,-22.04,2,21,507,529,21,"71.43%","76.19%","Peve_00036362",-0.450250423914068,0.702669421969368,0.978262075707395,"A9H2B4","Putative hydro-lyase GDI0188/Gdia_2258 (EC 4.2.1.-)","Gluconacetobacter diazotrophicus (strain ATCC 49037 / DSM 5601 / CCUG 37298 / CIP 103539 / LMG 7603 / PAl5)","","GO:0016829"
"3432",3432,"Cluster_6904","Porites_evermani_scaffold_586:68311-69311",159,-22.21,2,18,51,71,16,"81.25%","87.50%","Peve_00036548",0.299593633561026,0.806297806044947,0.995934364227446,NA,NA,NA,NA,NA
"3433",3433,"Cluster_6904","Porites_evermani_scaffold_616:77656-78656",158,-22.27,2,21,97,117,19,"68.42%","84.21%","Peve_00037476",NA,NA,NA,NA,NA,NA,NA,NA
"3434",3434,"Cluster_6904","Porites_evermani_scaffold_61:88103-89103",156,-21.91,2,20,960,982,20,"75.00%","80.00%","Peve_00037342",-0.998706114075126,0.0323884342508462,0.909244498015575,NA,NA,NA,NA,NA
"3435",3435,"Cluster_6904","Porites_evermani_scaffold_619:13066-14066",149,-20.76,2,21,956,980,22,"68.18%","77.27%","Peve_00037569",0.742592842212241,0.467191590606991,0.978262075707395,NA,NA,NA,NA,NA
"3436",3436,"Cluster_6904","Porites_evermani_scaffold_623:190876-191876",155,-21.07,2,19,756,777,18,"77.78%","83.33%","Peve_00037704",-0.998219553343417,0.0379947911463899,0.909359886114279,NA,NA,NA,NA,NA
"3437",3437,"Cluster_6904","Porites_evermani_scaffold_6237:4217-5217",159,-22.93,2,20,233,253,19,"78.95%","84.21%","Peve_00037715",-0.926738070792862,0.245200913024911,0.978262075707395,NA,NA,NA,NA,NA
"3438",3438,"Cluster_6904","Porites_evermani_scaffold_630:202739-203739",151,-23.47,2,21,395,416,21,"71.43%","80.95%","Peve_00037903",-0.312140146482791,0.797908299035441,0.995934364227446,"Q8VE62","Polyadenylate-binding protein-interacting protein 1 (PABP-interacting protein 1) (PAIP-1) (Poly(A)-binding protein-interacting protein 1)","Mus musculus (Mouse)","CRD-mediated mRNA stabilization [GO:0070934]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; positive regulation by host of viral process [GO:0044794]; positive regulation of cytoplasmic translation [GO:2000767]; regulation of translational initiation [GO:0006446]","GO:0003723; GO:0005829; GO:0006446; GO:0008494; GO:0044794; GO:0070934; GO:0106002; GO:1900152; GO:2000767"
"3439",3439,"Cluster_6904","Porites_evermani_scaffold_640:50057-51057",155,-21.76,2,21,340,362,20,"70.00%","75.00%","Peve_00038163",NA,NA,NA,NA,NA,NA,NA,NA
"3440",3440,"Cluster_6904","Porites_evermani_scaffold_666:125559-126559",157,-21.59,2,18,620,641,16,"75.00%","81.25%","Peve_00038734",-0.951310992493219,0.199475076059675,0.978262075707395,NA,NA,NA,NA,NA
"3441",3441,"Cluster_6904","Porites_evermani_scaffold_668:50187-51187",152,-22.46,2,17,822,841,15,"86.67%","86.67%","Peve_00038758",0.742592842212241,0.467191590606991,0.978262075707395,NA,NA,NA,NA,NA
"3442",3442,"Cluster_6904","Porites_evermani_scaffold_6700:982-1982",161,-21.41,2,18,298,319,16,"75.00%","87.50%","Peve_00038851",-0.951310992493219,0.199475076059675,0.978262075707395,NA,NA,NA,NA,NA
"3443",3443,"Cluster_6904","Porites_evermani_scaffold_673:162082-163082",162,-22.72,2,19,500,521,17,"76.47%","82.35%","Peve_00038906",NA,NA,NA,NA,NA,NA,NA,NA
"3444",3444,"Cluster_6904","Porites_evermani_scaffold_678:73960-74960",170,-23.55,2,19,794,815,17,"82.35%","88.24%","Peve_00039004",-0.583103320852298,0.603676544063376,0.978262075707395,"P00920","Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase II) (CA-II)","Mus musculus (Mouse)","angiotensin-activated signaling pathway [GO:0038166]; carbon dioxide transport [GO:0015670]; morphogenesis of an epithelium [GO:0002009]; neuron cellular homeostasis [GO:0070050]; one-carbon metabolic process [GO:0006730]; positive regulation of bone resorption [GO:0045780]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of dipeptide transmembrane transport [GO:2001150]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of anion transport [GO:0044070]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; secretion [GO:0046903]","GO:0002009; GO:0004064; GO:0004089; GO:0005615; GO:0005737; GO:0005829; GO:0005886; GO:0005902; GO:0006730; GO:0006885; GO:0008270; GO:0015670; GO:0016323; GO:0016836; GO:0030424; GO:0032230; GO:0032849; GO:0038166; GO:0043209; GO:0044070; GO:0045177; GO:0045672; GO:0045780; GO:0046903; GO:0051453; GO:0070050; GO:2001150; GO:2001225"
"3445",3445,"Cluster_6904","Porites_evermani_scaffold_68:16857-17857",160,-21.32,2,19,756,776,17,"82.35%","82.35%","Peve_00039022",-0.854237657389065,0.348048708495153,0.978262075707395,"Q9Y2K6","Ubiquitin carboxyl-terminal hydrolase 20 (EC 3.4.19.12) (Deubiquitinating enzyme 20) (Ubiquitin thioesterase 20) (Ubiquitin-specific-processing protease 20) (VHL-interacting deubiquitinating enzyme 2) (hVDU2)","Homo sapiens (Human)","endocytosis [GO:0006897]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0001664; GO:0004197; GO:0004843; GO:0005737; GO:0005813; GO:0005829; GO:0006511; GO:0006897; GO:0008270; GO:0008277; GO:0016579; GO:0048471; GO:0070536; GO:0071108"
"3446",3446,"Cluster_6904","Porites_evermani_scaffold_69:402939-403939",151,-20.25,2,19,477,496,17,"70.59%","82.35%","Peve_00039247",-0.811126016726608,0.397710081890783,0.978262075707395,NA,NA,NA,NA,NA
"3447",3447,"Cluster_6904","Porites_evermani_scaffold_69:576356-577356",155,-20.16,2,18,236,256,16,"81.25%","81.25%","Peve_00039256",NA,NA,NA,NA,NA,NA,NA,NA
"3448",3448,"Cluster_6904","Porites_evermani_scaffold_711:15435-16435",151,-20.89,2,21,303,328,23,"65.22%","69.57%","Peve_00039868",-0.153490185697653,0.901897305923853,0.999448381576871,NA,NA,NA,NA,NA
"3449",3449,"Cluster_6904","Porites_evermani_scaffold_71:134590-135590",153,-26.29,2,21,895,922,25,"72.00%","72.00%","Peve_00039820",NA,NA,NA,NA,NA,NA,NA,NA
"3450",3450,"Cluster_6904","Porites_evermani_scaffold_71:153868-154868",146,-20.36,2,21,839,864,23,"65.22%","69.57%","Peve_00039821",NA,NA,NA,NA,NA,NA,NA,NA
"3451",3451,"Cluster_6904","Porites_evermani_scaffold_7126:1565-2565",153,-22.9,2,21,510,535,23,"65.22%","82.61%","Peve_00039894",-0.951310992493219,0.199475076059675,0.978262075707395,NA,NA,NA,NA,NA
"3452",3452,"Cluster_6904","Porites_evermani_scaffold_717:143338-144338",153,-21.62,2,21,659,678,19,"73.68%","73.68%","Peve_00039958",0.208718150280978,0.866141742726342,0.996660710141104,"Q90964","Forkhead box protein G1 (FoxG1) (Brain factor 1) (BF-1) (BF1) (cBF-1) (CEQ 3-1) (Forkhead-related protein FKHL1) (N-62-5) (Proto-oncogene C-QIN)","Gallus gallus (Chicken)","axon midline choice point recognition [GO:0016199]; dorsal/ventral pattern formation [GO:0009953]; inner ear morphogenesis [GO:0042472]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; positive regulation of cell cycle [GO:0045787]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron differentiation [GO:0045666]; pyramidal neuron migration to cerebral cortex [GO:0021852]; regulation of mitotic cell cycle [GO:0007346]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000122; GO:0002052; GO:0003700; GO:0005634; GO:0006357; GO:0007346; GO:0007405; GO:0009953; GO:0016199; GO:0021852; GO:0042472; GO:0045665; GO:0045666; GO:0045787; GO:0048664; GO:1990837"
"3453",3453,"Cluster_6904","Porites_evermani_scaffold_719:21706-22706",157,-20.65,2,18,214,235,16,"75.00%","81.25%","Peve_00039988",-0.0328658066045187,0.979073209142382,0.999448381576871,"Q8IN35","Neuropeptide SIFamide receptor","Drosophila melanogaster (Fruit fly)","determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; mating behavior, sex discrimination [GO:0048047]; neuropeptide signaling pathway [GO:0007218]","GO:0004930; GO:0004983; GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0008340; GO:0008528; GO:0016020; GO:0042277; GO:0048047"
"3454",3454,"Cluster_6904","Porites_evermani_scaffold_725:110010-111010",157,-20.58,2,19,929,953,20,"70.00%","80.00%","Peve_00040141",-0.668023752136236,0.53428089248856,0.978262075707395,"Q8BWW4","La-related protein 4 (La ribonucleoprotein domain family member 4)","Mus musculus (Mouse)","cytoskeleton organization [GO:0007010]; positive regulation of translation [GO:0045727]; post-transcriptional regulation of gene expression [GO:0010608]; regulation of cell morphogenesis [GO:0022604]; translation [GO:0006412]","GO:0003723; GO:0003730; GO:0005829; GO:0005844; GO:0006412; GO:0007010; GO:0008143; GO:0010494; GO:0010608; GO:0022604; GO:0022627; GO:0045727"
"3455",3455,"Cluster_6904","Porites_evermani_scaffold_743:44593-45593",161,-21.69,2,19,329,351,18,"72.22%","88.89%","Peve_00040574",-0.377423210420485,0.753620428468596,0.988219883885475,"Q76IC6","Palmitoyltransferase ZDHHC23 (EC 2.3.1.225) (NNOS-interacting DHHC domain-containing protein with dendritic mRNA) (Zinc finger DHHC domain-containing protein 23) (DHHC-23) (zDHHC23)","Rattus norvegicus (Rat)","peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein localization to plasma membrane [GO:0072659]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]","GO:0000139; GO:0005783; GO:0005794; GO:0006612; GO:0018230; GO:0018345; GO:0019706; GO:0072659"
"3456",3456,"Cluster_6904","Porites_evermani_scaffold_75:273212-274212",153,-21.19,2,20,821,845,21,"71.43%","76.19%","Peve_00040676",-0.980482222614575,0.125985108434192,0.978262075707395,"Q96L93","Kinesin-like protein KIF16B (Sorting nexin-23)","Homo sapiens (Human)","early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; microtubule-based movement [GO:0007018]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919]","GO:0001704; GO:0001919; GO:0003777; GO:0005524; GO:0005547; GO:0005737; GO:0005768; GO:0005769; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0006895; GO:0007018; GO:0007173; GO:0007492; GO:0008017; GO:0008543; GO:0008574; GO:0016887; GO:0031901; GO:0032266; GO:0032801; GO:0043325; GO:0045022; GO:0080025"
"3457",3457,"Cluster_6904","Porites_evermani_scaffold_763:191311-192311",166,-22.42,2,19,554,575,17,"70.59%","94.12%","Peve_00040934",0.208718150280978,0.866141742726342,0.996660710141104,NA,NA,NA,NA,NA
"3458",3458,"Cluster_6904","Porites_evermani_scaffold_765:66869-67869",162,-23.8,2,19,156,177,17,"70.59%","88.24%","Peve_00040971",-0.824299664098541,0.383138309812799,0.978262075707395,NA,NA,NA,NA,NA
"3459",3459,"Cluster_6904","Porites_evermani_scaffold_770:80626-81626",158,-23.13,2,17,599,619,15,"80.00%","93.33%","Peve_00041075",NA,NA,NA,NA,NA,NA,NA,NA
"3460",3460,"Cluster_6904","Porites_evermani_scaffold_77:290114-291114",150,-22.99,2,21,157,183,24,"66.67%","70.83%","Peve_00041055",-0.283144951585886,0.817244496936397,0.995934364227446,NA,NA,NA,NA,NA
"3461",3461,"Cluster_6904","Porites_evermani_scaffold_776:151327-152327",151,-21.61,2,21,163,185,20,"65.00%","75.00%","Peve_00041173",-0.656076671994412,0.544429561899487,0.978262075707395,"P0CG68","Polyubiquitin-C [Cleaved into: Ubiquitin-related; Ubiquitin]","Sus scrofa (Pig)","modification-dependent protein catabolic process [GO:0019941]; protein ubiquitination [GO:0016567]","GO:0005634; GO:0005737; GO:0005741; GO:0016567; GO:0019941; GO:0031386; GO:0031625"
"3462",3462,"Cluster_6904","Porites_evermani_scaffold_778:44845-45845",154,-21.45,2,20,266,285,19,"78.95%","78.95%","Peve_00041206",-0.951310992493219,0.199475076059675,0.978262075707395,NA,NA,NA,NA,NA
"3463",3463,"Cluster_6904","Porites_evermani_scaffold_7:955374-956374",156,-22.19,2,19,922,942,17,"70.59%","88.24%","Peve_00039571",0.509545586782156,0.659627041706874,0.978262075707395,NA,NA,NA,NA,NA
"3464",3464,"Cluster_6904","Porites_evermani_scaffold_835:151815-152815",162,-28.79,2,21,767,791,22,"77.27%","77.27%","Peve_00042468",-0.887193334163652,0.305303843097562,0.978262075707395,NA,NA,NA,NA,NA
"3465",3465,"Cluster_6904","Porites_evermani_scaffold_838:73392-74392",155,-20.13,2,18,685,705,16,"75.00%","87.50%","Peve_00042498",0.224191762016248,0.856051606389914,0.995934364227446,NA,NA,NA,NA,NA
"3466",3466,"Cluster_6904","Porites_evermani_scaffold_844:40536-41536",161,-21.69,2,19,672,694,18,"72.22%","88.89%","Peve_00042648",-0.999469703920853,0.0207335430475651,0.81520158559417,"A5PMX1","Zinc transporter 7 (ZnT-7) (Solute carrier family 30 member 7)","Danio rerio (Zebrafish) (Brachydanio rerio)","cellular zinc ion homeostasis [GO:0006882]; metal ion transport [GO:0030001]; zinc ion import into Golgi lumen [GO:1904257]; zinc ion transport [GO:0006829]","GO:0005385; GO:0005794; GO:0006829; GO:0006882; GO:0016020; GO:0030001; GO:0031410; GO:0046873; GO:1904257"
"3467",3467,"Cluster_6904","Porites_evermani_scaffold_865:176011-177011",153,-20.46,2,20,16,34,18,"83.33%","83.33%","Peve_00043055",NA,NA,NA,NA,NA,NA,NA,NA
"3468",3468,"Cluster_6904","Porites_evermani_scaffold_871:89997-90997",150,-22.3,2,17,547,570,17,"76.47%","82.35%","Peve_00043160",-0.951310992493219,0.199475076059675,0.978262075707395,"Q766D5","N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 1 (NGalNAc-T1) (EC 2.4.1.244) (Beta-1,4-N-acetylgalactosaminyltransferase IV) (Beta4GalNAc-T4) (Beta4GalNAcT4)","Mus musculus (Mouse)","chondroitin sulfate biosynthetic process [GO:0030206]","GO:0008376; GO:0030206; GO:0032580; GO:0033842; GO:0047238"
"3469",3469,"Cluster_6904","Porites_evermani_scaffold_886:5266-6266",147,-25.77,2,21,804,830,24,"62.50%","66.67%","Peve_00043419",-0.951310992493219,0.199475076059675,0.978262075707395,NA,NA,NA,NA,NA
"3470",3470,"Cluster_6904","Porites_evermani_scaffold_907:123888-124888",155,-20.16,2,18,494,514,16,"81.25%","81.25%","Peve_00043864",0.208718150280978,0.866141742726342,0.996660710141104,"G5E8K5","Ankyrin-3 (ANK-3) (Ankyrin-G)","Mus musculus (Mouse)","anterograde axonal transport [GO:0008089]; axon development [GO:0061564]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; establishment of protein localization [GO:0045184]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in cell [GO:0032507]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; negative regulation of endocytosis [GO:0045806]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of action potential [GO:0045760]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; regulation of protein targeting [GO:1903533]; signal transduction [GO:0007165]; synapse organization [GO:0050808]","GO:0000281; GO:0005200; GO:0005737; GO:0005764; GO:0005886; GO:0005923; GO:0007009; GO:0007165; GO:0007409; GO:0007411; GO:0007528; GO:0008089; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014069; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030507; GO:0030674; GO:0030951; GO:0031594; GO:0032507; GO:0033268; GO:0033270; GO:0034112; GO:0042383; GO:0043001; GO:0043005; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045162; GO:0045184; GO:0045202; GO:0045211; GO:0045296; GO:0045760; GO:0045806; GO:0045838; GO:0050808; GO:0061564; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0099612; GO:0140031; GO:1900827; GO:1901224; GO:1902260; GO:1903533; GO:1904115; GO:2000651; GO:2001259"
"3471",3471,"Cluster_6904","Porites_evermani_scaffold_919:40937-41937",154,-20.57,2,20,149,171,19,"73.68%","73.68%","Peve_00044076",NA,NA,NA,NA,NA,NA,NA,NA
"3472",3472,"Cluster_6904","Porites_evermani_scaffold_923:164579-165579",156,-20.54,2,21,909,930,19,"57.89%","84.21%","Peve_00044170",NA,NA,NA,NA,NA,NA,NA,NA
"3473",3473,"Cluster_6904","Porites_evermani_scaffold_925:127604-128604",163,-25.87,2,18,177,201,19,"84.21%","84.21%","Peve_00044187",NA,NA,NA,"Q9UL51","Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 (Brain cyclic nucleotide-gated channel 2) (BCNG-2)","Homo sapiens (Human)","cell-cell signaling [GO:0007267]; cellular response to cAMP [GO:0071320]; cellular response to cGMP [GO:0071321]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; regulation of cation channel activity [GO:2001257]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane depolarization [GO:0003254]; regulation of membrane potential [GO:0042391]; regulation of SA node cell action potential [GO:0098907]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]","GO:0003254; GO:0005222; GO:0005248; GO:0005249; GO:0005886; GO:0007267; GO:0008076; GO:0030424; GO:0030425; GO:0030552; GO:0035725; GO:0042391; GO:0042802; GO:0071320; GO:0071321; GO:0071805; GO:0086012; GO:0086091; GO:0098719; GO:0098855; GO:0098907; GO:1990573; GO:2001257"
"3474",3474,"Cluster_6904","Porites_evermani_scaffold_9:533373-534373",162,-22.4,2,19,653,674,17,"76.47%","82.35%","Peve_00043615",0.758383361864789,0.451979053591162,0.978262075707395,"P55006","Retinol dehydrogenase 7 (EC 1.1.1.105) (Retinol dehydrogenase 3) (Retinol dehydrogenase type III) (RODH III)","Rattus norvegicus (Rat)","retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202]","GO:0004745; GO:0005783; GO:0008202; GO:0016491; GO:0042572; GO:0043231"
"3475",3475,"Cluster_6904","Porites_evermani_scaffold_954:121075-122075",156,-21.11,2,17,635,656,15,"66.67%","93.33%","Peve_00044645",-0.951310992493219,0.199475076059675,0.978262075707395,NA,NA,NA,NA,NA
"3476",3476,"Cluster_6904","Porites_evermani_scaffold_972:38504-39504",153,-21.1,2,18,543,564,16,"68.75%","81.25%","Peve_00044972",-0.842212498151687,0.362505591762348,0.978262075707395,NA,NA,NA,NA,NA
"3477",3477,"Cluster_6904","Porites_evermani_scaffold_978:19645-20645",155,-20.16,2,18,822,842,16,"81.25%","81.25%","Peve_00045031",-0.432259230570749,0.715433086015404,0.980230682515683,NA,NA,NA,NA,NA
"3478",3478,"Cluster_6904","Porites_evermani_scaffold_987:90468-91468",159,-23.32,2,21,184,206,20,"70.00%","80.00%","Peve_00045146",-0.977464932867213,0.135407746578031,0.978262075707395,NA,NA,NA,NA,NA
"3479",3479,"Cluster_6905","Porites_evermani_scaffold_10:263840-264840",147,-20.65,2,13,357,379,12,"83.33%","91.67%","Peve_00000180",0.971849002589803,0.151414034676697,0.978262075707395,NA,NA,NA,NA,NA
"3480",3480,"Cluster_6905","Porites_evermani_scaffold_103:433207-434207",156,-20.87,2,19,219,239,17,"70.59%","88.24%","Peve_00000670",NA,NA,NA,NA,NA,NA,NA,NA
"3481",3481,"Cluster_6905","Porites_evermani_scaffold_105:272347-273347",148,-20.74,2,20,251,272,19,"68.42%","78.95%","Peve_00000983",0.369137211937205,0.759306480535848,0.988219883885475,NA,NA,NA,NA,NA
"3482",3482,"Cluster_6905","Porites_evermani_scaffold_110:103189-104189",171,-24.72,2,21,699,721,20,"80.00%","85.00%","Peve_00001853",NA,NA,NA,NA,NA,NA,NA,NA
"3483",3483,"Cluster_6905","Porites_evermani_scaffold_110:103520-104520",171,-24.72,2,21,368,390,20,"80.00%","85.00%","Peve_00001854",-0.927762408209975,0.243459342970235,0.978262075707395,"Q2MV57","Tectonic-2","Mus musculus (Mouse)","cilium assembly [GO:0060271]; protein localization to ciliary transition zone [GO:1904491]; smoothened signaling pathway [GO:0007224]","GO:0005737; GO:0005856; GO:0007224; GO:0016020; GO:0035869; GO:0036038; GO:0060271; GO:1904491"
"3484",3484,"Cluster_6905","Porites_evermani_scaffold_1166:97781-98781",159,-21.85,2,21,96,118,20,"70.00%","80.00%","Peve_00002815",-0.929945104908788,0.239708228175045,0.978262075707395,NA,NA,NA,NA,NA
"3485",3485,"Cluster_6905","Porites_evermani_scaffold_1171:409-1409",160,-22.36,2,21,586,606,20,"80.00%","80.00%","Peve_00002898",-0.678279498031608,0.525451746597663,0.978262075707395,"Q5U4T7","Protein bicaudal C homolog 1-B (Bic-C-B)","Xenopus laevis (African clawed frog)","","GO:0003723"
"3486",3486,"Cluster_6905","Porites_evermani_scaffold_1350:123321-124321",154,-21.96,2,21,795,820,23,"69.57%","73.91%","Peve_00005531",0.495843663266958,0.669717801718245,0.978262075707395,"Q3UDE2","Tubulin--tyrosine ligase-like protein 12 (Inactive tubulin--tyrosine ligase-like protein 12)","Mus musculus (Mouse)","innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein modification process [GO:0036211]; regulation of mitotic cell cycle [GO:0007346]","GO:0005524; GO:0005634; GO:0005737; GO:0005815; GO:0005819; GO:0007346; GO:0015631; GO:0016881; GO:0030496; GO:0036211; GO:0045087; GO:0060339; GO:1990889"
"3487",3487,"Cluster_6905","Porites_evermani_scaffold_138:372076-373076",148,-23.55,2,18,758,780,17,"70.59%","76.47%","Peve_00005887",NA,NA,NA,NA,NA,NA,NA,NA
"3488",3488,"Cluster_6905","Porites_evermani_scaffold_1389:97766-98766",155,-22.28,2,12,369,390,10,"100.00%","100.00%","Peve_00006020",NA,NA,NA,NA,NA,NA,NA,NA
"3489",3489,"Cluster_6905","Porites_evermani_scaffold_1390:653-1653",155,-27.09,2,21,339,366,25,"64.00%","72.00%","Peve_00006052",-0.658790228846826,0.542136956599042,0.978262075707395,NA,NA,NA,NA,NA
"3490",3490,"Cluster_6905","Porites_evermani_scaffold_1442:66901-67901",155,-20.14,2,21,522,548,24,"66.67%","70.83%","Peve_00006756",0.400366443038374,0.737765682237004,0.986510932464122,"Q24439","ATP synthase subunit O, mitochondrial (Oligomycin sensitivity conferral protein) (OSCP)","Drosophila melanogaster (Fruit fly)","proton motive force-driven ATP synthesis [GO:0015986]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; proton transmembrane transport [GO:1902600]","GO:0000274; GO:0005739; GO:0015986; GO:0042776; GO:0045261; GO:0046933; GO:1902600"
"3491",3491,"Cluster_6905","Porites_evermani_scaffold_1470:92890-93890",164,-23.86,2,21,188,209,19,"68.42%","84.21%","Peve_00007110",0.146536410673757,0.906374894841712,0.999448381576871,"Q9FPH3","Probable low-specificity L-threonine aldolase 2 (EC 4.1.2.48) (Threonine aldolase 2)","Arabidopsis thaliana (Mouse-ear cress)","glycine biosynthetic process [GO:0006545]; threonine catabolic process [GO:0006567]","GO:0004793; GO:0005829; GO:0006545; GO:0006567; GO:0008732"
"3492",3492,"Cluster_6905","Porites_evermani_scaffold_150:287545-288545",154,-24.94,2,20,662,684,19,"63.16%","84.21%","Peve_00007520",NA,NA,NA,NA,NA,NA,NA,NA
"3493",3493,"Cluster_6905","Porites_evermani_scaffold_1526:77441-78441",164,-23.56,2,17,229,250,15,"86.67%","86.67%","Peve_00007835",-0.232305347144397,0.850746274868549,0.995934364227446,NA,NA,NA,NA,NA
"3494",3494,"Cluster_6905","Porites_evermani_scaffold_153:45324-46324",148,-20.59,2,20,658,680,20,"65.00%","80.00%","Peve_00007864",-0.929945104908788,0.239708228175045,0.978262075707395,NA,NA,NA,NA,NA
"3495",3495,"Cluster_6905","Porites_evermani_scaffold_1541:91143-92143",157,-20.15,2,20,779,803,21,"76.19%","76.19%","Peve_00008012",NA,NA,NA,"P14381","Transposon TX1 uncharacterized 149 kDa protein (ORF 2)","Xenopus laevis (African clawed frog)","","GO:0003824"
"3496",3496,"Cluster_6905","Porites_evermani_scaffold_1548:36365-37365",151,-20.57,2,20,90,110,19,"73.68%","78.95%","Peve_00008076",-0.76812393792375,0.442380914081131,0.978262075707395,"Q9Y5R2","Matrix metalloproteinase-24 (MMP-24) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 5) (MT-MMP 5) (MTMMP5) (Membrane-type-5 matrix metalloproteinase) (MT5-MMP) (MT5MMP) [Cleaved into: Processed matrix metalloproteinase-24]","Homo sapiens (Human)","cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; collagen catabolic process [GO:0030574]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; extracellular matrix organization [GO:0030198]; glial cell differentiation [GO:0010001]; neuronal stem cell population maintenance [GO:0097150]; proteolysis [GO:0006508]","GO:0004222; GO:0005886; GO:0006508; GO:0008047; GO:0008270; GO:0010001; GO:0030198; GO:0030574; GO:0031012; GO:0032588; GO:0044331; GO:0045296; GO:0050965; GO:0070062; GO:0097150; GO:0098742"
"3497",3497,"Cluster_6905","Porites_evermani_scaffold_1548:48792-49792",148,-20.28,2,13,72,93,11,"81.82%","90.91%","Peve_00008079",-0.895806183709774,0.293198110762343,0.978262075707395,"P07152","Stromelysin-2 (SL-2) (EC 3.4.24.22) (Matrix metalloproteinase-10) (MMP-10) (Transformation-associated protein 34A) (Transin-2)","Rattus norvegicus (Rat)","collagen catabolic process [GO:0030574]; extracellular matrix organization [GO:0030198]; proteolysis [GO:0006508]; regulation of cell migration [GO:0030334]","GO:0004222; GO:0005576; GO:0006508; GO:0008270; GO:0030198; GO:0030334; GO:0030574; GO:0031012"
"3498",3498,"Cluster_6905","Porites_evermani_scaffold_1:577221-578221",160,-21.9,2,17,33,54,15,"80.00%","86.67%","Peve_00000016",-0.903034295058815,0.282668629546232,0.978262075707395,NA,NA,NA,NA,NA
"3499",3499,"Cluster_6905","Porites_evermani_scaffold_1599:41770-42770",150,-22.17,2,17,52,72,15,"80.00%","80.00%","Peve_00008737",-0.929945104908788,0.239708228175045,0.978262075707395,"Q96CG8","Collagen triple helix repeat-containing protein 1","Homo sapiens (Human)","cell migration [GO:0016477]; cochlea morphogenesis [GO:0090103]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein binding [GO:0032092]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0001649; GO:0005109; GO:0005576; GO:0005581; GO:0005615; GO:0016477; GO:0016528; GO:0017147; GO:0032092; GO:0033687; GO:0033690; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0062023; GO:0090090; GO:0090103; GO:0090177"
"3500",3500,"Cluster_6905","Porites_evermani_scaffold_1651:10032-11032",154,-23.3,2,21,709,736,25,"68.00%","72.00%","Peve_00009438",NA,NA,NA,NA,NA,NA,NA,NA
"3501",3501,"Cluster_6905","Porites_evermani_scaffold_1665:90305-91305",158,-20.3,2,20,767,790,20,"75.00%","75.00%","Peve_00009566",-0.755097646199199,0.455178859880732,0.978262075707395,NA,NA,NA,NA,NA
"3502",3502,"Cluster_6905","Porites_evermani_scaffold_171:127622-128622",166,-22.27,2,19,769,790,17,"76.47%","88.24%","Peve_00010146",-0.96737377951625,0.16306712468948,0.978262075707395,"A0A0R4IBK5","E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (E3 ubiquitin-lipopolysaccharide ligase rnf213-alpha) (EC 2.3.2.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha)","Danio rerio (Zebrafish) (Brachydanio rerio)","blood circulation [GO:0008015]; defense response to bacterium [GO:0042742]; immune system process [GO:0002376]; lipid droplet formation [GO:0140042]; lipid ubiquitination [GO:0120323]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein K63-linked ubiquitination [GO:0070534]; regulation of lipid metabolic process [GO:0019216]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]; xenophagy [GO:0098792]","GO:0002040; GO:0002376; GO:0004842; GO:0005524; GO:0005730; GO:0005811; GO:0005829; GO:0006511; GO:0008015; GO:0016887; GO:0019216; GO:0042742; GO:0046872; GO:0061630; GO:0070534; GO:0098792; GO:0120323; GO:0140042; GO:2000051"
"3503",3503,"Cluster_6905","Porites_evermani_scaffold_1715:50160-51160",163,-21.5,2,21,516,540,22,"72.73%","77.27%","Peve_00010205",NA,NA,NA,NA,NA,NA,NA,NA
"3504",3504,"Cluster_6905","Porites_evermani_scaffold_171:64454-65454",155,-25.68,2,21,973,999,24,"66.67%","70.83%","Peve_00010140",-0.962969407078536,0.173790017922403,0.978262075707395,"Q9V6X7","GDP-fucose protein O-fucosyltransferase 1 (EC 2.4.1.221) (Neurotic protein) (Peptide-O-fucosyltransferase 1) (O-FucT-1)","Drosophila melanogaster (Fruit fly)","cell fate commitment [GO:0045165]; fucose metabolic process [GO:0006004]; Notch signaling pathway [GO:0007219]; O-glycan processing [GO:0016266]; positive regulation of endocytosis [GO:0045807]; positive regulation of Notch signaling pathway [GO:0045747]; protein O-linked fucosylation [GO:0036066]; protein O-linked glycosylation [GO:0006493]; regulation of Notch signaling pathway [GO:0008593]","GO:0005112; GO:0005783; GO:0006004; GO:0006493; GO:0007219; GO:0008417; GO:0008593; GO:0016266; GO:0036066; GO:0045165; GO:0045747; GO:0045807; GO:0046922"
"3505",3505,"Cluster_6905","Porites_evermani_scaffold_1773:87410-88410",148,-23.55,2,18,78,100,17,"70.59%","76.47%","Peve_00010809",-0.221959828748109,0.857509230108774,0.995934364227446,"Q9D1D6","Collagen triple helix repeat-containing protein 1","Mus musculus (Mouse)","cell migration [GO:0016477]; cochlea morphogenesis [GO:0090103]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein binding [GO:0032092]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0001649; GO:0005109; GO:0005581; GO:0005615; GO:0016477; GO:0016528; GO:0017147; GO:0031012; GO:0032092; GO:0033687; GO:0033690; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0090090; GO:0090103; GO:0090177"
"3506",3506,"Cluster_6905","Porites_evermani_scaffold_1789:88046-89046",153,-20.99,2,20,847,867,18,"66.67%","83.33%","Peve_00010992",NA,NA,NA,NA,NA,NA,NA,NA
"3507",3507,"Cluster_6905","Porites_evermani_scaffold_1799:72022-73022",164,-28.39,2,18,721,743,17,"82.35%","88.24%","Peve_00011065",-0.983383956787523,0.116214982800641,0.978262075707395,NA,NA,NA,NA,NA
"3508",3508,"Cluster_6905","Porites_evermani_scaffold_1807:47805-48805",156,-22.54,2,21,573,594,21,"76.19%","76.19%","Peve_00011243",NA,NA,NA,NA,NA,NA,NA,NA
"3509",3509,"Cluster_6905","Porites_evermani_scaffold_1844:42878-43878",160,-24.84,2,21,904,925,19,"63.16%","84.21%","Peve_00011627",-0.49007182857127,0.673941080362294,0.978262075707395,NA,NA,NA,NA,NA
"3510",3510,"Cluster_6905","Porites_evermani_scaffold_1856:31468-32468",172,-21.77,2,17,893,914,15,"93.33%","93.33%","Peve_00011770",-0.0221430457183258,0.985902147051629,0.999448381576871,"Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"3511",3511,"Cluster_6905","Porites_evermani_scaffold_191:241355-242355",166,-21.68,2,20,364,386,19,"73.68%","89.47%","Peve_00012402",0.62540189555949,0.569870093316167,0.978262075707395,NA,NA,NA,NA,NA
"3512",3512,"Cluster_6905","Porites_evermani_scaffold_1921:71290-72290",156,-20.72,2,21,15,36,19,"63.16%","78.95%","Peve_00012536",NA,NA,NA,NA,NA,NA,NA,NA
"3513",3513,"Cluster_6905","Porites_evermani_scaffold_2057:25819-26819",167,-21.22,2,21,670,692,20,"75.00%","85.00%","Peve_00014119",NA,NA,NA,NA,NA,NA,NA,NA
"3514",3514,"Cluster_6905","Porites_evermani_scaffold_21:535108-536108",150,-20.33,2,20,753,775,19,"68.42%","73.68%","Peve_00014523",0.250085977925206,0.83908222252133,0.995934364227446,"P23819","Glutamate receptor 2 (GluR-2) (AMPA-selective glutamate receptor 2) (GluR-B) (GluR-K2) (Glutamate receptor ionotropic, AMPA 2) (GluA2)","Mus musculus (Mouse)","cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to glycine [GO:1905430]; chemical synaptic transmission [GO:0007268]; establishment of protein localization [GO:0045184]; ionotropic glutamate receptor signaling pathway [GO:0035235]; positive regulation of synaptic transmission [GO:0050806]; protein tetramerization [GO:0051262]; receptor internalization [GO:0031623]; regulation of receptor recycling [GO:0001919]; regulation of synaptic transmission, glutamatergic [GO:0051966]","GO:0000149; GO:0001540; GO:0001919; GO:0004970; GO:0004971; GO:0005234; GO:0005783; GO:0005789; GO:0005886; GO:0007268; GO:0008021; GO:0008092; GO:0009986; GO:0014069; GO:0015276; GO:0015277; GO:0016020; GO:0019865; GO:0019901; GO:0030165; GO:0030424; GO:0030425; GO:0030426; GO:0030672; GO:0031623; GO:0032279; GO:0032281; GO:0032590; GO:0032839; GO:0032991; GO:0035235; GO:0035254; GO:0035255; GO:0036477; GO:0038023; GO:0042734; GO:0042802; GO:0043005; GO:0043025; GO:0043195; GO:0043197; GO:0043198; GO:0043204; GO:0044326; GO:0044327; GO:0044877; GO:0045184; GO:0045202; GO:0045211; GO:0048787; GO:0050806; GO:0051117; GO:0051262; GO:0051966; GO:0097060; GO:0097110; GO:0098685; GO:0098793; GO:0098839; GO:0098978; GO:0099507; GO:0099544; GO:0106033; GO:1904315; GO:1905430; GO:1990416"
"3515",3515,"Cluster_6905","Porites_evermani_scaffold_2252:78000-79000",148,-22.68,2,18,184,206,17,"70.59%","76.47%","Peve_00016076",-0.79162316329319,0.418472684509543,0.978262075707395,NA,NA,NA,NA,NA
"3516",3516,"Cluster_6905","Porites_evermani_scaffold_2288:16336-17336",148,-22.68,2,18,973,995,17,"70.59%","76.47%","Peve_00016364",NA,NA,NA,"Q6QNK2","Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) (G-protein coupled receptor PGR25)","Homo sapiens (Human)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]","GO:0004930; GO:0005654; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0016020"
"3517",3517,"Cluster_6905","Porites_evermani_scaffold_2533:39726-40726",148,-23.55,2,18,214,236,17,"70.59%","76.47%","Peve_00018731",-0.929945104908788,0.239708228175045,0.978262075707395,NA,NA,NA,NA,NA
"3518",3518,"Cluster_6905","Porites_evermani_scaffold_2571:18123-19123",176,-22.14,2,21,877,898,19,"84.21%","84.21%","Peve_00018995",-0.812603774944509,0.396098744555234,0.978262075707395,NA,NA,NA,NA,NA
"3519",3519,"Cluster_6905","Porites_evermani_scaffold_2572:34355-35355",152,-20.61,2,21,98,119,19,"63.16%","73.68%","Peve_00019003",-0.9078565930422,0.275435455674968,0.978262075707395,NA,NA,NA,NA,NA
"3520",3520,"Cluster_6905","Porites_evermani_scaffold_2733:46418-47418",161,-24.62,2,21,416,437,20,"80.00%","80.00%","Peve_00020372",NA,NA,NA,NA,NA,NA,NA,NA
"3521",3521,"Cluster_6905","Porites_evermani_scaffold_281:122251-123251",156,-21.66,2,20,848,874,23,"73.91%","78.26%","Peve_00020981",NA,NA,NA,NA,NA,NA,NA,NA
"3522",3522,"Cluster_6905","Porites_evermani_scaffold_2863:28179-29179",153,-21.83,2,15,923,945,14,"85.71%","85.71%","Peve_00021386",-0.978190460946867,0.133202032859544,0.978262075707395,NA,NA,NA,NA,NA
"3523",3523,"Cluster_6905","Porites_evermani_scaffold_2931:44010-45010",157,-26.54,2,20,406,426,18,"77.78%","77.78%","Peve_00021945",-0.999971374472759,0.00481695849265739,0.551398425649056,NA,NA,NA,NA,NA
"3524",3524,"Cluster_6905","Porites_evermani_scaffold_3042:38915-39915",148,-23.55,2,18,464,486,17,"70.59%","76.47%","Peve_00022941",-0.901519332263074,0.284905545065229,0.978262075707395,NA,NA,NA,NA,NA
"3525",3525,"Cluster_6905","Porites_evermani_scaffold_3089:27014-28014",148,-21.15,2,19,787,812,21,"66.67%","76.19%","Peve_00023254",-0.709975133959052,0.497412308939993,0.978262075707395,"A2AJ76","Hemicentin-2","Mus musculus (Mouse)","response to stimulus [GO:0050896]","GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005938; GO:0030054; GO:0031012; GO:0032154; GO:0050896; GO:0062023"
"3526",3526,"Cluster_6905","Porites_evermani_scaffold_3:1154428-1155428",146,-22.49,2,20,442,470,25,"56.00%","72.00%","Peve_00022491",NA,NA,NA,NA,NA,NA,NA,NA
"3527",3527,"Cluster_6905","Porites_evermani_scaffold_335:233548-234548",156,-22.4,2,21,161,182,19,"63.16%","78.95%","Peve_00024983",-0.977874620772173,0.134166624846142,0.978262075707395,"P16157","Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin)","Homo sapiens (Human)","cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]","GO:0005198; GO:0005200; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0014731; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030507; GO:0031430; GO:0043005; GO:0044325; GO:0045199; GO:0051117; GO:0072659"
"3528",3528,"Cluster_6905","Porites_evermani_scaffold_336:14130-15130",155,-25.68,2,20,358,379,18,"66.67%","77.78%","Peve_00025042",NA,NA,NA,NA,NA,NA,NA,NA
"3529",3529,"Cluster_6905","Porites_evermani_scaffold_3464:28409-29409",140,-20.34,2,9,661,682,7,"100.00%","100.00%","Peve_00025701",-0.771910947676898,0.438602202474846,0.978262075707395,"Q3UUJ4","STE20-related kinase adapter protein alpha (STRAD alpha) (STE20-related adapter protein)","Mus musculus (Mouse)","activation of protein kinase activity [GO:0032147]; G1 to G0 transition [GO:0070314]; protein export from nucleus [GO:0006611]; protein phosphorylation [GO:0006468]","GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0006611; GO:0019900; GO:0030295; GO:0032147; GO:0032991; GO:0043539; GO:0044877; GO:0070314; GO:0140535; GO:1902554"
"3530",3530,"Cluster_6905","Porites_evermani_scaffold_3754:26470-27470",160,-20.92,2,21,167,188,19,"73.68%","73.68%","Peve_00027367",-0.184616375450602,0.881791476904431,0.999199151813886,NA,NA,NA,NA,NA
"3531",3531,"Cluster_6905","Porites_evermani_scaffold_4035:32274-33265",167,-29.85,2,21,304,327,21,"76.19%","80.95%","Peve_00029019",NA,NA,NA,"E9Q236","ATP-binding cassette sub-family C member 4 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (Multidrug resistance-associated protein 4)","Mus musculus (Mouse)","bile acid and bile salt transport [GO:0015721]; cAMP transport [GO:0070730]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; fatty acid derivative transport [GO:1901571]; leukotriene transport [GO:0071716]; organic hydroxy compound transport [GO:0015850]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; prostaglandin transport [GO:0015732]; transmembrane transport [GO:0055085]; urate transport [GO:0015747]; xenobiotic transmembrane transport [GO:0006855]","GO:0001409; GO:0005524; GO:0005730; GO:0005794; GO:0005886; GO:0006855; GO:0008559; GO:0015132; GO:0015143; GO:0015216; GO:0015431; GO:0015432; GO:0015562; GO:0015665; GO:0015721; GO:0015732; GO:0015747; GO:0015850; GO:0016020; GO:0016323; GO:0016324; GO:0016887; GO:0031088; GO:0032310; GO:0034634; GO:0042626; GO:0042910; GO:0048661; GO:0055085; GO:0060271; GO:0070730; GO:0071716; GO:0098591; GO:0140115; GO:1901571"
"3532",3532,"Cluster_6905","Porites_evermani_scaffold_4163:27124-28124",153,-21.66,2,15,387,409,14,"85.71%","85.71%","Peve_00029672",NA,NA,NA,NA,NA,NA,NA,NA
"3533",3533,"Cluster_6905","Porites_evermani_scaffold_426:201423-202423",148,-22.68,2,18,128,150,17,"70.59%","76.47%","Peve_00030185",-0.546338578538092,0.632042389464689,0.978262075707395,NA,NA,NA,NA,NA
"3534",3534,"Cluster_6905","Porites_evermani_scaffold_429:172505-173505",153,-21.83,2,15,402,424,14,"85.71%","85.71%","Peve_00030336",-0.929945104908788,0.239708228175045,0.978262075707395,NA,NA,NA,NA,NA
"3535",3535,"Cluster_6905","Porites_evermani_scaffold_435:146090-147090",156,-20.17,2,21,676,694,19,"73.68%","78.95%","Peve_00030666",NA,NA,NA,NA,NA,NA,NA,NA
"3536",3536,"Cluster_6905","Porites_evermani_scaffold_446:229461-230461",153,-21.83,2,15,485,507,14,"85.71%","85.71%","Peve_00031242",NA,NA,NA,NA,NA,NA,NA,NA
"3537",3537,"Cluster_6905","Porites_evermani_scaffold_450:247702-248702",143,-20.36,2,17,196,220,18,"66.67%","72.22%","Peve_00031492",NA,NA,NA,NA,NA,NA,NA,NA
"3538",3538,"Cluster_6905","Porites_evermani_scaffold_453:55326-55938",166,-21.95,2,20,79,102,20,"80.00%","80.00%","Peve_00031586",0.0834737534693038,0.946797050466804,0.999448381576871,"Q8R4F0","Mucolipin-3 (Transient receptor potential channel mucolipin 3) (TRPML3)","Mus musculus (Mouse)","inner ear auditory receptor cell differentiation [GO:0042491]; locomotory behavior [GO:0007626]","GO:0000421; GO:0005737; GO:0005765; GO:0005886; GO:0007626; GO:0008289; GO:0016020; GO:0031901; GO:0031902; GO:0042491; GO:0060171; GO:0072345"
"3539",3539,"Cluster_6905","Porites_evermani_scaffold_453:55326-55938",166,-21.95,2,20,79,102,20,"80.00%","80.00%","Peve_00031587",-0.940644816066788,0.220443018755843,0.978262075707395,"Q5VYK3","Proteasome adapter and scaffold protein ECM29 (Ecm29 proteasome adapter and scaffold) (Proteasome-associated protein ECM29 homolog)","Homo sapiens (Human)","proteasome assembly [GO:0043248]; ubiquitin-dependent ERAD pathway [GO:0030433]","GO:0000502; GO:0005634; GO:0005654; GO:0005737; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005793; GO:0005813; GO:0016020; GO:0030134; GO:0030139; GO:0030433; GO:0031410; GO:0043248; GO:0060090; GO:0070628"
"3540",3540,"Cluster_6905","Porites_evermani_scaffold_45:361745-362745",148,-20.71,2,21,621,642,19,"63.16%","68.42%","Peve_00031465",-0.567317148892664,0.615962739128153,0.978262075707395,"Q9HAR2","Adhesion G protein-coupled receptor L3 (Calcium-independent alpha-latrotoxin receptor 3) (CIRL-3) (Latrophilin-3) (Lectomedin-3)","Homo sapiens (Human)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; G protein-coupled receptor signaling pathway [GO:0007186]; neuron migration [GO:0001764]; synapse assembly [GO:0007416]","GO:0001764; GO:0004930; GO:0005509; GO:0005886; GO:0005911; GO:0007166; GO:0007186; GO:0007189; GO:0007416; GO:0007420; GO:0016020; GO:0030246; GO:0030424; GO:0098742; GO:0098978"
"3541",3541,"Cluster_6905","Porites_evermani_scaffold_463:1505-2505",164,-21.9,2,21,688,707,19,"84.21%","84.21%","Peve_00032029",0.146536410673757,0.906374894841712,0.999448381576871,NA,NA,NA,NA,NA
"3542",3542,"Cluster_6905","Porites_evermani_scaffold_4732:9868-10868",153,-21.83,2,15,953,975,14,"85.71%","85.71%","Peve_00032484",-0.929945104908788,0.239708228175045,0.978262075707395,NA,NA,NA,NA,NA
"3543",3543,"Cluster_6905","Porites_evermani_scaffold_4760:6552-7552",164,-26.02,2,17,932,953,15,"86.67%","86.67%","Peve_00032587",-0.79804064896666,0.411739962710454,0.978262075707395,"P81274","G-protein-signaling modulator 2 (Mosaic protein LGN)","Homo sapiens (Human)","cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; G protein-coupled receptor signaling pathway [GO:0007186]; maintenance of centrosome location [GO:0051661]; mitotic spindle organization [GO:0007052]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of spindle assembly [GO:1905832]; Ran protein signal transduction [GO:0031291]; regulation of mitotic spindle organization [GO:0060236]","GO:0000132; GO:0000166; GO:0001965; GO:0005092; GO:0005737; GO:0005813; GO:0005829; GO:0005938; GO:0007052; GO:0007186; GO:0008022; GO:0016328; GO:0019904; GO:0031291; GO:0032991; GO:0042802; GO:0043621; GO:0051301; GO:0051661; GO:0060236; GO:0070840; GO:0097431; GO:0097575; GO:0099738; GO:1904778; GO:1905832"
"3544",3544,"Cluster_6905","Porites_evermani_scaffold_476:140009-141009",140,-20.95,2,9,758,779,7,"100.00%","100.00%","Peve_00032574",-0.811488756465051,0.3973150776331,0.978262075707395,NA,NA,NA,NA,NA
"3545",3545,"Cluster_6905","Porites_evermani_scaffold_4986:6355-7355",148,-23.55,2,18,621,643,17,"70.59%","76.47%","Peve_00033456",-0.875229538949933,0.321420520732145,0.978262075707395,NA,NA,NA,NA,NA
"3546",3546,"Cluster_6905","Porites_evermani_scaffold_5028:13690-14690",146,-20.04,2,11,48,69,9,"88.89%","100.00%","Peve_00033747",-0.636888949612884,0.560441938385718,0.978262075707395,NA,NA,NA,NA,NA
"3547",3547,"Cluster_6905","Porites_evermani_scaffold_5073:7254-8254",155,-21.81,2,17,450,473,17,"76.47%","82.35%","Peve_00033922",-0.906343851996112,0.277723445607,0.978262075707395,"A0JPI9","Leucine-rich repeat-containing protein 74A (Leucine-rich repeat-containing protein 74)","Rattus norvegicus (Rat)","",""
"3548",3548,"Cluster_6905","Porites_evermani_scaffold_512:48153-49153",173,-23.7,2,19,903,925,18,"88.89%","88.89%","Peve_00034128",-0.929945104908788,0.239708228175045,0.978262075707395,NA,NA,NA,NA,NA
"3549",3549,"Cluster_6905","Porites_evermani_scaffold_513:85641-86641",166,-21.68,2,20,364,386,19,"73.68%","89.47%","Peve_00034159",0.915225979797853,0.264024004673292,0.978262075707395,NA,NA,NA,NA,NA
"3550",3550,"Cluster_6905","Porites_evermani_scaffold_522:71983-72983",151,-21.1,2,21,902,919,19,"73.68%","73.68%","Peve_00034459",NA,NA,NA,NA,NA,NA,NA,NA
"3551",3551,"Cluster_6905","Porites_evermani_scaffold_527:111053-112053",148,-21.15,2,19,807,832,21,"66.67%","76.19%","Peve_00034614",0.764638382064254,0.445835204389818,0.978262075707395,NA,NA,NA,NA,NA
"3552",3552,"Cluster_6905","Porites_evermani_scaffold_53:353924-354924",150,-20.93,2,19,234,254,18,"72.22%","83.33%","Peve_00034753",NA,NA,NA,"Q8WS88","Phospholipase A2 A2-hormotoxin-Apt1a (A2-HRTX-Apt1a) (AcPLA2) (EC 3.1.1.4) (Acarc) (Phosphatidylcholine 2-acylhydrolase)","Adamsia palliata (Cloak anemone) (Adamsia carciniopados)","arachidonic acid secretion [GO:0050482]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644]","GO:0004623; GO:0005509; GO:0005576; GO:0006644; GO:0016042; GO:0042151; GO:0050482; GO:0090729"
"3553",3553,"Cluster_6905","Porites_evermani_scaffold_53:379047-380047",150,-21.4,2,19,834,854,18,"72.22%","83.33%","Peve_00034757",-0.929945104908788,0.239708228175045,0.978262075707395,NA,NA,NA,NA,NA
"3554",3554,"Cluster_6905","Porites_evermani_scaffold_5406:11695-12695",159,-20.15,2,16,633,654,14,"85.71%","85.71%","Peve_00035171",0.31449642590197,0.796328709223808,0.995934364227446,"U3JAG9","Centrosomal protein of 131 kDa (5-azacytidine-induced protein 1)","Danio rerio (Zebrafish) (Brachydanio rerio)","cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; intraciliary retrograde transport [GO:0035721]; intraciliary transport involved in cilium assembly [GO:0035735]; Kupffer's vesicle development [GO:0070121]; melanosome transport [GO:0032402]; negative regulation of intracellular protein transport [GO:0090317]; regulation of centrosome duplication [GO:0010824]; sensory perception of light stimulus [GO:0050953]","GO:0000775; GO:0001669; GO:0005576; GO:0005929; GO:0010824; GO:0030154; GO:0032402; GO:0034451; GO:0035721; GO:0035735; GO:0050953; GO:0060271; GO:0060287; GO:0070121; GO:0090317"
"3555",3555,"Cluster_6905","Porites_evermani_scaffold_582:139021-140021",144,-20.51,2,18,815,838,18,"66.67%","72.22%","Peve_00036456",-0.709454957754498,0.497882372423213,0.978262075707395,"Q7Z5K2","Wings apart-like protein homolog (Friend of EBNA2 protein) (WAPL cohesin release factor)","Homo sapiens (Human)","cell division [GO:0051301]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of chromatin binding [GO:0035562]; negative regulation of DNA replication [GO:0008156]; negative regulation of sister chromatid cohesion [GO:0045875]; protein localization to chromatin [GO:0071168]; regulation of cohesin loading [GO:0071922]","GO:0000070; GO:0000775; GO:0000785; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0008156; GO:0035562; GO:0043231; GO:0045171; GO:0045875; GO:0051301; GO:0071168; GO:0071922; GO:0072686; GO:0140083"
"3556",3556,"Cluster_6905","Porites_evermani_scaffold_607:123111-124111",155,-20.8,2,21,21,43,20,"65.00%","80.00%","Peve_00037256",-0.929945104908788,0.239708228175045,0.978262075707395,NA,NA,NA,NA,NA
"3557",3557,"Cluster_6905","Porites_evermani_scaffold_61:304-1304",164,-20.83,2,17,101,122,15,"86.67%","86.67%","Peve_00037318",-0.929945104908788,0.239708228175045,0.978262075707395,"Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"3558",3558,"Cluster_6905","Porites_evermani_scaffold_6200:6207-6963",153,-21.83,2,15,400,422,14,"85.71%","85.71%","Peve_00037653",0.700805887910853,0.505647818753527,0.978262075707395,NA,NA,NA,NA,NA
"3559",3559,"Cluster_6905","Porites_evermani_scaffold_637:127484-128484",162,-25.43,2,16,552,574,15,"86.67%","93.33%","Peve_00038041",0.78340869423503,0.426958438491622,0.978262075707395,"Q3UQ28","Peroxidasin homolog (EC 1.11.2.-) [Cleaved into: PXDN active fragment]","Mus musculus (Mouse)","angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; hydrogen peroxide catabolic process [GO:0042744]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979]","GO:0001525; GO:0001654; GO:0004601; GO:0005201; GO:0005604; GO:0005615; GO:0005783; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0030198; GO:0030199; GO:0031012; GO:0042744; GO:0043237; GO:0046872; GO:0051260; GO:0062023; GO:0070207; GO:0070831; GO:0071711; GO:0140825"
"3560",3560,"Cluster_6905","Porites_evermani_scaffold_640:50057-51057",145,-24.58,2,21,433,460,26,"61.54%","69.23%","Peve_00038163",NA,NA,NA,NA,NA,NA,NA,NA
"3561",3561,"Cluster_6905","Porites_evermani_scaffold_65:230574-231574",154,-23.3,2,21,849,876,25,"68.00%","72.00%","Peve_00038388",-0.94258297031859,0.21677824695107,0.978262075707395,"Q15269","Periodic tryptophan protein 2 homolog","Homo sapiens (Human)","maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit assembly [GO:0000028]","GO:0000028; GO:0000462; GO:0003723; GO:0005654; GO:0032040; GO:0034388"
"3562",3562,"Cluster_6905","Porites_evermani_scaffold_682:79922-80922",157,-21.16,2,20,323,348,22,"72.73%","77.27%","Peve_00039120",NA,NA,NA,NA,NA,NA,NA,NA
"3563",3563,"Cluster_6905","Porites_evermani_scaffold_682:79922-80922",157,-21.16,2,20,826,851,22,"72.73%","77.27%","Peve_00039120",NA,NA,NA,NA,NA,NA,NA,NA
"3564",3564,"Cluster_6905","Porites_evermani_scaffold_6971:2603-3603",162,-22.28,2,19,653,674,17,"76.47%","82.35%","Peve_00039475",NA,NA,NA,NA,NA,NA,NA,NA
"3565",3565,"Cluster_6905","Porites_evermani_scaffold_739:39176-40176",147,-20.28,2,19,633,655,19,"73.68%","73.68%","Peve_00040469",NA,NA,NA,NA,NA,NA,NA,NA
"3566",3566,"Cluster_6905","Porites_evermani_scaffold_80:571054-572054",152,-21.05,2,13,777,798,11,"90.91%","90.91%","Peve_00041756",0.84205694225456,0.362689229785705,0.978262075707395,NA,NA,NA,NA,NA
"3567",3567,"Cluster_6905","Porites_evermani_scaffold_834:34697-35697",164,-26.63,2,17,809,830,15,"86.67%","86.67%","Peve_00042462",-0.999901669120146,0.00892778333881972,0.587136688814728,"Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"3568",3568,"Cluster_6905","Porites_evermani_scaffold_960:18999-19999",161,-20.01,2,21,635,654,19,"73.68%","84.21%","Peve_00044748",0.519514071189454,0.652225977812413,0.978262075707395,"P47728","Calretinin (CR)","Rattus norvegicus (Rat)","regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]","GO:0005509; GO:0005634; GO:0005737; GO:0005829; GO:0005921; GO:0030425; GO:0032420; GO:0032437; GO:0043005; GO:0043195; GO:0045202; GO:0051480; GO:0098688; GO:0099509; GO:0099534; GO:1900271"
"3569",3569,"Cluster_6906","Porites_evermani_scaffold_100:75892-76892",152,-23.08,2,18,745,768,18,"72.22%","77.78%","Peve_00000210",-0.62272295663322,0.572052744467941,0.978262075707395,"Q9D8V0","Minor histocompatibility antigen H13 (EC 3.4.23.-) (Presenilin-like protein 3) (Signal peptide peptidase)","Mus musculus (Mouse)","in utero embryonic development [GO:0001701]; membrane protein proteolysis [GO:0033619]; membrane protein proteolysis involved in retrograde protein transport, ER to cytosol [GO:1904211]; signal peptide processing [GO:0006465]","GO:0001701; GO:0005783; GO:0005789; GO:0005791; GO:0005886; GO:0006465; GO:0008233; GO:0009986; GO:0031625; GO:0033619; GO:0036513; GO:0042500; GO:0042803; GO:0098553; GO:0098554; GO:1904211"
"3570",3570,"Cluster_6906","Porites_evermani_scaffold_1012:88345-89345",147,-20.43,2,21,550,573,21,"57.14%","76.19%","Peve_00000436",-0.991768759547065,0.0817383965917115,0.978262075707395,NA,NA,NA,NA,NA
"3571",3571,"Cluster_6906","Porites_evermani_scaffold_1016:71751-72751",168,-23.11,2,19,716,736,17,"82.35%","94.12%","Peve_00000479",NA,NA,NA,NA,NA,NA,NA,NA
"3572",3572,"Cluster_6906","Porites_evermani_scaffold_1044:38225-39225",153,-22.68,2,21,72,97,23,"65.22%","82.61%","Peve_00000915",NA,NA,NA,NA,NA,NA,NA,NA
"3573",3573,"Cluster_6906","Porites_evermani_scaffold_1073:55466-56466",168,-23.48,2,19,367,387,17,"88.24%","88.24%","Peve_00001344",-0.401372345323848,0.737066683524324,0.986358402699782,NA,NA,NA,NA,NA
"3574",3574,"Cluster_6906","Porites_evermani_scaffold_1082:141163-142163",164,-20.45,2,21,477,498,19,"68.42%","84.21%","Peve_00001491",-0.48676438805189,0.676354054213652,0.978262075707395,NA,NA,NA,NA,NA
"3575",3575,"Cluster_6906","Porites_evermani_scaffold_1090:117899-118899",150,-22.47,2,21,729,754,23,"65.22%","73.91%","Peve_00001609",NA,NA,NA,NA,NA,NA,NA,NA
"3576",3576,"Cluster_6906","Porites_evermani_scaffold_1112:125721-126721",159,-20.34,2,21,513,535,20,"70.00%","80.00%","Peve_00002053",-0.441893121413983,0.708614086151928,0.978286925229234,"Q149M9","NACHT domain- and WD repeat-containing protein 1","Homo sapiens (Human)","negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of gene expression [GO:0010628]","GO:0005524; GO:0005730; GO:0005829; GO:0010628; GO:0032088"
"3577",3577,"Cluster_6906","Porites_evermani_scaffold_1112:125721-126721",164,-22.77,2,18,495,517,17,"82.35%","88.24%","Peve_00002053",-0.441893121413983,0.708614086151928,0.978286925229234,"Q149M9","NACHT domain- and WD repeat-containing protein 1","Homo sapiens (Human)","negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of gene expression [GO:0010628]","GO:0005524; GO:0005730; GO:0005829; GO:0010628; GO:0032088"
"3578",3578,"Cluster_6906","Porites_evermani_scaffold_116:196443-197443",158,-20.13,2,17,884,904,15,"80.00%","93.33%","Peve_00002729",NA,NA,NA,NA,NA,NA,NA,NA
"3579",3579,"Cluster_6906","Porites_evermani_scaffold_1166:75879-76879",166,-20.28,2,19,415,436,17,"76.47%","88.24%","Peve_00002814",NA,NA,NA,NA,NA,NA,NA,NA
"3580",3580,"Cluster_6906","Porites_evermani_scaffold_117:424125-425125",168,-24.19,2,21,542,563,19,"68.42%","89.47%","Peve_00002847",NA,NA,NA,NA,NA,NA,NA,NA
"3581",3581,"Cluster_6906","Porites_evermani_scaffold_1192:7291-8291",155,-21.81,2,20,912,931,18,"77.78%","83.33%","Peve_00003222",-0.686063329690759,0.518674561276582,0.978262075707395,NA,NA,NA,NA,NA
"3582",3582,"Cluster_6906","Porites_evermani_scaffold_1199:23065-24065",159,-21.27,2,21,189,211,20,"70.00%","80.00%","Peve_00003291",NA,NA,NA,NA,NA,NA,NA,NA
"3583",3583,"Cluster_6906","Porites_evermani_scaffold_1256:19699-20699",163,-26.33,2,21,808,833,23,"69.57%","78.26%","Peve_00004166",NA,NA,NA,NA,NA,NA,NA,NA
"3584",3584,"Cluster_6906","Porites_evermani_scaffold_1264:123709-124709",165,-20.84,2,18,221,242,16,"81.25%","87.50%","Peve_00004281",-0.628087790324618,0.567675737145378,0.978262075707395,NA,NA,NA,NA,NA
"3585",3585,"Cluster_6906","Porites_evermani_scaffold_128:45145-46145",156,-23.49,2,21,570,589,19,"73.68%","84.21%","Peve_00004497",0.796411724740653,0.413457770324485,0.978262075707395,NA,NA,NA,NA,NA
"3586",3586,"Cluster_6906","Porites_evermani_scaffold_129:252266-253266",166,-22.72,2,20,120,142,19,"73.68%","89.47%","Peve_00004627",-0.287038038235336,0.814658772056752,0.995934364227446,NA,NA,NA,NA,NA
"3587",3587,"Cluster_6906","Porites_evermani_scaffold_130:28768-29670",162,-23.98,2,19,547,568,17,"76.47%","82.35%","Peve_00004785",0.372354050358088,0.757101432087081,0.988219883885475,NA,NA,NA,NA,NA
"3588",3588,"Cluster_6906","Porites_evermani_scaffold_130:28768-29670",162,-23.98,2,19,547,568,17,"76.47%","82.35%","Peve_00004788",-0.590100417503536,0.598176283833035,0.978262075707395,NA,NA,NA,NA,NA
"3589",3589,"Cluster_6906","Porites_evermani_scaffold_131:22001-23001",162,-21.6,2,21,227,247,19,"78.95%","78.95%","Peve_00004922",-0.647651604496832,0.551502488534421,0.978262075707395,"Q9BXF3","Chromatin remodeling regulator CECR2 (Cat eye syndrome critical region protein 2)","Homo sapiens (Human)","apoptotic DNA fragmentation [GO:0006309]; chromatin remodeling [GO:0006338]; cochlea development [GO:0090102]; cytoskeleton organization [GO:0007010]; cytoskeleton-dependent cytokinesis [GO:0061640]; execution phase of apoptosis [GO:0097194]; inner ear receptor cell stereocilium organization [GO:0060122]; neural fold formation [GO:0001842]; neural tube closure [GO:0001843]; single fertilization [GO:0007338]; vesicle-mediated transport [GO:0016192]","GO:0000791; GO:0001842; GO:0001843; GO:0005634; GO:0006309; GO:0006338; GO:0007010; GO:0007338; GO:0016192; GO:0060122; GO:0061640; GO:0090102; GO:0090537; GO:0097194; GO:0140658"
"3590",3590,"Cluster_6906","Porites_evermani_scaffold_144:15024-16024",159,-22.56,2,21,299,321,20,"65.00%","85.00%","Peve_00006721",0.959180638233901,0.182522626350777,0.978262075707395,NA,NA,NA,NA,NA
"3591",3591,"Cluster_6906","Porites_evermani_scaffold_1444:45783-46783",156,-23.95,2,21,440,459,19,"73.68%","84.21%","Peve_00006776",0.699763029158703,0.506577834579714,0.978262075707395,"P12527","Polyunsaturated fatty acid 5-lipoxygenase (EC 1.13.11.-) (Arachidonate 5-lipoxygenase) (5-LO) (5-lipoxygenase) (EC 1.13.11.34)","Rattus norvegicus (Rat)","acute inflammatory response [GO:0002526]; arachidonic acid metabolic process [GO:0019369]; dendritic cell migration [GO:0036336]; glucose homeostasis [GO:0042593]; hepoxilin biosynthetic process [GO:0051122]; humoral immune response [GO:0006959]; inflammatory response [GO:0006954]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; leukocyte migration involved in inflammatory response [GO:0002523]; leukotriene A4 biosynthetic process [GO:1901753]; leukotriene biosynthetic process [GO:0019370]; leukotriene metabolic process [GO:0006691]; leukotriene production involved in inflammatory response [GO:0002540]; linoleic acid metabolic process [GO:0043651]; lipid oxidation [GO:0034440]; lipoxin biosynthetic process [GO:2001301]; lipoxygenase pathway [GO:0019372]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of inflammatory response [GO:0050728]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular wound healing [GO:0061044]; negative regulation of wound healing [GO:0061045]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cytochrome-c oxidase activity [GO:1904960]; positive regulation of leukocyte adhesion to arterial endothelial cell [GO:1904999]; positive regulation of vasoconstriction [GO:0045907]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of fat cell differentiation [GO:0045598]; regulation of inflammatory response [GO:0050727]; regulation of inflammatory response to wounding [GO:0106014]; regulation of insulin secretion [GO:0050796]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; response to hyperoxia [GO:0055093]; response to nutrient [GO:0007584]; sensory perception of pain [GO:0019233]","GO:0001937; GO:0002232; GO:0002523; GO:0002526; GO:0002540; GO:0004051; GO:0004052; GO:0005506; GO:0005634; GO:0005635; GO:0005641; GO:0005737; GO:0005829; GO:0006691; GO:0006954; GO:0006959; GO:0007584; GO:0016363; GO:0016525; GO:0016702; GO:0016787; GO:0019233; GO:0019369; GO:0019370; GO:0019372; GO:0030425; GO:0030501; GO:0031965; GO:0034440; GO:0036336; GO:0036403; GO:0042383; GO:0042593; GO:0043651; GO:0045598; GO:0045907; GO:0048471; GO:0050727; GO:0050728; GO:0050796; GO:0051122; GO:0055093; GO:0061044; GO:0061045; GO:0106014; GO:1900015; GO:1900407; GO:1901753; GO:1903426; GO:1903573; GO:1903671; GO:1904960; GO:1904999; GO:2001301"
"3592",3592,"Cluster_6906","Porites_evermani_scaffold_1454:41224-42224",159,-23.18,2,21,873,896,21,"66.67%","80.95%","Peve_00006896",-0.317890647120949,0.794051021934151,0.995934364227446,"Q7ZWW7","Tetraspanin-31-B (Tspan-31-B) (Sarcoma-amplified sequence homolog B)","Xenopus laevis (African clawed frog)","","GO:0016020"
"3593",3593,"Cluster_6906","Porites_evermani_scaffold_1457:27387-28387",162,-26.98,2,20,746,772,23,"73.91%","73.91%","Peve_00006922",0.999971311671877,0.00482223952987791,0.551398425649056,"Q9NTG1","Polycystin family receptor for egg jelly (PKD and REJ homolog) (Polycystic kidney disease and receptor for egg jelly-related protein)","Homo sapiens (Human)","acrosome reaction [GO:0007340]; detection of mechanical stimulus [GO:0050982]","GO:0005262; GO:0005509; GO:0007340; GO:0016020; GO:0050982"
"3594",3594,"Cluster_6906","Porites_evermani_scaffold_1483:70481-71481",157,-21.5,2,19,934,956,18,"72.22%","83.33%","Peve_00007262",-0.838077310853807,0.367359534841473,0.978262075707395,"Q02763","Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (hTIE2) (p140 TEK) (CD antigen CD202b)","Homo sapiens (Human)","angiogenesis [GO:0001525]; cell-cell signaling [GO:0007267]; definitive hemopoiesis [GO:0060216]; endothelial cell proliferation [GO:0001935]; glomerulus vasculature development [GO:0072012]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of inflammatory response [GO:0050728]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; regulation of endothelial cell apoptotic process [GO:2000351]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of vascular permeability [GO:0043114]; signal transduction [GO:0007165]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]","GO:0001525; GO:0001934; GO:0001935; GO:0001938; GO:0002040; GO:0004672; GO:0004713; GO:0004714; GO:0005524; GO:0005576; GO:0005737; GO:0005886; GO:0005902; GO:0005911; GO:0005925; GO:0007165; GO:0007169; GO:0007267; GO:0007507; GO:0009925; GO:0009986; GO:0010595; GO:0014068; GO:0016323; GO:0016324; GO:0016525; GO:0018108; GO:0032878; GO:0033674; GO:0034446; GO:0034451; GO:0038023; GO:0042802; GO:0043066; GO:0043114; GO:0043235; GO:0043410; GO:0043552; GO:0045121; GO:0045766; GO:0046777; GO:0048014; GO:0050728; GO:0051894; GO:0051897; GO:0060216; GO:0060347; GO:0070374; GO:0072012; GO:1902533; GO:2000251; GO:2000351; GO:2000352"
"3595",3595,"Cluster_6906","Porites_evermani_scaffold_1538:101195-102195",154,-20.07,2,19,542,563,17,"64.71%","82.35%","Peve_00007962",NA,NA,NA,NA,NA,NA,NA,NA
"3596",3596,"Cluster_6906","Porites_evermani_scaffold_157:392265-393265",158,-21.64,2,21,967,987,19,"73.68%","78.95%","Peve_00008353",-0.686063329690759,0.518674561276582,0.978262075707395,NA,NA,NA,NA,NA
"3597",3597,"Cluster_6906","Porites_evermani_scaffold_1579:27881-28881",146,-21.67,2,20,32,57,22,"63.64%","68.18%","Peve_00008477",-0.506966924704845,0.661533239220075,0.978262075707395,"A5PJX7","Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Solute carrier family 6 member 13)","Bos taurus (Bovine)","amino acid import across plasma membrane [GO:0089718]; neurotransmitter transport [GO:0006836]; positive regulation of necrotic cell death [GO:0010940]; sodium ion transmembrane transport [GO:0035725]","GO:0005332; GO:0005886; GO:0006836; GO:0010940; GO:0016323; GO:0035725; GO:0043005; GO:0089718"
"3598",3598,"Cluster_6906","Porites_evermani_scaffold_158:326611-327611",158,-20.24,2,16,435,457,15,"80.00%","93.33%","Peve_00008516",-0.613133466873067,0.579817560915921,0.978262075707395,"Q6NUB7","Ubiquitin thioesterase zranb1-B (EC 3.4.19.12) (Zinc finger Ran-binding domain-containing protein 1B)","Xenopus laevis (African clawed frog)","cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; positive regulation of Wnt signaling pathway [GO:0030177]; protein K29-linked deubiquitination [GO:0035523]; protein K33-linked deubiquitination [GO:1990168]; protein K63-linked deubiquitination [GO:0070536]; regulation of cell morphogenesis [GO:0022604]; Wnt signaling pathway [GO:0016055]","GO:0004843; GO:0005634; GO:0005737; GO:0007010; GO:0016055; GO:0016477; GO:0022604; GO:0030177; GO:0035523; GO:0046872; GO:0070536; GO:1990168"
"3599",3599,"Cluster_6906","Porites_evermani_scaffold_158:79921-80921",152,-22.7,2,21,257,276,19,"68.42%","84.21%","Peve_00008497",-0.493760260737481,0.671244069926277,0.978262075707395,NA,NA,NA,NA,NA
"3600",3600,"Cluster_6906","Porites_evermani_scaffold_1612:53593-54593",155,-21.61,2,17,1,21,17,"70.59%","88.24%","Peve_00008982",0.078181678066453,0.950177153742693,0.999448381576871,"Q60847","Collagen alpha-1(XII) chain","Mus musculus (Mouse)","cell adhesion [GO:0007155]; endodermal cell differentiation [GO:0035987]","GO:0005595; GO:0005615; GO:0007155; GO:0035987; GO:0062023"
"3601",3601,"Cluster_6906","Porites_evermani_scaffold_1645:83866-84866",180,-27.4,2,21,10,31,19,"84.21%","89.47%","Peve_00009347",-0.812226739392041,0.396510400951272,0.978262075707395,NA,NA,NA,NA,NA
"3602",3602,"Cluster_6906","Porites_evermani_scaffold_1730:24455-25455",160,-20.79,2,18,65,87,17,"76.47%","88.24%","Peve_00010387",-0.287038038235336,0.814658772056752,0.995934364227446,NA,NA,NA,NA,NA
"3603",3603,"Cluster_6906","Porites_evermani_scaffold_1738:64915-65915",159,-22.69,2,19,25,49,20,"80.00%","85.00%","Peve_00010457",-0.268324912086215,0.82705984837686,0.995934364227446,"Q80T79","CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3)","Mus musculus (Mouse)","negative regulation of complement activation, classical pathway [GO:0045959]; regulation of dendrite development [GO:0050773]","GO:0005615; GO:0005886; GO:0045959; GO:0050773"
"3604",3604,"Cluster_6906","Porites_evermani_scaffold_1771:55153-56153",152,-22.19,2,21,22,44,21,"76.19%","76.19%","Peve_00010790",-0.686063329690759,0.518674561276582,0.978262075707395,NA,NA,NA,NA,NA
"3605",3605,"Cluster_6906","Porites_evermani_scaffold_1789:53279-54279",150,-23.54,2,21,503,530,25,"64.00%","72.00%","Peve_00010989",0.385615331993889,0.747978376271539,0.988164130891384,"Q7SXM0","Histone deacetylase 8 (HD8) (EC 3.5.1.98) (Protein deacetylase HDAC8) (EC 3.5.1.-) (Protein decrotonylase HDAC8) (EC 3.5.1.-)","Danio rerio (Zebrafish) (Brachydanio rerio)","central nervous system development [GO:0007417]; chromatin organization [GO:0006325]; histone deacetylation [GO:0016575]; neuron cellular homeostasis [GO:0070050]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000118; GO:0004407; GO:0005694; GO:0005737; GO:0006325; GO:0006357; GO:0007417; GO:0016575; GO:0046872; GO:0070050; GO:0160009"
"3606",3606,"Cluster_6906","Porites_evermani_scaffold_1805:39684-40684",157,-20.87,2,16,293,313,14,"85.71%","92.86%","Peve_00011224",0.937693512798374,0.22591387796675,0.978262075707395,"Q5ZM55","Protein fem-1 homolog B (FEM1b) (FEM1-beta)","Gallus gallus (Chicken)","apoptotic process [GO:0006915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627]","GO:0005634; GO:0005737; GO:0006915; GO:0016567; GO:0031462; GO:0043161; GO:0140627; GO:1990756; GO:2000001"
"3607",3607,"Cluster_6906","Porites_evermani_scaffold_1805:77289-78289",157,-21.8,2,16,300,320,14,"85.71%","92.86%","Peve_00011228",-0.837238348406833,0.368337391033239,0.978262075707395,"Q6GPE5","Protein fem-1 homolog B (FEM1b) (FEM1-beta)","Xenopus laevis (African clawed frog)","apoptotic process [GO:0006915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627]","GO:0005634; GO:0005737; GO:0006915; GO:0016567; GO:0031462; GO:0043161; GO:0140627; GO:1990756; GO:2000001"
"3608",3608,"Cluster_6906","Porites_evermani_scaffold_181:379902-380902",154,-21.28,2,18,541,560,16,"81.25%","81.25%","Peve_00011262",-0.287038038235336,0.814658772056752,0.995934364227446,NA,NA,NA,NA,NA
"3609",3609,"Cluster_6906","Porites_evermani_scaffold_182:132313-133313",167,-23.75,2,20,699,720,18,"66.67%","94.44%","Peve_00011385",-0.568147879191756,0.615320305966656,0.978262075707395,NA,NA,NA,NA,NA
"3610",3610,"Cluster_6906","Porites_evermani_scaffold_1828:68482-69240",155,-20.88,2,19,205,227,19,"78.95%","78.95%","Peve_00011466",0.916639236487777,0.261782183315889,0.978262075707395,"E9Q5F9","Histone-lysine N-methyltransferase SETD2 (EC 2.1.1.359) (Lysine N-methyltransferase 3A) (Protein-lysine N-methyltransferase SETD2) (EC 2.1.1.-) (SET domain-containing protein 2)","Mus musculus (Mouse)","angiogenesis [GO:0001525]; cell migration involved in vasculogenesis [GO:0035441]; coronary vasculature morphogenesis [GO:0060977]; defense response to virus [GO:0051607]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic organ development [GO:0048568]; embryonic placenta morphogenesis [GO:0060669]; endodermal cell differentiation [GO:0035987]; forebrain development [GO:0030900]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; mesoderm morphogenesis [GO:0048332]; microtubule cytoskeleton organization involved in mitosis [GO:1902850]; mismatch repair [GO:0006298]; morphogenesis of a branching structure [GO:0001763]; neural tube closure [GO:0001843]; nucleosome organization [GO:0034728]; peptidyl-lysine trimethylation [GO:0018023]; pericardium development [GO:0060039]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of ossification [GO:0045778]; regulation of cytokinesis [GO:0032465]; regulation of DNA-templated transcription [GO:0006355]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of gene expression [GO:0010468]; regulation of mRNA export from nucleus [GO:0010793]; regulation of protein localization to chromatin [GO:1905634]; response to type I interferon [GO:0034340]; stem cell development [GO:0048864]; stem cell differentiation [GO:0048863]; transcription elongation by RNA polymerase II promoter [GO:0006368]; vasculogenesis [GO:0001570]","GO:0001525; GO:0001570; GO:0001763; GO:0001843; GO:0005634; GO:0005694; GO:0006298; GO:0006355; GO:0006368; GO:0010468; GO:0010569; GO:0010793; GO:0016279; GO:0018023; GO:0030900; GO:0032465; GO:0032727; GO:0034340; GO:0034728; GO:0035441; GO:0035987; GO:0043014; GO:0045778; GO:0046872; GO:0046975; GO:0048332; GO:0048568; GO:0048701; GO:0048863; GO:0048864; GO:0051607; GO:0060039; GO:0060669; GO:0060977; GO:0097198; GO:0097676; GO:0140955; GO:1902850; GO:1905634"
"3611",3611,"Cluster_6906","Porites_evermani_scaffold_1828:68482-69240",155,-20.88,2,19,205,227,19,"78.95%","78.95%","Peve_00011468",-0.250535627402876,0.838786554331308,0.995934364227446,"P24859","SEC14 cytosolic factor (Phosphatidylinositol/phosphatidylcholine transfer protein) (PI/PC TP)","Kluyveromyces lactis (Yeast) (Candida sphaerica)","protein transport [GO:0015031]","GO:0000139; GO:0015031"
"3612",3612,"Cluster_6906","Porites_evermani_scaffold_186:285445-286445",163,-27.04,2,21,562,584,20,"70.00%","85.00%","Peve_00011813",-0.658217757429964,0.542621221384467,0.978262075707395,"P91685","Metabotropic glutamate receptor (DmGluRA)","Drosophila melanogaster (Fruit fly)","G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning [GO:0007612]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; neuromuscular junction development [GO:0007528]; regulation of synaptic transmission, glutamatergic [GO:0051966]; short-term memory [GO:0007614]; terminal button organization [GO:0072553]","GO:0001640; GO:0001641; GO:0004930; GO:0005886; GO:0007216; GO:0007528; GO:0007612; GO:0007614; GO:0007616; GO:0008049; GO:0008066; GO:0015485; GO:0016020; GO:0016595; GO:0038038; GO:0045121; GO:0051966; GO:0072553"
"3613",3613,"Cluster_6906","Porites_evermani_scaffold_1871:11342-12342",164,-24.24,2,21,341,362,19,"68.42%","84.21%","Peve_00011923",NA,NA,NA,NA,NA,NA,NA,NA
"3614",3614,"Cluster_6906","Porites_evermani_scaffold_1884:3233-4233",161,-22.7,2,21,608,632,22,"77.27%","81.82%","Peve_00012069",NA,NA,NA,NA,NA,NA,NA,NA
"3615",3615,"Cluster_6906","Porites_evermani_scaffold_1914:56730-57730",159,-22.9,2,21,971,994,21,"71.43%","76.19%","Peve_00012455",-0.287038038235336,0.814658772056752,0.995934364227446,NA,NA,NA,NA,NA
"3616",3616,"Cluster_6906","Porites_evermani_scaffold_1948:35899-36899",160,-20.79,2,18,340,362,17,"76.47%","88.24%","Peve_00012789",-0.449634311926881,0.703108619944429,0.978262075707395,"Q6GM59","Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12)","Xenopus laevis (African clawed frog)","creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449]","GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0046449"
"3617",3617,"Cluster_6906","Porites_evermani_scaffold_1959:80293-81293",168,-22.99,2,17,82,103,15,"86.67%","93.33%","Peve_00012910",0.851790100086317,0.35103435975451,0.978262075707395,NA,NA,NA,NA,NA
"3618",3618,"Cluster_6906","Porites_evermani_scaffold_1980:59509-60509",155,-21.48,2,17,940,962,16,"75.00%","87.50%","Peve_00013132",-0.283698114851575,0.816877284885664,0.995934364227446,NA,NA,NA,NA,NA
"3619",3619,"Cluster_6906","Porites_evermani_scaffold_2036:18308-19308",156,-22.18,2,21,758,777,19,"78.95%","78.95%","Peve_00013923",NA,NA,NA,NA,NA,NA,NA,NA
"3620",3620,"Cluster_6906","Porites_evermani_scaffold_2045:8264-9264",154,-22.44,2,21,477,500,21,"71.43%","76.19%","Peve_00014016",-0.941528578627034,0.218779263019976,0.978262075707395,NA,NA,NA,NA,NA
"3621",3621,"Cluster_6906","Porites_evermani_scaffold_204:79769-80769",166,-26.16,2,21,433,453,19,"73.68%","89.47%","Peve_00013945",-0.927982997472335,0.243082747051403,0.978262075707395,NA,NA,NA,NA,NA
"3622",3622,"Cluster_6906","Porites_evermani_scaffold_211:141024-142024",160,-20.01,2,21,433,454,19,"68.42%","78.95%","Peve_00014665",-0.686063329690759,0.518674561276582,0.978262075707395,"P35590","Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1)","Homo sapiens (Human)","angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; branching involved in lymph vessel morphogenesis [GO:0060854]; in utero embryonic development [GO:0001701]; lymphatic endothelial cell differentiation [GO:0060836]; mesoderm development [GO:0007498]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; plasma membrane fusion [GO:0045026]; positive regulation of angiogenesis [GO:0045766]; positive regulation of kinase activity [GO:0033674]; regulation of endothelial cell proliferation [GO:0001936]; regulation of extracellular matrix assembly [GO:1901201]; response to retinoic acid [GO:0032526]; signal transduction [GO:0007165]; tissue remodeling [GO:0048771]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vasculogenesis [GO:0001570]","GO:0001525; GO:0001570; GO:0001701; GO:0001936; GO:0003180; GO:0004714; GO:0005524; GO:0005886; GO:0007165; GO:0007169; GO:0007498; GO:0016525; GO:0030336; GO:0032526; GO:0033674; GO:0043235; GO:0045026; GO:0045766; GO:0048771; GO:0060836; GO:0060854; GO:1901201"
"3623",3623,"Cluster_6906","Porites_evermani_scaffold_2120:55495-56495",149,-22.45,2,20,590,613,20,"70.00%","75.00%","Peve_00014777",-0.633707681095771,0.563064429356841,0.978262075707395,NA,NA,NA,NA,NA
"3624",3624,"Cluster_6906","Porites_evermani_scaffold_2134:81858-82858",154,-21.21,2,19,246,267,17,"64.71%","82.35%","Peve_00014920",0.50228561350545,0.664985216325834,0.978262075707395,"P13804","Electron transfer flavoprotein subunit alpha, mitochondrial (Alpha-ETF)","Homo sapiens (Human)","amino acid catabolic process [GO:0009063]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904]","GO:0005739; GO:0005759; GO:0009055; GO:0009063; GO:0016491; GO:0022904; GO:0033539; GO:0045251; GO:0050660"
"3625",3625,"Cluster_6906","Porites_evermani_scaffold_2134:81957-82957",154,-21.21,2,19,147,168,17,"64.71%","82.35%","Peve_00014921",0.973101367926096,0.147992105390084,0.978262075707395,NA,NA,NA,NA,NA
"3626",3626,"Cluster_6906","Porites_evermani_scaffold_218:144503-145503",152,-20.03,2,18,463,486,18,"66.67%","83.33%","Peve_00015306",-0.610312075239851,0.582088094910261,0.978262075707395,"A7MB54","H2.0-like homeobox protein (Homeobox protein HLX1)","Bos taurus (Bovine)","embryonic digestive tract morphogenesis [GO:0048557]; enteric nervous system development [GO:0048484]; epithelial cell proliferation [GO:0050673]; liver development [GO:0001889]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; organ growth [GO:0035265]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of organ growth [GO:0046622]; positive regulation of T-helper 1 cell differentiation [GO:0045627]; skeletal muscle tissue development [GO:0007519]; T-helper 1 cell differentiation [GO:0045063]; T-helper 2 cell differentiation [GO:0045064]","GO:0000981; GO:0001889; GO:0005634; GO:0007519; GO:0035265; GO:0043565; GO:0045063; GO:0045064; GO:0045627; GO:0045629; GO:0046622; GO:0048484; GO:0048557; GO:0050673; GO:0050679"
"3627",3627,"Cluster_6906","Porites_evermani_scaffold_2215:0-559",163,-20.02,2,16,437,458,14,"85.71%","92.86%","Peve_00015716",0.973101367926095,0.147992105390085,0.978262075707395,NA,NA,NA,NA,NA
"3628",3628,"Cluster_6906","Porites_evermani_scaffold_22:405738-406738",155,-20.68,2,17,770,792,16,"81.25%","81.25%","Peve_00015501",0.501689486027193,0.665424015715374,0.978262075707395,NA,NA,NA,NA,NA
"3629",3629,"Cluster_6906","Porites_evermani_scaffold_2259:70606-71606",161,-23.95,2,21,588,607,19,"78.95%","78.95%","Peve_00016125",-0.265130858979513,0.829169682197557,0.995934364227446,"Q9H0H5","Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4)","Homo sapiens (Human)","actomyosin contractile ring assembly [GO:0000915]; erythrocyte differentiation [GO:0030218]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; neuroblast proliferation [GO:0007405]; positive regulation of cytokinesis [GO:0032467]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of embryonic development [GO:0045995]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; sulfate transport [GO:0008272]","GO:0000281; GO:0000915; GO:0001669; GO:0005096; GO:0005547; GO:0005634; GO:0005654; GO:0005819; GO:0005829; GO:0005874; GO:0007266; GO:0007283; GO:0007405; GO:0008017; GO:0008272; GO:0019901; GO:0030218; GO:0030496; GO:0031234; GO:0032154; GO:0032467; GO:0043014; GO:0043015; GO:0045995; GO:0046872; GO:0048487; GO:0051056; GO:0051233; GO:0051256; GO:0051988; GO:0070062; GO:0072686; GO:0090543; GO:0097149"
"3630",3630,"Cluster_6906","Porites_evermani_scaffold_22:602421-603421",161,-26.44,2,21,759,785,24,"75.00%","79.17%","Peve_00015525",-0.631681315769367,0.564730264650663,0.978262075707395,NA,NA,NA,NA,NA
"3631",3631,"Cluster_6906","Porites_evermani_scaffold_2276:9701-10701",154,-24.09,2,21,388,413,23,"69.57%","73.91%","Peve_00016269",NA,NA,NA,"P61315","Galactose-3-O-sulfotransferase 3 (Gal3ST-3) (EC 2.8.2.-) (Beta-galactose-3-O-sulfotransferase 3) (Gal-beta-1, 3-GalNAc 3'-sulfotransferase 3)","Mus musculus (Mouse)","glycolipid biosynthetic process [GO:0009247]","GO:0001733; GO:0008146; GO:0009247; GO:0032580; GO:0050694"
"3632",3632,"Cluster_6906","Porites_evermani_scaffold_2383:17791-18791",165,-23.86,2,19,181,203,18,"83.33%","83.33%","Peve_00017275",NA,NA,NA,NA,NA,NA,NA,NA
"3633",3633,"Cluster_6906","Porites_evermani_scaffold_2393:22171-23171",158,-23.05,2,19,268,289,17,"70.59%","82.35%","Peve_00017353",-0.443299385916689,0.707615719944447,0.978262075707395,NA,NA,NA,NA,NA
"3634",3634,"Cluster_6906","Porites_evermani_scaffold_241:75766-76766",157,-20.46,2,20,330,350,18,"72.22%","83.33%","Peve_00017587",-0.7042424010468,0.50257365295929,0.978262075707395,NA,NA,NA,NA,NA
"3635",3635,"Cluster_6906","Porites_evermani_scaffold_24:280731-281731",154,-23.25,2,16,353,376,16,"75.00%","87.50%","Peve_00017478",NA,NA,NA,NA,NA,NA,NA,NA
"3636",3636,"Cluster_6906","Porites_evermani_scaffold_2436:57085-58085",147,-22.62,2,21,334,357,21,"57.14%","76.19%","Peve_00017826",-0.936039061692088,0.228925931616342,0.978262075707395,NA,NA,NA,NA,NA
"3637",3637,"Cluster_6906","Porites_evermani_scaffold_246:105408-106408",154,-23.15,2,21,88,111,21,"71.43%","76.19%","Peve_00018011",NA,NA,NA,NA,NA,NA,NA,NA
"3638",3638,"Cluster_6906","Porites_evermani_scaffold_248:268130-269130",160,-22.85,2,17,685,706,15,"73.33%","93.33%","Peve_00018182",-0.451742812322057,0.701604932500219,0.978262075707395,"Q6AY39","UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 1 (Beta-1,3-GalNAc-T1) (EC 2.4.1.79) (Beta-1,3-galactosyltransferase 3) (Beta-1,3-GalTase 3) (Beta3Gal-T3) (Beta3GalT3) (b3Gal-T3) (Beta-3-Gx-T3) (Galactosylgalactosylglucosylceramide beta-D-acetyl-galactosaminyltransferase) (Globoside synthase) (UDP-N-acetylgalactosamine:globotriaosylceramide beta-1,3-N-acetylgalactosaminyltransferase)","Rattus norvegicus (Rat)","lipid metabolic process [GO:0006629]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]","GO:0000139; GO:0006486; GO:0006629; GO:0008194; GO:0008499; GO:0009312; GO:0016757; GO:0047273"
"3639",3639,"Cluster_6906","Porites_evermani_scaffold_250:185202-185838",155,-21.63,2,21,247,270,21,"61.90%","80.95%","Peve_00018442",0.237127491769834,0.847588173482549,0.995934364227446,"P05689","Cathepsin Z (EC 3.4.18.1)","Bos taurus (Bovine)","proteolysis involved in protein catabolic process [GO:0051603]","GO:0004197; GO:0005615; GO:0005764; GO:0051603"
"3640",3640,"Cluster_6906","Porites_evermani_scaffold_250:185202-185838",155,-21.63,2,21,247,270,21,"61.90%","80.95%","Peve_00018443",-0.175438059931145,0.887731650120222,0.999448381576871,"O08983","BLOC-3 complex member HPS1 (Hermansky-Pudlak syndrome 1 protein homolog)","Mus musculus (Mouse)","blood coagulation [GO:0007596]; cell morphogenesis [GO:0000902]; cellular zinc ion homeostasis [GO:0006882]; eye pigmentation [GO:0048069]; gene expression [GO:0010467]; inflammatory response [GO:0006954]; intracellular transport [GO:0046907]; lung development [GO:0030324]; lung morphogenesis [GO:0060425]; lysosome organization [GO:0007040]; melanocyte differentiation [GO:0030318]; melanosome assembly [GO:1903232]; organelle organization [GO:0006996]; pigmentation [GO:0043473]; platelet dense granule organization [GO:0060155]; positive regulation of natural killer cell activation [GO:0032816]; respiratory system process [GO:0003016]; retina development in camera-type eye [GO:0060041]; secretion of lysosomal enzymes [GO:0033299]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]; vesicle-mediated transport [GO:0016192]","GO:0000902; GO:0003016; GO:0005085; GO:0005737; GO:0006882; GO:0006954; GO:0006996; GO:0007040; GO:0007283; GO:0007338; GO:0007596; GO:0010467; GO:0016192; GO:0030318; GO:0030324; GO:0031085; GO:0031410; GO:0032816; GO:0033299; GO:0043473; GO:0046907; GO:0046983; GO:0048069; GO:0060041; GO:0060155; GO:0060425; GO:1903232"
"3641",3641,"Cluster_6906","Porites_evermani_scaffold_251:152518-153518",149,-21.9,2,21,839,863,23,"65.22%","73.91%","Peve_00018528",-0.041645942874121,0.973479699490296,0.999448381576871,"A1DWM3","Major facilitator superfamily domain-containing protein 6 (Macrophage MHC class I receptor 2 homolog)","Sus scrofa (Pig)","antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]","GO:0005886; GO:0016020; GO:0042590"
"3642",3642,"Cluster_6906","Porites_evermani_scaffold_254:137366-138366",166,-22.72,2,20,899,921,19,"73.68%","89.47%","Peve_00018769",-0.696212790405223,0.509734001286857,0.978262075707395,"Q9UPZ3","BLOC-2 complex member HPS5 (Alpha-integrin-binding protein 63) (Hermansky-Pudlak syndrome 5 protein) (Ruby-eye protein 2 homolog) (Ru2)","Homo sapiens (Human)","blood coagulation [GO:0007596]; developmental pigmentation [GO:0048066]; intracellular transport [GO:0046907]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155]","GO:0005737; GO:0005769; GO:0005829; GO:0007596; GO:0031084; GO:0046907; GO:0048066; GO:0060155; GO:1903232"
"3643",3643,"Cluster_6906","Porites_evermani_scaffold_2547:27197-28197",149,-21.18,2,21,496,517,20,"70.00%","75.00%","Peve_00018824",0.14409220461621,0.907947618778136,0.999448381576871,"Q8VE62","Polyadenylate-binding protein-interacting protein 1 (PABP-interacting protein 1) (PAIP-1) (Poly(A)-binding protein-interacting protein 1)","Mus musculus (Mouse)","CRD-mediated mRNA stabilization [GO:0070934]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; positive regulation by host of viral process [GO:0044794]; positive regulation of cytoplasmic translation [GO:2000767]; regulation of translational initiation [GO:0006446]","GO:0003723; GO:0005829; GO:0006446; GO:0008494; GO:0044794; GO:0070934; GO:0106002; GO:1900152; GO:2000767"
"3644",3644,"Cluster_6906","Porites_evermani_scaffold_2568:37495-38495",167,-22.74,2,20,546,567,18,"66.67%","94.44%","Peve_00018954",-0.377807578222602,0.753356167079615,0.988219883885475,NA,NA,NA,NA,NA
"3645",3645,"Cluster_6906","Porites_evermani_scaffold_261:162294-163294",159,-24.29,2,18,197,217,16,"81.25%","87.50%","Peve_00019351",-0.547068754802614,0.631487235807479,0.978262075707395,"O77562","Deformed epidermal autoregulatory factor 1 homolog (Nuclear DEAF-1-related transcriptional regulator) (NUDR)","Pan troglodytes (Chimpanzee)","embryonic skeletal system development [GO:0048706]; neural tube closure [GO:0001843]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000981; GO:0001843; GO:0003677; GO:0005634; GO:0006357; GO:0033599; GO:0046872; GO:0048706"
"3646",3646,"Cluster_6906","Porites_evermani_scaffold_2619:57559-58559",164,-21.43,2,21,341,362,19,"68.42%","84.21%","Peve_00019413",-0.640920185269114,0.557105892584889,0.978262075707395,"Q6DFB7","Centrosomal protein POC5 (Protein of centriole 5)","Xenopus laevis (African clawed frog)","cell cycle [GO:0007049]","GO:0005737; GO:0005814; GO:0007049"
"3647",3647,"Cluster_6906","Porites_evermani_scaffold_269:170868-171868",158,-20.91,2,20,436,458,19,"68.42%","84.21%","Peve_00019973",NA,NA,NA,NA,NA,NA,NA,NA
"3648",3648,"Cluster_6906","Porites_evermani_scaffold_271:195629-196629",158,-22.26,2,16,482,504,15,"86.67%","86.67%","Peve_00020185",-0.534998087124427,0.640624647924106,0.978262075707395,"Q8CFW1","Anoctamin-2 (Transmembrane protein 16B)","Mus musculus (Mouse)","chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; establishment of localization in cell [GO:0051649]; transmembrane transport [GO:0055085]","GO:0005229; GO:0005254; GO:0005654; GO:0005886; GO:0006821; GO:0034707; GO:0042734; GO:0042802; GO:0043005; GO:0046983; GO:0051649; GO:0055085; GO:0097730; GO:0098978; GO:1902476"
"3649",3649,"Cluster_6906","Porites_evermani_scaffold_2737:54318-55318",154,-21.86,2,21,171,194,21,"66.67%","80.95%","Peve_00020404",-0.338471072948566,0.780180545294415,0.993553846693913,"Q14679","Tubulin monoglutamylase TTLL4 (EC 6.3.2.-) (Protein monoglutamylase TTLL4) (Tubulin--tyrosine ligase-like protein 4)","Homo sapiens (Human)","microtubule cytoskeleton organization [GO:0000226]; peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]; regulation of blastocyst development [GO:0120222]","GO:0000226; GO:0005524; GO:0005829; GO:0005874; GO:0005929; GO:0015631; GO:0018095; GO:0018200; GO:0036064; GO:0046872; GO:0070739; GO:0070740; GO:0097731; GO:0120222"
"3650",3650,"Cluster_6906","Porites_evermani_scaffold_276:186670-187670",155,-22.11,2,18,795,819,19,"73.68%","84.21%","Peve_00020573",NA,NA,NA,NA,NA,NA,NA,NA
"3651",3651,"Cluster_6906","Porites_evermani_scaffold_2785:63000-63612",158,-20.2,2,21,206,226,19,"68.42%","84.21%","Peve_00020762",NA,NA,NA,NA,NA,NA,NA,NA
"3652",3652,"Cluster_6906","Porites_evermani_scaffold_278:59519-60519",162,-22.17,2,15,228,249,13,"84.62%","100.00%","Peve_00020719",-0.991416139762645,0.0834733013371978,0.978262075707395,"P07949","Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Cadherin family member 12) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment]","Homo sapiens (Human)","activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; axon guidance [GO:0007411]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; lymphocyte migration into lymphoid organs [GO:0097021]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of protein kinase B signaling [GO:0051897]; posterior midgut development [GO:0007497]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657]","GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0006468; GO:0006919; GO:0007156; GO:0007158; GO:0007165; GO:0007169; GO:0007411; GO:0007497; GO:0009410; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030155; GO:0030335; GO:0030424; GO:0030425; GO:0033141; GO:0033619; GO:0033630; GO:0033674; GO:0035799; GO:0035860; GO:0038023; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045121; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0097021; GO:0098797; GO:2001241"
"3653",3653,"Cluster_6906","Porites_evermani_scaffold_2870:27222-28222",158,-20.59,2,19,441,462,17,"76.47%","76.47%","Peve_00021454",NA,NA,NA,NA,NA,NA,NA,NA
"3654",3654,"Cluster_6906","Porites_evermani_scaffold_28:712998-713998",164,-23.78,2,17,234,255,15,"86.67%","86.67%","Peve_00020885",-0.686063329690759,0.518674561276582,0.978262075707395,NA,NA,NA,NA,NA
"3655",3655,"Cluster_6906","Porites_evermani_scaffold_2897:33535-33964",167,-21.88,2,16,17,38,14,"92.86%","92.86%","Peve_00021625",-0.230268003661427,0.852079436100052,0.995934364227446,"P14314","Glucosidase 2 subunit beta (80K-H protein) (Glucosidase II subunit beta) (Protein kinase C substrate 60.1 kDa protein heavy chain) (PKCSH)","Homo sapiens (Human)","intracellular signal transduction [GO:0035556]; liver development [GO:0001889]; N-glycan processing [GO:0006491]","GO:0001889; GO:0005080; GO:0005509; GO:0005783; GO:0005788; GO:0006491; GO:0017177; GO:0035556; GO:0043231; GO:0044325; GO:0051219"
"3656",3656,"Cluster_6906","Porites_evermani_scaffold_2897:33535-33964",167,-21.88,2,16,17,38,14,"92.86%","92.86%","Peve_00021626",-0.900174933019468,0.286876989598075,0.978262075707395,"Q2VJ60","E3 ubiquitin-protein ligase RNF19A (EC 2.3.2.31) (Double ring-finger protein) (Dorfin) (RING finger protein 19A)","Sus scrofa (Pig)","positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0000209; GO:0005737; GO:0005815; GO:0006511; GO:0016020; GO:0031624; GO:0032436; GO:0046872; GO:0061630; GO:0098686; GO:0098794; GO:0098978; GO:0099576"
"3657",3657,"Cluster_6906","Porites_evermani_scaffold_2944:26324-27324",157,-23.23,2,20,152,177,22,"72.73%","77.27%","Peve_00022011",-0.410779547926781,0.730513175620782,0.984665205065812,"P51950","CDK-activating kinase assembly factor MAT1 (CDK7/cyclin-H assembly factor) (Menage a trois) (RING finger protein MAT1)","Marthasterias glacialis (Spiny starfish)","cell cycle [GO:0007049]; cell division [GO:0051301]; nucleotide-excision repair [GO:0006289]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]","GO:0005675; GO:0006289; GO:0007049; GO:0045737; GO:0046872; GO:0051301; GO:0061575"
"3658",3658,"Cluster_6906","Porites_evermani_scaffold_2959:43155-44155",163,-20.9,2,19,647,666,17,"82.35%","88.24%","Peve_00022115",-0.686063329690759,0.518674561276582,0.978262075707395,NA,NA,NA,NA,NA
"3659",3659,"Cluster_6906","Porites_evermani_scaffold_2984:11773-12773",151,-20.77,2,12,213,234,10,"90.00%","100.00%","Peve_00022313",0.735482242665877,0.473911325563792,0.978262075707395,"Q9H0H5","Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4)","Homo sapiens (Human)","actomyosin contractile ring assembly [GO:0000915]; erythrocyte differentiation [GO:0030218]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; neuroblast proliferation [GO:0007405]; positive regulation of cytokinesis [GO:0032467]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of embryonic development [GO:0045995]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; sulfate transport [GO:0008272]","GO:0000281; GO:0000915; GO:0001669; GO:0005096; GO:0005547; GO:0005634; GO:0005654; GO:0005819; GO:0005829; GO:0005874; GO:0007266; GO:0007283; GO:0007405; GO:0008017; GO:0008272; GO:0019901; GO:0030218; GO:0030496; GO:0031234; GO:0032154; GO:0032467; GO:0043014; GO:0043015; GO:0045995; GO:0046872; GO:0048487; GO:0051056; GO:0051233; GO:0051256; GO:0051988; GO:0070062; GO:0072686; GO:0090543; GO:0097149"
"3660",3660,"Cluster_6906","Porites_evermani_scaffold_308:216060-217060",159,-20.64,2,19,531,550,17,"76.47%","88.24%","Peve_00023198",NA,NA,NA,NA,NA,NA,NA,NA
"3661",3661,"Cluster_6906","Porites_evermani_scaffold_313:11394-11891",152,-20.14,2,17,453,474,15,"73.33%","80.00%","Peve_00023596",-0.992177452626996,0.0796806257552336,0.978262075707395,"O35817","A-kinase anchor protein 14 (AKAP-14) (TAKAP-1.2) (Testis-specific A-kinase-anchoring protein TAKAP-80)","Rattus norvegicus (Rat)","spermatogenesis [GO:0007283]","GO:0005930; GO:0005952; GO:0007283; GO:0034237; GO:0035686; GO:0051018"
"3662",3662,"Cluster_6906","Porites_evermani_scaffold_313:11394-11891",152,-20.14,2,17,453,474,15,"73.33%","80.00%","Peve_00023598",-0.7493234076626,0.460757740882099,0.978262075707395,"P53356","Tyrosine-protein kinase HTK16 (EC 2.7.10.2)","Hydra vulgaris (Hydra) (Hydra attenuata)","","GO:0004715; GO:0005524"
"3663",3663,"Cluster_6906","Porites_evermani_scaffold_313:232219-233219",157,-20.45,2,19,104,126,18,"72.22%","83.33%","Peve_00023595",0.182659812186399,0.88305861300697,0.999448381576871,"Q24046","Sodium/potassium-transporting ATPase subunit beta-1 (Protein nervana 1) (Sodium/potassium-dependent ATPase subunit beta-1)","Drosophila melanogaster (Fruit fly)","cation transport [GO:0006812]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; positive regulation of P-type sodium:potassium-exchanging transporter activity [GO:1903408]; potassium ion import across plasma membrane [GO:1990573]; sodium ion export across plasma membrane [GO:0036376]","GO:0001671; GO:0005886; GO:0005890; GO:0006812; GO:0006883; GO:0030007; GO:0036376; GO:1903408; GO:1990573"
"3664",3664,"Cluster_6906","Porites_evermani_scaffold_3:1343395-1344395",157,-21.72,2,21,889,908,19,"73.68%","78.95%","Peve_00022527",NA,NA,NA,NA,NA,NA,NA,NA
"3665",3665,"Cluster_6906","Porites_evermani_scaffold_325:16527-17527",160,-25.06,2,21,128,149,19,"63.16%","84.21%","Peve_00024319",-0.536768382610747,0.639289795260199,0.978262075707395,"O75762","Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Transformation-sensitive protein p120) (p120) (Wasabi receptor)","Homo sapiens (Human)","calcium ion transmembrane transport [GO:0070588]; cell surface receptor signaling pathway [GO:0007166]; cellular calcium ion homeostasis [GO:0006874]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to organic substance [GO:0071310]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; ion transport [GO:0006811]; protein homotetramerization [GO:0051289]; response to cold [GO:0009409]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; sensory perception of pain [GO:0019233]; thermoception [GO:0050955]","GO:0005262; GO:0005886; GO:0006811; GO:0006874; GO:0007166; GO:0009409; GO:0009410; GO:0010033; GO:0014070; GO:0015267; GO:0015278; GO:0019233; GO:0032421; GO:0042802; GO:0048265; GO:0050955; GO:0050966; GO:0050968; GO:0051289; GO:0070301; GO:0070588; GO:0071310; GO:0097604"
"3666",3666,"Cluster_6906","Porites_evermani_scaffold_3364:43633-44633",159,-24.38,2,21,949,972,21,"66.67%","80.95%","Peve_00025070",NA,NA,NA,NA,NA,NA,NA,NA
"3667",3667,"Cluster_6906","Porites_evermani_scaffold_339:3825-4825",164,-22.02,2,17,250,271,15,"86.67%","86.67%","Peve_00025187",-0.548807357927734,0.630164098256766,0.978262075707395,"P42325","Neurocalcin homolog (DrosNCa)","Drosophila melanogaster (Fruit fly)","negative regulation of neuronal signal transduction [GO:1902848]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]","GO:0005509; GO:0045938; GO:1902848"
"3668",3668,"Cluster_6906","Porites_evermani_scaffold_3423:11033-12033",161,-20.51,2,18,716,737,16,"75.00%","87.50%","Peve_00025441",0.960072083707429,0.180504976259323,0.978262075707395,NA,NA,NA,NA,NA
"3669",3669,"Cluster_6906","Porites_evermani_scaffold_3423:7309-8309",161,-20.51,2,18,716,737,16,"75.00%","87.50%","Peve_00025440",0.959224692711999,0.182423425676769,0.978262075707395,NA,NA,NA,NA,NA
"3670",3670,"Cluster_6906","Porites_evermani_scaffold_343:52957-53957",150,-20.88,2,20,708,730,19,"63.16%","78.95%","Peve_00025484",-0.399801216095559,0.738158309710216,0.986630826362453,"Q8K2G4","Bardet-Biedl syndrome 7 protein homolog (BBS2-like protein 1)","Mus musculus (Mouse)","brain development [GO:0007420]; cilium assembly [GO:0060271]; eye development [GO:0001654]; fat cell differentiation [GO:0045444]; heart development [GO:0007507]; intracellular transport [GO:0046907]; limb development [GO:0060173]; non-motile cilium assembly [GO:1905515]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; primary palate development [GO:1903929]; protein localization [GO:0008104]; protein transport [GO:0015031]; regulation of transcription by RNA polymerase II [GO:0006357]; smoothened signaling pathway [GO:0007224]","GO:0001654; GO:0001750; GO:0005634; GO:0005813; GO:0005930; GO:0006357; GO:0007224; GO:0007420; GO:0007507; GO:0008104; GO:0015031; GO:0016020; GO:0032436; GO:0034464; GO:0036064; GO:0043005; GO:0045444; GO:0046907; GO:0060170; GO:0060173; GO:0060271; GO:0061629; GO:1903929; GO:1905515"
"3671",3671,"Cluster_6906","Porites_evermani_scaffold_346:180727-181491",163,-22.72,2,20,571,592,18,"72.22%","83.33%","Peve_00025680",NA,NA,NA,NA,NA,NA,NA,NA
"3672",3672,"Cluster_6906","Porites_evermani_scaffold_3509:46-1046",160,-20.85,2,20,405,426,19,"78.95%","84.21%","Peve_00026018",-0.53405882208387,0.641332160703501,0.978262075707395,"P25931","RYamide receptor (Neuropeptide Y-like receptor) (NPY-R)","Drosophila melanogaster (Fruit fly)","G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]","GO:0001653; GO:0004983; GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0016020"
"3673",3673,"Cluster_6906","Porites_evermani_scaffold_3539:38895-39895",152,-23.47,2,18,272,298,21,"66.67%","76.19%","Peve_00026173",-0.686063329690759,0.518674561276582,0.978262075707395,"Q2MJB4","Doublesex- and mab-3-related transcription factor A2 (Doublesex- and mab-3-related transcription factor 5)","Xenopus laevis (African clawed frog)","neurogenesis [GO:0022008]; regulation of DNA-templated transcription [GO:0006355]","GO:0005634; GO:0006355; GO:0022008; GO:0043565; GO:0046872"
"3674",3674,"Cluster_6906","Porites_evermani_scaffold_357:261899-262899",156,-20.78,2,20,581,602,19,"73.68%","84.21%","Peve_00026357",0.973101367926095,0.147992105390085,0.978262075707395,NA,NA,NA,NA,NA
"3675",3675,"Cluster_6906","Porites_evermani_scaffold_36:65892-66892",155,-26.22,2,21,257,285,26,"65.38%","69.23%","Peve_00026532",-0.686063329690759,0.518674561276582,0.978262075707395,NA,NA,NA,NA,NA
"3676",3676,"Cluster_6906","Porites_evermani_scaffold_3846:19456-20456",150,-20.76,2,20,344,367,20,"60.00%","80.00%","Peve_00027865",-0.177223936111879,0.886576627734647,0.999448381576871,"Q76KP1","N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 1 (NGalNAc-T1) (EC 2.4.1.244) (Beta-1,4-N-acetylgalactosaminyltransferase IV) (Beta4GalNAc-T4) (Beta4GalNAcT4)","Homo sapiens (Human)","","GO:0008376; GO:0032580; GO:0033842"
"3677",3677,"Cluster_6906","Porites_evermani_scaffold_389:269583-270583",158,-21.22,2,20,64,86,19,"68.42%","84.21%","Peve_00028094",-0.487977860419248,0.675469348410572,0.978262075707395,NA,NA,NA,NA,NA
"3678",3678,"Cluster_6906","Porites_evermani_scaffold_3903:2599-3599",164,-22.74,2,18,85,107,17,"82.35%","88.24%","Peve_00028212",NA,NA,NA,"Q6PC72",NA,NA,NA,NA
"3679",3679,"Cluster_6906","Porites_evermani_scaffold_4003:18500-19500",158,-20.66,2,20,413,436,20,"75.00%","75.00%","Peve_00028863",NA,NA,NA,NA,NA,NA,NA,NA
"3680",3680,"Cluster_6906","Porites_evermani_scaffold_40:295870-296870",153,-21.09,2,20,554,574,18,"72.22%","77.78%","Peve_00028827",-0.418277136917601,0.725268181807553,0.983142327494007,NA,NA,NA,NA,NA
"3681",3681,"Cluster_6906","Porites_evermani_scaffold_4058:13828-14828",166,-28.98,2,21,620,643,21,"76.19%","85.71%","Peve_00029153",NA,NA,NA,NA,NA,NA,NA,NA
"3682",3682,"Cluster_6906","Porites_evermani_scaffold_407:195366-196366",152,-21.83,2,17,232,253,15,"73.33%","80.00%","Peve_00029221",NA,NA,NA,NA,NA,NA,NA,NA
"3683",3683,"Cluster_6906","Porites_evermani_scaffold_407:195366-196366",152,-22.07,2,17,272,293,15,"73.33%","80.00%","Peve_00029221",NA,NA,NA,NA,NA,NA,NA,NA
"3684",3684,"Cluster_6906","Porites_evermani_scaffold_412:91263-92263",151,-20.21,2,21,290,316,24,"62.50%","70.83%","Peve_00029478",0.102448593400213,0.934664567731013,0.999448381576871,"Q2PC93","SCO-spondin","Gallus gallus (Chicken)","cell adhesion [GO:0007155]","GO:0005615; GO:0007155; GO:0031012"
"3685",3685,"Cluster_6906","Porites_evermani_scaffold_412:91263-92263",151,-20.21,2,21,776,802,24,"62.50%","70.83%","Peve_00029478",0.102448593400213,0.934664567731013,0.999448381576871,"Q2PC93","SCO-spondin","Gallus gallus (Chicken)","cell adhesion [GO:0007155]","GO:0005615; GO:0007155; GO:0031012"
"3686",3686,"Cluster_6906","Porites_evermani_scaffold_428:134688-135688",158,-23.18,2,16,50,72,15,"80.00%","93.33%","Peve_00030287",0.476964911242255,0.68347375018165,0.978262075707395,"Q8TF09","Dynein light chain roadblock-type 2 (Dynein light chain 2B, cytoplasmic) (Roadblock domain-containing protein 2)","Homo sapiens (Human)","microtubule-based movement [GO:0007018]","GO:0003777; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0005929; GO:0007018; GO:0045505; GO:0097542"
"3687",3687,"Cluster_6906","Porites_evermani_scaffold_434:21776-22776",151,-21.83,2,17,37,59,16,"75.00%","81.25%","Peve_00030627",-0.686063329690759,0.518674561276582,0.978262075707395,NA,NA,NA,NA,NA
"3688",3688,"Cluster_6906","Porites_evermani_scaffold_4346:9159-9515",164,-20.48,2,21,305,326,19,"73.68%","78.95%","Peve_00030646",-0.817418210270963,0.390809160130405,0.978262075707395,"Q15007","Pre-mRNA-splicing regulator WTAP (Female-lethal(2)D homolog) (hFL(2)D) (WT1-associated protein) (Wilms tumor 1-associating protein)","Homo sapiens (Human)","cell cycle [GO:0007049]; mRNA methylation [GO:0080009]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]","GO:0000381; GO:0005634; GO:0005654; GO:0005737; GO:0006397; GO:0007049; GO:0008380; GO:0016607; GO:0031965; GO:0036396; GO:0042802; GO:0080009"
"3689",3689,"Cluster_6906","Porites_evermani_scaffold_4346:9159-9515",164,-20.48,2,21,305,326,19,"73.68%","78.95%","Peve_00030647",0.881715689467879,0.312777515058231,0.978262075707395,"Q99ND9","RWD domain-containing protein 1 (Small androgen receptor-interacting protein)","Rattus norvegicus (Rat)","androgen receptor signaling pathway [GO:0030521]; cellular response to oxidative stress [GO:0034599]; cellular response to testosterone stimulus [GO:0071394]; cytoplasmic translation [GO:0002181]; positive regulation of androgen receptor activity [GO:2000825]","GO:0002181; GO:0005737; GO:0005844; GO:0030521; GO:0034599; GO:0071394; GO:2000825"
"3690",3690,"Cluster_6906","Porites_evermani_scaffold_4598:16130-17130",148,-20.58,2,21,742,767,24,"70.83%","70.83%","Peve_00031865",-0.686063329690759,0.518674561276582,0.978262075707395,NA,NA,NA,NA,NA
"3691",3691,"Cluster_6906","Porites_evermani_scaffold_4631:10462-11462",170,-23.71,2,19,546,567,17,"82.35%","88.24%","Peve_00032047",NA,NA,NA,NA,NA,NA,NA,NA
"3692",3692,"Cluster_6906","Porites_evermani_scaffold_46:360065-361065",154,-21.28,2,18,44,63,16,"81.25%","81.25%","Peve_00031871",NA,NA,NA,NA,NA,NA,NA,NA
"3693",3693,"Cluster_6906","Porites_evermani_scaffold_4659:0-585",142,-22.15,2,21,145,169,22,"59.09%","72.73%","Peve_00032145",-0.558491332452997,0.622760806543062,0.978262075707395,NA,NA,NA,NA,NA
"3694",3694,"Cluster_6906","Porites_evermani_scaffold_4722:19199-20199",146,-21.09,2,16,7,29,15,"66.67%","86.67%","Peve_00032451",-0.782183977406837,0.428211382809678,0.978262075707395,NA,NA,NA,NA,NA
"3695",3695,"Cluster_6906","Porites_evermani_scaffold_4722:19199-20199",146,-21.09,2,16,779,801,15,"66.67%","86.67%","Peve_00032451",-0.782183977406837,0.428211382809678,0.978262075707395,NA,NA,NA,NA,NA
"3696",3696,"Cluster_6906","Porites_evermani_scaffold_472:5070-6070",157,-21.23,2,18,788,809,16,"68.75%","87.50%","Peve_00032411",NA,NA,NA,NA,NA,NA,NA,NA
"3697",3697,"Cluster_6906","Porites_evermani_scaffold_4748:21064-22064",164,-20.12,2,19,557,577,17,"82.35%","88.24%","Peve_00032536",0.858182175296801,0.343187930452088,0.978262075707395,"A2AV25","Fibrinogen C domain-containing protein 1","Mus musculus (Mouse)","cell adhesion [GO:0007155]","GO:0005102; GO:0005615; GO:0007155; GO:0008061; GO:0016020; GO:0046872; GO:0062023"
"3698",3698,"Cluster_6906","Porites_evermani_scaffold_487:58647-59647",169,-25.35,2,18,446,467,16,"81.25%","93.75%","Peve_00033003",-0.983070306181567,0.117309798646625,0.978262075707395,NA,NA,NA,NA,NA
"3699",3699,"Cluster_6906","Porites_evermani_scaffold_507:188220-189220",157,-20.87,2,16,455,475,14,"85.71%","92.86%","Peve_00033913",0.973101367926096,0.147992105390084,0.978262075707395,"Q5ZM55","Protein fem-1 homolog B (FEM1b) (FEM1-beta)","Gallus gallus (Chicken)","apoptotic process [GO:0006915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627]","GO:0005634; GO:0005737; GO:0006915; GO:0016567; GO:0031462; GO:0043161; GO:0140627; GO:1990756; GO:2000001"
"3700",3700,"Cluster_6906","Porites_evermani_scaffold_51:378117-379117",164,-21.43,2,21,44,65,19,"68.42%","84.21%","Peve_00033998",-0.670386505811445,0.532256638705405,0.978262075707395,"P30349","Leukotriene A-4 hydrolase (LTA-4 hydrolase) (EC 3.3.2.6) (Leukotriene A(4) hydrolase) (Tripeptide aminopeptidase LTA4H) (EC 3.4.11.4)","Rattus norvegicus (Rat)","leukotriene biosynthetic process [GO:0019370]; leukotriene metabolic process [GO:0006691]; peptide catabolic process [GO:0043171]; protein metabolic process [GO:0019538]; proteolysis [GO:0006508]; response to peptide hormone [GO:0043434]; response to zinc ion [GO:0010043]; type I pneumocyte differentiation [GO:0060509]","GO:0004177; GO:0004301; GO:0004463; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006508; GO:0006691; GO:0008270; GO:0010043; GO:0019370; GO:0019538; GO:0043171; GO:0043434; GO:0045148; GO:0060509; GO:0070006"
"3701",3701,"Cluster_6906","Porites_evermani_scaffold_525:37130-38130",158,-20.38,2,19,634,655,17,"76.47%","76.47%","Peve_00034567",-0.286203099963657,0.815213588050956,0.995934364227446,"Q66K08","Cartilage intermediate layer protein 1 (CILP-1) [Cleaved into: Cartilage intermediate layer protein 1 C1; Cartilage intermediate layer protein 1 C2]","Mus musculus (Mouse)","cellular response to transforming growth factor beta stimulus [GO:0071560]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]","GO:0005615; GO:0010629; GO:0030512; GO:0043569; GO:0060392; GO:0062023; GO:0071560"
"3702",3702,"Cluster_6906","Porites_evermani_scaffold_5389:0-810",159,-23.18,2,21,385,409,22,"68.18%","77.27%","Peve_00035059",0.0922663630495661,0.941177746989478,0.999448381576871,"Q3MHG1","Serine palmitoyltransferase 1 (EC 2.3.1.50) (Long chain base biosynthesis protein 1) (LCB 1) (Serine-palmitoyl-CoA transferase 1) (SPT 1) (SPT1)","Bos taurus (Bovine)","ceramide biosynthetic process [GO:0046513]; positive regulation of lipophagy [GO:1904504]; regulation of fat cell apoptotic process [GO:1904649]; sphingolipid metabolic process [GO:0006665]; sphingosine biosynthetic process [GO:0046512]","GO:0004758; GO:0005783; GO:0005789; GO:0006665; GO:0030170; GO:0035339; GO:0046512; GO:0046513; GO:1904504; GO:1904649"
"3703",3703,"Cluster_6906","Porites_evermani_scaffold_5422:260-1260",155,-20.41,2,17,287,309,16,"75.00%","87.50%","Peve_00035221",NA,NA,NA,NA,NA,NA,NA,NA
"3704",3704,"Cluster_6906","Porites_evermani_scaffold_54:524920-525920",151,-20.59,2,17,492,514,16,"75.00%","81.25%","Peve_00035120",-0.351077204692827,0.77163093420673,0.991365615576119,NA,NA,NA,NA,NA
"3705",3705,"Cluster_6906","Porites_evermani_scaffold_5:502052-503052",164,-27.36,2,21,31,52,19,"68.42%","84.21%","Peve_00033513",NA,NA,NA,NA,NA,NA,NA,NA
"3706",3706,"Cluster_6906","Porites_evermani_scaffold_5532:910-1910",150,-20.11,2,21,828,848,19,"68.42%","73.68%","Peve_00035596",-0.858983569861145,0.34219278867065,0.978262075707395,NA,NA,NA,NA,NA
"3707",3707,"Cluster_6906","Porites_evermani_scaffold_554:18773-19773",166,-26.97,2,20,858,880,19,"73.68%","89.47%","Peve_00035620",-0.478341627518953,0.682476144431013,0.978262075707395,"P58307","Orexin/Hypocretin receptor type 1 (Hypocretin receptor type 1) (Orexin receptor type 1) (Ox-1-R) (Ox1-R) (Ox1R)","Mus musculus (Mouse)","feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of cytosolic calcium ion concentration [GO:0051480]","GO:0004930; GO:0005886; GO:0007186; GO:0007218; GO:0007631; GO:0016499; GO:0017046; GO:0051480; GO:0070374"
"3708",3708,"Cluster_6906","Porites_evermani_scaffold_570:62268-63268",162,-22.77,2,17,291,314,17,"88.24%","88.24%","Peve_00036130",NA,NA,NA,NA,NA,NA,NA,NA
"3709",3709,"Cluster_6906","Porites_evermani_scaffold_58:454799-455799",153,-22.04,2,21,507,529,21,"71.43%","76.19%","Peve_00036362",0.0343448434780711,0.978131092813725,0.999448381576871,"A9H2B4","Putative hydro-lyase GDI0188/Gdia_2258 (EC 4.2.1.-)","Gluconacetobacter diazotrophicus (strain ATCC 49037 / DSM 5601 / CCUG 37298 / CIP 103539 / LMG 7603 / PAl5)","","GO:0016829"
"3710",3710,"Cluster_6906","Porites_evermani_scaffold_586:68311-69311",155,-20.77,2,18,51,71,16,"75.00%","87.50%","Peve_00036548",-0.195856396255873,0.874502708738146,0.997476741937264,NA,NA,NA,NA,NA
"3711",3711,"Cluster_6906","Porites_evermani_scaffold_616:77656-78656",166,-26.25,2,21,97,117,19,"73.68%","89.47%","Peve_00037476",NA,NA,NA,NA,NA,NA,NA,NA
"3712",3712,"Cluster_6906","Porites_evermani_scaffold_61:88103-89103",152,-20.33,2,20,960,982,20,"70.00%","80.00%","Peve_00037342",-0.851334246186637,0.351587919467754,0.978262075707395,NA,NA,NA,NA,NA
"3713",3713,"Cluster_6906","Porites_evermani_scaffold_6212:309-1309",153,-21.02,2,21,380,402,21,"71.43%","76.19%","Peve_00037674",-0.239998732245639,0.845705938457984,0.995934364227446,NA,NA,NA,NA,NA
"3714",3714,"Cluster_6906","Porites_evermani_scaffold_6237:4217-5217",155,-20.91,2,20,233,253,19,"73.68%","84.21%","Peve_00037715",-0.632082917711679,0.564400398241818,0.978262075707395,NA,NA,NA,NA,NA
"3715",3715,"Cluster_6906","Porites_evermani_scaffold_624:157066-158066",154,-20.06,2,16,224,246,15,"73.33%","93.33%","Peve_00037726",-0.528189517841129,0.645742119259812,0.978262075707395,"O15550","Lysine-specific demethylase 6A (EC 1.14.11.68) (Histone demethylase UTX) (Ubiquitously-transcribed TPR protein on the X chromosome) (Ubiquitously-transcribed X chromosome tetratricopeptide repeat protein) ([histone H3]-trimethyl-L-lysine(27) demethylase 6A)","Homo sapiens (Human)","chromatin remodeling [GO:0006338]; heart development [GO:0007507]; histone H3-K27 demethylation [GO:0071557]; histone H3-K4 methylation [GO:0051568]; regulation of gene expression [GO:0010468]","GO:0000978; GO:0005634; GO:0005654; GO:0006338; GO:0007507; GO:0010468; GO:0031490; GO:0032452; GO:0035097; GO:0044666; GO:0046872; GO:0051568; GO:0071557; GO:0071558"
"3716",3716,"Cluster_6906","Porites_evermani_scaffold_630:202739-203739",149,-21.18,2,21,395,416,20,"70.00%","75.00%","Peve_00037903",-0.73035551908776,0.478708813818534,0.978262075707395,"Q8VE62","Polyadenylate-binding protein-interacting protein 1 (PABP-interacting protein 1) (PAIP-1) (Poly(A)-binding protein-interacting protein 1)","Mus musculus (Mouse)","CRD-mediated mRNA stabilization [GO:0070934]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; positive regulation by host of viral process [GO:0044794]; positive regulation of cytoplasmic translation [GO:2000767]; regulation of translational initiation [GO:0006446]","GO:0003723; GO:0005829; GO:0006446; GO:0008494; GO:0044794; GO:0070934; GO:0106002; GO:1900152; GO:2000767"
"3717",3717,"Cluster_6906","Porites_evermani_scaffold_640:50057-51057",163,-22.95,2,21,340,362,20,"75.00%","80.00%","Peve_00038163",NA,NA,NA,NA,NA,NA,NA,NA
"3718",3718,"Cluster_6906","Porites_evermani_scaffold_64:536142-537142",156,-23.09,2,21,241,262,19,"63.16%","78.95%","Peve_00038112",-0.118880790256572,0.924138730920846,0.999448381576871,NA,NA,NA,NA,NA
"3719",3719,"Cluster_6906","Porites_evermani_scaffold_666:125559-126559",156,-20.53,2,20,622,641,18,"77.78%","77.78%","Peve_00038734",-0.686063329690759,0.518674561276582,0.978262075707395,NA,NA,NA,NA,NA
"3720",3720,"Cluster_6906","Porites_evermani_scaffold_668:50187-51187",151,-20.44,2,16,820,841,14,"78.57%","78.57%","Peve_00038758",0.973101367926095,0.147992105390085,0.978262075707395,NA,NA,NA,NA,NA
"3721",3721,"Cluster_6906","Porites_evermani_scaffold_673:162082-163082",158,-20.94,2,19,500,521,17,"70.59%","82.35%","Peve_00038906",NA,NA,NA,NA,NA,NA,NA,NA
"3722",3722,"Cluster_6906","Porites_evermani_scaffold_678:73960-74960",166,-21.53,2,19,794,815,17,"76.47%","88.24%","Peve_00039004",-0.120849936675135,0.922876029280283,0.999448381576871,"P00920","Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase II) (CA-II)","Mus musculus (Mouse)","angiotensin-activated signaling pathway [GO:0038166]; carbon dioxide transport [GO:0015670]; morphogenesis of an epithelium [GO:0002009]; neuron cellular homeostasis [GO:0070050]; one-carbon metabolic process [GO:0006730]; positive regulation of bone resorption [GO:0045780]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of dipeptide transmembrane transport [GO:2001150]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of anion transport [GO:0044070]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; secretion [GO:0046903]","GO:0002009; GO:0004064; GO:0004089; GO:0005615; GO:0005737; GO:0005829; GO:0005886; GO:0005902; GO:0006730; GO:0006885; GO:0008270; GO:0015670; GO:0016323; GO:0016836; GO:0030424; GO:0032230; GO:0032849; GO:0038166; GO:0043209; GO:0044070; GO:0045177; GO:0045672; GO:0045780; GO:0046903; GO:0051453; GO:0070050; GO:2001150; GO:2001225"
"3723",3723,"Cluster_6906","Porites_evermani_scaffold_71:134590-135590",153,-24.68,2,21,895,922,25,"72.00%","72.00%","Peve_00039820",NA,NA,NA,NA,NA,NA,NA,NA
"3724",3724,"Cluster_6906","Porites_evermani_scaffold_71:153868-154868",150,-21.37,2,21,839,864,23,"65.22%","73.91%","Peve_00039821",NA,NA,NA,NA,NA,NA,NA,NA
"3725",3725,"Cluster_6906","Porites_evermani_scaffold_717:143338-144338",161,-22.99,2,21,659,678,19,"78.95%","78.95%","Peve_00039958",-0.287038038235336,0.814658772056752,0.995934364227446,"Q90964","Forkhead box protein G1 (FoxG1) (Brain factor 1) (BF-1) (BF1) (cBF-1) (CEQ 3-1) (Forkhead-related protein FKHL1) (N-62-5) (Proto-oncogene C-QIN)","Gallus gallus (Chicken)","axon midline choice point recognition [GO:0016199]; dorsal/ventral pattern formation [GO:0009953]; inner ear morphogenesis [GO:0042472]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; positive regulation of cell cycle [GO:0045787]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron differentiation [GO:0045666]; pyramidal neuron migration to cerebral cortex [GO:0021852]; regulation of mitotic cell cycle [GO:0007346]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000122; GO:0002052; GO:0003700; GO:0005634; GO:0006357; GO:0007346; GO:0007405; GO:0009953; GO:0016199; GO:0021852; GO:0042472; GO:0045665; GO:0045666; GO:0045787; GO:0048664; GO:1990837"
"3726",3726,"Cluster_6906","Porites_evermani_scaffold_720:39136-40136",161,-21.94,2,18,660,681,16,"81.25%","81.25%","Peve_00040051",NA,NA,NA,NA,NA,NA,NA,NA
"3727",3727,"Cluster_6906","Porites_evermani_scaffold_743:44593-45593",161,-22.35,2,19,329,351,18,"72.22%","88.89%","Peve_00040574",0.114135980221608,0.927180086314498,0.999448381576871,"Q76IC6","Palmitoyltransferase ZDHHC23 (EC 2.3.1.225) (NNOS-interacting DHHC domain-containing protein with dendritic mRNA) (Zinc finger DHHC domain-containing protein 23) (DHHC-23) (zDHHC23)","Rattus norvegicus (Rat)","peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein localization to plasma membrane [GO:0072659]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]","GO:0000139; GO:0005783; GO:0005794; GO:0006612; GO:0018230; GO:0018345; GO:0019706; GO:0072659"
"3728",3728,"Cluster_6906","Porites_evermani_scaffold_75:273212-274212",155,-21.68,2,20,821,845,22,"77.27%","77.27%","Peve_00040676",-0.765296605478424,0.445184593651099,0.978262075707395,"Q96L93","Kinesin-like protein KIF16B (Sorting nexin-23)","Homo sapiens (Human)","early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; microtubule-based movement [GO:0007018]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919]","GO:0001704; GO:0001919; GO:0003777; GO:0005524; GO:0005547; GO:0005737; GO:0005768; GO:0005769; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0006895; GO:0007018; GO:0007173; GO:0007492; GO:0008017; GO:0008543; GO:0008574; GO:0016887; GO:0031901; GO:0032266; GO:0032801; GO:0043325; GO:0045022; GO:0080025"
"3729",3729,"Cluster_6906","Porites_evermani_scaffold_763:191311-192311",162,-22.75,2,19,554,575,17,"64.71%","94.12%","Peve_00040934",-0.287038038235336,0.814658772056752,0.995934364227446,NA,NA,NA,NA,NA
"3730",3730,"Cluster_6906","Porites_evermani_scaffold_765:66869-67869",158,-21.52,2,19,156,177,17,"64.71%","88.24%","Peve_00040971",-0.450715492033615,0.702337795029706,0.978262075707395,NA,NA,NA,NA,NA
"3731",3731,"Cluster_6906","Porites_evermani_scaffold_770:80626-81626",156,-22.3,2,13,598,619,11,"90.91%","100.00%","Peve_00041075",NA,NA,NA,NA,NA,NA,NA,NA
"3732",3732,"Cluster_6906","Porites_evermani_scaffold_77:290114-291114",150,-22.99,2,21,157,183,24,"66.67%","70.83%","Peve_00041055",0.212688610508499,0.863556017846696,0.996660710141104,NA,NA,NA,NA,NA
"3733",3733,"Cluster_6906","Porites_evermani_scaffold_776:151327-152327",156,-24.44,2,21,165,185,20,"75.00%","80.00%","Peve_00041173",-0.212576519655986,0.863629047116393,0.996660710141104,"P0CG68","Polyubiquitin-C [Cleaved into: Ubiquitin-related; Ubiquitin]","Sus scrofa (Pig)","modification-dependent protein catabolic process [GO:0019941]; protein ubiquitination [GO:0016567]","GO:0005634; GO:0005737; GO:0005741; GO:0016567; GO:0019941; GO:0031386; GO:0031625"
"3734",3734,"Cluster_6906","Porites_evermani_scaffold_835:151815-152815",163,-24.51,2,20,770,791,18,"77.78%","77.78%","Peve_00042468",-0.556218751572337,0.624503328314469,0.978262075707395,NA,NA,NA,NA,NA
"3735",3735,"Cluster_6906","Porites_evermani_scaffold_844:40536-41536",161,-22.35,2,19,672,694,18,"72.22%","88.89%","Peve_00042648",-0.860795572866587,0.339933028264474,0.978262075707395,"A5PMX1","Zinc transporter 7 (ZnT-7) (Solute carrier family 30 member 7)","Danio rerio (Zebrafish) (Brachydanio rerio)","cellular zinc ion homeostasis [GO:0006882]; metal ion transport [GO:0030001]; zinc ion import into Golgi lumen [GO:1904257]; zinc ion transport [GO:0006829]","GO:0005385; GO:0005794; GO:0006829; GO:0006882; GO:0016020; GO:0030001; GO:0031410; GO:0046873; GO:1904257"
"3736",3736,"Cluster_6906","Porites_evermani_scaffold_84:522681-523681",154,-20.14,2,16,501,523,15,"80.00%","86.67%","Peve_00042534",-0.999911200410267,0.00848406162211117,0.573710369894872,NA,NA,NA,NA,NA
"3737",3737,"Cluster_6906","Porites_evermani_scaffold_852:45428-46428",157,-20.88,2,18,301,322,16,"75.00%","81.25%","Peve_00042830",0.991578624724798,0.0826783655638386,0.978262075707395,NA,NA,NA,NA,NA
"3738",3738,"Cluster_6906","Porites_evermani_scaffold_860:112497-113497",156,-20.28,2,17,510,531,15,"80.00%","80.00%","Peve_00042992",-0.864236295577706,0.33560428584668,0.978262075707395,"Q91147","Fibroblast growth factor receptor 2 (FGFR-2) (EC 2.7.10.1)","Notophthalmus viridescens (Eastern newt) (Triturus viridescens)","apoptotic process [GO:0006915]; positive regulation of cell population proliferation [GO:0008284]","GO:0005007; GO:0005524; GO:0005794; GO:0005886; GO:0006915; GO:0008284; GO:0031410"
"3739",3739,"Cluster_6906","Porites_evermani_scaffold_871:89997-90997",149,-20.28,2,15,548,570,14,"78.57%","85.71%","Peve_00043160",-0.686063329690759,0.518674561276582,0.978262075707395,"Q766D5","N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 1 (NGalNAc-T1) (EC 2.4.1.244) (Beta-1,4-N-acetylgalactosaminyltransferase IV) (Beta4GalNAc-T4) (Beta4GalNAcT4)","Mus musculus (Mouse)","chondroitin sulfate biosynthetic process [GO:0030206]","GO:0008376; GO:0030206; GO:0032580; GO:0033842; GO:0047238"
"3740",3740,"Cluster_6906","Porites_evermani_scaffold_885:86415-86556",157,-20.82,2,16,38,58,14,"85.71%","92.86%","Peve_00043398",-0.63648378930221,0.56077642862948,0.978262075707395,"Q8AVJ1","Proline-rich protein 5 (Protein observed with Rictor-1) (Protor-1)","Xenopus laevis (African clawed frog)","",""
"3741",3741,"Cluster_6906","Porites_evermani_scaffold_885:86415-86556",157,-20.82,2,16,38,58,14,"85.71%","92.86%","Peve_00043399",-0.661388568650829,0.53993489889962,0.978262075707395,"Q27245","Putative aminopeptidase W07G4.4 (EC 3.4.11.-)","Caenorhabditis elegans","proteolysis [GO:0006508]","GO:0005737; GO:0006508; GO:0008233; GO:0030145; GO:0070006"
"3742",3742,"Cluster_6906","Porites_evermani_scaffold_899:125706-126706",153,-21.26,2,19,666,690,20,"65.00%","80.00%","Peve_00043593",-0.997871906088051,0.0415401024981488,0.909359886114279,NA,NA,NA,NA,NA
"3743",3743,"Cluster_6906","Porites_evermani_scaffold_925:127604-128604",159,-23.85,2,18,177,201,19,"78.95%","84.21%","Peve_00044187",NA,NA,NA,"Q9UL51","Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 (Brain cyclic nucleotide-gated channel 2) (BCNG-2)","Homo sapiens (Human)","cell-cell signaling [GO:0007267]; cellular response to cAMP [GO:0071320]; cellular response to cGMP [GO:0071321]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; regulation of cation channel activity [GO:2001257]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane depolarization [GO:0003254]; regulation of membrane potential [GO:0042391]; regulation of SA node cell action potential [GO:0098907]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]","GO:0003254; GO:0005222; GO:0005248; GO:0005249; GO:0005886; GO:0007267; GO:0008076; GO:0030424; GO:0030425; GO:0030552; GO:0035725; GO:0042391; GO:0042802; GO:0071320; GO:0071321; GO:0071805; GO:0086012; GO:0086091; GO:0098719; GO:0098855; GO:0098907; GO:1990573; GO:2001257"
"3744",3744,"Cluster_6906","Porites_evermani_scaffold_9:533373-534373",158,-20.38,2,19,653,674,17,"70.59%","82.35%","Peve_00043615",0.978328083049548,0.132779568374256,0.978262075707395,"P55006","Retinol dehydrogenase 7 (EC 1.1.1.105) (Retinol dehydrogenase 3) (Retinol dehydrogenase type III) (RODH III)","Rattus norvegicus (Rat)","retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202]","GO:0004745; GO:0005783; GO:0008202; GO:0016491; GO:0042572; GO:0043231"
"3745",3745,"Cluster_6906","Porites_evermani_scaffold_954:121075-122075",152,-20.09,2,13,635,656,11,"81.82%","100.00%","Peve_00044645",-0.686063329690759,0.518674561276582,0.978262075707395,NA,NA,NA,NA,NA
"3746",3746,"Cluster_6906","Porites_evermani_scaffold_987:90468-91468",155,-21.54,2,21,184,206,20,"65.00%","80.00%","Peve_00045146",-0.958614977839187,0.183791738638876,0.978262075707395,NA,NA,NA,NA,NA
"3747",3747,"Cluster_6906","Porites_evermani_scaffold_993:107150-107880",158,-21.22,2,20,134,158,21,"71.43%","76.19%","Peve_00045274",NA,NA,NA,NA,NA,NA,NA,NA
"3748",3748,"Cluster_6914","Porites_evermani_scaffold_100:36597-37597",162,-22.04,2,17,22,41,15,"86.67%","93.33%","Peve_00000232",-0.99998857382088,0.00304330898553907,0.474160259106401,NA,NA,NA,NA,NA
"3749",3749,"Cluster_6914","Porites_evermani_scaffold_104:322144-323144",161,-21.19,2,20,582,604,20,"75.00%","85.00%","Peve_00000828",0.990177219105401,0.0893035019087193,0.978262075707395,NA,NA,NA,NA,NA
"3750",3750,"Cluster_6914","Porites_evermani_scaffold_1095:66375-67375",157,-21.06,2,20,96,121,23,"73.91%","73.91%","Peve_00001672",0.16752270999419,0.892846496669963,0.999448381576871,"Q7ZX53","Solute carrier family 22 member 15-like","Xenopus laevis (African clawed frog)","ion transport [GO:0006811]","GO:0006811; GO:0016020; GO:0022857"
"3751",3751,"Cluster_6914","Porites_evermani_scaffold_1097:114751-115751",158,-20.79,2,17,97,116,15,"80.00%","93.33%","Peve_00001684",NA,NA,NA,NA,NA,NA,NA,NA
"3752",3752,"Cluster_6914","Porites_evermani_scaffold_1110:83393-84393",156,-24.14,2,20,118,136,18,"77.78%","77.78%","Peve_00002030",0.342504693571997,0.777449475493512,0.992933767237102,NA,NA,NA,NA,NA
"3753",3753,"Cluster_6914","Porites_evermani_scaffold_1159:62615-63615",157,-20.12,2,20,727,751,22,"72.73%","77.27%","Peve_00002683",-0.83747257900626,0.368064614222357,0.978262075707395,"Q9Z2J0","Solute carrier family 23 member 1 (Na(+)/L-ascorbic acid transporter 1) (Sodium-dependent vitamin C transporter 1) (Yolk sac permease-like molecule 3)","Mus musculus (Mouse)","brain development [GO:0007420]; dehydroascorbic acid transport [GO:0070837]; L-ascorbic acid transmembrane transport [GO:0015882]; lung development [GO:0030324]; response to toxic substance [GO:0009636]; sodium ion transport [GO:0006814]","GO:0005737; GO:0005886; GO:0005903; GO:0006814; GO:0007420; GO:0008520; GO:0009636; GO:0009925; GO:0015081; GO:0015229; GO:0015882; GO:0016324; GO:0030324; GO:0033300; GO:0043229; GO:0070837"
"3754",3754,"Cluster_6914","Porites_evermani_scaffold_116:313834-314834",152,-20.12,2,20,309,332,21,"76.19%","76.19%","Peve_00002692",0.853558462702337,0.34887952241865,0.978262075707395,NA,NA,NA,NA,NA
"3755",3755,"Cluster_6914","Porites_evermani_scaffold_11:986485-987485",163,-21.67,2,17,784,805,16,"87.50%","87.50%","Peve_00001791",NA,NA,NA,NA,NA,NA,NA,NA
"3756",3756,"Cluster_6914","Porites_evermani_scaffold_1217:21562-22562",144,-20.73,2,20,42,65,22,"63.64%","72.73%","Peve_00003624",0.228025747767545,0.853545921352629,0.995934364227446,NA,NA,NA,NA,NA
"3757",3757,"Cluster_6914","Porites_evermani_scaffold_1217:5687-6687",144,-20.73,2,20,42,65,22,"63.64%","72.73%","Peve_00003614",-0.943981082611268,0.214097214929746,0.978262075707395,NA,NA,NA,NA,NA
"3758",3758,"Cluster_6914","Porites_evermani_scaffold_1226:98713-99713",158,-21.01,2,20,413,435,20,"70.00%","80.00%","Peve_00003748",0.965984252773419,0.166522893873786,0.978262075707395,"B8UU59","Polycystic kidney disease 1-related protein","Acropora millepora (Staghorn coral) (Heteropora millepora)","kidney development [GO:0001822]","GO:0001822; GO:0005929; GO:0016020"
"3759",3759,"Cluster_6914","Porites_evermani_scaffold_1294:46682-47682",146,-20.51,2,20,367,390,21,"61.90%","71.43%","Peve_00004675",0.927385017303798,0.244102353825691,0.978262075707395,"Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"3760",3760,"Cluster_6914","Porites_evermani_scaffold_1294:46682-47682",150,-21.42,2,20,487,510,21,"66.67%","71.43%","Peve_00004675",0.927385017303798,0.244102353825691,0.978262075707395,"Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"3761",3761,"Cluster_6914","Porites_evermani_scaffold_1351:129993-130993",173,-22.1,2,20,856,875,18,"88.89%","88.89%","Peve_00005542",0.0244174697248888,0.984453810914684,0.999448381576871,NA,NA,NA,NA,NA
"3762",3762,"Cluster_6914","Porites_evermani_scaffold_1493:52421-53421",173,-21.42,2,18,943,963,16,"87.50%","93.75%","Peve_00007390",-0.0328229980931692,0.979100476598552,0.999448381576871,"Q09128","1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial (24-OHase) (Vitamin D(3) 24-hydroxylase) (EC 1.14.15.16) (Cytochrome P450 24A1) (Cytochrome P450-CC24)","Rattus norvegicus (Rat)","cellular response to vitamin D [GO:0071305]; fatty acid omega-oxidation [GO:0010430]; osteoblast differentiation [GO:0001649]; response to vitamin D [GO:0033280]; vitamin D catabolic process [GO:0042369]; vitamin D metabolic process [GO:0042359]","GO:0001649; GO:0005506; GO:0005739; GO:0008403; GO:0010430; GO:0020037; GO:0030342; GO:0033280; GO:0042359; GO:0042369; GO:0062180; GO:0062181; GO:0070576; GO:0070643; GO:0071305"
"3763",3763,"Cluster_6914","Porites_evermani_scaffold_1504:115693-116693",170,-23.06,2,20,161,182,19,"84.21%","84.21%","Peve_00007597",NA,NA,NA,NA,NA,NA,NA,NA
"3764",3764,"Cluster_6914","Porites_evermani_scaffold_1523:49510-50510",155,-21.76,2,17,629,651,17,"70.59%","88.24%","Peve_00007814",0.989797584096673,0.0910157522607233,0.978262075707395,"G3V9H8","Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment]","Rattus norvegicus (Rat)","cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657]","GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0007156; GO:0007158; GO:0007169; GO:0007399; GO:0009410; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030155; GO:0030182; GO:0030335; GO:0030424; GO:0030425; GO:0033141; GO:0033619; GO:0033630; GO:0033674; GO:0035799; GO:0035860; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045121; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0098797"
"3765",3765,"Cluster_6914","Porites_evermani_scaffold_1542:116083-117083",153,-21.74,2,20,868,890,20,"70.00%","80.00%","Peve_00008022",NA,NA,NA,NA,NA,NA,NA,NA
"3766",3766,"Cluster_6914","Porites_evermani_scaffold_1630:62963-63963",171,-20.45,2,20,616,636,18,"83.33%","83.33%","Peve_00009190",NA,NA,NA,NA,NA,NA,NA,NA
"3767",3767,"Cluster_6914","Porites_evermani_scaffold_165:299342-300342",158,-20.07,2,19,943,963,17,"76.47%","76.47%","Peve_00009405",0.814695949959415,0.393807675584489,0.978262075707395,NA,NA,NA,NA,NA
"3768",3768,"Cluster_6914","Porites_evermani_scaffold_174:330079-331079",165,-20.63,2,18,958,978,16,"81.25%","87.50%","Peve_00010474",0.521150611525289,0.651005956291704,0.978262075707395,"P97292","Histamine H2 receptor (H2R) (HH2R) (Gastric receptor I)","Mus musculus (Mouse)","chemical synaptic transmission [GO:0007268]; digestive tract development [GO:0048565]; epithelial cell morphogenesis [GO:0003382]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; gastric acid secretion [GO:0001696]; gastrin-induced gastric acid secretion [GO:0001698]; gland development [GO:0048732]; histamine-induced gastric acid secretion [GO:0001697]; memory [GO:0007613]; negative regulation of arachidonic acid secretion [GO:1900139]; positive regulation of vasoconstriction [GO:0045907]; regulation of synaptic plasticity [GO:0048167]; toxin transport [GO:1901998]; visual learning [GO:0008542]","GO:0001696; GO:0001697; GO:0001698; GO:0003382; GO:0004969; GO:0004993; GO:0005886; GO:0007187; GO:0007268; GO:0007613; GO:0008542; GO:0016020; GO:0030425; GO:0030594; GO:0045202; GO:0045907; GO:0048167; GO:0048565; GO:0048732; GO:1900139; GO:1901363; GO:1901998"
"3769",3769,"Cluster_6914","Porites_evermani_scaffold_1773:54221-55221",154,-22.89,2,20,922,947,23,"65.22%","73.91%","Peve_00010805",NA,NA,NA,NA,NA,NA,NA,NA
"3770",3770,"Cluster_6914","Porites_evermani_scaffold_1834:13813-14813",162,-24.22,2,20,762,783,19,"78.95%","78.95%","Peve_00011538",0.577346800773877,0.608176152277996,0.978262075707395,"A6BM06","1-aminocyclopropane-1-carboxylate oxidase (ACC oxidase) (Dmaco) (EC 1.14.17.4) (Ethylene-forming enzyme) (EFE)","Dictyostelium mucoroides (Slime mold)","ethylene biosynthetic process [GO:0009693]","GO:0009693; GO:0009815; GO:0046872; GO:0051213"
"3771",3771,"Cluster_6914","Porites_evermani_scaffold_1914:90876-91876",166,-20.71,2,20,766,787,19,"73.68%","89.47%","Peve_00012456",0.962134801095128,0.175749963294543,0.978262075707395,NA,NA,NA,NA,NA
"3772",3772,"Cluster_6914","Porites_evermani_scaffold_1965:61322-62322",164,-22.53,2,20,906,926,19,"78.95%","89.47%","Peve_00012986",0.751765364731706,0.458405205594552,0.978262075707395,"Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"3773",3773,"Cluster_6914","Porites_evermani_scaffold_205:150646-151646",168,-20.54,2,19,322,344,19,"84.21%","89.47%","Peve_00014061",0.853558462702337,0.348879522418649,0.978262075707395,NA,NA,NA,NA,NA
"3774",3774,"Cluster_6914","Porites_evermani_scaffold_2053:76756-77756",159,-25.68,2,20,212,229,18,"77.78%","83.33%","Peve_00014092",0.853558462702337,0.348879522418649,0.978262075707395,NA,NA,NA,NA,NA
"3775",3775,"Cluster_6914","Porites_evermani_scaffold_2062:45445-46445",146,-20.51,2,20,169,192,21,"61.90%","71.43%","Peve_00014182",0.902218674047533,0.283874976568857,0.978262075707395,"Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"3776",3776,"Cluster_6914","Porites_evermani_scaffold_2062:45445-46445",158,-22.83,2,20,49,72,21,"71.43%","76.19%","Peve_00014182",0.902218674047533,0.283874976568857,0.978262075707395,"Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"3777",3777,"Cluster_6914","Porites_evermani_scaffold_212:78859-79859",176,-22.82,2,17,775,795,15,"93.33%","100.00%","Peve_00014757",NA,NA,NA,NA,NA,NA,NA,NA
"3778",3778,"Cluster_6914","Porites_evermani_scaffold_2139:63471-64471",158,-21.17,2,20,129,150,19,"73.68%","78.95%","Peve_00014959",0.63230543868905,0.564217564699149,0.978262075707395,"Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"3779",3779,"Cluster_6914","Porites_evermani_scaffold_220:69388-70388",161,-20.63,2,20,977,996,18,"77.78%","83.33%","Peve_00015568",0.743321456602847,0.466498592818375,0.978262075707395,"P10079","Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1)","Strongylocentrotus purpuratus (Purple sea urchin)","","GO:0005509; GO:0005615; GO:0009374; GO:0031410; GO:0032579"
"3780",3780,"Cluster_6914","Porites_evermani_scaffold_225:299821-300821",164,-22.03,2,20,537,555,18,"83.33%","83.33%","Peve_00016048",-0.502729293021547,0.66465851725125,0.978262075707395,"Q27HK4","Metaxin-1 (Mitochondrial outer membrane import complex protein 1)","Sus scrofa (Pig)","mitochondrion organization [GO:0007005]; protein transport [GO:0015031]","GO:0001401; GO:0005737; GO:0007005; GO:0015031"
"3781",3781,"Cluster_6914","Porites_evermani_scaffold_2327:64345-65345",190,-28.08,2,19,693,713,17,"100.00%","100.00%","Peve_00016798",0.647592095528393,0.551552208324736,0.978262075707395,NA,NA,NA,NA,NA
"3782",3782,"Cluster_6914","Porites_evermani_scaffold_240:181735-182735",152,-21.58,2,20,903,921,18,"72.22%","77.78%","Peve_00017495",0.524726657962422,0.648335068608169,0.978262075707395,NA,NA,NA,NA,NA
"3783",3783,"Cluster_6914","Porites_evermani_scaffold_240:181817-182817",152,-21.58,2,20,821,839,18,"72.22%","77.78%","Peve_00017496",0.873516140520794,0.32366839050697,0.978262075707395,"Q5ZIJ9","E3 ubiquitin-protein ligase MIB2 (EC 2.3.2.27) (Mind bomb homolog 2) (RING-type E3 ubiquitin transferase MIB2)","Gallus gallus (Chicken)","Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]","GO:0004842; GO:0005737; GO:0007219; GO:0008270; GO:0016567"
"3784",3784,"Cluster_6914","Porites_evermani_scaffold_24:493791-494791",170,-22.36,2,20,708,729,19,"84.21%","84.21%","Peve_00017409",0.716328344745542,0.491642579307673,0.978262075707395,"Q5XJ54","Glutaredoxin 3","Danio rerio (Zebrafish) (Brachydanio rerio)","cellular iron ion homeostasis [GO:0006879]; hemoglobin metabolic process [GO:0020027]; iron ion homeostasis [GO:0055072]","GO:0005634; GO:0005829; GO:0006879; GO:0020027; GO:0046872; GO:0051536; GO:0055072"
"3785",3785,"Cluster_6914","Porites_evermani_scaffold_2655:45318-46318",161,-21.17,2,20,546,569,21,"76.19%","80.95%","Peve_00019693",0.743965163490401,0.465885653887595,0.978262075707395,NA,NA,NA,NA,NA
"3786",3786,"Cluster_6914","Porites_evermani_scaffold_280:60610-61610",170,-24.08,2,20,206,227,19,"78.95%","89.47%","Peve_00020918",0.668651390885292,0.533743737254563,0.978262075707395,"Q3UGY8","Brefeldin A-inhibited guanine nucleotide-exchange protein 3 (ARFGEF family member 3)","Mus musculus (Mouse)","actin cytoskeleton organization [GO:0030036]; regulation of ARF protein signal transduction [GO:0032012]","GO:0005085; GO:0005794; GO:0030036; GO:0030658; GO:0032012"
"3787",3787,"Cluster_6914","Porites_evermani_scaffold_297:118751-119751",156,-20.19,2,20,481,501,19,"78.95%","78.95%","Peve_00022189",0.203967276242566,0.869232765934327,0.997315267828607,"Q8NFZ3","Neuroligin-4, Y-linked (Neuroligin Y)","Homo sapiens (Human)","chemical synaptic transmission [GO:0007268]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; neuron cell-cell adhesion [GO:0007158]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; social behavior [GO:0035176]; synaptic vesicle endocytosis [GO:0048488]; vocalization behavior [GO:0071625]","GO:0005886; GO:0007158; GO:0007268; GO:0007612; GO:0009986; GO:0016020; GO:0035176; GO:0038023; GO:0042043; GO:0045202; GO:0048488; GO:0050804; GO:0050839; GO:0071625; GO:0097104; GO:0097105; GO:0097110; GO:0098793; GO:0098839; GO:0098983; GO:0098985; GO:0099054; GO:0099634"
"3788",3788,"Cluster_6914","Porites_evermani_scaffold_3020:3519-4519",152,-20.2,2,18,6,28,18,"72.22%","77.78%","Peve_00022785",0.853558462702337,0.34887952241865,0.978262075707395,"O88322","Nidogen-2 (NID-2) (Entactin-2)","Mus musculus (Mouse)","cell-matrix adhesion [GO:0007160]","GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005886; GO:0007160; GO:0009986; GO:0031012; GO:0062023"
"3789",3789,"Cluster_6914","Porites_evermani_scaffold_3047:13425-14425",158,-21.84,2,20,625,648,21,"71.43%","76.19%","Peve_00022960",NA,NA,NA,NA,NA,NA,NA,NA
"3790",3790,"Cluster_6914","Porites_evermani_scaffold_308:293783-294783",161,-20.63,2,20,238,261,21,"71.43%","85.71%","Peve_00023208",0.969005979866139,0.158914020742162,0.978262075707395,NA,NA,NA,NA,NA
"3791",3791,"Cluster_6914","Porites_evermani_scaffold_3145:48457-49457",150,-21.36,2,20,553,569,18,"72.22%","77.78%","Peve_00023691",0.998994743896135,0.0285476174462189,0.903929377050813,"P36836","Solute carrier family 15 member 1 (Intestinal H(+)/peptide cotransporter) (Oligopeptide transporter, small intestine isoform) (Peptide transporter 1)","Oryctolagus cuniculus (Rabbit)","dipeptide import across plasma membrane [GO:0140206]; protein transport [GO:0015031]; tripeptide import across plasma membrane [GO:0140207]","GO:0015031; GO:0015333; GO:0016020; GO:0016324; GO:0042937; GO:0071916; GO:0140206; GO:0140207"
"3792",3792,"Cluster_6914","Porites_evermani_scaffold_328:161087-162087",157,-20.77,2,20,477,496,18,"72.22%","83.33%","Peve_00024480",0.924490326230528,0.248981937669617,0.978262075707395,"B8V7S0","CUB and peptidase domain-containing protein 1","Acropora millepora (Staghorn coral) (Heteropora millepora)","proteolysis [GO:0006508]","GO:0004252; GO:0005576; GO:0006508"
"3793",3793,"Cluster_6914","Porites_evermani_scaffold_3291:41816-42816",186,-30.09,2,20,84,105,19,"94.74%","94.74%","Peve_00024540",NA,NA,NA,NA,NA,NA,NA,NA
"3794",3794,"Cluster_6914","Porites_evermani_scaffold_3294:38717-39717",162,-20.53,2,20,99,120,19,"73.68%","84.21%","Peve_00024557",-0.845698843194881,0.358367904165774,0.978262075707395,NA,NA,NA,NA,NA
"3795",3795,"Cluster_6914","Porites_evermani_scaffold_3383:8349-9349",165,-21.27,2,20,166,185,18,"77.78%","88.89%","Peve_00025173",-0.877975932427226,0.317787144248017,0.978262075707395,NA,NA,NA,NA,NA
"3796",3796,"Cluster_6914","Porites_evermani_scaffold_3431:34577-35577",144,-20.34,2,17,526,546,15,"60.00%","80.00%","Peve_00025494",0.924626495492302,0.248754434062545,0.978262075707395,"A2AGT5","Cytoskeleton-associated protein 5","Mus musculus (Mouse)","cell division [GO:0051301]; central nervous system myelin formation [GO:0032289]; centrosome cycle [GO:0007098]; centrosome duplication [GO:0051298]; cytoplasmic translation [GO:0002181]; dendritic spine maintenance [GO:0097062]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; excitatory postsynaptic potential [GO:0060079]; habituation [GO:0046959]; locomotory behavior [GO:0007626]; long-term synaptic potentiation [GO:0060291]; microtubule polymerization [GO:0046785]; mitotic spindle organization [GO:0007052]; mRNA localization resulting in post-transcriptional regulation of gene expression [GO:0010609]; positive regulation of endocytosis [GO:0045807]; positive regulation of microtubule nucleation [GO:0090063]; ribonucleoprotein complex assembly [GO:0022618]; RNA transport [GO:0050658]; spindle organization [GO:0007051]; visual learning [GO:0008542]","GO:0000776; GO:0000922; GO:0002181; GO:0005730; GO:0005737; GO:0005813; GO:0005886; GO:0007051; GO:0007052; GO:0007098; GO:0007626; GO:0008017; GO:0008542; GO:0010609; GO:0022618; GO:0030425; GO:0030951; GO:0032289; GO:0032991; GO:0035371; GO:0043021; GO:0043204; GO:0045807; GO:0046785; GO:0046959; GO:0050658; GO:0051010; GO:0051298; GO:0051301; GO:0060079; GO:0060291; GO:0061863; GO:0071598; GO:0090063; GO:0097062; GO:0098794"
"3797",3797,"Cluster_6914","Porites_evermani_scaffold_3582:15336-16336",160,-20.43,2,20,593,611,18,"77.78%","83.33%","Peve_00026432",NA,NA,NA,NA,NA,NA,NA,NA
"3798",3798,"Cluster_6914","Porites_evermani_scaffold_366:70022-71022",167,-21.09,2,20,703,723,18,"72.22%","88.89%","Peve_00026869",0.933621614359874,0.233260154539278,0.978262075707395,NA,NA,NA,NA,NA
"3799",3799,"Cluster_6914","Porites_evermani_scaffold_372:47666-48666",153,-20.29,2,20,503,525,20,"70.00%","80.00%","Peve_00027201",-0.617817790245984,0.576033861229769,0.978262075707395,"Q5ZK82","Metallophosphoesterase 1 (EC 3.1.-.-) (Post-GPI attachment to proteins factor 5)","Gallus gallus (Chicken)","endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; GPI anchor biosynthetic process [GO:0006506]","GO:0005793; GO:0005801; GO:0006506; GO:0006888; GO:0030145; GO:0033116; GO:0034235; GO:0062050; GO:0070971"
"3800",3800,"Cluster_6914","Porites_evermani_scaffold_372:47666-48666",153,-20.29,2,20,662,684,20,"70.00%","80.00%","Peve_00027201",-0.617817790245984,0.576033861229769,0.978262075707395,"Q5ZK82","Metallophosphoesterase 1 (EC 3.1.-.-) (Post-GPI attachment to proteins factor 5)","Gallus gallus (Chicken)","endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; GPI anchor biosynthetic process [GO:0006506]","GO:0005793; GO:0005801; GO:0006506; GO:0006888; GO:0030145; GO:0033116; GO:0034235; GO:0062050; GO:0070971"
"3801",3801,"Cluster_6914","Porites_evermani_scaffold_405:100472-101472",147,-22.14,2,20,389,407,18,"72.22%","77.78%","Peve_00029110",NA,NA,NA,NA,NA,NA,NA,NA
"3802",3802,"Cluster_6914","Porites_evermani_scaffold_4:1281279-1282279",169,-21.61,2,20,435,454,18,"83.33%","88.89%","Peve_00028759",0.797963880311098,0.411821058011862,0.978262075707395,"Q8BVV7","Centrosomal protein of 95 kDa (Cep95) (Coiled-coil domain-containing protein 45)","Mus musculus (Mouse)","","GO:0000922; GO:0005737; GO:0005813"
"3803",3803,"Cluster_6914","Porites_evermani_scaffold_418:190698-191698",153,-20.29,2,20,671,693,20,"70.00%","80.00%","Peve_00029734",0.710603252860659,0.496844234929687,0.978262075707395,"Q8VI02","Serine/threonine-protein phosphatase 4 regulatory subunit 1","Rattus norvegicus (Rat)","protein dephosphorylation [GO:0006470]","GO:0006470; GO:0019888"
"3804",3804,"Cluster_6914","Porites_evermani_scaffold_4205:11623-12623",171,-21.49,2,20,475,495,18,"83.33%","83.33%","Peve_00029902",0.96405500131236,0.171207942618653,0.978262075707395,"B8VIU6","Uncharacterized skeletal organic matrix protein 5 (Uncharacterized SOMP-5)","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0005576"
"3805",3805,"Cluster_6914","Porites_evermani_scaffold_428:42015-43015",151,-21.52,2,20,428,446,18,"77.78%","77.78%","Peve_00030274",0.92647868359073,0.245640058958452,0.978262075707395,NA,NA,NA,NA,NA
"3806",3806,"Cluster_6914","Porites_evermani_scaffold_43:48832-49832",178,-21.51,2,19,876,896,17,"88.24%","94.12%","Peve_00030392",-0.168389696276784,0.892286602439868,0.999448381576871,"Q9DC48","Pre-mRNA-processing factor 17 (Cell division cycle 40 homolog) (PRP17 homolog)","Mus musculus (Mouse)","embryonic brain development [GO:1990403]; mRNA splicing, via spliceosome [GO:0000398]","GO:0000398; GO:0003729; GO:0005654; GO:0016607; GO:0071007; GO:0071013; GO:1990403"
"3807",3807,"Cluster_6914","Porites_evermani_scaffold_446:222246-222748",155,-20.65,2,20,385,405,18,"66.67%","77.78%","Peve_00031243",NA,NA,NA,NA,NA,NA,NA,NA
"3808",3808,"Cluster_6914","Porites_evermani_scaffold_446:95307-96307",140,-20.53,2,9,731,751,7,"100.00%","100.00%","Peve_00031254",NA,NA,NA,NA,NA,NA,NA,NA
"3809",3809,"Cluster_6914","Porites_evermani_scaffold_4541:13868-14868",169,-20.87,2,20,813,835,20,"85.00%","85.00%","Peve_00031633",0.610920279534617,0.581599167196905,0.978262075707395,"P68373","Tubulin alpha-1C chain (EC 3.6.5.-) (Alpha-tubulin 6) (Alpha-tubulin isotype M-alpha-6) (Tubulin alpha-6 chain) [Cleaved into: Detyrosinated tubulin alpha-1C chain]","Mus musculus (Mouse)","microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]","GO:0000226; GO:0000278; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005874; GO:0005881; GO:0015630; GO:0016787; GO:0045121; GO:0046872"
"3810",3810,"Cluster_6914","Porites_evermani_scaffold_45:87745-88745",175,-21.07,2,20,171,191,18,"77.78%","94.44%","Peve_00031456",0.0368514855147705,0.976534302440495,0.999448381576871,"Q32LE5","Isoaspartyl peptidase/L-asparaginase (EC 3.4.19.5) (EC 3.5.1.1) (Asparaginase-like protein 1) (Beta-aspartyl-peptidase) (Isoaspartyl dipeptidase) (L-asparagine amidohydrolase) [Cleaved into: Isoaspartyl peptidase/L-asparaginase alpha chain; Isoaspartyl peptidase/L-asparaginase beta chain]","Bos taurus (Bovine)","asparagine catabolic process via L-aspartate [GO:0033345]; proteolysis [GO:0006508]","GO:0001917; GO:0004067; GO:0005737; GO:0006508; GO:0008798; GO:0033345"
"3811",3811,"Cluster_6914","Porites_evermani_scaffold_4620:14848-15848",146,-20.51,2,20,259,282,21,"61.90%","71.43%","Peve_00032008",0.993976611517859,0.0699091131339437,0.978262075707395,"Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"3812",3812,"Cluster_6914","Porites_evermani_scaffold_4620:14848-15848",146,-20.51,2,20,379,402,21,"61.90%","71.43%","Peve_00032008",0.993976611517859,0.0699091131339437,0.978262075707395,"Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"3813",3813,"Cluster_6914","Porites_evermani_scaffold_4620:14848-15848",146,-20.51,2,20,499,522,21,"61.90%","71.43%","Peve_00032008",0.993976611517859,0.0699091131339437,0.978262075707395,"Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"3814",3814,"Cluster_6914","Porites_evermani_scaffold_475:48400-49400",150,-20.12,2,20,776,797,19,"63.16%","78.95%","Peve_00032543",NA,NA,NA,"O15439","ATP-binding cassette sub-family C member 4 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (MRP/cMOAT-related ABC transporter) (Multi-specific organic anion transporter B) (MOAT-B) (Multidrug resistance-associated protein 4)","Homo sapiens (Human)","bile acid and bile salt transport [GO:0015721]; cAMP transport [GO:0070730]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; leukotriene transport [GO:0071716]; platelet degranulation [GO:0002576]; prostaglandin secretion [GO:0032310]; prostaglandin transport [GO:0015732]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; urate transport [GO:0015747]; xenobiotic metabolic process [GO:0006805]; xenobiotic transmembrane transport [GO:0006855]","GO:0001409; GO:0002576; GO:0005524; GO:0005730; GO:0005794; GO:0005886; GO:0006805; GO:0006855; GO:0008559; GO:0015132; GO:0015143; GO:0015216; GO:0015431; GO:0015432; GO:0015562; GO:0015721; GO:0015732; GO:0015747; GO:0016020; GO:0016323; GO:0016324; GO:0016404; GO:0016887; GO:0031088; GO:0032310; GO:0034634; GO:0042626; GO:0042910; GO:0043225; GO:0055085; GO:0060271; GO:0070730; GO:0071716; GO:0098591; GO:0140115; GO:0140359; GO:0150104"
"3815",3815,"Cluster_6914","Porites_evermani_scaffold_476:241941-242941",166,-20.13,2,20,570,591,19,"78.95%","84.21%","Peve_00032586",-0.877975932427226,0.317787144248017,0.978262075707395,NA,NA,NA,NA,NA
"3816",3816,"Cluster_6914","Porites_evermani_scaffold_492:34660-35660",166,-23.5,2,20,126,147,19,"78.95%","84.21%","Peve_00033208",-0.975738295424916,0.140519879334383,0.978262075707395,NA,NA,NA,NA,NA
"3817",3817,"Cluster_6914","Porites_evermani_scaffold_508:239946-240946",152,-20.71,2,14,899,920,13,"84.62%","92.31%","Peve_00033935",-0.69952646551353,0.50678861556987,0.978262075707395,"P50533","Structural maintenance of chromosomes protein 2 (SMC protein 2) (SMC-2) (Chromosome assembly protein XCAP-E) (Chromosome-associated protein E)","Xenopus laevis (African clawed frog)","cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome condensation [GO:0030261]","GO:0005524; GO:0005634; GO:0005694; GO:0005829; GO:0007049; GO:0016887; GO:0030261; GO:0051301"
"3818",3818,"Cluster_6914","Porites_evermani_scaffold_545:114266-115266",161,-20.09,2,20,892,911,18,"77.78%","83.33%","Peve_00035296",0.892376938175185,0.298072572670681,0.978262075707395,"Q9D0K0","TBC1 domain family member 7","Mus musculus (Mouse)","activation of GTPase activity [GO:0090630]; negative regulation of cilium assembly [GO:1902018]; negative regulation of TOR signaling [GO:0032007]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein ubiquitination [GO:0031398]; response to growth factor [GO:0070848]","GO:0005096; GO:0031267; GO:0031398; GO:0031410; GO:0032007; GO:0033596; GO:0036064; GO:0043547; GO:0070848; GO:0090630; GO:1902018"
"3819",3819,"Cluster_6914","Porites_evermani_scaffold_5477:12258-13168",171,-21.07,2,20,584,604,18,"83.33%","83.33%","Peve_00035392",-0.153667741138073,0.901782913511313,0.999448381576871,"P40757","Allantoinase, mitochondrial (EC 3.5.2.5)","Lithobates catesbeianus (American bullfrog) (Rana catesbeiana)","allantoin catabolic process [GO:0000256]","GO:0000256; GO:0004038; GO:0005739; GO:0008270; GO:0050897"
"3820",3820,"Cluster_6914","Porites_evermani_scaffold_5617:8945-9945",171,-20.45,2,20,593,613,18,"83.33%","83.33%","Peve_00035855",NA,NA,NA,NA,NA,NA,NA,NA
"3821",3821,"Cluster_6914","Porites_evermani_scaffold_606:138137-139137",162,-21.18,2,20,397,420,21,"71.43%","80.95%","Peve_00037229",-0.180364148831859,0.884544764920619,0.999448381576871,NA,NA,NA,NA,NA
"3822",3822,"Cluster_6914","Porites_evermani_scaffold_627:96657-97657",171,-22.8,2,20,658,678,18,"77.78%","88.89%","Peve_00037783",NA,NA,NA,NA,NA,NA,NA,NA
"3823",3823,"Cluster_6914","Porites_evermani_scaffold_63:336056-337056",166,-22.44,2,15,437,457,13,"92.31%","100.00%","Peve_00037844",NA,NA,NA,NA,NA,NA,NA,NA
"3824",3824,"Cluster_6914","Porites_evermani_scaffold_737:151402-152402",149,-20.53,2,20,582,607,23,"65.22%","73.91%","Peve_00040429",0.988140071283382,0.0981445801808494,0.978262075707395,"F6VAN0","Cyclic AMP-dependent transcription factor ATF-6 alpha (cAMP-dependent transcription factor ATF-6 alpha) (Activating transcription factor 6 alpha) (ATF6-alpha) [Cleaved into: Processed cyclic AMP-dependent transcription factor ATF-6 alpha]","Mus musculus (Mouse)","endoplasmic reticulum unfolded protein response [GO:0030968]; eye development [GO:0001654]; positive regulation of apoptotic process [GO:0043065]; positive regulation of ATF6-mediated unfolded protein response [GO:1903893]; positive regulation of autophagy [GO:0010508]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; regulation of transcription by RNA polymerase II [GO:0006357]; visual perception [GO:0007601]","GO:0000139; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001654; GO:0003700; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0005794; GO:0006357; GO:0007601; GO:0010508; GO:0016020; GO:0030968; GO:0031625; GO:0042802; GO:0043065; GO:0043565; GO:0045944; GO:0046982; GO:0090575; GO:1903893; GO:1990440; GO:1990837"
"3825",3825,"Cluster_6914","Porites_evermani_scaffold_791:69618-70618",153,-22.71,2,20,969,995,24,"66.67%","75.00%","Peve_00041521",NA,NA,NA,NA,NA,NA,NA,NA
"3826",3826,"Cluster_6914","Porites_evermani_scaffold_798:50982-51982",163,-21.78,2,20,71,92,20,"85.00%","85.00%","Peve_00041625",NA,NA,NA,NA,NA,NA,NA,NA
"3827",3827,"Cluster_6914","Porites_evermani_scaffold_817:124426-125426",164,-23.52,2,20,872,892,19,"78.95%","89.47%","Peve_00042120",0.866423867027105,0.33282564349316,0.978262075707395,"Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"3828",3828,"Cluster_6914","Porites_evermani_scaffold_822:154124-155124",146,-20.01,2,20,25,48,21,"61.90%","71.43%","Peve_00042248",-0.99760688237923,0.0440518133990858,0.923915229231156,"Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"3829",3829,"Cluster_6914","Porites_evermani_scaffold_834:162110-163110",164,-23.52,2,20,846,866,19,"78.95%","89.47%","Peve_00042461",0.96658124566769,0.165046832451726,0.978262075707395,"Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"3830",3830,"Cluster_6914","Porites_evermani_scaffold_844:49082-50032",154,-21,2,19,904,924,17,"70.59%","76.47%","Peve_00042651",0.73585858897353,0.473557604199892,0.978262075707395,"P51687","Sulfite oxidase, mitochondrial (EC 1.8.3.1)","Homo sapiens (Human)","sulfur compound metabolic process [GO:0006790]","GO:0005739; GO:0005758; GO:0005759; GO:0006790; GO:0008482; GO:0020037; GO:0030151; GO:0043546"
"3831",3831,"Cluster_6914","Porites_evermani_scaffold_874:11179-12179",158,-21.61,2,20,73,94,19,"68.42%","84.21%","Peve_00043227",-0.653698550924588,0.546432881035072,0.978262075707395,"Q9WVA3","Mitotic checkpoint protein BUB3 (WD repeat type I transmembrane protein A72.5)","Mus musculus (Mouse)","attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; protein localization to kinetochore [GO:0034501]; regulation of chromosome segregation [GO:0051983]","GO:0000776; GO:0005654; GO:0007094; GO:0008608; GO:0033597; GO:0034501; GO:0043130; GO:0051301; GO:0051321; GO:0051444; GO:0051983; GO:1990298"
"3832",3832,"Cluster_6914","Porites_evermani_scaffold_874:142074-143074",160,-22.77,2,20,39,57,18,"77.78%","83.33%","Peve_00043229",NA,NA,NA,NA,NA,NA,NA,NA
"3833",3833,"Cluster_6914","Porites_evermani_scaffold_875:164325-165325",163,-20.57,2,17,728,750,17,"82.35%","88.24%","Peve_00043245",-0.538855516622382,0.63771374619926,0.978262075707395,NA,NA,NA,NA,NA
"3834",3834,"Cluster_6914","Porites_evermani_scaffold_894:50155-51155",174,-22.15,2,19,174,194,17,"82.35%","94.12%","Peve_00043529",NA,NA,NA,NA,NA,NA,NA,NA
"3835",3835,"Cluster_6914","Porites_evermani_scaffold_900:135508-136508",163,-21.67,2,17,141,162,16,"87.50%","87.50%","Peve_00043751",NA,NA,NA,NA,NA,NA,NA,NA
"3836",3836,"Cluster_6914","Porites_evermani_scaffold_938:130264-131264",170,-22.33,2,20,581,602,19,"78.95%","89.47%","Peve_00044370",NA,NA,NA,NA,NA,NA,NA,NA
"3837",3837,"Cluster_6914","Porites_evermani_scaffold_9:857557-858557",157,-21.67,2,20,818,840,20,"75.00%","80.00%","Peve_00043647",0.948703308243298,0.204792476985293,0.978262075707395,NA,NA,NA,NA,NA
"3838",3838,"Cluster_7053","Porites_evermani_scaffold_1066:73785-74785",165,-21.44,2,20,275,298,20,"80.00%","85.00%","Peve_00001234",NA,NA,NA,NA,NA,NA,NA,NA
"3839",3839,"Cluster_7053","Porites_evermani_scaffold_1075:51779-51873",167,-22.37,2,21,58,80,20,"75.00%","85.00%","Peve_00001376",-0.680349463473204,0.523656028991449,0.978262075707395,NA,NA,NA,NA,NA
"3840",3840,"Cluster_7053","Porites_evermani_scaffold_110:475129-476129",171,-21.64,2,21,837,859,20,"75.00%","90.00%","Peve_00001875",-0.645421364094123,0.553363608269895,0.978262075707395,NA,NA,NA,NA,NA
"3841",3841,"Cluster_7053","Porites_evermani_scaffold_1295:15747-16747",158,-20.4,2,21,659,679,19,"68.42%","84.21%","Peve_00004685",NA,NA,NA,NA,NA,NA,NA,NA
"3842",3842,"Cluster_7053","Porites_evermani_scaffold_1305:111305-112305",164,-21.06,2,21,540,561,19,"68.42%","84.21%","Peve_00004867",-0.393403462121784,0.74259511975665,0.986697151420032,NA,NA,NA,NA,NA
"3843",3843,"Cluster_7053","Porites_evermani_scaffold_1327:40972-41972",174,-22.8,2,20,393,415,19,"78.95%","94.74%","Peve_00005167",NA,NA,NA,NA,NA,NA,NA,NA
"3844",3844,"Cluster_7053","Porites_evermani_scaffold_1501:9063-10063",159,-22.27,2,21,931,953,20,"65.00%","85.00%","Peve_00007578",-0.368784275025259,0.759548223321603,0.988219883885475,NA,NA,NA,NA,NA
"3845",3845,"Cluster_7053","Porites_evermani_scaffold_15:264125-265125",166,-20.23,2,21,312,332,19,"78.95%","84.21%","Peve_00007499",0.753853521709967,0.456385626467333,0.978262075707395,"P36916","Guanine nucleotide-binding protein-like 1 (GTP-binding protein MMR1)","Mus musculus (Mouse)","cellular response to DNA damage stimulus [GO:0006974]","GO:0003924; GO:0005525; GO:0006974"
"3846",3846,"Cluster_7053","Porites_evermani_scaffold_1526:61297-62297",175,-23.26,2,21,439,461,20,"80.00%","90.00%","Peve_00007833",0.870406872792897,0.327711608747431,0.978262075707395,"Q5U4X7","Limb region 1 protein homolog","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","","GO:0016020"
"3847",3847,"Cluster_7053","Porites_evermani_scaffold_1531:12971-13971",154,-22.29,2,21,150,177,25,"64.00%","76.00%","Peve_00007907",0.998593755293202,0.0337657560132954,0.909359886114279,NA,NA,NA,NA,NA
"3848",3848,"Cluster_7053","Porites_evermani_scaffold_1632:83735-84735",156,-21.48,2,21,409,427,19,"73.68%","78.95%","Peve_00009220",-0.599492520986274,0.590738213576683,0.978262075707395,NA,NA,NA,NA,NA
"3849",3849,"Cluster_7053","Porites_evermani_scaffold_166:338442-338577",163,-20.19,2,20,57,75,18,"83.33%","83.33%","Peve_00009518",-0.599492520986274,0.590738213576683,0.978262075707395,NA,NA,NA,NA,NA
"3850",3850,"Cluster_7053","Porites_evermani_scaffold_1692:23145-24145",159,-22.54,2,21,527,550,21,"71.43%","76.19%","Peve_00009908",-0.055064016949071,0.964927419201632,0.999448381576871,"Q7TN88","Polycystic kidney disease protein 1-like 2 (PC1-like 2 protein) (Polycystin-1L2)","Mus musculus (Mouse)","detection of mechanical stimulus [GO:0050982]","GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982"
"3851",3851,"Cluster_7053","Porites_evermani_scaffold_182:215268-216268",154,-21.52,2,21,683,707,22,"63.64%","81.82%","Peve_00011389",-0.455773044820457,0.69872572967117,0.978262075707395,NA,NA,NA,NA,NA
"3852",3852,"Cluster_7053","Porites_evermani_scaffold_1873:26124-27124",155,-22.79,2,20,854,873,18,"72.22%","88.89%","Peve_00011954",NA,NA,NA,NA,NA,NA,NA,NA
"3853",3853,"Cluster_7053","Porites_evermani_scaffold_189:0-767",163,-21.31,2,21,324,348,22,"68.18%","81.82%","Peve_00012112",-0.93571186057268,0.22951714521495,0.978262075707395,NA,NA,NA,NA,NA
"3854",3854,"Cluster_7053","Porites_evermani_scaffold_2016:22295-23295",159,-20.72,2,21,630,654,22,"72.73%","72.73%","Peve_00013727",-0.825268243250414,0.382047816599803,0.978262075707395,NA,NA,NA,NA,NA
"3855",3855,"Cluster_7053","Porites_evermani_scaffold_2069:39181-40181",159,-20.72,2,21,630,654,22,"72.73%","72.73%","Peve_00014221",-0.999884527015562,0.00967474429161349,0.611343259425713,NA,NA,NA,NA,NA
"3856",3856,"Cluster_7053","Porites_evermani_scaffold_2125:28814-29814",159,-20.72,2,21,630,654,22,"72.73%","72.73%","Peve_00014821",-0.676918012115249,0.526630304959445,0.978262075707395,NA,NA,NA,NA,NA
"3857",3857,"Cluster_7053","Porites_evermani_scaffold_23:668178-669178",172,-23.5,2,21,262,283,19,"78.95%","84.21%","Peve_00016503",NA,NA,NA,"Q6VVW5","Atrial natriuretic peptide receptor 2 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type B) (ANP-B) (ANPR-B) (NPR-B) (Guanylate cyclase B) (GC-B)","Mus musculus (Mouse)","activation of meiosis involved in egg activation [GO:0060466]; axonogenesis [GO:0007409]; axonogenesis involved in innervation [GO:0060385]; blood circulation [GO:0008015]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; bone development [GO:0060348]; bone growth [GO:0098868]; c-di-GMP signaling [GO:0061939]; cartilage development [GO:0051216]; cellular response to cGMP [GO:0071321]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to peptide [GO:1901653]; cGMP biosynthetic process [GO:0006182]; cGMP metabolic process [GO:0046068]; cGMP-mediated signaling [GO:0019934]; chemical synaptic transmission [GO:0007268]; chondrocyte differentiation [GO:0002062]; chondrocyte proliferation [GO:0035988]; chromosome organization [GO:0051276]; collateral sprouting [GO:0048668]; cumulus cell differentiation [GO:0001549]; digestive tract development [GO:0048565]; digestive tract morphogenesis [GO:0048546]; endochondral ossification [GO:0001958]; epidermal growth factor receptor signaling pathway [GO:0007173]; execution phase of apoptosis [GO:0097194]; female genitalia development [GO:0030540]; gastric emptying [GO:0035483]; genitalia morphogenesis [GO:0035112]; germ cell development [GO:0007281]; growth plate cartilage development [GO:0003417]; limb development [GO:0060173]; limb morphogenesis [GO:0035108]; lymph vessel development [GO:0001945]; MAPK cascade [GO:0000165]; meiotic cell cycle [GO:0051321]; meiotic cell cycle process involved in oocyte maturation [GO:1903537]; multicellular organism growth [GO:0035264]; multicellular organism reproduction [GO:0032504]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of oocyte maturation [GO:1900194]; nerve development [GO:0021675]; neuron apoptotic process [GO:0051402]; neuronal action potential [GO:0019228]; oocyte development [GO:0048599]; ovarian follicle development [GO:0001541]; positive regulation of cGMP-mediated signaling [GO:0010753]; post-anal tail morphogenesis [GO:0036342]; protein phosphorylation [GO:0006468]; receptor guanylyl cyclase signaling pathway [GO:0007168]; reproductive process [GO:0022414]; response to fibroblast growth factor [GO:0071774]; response to hormone [GO:0009725]; response to luteinizing hormone [GO:0034699]; response to salt [GO:1902074]; response to wounding [GO:0009611]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]; single fertilization [GO:0007338]; smooth muscle tissue development [GO:0048745]; spermatogenesis [GO:0007283]; startle response [GO:0001964]; vacuole organization [GO:0007033]; vascular wound healing [GO:0061042]; vasculogenesis [GO:0001570]; vestibulocochlear nerve development [GO:0021562]; vestibulocochlear nerve maturation [GO:0021647]; white fat cell differentiation [GO:0050872]","GO:0000165; GO:0001541; GO:0001549; GO:0001568; GO:0001570; GO:0001653; GO:0001945; GO:0001958; GO:0001964; GO:0001974; GO:0002062; GO:0003417; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005634; GO:0005737; GO:0005886; GO:0005929; GO:0006182; GO:0006468; GO:0007033; GO:0007165; GO:0007168; GO:0007173; GO:0007268; GO:0007281; GO:0007283; GO:0007338; GO:0007409; GO:0007605; GO:0008015; GO:0009611; GO:0009725; GO:0010753; GO:0016941; GO:0017046; GO:0019228; GO:0019934; GO:0021562; GO:0021647; GO:0021675; GO:0022414; GO:0030540; GO:0032504; GO:0034699; GO:0035108; GO:0035112; GO:0035264; GO:0035483; GO:0035988; GO:0036342; GO:0042562; GO:0042802; GO:0043005; GO:0045202; GO:0046068; GO:0048546; GO:0048565; GO:0048599; GO:0048668; GO:0048745; GO:0050872; GO:0051216; GO:0051276; GO:0051321; GO:0051402; GO:0051447; GO:0060173; GO:0060348; GO:0060385; GO:0060466; GO:0061042; GO:0061939; GO:0071321; GO:0071774; GO:0097011; GO:0097194; GO:0098868; GO:1900194; GO:1901653; GO:1902074; GO:1903537"
"3858",3858,"Cluster_7053","Porites_evermani_scaffold_2526:66417-67417",159,-20.19,2,21,346,369,21,"66.67%","80.95%","Peve_00018663",-0.599492520986274,0.590738213576683,0.978262075707395,NA,NA,NA,NA,NA
"3859",3859,"Cluster_7053","Porites_evermani_scaffold_2577:47792-48792",155,-20.62,2,21,535,561,24,"66.67%","70.83%","Peve_00019043",-0.599492520986274,0.590738213576683,0.978262075707395,NA,NA,NA,NA,NA
"3860",3860,"Cluster_7053","Porites_evermani_scaffold_2703:58724-59724",156,-21.78,2,21,131,157,24,"75.00%","79.17%","Peve_00020132",-0.0887539858729469,0.94342301255906,0.999448381576871,NA,NA,NA,NA,NA
"3861",3861,"Cluster_7053","Porites_evermani_scaffold_2781:7463-8463",163,-23.04,2,21,864,882,19,"84.21%","84.21%","Peve_00020743",0.347773762209646,0.77387545800165,0.991991055372822,"F6QEU4","E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA metabolic process [GO:0010586]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube development [GO:0021915]; protein autoubiquitination [GO:0051865]; regulation of miRNA-mediated gene silencing [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089]","GO:0000082; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0010586; GO:0021915; GO:0035198; GO:0035278; GO:0051865; GO:0060964; GO:0072089; GO:2000177"
"3862",3862,"Cluster_7053","Porites_evermani_scaffold_29:125791-126791",155,-20.96,2,21,767,785,19,"73.68%","84.21%","Peve_00021685",-0.617273669707463,0.576474271285023,0.978262075707395,"Q29RV1","Protein disulfide-isomerase A4 (EC 5.3.4.1)","Bos taurus (Bovine)","","GO:0003756; GO:0005788; GO:0042470"
"3863",3863,"Cluster_7053","Porites_evermani_scaffold_301:22120-23120",171,-20.46,2,21,903,925,20,"80.00%","85.00%","Peve_00022698",-0.880383460445452,0.314570503669536,0.978262075707395,NA,NA,NA,NA,NA
"3864",3864,"Cluster_7053","Porites_evermani_scaffold_304:225478-226478",168,-24.72,2,21,591,612,19,"78.95%","78.95%","Peve_00022921",-0.841608005846316,0.363218748520985,0.978262075707395,"Q90481","Homeobox protein Nkx-2.2a (Homeobox protein NK-2 homolog B-A)","Danio rerio (Zebrafish) (Brachydanio rerio)","cell differentiation [GO:0030154]; endocrine pancreas development [GO:0031018]; floor plate development [GO:0033504]; floor plate formation [GO:0021508]; glial cell migration [GO:0008347]; motor neuron axon guidance [GO:0008045]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; Schwann cell development [GO:0014044]; spinal cord oligodendrocyte cell differentiation [GO:0021529]; spinal cord oligodendrocyte cell fate specification [GO:0021530]; ventral spinal cord interneuron differentiation [GO:0021514]","GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008045; GO:0008347; GO:0014044; GO:0021508; GO:0021514; GO:0021529; GO:0021530; GO:0030154; GO:0031018; GO:0033504; GO:0045893"
"3865",3865,"Cluster_7053","Porites_evermani_scaffold_31:395675-396675",150,-20.03,2,16,94,117,16,"68.75%","87.50%","Peve_00023382",NA,NA,NA,NA,NA,NA,NA,NA
"3866",3866,"Cluster_7053","Porites_evermani_scaffold_316:56019-57019",160,-21.25,2,21,375,394,19,"78.95%","84.21%","Peve_00023762",-0.591579425132504,0.5970092301631,0.978262075707395,"O75366","Advillin (p92)","Homo sapiens (Human)","actin filament organization [GO:0007015]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cilium assembly [GO:0060271]; nervous system development [GO:0007399]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuron projection development [GO:0010976]; regulation of diacylglycerol biosynthetic process [GO:1900480]","GO:0003779; GO:0005546; GO:0005737; GO:0005884; GO:0005925; GO:0007015; GO:0007399; GO:0008154; GO:0010592; GO:0010976; GO:0015629; GO:0030027; GO:0030424; GO:0042995; GO:0043005; GO:0051014; GO:0051015; GO:0051016; GO:0060271; GO:0071933; GO:1900480"
"3867",3867,"Cluster_7053","Porites_evermani_scaffold_3306:33216-34216",172,-23.9,2,21,416,437,19,"73.68%","89.47%","Peve_00024702",NA,NA,NA,"Q80XJ3","Tetratricopeptide repeat protein 28 (TPR repeat protein 28)","Mus musculus (Mouse)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0005737; GO:0005813; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301; GO:0072686; GO:0097431; GO:1990023"
"3868",3868,"Cluster_7053","Porites_evermani_scaffold_3742:20438-21438",150,-20.11,2,20,545,567,19,"63.16%","78.95%","Peve_00027302",0.816380503076921,0.391954527986791,0.978262075707395,NA,NA,NA,NA,NA
"3869",3869,"Cluster_7053","Porites_evermani_scaffold_4061:17475-18475",163,-21.12,2,21,398,422,22,"68.18%","81.82%","Peve_00029176",NA,NA,NA,NA,NA,NA,NA,NA
"3870",3870,"Cluster_7053","Porites_evermani_scaffold_416:164255-165255",169,-20.67,2,19,886,908,18,"83.33%","88.89%","Peve_00029655",0.527538385882516,0.646230179281865,0.978262075707395,NA,NA,NA,NA,NA
"3871",3871,"Cluster_7053","Porites_evermani_scaffold_44:258389-259389",159,-20.72,2,21,630,654,22,"72.73%","72.73%","Peve_00030937",-0.915860925698161,0.263019030439806,0.978262075707395,NA,NA,NA,NA,NA
"3872",3872,"Cluster_7053","Porites_evermani_scaffold_45:481420-482420",157,-20.48,2,21,214,235,20,"70.00%","85.00%","Peve_00031441",-0.234873357178151,0.849064914074288,0.995934364227446,"Q8IV20","Purine nucleoside phosphorylase LACC1 (EC 2.4.2.1) (Adenosine deaminase LACC1) (EC 3.5.4.4) (Fatty acid metabolism-immunity nexus) (Guanosine phosphorylase LACC1) (Laccase domain-containing protein 1) (S-methyl-5'-thioadenosine phosphorylase LACC1) (EC 2.4.2.28)","Homo sapiens (Human)","inflammatory response [GO:0006954]; innate immune response [GO:0045087]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of cytokine production involved in immune response [GO:0002720]; regulation of cellular pH [GO:0030641]; regulation of inflammatory response [GO:0050727]; regulation of purine nucleotide metabolic process [GO:1900542]","GO:0002221; GO:0002720; GO:0004000; GO:0004731; GO:0005507; GO:0005634; GO:0005777; GO:0005783; GO:0006954; GO:0017061; GO:0030641; GO:0045087; GO:0046936; GO:0047975; GO:0050727; GO:0070431; GO:1900542"
"3873",3873,"Cluster_7053","Porites_evermani_scaffold_53:553868-554868",166,-22.77,2,21,139,159,19,"73.68%","89.47%","Peve_00034717",NA,NA,NA,NA,NA,NA,NA,NA
"3874",3874,"Cluster_7053","Porites_evermani_scaffold_576:59003-60003",154,-22.29,2,21,210,237,25,"64.00%","76.00%","Peve_00036267",-0.821417912704876,0.386366831509109,0.978262075707395,"O75095","Multiple epidermal growth factor-like domains protein 6 (Multiple EGF-like domains protein 6) (Epidermal growth factor-like protein 3) (EGF-like protein 3)","Homo sapiens (Human)","","GO:0005509; GO:0005576"
"3875",3875,"Cluster_7053","Porites_evermani_scaffold_606:142701-143701",163,-20.47,2,21,299,321,20,"75.00%","80.00%","Peve_00037230",-0.267728290853318,0.827454094113325,0.995934364227446,NA,NA,NA,NA,NA
"3876",3876,"Cluster_7053","Porites_evermani_scaffold_63:172175-173175",171,-21.73,2,21,965,987,20,"80.00%","85.00%","Peve_00037866",-0.599492520986274,0.590738213576683,0.978262075707395,"Q5A762","Multiple drug resistance-associated protein-like transporter 1 (MRP-like transporter 1) (Vacuolar multi-drug resistance ABC transporter MTL1)","Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast)","cellular response to starvation [GO:0009267]; filamentous growth [GO:0030447]; filamentous growth of a population of unicellular organisms in response to biotic stimulus [GO:0036180]; filamentous growth of a population of unicellular organisms in response to starvation [GO:0036170]; transmembrane transport [GO:0055085]; vacuole fusion, non-autophagic [GO:0042144]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]","GO:0000324; GO:0000329; GO:0005524; GO:0005886; GO:0009267; GO:0015086; GO:0015127; GO:0015440; GO:0016020; GO:0016887; GO:0030447; GO:0036170; GO:0036180; GO:0042144; GO:0042626; GO:0055085; GO:1990961"
"3877",3877,"Cluster_7053","Porites_evermani_scaffold_63:28056-28931",175,-24.12,2,20,841,862,18,"77.78%","94.44%","Peve_00037868",NA,NA,NA,"Q5A762","Multiple drug resistance-associated protein-like transporter 1 (MRP-like transporter 1) (Vacuolar multi-drug resistance ABC transporter MTL1)","Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast)","cellular response to starvation [GO:0009267]; filamentous growth [GO:0030447]; filamentous growth of a population of unicellular organisms in response to biotic stimulus [GO:0036180]; filamentous growth of a population of unicellular organisms in response to starvation [GO:0036170]; transmembrane transport [GO:0055085]; vacuole fusion, non-autophagic [GO:0042144]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]","GO:0000324; GO:0000329; GO:0005524; GO:0005886; GO:0009267; GO:0015086; GO:0015127; GO:0015440; GO:0016020; GO:0016887; GO:0030447; GO:0036170; GO:0036180; GO:0042144; GO:0042626; GO:0055085; GO:1990961"
"3878",3878,"Cluster_7053","Porites_evermani_scaffold_6534:1245-2245",161,-20.5,2,20,74,94,18,"72.22%","88.89%","Peve_00038481",-0.791996869507513,0.418083160180509,0.978262075707395,NA,NA,NA,NA,NA
"3879",3879,"Cluster_7053","Porites_evermani_scaffold_714:113235-114235",159,-20.67,2,21,859,882,21,"71.43%","76.19%","Peve_00039906",-0.599492520986274,0.590738213576683,0.978262075707395,NA,NA,NA,NA,NA
"3880",3880,"Cluster_7053","Porites_evermani_scaffold_738:19259-19869",162,-20.71,2,21,341,364,21,"71.43%","85.71%","Peve_00040439",-0.428366726794818,0.718178298902345,0.981096173735779,"B2RYG6","Ubiquitin thioesterase OTUB1 (EC 3.4.19.12) (Deubiquitinating enzyme OTUB1) (OTU domain-containing ubiquitin aldehyde-binding protein 1) (Otubain-1) (Ubiquitin-specific-processing protease OTUB1)","Rattus norvegicus (Rat)","adaptive immune response [GO:0002250]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to interleukin-1 [GO:0071347]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; protein K48-linked deubiquitination [GO:0071108]","GO:0002250; GO:0004843; GO:0005634; GO:0005737; GO:0006281; GO:0006974; GO:0019784; GO:0031625; GO:0043130; GO:0071108; GO:0071347; GO:1901315; GO:2000780"
"3881",3881,"Cluster_7053","Porites_evermani_scaffold_738:19259-19869",162,-20.71,2,21,341,364,21,"71.43%","85.71%","Peve_00040456",-0.279951726171496,0.819363071138579,0.995934364227446,"Q9NRL2","Bromodomain adjacent to zinc finger domain protein 1A (ATP-dependent chromatin-remodeling protein) (ATP-utilizing chromatin assembly and remodeling factor 1) (hACF1) (CHRAC subunit ACF1) (Williams syndrome transcription factor-related chromatin-remodeling factor 180) (WCRF180) (hWALp1)","Homo sapiens (Human)","chromatin remodeling [GO:0006338]; DNA-templated DNA replication [GO:0006261]; nucleosome assembly [GO:0006334]; positive regulation of DNA replication [GO:0045740]; regulation of DNA replication [GO:0006275]; regulation of DNA-templated transcription [GO:0006355]; regulation of heterochromatin formation [GO:0031445]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000228; GO:0003677; GO:0005634; GO:0005721; GO:0006261; GO:0006275; GO:0006334; GO:0006338; GO:0006355; GO:0006357; GO:0008623; GO:0016590; GO:0031445; GO:0045740; GO:0046872"
"3882",3882,"Cluster_7053","Porites_evermani_scaffold_891:167820-168820",167,-24.62,2,21,721,743,20,"70.00%","90.00%","Peve_00043503",-0.393403462121784,0.74259511975665,0.986697151420032,NA,NA,NA,NA,NA
"3883",3883,"Cluster_7053","Porites_evermani_scaffold_908:74556-75556",144,-20.36,2,18,376,400,19,"57.89%","78.95%","Peve_00043872",-0.999374953775323,0.0225099128069867,0.838257076229427,"P35555","Fibrillin-1 [Cleaved into: Asprosin]","Homo sapiens (Human)","activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; positive regulation of appetite [GO:0032100]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]","GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0009653; GO:0010737; GO:0030023; GO:0031012; GO:0032100; GO:0033627; GO:0034199; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0062023; GO:0071560; GO:1990314; GO:2001205"
"3884",3884,"Cluster_7053","Porites_evermani_scaffold_916:97180-98180",156,-21.48,2,21,316,334,19,"73.68%","78.95%","Peve_00044024",NA,NA,NA,NA,NA,NA,NA,NA
"3885",3885,"Cluster_7053","Porites_evermani_scaffold_945:32878-33878",154,-20.49,2,21,683,703,19,"68.42%","78.95%","Peve_00044495",-0.00749125846798571,0.995230872132244,0.999448381576871,"Q9F234","Alpha-glucosidase 2 (EC 3.2.1.20) (Alpha-glucosidase II)","Bacillus thermoamyloliquefaciens","","GO:0030246; GO:0032450"
"3886",3886,"Cluster_7053","Porites_evermani_scaffold_945:44471-44691",176,-21.67,2,21,27,48,19,"78.95%","89.47%","Peve_00044496",NA,NA,NA,"P70684","15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Eicosanoid/docosanoid dehydrogenase [NAD(+)]) (EC 1.1.1.-, EC 1.1.1.232) (Prostaglandin dehydrogenase 1)","Cavia porcellus (Guinea pig)","ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; prostaglandin metabolic process [GO:0006693]; regulation of prostaglandin catabolic process [GO:1905828]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]","GO:0004957; GO:0005737; GO:0006693; GO:0007179; GO:0007565; GO:0007567; GO:0016404; GO:0016616; GO:0030728; GO:0045786; GO:0051287; GO:0070403; GO:0070493; GO:0097070; GO:1905828"
"3887",3887,"Cluster_7053","Porites_evermani_scaffold_97:163707-164707",161,-20.82,2,20,408,432,21,"76.19%","80.95%","Peve_00044918",-0.915860925698161,0.263019030439806,0.978262075707395,NA,NA,NA,NA,NA
"3888",3888,"Cluster_7657","Porites_evermani_scaffold_1087:29553-30553",170,-20.73,2,21,710,730,19,"84.21%","84.21%","Peve_00001553",NA,NA,NA,"P24045","Gamma-aminobutyric acid receptor subunit beta-4 (GABA(A) receptor subunit beta-4)","Gallus gallus (Chicken)","chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]","GO:0004890; GO:0005231; GO:0005254; GO:0005886; GO:0007165; GO:0007268; GO:0030594; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476; GO:1902711; GO:1904315"
"3889",3889,"Cluster_7657","Porites_evermani_scaffold_154:131282-132282",162,-20.17,2,21,83,103,19,"73.68%","84.21%","Peve_00007988",-0.515311139052295,0.65535273088464,0.978262075707395,"P15170","Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (Eukaryotic peptide chain release factor subunit 3a) (eRF3a) (G1 to S phase transition protein 1 homolog)","Homo sapiens (Human)","G1/S transition of mitotic cell cycle [GO:0000082]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; protein methylation [GO:0006479]; regulation of translational termination [GO:0006449]; translation [GO:0006412]; translational termination [GO:0006415]","GO:0000082; GO:0000184; GO:0003723; GO:0003747; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0006412; GO:0006415; GO:0006449; GO:0006479; GO:0018444"
"3890",3890,"Cluster_7657","Porites_evermani_scaffold_1661:34039-35039",168,-23.95,2,21,928,949,19,"73.68%","84.21%","Peve_00009534",0.880632441328499,0.314236124595195,0.978262075707395,NA,NA,NA,NA,NA
"3891",3891,"Cluster_7657","Porites_evermani_scaffold_1686:12193-13193",171,-21.94,2,21,916,939,21,"76.19%","85.71%","Peve_00009820",-0.28184557339664,0.818106830849933,0.995934364227446,"O15973","Rhodopsin, GQ-coupled (GQ-rhodopsin)","Mizuhopecten yessoensis (Japanese scallop) (Patinopecten yessoensis)","phototransduction [GO:0007602]; visual perception [GO:0007601]","GO:0004930; GO:0005886; GO:0007601; GO:0007602; GO:0009881"
"3892",3892,"Cluster_7657","Porites_evermani_scaffold_2050:38406-39406",173,-20.54,2,19,860,882,18,"88.89%","88.89%","Peve_00014076",0.96644797868175,0.165377450574415,0.978262075707395,NA,NA,NA,NA,NA
"3893",3893,"Cluster_7657","Porites_evermani_scaffold_210:238139-239139",164,-20.6,2,20,872,891,18,"77.78%","88.89%","Peve_00014599",NA,NA,NA,"B3EWZ8","Ectin","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0005576"
"3894",3894,"Cluster_7657","Porites_evermani_scaffold_2491:14291-15291",175,-20.32,2,20,519,540,18,"77.78%","94.44%","Peve_00018298",0.814310271138129,0.394230888385278,0.978262075707395,"Q8BV79","TPR and ankyrin repeat-containing protein 1 (Lupus brain antigen 1)","Mus musculus (Mouse)","",""
"3895",3895,"Cluster_7657","Porites_evermani_scaffold_28:212577-213306",172,-21.54,2,21,361,382,19,"73.68%","89.47%","Peve_00020856",NA,NA,NA,NA,NA,NA,NA,NA
"3896",3896,"Cluster_7657","Porites_evermani_scaffold_28:212577-213306",172,-21.54,2,21,361,382,19,"73.68%","89.47%","Peve_00020857",0.235033816305854,0.848959820698913,0.995934364227446,"P32320","Cytidine deaminase (EC 3.5.4.5) (Cytidine aminohydrolase)","Homo sapiens (Human)","cell surface receptor signaling pathway [GO:0007166]; cellular response to external biotic stimulus [GO:0071217]; cytidine deamination [GO:0009972]; cytosine metabolic process [GO:0019858]; negative regulation of cell growth [GO:0030308]; negative regulation of nucleotide metabolic process [GO:0045980]; pyrimidine-containing compound salvage [GO:0008655]; response to cycloheximide [GO:0046898]; UMP salvage [GO:0044206]","GO:0001882; GO:0004126; GO:0005576; GO:0005829; GO:0007166; GO:0008270; GO:0008655; GO:0009972; GO:0019858; GO:0030308; GO:0034774; GO:0042802; GO:0042803; GO:0044206; GO:0045980; GO:0046898; GO:0047844; GO:0071217; GO:1904724; GO:1904813"
"3897",3897,"Cluster_7657","Porites_evermani_scaffold_3820:24797-25797",170,-20.96,2,21,199,219,19,"73.68%","94.74%","Peve_00027758",NA,NA,NA,NA,NA,NA,NA,NA
"3898",3898,"Cluster_7657","Porites_evermani_scaffold_4229:19697-20697",162,-22.39,2,21,164,191,25,"72.00%","76.00%","Peve_00030026",-0.260774605488123,0.832044117241082,0.995934364227446,NA,NA,NA,NA,NA
"3899",3899,"Cluster_7657","Porites_evermani_scaffold_44:652053-653053",165,-20.59,2,14,300,321,12,"100.00%","100.00%","Peve_00030916",-0.260774605488123,0.832044117241082,0.995934364227446,NA,NA,NA,NA,NA
"3900",3900,"Cluster_7657","Porites_evermani_scaffold_478:199282-200282",171,-20.51,2,21,538,560,20,"80.00%","85.00%","Peve_00032647",-0.544806272834109,0.633206377885548,0.978262075707395,"O16025","Allene oxide synthase-lipoxygenase protein [Includes: Allene oxide synthase (AOS) (EC 4.2.1.-) (Hydroperoxidehydrase); Arachidonate 8-lipoxygenase (EC 1.13.11.40)]","Plexaura homomalla (Black sea rod)","arachidonic acid metabolic process [GO:0019369]; fatty acid biosynthetic process [GO:0006633]; lipid oxidation [GO:0034440]; oxylipin biosynthetic process [GO:0031408]","GO:0005506; GO:0005737; GO:0006633; GO:0009978; GO:0016020; GO:0019369; GO:0020037; GO:0031408; GO:0034440; GO:0047677"
"3901",3901,"Cluster_7657","Porites_evermani_scaffold_541:42685-43685",178,-21.85,2,21,100,120,19,"84.21%","94.74%","Peve_00035189",-0.867642735053805,0.331268278443034,0.978262075707395,"Q80XJ3","Tetratricopeptide repeat protein 28 (TPR repeat protein 28)","Mus musculus (Mouse)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0005737; GO:0005813; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301; GO:0072686; GO:0097431; GO:1990023"
"3902",3902,"Cluster_7657","Porites_evermani_scaffold_63:208413-209413",188,-28.04,2,21,767,788,19,"89.47%","94.74%","Peve_00037871",NA,NA,NA,NA,NA,NA,NA,NA
"3903",3903,"Cluster_7657","Porites_evermani_scaffold_640:48529-49526",165,-20.48,2,19,601,623,18,"77.78%","88.89%","Peve_00038164",NA,NA,NA,NA,NA,NA,NA,NA
"3904",3904,"Cluster_7657","Porites_evermani_scaffold_697:130424-131424",176,-21.51,2,21,87,108,19,"78.95%","89.47%","Peve_00039460",-0.088181080251682,0.943789171296509,0.999448381576871,"Q91V37","V-type proton ATPase 21 kDa proteolipid subunit c'' (V-ATPase 21 kDa proteolipid subunit c'') (23 kDa subunit of V-ATPase) (Vacuolar proton pump 21 kDa proteolipid subunit c'')","Mus musculus (Mouse)","proton transmembrane transport [GO:1902600]","GO:0000220; GO:0005768; GO:0008553; GO:0016020; GO:0016471; GO:0030665; GO:0033176; GO:0033179; GO:0046961; GO:1902495; GO:1902600; GO:1904949"
"3905",3905,"Cluster_7657","Porites_evermani_scaffold_9:696131-697131",174,-20.06,2,21,851,875,22,"81.82%","86.36%","Peve_00043632",0.240433131716452,0.845421049464748,0.995934364227446,"P82664","28S ribosomal protein S10, mitochondrial (MRP-S10) (S10mt) (Mitochondrial small ribosomal subunit protein uS10m)","Homo sapiens (Human)","mitochondrial translation [GO:0032543]","GO:0005739; GO:0005743; GO:0005763; GO:0032543"
"3906",3906,"Cluster_7658","Porites_evermani_scaffold_1087:29553-30553",170,-20.73,2,21,710,730,19,"84.21%","84.21%","Peve_00001553",NA,NA,NA,"P24045","Gamma-aminobutyric acid receptor subunit beta-4 (GABA(A) receptor subunit beta-4)","Gallus gallus (Chicken)","chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]","GO:0004890; GO:0005231; GO:0005254; GO:0005886; GO:0007165; GO:0007268; GO:0030594; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476; GO:1902711; GO:1904315"
"3907",3907,"Cluster_7658","Porites_evermani_scaffold_154:131282-132282",162,-20.17,2,21,83,103,19,"73.68%","84.21%","Peve_00007988",-0.254171632857681,0.83639437709857,0.995934364227446,"P15170","Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (Eukaryotic peptide chain release factor subunit 3a) (eRF3a) (G1 to S phase transition protein 1 homolog)","Homo sapiens (Human)","G1/S transition of mitotic cell cycle [GO:0000082]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; protein methylation [GO:0006479]; regulation of translational termination [GO:0006449]; translation [GO:0006412]; translational termination [GO:0006415]","GO:0000082; GO:0000184; GO:0003723; GO:0003747; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0006412; GO:0006415; GO:0006449; GO:0006479; GO:0018444"
"3908",3908,"Cluster_7658","Porites_evermani_scaffold_1661:34039-35039",168,-23.95,2,21,928,949,19,"73.68%","84.21%","Peve_00009534",-0.95391874772419,0.194016767421595,0.978262075707395,NA,NA,NA,NA,NA
"3909",3909,"Cluster_7658","Porites_evermani_scaffold_1686:12193-13193",171,-21.94,2,21,916,939,21,"76.19%","85.71%","Peve_00009820",-0.490483644149716,0.673640277133276,0.978262075707395,"O15973","Rhodopsin, GQ-coupled (GQ-rhodopsin)","Mizuhopecten yessoensis (Japanese scallop) (Patinopecten yessoensis)","phototransduction [GO:0007602]; visual perception [GO:0007601]","GO:0004930; GO:0005886; GO:0007601; GO:0007602; GO:0009881"
"3910",3910,"Cluster_7658","Porites_evermani_scaffold_2050:38406-39406",173,-20.54,2,19,860,882,18,"88.89%","88.89%","Peve_00014076",-0.858434050803566,0.342875441442375,0.978262075707395,NA,NA,NA,NA,NA
"3911",3911,"Cluster_7658","Porites_evermani_scaffold_210:238139-239139",164,-20.6,2,20,872,891,18,"77.78%","88.89%","Peve_00014599",NA,NA,NA,"B3EWZ8","Ectin","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0005576"
"3912",3912,"Cluster_7658","Porites_evermani_scaffold_2491:14291-15291",175,-20.32,2,20,519,540,18,"77.78%","94.44%","Peve_00018298",-0.984003468824788,0.114022003631513,0.978262075707395,"Q8BV79","TPR and ankyrin repeat-containing protein 1 (Lupus brain antigen 1)","Mus musculus (Mouse)","",""
"3913",3913,"Cluster_7658","Porites_evermani_scaffold_28:212577-213306",172,-21.54,2,21,361,382,19,"73.68%","89.47%","Peve_00020856",NA,NA,NA,NA,NA,NA,NA,NA
"3914",3914,"Cluster_7658","Porites_evermani_scaffold_28:212577-213306",172,-21.54,2,21,361,382,19,"73.68%","89.47%","Peve_00020857",0.532124983407911,0.642787287284297,0.978262075707395,"P32320","Cytidine deaminase (EC 3.5.4.5) (Cytidine aminohydrolase)","Homo sapiens (Human)","cell surface receptor signaling pathway [GO:0007166]; cellular response to external biotic stimulus [GO:0071217]; cytidine deamination [GO:0009972]; cytosine metabolic process [GO:0019858]; negative regulation of cell growth [GO:0030308]; negative regulation of nucleotide metabolic process [GO:0045980]; pyrimidine-containing compound salvage [GO:0008655]; response to cycloheximide [GO:0046898]; UMP salvage [GO:0044206]","GO:0001882; GO:0004126; GO:0005576; GO:0005829; GO:0007166; GO:0008270; GO:0008655; GO:0009972; GO:0019858; GO:0030308; GO:0034774; GO:0042802; GO:0042803; GO:0044206; GO:0045980; GO:0046898; GO:0047844; GO:0071217; GO:1904724; GO:1904813"
"3915",3915,"Cluster_7658","Porites_evermani_scaffold_3820:24797-25797",170,-20.96,2,21,199,219,19,"73.68%","94.74%","Peve_00027758",NA,NA,NA,NA,NA,NA,NA,NA
"3916",3916,"Cluster_7658","Porites_evermani_scaffold_4229:19697-20697",162,-22.39,2,21,164,191,25,"72.00%","76.00%","Peve_00030026",0.873422197946785,0.323791225224292,0.978262075707395,NA,NA,NA,NA,NA
"3917",3917,"Cluster_7658","Porites_evermani_scaffold_44:652053-653053",165,-20.59,2,14,300,321,12,"100.00%","100.00%","Peve_00030916",0.873422197946786,0.323791225224291,0.978262075707395,NA,NA,NA,NA,NA
"3918",3918,"Cluster_7658","Porites_evermani_scaffold_478:199282-200282",171,-20.51,2,21,538,560,20,"80.00%","85.00%","Peve_00032647",-0.22037967817144,0.858540730097662,0.995934364227446,"O16025","Allene oxide synthase-lipoxygenase protein [Includes: Allene oxide synthase (AOS) (EC 4.2.1.-) (Hydroperoxidehydrase); Arachidonate 8-lipoxygenase (EC 1.13.11.40)]","Plexaura homomalla (Black sea rod)","arachidonic acid metabolic process [GO:0019369]; fatty acid biosynthetic process [GO:0006633]; lipid oxidation [GO:0034440]; oxylipin biosynthetic process [GO:0031408]","GO:0005506; GO:0005737; GO:0006633; GO:0009978; GO:0016020; GO:0019369; GO:0020037; GO:0031408; GO:0034440; GO:0047677"
"3919",3919,"Cluster_7658","Porites_evermani_scaffold_541:42685-43685",178,-21.85,2,21,100,120,19,"84.21%","94.74%","Peve_00035189",0.249418330457708,0.839521170459825,0.995934364227446,"Q80XJ3","Tetratricopeptide repeat protein 28 (TPR repeat protein 28)","Mus musculus (Mouse)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0005737; GO:0005813; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301; GO:0072686; GO:0097431; GO:1990023"
"3920",3920,"Cluster_7658","Porites_evermani_scaffold_63:208413-209413",188,-28.04,2,21,767,788,19,"89.47%","94.74%","Peve_00037871",NA,NA,NA,NA,NA,NA,NA,NA
"3921",3921,"Cluster_7658","Porites_evermani_scaffold_640:48529-49526",165,-20.48,2,19,601,623,18,"77.78%","88.89%","Peve_00038164",NA,NA,NA,NA,NA,NA,NA,NA
"3922",3922,"Cluster_7658","Porites_evermani_scaffold_697:130424-131424",176,-21.51,2,21,87,108,19,"78.95%","89.47%","Peve_00039460",-0.651883831047504,0.547957936686701,0.978262075707395,"Q91V37","V-type proton ATPase 21 kDa proteolipid subunit c'' (V-ATPase 21 kDa proteolipid subunit c'') (23 kDa subunit of V-ATPase) (Vacuolar proton pump 21 kDa proteolipid subunit c'')","Mus musculus (Mouse)","proton transmembrane transport [GO:1902600]","GO:0000220; GO:0005768; GO:0008553; GO:0016020; GO:0016471; GO:0030665; GO:0033176; GO:0033179; GO:0046961; GO:1902495; GO:1902600; GO:1904949"
"3923",3923,"Cluster_7658","Porites_evermani_scaffold_9:696131-697131",174,-20.06,2,21,851,875,22,"81.82%","86.36%","Peve_00043632",-0.862997846236278,0.337168157447957,0.978262075707395,"P82664","28S ribosomal protein S10, mitochondrial (MRP-S10) (S10mt) (Mitochondrial small ribosomal subunit protein uS10m)","Homo sapiens (Human)","mitochondrial translation [GO:0032543]","GO:0005739; GO:0005743; GO:0005763; GO:0032543"
"3924",3924,"Cluster_7855","Porites_evermani_scaffold_1039:145610-146610",166,-20.96,2,20,196,219,20,"75.00%","85.00%","Peve_00000802",-0.968291773190294,0.160744228167722,0.978262075707395,NA,NA,NA,NA,NA
"3925",3925,"Cluster_7855","Porites_evermani_scaffold_10:959783-960783",171,-25.34,2,21,815,840,23,"73.91%","82.61%","Peve_00000159",NA,NA,NA,NA,NA,NA,NA,NA
"3926",3926,"Cluster_7855","Porites_evermani_scaffold_114:199138-200138",171,-21.63,2,20,804,825,18,"83.33%","83.33%","Peve_00002402",-0.802900572685237,0.406577930897643,0.978262075707395,"Q29496","Cytochrome P450 3A24 (EC 1.14.14.1) (CYPIIIA24)","Ovis aries (Sheep)","","GO:0004497; GO:0005506; GO:0005789; GO:0020037; GO:0070330"
"3927",3927,"Cluster_7855","Porites_evermani_scaffold_1246:30942-31942",157,-20.98,2,21,867,889,21,"71.43%","80.95%","Peve_00004045",0.31978296303301,0.792780000879853,0.995934364227446,"O60290","Zinc finger protein 862","Homo sapiens (Human)","regulation of DNA-templated transcription [GO:0006355]","GO:0005634; GO:0006355; GO:0046872; GO:0046983"
"3928",3928,"Cluster_7855","Porites_evermani_scaffold_1256:12762-13762",168,-21.91,2,21,168,189,19,"68.42%","89.47%","Peve_00004163",0.0325945714784778,0.979245975351128,0.999448381576871,"Q5UNW1","Uncharacterized protein R707","Acanthamoeba polyphaga mimivirus (APMV)","","GO:0016020; GO:0016757"
"3929",3929,"Cluster_7855","Porites_evermani_scaffold_1332:112707-113707",161,-20.15,2,21,655,678,22,"72.73%","81.82%","Peve_00005263",-0.551100717215019,0.628416004625547,0.978262075707395,NA,NA,NA,NA,NA
"3930",3930,"Cluster_7855","Porites_evermani_scaffold_1348:116775-117775",168,-21.21,2,19,380,400,17,"82.35%","94.12%","Peve_00005462",0.0325945714784778,0.979245975351128,0.999448381576871,"Q96PM5","RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING finger protein 199) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363) (p53-induced RING-H2 protein) (hPirh2)","Homo sapiens (Human)","error-free translesion synthesis [GO:0070987]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0002039; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042803; GO:0043231; GO:0051865; GO:0061630; GO:0070987"
"3931",3931,"Cluster_7855","Porites_evermani_scaffold_1374:112559-113559",166,-21.23,2,21,670,690,19,"73.68%","89.47%","Peve_00005831",NA,NA,NA,NA,NA,NA,NA,NA
"3932",3932,"Cluster_7855","Porites_evermani_scaffold_1484:50487-51487",156,-22.63,2,21,705,724,19,"68.42%","89.47%","Peve_00007264",0.0670312316139366,0.957294571208088,0.999448381576871,"Q5RDU7","Protein yippee-like 5","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","cell population proliferation [GO:0008283]","GO:0000151; GO:0005634; GO:0005737; GO:0005815; GO:0008283; GO:0030496; GO:0046872; GO:0097431"
"3933",3933,"Cluster_7855","Porites_evermani_scaffold_1529:45105-46105",157,-20.18,2,21,854,875,20,"70.00%","85.00%","Peve_00007859",-0.932714372437852,0.234867016725905,0.978262075707395,NA,NA,NA,NA,NA
"3934",3934,"Cluster_7855","Porites_evermani_scaffold_1550:66284-67284",168,-20.27,2,17,885,906,15,"86.67%","93.33%","Peve_00008125",0.030197379528678,0.980772828211902,0.999448381576871,"Q68EP9","Cysteine protease ATG4C (EC 3.4.22.-) (Autophagy-related protein 4 homolog C)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","autophagy [GO:0006914]; protein delipidation [GO:0051697]; protein transport [GO:0015031]; proteolysis [GO:0006508]","GO:0005737; GO:0006508; GO:0006914; GO:0008234; GO:0015031; GO:0019786; GO:0051697"
"3935",3935,"Cluster_7855","Porites_evermani_scaffold_1663:57625-58625",167,-22.49,2,18,574,594,16,"87.50%","93.75%","Peve_00009549",0.0325945714784778,0.979245975351128,0.999448381576871,NA,NA,NA,NA,NA
"3936",3936,"Cluster_7855","Porites_evermani_scaffold_1921:73953-74953",166,-20.83,2,17,269,289,15,"93.33%","93.33%","Peve_00012537",0.391855557857807,0.743666588874874,0.986951650662702,NA,NA,NA,NA,NA
"3937",3937,"Cluster_7855","Porites_evermani_scaffold_2030:0-957",172,-22.64,2,21,739,760,19,"73.68%","89.47%","Peve_00013875",0.0325945714784778,0.979245975351128,0.999448381576871,NA,NA,NA,NA,NA
"3938",3938,"Cluster_7855","Porites_evermani_scaffold_20:414258-415258",184,-26.1,2,21,130,151,19,"84.21%","94.74%","Peve_00013461",0.951227309111962,0.199647842268422,0.978262075707395,NA,NA,NA,NA,NA
"3939",3939,"Cluster_7855","Porites_evermani_scaffold_2085:15297-16297",175,-22.46,2,21,171,193,20,"80.00%","90.00%","Peve_00014391",-0.881862531941165,0.312579308684462,0.978262075707395,NA,NA,NA,NA,NA
"3940",3940,"Cluster_7855","Porites_evermani_scaffold_223:331662-332662",165,-20.93,2,21,334,355,20,"75.00%","90.00%","Peve_00015858",-0.31570286758524,0.795519439169887,0.995934364227446,NA,NA,NA,NA,NA
"3941",3941,"Cluster_7855","Porites_evermani_scaffold_2371:66169-67169",173,-21.69,2,19,268,291,19,"84.21%","89.47%","Peve_00017177",0.881833327425519,0.312618737815041,0.978262075707395,NA,NA,NA,NA,NA
"3942",3942,"Cluster_7855","Porites_evermani_scaffold_247:323747-324747",166,-22.6,2,20,767,789,19,"73.68%","89.47%","Peve_00018100",0.94739220612564,0.207416231435104,0.978262075707395,NA,NA,NA,NA,NA
"3943",3943,"Cluster_7855","Porites_evermani_scaffold_250:163762-164762",180,-20.37,2,21,40,61,19,"84.21%","89.47%","Peve_00018441",-0.385766895884624,0.747873796123002,0.98812520325496,"B8VIU6","Uncharacterized skeletal organic matrix protein 5 (Uncharacterized SOMP-5)","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0005576"
"3944",3944,"Cluster_7855","Porites_evermani_scaffold_2674:0-734",173,-23.32,2,18,468,489,16,"87.50%","93.75%","Peve_00019848",NA,NA,NA,NA,NA,NA,NA,NA
"3945",3945,"Cluster_7855","Porites_evermani_scaffold_304:203994-204994",169,-20.63,2,18,845,866,16,"81.25%","93.75%","Peve_00022920",0.0325945714784778,0.979245975351128,0.999448381576871,NA,NA,NA,NA,NA
"3946",3946,"Cluster_7855","Porites_evermani_scaffold_3070:24237-25237",184,-22.76,2,21,312,333,19,"89.47%","89.47%","Peve_00023153",0.381364210157251,0.750908771085717,0.988219883885475,"Q99L04","Dehydrogenase/reductase SDR family member 1 (EC 1.1.1.-) (Short chain dehydrogenase/reductase family 19C member 1) (Protein SDR19C1)","Mus musculus (Mouse)","","GO:0004090; GO:0005739; GO:0005743; GO:0005783; GO:0016616; GO:0047045"
"3947",3947,"Cluster_7855","Porites_evermani_scaffold_348:261313-262313",175,-22.08,2,21,824,847,21,"76.19%","90.48%","Peve_00025803",-0.998338998790929,0.0366978166950436,0.909359886114279,"Q6Q0C0","E3 ubiquitin-protein ligase TRAF7 (EC 2.3.2.27) (RING finger and WD repeat-containing protein 1) (RING finger protein 119) (RING-type E3 ubiquitin transferase TRAF7) (TNF receptor-associated factor 7)","Homo sapiens (Human)","apoptotic process [GO:0006915]; Notch signaling pathway [GO:0007219]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of MAPK cascade [GO:0043410]; protein ubiquitination [GO:0016567]; regulation of ERK1 and ERK2 cascade [GO:0070372]; ribosomal large subunit assembly [GO:0000027]","GO:0000027; GO:0000151; GO:0004842; GO:0005730; GO:0005886; GO:0006915; GO:0007219; GO:0008270; GO:0016567; GO:0031410; GO:0043231; GO:0043410; GO:0070372; GO:2001235"
"3948",3948,"Cluster_7855","Porites_evermani_scaffold_3:626197-627197",167,-22.15,2,21,825,847,20,"75.00%","85.00%","Peve_00022432",NA,NA,NA,NA,NA,NA,NA,NA
"3949",3949,"Cluster_7855","Porites_evermani_scaffold_3769:17351-18351",167,-20.35,2,21,556,579,21,"71.43%","85.71%","Peve_00027432",0.886288906211864,0.306549397337864,0.978262075707395,"Q7RTR2","NLR family CARD domain-containing protein 3 (CARD15-like protein) (Caterpiller protein 16.2) (CLR16.2) (NACHT, LRR and CARD domains-containing protein 3) (Nucleotide-binding oligomerization domain protein 3)","Homo sapiens (Human)","I-kappaB kinase/NF-kappaB signaling [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of tumor necrosis factor production [GO:0032720]; T cell activation [GO:0042110]","GO:0005524; GO:0005737; GO:0005829; GO:0007249; GO:0014067; GO:0032088; GO:0032687; GO:0032688; GO:0032715; GO:0032720; GO:0034451; GO:0035556; GO:0036312; GO:0042110; GO:0043124; GO:0043231; GO:0045824; GO:0048147; GO:0048471; GO:0050680; GO:0050728; GO:1900016; GO:1900226; GO:1901223"
"3950",3950,"Cluster_7855","Porites_evermani_scaffold_3807:13477-14477",169,-22.26,2,20,718,738,18,"83.33%","88.89%","Peve_00027669",-0.690704180573509,0.514601369557893,0.978262075707395,"A1A5Q4","Cilia- and flagella-associated protein 206","Rattus norvegicus (Rat)","axoneme assembly [GO:0035082]; cilium movement [GO:0003341]; regulation of cilium beat frequency [GO:0003356]; regulation of flagellated sperm motility [GO:1901317]; sperm axoneme assembly [GO:0007288]","GO:0001534; GO:0003341; GO:0003356; GO:0005930; GO:0007288; GO:0031514; GO:0035082; GO:0036064; GO:1901317"
"3951",3951,"Cluster_7855","Porites_evermani_scaffold_384:132855-133855",169,-22.77,2,20,138,158,18,"83.33%","88.89%","Peve_00027830",0.90607654493452,0.278125909995953,0.978262075707395,"Q4JAI4","Methionine synthase (EC 2.1.1.-) (Homocysteine methyltransferase)","Sulfolobus acidocaldarius (strain ATCC 33909 / DSM 639 / JCM 8929 / NBRC 15157 / NCIMB 11770)","methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]","GO:0003871; GO:0008270; GO:0009086; GO:0032259"
"3952",3952,"Cluster_7855","Porites_evermani_scaffold_387:2131-3131",168,-21.21,2,17,504,525,15,"80.00%","100.00%","Peve_00027987",NA,NA,NA,NA,NA,NA,NA,NA
"3953",3953,"Cluster_7855","Porites_evermani_scaffold_4015:754-1754",161,-20.63,2,21,366,387,20,"75.00%","85.00%","Peve_00028912",-0.614574341379842,0.578655581278865,0.978262075707395,NA,NA,NA,NA,NA
"3954",3954,"Cluster_7855","Porites_evermani_scaffold_4015:754-1754",161,-20.63,2,21,864,885,20,"75.00%","85.00%","Peve_00028912",-0.614574341379842,0.578655581278865,0.978262075707395,NA,NA,NA,NA,NA
"3955",3955,"Cluster_7855","Porites_evermani_scaffold_424:162037-163037",176,-20.58,2,21,470,491,19,"84.21%","84.21%","Peve_00030089",NA,NA,NA,NA,NA,NA,NA,NA
"3956",3956,"Cluster_7855","Porites_evermani_scaffold_4365:2305-3305",161,-20.41,2,20,198,218,18,"77.78%","83.33%","Peve_00030727",NA,NA,NA,NA,NA,NA,NA,NA
"3957",3957,"Cluster_7855","Porites_evermani_scaffold_4872:15887-16887",174,-23.12,2,21,253,273,19,"78.95%","94.74%","Peve_00033022",-0.359492594127,0.765899580351946,0.989885331570989,"A4FUB8","Transmembrane protein 115","Bos taurus (Bovine)","retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]","GO:0006890; GO:0032580; GO:0042802"
"3958",3958,"Cluster_7855","Porites_evermani_scaffold_5418:11894-12894",175,-22.23,2,21,703,725,20,"85.00%","85.00%","Peve_00035207",0.328995294102596,0.786579941287769,0.995049184804619,"P50532","Structural maintenance of chromosomes protein 4 (SMC protein 4) (SMC-4) (Chromosome assembly protein XCAP-C) (Chromosome-associated protein C)","Xenopus laevis (African clawed frog)","cell division [GO:0051301]; mitotic chromosome condensation [GO:0007076]","GO:0005524; GO:0005634; GO:0005694; GO:0005829; GO:0007076; GO:0016887; GO:0051301"
"3959",3959,"Cluster_7855","Porites_evermani_scaffold_610:188205-189205",169,-20.21,2,21,103,122,19,"78.95%","89.47%","Peve_00037365",0.317012380808899,0.7946406420532,0.995934364227446,"O46037","Vinculin","Drosophila melanogaster (Fruit fly)","cell adhesion [GO:0007155]","GO:0005198; GO:0005737; GO:0005856; GO:0005886; GO:0005912; GO:0005925; GO:0007155; GO:0008013; GO:0015629; GO:0044291; GO:0045294; GO:0051015; GO:0098592"
"3960",3960,"Cluster_7855","Porites_evermani_scaffold_614:166250-167250",170,-22.87,2,20,166,188,19,"78.95%","89.47%","Peve_00037436",0.0325945714784778,0.979245975351128,0.999448381576871,NA,NA,NA,NA,NA
"3961",3961,"Cluster_7855","Porites_evermani_scaffold_673:4689-5689",163,-20.43,2,18,813,833,16,"81.25%","93.75%","Peve_00038900",NA,NA,NA,NA,NA,NA,NA,NA
"3962",3962,"Cluster_7855","Porites_evermani_scaffold_698:45062-45920",174,-21.82,2,21,540,560,19,"78.95%","94.74%","Peve_00039485",-0.402630996372639,0.736191576302058,0.986141420198111,NA,NA,NA,NA,NA
"3963",3963,"Cluster_7855","Porites_evermani_scaffold_703:42041-43041",166,-21.21,2,21,207,227,19,"78.95%","84.21%","Peve_00039683",NA,NA,NA,NA,NA,NA,NA,NA
"3964",3964,"Cluster_7855","Porites_evermani_scaffold_717:73853-74853",150,-20.14,2,21,46,74,26,"61.54%","73.08%","Peve_00039952",NA,NA,NA,NA,NA,NA,NA,NA
"3965",3965,"Cluster_7855","Porites_evermani_scaffold_795:13409-14409",154,-20.71,2,20,780,805,22,"68.18%","72.73%","Peve_00041580",NA,NA,NA,"Q3U481","Major facilitator superfamily domain-containing protein 12 (Protein grizzled)","Mus musculus (Mouse)","carbohydrate transport [GO:0008643]; cysteine transmembrane transport [GO:1903712]; melanin biosynthetic process [GO:0042438]; negative regulation of melanin biosynthetic process [GO:0048022]; organic substance transport [GO:0071702]; pigment metabolic process involved in pigmentation [GO:0043474]; regulation of melanin biosynthetic process [GO:0048021]","GO:0005764; GO:0005765; GO:0005770; GO:0005886; GO:0008643; GO:0015293; GO:0033162; GO:0033229; GO:0042438; GO:0042470; GO:0043474; GO:0048021; GO:0048022; GO:0071702; GO:1903712"
"3966",3966,"Cluster_7855","Porites_evermani_scaffold_833:72708-73708",175,-22.46,2,21,160,182,20,"80.00%","90.00%","Peve_00042442",0.0325945714784778,0.979245975351128,0.999448381576871,NA,NA,NA,NA,NA
"3967",3967,"Cluster_7855","Porites_evermani_scaffold_84:533385-534385",166,-21.23,2,21,930,950,19,"78.95%","84.21%","Peve_00042535",0.951238629290668,0.199624479963566,0.978262075707395,"Q5ZK69","Proteasomal ATPase-associated factor 1 (WD repeat-containing protein 71)","Gallus gallus (Chicken)","","GO:0000502"
"3968",3968,"Cluster_7855","Porites_evermani_scaffold_956:62445-63445",169,-20.39,2,21,825,844,19,"84.21%","84.21%","Peve_00044670",0.863892066784318,0.336039627293542,0.978262075707395,"Q21540","Cuticlin-6 (Cuticulin 6)","Caenorhabditis elegans","","GO:0005886; GO:0042302; GO:0060111"
"3969",3969,"Cluster_796","Porites_evermani_scaffold_1004:144202-145202",152,-21.55,2,21,356,374,19,"68.42%","78.95%","Peve_00000302",0.898740270652305,0.288966974174018,0.978262075707395,"Q96CG8","Collagen triple helix repeat-containing protein 1","Homo sapiens (Human)","cell migration [GO:0016477]; cochlea morphogenesis [GO:0090103]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein binding [GO:0032092]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0001649; GO:0005109; GO:0005576; GO:0005581; GO:0005615; GO:0016477; GO:0016528; GO:0017147; GO:0032092; GO:0033687; GO:0033690; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0062023; GO:0090090; GO:0090103; GO:0090177"
"3970",3970,"Cluster_796","Porites_evermani_scaffold_1012:121314-122314",157,-23.54,2,21,937,956,19,"73.68%","78.95%","Peve_00000438",0.585895318999307,0.601485939951823,0.978262075707395,NA,NA,NA,NA,NA
"3971",3971,"Cluster_796","Porites_evermani_scaffold_1031:98941-99941",158,-21.02,2,20,915,937,19,"73.68%","78.95%","Peve_00000718",0.998052856721296,0.0397342088666192,0.909359886114279,"Q8IWZ3","Ankyrin repeat and KH domain-containing protein 1 (HIV-1 Vpr-binding ankyrin repeat protein) (Multiple ankyrin repeats single KH domain) (hMASK)","Homo sapiens (Human)","innate immune response [GO:0045087]","GO:0003723; GO:0005737; GO:0045087"
"3972",3972,"Cluster_796","Porites_evermani_scaffold_1044:73439-74439",143,-21,2,21,149,172,23,"69.57%","69.57%","Peve_00000910",NA,NA,NA,NA,NA,NA,NA,NA
"3973",3973,"Cluster_796","Porites_evermani_scaffold_10:493759-494759",156,-21.9,2,21,56,74,19,"73.68%","78.95%","Peve_00000193",NA,NA,NA,"C3ZQF9","QRFP-like peptide receptor","Branchiostoma floridae (Florida lancelet) (Amphioxus)","cellular response to peptide [GO:1901653]; G protein-coupled receptor signaling pathway [GO:0007186]","GO:0004930; GO:0004983; GO:0005886; GO:0007186; GO:1901653"
"3974",3974,"Cluster_796","Porites_evermani_scaffold_1055:72877-73877",155,-23.98,2,21,909,932,21,"71.43%","71.43%","Peve_00001078",0.487246119165714,0.676002920830723,0.978262075707395,NA,NA,NA,NA,NA
"3975",3975,"Cluster_796","Porites_evermani_scaffold_1055:78942-79942",155,-23.98,2,21,306,329,21,"71.43%","71.43%","Peve_00001079",0.611754378245514,0.58092817421252,0.978262075707395,NA,NA,NA,NA,NA
"3976",3976,"Cluster_796","Porites_evermani_scaffold_1057:138285-139285",164,-23.22,2,20,605,624,18,"83.33%","83.33%","Peve_00001103",0.023323351539754,0.985150546746574,0.999448381576871,"Q8N7X0","Androglobin (Calpain-7-like protein)","Homo sapiens (Human)","cell differentiation [GO:0030154]; proteolysis [GO:0006508]; spermatogenesis [GO:0007283]","GO:0004198; GO:0006508; GO:0007283; GO:0019825; GO:0020037; GO:0030154; GO:0031514"
"3977",3977,"Cluster_796","Porites_evermani_scaffold_1058:149442-150442",157,-24.17,2,21,112,131,19,"73.68%","78.95%","Peve_00001109",NA,NA,NA,NA,NA,NA,NA,NA
"3978",3978,"Cluster_796","Porites_evermani_scaffold_1083:126260-127260",158,-20.56,2,20,528,553,22,"72.73%","72.73%","Peve_00001501",0.952540564114941,0.196919699471481,0.978262075707395,"Q496Y0","LON peptidase N-terminal domain and RING finger protein 3 (RING finger protein 127)","Homo sapiens (Human)","","GO:0005737; GO:0046872; GO:0061630"
"3979",3979,"Cluster_796","Porites_evermani_scaffold_1097:114751-115751",150,-20.66,2,11,346,367,9,"100.00%","100.00%","Peve_00001684",NA,NA,NA,NA,NA,NA,NA,NA
"3980",3980,"Cluster_796","Porites_evermani_scaffold_1173:140788-141788",159,-20.54,2,21,964,987,21,"71.43%","76.19%","Peve_00002928",0.961840018833383,0.176437143176667,0.978262075707395,NA,NA,NA,NA,NA
"3981",3981,"Cluster_796","Porites_evermani_scaffold_1179:28510-29510",171,-26.29,2,20,279,300,18,"83.33%","83.33%","Peve_00002995",NA,NA,NA,NA,NA,NA,NA,NA
"3982",3982,"Cluster_796","Porites_evermani_scaffold_120:153762-154762",155,-22.33,2,17,330,354,18,"77.78%","77.78%","Peve_00003394",0.967624190154844,0.162436707605074,0.978262075707395,NA,NA,NA,NA,NA
"3983",3983,"Cluster_796","Porites_evermani_scaffold_1220:25746-26746",159,-21.14,2,20,856,877,18,"72.22%","77.78%","Peve_00003687",0.896041295083883,0.292861159135592,0.978262075707395,"Q9BUZ4","TNF receptor-associated factor 4 (EC 2.3.2.27) (Cysteine-rich domain associated with RING and Traf domains protein 1) (Metastatic lymph node gene 62 protein) (MLN 62) (RING finger protein 83)","Homo sapiens (Human)","activation of NF-kappaB-inducing kinase activity [GO:0007250]; apoptotic process [GO:0006915]; innate immune response [GO:0045087]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein kinase activity [GO:0045860]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of apoptotic process [GO:0042981]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; respiratory gaseous exchange by respiratory system [GO:0007585]; respiratory tube development [GO:0030323]","GO:0001650; GO:0005164; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005923; GO:0006915; GO:0007250; GO:0007585; GO:0008270; GO:0016740; GO:0019901; GO:0030323; GO:0031625; GO:0031996; GO:0042802; GO:0042981; GO:0043122; GO:0043161; GO:0045087; GO:0045860; GO:0046330; GO:0048471; GO:0050699"
"3984",3984,"Cluster_796","Porites_evermani_scaffold_1231:15846-16846",159,-21.5,2,20,652,673,18,"72.22%","77.78%","Peve_00003823",0.551466137042714,0.628137173913331,0.978262075707395,NA,NA,NA,NA,NA
"3985",3985,"Cluster_796","Porites_evermani_scaffold_1231:74169-74492",149,-20.62,2,18,182,203,16,"68.75%","75.00%","Peve_00003820",NA,NA,NA,NA,NA,NA,NA,NA
"3986",3986,"Cluster_796","Porites_evermani_scaffold_123:28197-29197",149,-20.16,2,21,716,737,20,"65.00%","80.00%","Peve_00003777",-0.263818554731366,0.830035967247487,0.995934364227446,"Q8BX17","Gem-associated protein 5 (Gemin5)","Mus musculus (Mouse)","regulation of translation [GO:0006417]; spliceosomal snRNP assembly [GO:0000387]; translation [GO:0006412]","GO:0000340; GO:0000387; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006412; GO:0006417; GO:0016604; GO:0017069; GO:0030619; GO:0030621; GO:0030622; GO:0032797; GO:0034718; GO:0034719; GO:0043022; GO:0097504"
"3987",3987,"Cluster_796","Porites_evermani_scaffold_123:28550-29550",149,-20.16,2,21,363,384,20,"65.00%","80.00%","Peve_00003796",0.972819121269784,0.148770052098636,0.978262075707395,"Q3SZX5","39S ribosomal protein L22, mitochondrial (L22mt) (MRP-L22)","Bos taurus (Bovine)","ribosome assembly [GO:0042255]; translation [GO:0006412]","GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0006412; GO:0015934; GO:0042255"
"3988",3988,"Cluster_796","Porites_evermani_scaffold_12:360887-361887",155,-21.3,2,21,311,334,21,"71.43%","71.43%","Peve_00003307",0.970364763865781,0.15537377839081,0.978262075707395,"Q3UZD5","Putative histone-lysine N-methyltransferase PRDM6 (EC 2.1.1.361) (PR domain zinc finger protein 6) (PR domain-containing protein 6) (PR domain-containing protein in smooth muscle)","Mus musculus (Mouse)","chromatin organization [GO:0006325]; histone methylation [GO:0016571]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of smooth muscle cell differentiation [GO:0051151]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008]; regulation of gene expression [GO:0010468]","GO:0000122; GO:0005634; GO:0006325; GO:0010468; GO:0016571; GO:0022008; GO:0042802; GO:0045892; GO:0046872; GO:0051151; GO:0140944"
"3989",3989,"Cluster_796","Porites_evermani_scaffold_126:287008-288008",154,-24.24,2,20,924,949,22,"68.18%","72.73%","Peve_00004194",NA,NA,NA,NA,NA,NA,NA,NA
"3990",3990,"Cluster_796","Porites_evermani_scaffold_1269:124091-125091",159,-21.52,2,21,284,306,20,"75.00%","75.00%","Peve_00004325",0.978984317525161,0.130746598857205,0.978262075707395,"Q5RKQ0","Pre-mRNA-splicing factor SPF27 (Protein BCAS2 homolog)","Danio rerio (Zebrafish) (Brachydanio rerio)","mRNA splicing, via spliceosome [GO:0000398]","GO:0000398; GO:0000974; GO:0005634; GO:0071007; GO:0071013"
"3991",3991,"Cluster_796","Porites_evermani_scaffold_127:149335-150335",153,-20.42,2,15,275,297,14,"85.71%","85.71%","Peve_00004338",0.976456950842253,0.138414704079759,0.978262075707395,"O08919","Numb-like protein","Mus musculus (Mouse)","adherens junction organization [GO:0034332]; axonogenesis [GO:0007409]; cytokine-mediated signaling pathway [GO:0019221]; forebrain development [GO:0030900]; lateral ventricle development [GO:0021670]; nervous system development [GO:0007399]; neuroblast division in subventricular zone [GO:0021849]; neuroblast proliferation [GO:0007405]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of neurogenesis [GO:0050769]; protein metabolic process [GO:0019538]; regulation of postsynapse assembly [GO:0150052]","GO:0005737; GO:0007399; GO:0007405; GO:0007409; GO:0019221; GO:0019538; GO:0021670; GO:0021849; GO:0030900; GO:0034332; GO:0050769; GO:0050775; GO:0098978; GO:0150052"
"3992",3992,"Cluster_796","Porites_evermani_scaffold_1284:137456-138456",160,-24.56,2,21,3,24,19,"73.68%","73.68%","Peve_00004552",0.974262551908609,0.144748395566316,0.978262075707395,"Q0PGG7","Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha)","Bos mutus grunniens (Wild yak) (Bos grunniens)","axonal transport of mitochondrion [GO:0019896]; cellular glucose homeostasis [GO:0001678]; cellular response to hypoxia [GO:0071456]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of gene expression [GO:0010468]; regulation of glycolytic process [GO:0006110]; regulation of protein neddylation [GO:2000434]; response to hypoxia [GO:0001666]; response to reactive oxygen species [GO:0000302]","GO:0000302; GO:0001223; GO:0001666; GO:0001678; GO:0003700; GO:0005634; GO:0005829; GO:0006110; GO:0010468; GO:0010575; GO:0016607; GO:0019896; GO:0043565; GO:0045893; GO:0045944; GO:0046982; GO:0061419; GO:0071456; GO:1900017; GO:1904115; GO:2000434"
"3993",3993,"Cluster_796","Porites_evermani_scaffold_1326:130879-131879",153,-20.05,2,21,554,573,19,"73.68%","73.68%","Peve_00005160",0.566381005350147,0.616686157310895,0.978262075707395,NA,NA,NA,NA,NA
"3994",3994,"Cluster_796","Porites_evermani_scaffold_1328:126358-127358",154,-21.63,2,18,880,899,16,"81.25%","81.25%","Peve_00005175",0.958427048217958,0.184211495156152,0.978262075707395,"Q9W6F8","Wnt inhibitory factor 1 (WIF-1)","Xenopus laevis (African clawed frog)","Wnt signaling pathway [GO:0016055]","GO:0005576; GO:0016055"
"3995",3995,"Cluster_796","Porites_evermani_scaffold_1339:101410-102410",146,-20.82,2,21,35,60,23,"65.22%","69.57%","Peve_00005330",-0.94700959824396,0.208175885915381,0.978262075707395,"Q923L3","CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1)","Mus musculus (Mouse)","conditioned place preference [GO:1990708]; female gonad development [GO:0008585]; glucose homeostasis [GO:0042593]; male gonad development [GO:0008584]; mammary gland branching involved in pregnancy [GO:0060745]; memory [GO:0007613]; oviduct epithelium development [GO:0035846]; startle response [GO:0001964]","GO:0001964; GO:0007613; GO:0008584; GO:0008585; GO:0016020; GO:0035846; GO:0042593; GO:0060745; GO:1990708"
"3996",3996,"Cluster_796","Porites_evermani_scaffold_135:308993-309993",147,-21.91,2,12,360,381,10,"90.00%","90.00%","Peve_00005510",NA,NA,NA,NA,NA,NA,NA,NA
"3997",3997,"Cluster_796","Porites_evermani_scaffold_135:308993-309993",151,-23,2,21,83,106,21,"66.67%","71.43%","Peve_00005510",NA,NA,NA,NA,NA,NA,NA,NA
"3998",3998,"Cluster_796","Porites_evermani_scaffold_1355:87735-88735",153,-22.47,2,19,222,245,19,"73.68%","73.68%","Peve_00005569",0.97495618963342,0.142776220137891,0.978262075707395,NA,NA,NA,NA,NA
"3999",3999,"Cluster_796","Porites_evermani_scaffold_1371:105876-106876",156,-20.59,2,17,974,995,15,"80.00%","80.00%","Peve_00005805",NA,NA,NA,NA,NA,NA,NA,NA
"4000",4000,"Cluster_796","Porites_evermani_scaffold_1454:40400-41400",164,-20.31,2,17,89,110,15,"86.67%","86.67%","Peve_00006895",0.764196238747659,0.446271791479654,0.978262075707395,"Q0IHH9","Speckle-type POZ protein B","Xenopus laevis (African clawed frog)","proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]","GO:0005634; GO:0016567; GO:0016607; GO:0031463; GO:0043161"
"4001",4001,"Cluster_796","Porites_evermani_scaffold_145:59442-60442",156,-21.68,2,20,566,587,19,"78.95%","78.95%","Peve_00006827",0.70111372196157,0.505373038839006,0.978262075707395,"Q9VX98","Density-regulated protein homolog","Drosophila melanogaster (Fruit fly)","formation of translation preinitiation complex [GO:0001731]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ecdysone receptor-mediated signaling pathway [GO:0120142]; positive regulation of insulin receptor signaling pathway [GO:0046628]; translation reinitiation [GO:0002188]","GO:0001731; GO:0002188; GO:0003729; GO:0003743; GO:0008284; GO:0032991; GO:0046628; GO:0048027; GO:0120142"
"4002",4002,"Cluster_796","Porites_evermani_scaffold_145:93479-94479",156,-21.68,2,20,582,603,19,"78.95%","78.95%","Peve_00006830",0.638913471981184,0.558768361393627,0.978262075707395,"Q9VX98","Density-regulated protein homolog","Drosophila melanogaster (Fruit fly)","formation of translation preinitiation complex [GO:0001731]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ecdysone receptor-mediated signaling pathway [GO:0120142]; positive regulation of insulin receptor signaling pathway [GO:0046628]; translation reinitiation [GO:0002188]","GO:0001731; GO:0002188; GO:0003729; GO:0003743; GO:0008284; GO:0032991; GO:0046628; GO:0048027; GO:0120142"
"4003",4003,"Cluster_796","Porites_evermani_scaffold_148:218375-219375",154,-20.36,2,16,188,211,16,"81.25%","81.25%","Peve_00007233",0.603367704040157,0.587650284922213,0.978262075707395,NA,NA,NA,NA,NA
"4004",4004,"Cluster_796","Porites_evermani_scaffold_1487:23375-24375",156,-23.78,2,19,591,617,22,"72.73%","77.27%","Peve_00007305",0.186938345559973,0.880287075619826,0.998813647719495,"Q9H6P5","Threonine aspartase 1 (Taspase-1) (EC 3.4.25.-) [Cleaved into: Threonine aspartase subunit alpha; Threonine aspartase subunit beta]","Homo sapiens (Human)","positive regulation of DNA-templated transcription [GO:0045893]; protein maturation [GO:0051604]; proteolysis [GO:0006508]","GO:0004298; GO:0005737; GO:0006508; GO:0042802; GO:0045893; GO:0051604"
"4005",4005,"Cluster_796","Porites_evermani_scaffold_1487:23375-24375",160,-24.97,2,13,74,95,11,"100.00%","100.00%","Peve_00007305",0.186938345559973,0.880287075619826,0.998813647719495,"Q9H6P5","Threonine aspartase 1 (Taspase-1) (EC 3.4.25.-) [Cleaved into: Threonine aspartase subunit alpha; Threonine aspartase subunit beta]","Homo sapiens (Human)","positive regulation of DNA-templated transcription [GO:0045893]; protein maturation [GO:0051604]; proteolysis [GO:0006508]","GO:0004298; GO:0005737; GO:0006508; GO:0042802; GO:0045893; GO:0051604"
"4006",4006,"Cluster_796","Porites_evermani_scaffold_1499:94388-95388",159,-20.2,2,21,701,723,20,"75.00%","75.00%","Peve_00007440",0.898740270652305,0.288966974174018,0.978262075707395,NA,NA,NA,NA,NA
"4007",4007,"Cluster_796","Porites_evermani_scaffold_1520:9908-10806",153,-22.62,2,19,399,421,18,"72.22%","77.78%","Peve_00007796",NA,NA,NA,NA,NA,NA,NA,NA
"4008",4008,"Cluster_796","Porites_evermani_scaffold_1542:111611-112611",141,-21.21,2,21,195,210,19,"68.42%","68.42%","Peve_00008021",0.965669677728435,0.167295558641099,0.978262075707395,NA,NA,NA,NA,NA
"4009",4009,"Cluster_796","Porites_evermani_scaffold_154:69154-70154",145,-20.14,2,10,903,924,8,"100.00%","100.00%","Peve_00007985",0.833297608729113,0.372900138966466,0.978262075707395,"P24733","Myosin heavy chain, striated muscle","Argopecten irradians (Bay scallop) (Aequipecten irradians)","","GO:0003774; GO:0005516; GO:0005524; GO:0016459; GO:0030016; GO:0032982; GO:0051015"
"4010",4010,"Cluster_796","Porites_evermani_scaffold_1582:37834-38834",154,-25.03,2,21,612,638,24,"70.83%","70.83%","Peve_00008546",-0.0696341159246928,0.955633640840684,0.999448381576871,NA,NA,NA,NA,NA
"4011",4011,"Cluster_796","Porites_evermani_scaffold_1582:4459-5459",141,-24.56,2,21,333,363,28,"64.29%","64.29%","Peve_00008549",-0.0696341159246929,0.955633640840684,0.999448381576871,NA,NA,NA,NA,NA
"4012",4012,"Cluster_796","Porites_evermani_scaffold_1615:21741-22741",161,-20.33,2,15,563,585,14,"92.86%","92.86%","Peve_00009015",0.973293871023552,0.147459204356048,0.978262075707395,NA,NA,NA,NA,NA
"4013",4013,"Cluster_796","Porites_evermani_scaffold_1645:56567-57567",167,-24.64,2,16,817,838,14,"92.86%","92.86%","Peve_00009349",-0.230619576706902,0.851849427203834,0.995934364227446,"P48733","Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form]","Bos taurus (Bovine)","antibacterial innate immune response [GO:0140367]; defense response to Gram-negative bacterium [GO:0050829]","GO:0000922; GO:0005201; GO:0005509; GO:0005576; GO:0005929; GO:0016020; GO:0016323; GO:0016324; GO:0031012; GO:0050829; GO:0060170; GO:0140367"
"4014",4014,"Cluster_796","Porites_evermani_scaffold_1685:2448-3448",151,-21.64,2,21,785,807,20,"70.00%","70.00%","Peve_00009803",0.49044438375108,0.673668957628754,0.978262075707395,"Q8BX80","Cytosolic endo-beta-N-acetylglucosaminidase (ENGase) (EC 3.2.1.96)","Mus musculus (Mouse)","protein deglycosylation [GO:0006517]","GO:0004553; GO:0005829; GO:0006517; GO:0033925"
"4015",4015,"Cluster_796","Porites_evermani_scaffold_1757:68318-69318",161,-25.57,2,21,542,563,20,"80.00%","80.00%","Peve_00010632",0.958509092507096,0.184028356834782,0.978262075707395,NA,NA,NA,NA,NA
"4016",4016,"Cluster_796","Porites_evermani_scaffold_176:69805-70805",156,-20.59,2,17,838,859,15,"80.00%","80.00%","Peve_00010660",NA,NA,NA,NA,NA,NA,NA,NA
"4017",4017,"Cluster_796","Porites_evermani_scaffold_178:318600-319600",162,-23.21,2,21,898,922,22,"77.27%","77.27%","Peve_00010867",0.962730061982991,0.174354279819385,0.978262075707395,NA,NA,NA,NA,NA
"4018",4018,"Cluster_796","Porites_evermani_scaffold_1839:25123-26123",154,-23.9,2,20,925,950,22,"68.18%","72.73%","Peve_00011578",NA,NA,NA,NA,NA,NA,NA,NA
"4019",4019,"Cluster_796","Porites_evermani_scaffold_185:147258-148258",150,-20.83,2,21,763,787,22,"68.18%","72.73%","Peve_00011701",0.935830149880896,0.229303578726346,0.978262075707395,"Q96I24","Far upstream element-binding protein 3 (FUSE-binding protein 3)","Homo sapiens (Human)","DNA-templated transcription [GO:0006351]; intracellular mRNA localization [GO:0008298]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]","GO:0003697; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005840; GO:0005844; GO:0006351; GO:0008298; GO:0010468; GO:0010628; GO:0016020; GO:0043025; GO:0043198; GO:0045893; GO:0045944"
"4020",4020,"Cluster_796","Porites_evermani_scaffold_1862:55071-56071",156,-23.41,2,15,64,84,13,"92.31%","92.31%","Peve_00011838",NA,NA,NA,NA,NA,NA,NA,NA
"4021",4021,"Cluster_796","Porites_evermani_scaffold_1863:41053-42053",154,-28.79,2,21,237,261,22,"72.73%","72.73%","Peve_00011847",-0.740964450036716,0.468737368422893,0.978262075707395,NA,NA,NA,NA,NA
"4022",4022,"Cluster_796","Porites_evermani_scaffold_1864:26530-27530",151,-24.18,2,20,478,499,18,"66.67%","72.22%","Peve_00011856",0.910098911601109,0.272010844915855,0.978262075707395,NA,NA,NA,NA,NA
"4023",4023,"Cluster_796","Porites_evermani_scaffold_1928:15476-16476",140,-21.31,2,9,107,128,7,"100.00%","100.00%","Peve_00012591",0.999716689332843,0.01515433341596,0.745846175256963,"Q8INF0","Soluble guanylate cyclase 88E (EC 4.6.1.2)","Drosophila melanogaster (Fruit fly)","cGMP-mediated signaling [GO:0019934]; nitric oxide-cGMP-mediated signaling pathway [GO:0038060]; response to hypoxia [GO:0001666]; response to oxygen levels [GO:0070482]; response to reactive oxygen species [GO:0000302]","GO:0000302; GO:0001666; GO:0003924; GO:0004383; GO:0005525; GO:0008074; GO:0019825; GO:0019826; GO:0019899; GO:0019934; GO:0020037; GO:0038060; GO:0042803; GO:0046872; GO:0046982; GO:0070025; GO:0070026; GO:0070482"
"4024",4024,"Cluster_796","Porites_evermani_scaffold_1944:74843-75843",161,-22.21,2,18,531,552,16,"81.25%","81.25%","Peve_00012770",NA,NA,NA,"P58544","BTB/POZ domain-containing protein 1 (Glucose signal-repressing protein)","Mus musculus (Mouse)","muscle organ development [GO:0007517]; neurogenesis [GO:0022008]; protein ubiquitination [GO:0016567]","GO:0000932; GO:0005654; GO:0005829; GO:0007517; GO:0016567; GO:0022008; GO:0032991; GO:0036464; GO:0042802; GO:0097602"
"4025",4025,"Cluster_796","Porites_evermani_scaffold_200:19346-20346",160,-24.94,2,20,694,713,18,"77.78%","83.33%","Peve_00013571",NA,NA,NA,"B8VIU6","Uncharacterized skeletal organic matrix protein 5 (Uncharacterized SOMP-5)","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0005576"
"4026",4026,"Cluster_796","Porites_evermani_scaffold_2102:9019-10019",148,-20.37,2,19,71,91,17,"70.59%","76.47%","Peve_00014622",-0.134133909627006,0.914349543642654,0.999448381576871,"Q5BK63","NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial (Complex I-39kD) (CI-39kD) (NADH-ubiquinone oxidoreductase 39 kDa subunit) (Sperm flagella protein 3)","Rattus norvegicus (Rat)","circadian rhythm [GO:0007623]; mitochondrial respiratory chain complex I assembly [GO:0032981]; response to glucose [GO:0009749]; ubiquinone-6 biosynthetic process [GO:1901006]","GO:0003954; GO:0005739; GO:0005743; GO:0005747; GO:0005759; GO:0007623; GO:0009749; GO:0031966; GO:0032981; GO:0044877; GO:1901006"
"4027",4027,"Cluster_796","Porites_evermani_scaffold_212:121484-122484",151,-21.45,2,21,272,290,19,"73.68%","78.95%","Peve_00014759",-0.689412973456555,0.515737126915123,0.978262075707395,NA,NA,NA,NA,NA
"4028",4028,"Cluster_796","Porites_evermani_scaffold_213:316304-317304",153,-21.62,2,16,360,380,14,"85.71%","85.71%","Peve_00014878",0.458454686085754,0.696806265643592,0.978262075707395,NA,NA,NA,NA,NA
"4029",4029,"Cluster_796","Porites_evermani_scaffold_2152:58408-59408",168,-23.35,2,21,249,270,19,"78.95%","78.95%","Peve_00015088",NA,NA,NA,NA,NA,NA,NA,NA
"4030",4030,"Cluster_796","Porites_evermani_scaffold_2160:6084-7084",154,-20.78,2,21,825,845,19,"68.42%","78.95%","Peve_00015159",NA,NA,NA,NA,NA,NA,NA,NA
"4031",4031,"Cluster_796","Porites_evermani_scaffold_2160:6588-7084",154,-20.78,2,21,321,341,19,"68.42%","78.95%","Peve_00015156",NA,NA,NA,NA,NA,NA,NA,NA
"4032",4032,"Cluster_796","Porites_evermani_scaffold_2252:5165-6165",145,-21.55,2,10,522,543,8,"100.00%","100.00%","Peve_00016078",0.653969693663706,0.546204747039265,0.978262075707395,"Q5TCS8","Adenylate kinase 9 (AK 9) (EC 2.7.4.4) (EC 2.7.4.6) (Adenylate kinase domain-containing protein 1) (Adenylate kinase domain-containing protein 2)","Homo sapiens (Human)","AMP phosphorylation [GO:0006756]; ATP generation from ADP [GO:0006757]; CDP phosphorylation [GO:0061508]; CMP phosphorylation [GO:0061566]; dADP phosphorylation [GO:0006174]; dAMP phosphorylation [GO:0061565]; dCDP phosphorylation [GO:0061570]; dCMP phosphorylation [GO:0061567]; dGDP phosphorylation [GO:0006186]; GDP phosphorylation [GO:0061568]; TDP phosphorylation [GO:0061571]; UDP phosphorylation [GO:0061569]","GO:0004017; GO:0004550; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006174; GO:0006186; GO:0006756; GO:0006757; GO:0031965; GO:0050145; GO:0061508; GO:0061565; GO:0061566; GO:0061567; GO:0061568; GO:0061569; GO:0061570; GO:0061571"
"4033",4033,"Cluster_796","Porites_evermani_scaffold_226:221368-222368",148,-20.33,2,21,562,583,19,"63.16%","68.42%","Peve_00016143",NA,NA,NA,NA,NA,NA,NA,NA
"4034",4034,"Cluster_796","Porites_evermani_scaffold_2305:36571-36754",164,-22.53,2,20,165,183,18,"83.33%","83.33%","Peve_00016626",-0.22175116957274,0.857645461615644,0.995934364227446,"B4LMA2","Ell-associated factor Eaf","Drosophila virilis (Fruit fly)","positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA-templated transcription in response to stress [GO:0043620]","GO:0005654; GO:0032783; GO:0043620; GO:0045893"
"4035",4035,"Cluster_796","Porites_evermani_scaffold_2305:36571-36754",164,-22.53,2,20,165,183,18,"83.33%","83.33%","Peve_00016622",0.543236220189774,0.634397607663781,0.978262075707395,"Q568B7","Glycosyltransferase-like domain-containing protein 1","Danio rerio (Zebrafish) (Brachydanio rerio)","central nervous system development [GO:0007417]","GO:0007417; GO:0016757"
"4036",4036,"Cluster_796","Porites_evermani_scaffold_2342:65381-66381",156,-21.34,2,21,411,434,22,"77.27%","77.27%","Peve_00016943",NA,NA,NA,NA,NA,NA,NA,NA
"4037",4037,"Cluster_796","Porites_evermani_scaffold_243:152672-153672",157,-24.44,2,19,913,935,18,"77.78%","77.78%","Peve_00017767",0.648923065626866,0.550439391500194,0.978262075707395,"Q5TJE1","Death domain-associated protein 6 (Daxx)","Canis lupus familiaris (Dog) (Canis familiaris)","androgen receptor signaling pathway [GO:0030521]; cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to diamide [GO:0072738]; cellular response to heat [GO:0034605]; cellular response to sodium arsenite [GO:1903936]; cellular response to unfolded protein [GO:0034620]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; JNK cascade [GO:0007254]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; nucleosome assembly [GO:0006334]; positive regulation of neuron death [GO:1901216]; positive regulation of protein kinase activity [GO:0045860]; regulation of apoptotic process [GO:0042981]; regulation of protein ubiquitination [GO:0031396]","GO:0000775; GO:0002039; GO:0003713; GO:0003714; GO:0005634; GO:0005730; GO:0005829; GO:0006334; GO:0007254; GO:0008625; GO:0010629; GO:0016605; GO:0019901; GO:0030295; GO:0030521; GO:0031396; GO:0031625; GO:0034605; GO:0034620; GO:0042393; GO:0042803; GO:0042981; GO:0045860; GO:0045892; GO:0047485; GO:0050681; GO:0061629; GO:0071276; GO:0071280; GO:0072738; GO:0140037; GO:0140416; GO:1901216; GO:1903936"
"4038",4038,"Cluster_796","Porites_evermani_scaffold_245:221376-222376",147,-21.12,2,21,437,462,23,"65.22%","65.22%","Peve_00017938",NA,NA,NA,NA,NA,NA,NA,NA
"4039",4039,"Cluster_796","Porites_evermani_scaffold_2491:12636-13636",147,-21.85,2,12,448,469,10,"90.00%","90.00%","Peve_00018297",NA,NA,NA,NA,NA,NA,NA,NA
"4040",4040,"Cluster_796","Porites_evermani_scaffold_249:330766-331766",158,-23.34,2,21,816,836,19,"73.68%","78.95%","Peve_00018268",0.898740270652305,0.288966974174018,0.978262075707395,NA,NA,NA,NA,NA
"4041",4041,"Cluster_796","Porites_evermani_scaffold_2521:44661-45661",153,-20.32,2,21,577,596,19,"73.68%","73.68%","Peve_00018633",0.0620423986634861,0.96047719899303,0.999448381576871,NA,NA,NA,NA,NA
"4042",4042,"Cluster_796","Porites_evermani_scaffold_2522:48083-49083",153,-20.56,2,21,950,971,20,"75.00%","75.00%","Peve_00018635",0.600212510635634,0.59016534315994,0.978262075707395,NA,NA,NA,NA,NA
"4043",4043,"Cluster_796","Porites_evermani_scaffold_2544:8111-9111",158,-23.04,2,20,636,658,19,"73.68%","78.95%","Peve_00018805",0.469552667185898,0.688830409851043,0.978262075707395,"Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"4044",4044,"Cluster_796","Porites_evermani_scaffold_2560:30294-31294",154,-21,2,21,764,787,21,"71.43%","76.19%","Peve_00018915",0.937592379919572,0.226099100090114,0.978262075707395,"B8VIU6","Uncharacterized skeletal organic matrix protein 5 (Uncharacterized SOMP-5)","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0005576"
"4045",4045,"Cluster_796","Porites_evermani_scaffold_2560:68398-69398",154,-21,2,21,630,653,21,"71.43%","76.19%","Peve_00018913",NA,NA,NA,NA,NA,NA,NA,NA
"4046",4046,"Cluster_796","Porites_evermani_scaffold_2571:3413-4413",145,-23.57,2,21,1,25,22,"68.18%","72.73%","Peve_00018994",NA,NA,NA,NA,NA,NA,NA,NA
"4047",4047,"Cluster_796","Porites_evermani_scaffold_260:90764-91764",164,-26.5,2,21,773,798,23,"82.61%","82.61%","Peve_00019274",NA,NA,NA,NA,NA,NA,NA,NA
"4048",4048,"Cluster_796","Porites_evermani_scaffold_2611:29263-30263",151,-20.35,2,20,321,342,18,"66.67%","72.22%","Peve_00019372",-0.0696341159246928,0.955633640840684,0.999448381576871,NA,NA,NA,NA,NA
"4049",4049,"Cluster_796","Porites_evermani_scaffold_2629:23846-24846",157,-21.41,2,20,275,295,18,"77.78%","77.78%","Peve_00019490",0.909478464653368,0.272962462023684,0.978262075707395,NA,NA,NA,NA,NA
"4050",4050,"Cluster_796","Porites_evermani_scaffold_2716:7447-8447",161,-25.96,2,21,879,900,20,"80.00%","80.00%","Peve_00020229",NA,NA,NA,"P79945","High-affinity lysophosphatidic acid receptor (PSP24)","Xenopus laevis (African clawed frog)","","GO:0004930; GO:0005886"
"4051",4051,"Cluster_796","Porites_evermani_scaffold_2778:14912-15912",173,-28.6,2,19,106,128,18,"88.89%","88.89%","Peve_00020700",0.898740270652305,0.288966974174018,0.978262075707395,NA,NA,NA,NA,NA
"4052",4052,"Cluster_796","Porites_evermani_scaffold_2782:51226-52226",153,-20.59,2,21,207,228,20,"75.00%","75.00%","Peve_00020747",-0.0696341159246928,0.955633640840684,0.999448381576871,NA,NA,NA,NA,NA
"4053",4053,"Cluster_796","Porites_evermani_scaffold_279:50709-51709",140,-22.4,2,9,19,40,7,"100.00%","100.00%","Peve_00020798",0.898740270652305,0.288966974174018,0.978262075707395,"Q2UPB1","Cytochrome P450 monooxygenase aclC (EC 1.-.-.-) (Aspirochlorine biosynthesis protein C)","Aspergillus oryzae (strain ATCC 42149 / RIB 40) (Yellow koji mold)","","GO:0004497; GO:0005506; GO:0016705; GO:0020037"
"4054",4054,"Cluster_796","Porites_evermani_scaffold_2806:35850-36850",154,-22.61,2,20,868,892,21,"71.43%","71.43%","Peve_00020963",NA,NA,NA,NA,NA,NA,NA,NA
"4055",4055,"Cluster_796","Porites_evermani_scaffold_2835:47496-48496",158,-23.73,2,21,733,753,19,"73.68%","78.95%","Peve_00021179",NA,NA,NA,"P52303","AP-1 complex subunit beta-1 (Adaptor protein complex AP-1 subunit beta-1) (Adaptor-related protein complex 1 subunit beta-1) (Beta-1-adaptin) (Beta-adaptin 1) (Clathrin assembly protein complex 1 beta large chain) (Golgi adaptor HA1/AP1 adaptin beta subunit)","Rattus norvegicus (Rat)","clathrin coat assembly [GO:0048268]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; kidney development [GO:0001822]; vesicle-mediated transport [GO:0016192]","GO:0001822; GO:0005794; GO:0006886; GO:0007368; GO:0007507; GO:0016192; GO:0019901; GO:0030118; GO:0030131; GO:0030276; GO:0030665; GO:0048268; GO:0120283"
"4056",4056,"Cluster_796","Porites_evermani_scaffold_287:25734-26734",148,-20.11,2,21,363,384,19,"57.89%","73.68%","Peve_00021437",NA,NA,NA,NA,NA,NA,NA,NA
"4057",4057,"Cluster_796","Porites_evermani_scaffold_295:150499-151499",152,-20.04,2,21,475,496,19,"68.42%","68.42%","Peve_00022048",NA,NA,NA,NA,NA,NA,NA,NA
"4058",4058,"Cluster_796","Porites_evermani_scaffold_2963:48245-49245",149,-20.34,2,20,155,179,21,"71.43%","71.43%","Peve_00022152",0.92600833540563,0.246434468438384,0.978262075707395,NA,NA,NA,NA,NA
"4059",4059,"Cluster_796","Porites_evermani_scaffold_2967:17295-18295",164,-23.43,2,21,979,1000,19,"73.68%","78.95%","Peve_00022170",0.898740270652305,0.288966974174018,0.978262075707395,NA,NA,NA,NA,NA
"4060",4060,"Cluster_796","Porites_evermani_scaffold_298:199356-200356",160,-23,2,21,956,977,19,"73.68%","73.68%","Peve_00022287",NA,NA,NA,NA,NA,NA,NA,NA
"4061",4061,"Cluster_796","Porites_evermani_scaffold_306:49756-50756",157,-22.21,2,21,594,616,21,"76.19%","76.19%","Peve_00023036",0.306535685137341,0.801660241324014,0.995934364227446,"Q8N0W4","Neuroligin-4, X-linked (Neuroligin X) (HNLX)","Homo sapiens (Human)","adult behavior [GO:0030534]; brainstem development [GO:0003360]; cell-cell junction organization [GO:0045216]; cerebellum development [GO:0021549]; chemical synaptic transmission [GO:0007268]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of excitatory postsynaptic potential [GO:0090394]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; organ growth [GO:0035265]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; social behavior [GO:0035176]; synapse organization [GO:0050808]; synaptic vesicle endocytosis [GO:0048488]; vocalization behavior [GO:0071625]","GO:0003360; GO:0005886; GO:0007158; GO:0007268; GO:0007612; GO:0009986; GO:0016020; GO:0021549; GO:0030182; GO:0030425; GO:0030534; GO:0031404; GO:0035176; GO:0035265; GO:0038023; GO:0042043; GO:0042803; GO:0045202; GO:0045216; GO:0048488; GO:0050804; GO:0050808; GO:0050839; GO:0060076; GO:0071625; GO:0090394; GO:0097104; GO:0097105; GO:0097110; GO:0098793; GO:0098839; GO:0098983; GO:0098985; GO:0099054; GO:0099634"
"4062",4062,"Cluster_796","Porites_evermani_scaffold_3130:32798-33798",163,-27.96,2,21,22,44,20,"75.00%","80.00%","Peve_00023602",NA,NA,NA,NA,NA,NA,NA,NA
"4063",4063,"Cluster_796","Porites_evermani_scaffold_315:130045-131045",164,-22.29,2,20,632,653,19,"84.21%","84.21%","Peve_00023721",-0.260673821044655,0.832110577241118,0.995934364227446,NA,NA,NA,NA,NA
"4064",4064,"Cluster_796","Porites_evermani_scaffold_317:122255-123255",152,-22.77,2,19,149,172,19,"73.68%","78.95%","Peve_00023833",NA,NA,NA,NA,NA,NA,NA,NA
"4065",4065,"Cluster_796","Porites_evermani_scaffold_317:127274-128274",159,-25.02,2,18,81,104,18,"83.33%","83.33%","Peve_00023834",NA,NA,NA,NA,NA,NA,NA,NA
"4066",4066,"Cluster_796","Porites_evermani_scaffold_3223:6291-7291",159,-23.11,2,21,199,217,19,"78.95%","84.21%","Peve_00024166",-0.499832479528843,0.666789804960188,0.978262075707395,"Q5T6L9","Endoplasmic reticulum membrane-associated RNA degradation protein (ER membrane-associated RNA degradation protein)","Homo sapiens (Human)","","GO:0005789"
"4067",4067,"Cluster_796","Porites_evermani_scaffold_3283:15525-16525",147,-21.87,2,17,655,677,16,"75.00%","75.00%","Peve_00024498",0.214437512206701,0.862416339066075,0.996660710141104,NA,NA,NA,NA,NA
"4068",4068,"Cluster_796","Porites_evermani_scaffold_333:117107-118107",163,-24.01,2,21,69,93,22,"72.73%","77.27%","Peve_00024838",NA,NA,NA,NA,NA,NA,NA,NA
"4069",4069,"Cluster_796","Porites_evermani_scaffold_3349:27581-28581",152,-20.99,2,13,973,994,11,"90.91%","90.91%","Peve_00024955",NA,NA,NA,NA,NA,NA,NA,NA
"4070",4070,"Cluster_796","Porites_evermani_scaffold_335:192927-193927",150,-23.45,2,21,878,898,19,"68.42%","73.68%","Peve_00024978",0.762513015856009,0.447930627854973,0.978262075707395,"Q9C026","E3 ubiquitin-protein ligase TRIM9 (EC 2.3.2.27) (RING finger protein 91) (RING-type E3 ubiquitin transferase TRIM9) (Tripartite motif-containing protein 9)","Homo sapiens (Human)","proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]","GO:0005737; GO:0005856; GO:0008021; GO:0008270; GO:0019904; GO:0030425; GO:0042803; GO:0043161; GO:0061630"
"4071",4071,"Cluster_796","Porites_evermani_scaffold_335:193226-194226",150,-23.45,2,21,579,599,19,"68.42%","73.68%","Peve_00024979",NA,NA,NA,"Q91ZY8","E3 ubiquitin-protein ligase TRIM9 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TRIM9) (SNAP-25-interacting RING finger protein) (Tripartite motif-containing protein 9)","Rattus norvegicus (Rat)","negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of SNARE complex assembly [GO:0035544]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; synaptic vesicle exocytosis [GO:0016079]","GO:0000149; GO:0005737; GO:0005856; GO:0008021; GO:0008270; GO:0016079; GO:0019904; GO:0030425; GO:0035544; GO:0042803; GO:0043161; GO:0045955; GO:0061630; GO:0099523"
"4072",4072,"Cluster_796","Porites_evermani_scaffold_34:286401-287401",158,-25.15,2,20,18,40,19,"73.68%","78.95%","Peve_00025281",NA,NA,NA,NA,NA,NA,NA,NA
"4073",4073,"Cluster_796","Porites_evermani_scaffold_3460:17255-18255",147,-20.25,2,21,724,748,22,"63.64%","68.18%","Peve_00025688",NA,NA,NA,NA,NA,NA,NA,NA
"4074",4074,"Cluster_796","Porites_evermani_scaffold_352:150396-151396",157,-20.85,2,19,156,179,19,"73.68%","78.95%","Peve_00026077",0.920961491027763,0.254810526947155,0.978262075707395,"Q4GZT3","Polycystin-2 (Polycystic kidney disease 2 protein homolog) (Transient receptor potential cation channel subfamily P member 2)","Bos taurus (Bovine)","calcium ion transmembrane transport [GO:0070588]; cell-cell signaling by wnt [GO:0198738]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus [GO:0050982]; inorganic cation transmembrane transport [GO:0098662]; potassium ion transmembrane transport [GO:0071805]; protein heterotetramerization [GO:0051290]; protein tetramerization [GO:0051262]; regulation of ion transmembrane transport [GO:0034765]; release of sequestered calcium ion into cytosol [GO:0051209]; Wnt signaling pathway [GO:0016055]","GO:0002133; GO:0005102; GO:0005245; GO:0005248; GO:0005261; GO:0005262; GO:0005267; GO:0005509; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0005929; GO:0015271; GO:0016020; GO:0016055; GO:0016323; GO:0030659; GO:0034703; GO:0034765; GO:0050982; GO:0051209; GO:0051262; GO:0051290; GO:0051371; GO:0060170; GO:0070588; GO:0071277; GO:0071805; GO:0098662; GO:0198738"
"4075",4075,"Cluster_796","Porites_evermani_scaffold_3592:21177-22177",154,-22.4,2,21,754,774,19,"73.68%","73.68%","Peve_00026480",0.997091645416707,0.0485650802695336,0.947582413903802,NA,NA,NA,NA,NA
"4076",4076,"Cluster_796","Porites_evermani_scaffold_3636:24038-25038",156,-21.58,2,19,363,388,21,"76.19%","76.19%","Peve_00026747",0.453879264571473,0.700079474452228,0.978262075707395,NA,NA,NA,NA,NA
"4077",4077,"Cluster_796","Porites_evermani_scaffold_3694:3460-4460",155,-20.58,2,20,852,873,18,"72.22%","72.22%","Peve_00027036",-0.802356983256044,0.407158102085476,0.978262075707395,NA,NA,NA,NA,NA
"4078",4078,"Cluster_796","Porites_evermani_scaffold_3741:4144-5144",159,-22.7,2,21,691,714,21,"71.43%","76.19%","Peve_00027294",0.443531930325746,0.707450552355467,0.978262075707395,"Q9NTJ4","Alpha-mannosidase 2C1 (EC 3.2.1.24) (Alpha mannosidase 6A8B) (Alpha-D-mannoside mannohydrolase) (Mannosidase alpha class 2C member 1)","Homo sapiens (Human)","mannose metabolic process [GO:0006013]; oligosaccharide catabolic process [GO:0009313]","GO:0004559; GO:0005654; GO:0005829; GO:0006013; GO:0009313; GO:0030246; GO:0046872"
"4079",4079,"Cluster_796","Porites_evermani_scaffold_3760:11579-12579",159,-23.9,2,21,856,878,20,"70.00%","80.00%","Peve_00027402",NA,NA,NA,"O43854","EGF-like repeat and discoidin I-like domain-containing protein 3 (Developmentally-regulated endothelial cell locus 1 protein) (Integrin-binding protein DEL1)","Homo sapiens (Human)","cell adhesion [GO:0007155]; positive regulation of cell-substrate adhesion [GO:0010811]","GO:0005178; GO:0005509; GO:0007155; GO:0010811; GO:0062023; GO:0070062; GO:1903561"
"4080",4080,"Cluster_796","Porites_evermani_scaffold_3849:16797-17797",155,-22.1,2,21,824,848,22,"63.64%","77.27%","Peve_00027875",-0.0696341159246928,0.955633640840684,0.999448381576871,NA,NA,NA,NA,NA
"4081",4081,"Cluster_796","Porites_evermani_scaffold_390:230931-231931",153,-22.06,2,19,523,546,19,"68.42%","78.95%","Peve_00028200",-0.999345888781346,0.0230273835955368,0.844611056711255,NA,NA,NA,NA,NA
"4082",4082,"Cluster_796","Porites_evermani_scaffold_393:218557-219557",168,-20.48,2,21,83,104,19,"78.95%","78.95%","Peve_00028355",0.898740270652305,0.288966974174018,0.978262075707395,NA,NA,NA,NA,NA
"4083",4083,"Cluster_796","Porites_evermani_scaffold_393:272703-273703",154,-20.11,2,15,205,226,13,"84.62%","84.62%","Peve_00028365",0.906302651854233,0.277785513165396,0.978262075707395,"Q91819","Aurora kinase A-B (EC 2.7.11.1) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (Serine/threonine-protein kinase 6-B) (Serine/threonine-protein kinase Eg2-B) (Serine/threonine-protein kinase aurora-A) (p46XlEg22)","Xenopus laevis (African clawed frog)","cell division [GO:0051301]; meiotic spindle organization [GO:0000212]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]","GO:0000212; GO:0000922; GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005813; GO:0005876; GO:0007100; GO:0008017; GO:0018105; GO:0019894; GO:0046777; GO:0051301; GO:0090307; GO:0106310"
"4084",4084,"Cluster_796","Porites_evermani_scaffold_401:273262-274262",151,-20.92,2,13,958,980,12,"91.67%","91.67%","Peve_00028903",-0.509666752167641,0.659537390867082,0.978262075707395,NA,NA,NA,NA,NA
"4085",4085,"Cluster_796","Porites_evermani_scaffold_402:30201-31201",148,-22.3,2,21,23,44,19,"63.16%","68.42%","Peve_00028934",-0.298735405666212,0.806870394585836,0.995934364227446,"Q3T1L0","Aldehyde dehydrogenase family 16 member A1","Rattus norvegicus (Rat)","","GO:0016620"
"4086",4086,"Cluster_796","Porites_evermani_scaffold_4033:17499-18499",154,-21.24,2,20,844,867,20,"70.00%","75.00%","Peve_00029017",0.886088384314953,0.306824919544725,0.978262075707395,NA,NA,NA,NA,NA
"4087",4087,"Cluster_796","Porites_evermani_scaffold_417:113360-114360",153,-20.43,2,15,261,283,14,"85.71%","85.71%","Peve_00029690",0.574508435125785,0.610386501422527,0.978262075707395,NA,NA,NA,NA,NA
"4088",4088,"Cluster_796","Porites_evermani_scaffold_4209:16800-17800",153,-20.05,2,21,415,434,19,"73.68%","73.68%","Peve_00029912",-0.829106154727612,0.377699692492649,0.978262075707395,NA,NA,NA,NA,NA
"4089",4089,"Cluster_796","Porites_evermani_scaffold_4255:16493-17493",159,-22.18,2,21,214,236,20,"75.00%","75.00%","Peve_00030158",NA,NA,NA,NA,NA,NA,NA,NA
"4090",4090,"Cluster_796","Porites_evermani_scaffold_426:173497-174497",153,-20.73,2,21,120,141,20,"75.00%","75.00%","Peve_00030181",NA,NA,NA,NA,NA,NA,NA,NA
"4091",4091,"Cluster_796","Porites_evermani_scaffold_426:247192-248192",153,-20.73,2,21,29,50,20,"75.00%","75.00%","Peve_00030188",0.807277041858456,0.401880690898384,0.978262075707395,"F1MBP6","Kelch-like protein 3","Bos taurus (Bovine)","distal tubule morphogenesis [GO:0072156]; gene expression [GO:0010467]; ion homeostasis [GO:0050801]; potassium ion homeostasis [GO:0055075]; protein K48-linked ubiquitination [GO:0070936]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; renal sodium ion absorption [GO:0070294]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0003779; GO:0005829; GO:0005856; GO:0006468; GO:0006511; GO:0010467; GO:0016567; GO:0031463; GO:0050801; GO:0055075; GO:0070294; GO:0070936; GO:0072156; GO:0097602"
"4092",4092,"Cluster_796","Porites_evermani_scaffold_427:180769-181769",150,-21.01,2,11,863,884,9,"100.00%","100.00%","Peve_00030235",0.0791385112047031,0.949566121537491,0.999448381576871,NA,NA,NA,NA,NA
"4093",4093,"Cluster_796","Porites_evermani_scaffold_4359:21467-22467",148,-20.91,2,21,116,135,19,"73.68%","73.68%","Peve_00030698",0.898740270652305,0.288966974174018,0.978262075707395,NA,NA,NA,NA,NA
"4094",4094,"Cluster_796","Porites_evermani_scaffold_4364:26050-27050",160,-21.81,2,20,56,77,19,"78.95%","84.21%","Peve_00030724",-0.0152016147554317,0.990321978702845,0.999448381576871,NA,NA,NA,NA,NA
"4095",4095,"Cluster_796","Porites_evermani_scaffold_43:7593-8593",160,-24.41,2,21,182,203,19,"68.42%","78.95%","Peve_00030409",0.97676207230191,0.1375113144891,0.978262075707395,NA,NA,NA,NA,NA
"4096",4096,"Cluster_796","Porites_evermani_scaffold_440:218431-219431",156,-21.82,2,21,462,483,19,"68.42%","73.68%","Peve_00030954",NA,NA,NA,NA,NA,NA,NA,NA
"4097",4097,"Cluster_796","Porites_evermani_scaffold_441:81231-81577",150,-20.94,2,21,53,79,24,"66.67%","70.83%","Peve_00031018",NA,NA,NA,NA,NA,NA,NA,NA
"4098",4098,"Cluster_796","Porites_evermani_scaffold_441:92747-93093",150,-20.94,2,21,53,79,24,"66.67%","70.83%","Peve_00031021",NA,NA,NA,NA,NA,NA,NA,NA
"4099",4099,"Cluster_796","Porites_evermani_scaffold_443:48290-49290",161,-22.64,2,21,764,783,19,"78.95%","78.95%","Peve_00031115",NA,NA,NA,NA,NA,NA,NA,NA
"4100",4100,"Cluster_796","Porites_evermani_scaffold_451:122070-123070",151,-20.8,2,21,979,996,19,"73.68%","73.68%","Peve_00031516",0.898740270652305,0.288966974174018,0.978262075707395,"Q96MS0","Roundabout homolog 3 (Roundabout-like protein 3)","Homo sapiens (Human)","axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]","GO:0005886; GO:0007156; GO:0007411; GO:0016020; GO:0016199; GO:0030424; GO:0070593; GO:0098632"
"4101",4101,"Cluster_796","Porites_evermani_scaffold_4520:5995-6995",158,-20.6,2,21,156,179,21,"76.19%","76.19%","Peve_00031570",NA,NA,NA,NA,NA,NA,NA,NA
"4102",4102,"Cluster_796","Porites_evermani_scaffold_45:429558-430558",157,-20.12,2,20,766,786,18,"77.78%","77.78%","Peve_00031471",0.816737378003045,0.391560956900691,0.978262075707395,NA,NA,NA,NA,NA
"4103",4103,"Cluster_796","Porites_evermani_scaffold_4633:4292-5292",146,-20.12,2,21,580,600,19,"68.42%","68.42%","Peve_00032049",-0.829106154727612,0.377699692492649,0.978262075707395,NA,NA,NA,NA,NA
"4104",4104,"Cluster_796","Porites_evermani_scaffold_467:171849-172849",166,-22.71,2,21,303,326,21,"76.19%","85.71%","Peve_00032194",0.53994701600748,0.636888532561546,0.978262075707395,"Q9V4P1","Anillin (Actin-binding protein 8) (ABP8) (Protein scraps)","Drosophila melanogaster (Fruit fly)","actomyosin contractile ring assembly [GO:0000915]; asymmetric cell division [GO:0008356]; cellularization [GO:0007349]; establishment of actomyosin contractile ring localization [GO:0032188]; intercellular bridge organization [GO:0043063]; male germline ring canal formation [GO:0030726]; male meiosis cytokinesis [GO:0007112]; mitotic cytokinesis [GO:0000281]; oogenesis [GO:0048477]; plasma membrane organization [GO:0007009]; pole cell formation [GO:0007279]; protein localization [GO:0008104]; regulation of cytokinesis [GO:0032465]; sensory organ development [GO:0007423]; sensory organ precursor cell division [GO:0045035]; septin ring organization [GO:0031106]","GO:0000281; GO:0000915; GO:0003779; GO:0005634; GO:0005737; GO:0005826; GO:0007009; GO:0007112; GO:0007279; GO:0007349; GO:0007423; GO:0008017; GO:0008104; GO:0008356; GO:0017022; GO:0030726; GO:0031106; GO:0032154; GO:0032188; GO:0032465; GO:0035323; GO:0043063; GO:0045035; GO:0045172; GO:0048477; GO:0051015; GO:0070938"
"4105",4105,"Cluster_796","Porites_evermani_scaffold_4742:0-976",159,-21.9,2,21,869,893,22,"72.73%","72.73%","Peve_00032522",NA,NA,NA,NA,NA,NA,NA,NA
"4106",4106,"Cluster_796","Porites_evermani_scaffold_480:91662-92662",151,-21.74,2,18,287,307,16,"75.00%","81.25%","Peve_00032762",0.655773560890289,0.544685205630072,0.978262075707395,NA,NA,NA,NA,NA
"4107",4107,"Cluster_796","Porites_evermani_scaffold_480:91662-92662",155,-23.74,2,18,248,268,16,"81.25%","81.25%","Peve_00032762",0.655773560890289,0.544685205630072,0.978262075707395,NA,NA,NA,NA,NA
"4108",4108,"Cluster_796","Porites_evermani_scaffold_48:711623-712623",153,-20.05,2,21,537,556,19,"73.68%","73.68%","Peve_00032726",0.8588453491702,0.342364612043199,0.978262075707395,NA,NA,NA,NA,NA
"4109",4109,"Cluster_796","Porites_evermani_scaffold_491:69417-70417",154,-22.48,2,21,680,705,23,"65.22%","78.26%","Peve_00033174",0.207533195982285,0.866912996968364,0.996752931127433,NA,NA,NA,NA,NA
"4110",4110,"Cluster_796","Porites_evermani_scaffold_496:191739-192739",154,-20.36,2,16,962,985,16,"81.25%","81.25%","Peve_00033362",0.771997239670134,0.438515782675808,0.978262075707395,NA,NA,NA,NA,NA
"4111",4111,"Cluster_796","Porites_evermani_scaffold_5027:2227-3227",152,-20.64,2,18,892,914,17,"76.47%","76.47%","Peve_00033746",0.942657095057371,0.216636905599029,0.978262075707395,"Q8TEK3","Histone-lysine N-methyltransferase, H3 lysine-79 specific (EC 2.1.1.360) (DOT1-like protein) (Histone H3-K79 methyltransferase) (H3-K79-HMTase) (Lysine N-methyltransferase 4)","Homo sapiens (Human)","DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; gene expression [GO:0010467]; heterochromatin formation [GO:0031507]; histone H3-K79 methylation [GO:0034729]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of transcription regulatory region DNA binding [GO:2000677]; telomere organization [GO:0032200]","GO:0000077; GO:0003676; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0008284; GO:0010467; GO:0018024; GO:0031151; GO:0031507; GO:0032200; GO:0032991; GO:0034729; GO:0042054; GO:0043231; GO:0045944; GO:0046425; GO:0061629; GO:0140956; GO:2000677"
"4112",4112,"Cluster_796","Porites_evermani_scaffold_507:213202-214202",152,-20.88,2,21,661,685,23,"73.91%","73.91%","Peve_00033915",NA,NA,NA,"Q6GPE5","Protein fem-1 homolog B (FEM1b) (FEM1-beta)","Xenopus laevis (African clawed frog)","apoptotic process [GO:0006915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627]","GO:0005634; GO:0005737; GO:0006915; GO:0016567; GO:0031462; GO:0043161; GO:0140627; GO:1990756; GO:2000001"
"4113",4113,"Cluster_796","Porites_evermani_scaffold_5102:9005-10005",164,-26.5,2,21,795,820,23,"82.61%","82.61%","Peve_00034080",NA,NA,NA,NA,NA,NA,NA,NA
"4114",4114,"Cluster_796","Porites_evermani_scaffold_5102:9626-10005",164,-26.5,2,21,174,199,23,"82.61%","82.61%","Peve_00034079",NA,NA,NA,NA,NA,NA,NA,NA
"4115",4115,"Cluster_796","Porites_evermani_scaffold_523:137533-138216",163,-20.82,2,16,503,524,14,"85.71%","92.86%","Peve_00034490",NA,NA,NA,NA,NA,NA,NA,NA
"4116",4116,"Cluster_796","Porites_evermani_scaffold_523:137533-138216",163,-20.82,2,16,503,524,14,"85.71%","92.86%","Peve_00034482",-0.0696341159246929,0.955633640840684,0.999448381576871,"Q8K4L3","Supervillin (Archvillin) (p205/p250)","Mus musculus (Mouse)","actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; positive regulation of cytokinesis [GO:0032467]; skeletal muscle tissue development [GO:0007519]","GO:0002102; GO:0005546; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007519; GO:0008154; GO:0015629; GO:0030496; GO:0032154; GO:0032467; GO:0036449; GO:0042995; GO:0043034; GO:0051014; GO:0051015; GO:0051016; GO:0070161"
"4117",4117,"Cluster_796","Porites_evermani_scaffold_538:104394-105394",155,-20.59,2,12,290,311,10,"100.00%","100.00%","Peve_00035047",NA,NA,NA,NA,NA,NA,NA,NA
"4118",4118,"Cluster_796","Porites_evermani_scaffold_5490:649-1649",140,-22.48,2,9,181,202,7,"100.00%","100.00%","Peve_00035430",0.999102854913975,0.0269686331853911,0.890748160714267,"Q9NRM2","Zinc finger protein 277 (Nuclear receptor-interacting factor 4)","Homo sapiens (Human)","cellular response to hydrogen peroxide [GO:0070301]; regulation of cellular senescence [GO:2000772]","GO:0000978; GO:0005634; GO:0046872; GO:0070301; GO:2000772"
"4119",4119,"Cluster_796","Porites_evermani_scaffold_55:197932-198932",157,-20.03,2,19,76,100,20,"75.00%","75.00%","Peve_00035464",0.898740270652305,0.288966974174018,0.978262075707395,NA,NA,NA,NA,NA
"4120",4120,"Cluster_796","Porites_evermani_scaffold_5684:1536-2536",168,-21.86,2,21,863,884,19,"73.68%","84.21%","Peve_00036031",0.898740270652305,0.288966974174018,0.978262075707395,"O43435","T-box transcription factor TBX1 (T-box protein 1) (Testis-specific T-box protein)","Homo sapiens (Human)","angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; aorta morphogenesis [GO:0035909]; artery morphogenesis [GO:0048844]; blood vessel development [GO:0001568]; blood vessel morphogenesis [GO:0048514]; cell fate specification [GO:0001708]; cell population proliferation [GO:0008283]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to retinoic acid [GO:0071300]; cochlea morphogenesis [GO:0090103]; coronary artery morphogenesis [GO:0060982]; determination of left/right symmetry [GO:0007368]; ear morphogenesis [GO:0042471]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic viscerocranium morphogenesis [GO:0048703]; enamel mineralization [GO:0070166]; epithelial cell differentiation [GO:0030855]; face morphogenesis [GO:0060325]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; inner ear morphogenesis [GO:0042472]; lymph vessel development [GO:0001945]; mesenchymal cell apoptotic process [GO:0097152]; mesoderm development [GO:0007498]; middle ear morphogenesis [GO:0042474]; muscle cell fate commitment [GO:0042693]; muscle organ development [GO:0007517]; muscle organ morphogenesis [GO:0048644]; muscle tissue morphogenesis [GO:0060415]; negative regulation of cell differentiation [GO:0045596]; negative regulation of mesenchymal cell apoptotic process [GO:2001054]; neural crest cell migration [GO:0001755]; odontogenesis of dentin-containing tooth [GO:0042475]; outer ear morphogenesis [GO:0042473]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; parathyroid gland development [GO:0060017]; pattern specification process [GO:0007389]; pharyngeal system development [GO:0060037]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of tongue muscle cell differentiation [GO:2001037]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of animal organ morphogenesis [GO:2000027]; regulation of transcription by RNA polymerase II [GO:0006357]; retinoic acid receptor signaling pathway [GO:0048384]; semicircular canal morphogenesis [GO:0048752]; sensory perception of sound [GO:0007605]; social behavior [GO:0035176]; soft palate development [GO:0060023]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; tongue morphogenesis [GO:0043587]; vagus nerve morphogenesis [GO:0021644]","GO:0000785; GO:0000978; GO:0000981; GO:0001525; GO:0001568; GO:0001708; GO:0001755; GO:0001934; GO:0001945; GO:0002053; GO:0003007; GO:0003148; GO:0003151; GO:0003677; GO:0005634; GO:0006357; GO:0007368; GO:0007389; GO:0007498; GO:0007507; GO:0007517; GO:0007605; GO:0008283; GO:0008284; GO:0009952; GO:0021644; GO:0030855; GO:0030878; GO:0035176; GO:0035909; GO:0042471; GO:0042472; GO:0042473; GO:0042474; GO:0042475; GO:0042693; GO:0042803; GO:0043410; GO:0043565; GO:0043587; GO:0044344; GO:0045596; GO:0045893; GO:0045944; GO:0046983; GO:0048384; GO:0048514; GO:0048538; GO:0048644; GO:0048701; GO:0048703; GO:0048752; GO:0048844; GO:0050679; GO:0060017; GO:0060023; GO:0060037; GO:0060325; GO:0060415; GO:0060982; GO:0070166; GO:0071300; GO:0090103; GO:0097152; GO:1990837; GO:2000027; GO:2001037; GO:2001054"
"4121",4121,"Cluster_796","Porites_evermani_scaffold_615:34990-35990",151,-33.18,2,21,208,238,28,"64.29%","64.29%","Peve_00037453",-0.900490946237669,0.286414720533626,0.978262075707395,"Q9BTT6","Leucine-rich repeat-containing protein 1 (LANO adapter protein) (LAP and no PDZ protein)","Homo sapiens (Human)","","GO:0005829; GO:0016020"
"4122",4122,"Cluster_796","Porites_evermani_scaffold_615:34990-35990",151,-33.18,2,21,346,376,28,"64.29%","64.29%","Peve_00037453",-0.900490946237669,0.286414720533626,0.978262075707395,"Q9BTT6","Leucine-rich repeat-containing protein 1 (LANO adapter protein) (LAP and no PDZ protein)","Homo sapiens (Human)","","GO:0005829; GO:0016020"
"4123",4123,"Cluster_796","Porites_evermani_scaffold_615:34990-35990",151,-33.18,2,21,484,514,28,"64.29%","64.29%","Peve_00037453",-0.900490946237669,0.286414720533626,0.978262075707395,"Q9BTT6","Leucine-rich repeat-containing protein 1 (LANO adapter protein) (LAP and no PDZ protein)","Homo sapiens (Human)","","GO:0005829; GO:0016020"
"4124",4124,"Cluster_796","Porites_evermani_scaffold_615:34990-35990",151,-33.18,2,21,622,652,28,"64.29%","64.29%","Peve_00037453",-0.900490946237669,0.286414720533626,0.978262075707395,"Q9BTT6","Leucine-rich repeat-containing protein 1 (LANO adapter protein) (LAP and no PDZ protein)","Homo sapiens (Human)","","GO:0005829; GO:0016020"
"4125",4125,"Cluster_796","Porites_evermani_scaffold_615:34990-35990",151,-33.18,2,21,70,100,28,"64.29%","64.29%","Peve_00037453",-0.900490946237669,0.286414720533626,0.978262075707395,"Q9BTT6","Leucine-rich repeat-containing protein 1 (LANO adapter protein) (LAP and no PDZ protein)","Homo sapiens (Human)","","GO:0005829; GO:0016020"
"4126",4126,"Cluster_796","Porites_evermani_scaffold_615:34990-35990",151,-33.18,2,21,760,790,28,"64.29%","64.29%","Peve_00037453",-0.900490946237669,0.286414720533626,0.978262075707395,"Q9BTT6","Leucine-rich repeat-containing protein 1 (LANO adapter protein) (LAP and no PDZ protein)","Homo sapiens (Human)","","GO:0005829; GO:0016020"
"4127",4127,"Cluster_796","Porites_evermani_scaffold_615:34990-35990",151,-33.18,2,21,898,928,28,"64.29%","64.29%","Peve_00037453",-0.900490946237669,0.286414720533626,0.978262075707395,"Q9BTT6","Leucine-rich repeat-containing protein 1 (LANO adapter protein) (LAP and no PDZ protein)","Homo sapiens (Human)","","GO:0005829; GO:0016020"
"4128",4128,"Cluster_796","Porites_evermani_scaffold_642:33638-34638",164,-23.07,2,21,673,694,19,"73.68%","78.95%","Peve_00038204",NA,NA,NA,NA,NA,NA,NA,NA
"4129",4129,"Cluster_796","Porites_evermani_scaffold_64:26149-27149",159,-27.28,2,21,502,524,20,"70.00%","80.00%","Peve_00038127",-0.650395549371734,0.549206319529226,0.978262075707395,"Q4LDE5","Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (CCP module-containing protein 22) (Polydom) (Selectin-like osteoblast-derived protein) (SEL-OB) (Serologically defined breast cancer antigen NY-BR-38)","Homo sapiens (Human)","cell adhesion [GO:0007155]; epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel morphogenesis [GO:0036303]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193]","GO:0003017; GO:0003682; GO:0005509; GO:0005615; GO:0005634; GO:0005737; GO:0007155; GO:0008544; GO:0010467; GO:0016020; GO:0036303; GO:0048014; GO:0120193"
"4130",4130,"Cluster_796","Porites_evermani_scaffold_645:34242-35242",162,-25.27,2,15,824,845,13,"92.31%","92.31%","Peve_00038286",0.986412204693695,0.10506609885677,0.978262075707395,"Q9MYM7","Beta-1,3-galactosyltransferase 1 (Beta-1,3-GalTase 1) (Beta3Gal-T1) (Beta3GalT1) (EC 2.4.1.86) (UDP-galactose:beta-N-acetyl-glucosamine-beta-1,3-galactosyltransferase 1)","Pongo pygmaeus (Bornean orangutan)","lipid metabolic process [GO:0006629]; protein glycosylation [GO:0006486]","GO:0000139; GO:0006486; GO:0006629; GO:0047275"
"4131",4131,"Cluster_796","Porites_evermani_scaffold_645:46199-47199",162,-25.27,2,15,824,845,13,"92.31%","92.31%","Peve_00038287",NA,NA,NA,"Q9MYM7","Beta-1,3-galactosyltransferase 1 (Beta-1,3-GalTase 1) (Beta3Gal-T1) (Beta3GalT1) (EC 2.4.1.86) (UDP-galactose:beta-N-acetyl-glucosamine-beta-1,3-galactosyltransferase 1)","Pongo pygmaeus (Bornean orangutan)","lipid metabolic process [GO:0006629]; protein glycosylation [GO:0006486]","GO:0000139; GO:0006486; GO:0006629; GO:0047275"
"4132",4132,"Cluster_796","Porites_evermani_scaffold_660:53887-54887",156,-24.39,2,20,710,731,19,"73.68%","84.21%","Peve_00038623",-0.956003424309392,0.189543916240944,0.978262075707395,"Q6DG99","BTB/POZ domain-containing protein KCTD6","Danio rerio (Zebrafish) (Brachydanio rerio)","protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]","GO:0016567; GO:0051260"
"4133",4133,"Cluster_796","Porites_evermani_scaffold_660:54427-54887",156,-24.39,2,20,170,191,19,"73.68%","84.21%","Peve_00038622",-0.829106154727612,0.377699692492649,0.978262075707395,NA,NA,NA,NA,NA
"4134",4134,"Cluster_796","Porites_evermani_scaffold_6:694875-695875",151,-20.54,2,21,403,428,23,"60.87%","73.91%","Peve_00036964",0.997077513398696,0.0486829862370013,0.94805481250488,"Q80TN7","Neuron navigator 3 (Pore membrane and/or filament-interacting-like protein 1)","Mus musculus (Mouse)","negative regulation of cell migration [GO:0030336]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; positive regulation of microtubule polymerization [GO:0031116]","GO:0005524; GO:0005634; GO:0005635; GO:0005640; GO:0007026; GO:0007399; GO:0008017; GO:0016887; GO:0022008; GO:0030336; GO:0031116; GO:0032703; GO:1990752"
"4135",4135,"Cluster_796","Porites_evermani_scaffold_67:481199-482199",167,-24.54,2,20,607,628,18,"77.78%","83.33%","Peve_00038826",-0.713259834561872,0.49443591983631,0.978262075707395,NA,NA,NA,NA,NA
"4136",4136,"Cluster_796","Porites_evermani_scaffold_6843:1025-2025",155,-20.56,2,21,519,537,19,"73.68%","84.21%","Peve_00039162",-0.923096672193702,0.251299141778145,0.978262075707395,"P52432","DNA-directed RNA polymerases I and III subunit RPAC1 (DNA-directed RNA polymerase I subunit C) (RNA polymerases I and III subunit AC1) (AC40) (DNA-directed RNA polymerases I and III 40 kDa polypeptide) (RPA40) (RPC40)","Mus musculus (Mouse)","","GO:0001054; GO:0001056; GO:0001650; GO:0003677; GO:0005654; GO:0005666; GO:0005736; GO:0046983"
"4137",4137,"Cluster_796","Porites_evermani_scaffold_69:324019-325019",163,-28.8,2,21,729,755,24,"70.83%","75.00%","Peve_00039279",0.898740270652305,0.288966974174018,0.978262075707395,NA,NA,NA,NA,NA
"4138",4138,"Cluster_796","Porites_evermani_scaffold_698:23290-24290",160,-23.9,2,21,629,650,19,"68.42%","78.95%","Peve_00039481",0.00253724110179138,0.998384740414269,0.999661203410867,NA,NA,NA,NA,NA
"4139",4139,"Cluster_796","Porites_evermani_scaffold_700:154127-155127",164,-23.77,2,21,787,808,19,"73.68%","78.95%","Peve_00039639",NA,NA,NA,NA,NA,NA,NA,NA
"4140",4140,"Cluster_796","Porites_evermani_scaffold_70:138120-139120",155,-20.14,2,12,896,917,10,"100.00%","100.00%","Peve_00039614",0.944095651908951,0.21387608332111,0.978262075707395,"Q6P5E4","UDP-glucose:glycoprotein glucosyltransferase 1 (UGT1) (EC 2.4.1.-) (UDP--Glc:glycoprotein glucosyltransferase) (UDP-glucose ceramide glucosyltransferase-like 1)","Mus musculus (Mouse)","ER-associated misfolded protein catabolic process [GO:0071712]; protein N-linked glycosylation via asparagine [GO:0018279]","GO:0003980; GO:0005783; GO:0005788; GO:0005793; GO:0018279; GO:0032991; GO:0051082; GO:0071712"
"4141",4141,"Cluster_796","Porites_evermani_scaffold_712:62036-63036",158,-20.16,2,16,94,116,15,"86.67%","86.67%","Peve_00039877",0.806646716344191,0.402560127767647,0.978262075707395,"P50429","Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S)","Mus musculus (Mouse)","anterior head development [GO:0097065]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; chondroitin sulfate catabolic process [GO:0030207]; colon epithelial cell migration [GO:0061580]; dermatan sulfate catabolic process [GO:0030209]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]","GO:0003943; GO:0004065; GO:0005739; GO:0005764; GO:0005791; GO:0005794; GO:0006914; GO:0007417; GO:0007584; GO:0008484; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0030207; GO:0030209; GO:0043627; GO:0043890; GO:0046872; GO:0051597; GO:0061580; GO:0097065"
"4142",4142,"Cluster_796","Porites_evermani_scaffold_712:68459-69459",166,-26.33,2,21,209,232,21,"76.19%","85.71%","Peve_00039879",-0.99253307716016,0.077846046301011,0.978262075707395,"P50430","Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S)","Rattus norvegicus (Rat)","anterior head development [GO:0097065]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; dermatan sulfate catabolic process [GO:0030209]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]","GO:0003943; GO:0004065; GO:0005739; GO:0005764; GO:0005791; GO:0005794; GO:0006914; GO:0007417; GO:0007584; GO:0008484; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0030209; GO:0043627; GO:0043890; GO:0046872; GO:0051597; GO:0061580; GO:0097065"
"4143",4143,"Cluster_796","Porites_evermani_scaffold_738:86618-87618",160,-24.97,2,13,143,164,11,"100.00%","100.00%","Peve_00040443",-0.995982916004459,0.0570815907430698,0.978262075707395,"Q9H6P5","Threonine aspartase 1 (Taspase-1) (EC 3.4.25.-) [Cleaved into: Threonine aspartase subunit alpha; Threonine aspartase subunit beta]","Homo sapiens (Human)","positive regulation of DNA-templated transcription [GO:0045893]; protein maturation [GO:0051604]; proteolysis [GO:0006508]","GO:0004298; GO:0005737; GO:0006508; GO:0042802; GO:0045893; GO:0051604"
"4144",4144,"Cluster_796","Porites_evermani_scaffold_753:141228-142228",156,-22.55,2,14,28,50,13,"92.31%","92.31%","Peve_00040753",-0.547882724241639,0.630868000938764,0.978262075707395,NA,NA,NA,NA,NA
"4145",4145,"Cluster_796","Porites_evermani_scaffold_758:51594-52594",158,-22.7,2,18,292,311,16,"81.25%","87.50%","Peve_00040823",NA,NA,NA,NA,NA,NA,NA,NA
"4146",4146,"Cluster_796","Porites_evermani_scaffold_775:146651-147651",153,-21.83,2,21,222,243,20,"75.00%","75.00%","Peve_00041158",0.952970333802886,0.196018922619321,0.978262075707395,"A0JN27","General transcription factor IIH subunit 2 (Basic transcription factor 2 44 kDa subunit) (BTF2 p44) (General transcription factor IIH polypeptide 2) (TFIIH basal transcription factor complex p44 subunit)","Rattus norvegicus (Rat)","nucleotide-excision repair [GO:0006289]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]","GO:0000438; GO:0005634; GO:0005675; GO:0006289; GO:0006357; GO:0006366; GO:0008270"
"4147",4147,"Cluster_796","Porites_evermani_scaffold_809:151681-152681",152,-20.11,2,14,944,967,14,"85.71%","85.71%","Peve_00041960",0.0183046244356579,0.98834626331461,0.999448381576871,NA,NA,NA,NA,NA
"4148",4148,"Cluster_796","Porites_evermani_scaffold_826:142445-143445",163,-21.93,2,16,954,975,14,"85.71%","92.86%","Peve_00042317",NA,NA,NA,NA,NA,NA,NA,NA
"4149",4149,"Cluster_796","Porites_evermani_scaffold_842:159924-160924",154,-21.52,2,20,680,702,19,"73.68%","73.68%","Peve_00042625",NA,NA,NA,NA,NA,NA,NA,NA
"4150",4150,"Cluster_796","Porites_evermani_scaffold_862:11876-12876",161,-25.96,2,21,166,187,20,"80.00%","80.00%","Peve_00043018",0.0676364245019842,0.956908417067613,0.999448381576871,"A0JN27","General transcription factor IIH subunit 2 (Basic transcription factor 2 44 kDa subunit) (BTF2 p44) (General transcription factor IIH polypeptide 2) (TFIIH basal transcription factor complex p44 subunit)","Rattus norvegicus (Rat)","nucleotide-excision repair [GO:0006289]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]","GO:0000438; GO:0005634; GO:0005675; GO:0006289; GO:0006357; GO:0006366; GO:0008270"
"4151",4151,"Cluster_796","Porites_evermani_scaffold_862:75662-76662",147,-25.67,2,20,301,322,18,"61.11%","72.22%","Peve_00043015",0.982168935705027,0.1204013070498,0.978262075707395,NA,NA,NA,NA,NA
"4152",4152,"Cluster_796","Porites_evermani_scaffold_874:63587-64587",147,-21.53,2,21,120,144,22,"63.64%","68.18%","Peve_00043222",NA,NA,NA,NA,NA,NA,NA,NA
"4153",4153,"Cluster_796","Porites_evermani_scaffold_88:290229-291229",158,-22.14,2,21,524,544,19,"73.68%","78.95%","Peve_00043318",0.983568287718476,0.115566780535706,0.978262075707395,"Q58DZ6","Zinc finger protein 143 (Selenocysteine tRNA gene transcription-activating factor)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","","GO:0003677; GO:0005634; GO:0046872"
"4154",4154,"Cluster_796","Porites_evermani_scaffold_883:67274-68274",161,-21.33,2,19,732,754,18,"77.78%","83.33%","Peve_00043371",0.665783729845509,0.536194676320856,0.978262075707395,"Q3T0T0","Glycerophosphodiester phosphodiesterase 1 (Glycerophosphoinositol glycerophosphodiesterase GDE1) (EC 3.1.4.44) (Lysophospholipase D GDE1) (EC 3.1.4.-) (Membrane-interacting protein of RGS16)","Bos taurus (Bovine)","ethanolamine metabolic process [GO:0006580]; N-acylethanolamine metabolic process [GO:0070291]; phospholipid metabolic process [GO:0006644]","GO:0004622; GO:0005886; GO:0006580; GO:0006644; GO:0008889; GO:0030659; GO:0046872; GO:0047395; GO:0070291"
"4155",4155,"Cluster_796","Porites_evermani_scaffold_884:175724-176715",162,-26.61,2,21,949,974,23,"73.91%","78.26%","Peve_00043394",0.692159209682113,0.513319188991269,0.978262075707395,NA,NA,NA,NA,NA
"4156",4156,"Cluster_796","Porites_evermani_scaffold_885:119317-120317",154,-22.65,2,21,573,593,19,"73.68%","73.68%","Peve_00043400",0.993342702749615,0.0734996592067551,0.978262075707395,"Q27245","Putative aminopeptidase W07G4.4 (EC 3.4.11.-)","Caenorhabditis elegans","proteolysis [GO:0006508]","GO:0005737; GO:0006508; GO:0008233; GO:0030145; GO:0070006"
"4157",4157,"Cluster_796","Porites_evermani_scaffold_890:171827-172827",155,-22.52,2,21,213,235,20,"70.00%","75.00%","Peve_00043493",NA,NA,NA,"P25291","Pancreatic secretory granule membrane major glycoprotein GP2 (Pancreatic zymogen granule membrane protein GP-2) (ZAP75)","Canis lupus familiaris (Dog) (Canis familiaris)","antigen transcytosis by M cells in mucosal-associated lymphoid tissue [GO:0002412]; innate immune response [GO:0045087]; neutrophil migration [GO:1990266]","GO:0002412; GO:0005201; GO:0005615; GO:0005768; GO:0009897; GO:0009986; GO:0016324; GO:0042589; GO:0045087; GO:0045121; GO:1990266"
"4158",4158,"Cluster_796","Porites_evermani_scaffold_9:1163988-1164988",155,-20.75,2,21,799,817,19,"78.95%","78.95%","Peve_00043674",0.898740270652305,0.288966974174018,0.978262075707395,"Q61184","Melatonin receptor type 1A (Mel-1A-R) (Mel1a receptor)","Mus musculus (Mouse)","adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; circadian rhythm [GO:0007623]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of insulin secretion [GO:0046676]","GO:0004930; GO:0005886; GO:0007186; GO:0007193; GO:0007623; GO:0008502; GO:0042562; GO:0043025; GO:0043235; GO:0046676; GO:0097159"
"4159",4159,"Cluster_796","Porites_evermani_scaffold_940:137299-138299",150,-20.5,2,19,20,39,17,"76.47%","82.35%","Peve_00044439",-0.0696341159246929,0.955633640840684,0.999448381576871,NA,NA,NA,NA,NA
"4160",4160,"Cluster_796","Porites_evermani_scaffold_940:140929-141929",150,-20.5,2,19,22,41,17,"76.47%","82.35%","Peve_00044440",-0.923096672193702,0.251299141778145,0.978262075707395,NA,NA,NA,NA,NA
"4161",4161,"Cluster_796","Porites_evermani_scaffold_95:2614-3614",163,-20.15,2,20,372,393,18,"72.22%","83.33%","Peve_00044547",0.850914843530427,0.35209652611451,0.978262075707395,NA,NA,NA,NA,NA
"4162",4162,"Cluster_796","Porites_evermani_scaffold_975:17265-18265",159,-20.87,2,16,560,581,14,"85.71%","85.71%","Peve_00044993",0.898740270652305,0.288966974174018,0.978262075707395,"Q5XXP2","Melanopsin (Opsin-4)","Phodopus sungorus (Striped hairy-footed hamster) (Djungarian hamster)","hyaloid vascular plexus regression [GO:1990384]; optokinetic behavior [GO:0007634]; phototransduction [GO:0007602]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; visual perception [GO:0007601]","GO:0005502; GO:0005886; GO:0007601; GO:0007602; GO:0007634; GO:0008020; GO:0016020; GO:0030424; GO:0030425; GO:0042752; GO:0043204; GO:0048511; GO:1990384"
"4163",4163,"Cluster_796","Porites_evermani_scaffold_980:56501-57501",151,-20.53,2,21,968,993,23,"65.22%","69.57%","Peve_00045066",0.586899706326237,0.600696564097838,0.978262075707395,"B8V7R6","Collagen alpha chain","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0005201; GO:0005576; GO:0005581"
"4164",4164,"Cluster_796","Porites_evermani_scaffold_997:95498-96498",153,-22.45,2,18,592,613,16,"68.75%","81.25%","Peve_00045329",-0.778979265609694,0.431475414446202,0.978262075707395,NA,NA,NA,NA,NA
"4165",4165,"Cluster_8634","Porites_evermani_scaffold_1032:57299-58299",164,-21.28,2,21,429,450,19,"73.68%","78.95%","Peve_00000720",NA,NA,NA,NA,NA,NA,NA,NA
"4166",4166,"Cluster_8634","Porites_evermani_scaffold_1043:69671-70671",173,-20.44,2,19,736,759,19,"84.21%","89.47%","Peve_00000894",NA,NA,NA,NA,NA,NA,NA,NA
"4167",4167,"Cluster_8634","Porites_evermani_scaffold_11:276677-277677",168,-20.25,2,21,16,37,19,"78.95%","78.95%","Peve_00001833",0.982074297069193,0.120721358425151,0.978262075707395,"Q3KR73","KAT8 regulatory NSL complex subunit 3 (NSL complex protein NSL3) (Non-specific lethal 3 homolog)","Rattus norvegicus (Rat)","chromatin organization [GO:0006325]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of dosage compensation by inactivation of X chromosome [GO:1900095]","GO:0000123; GO:0005654; GO:0006325; GO:0043981; GO:0043982; GO:0043984; GO:0044545; GO:0045944; GO:0051571; GO:1900095"
"4168",4168,"Cluster_8634","Porites_evermani_scaffold_115:148245-149245",159,-20.69,2,16,722,743,14,"85.71%","85.71%","Peve_00002553",-0.00448412973687288,0.997145304780832,0.999448381576871,NA,NA,NA,NA,NA
"4169",4169,"Cluster_8634","Porites_evermani_scaffold_120:9608-10608",165,-22.16,2,18,704,725,16,"81.25%","87.50%","Peve_00003391",0.995758833049273,0.0586531603168953,0.978262075707395,NA,NA,NA,NA,NA
"4170",4170,"Cluster_8634","Porites_evermani_scaffold_1364:2240-3240",170,-22.29,2,15,940,961,13,"100.00%","100.00%","Peve_00005709",-0.658267160686224,0.542579442905005,0.978262075707395,"Q5EA86","Transmembrane protein 183","Bos taurus (Bovine)","regulation of protein stability [GO:0031647]","GO:0016020; GO:0019005; GO:0031647"
"4171",4171,"Cluster_8634","Porites_evermani_scaffold_1364:3123-4123",170,-22.29,2,15,57,78,13,"100.00%","100.00%","Peve_00005717",NA,NA,NA,NA,NA,NA,NA,NA
"4172",4172,"Cluster_8634","Porites_evermani_scaffold_1436:5436-6436",158,-21.5,2,16,235,257,15,"86.67%","86.67%","Peve_00006676",-0.916717689500193,0.261657204475411,0.978262075707395,"Q4R8N2","Protein lin-9 homolog","Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)","cell cycle [GO:0007049]; DNA biosynthetic process [GO:0071897]; DNA-templated transcription [GO:0006351]","GO:0005654; GO:0006351; GO:0007049; GO:0017053; GO:0071897"
"4173",4173,"Cluster_8634","Porites_evermani_scaffold_1503:12462-13462",172,-22.37,2,17,686,707,15,"86.67%","100.00%","Peve_00007589",0.956227319072805,0.189057429551567,0.978262075707395,"P70490","Lactadherin (MFGM) (Milk fat globule-EGF factor 8) (MFG-E8) (O-acetyl GD3 ganglioside synthase) (AGS) (SED1)","Rattus norvegicus (Rat)","angiogenesis [GO:0001525]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of phagocytosis [GO:0050766]; response to estrogen [GO:0043627]; single fertilization [GO:0007338]","GO:0001525; GO:0001786; GO:0002080; GO:0005178; GO:0005615; GO:0006910; GO:0006911; GO:0007155; GO:0007338; GO:0008284; GO:0008429; GO:0009897; GO:0019897; GO:0043277; GO:0043627; GO:0050766"
"4174",4174,"Cluster_8634","Porites_evermani_scaffold_1519:58241-59241",164,-23.32,2,18,345,369,19,"78.95%","84.21%","Peve_00007755",0.956227319072805,0.189057429551567,0.978262075707395,NA,NA,NA,NA,NA
"4175",4175,"Cluster_8634","Porites_evermani_scaffold_1548:71038-72038",167,-21.28,2,18,774,794,16,"87.50%","93.75%","Peve_00008072",0.999978963950975,0.00412931457669044,0.54328949385489,NA,NA,NA,NA,NA
"4176",4176,"Cluster_8634","Porites_evermani_scaffold_1636:73375-74156",179,-23.15,2,20,390,411,18,"88.89%","88.89%","Peve_00009250",0.800098464633019,0.409561043744847,0.978262075707395,"Q9Y512","Sorting and assembly machinery component 50 homolog (Transformation-related gene 3 protein) (TRG-3)","Homo sapiens (Human)","cristae formation [GO:0042407]; inner mitochondrial membrane organization [GO:0007007]; mitochondrial respiratory chain complex assembly [GO:0033108]; protein insertion into mitochondrial outer membrane [GO:0045040]","GO:0001401; GO:0005739; GO:0005741; GO:0007007; GO:0016020; GO:0033108; GO:0042407; GO:0045040; GO:0070062; GO:0140275"
"4177",4177,"Cluster_8634","Porites_evermani_scaffold_1636:73375-74156",179,-23.15,2,20,390,411,18,"88.89%","88.89%","Peve_00009251",0.963191996313888,0.173263650536862,0.978262075707395,"Q99P31","Hsp70-binding protein 1 (HspBP1) (Heat shock protein-binding protein 1) (Hsp70-interacting protein 1)","Mus musculus (Mouse)","positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]","GO:0000774; GO:0031398; GO:0031625; GO:0032436"
"4178",4178,"Cluster_8634","Porites_evermani_scaffold_1706:40010-41010",170,-20.16,2,21,664,687,21,"80.95%","85.71%","Peve_00010110",-0.224693088757062,0.855724096218234,0.995934364227446,"B3EX02","MAM and fibronectin type III domain-containing protein 1","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0005576; GO:0016020"
"4179",4179,"Cluster_8634","Porites_evermani_scaffold_1710:47936-48936",165,-22.16,2,18,241,262,16,"81.25%","87.50%","Peve_00010162",0.676397727711386,0.527080154818885,0.978262075707395,NA,NA,NA,NA,NA
"4180",4180,"Cluster_8634","Porites_evermani_scaffold_1742:29304-30304",164,-22.07,2,18,487,511,19,"78.95%","84.21%","Peve_00010516",NA,NA,NA,NA,NA,NA,NA,NA
"4181",4181,"Cluster_8634","Porites_evermani_scaffold_1811:0-894",171,-21.23,2,20,724,745,18,"77.78%","88.89%","Peve_00011298",0.875128187357574,0.321553886783071,0.978262075707395,NA,NA,NA,NA,NA
"4182",4182,"Cluster_8634","Porites_evermani_scaffold_183:321012-322012",163,-20.62,2,17,870,892,16,"87.50%","87.50%","Peve_00011493",0.966931820966223,0.164173992785996,0.978262075707395,"P33731","Signal recognition particle subunit SRP72 (SRP72) (Signal recognition particle 72 kDa protein)","Canis lupus familiaris (Dog) (Canis familiaris)","SRP-dependent cotranslational protein targeting to membrane [GO:0006614]","GO:0005047; GO:0005783; GO:0005786; GO:0005829; GO:0006614; GO:0008312; GO:0030911; GO:0043022"
"4183",4183,"Cluster_8634","Porites_evermani_scaffold_195:233155-234155",170,-20.13,2,19,504,525,17,"76.47%","94.12%","Peve_00012826",NA,NA,NA,NA,NA,NA,NA,NA
"4184",4184,"Cluster_8634","Porites_evermani_scaffold_2095:41978-42978",174,-22.15,2,20,903,925,19,"84.21%","89.47%","Peve_00014480",0.857227794418918,0.344369663058383,0.978262075707395,"Q2KHW8","Gem-associated protein 6 (Gemin-6)","Bos taurus (Bovine)","spliceosomal complex assembly [GO:0000245]; spliceosomal snRNP assembly [GO:0000387]","GO:0000245; GO:0000387; GO:0005829; GO:0032797; GO:0034719; GO:0097504"
"4185",4185,"Cluster_8634","Porites_evermani_scaffold_211:357291-358291",173,-22.86,2,19,323,346,19,"84.21%","89.47%","Peve_00014686",-0.824810788938867,0.382563189779791,0.978262075707395,NA,NA,NA,NA,NA
"4186",4186,"Cluster_8634","Porites_evermani_scaffold_2525:12561-13561",158,-20.76,2,21,899,919,19,"73.68%","78.95%","Peve_00018658",NA,NA,NA,NA,NA,NA,NA,NA
"4187",4187,"Cluster_8634","Porites_evermani_scaffold_25:786971-787971",168,-23.21,2,18,785,809,19,"84.21%","84.21%","Peve_00018391",0.998840656587306,0.030657951802389,0.903929377050813,"Q9CQI7","U2 small nuclear ribonucleoprotein B'' (U2 snRNP B'')","Mus musculus (Mouse)","mRNA splicing, via spliceosome [GO:0000398]","GO:0000398; GO:0001650; GO:0005634; GO:0005681; GO:0005685; GO:0005686; GO:0016607; GO:0030532; GO:0030619; GO:0036464; GO:0070990; GO:0071005; GO:0071007; GO:0071013"
"4188",4188,"Cluster_8634","Porites_evermani_scaffold_2705:38416-39416",173,-21.43,2,18,898,919,16,"87.50%","93.75%","Peve_00020143",0.977029080460152,0.136715948495261,0.978262075707395,"Q9Y5X5","Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (G-protein coupled receptor HLWAR77) (Neuropeptide G-protein coupled receptor)","Homo sapiens (Human)","detection of abiotic stimulus [GO:0009582]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of adenylate cyclase activity [GO:0045761]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of MAPK cascade [GO:0043408]","GO:0004930; GO:0005886; GO:0007186; GO:0008188; GO:0009582; GO:0015629; GO:0031628; GO:0042277; GO:0043408; GO:0045761; GO:2000479"
"4189",4189,"Cluster_8634","Porites_evermani_scaffold_2797:31030-32030",161,-24.23,2,21,800,821,20,"80.00%","80.00%","Peve_00020847",-0.486752568097145,0.676362668411313,0.978262075707395,NA,NA,NA,NA,NA
"4190",4190,"Cluster_8634","Porites_evermani_scaffold_2858:59435-60435",177,-22.8,2,20,481,501,18,"88.89%","94.44%","Peve_00021332",0.821183376453286,0.386628552051274,0.978262075707395,"Q62283","Tetraspanin-7 (Tspan-7) (Cell surface glycoprotein A15) (PE31) (TALLA homolog) (Transmembrane 4 superfamily member 2) (CD antigen CD231)","Mus musculus (Mouse)","regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]","GO:0005886; GO:0099149"
"4191",4191,"Cluster_8634","Porites_evermani_scaffold_293:199433-200433",168,-23.5,2,18,826,848,17,"82.35%","94.12%","Peve_00021923",-0.0155746613973387,0.990084461710154,0.999448381576871,"Q09470","Potassium voltage-gated channel subfamily A member 1 (Voltage-gated K(+) channel HuKI) (Voltage-gated potassium channel HBK1) (Voltage-gated potassium channel subunit Kv1.1)","Homo sapiens (Human)","axon development [GO:0061564]; cell communication by electrical coupling [GO:0010644]; cellular response to magnesium ion [GO:0071286]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; corpus callosum development [GO:0022038]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; hippocampus development [GO:0021766]; magnesium ion homeostasis [GO:0010960]; neuroblast proliferation [GO:0007405]; neuromuscular process [GO:0050905]; neuronal action potential [GO:0019228]; neuronal signal transduction [GO:0023041]; optic nerve development [GO:0021554]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization [GO:0008104]; regulation of membrane potential [GO:0042391]; regulation of muscle contraction [GO:0006937]; startle response [GO:0001964]","GO:0001964; GO:0005249; GO:0005251; GO:0005267; GO:0005783; GO:0005829; GO:0005886; GO:0006813; GO:0006937; GO:0007268; GO:0007405; GO:0008076; GO:0008104; GO:0009986; GO:0010644; GO:0010960; GO:0015079; GO:0016020; GO:0016324; GO:0019228; GO:0021554; GO:0021766; GO:0021987; GO:0022038; GO:0023041; GO:0030054; GO:0030425; GO:0031410; GO:0033270; GO:0042391; GO:0042734; GO:0043025; GO:0043194; GO:0043204; GO:0043679; GO:0044224; GO:0044305; GO:0045202; GO:0045211; GO:0050905; GO:0050966; GO:0050976; GO:0051260; GO:0061564; GO:0070161; GO:0071286; GO:0071805; GO:0097718; GO:0098978; GO:0099508; GO:1903818; GO:1905030"
"4192",4192,"Cluster_8634","Porites_evermani_scaffold_2:956682-957682",167,-21.89,2,21,266,289,21,"76.19%","80.95%","Peve_00013384",0.999374263578392,0.0225223387727307,0.83828463858421,NA,NA,NA,NA,NA
"4193",4193,"Cluster_8634","Porites_evermani_scaffold_29:804385-805385",168,-21.52,2,17,565,586,15,"86.67%","93.33%","Peve_00021673",-0.731534230315743,0.477609237115099,0.978262075707395,NA,NA,NA,NA,NA
"4194",4194,"Cluster_8634","Porites_evermani_scaffold_2984:11773-12773",165,-21.57,2,19,224,247,19,"78.95%","84.21%","Peve_00022313",0.281468994635192,0.818356683608058,0.995934364227446,"Q9H0H5","Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4)","Homo sapiens (Human)","actomyosin contractile ring assembly [GO:0000915]; erythrocyte differentiation [GO:0030218]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; neuroblast proliferation [GO:0007405]; positive regulation of cytokinesis [GO:0032467]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of embryonic development [GO:0045995]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; sulfate transport [GO:0008272]","GO:0000281; GO:0000915; GO:0001669; GO:0005096; GO:0005547; GO:0005634; GO:0005654; GO:0005819; GO:0005829; GO:0005874; GO:0007266; GO:0007283; GO:0007405; GO:0008017; GO:0008272; GO:0019901; GO:0030218; GO:0030496; GO:0031234; GO:0032154; GO:0032467; GO:0043014; GO:0043015; GO:0045995; GO:0046872; GO:0048487; GO:0051056; GO:0051233; GO:0051256; GO:0051988; GO:0070062; GO:0072686; GO:0090543; GO:0097149"
"4195",4195,"Cluster_8634","Porites_evermani_scaffold_3013:14244-15244",170,-20.13,2,19,100,121,17,"76.47%","94.12%","Peve_00022727",-0.97880598499318,0.131302130942163,0.978262075707395,NA,NA,NA,NA,NA
"4196",4196,"Cluster_8634","Porites_evermani_scaffold_3027:2018-3018",165,-21.63,2,19,509,531,18,"77.78%","88.89%","Peve_00022824",0.385988835225252,0.747720643456924,0.988061521013803,NA,NA,NA,NA,NA
"4197",4197,"Cluster_8634","Porites_evermani_scaffold_30:537136-538136",175,-23.79,2,21,128,150,20,"80.00%","90.00%","Peve_00022557",0.92088895502329,0.254929010903152,0.978262075707395,NA,NA,NA,NA,NA
"4198",4198,"Cluster_8634","Porites_evermani_scaffold_3111:31887-32887",157,-20.66,2,21,21,42,20,"70.00%","85.00%","Peve_00023486",0.965914266649893,0.166695097656503,0.978262075707395,"Q6GMR7","Fatty-acid amide hydrolase 2 (EC 3.5.1.99) (Amidase domain-containing protein) (Anandamide amidohydrolase 2) (Oleamide hydrolase 2)","Homo sapiens (Human)","arachidonic acid metabolic process [GO:0019369]; lipid catabolic process [GO:0016042]","GO:0005811; GO:0016020; GO:0016042; GO:0017064; GO:0019369"
"4199",4199,"Cluster_8634","Porites_evermani_scaffold_3192:35726-36726",159,-21.76,2,18,205,228,18,"77.78%","88.89%","Peve_00023952",NA,NA,NA,NA,NA,NA,NA,NA
"4200",4200,"Cluster_8634","Porites_evermani_scaffold_349:212165-212859",167,-21.25,2,21,466,488,20,"75.00%","85.00%","Peve_00025849",-0.415698301810837,0.727074449191263,0.983664198460047,"Q54KA7","Ankyrin repeat, PH and SEC7 domain containing protein secG","Dictyostelium discoideum (Social amoeba)","actin cytoskeleton organization [GO:0030036]; cell-substrate adhesion [GO:0031589]; chemotaxis [GO:0006935]; chemotaxis to cAMP [GO:0043327]; culmination involved in sorocarp development [GO:0031154]; regulation of ARF protein signal transduction [GO:0032012]","GO:0005085; GO:0005764; GO:0005829; GO:0006935; GO:0030036; GO:0031154; GO:0031589; GO:0032012; GO:0043327"
"4201",4201,"Cluster_8634","Porites_evermani_scaffold_349:212165-212859",167,-21.25,2,21,466,488,20,"75.00%","85.00%","Peve_00025850",0.999912402411178,0.00842644454811202,0.573710369894872,"O54990","Prominin-1 (Antigen AC133 homolog) (Prominin-like protein 1) (CD antigen CD133)","Mus musculus (Mouse)","camera-type eye photoreceptor cell differentiation [GO:0060219]; glomerular parietal epithelial cell differentiation [GO:0072139]; photoreceptor cell maintenance [GO:0045494]; podocyte differentiation [GO:0072112]; positive regulation of nephron tubule epithelial cell differentiation [GO:2000768]; retina layer formation [GO:0010842]; retina morphogenesis in camera-type eye [GO:0060042]","GO:0001750; GO:0005615; GO:0005783; GO:0005793; GO:0005886; GO:0005902; GO:0005903; GO:0005929; GO:0009986; GO:0010842; GO:0015485; GO:0016324; GO:0031528; GO:0032420; GO:0042622; GO:0042805; GO:0042995; GO:0045296; GO:0045494; GO:0060042; GO:0060219; GO:0070062; GO:0071914; GO:0072112; GO:0072139; GO:2000768"
"4202",4202,"Cluster_8634","Porites_evermani_scaffold_359:164825-165825",170,-23.15,2,20,798,821,20,"80.00%","85.00%","Peve_00026460",0.969873849807753,0.156661872581452,0.978262075707395,"Q5T8I3","EEIG family member 2 (EEIG2)","Homo sapiens (Human)","",""
"4203",4203,"Cluster_8634","Porites_evermani_scaffold_360:253840-254840",156,-21.85,2,19,311,336,21,"76.19%","76.19%","Peve_00026570",0.788217017117022,0.42200889135295,0.978262075707395,"P98133","Fibrillin-1 (MP340) [Cleaved into: Asprosin]","Bos taurus (Bovine)","activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; protein kinase A signaling [GO:0010737]","GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0008201; GO:0009653; GO:0010737; GO:0031012; GO:0034199; GO:0042593"
"4204",4204,"Cluster_8634","Porites_evermani_scaffold_372:203458-204458",171,-21.51,2,20,137,158,18,"77.78%","88.89%","Peve_00027210",-0.748372962079554,0.461670725254087,0.978262075707395,"Q00168","Calcium/calmodulin-dependent protein kinase type II alpha chain (CaM-kinase II alpha chain) (EC 2.7.11.17)","Drosophila melanogaster (Fruit fly)","cellular response to starvation [GO:0009267]; chemical synaptic transmission [GO:0007268]; courtship behavior [GO:0007619]; learning or memory [GO:0007611]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; negative regulation of cytokine production [GO:0001818]; negative regulation of lipid storage [GO:0010888]; neuromuscular junction development [GO:0007528]; peptidyl-threonine autophosphorylation [GO:1990443]; positive regulation of synaptic transmission, dopaminergic [GO:0032226]; protein phosphorylation [GO:0006468]; regulation of filopodium assembly [GO:0051489]; regulation of ovulation [GO:0060278]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]","GO:0001818; GO:0004674; GO:0004683; GO:0005516; GO:0005524; GO:0005737; GO:0006468; GO:0007268; GO:0007528; GO:0007611; GO:0007616; GO:0007619; GO:0008049; GO:0008582; GO:0009267; GO:0010888; GO:0030424; GO:0030425; GO:0032226; GO:0043005; GO:0045211; GO:0048786; GO:0051489; GO:0060278; GO:0106310; GO:1990443"
"4205",4205,"Cluster_8634","Porites_evermani_scaffold_382:276890-277890",167,-22.07,2,21,408,432,22,"77.27%","77.27%","Peve_00027756",0.567738558905248,0.615636903717219,0.978262075707395,NA,NA,NA,NA,NA
"4206",4206,"Cluster_8634","Porites_evermani_scaffold_3954:5333-6333",158,-21.5,2,16,230,252,15,"86.67%","86.67%","Peve_00028488",NA,NA,NA,NA,NA,NA,NA,NA
"4207",4207,"Cluster_8634","Porites_evermani_scaffold_402:114149-115149",161,-20.43,2,19,526,548,18,"72.22%","88.89%","Peve_00028939",0.983772891422051,0.114843051989096,0.978262075707395,"Q6PFX9","Poly [ADP-ribose] polymerase tankyrase-1 (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 5) (ARTD5) (Protein poly-ADP-ribosyltransferase tankyrase-1) (EC 2.4.2.-) (TRF1-interacting ankyrin-related ADP-ribose polymerase 1) (Tankyrase I) (Tankyrase-1) (TANK1)","Mus musculus (Mouse)","cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to nutrient [GO:0031670]; mRNA transport [GO:0051028]; negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric [GO:1904908]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of telomeric DNA binding [GO:1904743]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; Wnt signaling pathway [GO:0016055]","GO:0000139; GO:0000209; GO:0000781; GO:0003950; GO:0005634; GO:0005643; GO:0005654; GO:0005737; GO:0005794; GO:0005815; GO:0005829; GO:0007049; GO:0008270; GO:0015031; GO:0016055; GO:0016604; GO:0016779; GO:0018105; GO:0018107; GO:0031670; GO:0031965; GO:0032212; GO:0042393; GO:0045944; GO:0051028; GO:0051301; GO:0051973; GO:0070198; GO:0070212; GO:0070213; GO:0090263; GO:0097431; GO:1904355; GO:1904357; GO:1904743; GO:1904908; GO:1990404"
"4208",4208,"Cluster_8634","Porites_evermani_scaffold_4027:1510-2070",164,-22.07,2,18,486,510,19,"78.95%","84.21%","Peve_00028969",NA,NA,NA,NA,NA,NA,NA,NA
"4209",4209,"Cluster_8634","Porites_evermani_scaffold_413:58272-59272",165,-22.16,2,18,671,692,16,"81.25%","87.50%","Peve_00029526",0.995631543626943,0.0595274595667544,0.978262075707395,"Q09225","Nose resistant to fluoxetine protein 6 (Protein nrf-6)","Caenorhabditis elegans","lipid transport [GO:0006869]","GO:0006869; GO:0008289; GO:0016020; GO:0016747"
"4210",4210,"Cluster_8634","Porites_evermani_scaffold_433:25715-26715",171,-22.05,2,18,760,780,16,"93.75%","93.75%","Peve_00030571",0.797113558393705,0.412718390938479,0.978262075707395,"Q61655","ATP-dependent RNA helicase DDX19A (EC 3.6.4.13) (DEAD box RNA helicase DEAD5) (mDEAD5) (DEAD box protein 19A) (Eukaryotic translation initiation factor 4A-related sequence 1)","Mus musculus (Mouse)","poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of apoptotic process [GO:0043065]; response to zinc ion [GO:0010043]","GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0010043; GO:0010494; GO:0016887; GO:0016973; GO:0043065"
"4211",4211,"Cluster_8634","Porites_evermani_scaffold_473:18188-18819",173,-23.9,2,20,216,236,18,"88.89%","88.89%","Peve_00032466",-0.731534230315743,0.477609237115099,0.978262075707395,NA,NA,NA,NA,NA
"4212",4212,"Cluster_8634","Porites_evermani_scaffold_477:115320-116320",164,-20.27,2,21,526,545,19,"84.21%","84.21%","Peve_00032611",0.983736278603019,0.114972890636881,0.978262075707395,NA,NA,NA,NA,NA
"4213",4213,"Cluster_8634","Porites_evermani_scaffold_4915:369-1369",168,-20.31,2,21,280,301,19,"73.68%","84.21%","Peve_00033195",NA,NA,NA,NA,NA,NA,NA,NA
"4214",4214,"Cluster_8634","Porites_evermani_scaffold_497:82582-83582",162,-20.49,2,20,569,592,20,"75.00%","80.00%","Peve_00033393",0.93047493657452,0.238789218718263,0.978262075707395,NA,NA,NA,NA,NA
"4215",4215,"Cluster_8634","Porites_evermani_scaffold_5:1079917-1080917",165,-20.97,2,21,838,857,19,"78.95%","84.21%","Peve_00033558",NA,NA,NA,NA,NA,NA,NA,NA
"4216",4216,"Cluster_8634","Porites_evermani_scaffold_51:347251-348251",168,-20.46,2,20,231,255,21,"85.71%","85.71%","Peve_00034046",0.956227319072805,0.189057429551567,0.978262075707395,NA,NA,NA,NA,NA
"4217",4217,"Cluster_8634","Porites_evermani_scaffold_516:194223-195223",188,-30.51,2,21,896,917,19,"89.47%","94.74%","Peve_00034247",0.41483709974355,0.727677130015268,0.983812226334838,NA,NA,NA,NA,NA
"4218",4218,"Cluster_8634","Porites_evermani_scaffold_5280:5512-6512",159,-20.58,2,21,127,149,20,"70.00%","80.00%","Peve_00034661",-0.991834912872538,0.0814088238192942,0.978262075707395,NA,NA,NA,NA,NA
"4219",4219,"Cluster_8634","Porites_evermani_scaffold_56:1125-2125",169,-20.19,2,18,160,181,16,"81.25%","93.75%","Peve_00035786",0.730453821746963,0.47861718852703,0.978262075707395,"Q99615","DnaJ homolog subfamily C member 7 (Tetratricopeptide repeat protein 2) (TPR repeat protein 2)","Homo sapiens (Human)","chaperone cofactor-dependent protein refolding [GO:0051085]; protein folding [GO:0006457]; regulation of cellular response to heat [GO:1900034]","GO:0001671; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006457; GO:0016020; GO:0031072; GO:0051085; GO:0070062; GO:1900034"
"4220",4220,"Cluster_8634","Porites_evermani_scaffold_596:78654-79654",166,-21.8,2,21,711,731,19,"73.68%","89.47%","Peve_00036849",0.404710007324342,0.734744933484876,0.985794827088676,"O14649","Potassium channel subfamily K member 3 (Acid-sensitive potassium channel protein TASK-1) (TWIK-related acid-sensitive K(+) channel 1) (Two pore potassium channel KT3.1) (Two pore K(+) channel KT3.1)","Homo sapiens (Human)","brain development [GO:0007420]; cellular response to hypoxia [GO:0071456]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; cochlea development [GO:0090102]; ion transmembrane transport [GO:0034220]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of resting membrane potential [GO:0060075]; response to xenobiotic stimulus [GO:0009410]; stabilization of membrane potential [GO:0030322]","GO:0005216; GO:0005252; GO:0005267; GO:0005886; GO:0006813; GO:0007268; GO:0007420; GO:0008022; GO:0009410; GO:0015271; GO:0022841; GO:0030322; GO:0034220; GO:0044548; GO:0045202; GO:0051481; GO:0060075; GO:0071294; GO:0071456; GO:0071805; GO:0090102; GO:1903818"
"4221",4221,"Cluster_8634","Porites_evermani_scaffold_62:478529-479529",173,-24.25,2,18,893,914,16,"87.50%","93.75%","Peve_00037594",-0.345127040693983,0.775671655625907,0.992476593270171,"Q9D9M5","Pyridoxal phosphate phosphatase PHOSPHO2 (EC 3.1.3.74)","Mus musculus (Mouse)","","GO:0016791; GO:0033883; GO:0046872"
"4222",4222,"Cluster_8634","Porites_evermani_scaffold_6:486709-487709",162,-20.27,2,19,74,95,17,"76.47%","82.35%","Peve_00036952",0.464912017104023,0.692171910037306,0.978262075707395,NA,NA,NA,NA,NA
"4223",4223,"Cluster_8634","Porites_evermani_scaffold_672:115782-116782",171,-23.07,2,21,935,957,20,"80.00%","85.00%","Peve_00038875",0.99912526170216,0.0266296742754265,0.887027605960946,"Q9CSN1","SNW domain-containing protein 1 (Nuclear protein SkiP) (Ski-interacting protein)","Mus musculus (Mouse)","cellular response to retinoic acid [GO:0071300]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of neurogenesis [GO:0050769]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of vitamin D receptor signaling pathway [GO:0070564]; regulation of retinoic acid receptor signaling pathway [GO:0048385]; regulation of vitamin D receptor signaling pathway [GO:0070562]; retinoic acid receptor signaling pathway [GO:0048384]; skeletal muscle cell differentiation [GO:0035914]","GO:0000122; GO:0000398; GO:0000785; GO:0003713; GO:0003714; GO:0005112; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0008024; GO:0016363; GO:0016604; GO:0016607; GO:0016922; GO:0019899; GO:0030511; GO:0035914; GO:0042771; GO:0042809; GO:0042974; GO:0043923; GO:0045892; GO:0045944; GO:0046332; GO:0048026; GO:0048384; GO:0048385; GO:0050681; GO:0050769; GO:0051571; GO:0070562; GO:0070564; GO:0071007; GO:0071013; GO:0071141; GO:0071300"
"4224",4224,"Cluster_8634","Porites_evermani_scaffold_7009:3036-4036",157,-23.65,2,21,971,999,26,"73.08%","73.08%","Peve_00039646",0.230629505354438,0.851842931319755,0.995934364227446,NA,NA,NA,NA,NA
"4225",4225,"Cluster_8634","Porites_evermani_scaffold_717:28364-29364",157,-22.15,2,21,443,464,20,"75.00%","80.00%","Peve_00039962",NA,NA,NA,NA,NA,NA,NA,NA
"4226",4226,"Cluster_8634","Porites_evermani_scaffold_76:354178-355178",169,-21.02,2,18,651,672,16,"87.50%","87.50%","Peve_00040871",0.592237691350604,0.596489301308638,0.978262075707395,NA,NA,NA,NA,NA
"4227",4227,"Cluster_8634","Porites_evermani_scaffold_765:163011-164011",173,-21.62,2,18,961,982,16,"87.50%","93.75%","Peve_00040976",0.579775643599726,0.606280398301717,0.978262075707395,NA,NA,NA,NA,NA
"4228",4228,"Cluster_8634","Porites_evermani_scaffold_77:256641-257641",169,-20.66,2,18,804,825,16,"87.50%","87.50%","Peve_00041049",0.998453622764511,0.0354086057088602,0.909359886114279,"Q9Y5X5","Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (G-protein coupled receptor HLWAR77) (Neuropeptide G-protein coupled receptor)","Homo sapiens (Human)","detection of abiotic stimulus [GO:0009582]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of adenylate cyclase activity [GO:0045761]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of MAPK cascade [GO:0043408]","GO:0004930; GO:0005886; GO:0007186; GO:0008188; GO:0009582; GO:0015629; GO:0031628; GO:0042277; GO:0043408; GO:0045761; GO:2000479"
"4229",4229,"Cluster_8634","Porites_evermani_scaffold_80:365646-366646",170,-20.6,2,21,342,362,19,"84.21%","84.21%","Peve_00041784",-0.720683985836707,0.487655772417912,0.978262075707395,"Q9UHC6","Contactin-associated protein-like 2 (Cell recognition molecule Caspr2)","Homo sapiens (Human)","adult behavior [GO:0030534]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; clustering of voltage-gated potassium channels [GO:0045163]; learning [GO:0007612]; limbic system development [GO:0021761]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; neuron recognition [GO:0008038]; positive regulation of gap junction assembly [GO:1903598]; protein localization to juxtaparanode region of axon [GO:0071205]; social behavior [GO:0035176]; striatum development [GO:0021756]; superior temporal gyrus development [GO:0071109]; thalamus development [GO:0021794]; transmission of nerve impulse [GO:0019226]; vocal learning [GO:0042297]; vocalization behavior [GO:0071625]","GO:0005769; GO:0005794; GO:0007155; GO:0007420; GO:0007612; GO:0008038; GO:0008076; GO:0008283; GO:0009986; GO:0016020; GO:0019226; GO:0019899; GO:0021756; GO:0021761; GO:0021794; GO:0021987; GO:0030424; GO:0030425; GO:0030534; GO:0030673; GO:0031175; GO:0033010; GO:0035176; GO:0042297; GO:0043025; GO:0043204; GO:0044224; GO:0045163; GO:0048812; GO:0071109; GO:0071205; GO:0071625; GO:1903598"
"4230",4230,"Cluster_8634","Porites_evermani_scaffold_826:147756-148756",166,-21.63,2,21,573,593,19,"78.95%","84.21%","Peve_00042318",NA,NA,NA,NA,NA,NA,NA,NA
"4231",4231,"Cluster_8634","Porites_evermani_scaffold_86:181515-182515",174,-20.64,2,19,859,880,17,"82.35%","94.12%","Peve_00042974",-0.509237172674059,0.659855205035417,0.978262075707395,NA,NA,NA,NA,NA
"4232",4232,"Cluster_8634","Porites_evermani_scaffold_95:237800-238303",157,-21.18,2,18,103,124,16,"68.75%","87.50%","Peve_00044553",0.983516448487543,0.115749436725452,0.978262075707395,"P29728","2'-5'-oligoadenylate synthase 2 ((2-5')oligo(A) synthase 2) (2-5A synthase 2) (EC 2.7.7.84) (p69 OAS / p71 OAS) (p69OAS / p71OAS)","Homo sapiens (Human)","defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; interleukin-27-mediated signaling pathway [GO:0070106]; negative regulation of viral genome replication [GO:0045071]; nucleobase-containing compound metabolic process [GO:0006139]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of lactation [GO:1903487]; regulation of ribonuclease activity [GO:0060700]; response to virus [GO:0009615]; RNA catabolic process [GO:0006401]; type I interferon-mediated signaling pathway [GO:0060337]","GO:0001730; GO:0003725; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006139; GO:0006401; GO:0009615; GO:0016020; GO:0032728; GO:0032760; GO:0042742; GO:0043231; GO:0045071; GO:0046872; GO:0048471; GO:0051607; GO:0060337; GO:0060700; GO:0070106; GO:1903487"
"4233",4233,"Cluster_8884","Porites_evermani_scaffold_1037:111547-112547",155,-20.71,2,12,14,34,10,"100.00%","100.00%","Peve_00000771",-0.984439535435929,0.112453031005175,0.978262075707395,NA,NA,NA,NA,NA
"4234",4234,"Cluster_8884","Porites_evermani_scaffold_1037:99293-100293",155,-20.71,2,12,14,34,10,"100.00%","100.00%","Peve_00000770",-0.970500971966687,0.155014527442118,0.978262075707395,NA,NA,NA,NA,NA
"4235",4235,"Cluster_8884","Porites_evermani_scaffold_1052:112443-113443",154,-20.09,2,20,684,701,18,"77.78%","83.33%","Peve_00001054",-0.312235126052594,0.797844652119919,0.995934364227446,"Q9U518","L-asparaginase (EC 3.5.1.1) (DiAsp) (L-asparagine amidohydrolase)","Dirofilaria immitis (Canine heartworm)","asparagine metabolic process [GO:0006528]","GO:0004067; GO:0006528"
"4236",4236,"Cluster_8884","Porites_evermani_scaffold_111:45436-46436",155,-20.01,2,12,862,882,10,"100.00%","100.00%","Peve_00002001",-0.239653524656105,0.845932310922818,0.995934364227446,NA,NA,NA,NA,NA
"4237",4237,"Cluster_8884","Porites_evermani_scaffold_111:67318-68318",149,-20.97,2,20,477,501,22,"63.64%","77.27%","Peve_00002007",NA,NA,NA,NA,NA,NA,NA,NA
"4238",4238,"Cluster_8884","Porites_evermani_scaffold_1158:51791-52791",174,-28.76,2,19,796,816,17,"82.35%","94.12%","Peve_00002662",-0.709043287101238,0.498254136015962,0.978262075707395,"Q5RGU1","Atypical kinase COQ8A, mitochondrial (EC 2.7.-.-) (Chaperone activity of bc1 complex-like) (Chaperone-ABC1-like) (Coenzyme Q protein 8A) (aarF domain-containing protein kinase 3)","Danio rerio (Zebrafish) (Brachydanio rerio)","phosphorylation [GO:0016310]; ubiquinone biosynthetic process [GO:0006744]","GO:0005524; GO:0005739; GO:0006744; GO:0016301; GO:0016310; GO:0031314; GO:0043531"
"4239",4239,"Cluster_8884","Porites_evermani_scaffold_1169:52945-53945",165,-21.12,2,19,518,539,18,"77.78%","88.89%","Peve_00002839",-0.9473347077131,0.207530563699729,0.978262075707395,"Q60520","Paired amphipathic helix protein Sin3a (Histone deacetylase complex subunit Sin3a) (Transcriptional corepressor Sin3a)","Mus musculus (Mouse)","activation of innate immune response [GO:0002218]; aging [GO:0007568]; cellular response to dopamine [GO:1903351]; cellular response to glucose stimulus [GO:0071333]; cerebral cortex neuron differentiation [GO:0021895]; DNA replication [GO:0006260]; hematopoietic progenitor cell differentiation [GO:0002244]; histone deacetylation [GO:0016575]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of histone H3-K27 acetylation [GO:1901675]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of heterochromatin formation [GO:0031453]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deacetylation [GO:0006476]; protein localization [GO:0008104]; regulation of axon extension [GO:0030516]; regulation of DNA-templated transcription [GO:0006355]; regulation of hormone levels [GO:0010817]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; response to methylglyoxal [GO:0051595]; response to organonitrogen compound [GO:0010243]; rhythmic process [GO:0048511]","GO:0000118; GO:0000122; GO:0000776; GO:0000785; GO:0001701; GO:0002218; GO:0002230; GO:0002244; GO:0003677; GO:0003682; GO:0003713; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0006260; GO:0006355; GO:0006476; GO:0007568; GO:0008104; GO:0010243; GO:0010817; GO:0010971; GO:0016575; GO:0016580; GO:0017053; GO:0021895; GO:0030336; GO:0030512; GO:0030516; GO:0031453; GO:0032991; GO:0042754; GO:0043066; GO:0043619; GO:0044877; GO:0045666; GO:0045892; GO:0045944; GO:0048511; GO:0051595; GO:0061629; GO:0071333; GO:0140416; GO:1900181; GO:1901675; GO:1902455; GO:1902459; GO:1903351; GO:2000678"
"4240",4240,"Cluster_8884","Porites_evermani_scaffold_131:196442-196876",154,-21.81,2,20,374,395,19,"63.16%","84.21%","Peve_00004929",-0.769485830885051,0.441025118405088,0.978262075707395,"Q6YGZ4","Circadian locomoter output cycles protein kaput","Tyto alba (Barn owl)","cellular response to DNA damage stimulus [GO:0006974]; protein acetylation [GO:0006473]; response to redox state [GO:0051775]; rhythmic process [GO:0048511]","GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0005829; GO:0006473; GO:0006974; GO:0046983; GO:0048511; GO:0051775"
"4241",4241,"Cluster_8884","Porites_evermani_scaffold_131:196442-196876",154,-21.81,2,20,374,395,19,"63.16%","84.21%","Peve_00004930",0.162337594809896,0.896193281015589,0.999448381576871,NA,NA,NA,NA,NA
"4242",4242,"Cluster_8884","Porites_evermani_scaffold_1328:15232-16232",164,-22.67,2,18,606,628,18,"77.78%","88.89%","Peve_00005177",-0.993157225684681,0.0745176565453628,0.978262075707395,"Q5YLG1","Endoglucanase A (EC 3.2.1.4) (Endo-1,4-beta-glucanase A)","Bacillus pumilus (Bacillus mesentericus)","cellulose catabolic process [GO:0030245]","GO:0005576; GO:0008810; GO:0030245; GO:0030248"
"4243",4243,"Cluster_8884","Porites_evermani_scaffold_1385:40912-41912",153,-20.93,2,20,457,479,20,"65.00%","85.00%","Peve_00005969",NA,NA,NA,"Q80XJ3","Tetratricopeptide repeat protein 28 (TPR repeat protein 28)","Mus musculus (Mouse)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0005737; GO:0005813; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301; GO:0072686; GO:0097431; GO:1990023"
"4244",4244,"Cluster_8884","Porites_evermani_scaffold_1409:29639-30639",172,-20.86,2,18,925,946,17,"88.24%","94.12%","Peve_00006360",NA,NA,NA,NA,NA,NA,NA,NA
"4245",4245,"Cluster_8884","Porites_evermani_scaffold_14:2921-3921",166,-22.08,2,20,832,853,19,"78.95%","84.21%","Peve_00006152",-0.92018455743218,0.256076912255551,0.978262075707395,NA,NA,NA,NA,NA
"4246",4246,"Cluster_8884","Porites_evermani_scaffold_1445:2248-3248",167,-23.71,2,20,821,841,18,"66.67%","94.44%","Peve_00006778",-0.974579324403798,0.143851033984601,0.978262075707395,"F1MWM0","Retinal-specific phospholipid-transporting ATPase ABCA4 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 4) (RIM ABC transporter) (RIM protein) (RmP) (Retinal-specific ATP-binding cassette transporter)","Bos taurus (Bovine)","lipid transport [GO:0006869]; phospholipid transfer to membrane [GO:0006649]; phospholipid translocation [GO:0045332]; photoreceptor cell maintenance [GO:0045494]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; visual perception [GO:0007601]","GO:0001523; GO:0001750; GO:0003924; GO:0005319; GO:0005501; GO:0005502; GO:0005503; GO:0005524; GO:0005525; GO:0005548; GO:0005783; GO:0005886; GO:0006649; GO:0006869; GO:0007601; GO:0016887; GO:0034632; GO:0042574; GO:0042626; GO:0043231; GO:0045332; GO:0045494; GO:0090555; GO:0097381; GO:0120202; GO:0140326; GO:0140347; GO:0140359"
"4247",4247,"Cluster_8884","Porites_evermani_scaffold_146:227917-228917",150,-22.39,2,20,735,757,20,"60.00%","80.00%","Peve_00006972",0.340233020503664,0.778988093671919,0.993239512438958,NA,NA,NA,NA,NA
"4248",4248,"Cluster_8884","Porites_evermani_scaffold_1546:44152-44887",161,-20.47,2,20,228,251,21,"71.43%","85.71%","Peve_00008046",NA,NA,NA,NA,NA,NA,NA,NA
"4249",4249,"Cluster_8884","Porites_evermani_scaffold_1546:44152-44887",161,-20.47,2,20,228,251,21,"71.43%","85.71%","Peve_00008047",-0.936970683851746,0.227234543409307,0.978262075707395,NA,NA,NA,NA,NA
"4250",4250,"Cluster_8884","Porites_evermani_scaffold_1706:66049-67049",153,-20.49,2,20,814,837,21,"71.43%","76.19%","Peve_00010109",0.195666758587174,0.874625817801006,0.997476741937264,"B8V7S0","CUB and peptidase domain-containing protein 1","Acropora millepora (Staghorn coral) (Heteropora millepora)","proteolysis [GO:0006508]","GO:0004252; GO:0005576; GO:0006508"
"4251",4251,"Cluster_8884","Porites_evermani_scaffold_17:1004173-1005173",162,-24.98,2,20,39,62,21,"71.43%","80.95%","Peve_00010007",NA,NA,NA,NA,NA,NA,NA,NA
"4252",4252,"Cluster_8884","Porites_evermani_scaffold_1719:82797-83797",154,-20.09,2,20,290,307,18,"77.78%","83.33%","Peve_00010247",-0.987001970546152,0.10275558085586,0.978262075707395,"Q8NEL9","Phospholipase DDHD1 (EC 3.1.1.111) (EC 3.1.1.32) (DDHD domain-containing protein 1) (Phosphatidic acid-preferring phospholipase A1 homolog) (PA-PLA1) (EC 3.1.1.118) (Phospholipid sn-1 acylhydrolase)","Homo sapiens (Human)","lipid metabolic process [GO:0006629]; positive regulation of mitochondrial fission [GO:0090141]","GO:0004620; GO:0005737; GO:0005829; GO:0006629; GO:0008970; GO:0046872; GO:0090141"
"4253",4253,"Cluster_8884","Porites_evermani_scaffold_1777:59749-60749",166,-21.28,2,20,460,483,21,"76.19%","80.95%","Peve_00010842",NA,NA,NA,"F1R332","Galanin receptor 2a","Danio rerio (Zebrafish) (Brachydanio rerio)","adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; neuropeptide signaling pathway [GO:0007218]","GO:0004966; GO:0005886; GO:0007188; GO:0007218; GO:0008528"
"4254",4254,"Cluster_8884","Porites_evermani_scaffold_1915:20732-21732",154,-20.67,2,20,81,103,20,"65.00%","80.00%","Peve_00012461",-0.985925883548413,0.106934137164324,0.978262075707395,"G1SIT5",NA,NA,NA,NA
"4255",4255,"Cluster_8884","Porites_evermani_scaffold_1931:936-1936",155,-20.43,2,18,610,632,18,"72.22%","88.89%","Peve_00012641",-0.947118896471404,0.207959151134339,0.978262075707395,"P35546","Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment]","Mus musculus (Mouse)","activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; anatomical structure morphogenesis [GO:0009653]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657]","GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0006919; GO:0007156; GO:0007158; GO:0007169; GO:0007399; GO:0009410; GO:0009653; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030155; GO:0030182; GO:0030335; GO:0030424; GO:0030425; GO:0033141; GO:0033619; GO:0033630; GO:0033674; GO:0035799; GO:0035860; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045121; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0098797; GO:2001241"
"4256",4256,"Cluster_8884","Porites_evermani_scaffold_1951:50481-51481",162,-23.81,2,15,219,239,13,"84.62%","100.00%","Peve_00012846",-0.980896649722505,0.124636056032984,0.978262075707395,NA,NA,NA,NA,NA
"4257",4257,"Cluster_8884","Porites_evermani_scaffold_197:340333-341333",156,-20.62,2,18,298,319,17,"70.59%","88.24%","Peve_00013037",-0.990874293895798,0.0860714628347162,0.978262075707395,"Q8N9F7","Lysophospholipase D GDPD1 (EC 3.1.4.-) (Glycerophosphodiester phosphodiesterase 4) (Glycerophosphodiester phosphodiesterase domain-containing protein 1)","Homo sapiens (Human)","glycerophospholipid catabolic process [GO:0046475]; N-acylethanolamine metabolic process [GO:0070291]","GO:0004622; GO:0005783; GO:0005789; GO:0008081; GO:0016020; GO:0046475; GO:0046872; GO:0048471; GO:0070291"
"4258",4258,"Cluster_8884","Porites_evermani_scaffold_199:252275-253275",167,-22.14,2,20,486,506,18,"72.22%","88.89%","Peve_00013242",0.745028044552036,0.464872135560686,0.978262075707395,NA,NA,NA,NA,NA
"4259",4259,"Cluster_8884","Porites_evermani_scaffold_20:382668-383668",161,-21.36,2,19,895,919,21,"76.19%","76.19%","Peve_00013541",-0.947118896471403,0.20795915113434,0.978262075707395,NA,NA,NA,NA,NA
"4260",4260,"Cluster_8884","Porites_evermani_scaffold_2057:85243-86243",168,-22.56,2,17,786,806,15,"86.67%","93.33%","Peve_00014118",-0.979854752588585,0.128000955661518,0.978262075707395,"Q9DBN1","Stimulated by retinoic acid gene 6 protein-like (STRA6-like protein) (Retinol-binding protein 4 receptor 2) (RBP4 receptor 2)","Mus musculus (Mouse)","establishment of localization in cell [GO:0051649]; retinol transport [GO:0034633]; vitamin A import into cell [GO:0071939]","GO:0005886; GO:0034633; GO:0051649; GO:0071939"
"4261",4261,"Cluster_8884","Porites_evermani_scaffold_2058:85752-86752",160,-21.74,2,18,771,792,17,"76.47%","88.24%","Peve_00014126",-0.97705540171245,0.136637295734894,0.978262075707395,"Q9UGM3","Deleted in malignant brain tumors 1 protein (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein)","Homo sapiens (Human)","antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; detection of bacterial lipoprotein [GO:0042494]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]","GO:0001530; GO:0003677; GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006898; GO:0006952; GO:0015031; GO:0019898; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042494; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0050840; GO:0051607; GO:0061844; GO:0070062; GO:0070891; GO:1904399"
"4262",4262,"Cluster_8884","Porites_evermani_scaffold_2074:81843-82843",154,-20.18,2,20,376,398,20,"70.00%","75.00%","Peve_00014276",NA,NA,NA,NA,NA,NA,NA,NA
"4263",4263,"Cluster_8884","Porites_evermani_scaffold_211:153370-154370",150,-20.85,2,20,271,295,22,"59.09%","77.27%","Peve_00014666",-0.653058515325958,0.546971114156543,0.978262075707395,NA,NA,NA,NA,NA
"4264",4264,"Cluster_8884","Porites_evermani_scaffold_2126:10526-11526",165,-22.6,2,14,219,239,12,"100.00%","100.00%","Peve_00014823",NA,NA,NA,NA,NA,NA,NA,NA
"4265",4265,"Cluster_8884","Porites_evermani_scaffold_215:251168-252168",153,-20.46,2,20,572,594,20,"70.00%","80.00%","Peve_00015062",-0.964747457491458,0.169540906942101,0.978262075707395,"P55115","Zinc metalloproteinase nas-15 (EC 3.4.24.-) (Nematode astacin 15)","Caenorhabditis elegans","proteolysis [GO:0006508]","GO:0004222; GO:0005576; GO:0006508; GO:0008270"
"4266",4266,"Cluster_8884","Porites_evermani_scaffold_2193:1803-2803",166,-24.78,2,20,419,441,20,"70.00%","90.00%","Peve_00015452",NA,NA,NA,NA,NA,NA,NA,NA
"4267",4267,"Cluster_8884","Porites_evermani_scaffold_225:127102-128102",155,-20.01,2,12,151,171,10,"100.00%","100.00%","Peve_00016035",-0.0452043849628163,0.971212184707492,0.999448381576871,"Q7L5Y6","DET1 homolog (De-etiolated-1 homolog)","Homo sapiens (Human)","positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein ubiquitination [GO:0016567]; protein-containing complex assembly [GO:0065003]","GO:0005634; GO:0016567; GO:0031461; GO:0031464; GO:0031625; GO:0032436; GO:0044877; GO:0065003; GO:0080008; GO:1990756"
"4268",4268,"Cluster_8884","Porites_evermani_scaffold_2259:11207-12207",158,-21.32,2,20,57,81,22,"68.18%","77.27%","Peve_00016127",NA,NA,NA,NA,NA,NA,NA,NA
"4269",4269,"Cluster_8884","Porites_evermani_scaffold_2296:62926-63926",157,-20.85,2,20,464,483,18,"66.67%","88.89%","Peve_00016450",-0.947118896471404,0.207959151134339,0.978262075707395,NA,NA,NA,NA,NA
"4270",4270,"Cluster_8884","Porites_evermani_scaffold_2328:7597-8597",164,-20.88,2,20,842,860,18,"83.33%","83.33%","Peve_00016805",0.743638094106038,0.466197172009016,0.978262075707395,"Q5FWU8","Zinc finger MYND domain-containing protein 10","Xenopus laevis (African clawed frog)","inner dynein arm assembly [GO:0036159]; motile cilium assembly [GO:0044458]; outer dynein arm assembly [GO:0036158]; positive regulation of motile cilium assembly [GO:1905505]","GO:0005929; GO:0016324; GO:0034451; GO:0036158; GO:0036159; GO:0044458; GO:0046872; GO:0120293; GO:1905505"
"4271",4271,"Cluster_8884","Porites_evermani_scaffold_249:268447-269447",173,-24.03,2,20,513,532,18,"83.33%","94.44%","Peve_00018258",NA,NA,NA,NA,NA,NA,NA,NA
"4272",4272,"Cluster_8884","Porites_evermani_scaffold_2732:37422-38422",166,-23.75,2,20,555,577,20,"75.00%","85.00%","Peve_00020369",NA,NA,NA,"Q95JD5","Sulfotransferase 1B1 (ST1B1) (cSULT1B1) (EC 2.8.2.1) (Sulfotransferase family cytosolic 1B member 1)","Canis lupus familiaris (Dog) (Canis familiaris)","3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; epithelial cell differentiation [GO:0030855]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805]","GO:0004062; GO:0005737; GO:0006068; GO:0006805; GO:0008146; GO:0009812; GO:0030855; GO:0042403; GO:0050427; GO:0051923"
"4273",4273,"Cluster_8884","Porites_evermani_scaffold_2820:18391-19391",154,-20.09,2,20,827,844,18,"77.78%","83.33%","Peve_00021083",-0.781486660907788,0.428923389689948,0.978262075707395,"Q5RKZ7","Molybdenum cofactor biosynthesis protein 1 [Includes: GTP 3',8-cyclase (EC 4.1.99.22) (Molybdenum cofactor biosynthesis protein A); Cyclic pyranopterin monophosphate synthase (EC 4.6.1.17) (Molybdenum cofactor biosynthesis protein C)]","Mus musculus (Mouse)","Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324]","GO:0005525; GO:0005829; GO:0006777; GO:0019008; GO:0032324; GO:0046872; GO:0051539; GO:0061798; GO:0061799"
"4274",4274,"Cluster_8884","Porites_evermani_scaffold_292:178317-179317",162,-20.88,2,17,601,620,15,"86.67%","93.33%","Peve_00021857",0.482423351924379,0.679513389789296,0.978262075707395,NA,NA,NA,NA,NA
"4275",4275,"Cluster_8884","Porites_evermani_scaffold_307:255607-256607",158,-21.52,2,15,709,729,13,"76.92%","100.00%","Peve_00023144",-0.795582754701038,0.414329633456707,0.978262075707395,NA,NA,NA,NA,NA
"4276",4276,"Cluster_8884","Porites_evermani_scaffold_3105:6022-7022",154,-21.02,2,20,468,492,22,"68.18%","72.73%","Peve_00023433",-0.996600418446106,0.0525086635251301,0.965318571973143,"Q7T2C4",NA,NA,NA,NA
"4277",4277,"Cluster_8884","Porites_evermani_scaffold_3252:40089-41089",173,-21.25,2,19,279,300,18,"88.89%","88.89%","Peve_00024343",NA,NA,NA,"P55023","Tyrosinase (EC 1.14.18.1) (Monophenol monooxygenase)","Streptomyces lincolnensis","melanin biosynthetic process [GO:0042438]","GO:0004503; GO:0042438; GO:0046872"
"4278",4278,"Cluster_8884","Porites_evermani_scaffold_3530:16210-17210",153,-20.15,2,20,649,673,22,"68.18%","77.27%","Peve_00026145",0.997253647308052,0.047192471195222,0.941791888778827,NA,NA,NA,NA,NA
"4279",4279,"Cluster_8884","Porites_evermani_scaffold_3690:38665-39665",175,-21.58,2,20,190,210,18,"83.33%","88.89%","Peve_00027023",-0.573144908828194,0.611446419213155,0.978262075707395,"Q5U3N5","Protein phosphatase PTC7 homolog (EC 3.1.3.16)","Danio rerio (Zebrafish) (Brachydanio rerio)","","GO:0005739; GO:0005759; GO:0017018; GO:0046872"
"4280",4280,"Cluster_8884","Porites_evermani_scaffold_3701:24053-25053",154,-20.09,2,20,166,183,18,"77.78%","83.33%","Peve_00027133",-0.750081043848819,0.460028903933372,0.978262075707395,NA,NA,NA,NA,NA
"4281",4281,"Cluster_8884","Porites_evermani_scaffold_37:21676-22676",153,-20.81,2,20,84,108,22,"68.18%","77.27%","Peve_00027097",0.57919791843343,0.606731686117287,0.978262075707395,"Q9Z0E8","Organic cation/carnitine transporter 2 (High-affinity sodium-dependent carnitine cotransporter) (Solute carrier family 22 member 5)","Mus musculus (Mouse)","(R)-carnitine transmembrane transport [GO:1902270]; (R)-carnitine transport [GO:1900749]; adult heart development [GO:0007512]; carnitine metabolic process [GO:0009437]; carnitine transport [GO:0015879]; establishment of localization in cell [GO:0051649]; locomotory behavior [GO:0007626]; mitochondrion organization [GO:0007005]; positive regulation of intestinal epithelial structure maintenance [GO:0060731]; quaternary ammonium group transport [GO:0015697]; reproductive structure development [GO:0048608]; response to symbiotic bacterium [GO:0009609]; response to tumor necrosis factor [GO:0034612]; response to type II interferon [GO:0034341]; sodium ion transport [GO:0006814]; sodium-dependent organic cation transport [GO:0070715]; transport across blood-brain barrier [GO:0150104]","GO:0005524; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0006814; GO:0007005; GO:0007512; GO:0007626; GO:0009437; GO:0009609; GO:0009925; GO:0015226; GO:0015293; GO:0015651; GO:0015697; GO:0015879; GO:0016020; GO:0016323; GO:0016324; GO:0030165; GO:0031526; GO:0034341; GO:0034612; GO:0048608; GO:0051649; GO:0060731; GO:0070715; GO:0150104; GO:1900749; GO:1901235; GO:1902270"
"4282",4282,"Cluster_8884","Porites_evermani_scaffold_3779:4982-5982",159,-23.05,2,20,925,945,18,"72.22%","77.78%","Peve_00027474",NA,NA,NA,NA,NA,NA,NA,NA
"4283",4283,"Cluster_8884","Porites_evermani_scaffold_378:44030-45030",166,-21.65,2,20,784,806,20,"75.00%","85.00%","Peve_00027488",NA,NA,NA,NA,NA,NA,NA,NA
"4284",4284,"Cluster_8884","Porites_evermani_scaffold_397:4173-5173",166,-20.49,2,19,605,625,17,"76.47%","88.24%","Peve_00028555",-0.997387077455361,0.0460312744260222,0.935169468683523,NA,NA,NA,NA,NA
"4285",4285,"Cluster_8884","Porites_evermani_scaffold_4061:17475-18475",158,-21.63,2,20,474,498,22,"68.18%","77.27%","Peve_00029176",NA,NA,NA,NA,NA,NA,NA,NA
"4286",4286,"Cluster_8884","Porites_evermani_scaffold_4094:30141-31141",153,-22.19,2,19,128,152,21,"66.67%","76.19%","Peve_00029315",-0.803911303117878,0.405497283887094,0.978262075707395,"Q5R4U9","Sorcin","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","calcium ion transport [GO:0006816]; cytoplasmic sequestering of transcription factor [GO:0042994]; negative regulation of cardiac muscle contraction [GO:0055118]; negative regulation of heart rate [GO:0010459]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of high voltage-gated calcium channel activity [GO:1901841]; regulation of relaxation of muscle [GO:1901077]","GO:0002020; GO:0005509; GO:0005654; GO:0005829; GO:0005886; GO:0006816; GO:0010459; GO:0030018; GO:0033017; GO:0035774; GO:0042584; GO:0042994; GO:0046982; GO:0051281; GO:0055118; GO:0060315; GO:0070062; GO:0086004; GO:0140297; GO:1901077; GO:1901841; GO:1901844; GO:2000678"
"4287",4287,"Cluster_8884","Porites_evermani_scaffold_424:170405-171405",162,-22.46,2,19,261,281,17,"70.59%","88.24%","Peve_00030092",0.75145213788423,0.458707515532327,0.978262075707395,NA,NA,NA,NA,NA
"4288",4288,"Cluster_8884","Porites_evermani_scaffold_42:720849-721849",159,-20.4,2,20,401,421,18,"66.67%","83.33%","Peve_00029837",NA,NA,NA,NA,NA,NA,NA,NA
"4289",4289,"Cluster_8884","Porites_evermani_scaffold_4311:27909-28594",150,-20.58,2,20,124,146,20,"65.00%","75.00%","Peve_00030506",NA,NA,NA,NA,NA,NA,NA,NA
"4290",4290,"Cluster_8884","Porites_evermani_scaffold_436:261196-262196",160,-21.01,2,19,802,824,19,"73.68%","89.47%","Peve_00030713",0.627635822863424,0.568045417541707,0.978262075707395,NA,NA,NA,NA,NA
"4291",4291,"Cluster_8884","Porites_evermani_scaffold_4452:7506-8506",155,-20.01,2,12,261,281,10,"100.00%","100.00%","Peve_00031227",NA,NA,NA,NA,NA,NA,NA,NA
"4292",4292,"Cluster_8884","Porites_evermani_scaffold_4640:169-1169",168,-20.46,2,18,82,103,17,"82.35%","94.12%","Peve_00032082",NA,NA,NA,NA,NA,NA,NA,NA
"4293",4293,"Cluster_8884","Porites_evermani_scaffold_477:96159-97159",163,-20.31,2,20,378,398,18,"72.22%","83.33%","Peve_00032609",NA,NA,NA,NA,NA,NA,NA,NA
"4294",4294,"Cluster_8884","Porites_evermani_scaffold_479:204727-205727",162,-22.15,2,20,214,235,19,"73.68%","84.21%","Peve_00032682",-0.975814104248265,0.14029927705355,0.978262075707395,"O15381","Nuclear valosin-containing protein-like (NVLp) (Nuclear VCP-like protein)","Homo sapiens (Human)","positive regulation of protein binding [GO:0032092]; positive regulation of telomerase activity [GO:0051973]; regulation of protein localization to nucleolus [GO:1904749]; ribosomal large subunit biogenesis [GO:0042273]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]","GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005697; GO:0005730; GO:0006364; GO:0016020; GO:0016887; GO:0032092; GO:0042254; GO:0042273; GO:0051973; GO:1904749; GO:1990275"
"4295",4295,"Cluster_8884","Porites_evermani_scaffold_5:1251981-1252981",170,-25.76,2,15,706,726,13,"100.00%","100.00%","Peve_00033569",-0.947118896471404,0.207959151134339,0.978262075707395,"I3PB37","4-coumarate:CoA ligase 1 (Ph-4CL1) (Ph4CL1) (EC 6.2.1.12) ((E)-caffeate:CoA ligase 4CL1) (EC 6.2.1.-) (Benzoate:CoA ligase 4CL1) (EC 6.2.1.25) (Trans-cinnamate:CoA ligase 4CL1) (EC 6.2.1.-) (Trans-ferulate:CoA ligase 4CL1) (EC 6.2.1.-)","Petunia hybrida (Petunia)","cinnamic acid biosynthetic process [GO:0009800]; cinnamic acid metabolic process [GO:0009803]; circadian rhythm [GO:0007623]; ferulate metabolic process [GO:0033494]; phenylpropanoid metabolic process [GO:0009698]; phytoalexin biosynthetic process [GO:0052315]","GO:0005524; GO:0005829; GO:0007623; GO:0009698; GO:0009800; GO:0009803; GO:0016207; GO:0016405; GO:0018858; GO:0033494; GO:0050563; GO:0052315; GO:0106286; GO:0106290"
"4296",4296,"Cluster_8884","Porites_evermani_scaffold_5207:6131-7131",164,-22.03,2,20,13,31,18,"77.78%","88.89%","Peve_00034421",0.266915822315431,0.827990862136248,0.995934364227446,NA,NA,NA,NA,NA
"4297",4297,"Cluster_8884","Porites_evermani_scaffold_545:82602-83602",157,-20.57,2,20,73,95,20,"75.00%","80.00%","Peve_00035294",-0.901281075489059,0.28525585356926,0.978262075707395,"Q9UDY8","Mucosa-associated lymphoid tissue lymphoma translocation protein 1 (EC 3.4.22.-) (MALT lymphoma-associated translocation) (Paracaspase)","Homo sapiens (Human)","activation of NF-kappaB-inducing kinase activity [GO:0007250]; B cell activation [GO:0042113]; B-1 B cell differentiation [GO:0001923]; defense response [GO:0006952]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of apoptotic process [GO:0043066]; nuclear export [GO:0051168]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T-helper 17 cell differentiation [GO:2000321]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; regulation of T cell receptor signaling pathway [GO:0050856]; response to fungus [GO:0009620]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]","GO:0001650; GO:0001923; GO:0002020; GO:0002096; GO:0002726; GO:0004175; GO:0004197; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006952; GO:0007250; GO:0008233; GO:0009620; GO:0031398; GO:0031663; GO:0032449; GO:0032731; GO:0032743; GO:0032991; GO:0036094; GO:0042098; GO:0042113; GO:0042802; GO:0042981; GO:0043066; GO:0043123; GO:0043280; GO:0043621; GO:0045087; GO:0048471; GO:0050852; GO:0050856; GO:0051092; GO:0051168; GO:0051603; GO:2000321"
"4298",4298,"Cluster_8884","Porites_evermani_scaffold_564:190762-191762",156,-20.97,2,19,805,829,21,"71.43%","80.95%","Peve_00035926",0.9297370541442,0.24006818244801,0.978262075707395,NA,NA,NA,NA,NA
"4299",4299,"Cluster_8884","Porites_evermani_scaffold_628:121037-122037",169,-23.93,2,20,960,984,22,"81.82%","81.82%","Peve_00037798",0.370397067527589,0.758443249500351,0.988219883885475,"P0CG13","Chromosome transmission fidelity protein 8 homolog (hCTF8)","Homo sapiens (Human)","DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; mitotic sister chromatid cohesion [GO:0007064]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]","GO:0003677; GO:0005654; GO:0006260; GO:0007064; GO:0031390; GO:0032508; GO:1900264"
"4300",4300,"Cluster_8884","Porites_evermani_scaffold_743:39942-40942",154,-20.09,2,20,501,518,18,"77.78%","83.33%","Peve_00040567",-0.535829000203779,0.639998337268234,0.978262075707395,NA,NA,NA,NA,NA
"4301",4301,"Cluster_8884","Porites_evermani_scaffold_749:127862-128862",166,-22.08,2,19,513,533,17,"76.47%","88.24%","Peve_00040645",NA,NA,NA,NA,NA,NA,NA,NA
"4302",4302,"Cluster_8884","Porites_evermani_scaffold_779:110486-111486",153,-20.28,2,20,658,681,21,"71.43%","76.19%","Peve_00041230",0.81195522973831,0.39680661224786,0.978262075707395,NA,NA,NA,NA,NA
"4303",4303,"Cluster_8884","Porites_evermani_scaffold_811:137811-138811",157,-21.35,2,20,468,492,22,"72.73%","77.27%","Peve_00042036",-0.222988010838404,0.856837843156433,0.995934364227446,"Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"4304",4304,"Cluster_8884","Porites_evermani_scaffold_843:48787-49787",160,-21.57,2,19,387,406,17,"76.47%","88.24%","Peve_00042633",-0.978261711419544,0.132983477326865,0.978262075707395,NA,NA,NA,NA,NA
"4305",4305,"Cluster_8884","Porites_evermani_scaffold_900:112473-113473",146,-20.12,2,20,527,551,22,"59.09%","72.73%","Peve_00043776",0.75145213788423,0.458707515532327,0.978262075707395,NA,NA,NA,NA,NA
"4306",4306,"Cluster_8884","Porites_evermani_scaffold_921:19047-20047",155,-22.99,2,12,486,506,10,"100.00%","100.00%","Peve_00044134",-0.966045701309951,0.166371553599702,0.978262075707395,"Q6ITT3","Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C (EC 2.4.1.145) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase IVc) (GnT-IVc) (N-acetylglucosaminyltransferase IVc) (UDP-N-acetylglucosamine: alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IVc)","Sus scrofa (Pig)","protein N-linked glycosylation [GO:0006487]","GO:0000139; GO:0006487; GO:0008375; GO:0008454; GO:0046872"
"4307",4307,"Cluster_8884","Porites_evermani_scaffold_935:165818-166818",156,-21.23,2,19,908,932,21,"76.19%","76.19%","Peve_00044333",-0.780074491413758,0.430362263650012,0.978262075707395,NA,NA,NA,NA,NA
"4308",4308,"Cluster_8884","Porites_evermani_scaffold_947:40316-41316",153,-23.61,2,20,469,494,23,"69.57%","73.91%","Peve_00044509",NA,NA,NA,NA,NA,NA,NA,NA
"4309",4309,"Cluster_8884","Porites_evermani_scaffold_95:430111-431111",156,-22.9,2,19,820,839,17,"70.59%","88.24%","Peve_00044570",-0.886216780995398,0.306648525494423,0.978262075707395,"Q71SG7","Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 4 (EC 2.4.1.102)","Danio rerio (Zebrafish) (Brachydanio rerio)","protein glycosylation [GO:0006486]","GO:0000139; GO:0003829; GO:0006486; GO:0008375"
"4310",4310,"Cluster_8887","Porites_evermani_scaffold_1037:111547-112547",155,-21.06,2,12,14,34,10,"100.00%","100.00%","Peve_00000771",-0.897805900530571,0.290320613278739,0.978262075707395,NA,NA,NA,NA,NA
"4311",4311,"Cluster_8887","Porites_evermani_scaffold_1037:99293-100293",155,-21.06,2,12,14,34,10,"100.00%","100.00%","Peve_00000770",-0.866379576422917,0.332882109715683,0.978262075707395,NA,NA,NA,NA,NA
"4312",4312,"Cluster_8887","Porites_evermani_scaffold_1052:112443-113443",154,-20.45,2,20,684,701,18,"77.78%","83.33%","Peve_00001054",-0.562113167772816,0.619977069846354,0.978262075707395,"Q9U518","L-asparaginase (EC 3.5.1.1) (DiAsp) (L-asparagine amidohydrolase)","Dirofilaria immitis (Canine heartworm)","asparagine metabolic process [GO:0006528]","GO:0004067; GO:0006528"
"4313",4313,"Cluster_8887","Porites_evermani_scaffold_111:45436-46436",155,-20.37,2,12,862,882,10,"100.00%","100.00%","Peve_00002001",-0.498096942896238,0.668064728649254,0.978262075707395,NA,NA,NA,NA,NA
"4314",4314,"Cluster_8887","Porites_evermani_scaffold_111:67318-68318",149,-20.6,2,20,477,501,22,"63.64%","77.27%","Peve_00002007",NA,NA,NA,NA,NA,NA,NA,NA
"4315",4315,"Cluster_8887","Porites_evermani_scaffold_1158:51791-52791",174,-28.39,2,19,796,816,17,"82.35%","94.12%","Peve_00002662",-0.87601399903841,0.320386553742398,0.978262075707395,"Q5RGU1","Atypical kinase COQ8A, mitochondrial (EC 2.7.-.-) (Chaperone activity of bc1 complex-like) (Chaperone-ABC1-like) (Coenzyme Q protein 8A) (aarF domain-containing protein kinase 3)","Danio rerio (Zebrafish) (Brachydanio rerio)","phosphorylation [GO:0016310]; ubiquinone biosynthetic process [GO:0006744]","GO:0005524; GO:0005739; GO:0006744; GO:0016301; GO:0016310; GO:0031314; GO:0043531"
"4316",4316,"Cluster_8887","Porites_evermani_scaffold_1164:57716-58716",156,-21.95,2,19,6,25,17,"70.59%","88.24%","Peve_00002787",-0.572988274389156,0.611568097687728,0.978262075707395,"Q5U374","Kelch-like protein 12","Danio rerio (Zebrafish) (Brachydanio rerio)","anterior/posterior pattern specification [GO:0009952]; convergent extension involved in axis elongation [GO:0060028]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; protein monoubiquitination [GO:0006513]; Wnt signaling pathway [GO:0016055]","GO:0006513; GO:0006888; GO:0009952; GO:0014029; GO:0014032; GO:0016055; GO:0030127; GO:0030134; GO:0031463; GO:0048208; GO:0060028"
"4317",4317,"Cluster_8887","Porites_evermani_scaffold_1164:64504-65504",156,-21.95,2,19,6,25,17,"70.59%","88.24%","Peve_00002789",0.298298171934551,0.807162044170383,0.995934364227446,"Q56A24","Kelch-like protein 24 (Kainate receptor-interacting protein for GluR6) (KRIP6) (Protein DRE1)","Rattus norvegicus (Rat)","intermediate filament organization [GO:0045109]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of kainate selective glutamate receptor activity [GO:2000312]","GO:0005737; GO:0005912; GO:0016567; GO:0030057; GO:0030424; GO:0031463; GO:0043204; GO:0045109; GO:0051865; GO:2000312"
"4318",4318,"Cluster_8887","Porites_evermani_scaffold_1169:52945-53945",165,-22.83,2,19,518,539,18,"77.78%","88.89%","Peve_00002839",-0.822284775038195,0.385398145973294,0.978262075707395,"Q60520","Paired amphipathic helix protein Sin3a (Histone deacetylase complex subunit Sin3a) (Transcriptional corepressor Sin3a)","Mus musculus (Mouse)","activation of innate immune response [GO:0002218]; aging [GO:0007568]; cellular response to dopamine [GO:1903351]; cellular response to glucose stimulus [GO:0071333]; cerebral cortex neuron differentiation [GO:0021895]; DNA replication [GO:0006260]; hematopoietic progenitor cell differentiation [GO:0002244]; histone deacetylation [GO:0016575]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of histone H3-K27 acetylation [GO:1901675]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of heterochromatin formation [GO:0031453]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deacetylation [GO:0006476]; protein localization [GO:0008104]; regulation of axon extension [GO:0030516]; regulation of DNA-templated transcription [GO:0006355]; regulation of hormone levels [GO:0010817]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; response to methylglyoxal [GO:0051595]; response to organonitrogen compound [GO:0010243]; rhythmic process [GO:0048511]","GO:0000118; GO:0000122; GO:0000776; GO:0000785; GO:0001701; GO:0002218; GO:0002230; GO:0002244; GO:0003677; GO:0003682; GO:0003713; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0006260; GO:0006355; GO:0006476; GO:0007568; GO:0008104; GO:0010243; GO:0010817; GO:0010971; GO:0016575; GO:0016580; GO:0017053; GO:0021895; GO:0030336; GO:0030512; GO:0030516; GO:0031453; GO:0032991; GO:0042754; GO:0043066; GO:0043619; GO:0044877; GO:0045666; GO:0045892; GO:0045944; GO:0048511; GO:0051595; GO:0061629; GO:0071333; GO:0140416; GO:1900181; GO:1901675; GO:1902455; GO:1902459; GO:1903351; GO:2000678"
"4319",4319,"Cluster_8887","Porites_evermani_scaffold_131:196442-196876",154,-21.44,2,20,374,395,19,"63.16%","84.21%","Peve_00004929",-0.56352110262646,0.618892700678653,0.978262075707395,"Q6YGZ4","Circadian locomoter output cycles protein kaput","Tyto alba (Barn owl)","cellular response to DNA damage stimulus [GO:0006974]; protein acetylation [GO:0006473]; response to redox state [GO:0051775]; rhythmic process [GO:0048511]","GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0005829; GO:0006473; GO:0006974; GO:0046983; GO:0048511; GO:0051775"
"4320",4320,"Cluster_8887","Porites_evermani_scaffold_131:196442-196876",154,-21.44,2,20,374,395,19,"63.16%","84.21%","Peve_00004930",-0.116072302961707,0.925939136710846,0.999448381576871,NA,NA,NA,NA,NA
"4321",4321,"Cluster_8887","Porites_evermani_scaffold_1328:15232-16232",164,-23.39,2,18,606,628,18,"77.78%","88.89%","Peve_00005177",-0.986851504147132,0.103349925728202,0.978262075707395,"Q5YLG1","Endoglucanase A (EC 3.2.1.4) (Endo-1,4-beta-glucanase A)","Bacillus pumilus (Bacillus mesentericus)","cellulose catabolic process [GO:0030245]","GO:0005576; GO:0008810; GO:0030245; GO:0030248"
"4322",4322,"Cluster_8887","Porites_evermani_scaffold_1385:40912-41912",153,-21.28,2,20,457,479,20,"65.00%","85.00%","Peve_00005969",NA,NA,NA,"Q80XJ3","Tetratricopeptide repeat protein 28 (TPR repeat protein 28)","Mus musculus (Mouse)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0005737; GO:0005813; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301; GO:0072686; GO:0097431; GO:1990023"
"4323",4323,"Cluster_8887","Porites_evermani_scaffold_1409:29639-30639",172,-20.86,2,18,925,946,17,"88.24%","94.12%","Peve_00006360",NA,NA,NA,NA,NA,NA,NA,NA
"4324",4324,"Cluster_8887","Porites_evermani_scaffold_14:2921-3921",166,-21.71,2,20,832,853,19,"78.95%","84.21%","Peve_00006152",-0.776541449715192,0.433944494529115,0.978262075707395,NA,NA,NA,NA,NA
"4325",4325,"Cluster_8887","Porites_evermani_scaffold_1445:2248-3248",167,-23.34,2,20,821,841,18,"66.67%","94.44%","Peve_00006778",-0.875002948100777,0.321718616258166,0.978262075707395,"F1MWM0","Retinal-specific phospholipid-transporting ATPase ABCA4 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 4) (RIM ABC transporter) (RIM protein) (RmP) (Retinal-specific ATP-binding cassette transporter)","Bos taurus (Bovine)","lipid transport [GO:0006869]; phospholipid transfer to membrane [GO:0006649]; phospholipid translocation [GO:0045332]; photoreceptor cell maintenance [GO:0045494]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; visual perception [GO:0007601]","GO:0001523; GO:0001750; GO:0003924; GO:0005319; GO:0005501; GO:0005502; GO:0005503; GO:0005524; GO:0005525; GO:0005548; GO:0005783; GO:0005886; GO:0006649; GO:0006869; GO:0007601; GO:0016887; GO:0034632; GO:0042574; GO:0042626; GO:0043231; GO:0045332; GO:0045494; GO:0090555; GO:0097381; GO:0120202; GO:0140326; GO:0140347; GO:0140359"
"4326",4326,"Cluster_8887","Porites_evermani_scaffold_146:227917-228917",150,-22.02,2,20,735,757,20,"60.00%","80.00%","Peve_00006972",0.0677190801172647,0.956855675945484,0.999448381576871,NA,NA,NA,NA,NA
"4327",4327,"Cluster_8887","Porites_evermani_scaffold_1546:44152-44887",161,-20.47,2,20,228,251,21,"71.43%","85.71%","Peve_00008046",NA,NA,NA,NA,NA,NA,NA,NA
"4328",4328,"Cluster_8887","Porites_evermani_scaffold_1546:44152-44887",161,-20.47,2,20,228,251,21,"71.43%","85.71%","Peve_00008047",-0.804280316823157,0.405102125682872,0.978262075707395,NA,NA,NA,NA,NA
"4329",4329,"Cluster_8887","Porites_evermani_scaffold_166:60790-61790",159,-20.65,2,20,173,193,18,"72.22%","77.78%","Peve_00009517",-0.948361248863915,0.205480116685906,0.978262075707395,"Q0E3L5","Urease accessory protein F (AtUREF)","Oryza sativa subsp. japonica (Rice)","nitrogen compound metabolic process [GO:0006807]","GO:0006807; GO:0016151"
"4330",4330,"Cluster_8887","Porites_evermani_scaffold_166:60790-61790",159,-20.65,2,20,742,762,18,"72.22%","77.78%","Peve_00009517",-0.948361248863915,0.205480116685906,0.978262075707395,"Q0E3L5","Urease accessory protein F (AtUREF)","Oryza sativa subsp. japonica (Rice)","nitrogen compound metabolic process [GO:0006807]","GO:0006807; GO:0016151"
"4331",4331,"Cluster_8887","Porites_evermani_scaffold_1706:66049-67049",153,-20.85,2,20,814,837,21,"71.43%","76.19%","Peve_00010109",-0.0823630340017489,0.947506599925429,0.999448381576871,"B8V7S0","CUB and peptidase domain-containing protein 1","Acropora millepora (Staghorn coral) (Heteropora millepora)","proteolysis [GO:0006508]","GO:0004252; GO:0005576; GO:0006508"
"4332",4332,"Cluster_8887","Porites_evermani_scaffold_17:1004173-1005173",162,-27.64,2,20,39,62,21,"71.43%","80.95%","Peve_00010007",NA,NA,NA,NA,NA,NA,NA,NA
"4333",4333,"Cluster_8887","Porites_evermani_scaffold_1719:82797-83797",154,-20.45,2,20,290,307,18,"77.78%","83.33%","Peve_00010247",-0.904409839722939,0.280623163129425,0.978262075707395,"Q8NEL9","Phospholipase DDHD1 (EC 3.1.1.111) (EC 3.1.1.32) (DDHD domain-containing protein 1) (Phosphatidic acid-preferring phospholipase A1 homolog) (PA-PLA1) (EC 3.1.1.118) (Phospholipid sn-1 acylhydrolase)","Homo sapiens (Human)","lipid metabolic process [GO:0006629]; positive regulation of mitochondrial fission [GO:0090141]","GO:0004620; GO:0005737; GO:0005829; GO:0006629; GO:0008970; GO:0046872; GO:0090141"
"4334",4334,"Cluster_8887","Porites_evermani_scaffold_1777:59749-60749",166,-21.6,2,20,460,483,21,"76.19%","80.95%","Peve_00010842",NA,NA,NA,"F1R332","Galanin receptor 2a","Danio rerio (Zebrafish) (Brachydanio rerio)","adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; neuropeptide signaling pathway [GO:0007218]","GO:0004966; GO:0005886; GO:0007188; GO:0007218; GO:0008528"
"4335",4335,"Cluster_8887","Porites_evermani_scaffold_1915:20732-21732",154,-20.45,2,20,81,103,20,"65.00%","80.00%","Peve_00012461",-0.901589895179041,0.284801719437889,0.978262075707395,"G1SIT5",NA,NA,NA,NA
"4336",4336,"Cluster_8887","Porites_evermani_scaffold_1931:936-1936",155,-22.38,2,18,610,632,18,"72.22%","88.89%","Peve_00012641",-0.821901473199095,0.385826733407904,0.978262075707395,"P35546","Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment]","Mus musculus (Mouse)","activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; anatomical structure morphogenesis [GO:0009653]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657]","GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0006919; GO:0007156; GO:0007158; GO:0007169; GO:0007399; GO:0009410; GO:0009653; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030155; GO:0030182; GO:0030335; GO:0030424; GO:0030425; GO:0033141; GO:0033619; GO:0033630; GO:0033674; GO:0035799; GO:0035860; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045121; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0098797; GO:2001241"
"4337",4337,"Cluster_8887","Porites_evermani_scaffold_1951:50481-51481",162,-23.44,2,15,219,239,13,"84.62%","100.00%","Peve_00012846",-0.889214227471233,0.302503638306549,0.978262075707395,NA,NA,NA,NA,NA
"4338",4338,"Cluster_8887","Porites_evermani_scaffold_1966:24187-25187",161,-20.09,2,20,531,550,18,"77.78%","83.33%","Peve_00012990",0.643605666571385,0.554875405945067,0.978262075707395,"Q9EPB1","Dipeptidyl peptidase 2 (EC 3.4.14.2) (Dipeptidyl aminopeptidase II) (Dipeptidyl peptidase 7) (Dipeptidyl peptidase II) (DPP II) (Quiescent cell proline dipeptidase)","Rattus norvegicus (Rat)","lysosomal protein catabolic process [GO:1905146]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]","GO:0004177; GO:0005576; GO:0005764; GO:0005829; GO:0006508; GO:0008236; GO:0008239; GO:0030163; GO:0031410; GO:0031982; GO:1905146"
"4339",4339,"Cluster_8887","Porites_evermani_scaffold_197:340333-341333",156,-20.25,2,18,298,319,17,"70.59%","88.24%","Peve_00013037",-0.915279745798163,0.26393904510828,0.978262075707395,"Q8N9F7","Lysophospholipase D GDPD1 (EC 3.1.4.-) (Glycerophosphodiester phosphodiesterase 4) (Glycerophosphodiester phosphodiesterase domain-containing protein 1)","Homo sapiens (Human)","glycerophospholipid catabolic process [GO:0046475]; N-acylethanolamine metabolic process [GO:0070291]","GO:0004622; GO:0005783; GO:0005789; GO:0008081; GO:0016020; GO:0046475; GO:0046872; GO:0048471; GO:0070291"
"4340",4340,"Cluster_8887","Porites_evermani_scaffold_199:252275-253275",167,-21.77,2,20,486,506,18,"72.22%","88.89%","Peve_00013242",0.900087645236302,0.287004553287122,0.978262075707395,NA,NA,NA,NA,NA
"4341",4341,"Cluster_8887","Porites_evermani_scaffold_20:382668-383668",161,-21.5,2,19,895,919,21,"76.19%","76.19%","Peve_00013541",-0.821901473199095,0.385826733407904,0.978262075707395,NA,NA,NA,NA,NA
"4342",4342,"Cluster_8887","Porites_evermani_scaffold_2057:85243-86243",168,-22.56,2,17,786,806,15,"86.67%","93.33%","Peve_00014118",-0.886783715794753,0.305868537935083,0.978262075707395,"Q9DBN1","Stimulated by retinoic acid gene 6 protein-like (STRA6-like protein) (Retinol-binding protein 4 receptor 2) (RBP4 receptor 2)","Mus musculus (Mouse)","establishment of localization in cell [GO:0051649]; retinol transport [GO:0034633]; vitamin A import into cell [GO:0071939]","GO:0005886; GO:0034633; GO:0051649; GO:0071939"
"4343",4343,"Cluster_8887","Porites_evermani_scaffold_2058:85752-86752",160,-21.74,2,18,771,792,17,"76.47%","88.24%","Peve_00014126",-0.880432344907591,0.314504878008459,0.978262075707395,"Q9UGM3","Deleted in malignant brain tumors 1 protein (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein)","Homo sapiens (Human)","antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; detection of bacterial lipoprotein [GO:0042494]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]","GO:0001530; GO:0003677; GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006898; GO:0006952; GO:0015031; GO:0019898; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042494; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0050840; GO:0051607; GO:0061844; GO:0070062; GO:0070891; GO:1904399"
"4344",4344,"Cluster_8887","Porites_evermani_scaffold_2074:81843-82843",154,-22.84,2,20,376,398,20,"70.00%","75.00%","Peve_00014276",NA,NA,NA,NA,NA,NA,NA,NA
"4345",4345,"Cluster_8887","Porites_evermani_scaffold_211:153370-154370",150,-20.85,2,20,271,295,22,"59.09%","77.27%","Peve_00014666",-0.418889824922909,0.724838696430107,0.983017284164521,NA,NA,NA,NA,NA
"4346",4346,"Cluster_8887","Porites_evermani_scaffold_2126:10526-11526",165,-22.6,2,14,219,239,12,"100.00%","100.00%","Peve_00014823",NA,NA,NA,NA,NA,NA,NA,NA
"4347",4347,"Cluster_8887","Porites_evermani_scaffold_215:251168-252168",153,-24.97,2,20,572,594,20,"70.00%","80.00%","Peve_00015062",-0.99991446441509,0.00832667533146618,0.573710369894872,"P55115","Zinc metalloproteinase nas-15 (EC 3.4.24.-) (Nematode astacin 15)","Caenorhabditis elegans","proteolysis [GO:0006508]","GO:0004222; GO:0005576; GO:0006508; GO:0008270"
"4348",4348,"Cluster_8887","Porites_evermani_scaffold_2193:1803-2803",166,-25.1,2,20,419,441,20,"70.00%","90.00%","Peve_00015452",NA,NA,NA,NA,NA,NA,NA,NA
"4349",4349,"Cluster_8887","Porites_evermani_scaffold_2196:16873-17873",146,-20.2,2,20,727,749,20,"60.00%","75.00%","Peve_00015474",NA,NA,NA,NA,NA,NA,NA,NA
"4350",4350,"Cluster_8887","Porites_evermani_scaffold_225:127102-128102",155,-20.37,2,12,151,171,10,"100.00%","100.00%","Peve_00016035",0.232039561054012,0.850920233018944,0.995934364227446,"Q7L5Y6","DET1 homolog (De-etiolated-1 homolog)","Homo sapiens (Human)","positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein ubiquitination [GO:0016567]; protein-containing complex assembly [GO:0065003]","GO:0005634; GO:0016567; GO:0031461; GO:0031464; GO:0031625; GO:0032436; GO:0044877; GO:0065003; GO:0080008; GO:1990756"
"4351",4351,"Cluster_8887","Porites_evermani_scaffold_2259:11207-12207",158,-20.95,2,20,57,81,22,"68.18%","77.27%","Peve_00016127",NA,NA,NA,NA,NA,NA,NA,NA
"4352",4352,"Cluster_8887","Porites_evermani_scaffold_2296:62926-63926",157,-20.85,2,20,464,483,18,"66.67%","88.89%","Peve_00016450",-0.821901473199095,0.385826733407904,0.978262075707395,NA,NA,NA,NA,NA
"4353",4353,"Cluster_8887","Porites_evermani_scaffold_2328:7597-8597",164,-21.2,2,20,842,860,18,"83.33%","83.33%","Peve_00016805",0.899178828190028,0.288329589735452,0.978262075707395,"Q5FWU8","Zinc finger MYND domain-containing protein 10","Xenopus laevis (African clawed frog)","inner dynein arm assembly [GO:0036159]; motile cilium assembly [GO:0044458]; outer dynein arm assembly [GO:0036158]; positive regulation of motile cilium assembly [GO:1905505]","GO:0005929; GO:0016324; GO:0034451; GO:0036158; GO:0036159; GO:0044458; GO:0046872; GO:0120293; GO:1905505"
"4354",4354,"Cluster_8887","Porites_evermani_scaffold_249:268447-269447",173,-24.03,2,20,513,532,18,"83.33%","94.44%","Peve_00018258",NA,NA,NA,NA,NA,NA,NA,NA
"4355",4355,"Cluster_8887","Porites_evermani_scaffold_2732:37422-38422",166,-23.75,2,20,555,577,20,"75.00%","85.00%","Peve_00020369",NA,NA,NA,"Q95JD5","Sulfotransferase 1B1 (ST1B1) (cSULT1B1) (EC 2.8.2.1) (Sulfotransferase family cytosolic 1B member 1)","Canis lupus familiaris (Dog) (Canis familiaris)","3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; epithelial cell differentiation [GO:0030855]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805]","GO:0004062; GO:0005737; GO:0006068; GO:0006805; GO:0008146; GO:0009812; GO:0030855; GO:0042403; GO:0050427; GO:0051923"
"4356",4356,"Cluster_8887","Porites_evermani_scaffold_2805:3700-4700",158,-22.21,2,20,114,135,19,"73.68%","78.95%","Peve_00020956",NA,NA,NA,NA,NA,NA,NA,NA
"4357",4357,"Cluster_8887","Porites_evermani_scaffold_2820:18391-19391",154,-20.45,2,20,827,844,18,"77.78%","83.33%","Peve_00021083",-0.579122000830227,0.606790971963513,0.978262075707395,"Q5RKZ7","Molybdenum cofactor biosynthesis protein 1 [Includes: GTP 3',8-cyclase (EC 4.1.99.22) (Molybdenum cofactor biosynthesis protein A); Cyclic pyranopterin monophosphate synthase (EC 4.6.1.17) (Molybdenum cofactor biosynthesis protein C)]","Mus musculus (Mouse)","Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324]","GO:0005525; GO:0005829; GO:0006777; GO:0019008; GO:0032324; GO:0046872; GO:0051539; GO:0061798; GO:0061799"
"4358",4358,"Cluster_8887","Porites_evermani_scaffold_292:178317-179317",162,-20.88,2,17,601,620,15,"86.67%","93.33%","Peve_00021857",0.705276387750516,0.501645807515732,0.978262075707395,NA,NA,NA,NA,NA
"4359",4359,"Cluster_8887","Porites_evermani_scaffold_301:37669-38669",162,-20.53,2,20,400,421,19,"73.68%","84.21%","Peve_00022682",-0.86444952226493,0.335334364291836,0.978262075707395,"Q8BG19","Protein O-mannosyl-transferase TMTC4 (EC 2.4.1.109) (Transmembrane and TPR repeat-containing protein 4)","Mus musculus (Mouse)","endoplasmic reticulum unfolded protein response [GO:0030968]; outer hair cell apoptotic process [GO:1905584]; positive regulation of endoplasmic reticulum calcium ion concentration [GO:0032470]; protein O-linked mannosylation [GO:0035269]; sensory perception of sound [GO:0007605]","GO:0000030; GO:0004169; GO:0005783; GO:0007605; GO:0016020; GO:0030968; GO:0032470; GO:0035269; GO:0051117; GO:1905584"
"4360",4360,"Cluster_8887","Porites_evermani_scaffold_307:255607-256607",158,-21.15,2,15,709,729,13,"76.92%","100.00%","Peve_00023144",-0.597656640346523,0.592197215730272,0.978262075707395,NA,NA,NA,NA,NA
"4361",4361,"Cluster_8887","Porites_evermani_scaffold_3105:6022-7022",154,-20.65,2,20,468,492,22,"68.18%","72.73%","Peve_00023433",-0.980675134902668,0.125358918748434,0.978262075707395,"Q7T2C4",NA,NA,NA,NA
"4362",4362,"Cluster_8887","Porites_evermani_scaffold_3252:40089-41089",173,-21.57,2,19,279,300,18,"88.89%","88.89%","Peve_00024343",NA,NA,NA,"P55023","Tyrosinase (EC 1.14.18.1) (Monophenol monooxygenase)","Streptomyces lincolnensis","melanin biosynthetic process [GO:0042438]","GO:0004503; GO:0042438; GO:0046872"
"4363",4363,"Cluster_8887","Porites_evermani_scaffold_3530:16210-17210",153,-20.47,2,20,649,673,22,"68.18%","77.27%","Peve_00026145",0.979007211833875,0.130675111078343,0.978262075707395,NA,NA,NA,NA,NA
"4364",4364,"Cluster_8887","Porites_evermani_scaffold_3690:38665-39665",175,-21.58,2,20,190,210,18,"83.33%","88.89%","Peve_00027023",-0.324936697414905,0.789314001486719,0.995726199786583,"Q5U3N5","Protein phosphatase PTC7 homolog (EC 3.1.3.16)","Danio rerio (Zebrafish) (Brachydanio rerio)","","GO:0005739; GO:0005759; GO:0017018; GO:0046872"
"4365",4365,"Cluster_8887","Porites_evermani_scaffold_3701:24053-25053",154,-20.45,2,20,166,183,18,"77.78%","83.33%","Peve_00027133",-0.903376321685512,0.282161321659808,0.978262075707395,NA,NA,NA,NA,NA
"4366",4366,"Cluster_8887","Porites_evermani_scaffold_37:21676-22676",153,-20.93,2,20,84,108,22,"68.18%","77.27%","Peve_00027097",0.781544760867891,0.428864103843722,0.978262075707395,"Q9Z0E8","Organic cation/carnitine transporter 2 (High-affinity sodium-dependent carnitine cotransporter) (Solute carrier family 22 member 5)","Mus musculus (Mouse)","(R)-carnitine transmembrane transport [GO:1902270]; (R)-carnitine transport [GO:1900749]; adult heart development [GO:0007512]; carnitine metabolic process [GO:0009437]; carnitine transport [GO:0015879]; establishment of localization in cell [GO:0051649]; locomotory behavior [GO:0007626]; mitochondrion organization [GO:0007005]; positive regulation of intestinal epithelial structure maintenance [GO:0060731]; quaternary ammonium group transport [GO:0015697]; reproductive structure development [GO:0048608]; response to symbiotic bacterium [GO:0009609]; response to tumor necrosis factor [GO:0034612]; response to type II interferon [GO:0034341]; sodium ion transport [GO:0006814]; sodium-dependent organic cation transport [GO:0070715]; transport across blood-brain barrier [GO:0150104]","GO:0005524; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0006814; GO:0007005; GO:0007512; GO:0007626; GO:0009437; GO:0009609; GO:0009925; GO:0015226; GO:0015293; GO:0015651; GO:0015697; GO:0015879; GO:0016020; GO:0016323; GO:0016324; GO:0030165; GO:0031526; GO:0034341; GO:0034612; GO:0048608; GO:0051649; GO:0060731; GO:0070715; GO:0150104; GO:1900749; GO:1901235; GO:1902270"
"4367",4367,"Cluster_8887","Porites_evermani_scaffold_3779:4982-5982",159,-25.71,2,20,925,945,18,"72.22%","77.78%","Peve_00027474",NA,NA,NA,NA,NA,NA,NA,NA
"4368",4368,"Cluster_8887","Porites_evermani_scaffold_378:44030-45030",166,-21.65,2,20,784,806,20,"75.00%","85.00%","Peve_00027488",NA,NA,NA,NA,NA,NA,NA,NA
"4369",4369,"Cluster_8887","Porites_evermani_scaffold_3805:75-1075",146,-20.03,2,20,533,557,22,"59.09%","72.73%","Peve_00027664",-0.65802916310954,0.542780686486303,0.978262075707395,"B2RW38","Cilia- and flagella-associated protein 58","Mus musculus (Mouse)","cilium assembly [GO:0060271]; flagellated sperm motility [GO:0030317]; Notch signaling pathway [GO:0007219]; protein localization to motile cilium [GO:0120229]; sperm axoneme assembly [GO:0007288]; sperm flagellum assembly [GO:0120316]; sperm mitochondrial sheath assembly [GO:0120317]","GO:0005737; GO:0005813; GO:0005856; GO:0007219; GO:0007288; GO:0030317; GO:0036126; GO:0060271; GO:0097225; GO:0120229; GO:0120316; GO:0120317"
"4370",4370,"Cluster_8887","Porites_evermani_scaffold_397:4173-5173",166,-20.49,2,19,605,625,17,"76.47%","88.24%","Peve_00028555",-0.978633804817342,0.13183630784754,0.978262075707395,NA,NA,NA,NA,NA
"4371",4371,"Cluster_8887","Porites_evermani_scaffold_401:189213-190213",158,-20.43,2,20,557,578,19,"68.42%","84.21%","Peve_00028895",0.434221636895474,0.714046935956867,0.979875142036809,NA,NA,NA,NA,NA
"4372",4372,"Cluster_8887","Porites_evermani_scaffold_4061:17475-18475",158,-21.63,2,20,474,498,22,"68.18%","77.27%","Peve_00029176",NA,NA,NA,NA,NA,NA,NA,NA
"4373",4373,"Cluster_8887","Porites_evermani_scaffold_408:71266-72266",154,-21.07,2,20,970,994,22,"63.64%","77.27%","Peve_00029249",NA,NA,NA,"P79218","Substance-K receptor (SKR) (NK-2 receptor) (NK-2R) (Neurokinin A receptor) (Tachykinin receptor 2)","Oryctolagus cuniculus (Rabbit)","positive regulation of flagellated sperm motility [GO:1902093]; regulation of uterine smooth muscle contraction [GO:0070472]","GO:0004995; GO:0005886; GO:0061827; GO:0070472; GO:0097225; GO:1902093"
"4374",4374,"Cluster_8887","Porites_evermani_scaffold_4094:30141-31141",153,-23.34,2,19,128,152,21,"66.67%","76.19%","Peve_00029315",-0.608722132162522,0.58336486616066,0.978262075707395,"Q5R4U9","Sorcin","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","calcium ion transport [GO:0006816]; cytoplasmic sequestering of transcription factor [GO:0042994]; negative regulation of cardiac muscle contraction [GO:0055118]; negative regulation of heart rate [GO:0010459]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of high voltage-gated calcium channel activity [GO:1901841]; regulation of relaxation of muscle [GO:1901077]","GO:0002020; GO:0005509; GO:0005654; GO:0005829; GO:0005886; GO:0006816; GO:0010459; GO:0030018; GO:0033017; GO:0035774; GO:0042584; GO:0042994; GO:0046982; GO:0051281; GO:0055118; GO:0060315; GO:0070062; GO:0086004; GO:0140297; GO:1901077; GO:1901841; GO:1901844; GO:2000678"
"4375",4375,"Cluster_8887","Porites_evermani_scaffold_424:170405-171405",162,-22.81,2,19,261,281,17,"70.59%","88.24%","Peve_00030092",0.904264507200844,0.280839933258762,0.978262075707395,NA,NA,NA,NA,NA
"4376",4376,"Cluster_8887","Porites_evermani_scaffold_42:720849-721849",159,-20.76,2,20,401,421,18,"66.67%","83.33%","Peve_00029837",NA,NA,NA,NA,NA,NA,NA,NA
"4377",4377,"Cluster_8887","Porites_evermani_scaffold_4311:27909-28594",150,-20.21,2,20,124,146,20,"65.00%","75.00%","Peve_00030506",NA,NA,NA,NA,NA,NA,NA,NA
"4378",4378,"Cluster_8887","Porites_evermani_scaffold_436:261196-262196",160,-21.01,2,19,802,824,19,"73.68%","89.47%","Peve_00030713",0.817989061821921,0.390177835268143,0.978262075707395,NA,NA,NA,NA,NA
"4379",4379,"Cluster_8887","Porites_evermani_scaffold_4452:7506-8506",155,-20.37,2,12,261,281,10,"100.00%","100.00%","Peve_00031227",NA,NA,NA,NA,NA,NA,NA,NA
"4380",4380,"Cluster_8887","Porites_evermani_scaffold_4640:169-1169",168,-20.46,2,18,82,103,17,"82.35%","94.12%","Peve_00032082",NA,NA,NA,NA,NA,NA,NA,NA
"4381",4381,"Cluster_8887","Porites_evermani_scaffold_477:96159-97159",163,-20.31,2,20,378,398,18,"72.22%","83.33%","Peve_00032609",NA,NA,NA,NA,NA,NA,NA,NA
"4382",4382,"Cluster_8887","Porites_evermani_scaffold_479:204727-205727",162,-23.29,2,20,214,235,19,"73.68%","84.21%","Peve_00032682",-0.99825928797896,0.0375683052200161,0.909359886114279,"O15381","Nuclear valosin-containing protein-like (NVLp) (Nuclear VCP-like protein)","Homo sapiens (Human)","positive regulation of protein binding [GO:0032092]; positive regulation of telomerase activity [GO:0051973]; regulation of protein localization to nucleolus [GO:1904749]; ribosomal large subunit biogenesis [GO:0042273]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]","GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005697; GO:0005730; GO:0006364; GO:0016020; GO:0016887; GO:0032092; GO:0042254; GO:0042273; GO:0051973; GO:1904749; GO:1990275"
"4383",4383,"Cluster_8887","Porites_evermani_scaffold_5:1251981-1252981",170,-26.12,2,15,706,726,13,"100.00%","100.00%","Peve_00033569",-0.821901473199095,0.385826733407904,0.978262075707395,"I3PB37","4-coumarate:CoA ligase 1 (Ph-4CL1) (Ph4CL1) (EC 6.2.1.12) ((E)-caffeate:CoA ligase 4CL1) (EC 6.2.1.-) (Benzoate:CoA ligase 4CL1) (EC 6.2.1.25) (Trans-cinnamate:CoA ligase 4CL1) (EC 6.2.1.-) (Trans-ferulate:CoA ligase 4CL1) (EC 6.2.1.-)","Petunia hybrida (Petunia)","cinnamic acid biosynthetic process [GO:0009800]; cinnamic acid metabolic process [GO:0009803]; circadian rhythm [GO:0007623]; ferulate metabolic process [GO:0033494]; phenylpropanoid metabolic process [GO:0009698]; phytoalexin biosynthetic process [GO:0052315]","GO:0005524; GO:0005829; GO:0007623; GO:0009698; GO:0009800; GO:0009803; GO:0016207; GO:0016405; GO:0018858; GO:0033494; GO:0050563; GO:0052315; GO:0106286; GO:0106290"
"4384",4384,"Cluster_8887","Porites_evermani_scaffold_5207:6131-7131",164,-21.66,2,20,13,31,18,"77.78%","88.89%","Peve_00034421",-0.00920229307631503,0.994141555590188,0.999448381576871,NA,NA,NA,NA,NA
"4385",4385,"Cluster_8887","Porites_evermani_scaffold_545:82602-83602",157,-20.89,2,20,73,95,20,"75.00%","80.00%","Peve_00035294",-0.746857472276402,0.463123435842825,0.978262075707395,"Q9UDY8","Mucosa-associated lymphoid tissue lymphoma translocation protein 1 (EC 3.4.22.-) (MALT lymphoma-associated translocation) (Paracaspase)","Homo sapiens (Human)","activation of NF-kappaB-inducing kinase activity [GO:0007250]; B cell activation [GO:0042113]; B-1 B cell differentiation [GO:0001923]; defense response [GO:0006952]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of apoptotic process [GO:0043066]; nuclear export [GO:0051168]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T-helper 17 cell differentiation [GO:2000321]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; regulation of T cell receptor signaling pathway [GO:0050856]; response to fungus [GO:0009620]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]","GO:0001650; GO:0001923; GO:0002020; GO:0002096; GO:0002726; GO:0004175; GO:0004197; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006952; GO:0007250; GO:0008233; GO:0009620; GO:0031398; GO:0031663; GO:0032449; GO:0032731; GO:0032743; GO:0032991; GO:0036094; GO:0042098; GO:0042113; GO:0042802; GO:0042981; GO:0043066; GO:0043123; GO:0043280; GO:0043621; GO:0045087; GO:0048471; GO:0050852; GO:0050856; GO:0051092; GO:0051168; GO:0051603; GO:2000321"
"4386",4386,"Cluster_8887","Porites_evermani_scaffold_564:190762-191762",156,-20.97,2,19,805,829,21,"71.43%","80.95%","Peve_00035926",0.792138202095408,0.417935764721575,0.978262075707395,NA,NA,NA,NA,NA
"4387",4387,"Cluster_8887","Porites_evermani_scaffold_60:25097-26097",153,-20.21,2,20,93,117,22,"68.18%","77.27%","Peve_00037084",0.796896448177754,0.412947236812533,0.978262075707395,"Q90XE6","Kruppel-like factor 1 (Erythroid krueppel-like transcription factor) (Kruppel-like factor d)","Danio rerio (Zebrafish) (Brachydanio rerio)","animal organ regeneration [GO:0031100]; cardiac muscle cell differentiation [GO:0055007]; cardiac muscle cell proliferation [GO:0060038]; cell dedifferentiation [GO:0043697]; positive regulation of gene expression [GO:0010628]; primitive erythrocyte differentiation [GO:0060319]; regulation of transcription by RNA polymerase II [GO:0006357]; sarcomere organization [GO:0045214]","GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005829; GO:0006357; GO:0010628; GO:0031100; GO:0043565; GO:0043697; GO:0045214; GO:0046872; GO:0055007; GO:0060038; GO:0060319"
"4388",4388,"Cluster_8887","Porites_evermani_scaffold_61:296734-297734",159,-21.29,2,20,929,949,18,"72.22%","77.78%","Peve_00037353",-0.295650019635689,0.808927561342391,0.995934364227446,NA,NA,NA,NA,NA
"4389",4389,"Cluster_8887","Porites_evermani_scaffold_628:121037-122037",169,-23.56,2,20,960,984,22,"81.82%","81.82%","Peve_00037798",0.612192300786352,0.580575667226786,0.978262075707395,"P0CG13","Chromosome transmission fidelity protein 8 homolog (hCTF8)","Homo sapiens (Human)","DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; mitotic sister chromatid cohesion [GO:0007064]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]","GO:0003677; GO:0005654; GO:0006260; GO:0007064; GO:0031390; GO:0032508; GO:1900264"
"4390",4390,"Cluster_8887","Porites_evermani_scaffold_699:74664-75664",166,-21.5,2,19,687,707,17,"82.35%","82.35%","Peve_00039506",-0.196812817905252,0.873881745952362,0.997476741937264,"P54316","Inactive pancreatic lipase-related protein 1 (PL-RP1)","Rattus norvegicus (Rat)","lipid metabolic process [GO:0006629]; pancreas development [GO:0031016]; response to glucocorticoid [GO:0051384]; response to peptide hormone [GO:0043434]","GO:0005509; GO:0005615; GO:0006629; GO:0016298; GO:0031016; GO:0043434; GO:0051384"
"4391",4391,"Cluster_8887","Porites_evermani_scaffold_743:39942-40942",154,-20.45,2,20,501,518,18,"77.78%","83.33%","Peve_00040567",-0.747893473298023,0.46213075499467,0.978262075707395,NA,NA,NA,NA,NA
"4392",4392,"Cluster_8887","Porites_evermani_scaffold_749:127862-128862",166,-22.08,2,19,513,533,17,"76.47%","88.24%","Peve_00040645",NA,NA,NA,NA,NA,NA,NA,NA
"4393",4393,"Cluster_8887","Porites_evermani_scaffold_779:110486-111486",153,-22.94,2,20,658,681,21,"71.43%","76.19%","Peve_00041230",0.619495773043476,0.574674194521425,0.978262075707395,NA,NA,NA,NA,NA
"4394",4394,"Cluster_8887","Porites_evermani_scaffold_811:137811-138811",157,-21.35,2,20,468,492,22,"72.73%","77.27%","Peve_00042036",-0.483170478456569,0.678970260882868,0.978262075707395,"Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"4395",4395,"Cluster_8887","Porites_evermani_scaffold_817:124426-125426",166,-21.15,2,19,561,581,17,"76.47%","88.24%","Peve_00042120",-0.807277114691421,0.401880612333394,0.978262075707395,"Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"4396",4396,"Cluster_8887","Porites_evermani_scaffold_843:48787-49787",160,-21.57,2,19,387,406,17,"76.47%","88.24%","Peve_00042633",-0.883139292668119,0.310851059600429,0.978262075707395,NA,NA,NA,NA,NA
"4397",4397,"Cluster_8887","Porites_evermani_scaffold_921:19047-20047",155,-23.35,2,12,486,506,10,"100.00%","100.00%","Peve_00044134",-0.999836960200136,0.0114960286738644,0.661528833813137,"Q6ITT3","Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C (EC 2.4.1.145) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase IVc) (GnT-IVc) (N-acetylglucosaminyltransferase IVc) (UDP-N-acetylglucosamine: alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IVc)","Sus scrofa (Pig)","protein N-linked glycosylation [GO:0006487]","GO:0000139; GO:0006487; GO:0008375; GO:0008454; GO:0046872"
"4398",4398,"Cluster_8887","Porites_evermani_scaffold_935:165818-166818",156,-21.19,2,19,908,932,21,"76.19%","76.19%","Peve_00044333",-0.577277933737598,0.608229845923578,0.978262075707395,NA,NA,NA,NA,NA
"4399",4399,"Cluster_8887","Porites_evermani_scaffold_947:40316-41316",153,-23.97,2,20,469,494,23,"69.57%","73.91%","Peve_00044509",NA,NA,NA,NA,NA,NA,NA,NA
"4400",4400,"Cluster_8887","Porites_evermani_scaffold_95:430111-431111",156,-27.42,2,19,820,839,17,"70.59%","88.24%","Peve_00044570",-0.724094227421868,0.484516107767987,0.978262075707395,"Q71SG7","Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 4 (EC 2.4.1.102)","Danio rerio (Zebrafish) (Brachydanio rerio)","protein glycosylation [GO:0006486]","GO:0000139; GO:0003829; GO:0006486; GO:0008375"
"4401",4401,"Cluster_8888","Porites_evermani_scaffold_1005:60605-61605",152,-21.1,2,20,761,785,22,"72.73%","77.27%","Peve_00000315",NA,NA,NA,NA,NA,NA,NA,NA
"4402",4402,"Cluster_8888","Porites_evermani_scaffold_1046:152428-153428",158,-20.43,2,20,762,783,19,"68.42%","84.21%","Peve_00000948",0.9433449516325,0.215321044913294,0.978262075707395,"Q70CQ4","Ubiquitin carboxyl-terminal hydrolase 31 (EC 3.4.19.12) (Deubiquitinating enzyme 31) (Ubiquitin thioesterase 31) (Ubiquitin-specific-processing protease 31)","Homo sapiens (Human)","protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0004843; GO:0005634; GO:0006511; GO:0016579"
"4403",4403,"Cluster_8888","Porites_evermani_scaffold_1052:112443-113443",154,-22.08,2,20,684,701,18,"77.78%","83.33%","Peve_00001054",-0.973511501502481,0.146854456975625,0.978262075707395,"Q9U518","L-asparaginase (EC 3.5.1.1) (DiAsp) (L-asparagine amidohydrolase)","Dirofilaria immitis (Canine heartworm)","asparagine metabolic process [GO:0006528]","GO:0004067; GO:0006528"
"4404",4404,"Cluster_8888","Porites_evermani_scaffold_111:67318-68318",149,-20.84,2,20,477,501,22,"63.64%","77.27%","Peve_00002007",NA,NA,NA,NA,NA,NA,NA,NA
"4405",4405,"Cluster_8888","Porites_evermani_scaffold_1158:51791-52791",174,-24.15,2,19,796,816,17,"82.35%","94.12%","Peve_00002662",-0.971357643640959,0.152736059128332,0.978262075707395,"Q5RGU1","Atypical kinase COQ8A, mitochondrial (EC 2.7.-.-) (Chaperone activity of bc1 complex-like) (Chaperone-ABC1-like) (Coenzyme Q protein 8A) (aarF domain-containing protein kinase 3)","Danio rerio (Zebrafish) (Brachydanio rerio)","phosphorylation [GO:0016310]; ubiquinone biosynthetic process [GO:0006744]","GO:0005524; GO:0005739; GO:0006744; GO:0016301; GO:0016310; GO:0031314; GO:0043531"
"4406",4406,"Cluster_8888","Porites_evermani_scaffold_1409:29639-30639",172,-21.1,2,18,925,946,17,"88.24%","94.12%","Peve_00006360",NA,NA,NA,NA,NA,NA,NA,NA
"4407",4407,"Cluster_8888","Porites_evermani_scaffold_1445:2248-3248",167,-23.72,2,20,821,841,18,"66.67%","94.44%","Peve_00006778",-0.316713535096137,0.794841229128895,0.995934364227446,"F1MWM0","Retinal-specific phospholipid-transporting ATPase ABCA4 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 4) (RIM ABC transporter) (RIM protein) (RmP) (Retinal-specific ATP-binding cassette transporter)","Bos taurus (Bovine)","lipid transport [GO:0006869]; phospholipid transfer to membrane [GO:0006649]; phospholipid translocation [GO:0045332]; photoreceptor cell maintenance [GO:0045494]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; visual perception [GO:0007601]","GO:0001523; GO:0001750; GO:0003924; GO:0005319; GO:0005501; GO:0005502; GO:0005503; GO:0005524; GO:0005525; GO:0005548; GO:0005783; GO:0005886; GO:0006649; GO:0006869; GO:0007601; GO:0016887; GO:0034632; GO:0042574; GO:0042626; GO:0043231; GO:0045332; GO:0045494; GO:0090555; GO:0097381; GO:0120202; GO:0140326; GO:0140347; GO:0140359"
"4408",4408,"Cluster_8888","Porites_evermani_scaffold_1541:94815-95815",169,-21.62,2,19,10,31,18,"77.78%","94.44%","Peve_00008013",NA,NA,NA,NA,NA,NA,NA,NA
"4409",4409,"Cluster_8888","Porites_evermani_scaffold_1547:2200-2852",169,-20.1,2,18,249,269,16,"81.25%","93.75%","Peve_00008061",-0.734978994113776,0.4743839870547,0.978262075707395,"Q8VIG3","Radial spoke head 1 homolog (Male meiotic metaphase chromosome-associated acidic protein) (Meichroacidin) (Testis-specific gene A2 protein)","Mus musculus (Mouse)","axoneme assembly [GO:0035082]; meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286]","GO:0000794; GO:0001520; GO:0005634; GO:0005737; GO:0005829; GO:0005929; GO:0007286; GO:0031514; GO:0035082; GO:0036126; GO:0051321; GO:0072687"
"4410",4410,"Cluster_8888","Porites_evermani_scaffold_1547:2200-2852",169,-20.1,2,18,249,269,16,"81.25%","93.75%","Peve_00008062",-0.781480028959592,0.428930156563995,0.978262075707395,"Q7KWX9","Putative exosome complex component rrp40 (Exosome component 3) (Ribosomal RNA-processing protein 40)","Dictyostelium discoideum (Social amoeba)","CUT catabolic process [GO:0071034]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; U4 snRNA 3'-end processing [GO:0034475]","GO:0000176; GO:0000177; GO:0000178; GO:0000467; GO:0003723; GO:0005730; GO:0034427; GO:0034475; GO:0043928; GO:0071034; GO:0071035; GO:0071038; GO:0071051"
"4411",4411,"Cluster_8888","Porites_evermani_scaffold_1572:14034-15034",154,-20.03,2,19,293,313,17,"64.71%","82.35%","Peve_00008402",-0.39665420985904,0.740342412207047,0.986697151420032,"P04353","Calmodulin (CaM)","Spinacia oleracea (Spinach)","","GO:0005509"
"4412",4412,"Cluster_8888","Porites_evermani_scaffold_166:60790-61790",159,-22.28,2,20,173,193,18,"72.22%","77.78%","Peve_00009517",-0.912920926775466,0.267642496184823,0.978262075707395,"Q0E3L5","Urease accessory protein F (AtUREF)","Oryza sativa subsp. japonica (Rice)","nitrogen compound metabolic process [GO:0006807]","GO:0006807; GO:0016151"
"4413",4413,"Cluster_8888","Porites_evermani_scaffold_166:60790-61790",159,-22.28,2,20,742,762,18,"72.22%","77.78%","Peve_00009517",-0.912920926775466,0.267642496184823,0.978262075707395,"Q0E3L5","Urease accessory protein F (AtUREF)","Oryza sativa subsp. japonica (Rice)","nitrogen compound metabolic process [GO:0006807]","GO:0006807; GO:0016151"
"4414",4414,"Cluster_8888","Porites_evermani_scaffold_1708:95868-96603",166,-20.16,2,20,542,563,19,"78.95%","84.21%","Peve_00010124",-0.734978994113776,0.474383987054699,0.978262075707395,NA,NA,NA,NA,NA
"4415",4415,"Cluster_8888","Porites_evermani_scaffold_17:1004173-1005173",162,-23.4,2,20,39,62,21,"71.43%","80.95%","Peve_00010007",NA,NA,NA,NA,NA,NA,NA,NA
"4416",4416,"Cluster_8888","Porites_evermani_scaffold_1719:82797-83797",154,-22.08,2,20,290,307,18,"77.78%","83.33%","Peve_00010247",-0.377240869876279,0.753745776000154,0.988219883885475,"Q8NEL9","Phospholipase DDHD1 (EC 3.1.1.111) (EC 3.1.1.32) (DDHD domain-containing protein 1) (Phosphatidic acid-preferring phospholipase A1 homolog) (PA-PLA1) (EC 3.1.1.118) (Phospholipid sn-1 acylhydrolase)","Homo sapiens (Human)","lipid metabolic process [GO:0006629]; positive regulation of mitochondrial fission [GO:0090141]","GO:0004620; GO:0005737; GO:0005829; GO:0006629; GO:0008970; GO:0046872; GO:0090141"
"4417",4417,"Cluster_8888","Porites_evermani_scaffold_1777:59749-60749",166,-23.23,2,20,460,483,21,"76.19%","80.95%","Peve_00010842",NA,NA,NA,"F1R332","Galanin receptor 2a","Danio rerio (Zebrafish) (Brachydanio rerio)","adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; neuropeptide signaling pathway [GO:0007218]","GO:0004966; GO:0005886; GO:0007188; GO:0007218; GO:0008528"
"4418",4418,"Cluster_8888","Porites_evermani_scaffold_1821:37810-38810",161,-21.55,2,19,660,686,23,"73.91%","73.91%","Peve_00011423",NA,NA,NA,NA,NA,NA,NA,NA
"4419",4419,"Cluster_8888","Porites_evermani_scaffold_1915:20732-21732",154,-22.08,2,20,81,103,20,"65.00%","80.00%","Peve_00012461",-0.371154081479052,0.757924332308618,0.988219883885475,"G1SIT5",NA,NA,NA,NA
"4420",4420,"Cluster_8888","Porites_evermani_scaffold_192:76594-77594",173,-21.11,2,18,136,156,16,"81.25%","100.00%","Peve_00012505",NA,NA,NA,"P79385","Lactadherin (MFGM) (Milk fat globule-EGF factor 8) (MFG-E8) (SED1) (Sperm surface protein SP47) (PP47)","Sus scrofa (Pig)","angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; single fertilization [GO:0007338]","GO:0001525; GO:0002080; GO:0005576; GO:0007155; GO:0007338"
"4421",4421,"Cluster_8888","Porites_evermani_scaffold_1951:50481-51481",162,-23.68,2,15,219,239,13,"84.62%","100.00%","Peve_00012846",-0.345193978699582,0.775626251177278,0.992471997585103,NA,NA,NA,NA,NA
"4422",4422,"Cluster_8888","Porites_evermani_scaffold_1966:24187-25187",161,-20.33,2,20,531,550,18,"77.78%","83.33%","Peve_00012990",0.991765863761421,0.081752793074337,0.978262075707395,"Q9EPB1","Dipeptidyl peptidase 2 (EC 3.4.14.2) (Dipeptidyl aminopeptidase II) (Dipeptidyl peptidase 7) (Dipeptidyl peptidase II) (DPP II) (Quiescent cell proline dipeptidase)","Rattus norvegicus (Rat)","lysosomal protein catabolic process [GO:1905146]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]","GO:0004177; GO:0005576; GO:0005764; GO:0005829; GO:0006508; GO:0008236; GO:0008239; GO:0030163; GO:0031410; GO:0031982; GO:1905146"
"4423",4423,"Cluster_8888","Porites_evermani_scaffold_197:340333-341333",156,-20.63,2,18,298,319,17,"70.59%","88.24%","Peve_00013037",-0.401379575643178,0.737061657979009,0.986358402699782,"Q8N9F7","Lysophospholipase D GDPD1 (EC 3.1.4.-) (Glycerophosphodiester phosphodiesterase 4) (Glycerophosphodiester phosphodiesterase domain-containing protein 1)","Homo sapiens (Human)","glycerophospholipid catabolic process [GO:0046475]; N-acylethanolamine metabolic process [GO:0070291]","GO:0004622; GO:0005783; GO:0005789; GO:0008081; GO:0016020; GO:0046475; GO:0046872; GO:0048471; GO:0070291"
"4424",4424,"Cluster_8888","Porites_evermani_scaffold_199:252275-253275",167,-23.4,2,20,486,506,18,"72.22%","88.89%","Peve_00013242",0.957568215190681,0.186118059583607,0.978262075707395,NA,NA,NA,NA,NA
"4425",4425,"Cluster_8888","Porites_evermani_scaffold_2009:48297-48801",160,-20.37,2,13,178,198,11,"100.00%","100.00%","Peve_00013648",-0.535209585670261,0.640465265417936,0.978262075707395,"Q8WPW2","Pyridoxal 5'-phosphate synthase subunit SNZERR (PLP synthase subunit SNZERR) (EC 4.3.3.6) (Ethylene response protein) (PDX1)","Suberites domuncula (Sponge)","pyridoxal phosphate biosynthetic process [GO:0042823]","GO:0036381; GO:0042823"
"4426",4426,"Cluster_8888","Porites_evermani_scaffold_2009:48297-48801",160,-20.37,2,13,178,198,11,"100.00%","100.00%","Peve_00013641",-0.649214372735432,0.550195609971337,0.978262075707395,"Q8LAD0","Probable pyridoxal 5'-phosphate synthase subunit PDX2 (AtPDX2) (EC 4.3.3.6) (Protein EMBRYO DEFECTIVE 2407) (Pyridoxal 5'-phosphate synthase glutaminase subunit) (EC 3.5.1.2)","Arabidopsis thaliana (Mouse-ear cress)","glutamine metabolic process [GO:0006541]; pyridoxal phosphate biosynthetic process [GO:0042823]; pyridoxine metabolic process [GO:0008614]; vitamin B6 biosynthetic process [GO:0042819]","GO:0004359; GO:0005829; GO:0006541; GO:0008614; GO:0036381; GO:0042819; GO:0042823; GO:0046982; GO:1903600"
"4427",4427,"Cluster_8888","Porites_evermani_scaffold_2021:25811-26811",150,-20.47,2,20,564,585,19,"57.89%","84.21%","Peve_00013800",0.47985057519825,0.681381741101582,0.978262075707395,"D3YYI7","E3 ubiquitin-protein ligase RNF217 (EC 2.3.2.31) (IBR domain-containing protein 1) (RING finger protein 217)","Mus musculus (Mouse)","positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0000209; GO:0005737; GO:0006511; GO:0016020; GO:0031624; GO:0032436; GO:0046872; GO:0061630"
"4428",4428,"Cluster_8888","Porites_evermani_scaffold_2021:25982-26982",150,-20.47,2,20,393,414,19,"57.89%","84.21%","Peve_00013801",-0.82816270980945,0.378772623590739,0.978262075707395,NA,NA,NA,NA,NA
"4429",4429,"Cluster_8888","Porites_evermani_scaffold_215:251168-252168",153,-20.73,2,20,572,594,20,"70.00%","80.00%","Peve_00015062",-0.727408343254617,0.481449288202193,0.978262075707395,"P55115","Zinc metalloproteinase nas-15 (EC 3.4.24.-) (Nematode astacin 15)","Caenorhabditis elegans","proteolysis [GO:0006508]","GO:0004222; GO:0005576; GO:0006508; GO:0008270"
"4430",4430,"Cluster_8888","Porites_evermani_scaffold_2184:31525-32525",168,-20.45,2,19,87,106,17,"82.35%","94.12%","Peve_00015350",0.954732554622175,0.192282679611967,0.978262075707395,"Q9NZJ4","Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29)","Homo sapiens (Human)","negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]","GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0042802; GO:0051087; GO:0070628; GO:0070852; GO:0090084"
"4431",4431,"Cluster_8888","Porites_evermani_scaffold_2193:1803-2803",166,-25.34,2,20,419,441,20,"70.00%","90.00%","Peve_00015452",NA,NA,NA,NA,NA,NA,NA,NA
"4432",4432,"Cluster_8888","Porites_evermani_scaffold_2196:16873-17873",146,-21.83,2,20,727,749,20,"60.00%","75.00%","Peve_00015474",NA,NA,NA,NA,NA,NA,NA,NA
"4433",4433,"Cluster_8888","Porites_evermani_scaffold_2259:11207-12207",158,-21.19,2,20,57,81,22,"68.18%","77.27%","Peve_00016127",NA,NA,NA,NA,NA,NA,NA,NA
"4434",4434,"Cluster_8888","Porites_evermani_scaffold_249:268447-269447",173,-24.41,2,20,513,532,18,"83.33%","94.44%","Peve_00018258",NA,NA,NA,NA,NA,NA,NA,NA
"4435",4435,"Cluster_8888","Porites_evermani_scaffold_2632:31765-32765",164,-20.09,2,19,812,835,20,"80.00%","85.00%","Peve_00019528",NA,NA,NA,NA,NA,NA,NA,NA
"4436",4436,"Cluster_8888","Porites_evermani_scaffold_2633:30374-31374",154,-20.23,2,20,836,858,20,"70.00%","75.00%","Peve_00019537",-0.219753560508399,0.858949346278634,0.995934364227446,NA,NA,NA,NA,NA
"4437",4437,"Cluster_8888","Porites_evermani_scaffold_274:89202-90202",166,-21.09,2,20,812,834,20,"75.00%","85.00%","Peve_00020415",NA,NA,NA,NA,NA,NA,NA,NA
"4438",4438,"Cluster_8888","Porites_evermani_scaffold_2805:3700-4700",158,-22.45,2,20,114,135,19,"73.68%","78.95%","Peve_00020956",NA,NA,NA,NA,NA,NA,NA,NA
"4439",4439,"Cluster_8888","Porites_evermani_scaffold_2820:18391-19391",154,-22.08,2,20,827,844,18,"77.78%","83.33%","Peve_00021083",0.125198562140473,0.920086415165758,0.999448381576871,"Q5RKZ7","Molybdenum cofactor biosynthesis protein 1 [Includes: GTP 3',8-cyclase (EC 4.1.99.22) (Molybdenum cofactor biosynthesis protein A); Cyclic pyranopterin monophosphate synthase (EC 4.6.1.17) (Molybdenum cofactor biosynthesis protein C)]","Mus musculus (Mouse)","Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324]","GO:0005525; GO:0005829; GO:0006777; GO:0019008; GO:0032324; GO:0046872; GO:0051539; GO:0061798; GO:0061799"
"4440",4440,"Cluster_8888","Porites_evermani_scaffold_307:255607-256607",158,-21.39,2,15,709,729,13,"76.92%","100.00%","Peve_00023144",0.102424212150319,0.934680171398999,0.999448381576871,NA,NA,NA,NA,NA
"4441",4441,"Cluster_8888","Porites_evermani_scaffold_3252:40089-41089",173,-23.2,2,19,279,300,18,"88.89%","88.89%","Peve_00024343",NA,NA,NA,"P55023","Tyrosinase (EC 1.14.18.1) (Monophenol monooxygenase)","Streptomyces lincolnensis","melanin biosynthetic process [GO:0042438]","GO:0004503; GO:0042438; GO:0046872"
"4442",4442,"Cluster_8888","Porites_evermani_scaffold_335:222995-223995",161,-21.55,2,20,962,981,18,"77.78%","83.33%","Peve_00024982",0.943235233709322,0.215531451564427,0.978262075707395,"Q8BH16","F-box/LRR-repeat protein 2 (F-box and leucine-rich repeat protein 2)","Mus musculus (Mouse)","modulation by host of viral RNA genome replication [GO:0044830]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; regulation of autophagy [GO:0010506]; regulation of inflammatory response [GO:0050727]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0005516; GO:0006511; GO:0006513; GO:0010506; GO:0014066; GO:0016020; GO:0016567; GO:0019005; GO:0019903; GO:0031146; GO:0036312; GO:0044830; GO:0050727; GO:1900226; GO:1990756"
"4443",4443,"Cluster_8888","Porites_evermani_scaffold_3690:38665-39665",175,-21.96,2,20,190,210,18,"83.33%","88.89%","Peve_00027023",0.400657610006785,0.737563385642552,0.986508276825124,"Q5U3N5","Protein phosphatase PTC7 homolog (EC 3.1.3.16)","Danio rerio (Zebrafish) (Brachydanio rerio)","","GO:0005739; GO:0005759; GO:0017018; GO:0046872"
"4444",4444,"Cluster_8888","Porites_evermani_scaffold_3701:24053-25053",154,-22.08,2,20,166,183,18,"77.78%","83.33%","Peve_00027133",-0.955347926580451,0.190961291210921,0.978262075707395,NA,NA,NA,NA,NA
"4445",4445,"Cluster_8888","Porites_evermani_scaffold_3779:4982-5982",159,-21.47,2,20,925,945,18,"72.22%","77.78%","Peve_00027474",NA,NA,NA,NA,NA,NA,NA,NA
"4446",4446,"Cluster_8888","Porites_evermani_scaffold_3849:11680-12680",157,-20.28,2,18,859,879,16,"68.75%","87.50%","Peve_00027874",-0.219753560508399,0.858949346278634,0.995934364227446,NA,NA,NA,NA,NA
"4447",4447,"Cluster_8888","Porites_evermani_scaffold_401:189213-190213",158,-20.81,2,20,557,578,19,"68.42%","84.21%","Peve_00028895",0.92924101743554,0.240924323086138,0.978262075707395,NA,NA,NA,NA,NA
"4448",4448,"Cluster_8888","Porites_evermani_scaffold_408:71266-72266",154,-22.7,2,20,970,994,22,"63.64%","77.27%","Peve_00029249",NA,NA,NA,"P79218","Substance-K receptor (SKR) (NK-2 receptor) (NK-2R) (Neurokinin A receptor) (Tachykinin receptor 2)","Oryctolagus cuniculus (Rabbit)","positive regulation of flagellated sperm motility [GO:1902093]; regulation of uterine smooth muscle contraction [GO:0070472]","GO:0004995; GO:0005886; GO:0061827; GO:0070472; GO:0097225; GO:1902093"
"4449",4449,"Cluster_8888","Porites_evermani_scaffold_4611:15517-16517",173,-21.11,2,18,127,147,16,"81.25%","100.00%","Peve_00031974",NA,NA,NA,"P70490","Lactadherin (MFGM) (Milk fat globule-EGF factor 8) (MFG-E8) (O-acetyl GD3 ganglioside synthase) (AGS) (SED1)","Rattus norvegicus (Rat)","angiogenesis [GO:0001525]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of phagocytosis [GO:0050766]; response to estrogen [GO:0043627]; single fertilization [GO:0007338]","GO:0001525; GO:0001786; GO:0002080; GO:0005178; GO:0005615; GO:0006910; GO:0006911; GO:0007155; GO:0007338; GO:0008284; GO:0008429; GO:0009897; GO:0019897; GO:0043277; GO:0043627; GO:0050766"
"4450",4450,"Cluster_8888","Porites_evermani_scaffold_4640:169-1169",168,-20.7,2,18,82,103,17,"82.35%","94.12%","Peve_00032082",NA,NA,NA,NA,NA,NA,NA,NA
"4451",4451,"Cluster_8888","Porites_evermani_scaffold_5:1251981-1252981",170,-26.5,2,15,706,726,13,"100.00%","100.00%","Peve_00033569",-0.219753560508399,0.858949346278634,0.995934364227446,"I3PB37","4-coumarate:CoA ligase 1 (Ph-4CL1) (Ph4CL1) (EC 6.2.1.12) ((E)-caffeate:CoA ligase 4CL1) (EC 6.2.1.-) (Benzoate:CoA ligase 4CL1) (EC 6.2.1.25) (Trans-cinnamate:CoA ligase 4CL1) (EC 6.2.1.-) (Trans-ferulate:CoA ligase 4CL1) (EC 6.2.1.-)","Petunia hybrida (Petunia)","cinnamic acid biosynthetic process [GO:0009800]; cinnamic acid metabolic process [GO:0009803]; circadian rhythm [GO:0007623]; ferulate metabolic process [GO:0033494]; phenylpropanoid metabolic process [GO:0009698]; phytoalexin biosynthetic process [GO:0052315]","GO:0005524; GO:0005829; GO:0007623; GO:0009698; GO:0009800; GO:0009803; GO:0016207; GO:0016405; GO:0018858; GO:0033494; GO:0050563; GO:0052315; GO:0106286; GO:0106290"
"4452",4452,"Cluster_8888","Porites_evermani_scaffold_5127:13491-14491",160,-20.72,2,20,703,721,18,"77.78%","83.33%","Peve_00034152",NA,NA,NA,NA,NA,NA,NA,NA
"4453",4453,"Cluster_8888","Porites_evermani_scaffold_5207:6131-7131",164,-23.29,2,20,13,31,18,"77.78%","88.89%","Peve_00034421",-0.683379477786432,0.521018942719459,0.978262075707395,NA,NA,NA,NA,NA
"4454",4454,"Cluster_8888","Porites_evermani_scaffold_5:826300-827300",166,-20.19,2,20,902,924,20,"75.00%","85.00%","Peve_00033539",-0.996892468090041,0.0502013560687792,0.954773057005431,NA,NA,NA,NA,NA
"4455",4455,"Cluster_8888","Porites_evermani_scaffold_60:25097-26097",153,-20.45,2,20,93,117,22,"68.18%","77.27%","Peve_00037084",0.995536001862619,0.0601753760581957,0.978262075707395,"Q90XE6","Kruppel-like factor 1 (Erythroid krueppel-like transcription factor) (Kruppel-like factor d)","Danio rerio (Zebrafish) (Brachydanio rerio)","animal organ regeneration [GO:0031100]; cardiac muscle cell differentiation [GO:0055007]; cardiac muscle cell proliferation [GO:0060038]; cell dedifferentiation [GO:0043697]; positive regulation of gene expression [GO:0010628]; primitive erythrocyte differentiation [GO:0060319]; regulation of transcription by RNA polymerase II [GO:0006357]; sarcomere organization [GO:0045214]","GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005829; GO:0006357; GO:0010628; GO:0031100; GO:0043565; GO:0043697; GO:0045214; GO:0046872; GO:0055007; GO:0060038; GO:0060319"
"4456",4456,"Cluster_8888","Porites_evermani_scaffold_61:296734-297734",159,-21.67,2,20,929,949,18,"72.22%","77.78%","Peve_00037353",0.428690989228696,0.71794982578688,0.981001799035175,NA,NA,NA,NA,NA
"4457",4457,"Cluster_8888","Porites_evermani_scaffold_628:121037-122037",169,-25.19,2,20,960,984,22,"81.82%","81.82%","Peve_00037798",0.985789282969132,0.107453054356057,0.978262075707395,"P0CG13","Chromosome transmission fidelity protein 8 homolog (hCTF8)","Homo sapiens (Human)","DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; mitotic sister chromatid cohesion [GO:0007064]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]","GO:0003677; GO:0005654; GO:0006260; GO:0007064; GO:0031390; GO:0032508; GO:1900264"
"4458",4458,"Cluster_8888","Porites_evermani_scaffold_667:95488-96488",160,-20.8,2,19,518,541,20,"75.00%","85.00%","Peve_00038750",-0.999995310085062,0.00194974481237643,0.362847063101065,"Q9WVK8","Cholesterol 24-hydroxylase (CH24H) (EC 1.14.14.25) (Cholesterol 24-monooxygenase) (Cholesterol 24S-hydroxylase) (Cytochrome P450 46A1)","Mus musculus (Mouse)","cholesterol catabolic process [GO:0006707]; progesterone metabolic process [GO:0042448]; protein localization to membrane raft [GO:1903044]; regulation of long-term synaptic potentiation [GO:1900271]; xenobiotic metabolic process [GO:0006805]","GO:0005506; GO:0005789; GO:0006707; GO:0006805; GO:0008395; GO:0020037; GO:0030425; GO:0033781; GO:0042448; GO:0062184; GO:0098793; GO:0098794; GO:1900271; GO:1903044"
"4459",4459,"Cluster_8888","Porites_evermani_scaffold_679:179834-180834",154,-20.28,2,20,117,139,20,"70.00%","75.00%","Peve_00039014",-0.204621240563633,0.868807469606318,0.997252323136946,NA,NA,NA,NA,NA
"4460",4460,"Cluster_8888","Porites_evermani_scaffold_709:61615-62615",168,-20.37,2,18,451,474,19,"84.21%","84.21%","Peve_00039778",NA,NA,NA,NA,NA,NA,NA,NA
"4461",4461,"Cluster_8888","Porites_evermani_scaffold_733:65093-66093",150,-20.57,2,20,943,965,20,"70.00%","70.00%","Peve_00040372",-0.605993248105401,0.585551675806151,0.978262075707395,"P48970","Univin","Strongylocentrotus purpuratus (Purple sea urchin)","BMP signaling pathway [GO:0030509]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; SMAD protein signal transduction [GO:0060395]","GO:0005125; GO:0005615; GO:0008083; GO:0010862; GO:0030509; GO:0060395"
"4462",4462,"Cluster_8888","Porites_evermani_scaffold_743:39942-40942",154,-22.08,2,20,501,518,18,"77.78%","83.33%","Peve_00040567",-0.999850946843342,0.0109918578760632,0.647820986329688,NA,NA,NA,NA,NA
"4463",4463,"Cluster_8888","Porites_evermani_scaffold_748:60689-61689",163,-21.19,2,20,696,716,18,"77.78%","77.78%","Peve_00040628",NA,NA,NA,NA,NA,NA,NA,NA
"4464",4464,"Cluster_8888","Porites_evermani_scaffold_817:124426-125426",166,-21.53,2,19,561,581,17,"76.47%","88.24%","Peve_00042120",-0.19508535321927,0.875003225204124,0.997550434154142,"Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"4465",4465,"Cluster_8888","Porites_evermani_scaffold_82:146725-147725",158,-20.61,2,19,919,939,17,"64.71%","88.24%","Peve_00042185",NA,NA,NA,NA,NA,NA,NA,NA
"4466",4466,"Cluster_8888","Porites_evermani_scaffold_8:927847-928847",159,-20.12,2,18,668,691,19,"78.95%","84.21%","Peve_00041714",NA,NA,NA,NA,NA,NA,NA,NA
"4467",4467,"Cluster_8888","Porites_evermani_scaffold_92:299679-300679",157,-20.28,2,18,859,879,16,"68.75%","87.50%","Peve_00044106",-0.219753560508399,0.858949346278634,0.995934364227446,NA,NA,NA,NA,NA
"4468",4468,"Cluster_8888","Porites_evermani_scaffold_95:430111-431111",156,-23.18,2,19,820,839,17,"70.59%","88.24%","Peve_00044570",-0.0664918490342374,0.957638720638717,0.999448381576871,"Q71SG7","Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 4 (EC 2.4.1.102)","Danio rerio (Zebrafish) (Brachydanio rerio)","protein glycosylation [GO:0006486]","GO:0000139; GO:0003829; GO:0006486; GO:0008375"
"4469",4469,"Cluster_8988","Porites_evermani_scaffold_1006:143248-144248",162,-23.07,2,21,13,38,23,"73.91%","78.26%","Peve_00000340",0.160835445204462,0.897162313751018,0.999448381576871,NA,NA,NA,NA,NA
"4470",4470,"Cluster_8988","Porites_evermani_scaffold_1021:41236-42236",162,-20.2,2,16,130,152,15,"86.67%","93.33%","Peve_00000576",NA,NA,NA,NA,NA,NA,NA,NA
"4471",4471,"Cluster_8988","Porites_evermani_scaffold_1068:106397-107397",166,-20.46,2,21,562,582,19,"78.95%","84.21%","Peve_00001259",0.994081018583608,0.0692999716482651,0.978262075707395,"O54750","Cytochrome P450 2J6 (EC 1.14.14.1) (Arachidonic acid epoxygenase) (CYPIIJ6)","Mus musculus (Mouse)","arachidonic acid metabolic process [GO:0019369]; epoxygenase P450 pathway [GO:0019373]; icosanoid metabolic process [GO:0006690]; linoleic acid metabolic process [GO:0043651]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; organic acid metabolic process [GO:0006082]; positive regulation of extracellular matrix organization [GO:1903055]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of tumor necrosis factor production [GO:0032760]; retinoid metabolic process [GO:0001523]; xenobiotic metabolic process [GO:0006805]","GO:0001523; GO:0003958; GO:0005506; GO:0005737; GO:0005783; GO:0005789; GO:0006082; GO:0006690; GO:0006805; GO:0008391; GO:0008392; GO:0008395; GO:0008404; GO:0008405; GO:0016712; GO:0016853; GO:0019369; GO:0019373; GO:0020037; GO:0032760; GO:0032966; GO:0035359; GO:0043231; GO:0043651; GO:0045722; GO:0070330; GO:0071614; GO:1903055"
"4472",4472,"Cluster_8988","Porites_evermani_scaffold_1137:20018-21018",166,-23.85,2,21,21,44,21,"71.43%","90.48%","Peve_00002360",0.443953598886502,0.707151002851587,0.978262075707395,"Q7ZSX3","Pancreas transcription factor 1 subunit alpha (Pancreas-specific transcription factor 1a) (bHLH transcription factor p48)","Danio rerio (Zebrafish) (Brachydanio rerio)","amacrine cell differentiation [GO:0035881]; animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; developmental process [GO:0032502]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; hindbrain development [GO:0030902]; pancreas development [GO:0031016]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; retinoic acid receptor signaling pathway [GO:0048384]; tissue development [GO:0009888]","GO:0000977; GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0005737; GO:0006355; GO:0006357; GO:0009887; GO:0009888; GO:0030154; GO:0030902; GO:0031016; GO:0031017; GO:0032502; GO:0035881; GO:0043565; GO:0045893; GO:0046983; GO:0048384; GO:0048699"
"4473",4473,"Cluster_8988","Porites_evermani_scaffold_116:298851-299851",162,-20.88,2,21,573,593,19,"73.68%","84.21%","Peve_00002690",NA,NA,NA,NA,NA,NA,NA,NA
"4474",4474,"Cluster_8988","Porites_evermani_scaffold_1168:10717-11717",172,-23.61,2,19,22,42,17,"88.24%","94.12%","Peve_00002828",NA,NA,NA,NA,NA,NA,NA,NA
"4475",4475,"Cluster_8988","Porites_evermani_scaffold_1206:72802-73802",146,-22.49,2,21,846,875,27,"62.96%","66.67%","Peve_00003473",NA,NA,NA,NA,NA,NA,NA,NA
"4476",4476,"Cluster_8988","Porites_evermani_scaffold_1233:98639-99639",179,-24.22,2,20,163,184,18,"83.33%","94.44%","Peve_00003841",-0.607471446592874,0.584367824474721,0.978262075707395,NA,NA,NA,NA,NA
"4477",4477,"Cluster_8988","Porites_evermani_scaffold_1251:49303-50303",161,-23.12,2,21,679,700,20,"75.00%","85.00%","Peve_00004117",0.0860148226113438,0.945173514868548,0.999448381576871,NA,NA,NA,NA,NA
"4478",4478,"Cluster_8988","Porites_evermani_scaffold_128:183800-184800",163,-22.2,2,21,314,336,20,"70.00%","85.00%","Peve_00004494",NA,NA,NA,NA,NA,NA,NA,NA
"4479",4479,"Cluster_8988","Porites_evermani_scaffold_1314:67828-68828",160,-21.21,2,21,740,761,19,"63.16%","84.21%","Peve_00004988",0.0860148226113438,0.945173514868548,0.999448381576871,NA,NA,NA,NA,NA
"4480",4480,"Cluster_8988","Porites_evermani_scaffold_1316:123913-124913",155,-21.51,2,21,113,138,23,"65.22%","73.91%","Peve_00005011",-0.905823201447666,0.278506848201881,0.978262075707395,NA,NA,NA,NA,NA
"4481",4481,"Cluster_8988","Porites_evermani_scaffold_1378:55485-56485",157,-23.01,2,21,351,370,19,"68.42%","84.21%","Peve_00005862",0.819808378836323,0.388159818464786,0.978262075707395,NA,NA,NA,NA,NA
"4482",4482,"Cluster_8988","Porites_evermani_scaffold_1449:47858-48858",157,-21.13,2,19,262,284,18,"72.22%","83.33%","Peve_00006819",NA,NA,NA,NA,NA,NA,NA,NA
"4483",4483,"Cluster_8988","Porites_evermani_scaffold_146:70259-71259",157,-20.85,2,20,860,884,21,"66.67%","85.71%","Peve_00006971",0.486876469138097,0.676272368047189,0.978262075707395,"O88351","Inhibitor of nuclear factor kappa-B kinase subunit beta (I-kappa-B-kinase beta) (IKK-B) (IKK-beta) (IkBKB) (EC 2.7.11.10) (I-kappa-B kinase 2) (IKK2) (Nuclear factor NF-kappa-B inhibitor kinase beta) (NFKBIKB) (Serine/threonine protein kinase IKBKB) (EC 2.7.11.1)","Mus musculus (Mouse)","B cell homeostasis [GO:0001782]; cellular response to tumor necrosis factor [GO:0071356]; cortical actin cytoskeleton organization [GO:0030866]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; I-kappaB phosphorylation [GO:0007252]; interleukin-1-mediated signaling pathway [GO:0070498]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; neuron projection development [GO:0031175]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of phosphorylation [GO:0042325]; response to cholecystokinin [GO:0061847]; tumor necrosis factor-mediated signaling pathway [GO:0033209]","GO:0001782; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006468; GO:0007249; GO:0007252; GO:0008284; GO:0008384; GO:0008385; GO:0009898; GO:0010765; GO:0010976; GO:0018105; GO:0019901; GO:0019903; GO:0030866; GO:0031175; GO:0033209; GO:0035509; GO:0035631; GO:0042325; GO:0042802; GO:0042803; GO:0043123; GO:0043231; GO:0044877; GO:0045121; GO:0045944; GO:0046982; GO:0051092; GO:0061847; GO:0070498; GO:0071356; GO:0072659; GO:0097110; GO:0106310; GO:1901216; GO:1903140; GO:1903347; GO:1990459; GO:2001259"
"4484",4484,"Cluster_8988","Porites_evermani_scaffold_1608:13411-14411",154,-20.89,2,20,820,842,19,"63.16%","84.21%","Peve_00008921",NA,NA,NA,NA,NA,NA,NA,NA
"4485",4485,"Cluster_8988","Porites_evermani_scaffold_1629:88240-89240",176,-22.27,2,21,766,787,19,"78.95%","89.47%","Peve_00009144",NA,NA,NA,"P00767","Chymotrypsinogen B (EC 3.4.21.1) [Cleaved into: Chymotrypsin B chain A; Chymotrypsin B chain B; Chymotrypsin B chain C]","Bos taurus (Bovine)","digestion [GO:0007586]; proteolysis [GO:0006508]","GO:0004252; GO:0005615; GO:0006508; GO:0007586"
"4486",4486,"Cluster_8988","Porites_evermani_scaffold_1671:17599-18599",166,-20.94,2,19,574,595,17,"82.35%","82.35%","Peve_00009637",-0.973677063778834,0.146392752466025,0.978262075707395,NA,NA,NA,NA,NA
"4487",4487,"Cluster_8988","Porites_evermani_scaffold_167:201519-202519",172,-23.19,2,21,722,743,19,"73.68%","89.47%","Peve_00009606",0.859643022489603,0.341371943595937,0.978262075707395,"Q54BU4","ABC transporter B family member 1 (ABC transporter ABCB.1)","Dictyostelium discoideum (Social amoeba)","chemotaxis [GO:0006935]; culmination involved in sorocarp development [GO:0031154]; hyperosmotic response [GO:0006972]; transmembrane transport [GO:0055085]","GO:0005524; GO:0006935; GO:0006972; GO:0016020; GO:0016887; GO:0031154; GO:0042626; GO:0055085; GO:0140359"
"4488",4488,"Cluster_8988","Porites_evermani_scaffold_1685:68738-69738",151,-21.29,2,21,946,971,23,"60.87%","73.91%","Peve_00009804",-0.686776169291063,0.518050517848782,0.978262075707395,NA,NA,NA,NA,NA
"4489",4489,"Cluster_8988","Porites_evermani_scaffold_1701:74210-75210",149,-21.34,2,19,961,983,18,"66.67%","77.78%","Peve_00010079",0.585966046114306,0.601430376727384,0.978262075707395,"Q5RCR5","Inactive C-alpha-formylglycine-generating enzyme 2 (Sulfatase-modifying factor 2)","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","","GO:0005783; GO:0005788; GO:0046872"
"4490",4490,"Cluster_8988","Porites_evermani_scaffold_1724:90445-91445",167,-23.57,2,18,174,194,16,"87.50%","93.75%","Peve_00010318",-0.262545071184633,0.83087631762442,0.995934364227446,"Q9SVG0","Amino acid transporter AVT3C (AtAvt3C) (Aromatic and neutral amino acid transporter-like protein 2)","Arabidopsis thaliana (Mouse-ear cress)","amino acid transmembrane transport [GO:0003333]; neutral amino acid transport [GO:0015804]","GO:0003333; GO:0005774; GO:0015175; GO:0015179; GO:0015804"
"4491",4491,"Cluster_8988","Porites_evermani_scaffold_1800:74074-75074",168,-20.14,2,17,259,280,15,"86.67%","93.33%","Peve_00011185",NA,NA,NA,NA,NA,NA,NA,NA
"4492",4492,"Cluster_8988","Porites_evermani_scaffold_1844:27707-28707",154,-21.75,2,20,650,673,20,"60.00%","85.00%","Peve_00011634",0.99725770910753,0.0471575439540669,0.941529418834028,NA,NA,NA,NA,NA
"4493",4493,"Cluster_8988","Porites_evermani_scaffold_1859:85811-86811",166,-21.59,2,21,977,997,19,"73.68%","89.47%","Peve_00011785",-0.905823201447666,0.278506848201881,0.978262075707395,NA,NA,NA,NA,NA
"4494",4494,"Cluster_8988","Porites_evermani_scaffold_1877:12420-13420",164,-21.47,2,19,657,677,17,"76.47%","94.12%","Peve_00011991",0.792527029734006,0.417530028439537,0.978262075707395,NA,NA,NA,NA,NA
"4495",4495,"Cluster_8988","Porites_evermani_scaffold_1882:82420-83420",170,-23.24,2,21,633,653,19,"78.95%","89.47%","Peve_00012061",0.0115637844439892,0.992638102099816,0.999448381576871,NA,NA,NA,NA,NA
"4496",4496,"Cluster_8988","Porites_evermani_scaffold_1906:82275-83275",167,-20.64,2,21,617,640,21,"76.19%","80.95%","Peve_00012359",-0.101765687210518,0.935101603530967,0.999448381576871,"Q9BX70","BTB/POZ domain-containing protein 2","Homo sapiens (Human)","neurogenesis [GO:0022008]","GO:0000932; GO:0005829; GO:0022008"
"4497",4497,"Cluster_8988","Porites_evermani_scaffold_19:509763-510763",158,-20.23,2,21,389,409,19,"63.16%","89.47%","Peve_00012223",0.100518024215145,0.935899984603386,0.999448381576871,"Q0VFD8","Biogenesis of lysosome-related organelles complex 1 subunit 1 (BLOC-1 subunit 1)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","aerobic respiration [GO:0009060]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; lysosome localization [GO:0032418]; neuron projection development [GO:0031175]; peptidyl-lysine acetylation [GO:0018394]","GO:0005758; GO:0005759; GO:0005765; GO:0005829; GO:0008089; GO:0009060; GO:0018394; GO:0031083; GO:0031175; GO:0032418; GO:0048490; GO:0099078; GO:1904115"
"4498",4498,"Cluster_8988","Porites_evermani_scaffold_195:373623-374623",176,-27.39,2,21,213,234,19,"73.68%","94.74%","Peve_00012839",NA,NA,NA,"Q91Y77","Monocarboxylate transporter 10 (MCT 10) (Aromatic amino acid transporter 1) (Solute carrier family 16 member 10) (T-type amino acid transporter 1)","Rattus norvegicus (Rat)","aromatic amino acid transport [GO:0015801]; thyroid hormone generation [GO:0006590]; thyroid hormone transport [GO:0070327]; thyroid-stimulating hormone secretion [GO:0070460]","GO:0005302; GO:0005886; GO:0006590; GO:0015173; GO:0015192; GO:0015196; GO:0015349; GO:0015801; GO:0016020; GO:0016323; GO:0070327; GO:0070460"
"4499",4499,"Cluster_8988","Porites_evermani_scaffold_1954:63091-64091",163,-20.13,2,21,344,366,20,"70.00%","85.00%","Peve_00012869",-0.997041894647782,0.0489789031235421,0.949444666171571,NA,NA,NA,NA,NA
"4500",4500,"Cluster_8988","Porites_evermani_scaffold_1957:86309-87309",170,-21.66,2,20,765,787,19,"78.95%","89.47%","Peve_00012895",NA,NA,NA,NA,NA,NA,NA,NA
"4501",4501,"Cluster_8988","Porites_evermani_scaffold_2053:11101-12101",171,-20.66,2,21,689,712,21,"76.19%","85.71%","Peve_00014087",NA,NA,NA,NA,NA,NA,NA,NA
"4502",4502,"Cluster_8988","Porites_evermani_scaffold_2073:48647-49647",164,-20.36,2,17,659,680,15,"80.00%","93.33%","Peve_00014275",NA,NA,NA,NA,NA,NA,NA,NA
"4503",4503,"Cluster_8988","Porites_evermani_scaffold_2085:64534-65534",176,-21.87,2,21,959,980,19,"84.21%","84.21%","Peve_00014387",0.137491467368391,0.912192064867334,0.999448381576871,NA,NA,NA,NA,NA
"4504",4504,"Cluster_8988","Porites_evermani_scaffold_2108:30301-31301",156,-21.97,2,21,571,589,19,"68.42%","84.21%","Peve_00014656",0.846673004106776,0.357204111591375,0.978262075707395,"P13903","Twist-related protein (T18) (X-twist)","Xenopus laevis (African clawed frog)","neural crest formation [GO:0014029]","GO:0003677; GO:0005634; GO:0014029; GO:0046983"
"4505",4505,"Cluster_8988","Porites_evermani_scaffold_213:149450-150450",168,-23.06,2,18,764,786,17,"88.24%","88.24%","Peve_00014867",0.204998754775616,0.868561931617137,0.99718107283055,NA,NA,NA,NA,NA
"4506",4506,"Cluster_8988","Porites_evermani_scaffold_2154:42504-43504",166,-22.8,2,21,424,444,19,"73.68%","89.47%","Peve_00015097",NA,NA,NA,"P21804","Fibroblast growth factor receptor 1 (FGFR-1) (bFGF-R-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (Tyrosine kinase receptor CEK1)","Gallus gallus (Chicken)","epicardial cell to mesenchymal cell transition [GO:0003347]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of phospholipase C activity [GO:0010863]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]","GO:0003347; GO:0004714; GO:0005007; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0007169; GO:0008201; GO:0008284; GO:0010863; GO:0017134; GO:0018108; GO:0031410; GO:0033674; GO:0043235; GO:0043406; GO:0045597; GO:0045893"
"4507",4507,"Cluster_8988","Porites_evermani_scaffold_2:1672463-1673463",153,-20.12,2,21,12,31,19,"63.16%","84.21%","Peve_00013437",0.766566022971952,0.443927619315307,0.978262075707395,"O14578","Citron Rho-interacting kinase (CRIK) (EC 2.7.11.1) (Serine/threonine-protein kinase 21)","Homo sapiens (Human)","actomyosin structure organization [GO:0031032]; G2/M transition of mitotic cell cycle [GO:0000086]; generation of neurons [GO:0048699]; Golgi organization [GO:0007030]; liver development [GO:0001889]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; negative regulation of hippo signaling [GO:0035331]; neuron apoptotic process [GO:0051402]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cytokinesis [GO:0032467]; regulation of actin polymerization or depolymerization [GO:0008064]","GO:0000086; GO:0000278; GO:0000281; GO:0001223; GO:0001889; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0007030; GO:0008064; GO:0016020; GO:0017124; GO:0018107; GO:0019901; GO:0030165; GO:0030291; GO:0030496; GO:0031032; GO:0031985; GO:0032154; GO:0032467; GO:0035331; GO:0043025; GO:0046872; GO:0048699; GO:0051402; GO:0097110; GO:0106310"
"4508",4508,"Cluster_8988","Porites_evermani_scaffold_2172:83890-84890",170,-21.66,2,20,428,450,19,"78.95%","89.47%","Peve_00015259",0.819808378836323,0.388159818464786,0.978262075707395,NA,NA,NA,NA,NA
"4509",4509,"Cluster_8988","Porites_evermani_scaffold_2207:27214-28214",160,-20.95,2,19,674,697,19,"78.95%","84.21%","Peve_00015647",0.0740121618585332,0.95283927117713,0.999448381576871,NA,NA,NA,NA,NA
"4510",4510,"Cluster_8988","Porites_evermani_scaffold_2207:38613-39613",160,-20.95,2,19,220,243,19,"78.95%","84.21%","Peve_00015642",-0.105375327959492,0.932791208516262,0.999448381576871,"P34994","Somatostatin receptor type 2 (SS-2-R) (SS2-R) (SS2R) (SRIF-1)","Sus scrofa (Pig)","adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cellular response to estradiol stimulus [GO:0071392]; cellular response to glucocorticoid stimulus [GO:0071385]; negative regulation of growth hormone secretion [GO:0060125]; neuropeptide signaling pathway [GO:0007218]","GO:0004930; GO:0004994; GO:0005829; GO:0005886; GO:0007193; GO:0007218; GO:0030165; GO:0038039; GO:0042277; GO:0042923; GO:0043005; GO:0046982; GO:0060125; GO:0071385; GO:0071392"
"4511",4511,"Cluster_8988","Porites_evermani_scaffold_2213:67171-68171",158,-21.58,2,15,743,764,13,"76.92%","100.00%","Peve_00015699",NA,NA,NA,NA,NA,NA,NA,NA
"4512",4512,"Cluster_8988","Porites_evermani_scaffold_2237:1197-2197",171,-20.66,2,21,638,661,21,"76.19%","85.71%","Peve_00015921",NA,NA,NA,NA,NA,NA,NA,NA
"4513",4513,"Cluster_8988","Porites_evermani_scaffold_234:33313-34313",166,-20.52,2,21,37,57,19,"78.95%","84.21%","Peve_00016903",0.811764891590831,0.397014152886313,0.978262075707395,NA,NA,NA,NA,NA
"4514",4514,"Cluster_8988","Porites_evermani_scaffold_247:217655-218655",158,-20.69,2,20,855,877,19,"68.42%","84.21%","Peve_00018096",0.0860148226113438,0.945173514868548,0.999448381576871,NA,NA,NA,NA,NA
"4515",4515,"Cluster_8988","Porites_evermani_scaffold_2499:11108-12108",174,-23.4,2,20,646,669,20,"85.00%","85.00%","Peve_00018346",-0.691298422882787,0.514078018094829,0.978262075707395,NA,NA,NA,NA,NA
"4516",4516,"Cluster_8988","Porites_evermani_scaffold_2500:34746-35746",160,-20.95,2,21,117,138,19,"68.42%","78.95%","Peve_00018464",NA,NA,NA,NA,NA,NA,NA,NA
"4517",4517,"Cluster_8988","Porites_evermani_scaffold_251:283042-284042",168,-21.61,2,21,238,259,19,"73.68%","84.21%","Peve_00018542",0.999797047339721,0.0128262541271408,0.695994506963882,NA,NA,NA,NA,NA
"4518",4518,"Cluster_8988","Porites_evermani_scaffold_2593:18300-19300",152,-21.4,2,21,677,695,19,"68.42%","78.95%","Peve_00019165",0.63034416240452,0.565827569104852,0.978262075707395,NA,NA,NA,NA,NA
"4519",4519,"Cluster_8988","Porites_evermani_scaffold_262:241281-242281",172,-22.54,2,21,222,243,19,"78.95%","84.21%","Peve_00019429",0.638109920987178,0.559433055347361,0.978262075707395,"Q07263","Neuronal acetylcholine receptor subunit alpha-3","Bos taurus (Bovine)","behavioral response to nicotine [GO:0035095]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission involved in micturition [GO:0060084]","GO:0005231; GO:0005886; GO:0005892; GO:0007165; GO:0007268; GO:0007399; GO:0015464; GO:0022848; GO:0030594; GO:0034220; GO:0035095; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0060084; GO:1904315"
"4520",4520,"Cluster_8988","Porites_evermani_scaffold_2680:7749-8749",167,-20.14,2,21,667,689,20,"75.00%","85.00%","Peve_00019914",0.819808378836323,0.388159818464786,0.978262075707395,NA,NA,NA,NA,NA
"4521",4521,"Cluster_8988","Porites_evermani_scaffold_2702:39683-40683",170,-22.45,2,21,31,51,19,"78.95%","89.47%","Peve_00020128",0.945803999106592,0.210552278247974,0.978262075707395,NA,NA,NA,NA,NA
"4522",4522,"Cluster_8988","Porites_evermani_scaffold_27:391239-392239",163,-22.97,2,21,201,223,20,"70.00%","85.00%","Peve_00020044",0.217034958156993,0.860722874813732,0.996335300269428,NA,NA,NA,NA,NA
"4523",4523,"Cluster_8988","Porites_evermani_scaffold_2826:57055-58055",176,-21.68,2,21,320,341,19,"73.68%","94.74%","Peve_00021107",0.233059777903168,0.850252434756805,0.995934364227446,"B8VIU6","Uncharacterized skeletal organic matrix protein 5 (Uncharacterized SOMP-5)","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0005576"
"4524",4524,"Cluster_8988","Porites_evermani_scaffold_2959:43155-44155",147,-20.33,2,21,608,635,25,"64.00%","64.00%","Peve_00022115",0.0860148226113438,0.945173514868548,0.999448381576871,NA,NA,NA,NA,NA
"4525",4525,"Cluster_8988","Porites_evermani_scaffold_296:192218-193218",160,-20.45,2,13,385,406,11,"100.00%","100.00%","Peve_00022127",-0.380056196806972,0.751809292665981,0.988219883885475,NA,NA,NA,NA,NA
"4526",4526,"Cluster_8988","Porites_evermani_scaffold_3017:28588-29588",163,-20.03,2,20,62,83,18,"66.67%","88.89%","Peve_00022750",-0.963997061790903,0.171346709959806,0.978262075707395,NA,NA,NA,NA,NA
"4527",4527,"Cluster_8988","Porites_evermani_scaffold_302:78236-79236",160,-20.34,2,21,104,125,19,"63.16%","84.21%","Peve_00022762",0.885949174062344,0.307016064000451,0.978262075707395,"O42819","Ras-related protein SEC4","Candida glabrata (Yeast) (Torulopsis glabrata)","ascospore-type prospore assembly [GO:0031321]; autophagy [GO:0006914]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; membrane addition at site of cytokinesis [GO:0007107]; protein transport [GO:0015031]; vesicle fusion [GO:0006906]","GO:0000131; GO:0003924; GO:0005525; GO:0005886; GO:0006887; GO:0006893; GO:0006906; GO:0006914; GO:0007107; GO:0015031; GO:0030658; GO:0031321; GO:0043332; GO:0062040"
"4528",4528,"Cluster_8988","Porites_evermani_scaffold_3:1236602-1237602",175,-22.17,2,20,643,664,18,"77.78%","94.44%","Peve_00022508",0.538526153509982,0.637962622396444,0.978262075707395,NA,NA,NA,NA,NA
"4529",4529,"Cluster_8988","Porites_evermani_scaffold_3569:22541-23541",168,-22.99,2,21,225,246,19,"68.42%","89.47%","Peve_00026341",NA,NA,NA,"Q91Y77","Monocarboxylate transporter 10 (MCT 10) (Aromatic amino acid transporter 1) (Solute carrier family 16 member 10) (T-type amino acid transporter 1)","Rattus norvegicus (Rat)","aromatic amino acid transport [GO:0015801]; thyroid hormone generation [GO:0006590]; thyroid hormone transport [GO:0070327]; thyroid-stimulating hormone secretion [GO:0070460]","GO:0005302; GO:0005886; GO:0006590; GO:0015173; GO:0015192; GO:0015196; GO:0015349; GO:0015801; GO:0016020; GO:0016323; GO:0070327; GO:0070460"
"4530",4530,"Cluster_8988","Porites_evermani_scaffold_3575:28525-29448",167,-20.22,2,21,706,728,20,"75.00%","85.00%","Peve_00026377",-0.905823201447666,0.278506848201881,0.978262075707395,NA,NA,NA,NA,NA
"4531",4531,"Cluster_8988","Porites_evermani_scaffold_3599:33431-34431",156,-20.04,2,17,774,795,15,"80.00%","80.00%","Peve_00026506",0.397004932273722,0.74009916272816,0.986697151420032,NA,NA,NA,NA,NA
"4532",4532,"Cluster_8988","Porites_evermani_scaffold_3658:13321-14321",152,-20.95,2,18,825,847,17,"70.59%","82.35%","Peve_00026860",0.463134721388588,0.693449210348473,0.978262075707395,"P49748","Very long-chain specific acyl-CoA dehydrogenase, mitochondrial (VLCAD) (EC 1.3.8.9)","Homo sapiens (Human)","energy derivation by oxidation of organic compounds [GO:0015980]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of fatty acid oxidation [GO:0046322]; regulation of cholesterol metabolic process [GO:0090181]; response to cold [GO:0009409]; temperature homeostasis [GO:0001659]","GO:0000062; GO:0001659; GO:0003995; GO:0004466; GO:0005654; GO:0005730; GO:0005739; GO:0005759; GO:0009409; GO:0015980; GO:0017099; GO:0030855; GO:0031314; GO:0031966; GO:0033539; GO:0042645; GO:0042802; GO:0045717; GO:0046322; GO:0050660; GO:0090181"
"4533",4533,"Cluster_8988","Porites_evermani_scaffold_3750:15324-15661",159,-20.75,2,21,242,269,25,"68.00%","72.00%","Peve_00027355",NA,NA,NA,NA,NA,NA,NA,NA
"4534",4534,"Cluster_8988","Porites_evermani_scaffold_3990:471-1471",163,-20.31,2,20,229,250,18,"72.22%","83.33%","Peve_00028661",0.990791156628571,0.086463240317566,0.978262075707395,"Q9DE14","Serine/threonine-protein kinase atr (Xatr) (EC 2.7.11.1) (Ataxia telangiectasia and Rad3-related protein)","Xenopus laevis (African clawed frog)","DNA repair [GO:0006281]; peptidyl-serine phosphorylation [GO:0018105]","GO:0003677; GO:0004674; GO:0005524; GO:0005694; GO:0006281; GO:0016605; GO:0018105; GO:0046982; GO:0106310"
"4535",4535,"Cluster_8988","Porites_evermani_scaffold_404:88230-89230",165,-24.01,2,20,384,404,18,"72.22%","94.44%","Peve_00029037",-0.241259147048016,0.84487924275706,0.995934364227446,"Q8K2J9","BTB/POZ domain-containing protein 6","Mus musculus (Mouse)","neurogenesis [GO:0022008]","GO:0005829; GO:0022008"
"4536",4536,"Cluster_8988","Porites_evermani_scaffold_42:30593-31393",174,-25.04,2,21,709,729,19,"84.21%","89.47%","Peve_00029827",0.0860148226113438,0.945173514868548,0.999448381576871,NA,NA,NA,NA,NA
"4537",4537,"Cluster_8988","Porites_evermani_scaffold_423:155022-156022",163,-20.03,2,20,475,496,18,"61.11%","94.44%","Peve_00030038",-0.999550307649831,0.0190927790579351,0.790551218379749,NA,NA,NA,NA,NA
"4538",4538,"Cluster_8988","Porites_evermani_scaffold_452:208600-209600",160,-20.45,2,13,385,406,11,"100.00%","100.00%","Peve_00031565",-0.251852339954707,0.837920541847498,0.995934364227446,NA,NA,NA,NA,NA
"4539",4539,"Cluster_8988","Porites_evermani_scaffold_458:151252-152252",165,-21.1,2,19,685,708,19,"78.95%","84.21%","Peve_00031789",-0.945545080043363,0.211059277883331,0.978262075707395,"Q9D119","Protein phosphatase 1 regulatory subunit 27 (Dysferlin-interacting protein 1)","Mus musculus (Mouse)","","GO:0004864; GO:0019902"
"4540",4540,"Cluster_8988","Porites_evermani_scaffold_47:78575-79575",164,-20.29,2,21,202,223,19,"68.42%","84.21%","Peve_00032320",0.944479461670204,0.213133679120545,0.978262075707395,"P98088","Mucin-5AC (MUC-5AC) (Gastric mucin) (Major airway glycoprotein) (Mucin-5 subtype AC, tracheobronchial) (Tracheobronchial mucin) (TBM)","Homo sapiens (Human)","phosphatidylinositol-mediated signaling [GO:0048015]","GO:0005201; GO:0005615; GO:0005737; GO:0005796; GO:0005886; GO:0031012; GO:0048015; GO:0070062; GO:0070701"
"4541",4541,"Cluster_8988","Porites_evermani_scaffold_491:91750-92750",168,-21.13,2,21,499,520,19,"68.42%","89.47%","Peve_00033175",0.78631946942776,0.423968019296909,0.978262075707395,"O07834","Dipeptidyl aminopeptidase BI (DAP BI) (EC 3.4.14.-)","Pseudoxanthomonas mexicana","proteolysis involved in protein catabolic process [GO:0051603]","GO:0004177; GO:0004252; GO:0008239; GO:0051603"
"4542",4542,"Cluster_8988","Porites_evermani_scaffold_4938:1080-2080",169,-22.25,2,18,618,639,16,"81.25%","93.75%","Peve_00033284",0.998215951089572,0.0380332192580478,0.909359886114279,NA,NA,NA,NA,NA
"4543",4543,"Cluster_8988","Porites_evermani_scaffold_5105:8287-9287",162,-20.17,2,21,614,634,19,"68.42%","89.47%","Peve_00034086",NA,NA,NA,NA,NA,NA,NA,NA
"4544",4544,"Cluster_8988","Porites_evermani_scaffold_51:64934-65934",163,-22.06,2,21,292,315,21,"71.43%","80.95%","Peve_00034013",-0.279949283139042,0.819364691200433,0.995934364227446,"Q8TCT0","Ceramide kinase (hCERK) (EC 2.7.1.138) (Acylsphingosine kinase) (Lipid kinase 4) (LK4)","Homo sapiens (Human)","ceramide metabolic process [GO:0006672]; glycosphingolipid metabolic process [GO:0006687]; phosphorylation [GO:0016310]; sphingolipid metabolic process [GO:0006665]","GO:0000287; GO:0001727; GO:0001729; GO:0005524; GO:0005737; GO:0005886; GO:0006665; GO:0006672; GO:0006687; GO:0016020; GO:0016310; GO:0102773"
"4545",4545,"Cluster_8988","Porites_evermani_scaffold_5273:0-760",165,-20.45,2,18,1,17,16,"81.25%","87.50%","Peve_00034629",NA,NA,NA,NA,NA,NA,NA,NA
"4546",4546,"Cluster_8988","Porites_evermani_scaffold_5348:2067-3067",174,-20.47,2,20,158,180,19,"84.21%","89.47%","Peve_00034904",0.376675757720094,0.754134190857373,0.988219883885475,NA,NA,NA,NA,NA
"4547",4547,"Cluster_8988","Porites_evermani_scaffold_535:140115-141006",153,-20.12,2,21,339,358,19,"63.16%","84.21%","Peve_00034917",0.245870153513634,0.841852634250364,0.995934364227446,NA,NA,NA,NA,NA
"4548",4548,"Cluster_8988","Porites_evermani_scaffold_535:140115-141006",153,-20.12,2,21,339,358,19,"63.16%","84.21%","Peve_00034918",-0.00980920089830516,0.993755168607564,0.999448381576871,"P42356","Phosphatidylinositol 4-kinase alpha (PI4-kinase alpha) (PI4K-alpha) (PtdIns-4-kinase alpha) (EC 2.7.1.67) (Phosphatidylinositol 4-Kinase III alpha)","Homo sapiens (Human)","modulation by host of viral process [GO:0044788]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphorylation [GO:0016310]; reorganization of cellular membranes to establish viral sites of replication [GO:0140754]; signal transduction [GO:0007165]","GO:0004430; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0006661; GO:0007165; GO:0016020; GO:0016301; GO:0016310; GO:0030660; GO:0044788; GO:0045296; GO:0046854; GO:0048015; GO:0052742; GO:0070062; GO:0140754"
"4549",4549,"Cluster_8988","Porites_evermani_scaffold_543:142472-143472",169,-22.45,2,21,233,254,20,"80.00%","90.00%","Peve_00035229",NA,NA,NA,NA,NA,NA,NA,NA
"4550",4550,"Cluster_8988","Porites_evermani_scaffold_550:175206-176206",159,-20.84,2,21,310,332,20,"60.00%","90.00%","Peve_00035491",NA,NA,NA,NA,NA,NA,NA,NA
"4551",4551,"Cluster_8988","Porites_evermani_scaffold_55:90432-91432",148,-21.34,2,21,936,954,19,"63.16%","78.95%","Peve_00035453",-0.490236421330047,0.673820866154391,0.978262075707395,NA,NA,NA,NA,NA
"4552",4552,"Cluster_8988","Porites_evermani_scaffold_5895:3896-4896",165,-20.21,2,19,751,773,18,"83.33%","83.33%","Peve_00036643",NA,NA,NA,NA,NA,NA,NA,NA
"4553",4553,"Cluster_8988","Porites_evermani_scaffold_62:430548-431548",180,-22.65,2,21,616,637,19,"84.21%","89.47%","Peve_00037589",NA,NA,NA,NA,NA,NA,NA,NA
"4554",4554,"Cluster_8988","Porites_evermani_scaffold_630:160130-161130",159,-20.27,2,21,406,428,20,"60.00%","90.00%","Peve_00037899",0.0252394523036946,0.983930359171272,0.999448381576871,"O02813","Neuropeptide Y receptor type 1 (NPY1-R)","Canis lupus familiaris (Dog) (Canis familiaris)","feeding behavior [GO:0007631]; glucose metabolic process [GO:0006006]; locomotory behavior [GO:0007626]; outflow tract morphogenesis [GO:0003151]; regulation of blood pressure [GO:0008217]; regulation of multicellular organism growth [GO:0040014]; sensory perception of pain [GO:0019233]","GO:0001601; GO:0001602; GO:0003151; GO:0005886; GO:0006006; GO:0007626; GO:0007631; GO:0008188; GO:0008217; GO:0019233; GO:0040014; GO:0042923; GO:0043005"
"4555",4555,"Cluster_8988","Porites_evermani_scaffold_680:36405-37405",169,-20.68,2,20,394,414,18,"83.33%","88.89%","Peve_00039077",-0.278882201212728,0.820072196480012,0.995934364227446,NA,NA,NA,NA,NA
"4556",4556,"Cluster_8988","Porites_evermani_scaffold_703:42041-43041",167,-22.34,2,20,944,965,18,"72.22%","88.89%","Peve_00039683",NA,NA,NA,NA,NA,NA,NA,NA
"4557",4557,"Cluster_8988","Porites_evermani_scaffold_7098:999-1999",163,-22.03,2,18,696,716,16,"81.25%","93.75%","Peve_00039792",0.0860148226113438,0.945173514868548,0.999448381576871,NA,NA,NA,NA,NA
"4558",4558,"Cluster_8988","Porites_evermani_scaffold_761:122986-123986",165,-21.01,2,21,25,44,19,"78.95%","84.21%","Peve_00040895",NA,NA,NA,NA,NA,NA,NA,NA
"4559",4559,"Cluster_8988","Porites_evermani_scaffold_773:190187-191187",166,-21.47,2,21,10,30,19,"78.95%","84.21%","Peve_00041129",0.819808378836323,0.388159818464786,0.978262075707395,NA,NA,NA,NA,NA
"4560",4560,"Cluster_8988","Porites_evermani_scaffold_896:119418-120418",169,-21.28,2,18,773,794,16,"87.50%","87.50%","Peve_00043552",NA,NA,NA,NA,NA,NA,NA,NA
"4561",4561,"Cluster_8988","Porites_evermani_scaffold_912:43853-44853",159,-20.89,2,18,496,520,19,"78.95%","84.21%","Peve_00043959",-0.529974375280076,0.644403072387032,0.978262075707395,"P29029","Endochitinase (EC 3.2.1.14) (Soluble cell wall protein 2)","Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)","cell wall organization [GO:0071555]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]; septum digestion after cytokinesis [GO:0000920]","GO:0000272; GO:0000324; GO:0000920; GO:0004568; GO:0005576; GO:0005635; GO:0005783; GO:0005935; GO:0006032; GO:0008061; GO:0008843; GO:0009277; GO:0071555"
"4562",4562,"Cluster_8988","Porites_evermani_scaffold_975:61028-61249",160,-20.61,2,18,127,149,17,"76.47%","88.24%","Peve_00044988",0.963641456941343,0.172196006998014,0.978262075707395,"Q7ZT46","DNA replication complex GINS protein PSF2 (GINS complex subunit 2)","Xenopus laevis (African clawed frog)","DNA replication [GO:0006260]; DNA strand elongation involved in DNA replication [GO:0006271]; regulation of DNA-templated transcription elongation [GO:0032784]","GO:0000811; GO:0003682; GO:0005634; GO:0005654; GO:0006260; GO:0006271; GO:0032784; GO:0071162"
"4563",4563,"Cluster_8988","Porites_evermani_scaffold_975:61028-61249",160,-20.61,2,18,127,149,17,"76.47%","88.24%","Peve_00044989",0.885075670736756,0.308212946631144,0.978262075707395,"Q6PGV1","V-type proton ATPase subunit d 1 (V-ATPase subunit d 1) (Vacuolar proton pump subunit d 1)","Danio rerio (Zebrafish) (Brachydanio rerio)","cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; cilium assembly [GO:0060271]; eye pigment granule organization [GO:0008057]; heart looping [GO:0001947]; left/right axis specification [GO:0070986]; melanosome organization [GO:0032438]; neuromast hair cell development [GO:0035675]; pronephric duct development [GO:0039022]; response to copper ion [GO:0046688]; retina development in camera-type eye [GO:0060041]; retinal pigment epithelium development [GO:0003406]; vacuolar acidification [GO:0007035]; vacuolar transport [GO:0007034]","GO:0001947; GO:0003406; GO:0005765; GO:0005769; GO:0006879; GO:0007034; GO:0007035; GO:0008057; GO:0016471; GO:0032438; GO:0033179; GO:0033181; GO:0035675; GO:0036295; GO:0039022; GO:0046688; GO:0046961; GO:0060041; GO:0060271; GO:0070986"
"4564",4564,"Cluster_9149","Porites_evermani_scaffold_1000:19682-20682",148,-20.87,2,21,161,180,19,"68.42%","78.95%","Peve_00000240",-0.5,0.666666666666667,0.978262075707395,"Q09328","Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (EC 2.4.1.155) (Alpha-mannoside beta-1,6-N-acetylglucosaminyltransferase V) (GlcNAc-T V) (GNT-V) (Mannoside acetylglucosaminyltransferase 5) (N-acetylglucosaminyl-transferase V) [Cleaved into: Secreted alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (Secreted beta-1,6-N-acetylglucosaminyltransferase V) (Secreted GNT-V)]","Homo sapiens (Human)","negative regulation of protein tyrosine phosphatase activity [GO:1903614]; positive regulation of cell migration [GO:0030335]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; viral protein processing [GO:0019082]","GO:0000139; GO:0004864; GO:0005794; GO:0006487; GO:0016020; GO:0018279; GO:0019082; GO:0030144; GO:0030145; GO:0030335; GO:0070062; GO:1903614; GO:1904894"
"4565",4565,"Cluster_9149","Porites_evermani_scaffold_101:325818-326818",155,-26.71,2,18,584,604,16,"81.25%","81.25%","Peve_00000398",-0.5,0.666666666666667,0.978262075707395,NA,NA,NA,NA,NA
"4566",4566,"Cluster_9149","Porites_evermani_scaffold_1013:7752-8752",148,-20.24,2,13,588,609,11,"81.82%","90.91%","Peve_00000454",-0.754481446457864,0.455776885382805,0.978262075707395,NA,NA,NA,NA,NA
"4567",4567,"Cluster_9149","Porites_evermani_scaffold_1024:160510-161243",147,-20.92,2,21,391,413,20,"60.00%","75.00%","Peve_00000610",NA,NA,NA,NA,NA,NA,NA,NA
"4568",4568,"Cluster_9149","Porites_evermani_scaffold_1024:160510-161243",152,-24.35,2,13,465,486,11,"90.91%","90.91%","Peve_00000610",NA,NA,NA,NA,NA,NA,NA,NA
"4569",4569,"Cluster_9149","Porites_evermani_scaffold_104:121016-122016",162,-26.91,2,21,179,199,19,"73.68%","84.21%","Peve_00000813",0.656475695464363,0.544092889596712,0.978262075707395,"Q05973","Sodium channel protein 1 brain (Sodium channel protein I brain)","Heterololigo bleekeri (Spear squid) (Loligo bleekeri)","regulation of ion transmembrane transport [GO:0034765]","GO:0001518; GO:0005244; GO:0005248; GO:0034765"
"4570",4570,"Cluster_9149","Porites_evermani_scaffold_104:15386-16386",151,-21.47,2,21,27,49,20,"60.00%","80.00%","Peve_00000825",0.999999240744832,0.000784492916512268,0.239778920002343,"Q8IW35","Centrosomal protein of 97 kDa (Cep97) (Leucine-rich repeat and IQ domain-containing protein 2)","Homo sapiens (Human)","cell projection organization [GO:0030030]; negative regulation of cilium assembly [GO:1902018]; regulation of mitotic spindle assembly [GO:1901673]","GO:0005516; GO:0005813; GO:0005814; GO:0005829; GO:0030030; GO:0032991; GO:1901673; GO:1902018"
"4571",4571,"Cluster_9149","Porites_evermani_scaffold_1063:38617-39617",146,-24.67,2,15,955,976,13,"69.23%","84.62%","Peve_00001209",-0.913992859207052,0.265965531277221,0.978262075707395,"Q9VJ26","EF-hand domain-containing protein D2 homolog (Swiprosin-1 homolog)","Drosophila melanogaster (Fruit fly)","mesoderm development [GO:0007498]","GO:0005509; GO:0005886; GO:0005927; GO:0007498"
"4572",4572,"Cluster_9149","Porites_evermani_scaffold_1072:24129-25129",153,-21.13,2,15,89,111,14,"78.57%","92.86%","Peve_00001340",-0.5,0.666666666666667,0.978262075707395,NA,NA,NA,NA,NA
"4573",4573,"Cluster_9149","Porites_evermani_scaffold_1080:11188-12188",160,-22.82,2,21,944,965,19,"68.42%","78.95%","Peve_00001460",-0.115598696738661,0.926242687176597,0.999448381576871,NA,NA,NA,NA,NA
"4574",4574,"Cluster_9149","Porites_evermani_scaffold_1086:134543-135543",154,-21.67,2,21,794,818,22,"63.64%","81.82%","Peve_00001535",-0.5,0.666666666666667,0.978262075707395,NA,NA,NA,NA,NA
"4575",4575,"Cluster_9149","Porites_evermani_scaffold_10:891255-892255",164,-24.39,2,21,974,995,19,"63.16%","89.47%","Peve_00000155",-0.350663557916871,0.771912148388789,0.99142781492559,"Q9SLK6","Phospholipid-transporting ATPase 6 (AtALA6) (EC 7.6.2.1) (Aminophospholipid flippase 6)","Arabidopsis thaliana (Mouse-ear cress)","heat acclimation [GO:0010286]; phospholipid translocation [GO:0045332]; pollen tube growth [GO:0009860]; regulation of membrane lipid metabolic process [GO:1905038]","GO:0000287; GO:0005524; GO:0005886; GO:0008270; GO:0009860; GO:0010286; GO:0012505; GO:0016887; GO:0045332; GO:0140326; GO:1905038"
"4576",4576,"Cluster_9149","Porites_evermani_scaffold_1096:114893-115893",166,-27.88,2,21,963,983,19,"78.95%","84.21%","Peve_00001678",-0.5,0.666666666666667,0.978262075707395,NA,NA,NA,NA,NA
"4577",4577,"Cluster_9149","Porites_evermani_scaffold_1098:123259-124259",153,-22.36,2,18,448,466,16,"81.25%","81.25%","Peve_00001696",0.956412065970104,0.188655088118017,0.978262075707395,"O43399","Tumor protein D54 (hD54) (Tumor protein D52-like 2)","Homo sapiens (Human)","carbohydrate metabolic process [GO:0005975]; regulation of cell population proliferation [GO:0042127]","GO:0003723; GO:0005737; GO:0005975; GO:0042127; GO:0042803; GO:0048471"
"4578",4578,"Cluster_9149","Porites_evermani_scaffold_110:220248-221248",153,-20.43,2,18,974,995,16,"75.00%","75.00%","Peve_00001859",-0.5,0.666666666666667,0.978262075707395,"Q90WN7","Synaptonemal complex protein 2-like (SCP-2-like) (145 kDa nucleolar protein)","Xenopus laevis (African clawed frog)","","GO:0000775; GO:0005730"
"4579",4579,"Cluster_9149","Porites_evermani_scaffold_1105:129135-130135",151,-21.44,2,16,819,840,14,"71.43%","85.71%","Peve_00001929",-0.495063915411123,0.670289276891286,0.978262075707395,"Q0EEE2","Patched domain-containing protein 3 (RND-type protein RNDEu-3)","Mus musculus (Mouse)","","GO:0005783; GO:0005789; GO:0005886; GO:0016020; GO:0097225"
"4580",4580,"Cluster_9149","Porites_evermani_scaffold_1105:46928-47928",149,-23,2,20,300,324,21,"66.67%","76.19%","Peve_00001925",-0.847645570217893,0.356038837535223,0.978262075707395,"Q5M8H5","2-acylglycerol O-acyltransferase 2 (EC 2.3.1.22) (Acyl-CoA:monoacylglycerol acyltransferase 2) (MGAT2) (Monoacylglycerol O-acyltransferase 2)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","glycerol metabolic process [GO:0006071]; monoacylglycerol biosynthetic process [GO:0006640]; triglyceride biosynthetic process [GO:0019432]","GO:0003846; GO:0005789; GO:0006071; GO:0006640; GO:0019432; GO:1990578"
"4581",4581,"Cluster_9149","Porites_evermani_scaffold_1106:65548-66548",162,-22.76,2,21,894,914,19,"73.68%","84.21%","Peve_00001942",-0.588029035661831,0.599808144564309,0.978262075707395,"Q5ZKD5","RRP12-like protein","Gallus gallus (Chicken)","rRNA processing [GO:0006364]","GO:0005730; GO:0006364; GO:0031965"
"4582",4582,"Cluster_9149","Porites_evermani_scaffold_1108:100975-101975",156,-20.06,2,13,602,623,11,"90.91%","100.00%","Peve_00001961",-0.657669689990528,0.543084540780675,0.978262075707395,"Q6NYB7","Ras-related protein Rab-1A (EC 3.6.5.2)","Rattus norvegicus (Rat)","autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; cell migration [GO:0016477]; COPII-coated vesicle cargo loading [GO:0090110]; defense response to bacterium [GO:0042742]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; growth hormone secretion [GO:0030252]; intracellular protein transport [GO:0006886]; melanosome transport [GO:0032402]; positive regulation of glycoprotein metabolic process [GO:1903020]; positive regulation of interleukin-8 production [GO:0032757]; Rab protein signal transduction [GO:0032482]; substrate adhesion-dependent cell spreading [GO:0034446]; vesicle transport along microtubule [GO:0047496]; virion assembly [GO:0019068]","GO:0000045; GO:0000139; GO:0003924; GO:0003925; GO:0005525; GO:0005769; GO:0005789; GO:0005794; GO:0005829; GO:0006886; GO:0006888; GO:0006897; GO:0006914; GO:0007030; GO:0012505; GO:0016477; GO:0019068; GO:0030252; GO:0032402; GO:0032482; GO:0032757; GO:0034446; GO:0042470; GO:0042742; GO:0043025; GO:0047496; GO:0090110; GO:0098793; GO:1903020"
"4583",4583,"Cluster_9149","Porites_evermani_scaffold_1117:0-853",149,-21.1,2,15,576,599,15,"73.33%","86.67%","Peve_00002110",0.407329149462671,0.73292037546504,0.985284813434432,"O75581","Low-density lipoprotein receptor-related protein 6 (LRP-6)","Homo sapiens (Human)","canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in neural crest cell differentiation [GO:0044335]; canonical Wnt signaling pathway involved in regulation of cell proliferation [GO:0044340]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; chemical synaptic transmission [GO:0007268]; dopaminergic neuron differentiation [GO:0071542]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; response to peptide hormone [GO:0043434]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]; Wnt signaling pathway involved in somitogenesis [GO:0090244]","GO:0001933; GO:0005041; GO:0005102; GO:0005109; GO:0005576; GO:0005783; GO:0005886; GO:0006469; GO:0007204; GO:0007268; GO:0009986; GO:0014029; GO:0014033; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0031410; GO:0031901; GO:0034392; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043434; GO:0044335; GO:0044340; GO:0045121; GO:0045202; GO:0045787; GO:0045893; GO:0045944; GO:0051091; GO:0060070; GO:0071397; GO:0071542; GO:0071901; GO:0071936; GO:0072659; GO:0090118; GO:0090244; GO:0098609; GO:1904928; GO:1904948; GO:1904953; GO:1990851; GO:1990909"
"4584",4584,"Cluster_9149","Porites_evermani_scaffold_1117:85347-86347",147,-20.73,2,21,609,631,20,"60.00%","75.00%","Peve_00002109",-0.959726024668794,0.181290821735907,0.978262075707395,"P11369","LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","Mus musculus (Mouse)","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"4585",4585,"Cluster_9149","Porites_evermani_scaffold_111:93428-94428",140,-20.26,2,9,218,239,7,"100.00%","100.00%","Peve_00002012",NA,NA,NA,NA,NA,NA,NA,NA
"4586",4586,"Cluster_9149","Porites_evermani_scaffold_112:147847-148847",162,-27.25,2,19,751,772,17,"70.59%","88.24%","Peve_00002142",-0.5,0.666666666666667,0.978262075707395,NA,NA,NA,NA,NA
"4587",4587,"Cluster_9149","Porites_evermani_scaffold_1126:127045-128045",155,-25.78,2,12,131,152,10,"100.00%","100.00%","Peve_00002237",NA,NA,NA,NA,NA,NA,NA,NA
"4588",4588,"Cluster_9149","Porites_evermani_scaffold_1132:33092-34092",150,-21.69,2,11,318,339,9,"100.00%","100.00%","Peve_00002320",-0.998696026270262,0.0325144749625038,0.909359886114279,"Q8NDA2","Hemicentin-2","Homo sapiens (Human)","axon guidance [GO:0007411]; cell adhesion [GO:0007155]","GO:0005509; GO:0005615; GO:0007155; GO:0007411; GO:0031012; GO:0032154; GO:0062023"
"4589",4589,"Cluster_9149","Porites_evermani_scaffold_1141:0-891",147,-24.35,2,17,236,259,17,"64.71%","82.35%","Peve_00002444",-0.994684999801537,0.0656658102397528,0.978262075707395,"Q58116","3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase) (EC 1.1.1.34)","Methanocaldococcus jannaschii (strain ATCC 43067 / DSM 2661 / JAL-1 / JCM 10045 / NBRC 100440) (Methanococcus jannaschii)","coenzyme A metabolic process [GO:0015936]; isoprenoid biosynthetic process [GO:0008299]; sterol biosynthetic process [GO:0016126]","GO:0004420; GO:0008299; GO:0015936; GO:0016126"
"4590",4590,"Cluster_9149","Porites_evermani_scaffold_117:229323-230323",162,-28.68,2,17,776,796,15,"86.67%","93.33%","Peve_00002866",NA,NA,NA,NA,NA,NA,NA,NA
"4591",4591,"Cluster_9149","Porites_evermani_scaffold_119:330997-331997",143,-22.1,2,17,467,491,18,"66.67%","72.22%","Peve_00003157",NA,NA,NA,NA,NA,NA,NA,NA
"4592",4592,"Cluster_9149","Porites_evermani_scaffold_1193:47035-48035",156,-23.76,2,18,827,849,17,"76.47%","82.35%","Peve_00003234",0.999997860909741,0.0013167694840572,0.317099882619675,"Q01528","Hemagglutinin/amebocyte aggregation factor (18K-LAF)","Limulus polyphemus (Atlantic horseshoe crab)","","GO:0005576"
"4593",4593,"Cluster_9149","Porites_evermani_scaffold_1195:106266-107266",146,-21.28,2,19,660,681,17,"64.71%","70.59%","Peve_00003253",-0.5,0.666666666666667,0.978262075707395,NA,NA,NA,NA,NA
"4594",4594,"Cluster_9149","Porites_evermani_scaffold_1208:49345-50345",166,-22.14,2,21,820,840,19,"78.95%","84.21%","Peve_00003498",NA,NA,NA,NA,NA,NA,NA,NA
"4595",4595,"Cluster_9149","Porites_evermani_scaffold_121:117064-118064",160,-23.17,2,19,19,39,17,"76.47%","88.24%","Peve_00003530",-0.937042880262254,0.22710296541008,0.978262075707395,"Q96BH1","E3 ubiquitin-protein ligase RNF25 (EC 2.3.2.27) (RING finger protein 25) (RING-type E3 ubiquitin transferase RNF25)","Homo sapiens (Human)","positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein ubiquitination [GO:0016567]","GO:0004842; GO:0005634; GO:0005829; GO:0016567; GO:0046872; GO:0051059; GO:0051092; GO:0061630"
"4596",4596,"Cluster_9149","Porites_evermani_scaffold_121:6106-7106",162,-26.35,2,20,817,839,19,"73.68%","84.21%","Peve_00003533",0.178230912421416,0.885925195717157,0.999448381576871,"Q92051","Carbonic anhydrase (EC 4.2.1.1) (Carbonate dehydratase)","Danio rerio (Zebrafish) (Brachydanio rerio)","carbon dioxide transport [GO:0015670]; hypotonic salinity response [GO:0042539]; one-carbon metabolic process [GO:0006730]","GO:0004089; GO:0005737; GO:0006730; GO:0008270; GO:0015670; GO:0016836; GO:0042539"
"4597",4597,"Cluster_9149","Porites_evermani_scaffold_1235:119774-120774",147,-22.51,2,12,559,580,10,"80.00%","100.00%","Peve_00003871",NA,NA,NA,NA,NA,NA,NA,NA
"4598",4598,"Cluster_9149","Porites_evermani_scaffold_1235:54935-55935",143,-23.27,2,21,857,880,21,"61.90%","66.67%","Peve_00003880",-0.620469903201672,0.573883806444781,0.978262075707395,"Q8R2K4","TAF6-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 6L (TAF6L) (PCAF-associated factor 65-alpha) (PAF65-alpha)","Mus musculus (Mouse)","histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of DNA-templated transcription [GO:0006355]; regulation of RNA splicing [GO:0043484]; regulation of somatic stem cell population maintenance [GO:1904672]; RNA polymerase II preinitiation complex assembly [GO:0051123]","GO:0000124; GO:0003713; GO:0005634; GO:0005654; GO:0005669; GO:0006282; GO:0006355; GO:0016251; GO:0016573; GO:0035521; GO:0035522; GO:0043484; GO:0043966; GO:0045893; GO:0046695; GO:0046982; GO:0051123; GO:1904672"
"4599",4599,"Cluster_9149","Porites_evermani_scaffold_1243:135904-136904",147,-20.45,2,12,963,984,10,"90.00%","90.00%","Peve_00004020",-0.842736845631278,0.361885974525031,0.978262075707395,NA,NA,NA,NA,NA
"4600",4600,"Cluster_9149","Porites_evermani_scaffold_1281:60683-61683",161,-26.99,2,21,656,677,20,"75.00%","85.00%","Peve_00004521",-0.997395120221082,0.0459603451867603,0.934642337937236,NA,NA,NA,NA,NA
"4601",4601,"Cluster_9149","Porites_evermani_scaffold_1281:60956-61956",161,-26.99,2,21,383,404,20,"75.00%","85.00%","Peve_00004512",-0.999408825461995,0.021891442456906,0.830089015811238,"Q91ZA8","Notch-regulated ankyrin repeat-containing protein","Mus musculus (Mouse)","blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; branching involved in blood vessel morphogenesis [GO:0001569]; endothelial cell proliferation [GO:0001935]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of Notch signaling pathway involved in somitogenesis [GO:1902367]; negative regulation of T cell differentiation [GO:0045581]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of cell-cell adhesion [GO:0022407]; somite rostral/caudal axis specification [GO:0032525]; sprouting angiogenesis [GO:0002040]; T cell differentiation [GO:0030217]; vascular endothelial cell proliferation [GO:0101023]","GO:0000122; GO:0001569; GO:0001935; GO:0001938; GO:0002040; GO:0002043; GO:0007219; GO:0022407; GO:0030217; GO:0032525; GO:0045581; GO:0045746; GO:0090263; GO:0101023; GO:1902367; GO:1905564"
"4602",4602,"Cluster_9149","Porites_evermani_scaffold_1282:130024-130782",149,-22.16,2,14,359,380,12,"66.67%","100.00%","Peve_00004528",0.392068367140444,0.74351932655626,0.986911817903063,"O95427","GPI ethanolamine phosphate transferase 1 (EC 2.-.-.-) (MCD4 homolog) (Phosphatidylinositol-glycan biosynthesis class N protein) (PIG-N)","Homo sapiens (Human)","GPI anchor biosynthetic process [GO:0006506]; preassembly of GPI anchor in ER membrane [GO:0016254]","GO:0005789; GO:0005829; GO:0005886; GO:0006506; GO:0016020; GO:0016254; GO:0051377"
"4603",4603,"Cluster_9149","Porites_evermani_scaffold_1282:130024-130782",149,-22.16,2,14,359,380,12,"66.67%","100.00%","Peve_00004529",0.720840859736756,0.487511699141331,0.978262075707395,"P22623","Heat shock 70 kDa protein II (HSP70 II)","Paracentrotus lividus (Common sea urchin)","","GO:0005524; GO:0140662"
"4604",4604,"Cluster_9149","Porites_evermani_scaffold_128:456201-457201",157,-23.24,2,18,391,412,16,"68.75%","87.50%","Peve_00004481",0.863077391517348,0.337067907746712,0.978262075707395,NA,NA,NA,NA,NA
"4605",4605,"Cluster_9149","Porites_evermani_scaffold_1284:56989-57989",163,-28.34,2,18,177,197,16,"87.50%","87.50%","Peve_00004555",NA,NA,NA,NA,NA,NA,NA,NA
"4606",4606,"Cluster_9149","Porites_evermani_scaffold_129:387295-388295",156,-25.48,2,17,515,536,15,"73.33%","86.67%","Peve_00004611",-0.5,0.666666666666667,0.978262075707395,NA,NA,NA,NA,NA
"4607",4607,"Cluster_9149","Porites_evermani_scaffold_1295:82957-83892",151,-23.65,2,17,576,598,16,"75.00%","81.25%","Peve_00004680",0.645239967586468,0.553514780016831,0.978262075707395,NA,NA,NA,NA,NA
"4608",4608,"Cluster_9149","Porites_evermani_scaffold_130:28768-29670",149,-22.51,2,21,873,899,24,"70.83%","70.83%","Peve_00004785",-0.995915721613059,0.0575573399696703,0.978262075707395,NA,NA,NA,NA,NA
"4609",4609,"Cluster_9149","Porites_evermani_scaffold_130:28768-29670",149,-22.51,2,21,873,899,24,"70.83%","70.83%","Peve_00004788",-0.60397549183938,0.587164944110213,0.978262075707395,NA,NA,NA,NA,NA
"4610",4610,"Cluster_9149","Porites_evermani_scaffold_1311:70744-71744",153,-24.47,2,19,790,812,18,"72.22%","77.78%","Peve_00004947",-0.931944095681919,0.236223103645688,0.978262075707395,"P12259","Coagulation factor V (Activated protein C cofactor) (Proaccelerin, labile factor) [Cleaved into: Coagulation factor V heavy chain; Coagulation factor V light chain]","Homo sapiens (Human)","blood circulation [GO:0008015]; blood coagulation [GO:0007596]; blood coagulation, common pathway [GO:0072377]; blood coagulation, extrinsic pathway [GO:0007598]; proteolysis [GO:0006508]; response to vitamin K [GO:0032571]; zymogen activation [GO:0031638]","GO:0005507; GO:0005576; GO:0005615; GO:0005788; GO:0005794; GO:0005886; GO:0006508; GO:0007596; GO:0007598; GO:0008015; GO:0016020; GO:0030134; GO:0031091; GO:0031093; GO:0031638; GO:0032571; GO:0032991; GO:0033116; GO:0072377; GO:1903561; GO:1905370"
"4611",4611,"Cluster_9149","Porites_evermani_scaffold_132:223451-224451",164,-24.39,2,21,30,51,19,"68.42%","84.21%","Peve_00005079",-0.448782600065277,0.703715515260529,0.978262075707395,"Q5R5N8","DIS3-like exonuclease 1 (EC 3.1.13.-)","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","","GO:0000175; GO:0000177; GO:0003723"
"4612",4612,"Cluster_9149","Porites_evermani_scaffold_1323:34590-35590",148,-22.15,2,14,336,358,13,"76.92%","92.31%","Peve_00005124",-0.5,0.666666666666667,0.978262075707395,NA,NA,NA,NA,NA
"4613",4613,"Cluster_9149","Porites_evermani_scaffold_1324:61792-62792",146,-20.18,2,12,797,819,11,"90.91%","90.91%","Peve_00005143",-0.681403525049819,0.522739810735628,0.978262075707395,"O16374","Beta-1,4-galactosyltransferase galt-1 (EC 2.4.1.-)","Caenorhabditis elegans","N-glycan processing [GO:0006491]; protein galactosylation [GO:0042125]","GO:0003831; GO:0006491; GO:0032580; GO:0035250; GO:0042125; GO:0043229; GO:0046872"
"4614",4614,"Cluster_9149","Porites_evermani_scaffold_134:323540-324540",145,-20.64,2,17,42,61,15,"66.67%","86.67%","Peve_00005360",-0.593331131682641,0.595624961324403,0.978262075707395,NA,NA,NA,NA,NA
"4615",4615,"Cluster_9149","Porites_evermani_scaffold_134:323540-324540",159,-25.02,2,16,63,84,14,"85.71%","85.71%","Peve_00005360",-0.593331131682641,0.595624961324403,0.978262075707395,NA,NA,NA,NA,NA
"4616",4616,"Cluster_9149","Porites_evermani_scaffold_135:316704-317704",158,-24.13,2,21,210,235,23,"73.91%","73.91%","Peve_00005513",NA,NA,NA,NA,NA,NA,NA,NA
"4617",4617,"Cluster_9149","Porites_evermani_scaffold_1369:125364-126364",143,-21.53,2,13,565,587,12,"83.33%","83.33%","Peve_00005756",0.695935079619693,0.509980245774106,0.978262075707395,NA,NA,NA,NA,NA
"4618",4618,"Cluster_9149","Porites_evermani_scaffold_137:258672-259672",153,-23.33,2,18,328,349,16,"68.75%","81.25%","Peve_00005771",-0.5,0.666666666666667,0.978262075707395,NA,NA,NA,NA,NA
"4619",4619,"Cluster_9149","Porites_evermani_scaffold_1390:3374-4374",160,-24.3,2,13,973,994,11,"100.00%","100.00%","Peve_00006057",-0.806441862212245,0.402780729938402,0.978262075707395,"Q8NEM0","Microcephalin","Homo sapiens (Human)","bone development [GO:0060348]; cerebral cortex development [GO:0021987]; establishment of mitotic spindle orientation [GO:0000132]; mitotic cell cycle [GO:0000278]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuronal stem cell population maintenance [GO:0097150]; protein localization to centrosome [GO:0071539]; regulation of centrosome cycle [GO:0046605]; regulation of chromosome condensation [GO:0060623]; regulation of inflammatory response [GO:0050727]; regulation of kinase activity [GO:0043549]","GO:0000122; GO:0000132; GO:0000278; GO:0005654; GO:0005737; GO:0005815; GO:0021987; GO:0042802; GO:0043549; GO:0046605; GO:0050727; GO:0060348; GO:0060623; GO:0071539; GO:0097150"
"4620",4620,"Cluster_9149","Porites_evermani_scaffold_139:203635-204635",159,-22.26,2,21,397,420,21,"71.43%","76.19%","Peve_00006040",-0.675548829306145,0.527813505951373,0.978262075707395,"Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"4621",4621,"Cluster_9149","Porites_evermani_scaffold_1433:45922-46922",157,-21.38,2,21,778,799,20,"75.00%","80.00%","Peve_00006663",-0.537183751180469,0.638976337885844,0.978262075707395,"C3ZQF9","QRFP-like peptide receptor","Branchiostoma floridae (Florida lancelet) (Amphioxus)","cellular response to peptide [GO:1901653]; G protein-coupled receptor signaling pathway [GO:0007186]","GO:0004930; GO:0004983; GO:0005886; GO:0007186; GO:1901653"
"4622",4622,"Cluster_9149","Porites_evermani_scaffold_14:334765-335765",144,-20.23,2,17,980,999,15,"80.00%","80.00%","Peve_00006233",-0.661770236920006,0.539610874846421,0.978262075707395,"Q90YK3","L-gulonolactone oxidase (LGO) (EC 1.1.3.8) (L-gulono-gamma-lactone oxidase) (GLO)","Scyliorhinus torazame (Cloudy catshark)","L-ascorbic acid biosynthetic process [GO:0019853]","GO:0003885; GO:0005789; GO:0019853; GO:0050105; GO:0050660; GO:0071949"
"4623",4623,"Cluster_9149","Porites_evermani_scaffold_1450:55600-56600",157,-22.01,2,14,789,810,12,"91.67%","91.67%","Peve_00006860",-0.899871145993034,0.287320720902971,0.978262075707395,"Q91029","Protein Wnt-1","Gallus gallus (Chicken)","apoptotic process [GO:0006915]; BMP signaling pathway [GO:0030509]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; determination of dorsal identity [GO:0048263]; dorsal/ventral pattern formation [GO:0009953]; neuron differentiation [GO:0030182]; positive regulation of protein-containing complex assembly [GO:0031334]","GO:0005109; GO:0005125; GO:0005615; GO:0006915; GO:0009953; GO:0030182; GO:0030509; GO:0031334; GO:0045165; GO:0048263; GO:0060070"
"4624",4624,"Cluster_9149","Porites_evermani_scaffold_1462:56333-57333",143,-20.51,2,19,321,342,18,"66.67%","77.78%","Peve_00006989",-0.448913512017417,0.703622251627374,0.978262075707395,"P35546","Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment]","Mus musculus (Mouse)","activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; anatomical structure morphogenesis [GO:0009653]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657]","GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0006919; GO:0007156; GO:0007158; GO:0007169; GO:0007399; GO:0009410; GO:0009653; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030155; GO:0030182; GO:0030335; GO:0030424; GO:0030425; GO:0033141; GO:0033619; GO:0033630; GO:0033674; GO:0035799; GO:0035860; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045121; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0098797; GO:2001241"
"4625",4625,"Cluster_9149","Porites_evermani_scaffold_1477:48504-49504",148,-20.41,2,16,312,331,14,"78.57%","85.71%","Peve_00007165",-0.683706411627897,0.52073379459277,0.978262075707395,"Q5FWY3","Cytochrome c oxidase assembly factor 7B (Beta-lactamase hcp-like protein) (Sel1 repeat-containing protein 1B)","Xenopus laevis (African clawed frog)","","GO:0005758"
"4626",4626,"Cluster_9149","Porites_evermani_scaffold_1477:48568-49568",148,-20.41,2,16,248,267,14,"78.57%","85.71%","Peve_00007166",-0.163900653832127,0.895184698048193,0.999448381576871,"P27986","Phosphatidylinositol 3-kinase regulatory subunit alpha (PI3-kinase regulatory subunit alpha) (PI3K regulatory subunit alpha) (PtdIns-3-kinase regulatory subunit alpha) (Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha) (PI3-kinase subunit p85-alpha) (PtdIns-3-kinase regulatory subunit p85-alpha)","Homo sapiens (Human)","B cell differentiation [GO:0030183]; cellular glucose homeostasis [GO:0001678]; cellular response to insulin stimulus [GO:0032869]; cellular response to UV [GO:0034644]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; growth hormone receptor signaling pathway [GO:0060396]; immune response [GO:0006955]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; myeloid leukocyte migration [GO:0097529]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of stress fiber assembly [GO:0051497]; osteoclast differentiation [GO:0030316]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of glucose import [GO:0046326]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of RNA splicing [GO:0033120]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; response to endoplasmic reticulum stress [GO:0034976]; substrate adhesion-dependent cell spreading [GO:0034446]; T cell differentiation [GO:0030217]; transcription by RNA polymerase II [GO:0006366]","GO:0001678; GO:0001784; GO:0001953; GO:0002687; GO:0005068; GO:0005158; GO:0005159; GO:0005168; GO:0005634; GO:0005737; GO:0005801; GO:0005829; GO:0005886; GO:0005911; GO:0005942; GO:0005943; GO:0006366; GO:0006468; GO:0006606; GO:0006955; GO:0008286; GO:0008625; GO:0008630; GO:0010592; GO:0014065; GO:0016020; GO:0019903; GO:0030183; GO:0030217; GO:0030316; GO:0032760; GO:0032869; GO:0033120; GO:0034446; GO:0034644; GO:0034976; GO:0035014; GO:0036312; GO:0042307; GO:0043066; GO:0043125; GO:0043539; GO:0043548; GO:0043551; GO:0043559; GO:0043560; GO:0045671; GO:0045944; GO:0046326; GO:0046626; GO:0046854; GO:0046935; GO:0046982; GO:0048009; GO:0048471; GO:0050821; GO:0051491; GO:0051497; GO:0060396; GO:0097529; GO:0120183; GO:1900103; GO:1903078; GO:1990578"
"4627",4627,"Cluster_9149","Porites_evermani_scaffold_1478:27160-28160",151,-21.71,2,12,700,721,10,"90.00%","100.00%","Peve_00007191",NA,NA,NA,NA,NA,NA,NA,NA
"4628",4628,"Cluster_9149","Porites_evermani_scaffold_1485:53278-54125",149,-20.98,2,14,362,383,12,"75.00%","91.67%","Peve_00007276",0.846152478797227,0.357826383411105,0.978262075707395,"F1LZF0","Kelch-like protein 2 (Mayven)","Rattus norvegicus (Rat)","protein ubiquitination [GO:0016567]","GO:0001726; GO:0003779; GO:0005737; GO:0005829; GO:0015629; GO:0016567; GO:0030027; GO:0031463; GO:0042802"
"4629",4629,"Cluster_9149","Porites_evermani_scaffold_1485:53278-54125",149,-20.98,2,14,362,383,12,"75.00%","91.67%","Peve_00007277",NA,NA,NA,NA,NA,NA,NA,NA
"4630",4630,"Cluster_9149","Porites_evermani_scaffold_1487:24913-25913",146,-24.7,2,16,209,233,17,"70.59%","76.47%","Peve_00007306",-0.5,0.666666666666667,0.978262075707395,NA,NA,NA,NA,NA
"4631",4631,"Cluster_9149","Porites_evermani_scaffold_1491:26089-27089",161,-24.06,2,18,339,360,16,"75.00%","87.50%","Peve_00007360",-0.529822321657397,0.644517215501806,0.978262075707395,"Q9EQG7","Ectonucleotide pyrophosphatase/phosphodiesterase family member 5 (E-NPP 5) (NPP-5) (EC 3.1.-.-)","Mus musculus (Mouse)","cell communication [GO:0007154]; nucleotide catabolic process [GO:0009166]","GO:0000210; GO:0004551; GO:0005576; GO:0005886; GO:0007154; GO:0008270; GO:0009166; GO:0016020"
"4632",4632,"Cluster_9149","Porites_evermani_scaffold_1492:30621-31621",155,-20.6,2,16,103,124,14,"78.57%","85.71%","Peve_00007382",-0.681403525049819,0.522739810735628,0.978262075707395,"A0A481NSZ4",NA,NA,NA,NA
"4633",4633,"Cluster_9149","Porites_evermani_scaffold_149:75931-76073",155,-23.37,2,21,23,46,21,"61.90%","80.95%","Peve_00007329",-0.965643548290682,0.167359581462322,0.978262075707395,"B1L938","50S ribosomal protein L1","Thermotoga sp. (strain RQ2)","regulation of translation [GO:0006417]; translation [GO:0006412]","GO:0000049; GO:0003735; GO:0006412; GO:0006417; GO:0015934; GO:0019843"
"4634",4634,"Cluster_9149","Porites_evermani_scaffold_149:75931-76073",155,-23.37,2,21,23,46,21,"61.90%","80.95%","Peve_00007330",-0.982163871442232,0.120418454787647,0.978262075707395,"Q8CI66","Stomatin-like protein 1 (SLP-1)","Mus musculus (Mouse)","cellular response to leukemia inhibitory factor [GO:1990830]; lipid transport [GO:0006869]; negative regulation of acid-sensing ion channel activity [GO:1901586]; SMAD protein signal transduction [GO:0060395]","GO:0005886; GO:0006869; GO:0008200; GO:0031410; GO:0031902; GO:0045121; GO:0060395; GO:1901586; GO:1990830"
"4635",4635,"Cluster_9149","Porites_evermani_scaffold_1502:79799-80799",144,-21.8,2,18,452,476,19,"63.16%","73.68%","Peve_00007586",NA,NA,NA,"Q3UQ28","Peroxidasin homolog (EC 1.11.2.-) [Cleaved into: PXDN active fragment]","Mus musculus (Mouse)","angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; hydrogen peroxide catabolic process [GO:0042744]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979]","GO:0001525; GO:0001654; GO:0004601; GO:0005201; GO:0005604; GO:0005615; GO:0005783; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0030198; GO:0030199; GO:0031012; GO:0042744; GO:0043237; GO:0046872; GO:0051260; GO:0062023; GO:0070207; GO:0070831; GO:0071711; GO:0140825"
"4636",4636,"Cluster_9149","Porites_evermani_scaffold_1507:95365-96365",159,-25.46,2,21,310,333,21,"66.67%","80.95%","Peve_00007626",-0.798662208178576,0.411082868116261,0.978262075707395,NA,NA,NA,NA,NA
"4637",4637,"Cluster_9149","Porites_evermani_scaffold_1519:17776-18776",145,-20.62,2,15,160,182,14,"71.43%","85.71%","Peve_00007750",-0.5,0.666666666666667,0.978262075707395,NA,NA,NA,NA,NA
"4638",4638,"Cluster_9149","Porites_evermani_scaffold_152:255564-256564",148,-20.72,2,15,328,348,13,"76.92%","92.31%","Peve_00007765",-0.422473941648305,0.722323593539093,0.982187204976866,NA,NA,NA,NA,NA
"4639",4639,"Cluster_9149","Porites_evermani_scaffold_1528:56765-57765",151,-22.24,2,14,176,196,12,"91.67%","91.67%","Peve_00007849",-0.349940273032488,0.772403755653807,0.991550700921138,"Q58DT1","60S ribosomal protein L7","Bos taurus (Bovine)","maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]","GO:0000463; GO:0003723; GO:0003735; GO:0022625"
"4640",4640,"Cluster_9149","Porites_evermani_scaffold_1536:32602-33602",161,-24.06,2,19,555,577,18,"77.78%","83.33%","Peve_00007943",NA,NA,NA,NA,NA,NA,NA,NA
"4641",4641,"Cluster_9149","Porites_evermani_scaffold_155:112911-113911",147,-20.09,2,12,450,471,10,"80.00%","100.00%","Peve_00008098",NA,NA,NA,NA,NA,NA,NA,NA
"4642",4642,"Cluster_9149","Porites_evermani_scaffold_155:272750-273750",151,-21.06,2,16,825,846,14,"64.29%","92.86%","Peve_00008110",NA,NA,NA,NA,NA,NA,NA,NA
"4643",4643,"Cluster_9149","Porites_evermani_scaffold_1565:21850-22850",142,-21.75,2,20,389,406,18,"66.67%","72.22%","Peve_00008295",-0.423899943934883,0.721321630036407,0.981867681005495,NA,NA,NA,NA,NA
"4644",4644,"Cluster_9149","Porites_evermani_scaffold_1572:107-1107",161,-23.43,2,15,813,835,14,"92.86%","92.86%","Peve_00008395",-0.5,0.666666666666667,0.978262075707395,"Q8STF0","Calmodulin (CaM)","Strongylocentrotus intermedius (Sea urchin)","","GO:0005509"
"4645",4645,"Cluster_9149","Porites_evermani_scaffold_157:24728-25728",162,-24.97,2,20,442,464,19,"78.95%","78.95%","Peve_00008329",NA,NA,NA,NA,NA,NA,NA,NA
"4646",4646,"Cluster_9149","Porites_evermani_scaffold_157:260874-261874",156,-23.92,2,19,75,99,20,"75.00%","80.00%","Peve_00008374",-0.684818323628023,0.519763099918352,0.978262075707395,NA,NA,NA,NA,NA
"4647",4647,"Cluster_9149","Porites_evermani_scaffold_1584:78315-79315",143,-22.39,2,12,29,50,10,"70.00%","100.00%","Peve_00008562",-0.5,0.666666666666667,0.978262075707395,NA,NA,NA,NA,NA
"4648",4648,"Cluster_9149","Porites_evermani_scaffold_1589:78839-79839",155,-20.28,2,12,929,950,10,"100.00%","100.00%","Peve_00008600",-0.712937296849793,0.49472880886529,0.978262075707395,"Q99471","Prefoldin subunit 5 (Myc modulator 1) (c-Myc-binding protein Mm-1)","Homo sapiens (Human)","negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of DNA-templated transcription [GO:0045892]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of DNA-templated transcription [GO:0006355]; retina development in camera-type eye [GO:0060041]","GO:0001540; GO:0003714; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0006457; GO:0016272; GO:0045111; GO:0045892; GO:0050821; GO:0051082; GO:0060041; GO:0090090; GO:1905907"
"4649",4649,"Cluster_9149","Porites_evermani_scaffold_1596:30977-31977",151,-21.77,2,18,334,354,16,"75.00%","81.25%","Peve_00008713",NA,NA,NA,NA,NA,NA,NA,NA
"4650",4650,"Cluster_9149","Porites_evermani_scaffold_1596:42536-43536",151,-21.77,2,18,334,354,16,"75.00%","81.25%","Peve_00008714",NA,NA,NA,"Q9TLY2","Protein CfxQ homolog","Cyanidium caldarium (Red alga)","","GO:0005524; GO:0009507; GO:0016887"
"4651",4651,"Cluster_9149","Porites_evermani_scaffold_1597:111600-112600",147,-20.21,2,12,475,496,10,"90.00%","90.00%","Peve_00008723",-0.925971657018979,0.246496315365134,0.978262075707395,NA,NA,NA,NA,NA
"4652",4652,"Cluster_9149","Porites_evermani_scaffold_1610:40482-41482",153,-22.76,2,20,184,204,18,"66.67%","83.33%","Peve_00008973",-0.633881612907115,0.562921277143593,0.978262075707395,"P53810","Phosphatidylinositol transfer protein alpha isoform (PI-TP-alpha) (PtdIns transfer protein alpha) (PtdInsTP alpha)","Mus musculus (Mouse)","axonogenesis [GO:0007409]; phospholipid transport [GO:0015914]","GO:0000062; GO:0005543; GO:0005634; GO:0005737; GO:0005829; GO:0007409; GO:0008289; GO:0008525; GO:0008526; GO:0015914; GO:0016020; GO:0031210; GO:0035091; GO:0043209; GO:0070540; GO:0120019"
"4653",4653,"Cluster_9149","Porites_evermani_scaffold_1628:81063-82063",143,-23.65,2,16,609,630,14,"64.29%","78.57%","Peve_00009135",-0.398140085131335,0.739311582241672,0.986697151420032,"Q9NS73","MAP3K12-binding inhibitory protein 1 (MAPK upstream kinase-binding inhibitory protein) (MUK-binding inhibitory protein)","Homo sapiens (Human)","histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; positive regulation of gene expression [GO:0010628]; positive regulation of JNK cascade [GO:0046330]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of DNA-templated transcription [GO:0006355]; regulation of embryonic development [GO:0045995]; regulation of histone deacetylation [GO:0031063]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tubulin deacetylation [GO:0090043]","GO:0004860; GO:0005654; GO:0005730; GO:0005829; GO:0006355; GO:0006357; GO:0010628; GO:0031063; GO:0042802; GO:0043966; GO:0044154; GO:0045995; GO:0046330; GO:0051302; GO:0051726; GO:0072686; GO:0090043; GO:0140672"
"4654",4654,"Cluster_9149","Porites_evermani_scaffold_1631:18904-19063",147,-20.13,2,21,9,32,21,"66.67%","66.67%","Peve_00009209",NA,NA,NA,"P40724","ATP-dependent DNA helicase RecQ (EC 3.6.4.12)","Salmonella typhimurium (strain LT2 / SGSC1412 / ATCC 700720)","DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; SOS response [GO:0009432]","GO:0003677; GO:0005524; GO:0005694; GO:0005737; GO:0006260; GO:0006281; GO:0006310; GO:0009378; GO:0009432; GO:0016887; GO:0030894; GO:0032508; GO:0043138; GO:0043590"
"4655",4655,"Cluster_9149","Porites_evermani_scaffold_163:355828-356828",143,-20.14,2,18,672,696,19,"68.42%","73.68%","Peve_00009150",0.99584540001013,0.058051066553807,0.978262075707395,NA,NA,NA,NA,NA
"4656",4656,"Cluster_9149","Porites_evermani_scaffold_163:356130-357130",143,-20.14,2,18,370,394,19,"68.42%","73.68%","Peve_00009152",-0.460696171451473,0.695199563313721,0.978262075707395,"Q9N126","Retinol dehydrogenase 8 (EC 1.1.1.300) (Photoreceptor outer segment all-trans retinol dehydrogenase)","Bos taurus (Bovine)","estrogen biosynthetic process [GO:0006703]; response to stimulus [GO:0050896]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601]","GO:0004303; GO:0004745; GO:0005829; GO:0006703; GO:0007601; GO:0016491; GO:0042572; GO:0042622; GO:0050896; GO:0052650"
"4657",4657,"Cluster_9149","Porites_evermani_scaffold_164:133796-134796",153,-21.22,2,20,378,398,18,"72.22%","77.78%","Peve_00009284",0.00809972833720884,0.994843496406094,0.999448381576871,"Q6ZWL3","Cytochrome P450 4V2 (Docosahexaenoic acid omega-hydroxylase CYP4V2) (EC 1.14.14.79) (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80)","Homo sapiens (Human)","fatty acid omega-oxidation [GO:0010430]; response to stimulus [GO:0050896]; retinoid metabolic process [GO:0001523]; sterol metabolic process [GO:0016125]; visual perception [GO:0007601]","GO:0001523; GO:0004497; GO:0005506; GO:0005789; GO:0007601; GO:0010430; GO:0016125; GO:0020037; GO:0050896; GO:0102033"
"4658",4658,"Cluster_9149","Porites_evermani_scaffold_1648:0-297",147,-22.51,2,12,77,98,10,"80.00%","100.00%","Peve_00009368",-0.5,0.666666666666667,0.978262075707395,NA,NA,NA,NA,NA
"4659",4659,"Cluster_9149","Porites_evermani_scaffold_165:209548-210548",161,-21.17,2,19,232,254,18,"77.78%","83.33%","Peve_00009391",NA,NA,NA,NA,NA,NA,NA,NA
"4660",4660,"Cluster_9149","Porites_evermani_scaffold_1653:104510-105510",156,-23.69,2,21,746,767,19,"63.16%","78.95%","Peve_00009450",-0.374922056269857,0.755338938647715,0.988219883885475,NA,NA,NA,NA,NA
"4661",4661,"Cluster_9149","Porites_evermani_scaffold_1665:52446-53446",154,-23.82,2,19,222,243,17,"70.59%","76.47%","Peve_00009564",NA,NA,NA,NA,NA,NA,NA,NA
"4662",4662,"Cluster_9149","Porites_evermani_scaffold_1665:52446-53446",154,-23.82,2,19,556,577,17,"70.59%","76.47%","Peve_00009564",NA,NA,NA,NA,NA,NA,NA,NA
"4663",4663,"Cluster_9149","Porites_evermani_scaffold_1670:20727-21727",140,-20.26,2,9,96,117,7,"100.00%","100.00%","Peve_00009627",NA,NA,NA,NA,NA,NA,NA,NA
"4664",4664,"Cluster_9149","Porites_evermani_scaffold_168:276987-277987",150,-21.59,2,18,722,741,16,"75.00%","81.25%","Peve_00009730",-0.580553092872348,0.605672737186244,0.978262075707395,"Q5ZL33","Serine-threonine kinase receptor-associated protein","Gallus gallus (Chicken)","alternative mRNA splicing, via spliceosome [GO:0000380]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron differentiation [GO:0030182]; spliceosomal snRNP assembly [GO:0000387]","GO:0000122; GO:0000380; GO:0000387; GO:0003729; GO:0004857; GO:0005102; GO:0005634; GO:0005829; GO:0030182; GO:0030277; GO:0030512; GO:0032797; GO:0034719; GO:0140416; GO:1990447"
"4665",4665,"Cluster_9149","Porites_evermani_scaffold_1692:30840-31840",163,-22.77,2,21,131,153,20,"70.00%","85.00%","Peve_00009906",NA,NA,NA,NA,NA,NA,NA,NA
"4666",4666,"Cluster_9149","Porites_evermani_scaffold_1696:43245-44245",152,-23.5,2,15,917,937,13,"84.62%","92.31%","Peve_00009939",NA,NA,NA,NA,NA,NA,NA,NA
"4667",4667,"Cluster_9149","Porites_evermani_scaffold_171:239022-239742",163,-27.15,2,18,545,565,16,"87.50%","87.50%","Peve_00010153",-0.995107118893319,0.0630020513832668,0.978262075707395,NA,NA,NA,NA,NA
"4668",4668,"Cluster_9149","Porites_evermani_scaffold_1748:100427-101427",146,-24.75,2,21,570,597,25,"60.00%","72.00%","Peve_00010550",NA,NA,NA,NA,NA,NA,NA,NA
"4669",4669,"Cluster_9149","Porites_evermani_scaffold_178:73265-74265",147,-22.65,2,14,120,140,12,"83.33%","91.67%","Peve_00010881",NA,NA,NA,NA,NA,NA,NA,NA
"4670",4670,"Cluster_9149","Porites_evermani_scaffold_1800:74074-75074",155,-20.9,2,12,495,516,10,"100.00%","100.00%","Peve_00011185",NA,NA,NA,NA,NA,NA,NA,NA
"4671",4671,"Cluster_9149","Porites_evermani_scaffold_1829:79755-80755",153,-20.38,2,18,713,734,16,"75.00%","75.00%","Peve_00011479",-0.5,0.666666666666667,0.978262075707395,NA,NA,NA,NA,NA
"4672",4672,"Cluster_9149","Porites_evermani_scaffold_1840:21072-22072",146,-20.69,2,18,239,258,16,"75.00%","75.00%","Peve_00011601",NA,NA,NA,NA,NA,NA,NA,NA
"4673",4673,"Cluster_9149","Porites_evermani_scaffold_184:291482-292482",149,-21.89,2,14,506,527,12,"83.33%","83.33%","Peve_00011585",-0.579206747951161,0.606724790684081,0.978262075707395,NA,NA,NA,NA,NA
"4674",4674,"Cluster_9149","Porites_evermani_scaffold_1848:6787-7787",154,-21.52,2,20,171,193,19,"68.42%","78.95%","Peve_00011667",NA,NA,NA,NA,NA,NA,NA,NA
"4675",4675,"Cluster_9149","Porites_evermani_scaffold_185:242618-243618",152,-21.31,2,21,516,537,19,"63.16%","73.68%","Peve_00011719",-0.5,0.666666666666667,0.978262075707395,NA,NA,NA,NA,NA
"4676",4676,"Cluster_9149","Porites_evermani_scaffold_18:808568-809568",163,-26.55,2,17,41,63,16,"87.50%","87.50%","Peve_00011108",-0.657889821471925,0.542898483778192,0.978262075707395,"P60522","Gamma-aminobutyric acid receptor-associated protein-like 2 (GABA(A) receptor-associated protein-like 2) (Ganglioside expression factor 2) (GEF-2) (Golgi-associated ATPase enhancer of 16 kDa) (GATE-16)","Rattus norvegicus (Rat)","autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; macroautophagy [GO:0016236]; negative regulation of proteasomal protein catabolic process [GO:1901799]; protein localization to endoplasmic reticulum [GO:0070972]; protein transport [GO:0015031]","GO:0000045; GO:0000139; GO:0000421; GO:0000422; GO:0005737; GO:0005776; GO:0005789; GO:0005794; GO:0005829; GO:0006995; GO:0015031; GO:0016236; GO:0031410; GO:0031625; GO:0070972; GO:1901799"
"4677",4677,"Cluster_9149","Porites_evermani_scaffold_189:331947-332947",141,-22.48,2,19,913,938,21,"61.90%","66.67%","Peve_00012139",-0.866287904686218,0.332998954689863,0.978262075707395,"Q9D4H1","Exocyst complex component 2 (Exocyst complex component Sec5)","Mus musculus (Mouse)","exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; regulation of entry of bacterium into host cell [GO:2000535]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522]","GO:0000145; GO:0000281; GO:0005886; GO:0006887; GO:0006893; GO:0006904; GO:0015031; GO:0019901; GO:0031267; GO:0045921; GO:0047485; GO:0090148; GO:0090522; GO:0090543; GO:2000535"
"4678",4678,"Cluster_9149","Porites_evermani_scaffold_1895:69976-70976",159,-26.3,2,21,17,39,20,"65.00%","85.00%","Peve_00012181",-0.820971042616331,0.386865363305344,0.978262075707395,"Q8K2J9","BTB/POZ domain-containing protein 6","Mus musculus (Mouse)","neurogenesis [GO:0022008]","GO:0005829; GO:0022008"
"4679",4679,"Cluster_9149","Porites_evermani_scaffold_1895:86929-87929",149,-22.18,2,17,322,341,15,"73.33%","86.67%","Peve_00012183",-0.696321001181866,0.509638026428254,0.978262075707395,"P42768","Actin nucleation-promoting factor WAS (Wiskott-Aldrich syndrome protein) (WASp)","Homo sapiens (Human)","actin filament polymerization [GO:0030041]; actin filament-based movement [GO:0030048]; actin polymerization or depolymerization [GO:0008154]; blood coagulation [GO:0007596]; Cdc42 protein signal transduction [GO:0032488]; cellular response to type II interferon [GO:0071346]; defense response [GO:0006952]; endosomal transport [GO:0016197]; epidermis development [GO:0008544]; immune response [GO:0006955]; negative regulation of cell motility [GO:2000146]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of lamellipodium assembly [GO:0010591]; regulation of stress fiber assembly [GO:0051492]; regulation of T cell antigen processing and presentation [GO:0002625]; T cell activation [GO:0042110]","GO:0002625; GO:0003779; GO:0005634; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0006952; GO:0006955; GO:0007596; GO:0008064; GO:0008154; GO:0008544; GO:0010591; GO:0012506; GO:0015629; GO:0016197; GO:0017124; GO:0019901; GO:0030041; GO:0030048; GO:0030695; GO:0031267; GO:0032488; GO:0035861; GO:0042110; GO:0042802; GO:0043274; GO:0045335; GO:0045944; GO:0051492; GO:0051497; GO:0065003; GO:0070062; GO:0071346; GO:1905168; GO:2000146"
"4680",4680,"Cluster_9149","Porites_evermani_scaffold_1895:86929-87929",149,-22.18,2,17,740,759,15,"73.33%","86.67%","Peve_00012183",-0.696321001181866,0.509638026428254,0.978262075707395,"P42768","Actin nucleation-promoting factor WAS (Wiskott-Aldrich syndrome protein) (WASp)","Homo sapiens (Human)","actin filament polymerization [GO:0030041]; actin filament-based movement [GO:0030048]; actin polymerization or depolymerization [GO:0008154]; blood coagulation [GO:0007596]; Cdc42 protein signal transduction [GO:0032488]; cellular response to type II interferon [GO:0071346]; defense response [GO:0006952]; endosomal transport [GO:0016197]; epidermis development [GO:0008544]; immune response [GO:0006955]; negative regulation of cell motility [GO:2000146]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of lamellipodium assembly [GO:0010591]; regulation of stress fiber assembly [GO:0051492]; regulation of T cell antigen processing and presentation [GO:0002625]; T cell activation [GO:0042110]","GO:0002625; GO:0003779; GO:0005634; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0006952; GO:0006955; GO:0007596; GO:0008064; GO:0008154; GO:0008544; GO:0010591; GO:0012506; GO:0015629; GO:0016197; GO:0017124; GO:0019901; GO:0030041; GO:0030048; GO:0030695; GO:0031267; GO:0032488; GO:0035861; GO:0042110; GO:0042802; GO:0043274; GO:0045335; GO:0045944; GO:0051492; GO:0051497; GO:0065003; GO:0070062; GO:0071346; GO:1905168; GO:2000146"
"4681",4681,"Cluster_9149","Porites_evermani_scaffold_1898:68217-69217",150,-21.59,2,18,863,882,16,"75.00%","81.25%","Peve_00012208",-0.999327894094028,0.0233420128583658,0.848872825778705,"Q9NZJ4","Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29)","Homo sapiens (Human)","negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]","GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0042802; GO:0051087; GO:0070628; GO:0070852; GO:0090084"
"4682",4682,"Cluster_9149","Porites_evermani_scaffold_190:283919-284296",146,-20.99,2,12,30,52,11,"90.91%","90.91%","Peve_00012301",0.799791364037855,0.40988684774031,0.978262075707395,"Q95J53","BTB/POZ domain-containing protein 16","Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)","",""
"4683",4683,"Cluster_9149","Porites_evermani_scaffold_190:283919-284296",146,-20.99,2,12,30,52,11,"90.91%","90.91%","Peve_00012302",-0.999865571060301,0.0104386989464617,0.634381120973208,NA,NA,NA,NA,NA
"4684",4684,"Cluster_9149","Porites_evermani_scaffold_1903:73367-74367",153,-21.21,2,14,959,980,12,"75.00%","100.00%","Peve_00012338",-0.5,0.666666666666667,0.978262075707395,NA,NA,NA,NA,NA
"4685",4685,"Cluster_9149","Porites_evermani_scaffold_191:250133-251133",145,-20.88,2,20,505,531,23,"65.22%","69.57%","Peve_00012404",0.999998523194906,0.00109409936293585,0.275560959970807,NA,NA,NA,NA,NA
"4686",4686,"Cluster_9149","Porites_evermani_scaffold_1916:36059-37059",145,-20.86,2,10,721,742,8,"100.00%","100.00%","Peve_00012478",0.0722108419383955,0.953989104427768,0.999448381576871,NA,NA,NA,NA,NA
"4687",4687,"Cluster_9149","Porites_evermani_scaffold_1923:2853-3853",148,-20.74,2,18,111,133,17,"70.59%","76.47%","Peve_00012545",-0.475414829971381,0.684595966658222,0.978262075707395,"Q8C1F5","Tetratricopeptide repeat protein 16 (TPR repeat protein 16)","Mus musculus (Mouse)","",""
"4688",4688,"Cluster_9149","Porites_evermani_scaffold_194:101567-102567",147,-21.2,2,14,286,306,12,"83.33%","91.67%","Peve_00012710",-0.660805018015756,0.540430033637096,0.978262075707395,"Q18PE0","Protein Dok-7 (Downstream of tyrosine kinase 7)","Mus musculus (Mouse)","neuromuscular junction development [GO:0007528]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]; protein phosphorylation [GO:0006468]; receptor clustering [GO:0043113]","GO:0001934; GO:0005654; GO:0005739; GO:0005886; GO:0006468; GO:0007528; GO:0019901; GO:0031594; GO:0035091; GO:0043113; GO:0061098"
"4689",4689,"Cluster_9149","Porites_evermani_scaffold_197:104174-105111",151,-24.46,2,16,666,687,14,"71.43%","85.71%","Peve_00013017",-0.5,0.666666666666667,0.978262075707395,NA,NA,NA,NA,NA
"4690",4690,"Cluster_9149","Porites_evermani_scaffold_197:104174-105111",151,-24.46,2,16,666,687,14,"71.43%","85.71%","Peve_00013018",NA,NA,NA,NA,NA,NA,NA,NA
"4691",4691,"Cluster_9149","Porites_evermani_scaffold_1992:7767-8767",153,-20.78,2,14,620,641,12,"83.33%","91.67%","Peve_00013274",-0.205687530108754,0.868113895989673,0.997061152673081,NA,NA,NA,NA,NA
"4692",4692,"Cluster_9149","Porites_evermani_scaffold_2006:68233-69233",149,-23.83,2,16,163,183,14,"78.57%","85.71%","Peve_00013624",NA,NA,NA,NA,NA,NA,NA,NA
"4693",4693,"Cluster_9149","Porites_evermani_scaffold_2007:69211-70211",159,-23.2,2,19,204,223,17,"82.35%","82.35%","Peve_00013631",-0.5,0.666666666666667,0.978262075707395,NA,NA,NA,NA,NA
"4694",4694,"Cluster_9149","Porites_evermani_scaffold_2008:16402-17402",150,-20.36,2,19,972,993,17,"64.71%","76.47%","Peve_00013637",NA,NA,NA,NA,NA,NA,NA,NA
"4695",4695,"Cluster_9149","Porites_evermani_scaffold_20:231387-232387",148,-21.51,2,15,422,442,13,"84.62%","84.62%","Peve_00013526",-0.974521632314095,0.14401487496199,0.978262075707395,NA,NA,NA,NA,NA
"4696",4696,"Cluster_9149","Porites_evermani_scaffold_2025:19966-20966",152,-21.3,2,14,225,247,13,"84.62%","92.31%","Peve_00013815",-0.5,0.666666666666667,0.978262075707395,NA,NA,NA,NA,NA
"4697",4697,"Cluster_9149","Porites_evermani_scaffold_2036:40488-41488",147,-22.51,2,12,334,355,10,"80.00%","100.00%","Peve_00013917",-0.5,0.666666666666667,0.978262075707395,NA,NA,NA,NA,NA
"4698",4698,"Cluster_9149","Porites_evermani_scaffold_2061:87936-88936",143,-20.34,2,14,761,781,12,"75.00%","91.67%","Peve_00014176",-0.662581529476592,0.538921629453404,0.978262075707395,NA,NA,NA,NA,NA
"4699",4699,"Cluster_9149","Porites_evermani_scaffold_2064:63565-63947",150,-20.25,2,19,286,307,17,"58.82%","82.35%","Peve_00014195",-0.367185002377005,0.760643183396708,0.9884252792384,"Q9Y4D2","Diacylglycerol lipase-alpha (DAGL-alpha) (DGL-alpha) (EC 3.1.1.116) (Neural stem cell-derived dendrite regulator) (Sn1-specific diacylglycerol lipase alpha)","Homo sapiens (Human)","arachidonic acid metabolic process [GO:0019369]; diacylglycerol catabolic process [GO:0046340]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; lipid catabolic process [GO:0016042]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; regulation of neuroinflammatory response [GO:0150077]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]","GO:0004465; GO:0004806; GO:0005737; GO:0005886; GO:0007216; GO:0007405; GO:0016042; GO:0016298; GO:0019369; GO:0022008; GO:0031901; GO:0032590; GO:0032591; GO:0042136; GO:0043196; GO:0045211; GO:0046340; GO:0046872; GO:0047372; GO:0071926; GO:0098839; GO:0098921; GO:0150077"
"4700",4700,"Cluster_9149","Porites_evermani_scaffold_2064:63565-63947",150,-20.25,2,19,286,307,17,"58.82%","82.35%","Peve_00014191",-0.963142207561919,0.173381523664775,0.978262075707395,"O13024","Inner centromere protein A (XL-INCENP) (xINC) (xIncenp) (Mitotic phosphoprotein 130)","Xenopus laevis (African clawed frog)","chromosome segregation [GO:0007059]; mitotic cytokinesis [GO:0000281]; spindle assembly [GO:0051225]","GO:0000281; GO:0000775; GO:0000776; GO:0005634; GO:0005694; GO:0005721; GO:0005737; GO:0005819; GO:0005874; GO:0007059; GO:0019901; GO:0030496; GO:0032133; GO:0051225"
"4701",4701,"Cluster_9149","Porites_evermani_scaffold_2067:60672-61672",152,-26.19,2,18,415,439,19,"68.42%","78.95%","Peve_00014210",-0.731733971643901,0.477422703832264,0.978262075707395,"Q92626","Peroxidasin homolog (EC 1.11.2.-) (Melanoma-associated antigen MG50) (Peroxidasin 1) (hsPxd01) (Vascular peroxidase 1) (p53-responsive gene 2 protein) [Cleaved into: PXDN active fragment]","Homo sapiens (Human)","angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; hydrogen peroxide catabolic process [GO:0042744]; immune response [GO:0006955]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979]","GO:0001525; GO:0001654; GO:0004601; GO:0005152; GO:0005201; GO:0005576; GO:0005604; GO:0005615; GO:0005783; GO:0006955; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0030198; GO:0030199; GO:0031012; GO:0042744; GO:0043237; GO:0046872; GO:0051260; GO:0062023; GO:0070062; GO:0070207; GO:0070831; GO:0071711; GO:0140825"
"4702",4702,"Cluster_9149","Porites_evermani_scaffold_209:134407-135407",146,-20.35,2,20,308,330,19,"63.16%","73.68%","Peve_00014451",1,0,0,NA,NA,NA,NA,NA
"4703",4703,"Cluster_9149","Porites_evermani_scaffold_209:333075-334075",145,-21.01,2,20,505,530,22,"59.09%","77.27%","Peve_00014427",-0.450765192264071,0.702302350041961,0.978262075707395,"O14662","Syntaxin-16 (Syn16)","Homo sapiens (Human)","endocytic recycling [GO:0032456]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]","GO:0000139; GO:0000149; GO:0005484; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0005925; GO:0006886; GO:0006906; GO:0012505; GO:0016020; GO:0019905; GO:0030672; GO:0031201; GO:0031985; GO:0032456; GO:0032588; GO:0042147; GO:0043231; GO:0048278; GO:0048471"
"4704",4704,"Cluster_9149","Porites_evermani_scaffold_2095:87576-88576",153,-22.05,2,14,60,81,12,"75.00%","100.00%","Peve_00014483",-0.808497636030808,0.400562166244085,0.978262075707395,"F1QCP6","Tafazzin (Taz) (EC 2.3.1.-)","Danio rerio (Zebrafish) (Brachydanio rerio)","cardiolipin acyl-chain remodeling [GO:0035965]; cardiolipin metabolic process [GO:0032048]; heart development [GO:0007507]; heart looping [GO:0001947]; inner mitochondrial membrane organization [GO:0007007]; mitophagy [GO:0000423]; positive regulation of heart contraction [GO:0045823]","GO:0000423; GO:0001947; GO:0005739; GO:0005741; GO:0005743; GO:0007007; GO:0007507; GO:0008374; GO:0031966; GO:0032048; GO:0035965; GO:0045823; GO:0047184"
"4705",4705,"Cluster_9149","Porites_evermani_scaffold_2096:73765-74765",149,-21.95,2,18,138,157,16,"81.25%","81.25%","Peve_00014488",-0.5,0.666666666666667,0.978262075707395,NA,NA,NA,NA,NA
"4706",4706,"Cluster_9149","Porites_evermani_scaffold_2107:32005-33005",146,-20.55,2,21,413,433,19,"57.89%","78.95%","Peve_00014649",-0.674147763812466,0.529022176762571,0.978262075707395,"B8WI85","Uncharacterized skeletal organic matrix protein 7 (Uncharacterized SOMP-7)","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0005576"
"4707",4707,"Cluster_9149","Porites_evermani_scaffold_2:1144979-1145979",144,-22.19,2,14,624,646,13,"69.23%","92.31%","Peve_00013398",0.927222025966289,0.24437956642768,0.978262075707395,NA,NA,NA,NA,NA
"4708",4708,"Cluster_9149","Porites_evermani_scaffold_2117:30053-31053",160,-22.39,2,21,337,358,19,"73.68%","73.68%","Peve_00014732",0.588737986765025,0.599249967001897,0.978262075707395,"Q96KE9","BTB/POZ domain-containing protein 6 (Lens BTB domain protein)","Homo sapiens (Human)","neurogenesis [GO:0022008]","GO:0005829; GO:0022008"
"4709",4709,"Cluster_9149","Porites_evermani_scaffold_2122:48776-49776",155,-20.41,2,17,770,792,16,"81.25%","81.25%","Peve_00014797",-0.5,0.666666666666667,0.978262075707395,"Q9BUQ8","Probable ATP-dependent RNA helicase DDX23 (EC 3.6.4.13) (100 kDa U5 snRNP-specific protein) (DEAD box protein 23) (PRP28 homolog) (U5-100kD)","Homo sapiens (Human)","cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; R-loop processing [GO:0062176]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]","GO:0000354; GO:0000375; GO:0000398; GO:0000785; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005682; GO:0005730; GO:0008380; GO:0016887; GO:0046540; GO:0062176; GO:0070062; GO:0071013"
"4710",4710,"Cluster_9149","Porites_evermani_scaffold_2185:72829-73829",156,-21.62,2,14,637,659,13,"92.31%","92.31%","Peve_00015353",-0.607762056715938,0.584134884310429,0.978262075707395,"Q8JI28","Tolloid-like protein 1 (EC 3.4.24.-) (Metalloprotease xolloid-like) (Xenopus tolloid-like protein 1) (Xlr)","Xenopus laevis (African clawed frog)","cell differentiation [GO:0030154]; proteolysis [GO:0006508]","GO:0004222; GO:0005509; GO:0005576; GO:0006508; GO:0008270; GO:0030154"
"4711",4711,"Cluster_9149","Porites_evermani_scaffold_2188:38110-39110",158,-26.01,2,20,966,990,21,"66.67%","80.95%","Peve_00015379",NA,NA,NA,NA,NA,NA,NA,NA
"4712",4712,"Cluster_9149","Porites_evermani_scaffold_2188:79269-79404",150,-23.58,2,16,102,126,17,"76.47%","76.47%","Peve_00015382",0.322790466437021,0.790758170179273,0.995934364227446,"Q9BU70","tRNA (adenine(37)-N6)-methyltransferase (EC 2.1.1.-) (tRNA methyltransferase O)","Homo sapiens (Human)","tRNA methylation [GO:0030488]","GO:0030488; GO:0089715"
"4713",4713,"Cluster_9149","Porites_evermani_scaffold_2188:79269-79404",150,-23.58,2,16,102,126,17,"76.47%","76.47%","Peve_00015385",-0.930330240879618,0.239040531919057,0.978262075707395,NA,NA,NA,NA,NA
"4714",4714,"Cluster_9149","Porites_evermani_scaffold_221:269798-270798",151,-21.38,2,18,257,281,19,"73.68%","78.95%","Peve_00015671",-0.587942119073159,0.599876551999851,0.978262075707395,NA,NA,NA,NA,NA
"4715",4715,"Cluster_9149","Porites_evermani_scaffold_2214:16300-17300",167,-26.85,2,21,519,541,20,"75.00%","85.00%","Peve_00015705",0.116309937356937,0.92578682231128,0.999448381576871,"Q96S06","Lipase maturation factor 1 (Transmembrane protein 112)","Homo sapiens (Human)","protein maturation [GO:0051604]; triglyceride metabolic process [GO:0006641]","GO:0005789; GO:0006641; GO:0051604"
"4716",4716,"Cluster_9149","Porites_evermani_scaffold_2214:18335-19335",167,-26.85,2,21,318,340,20,"75.00%","85.00%","Peve_00015711",0.981189009548116,0.123675622453489,0.978262075707395,"Q3U3R4","Lipase maturation factor 1 (Transmembrane protein 112)","Mus musculus (Mouse)","chylomicron remnant clearance [GO:0034382]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; positive regulation of lipoprotein lipase activity [GO:0051006]; protein glycosylation [GO:0006486]; protein maturation [GO:0051604]; protein secretion [GO:0009306]; regulation of cholesterol metabolic process [GO:0090181]; regulation of triglyceride metabolic process [GO:0090207]; triglyceride metabolic process [GO:0006641]","GO:0005789; GO:0006486; GO:0006641; GO:0006888; GO:0009306; GO:0034382; GO:0051006; GO:0051604; GO:0090181; GO:0090207"
"4717",4717,"Cluster_9149","Porites_evermani_scaffold_2222:25620-26620",152,-22.24,2,18,701,725,19,"68.42%","78.95%","Peve_00015799",0.00889263602931692,0.994338697458596,0.999448381576871,"Q9BZJ0","Crooked neck-like protein 1 (Crooked neck homolog) (hCrn)","Homo sapiens (Human)","mRNA splicing, via spliceosome [GO:0000398]; spliceosomal complex assembly [GO:0000245]","GO:0000245; GO:0000398; GO:0000974; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0016607; GO:0071007; GO:0071013; GO:0071014"
"4718",4718,"Cluster_9149","Porites_evermani_scaffold_2228:34897-35897",156,-24.03,2,20,524,543,18,"77.78%","77.78%","Peve_00015839",NA,NA,NA,NA,NA,NA,NA,NA
"4719",4719,"Cluster_9149","Porites_evermani_scaffold_2228:35212-36212",156,-24.03,2,20,209,228,18,"77.78%","77.78%","Peve_00015841",NA,NA,NA,NA,NA,NA,NA,NA
"4720",4720,"Cluster_9149","Porites_evermani_scaffold_2252:78000-79000",147,-22.51,2,12,598,619,10,"80.00%","100.00%","Peve_00016076",0.488412332934084,0.675152420648746,0.978262075707395,NA,NA,NA,NA,NA
"4721",4721,"Cluster_9149","Porites_evermani_scaffold_2252:78501-79501",147,-22.51,2,12,97,118,10,"80.00%","100.00%","Peve_00016077",NA,NA,NA,NA,NA,NA,NA,NA
"4722",4722,"Cluster_9149","Porites_evermani_scaffold_225:330409-331409",154,-24.36,2,16,644,666,15,"80.00%","86.67%","Peve_00016050",-0.5,0.666666666666667,0.978262075707395,"P21555","Neuropeptide Y receptor type 1 (NPY1-R) (FC5)","Rattus norvegicus (Rat)","aging [GO:0007568]; feeding behavior [GO:0007631]; glucose metabolic process [GO:0006006]; locomotory behavior [GO:0007626]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of hormone secretion [GO:0046888]; neuropeptide signaling pathway [GO:0007218]; outflow tract morphogenesis [GO:0003151]; peristalsis [GO:0030432]; positive regulation of vasoconstriction [GO:0045907]; regulation of blood pressure [GO:0008217]; regulation of multicellular organism growth [GO:0040014]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to estradiol [GO:0032355]; sensory perception of pain [GO:0019233]; synaptic signaling via neuropeptide [GO:0099538]","GO:0001601; GO:0001602; GO:0003151; GO:0004983; GO:0005829; GO:0005886; GO:0006006; GO:0007218; GO:0007568; GO:0007626; GO:0007631; GO:0008021; GO:0008188; GO:0008217; GO:0019233; GO:0030424; GO:0030432; GO:0032355; GO:0040014; GO:0042734; GO:0042923; GO:0043005; GO:0045907; GO:0046888; GO:0051481; GO:0098978; GO:0098992; GO:0099509; GO:0099538; GO:2000300"
"4723",4723,"Cluster_9149","Porites_evermani_scaffold_2253:73293-74293",147,-23.08,2,18,298,322,19,"68.42%","78.95%","Peve_00016084",-0.194376355413675,0.875463396425795,0.99763356481098,"B2RW38","Cilia- and flagella-associated protein 58","Mus musculus (Mouse)","cilium assembly [GO:0060271]; flagellated sperm motility [GO:0030317]; Notch signaling pathway [GO:0007219]; protein localization to motile cilium [GO:0120229]; sperm axoneme assembly [GO:0007288]; sperm flagellum assembly [GO:0120316]; sperm mitochondrial sheath assembly [GO:0120317]","GO:0005737; GO:0005813; GO:0005856; GO:0007219; GO:0007288; GO:0030317; GO:0036126; GO:0060271; GO:0097225; GO:0120229; GO:0120316; GO:0120317"
"4724",4724,"Cluster_9149","Porites_evermani_scaffold_226:110078-111078",144,-23.91,2,13,558,579,11,"72.73%","90.91%","Peve_00016134",-0.563271290040142,0.619085194218774,0.978262075707395,"P43351","DNA repair protein RAD52 homolog","Homo sapiens (Human)","cellular response to oxidative stress [GO:0034599]; DNA double-strand break processing involved in repair via single-strand annealing [GO:0010792]; DNA recombinase assembly [GO:0000730]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via single-strand annealing [GO:0045002]; mitotic recombination [GO:0006312]; regulation of nucleotide-excision repair [GO:2000819]","GO:0000724; GO:0000730; GO:0003677; GO:0003697; GO:0005634; GO:0005654; GO:0006302; GO:0006310; GO:0006312; GO:0010792; GO:0032991; GO:0032993; GO:0034599; GO:0042802; GO:0045002; GO:2000819"
"4725",4725,"Cluster_9149","Porites_evermani_scaffold_226:125913-126913",147,-22.13,2,12,662,683,10,"80.00%","100.00%","Peve_00016136",-0.712706470002303,0.494938333300336,0.978262075707395,NA,NA,NA,NA,NA
"4726",4726,"Cluster_9149","Porites_evermani_scaffold_226:142468-143468",158,-20.07,2,21,152,176,22,"72.73%","77.27%","Peve_00016138",0.365440279392653,0.761836880481945,0.988711410005406,"O08962","Potassium voltage-gated channel subfamily H member 2 (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (RERG) (r-ERG) (Voltage-gated potassium channel subunit Kv11.1)","Rattus norvegicus (Rat)","brain development [GO:0007420]; cardiac muscle contraction [GO:0060048]; cellular response to xenobiotic stimulus [GO:0071466]; membrane depolarization during action potential [GO:0086010]; membrane repolarization [GO:0086009]; membrane repolarization during action potential [GO:0086011]; membrane repolarization during cardiac muscle cell action potential [GO:0086013]; membrane repolarization during ventricular cardiac muscle cell action potential [GO:0098915]; negative regulation of potassium ion export across plasma membrane [GO:1903765]; negative regulation of potassium ion transmembrane transport [GO:1901380]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of potassium ion transmembrane transport [GO:1901381]; potassium ion export across plasma membrane [GO:0097623]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane potential [GO:0042391]; regulation of membrane repolarization [GO:0060306]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; spinal cord development [GO:0021510]; ventricular cardiac muscle cell action potential [GO:0086005]","GO:0000976; GO:0005216; GO:0005242; GO:0005249; GO:0005251; GO:0005267; GO:0005635; GO:0005737; GO:0005886; GO:0006813; GO:0007420; GO:0008076; GO:0009986; GO:0021510; GO:0031625; GO:0042391; GO:0042802; GO:0042803; GO:0044877; GO:0045893; GO:0048471; GO:0055075; GO:0055131; GO:0060048; GO:0060306; GO:0060307; GO:0071466; GO:0071805; GO:0086005; GO:0086009; GO:0086010; GO:0086011; GO:0086013; GO:0086091; GO:0097110; GO:0097623; GO:0098915; GO:1901379; GO:1901380; GO:1901381; GO:1902282; GO:1902937; GO:1903765; GO:1990573"
"4727",4727,"Cluster_9149","Porites_evermani_scaffold_2295:40047-41047",154,-20.2,2,20,704,727,20,"70.00%","75.00%","Peve_00016448",-0.681403525049819,0.522739810735628,0.978262075707395,NA,NA,NA,NA,NA
"4728",4728,"Cluster_9149","Porites_evermani_scaffold_2315:37319-38319",155,-27.83,2,17,882,908,20,"75.00%","75.00%","Peve_00016702",-0.530568559867996,0.643956909117376,0.978262075707395,"P16951","Cyclic AMP-dependent transcription factor ATF-2 (cAMP-dependent transcription factor ATF-2) (Activating transcription factor 2) (MXBP protein) (cAMP response element-binding protein CRE-BP1)","Mus musculus (Mouse)","abducens nucleus development [GO:0021742]; adipose tissue development [GO:0060612]; amelogenesis [GO:0097186]; apoptotic process [GO:0006915]; apoptotic process involved in development [GO:1902742]; BMP signaling pathway [GO:0030509]; brainstem development [GO:0003360]; cellular lipid metabolic process [GO:0044255]; cellular response to anisomycin [GO:0072740]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to leucine starvation [GO:1990253]; cellular response to oxidative stress [GO:0034599]; cellular response to virus [GO:0098586]; detection of cell density [GO:0060245]; facial nucleus development [GO:0021754]; gene expression [GO:0010467]; growth plate cartilage chondrocyte differentiation [GO:0003418]; growth plate cartilage chondrocyte proliferation [GO:0003419]; heart development [GO:0007507]; hematopoietic progenitor cell differentiation [GO:0002244]; hepatocyte apoptotic process [GO:0097284]; histone H2B acetylation [GO:0043969]; histone H4 acetylation [GO:0043967]; hypoglossal nucleus development [GO:0021743]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway in response to hypoxia [GO:1990144]; JNK cascade [GO:0007254]; liver development [GO:0001889]; MAPK cascade [GO:0000165]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; motor neuron apoptotic process [GO:0097049]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of angiogenesis [GO:0016525]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurofilament cytoskeleton organization [GO:0060052]; NK T cell differentiation [GO:0001865]; outflow tract morphogenesis [GO:0003151]; p38MAPK cascade [GO:0038066]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cardiac muscle myoblast proliferation [GO:0110024]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902110]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus [GO:1901522]; positive regulation of transforming growth factor beta2 production [GO:0032915]; protein import into nucleus [GO:0006606]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to organic cyclic compound [GO:0014070]; response to osmotic stress [GO:0006970]; response to water deprivation [GO:0009414]; vacuole organization [GO:0007033]; white fat cell differentiation [GO:0050872]","GO:0000122; GO:0000165; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0000987; GO:0001228; GO:0001701; GO:0001865; GO:0001889; GO:0001934; GO:0002244; GO:0003151; GO:0003360; GO:0003418; GO:0003419; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005741; GO:0006355; GO:0006357; GO:0006606; GO:0006915; GO:0006970; GO:0006974; GO:0007033; GO:0007254; GO:0007507; GO:0008140; GO:0009414; GO:0010467; GO:0010485; GO:0010628; GO:0014070; GO:0016020; GO:0016525; GO:0016602; GO:0018107; GO:0019901; GO:0021742; GO:0021743; GO:0021754; GO:0030509; GO:0031573; GO:0032915; GO:0034599; GO:0035497; GO:0035861; GO:0038066; GO:0042789; GO:0042802; GO:0042803; GO:0043522; GO:0043525; GO:0043565; GO:0043967; GO:0043969; GO:0044013; GO:0044255; GO:0044877; GO:0045944; GO:0046872; GO:0046982; GO:0050680; GO:0050872; GO:0051091; GO:0060052; GO:0060245; GO:0060612; GO:0061629; GO:0072740; GO:0090575; GO:0097049; GO:0097186; GO:0097284; GO:0098586; GO:0110024; GO:1901522; GO:1902110; GO:1902562; GO:1902742; GO:1990144; GO:1990253; GO:1990837; GO:1990841"
"4729",4729,"Cluster_9149","Porites_evermani_scaffold_2326:23017-24017",171,-24.95,2,21,576,598,20,"80.00%","85.00%","Peve_00016786",1,0,0,NA,NA,NA,NA,NA
"4730",4730,"Cluster_9149","Porites_evermani_scaffold_2327:11727-12727",151,-20.32,2,20,816,835,18,"72.22%","83.33%","Peve_00016800",-0.5,0.666666666666667,0.978262075707395,NA,NA,NA,NA,NA
"4731",4731,"Cluster_9149","Porites_evermani_scaffold_2327:11727-12727",161,-25.47,2,14,330,351,12,"91.67%","100.00%","Peve_00016800",-0.5,0.666666666666667,0.978262075707395,NA,NA,NA,NA,NA
"4732",4732,"Cluster_9149","Porites_evermani_scaffold_233:235186-236186",154,-21.98,2,20,735,762,24,"66.67%","70.83%","Peve_00016830",0.997175508499252,0.0478594310724678,0.945152902495684,"O94923","D-glucuronyl C5-epimerase (EC 5.1.3.17) (Heparan sulfate C5-epimerase) (Hsepi) (Heparin/heparan sulfate:glucuronic acid C5-epimerase) (Heparosan-N-sulfate-glucuronate 5-epimerase)","Homo sapiens (Human)","heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin biosynthetic process [GO:0030210]","GO:0000139; GO:0005509; GO:0005794; GO:0015012; GO:0016857; GO:0030210; GO:0042803; GO:0047464"
"4733",4733,"Cluster_9149","Porites_evermani_scaffold_233:256121-257121",159,-24.15,2,21,63,85,20,"75.00%","75.00%","Peve_00016834",0.33289352625109,0.783950053705476,0.994487684309172,"Q1PSW8","E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (mLin41) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71)","Mus musculus (Mouse)","3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to organic substance [GO:0071310]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA metabolic process [GO:0010586]; miRNA processing [GO:0035196]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of translation [GO:0017148]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; post-transcriptional regulation of gene expression [GO:0010608]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of miRNA-mediated gene silencing [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of protein metabolic process [GO:0051246]; stem cell proliferation [GO:0072089]","GO:0000082; GO:0000209; GO:0000932; GO:0001843; GO:0004842; GO:0008270; GO:0008543; GO:0010586; GO:0010608; GO:0017148; GO:0021915; GO:0030371; GO:0035196; GO:0035198; GO:0035278; GO:0043161; GO:0051246; GO:0051865; GO:0060964; GO:0061158; GO:0061630; GO:0071310; GO:0072089; GO:2000177; GO:2000637"
"4734",4734,"Cluster_9149","Porites_evermani_scaffold_2348:18099-19099",154,-22.14,2,21,913,937,22,"72.73%","72.73%","Peve_00016982",-0.725848614935904,0.482894572891968,0.978262075707395,NA,NA,NA,NA,NA
"4735",4735,"Cluster_9149","Porites_evermani_scaffold_2352:38535-39535",153,-24.4,2,14,504,525,12,"75.00%","100.00%","Peve_00017033",NA,NA,NA,NA,NA,NA,NA,NA
"4736",4736,"Cluster_9149","Porites_evermani_scaffold_2356:37168-37544",163,-22.74,2,20,71,92,18,"72.22%","83.33%","Peve_00017054",-0.948974503040543,0.204245707878867,0.978262075707395,NA,NA,NA,NA,NA
"4737",4737,"Cluster_9149","Porites_evermani_scaffold_2356:37168-37544",163,-22.74,2,20,71,92,18,"72.22%","83.33%","Peve_00017055",-0.97728672899525,0.135944119895407,0.978262075707395,"A7RL75","Tetratricopeptide repeat protein 36 homolog (TPR repeat protein 36 homolog)","Nematostella vectensis (Starlet sea anemone)","cilium assembly [GO:0060271]","GO:0060271"
"4738",4738,"Cluster_9149","Porites_evermani_scaffold_2362:21457-21670",149,-22.16,2,14,14,35,12,"66.67%","100.00%","Peve_00017114",0.0609886380352284,0.961149316781481,0.999448381576871,"O95427","GPI ethanolamine phosphate transferase 1 (EC 2.-.-.-) (MCD4 homolog) (Phosphatidylinositol-glycan biosynthesis class N protein) (PIG-N)","Homo sapiens (Human)","GPI anchor biosynthetic process [GO:0006506]; preassembly of GPI anchor in ER membrane [GO:0016254]","GO:0005789; GO:0005829; GO:0005886; GO:0006506; GO:0016020; GO:0016254; GO:0051377"
"4739",4739,"Cluster_9149","Porites_evermani_scaffold_2362:21457-21670",149,-22.16,2,14,14,35,12,"66.67%","100.00%","Peve_00017115",-0.491692575198978,0.672756772624105,0.978262075707395,"P41826","Heat shock protein 70 A2","Anopheles albimanus (New world malaria mosquito)","","GO:0005524; GO:0140662"
"4740",4740,"Cluster_9149","Porites_evermani_scaffold_2375:6823-7823",161,-21.4,2,19,794,816,18,"77.78%","83.33%","Peve_00017202",-0.0710493699273802,0.954730424773149,0.999448381576871,NA,NA,NA,NA,NA
"4741",4741,"Cluster_9149","Porites_evermani_scaffold_243:321051-322051",145,-20.9,2,19,128,146,17,"76.47%","76.47%","Peve_00017781",0.99695799908616,0.0496689462152669,0.952044988713482,NA,NA,NA,NA,NA
"4742",4742,"Cluster_9149","Porites_evermani_scaffold_2443:61293-62293",147,-22.51,2,12,701,722,10,"80.00%","100.00%","Peve_00017888",NA,NA,NA,"Q96JN8","Neuralized-like protein 4","Homo sapiens (Human)","","GO:0005737; GO:0005814; GO:0061630"
"4743",4743,"Cluster_9149","Porites_evermani_scaffold_2490:35537-36537",150,-20.8,2,20,514,536,19,"63.16%","78.95%","Peve_00018289",-0.513807771023029,0.656468911208282,0.978262075707395,"Q8IW92","Beta-galactosidase-1-like protein 2 (EC 3.2.1.-)","Homo sapiens (Human)","carbohydrate metabolic process [GO:0005975]","GO:0004565; GO:0005576; GO:0005764; GO:0005773; GO:0005975"
"4744",4744,"Cluster_9149","Porites_evermani_scaffold_2493:67411-68411",149,-22.35,2,18,78,99,16,"68.75%","75.00%","Peve_00018305",-0.871971361035331,0.325682902222435,0.978262075707395,"Q6IFT6","Anoctamin-7 (New gene expressed in prostate homolog) (Transmembrane protein 16G)","Rattus norvegicus (Rat)","calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; calcium activated phospholipid scrambling [GO:0061588]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; establishment of localization in cell [GO:0051649]; plasma membrane phospholipid scrambling [GO:0017121]; transmembrane transport [GO:0055085]","GO:0005229; GO:0005254; GO:0005783; GO:0005886; GO:0006821; GO:0017121; GO:0017128; GO:0046983; GO:0051649; GO:0055085; GO:0061588; GO:0061589; GO:0061590; GO:0061591; GO:1902476"
"4745",4745,"Cluster_9149","Porites_evermani_scaffold_25:18922-19922",146,-22.64,2,18,368,393,20,"70.00%","80.00%","Peve_00018407",-0.903991667305353,0.281246464876591,0.978262075707395,"Q9N126","Retinol dehydrogenase 8 (EC 1.1.1.300) (Photoreceptor outer segment all-trans retinol dehydrogenase)","Bos taurus (Bovine)","estrogen biosynthetic process [GO:0006703]; response to stimulus [GO:0050896]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601]","GO:0004303; GO:0004745; GO:0005829; GO:0006703; GO:0007601; GO:0016491; GO:0042572; GO:0042622; GO:0050896; GO:0052650"
"4746",4746,"Cluster_9149","Porites_evermani_scaffold_2538:1886-2886",163,-21.45,2,20,615,636,18,"72.22%","83.33%","Peve_00018755",-0.5,0.666666666666667,0.978262075707395,"Q7ZX22","GATOR complex protein WDR24","Xenopus laevis (African clawed frog)","autophagy [GO:0006914]; positive regulation of TOR signaling [GO:0032008]","GO:0005765; GO:0006914; GO:0032008"
"4747",4747,"Cluster_9149","Porites_evermani_scaffold_2539:44176-45176",157,-23.9,2,18,212,233,16,"75.00%","81.25%","Peve_00018759",-0.789345218673852,0.420840408862425,0.978262075707395,NA,NA,NA,NA,NA
"4748",4748,"Cluster_9149","Porites_evermani_scaffold_2539:44176-45176",168,-22.79,2,21,174,195,19,"73.68%","84.21%","Peve_00018759",-0.789345218673852,0.420840408862425,0.978262075707395,NA,NA,NA,NA,NA
"4749",4749,"Cluster_9149","Porites_evermani_scaffold_2539:44176-45176",168,-27.32,2,21,233,254,19,"73.68%","84.21%","Peve_00018759",-0.789345218673852,0.420840408862425,0.978262075707395,NA,NA,NA,NA,NA
"4750",4750,"Cluster_9149","Porites_evermani_scaffold_25:412400-413400",160,-23.82,2,21,416,437,19,"68.42%","78.95%","Peve_00018352",NA,NA,NA,NA,NA,NA,NA,NA
"4751",4751,"Cluster_9149","Porites_evermani_scaffold_25:412400-413400",168,-22.79,2,21,378,399,19,"73.68%","84.21%","Peve_00018352",NA,NA,NA,NA,NA,NA,NA,NA
"4752",4752,"Cluster_9149","Porites_evermani_scaffold_25:412400-413400",168,-27.32,2,21,437,458,19,"73.68%","84.21%","Peve_00018352",NA,NA,NA,NA,NA,NA,NA,NA
"4753",4753,"Cluster_9149","Porites_evermani_scaffold_2552:27296-28296",140,-21.24,2,9,907,928,7,"100.00%","100.00%","Peve_00018864",NA,NA,NA,"P12263","Coagulation factor VIII (Procoagulant component)","Sus scrofa (Pig)","acute-phase response [GO:0006953]; blood coagulation [GO:0007596]","GO:0005507; GO:0005615; GO:0006953; GO:0007596; GO:0016491"
"4754",4754,"Cluster_9149","Porites_evermani_scaffold_2560:68398-69398",151,-22,2,12,959,980,10,"90.00%","100.00%","Peve_00018913",NA,NA,NA,NA,NA,NA,NA,NA
"4755",4755,"Cluster_9149","Porites_evermani_scaffold_2583:68808-69808",153,-21.92,2,19,383,405,18,"66.67%","83.33%","Peve_00019088",-0.5,0.666666666666667,0.978262075707395,NA,NA,NA,NA,NA
"4756",4756,"Cluster_9149","Porites_evermani_scaffold_261:216873-217873",150,-26.02,2,21,708,733,23,"65.22%","73.91%","Peve_00019359",-0.974972016310406,0.1427309086122,0.978262075707395,NA,NA,NA,NA,NA
"4757",4757,"Cluster_9149","Porites_evermani_scaffold_263:123829-124657",141,-21.04,2,10,764,785,8,"87.50%","100.00%","Peve_00019500",-0.966409056598461,0.16547388939217,0.978262075707395,"Q8NBS3","Solute carrier family 4 member 11 (Sodium borate cotransporter 1) (NaBC1)","Homo sapiens (Human)","bicarbonate transport [GO:0015701]; borate transport [GO:0046713]; cellular cation homeostasis [GO:0030003]; cellular hypotonic response [GO:0071476]; cellular response to oxidative stress [GO:0034599]; fluid transport [GO:0042044]; ion homeostasis [GO:0050801]; proton transmembrane transport [GO:1902600]; regulation of mesenchymal stem cell differentiation [GO:2000739]; regulation of mitochondrial membrane potential [GO:0051881]; sodium ion transport [GO:0006814]; transmembrane transport [GO:0055085]","GO:0005272; GO:0005372; GO:0005452; GO:0005886; GO:0006814; GO:0012506; GO:0015078; GO:0015106; GO:0015252; GO:0015293; GO:0015701; GO:0016323; GO:0016324; GO:0022857; GO:0030003; GO:0034599; GO:0042044; GO:0046713; GO:0046715; GO:0046983; GO:0050801; GO:0051881; GO:0055085; GO:0071476; GO:1902600; GO:2000739"
"4758",4758,"Cluster_9149","Porites_evermani_scaffold_263:208141-209141",146,-20.3,2,11,507,528,9,"88.89%","100.00%","Peve_00019504",-0.337557073645083,0.780798805497679,0.993749271382415,"Q6PCS4","Rho GTPase-activating protein 29 (Rho-type GTPase-activating protein 29)","Danio rerio (Zebrafish) (Brachydanio rerio)","activation of GTPase activity [GO:0090630]; animal organ development [GO:0048513]; cell development [GO:0048468]; signal transduction [GO:0007165]","GO:0005096; GO:0005737; GO:0007165; GO:0046872; GO:0048468; GO:0048513; GO:0090630"
"4759",4759,"Cluster_9149","Porites_evermani_scaffold_264:323772-324772",180,-32.47,2,21,156,177,19,"84.21%","89.47%","Peve_00019581",-0.959298262084438,0.182257647109958,0.978262075707395,NA,NA,NA,NA,NA
"4760",4760,"Cluster_9149","Porites_evermani_scaffold_266:76062-77062",171,-29.35,2,21,23,45,20,"80.00%","85.00%","Peve_00019726",NA,NA,NA,NA,NA,NA,NA,NA
"4761",4761,"Cluster_9149","Porites_evermani_scaffold_2680:17123-18013",147,-20.86,2,12,749,770,10,"90.00%","90.00%","Peve_00019909",NA,NA,NA,NA,NA,NA,NA,NA
"4762",4762,"Cluster_9149","Porites_evermani_scaffold_2680:17123-18013",147,-20.86,2,12,749,770,10,"90.00%","90.00%","Peve_00019911",-0.959726024668794,0.181290821735907,0.978262075707395,NA,NA,NA,NA,NA
"4763",4763,"Cluster_9149","Porites_evermani_scaffold_2682:16570-17553",163,-21.15,2,21,81,103,20,"75.00%","80.00%","Peve_00019929",NA,NA,NA,NA,NA,NA,NA,NA
"4764",4764,"Cluster_9149","Porites_evermani_scaffold_268:298276-298817",151,-20.39,2,12,457,478,10,"90.00%","100.00%","Peve_00019906",-0.5,0.666666666666667,0.978262075707395,NA,NA,NA,NA,NA
"4765",4765,"Cluster_9149","Porites_evermani_scaffold_2709:61150-62150",155,-20.63,2,21,239,261,20,"65.00%","80.00%","Peve_00020165",NA,NA,NA,NA,NA,NA,NA,NA
"4766",4766,"Cluster_9149","Porites_evermani_scaffold_271:195629-196629",150,-21.64,2,20,376,399,20,"65.00%","75.00%","Peve_00020185",-0.65573635368639,0.544716580019143,0.978262075707395,"Q8CFW1","Anoctamin-2 (Transmembrane protein 16B)","Mus musculus (Mouse)","chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; establishment of localization in cell [GO:0051649]; transmembrane transport [GO:0055085]","GO:0005229; GO:0005254; GO:0005654; GO:0005886; GO:0006821; GO:0034707; GO:0042734; GO:0042802; GO:0043005; GO:0046983; GO:0051649; GO:0055085; GO:0097730; GO:0098978; GO:1902476"
"4767",4767,"Cluster_9149","Porites_evermani_scaffold_271:195629-196629",156,-22.47,2,18,743,765,17,"76.47%","82.35%","Peve_00020185",-0.65573635368639,0.544716580019143,0.978262075707395,"Q8CFW1","Anoctamin-2 (Transmembrane protein 16B)","Mus musculus (Mouse)","chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; establishment of localization in cell [GO:0051649]; transmembrane transport [GO:0055085]","GO:0005229; GO:0005254; GO:0005654; GO:0005886; GO:0006821; GO:0034707; GO:0042734; GO:0042802; GO:0043005; GO:0046983; GO:0051649; GO:0055085; GO:0097730; GO:0098978; GO:1902476"
"4768",4768,"Cluster_9149","Porites_evermani_scaffold_2720:60003-61003",155,-22.35,2,21,681,707,24,"66.67%","70.83%","Peve_00020277",0.120534266883564,0.923078470761237,0.999448381576871,NA,NA,NA,NA,NA
"4769",4769,"Cluster_9149","Porites_evermani_scaffold_27:211246-212246",170,-29.18,2,21,40,60,19,"84.21%","84.21%","Peve_00020089",0.265556898049487,0.828888373460968,0.995934364227446,NA,NA,NA,NA,NA
"4770",4770,"Cluster_9149","Porites_evermani_scaffold_272:21822-22822",155,-22.43,2,21,302,324,20,"70.00%","75.00%","Peve_00020256",NA,NA,NA,NA,NA,NA,NA,NA
"4771",4771,"Cluster_9149","Porites_evermani_scaffold_2722:2929-3929",152,-26.19,2,18,212,236,19,"68.42%","78.95%","Peve_00020287",-0.5046439552624,0.663247553628504,0.978262075707395,"B8V7S0","CUB and peptidase domain-containing protein 1","Acropora millepora (Staghorn coral) (Heteropora millepora)","proteolysis [GO:0006508]","GO:0004252; GO:0005576; GO:0006508"
"4772",4772,"Cluster_9149","Porites_evermani_scaffold_2733:42877-43357",151,-20.7,2,12,330,351,10,"90.00%","100.00%","Peve_00020374",-0.770560385602015,0.439952914547501,0.978262075707395,NA,NA,NA,NA,NA
"4773",4773,"Cluster_9149","Porites_evermani_scaffold_2733:42877-43357",151,-20.7,2,12,330,351,10,"90.00%","100.00%","Peve_00020375",NA,NA,NA,NA,NA,NA,NA,NA
"4774",4774,"Cluster_9149","Porites_evermani_scaffold_2733:44224-45224",151,-20.7,2,12,850,871,10,"90.00%","100.00%","Peve_00020376",NA,NA,NA,NA,NA,NA,NA,NA
"4775",4775,"Cluster_9149","Porites_evermani_scaffold_2747:3260-4260",159,-24.41,2,21,944,966,20,"70.00%","80.00%","Peve_00020492",-0.999191159467906,0.0256068319396386,0.875231632834556,NA,NA,NA,NA,NA
"4776",4776,"Cluster_9149","Porites_evermani_scaffold_2748:19017-20017",161,-24.59,2,14,89,110,12,"91.67%","100.00%","Peve_00020501",-0.299653492910605,0.80625786333147,0.995934364227446,"A3KQ55","7SK snRNA methylphosphate capping enzyme (MePCE) (EC 2.1.1.-) (Bicoid-interacting protein 3 homolog) (Bin3 homolog) (zBCDIN3)","Danio rerio (Zebrafish) (Brachydanio rerio)","positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of snRNA transcription by RNA polymerase II [GO:1905382]; RNA methylation [GO:0001510]; snRNA metabolic process [GO:0016073]; snRNA modification [GO:0040031]","GO:0001510; GO:0005634; GO:0008171; GO:0008173; GO:0008757; GO:0016073; GO:0017069; GO:0040031; GO:1904871; GO:1905382; GO:1990276; GO:1990904"
"4777",4777,"Cluster_9149","Porites_evermani_scaffold_2783:51699-52699",152,-20.29,2,21,459,480,19,"57.89%","78.95%","Peve_00020754",-0.5,0.666666666666667,0.978262075707395,"Q7TN88","Polycystic kidney disease protein 1-like 2 (PC1-like 2 protein) (Polycystin-1L2)","Mus musculus (Mouse)","detection of mechanical stimulus [GO:0050982]","GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982"
"4778",4778,"Cluster_9149","Porites_evermani_scaffold_2784:31749-32749",147,-20.9,2,12,522,543,10,"80.00%","100.00%","Peve_00020756",NA,NA,NA,NA,NA,NA,NA,NA
"4779",4779,"Cluster_9149","Porites_evermani_scaffold_2791:8754-9754",144,-20.75,2,19,791,808,17,"76.47%","76.47%","Peve_00020810",NA,NA,NA,NA,NA,NA,NA,NA
"4780",4780,"Cluster_9149","Porites_evermani_scaffold_281:196120-197120",142,-21.52,2,21,897,920,21,"61.90%","71.43%","Peve_00020989",-0.522783899859873,0.649786934002233,0.978262075707395,"A0JC51","Zinc finger protein ZIC 4 (XlZic4) (Zinc finger protein of the cerebellum 4)","Xenopus laevis (African clawed frog)","nervous system development [GO:0007399]; neural crest formation [GO:0014029]","GO:0003677; GO:0005634; GO:0007399; GO:0014029; GO:0046872"
"4781",4781,"Cluster_9149","Porites_evermani_scaffold_2816:42383-43383",149,-24.27,2,14,33,54,12,"75.00%","91.67%","Peve_00021029",-0.615295196721274,0.578073634001099,0.978262075707395,"A1A4L5","Alkylated DNA repair protein alkB homolog 8 (Probable alpha-ketoglutarate-dependent dioxygenase ABH8) (S-adenosyl-L-methionine-dependent tRNA methyltransferase ABH8) (tRNA (carboxymethyluridine(34)-5-O)-methyltransferase ABH8) (EC 2.1.1.229)","Bos taurus (Bovine)","cellular response to DNA damage stimulus [GO:0006974]; tRNA methylation [GO:0030488]; tRNA wobble uridine modification [GO:0002098]","GO:0000049; GO:0002098; GO:0005506; GO:0005634; GO:0005737; GO:0005829; GO:0006974; GO:0008270; GO:0016300; GO:0016706; GO:0030488; GO:0106335"
"4782",4782,"Cluster_9149","Porites_evermani_scaffold_282:215373-216373",163,-22.9,2,20,277,298,18,"72.22%","83.33%","Peve_00021066",-0.585359208626915,0.601906994355863,0.978262075707395,"Q9TU53","Cubilin","Canis lupus familiaris (Dog) (Canis familiaris)","cholesterol metabolic process [GO:0008203]; protein transport [GO:0015031]","GO:0005509; GO:0005765; GO:0005768; GO:0005905; GO:0008203; GO:0015031; GO:0016324; GO:0031419; GO:0031526; GO:0043235"
"4783",4783,"Cluster_9149","Porites_evermani_scaffold_2829:4694-5694",161,-26.71,2,14,714,735,12,"91.67%","100.00%","Peve_00021121",0.104315121261543,0.933469897656308,0.999448381576871,"O43741","5'-AMP-activated protein kinase subunit beta-2 (AMPK subunit beta-2)","Homo sapiens (Human)","cellular response to nutrient levels [GO:0031669]; fatty acid biosynthetic process [GO:0006633]; positive regulation of cold-induced thermogenesis [GO:0120162]; signal transduction [GO:0007165]","GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006633; GO:0007165; GO:0019901; GO:0031588; GO:0031669; GO:0120162"
"4784",4784,"Cluster_9149","Porites_evermani_scaffold_2830:34460-35460",143,-22.03,2,12,876,897,10,"80.00%","90.00%","Peve_00021149",0.991273534031711,0.084164829563253,0.978262075707395,"P35555","Fibrillin-1 [Cleaved into: Asprosin]","Homo sapiens (Human)","activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; positive regulation of appetite [GO:0032100]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]","GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0009653; GO:0010737; GO:0030023; GO:0031012; GO:0032100; GO:0033627; GO:0034199; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0062023; GO:0071560; GO:1990314; GO:2001205"
"4785",4785,"Cluster_9149","Porites_evermani_scaffold_2853:43629-44629",143,-22.54,2,12,874,895,10,"70.00%","100.00%","Peve_00021302",NA,NA,NA,NA,NA,NA,NA,NA
"4786",4786,"Cluster_9149","Porites_evermani_scaffold_286:241825-242825",152,-22.92,2,16,138,157,14,"85.71%","85.71%","Peve_00021361",0.265556898049487,0.828888373460968,0.995934364227446,NA,NA,NA,NA,NA
"4787",4787,"Cluster_9149","Porites_evermani_scaffold_287:49913-50913",149,-22.82,2,20,409,429,18,"66.67%","77.78%","Peve_00021438",0.0239885187997039,0.984726969574964,0.999448381576871,"P35520","Cystathionine beta-synthase (EC 4.2.1.22) (Beta-thionase) (Serine sulfhydrase)","Homo sapiens (Human)","blood vessel diameter maintenance [GO:0097746]; blood vessel remodeling [GO:0001974]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cellular response to hypoxia [GO:0071456]; cerebellum morphogenesis [GO:0021587]; cysteine biosynthetic process [GO:0019344]; cysteine biosynthetic process from serine [GO:0006535]; cysteine biosynthetic process via cystathionine [GO:0019343]; DNA protection [GO:0042262]; endochondral ossification [GO:0001958]; homocysteine catabolic process [GO:0043418]; homocysteine metabolic process [GO:0050667]; hydrogen sulfide biosynthetic process [GO:0070814]; L-cysteine catabolic process [GO:0019448]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of apoptotic process [GO:0043066]; regulation of JUN kinase activity [GO:0043506]; regulation of nitric oxide mediated signal transduction [GO:0010749]; response to folic acid [GO:0051593]; superoxide metabolic process [GO:0006801]; transsulfuration [GO:0019346]","GO:0001958; GO:0001974; GO:0004122; GO:0005634; GO:0005737; GO:0005829; GO:0006535; GO:0006563; GO:0006565; GO:0006801; GO:0010749; GO:0019343; GO:0019344; GO:0019346; GO:0019448; GO:0019825; GO:0019899; GO:0020037; GO:0021587; GO:0030170; GO:0031625; GO:0042262; GO:0042802; GO:0042803; GO:0043066; GO:0043167; GO:0043418; GO:0043506; GO:0046872; GO:0050421; GO:0050667; GO:0051593; GO:0060135; GO:0060351; GO:0070025; GO:0070026; GO:0070814; GO:0071456; GO:0072341; GO:0097746; GO:1904047"
"4788",4788,"Cluster_9149","Porites_evermani_scaffold_2876:38795-39795",152,-24.04,2,18,223,245,17,"70.59%","82.35%","Peve_00021482",NA,NA,NA,NA,NA,NA,NA,NA
"4789",4789,"Cluster_9149","Porites_evermani_scaffold_290:2795-3795",150,-20.77,2,11,800,821,9,"100.00%","100.00%","Peve_00021711",NA,NA,NA,NA,NA,NA,NA,NA
"4790",4790,"Cluster_9149","Porites_evermani_scaffold_2917:52365-53365",164,-22.97,2,21,758,779,19,"68.42%","84.21%","Peve_00021829",0.369206411602623,0.759259078215887,0.988219883885475,NA,NA,NA,NA,NA
"4791",4791,"Cluster_9149","Porites_evermani_scaffold_2930:41273-42273",150,-24.03,2,11,293,314,9,"100.00%","100.00%","Peve_00021933",NA,NA,NA,NA,NA,NA,NA,NA
"4792",4792,"Cluster_9149","Porites_evermani_scaffold_295:213327-214327",154,-25.38,2,21,557,577,19,"63.16%","84.21%","Peve_00022050",-0.456991821393956,0.697853722965774,0.978262075707395,"Q9NR09","Baculoviral IAP repeat-containing protein 6 (EC 2.3.2.27) (BIR repeat-containing ubiquitin-conjugating enzyme) (BRUCE) (RING-type E3 ubiquitin transferase BIRC6) (Ubiquitin-conjugating BIR domain enzyme apollon) (APOLLON)","Homo sapiens (Human)","apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; labyrinthine layer development [GO:0060711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of peptidase activity [GO:0010466]; positive regulation of cell population proliferation [GO:0008284]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cell population proliferation [GO:0042127]; regulation of cytokinesis [GO:0032465]; regulation of endopeptidase activity [GO:0052548]; spongiotrophoblast layer development [GO:0060712]","GO:0000922; GO:0004842; GO:0004869; GO:0005634; GO:0005768; GO:0005802; GO:0005815; GO:0005829; GO:0006468; GO:0006915; GO:0007049; GO:0008283; GO:0008284; GO:0010466; GO:0016020; GO:0016567; GO:0030496; GO:0032465; GO:0042127; GO:0043066; GO:0051301; GO:0052548; GO:0060711; GO:0060712; GO:0061631; GO:0090543; GO:2001237"
"4793",4793,"Cluster_9149","Porites_evermani_scaffold_2952:24985-25985",151,-20.86,2,14,487,507,12,"91.67%","91.67%","Peve_00022077",NA,NA,NA,NA,NA,NA,NA,NA
"4794",4794,"Cluster_9149","Porites_evermani_scaffold_29:546647-547647",147,-20.39,2,20,929,948,18,"72.22%","77.78%","Peve_00021650",-0.431947585084135,0.715653084225726,0.980326753756855,"Q13797","Integrin alpha-9 (Integrin alpha-RLC)","Homo sapiens (Human)","cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; integrin-mediated signaling pathway [GO:0007229]; leukocyte migration [GO:0050900]; neutrophil chemotaxis [GO:0030593]","GO:0005178; GO:0005886; GO:0007155; GO:0007160; GO:0007229; GO:0008305; GO:0009897; GO:0009925; GO:0030593; GO:0033627; GO:0046872; GO:0050900; GO:0098609"
"4795",4795,"Cluster_9149","Porites_evermani_scaffold_2967:11730-12730",157,-23.79,2,14,1,21,12,"91.67%","91.67%","Peve_00022167",NA,NA,NA,NA,NA,NA,NA,NA
"4796",4796,"Cluster_9149","Porites_evermani_scaffold_2968:16590-17339",163,-22.85,2,21,303,325,20,"70.00%","85.00%","Peve_00022173",-0.805716651108881,0.403560854964625,0.978262075707395,NA,NA,NA,NA,NA
"4797",4797,"Cluster_9149","Porites_evermani_scaffold_2968:46376-47376",155,-20.59,2,21,562,584,20,"65.00%","80.00%","Peve_00022175",-0.993023805465384,0.0752414597301934,0.978262075707395,NA,NA,NA,NA,NA
"4798",4798,"Cluster_9149","Porites_evermani_scaffold_297:93637-94637",155,-20.41,2,21,325,347,20,"70.00%","75.00%","Peve_00022188",-0.672032489844692,0.530843024273362,0.978262075707395,"Q9D9H8","Mitochondrial protein C2orf69 homolog","Mus musculus (Mouse)","oxidative phosphorylation [GO:0006119]","GO:0005739; GO:0005759; GO:0006119; GO:0070469"
"4799",4799,"Cluster_9149","Porites_evermani_scaffold_3016:53699-54699",153,-21.17,2,15,767,791,16,"81.25%","81.25%","Peve_00022745",0.958173739951627,0.184775813734806,0.978262075707395,"Q8VE88","Protein FAM114A2","Mus musculus (Mouse)","",""
"4800",4800,"Cluster_9149","Porites_evermani_scaffold_302:234649-235649",160,-24.25,2,19,196,216,17,"76.47%","88.24%","Peve_00022773",1,0,0,"Q8VCK5","Kelch-like protein 20 (Kelch-like ECT2-interacting protein)","Mus musculus (Mouse)","Golgi to endosome transport [GO:0006895]; negative regulation of apoptotic process [GO:0043066]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K33-linked ubiquitination [GO:1990390]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]","GO:0003779; GO:0004842; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0006895; GO:0015031; GO:0016567; GO:0016605; GO:0019964; GO:0030424; GO:0030425; GO:0031463; GO:0043066; GO:0043161; GO:0048471; GO:1990390"
"4801",4801,"Cluster_9149","Porites_evermani_scaffold_3025:30316-31316",159,-21.13,2,21,739,764,23,"69.57%","73.91%","Peve_00022813",-0.998924716861794,0.0295253777049622,0.903929377050813,NA,NA,NA,NA,NA
"4802",4802,"Cluster_9149","Porites_evermani_scaffold_30:271962-272962",152,-20.86,2,18,301,325,19,"73.68%","73.68%","Peve_00022605",-0.634819309503788,0.56214906356641,0.978262075707395,NA,NA,NA,NA,NA
"4803",4803,"Cluster_9149","Porites_evermani_scaffold_3031:48921-49298",157,-27.85,2,15,60,82,14,"85.71%","92.86%","Peve_00022868",-0.10805011296845,0.931078607831781,0.999448381576871,"Q08D69","Mediator of RNA polymerase II transcription subunit 16 (Mediator complex subunit 16)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","","GO:0016592"
"4804",4804,"Cluster_9149","Porites_evermani_scaffold_3031:48921-49298",157,-27.85,2,15,60,82,14,"85.71%","92.86%","Peve_00022864",-0.595172202703719,0.594167677637641,0.978262075707395,NA,NA,NA,NA,NA
"4805",4805,"Cluster_9149","Porites_evermani_scaffold_3049:22976-23976",147,-25.55,2,12,267,288,10,"80.00%","100.00%","Peve_00022964",-0.385790167457515,0.747857737938253,0.98812224693389,"P0C1F8","DELTA-stichotoxin-Hcr4b (DELTA-SHTX-Hcr4b) (Cytolysin RTX-S II) (RTX-SII)","Heteractis crispa (Leathery sea anemone) (Radianthus macrodactylus)","cation transport [GO:0006812]; cytolysis in another organism [GO:0051715]; pore complex assembly [GO:0046931]","GO:0005576; GO:0006812; GO:0015267; GO:0042151; GO:0044218; GO:0046930; GO:0046931; GO:0051715; GO:0090729"
"4806",4806,"Cluster_9149","Porites_evermani_scaffold_3059:9641-10641",154,-24.38,2,15,328,349,13,"76.92%","92.31%","Peve_00023032",-0.804264515884725,0.405119052914296,0.978262075707395,"Q9S7E9","Glutamate--glyoxylate aminotransferase 2 (AtGGT2) (EC 2.6.1.4) (Alanine aminotransferase GGT2) (EC 2.6.1.2) (Alanine--glyoxylate aminotransferase GGT2) (EC 2.6.1.44) (Alanine-2-oxoglutarate aminotransferase 2) (EC 2.6.1.-)","Arabidopsis thaliana (Mouse-ear cress)","biosynthetic process [GO:0009058]; L-alanine catabolic process [GO:0042853]; photorespiration [GO:0009853]","GO:0003729; GO:0004021; GO:0005739; GO:0005777; GO:0005829; GO:0008453; GO:0009058; GO:0009507; GO:0009570; GO:0009853; GO:0030170; GO:0042853; GO:0047958"
"4807",4807,"Cluster_9149","Porites_evermani_scaffold_3089:27014-28014",157,-21.59,2,18,89,110,16,"75.00%","81.25%","Peve_00023254",-0.800662020816493,0.408962585901718,0.978262075707395,"A2AJ76","Hemicentin-2","Mus musculus (Mouse)","response to stimulus [GO:0050896]","GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005938; GO:0030054; GO:0031012; GO:0032154; GO:0050896; GO:0062023"
"4808",4808,"Cluster_9149","Porites_evermani_scaffold_309:125909-126909",144,-21.22,2,20,317,345,25,"68.00%","68.00%","Peve_00023263",0.0602452242801208,0.961623460589691,0.999448381576871,"Q9WVA3","Mitotic checkpoint protein BUB3 (WD repeat type I transmembrane protein A72.5)","Mus musculus (Mouse)","attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; protein localization to kinetochore [GO:0034501]; regulation of chromosome segregation [GO:0051983]","GO:0000776; GO:0005654; GO:0007094; GO:0008608; GO:0033597; GO:0034501; GO:0043130; GO:0051301; GO:0051321; GO:0051444; GO:0051983; GO:1990298"
"4809",4809,"Cluster_9149","Porites_evermani_scaffold_310:31452-32452",153,-24.07,2,14,27,48,12,"83.33%","91.67%","Peve_00023393",NA,NA,NA,"O95271","Poly [ADP-ribose] polymerase tankyrase-1 (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 5) (ARTD5) (Poly [ADP-ribose] polymerase 5A) (Protein poly-ADP-ribosyltransferase tankyrase-1) (EC 2.4.2.-) (TNKS-1) (TRF1-interacting ankyrin-related ADP-ribose polymerase) (Tankyrase I) (Tankyrase-1) (TANK1)","Homo sapiens (Human)","cell division [GO:0051301]; mitotic spindle organization [GO:0007052]; mRNA transport [GO:0051028]; negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric [GO:1904908]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of telomeric DNA binding [GO:1904743]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; regulation of telomere maintenance via telomerase [GO:0032210]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055]","GO:0000139; GO:0000209; GO:0000242; GO:0000781; GO:0003950; GO:0005634; GO:0005643; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0007052; GO:0008270; GO:0015031; GO:0016055; GO:0016604; GO:0016779; GO:0018105; GO:0018107; GO:0031965; GO:0032210; GO:0032212; GO:0042393; GO:0045944; GO:0051028; GO:0051225; GO:0051301; GO:0051973; GO:0070198; GO:0070212; GO:0070213; GO:0090263; GO:0097431; GO:1904355; GO:1904357; GO:1904743; GO:1904908; GO:1990404"
"4810",4810,"Cluster_9149","Porites_evermani_scaffold_3:1154428-1155428",148,-20.01,2,14,814,837,14,"78.57%","85.71%","Peve_00022491",NA,NA,NA,NA,NA,NA,NA,NA
"4811",4811,"Cluster_9149","Porites_evermani_scaffold_3:1178008-1179008",157,-23.68,2,14,872,893,12,"83.33%","100.00%","Peve_00022500",NA,NA,NA,NA,NA,NA,NA,NA
"4812",4812,"Cluster_9149","Porites_evermani_scaffold_3167:4216-5216",147,-20.45,2,12,916,937,10,"80.00%","100.00%","Peve_00023808",-0.998460036492421,0.0353350804494513,0.909359886114279,NA,NA,NA,NA,NA
"4813",4813,"Cluster_9149","Porites_evermani_scaffold_3167:4260-5260",147,-20.45,2,12,872,893,10,"80.00%","100.00%","Peve_00023810",-0.593495557050941,0.595494911981282,0.978262075707395,"Q2KJI2","Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A (Oligosaccharyl transferase subunit STT3A) (STT3-A) (EC 2.4.99.18)","Bos taurus (Bovine)","co-translational protein modification [GO:0043686]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation via asparagine [GO:0018279]","GO:0004579; GO:0018279; GO:0035000; GO:0043686; GO:0043687; GO:0046872"
"4814",4814,"Cluster_9149","Porites_evermani_scaffold_3181:49926-50926",150,-24.91,2,16,352,374,15,"80.00%","80.00%","Peve_00023895",0.605450093388749,0.585986253182031,0.978262075707395,NA,NA,NA,NA,NA
"4815",4815,"Cluster_9149","Porites_evermani_scaffold_3183:42407-43407",152,-20.42,2,19,350,373,19,"73.68%","78.95%","Peve_00023903",-0.5,0.666666666666667,0.978262075707395,NA,NA,NA,NA,NA
"4816",4816,"Cluster_9149","Porites_evermani_scaffold_322:170557-171557",156,-28.43,2,20,552,573,19,"73.68%","84.21%","Peve_00024137",-0.676510395050949,0.526982764820446,0.978262075707395,"O73787","Gamma-tubulin complex component 3 homolog (Gamma-ring complex protein 109) (Xgrip109) (x109p)","Xenopus laevis (African clawed frog)","microtubule nucleation [GO:0007020]","GO:0000922; GO:0005813; GO:0005829; GO:0005874; GO:0007020; GO:0043015"
"4817",4817,"Cluster_9149","Porites_evermani_scaffold_3226:16465-17465",145,-22.36,2,15,270,292,14,"71.43%","85.71%","Peve_00024176",NA,NA,NA,"P71359","ATP-dependent DNA helicase RecQ (EC 3.6.4.12)","Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd)","DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; SOS response [GO:0009432]","GO:0003677; GO:0005524; GO:0005694; GO:0005737; GO:0006260; GO:0006281; GO:0006310; GO:0009378; GO:0009432; GO:0016887; GO:0030894; GO:0032508; GO:0043138; GO:0043590"
"4818",4818,"Cluster_9149","Porites_evermani_scaffold_328:161087-162087",150,-24.37,2,17,299,319,15,"73.33%","86.67%","Peve_00024480",-0.358518133258088,0.7665642514157,0.990082110211811,"B8V7S0","CUB and peptidase domain-containing protein 1","Acropora millepora (Staghorn coral) (Heteropora millepora)","proteolysis [GO:0006508]","GO:0004252; GO:0005576; GO:0006508"
"4819",4819,"Cluster_9149","Porites_evermani_scaffold_3299:9578-10409",156,-20.03,2,21,561,579,19,"73.68%","78.95%","Peve_00024578",-0.121615713409301,0.922384898122721,0.999448381576871,NA,NA,NA,NA,NA
"4820",4820,"Cluster_9149","Porites_evermani_scaffold_3311:14127-15127",153,-24.77,2,21,32,59,25,"72.00%","72.00%","Peve_00024747",0.223686650316285,0.856381550030193,0.995934364227446,"O60290","Zinc finger protein 862","Homo sapiens (Human)","regulation of DNA-templated transcription [GO:0006355]","GO:0005634; GO:0006355; GO:0046872; GO:0046983"
"4821",4821,"Cluster_9149","Porites_evermani_scaffold_3321:21740-22740",151,-21.29,2,14,567,587,12,"91.67%","91.67%","Peve_00024793",-0.5,0.666666666666667,0.978262075707395,"Q96CG8","Collagen triple helix repeat-containing protein 1","Homo sapiens (Human)","cell migration [GO:0016477]; cochlea morphogenesis [GO:0090103]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein binding [GO:0032092]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0001649; GO:0005109; GO:0005576; GO:0005581; GO:0005615; GO:0016477; GO:0016528; GO:0017147; GO:0032092; GO:0033687; GO:0033690; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0062023; GO:0090090; GO:0090103; GO:0090177"
"4822",4822,"Cluster_9149","Porites_evermani_scaffold_3322:25716-26716",168,-24.85,2,21,563,584,19,"78.95%","78.95%","Peve_00024796",-0.780077851543352,0.430358844794763,0.978262075707395,NA,NA,NA,NA,NA
"4823",4823,"Cluster_9149","Porites_evermani_scaffold_3327:14814-15814",152,-20.25,2,21,69,88,19,"73.68%","78.95%","Peve_00024816",NA,NA,NA,NA,NA,NA,NA,NA
"4824",4824,"Cluster_9149","Porites_evermani_scaffold_3336:19951-20951",148,-20.7,2,21,892,913,19,"63.16%","68.42%","Peve_00024878",-0.937231180899058,0.226759443522448,0.978262075707395,NA,NA,NA,NA,NA
"4825",4825,"Cluster_9149","Porites_evermani_scaffold_3344:45501-46501",156,-22.67,2,21,885,906,19,"63.16%","78.95%","Peve_00024938",1,0,0,"A2AJ88","Patatin-like phospholipase domain-containing protein 7 (EC 3.1.1.-) (EC 3.1.1.5) (Neuropathy target esterase-related esterase) (NRE) (NTE-related esterase)","Mus musculus (Mouse)","phosphatidylcholine catabolic process [GO:0034638]","GO:0004622; GO:0005783; GO:0005789; GO:0005811; GO:0034638; GO:0102545"
"4826",4826,"Cluster_9149","Porites_evermani_scaffold_33:629907-630907",148,-21.76,2,20,60,81,19,"68.42%","78.95%","Peve_00024604",-0.843651853946295,0.36080244890708,0.978262075707395,"O02824","Alpha-1A adrenergic receptor (Alpha-1A adrenoreceptor) (Alpha-1A adrenoceptor) (Alpha-1C adrenergic receptor)","Oryctolagus cuniculus (Rabbit)","adult heart development [GO:0007512]; cell growth involved in cardiac muscle cell development [GO:0061049]; MAPK cascade [GO:0000165]; multicellular organism aging [GO:0010259]; negative regulation of autophagy [GO:0010507]; negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure [GO:0001985]; neuron-glial cell signaling [GO:0150099]; norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001994]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; pilomotor reflex [GO:0097195]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of heart rate by epinephrine-norepinephrine [GO:0001996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of non-membrane spanning protein tyrosine kinase activity [GO:1903997]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of the force of heart contraction by epinephrine-norepinephrine [GO:0001997]; regulation of cardiac muscle contraction [GO:0055117]; regulation of vasoconstriction [GO:0019229]","GO:0000165; GO:0001985; GO:0001994; GO:0001996; GO:0001997; GO:0004937; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005901; GO:0007200; GO:0007512; GO:0010259; GO:0010507; GO:0010613; GO:0019229; GO:0031965; GO:0043410; GO:0045987; GO:0046982; GO:0055117; GO:0061049; GO:0097195; GO:0150099; GO:1903997"
"4827",4827,"Cluster_9149","Porites_evermani_scaffold_337:70017-71017",153,-20.09,2,14,423,444,12,"83.33%","91.67%","Peve_00025085",0.357380272522533,0.767340038984271,0.990292206410484,NA,NA,NA,NA,NA
"4828",4828,"Cluster_9149","Porites_evermani_scaffold_3384:11374-12374",149,-28.41,2,21,836,863,25,"64.00%","76.00%","Peve_00025174",0.486831365054695,0.676305241197456,0.978262075707395,"Q90XE6","Kruppel-like factor 1 (Erythroid krueppel-like transcription factor) (Kruppel-like factor d)","Danio rerio (Zebrafish) (Brachydanio rerio)","animal organ regeneration [GO:0031100]; cardiac muscle cell differentiation [GO:0055007]; cardiac muscle cell proliferation [GO:0060038]; cell dedifferentiation [GO:0043697]; positive regulation of gene expression [GO:0010628]; primitive erythrocyte differentiation [GO:0060319]; regulation of transcription by RNA polymerase II [GO:0006357]; sarcomere organization [GO:0045214]","GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005829; GO:0006357; GO:0010628; GO:0031100; GO:0043565; GO:0043697; GO:0045214; GO:0046872; GO:0055007; GO:0060038; GO:0060319"
"4829",4829,"Cluster_9149","Porites_evermani_scaffold_3391:34473-34834",155,-23.01,2,20,81,102,18,"66.67%","77.78%","Peve_00025220",-0.707860383033425,0.499321157900396,0.978262075707395,"Q8N5C6","S1 RNA-binding domain-containing protein 1","Homo sapiens (Human)","nucleobase-containing compound metabolic process [GO:0006139]; translation [GO:0006412]","GO:0003729; GO:0003735; GO:0006139; GO:0006412"
"4830",4830,"Cluster_9149","Porites_evermani_scaffold_3391:34473-34834",155,-23.01,2,20,81,102,18,"66.67%","77.78%","Peve_00025217",-0.731981100345654,0.477191835459729,0.978262075707395,"Q0P6H9","Transmembrane protein 62","Homo sapiens (Human)","","GO:0016020; GO:0016787"
"4831",4831,"Cluster_9149","Porites_evermani_scaffold_3428:44683-45681",167,-24.16,2,21,723,745,20,"75.00%","85.00%","Peve_00025464",NA,NA,NA,"Q8C7U7","Polypeptide N-acetylgalactosaminyltransferase 6 (EC 2.4.1.41) (Polypeptide GalNAc transferase 6) (GalNAc-T6) (pp-GaNTase 6) (Protein-UDP acetylgalactosaminyltransferase 6) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 6)","Mus musculus (Mouse)","protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via threonine [GO:0018243]","GO:0000139; GO:0004653; GO:0005794; GO:0006493; GO:0018243; GO:0030246; GO:0046872; GO:0048471"
"4832",4832,"Cluster_9149","Porites_evermani_scaffold_3429:26924-27924",154,-20.97,2,15,956,977,13,"84.62%","84.62%","Peve_00025468",-0.820648545301736,0.387224795390491,0.978262075707395,"A7RFA1","Phosphotriesterase-related protein (EC 3.1.-.-) (Parathion hydrolase-related protein)","Nematostella vectensis (Starlet sea anemone)","catabolic process [GO:0009056]","GO:0008270; GO:0009056; GO:0016787"
"4833",4833,"Cluster_9149","Porites_evermani_scaffold_345:261915-262915",169,-29.41,2,18,364,385,16,"81.25%","93.75%","Peve_00025615",-0.448738209337404,0.703747138321299,0.978262075707395,NA,NA,NA,NA,NA
"4834",4834,"Cluster_9149","Porites_evermani_scaffold_35:124310-125310",162,-26.91,2,21,594,614,19,"73.68%","84.21%","Peve_00025955",-0.941950203196103,0.217981224692666,0.978262075707395,"Q8QGX4","DNA-dependent protein kinase catalytic subunit (DNA-PK catalytic subunit) (DNA-PKcs) (EC 2.7.11.1)","Gallus gallus (Chicken)","double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; immunoglobulin V(D)J recombination [GO:0033152]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; protein phosphorylation [GO:0006468]; ribosome biogenesis [GO:0042254]; telomere maintenance [GO:0000723]","GO:0000723; GO:0000724; GO:0004674; GO:0004677; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006302; GO:0006303; GO:0006468; GO:0008630; GO:0031571; GO:0033152; GO:0042254; GO:0070419; GO:0106310"
"4835",4835,"Cluster_9149","Porites_evermani_scaffold_3548:6188-7188",150,-21.47,2,21,855,872,19,"73.68%","78.95%","Peve_00026225",-0.5,0.666666666666667,0.978262075707395,"Q708S4","Acid-sensing ion channel 4-A (ASIC4-A) (Acid-sensing ion channel 4.1) (Amiloride-sensitive cation channel 4-A) (ZASIC4.1)","Danio rerio (Zebrafish) (Brachydanio rerio)","sodium ion transmembrane transport [GO:0035725]","GO:0005248; GO:0005261; GO:0005886; GO:0015280; GO:0035725; GO:0045177"
"4836",4836,"Cluster_9149","Porites_evermani_scaffold_3578:35455-36455",154,-22.15,2,17,778,798,15,"73.33%","93.33%","Peve_00026389",-0.957595388861141,0.186058026263019,0.978262075707395,"Q60847","Collagen alpha-1(XII) chain","Mus musculus (Mouse)","cell adhesion [GO:0007155]; endodermal cell differentiation [GO:0035987]","GO:0005595; GO:0005615; GO:0007155; GO:0035987; GO:0062023"
"4837",4837,"Cluster_9149","Porites_evermani_scaffold_3584:6107-7107",150,-21.01,2,15,167,188,13,"69.23%","92.31%","Peve_00026435",-0.621813945373322,0.572792003204132,0.978262075707395,"Q9S7E9","Glutamate--glyoxylate aminotransferase 2 (AtGGT2) (EC 2.6.1.4) (Alanine aminotransferase GGT2) (EC 2.6.1.2) (Alanine--glyoxylate aminotransferase GGT2) (EC 2.6.1.44) (Alanine-2-oxoglutarate aminotransferase 2) (EC 2.6.1.-)","Arabidopsis thaliana (Mouse-ear cress)","biosynthetic process [GO:0009058]; L-alanine catabolic process [GO:0042853]; photorespiration [GO:0009853]","GO:0003729; GO:0004021; GO:0005739; GO:0005777; GO:0005829; GO:0008453; GO:0009058; GO:0009507; GO:0009570; GO:0009853; GO:0030170; GO:0042853; GO:0047958"
"4838",4838,"Cluster_9149","Porites_evermani_scaffold_3590:27717-28717",148,-20.74,2,15,899,919,13,"76.92%","92.31%","Peve_00026474",0.87053325512363,0.327548150800723,0.978262075707395,NA,NA,NA,NA,NA
"4839",4839,"Cluster_9149","Porites_evermani_scaffold_3590:27717-28717",148,-23.7,2,21,482,501,19,"68.42%","78.95%","Peve_00026474",0.87053325512363,0.327548150800723,0.978262075707395,NA,NA,NA,NA,NA
"4840",4840,"Cluster_9149","Porites_evermani_scaffold_3592:8928-9928",159,-30.42,2,16,856,877,14,"78.57%","92.86%","Peve_00026478",0.950528845267819,0.201084237679873,0.978262075707395,NA,NA,NA,NA,NA
"4841",4841,"Cluster_9149","Porites_evermani_scaffold_361:170652-171652",143,-20.34,2,14,140,160,12,"75.00%","91.67%","Peve_00026617",1,0,0,NA,NA,NA,NA,NA
"4842",4842,"Cluster_9149","Porites_evermani_scaffold_361:170652-171652",143,-20.34,2,14,456,476,12,"75.00%","91.67%","Peve_00026617",1,0,0,NA,NA,NA,NA,NA
"4843",4843,"Cluster_9149","Porites_evermani_scaffold_36:37180-38180",154,-21.15,2,20,21,43,19,"68.42%","78.95%","Peve_00026541",0.99287527288683,0.076039180592159,0.978262075707395,"Q5BIR6","Mediator of RNA polymerase II transcription subunit 17 (Cofactor required for Sp1 transcriptional activation subunit 6) (CRSP complex subunit 6) (Mediator complex subunit 17)","Bos taurus (Bovine)","positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of transcription by RNA polymerase II [GO:0006357]; somatic stem cell population maintenance [GO:0035019]","GO:0003712; GO:0006357; GO:0016592; GO:0030374; GO:0035019; GO:0046966; GO:0060261; GO:0070847"
"4844",4844,"Cluster_9149","Porites_evermani_scaffold_3663:9814-10814",155,-20.29,2,20,642,663,18,"72.22%","72.22%","Peve_00026892",NA,NA,NA,NA,NA,NA,NA,NA
"4845",4845,"Cluster_9149","Porites_evermani_scaffold_366:47416-48416",159,-28.76,2,21,489,506,19,"78.95%","78.95%","Peve_00026866",0.0994832493648622,0.936562061508109,0.999448381576871,"P17971","Potassium voltage-gated channel protein Shal (Shaker cognate l) (Shal2)","Drosophila melanogaster (Fruit fly)","associative learning [GO:0008306]; chemical synaptic transmission [GO:0007268]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]","GO:0005249; GO:0005250; GO:0005886; GO:0006813; GO:0007268; GO:0008076; GO:0008306; GO:0016020; GO:0030425; GO:0034765; GO:0043204; GO:0045202; GO:0051260; GO:0071805"
"4846",4846,"Cluster_9149","Porites_evermani_scaffold_368:158231-159231",152,-26.19,2,18,764,788,19,"68.42%","78.95%","Peve_00026969",-0.5,0.666666666666667,0.978262075707395,NA,NA,NA,NA,NA
"4847",4847,"Cluster_9149","Porites_evermani_scaffold_37:257698-258698",154,-22.87,2,19,136,157,17,"64.71%","82.35%","Peve_00027095",0.872501484374676,0.324992863606249,0.978262075707395,"Q4R8T0","Vesicle-associated membrane protein 3 (VAMP-3) (Synaptobrevin-3)","Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)","positive regulation of receptor recycling [GO:0001921]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]; substrate adhesion-dependent cell spreading [GO:0034446]; vesicle-mediated transport [GO:0016192]","GO:0001921; GO:0005829; GO:0005886; GO:0015031; GO:0016192; GO:0031901; GO:0034446; GO:0042147; GO:0043005; GO:0045202; GO:0055038"
"4848",4848,"Cluster_9149","Porites_evermani_scaffold_37:277965-278965",153,-23.74,2,18,968,989,16,"68.75%","81.25%","Peve_00027096",-0.625208025473825,0.570028248898732,0.978262075707395,"Q9Y6Y1","Calmodulin-binding transcription activator 1","Homo sapiens (Human)","neuromuscular process controlling balance [GO:0050885]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0003690; GO:0003712; GO:0005634; GO:0005730; GO:0005829; GO:0006357; GO:0035307; GO:0043565; GO:0045944; GO:0050885; GO:0070886"
"4849",4849,"Cluster_9149","Porites_evermani_scaffold_3736:37216-38216",160,-21.62,2,21,662,681,19,"78.95%","84.21%","Peve_00027268",-0.5,0.666666666666667,0.978262075707395,NA,NA,NA,NA,NA
"4850",4850,"Cluster_9149","Porites_evermani_scaffold_3737:27795-28795",145,-20.7,2,16,971,991,14,"71.43%","85.71%","Peve_00027272",0.959814189685585,0.181090927864322,0.978262075707395,NA,NA,NA,NA,NA
"4851",4851,"Cluster_9149","Porites_evermani_scaffold_374:107060-108060",167,-31.42,2,21,339,362,21,"71.43%","85.71%","Peve_00027281",0.639266978973616,0.558475759325763,0.978262075707395,"M9NDE3","Protein bark beetle (Protein anakonda)","Drosophila melanogaster (Fruit fly)","cell-cell junction maintenance [GO:0045217]; liquid clearance, open tracheal system [GO:0035002]; regulation of tube length, open tracheal system [GO:0035159]; response to endoplasmic reticulum stress [GO:0034976]; tricellular tight junction assembly [GO:1904274]","GO:0005044; GO:0005912; GO:0005918; GO:0005923; GO:0016328; GO:0030246; GO:0034976; GO:0035002; GO:0035159; GO:0045217; GO:0061689; GO:1904274"
"4852",4852,"Cluster_9149","Porites_evermani_scaffold_3803:18876-19876",155,-21.26,2,20,13,34,18,"66.67%","77.78%","Peve_00027659",0.638594712371964,0.559032106891864,0.978262075707395,"Q8WU66","Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR)","Homo sapiens (Human)","hair cycle process [GO:0022405]; Notch signaling pathway [GO:0007219]; regulation of Notch signaling pathway [GO:0008593]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]; tooth mineralization [GO:0034505]","GO:0005576; GO:0007165; GO:0007219; GO:0007605; GO:0008593; GO:0009986; GO:0022405; GO:0032420; GO:0034505; GO:0060170"
"4853",4853,"Cluster_9149","Porites_evermani_scaffold_3804:13575-14575",160,-24.53,2,20,629,650,19,"73.68%","89.47%","Peve_00027663",-0.5,0.666666666666667,0.978262075707395,"O02691","3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-estradiol 17-dehydrogenase) (EC 1.1.1.62) (2-methyl-3-hydroxybutyryl-CoA dehydrogenase) (MHBD) (3-alpha-(17-beta)-hydroxysteroid dehydrogenase (NAD(+))) (EC 1.1.1.239) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (3alpha(or 20beta)-hydroxysteroid dehydrogenase) (EC 1.1.1.53) (7-alpha-hydroxysteroid dehydrogenase) (EC 1.1.1.159) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH)","Bos taurus (Bovine)","androgen metabolic process [GO:0008209]; bile acid biosynthetic process [GO:0006699]; brexanolone metabolic process [GO:0062173]; C21-steroid hormone metabolic process [GO:0008207]; estrogen metabolic process [GO:0008210]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; isoleucine catabolic process [GO:0006550]; mitochondrial tRNA 3'-end processing [GO:1990180]; mitochondrial tRNA 5'-end processing [GO:0097745]; mitochondrial tRNA methylation [GO:0070901]; mitochondrion organization [GO:0007005]; protein homotetramerization [GO:0051289]","GO:0000049; GO:0003857; GO:0004303; GO:0005739; GO:0006550; GO:0006631; GO:0006635; GO:0006699; GO:0007005; GO:0008207; GO:0008209; GO:0008210; GO:0008709; GO:0030283; GO:0030678; GO:0042645; GO:0043527; GO:0044594; GO:0047015; GO:0047035; GO:0047044; GO:0051289; GO:0062173; GO:0070901; GO:0097745; GO:0106281; GO:0106282; GO:0106283; GO:1990180"
"4854",4854,"Cluster_9149","Porites_evermani_scaffold_381:180963-181963",152,-20.2,2,13,825,846,11,"90.91%","90.91%","Peve_00027692",-0.592841279831332,0.596012285004377,0.978262075707395,NA,NA,NA,NA,NA
"4855",4855,"Cluster_9149","Porites_evermani_scaffold_3835:12664-13664",160,-21.62,2,21,675,694,19,"78.95%","84.21%","Peve_00027810",-0.966316759708719,0.165702357840952,0.978262075707395,"Q9D8W5","26S proteasome non-ATPase regulatory subunit 12 (26S proteasome regulatory subunit RPN5) (26S proteasome regulatory subunit p55)","Mus musculus (Mouse)","","GO:0000502; GO:0005737; GO:0005838; GO:0008541; GO:0022624"
"4856",4856,"Cluster_9149","Porites_evermani_scaffold_38:392969-393969",157,-26.32,2,19,776,798,18,"77.78%","77.78%","Peve_00027573",NA,NA,NA,NA,NA,NA,NA,NA
"4857",4857,"Cluster_9149","Porites_evermani_scaffold_3839:35673-36673",159,-21.67,2,20,520,541,18,"72.22%","77.78%","Peve_00027820",-0.986971671134313,0.102875537745565,0.978262075707395,"A7RUD5","Cytosolic Fe-S cluster assembly factor NUBP1 homolog","Nematostella vectensis (Starlet sea anemone)","iron-sulfur cluster assembly [GO:0016226]","GO:0005524; GO:0005829; GO:0016226; GO:0046872; GO:0051536; GO:0051539; GO:0140663"
"4858",4858,"Cluster_9149","Porites_evermani_scaffold_3862:36047-36431",146,-21.81,2,21,281,301,19,"63.16%","73.68%","Peve_00027960",0.178483163898179,0.885761990581083,0.999448381576871,"Q28FF3","Solute carrier family 49 member A3 (Major facilitator superfamily domain-containing protein 7-a) (Major facilitator superfamily domain-containing protein 7-b) (Myosin light polypeptide 5 regulatory protein) (MYL5)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","","GO:0016020; GO:0022857"
"4859",4859,"Cluster_9149","Porites_evermani_scaffold_391:39171-39554",147,-20.45,2,21,293,316,21,"61.90%","71.43%","Peve_00028235",-0.747706700400375,0.462309846770081,0.978262075707395,NA,NA,NA,NA,NA
"4860",4860,"Cluster_9149","Porites_evermani_scaffold_391:39171-39554",147,-20.45,2,21,293,316,21,"61.90%","71.43%","Peve_00028236",-0.973695138105268,0.146342261857213,0.978262075707395,NA,NA,NA,NA,NA
"4861",4861,"Cluster_9149","Porites_evermani_scaffold_3915:7447-8447",155,-22.44,2,21,78,100,20,"70.00%","75.00%","Peve_00028286",NA,NA,NA,NA,NA,NA,NA,NA
"4862",4862,"Cluster_9149","Porites_evermani_scaffold_39:230265-231265",143,-20.89,2,21,577,595,19,"63.16%","78.95%","Peve_00028185",-0.849522544347357,0.353780260066785,0.978262075707395,"Q96AC1","Fermitin family homolog 2 (Kindlin-2) (Mitogen-inducible gene 2 protein) (MIG-2) (Pleckstrin homology domain-containing family C member 1) (PH domain-containing family C member 1)","Homo sapiens (Human)","adherens junction maintenance [GO:0034334]; cell adhesion [GO:0007155]; cell-matrix adhesion [GO:0007160]; focal adhesion assembly [GO:0048041]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; limb development [GO:0060173]; negative regulation of cell death [GO:0060548]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of vascular permeability [GO:0043116]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of GTPase activity [GO:0043547]; positive regulation of integrin activation [GO:0033625]; positive regulation of mesenchymal stem cell proliferation [GO:1902462]; positive regulation of myosin light chain kinase activity [GO:0035505]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of wound healing, spreading of epidermal cells [GO:1903691]; protein localization to cell junction [GO:1902414]; protein localization to membrane [GO:0072657]; regulation of cell morphogenesis [GO:0022604]; regulation of cell shape [GO:0008360]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; Wnt signaling pathway [GO:0016055]","GO:0001725; GO:0003779; GO:0005178; GO:0005547; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005912; GO:0005925; GO:0005938; GO:0007155; GO:0007160; GO:0007179; GO:0007229; GO:0008360; GO:0009986; GO:0010718; GO:0016055; GO:0019901; GO:0022604; GO:0030054; GO:0030055; GO:0030335; GO:0031234; GO:0031258; GO:0031674; GO:0033622; GO:0033625; GO:0034334; GO:0034446; GO:0034713; GO:0035505; GO:0043116; GO:0043547; GO:0045599; GO:0045669; GO:0046332; GO:0048041; GO:0051015; GO:0051496; GO:0051894; GO:0051897; GO:0060173; GO:0060548; GO:0070374; GO:0072657; GO:1900026; GO:1900182; GO:1902414; GO:1902462; GO:1903691"
"4863",4863,"Cluster_9149","Porites_evermani_scaffold_396:100831-101831",151,-20.29,2,21,918,940,20,"65.00%","75.00%","Peve_00028516",-0.510400630194696,0.658994231082769,0.978262075707395,NA,NA,NA,NA,NA
"4864",4864,"Cluster_9149","Porites_evermani_scaffold_3966:30935-31935",149,-22.38,2,16,304,324,14,"71.43%","92.86%","Peve_00028542",NA,NA,NA,NA,NA,NA,NA,NA
"4865",4865,"Cluster_9149","Porites_evermani_scaffold_397:255999-256999",157,-26.11,2,21,783,805,21,"71.43%","80.95%","Peve_00028570",-0.680195995348526,0.523789325441202,0.978262075707395,"Q5R5H1","S-adenosylmethionine synthase isoform type-2 (AdoMet synthase 2) (EC 2.5.1.6) (Methionine adenosyltransferase 2) (MAT 2)","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","cellular response to leukemia inhibitory factor [GO:1990830]; one-carbon metabolic process [GO:0006730]; protein heterooligomerization [GO:0051291]; protein hexamerization [GO:0034214]; S-adenosylmethionine biosynthetic process [GO:0006556]","GO:0004478; GO:0005524; GO:0006556; GO:0006730; GO:0034214; GO:0042802; GO:0046872; GO:0048269; GO:0051291; GO:1990830"
"4866",4866,"Cluster_9149","Porites_evermani_scaffold_3986:21253-22253",150,-20.69,2,15,864,885,13,"76.92%","84.62%","Peve_00028629",-0.567201011741218,0.616052516505504,0.978262075707395,NA,NA,NA,NA,NA
"4867",4867,"Cluster_9149","Porites_evermani_scaffold_3986:21738-22738",150,-20.69,2,15,379,400,13,"76.92%","84.62%","Peve_00028630",0.253589720749393,0.836777382832892,0.995934364227446,"Q8WQI5","40S ribosomal protein S8","Spodoptera frugiperda (Fall armyworm)","translation [GO:0006412]","GO:0003735; GO:0005840; GO:0006412; GO:1990904"
"4868",4868,"Cluster_9149","Porites_evermani_scaffold_4017:25046-26046",145,-20.4,2,20,426,454,25,"64.00%","68.00%","Peve_00028917",1,0,0,"Q6DG99","BTB/POZ domain-containing protein KCTD6","Danio rerio (Zebrafish) (Brachydanio rerio)","protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]","GO:0016567; GO:0051260"
"4869",4869,"Cluster_9149","Porites_evermani_scaffold_40:321832-322832",170,-30.76,2,21,204,224,19,"78.95%","89.47%","Peve_00028830",0.92341609605881,0.250769834345545,0.978262075707395,NA,NA,NA,NA,NA
"4870",4870,"Cluster_9149","Porites_evermani_scaffold_403:244861-245861",147,-22.51,2,12,583,604,10,"80.00%","100.00%","Peve_00028992",NA,NA,NA,NA,NA,NA,NA,NA
"4871",4871,"Cluster_9149","Porites_evermani_scaffold_40:548099-549099",142,-21.08,2,21,328,355,25,"64.00%","64.00%","Peve_00028798",0.23801015408869,0.847009691650554,0.995934364227446,"Q21279","Probable tubulin polyglutamylase ttll-15 (EC 6.-.-.-) (Tubulin--tyrosine ligase-like protein 15)","Caenorhabditis elegans","oviposition [GO:0018991]; protein modification process [GO:0036211]","GO:0005524; GO:0016874; GO:0018991; GO:0036211"
"4872",4872,"Cluster_9149","Porites_evermani_scaffold_4086:21075-21374",145,-21.05,2,10,135,156,8,"100.00%","100.00%","Peve_00029280",-0.446541531769109,0.705311024711434,0.978262075707395,"Q9LU46","DEAD-box ATP-dependent RNA helicase 35 (EC 3.6.4.13)","Arabidopsis thaliana (Mouse-ear cress)","mRNA splicing, via spliceosome [GO:0000398]","GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005681; GO:0008270; GO:0016887"
"4873",4873,"Cluster_9149","Porites_evermani_scaffold_4086:21075-21374",145,-21.05,2,10,135,156,8,"100.00%","100.00%","Peve_00029281",-0.684009033513364,0.520469744404315,0.978262075707395,"Q9H3E2","Sorting nexin-25","Homo sapiens (Human)","negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; protein transport [GO:0015031]; receptor catabolic process [GO:0032801]","GO:0005768; GO:0010008; GO:0015031; GO:0030512; GO:0032801; GO:0035091; GO:0043231; GO:0060394"
"4874",4874,"Cluster_9149","Porites_evermani_scaffold_410:74424-74574",152,-21.73,2,21,116,137,19,"63.16%","73.68%","Peve_00029390",0.523676600320305,0.649120052302476,0.978262075707395,"Q1JPG1","Radial spoke head 10 homolog B","Bos taurus (Bovine)","",""
"4875",4875,"Cluster_9149","Porites_evermani_scaffold_410:74424-74574",152,-21.73,2,21,116,137,19,"63.16%","73.68%","Peve_00029391",-0.489816043931122,0.674127873392135,0.978262075707395,"Q9NYG2","Palmitoyltransferase ZDHHC3 (EC 2.3.1.225) (Acyltransferase ZDHHC3) (EC 2.3.1.-) (Protein DHHC1) (Zinc finger DHHC domain-containing protein 3) (DHHC-3)","Homo sapiens (Human)","lipoprotein localization to membrane [GO:0044873]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; protein localization to photoreceptor outer segment [GO:1903546]; protein localization to plasma membrane [GO:0072659]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; TRAIL-activated apoptotic signaling pathway [GO:0036462]","GO:0000139; GO:0005783; GO:0005794; GO:0006612; GO:0008277; GO:0016020; GO:0016409; GO:0018230; GO:0018345; GO:0019705; GO:0019706; GO:0032230; GO:0036462; GO:0042803; GO:0044873; GO:0072659; GO:0140439; GO:1902685; GO:1903546"
"4876",4876,"Cluster_9149","Porites_evermani_scaffold_412:136039-137039",149,-22.78,2,19,138,163,21,"66.67%","71.43%","Peve_00029481",-0.500423355780164,0.666355411691336,0.978262075707395,NA,NA,NA,NA,NA
"4877",4877,"Cluster_9149","Porites_evermani_scaffold_4163:27124-28124",148,-20.07,2,13,776,797,11,"72.73%","100.00%","Peve_00029672",NA,NA,NA,NA,NA,NA,NA,NA
"4878",4878,"Cluster_9149","Porites_evermani_scaffold_4163:27124-28124",148,-23.17,2,14,563,585,13,"76.92%","92.31%","Peve_00029672",NA,NA,NA,NA,NA,NA,NA,NA
"4879",4879,"Cluster_9149","Porites_evermani_scaffold_4191:4566-5566",156,-22.67,2,18,614,636,17,"76.47%","82.35%","Peve_00029780",-0.258549243890095,0.833511146532765,0.995934364227446,"P40429","60S ribosomal protein L13a (23 kDa highly basic protein) (Large ribosomal subunit protein uL13)","Homo sapiens (Human)","cellular response to type II interferon [GO:0071346]; cytoplasmic translation [GO:0002181]; homeostatic process [GO:0042592]; lung morphogenesis [GO:0060425]; macrophage chemotaxis [GO:0048246]; negative regulation of formation of translation preinitiation complex [GO:1901194]; negative regulation of translation [GO:0017148]; response to lipopolysaccharide [GO:0032496]; translation [GO:0006412]","GO:0002181; GO:0003723; GO:0003729; GO:0003735; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005840; GO:0005925; GO:0006412; GO:0015934; GO:0016020; GO:0017148; GO:0022625; GO:0022626; GO:0032496; GO:0042592; GO:0045202; GO:0048246; GO:0060425; GO:0071346; GO:0097452; GO:1901194; GO:1990904"
"4880",4880,"Cluster_9149","Porites_evermani_scaffold_424:66643-67643",153,-22.1,2,16,711,731,14,"78.57%","92.86%","Peve_00030075",-0.942826746802708,0.216313078917741,0.978262075707395,NA,NA,NA,NA,NA
"4881",4881,"Cluster_9149","Porites_evermani_scaffold_424:713-1713",148,-20.86,2,15,153,173,13,"76.92%","92.31%","Peve_00030074",-0.765286190019585,0.445194894803774,0.978262075707395,"Q9TTK4","Lysosomal-trafficking regulator","Bos taurus (Bovine)","endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; natural killer cell mediated cytotoxicity [GO:0042267]; pigmentation [GO:0043473]; protein transport [GO:0015031]","GO:0005737; GO:0015031; GO:0015630; GO:0032510; GO:0042267; GO:0043473"
"4882",4882,"Cluster_9149","Porites_evermani_scaffold_4302:20698-21698",147,-23.08,2,18,503,527,19,"68.42%","78.95%","Peve_00030469",0.899372787492073,0.288047277390325,0.978262075707395,"B2RW38","Cilia- and flagella-associated protein 58","Mus musculus (Mouse)","cilium assembly [GO:0060271]; flagellated sperm motility [GO:0030317]; Notch signaling pathway [GO:0007219]; protein localization to motile cilium [GO:0120229]; sperm axoneme assembly [GO:0007288]; sperm flagellum assembly [GO:0120316]; sperm mitochondrial sheath assembly [GO:0120317]","GO:0005737; GO:0005813; GO:0005856; GO:0007219; GO:0007288; GO:0030317; GO:0036126; GO:0060271; GO:0097225; GO:0120229; GO:0120316; GO:0120317"
"4883",4883,"Cluster_9149","Porites_evermani_scaffold_431:175796-176796",148,-23.17,2,14,847,869,13,"76.92%","92.31%","Peve_00030490",-0.213045555219399,0.863323449591425,0.996660710141104,"B8V7S0","CUB and peptidase domain-containing protein 1","Acropora millepora (Staghorn coral) (Heteropora millepora)","proteolysis [GO:0006508]","GO:0004252; GO:0005576; GO:0006508"
"4884",4884,"Cluster_9149","Porites_evermani_scaffold_433:25715-26715",155,-24.14,2,19,323,342,17,"76.47%","82.35%","Peve_00030571",-0.994809602945837,0.0648908461766201,0.978262075707395,"Q61655","ATP-dependent RNA helicase DDX19A (EC 3.6.4.13) (DEAD box RNA helicase DEAD5) (mDEAD5) (DEAD box protein 19A) (Eukaryotic translation initiation factor 4A-related sequence 1)","Mus musculus (Mouse)","poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of apoptotic process [GO:0043065]; response to zinc ion [GO:0010043]","GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0010043; GO:0010494; GO:0016887; GO:0016973; GO:0043065"
"4885",4885,"Cluster_9149","Porites_evermani_scaffold_436:144052-145052",153,-20.71,2,14,769,790,12,"75.00%","100.00%","Peve_00030699",NA,NA,NA,NA,NA,NA,NA,NA
"4886",4886,"Cluster_9149","Porites_evermani_scaffold_4367:8698-9698",145,-21.22,2,10,552,573,8,"100.00%","100.00%","Peve_00030734",-0.957399694528457,0.186489943978772,0.978262075707395,NA,NA,NA,NA,NA
"4887",4887,"Cluster_9149","Porites_evermani_scaffold_437:85247-85390",156,-24.33,2,13,32,53,11,"90.91%","100.00%","Peve_00030742",-0.598668426277747,0.591393443217513,0.978262075707395,"Q2TBP4","POC1 centriolar protein homolog A (WD repeat-containing protein 51A)","Bos taurus (Bovine)","cilium assembly [GO:0060271]","GO:0000922; GO:0005737; GO:0005814; GO:0036064; GO:0060271"
"4888",4888,"Cluster_9149","Porites_evermani_scaffold_437:85247-85390",156,-24.33,2,13,32,53,11,"90.91%","100.00%","Peve_00030743",-0.438575775859326,0.710966163392125,0.979057141313976,"F4KF65","Importin subunit alpha-9 (IMPa-9)","Arabidopsis thaliana (Mouse-ear cress)","NLS-bearing protein import into nucleus [GO:0006607]","GO:0005634; GO:0005635; GO:0005737; GO:0006607; GO:0008139; GO:0061608"
"4889",4889,"Cluster_9149","Porites_evermani_scaffold_438:134100-135100",165,-24.19,2,18,542,563,16,"81.25%","87.50%","Peve_00030789",NA,NA,NA,NA,NA,NA,NA,NA
"4890",4890,"Cluster_9149","Porites_evermani_scaffold_44:222612-223612",157,-23.98,2,18,401,422,16,"75.00%","81.25%","Peve_00030932",-0.91063645670486,0.271183846424891,0.978262075707395,NA,NA,NA,NA,NA
"4891",4891,"Cluster_9149","Porites_evermani_scaffold_442:91476-92476",155,-21.89,2,17,824,846,16,"75.00%","87.50%","Peve_00031065",-0.861583646859519,0.338945973521631,0.978262075707395,NA,NA,NA,NA,NA
"4892",4892,"Cluster_9149","Porites_evermani_scaffold_446:229461-230461",150,-23.54,2,16,655,677,15,"73.33%","86.67%","Peve_00031242",NA,NA,NA,NA,NA,NA,NA,NA
"4893",4893,"Cluster_9149","Porites_evermani_scaffold_450:146129-147129",146,-20.34,2,15,667,688,13,"76.92%","76.92%","Peve_00031482",NA,NA,NA,NA,NA,NA,NA,NA
"4894",4894,"Cluster_9149","Porites_evermani_scaffold_4506:1856-2856",155,-22.44,2,21,166,188,20,"70.00%","75.00%","Peve_00031507",NA,NA,NA,NA,NA,NA,NA,NA
"4895",4895,"Cluster_9149","Porites_evermani_scaffold_4537:10783-11783",153,-20.75,2,15,835,857,14,"85.71%","85.71%","Peve_00031614",NA,NA,NA,NA,NA,NA,NA,NA
"4896",4896,"Cluster_9149","Porites_evermani_scaffold_4565:12252-13252",155,-21.81,2,21,199,221,20,"70.00%","75.00%","Peve_00031724",NA,NA,NA,NA,NA,NA,NA,NA
"4897",4897,"Cluster_9149","Porites_evermani_scaffold_4585:7057-8057",145,-21.24,2,19,70,97,23,"60.87%","69.57%","Peve_00031809",-0.57530261944644,0.609768582505021,0.978262075707395,"Q96N96","Spermatogenesis-associated protein 13 (APC-stimulated guanine nucleotide exchange factor 2) (Asef2)","Homo sapiens (Human)","cell migration [GO:0016477]; filopodium assembly [GO:0046847]; lamellipodium assembly [GO:0030032]; regulation of cell migration [GO:0030334]; regulation of small GTPase mediated signal transduction [GO:0051056]","GO:0005085; GO:0005654; GO:0005737; GO:0005829; GO:0016477; GO:0030027; GO:0030032; GO:0030175; GO:0030334; GO:0032587; GO:0042802; GO:0046847; GO:0051056"
"4898",4898,"Cluster_9149","Porites_evermani_scaffold_459:233227-234227",155,-23.24,2,12,837,858,10,"100.00%","100.00%","Peve_00031837",-0.68189266031582,0.522314224238343,0.978262075707395,"E1C1L6","Ectonucleoside triphosphate diphosphohydrolase 5 (NTPDase 5) (EC 3.6.1.6) (Guanosine-diphosphatase ENTPD5) (GDPase ENTPD5) (Uridine-diphosphatase ENTPD5) (UDPase ENTPD5)","Gallus gallus (Chicken)","'de novo' post-translational protein folding [GO:0051084]; nucleoside diphosphate catabolic process [GO:0009134]; protein N-linked glycosylation [GO:0006487]; UDP catabolic process [GO:0006256]; UDP-glucose metabolic process [GO:0006011]","GO:0004382; GO:0005576; GO:0005783; GO:0006011; GO:0006256; GO:0006487; GO:0009134; GO:0016020; GO:0017110; GO:0036384; GO:0043262; GO:0045134; GO:0051084; GO:1990003"
"4899",4899,"Cluster_9149","Porites_evermani_scaffold_459:7478-8478",152,-20.12,2,21,732,753,19,"63.16%","73.68%","Peve_00031841",-0.580527115348408,0.605693048120219,0.978262075707395,"F1Q8R9","Protein O-mannosyl-transferase 2 (EC 2.4.1.109)","Danio rerio (Zebrafish) (Brachydanio rerio)","protein O-linked mannosylation [GO:0035269]","GO:0004169; GO:0005783; GO:0005789; GO:0035269"
"4900",4900,"Cluster_9149","Porites_evermani_scaffold_4603:16101-17101",147,-25.15,2,21,949,975,24,"58.33%","70.83%","Peve_00031937",-0.364566473976554,0.76243438653287,0.988924990146721,"Q6ZMW3","Echinoderm microtubule-associated protein-like 6 (EMAP-6) (Echinoderm microtubule-associated protein-like 5-like)","Homo sapiens (Human)","","GO:0005737; GO:0005874; GO:0008017"
"4901",4901,"Cluster_9149","Porites_evermani_scaffold_463:197087-198087",145,-20.82,2,10,922,943,8,"100.00%","100.00%","Peve_00032037",-0.61098291145888,0.581548801735931,0.978262075707395,"Q9NYP7","Elongation of very long chain fatty acids protein 5 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL5) (ELOVL fatty acid elongase 5) (ELOVL FA elongase 5) (Fatty acid elongase 1) (hELO1) (Very long chain 3-ketoacyl-CoA synthase 5) (Very long chain 3-oxoacyl-CoA synthase 5)","Homo sapiens (Human)","alpha-linolenic acid metabolic process [GO:0036109]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; linoleic acid metabolic process [GO:0043651]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of fatty acid biosynthetic process [GO:0045723]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]","GO:0005783; GO:0005789; GO:0006636; GO:0009922; GO:0016020; GO:0019367; GO:0030148; GO:0030425; GO:0034625; GO:0034626; GO:0035338; GO:0036109; GO:0042761; GO:0043025; GO:0043651; GO:0045723; GO:0097447; GO:0102756"
"4902",4902,"Cluster_9149","Porites_evermani_scaffold_46:360065-361065",156,-24.63,2,21,890,911,19,"68.42%","73.68%","Peve_00031871",NA,NA,NA,NA,NA,NA,NA,NA
"4903",4903,"Cluster_9149","Porites_evermani_scaffold_4668:19797-20797",153,-21.34,2,20,376,399,20,"70.00%","80.00%","Peve_00032178",-0.0748472362553173,0.952306167599905,0.999448381576871,"Q10743","Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease) (CD antigen CD156c)","Rattus norvegicus (Rat)","adherens junction organization [GO:0034332]; amyloid precursor protein catabolic process [GO:0042987]; amyloid-beta formation [GO:0034205]; cochlea development [GO:0090102]; constitutive protein ectodomain proteolysis [GO:0051089]; epidermal growth factor receptor ligand maturation [GO:0038004]; in utero embryonic development [GO:0001701]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte activation [GO:0042117]; negative regulation of cell adhesion [GO:0007162]; negative regulation of gene expression [GO:0010629]; Notch signaling pathway [GO:0007219]; pore complex assembly [GO:0046931]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of T cell chemotaxis [GO:0010820]; postsynapse organization [GO:0099173]; protein catabolic process at postsynapse [GO:0140249]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Notch signaling pathway [GO:0008593]; regulation of osteoclast differentiation [GO:0045670]; regulation of postsynapse organization [GO:0099175]; regulation of vasculature development [GO:1901342]; response to antineoplastic agent [GO:0097327]; response to tumor necrosis factor [GO:0034612]; signaling receptor ligand precursor processing [GO:0140448]; spermatogenesis [GO:0007283]; toxin transport [GO:1901998]","GO:0000139; GO:0001701; GO:0004175; GO:0004222; GO:0005634; GO:0005737; GO:0005794; GO:0005798; GO:0005802; GO:0005886; GO:0005912; GO:0006468; GO:0006509; GO:0007162; GO:0007219; GO:0007283; GO:0008021; GO:0008237; GO:0008284; GO:0008593; GO:0009986; GO:0010629; GO:0010820; GO:0014069; GO:0016020; GO:0016485; GO:0017124; GO:0019901; GO:0030136; GO:0030307; GO:0030335; GO:0030424; GO:0030425; GO:0034205; GO:0034332; GO:0034612; GO:0038004; GO:0042117; GO:0042803; GO:0042987; GO:0043025; GO:0043065; GO:0043197; GO:0045211; GO:0045670; GO:0046872; GO:0046930; GO:0046931; GO:0051089; GO:0060090; GO:0061001; GO:0070573; GO:0090102; GO:0097038; GO:0097060; GO:0097197; GO:0097327; GO:0098696; GO:0098794; GO:0098978; GO:0099173; GO:0099175; GO:0140249; GO:0140448; GO:1901342; GO:1901998; GO:1902945"
"4904",4904,"Cluster_9149","Porites_evermani_scaffold_466:93834-94834",147,-21.93,2,14,620,640,12,"83.33%","91.67%","Peve_00032153",-0.784576154101942,0.425761170260655,0.978262075707395,NA,NA,NA,NA,NA
"4905",4905,"Cluster_9149","Porites_evermani_scaffold_473:238722-239722",159,-30.33,2,18,868,888,16,"75.00%","93.75%","Peve_00032481",-0.867415130033565,0.331559596772564,0.978262075707395,NA,NA,NA,NA,NA
"4906",4906,"Cluster_9149","Porites_evermani_scaffold_474:163331-164331",157,-24.04,2,19,370,393,19,"73.68%","78.95%","Peve_00032506",0.885364518720971,0.307817638647286,0.978262075707395,"Q8R4Y8","Rotatin","Mus musculus (Mouse)","centriole replication [GO:0007099]; centriole-centriole cohesion [GO:0010457]; ciliary basal body organization [GO:0032053]; determination of left/right symmetry [GO:0007368]","GO:0005737; GO:0005813; GO:0005814; GO:0007099; GO:0007368; GO:0010457; GO:0016020; GO:0032053; GO:0036064"
"4907",4907,"Cluster_9149","Porites_evermani_scaffold_47:439914-440914",148,-20.86,2,15,131,151,13,"76.92%","92.31%","Peve_00032299",-0.203536858629636,0.86951264955254,0.997416999308104,NA,NA,NA,NA,NA
"4908",4908,"Cluster_9149","Porites_evermani_scaffold_4785:4467-5467",146,-21.09,2,16,232,255,16,"75.00%","75.00%","Peve_00032668",-0.239739198368181,0.845876131598714,0.995934364227446,"Q6NVP8","Alpha-(1,6)-fucosyltransferase (Alpha1-6FucT) (EC 2.4.1.68) (GDP-L-Fuc:N-acetyl-beta-D-glucosaminide alpha1,6-fucosyltransferase) (GDP-fucose--glycoprotein fucosyltransferase) (Glycoprotein 6-alpha-L-fucosyltransferase)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","GDP-L-fucose metabolic process [GO:0046368]; protein N-linked glycosylation via asparagine [GO:0018279]","GO:0008424; GO:0017124; GO:0018279; GO:0032580; GO:0046368"
"4909",4909,"Cluster_9149","Porites_evermani_scaffold_4:797979-798979",154,-24.96,2,21,53,81,26,"69.23%","69.23%","Peve_00028721",0.74835822283985,0.461684871919011,0.978262075707395,"E9Q3T6","PR domain zinc finger protein 14 (EC 2.1.1.-) (PR domain-containing protein 14)","Mus musculus (Mouse)","cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; embryo implantation [GO:0007566]; epigenetic regulation of gene expression [GO:0040029]; fertilization [GO:0009566]; fibroblast growth factor receptor signaling pathway [GO:0008543]; germ cell development [GO:0007281]; germ-line stem cell population maintenance [GO:0030718]; histone H3-R26 methylation [GO:0034972]; homeostasis of number of cells within a tissue [GO:0048873]; inactivation of paternal X chromosome [GO:0060817]; inner cell mass cell fate commitment [GO:0001827]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of DNA methylation [GO:0044030]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell population maintenance [GO:0019827]","GO:0000122; GO:0000902; GO:0000977; GO:0001227; GO:0001708; GO:0001827; GO:0003723; GO:0005634; GO:0005654; GO:0006357; GO:0007281; GO:0007566; GO:0008168; GO:0008543; GO:0009566; GO:0010468; GO:0019827; GO:0030718; GO:0031490; GO:0034972; GO:0040029; GO:0040037; GO:0044030; GO:0046872; GO:0048873; GO:0060817; GO:1902093; GO:1902459"
"4910",4910,"Cluster_9149","Porites_evermani_scaffold_4:827791-828791",156,-20.71,2,15,1,14,13,"92.31%","92.31%","Peve_00028726",-0.00881857220336641,0.994385849803544,0.999448381576871,NA,NA,NA,NA,NA
"4911",4911,"Cluster_9149","Porites_evermani_scaffold_487:240390-241390",161,-24.84,2,21,557,576,19,"73.68%","84.21%","Peve_00033016",-0.433982363458161,0.714216025018287,0.979909465515968,"P97357","TATA box-binding protein-associated factor RNA polymerase I subunit A (RNA polymerase I-specific TBP-associated factor 48 kDa) (TAFI48) (TATA box-binding protein-associated factor 1A) (TBP-associated factor 1A) (Transcription initiation factor SL1/TIF-IB subunit A)","Mus musculus (Mouse)","transcription by RNA polymerase I [GO:0006360]","GO:0000120; GO:0003677; GO:0005654; GO:0005668; GO:0006360; GO:0015630"
"4912",4912,"Cluster_9149","Porites_evermani_scaffold_488:161158-162158",162,-23.72,2,15,291,312,13,"84.62%","100.00%","Peve_00033044",-0.47873352695053,0.682192007901918,0.978262075707395,NA,NA,NA,NA,NA
"4913",4913,"Cluster_9149","Porites_evermani_scaffold_4986:17500-18500",155,-22.44,2,21,507,529,20,"70.00%","75.00%","Peve_00033455",-0.5,0.666666666666667,0.978262075707395,NA,NA,NA,NA,NA
"4914",4914,"Cluster_9149","Porites_evermani_scaffold_502:226044-227044",150,-23.99,2,19,196,217,17,"64.71%","76.47%","Peve_00033734",-0.732484085051293,0.476721667546734,0.978262075707395,"Q6QNK2","Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) (G-protein coupled receptor PGR25)","Homo sapiens (Human)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]","GO:0004930; GO:0005654; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0016020"
"4915",4915,"Cluster_9149","Porites_evermani_scaffold_5063:0-472",157,-25.85,2,14,43,64,12,"83.33%","100.00%","Peve_00033874",-0.852863839299496,0.349727375961065,0.978262075707395,"P25788","Proteasome subunit alpha type-3 (Macropain subunit C8) (Multicatalytic endopeptidase complex subunit C8) (Proteasome component C8)","Homo sapiens (Human)","proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of endopeptidase activity [GO:0052548]","GO:0000502; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0010498; GO:0019773; GO:0031625; GO:0043161; GO:0045202; GO:0052548; GO:0070062"
"4916",4916,"Cluster_9149","Porites_evermani_scaffold_50:704697-705697",170,-28.58,2,19,694,715,17,"82.35%","88.24%","Peve_00033628",-0.570967742074362,0.613136256051471,0.978262075707395,NA,NA,NA,NA,NA
"4917",4917,"Cluster_9149","Porites_evermani_scaffold_5128:16143-17057",152,-20.96,2,21,779,798,19,"73.68%","78.95%","Peve_00034155",NA,NA,NA,"P16066","Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A)","Homo sapiens (Human)","blood vessel diameter maintenance [GO:0097746]; body fluid secretion [GO:0007589]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of urine volume [GO:0035810]; protein phosphorylation [GO:0006468]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; regulation of vascular permeability [GO:0043114]; signal transduction [GO:0007165]","GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0006468; GO:0007165; GO:0007166; GO:0007168; GO:0007589; GO:0008217; GO:0008528; GO:0010753; GO:0016525; GO:0016941; GO:0017046; GO:0019934; GO:0030308; GO:0035810; GO:0035815; GO:0042417; GO:0042562; GO:0043114; GO:0043235; GO:0048662; GO:0097746; GO:1990620"
"4918",4918,"Cluster_9149","Porites_evermani_scaffold_5:16916-17916",152,-21.07,2,14,223,246,14,"85.71%","85.71%","Peve_00033505",-0.529398715576999,0.644835139335309,0.978262075707395,NA,NA,NA,NA,NA
"4919",4919,"Cluster_9149","Porites_evermani_scaffold_5170:8304-9304",166,-24.66,2,21,331,351,19,"78.95%","84.21%","Peve_00034286",NA,NA,NA,"P54277","PMS1 protein homolog 1 (DNA mismatch repair protein PMS1)","Homo sapiens (Human)","mismatch repair [GO:0006298]; response to xenobiotic stimulus [GO:0009410]","GO:0003677; GO:0005524; GO:0005634; GO:0006298; GO:0009410; GO:0016887; GO:0019899; GO:0030983; GO:0032300; GO:0140664"
"4920",4920,"Cluster_9149","Porites_evermani_scaffold_52:184019-185019",152,-20.29,2,18,245,268,18,"72.22%","77.78%","Peve_00034394",NA,NA,NA,"Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"4921",4921,"Cluster_9149","Porites_evermani_scaffold_52:438734-439734",157,-27.58,2,18,633,654,16,"75.00%","81.25%","Peve_00034365",-0.903219367976226,0.282394227450761,0.978262075707395,"A0A2C9JXL4",NA,NA,NA,NA
"4922",4922,"Cluster_9149","Porites_evermani_scaffold_525:165657-166657",156,-21.62,2,14,630,652,13,"92.31%","92.31%","Peve_00034565",0.605194527184766,0.586190653299458,0.978262075707395,"Q8JI28","Tolloid-like protein 1 (EC 3.4.24.-) (Metalloprotease xolloid-like) (Xenopus tolloid-like protein 1) (Xlr)","Xenopus laevis (African clawed frog)","cell differentiation [GO:0030154]; proteolysis [GO:0006508]","GO:0004222; GO:0005509; GO:0005576; GO:0006508; GO:0008270; GO:0030154"
"4923",4923,"Cluster_9149","Porites_evermani_scaffold_5274:2201-3201",158,-22.17,2,15,232,253,13,"84.62%","92.31%","Peve_00034632",NA,NA,NA,NA,NA,NA,NA,NA
"4924",4924,"Cluster_9149","Porites_evermani_scaffold_5302:461-1461",144,-21.61,2,14,871,893,13,"76.92%","84.62%","Peve_00034783",-0.5,0.666666666666667,0.978262075707395,NA,NA,NA,NA,NA
"4925",4925,"Cluster_9149","Porites_evermani_scaffold_5334:13703-14703",161,-23.64,2,21,538,561,22,"77.27%","77.27%","Peve_00034873",-0.175187199988965,0.887893864768339,0.999448381576871,NA,NA,NA,NA,NA
"4926",4926,"Cluster_9149","Porites_evermani_scaffold_535:192534-193534",155,-28.84,2,18,362,382,16,"81.25%","81.25%","Peve_00034921",-0.717453559437217,0.490615113251954,0.978262075707395,NA,NA,NA,NA,NA
"4927",4927,"Cluster_9149","Porites_evermani_scaffold_536:180732-181732",156,-20.95,2,21,881,900,19,"78.95%","78.95%","Peve_00034955",NA,NA,NA,"B8EIZ7",NA,NA,NA,NA
"4928",4928,"Cluster_9149","Porites_evermani_scaffold_537:181395-182395",151,-23.14,2,12,793,814,10,"90.00%","100.00%","Peve_00034988",-0.391891641661501,0.743641620193523,0.986945224999907,"B4NIN8","Mesencephalic astrocyte-derived neurotrophic factor homolog (MANF/CDNF-like protein)","Drosophila willistoni (Fruit fly)","dopamine metabolic process [GO:0042417]; neuron cellular homeostasis [GO:0070050]; neuron projection development [GO:0031175]; synaptic transmission, dopaminergic [GO:0001963]","GO:0001963; GO:0005509; GO:0005576; GO:0005783; GO:0031175; GO:0042417; GO:0045202; GO:0070050"
"4929",4929,"Cluster_9149","Porites_evermani_scaffold_5455:12499-13499",163,-23.83,2,20,961,982,18,"72.22%","83.33%","Peve_00035321",-0.917594856233122,0.260255988165644,0.978262075707395,"P46023","G-protein coupled receptor GRL101","Lymnaea stagnalis (Great pond snail) (Helix stagnalis)","","GO:0004930; GO:0005886"
"4930",4930,"Cluster_9149","Porites_evermani_scaffold_5558:8411-9411",146,-21.24,2,11,139,160,9,"88.89%","100.00%","Peve_00035660",-0.691257286172083,0.514114260608608,0.978262075707395,"Q8C1F5","Tetratricopeptide repeat protein 16 (TPR repeat protein 16)","Mus musculus (Mouse)","",""
"4931",4931,"Cluster_9149","Porites_evermani_scaffold_556:122052-123052",157,-22.15,2,14,960,981,12,"83.33%","100.00%","Peve_00035672",-0.640498941591695,0.557455173496405,0.978262075707395,NA,NA,NA,NA,NA
"4932",4932,"Cluster_9149","Porites_evermani_scaffold_5594:4012-5012",143,-20.44,2,20,955,976,18,"55.56%","72.22%","Peve_00035777",0.628970072329557,0.566953587210327,0.978262075707395,"Q6ZMV9","Kinesin-like protein KIF6","Homo sapiens (Human)","microtubule-based movement [GO:0007018]","GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0016887"
"4933",4933,"Cluster_9149","Porites_evermani_scaffold_5613:9486-10486",148,-20.85,2,13,492,513,11,"81.82%","90.91%","Peve_00035847",-0.5,0.666666666666667,0.978262075707395,NA,NA,NA,NA,NA
"4934",4934,"Cluster_9149","Porites_evermani_scaffold_5613:9486-10486",150,-20.23,2,17,820,840,15,"80.00%","80.00%","Peve_00035847",-0.5,0.666666666666667,0.978262075707395,NA,NA,NA,NA,NA
"4935",4935,"Cluster_9149","Porites_evermani_scaffold_567:1653-2602",148,-22.73,2,15,338,358,13,"76.92%","92.31%","Peve_00035985",-0.941131910961016,0.219527519839839,0.978262075707395,NA,NA,NA,NA,NA
"4936",4936,"Cluster_9149","Porites_evermani_scaffold_567:1653-2602",148,-22.73,2,15,338,358,13,"76.92%","92.31%","Peve_00035990",NA,NA,NA,NA,NA,NA,NA,NA
"4937",4937,"Cluster_9149","Porites_evermani_scaffold_5:695866-696866",153,-23.98,2,21,30,53,22,"68.18%","77.27%","Peve_00033531",-0.460404733869225,0.695408585306315,0.978262075707395,"Q91W50","Cold shock domain-containing protein E1","Mus musculus (Mouse)","CRD-mediated mRNA stabilization [GO:0070934]; IRES-dependent viral translational initiation [GO:0075522]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; positive regulation of cytoplasmic translation [GO:2000767]; stress granule assembly [GO:0034063]","GO:0000932; GO:0005743; GO:0005794; GO:0005829; GO:0005886; GO:0010494; GO:0034063; GO:0035613; GO:0070934; GO:0070937; GO:0070966; GO:0075522; GO:0106002; GO:1900152; GO:2000767"
"4938",4938,"Cluster_9149","Porites_evermani_scaffold_570:62268-63268",141,-20.63,2,10,154,175,8,"87.50%","100.00%","Peve_00036130",NA,NA,NA,NA,NA,NA,NA,NA
"4939",4939,"Cluster_9149","Porites_evermani_scaffold_574:34397-35397",150,-20.09,2,11,96,117,9,"100.00%","100.00%","Peve_00036241",-0.5,0.666666666666667,0.978262075707395,"A0A0R4IBK5","E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (E3 ubiquitin-lipopolysaccharide ligase rnf213-alpha) (EC 2.3.2.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha)","Danio rerio (Zebrafish) (Brachydanio rerio)","blood circulation [GO:0008015]; defense response to bacterium [GO:0042742]; immune system process [GO:0002376]; lipid droplet formation [GO:0140042]; lipid ubiquitination [GO:0120323]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein K63-linked ubiquitination [GO:0070534]; regulation of lipid metabolic process [GO:0019216]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]; xenophagy [GO:0098792]","GO:0002040; GO:0002376; GO:0004842; GO:0005524; GO:0005730; GO:0005811; GO:0005829; GO:0006511; GO:0008015; GO:0016887; GO:0019216; GO:0042742; GO:0046872; GO:0061630; GO:0070534; GO:0098792; GO:0120323; GO:0140042; GO:2000051"
"4940",4940,"Cluster_9149","Porites_evermani_scaffold_580:105785-106785",161,-26.25,2,21,300,319,19,"73.68%","84.21%","Peve_00036393",-0.399924106089388,0.738072954780913,0.986607120216815,NA,NA,NA,NA,NA
"4941",4941,"Cluster_9149","Porites_evermani_scaffold_583:179698-180698",161,-29.09,2,16,624,644,14,"92.86%","92.86%","Peve_00036494",-0.272340672758863,0.82440446540736,0.995934364227446,"Q13217","DnaJ homolog subfamily C member 3 (Endoplasmic reticulum DNA J domain-containing protein 6) (ER-resident protein ERdj6) (ERdj6) (Interferon-induced, double-stranded RNA-activated protein kinase inhibitor) (Protein kinase inhibitor of 58 kDa) (Protein kinase inhibitor p58)","Homo sapiens (Human)","cellular response to cold [GO:0070417]; defense response to virus [GO:0051607]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; positive regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036494]; protein folding in endoplasmic reticulum [GO:0034975]; proteolysis involved in protein catabolic process [GO:0051603]; response to unfolded protein [GO:0006986]","GO:0004860; GO:0005576; GO:0005737; GO:0005783; GO:0005788; GO:0005790; GO:0005829; GO:0006986; GO:0016020; GO:0019901; GO:0034975; GO:0035578; GO:0036494; GO:0043066; GO:0051087; GO:0051603; GO:0051607; GO:0051787; GO:0070062; GO:0070417; GO:1903561; GO:1903912"
"4942",4942,"Cluster_9149","Porites_evermani_scaffold_583:55562-56562",157,-20.85,2,18,79,100,16,"68.75%","87.50%","Peve_00036499",-0.496082862870397,0.669542434254485,0.978262075707395,"O00571","ATP-dependent RNA helicase DDX3X (EC 3.6.4.13) (CAP-Rf) (DEAD box protein 3, X-chromosomal) (DEAD box, X isoform) (DBX) (Helicase-like protein 2) (HLP2)","Homo sapiens (Human)","cell differentiation [GO:0030154]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to osmotic stress [GO:0071470]; cellular response to virus [GO:0098586]; chromosome segregation [GO:0007059]; cytosolic ribosome assembly [GO:0042256]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; gamete generation [GO:0007276]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway [GO:0097193]; lipid homeostasis [GO:0055088]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of translation [GO:0017148]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of chemokine (C-C motif) ligand 5 production [GO:0071651]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of protein acetylation [GO:1901985]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 8 signaling pathway [GO:0034161]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; positive regulation of translational initiation [GO:0045948]; positive regulation of viral genome replication [GO:0045070]; primary miRNA processing [GO:0031053]; protein localization to cytoplasmic stress granule [GO:1903608]; response to virus [GO:0009615]; RNA secondary structure unwinding [GO:0010501]; stress granule assembly [GO:0034063]; translational initiation [GO:0006413]; Wnt signaling pathway [GO:0016055]","GO:0003677; GO:0003678; GO:0003723; GO:0003724; GO:0003729; GO:0003924; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0006413; GO:0007059; GO:0007276; GO:0008134; GO:0008143; GO:0008190; GO:0008625; GO:0009615; GO:0010494; GO:0010501; GO:0010628; GO:0016055; GO:0016887; GO:0017111; GO:0017148; GO:0030027; GO:0030154; GO:0030307; GO:0030308; GO:0031053; GO:0031252; GO:0031333; GO:0031369; GO:0031954; GO:0032727; GO:0032728; GO:0033592; GO:0034063; GO:0034157; GO:0034161; GO:0034774; GO:0035556; GO:0035613; GO:0036493; GO:0042256; GO:0043015; GO:0043024; GO:0043065; GO:0043066; GO:0043154; GO:0043186; GO:0043273; GO:0043280; GO:0043539; GO:0045070; GO:0045087; GO:0045296; GO:0045727; GO:0045944; GO:0045948; GO:0048027; GO:0055088; GO:0070062; GO:0070878; GO:0071243; GO:0071470; GO:0071651; GO:0071902; GO:0072559; GO:0090263; GO:0097193; GO:0098586; GO:1900087; GO:1900227; GO:1901223; GO:1901224; GO:1901985; GO:1902042; GO:1902523; GO:1903608; GO:1904813; GO:2001243"
"4943",4943,"Cluster_9149","Porites_evermani_scaffold_591:225411-226124",157,-24.26,2,21,287,306,19,"73.68%","78.95%","Peve_00036750",-0.5,0.666666666666667,0.978262075707395,NA,NA,NA,NA,NA
"4944",4944,"Cluster_9149","Porites_evermani_scaffold_592:140870-141870",160,-20.5,2,21,880,898,19,"78.95%","78.95%","Peve_00036767",-0.837478919423248,0.368057227903535,0.978262075707395,"O88451","Retinol dehydrogenase 7 (EC 1.1.1.105) (Cis-retinol/3alpha-hydroxysterol short-chain dehydrogenase isozyme 2) (Cis-retinol/androgen dehydrogenase type 2) (CRAD-2)","Mus musculus (Mouse)","retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202]","GO:0003824; GO:0004745; GO:0005783; GO:0008202; GO:0016491; GO:0042572; GO:0043231; GO:0047023; GO:0047044"
"4945",4945,"Cluster_9149","Porites_evermani_scaffold_59:244529-245529",155,-23.65,2,21,289,311,20,"70.00%","75.00%","Peve_00036654",NA,NA,NA,NA,NA,NA,NA,NA
"4946",4946,"Cluster_9149","Porites_evermani_scaffold_59:251557-252557",150,-20.02,2,15,873,894,13,"69.23%","92.31%","Peve_00036656",NA,NA,NA,NA,NA,NA,NA,NA
"4947",4947,"Cluster_9149","Porites_evermani_scaffold_594:137964-138964",154,-24.32,2,15,876,897,13,"76.92%","92.31%","Peve_00036808",-0.476431660778434,0.683859929857233,0.978262075707395,"Q5FVN0","Lysophospholipid acyltransferase 5 (LPLAT 5) (EC 2.3.1.-) (1-acylglycerophosphocholine O-acyltransferase) (EC 2.3.1.23) (1-acylglycerophosphoethanolamine O-acyltransferase) (EC 2.3.1.n7) (1-acylglycerophosphoserine O-acyltransferase) (EC 2.3.1.n6) (Lysophosphatidylcholine acyltransferase 3) (Lyso-PC acyltransferase 3) (Membrane-bound O-acyltransferase domain-containing protein 5) (O-acyltransferase domain-containing protein 5)","Rattus norvegicus (Rat)","chylomicron assembly [GO:0034378]; endoplasmic reticulum membrane organization [GO:0090158]; intestinal stem cell homeostasis [GO:0036335]; lipid modification [GO:0030258]; negative regulation of inflammatory response [GO:0050728]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylserine acyl-chain remodeling [GO:0036150]; positive regulation of intestinal cholesterol absorption [GO:0045797]; positive regulation of sterol regulatory element binding protein cleavage [GO:1901310]; positive regulation of triglyceride transport [GO:1905885]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of plasma lipoprotein particle levels [GO:0097006]; very-low-density lipoprotein particle assembly [GO:0034379]","GO:0005789; GO:0006656; GO:0016020; GO:0016746; GO:0030258; GO:0034378; GO:0034379; GO:0036150; GO:0036151; GO:0036152; GO:0036335; GO:0045540; GO:0045797; GO:0047184; GO:0050728; GO:0071617; GO:0090158; GO:0097006; GO:0106262; GO:0106263; GO:1901310; GO:1903573; GO:1905885"
"4948",4948,"Cluster_9149","Porites_evermani_scaffold_596:13069-14069",160,-23.52,2,21,813,834,19,"63.16%","84.21%","Peve_00036859",-0.996982195269473,0.0494709177037855,0.950846381223965,"Q9CZR2","N-acetylated-alpha-linked acidic dipeptidase 2 (EC 3.4.17.21) (Glutamate carboxypeptidase III) (GCPIII) (N-acetylaspartylglutamate peptidase II) (NAAG-peptidase II) (N-acetylated-alpha-linked acidic dipeptidase II) (NAALADase II)","Mus musculus (Mouse)","neurotransmitter catabolic process [GO:0042135]; proteolysis [GO:0006508]","GO:0004180; GO:0004181; GO:0005886; GO:0006508; GO:0008233; GO:0016020; GO:0016805; GO:0042135; GO:0046872; GO:0050129"
"4949",4949,"Cluster_9149","Porites_evermani_scaffold_603:197015-198015",167,-29.14,2,21,239,261,20,"75.00%","85.00%","Peve_00037164",-0.0173610954292456,0.988947028090671,0.999448381576871,"P19137","Laminin subunit alpha-1 (Laminin A chain) (Laminin-1 subunit alpha) (Laminin-3 subunit alpha) (S-laminin subunit alpha) (S-LAM alpha)","Mus musculus (Mouse)","animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; blood vessel morphogenesis [GO:0048514]; branching involved in salivary gland morphogenesis [GO:0060445]; camera-type eye development [GO:0043010]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment of epithelial cell apical/basal polarity [GO:0045198]; morphogenesis of an epithelial sheet [GO:0002011]; neuron projection development [GO:0031175]; positive regulation of cell adhesion [GO:0045785]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; protein phosphorylation [GO:0006468]; regulation of basement membrane organization [GO:0110011]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; retina development in camera-type eye [GO:0060041]; retinal blood vessel morphogenesis [GO:0061304]; tissue development [GO:0009888]","GO:0002011; GO:0005102; GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005608; GO:0005615; GO:0005911; GO:0006468; GO:0007155; GO:0007166; GO:0007411; GO:0008022; GO:0009887; GO:0009888; GO:0016020; GO:0030334; GO:0031012; GO:0031175; GO:0043010; GO:0043208; GO:0043256; GO:0045198; GO:0045785; GO:0045995; GO:0048514; GO:0051149; GO:0060041; GO:0060441; GO:0060445; GO:0061304; GO:0062023; GO:0098637; GO:0110011; GO:2001046"
"4950",4950,"Cluster_9149","Porites_evermani_scaffold_603:76669-77669",149,-24.34,2,18,509,528,16,"75.00%","87.50%","Peve_00037160",-0.595784173003012,0.593682730848498,0.978262075707395,"Q9VCA2","Organic cation transporter protein","Drosophila melanogaster (Fruit fly)","apoptotic process [GO:0006915]; ion transport [GO:0006811]","GO:0006811; GO:0006915; GO:0016020; GO:0022857"
"4951",4951,"Cluster_9149","Porites_evermani_scaffold_60:5149-6149",145,-24.07,2,21,812,839,25,"64.00%","72.00%","Peve_00037053",-0.836858390668579,0.368779496449928,0.978262075707395,"Q90XE6","Kruppel-like factor 1 (Erythroid krueppel-like transcription factor) (Kruppel-like factor d)","Danio rerio (Zebrafish) (Brachydanio rerio)","animal organ regeneration [GO:0031100]; cardiac muscle cell differentiation [GO:0055007]; cardiac muscle cell proliferation [GO:0060038]; cell dedifferentiation [GO:0043697]; positive regulation of gene expression [GO:0010628]; primitive erythrocyte differentiation [GO:0060319]; regulation of transcription by RNA polymerase II [GO:0006357]; sarcomere organization [GO:0045214]","GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005829; GO:0006357; GO:0010628; GO:0031100; GO:0043565; GO:0043697; GO:0045214; GO:0046872; GO:0055007; GO:0060038; GO:0060319"
"4952",4952,"Cluster_9149","Porites_evermani_scaffold_608:131681-132681",152,-22.93,2,18,724,747,18,"66.67%","83.33%","Peve_00037280",-0.340922787286344,0.778521053070993,0.993122038648698,"Q90593","Endoplasmic reticulum chaperone BiP (EC 3.6.4.10) (78 kDa glucose-regulated protein) (GRP-78) (Binding-immunoglobulin protein) (BiP) (Heat shock protein 70 family protein 5) (HSP70 family protein 5) (Heat shock protein family A member 5) (Immunoglobulin heavy chain-binding protein)","Gallus gallus (Chicken)","cellular response to glucose starvation [GO:0042149]; cellular response to interleukin-4 [GO:0071353]; cellular response to unfolded protein [GO:0034620]; cerebellar Purkinje cell layer development [GO:0021680]; cerebellum structural organization [GO:0021589]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER overload response [GO:0006983]; maintenance of protein localization in endoplasmic reticulum [GO:0035437]; negative regulation of apoptotic process [GO:0043066]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of cell migration [GO:0030335]; positive regulation of protein ubiquitination [GO:0031398]; post-translational protein targeting to membrane, translocation [GO:0031204]; protein refolding [GO:0042026]; toxin transport [GO:1901998]; ubiquitin-dependent ERAD pathway [GO:0030433]","GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005788; GO:0005789; GO:0005793; GO:0005829; GO:0005886; GO:0006983; GO:0008180; GO:0009986; GO:0016020; GO:0016887; GO:0019904; GO:0021589; GO:0021680; GO:0030335; GO:0030433; GO:0030496; GO:0030512; GO:0030968; GO:0031072; GO:0031204; GO:0031333; GO:0031398; GO:0031625; GO:0034620; GO:0034663; GO:0035437; GO:0042026; GO:0042149; GO:0042470; GO:0043022; GO:0043066; GO:0044183; GO:0051082; GO:0051085; GO:0051787; GO:0071353; GO:0140662; GO:1901998; GO:1903895"
"4953",4953,"Cluster_9149","Porites_evermani_scaffold_613:192187-193187",154,-20.57,2,21,696,713,19,"78.95%","78.95%","Peve_00037426",-0.584709563162751,0.602416948545054,0.978262075707395,"Q8C9X6","Enhancer of polycomb homolog 1","Mus musculus (Mouse)","double-strand break repair via homologous recombination [GO:0000724]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of striated muscle cell differentiation [GO:0051155]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of chromatin organization [GO:1902275]; regulation of double-strand break repair [GO:2000779]; regulation of transcription by RNA polymerase II [GO:0006357]; sperm DNA condensation [GO:0035092]; spermatid development [GO:0007286]","GO:0000122; GO:0000724; GO:0000786; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007286; GO:0016573; GO:0031965; GO:0032777; GO:0035092; GO:0035267; GO:0042981; GO:0043231; GO:0043967; GO:0043968; GO:0045814; GO:0045892; GO:0045893; GO:0045944; GO:0051155; GO:0051726; GO:0140463; GO:0140767; GO:1902275; GO:1905168; GO:2000779"
"4954",4954,"Cluster_9149","Porites_evermani_scaffold_6159:37-1037",152,-22.13,2,21,31,49,19,"73.68%","73.68%","Peve_00037471",-0.838717660021716,0.366611617834179,0.978262075707395,NA,NA,NA,NA,NA
"4955",4955,"Cluster_9149","Porites_evermani_scaffold_618:194064-195064",144,-23,2,14,760,783,14,"78.57%","78.57%","Peve_00037544",-0.5,0.666666666666667,0.978262075707395,NA,NA,NA,NA,NA
"4956",4956,"Cluster_9149","Porites_evermani_scaffold_618:201394-202394",144,-23,2,14,742,765,14,"78.57%","78.57%","Peve_00037545",-0.5,0.666666666666667,0.978262075707395,NA,NA,NA,NA,NA
"4957",4957,"Cluster_9149","Porites_evermani_scaffold_6200:6207-6963",148,-23.17,2,14,588,610,13,"76.92%","92.31%","Peve_00037653",0.808345164146889,0.400727076088185,0.978262075707395,NA,NA,NA,NA,NA
"4958",4958,"Cluster_9149","Porites_evermani_scaffold_6212:309-1309",155,-20.08,2,21,813,835,20,"65.00%","80.00%","Peve_00037674",-0.86103350840934,0.339635289485264,0.978262075707395,NA,NA,NA,NA,NA
"4959",4959,"Cluster_9149","Porites_evermani_scaffold_62:303194-304194",155,-21.87,2,21,80,105,23,"65.22%","73.91%","Peve_00037636",-0.526880369796215,0.646723163412307,0.978262075707395,"Q5R802","KAT8 regulatory NSL complex subunit 2 (NSL complex protein NSL2) (Non-specific lethal 2 homolog)","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","chromatin organization [GO:0006325]","GO:0000123; GO:0005634; GO:0006325"
"4960",4960,"Cluster_9149","Porites_evermani_scaffold_625:109258-110258",155,-21.92,2,19,370,389,17,"76.47%","82.35%","Peve_00037747",0.566556345896041,0.616550703452424,0.978262075707395,"Q6P5H6","FERM domain-containing protein 5","Mus musculus (Mouse)","actomyosin structure organization [GO:0031032]; negative regulation of cell motility [GO:2000146]; positive regulation of cell adhesion [GO:0045785]; regulation of cell migration [GO:0030334]","GO:0005178; GO:0005856; GO:0005912; GO:0008092; GO:0019901; GO:0030334; GO:0031032; GO:0045785; GO:2000146"
"4961",4961,"Cluster_9149","Porites_evermani_scaffold_626:24567-25567",157,-22.03,2,15,587,609,14,"85.71%","92.86%","Peve_00037774",NA,NA,NA,"Q96N67","Dedicator of cytokinesis protein 7","Homo sapiens (Human)","activation of GTPase activity [GO:0090630]; axonogenesis [GO:0007409]; establishment of neuroblast polarity [GO:0045200]; interkinetic nuclear migration [GO:0022027]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of cold-induced thermogenesis [GO:0120163]; neuron projection development [GO:0031175]; positive regulation of GTPase activity [GO:0043547]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; regulation of neurogenesis [GO:0050767]; small GTPase mediated signal transduction [GO:0007264]","GO:0000226; GO:0005085; GO:0005925; GO:0007264; GO:0007409; GO:0022027; GO:0030424; GO:0030426; GO:0031175; GO:0031267; GO:0033138; GO:0043005; GO:0043547; GO:0045178; GO:0045200; GO:0050767; GO:0090630; GO:0120163; GO:1904754"
"4962",4962,"Cluster_9149","Porites_evermani_scaffold_634:126226-127226",162,-22.57,2,20,577,599,19,"78.95%","78.95%","Peve_00037970",-0.713939574089734,0.493818214578089,0.978262075707395,NA,NA,NA,NA,NA
"4963",4963,"Cluster_9149","Porites_evermani_scaffold_6473:3659-4659",145,-22.08,2,10,173,194,8,"100.00%","100.00%","Peve_00038323",NA,NA,NA,NA,NA,NA,NA,NA
"4964",4964,"Cluster_9149","Porites_evermani_scaffold_649:96774-97774",156,-24.65,2,21,44,65,19,"68.42%","73.68%","Peve_00038342",NA,NA,NA,NA,NA,NA,NA,NA
"4965",4965,"Cluster_9149","Porites_evermani_scaffold_65:0-584",155,-20.94,2,20,364,385,18,"66.67%","77.78%","Peve_00038357",-0.710754782876578,0.496707113742219,0.978262075707395,"A0JM13","C2 domain-containing protein 3","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","centriole elongation [GO:0061511]; non-motile cilium assembly [GO:1905515]; protein localization to centrosome [GO:0071539]","GO:0005737; GO:0005814; GO:0005929; GO:0034451; GO:0061511; GO:0071539; GO:1905515"
"4966",4966,"Cluster_9149","Porites_evermani_scaffold_654:39400-40400",156,-20.3,2,21,94,115,19,"68.42%","73.68%","Peve_00038494",-0.5,0.666666666666667,0.978262075707395,NA,NA,NA,NA,NA
"4967",4967,"Cluster_9149","Porites_evermani_scaffold_6576:4201-5201",151,-20.18,2,21,549,572,21,"66.67%","71.43%","Peve_00038541",-0.414539415330603,0.727885393067231,0.9838766926797,"Q5M990","Tetratricopeptide repeat protein 33 (TPR repeat protein 33)","Xenopus laevis (African clawed frog)","",""
"4968",4968,"Cluster_9149","Porites_evermani_scaffold_658:208794-209794",159,-24.81,2,21,209,233,22,"68.18%","77.27%","Peve_00038559",-0.755309745184956,0.454972866847148,0.978262075707395,NA,NA,NA,NA,NA
"4969",4969,"Cluster_9149","Porites_evermani_scaffold_661:181199-182199",156,-22.83,2,21,352,373,19,"63.16%","78.95%","Peve_00038643",-0.0104680018279963,0.993335741344803,0.999448381576871,"Q91YK0","Leucine-rich repeat-containing protein 49 (Tubulin polyglutamylase complex subunit 4) (PGs4) (p79)","Mus musculus (Mouse)","outer dynein arm assembly [GO:0036158]","GO:0005737; GO:0005829; GO:0005874; GO:0034451; GO:0036158"
"4970",4970,"Cluster_9149","Porites_evermani_scaffold_6636:1874-2874",152,-25.61,2,17,294,313,15,"86.67%","86.67%","Peve_00038692",1,0,0,NA,NA,NA,NA,NA
"4971",4971,"Cluster_9149","Porites_evermani_scaffold_66:525406-526406",142,-22.91,2,16,314,338,17,"64.71%","76.47%","Peve_00038616",-0.126244732511316,0.919415075684546,0.999448381576871,"Q9N294","Beta-1,3-galactosyltransferase 5 (Beta-1,3-GalTase 5) (Beta3Gal-T5) (Beta3GalT5) (b3Gal-T5) (EC 2.4.1.-) (Beta-3-Gx-T5) (UDP-Gal:beta-GlcNAc beta-1,3-galactosyltransferase 5) (UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 5)","Pan paniscus (Pygmy chimpanzee) (Bonobo)","lipid metabolic process [GO:0006629]; protein glycosylation [GO:0006486]","GO:0000139; GO:0006486; GO:0006629; GO:0016758"
"4972",4972,"Cluster_9149","Porites_evermani_scaffold_669:10331-11331",154,-25.06,2,21,688,715,25,"68.00%","72.00%","Peve_00038781",-0.0820144647626005,0.94772925930155,0.999448381576871,"Q96KE9","BTB/POZ domain-containing protein 6 (Lens BTB domain protein)","Homo sapiens (Human)","neurogenesis [GO:0022008]","GO:0005829; GO:0022008"
"4973",4973,"Cluster_9149","Porites_evermani_scaffold_67:473630-474630",147,-22.28,2,21,694,719,23,"60.87%","69.57%","Peve_00038822",-0.997148176496447,0.0480905459806356,0.945590536869992,"Q8VHI5","Vitrin (Akhirin)","Mus musculus (Mouse)","extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811]; spinal cord development [GO:0021510]","GO:0005539; GO:0005576; GO:0005614; GO:0010811; GO:0021510; GO:0030198; GO:0031012; GO:0062023"
"4974",4974,"Cluster_9149","Porites_evermani_scaffold_6809:3961-4961",159,-23.66,2,16,661,682,14,"85.71%","85.71%","Peve_00039094",-0.464393088648603,0.692544990447614,0.978262075707395,NA,NA,NA,NA,NA
"4975",4975,"Cluster_9149","Porites_evermani_scaffold_68:300407-301407",157,-22.41,2,14,950,971,12,"83.33%","100.00%","Peve_00039058",NA,NA,NA,NA,NA,NA,NA,NA
"4976",4976,"Cluster_9149","Porites_evermani_scaffold_68:532439-533439",175,-24.8,2,20,638,659,18,"83.33%","88.89%","Peve_00039029",-0.90118781435221,0.285392866087474,0.978262075707395,"Q5T280","Putative methyltransferase C9orf114 (EC 2.1.1.-) (Centromere protein 32) (CENP-32) (Kinetochore-associated protein) (SPOUT domain-containing methyltransferase 1)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; maintenance of centrosome location [GO:0051661]; methylation [GO:0032259]; miRNA processing [GO:0035196]; post-transcriptional regulation of gene expression [GO:0010608]","GO:0000776; GO:0003723; GO:0005737; GO:0007049; GO:0008168; GO:0010608; GO:0031616; GO:0032259; GO:0035196; GO:0035198; GO:0051301; GO:0051661; GO:0072686"
"4977",4977,"Cluster_9149","Porites_evermani_scaffold_686:179876-180876",147,-20.71,2,21,521,543,20,"60.00%","75.00%","Peve_00039190",-0.316784305049858,0.794793729809598,0.995934364227446,"Q9NRK6","ATP-binding cassette sub-family B member 10, mitochondrial (ABC-mitochondrial erythroid protein) (ABC-me protein) (ATP-binding cassette transporter 10) (ABC transporter 10 protein) (Mitochondrial ATP-binding cassette 2) (M-ABC2)","Homo sapiens (Human)","erythrocyte development [GO:0048821]; heme biosynthetic process [GO:0006783]; mitochondrial transport [GO:0006839]; mitochondrial unfolded protein response [GO:0034514]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of heme biosynthetic process [GO:0070455]; positive regulation of hemoglobin biosynthetic process [GO:0046985]","GO:0005524; GO:0005739; GO:0005743; GO:0006783; GO:0006839; GO:0016887; GO:0031966; GO:0034514; GO:0042803; GO:0045648; GO:0046985; GO:0048821; GO:0070455; GO:0140359"
"4978",4978,"Cluster_9149","Porites_evermani_scaffold_690:66934-67596",149,-20.52,2,20,89,109,18,"66.67%","77.78%","Peve_00039293",NA,NA,NA,NA,NA,NA,NA,NA
"4979",4979,"Cluster_9149","Porites_evermani_scaffold_695:18019-19019",144,-23.42,2,14,286,309,14,"71.43%","85.71%","Peve_00039403",NA,NA,NA,NA,NA,NA,NA,NA
"4980",4980,"Cluster_9149","Porites_evermani_scaffold_695:18019-19019",151,-22.98,2,12,713,734,10,"90.00%","100.00%","Peve_00039403",NA,NA,NA,NA,NA,NA,NA,NA
"4981",4981,"Cluster_9149","Porites_evermani_scaffold_710:66234-67234",153,-22.5,2,15,603,626,15,"80.00%","86.67%","Peve_00039838",0.634923161658432,0.562063491733362,0.978262075707395,NA,NA,NA,NA,NA
"4982",4982,"Cluster_9149","Porites_evermani_scaffold_711:98383-99383",161,-24.67,2,14,33,54,12,"91.67%","100.00%","Peve_00039857",-0.444692996906345,0.706625572537911,0.978262075707395,"Q8N531","F-box/LRR-repeat protein 6 (F-box and leucine-rich repeat protein 6) (F-box protein FBL6) (FBL6A)","Homo sapiens (Human)","entrainment of circadian clock by photoperiod [GO:0043153]; G2/M transition of mitotic cell cycle [GO:0000086]; proteolysis [GO:0006508]; regulation of cell cycle [GO:0051726]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]","GO:0000086; GO:0004842; GO:0005634; GO:0005829; GO:0006508; GO:0019005; GO:0031146; GO:0043153; GO:0051726"
"4983",4983,"Cluster_9149","Porites_evermani_scaffold_7:1228872-1229769",165,-33.24,2,20,333,358,22,"77.27%","81.82%","Peve_00039590",-0.80860411612507,0.400446965178295,0.978262075707395,"Q5REB8","Acyl-CoA synthetase short-chain family member 3, mitochondrial (EC 6.2.1.1) (Acetate--CoA ligase 3) (Propionate--CoA ligase) (EC 6.2.1.17)","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","lipid metabolic process [GO:0006629]","GO:0003987; GO:0005524; GO:0005759; GO:0006629; GO:0047760; GO:0050218"
"4984",4984,"Cluster_9149","Porites_evermani_scaffold_7:1228872-1229769",165,-33.24,2,20,333,358,22,"77.27%","81.82%","Peve_00039592",NA,NA,NA,NA,NA,NA,NA,NA
"4985",4985,"Cluster_9149","Porites_evermani_scaffold_712:68459-69459",152,-22.24,2,18,548,572,19,"68.42%","78.95%","Peve_00039879",0.891110869437577,0.299853646191638,0.978262075707395,"P50430","Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S)","Rattus norvegicus (Rat)","anterior head development [GO:0097065]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; dermatan sulfate catabolic process [GO:0030209]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]","GO:0003943; GO:0004065; GO:0005739; GO:0005764; GO:0005791; GO:0005794; GO:0006914; GO:0007417; GO:0007584; GO:0008484; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0030209; GO:0043627; GO:0043890; GO:0046872; GO:0051597; GO:0061580; GO:0097065"
"4986",4986,"Cluster_9149","Porites_evermani_scaffold_732:182460-183460",159,-21.62,2,21,760,778,19,"78.95%","84.21%","Peve_00040341",NA,NA,NA,NA,NA,NA,NA,NA
"4987",4987,"Cluster_9149","Porites_evermani_scaffold_73:327526-328526",147,-22.85,2,12,920,941,10,"80.00%","100.00%","Peve_00040250",1,9.48637384723993e-09,6.86838308108347e-06,NA,NA,NA,NA,NA
"4988",4988,"Cluster_9149","Porites_evermani_scaffold_748:85486-86486",145,-22.2,2,21,940,959,19,"57.89%","78.95%","Peve_00040630",-0.697574176482153,0.508525528848406,0.978262075707395,"A0LNR4","Putative hydro-lyase Sfum_3393 (EC 4.2.1.-)","Syntrophobacter fumaroxidans (strain DSM 10017 / MPOB)","","GO:0016829"
"4989",4989,"Cluster_9149","Porites_evermani_scaffold_752:187006-188006",152,-22.01,2,15,192,212,13,"84.62%","92.31%","Peve_00040743",-0.918550400282578,0.258721422076189,0.978262075707395,NA,NA,NA,NA,NA
"4990",4990,"Cluster_9149","Porites_evermani_scaffold_75:421429-422429",155,-25.07,2,20,326,347,18,"66.67%","77.78%","Peve_00040690",-0.928253646340744,0.242619928688184,0.978262075707395,NA,NA,NA,NA,NA
"4991",4991,"Cluster_9149","Porites_evermani_scaffold_762:121581-122581",152,-24.16,2,21,802,823,19,"57.89%","78.95%","Peve_00040917",NA,NA,NA,NA,NA,NA,NA,NA
"4992",4992,"Cluster_9149","Porites_evermani_scaffold_763:40989-41989",157,-25.18,2,17,170,189,15,"86.67%","86.67%","Peve_00040936",NA,NA,NA,NA,NA,NA,NA,NA
"4993",4993,"Cluster_9149","Porites_evermani_scaffold_776:20941-21941",155,-23.26,2,12,172,193,10,"100.00%","100.00%","Peve_00041177",-0.00433401808748952,0.997240869753874,0.999448381576871,NA,NA,NA,NA,NA
"4994",4994,"Cluster_9149","Porites_evermani_scaffold_777:24922-25922",168,-24.24,2,21,562,583,19,"78.95%","78.95%","Peve_00041186",-0.961478593061252,0.177276136789582,0.978262075707395,NA,NA,NA,NA,NA
"4995",4995,"Cluster_9149","Porites_evermani_scaffold_77:88110-89110",152,-26.19,2,18,599,623,19,"68.42%","78.95%","Peve_00041051",NA,NA,NA,"Q86TP1","Exopolyphosphatase PRUNE1 (EC 3.6.1.1) (Drosophila-related expressed sequence 17) (DRES-17) (DRES17) (HTcD37) (Protein prune homolog 1) (hPrune)","Homo sapiens (Human)","regulation of microtubule polymerization [GO:0031113]; regulation of neurogenesis [GO:0050767]","GO:0004309; GO:0004427; GO:0005634; GO:0005737; GO:0005829; GO:0005925; GO:0015631; GO:0016791; GO:0031113; GO:0046872; GO:0050767"
"4996",4996,"Cluster_9149","Porites_evermani_scaffold_789:111675-112675",145,-20.71,2,15,464,486,14,"78.57%","78.57%","Peve_00041456",NA,NA,NA,NA,NA,NA,NA,NA
"4997",4997,"Cluster_9149","Porites_evermani_scaffold_793:59127-60127",147,-20.75,2,13,581,603,12,"83.33%","91.67%","Peve_00041563",-0.5,0.666666666666667,0.978262075707395,NA,NA,NA,NA,NA
"4998",4998,"Cluster_9149","Porites_evermani_scaffold_79:89487-90487",162,-26.49,2,20,53,75,19,"78.95%","78.95%","Peve_00041485",-0.0853350611115564,0.945607861519114,0.999448381576871,NA,NA,NA,NA,NA
"4999",4999,"Cluster_9149","Porites_evermani_scaffold_808:174124-175124",151,-22.92,2,12,391,412,10,"90.00%","100.00%","Peve_00041927",0.883520831523187,0.310332884748395,0.978262075707395,NA,NA,NA,NA,NA
"5000",5000,"Cluster_9149","Porites_evermani_scaffold_808:95156-96156",155,-22.57,2,12,583,604,10,"100.00%","100.00%","Peve_00041924",-0.352778877014107,0.77047357614903,0.991116147537857,"O75581","Low-density lipoprotein receptor-related protein 6 (LRP-6)","Homo sapiens (Human)","canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in neural crest cell differentiation [GO:0044335]; canonical Wnt signaling pathway involved in regulation of cell proliferation [GO:0044340]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; chemical synaptic transmission [GO:0007268]; dopaminergic neuron differentiation [GO:0071542]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; response to peptide hormone [GO:0043434]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]; Wnt signaling pathway involved in somitogenesis [GO:0090244]","GO:0001933; GO:0005041; GO:0005102; GO:0005109; GO:0005576; GO:0005783; GO:0005886; GO:0006469; GO:0007204; GO:0007268; GO:0009986; GO:0014029; GO:0014033; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0031410; GO:0031901; GO:0034392; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043434; GO:0044335; GO:0044340; GO:0045121; GO:0045202; GO:0045787; GO:0045893; GO:0045944; GO:0051091; GO:0060070; GO:0071397; GO:0071542; GO:0071901; GO:0071936; GO:0072659; GO:0090118; GO:0090244; GO:0098609; GO:1904928; GO:1904948; GO:1904953; GO:1990851; GO:1990909"
"5001",5001,"Cluster_9149","Porites_evermani_scaffold_809:24118-25118",161,-29.05,2,14,65,86,12,"91.67%","100.00%","Peve_00041946",0.269105872457146,0.826543689009241,0.995934364227446,NA,NA,NA,NA,NA
"5002",5002,"Cluster_9149","Porites_evermani_scaffold_81:217126-218126",156,-22.31,2,21,228,249,19,"68.42%","73.68%","Peve_00041995",NA,NA,NA,NA,NA,NA,NA,NA
"5003",5003,"Cluster_9149","Porites_evermani_scaffold_815:161754-162754",146,-20.27,2,11,832,853,9,"88.89%","100.00%","Peve_00042097",-0.686867316036735,0.517970683296445,0.978262075707395,"Q8BH60","Golgi-associated PDZ and coiled-coil motif-containing protein (CFTR-associated ligand) (PDZ protein interacting specifically with TC10) (PIST)","Mus musculus (Mouse)","autophagy [GO:0006914]; negative regulation of anion channel activity [GO:0010360]; negative regulation of protein localization to cell surface [GO:2000009]; protein transport [GO:0015031]; spermatid nucleus differentiation [GO:0007289]","GO:0000139; GO:0005109; GO:0005737; GO:0005794; GO:0005886; GO:0006914; GO:0007289; GO:0008022; GO:0010360; GO:0014069; GO:0015031; GO:0016020; GO:0019905; GO:0030140; GO:0030425; GO:0030695; GO:0032991; GO:0042802; GO:0042803; GO:0044325; GO:0045202; GO:0140313; GO:2000009"
"5004",5004,"Cluster_9149","Porites_evermani_scaffold_82:101100-102050",158,-22.27,2,20,8,31,20,"75.00%","75.00%","Peve_00042180",-0.5,0.666666666666667,0.978262075707395,NA,NA,NA,NA,NA
"5005",5005,"Cluster_9149","Porites_evermani_scaffold_8:2702-3702",150,-20.63,2,21,366,391,23,"65.22%","73.91%","Peve_00041675",-0.953567917020549,0.194759713954855,0.978262075707395,"P34897","Serine hydroxymethyltransferase, mitochondrial (SHMT) (EC 2.1.2.1) (Glycine hydroxymethyltransferase) (Serine methylase)","Homo sapiens (Human)","folic acid metabolic process [GO:0046655]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine biosynthetic process [GO:0006564]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563]; one-carbon metabolic process [GO:0006730]; positive regulation of cell population proliferation [GO:0008284]; protein homotetramerization [GO:0051289]; protein K63-linked deubiquitination [GO:0070536]; protein tetramerization [GO:0051262]; purine nucleobase biosynthetic process [GO:0009113]; regulation of aerobic respiration [GO:1903715]; regulation of mitochondrial translation [GO:0070129]; regulation of oxidative phosphorylation [GO:0002082]; response to type I interferon [GO:0034340]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]","GO:0000900; GO:0002082; GO:0003682; GO:0004372; GO:0005634; GO:0005737; GO:0005739; GO:0005743; GO:0005758; GO:0005759; GO:0005829; GO:0006544; GO:0006563; GO:0006564; GO:0006565; GO:0006730; GO:0008270; GO:0008284; GO:0008732; GO:0009113; GO:0015630; GO:0019264; GO:0030170; GO:0034340; GO:0035999; GO:0042645; GO:0042803; GO:0046653; GO:0046655; GO:0048027; GO:0051262; GO:0051289; GO:0070062; GO:0070129; GO:0070536; GO:0070552; GO:0070905; GO:1903715"
"5006",5006,"Cluster_9149","Porites_evermani_scaffold_833:128373-129373",148,-22.31,2,17,97,115,15,"80.00%","80.00%","Peve_00042450",-0.936139832049583,0.228743557181834,0.978262075707395,"Q7Z494","Nephrocystin-3","Homo sapiens (Human)","atrial septum development [GO:0003283]; cilium assembly [GO:0060271]; convergent extension [GO:0060026]; convergent extension involved in gastrulation [GO:0060027]; determination of intestine left/right asymmetry [GO:0071908]; determination of left/right symmetry [GO:0007368]; determination of liver left/right asymmetry [GO:0071910]; determination of pancreatic left/right asymmetry [GO:0035469]; determination of stomach left/right asymmetry [GO:0071909]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; establishment or maintenance of cell polarity [GO:0007163]; extracellular matrix organization [GO:0030198]; heart looping [GO:0001947]; kidney development [GO:0001822]; kidney morphogenesis [GO:0060993]; lipid metabolic process [GO:0006629]; lung development [GO:0030324]; maintenance of animal organ identity [GO:0048496]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; positive regulation of protein binding [GO:0032092]; regulation of planar cell polarity pathway involved in neural tube closure [GO:2000167]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; ureter development [GO:0072189]; Wnt signaling pathway [GO:0016055]","GO:0001822; GO:0001947; GO:0003283; GO:0005576; GO:0005829; GO:0005929; GO:0006629; GO:0007163; GO:0007368; GO:0016055; GO:0030198; GO:0030324; GO:0032092; GO:0035469; GO:0045494; GO:0048496; GO:0060026; GO:0060027; GO:0060271; GO:0060287; GO:0060993; GO:0071908; GO:0071909; GO:0071910; GO:0072189; GO:0090090; GO:0097543; GO:0097546; GO:1905515; GO:2000095; GO:2000167"
"5007",5007,"Cluster_9149","Porites_evermani_scaffold_835:94302-95302",147,-20.33,2,12,603,624,10,"80.00%","100.00%","Peve_00042471",0.293805297378114,0.810156537785153,0.995934364227446,"Q9NZJ4","Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29)","Homo sapiens (Human)","negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]","GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0042802; GO:0051087; GO:0070628; GO:0070852; GO:0090084"
"5008",5008,"Cluster_9149","Porites_evermani_scaffold_84:338535-339535",160,-21,2,21,593,614,19,"68.42%","78.95%","Peve_00042525",-0.999972017506869,0.00476254767800266,0.551398425649056,"Q5ZI57","Trafficking protein particle complex subunit 3","Gallus gallus (Chicken)","endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]","GO:0005783; GO:0005829; GO:0006888; GO:0006891; GO:0030008; GO:0033106"
"5009",5009,"Cluster_9149","Porites_evermani_scaffold_843:48787-49787",157,-29.37,2,19,627,649,18,"66.67%","88.89%","Peve_00042633",-0.598293983028708,0.591690992859192,0.978262075707395,NA,NA,NA,NA,NA
"5010",5010,"Cluster_9149","Porites_evermani_scaffold_844:49082-50032",144,-22.19,2,14,709,731,13,"69.23%","92.31%","Peve_00042651",-0.658965549520532,0.541988584885425,0.978262075707395,"P51687","Sulfite oxidase, mitochondrial (EC 1.8.3.1)","Homo sapiens (Human)","sulfur compound metabolic process [GO:0006790]","GO:0005739; GO:0005758; GO:0005759; GO:0006790; GO:0008482; GO:0020037; GO:0030151; GO:0043546"
"5011",5011,"Cluster_9149","Porites_evermani_scaffold_846:97271-98271",161,-28.23,2,18,584,605,16,"81.25%","81.25%","Peve_00042685",NA,NA,NA,NA,NA,NA,NA,NA
"5012",5012,"Cluster_9149","Porites_evermani_scaffold_857:42870-43870",147,-22.35,2,13,810,832,12,"83.33%","91.67%","Peve_00042896",0.315065249824341,0.795947189889497,0.995934364227446,NA,NA,NA,NA,NA
"5013",5013,"Cluster_9149","Porites_evermani_scaffold_862:108087-109087",152,-22.77,2,13,14,35,11,"81.82%","100.00%","Peve_00043020",-0.96038979742484,0.179780555872127,0.978262075707395,NA,NA,NA,NA,NA
"5014",5014,"Cluster_9149","Porites_evermani_scaffold_865:123545-124545",150,-21.67,2,20,937,960,20,"60.00%","80.00%","Peve_00043050",NA,NA,NA,NA,NA,NA,NA,NA
"5015",5015,"Cluster_9149","Porites_evermani_scaffold_868:40193-41193",155,-21.81,2,21,198,220,20,"70.00%","75.00%","Peve_00043082",NA,NA,NA,NA,NA,NA,NA,NA
"5016",5016,"Cluster_9149","Porites_evermani_scaffold_870:37579-38579",140,-21.58,2,9,196,217,7,"100.00%","100.00%","Peve_00043146",NA,NA,NA,NA,NA,NA,NA,NA
"5017",5017,"Cluster_9149","Porites_evermani_scaffold_880:74242-75242",161,-25,2,18,224,245,16,"81.25%","81.25%","Peve_00043333",NA,NA,NA,NA,NA,NA,NA,NA
"5018",5018,"Cluster_9149","Porites_evermani_scaffold_910:160786-161786",161,-26.16,2,20,8,28,18,"72.22%","88.89%","Peve_00043941",NA,NA,NA,NA,NA,NA,NA,NA
"5019",5019,"Cluster_9149","Porites_evermani_scaffold_917:109854-110854",156,-21.2,2,19,245,265,17,"76.47%","82.35%","Peve_00044037",NA,NA,NA,NA,NA,NA,NA,NA
"5020",5020,"Cluster_9149","Porites_evermani_scaffold_920:57349-58349",155,-25.42,2,21,352,377,23,"60.87%","78.26%","Peve_00044119",-0.759583322378938,0.450805797015059,0.978262075707395,"Q5RF67","Secreted frizzled-related protein 3 (sFRP-3) (Frizzled-related protein 1) (FrzB-1)","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","cochlea morphogenesis [GO:0090103]; convergent extension involved in organogenesis [GO:0060029]; epithelial cell development [GO:0002064]; hepatocyte differentiation [GO:0070365]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cartilage development [GO:0061037]; negative regulation of cell development [GO:0010721]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hepatocyte differentiation [GO:0070367]; neural crest cell differentiation [GO:0014033]; positive regulation of apoptotic process [GO:0043065]; positive regulation of fat cell differentiation [GO:0045600]; somite development [GO:0061053]; Wnt signaling pathway [GO:0016055]","GO:0002064; GO:0005576; GO:0008285; GO:0010721; GO:0014033; GO:0016055; GO:0017147; GO:0030308; GO:0043065; GO:0045600; GO:0060029; GO:0061037; GO:0061053; GO:0070365; GO:0070367; GO:0090090; GO:0090103"
"5021",5021,"Cluster_9149","Porites_evermani_scaffold_925:13223-14223",160,-26.9,2,17,126,147,15,"73.33%","93.33%","Peve_00044181",-0.872066694747455,0.325558908755733,0.978262075707395,"Q9HD67","Unconventional myosin-X (Unconventional myosin-10)","Homo sapiens (Human)","cytoskeleton-dependent intracellular transport [GO:0030705]; positive regulation of cell-cell adhesion [GO:0022409]; regulation of cell shape [GO:0008360]; regulation of filopodium assembly [GO:0051489]; signal transduction [GO:0007165]","GO:0000146; GO:0001726; GO:0005516; GO:0005524; GO:0005547; GO:0005730; GO:0005829; GO:0005886; GO:0005938; GO:0007165; GO:0008360; GO:0016459; GO:0022409; GO:0030027; GO:0030175; GO:0030507; GO:0030705; GO:0031527; GO:0032433; GO:0043005; GO:0043025; GO:0051015; GO:0051489; GO:0060002"
"5022",5022,"Cluster_9149","Porites_evermani_scaffold_93:381032-382032",154,-23.83,2,21,926,951,23,"65.22%","78.26%","Peve_00044262",0.0613603428441878,0.960912238121516,0.999448381576871,"Q2PZL6","Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J)","Mus musculus (Mouse)","branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion [GO:0098609]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]","GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0008543; GO:0021987; GO:0022008; GO:0035329; GO:0043931; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307; GO:0098609"
"5023",5023,"Cluster_9149","Porites_evermani_scaffold_942:36485-37485",142,-20.16,2,16,815,837,15,"66.67%","80.00%","Peve_00044470",0.99261854582446,0.0773986865460533,0.978262075707395,NA,NA,NA,NA,NA
"5024",5024,"Cluster_9149","Porites_evermani_scaffold_94:33867-34867",153,-21.67,2,14,906,927,12,"83.33%","91.67%","Peve_00044394",-0.318525479293848,0.793624716223877,0.995934364227446,"E2RQ08","Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 (Ribophorin I) (RPN-I) (Ribophorin-1)","Canis lupus familiaris (Dog) (Canis familiaris)","protein glycosylation [GO:0006486]; protein N-linked glycosylation via asparagine [GO:0018279]","GO:0005791; GO:0005829; GO:0006486; GO:0008250; GO:0018279"
"5025",5025,"Cluster_9149","Porites_evermani_scaffold_9:480800-480940",157,-26.95,2,14,40,61,12,"83.33%","100.00%","Peve_00043608",-0.857200935113211,0.344402867916562,0.978262075707395,"Q28FH2","N-terminal kinase-like protein (SCY1-like protein 1)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","protein phosphorylation [GO:0006468]","GO:0004672; GO:0005524; GO:0006468"
"5026",5026,"Cluster_9149","Porites_evermani_scaffold_9:480800-480940",157,-26.95,2,14,40,61,12,"83.33%","100.00%","Peve_00043609",-0.855682860027298,0.346274930180404,0.978262075707395,"Q6P819","CCR4-NOT transcription complex subunit 9 (Cell differentiation protein RQCD1 homolog) (Rcd-1)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","mRNA catabolic process [GO:0006402]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; regulation of translation [GO:0006417]; RNA-mediated gene silencing [GO:0031047]","GO:0000932; GO:0005634; GO:0006402; GO:0006417; GO:0030014; GO:0030374; GO:0031047; GO:0033147"
"5027",5027,"Cluster_9149","Porites_evermani_scaffold_951:64503-65503",159,-28.87,2,21,664,690,24,"66.67%","75.00%","Peve_00044597",NA,NA,NA,"Q4VBJ9","MORN repeat-containing protein 5","Danio rerio (Zebrafish) (Brachydanio rerio)","",""
"5028",5028,"Cluster_9149","Porites_evermani_scaffold_95:308400-309400",159,-30.33,2,18,868,888,16,"75.00%","93.75%","Peve_00044561",-0.5,0.666666666666667,0.978262075707395,NA,NA,NA,NA,NA
"5029",5029,"Cluster_9149","Porites_evermani_scaffold_954:39756-40756",150,-20.26,2,15,589,610,13,"76.92%","84.62%","Peve_00044638",NA,NA,NA,NA,NA,NA,NA,NA
"5030",5030,"Cluster_9149","Porites_evermani_scaffold_96:336746-337746",147,-20.07,2,14,32,52,12,"83.33%","91.67%","Peve_00044742",0.640833343026314,0.557177912303365,0.978262075707395,NA,NA,NA,NA,NA
"5031",5031,"Cluster_9149","Porites_evermani_scaffold_9:655553-655966",149,-20.63,2,15,1,15,14,"71.43%","92.86%","Peve_00043625",-0.576860638196104,0.608555130805805,0.978262075707395,"A1A5F2","HEAT repeat-containing protein 5B","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","protein transport [GO:0015031]","GO:0015031; GO:0030136"
"5032",5032,"Cluster_9149","Porites_evermani_scaffold_9:655553-655966",149,-20.63,2,15,1,15,14,"71.43%","92.86%","Peve_00043626",-0.440140071025353,0.709857571559497,0.978659742723238,NA,NA,NA,NA,NA
"5033",5033,"Cluster_9149","Porites_evermani_scaffold_976:98758-99758",160,-20.39,2,19,596,619,19,"78.95%","84.21%","Peve_00045000",NA,NA,NA,NA,NA,NA,NA,NA
"5034",5034,"Cluster_9149","Porites_evermani_scaffold_98:109116-110116",164,-29.67,2,17,266,287,15,"80.00%","93.33%","Peve_00045047",-0.999996728114699,0.00162852441741808,0.362847063101065,NA,NA,NA,NA,NA
"5035",5035,"Cluster_9149","Porites_evermani_scaffold_984:124028-125028",150,-20.77,2,11,32,53,9,"100.00%","100.00%","Peve_00045102",0.865074461135316,0.334542124136915,0.978262075707395,NA,NA,NA,NA,NA
"5036",5036,"Cluster_9149","Porites_evermani_scaffold_999:81464-82464",155,-22.89,2,20,469,487,18,"72.22%","83.33%","Peve_00045348",0.911324293686763,0.270122162018333,0.978262075707395,NA,NA,NA,NA,NA
"5037",5037,"Cluster_9983","Porites_evermani_scaffold_1086:116312-117312",159,-20.74,2,20,160,179,19,"78.95%","84.21%","Peve_00001532",NA,NA,NA,NA,NA,NA,NA,NA
"5038",5038,"Cluster_9983","Porites_evermani_scaffold_110:67113-68113",159,-20.08,2,19,458,482,21,"80.95%","80.95%","Peve_00001848",0.996860943830899,0.0504554792781256,0.955606920760092,NA,NA,NA,NA,NA
"5039",5039,"Cluster_9983","Porites_evermani_scaffold_1121:21463-22281",145,-20.08,2,19,466,488,19,"63.16%","73.68%","Peve_00002173",0.951559319212813,0.198961546010198,0.978262075707395,"Q7TQ79","Transmembrane protein 170B (Liver regeneration-related protein LRRG102)","Rattus norvegicus (Rat)","negative regulation of canonical Wnt signaling pathway [GO:0090090]","GO:0005886; GO:0090090"
"5040",5040,"Cluster_9983","Porites_evermani_scaffold_1385:26357-27357",159,-22.48,2,19,47,65,17,"76.47%","88.24%","Peve_00005968",NA,NA,NA,NA,NA,NA,NA,NA
"5041",5041,"Cluster_9983","Porites_evermani_scaffold_20:205094-206094",153,-21.91,2,18,178,198,16,"68.75%","81.25%","Peve_00013523",0.942025917036361,0.217837618407389,0.978262075707395,NA,NA,NA,NA,NA
"5042",5042,"Cluster_9983","Porites_evermani_scaffold_23:429510-430510",159,-22.76,2,20,799,816,18,"77.78%","83.33%","Peve_00016482",-0.999812133109256,0.0123403376847463,0.684071498890361,"E9Q3T6","PR domain zinc finger protein 14 (EC 2.1.1.-) (PR domain-containing protein 14)","Mus musculus (Mouse)","cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; embryo implantation [GO:0007566]; epigenetic regulation of gene expression [GO:0040029]; fertilization [GO:0009566]; fibroblast growth factor receptor signaling pathway [GO:0008543]; germ cell development [GO:0007281]; germ-line stem cell population maintenance [GO:0030718]; histone H3-R26 methylation [GO:0034972]; homeostasis of number of cells within a tissue [GO:0048873]; inactivation of paternal X chromosome [GO:0060817]; inner cell mass cell fate commitment [GO:0001827]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of DNA methylation [GO:0044030]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell population maintenance [GO:0019827]","GO:0000122; GO:0000902; GO:0000977; GO:0001227; GO:0001708; GO:0001827; GO:0003723; GO:0005634; GO:0005654; GO:0006357; GO:0007281; GO:0007566; GO:0008168; GO:0008543; GO:0009566; GO:0010468; GO:0019827; GO:0030718; GO:0031490; GO:0034972; GO:0040029; GO:0040037; GO:0044030; GO:0046872; GO:0048873; GO:0060817; GO:1902093; GO:1902459"
"5043",5043,"Cluster_9983","Porites_evermani_scaffold_241:184879-185879",173,-21.93,2,19,270,291,18,"83.33%","94.44%","Peve_00017597",NA,NA,NA,"Q9NPF2","Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1)","Homo sapiens (Human)","apoptotic process [GO:0006915]; carbohydrate biosynthetic process [GO:0016051]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]; transforming growth factor beta receptor signaling pathway [GO:0007179]","GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0006915; GO:0007179; GO:0007585; GO:0008146; GO:0009791; GO:0016020; GO:0016051; GO:0030166; GO:0030206; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0050659"
"5044",5044,"Cluster_9983","Porites_evermani_scaffold_2488:50622-51622",153,-21.7,2,20,815,838,21,"71.43%","76.19%","Peve_00018236",NA,NA,NA,NA,NA,NA,NA,NA
"5045",5045,"Cluster_9983","Porites_evermani_scaffold_2657:45410-46410",175,-22.11,2,20,240,260,18,"77.78%","94.44%","Peve_00019713",NA,NA,NA,NA,NA,NA,NA,NA
"5046",5046,"Cluster_9983","Porites_evermani_scaffold_2949:26148-27148",170,-20.7,2,19,901,921,17,"82.35%","88.24%","Peve_00022029",0.498751907423741,0.667583764936494,0.978262075707395,NA,NA,NA,NA,NA
"5047",5047,"Cluster_9983","Porites_evermani_scaffold_3803:36155-37155",156,-21.42,2,20,581,599,18,"72.22%","83.33%","Peve_00027660",0.515711810893376,0.65505505230101,0.978262075707395,"Q8WU66","Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR)","Homo sapiens (Human)","hair cycle process [GO:0022405]; Notch signaling pathway [GO:0007219]; regulation of Notch signaling pathway [GO:0008593]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]; tooth mineralization [GO:0034505]","GO:0005576; GO:0007165; GO:0007219; GO:0007605; GO:0008593; GO:0009986; GO:0022405; GO:0032420; GO:0034505; GO:0060170"
"5048",5048,"Cluster_9983","Porites_evermani_scaffold_44:256373-257373",145,-20.46,2,14,144,164,12,"75.00%","83.33%","Peve_00030936",NA,NA,NA,"P48039","Melatonin receptor type 1A (Mel-1A-R) (Mel1a receptor)","Homo sapiens (Human)","adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; circadian rhythm [GO:0007623]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; mating behavior [GO:0007617]","GO:0004930; GO:0005886; GO:0007186; GO:0007187; GO:0007193; GO:0007617; GO:0007623; GO:0008502; GO:0042562; GO:0043235; GO:0097159"
"5049",5049,"Cluster_9983","Porites_evermani_scaffold_547:158568-159568",148,-20.15,2,19,730,754,21,"66.67%","76.19%","Peve_00035352",NA,NA,NA,NA,NA,NA,NA,NA
"5050",5050,"Cluster_9983","Porites_evermani_scaffold_588:201967-202967",168,-21.19,2,17,372,392,15,"86.67%","93.33%","Peve_00036606",0.866113127552442,0.333221622986249,0.978262075707395,"Q6NUB3","Solute carrier family 22 member 15","Xenopus laevis (African clawed frog)","ion transport [GO:0006811]","GO:0006811; GO:0016020; GO:0022857"
"5051",5051,"Cluster_9983","Porites_evermani_scaffold_748:48080-49080",162,-20.07,2,19,472,492,17,"76.47%","82.35%","Peve_00040626",NA,NA,NA,NA,NA,NA,NA,NA
"5052",5052,"Cluster_9983","Porites_evermani_scaffold_784:81211-82211",158,-22.06,2,20,603,626,21,"71.43%","76.19%","Peve_00041367",-0.930769394838533,0.238277012205972,0.978262075707395,NA,NA,NA,NA,NA
"5053",5053,"Cluster_9983","Porites_evermani_scaffold_872:155604-156604",150,-20.4,2,19,348,368,17,"70.59%","70.59%","Peve_00043182",0.677972876122544,0.52571734666928,0.978262075707395,NA,NA,NA,NA,NA
"5054",5054,"Cluster_9983","Porites_evermani_scaffold_909:98089-99089",145,-22.12,2,20,498,517,18,"66.67%","72.22%","Peve_00043878",0.542449151744545,0.634994229302714,0.978262075707395,NA,NA,NA,NA,NA
